PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Eschbach, RS; Fendler, WP; Kazmierczak, PM; Hacker, M; Rominger, A; Carlsen, J; Hirner-Eppeneder, H; Schuster, J; Moser, M; Havla, L; Schneider, MJ; Ingrisch, M; Spaeth, L; Reiser, MF; Nikolaou, K; Cyran, CC				Eschbach, Ralf S.; Fendler, Wolfgang P.; Kazmierczak, Philipp M.; Hacker, Marcus; Rominger, Axel; Carlsen, Janette; Hirner-Eppeneder, Heidrun; Schuster, Jessica; Moser, Matthias; Havla, Lukas; Schneider, Moritz J.; Ingrisch, Michael; Spaeth, Lukas; Reiser, Maximilian F.; Nikolaou, Konstantin; Cyran, Clemens C.			Correlation of Perfusion MRI and F-18-FDG PET Imaging Biomarkers for Monitoring Regorafenib Therapy in Experimental Colon Carcinomas with Immunohistochemical Validation	PLOS ONE			English	Article							CONTRAST-ENHANCED MRI; ANTI-ANGIOGENIC THERAPY; PHASE-II; UNCONTROLLED TRIAL; BREAST-CANCER; NUDE-MICE; SORAFENIB; MULTICENTER; GROWTH; CHEMOTHERAPY	Objectives To investigate a multimodal, multiparametric perfusion MRI/F-18-fluoro-deoxyglucose (F-18-FDG)-PET imaging protocol for monitoring regorafenib therapy effects on experimental colorectal adenocarcinomas in rats with immunohistochemical validation. Materials and Methods Human colorectal adenocarcinoma xenografts (HT-29) were implanted subcutaneously in n = 17 (n = 10 therapy group; n = 7 control group) female athymic nude rats (Hsd: RH-Foxn1(mu)). Animals were imaged at baseline and after a one-week daily treatment protocol with regorafenib (10 mg/kg bodyweight) using a multimodal, multiparametric perfusion MRI/F-18-FDG-PET imaging protocol. In perfusion MRI, quantitative parameters of plasma flow (PF, mL/100 mL/min), plasma volume (PV, %) and endothelial permeability-surface area product (PS, mL/100 mL/min) were calculated. In F-18-FDG-PET, tumor-to-background-ratio (TTB) was calculated. Perfusion MRI parameters were correlated with TTB and immunohistochemical assessments of tumor microvascular density (CD-31) and cell proliferation (Ki-67). Results Regorafenib significantly (p<0.01) suppressed PF (81.1 +/- 7.5 to 50.6 +/- 16.0 mL/100mL/min), PV (12.1 +/- 3.6 to 7.5 +/- 1.6%) and PS (13.6 +/- 3.2 to 7.9 +/- 2.3 mL/100mL/min) as well as TTB (3.4 +/- 0.6 to 1.9 +/- 1.1) between baseline and day 7. Immunohistochemistry revealed significantly (p<0.03) lower tumor microvascular density (CD-31, 7.0 +/- 2.4 vs. 16.1 +/- 5.9) and tumor cell proliferation (Ki-67, 434.0 +/- 62.9 vs. 663.0 +/- 98.3) in the therapy group. Perfusion MRI parameters Delta PF, Delta PV and Delta PS showed strong and significant (r = 0.67-0.78; p<0.01) correlations to the PET parameter Delta TTB and significant correlations (r = 0.57-0.67; p<0.03) to immunohistochemical Ki-67 as well as to CD-31-stainings (r = 0.49-0.55; p<0.05). Conclusions A multimodal, multiparametric perfusion MRI/PET imaging protocol allowed for non-invasive monitoring of regorafenib therapy effects on experimental colorectal adenocarcinomas in vivo with significant correlations between perfusion MRI parameters and F-18-FDG-PET validated by immunohistochemistry.	[Eschbach, Ralf S.; Kazmierczak, Philipp M.; Hirner-Eppeneder, Heidrun; Schuster, Jessica; Moser, Matthias; Spaeth, Lukas; Reiser, Maximilian F.; Cyran, Clemens C.] Univ Munich, Univ Hosp Munich, Expt Radiol Lab, Dept Clin Radiol, D-81377 Munich, Germany; [Fendler, Wolfgang P.; Rominger, Axel; Carlsen, Janette] Univ Munich, Univ Hosp Munich, Dept Nucl Med, D-81377 Munich, Germany; [Hacker, Marcus] Med Univ Vienna, Univ Hosp Vienna, Dept Nucl Med, A-1090 Vienna, Austria; [Havla, Lukas; Schneider, Moritz J.; Ingrisch, Michael] Univ Munich, Univ Hosp Munich, Dept Clin Radiol, Josef Lissner Lab Biomed Imaging, D-81377 Munich, Germany; [Nikolaou, Konstantin] Univ Tubingen Hosp, Dept Diagnost & Intervent Radiol, D-72076 Tubingen, Germany	University of Munich; University of Munich; Medical University of Vienna; University Hospital Vienna; University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Cyran, CC (corresponding author), Univ Munich, Univ Hosp Munich, Expt Radiol Lab, Dept Clin Radiol, Marchioninistr 15, D-81377 Munich, Germany.	Clemens.Cyran@med.lmu.de	Rominger, Axel/K-5891-2019; Ingrisch, Michael/T-3408-2017; Hacker, Marcus/GRJ-2825-2022; Fendler, Wolfgang/AAH-1611-2021	Ingrisch, Michael/0000-0003-0268-9078; Fendler, Wolfgang/0000-0002-5106-3584; Rominger, Axel/0000-0002-1954-736X	Bayer Healthcare; German Federal Ministry of Education and Research (BMBF) Excellence Cluster M4 [01EX1021X]	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); German Federal Ministry of Education and Research (BMBF) Excellence Cluster M4(Federal Ministry of Education & Research (BMBF))	This study was supported by a research grant (research material only) of Bayer Healthcare (www.bayer.com) and by the German Federal Ministry of Education and Research (BMBF) Excellence Cluster M4 (www.m4.de; Grant No. 01EX1021X). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elkacem L, 2013, MOL CANCER THER, V12, P1322, DOI 10.1158/1535-7163.MCT-12-1162; Aragon-Ching JB, 2009, BJU INT, V103, P1636, DOI 10.1111/j.1464-410X.2008.08327.x; Atkin G, 2006, BRIT J SURG, V93, P992, DOI 10.1002/bjs.5352; Bianchi G, 2009, ANTI-CANCER DRUG, V20, P616, DOI 10.1097/CAD.0b013e32832b2ea0; Blumenschein GR, 2009, J CLIN ONCOL, V27, P4274, DOI 10.1200/JCO.2009.22.0541; Bruns CJ, 2000, CLIN CANCER RES, V6, P1936; Cai WB, 2008, J NUCL MED, V49, p113S, DOI 10.2967/jnumed.107.045922; Calcagno C, 2013, EUR J NUCL MED MOL I, V40, P1884, DOI 10.1007/s00259-013-2518-4; Chang YS, 2007, CANCER CHEMOTH PHARM, V59, P561, DOI 10.1007/s00280-006-0393-4; Cyran CC, 2008, J MAGN RESON IMAGING, V27, P581, DOI 10.1002/jmri.21245; Cyran CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076009; Cyran CC, 2012, AM J ROENTGENOL, V198, P384, DOI 10.2214/AJR.11.6951; Daldrup-Link HE, 2006, CURR PHARM DESIGN, V12, P2661, DOI 10.2174/138161206777698774; De Visschere P, 2010, JBR-BTR, V93, P62, DOI 10.5334/jbr-btr.121; Ehling J, 2013, THROMB HAEMOSTASIS, V109, P375, DOI 10.1160/TH12-10-0721; Fan XB, 2004, MAGNET RESON MED, V51, P487, DOI 10.1002/mrm.10737; Figlin R, 2012, J UROLOGY, V188, P707, DOI 10.1016/j.juro.2012.04.108; Gatidis S, 2013, RADIOLOGE, V53, P669, DOI 10.1007/s00117-013-2496-3; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Holubec L, 2012, ANTICANCER RES, V32, P4007; Huellner MW, 2012, CANCER IMAGING, V12, P212, DOI 10.1102/1470-7330.2012.0021; Ingrisch M, 2013, J PHARMACOKINET PHAR, V40, P281, DOI 10.1007/s10928-013-9315-3; JAIN RK, 1987, CANCER METAST REV, V6, P559, DOI 10.1007/BF00047468; Kiessling F, 2004, NEOPLASIA, V6, P213, DOI 10.1593/neo.03394; Komatsu Yoshito, 2014, Nihon Rinsho, V72, P120; Kristian A, 2013, ACTA ONCOL, V52, P1566, DOI 10.3109/0284186X.2013.813634; Kwee RM, 2014, WORLD J GASTROENTERO, V20, P1650, DOI 10.3748/wjg.v20.i7.1650; Lam ET, 2010, J CLIN ONCOL, V28, P2323, DOI 10.1200/JCO.2009.25.0068; Marques I, 2013, WORLD J GASTROENTERO, V19, P7955, DOI 10.3748/wjg.v19.i44.7955; Meier R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094972; Metz S, 2010, J NUCL MED, V51, P1691, DOI 10.2967/jnumed.110.077719; Miles KA, 2010, CLIN RADIOL, V65, P549, DOI 10.1016/j.crad.2010.04.007; Mross K, 2012, CLIN CANCER RES, V18, P2658, DOI 10.1158/1078-0432.CCR-11-1900; Ng TSC, 2012, J NUCL MED, V53, P1102, DOI 10.2967/jnumed.111.099861; Nikolaou K, 2012, RADIOLOGE, V52, P252, DOI 10.1007/s00117-011-2194-y; Padhani Anwar R, 2004, Top Magn Reson Imaging, V15, P41, DOI 10.1097/00002142-200402000-00005; Preda A, 2005, INVEST RADIOL, V40, P349, DOI 10.1097/01.rli.0000163740.40474.48; Pujol JL, 2007, J CLIN ONCOL, V25, P3945, DOI 10.1200/JCO.2007.11.8109; Ratain MJ, 2004, J CLIN ONCOL, V22, P4442, DOI 10.1200/JCO.2004.07.960; Smeets Peter, 2009, Surg Technol Int, V18, P93; Sohaib A, 2012, CANCER IMAGING, V12, P345, DOI 10.1102/1470-7330.2012.9011; Song T, 2009, MAGN RESON MED, V61, P1242, DOI 10.1002/mrm.21901; Sourbron SP, 2012, PHYS MED BIOL, V57, pR1, DOI 10.1088/0031-9155/57/2/R1; Sourbron S, 2009, MAGN RESON MED, V62, P205, DOI 10.1002/mrm.22005; Sterzik A, 2014, ACTA RADIOL; Vriens Dennis, 2011, Clin Colorectal Cancer, V10, pE1, DOI 10.3816/CCC.2011.n.010; Weber WA, 2006, EUR J NUCL MED MOL I, V33, pS27, DOI 10.1007/s00259-006-0133-3; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Zagouri F, 2012, GYNECOL ONCOL, V127, P662, DOI 10.1016/j.ygyno.2012.08.040	49	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0115543	10.1371/journal.pone.0115543	http://dx.doi.org/10.1371/journal.pone.0115543			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668193	Green Published, gold, Green Submitted			2022-12-27	WOS:000349493000003
J	Roesch, SL; Styer, AM; Wood, GC; Kosak, Z; Seiler, J; Benotti, P; Petrick, AT; Gabrielsen, J; Strodel, WE; Gerhard, GS; Still, CD; Argyropoulos, G				Roesch, Stephen L.; Styer, Amanda M.; Wood, G. Craig; Kosak, Zachary; Seiler, Jamie; Benotti, Peter; Petrick, Anthony T.; Gabrielsen, Jon; Strodel, William E.; Gerhard, Glenn S.; Still, Christopher D.; Argyropoulos, George			Perturbations of Fibroblast Growth Factors 19 and 21 in Type 2 Diabetes	PLOS ONE			English	Article							BILE-ACIDS; EXPRESSION; REMISSION	Fibroblast growth factors 19 and 21 (FGF19 and FGF21) have been implicated, independently, in type 2 diabetes (T2D) but it is not known if their circulating levels correlate with each other or whether the associated hepatic signaling mechanisms that play a role in glucose metabolism are dysregulated in diabetes. We used a cross-sectional, case/control, experimental design involving Class III obese patients undergoing Roux-en-Y bariatric surgery (RYGB), and measured FGF19 and FGF21 serum levels and hepatic gene expression (mRNA) in perioperative liver wedge biopsies. We found that T2D patients had lower FGF19 and higher FGF21 serum levels. The latter was corroborated transcriptionally, whereby, FGF21, as well as CYP7A1, beta-Klotho, FGFR4, HNF4 alpha, and glycogen synthase, but not of SHP or FXR mRNA levels in liver biopsies were higher in T2D patients that did not remit diabetes after RYGB surgery, compared to T2D patients that remitted diabetes after RYGB surgery or did not have diabetes. In a Phenome-wide association analysis using 205 clinical variables, higher FGF21 serum levels were associated with higher glucose levels and various cardiometabolic disease phenotypes. When serum levels of FGF19 were < 200 mg/mL and FGF21 > 500 mg/mL, 91% of patients had diabetes. These data suggest that FGF19/FGF21 circulating levels and hepatic gene expression of the associated signaling pathway are significantly dysregulated in type 2 diabetes.	[Roesch, Stephen L.; Styer, Amanda M.; Wood, G. Craig; Kosak, Zachary; Seiler, Jamie; Benotti, Peter; Gerhard, Glenn S.; Still, Christopher D.; Argyropoulos, George] Geisinger Hlth Syst, Inst Obes, Danville, PA 17822 USA; [Petrick, Anthony T.; Gabrielsen, Jon; Strodel, William E.] Geisinger Hlth Syst, Dept Surg, Danville, PA USA; [Gerhard, Glenn S.] Penn State Univ, Dept Biochem & Mol Biol, Hershey, PA USA; [Gerhard, Glenn S.] Penn State Univ, Dept Pathol & Lab Med, Hershey, PA USA	Geisinger Health System; Geisinger Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Argyropoulos, G (corresponding author), Geisinger Hlth Syst, Inst Obes, Danville, PA 17822 USA.	gargyropoulos1@geisinger.edu			Geisinger Health System; National Institute of Health [DK072488, DK088231, DK091601]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091601, R01DK088231, P30DK072488] Funding Source: NIH RePORTER	Geisinger Health System; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by research funds from the Geisinger Health System and the National Institute of Health grants DK072488 (GSG, CDS, GA) and DK088231 (GSG) and DK091601 (GSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Angelin B, 2012, CELL METAB, V16, P693, DOI 10.1016/j.cmet.2012.11.001; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Cicione C, 2012, HEPATOLOGY, V56, P2404, DOI 10.1002/hep.25929; Cyphert HA, 2012, J BIOL CHEM, V287, P25123, DOI 10.1074/jbc.M112.375907; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Gallego-Escuredo JM, 2014, INT J OBES LOND; Gerhard GS, 2014, INT J OBESITY, V38, P371, DOI 10.1038/ijo.2013.152; Gerhard GS, 2013, DIABETES CARE, V36, P1859, DOI 10.2337/dc12-2255; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jansen PLM, 2011, DIGEST DIS, V29, P48, DOI 10.1159/000324128; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; LIPS MA, 2014, CLIN ENDOCRINOL OXF, P87044; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Miura S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-56; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Still CD, 2014, LANCET DIABETES ENDO, V2, P38, DOI 10.1016/S2213-8587(13)70070-6; Stutz AM, 2007, OBESITY, V15, P607, DOI 10.1038/oby.2007.564; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Wood GC, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-45; Zhou M, 2014, CANCER RES, V74, P3306, DOI 10.1158/0008-5472.CAN-14-0208	25	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0116928	10.1371/journal.pone.0116928	http://dx.doi.org/10.1371/journal.pone.0116928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664662	gold, Green Published, Green Submitted			2022-12-27	WOS:000349123100015
J	Bakhshi, S; Gilbert, E				Bakhshi, Saeideh; Gilbert, Eric			Red, Purple and Pink: The Colors of Diffusion on Pinterest	PLOS ONE			English	Article							PERFORMANCE; BEHAVIOR; EMOTION; SYSTEM	Many lab studies have shown that colors can evoke powerful emotions and impact human behavior. Might these phenomena drive how we act online? A key research challenge for image-sharing communities is uncovering the mechanisms by which content spreads through the community. In this paper, we investigate whether there is link between color and diffusion. Drawing on a corpus of one million images crawled from Pinterest, we find that color significantly impacts the diffusion of images and adoption of content on image sharing communities such as Pinterest, even after partially controlling for network structure and activity. Specifically, Red, Purple and pink seem to promote diffusion, while Green, Blue, Black and Yellow suppress it. To our knowledge, our study is the first to investigate how colors relate to online user behavior. In addition to contributing to the research conversation surrounding diffusion, these findings suggest future work using sophisticated computer vision techniques. We conclude with a discussion on the theoretical, practical and design implications suggested by this work-e.g. design of engaging image filters.	[Bakhshi, Saeideh] Yahoo Labs, HCI Res Grp, San Francisco, CA USA; [Gilbert, Eric] Georgia Tech, Coll Comp, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology	Bakhshi, S (corresponding author), Yahoo Labs, HCI Res Grp, San Francisco, CA USA.	sbakhshi@yahoo-inc.com			Defense Advanced Research Projects Agency (DARPA) [W911NF-12-1-0043]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This material is based upon work supported in part by the Defense Advanced Research Projects Agency (DARPA) under Contract No. W911NF-12-1-0043. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of DARPA or the United States Government. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressly or implied, of the Defense Advanced Research Projects Agency or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS FM, 1973, J CROSS CULT PSYCHOL, V4, P135, DOI 10.1177/002202217300400201; [Anonymous], 2012, P WORKSH SOC MED VIS; APTER MJ, 1976, PERCEPT MOTOR SKILL, V43, P1209, DOI 10.2466/pms.1976.43.3f.1209; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Aslam M. M., 2006, J MARK COMMUN, V12, P15, DOI DOI 10.1080/13527260500247827; Bakhshi S, 2014, P SIGCHI C HUM FACT; Bakshy E, 2009, 10TH ACM CONFERENCE ON ELECTRONIC COMMERCE - EC 2009, P325; Barua H, 1956, RED RIVER BLUE HILL; BELLIZZI JA, 1983, J RETAILING, V59, P21; Berger J, 2012, J MARKETING RES, V49, P192, DOI 10.1509/jmr.10.0353; Berlyne D.E., 1960, CONFLICT AROUSAL CUR, DOI [10.1037/11164-000, DOI 10.1037/11164-000]; Birren F, 1997, THE POWER OF COLOR; Bohle RH, 1986, READER REACTIONS COL; Burke M, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P945; Byrne D., CABINETMAGAZINE; Cameron A.C., 1998, ECONOMETRIC SOC MONO, V30, pxvii, 412; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Cha M., 2010, 4 INT AAAI C WEBL SO, V14, P8; CLICK JW, 1976, JOURNALISM QUART, V53, P736, DOI 10.1177/107769907605300421; Courtis J.K., 2004, ACCOUNT FORUM, V28, P265, DOI DOI 10.1016/J.ACCFOR.2004.07.003; Crowley A. E., 1993, MARKET LETT, V4, P59, DOI [10.1007/BF00994188, DOI 10.1007/BF00994188]; Davey P, 1998, ARCHIT REV, V204, P34; Elliot AJ, 2008, J PERS SOC PSYCHOL, V95, P1150, DOI 10.1037/0022-3514.95.5.1150; Elliot AJ, 2007, J EXP PSYCHOL GEN, V136, P154, DOI 10.1037/0096-3445.136.1.154; Elliot AJ, 2014, ANNU REV PSYCHOL, V65, P95, DOI 10.1146/annurev-psych-010213-115035; Ellison NB, 2011, NEW MEDIA SOC, V13, P873, DOI 10.1177/1461444810385389; Erdoes Richard, 1984, AM INDIAN MYTHS LEGE; Gilbert E., 2013, P SIGCHI C HUM FACT, P2427, DOI DOI 10.1145/2470654.2481336; Goldstein K., 1942, OCCUP THER J RES, V21, P147, DOI DOI 10.4314/NJBAS.V21I2.9; Gorn GJ, 1997, MANAGE SCI, V43, P1387, DOI 10.1287/mnsc.43.10.1387; Guilford JP, 1934, J EXP PSYCHOL, V17, P342, DOI 10.1037/h0071517; GUILFORD JP, 1959, AM J PSYCHOL, V72, P487, DOI 10.2307/1419491; Hemphill M, 1996, J GENET PSYCHOL, V157, P275, DOI 10.1080/00221325.1996.9914865; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Hill RA, 2005, NATURE, V435, P293, DOI 10.1038/435293a; Hupka RB, 1997, J CROSS CULT PSYCHOL, V28, P156, DOI 10.1177/0022022197282002; Hutchings J, 2004, COLOR RES APPL, V29, P57, DOI 10.1002/col.10212; Jacobs L, 1991, INT MARKETING REV, V8; Jamali S, 2009, WISM: 2009 INTERNATIONAL CONFERENCE ON WEB INFORMATION SYSTEMS AND MINING, PROCEEDINGS, P32, DOI 10.1109/WISM.2009.15; James WT, 1953, J GEN PSYCHOL, V48, P187, DOI 10.1080/00221309.1953.9920190; Jobes G, 1962, DICT MYTHOLOGY FOL 3; Kaya N., 2004, COLL STUD J, V38, P396; Knight C, 1995, CAMB ARCHAEOL J, V5, P75, DOI [10.1017/S0959774300001190, DOI 10.1017/S0959774300001190]; Kuhbandner C, 2013, EMOTION, V13, P375, DOI 10.1037/a0031821; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lane R., 1991, FORBES, V148, P144; Lang J., 1987, CREATING ARCHITECTUR; Lee CS, 2012, COMPUT HUM BEHAV, V28, P331, DOI 10.1016/j.chb.2011.10.002; Lee S, 1989, J ADVERTISING RES; Lee Y, 2000, MAN PRAYER ORIGIN NA; Lichtenfeld S, 2012, PERS SOC PSYCHOL B, V38, P784, DOI 10.1177/0146167212436611; Mahnke F., 1996, COLOR ENV HUMAN RESP; MCMANUS IC, 1981, PERCEPTION, V10, P651, DOI 10.1068/p100651; Mehta R, 2009, SCIENCE, V323, P1226, DOI 10.1126/science.1169144; Meier BP, 2004, PSYCHOL SCI, V15, P82, DOI 10.1111/j.0963-7214.2004.01502002.x; MEYERSLEVY J, 1995, J CONSUM RES, V22, P121, DOI 10.1086/209440; MIDDLESTADT SE, 1990, ADV CONSUM RES, V17, P244; Mikellides B, 1990, J ARCHITECTURAL PLAN; Munshell AH, 1912, AM J PSYCHOL, V23, P236, DOI 10.2307/1412843; Neto F, 2002, PERCEPT MOTOR SKILL, V94, P1303, DOI 10.2466/pms.2002.94.3c.1303; OLNEY TJ, 1991, J CONSUM RES, V17, P440, DOI 10.1086/208569; OTT JN, 1976, J LEARN DISABIL, V9, P417, DOI 10.1177/002221947600900704; PALLAK SR, 1983, SOC COGNITION, V2, P158, DOI 10.1521/soco.1983.2.2.158; PETTY RE, 1983, J CONSUM RES, V10, P135, DOI 10.1086/208954; Sakamoto Y., 1986, AKAIKE INFORM CRITER; SALTARELLI CG, 1979, LAB ANIM SCI, V29, P319; SANBONMATSU DM, 1988, J CONSUM RES, V15, P379, DOI 10.1086/209175; SCHAUSS AG, 1979, J ORTHOMOL MED, V8, P218; Schindler PS, 1986, PSYCHOL MARKET, V3, P69, DOI DOI 10.1002/MAR.4220030203; Sharpe DT, 1975, PSYCHOL COLOR DESIGN; Smith KCP, 1975, THEORY PSYCHOL REVER; Sparkman R., 1980, J ADVERTISING, V9, P39, DOI [10.1080/00913367.1980.10673336, DOI 10.1080/00913367.1980.10673336]; Sun E., 2009, P INT AAAI C WEBL SO, P22; Tom G., 1987, J CONSUM MARK, V4, P23; VALDEZ P, 1994, J EXP PSYCHOL GEN, V123, P394, DOI 10.1037/0096-3445.123.4.394; WALTERS J, 1982, Motivation and Emotion, V6, P193, DOI 10.1007/BF00992245; Wexner LB, 1954, J APPL PSYCHOL, V38, P432, DOI 10.1037/h0062181; Wojnicki A.C., 2008, 0601 HBS MARK RES, DOI [10.2139/ssrn.9089999, DOI 10.2139/SSRN.9089999]	78	9	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117148	10.1371/journal.pone.0117148	http://dx.doi.org/10.1371/journal.pone.0117148			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658423	gold, Green Submitted, Green Published			2022-12-27	WOS:000349444900108
J	Hakuno, D; Hamba, Y; Toya, T; Adachi, T				Hakuno, Daihiko; Hamba, Yasuhito; Toya, Takumi; Adachi, Takeshi			Plasma Amino Acid Profiling Identifies Specific Amino Acid Associations with Cardiovascular Function in Patients with Systolic Heart Failure	PLOS ONE			English	Article							SKELETAL-MUSCLE; ENDOTHELIAL DYSFUNCTION; NITRIC-OXIDE; RISK; EXERCISE; SURVIVAL; DISEASE; STRESS	Background The heart has close interactions with other organs' functions and concomitant systemic factors such as oxidative stress, nitric oxide (NO), inflammation, and nutrition in systolic heart failure (HF). Recently, plasma amino acid (AA) profiling as a systemic metabolic indicator has attracted considerable attention in predicting the future risk of human cardiometabolic diseases, but it has been scarcely studied in HF. Methods Thirty-eight stable but greater than New York Heart Association class II symptomatic patients with left ventricular (LV) ejection fraction <45% and 33 asymptomatic individuals with normal B-type natriuretic peptide (BNP) value were registered as the HF and control groups, respectively. We analyzed fasting plasma concentrations of 41 AAs using high-performance liquid chromatography, serum NO metabolite concentration, hydroperoxide and high-sensitivity C-reactive protein measurements, echocardiography, and flow-mediated dilatation. Results We found that 17 AAs and two ratios significantly changed in the HF group compared with those in the control group (p < 0.05). In the HF group, subsequent univariate and stepwise multivariate analyses with clinical variables revealed that Fischer ratio and five specific AAs, ie, monoethanolamine, methionine, tyrosine, 1-methylhistidine, and histidine have significant correlation with BNP, LV ejection fraction, LV end-diastolic volume index, inferior vena cava diameter, the ratio of early diastolic velocity of the mitral inflow to mitral annulus, and BNP, respectively (p < 0.05). Interestingly, further exploratory factor analysis categorized these AAs into hepatic-related (monoethanolamine, tyrosine, and Fischer ratio) and skeletal muscle-related (histidine, methionine, and 1-methylhistidine) components. Some categorized AAs showed unique correlations with concomitant factors: monoethanolamine, tyrosine, and Fischer ratio with serum NO concentration; histidine with serum albumin; and 1-methylhistidine with flow-mediated dilatation (p < 0.05). Conclusions Plasma AA profiling identified correlations of specific AAs with cardiac function and concomitant factors, highlighting the cardio-hepatic-skeletal muscle axis in patients with systolic HF.	[Hakuno, Daihiko; Toya, Takumi; Adachi, Takeshi] Natl Def Med Coll, Dept Internal Med, Div Cardiol, Tokorozawa, Saitama 359, Japan; [Hamba, Yasuhito] Natl Def Med Coll, Dept Lab Med, Tokorozawa, Saitama 359, Japan	National Defense Medical College - Japan; National Defense Medical College - Japan	Hakuno, D (corresponding author), Kyoto Univ Hosp, Dept Cardiovasc Med, Kyoto 606, Japan.	hakuno@kuhp.kyoto-u.ac.jp		Toya, Takumi/0000-0002-4681-2798	National Defense Medical College; Japan Heart Foundation Research Grant (Tokyo); Takeda Science Foundation (Osaka)	National Defense Medical College; Japan Heart Foundation Research Grant (Tokyo); Takeda Science Foundation (Osaka)(Takeda Science Foundation (TSF))	This work was supported by the National Defense Medical College Grants-in-Aid for Encouragement of Scientists (Saitama); Japan Heart Foundation Research Grant (Tokyo); and a grant from Takeda Science Foundation (Osaka) to D.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; Anker SD, 1997, EUR HEART J, V18, P259; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Dejong CHC, 2007, J NUTR, V137, p1579S, DOI 10.1093/jn/137.6.1579S; Diercks DB, 2012, ACAD EMERG MED, V19, P18, DOI 10.1111/j.1553-2712.2011.01239.x; DREXLER H, 1992, CIRCULATION, V85, P1751, DOI 10.1161/01.CIR.85.5.1751; Givertz MM, 2014, CIRC-HEART FAIL, V7, P59, DOI 10.1161/CIRCHEARTFAILURE.113.000556; Griffin JL, 2011, NAT REV CARDIOL, V8, P630, DOI 10.1038/nrcardio.2011.138; Gupta TK, 1998, HEPATOLOGY, V28, P926, DOI 10.1002/hep.510280405; Heuman DM, 2007, LIVER TRANSPLANT, V13, P30, DOI 10.1002/lt.20906; Horwich TB, 2008, AM HEART J, V155, P883, DOI 10.1016/j.ahj.2007.11.043; Indik JH, 2001, AM J PHYSIOL-HEART C, V281, pH1767, DOI 10.1152/ajpheart.2001.281.4.H1767; Kalantar-Zadeh K, 2008, AM J CARDIOL, V101, p89E, DOI 10.1016/j.amjcard.2008.03.007; Kim MS, 2013, J AM COLL CARDIOL, V61, P2253, DOI 10.1016/j.jacc.2012.12.056; Lin D, 2011, J CARD FAIL, V17, P867, DOI 10.1016/j.cardfail.2011.07.001; Melenovsky V, 2013, J AM COLL CARDIOL, V62, P1660, DOI 10.1016/j.jacc.2013.06.046; Okita K, 2013, CIRC J, V77, P293, DOI 10.1253/circj.CJ-12-1235; Okura Y, 2008, CIRC J, V72, P489, DOI 10.1253/circj.72.489; Pitkanen HT, 2003, MED SCI SPORT EXER, V35, P784, DOI 10.1249/01.MSS.0000064934.51751.F9; Poelzl G, 2009, CIRC-HEART FAIL, V2, P294, DOI 10.1161/CIRCHEARTFAILURE.108.826735; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Samsky MD, 2013, J AM COLL CARDIOL, V61, P2397, DOI 10.1016/j.jacc.2013.03.042; Shah SH, 2012, CIRCULATION, V126, P1110, DOI 10.1161/CIRCULATIONAHA.111.060368; Shah SH, 2010, CIRC-CARDIOVASC GENE, V3, P207, DOI 10.1161/CIRCGENETICS.109.852814; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Vesali RF, 2004, METABOLISM, V53, P1076, DOI 10.1016/j.metabol.2004.02.017; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076538	32	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117325	10.1371/journal.pone.0117325	http://dx.doi.org/10.1371/journal.pone.0117325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658112	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900133
J	Lutken, SC; Frokiaer, J; Nielsen, S				Lutken, Sophie Constantin; Frokiaer, Jorgen; Nielsen, Soren			AVP-Induced Increase in AQP2 and p-AQP2 Is Blunted in Heart Failure during Cardiac Remodeling and Is Associated with Decreased AT1R Abundance in Rat Kidney	PLOS ONE			English	Article							MEDULLARY COLLECTING DUCT; AQUAPORIN-2 WATER CHANNEL; RENIN-ANGIOTENSIN SYSTEM; HYPERTONICITY-INDUCED AQUAPORIN-1; INDUCED NEPHROTIC SYNDROME; THICK ASCENDING LIMB; LIVER-CIRRHOSIS; ARGININE-VASOPRESSIN; (PRO)RENIN RECEPTOR; CARDIOMYOPATHIC HAMSTERS	Aim The objective was to examine the renal effects of long-term increased angiotensin II and vasopressin plasma levels in early-stage heart failure (HF). We investigated the regulations of the V2 vasopressin receptor, the type 1A angiotensin II receptor, the (pro) renin receptor, and the water channels AQP2, AQP1, AQP3, and AQP4 in the inner medulla of rat kidney. Methods HF was induced by coronary artery ligation. Sixty-eight rats were allocated to six groups: Sham (N = 11), HF (N = 11), sodium restricted sham (N = 11), sodiumrestricted HF (N = 11), sodium restricted sham + DDAVP (N = 12), and sodium restricted HF + DDAVP (N = 12). 1-desamino-8-D-arginine vasopressin (0.5 ng h-1 for 7 days) or vehicle was administered. Pre-and post-treatment echocardiographic evaluation was performed. The rats were sacrificed at day 17 after surgery, before cardiac remodeling in rat is known to be completed. Results HF rats on standard sodium diet and sodium restriction displayed biochemical markers of HF. These rats developed hyponatremia, hypo-osmolality, and decreased fractional excretion of sodium. Increase of AQP2 and p(Ser256)-AQP2 abundance in all HF groups was blunted compared with control groups even when infused with DDAVP and despite increased vasopressin V2 receptor and Gs alpha abundance. This was associated with decreased protein abundance of the AT1A receptor in HF groups vs. controls. Conclusion Early-stage HF is associated with blunted increase in AQP2 and p(Ser256)-AQP2 despite of hyponatremia, hypo-osmolality, and increased inner medullary vasopressin V2 receptor expression. Decreased type 1A angiotensin II receptor abundance likely plays a role in the transduction of these effects.	[Lutken, Sophie Constantin; Nielsen, Soren] Univ Aarhus, Dept Biomed Anat, DK-8000 Aarhus C, Denmark; [Lutken, Sophie Constantin; Frokiaer, Jorgen] Aarhus Univ Hosp, Inst Clin Med, DK-8200 Aarhus N, Denmark; [Nielsen, Soren] Aalborg Univ, Dept Hlth Sci & Technol, DK-9220 Aalborg O, Denmark	Aarhus University; Aarhus University; Aalborg University	Lutken, SC (corresponding author), Univ Aarhus, Dept Biomed Anat, DK-8000 Aarhus C, Denmark.	sche@ana.au.dk			Karen Elise Jensen Foundation; Aase and Ejnar Danielsen Foundation; Danish Heart Foundation; Carl and Ellen Hertz Foundation; A.P. Mc-Kinney Moller Foundation for Medical Scientific Promotion; Human Frontier Science Program; European Commission [QRLT 2000 00778, QRLT 2000 00987]; intramural budget of the National Heart, Lung, and Blood Institute, National Institutes of Health	Karen Elise Jensen Foundation; Aase and Ejnar Danielsen Foundation; Danish Heart Foundation; Carl and Ellen Hertz Foundation; A.P. Mc-Kinney Moller Foundation for Medical Scientific Promotion; Human Frontier Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); intramural budget of the National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support for this study was provided by the Karen Elise Jensen Foundation (www.kejfond.dk), Aase and Ejnar Danielsen Foundation (www.danielsensfond.dk), The Danish Heart Foundation (www.hjerteforeningen.dk), Carl and Ellen Hertz Foundation (poulroepstorff@mail.dk), The A.P. Mc-Kinney Moller Foundation for Medical Scientific Promotion (www.apmollerfonde.dk), Human Frontier Science Program, the European Commission (QRLT 2000 00778 and QRLT 2000 00987) (www.hfsp.org), and the intramural budget of the National Heart, Lung, and Blood Institute, National Institutes of Health (www.nhlbi.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors confirm that there are no restrictions on sharing of data and/or materials from any funders or organisations listed above.	Apostol E, 1997, J AM SOC NEPHROL, V8, P15; Biner HL, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134836; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bouby N, 1997, J AM SOC NEPHROL, V8, P1658; Brond L, 2013, AM J PHYSIOL-RENAL, V305, pF1547, DOI 10.1152/ajprenal.00461.2012; Brooks HL, 2001, J PHYSIOL-LONDON, V530, P359, DOI 10.1111/j.1469-7793.2001.0359k.x; Bustamante M, 2005, AM J PHYSIOL-RENAL, V288, pF334, DOI 10.1152/ajprenal.00180.2004; CHAMPIGNEULLE A, 1993, AM J PHYSIOL, V265, pF35, DOI 10.1152/ajprenal.1993.265.1.F35; Chou CL, 1998, AM J PHYSIOL-CELL PH, V274, pC549, DOI 10.1152/ajpcell.1998.274.2.C549; Chou CL, 2000, J BIOL CHEM, V275, P36839, DOI 10.1074/jbc.M005552200; Christensen BM, 2003, AM J PHYSIOL-RENAL, V284, pF701, DOI 10.1152/ajprenal.00234.2002; Christensen BM, 2000, AM J PHYSIOL-RENAL, V278, pF29, DOI 10.1152/ajprenal.2000.278.1.F29; Contrepas A, 2009, AM J PHYSIOL-REG I, V297, pR250, DOI 10.1152/ajpregu.90832.2008; Ecelbarger CA, 1996, AM J PHYSIOL-RENAL, V270, pF623, DOI 10.1152/ajprenal.1996.270.4.F623; Ecelbarger CA, 1997, J CLIN INVEST, V99, P1852, DOI 10.1172/JCI119352; ECELBARGER CA, 1995, AM J PHYSIOL-RENAL, V269, pF663, DOI 10.1152/ajprenal.1995.269.5.F663; Fenton RA, 2007, AM J PHYSIOL-RENAL, V293, pF748, DOI 10.1152/ajprenal.00316.2006; Fenton RA, 2009, PFLUG ARCH EUR J PHY, V458, P169, DOI 10.1007/s00424-008-0612-4; Fernandez-Llama P, 1999, J AM SOC NEPHROL, V10, P1950; FISHBEIN MC, 1978, AM J PATHOL, V90, P57; Funayama H, 2004, KIDNEY INT, V66, P1387, DOI 10.1111/j.1523-1755.2004.00902.x; Gilbert RE, 1999, AM J PATHOL, V155, P429, DOI 10.1016/S0002-9440(10)65139-5; GOLDBERG M, 1981, MED CLIN N AM, V65, P251, DOI 10.1016/S0025-7125(16)31523-1; Hasler U, 2008, J BIOL CHEM, V283, P28095, DOI 10.1074/jbc.M801071200; ICHIKAWA I, 1984, CIRC RES, V55, P669, DOI 10.1161/01.RES.55.5.669; Jensen AM, 2009, AM J PHYSIOL-RENAL, V296, pF127, DOI 10.1152/ajprenal.90479.2008; JOHNS TNP, 1954, ANN SURG, V140, P675, DOI 10.1097/00000658-195411000-00006; Jonassen TEN, 1998, AM J PHYSIOL-RENAL, V275, pF216, DOI 10.1152/ajprenal.1998.275.2.F216; Jonassen TEN, 2000, AM J PHYSIOL-RENAL, V279, pF1101, DOI 10.1152/ajprenal.2000.279.6.F1101; Kamsteeg EJ, 2000, J CELL BIOL, V151, P919, DOI 10.1083/jcb.151.4.919; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; KIM JK, 1990, KIDNEY INT, V38, P818, DOI 10.1038/ki.1990.276; Kim SW, 2005, BIOL CELL, V97, P765, DOI 10.1042/BC20040148; Kim SW, 2004, AM J PHYSIOL-RENAL, V286, pF922, DOI 10.1152/ajprenal.00277.2003; Kim SW, 2001, J AM SOC NEPHROL, V12, P2019, DOI 10.1681/ASN.V12102019; Kishore BK, 1995, AM J PHYSIOL-RENAL, V269, pF863, DOI 10.1152/ajprenal.1995.269.6.F863; Klingler C, 1998, CELL SIGNAL, V10, P65, DOI 10.1016/S0898-6568(97)00077-6; Kwon TH, 2005, AM J PHYSIOL-RENAL, V288, pF673, DOI 10.1152/ajprenal.00304.2004; Kwon TH, 2003, AM J PHYSIOL-RENAL, V285, pF152, DOI 10.1152/ajprenal.00307.2002; Kwon TH, 2002, AM J PHYSIOL-RENAL, V283, pF1403, DOI 10.1152/ajprenal.00059.2002; Lanaspa MA, 2010, J BIOL CHEM, V285, P31694, DOI 10.1074/jbc.M109.093690; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee YJ, 2007, AM J PHYSIOL-RENAL, V292, pF340, DOI 10.1152/ajprenal.00090.2006; LUK JKH, 1993, CARDIOLOGY, V83, P49, DOI 10.1159/000175947; Lutken SC, 2009, AM J PHYSIOL-RENAL, V297, pF1678, DOI 10.1152/ajprenal.00010.2009; MA TH, 1994, J BIOL CHEM, V269, P21845; MAEDA Y, 1993, AM J PHYSIOL, V265, pF15, DOI 10.1152/ajprenal.1993.265.1.F15; Marples D, 1998, AM J PHYSIOL-RENAL, V275, pF400, DOI 10.1152/ajprenal.1998.275.3.F400; MARPLES D, 1995, AM J PHYSIOL-CELL PH, V269, pC655, DOI 10.1152/ajpcell.1995.269.3.C655; Mccoy ES, 2010, NEUROSCIENCE, V168, P971, DOI 10.1016/j.neuroscience.2009.09.020; Moeller HB, 2009, NEUROSCIENCE, V164, P1674, DOI 10.1016/j.neuroscience.2009.09.072; NADLER SP, 1992, J CLIN INVEST, V90, P1458, DOI 10.1172/JCI116013; Nguyen G, 2006, KIDNEY INT, V69, P1503, DOI 10.1038/sj.ki.5000265; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nielsen J, 2006, AM J PHYSIOL-RENAL, V290, pF438, DOI 10.1152/ajprenal.00158.2005; Nielsen J, 2003, AM J PHYSIOL-RENAL, V285, pF1198, DOI 10.1152/ajprenal.00118.2003; Nielsen S, 1997, P NATL ACAD SCI USA, V94, P5450, DOI 10.1073/pnas.94.10.5450; NIELSEN S, 1993, J CELL BIOL, V120, P371, DOI 10.1083/jcb.120.2.371; O'Neill H, 2008, NEPHROL DIAL TRANSPL, V23, P1546, DOI 10.1093/ndt/gfm814; Oren RM, 2005, AM J CARDIOL, V95, p2B; Ostrom RS, 2003, J BIOL CHEM, V278, P24461, DOI 10.1074/jbc.M212659200; Patrucco E, 2014, P NATL ACAD SCI USA, V111, P12925, DOI 10.1073/pnas.1414364111; Pedersen RS, 2003, KIDNEY INT, V63, P1417, DOI 10.1046/j.1523-1755.2003.00858.x; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; POGGIOLI J, 1992, AM J PHYSIOL, V263, pC750, DOI 10.1152/ajpcell.1992.263.4.C750; PURI PL, 1995, J BIOL CHEM, V270, P22129, DOI 10.1074/jbc.270.38.22129; Qin YW, 2012, INVEST OPHTH VIS SCI, V53, P3047, DOI 10.1167/iovs.11-9154; ROSE BD, 1986, AM J MED, V81, P1033, DOI 10.1016/0002-9343(86)90401-8; SANDS JM, 1987, AM J PHYSIOL, V253, pF823, DOI 10.1152/ajprenal.1987.253.5.F823; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shao WJ, 2013, AM J PHYSIOL-RENAL, V304, pF505, DOI 10.1152/ajprenal.00587.2012; Staahltoft D, 2002, AM J PHYSIOL-RENAL, V282, pF307, DOI 10.1152/ajprenal.00132.2001; STAR RA, 1988, J CLIN INVEST, V81, P1879, DOI 10.1172/JCI113534; Stegbauer J, 2011, J AM SOC NEPHROL, V22, P2237, DOI 10.1681/ASN.2010101095; Takahashi K, 2010, J NEUROENDOCRINOL, V22, P453, DOI 10.1111/j.1365-2826.2010.01980.x; Takahashi K, 2013, ACTA HISTOCHEM CYTOC, V46, P47, DOI 10.1267/ahc.12030; Tamma G, 2007, ENDOCRINOLOGY, V148, P1118, DOI 10.1210/en.2006-1277; Terris J, 1996, AM J PHYSIOL-RENAL, V271, pF414, DOI 10.1152/ajprenal.1996.271.2.F414; Torp M, 2007, ACTA PHYSIOL, V190, P339, DOI 10.1111/j.1748-1716.2007.01722.x; Umenishi F, 2003, J BIOL CHEM, V278, P15765, DOI 10.1074/jbc.M209980200; Umenishi F, 2005, J AM SOC NEPHROL, V16, P600, DOI 10.1681/ASN.2004030241; Umenishi F, 2006, BBA-BIOMEMBRANES, V1758, P1100, DOI 10.1016/j.bbamem.2006.06.001; van Balkom BWM, 2003, J BIOL CHEM, V278, P1101, DOI 10.1074/jbc.M207339200; van Balkom BWM, 2002, J BIOL CHEM, V277, P41473, DOI 10.1074/jbc.M207525200; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; Van Hoek AN, 2009, AM J PHYSIOL-RENAL, V296, pF1396, DOI 10.1152/ajprenal.00018.2009; Veeraveedu PT, 2007, BIOCHEM PHARMACOL, V74, P1466, DOI 10.1016/j.bcp.2007.07.027; Wasmeier GH, 2007, CORONARY ARTERY DIS, V18, P283, DOI 10.1097/MCA.0b013e3280d5a7e3; Wong NLM, 2002, METABOLISM, V51, P970, DOI 10.1053/meta.2002.34015; WYATT HL, 1980, AM HEART J, V100, P821, DOI 10.1016/0002-8703(80)90062-9; Xu DL, 1997, J CLIN INVEST, V99, P1500, DOI 10.1172/JCI119312; Yamazaki T, 1999, AM J CARDIOL, V83, p53H; Yip KP, 2006, AM J PHYSIOL-RENAL, V291, pF882, DOI 10.1152/ajprenal.00411.2005; Yu CM, 2004, J MOL CELL CARDIOL, V36, P445, DOI 10.1016/j.yjmcc.2004.01.002; Zhai XY, 2007, J AM SOC NEPHROL, V18, P2937, DOI 10.1681/ASN.2007010056	96	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116501	10.1371/journal.pone.0116501	http://dx.doi.org/10.1371/journal.pone.0116501			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658446	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900045
J	Ndlovu, T; Le Roux, M; Khan, W; Khan, S				Ndlovu, Thando; Le Roux, Marcellous; Khan, Wesaal; Khan, Sehaam			Co-Detection of Virulent Escherichia coli Genes in Surface Water Sources	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MULTIPLEX PCR; RAPID DETECTION; SOUTH-AFRICA; WESTERN-CAPE; ASSAY; IDENTIFICATION; SEQUENCE; STRAINS	McNemar's test and the Pearson Chi-square were used to assess the co-detection and observed frequency, respectively, for potentially virulent E. coli genes in river water. Conventional multiplex Polymerase Chain Reaction (PCR) assays confirmed the presence of the aggR gene (69%), ipaH gene (23%) and the stx gene (15%) carried by Enteroaggregative E. coli (EAEC), Enteroinvasive E. coli (EIEC) and Enterohermorrhagic E. coli (EHEC), respectively, in river water samples collected from the Berg River (Paarl, South Africa). Only the aggR gene was present in 23% of samples collected from the Plankenburg River system (Stellenbosch, South Africa). In a comparative study, real-time multiplex PCR assays confirmed the presence of aggR (EAEC) in 69%, stx (EHEC) in 15%, ipaH (EIEC) in 31% and eae (EPEC) in 8% of the river water samples collected from the Berg River. In the Plankenburg River, aggR (EAEC) was detected in 46% of the samples, while eae (EPEC) was present in 15% of the water samples analyzed using real-time multiplex PCR in the Plankenburg River. Pearson Chi-square showed that there was no statistical difference (p > 0.05) between the conventional and real-time multiplex PCRs for the detection of virulent E. coli genes in water samples. However, the McNemar's test showed some variation in the co-detection of virulent E. coli genes, for example, there was no statistical difference in the misclassification of the discordant results for stx versus ipaH, which implies that the ipaH gene was frequently detected with the stx gene. This study thus highlights the presence of virulent E. coli genes in river water and while early detection is crucial, quantitative microbial risk analysis has to be performed to identify and estimate the risk to human health.	[Ndlovu, Thando; Le Roux, Marcellous; Khan, Sehaam] Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Dept Biomed Sci, ZA-7535 Bellville, South Africa; [Khan, Wesaal] Univ Stellenbosch, Fac Sci, Dept Microbiol, ZA-7602 Stellenbosch, South Africa	Cape Peninsula University of Technology; Stellenbosch University	Khan, S (corresponding author), Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Dept Biomed Sci, POB 1906, ZA-7535 Bellville, South Africa.	khans@cput.ac.za	Ndlovu, Thando/L-3694-2018	Ndlovu, Thando/0000-0002-5624-8975; Khan, Sehaam/0000-0002-6030-6058	National Research Foundation; Cape Peninsula University of Technology	National Research Foundation; Cape Peninsula University of Technology	The authors would like to thank the National Research Foundation and Cape Peninsula University of Technology for financial support.	Ackermann A, 2010, THESIS U STELLENBOSC; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1997, B DEP MED SCI; Aranda KRS, 2007, FEMS MICROBIOL LETT, V267, P145, DOI 10.1111/j.1574-6968.2006.00580.x; Barnes JM, 2003, THESIS U STELLENBOSC; Ken BTT, 2007, J MED MICROBIOL, V56, P1086, DOI 10.1099/jmm.0.47093-0; Buckalew DW, 2006, J ENVIRON MANAGE, V80, P191, DOI 10.1016/j.jenvman.2005.08.024; BURGART LJ, 1992, MODERN PATHOL, V5, P320; Department of Water Affairs and Forestry, 1996, BACT GUID S AFR WAT, V1-8; Doughari HJ, 2012, J MICROBIOL BIOTECHN, V22, P25, DOI 10.4014/jmb.1107.07029; EDWARDS MC, 1994, PCR METH APPL, V3, pS65; European Centre for Disease Prevention and Control, 2011, SHIG TOX VER PROD ES; Gemmell ME., 2010, CURRENT RES, P1190; Gizinger DG, 2003, EXP HEMATOL, V30, P503; Gomez-Duarte OG, 2010, FOODBORNE PATHOG DIS, V7, P199, DOI 10.1089/fpd.2009.0355; Hsu BM, 2010, WATER RES, V44, P949, DOI 10.1016/j.watres.2009.10.004; Hsu WB, 2007, FEMS MICROBIOL LETT, V270, P291, DOI 10.1111/j.1574-6968.2007.00686.x; Hunter Paul R., 2003, Journal of Water and Health, V1, P65; Kong RYC, 1999, MAR POLLUT BULL, V38, P1207, DOI 10.1016/S0025-326X(99)00164-2; Lorusso V, 2011, J FOOD PROTECT, V74, P13, DOI 10.4315/0362-028X.JFP-10-201; Lu YQ, 2010, COMMUN STAT-THEOR M, V39, P3525, DOI 10.1080/03610920903289218; Mgese S, 2010, THESIS U CAPE TOWN; O'Sullivan J, 2007, METHODS DETECTION MO, P6; Omar KB, 2010, WATER SA, V36, P172; Oswald E, 2000, INFECT IMMUN, V68, P64, DOI [10.1128/IAI.68.1.64-71.2000, 10.1128/IAI.68.11.6402-6410.2000]; Paulse AN, 2007, WATER SA, V33, P165; Paulse AN, 2009, WATER SA, V35, P469; Persson S, 2007, J CLIN MICROBIOL, V45, P2020, DOI 10.1128/JCM.02591-06; Phantouamath B, 2003, JPN J INFECT DIS, V56, P103; Reischl U, 2004, J CLIN MICROBIOL, V42, P4092, DOI 10.1128/JCM.42.9.4092-4100.2004; Salem Imen Ben, 2011, BMC Res Notes, V4, P144, DOI 10.1186/1756-0500-4-144; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; SETHABUTR O, 1993, J INFECT DIS, V167, P458, DOI 10.1093/infdis/167.2.458; Sidhu JPS, 2013, APPL ENVIRON MICROB, V79, P328, DOI 10.1128/AEM.02888-12; Sooka A., 2004, Southern African Journal of Epidemiology & Infection, V19, P23; Tobias J, 2012, MICROBIOL RES, V167, P564, DOI 10.1016/j.micres.2011.11.006; Toma C, 2003, J CLIN MICROBIOL, V41, P2669, DOI 10.1128/JCM.41.6.2669-2671.2003; Valasek MA, 2005, ADV PHYSIOL EDUC, V29, P151, DOI 10.1152/advan.00019.2005; Watterworth L, 2005, J MICROBIOL METH, V60, P93, DOI 10.1016/j.mimet.2004.08.016; Weggerhof FO, 1987, THESIS U WITWATERSRA; Wiley JM, 2014, PRESCOTTS MICROBIOLO, P920, DOI [10.1152/jn.00982.2014, DOI 10.1152/JN.00982.2014]; Yamasaki S, 1996, MICROBIOL IMMUNOL, V40, P345, DOI 10.1111/j.1348-0421.1996.tb01078.x	42	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116808	10.1371/journal.pone.0116808	http://dx.doi.org/10.1371/journal.pone.0116808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659126	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900069
J	Prykhodko, O; Pierzynowski, SG; Nikpey, E; Sureda, EA; Fedkiv, O; Westrom, BR				Prykhodko, Olena; Pierzynowski, Stefan G.; Nikpey, Elham; Sureda, Ester Arevalo; Fedkiv, Olexandr; Westrom, Bjorn R.			Pancreatic and Pancreatic-Like Microbial Proteases Accelerate Gut Maturation in Neonatal Rats	PLOS ONE			English	Article							SUCKLING RATS; GASTROINTESTINAL-TRACT; POSTNATAL-DEVELOPMENT; SMALL-INTESTINE; YOUNG; TRYPSIN; TRANSMISSION; INHIBITORS; DIGESTION; RECEPTOR	Objectives Postnatal gut maturation in neonatal mammals, either at natural weaning or after precocious inducement, is coinciding with enhanced enzymes production by exocrine pancreas. Since the involvement of enzymes in gut functional maturation was overlooked, the present study aimed to investigate the role of enzymes in gut functional maturation using neonatal rats. Methods Suckling rats (Rattus norvegicus) were instagastrically gavaged with porcine pancreatic enzymes (Creon), microbial-derived amylase, protease, lipase and mixture thereof, while controls received a-lactalbumin or water once per day during 14-16 d of age. At 17 d of age the animals were euthanized and visceral organs were dissected, weighed and analyzed for structural and functional properties. For some of the rats, gavage with the macromolecular markers such as bovine serum albumin and bovine IgG was performed 3 hours prior to blood collection to assess the intestinal permeability. Results Gavage with the pancreatic or pancreatic-like enzymes resulted in stimulated gut growth, increased gastric acid secretion and switched intestinal disaccharidases, with decreased lactase and increased maltase and sucrase activities. The fetal-type vacuolated enterocytes were replaced by the adult-type in the distal intestine, and macromolecular transfer to the blood was declined. Enzyme exposure also promoted pancreas growth with increased amylase and trypsin production. These effects were confined to the proteases in a dose-dependent manner. Conclusion Feeding exogenous enzymes, containing proteases, induced precocious gut maturation in suckling rats. This suggests that luminal exposure to proteases by oral loading or, possibly, via enhanced pancreatic secretion involves in the gut maturation of young mammals.	[Prykhodko, Olena; Pierzynowski, Stefan G.; Nikpey, Elham; Sureda, Ester Arevalo; Fedkiv, Olexandr; Westrom, Bjorn R.] Lund Univ, Dept Biol, Lund, Sweden; [Pierzynowski, Stefan G.] Inst Rural Hlth, Dept Med Biol, Lublin, Poland	Lund University; Institute of Rural Health in Lublin, Poland	Prykhodko, O (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Olena.Prykhodko@biol.lu.se	Pierzynowski, Stefan Grzegorz/AAU-6107-2021; Prykhodko, Olena/D-4224-2014; Weström, Björn R/N-2232-2016; Sureda, Ester Arévalo/AAN-2171-2020	Pierzynowski, Stefan Grzegorz/0000-0002-0308-3214; Prykhodko, Olena/0000-0002-5788-9176; Weström, Björn R/0000-0001-9296-2845; Sureda, Ester Arévalo/0000-0002-3299-1510	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) [229-2010-1674]; Royal Physiographic Society of Lund; Albert Pahlsson's Foundation	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Royal Physiographic Society of Lund; Albert Pahlsson's Foundation	This work was funded through Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS, no 229-2010-1674), the Royal Physiographic Society of Lund (www.fysiografen.se) and Director Albert Pahlsson's Foundation (www.pahlssonsstiftelse.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbemafle BM, 2005, AM J PHYSIOL-GASTR L, V288, pG897, DOI 10.1152/ajpgi.00454.2004; ALTMANN GG, 1971, AM J ANAT, V132, P167, DOI 10.1002/aja.1001320204; ALTMANN GG, 1970, AM J ANAT, V127, P15, DOI 10.1002/aja.1001270104; Baintner K, 2002, BIOL GROW ANIM, V1, P55, DOI 10.1016/S1877-1823(09)70118-3; Cranwell P. D., 1995, P99; DAHLQVIST A, 1984, SCAND J CLIN LAB INV, V44, P169, DOI 10.3109/00365518409161400; FRITZ H, 1966, H-S Z PHYSIOL CHEM, V345, P150, DOI 10.1515/bchm2.1966.345.1.150; HARADA E, 1991, COMP BIOCHEM PHYS A, V100, P467, DOI 10.1016/0300-9629(91)90501-3; HARADA E, 1992, AM J PHYSIOL, V263, pR996, DOI 10.1152/ajpregu.1992.263.5.R996; HENNING SJ, 1981, AM J PHYSIOL, V241, pG199, DOI 10.1152/ajpgi.1981.241.3.G199; HENNING SJ, 1979, ENVIRON HEALTH PERSP, V33, P9, DOI 10.2307/3429067; Kageyama T, 2002, CELL MOL LIFE SCI, V59, P288, DOI 10.1007/s00018-002-8423-9; KISFALVI K, 1993, J DEV PHYSIOL, V19, P149; KLEIN RM, 1983, J PEDIATR GASTR NUTR, V2, P204, DOI 10.1097/00005176-198305000-00002; Kong WY, 1997, P NATL ACAD SCI USA, V94, P8884, DOI 10.1073/pnas.94.16.8884; LAURELL CB, 1972, SCAND J CLIN LAB INV, V29, P21, DOI 10.3109/00365517209102748; Li X, 2007, PEDIATR RES, V62, P537, DOI 10.1203/PDR.0b013e3181559e75; Linderoth A, 2006, BRIT J NUTR, V95, P105, DOI 10.1079/BJN20051612; Linderoth A, 2005, J PEDIATR GASTR NUTR, V41, P195, DOI 10.1097/01.mpg.0000172262.05297.98; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Peulen O, 2000, LIVEST PROD SCI, V66, P109, DOI 10.1016/S0301-6226(00)00218-9; PIERZYNOWSKI SG, 1993, J PEDIATR GASTR NUTR, V16, P287, DOI 10.1097/00005176-199304000-00012; PIERZYNOWSKI SG, 1990, J PEDIATR GASTR NUTR, V10, P206, DOI 10.1097/00005176-199002000-00011; Rakhimov K R, 2002, Zh Evol Biokhim Fiziol, V38, P142; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Slupecka M, 2012, J ANIM SCI, V90, P311, DOI [10.2527/jas.53921, 10.2527/jas53921]; TELEMO E, 1987, BIOL NEONATE, V52, P141, DOI 10.1159/000242703; Walthall K, 2005, BIRTH DEFECTS RES B, V74, P132, DOI 10.1002/bdrb.20040; WESTROM BR, 1985, BIOL NEONATE, V47, P359, DOI 10.1159/000242140; WILSON JM, 1991, J CELL SCI, V100, P133	30	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116947	10.1371/journal.pone.0116947	http://dx.doi.org/10.1371/journal.pone.0116947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658606	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900082
J	Robinson, MD; Fetterman, AK				Robinson, Michael D.; Fetterman, Adam K.			The Embodiment of Success and Failure as Forward versus Backward Movements	PLOS ONE			English	Article							TIME; METAPHORS; COGNITION; REPRESENTATION; MOTIVATION; SYSTEMS; FUTURE; FRONT; TASK	People often speak of success (e.g., "advance") and failure (e.g., "setback") as if they were forward versus backward movements through space. Two experiments sought to examine whether grounded associations of this type influence motor behavior. In Experiment 1, participants categorized success versus failure words by moving a joystick forward or backward. Failure categorizations were faster when moving backward, whereas success categorizations were faster when moving forward. Experiment 2 removed the requirement to categorize stimuli and used a word rehearsal task instead. Even without Experiment 1's response procedures, a similar cross-over interaction was obtained (e.g., failure memorizations sped backward movements relative to forward ones). The findings are novel yet consistent with theories of embodied cognition and self-regulation.	[Robinson, Michael D.] N Dakota State Univ, Fargo, ND 58105 USA; [Fetterman, Adam K.] Knowledge Media Ctr, Tubingen, Germany	North Dakota State University Fargo; Eberhard Karls University of Tubingen	Robinson, MD (corresponding author), N Dakota State Univ, Fargo, ND 58105 USA.	Michael.D.Robinson@ndsu.edu	Fetterman, Adam/ABG-1483-2020	Fetterman, Adam/0000-0001-5957-7670	COBRE Institute of General Medical Sciences (NIGMS) [P20 GM103505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103505] Funding Source: NIH RePORTER	COBRE Institute of General Medical Sciences (NIGMS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This publication was made possible by COBRE Grant P20 GM103505 from the Institute of General Medical Sciences (NIGMS), a component of the National Institutes of Health (NIH). Its contents are the sole responsibility of the authors and do not necessarily reflect the official views of NIGMS or NIH. The funders had no role in study design, data	Aberson CL., 2019, APPL POWER ANAL BEHA, DOI 10.4324/9781315171500; [Anonymous], 1998, SELF REGULATION BEHA, DOI DOI 10.1017/CBO9781139174794; Bargh J. A., 2000, HDB RES METHODS SOCI, P253; Barsalou LW, 2010, TOP COGN SCI, V2, P716, DOI 10.1111/j.1756-8765.2010.01115.x; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6; Boyd RL, 2011, J EXP SOC PSYCHOL, V47, P1192, DOI 10.1016/j.jesp.2011.04.017; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; Cacioppo J T, 1997, Pers Soc Psychol Rev, V1, P3, DOI 10.1207/s15327957pspr0101_2; Crawford LE, 2009, EMOT REV, V1, P129, DOI 10.1177/1754073908100438; Elliot AJ, 2006, MOTIV EMOTION, V30, P111, DOI 10.1007/s11031-006-9028-7; Field M, 2011, PSYCHOL ADDICT BEHAV, V25, P697, DOI 10.1037/a0023285; Fodor J. A., 1975, LANGUAGE THOUGHT; Gibbs Raymond W., 1994, POETICS MIND FIGURAT; Grady JE, 1999, AMST STUD THEORY HIS, V175, P79; Heckhausen J., 2008, MOTIVATION ACTION, V2nd; Kan IP, 2003, COGN NEUROPSYCHOL, V20, P525, DOI 10.1080/02643290244000257; Koch SC, 2011, SOC PSYCHOL-GERMANY, V42, P214, DOI 10.1027/1864-9335/a000065; Krieglmeyer R, 2013, EMOT REV, V5, P280, DOI 10.1177/1754073913477501; Krieglmeyer R, 2010, COGNITION EMOTION, V24, P810, DOI 10.1080/02699930903047298; Kruglanski AW, 2002, ADV EXP SOC PSYCHOL, V34, P331, DOI 10.1016/S0065-2601(02)80008-9; Lakoff George, 2003, METAPHOR WE LIVE BY; Lakoff George., 1999, PHILOS FLESH EMBODIE; Lamb W, 1979, BODY CODE MEANING MO; Landau MJ, 2014, J PERS SOC PSYCHOL, V106, P679, DOI 10.1037/a0036414; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Lavender T, 2007, COGNITION EMOTION, V21, P1270, DOI 10.1080/02699930701438152; Markman AB, 2005, PSYCHOL SCI, V16, P6, DOI 10.1111/j.0956-7976.2005.00772.x; Meier BP, 2006, J RES PERS, V40, P451, DOI 10.1016/j.jrp.2005.03.001; Meier BP, 2005, METAPHOR SYMBOL, V20, P239, DOI 10.1207/s15327868ms2004_1; Miles LK, 2010, PSYCHOL SCI, V21, P222, DOI 10.1177/0956797609359333; Natanzon M, 2012, J EXP SOC PSYCHOL, V48, P379, DOI 10.1016/j.jesp.2011.06.021; Pecher D, 2003, PSYCHOL SCI, V14, P119, DOI 10.1111/1467-9280.t01-1-01429; Pecher D, 2011, PSYCHOL LEARN MOTIV, V54, P217, DOI 10.1016/B978-0-12-385527-5.00007-3; Proctor RW, 2006, PSYCHOL BULL, V132, P416, DOI 10.1037/0033-2909.132.3.416; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Ranganathan R, 2008, HUM MOVEMENT SCI, V27, P577, DOI 10.1016/j.humov.2008.01.002; Robinson M.D, 2007, HDB RES METHODS PERS, P345; Rotteveel M, 2004, EMOTION, V4, P156, DOI 10.1037/1528-3542.4.2.156; Schneirla TC, 1959, NEBRASKA S MOTIVATIO, P1; Sedekides C, 1997, Pers Soc Psychol Rev, V1, P80; Seibt B, 2008, J EXP SOC PSYCHOL, V44, P713, DOI 10.1016/j.jesp.2007.04.013; Sell AJ, 2011, BRAIN LANG, V117, P39, DOI 10.1016/j.bandl.2010.07.003; Sheets-Johnstone Maxine, 1999, PRIMACY MOVEMENT; Spivey M., 2009, CAMBRIDGE HDB SITUAT, P382; Stanfield RA, 2001, PSYCHOL SCI, V12, P153, DOI 10.1111/1467-9280.00326; Teuscher U, 2008, COGNITIVE SCI, V32, P563, DOI 10.1080/03640210802035084; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; Ulrich R, 2012, MEM COGNITION, V40, P483, DOI 10.3758/s13421-011-0162-4; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Wilson NL, 2007, COGNITIVE SCI, V31, P721, DOI 10.1080/15326900701399962; Winkielman P, APA HDB PER IN PRESS, V1, P151	52	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117285	10.1371/journal.pone.0117285	http://dx.doi.org/10.1371/journal.pone.0117285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658923	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000349444900130
J	Sendlhofer, G; Mosbacher, N; Karina, L; Kober, B; Jantscher, L; Berghold, A; Pregartner, G; Brunner, G; Kamolz, LP				Sendlhofer, Gerald; Mosbacher, Nina; Karina, Leitgeb; Kober, Brigitte; Jantscher, Lydia; Berghold, Andrea; Pregartner, Gudrun; Brunner, Gernot; Kamolz, Lars Peter			Implementation of a Surgical Safety Checklist: Interventions to Optimize the Process and Hints to Increase Compliance	PLOS ONE			English	Article							ADVERSE EVENTS	Background A surgical safety checklist (SSC) was implemented and routinely evaluated within our hospital. The purpose of this study was to analyze compliance, knowledge of and satisfaction with the SSC to determine further improvements. Methods The implementation of the SSC was observed in a pilot unit. After roll-out into each operating theater, compliance with the SSC was routinely measured. To assess subjective and objective knowledge, as well as satisfaction with the SSC implementation, an online survey (N = 891) was performed. Results During two test runs in a piloting unit, 305 operations were observed, 175 in test run 1 and 130 in test run 2. The SSC was used in 77.1% of all operations in test run 1 and in 99.2% in test run 2. Within used SSCs, completion rates were 36.3% in test run 1 and 1.6% in test run 2. After roll-out, three unannounced audits took place and showed that the SSC was used in 95.3%, 91.9% and 89.9%. Within used SSCs, completion rates decreased from 81.7% to 60.6% and 53.2%. In 2014, 164 (18.4%) operating team members responded to the online survey, 160 of which were included in the analysis. 146 (91.3%) consultants and nursing staff reported to use the SSC regularly in daily routine. Conclusion These data show that the implementation of new tools such as the adapted WHO SSC needs constant supervision and instruction until it becomes self-evident and accepted. Further efforts, consisting mainly of hands-on leadership and training are necessary.	[Sendlhofer, Gerald; Karina, Leitgeb; Kober, Brigitte; Jantscher, Lydia] Univ Hosp Graz, Execut Dept Qual & Risk Management, Graz, Austria; [Sendlhofer, Gerald; Mosbacher, Nina; Kamolz, Lars Peter] Med Univ Graz, Dept Surg, Div Plast Aesthet & Reconstruct Surg, Graz, Austria; [Berghold, Andrea; Pregartner, Gudrun] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Brunner, Gernot] Univ Hosp Graz, Graz, Austria	Medical University of Graz; Medical University of Graz	Sendlhofer, G (corresponding author), Univ Hosp Graz, Execut Dept Qual & Risk Management, Graz, Austria.	gerald.sendlhofer@klinikum-graz.at		Kamolz, Lars-Peter/0000-0002-5975-876X				[Anonymous], 2012, LITMUS          1019; Battles JB, 2003, QUAL SAF HLTH CAR S2, V12, pii2; Bliss LA, 2012, J AM COLL SURGEONS, V215, P766, DOI 10.1016/j.jamcollsurg.2012.07.015; Borchard A, 2012, ANN SURG, V256, P925, DOI 10.1097/SLA.0b013e3182682f27; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Carney Brian T, 2010, AORN J, V91, P722, DOI 10.1016/j.aorn.2009.11.066; Conley DM, 2011, J AM COLL SURGEONS, V212, P873, DOI 10.1016/j.jamcollsurg.2011.01.052; Cullati S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101915; Gawande AA, 1999, SURGERY, V126, P66, DOI 10.1067/msy.1999.98664; Ginsburg LR, 2013, BMJ QUAL SAF, V0, P1; Haugen AS, 2013, BRIT J ANAESTH, V110, P807, DOI 10.1093/bja/aet005; Hayes Chris, 2012, Healthc Q, V15 Spec No, P57; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Kable AK, 2002, INT J QUAL HEALTH C, V14, P269, DOI 10.1093/intqhc/14.4.269; Klei WA, 2011, ANN SURG, P1, DOI DOI 10.1097/SLA.0B013E3181FCD991; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Levy SM, 2012, SURGERY, V152, P331, DOI 10.1016/j.surg.2012.05.034; Mascherek AC, 2013, PATIENT SAF SURG, V7, DOI 10.1186/1754-9493-7-36; NHS, NOT DO SURG SAF CHEC; O'Connor P, 2013, PATIENT SAF SURG, V7, DOI 10.1186/1754-9493-7-14; Saturno PJ, 2014, WORLD J SURG, V38, P287, DOI 10.1007/s00268-013-2300-6; Schimpff SC, 2007, SURG INNOV, V14, P127, DOI 10.1177/1553350607301746; Sendlhofer G, 2015, WIEN KLIN WOCHENSCHR, V127, P1, DOI 10.1007/s00508-014-0620-7; Sewell M, 2011, INT ORTHOP, V35, P897, DOI 10.1007/s00264-010-1112-7; Tang R, 2014, ANZ J SURG, V84, P148, DOI 10.1111/ans.12168; Taylor B, 2010, SURG-J R COLL SURG E, V8, P1, DOI 10.1016/j.surge.2009.11.012; Treadwell JR, 2014, BMJ QUAL SAF, V23, P299, DOI 10.1136/bmjqs-2012-001797; Urbach DR, 2014, NEW ENGL J MED, V370, P1029, DOI 10.1056/NEJMsa1308261; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; World Health Organization, 2008, SAF WP 2 GLOB PAT SA	30	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116926	10.1371/journal.pone.0116926	http://dx.doi.org/10.1371/journal.pone.0116926			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658317	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900080
J	Wu, TH; Chang, CC; Chen, CY; Wang, JD; Lin, CY				Wu, Tsung-Hsien; Chang, Chih-Cheng; Chen, Chih-Yin; Wang, Jung-Der; Lin, Chung-Ying			Further Psychometric Evaluation of the SelfStigma Scale-Short: Measurement Invariance across Mental Illness and Gender	PLOS ONE			English	Article							OF-FIT INDEXES; SELF-STIGMA; INTERNALIZED STIGMA; PERCEIVED DISCRIMINATION; EUROPEAN COUNTRIES; BRIEF VERSION; WHOQOL-BREF; ISMI SCALE; PEOPLE; EMPOWERMENT	Background This study cross-validated the factor structure of the Self-Stigma Scale-Short (SSS-S) in a cohort of patients with mental illness in southern Taiwan. The measurement invariance of the SSS-S factor structure across mental illness and gender was also examined. Methods The sample consisted of 161 patients with schizophrenia (51.6% males; mean age +/- SD = 40.53 +/- 10.38 years) and 189 patients with other mental illnesses (34.9% males; mean age = 46.52 +/- 11.29 years). Results The internal reliability (total score: alpha = 0.948) and concurrent validity (r = 0.335 to 0.457 with Depression and Somatic Symptoms Scale; r = -0.447 to -0.556 with WHOQOL-BREF) of the SSS-S were both satisfactory, and the results verified that the factor structure in our Taiwan sample (RMSEA = 0.0796, CFA = 0.992) was the same as that of the Hong Kong population. In addition, the results supported the measurement invariance of the SSS-S across mental illness (Delta RMSEAs = -0.0082 to -0.0037,Delta CFAs = 0.000) and gender (Delta RMSEAs = -0.0054 to -0.0008,Delta CFAs = -0.001 to 0.000). Conclusion Future studies can use the SSS-S to compare self-stigma between genders and between patients with different kinds of mental illnesses.	[Wu, Tsung-Hsien; Chang, Chih-Cheng] Chi Mei Med Ctr, Dept Psychiat, Tainan, Taiwan; [Chang, Chih-Cheng] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London, England; [Chang, Chih-Cheng; Chen, Chih-Yin] Chia Nan Univ Pharm & Sci, Dept Senior Citizen Serv Management, Coll Recreat & Hlth Management, Tainan, Taiwan; [Chen, Chih-Yin] Chang Jung Christian Univ, Dept Nursing, Coll Hlth Sci, Tainan, Taiwan; [Wang, Jung-Der; Lin, Chung-Ying] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Internal Med & Occupat Environm Med, Tainan 70428, Taiwan	Chi Mei Hospital; University of London; King's College London; Chia Nan University of Pharmacy & Science; Chang Jung Christian University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Lin, CY (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan.	cylin36933@gmail.com	Lin, Chung-Ying/I-5434-2016	Lin, Chung-Ying/0000-0002-2129-4242	Chi Mei Medical Center, Liouying, Taiwan [CLFHR10028]; Ministry of Education, Taiwan, R.O.C.	Chi Mei Medical Center, Liouying, Taiwan; Ministry of Education, Taiwan, R.O.C.(Ministry of Education, Taiwan)	This study was supported by grant CLFHR10028 from the Chi Mei Medical Center, Liouying, Taiwan. This research was, in part, supported by the Ministry of Education, Taiwan, R.O. C. The Aim for the Top University Project to the National Cheng Kung University (NCKU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JC, 1984, PSYCHOMETRIKA, V49, P155, DOI 10.1007/BF02294170; Barlow DH, 2004, BEHAV THER, V35, P205, DOI 10.1016/S0005-7894(04)80036-4; Boyd JE, 2014, PSYCHIATR REHABIL J, V37, P17, DOI 10.1037/prj0000035; Boyd JE, 2014, COMPR PSYCHIAT, V55, P221, DOI 10.1016/j.comppsych.2013.06.005; Brohan E, 2011, J AFFECT DISORDERS, V129, P56, DOI 10.1016/j.jad.2010.09.001; Brohan E, 2010, SCHIZOPHR RES, V122, P232, DOI 10.1016/j.schres.2010.02.1065; Brohan E, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-80; Chang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098767; Chen FF, 2005, STRUCT EQU MODELING, V12, P471, DOI 10.1080/10705510701301834; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Corrigan PW, 2006, J SOC CLIN PSYCHOL, V25, P875, DOI 10.1521/jscp.2006.25.8.875; Corrigan PW, 2012, PSYCHIAT RES, V199, P65, DOI 10.1016/j.psychres.2012.04.009; Corrigan PW, 2011, PSYCHIAT RES, V189, P339, DOI 10.1016/j.psychres.2011.05.024; Eremenco SL, 2005, EVAL HEALTH PROF, V28, P212, DOI 10.1177/0163278705275342; Girma E, 2013, INT J MENT HEALTH SY, V7, DOI 10.1186/1752-4458-7-21; Hung CI, 2006, PSYCHIAT CLIN NEUROS, V60, P700, DOI 10.1111/j.1440-1819.2006.01585.x; Jacobsson L, 2013, OJPSYCH, V3, P370, DOI DOI 10.4236/ojpsych.2013.34039; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Limbers CA, 2008, VALUE HEALTH, V11, P659, DOI 10.1111/j.1524-4733.2007.00289.x; Lin CY, 2014, EUR J PSYCHOL ASSESS, V30, P100, DOI 10.1027/1015-5759/a000175; Lin CY, 2013, CHILD PSYCHIAT HUM D, V44, P583, DOI 10.1007/s10578-012-0352-8; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Livingston JD, 2010, SOC SCI MED, V71, P2150, DOI 10.1016/j.socscimed.2010.09.030; Lv Y, 2013, GEN HOSP PSYCHIAT, V35, P83, DOI 10.1016/j.genhosppsych.2012.07.007; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Mak WWS, 2007, SOC SCI MED, V65, P245, DOI 10.1016/j.socscimed.2007.03.015; Mak WWS, 2010, AM J ORTHOPSYCHIAT, V80, P267, DOI 10.1111/j.1939-0025.2010.01030.x; Meade AW, 2008, J APPL PSYCHOL, V93, P568, DOI 10.1037/0021-9010.93.3.568; Ritsher JB, 2003, PSYCHIAT RES, V121, P31, DOI 10.1016/j.physchres.2003.08.008; Rusch N, 2006, PSYCHIAT SERV, V57, P399, DOI 10.1176/appi.ps.57.3.399; Schweizer K, 2010, EUR J PSYCHOL ASSESS, V26, P1, DOI 10.1027/1015-5759/a000001; Stevelink S., 2012, STIGMA RES ACTION, V2, P100, DOI [10.5463/sra.v1i3.35, DOI 10.5463/SRA.V1I1.11, 10.5463/sra.v1i1.11]; Su CT, 2014, PSYCHOL ASSESSMENT, V26, P980, DOI 10.1037/a0036764; van de Schoot R, 2012, EUR J DEV PSYCHOL, V9, P486, DOI 10.1080/17405629.2012.686740; Wahl OF, 1999, SCHIZOPHRENIA BULL, V25, P467, DOI 10.1093/oxfordjournals.schbul.a033394; Watson AC, 2007, SCHIZOPHRENIA BULL, V33, P1312, DOI 10.1093/schbul/sbl076; Yanos PT, 2008, PSYCHIAT SERV, V59, P1437, DOI 10.1176/appi.ps.59.12.1437; Yao G, 2002, J FORMOS MED ASSOC, V101, P342; Yao G, 2009, SOC INDIC RES, V91, P79, DOI 10.1007/s11205-008-9326-4	39	67	69	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117592	10.1371/journal.pone.0117592	http://dx.doi.org/10.1371/journal.pone.0117592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25659115	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900185
J	Xu, JL; Zhao, QZ; Wei, L; Yang, Y; Xu, R; Yu, NJ; Zhao, YM				Xu, Jinlong; Zhao, Qizhi; Wei, Lei; Yang, Yu; Xu, Rui; Yu, Nengjiang; Zhao, Yimin			Phytochemical Composition and Antinociceptive Activity of Bauhinia glauca subsp hupehana in Rats	PLOS ONE			English	Article							ACUTE TOXICITY; EXTRACTS; PAIN	In traditional medicine, Bauhinia glauca subsp. hupehana has long been used as an analgesic agent in China. The aim of this study was to evaluate the antinociceptive activity of the ethanol extract of the aerial parts of Bauhinia glauca subsp. hupehana (BHE) in rats and its chemical fingerprint. The antinociceptive activity of BHE was assessed in mice using chemically and heat-induced pain models, such as the acetic acid-induced writhing, hot plate, tail-flick and glutamate tests. Naltrexone hydrochloride, a non-selective opioid receptor antagonist, was utilized to determine the involvement of the opioid system. In addition to this, the involvements of the cGMP and ATP-sensitive K+ channel pathways were also detected using methylene blue and glibenclamide. The oral administration of BHE (at doses of 50, 100 and 200 mg/kg) produced significant and dose-related inhibitions in both the chemically and heat-induced pain models. Interestingly, in the abdominal constriction test, when the dose of BHE was increased to 800 mg/kg (p.o., n = 10), the inhibition rate was 100%. The antinociceptive mechanism may involve the cGMP pathway and ATP-sensitive K+ channel pathway. The central antinociceptive effect was not antagonized by naltrexone. One phenolic acid, one lignin and five flavonoids were isolated from BHE. The antinociceptive activity of BHE was most likely due to the presence of the flavonoids. The acute toxicity results showed that BHE was safe at a high dose (2 g/kg, p.o.). The current investigation demonstrates that Bauhinia glauca subsp. hupehana is a potential candidate for the development of novel, non-opioid, analgesic phytomedicines.	[Xu, Jinlong; Zhao, Qizhi; Wei, Lei; Yang, Yu; Xu, Rui; Yu, Nengjiang; Zhao, Yimin] Beijing Inst Pharmacol & Toxicol, Dept Nat Prod Chem, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Zhao, YM (corresponding author), Beijing Inst Pharmacol & Toxicol, Dept Nat Prod Chem, Beijing, Peoples R China.	zhaoyimin1960@163.com			National Twelfth-Five Year Research Program of China; National S...T Major Special Project on Major New Drug Innovation [2012ZX09301003-001, 2013ZX09102-018]	National Twelfth-Five Year Research Program of China; National S...T Major Special Project on Major New Drug Innovation	This research was supported by National Twelfth-Five Year Research Program of China and National S...T Major Special Project on Major New Drug Innovation (No. 2012ZX09301003-001; No. 2013ZX09102-018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abacioglu N, 2000, LIFE SCI, V67, P1127, DOI 10.1016/S0024-3205(00)00711-6; Annegowda H. V., 2010, Asian Journal of Plant Sciences, V9, P479; Beirith A, 2002, BRAIN RES, V924, P219, DOI 10.1016/S0006-8993(01)03240-1; BENTLEY GA, 1983, BRIT J PHARMACOL, V79, P125, DOI 10.1111/j.1476-5381.1983.tb10504.x; BRUCE RD, 1985, FUND APPL TOXICOL, V5, P151, DOI 10.1016/0272-0590(85)90059-4; Calixto JB, 2000, PHYTOTHER RES, V14, P401, DOI 10.1002/1099-1573(200009)14:6&lt;401::AID-PTR762&gt;3.0.CO;2-H; Cechinel V, 2009, PHYTOTHER RES, V23, P1347, DOI 10.1002/ptr.2756; Chen YF, 2008, PHYTOMEDICINE, V15, P427, DOI 10.1016/j.phymed.2007.09.023; Franzotti EM, 2000, J ETHNOPHARMACOL, V72, P273, DOI 10.1016/S0378-8741(00)00205-1; Garcia MD, 2004, J ETHNOPHARMACOL, V91, P69, DOI 10.1016/j.jep.2003.11.018; Khan H, 2011, PHYTOTHER RES, V25, P1024, DOI 10.1002/ptr.3369; Lawson K, 1996, PHARMACOL THERAPEUT, V70, P39, DOI 10.1016/0163-7258(96)00003-4; Lu TC, 2007, J ETHNOPHARMACOL, V113, P142, DOI 10.1016/j.jep.2007.05.024; Neugebauer V, 2001, Expert Rev Neurother, V1, P207, DOI 10.1002/1615-9861(200102)1:2<207::AID-PROT207>3.0.CO;2-3; Ramesh M, 1998, J ETHNOPHARMACOL, V62, P63, DOI 10.1016/S0378-8741(98)00048-8; Sanchez-Mateo CC, 2006, J ETHNOPHARMACOL, V107, P1, DOI 10.1016/j.jep.2006.01.032; Srinivasan K, 2003, PHYTOTHER RES, V17, P259, DOI 10.1002/ptr.1126; Wang Y, 2014, J ETHNOPHARMACOL, V151, P944, DOI 10.1016/j.jep.2013.12.003; Wibool R, 2008, J ETHNOPHARMACOL, V118, P225, DOI 10.1016/j.jep.2008.04.002; Wu Z., 1995, FLORA CHINA; [颜玲娣 Yan lingdi], 2003, [药学学报, Acta Pharmaceutica Sinica], V38, P578; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	23	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117801	10.1371/journal.pone.0117801	http://dx.doi.org/10.1371/journal.pone.0117801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658740	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900227
J	Xu, P; Luo, H; Huang, GL; Yin, XH; Luo, SY; Song, JK				Xu, Ping; Luo, Hong; Huang, Guang-Lei; Yin, Xin-Hai; Luo, Si-Yang; Song, Ju-Kun			Exposure to Ionizing Radiation during Dental X-Rays Is Not Associated with Risk of Developing Meningioma: A Meta-Analysis Based on Seven Case-Control Studies	PLOS ONE			English	Article							INTRACRANIAL MENINGIOMAS; AMALGAM FILLINGS; BRAIN; EPIDEMIOLOGY; TUMORS; RADIOGRAPHY; CANCER	Background Many observational studies have found that exposure to dental X-rays is associated with the risk of development of meningioma. However, these findings are inconsistent. We conducted a meta-analysis to assess the relationship between exposure to dental X-rays and the risk of development of meningioma. Methods The PubMed and EMBASE databases were searched to identify eligible studies. Summary odds ratio (OR) estimates and 95% confidence intervals (95% CIs) were used to compute the risk of meningioma development according to heterogeneity. Subgroup and sensitivity analyses were performed to further explore the potential heterogeneity. Finally, publication bias was assessed. Results Seven case-control studies involving 6,174 patients and 19,459 controls were included in the meta-analysis. Neither exposure to dental X-rays nor performance of full-mouth panorex X-rays was associated with an increased risk of development of meningioma (overall: OR, 0.97; 95% CI, 0.70-1.32; dental X-rays: OR, 1.05; 95% CI, 0.89-1.25; panorex X-rays: OR, 1.01; 95% CI, 0.76-1.34). However, exposure to bitewing X-rays was associated with a slightly increased risk of development of meningioma (OR, 1.73; 95% CI, 1.28-2.34). Similar results were obtained in the subgroup and sensitivity analyses. Little evidence of publication bias was observed. Conclusion Based on the currently limited data, there is no association between exposure to dental X-rays and the risk of development of meningioma. However, these results should be cautiously interpreted because of the heterogeneity among studies. Additional large, high-quality clinical trials are needed to evaluate the association between exposure to dental X-rays and the risk of development of meningioma.	[Xu, Ping; Luo, Hong; Huang, Guang-Lei; Yin, Xin-Hai; Luo, Si-Yang; Song, Ju-Kun] Gui Zhou Prov Peoples Hosp, Guiyang 550002, Peoples R China		Song, JK (corresponding author), Gui Zhou Prov Peoples Hosp, Guiyang 550002, Peoples R China.	songjukun@163.com						Abt Elliot, 2012, Evid Based Dent, V13, P37, DOI 10.1038/sj.ebd.6400852; [Anonymous], 2013, Prescrire Int, V22, P16; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bondy M, 1996, J NEURO-ONCOL, V29, P197, DOI 10.1007/BF00165649; Calnon WR, 2013, CANCER-AM CANCER SOC, V119, P464, DOI 10.1002/cncr.27812; Claus EB, 2005, NEUROSURGERY, V57, P1088, DOI 10.1227/01.NEU.0000188281.91351.B9; Claus EB, 2013, CANCER-AM CANCER SOC, V119, P465, DOI 10.1002/cncr.27708; Claus EB, 2012, CANCER-AM CANCER SOC, V118, P4530, DOI 10.1002/cncr.26625; Davis F, 2011, RADIAT RES, V175, P790, DOI 10.1667/RR2186.1; Dirksen D, 2013, J DENT RES, V92, P397, DOI 10.1177/0022034513484338; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fonzar F, 2012, EUR J ORAL IMPLANTOL, V5, P107; Hartling L, 2013, J CLIN EPIDEMIOL, V66, P982, DOI 10.1016/j.jclinepi.2013.03.003; Jorgensen TJ, 2013, CANCER-AM CANCER SOC, V119, P463, DOI 10.1002/cncr.27710; Lin MC, 2013, ANN ONCOL, V24, P1675, DOI 10.1093/annonc/mdt016; Longstreth WT, 2004, CANCER-AM CANCER SOC, V100, P1026, DOI 10.1002/cncr.20036; LONGSTRETH WT, 1993, CANCER, V72, P639, DOI 10.1002/1097-0142(19930801)72:3<639::AID-CNCR2820720304>3.0.CO;2-P; MAILLIE HD, 1993, ORAL SURG ORAL MED O, V75, P631, DOI 10.1016/0030-4220(93)90239-Z; McCarthy BJ, 1998, J NEUROSURG, V88, P831, DOI 10.3171/jns.1998.88.5.0831; NEUBERGER JS, 1991, CANCER DETECT PREV, V15, P31; Potera C, 2012, AM J NURS, V112, P18, DOI 10.1097/01.NAJ.0000415943.02290.ea; PRESTON-MARTIN S, 1983, Neuroepidemiology, V2, P164, DOI 10.1159/000110522; Preston-Martin S, 1985, Natl Cancer Inst Monogr, V69, P175; PRESTONMARTIN S, 1980, JNCI-J NATL CANCER I, V65, P67; PRESTONMARTIN S, 1989, CANCER RES, V49, P6137; PRESTONMARTIN S, 1990, J AM DENT ASSOC, V120, P151, DOI 10.14219/jada.archive.1990.0026; PRESTONMARTIN S, 1983, J NATL CANCER I, V70, P863; RICHARDS AG, 1981, J AM DENT ASSOC, V103, P713, DOI 10.14219/jada.archive.1981.0378; Rodvall Y, 1998, ORAL ONCOL, V34, P265, DOI 10.1016/S1368-8375(98)80006-7; RYAN P, 1992, ORAL ONCOL, V28B, P91; Sadamori N, 1996, INT J CANCER, V67, P318, DOI 10.1002/(SICI)1097-0215(19960729)67:3<318::AID-IJC2>3.0.CO;2-U; Shintani T, 1999, J RADIAT RES, V40, P49, DOI 10.1269/jrr.40.49; Surawicz T S, 1999, Neuro Oncol, V1, P14, DOI 10.1093/neuonc/1.1.14; Tetradis Sotirios, 2012, J Evid Based Dent Pract, V12, P174, DOI 10.1016/j.jebdp.2012.06.012; Umansky F, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/5/E7; White SC, 2013, CANCER-AM CANCER SOC, V119, P464, DOI 10.1002/cncr.27709	36	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0113210	10.1371/journal.pone.0113210	http://dx.doi.org/10.1371/journal.pone.0113210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658814	Green Published, gold			2022-12-27	WOS:000349444900003
J	Yang, YB; Gu, LH; Xiao, Y; Liu, Q; Hu, HJ; Wang, ZT; Chen, KX				Yang, Yingbo; Gu, Lihua; Xiao, Ying; Liu, Qing; Hu, Haijun; Wang, Zhengtao; Chen, Kaixian			Rapid Identification of alpha-Glucosidase Inhibitors from Phlomis tuberosa by Sepbox Chromatography and Thin-Layer Chromatography Bioautography	PLOS ONE			English	Article							IRIDOID GLUCOSIDES; GLYCOSIDES; DERIVATIVES; FLAVONOIDS; EXTRACTS	Alpha-glucosidase inhibitors currently form an important basis for developing novel drugs for diabetes treatment. In our preliminary tests, the ethyl acetate fraction of Phlomis tuberosa extracts showed significant alpha-glucosidase inhibitory activity (IC50 = 100 mu g/mL). In the present study, a combined method using Sepbox chromatography and thin-layer chromatography (TLC) bioautography was developed to probe alpha-glucosidase inhibitors further. The ethyl acetate fraction of P. tuberosa extracts was separated into 150 individual subfractions within 20 h using Sepbox chromatography. Then, under the guidance of TLC bioautography, 20 compounds were successfully isolated from these fractions, including four new diterpenoids [14-hydroxyabieta-8,11,13-triene-11-carbaldehyde-18-oic-12-carboxy-13-(1-hydroxy-1-methylethyl)-lactone (1), 14-hydroxyabieta-8,11,13-triene-17-oic-12-carboxy-13-(1-hydroxy-1-methylethyl)-lactone (2), 14,16-dihydroxyabieta-8,11,13-triene-15,17-dioic acid (3), and phlomisol (15,16-eposy-8,13(16),14-labdatrien-19-ol) (4)], and 16 known compounds. Activity estimation indicated that 15 compounds showed more potent alpha-glucosidase inhibitory effects (with IC50 values in the range 0.067-1.203 mM) than the positive control, acarbose (IC50 = 3.72 +/- 0.113 mM). This is the first report of separation of alpha-glucosidase inhibitors from P. tuberosa.	[Yang, Yingbo; Gu, Lihua; Xiao, Ying; Liu, Qing; Hu, Haijun; Wang, Zhengtao; Chen, Kaixian] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, MOE Key Lab Standardizat Chinese Med, Shanghai, Peoples R China; [Liu, Qing; Wang, Zhengtao] Shanghai R&D Ctr Standardizat Chinese Med, Shanghai, Peoples R China; [Xiao, Ying] Second Mil Med Univ, Changzheng Hosp, Dept Pharm, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Naval Medical University	Wang, ZT (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, MOE Key Lab Standardizat Chinese Med, Shanghai, Peoples R China.	ztwang@shutcm.edu.cn	Wang, Zhengtao/AAH-7360-2019	Wang, Zhengtao/0000-0003-2797-4625	Program for Changjiang Scholars and Innovative Research Team in University [IRT1071]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	The authors gratefully acknowledge the Program for Changjiang Scholars and Innovative Research Team in University (IRT1071) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari M, 2011, J YOUNG PHARM, V3, P226, DOI 10.4103/0975-1483.83771; Calis I, 2005, Z NATURFORSCH B, V60, P1295, DOI 10.1515/znb-2005-1214; CALIS I, 1992, PHYTOCHEMISTRY, V31, P3624, DOI 10.1016/0031-9422(92)83740-P; Cheng ZH, 2013, COMB CHEM HIGH T SCR, V16, P531, DOI 10.2174/1386207311316070004; Gao JT, 2011, J NAT PROD, V74, P1636, DOI 10.1021/np200147c; Hanamura T, 2008, J FOOD SCI, V73, pT55, DOI 10.1111/j.1750-3841.2008.00708.x; Hanefeld M, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-20; Kanchanapoom T, 2002, PHYTOCHEMISTRY, V59, P557, DOI 10.1016/S0031-9422(01)00466-6; KATAGIRI M, 1994, PHYTOCHEMISTRY, V35, P439, DOI 10.1016/S0031-9422(00)94777-0; Kim JS, 2011, FOOD CHEM, V124, P1647, DOI 10.1016/j.foodchem.2010.08.020; Kwon HC, 2011, BIOMOL THER, V19, P90, DOI 10.4062/biomolther.2011.19.1.090; Li DL, 2008, CHEM PHARM BULL, V56, P1282, DOI 10.1248/cpb.56.1282; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Li YL, 2008, MOLECULES, V13, P1931, DOI 10.3390/molecules13081931; Liu YL, 2013, J ETHNOPHARMACOL, V149, P431, DOI 10.1016/j.jep.2013.06.042; Mahmoud IN, 2009, PHARMACOGN RES, V1, P342; Misbah H, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-118; Modaressi M, 2009, PHYTOTHER RES, V23, P99, DOI 10.1002/ptr.2568; NISHIZAWA M, 1987, J ORG CHEM, V52, P4878, DOI 10.1021/jo00231a011; Simoes-Pires CA, 2009, PHYTOCHEM ANALYSIS, V20, P511, DOI 10.1002/pca.1154; Standl E, 2012, DIABETES VASC DIS RE, V9, P163, DOI 10.1177/1479164112441524; Takeda Y, 2000, PHYTOCHEMISTRY, V53, P931, DOI 10.1016/S0031-9422(99)00431-8; Xu MF, 2009, FITOTERAPIA, V80, P461, DOI 10.1016/j.fitote.2009.06.006; ZHANG CZ, 1991, PHYTOCHEMISTRY, V30, P4156, DOI 10.1016/0031-9422(91)83486-5; Zhang TT, 2007, BIOCHEM SYST ECOL, V35, P801, DOI 10.1016/j.bse.2007.03.023	25	26	28	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116922	10.1371/journal.pone.0116922	http://dx.doi.org/10.1371/journal.pone.0116922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658100	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900079
J	Zhang, YY; Jiang, WJ; Teng, ZE; Wu, JF; Hu, YY; Lu, TL; Wu, H; Sun, W; Wang, XR; Bi, HS; Jonas, JB				Zhang, Yue Ying; Jiang, Wen Jun; Teng, Zhao E.; Wu, Jian Feng; Hu, Yuan Yuan; Lu, Tai Liang; Wu, Hui; Sun, Wei; Wang, Xing Rong; Bi, Hong Sheng; Jonas, Jost B.			Corneal Curvature Radius and Associated Factors in Chinese Children: The Shandong Children Eye Study	PLOS ONE			English	Article							OCULAR BIOMETRIC PARAMETERS; POPULATION-BASED SAMPLE; AUSTRALIAN CHILDREN; INTRAOCULAR-PRESSURE; PRESCHOOL-CHILDREN; ETHNIC-DIFFERENCES; ADULT-POPULATION; REYKJAVIK EYE; REFRACTION; STATURE	Purpose To investigate the distribution of the (CCR) and its associated factors in children. Methods Using a random cluster sampling method, the school-based, cross-sectional Shandong Children Eye Study included children aged 4 to 18 years from the rural county of Guanxian and the city of Weihai in the province of Shandong in East China. CCR was measured by ocular biometry. Results CCR measurements were available for 5913 (92.9%) out of 6364 eligible children. Mean age was 10.0 +/- 3.3 years, and mean CCR was 7.84 +/- 0.27 mm (range: 6.98 to 9.35 mm). In multivariate linear regression analysis, longer CCR (i. e. flatter cornea) was significantly associated with the systemic parameters of male sex (P<0001; standardized regression coefficient beta: -0.08; regression coefficient B:-0.04; 95% Confidence Interval (CI):-0.05,-0.03), younger age (P<0.001; beta:-0.37; B:-0.03; 95% CI:-0.04,-0.03), taller body height (P = 0.002; beta: 0.06; B: 0.001; 95% CI:0.000,0.001), lower level of education of the father (P = 0.001; beta:-0.04; B:-0.01; 95% CI:-0.02,-0.01) and maternal myopia (P< 0.001; beta:0.07; B:-0.04; 95% CI:-0.06,-0.03), and with the ocular parameters of longer ocular axial length (P< 0.001; beta: 0.59; B:0.13; 95% CI:0.12,0.14), larger horizontal corneal diameter (P< 0.001; beta:0.19; B:0.13; 95% CI:0.11,0.14), and smaller amount of cylindrical refractive error (P = 0.001; beta:-0.09; B:-0.05; 95% CI:-0.06,-0.04). Conclusions Longer CCR (i.e., flatter corneas) (mean: 7.84 +/- 0.27mm) was correlated with male sex, younger age, taller body height, lower paternal educational level, maternal myopia, longer axial length, larger corneas (i.e., longer horizontal corneal diameter), and smaller amount of cylindrical refractive error. These findings may be of interest for elucidation of the process of emmetropization and myopization and for corneal refractive surgery.	[Zhang, Yue Ying] Shandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan, Shandong, Peoples R China; [Zhang, Yue Ying] Shandong Acad Med Sci, Inst Basic Med, Jinan, Shandong, Peoples R China; [Jiang, Wen Jun; Wu, Hui; Wang, Xing Rong; Bi, Hong Sheng] Shandong Univ Tradit Chinese Med, Inst Eye, Jinan, Shandong, Peoples R China; [Teng, Zhao E.] Wulian Peoples Hosp, Dept Ophthalmol, Rizhao, Shandong, Peoples R China; [Wu, Jian Feng] Shandong Univ Tradit Chinese Med, Dept Ophthalmol, Jinan, Shandong, Peoples R China; [Hu, Yuan Yuan; Lu, Tai Liang; Sun, Wei; Wang, Xing Rong; Bi, Hong Sheng] Shandong Univ Tradit Chinese Med, Affiliated Hosp Shandong 2, Dept Ophthalmol, Jinan, Shandong, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, D-69115 Heidelberg, Germany	Shandong University of Traditional Chinese Medicine; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; Ruprecht Karls University Heidelberg	Bi, HS (corresponding author), Shandong Univ Tradit Chinese Med, Inst Eye, Jinan, Shandong, Peoples R China.	hongshengbi@126.com						ABRAHAMSSON M, 1990, ACTA OPHTHALMOL, V68, P435; Chang SW, 2001, BRIT J OPHTHALMOL, V85, P916, DOI 10.1136/bjo.85.8.916; Eysteinsson T, 2005, ACTA OPHTHALMOL SCAN, V83, P734, DOI 10.1111/j.1600-0420.2005.00540.x; Eysteinsson T, 2002, ACTA OPHTHALMOL SCAN, V80, P11, DOI 10.1034/j.1600-0420.2002.800103.x; Fan DSP, 2004, BRIT J OPHTHALMOL, V88, P938, DOI 10.1136/bjo.2003.030338; Fotedar R, 2010, OPHTHALMOLOGY, V117, P417, DOI 10.1016/j.ophtha.2009.07.028; GARNER LF, 1995, OPTOMETRY VISION SCI, V72, P266, DOI 10.1097/00006324-199504000-00007; George R, 2003, BRIT J OPHTHALMOL, V87, P399, DOI 10.1136/bjo.87.4.399; Blanco FG, 2008, OPTOMETRY VISION SCI, V85, P89, DOI 10.1097/OPX.0b013e3181622602; Goto T, 2001, CORNEA, V20, P270, DOI 10.1097/00003226-200104000-00007; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075260; Ip JM, 2008, EYE, V22, P649, DOI 10.1038/sj.eye.6702701; Jiang WJ, 2014, INVEST OPHTH VIS SCI, V55, P4128, DOI 10.1167/iovs.14-14244; Jonas J B, 1994, Ger J Ophthalmol, V3, P179; Jonas JB, 2011, OPHTHALMOLOGY, V118, P1805, DOI 10.1016/j.ophtha.2011.02.001; Lee KE, 2009, ARCH OPHTHALMOL-CHIC, V127, P88, DOI 10.1001/archophthalmol.2008.521; Lim LS, 2010, INVEST OPHTH VIS SCI, V51, P103, DOI 10.1167/iovs.09-3553; Lin LLK, 1999, OPTOMETRY VISION SCI, V76, P275, DOI 10.1097/00006324-199905000-00013; Logan NS, 2011, OPHTHAL PHYSL OPT, V31, P550, DOI 10.1111/j.1475-1313.2011.00862.x; McKean-Cowdin R, 2013, OPHTHALMOLOGY, V120, P2117, DOI 10.1016/j.ophtha.2013.03.001; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Mutti DO, 2005, INVEST OPHTH VIS SCI, V46, P3074, DOI 10.1167/iovs.04-1040; Nangia V, 2010, OPHTHALMOLOGY, V117, P705, DOI 10.1016/j.ophtha.2009.09.003; Nieto-Bona A, 2009, GRAEF ARCH CLIN EXP, V247, P815, DOI 10.1007/s00417-008-1013-2; Northstone K, 2013, OPHTHALMOLOGY, V120, P1064, DOI 10.1016/j.ophtha.2012.11.004; O'Donoghue L, 2011, INVEST OPHTH VIS SCI, V52, P4048, DOI 10.1167/iovs.10-6100; Ojaimi E, 2005, INVEST OPHTH VIS SCI, V46, P4424, DOI 10.1167/iovs.05-0077; Ojaimi E, 2005, INVEST OPHTH VIS SCI, V46, P2748, DOI 10.1167/iovs.04-1324; PandaJonas S, 1996, AM J OPHTHALMOL, V121, P181, DOI 10.1016/S0002-9394(14)70583-5; PANDAJONAS S, 1994, OPHTHALMOLOGY, V101, P519; PAPASTATHOPOULOS KI, 1995, EXP EYE RES, V60, P459, DOI 10.1016/S0014-4835(05)80102-2; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P1408; Saw SM, 2002, OPHTHALMOLOGY, V109, P2065, DOI 10.1016/S0161-6420(02)01220-4; Scholz K, 2009, J CATARACT REFR SURG, V35, P1046, DOI 10.1016/j.jcrs.2009.01.019; Shufelt C, 2005, INVEST OPHTH VIS SCI, V46, P4450, DOI 10.1167/iovs.05-0435; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P73; Wu HM, 2007, CLIN EXP OPHTHALMOL, V35, P834, DOI 10.1111/j.1442-9071.2007.01638.x; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Yuen LH, 2010, INVEST OPHTH VIS SCI, V51, P3433, DOI 10.1167/iovs.09-4307	40	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117481	10.1371/journal.pone.0117481	http://dx.doi.org/10.1371/journal.pone.0117481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658095	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900160
J	Kanaani, J; Cianciaruso, C; Phelps, EA; Pasquier, M; Brioudes, E; Billestrup, N; Baekkeskov, S				Kanaani, Jamil; Cianciaruso, Chiara; Phelps, Edward A.; Pasquier, Miriella; Brioudes, Estelle; Billestrup, Nils; Baekkeskov, Steinunn			Compartmentalization of GABA Synthesis by GAD67 Differs between Pancreatic Beta Cells and Neurons	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GAMMA-AMINOBUTYRIC-ACID; 65-KDA ISOFORM; DIFFERENTIAL EXPRESSION; MONOCLONAL-ANTIBODIES; GLUCOSE-INHIBITION; GLUCAGON-SECRETION; INSULIN-SECRETION; MICE DEFICIENT; ENZYME GAD65	The inhibitory neurotransmitter GABA is synthesized by the enzyme glutamic acid decarboxylase (GAD) in neurons and in pancreatic beta-cells in islets of Langerhans where it functions as a paracrine and autocrine signaling molecule regulating the function of islet endocrine cells. The localization of the two non-allelic isoforms GAD65 and GAD67 to vesicular membranes is important for rapid delivery and accumulation of GABA for regulated secretion. While the membrane anchoring and trafficking of GAD65 are mediated by intrinsic hydrophobic modifications, GAD67 remains hydrophilic, and yet is targeted to vesicular membrane pathways and synaptic clusters in neurons by both a GAD65-dependent and a distinct GAD65-independent mechanism. Herein we have investigated the membrane association and targeting of GAD67 and GAD65 in monolayer cultures of primary rat, human, and mouse islets and in insulinoma cells. GAD65 is primarily detected in Golgi membranes and in peripheral vesicles distinct from insulin vesicles in beta-cells. In the absence of GAD65, GAD67 is in contrast primarily cytosolic in beta-cells; its co-expression with GAD65 is necessary for targeting to Golgi membranes and vesicular compartments. Thus, the GAD65-independent mechanism for targeting of GAD67 to synaptic vesicles in neurons is not functional in islet beta-cells. Therefore, only GAD65:GAD65 homodimers and GAD67:GAD65 heterodimers, but not the GAD67:GAD67 homodimer gain access to vesicular compartments in beta-cells to facilitate rapid accumulation of newly synthesized GABA for regulated secretion and fine tuning of GABA-signaling in islets of Langerhans.	[Kanaani, Jamil; Baekkeskov, Steinunn] Univ Calif San Francisco, Ctr Diabet, Dept Med, San Francisco, CA 94143 USA; [Kanaani, Jamil; Baekkeskov, Steinunn] Univ Calif San Francisco, Ctr Diabet, Dept Microbiol Immunol, San Francisco, CA 94143 USA; [Cianciaruso, Chiara; Phelps, Edward A.; Pasquier, Miriella; Baekkeskov, Steinunn] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland; [Brioudes, Estelle] Univ Hosp Geneva, Dept Surg, Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [Brioudes, Estelle] Univ Geneva, Geneva, Switzerland; [Billestrup, Nils] Univ Copenhagen, Inst Biomed Sci, Copenhagen, Denmark	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Geneva; University of Copenhagen	Baekkeskov, S (corresponding author), Univ Calif San Francisco, Ctr Diabet, Dept Med, San Francisco, CA 94143 USA.	steinunn.baekkeskov@epfl.ch	Phelps, Edward A/Q-1302-2016	Phelps, Edward A/0000-0001-8666-805X; Billestrup, Nils/0000-0002-4968-8067; Baekkeskov, Steinunn/0000-0003-0878-3188; Cianciaruso, Chiara/0000-0002-5635-5404	Nora Eccles Treadwell Foundation; International Network Program from the Danish Ministry of Science, Innovation and Higher Education [INP-2010-0102]; National Institute of Health Diabetes Education and Research Center grant [P30 DK063720]; Microscopy Core and Islet Isolation Core [31-2012-783]; JFRF Advanced Postdoctoral Fellowship [3-APF-2014-208-A-N]; JDRF award	Nora Eccles Treadwell Foundation; International Network Program from the Danish Ministry of Science, Innovation and Higher Education; National Institute of Health Diabetes Education and Research Center grant; Microscopy Core and Islet Isolation Core; JFRF Advanced Postdoctoral Fellowship; JDRF award	This study was supported by the Nora Eccles Treadwell Foundation (S. B., J. K.), by an International Network Program from the Danish Ministry of Science, Innovation and Higher Education (INP-2010-0102) (N. B., S. B.), by a National Institute of Health Diabetes Education and Research Center grant (P30 DK063720) Microscopy Core and Islet Isolation Core, a JDRF award (31-2012-783) (E. B.) to the ECIT Islets for Basic Research Program, and by a JFRF Advanced Postdoctoral Fellowship (3-APF-2014-208-A-N) (E. A. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; Bailey SJ, 2007, DIABETES, V56, P320, DOI 10.2337/db06-0712; Bonaventura MM, 2012, EUR J PHARMACOL, V677, P188, DOI 10.1016/j.ejphar.2011.12.013; Braun M, 2004, J GEN PHYSIOL, V123, P191, DOI 10.1085/jgp.200308966; Braun M, 2012, DIABETES OBES METAB, V14, P143, DOI 10.1111/j.1463-1326.2012.01642.x; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brice NL, 2002, DIABETOLOGIA, V45, P242, DOI 10.1007/s00125-001-0750-0; Bridgett M, 1998, DIABETES, V47, P1848, DOI 10.2337/diabetes.47.12.1848; Brunstedt J, 1984, METHODS DIABETES R C, P245; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; CHANG YC, 1988, J NEUROSCI, V8, P2123; Chessler SD, 2002, DIABETES, V51, P1763, DOI 10.2337/diabetes.51.6.1763; CHRISTGAU S, 1991, J BIOL CHEM, V266, P21257; CHRISTGAU S, 1992, J CELL BIOL, V118, P309, DOI 10.1083/jcb.118.2.309; Codazzi F, 2006, J NEUROSCI, V26, P3404, DOI 10.1523/JNEUROSCI.0478-06.2006; DIRKX R, 1995, J BIOL CHEM, V270, P2241, DOI 10.1074/jbc.270.5.2241; Durst MA, 2012, CAN J DIABETES, V36, P100, DOI 10.1016/j.jcjd.2012.06.002; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Gammelsaeter R, 2004, J CELL SCI, V117, P3749, DOI 10.1242/jcs.01209; GILON P, 1991, ENDOCRINOLOGY, V129, P2521, DOI 10.1210/endo-129-5-2521; Hayashi M, 2003, J BIOL CHEM, V278, P1966, DOI 10.1074/jbc.M206758200; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067228; Kanaani J, 1999, J BIOL CHEM, V274, P37200, DOI 10.1074/jbc.274.52.37200; Kanaani J, 2004, J CELL SCI, V117, P2001, DOI 10.1242/jcs.01030; Kanaani J, 2002, J CELL BIOL, V158, P1229, DOI 10.1083/jcb.200205053; Kanaani J, 2008, J CELL SCI, V121, P437, DOI 10.1242/jcs.011916; Kanaani J, 2010, J CELL BIOL, V190, P911, DOI 10.1083/jcb.200912101; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Kass I, 2014, P NATL ACAD SCI USA, V111, pE2524, DOI 10.1073/pnas.1403182111; KIM J, 1993, DIABETES, V42, P1799, DOI 10.2337/diabetes.42.12.1799; Maekawa S, 2013, NEUROSCI LETT, V537, P50, DOI 10.1016/j.neulet.2013.01.030; Minami K, 2000, AM J PHYSIOL-ENDOC M, V279, pE773, DOI 10.1152/ajpendo.2000.279.4.E773; Obata K, 1999, NEUROSCIENCE, V93, P1475, DOI 10.1016/S0306-4522(99)00274-2; OKADA Y, 1976, SCIENCE, V194, P620, DOI 10.1126/science.185693; Owens DF, 2002, NEURON, V36, P989, DOI 10.1016/S0896-6273(02)01136-4; Patel AB, 2006, J NEUROCHEM, V97, P385, DOI 10.1111/j.1471-4159.2006.03741.x; PETERSEN JS, 1993, DIABETES, V42, P484, DOI 10.2337/diabetes.42.3.484; RICHTER W, 1993, P NATL ACAD SCI USA, V90, P2832, DOI 10.1073/pnas.90.7.2832; ROBBINS MS, 1981, DIABETES, V30, P168, DOI 10.2337/diabetes.30.2.168; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; Sheikh SN, 1998, J NEUROSCI RES, V52, P736, DOI 10.1002/(SICI)1097-4547(19980615)52:6<736::AID-JNR12>3.0.CO;2-X; Shi YG, 2000, AM J PHYSIOL-ENDOC M, V279, pE684, DOI 10.1152/ajpendo.2000.279.3.E684; SHI YG, 1994, J CELL BIOL, V124, P927, DOI 10.1083/jcb.124.6.927; SOLIMENA M, 1990, NEW ENGL J MED, V322, P1555, DOI 10.1056/NEJM199005313222202; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; SORENSON RL, 1991, DIABETES, V40, P1365, DOI 10.2337/diabetes.40.11.1365; Szot GL, 2007, JOVE-J VIS EXP, V7, P255, DOI DOI 10.3791/255; Taneera J, 2012, DIABETOLOGIA, V55, P1985, DOI 10.1007/s00125-012-2548-7; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; VELLOSO LA, 1994, CLIN EXP IMMUNOL, V96, P129; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015	59	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117130	10.1371/journal.pone.0117130	http://dx.doi.org/10.1371/journal.pone.0117130			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647668	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600056
J	Lee, S; Yang, G; Bushman, W				Lee, Sanghee; Yang, Guang; Bushman, Wade			Prostatic Inflammation Induces Urinary Frequency in Adult Mice	PLOS ONE			English	Article							COLONIC INFLAMMATION; SENSORY INNERVATION; OVERACTIVE BLADDER; CROSS-TALK; NITROFURANTOIN; IRRITATION; NEURONS; SENSITIZATION; CONVERGENCE; HYPERPLASIA	Lower urinary tract symptoms (LUTS) including urinary frequency and nocturia are common in aging men. Recent studies have revealed a strong association of prostatic inflammation with LUTS. We developed an animal model of bacterial induced, isolated prostatic inflammation and examined the effect of prostatic inflammation on voiding behavior in adult C57BL/6J mice. Prostatic inflammation was induced by transurethral inoculation of uropathogenic E. coli-1677. Bacterial cystitis was prevented by continuous administration of nitrofurantoin. Hematoxylin and eosin (H& E) staining and bacterial culture were preformed to validate our animal model. Voiding behavior was examined by metabolic cage testing on post-instillation day 1 (PID 1), PID 4, PID 7 and PID 14 and both voiding frequency and volume per void were determined. Mice with prostatic inflammation showed significantly increased voiding frequency at PID 1, 7 and 14, and decreased volume per void at all time points, as compared to mice instilled with saline and receiving nitrofurantoin (NTF). Linked analysis of voiding frequency and voided volumes revealed an overwhelming preponderance of high frequency, low volume voiding in mice with prostatic inflammation. These observations suggest that prostatic inflammation may be causal for symptoms of urinary frequency and nocturia.	[Lee, Sanghee; Yang, Guang; Bushman, Wade] Univ Wisconsin, Sch Med & Publ Hlth, Dept Urol, Madison, WI 53706 USA; [Bushman, Wade] Univ Wisconsin, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI USA; [Lee, Sanghee] Univ Wisconsin, Sch Med & Publ Hlth, Cellular & Mol Biol Program, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bushman, W (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Urol, Madison, WI 53706 USA.	bushman@urology.wisc.edu		Lee, Sanghee/0000-0002-6574-8656	National Institutes of Health (NIH) [R01DK075700]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075700] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the National Institutes of Health (NIH), R01DK075700. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Andreu A, 1997, J INFECT DIS, V176, P464, DOI 10.1086/514065; Bautista OM, 2003, CONTROL CLIN TRIALS, V24, P224, DOI 10.1016/S0197-2456(02)00263-5; Bielefeldt K, 2006, AM J PHYSIOL-GASTR L, V291, pG658, DOI 10.1152/ajpgi.00585.2005; Birder LA, 2013, INT J UROL, V20, P4, DOI 10.1111/j.1442-2042.2012.03210.x; Bjorling DE, 2011, NEUROUROL URODYNAM, V30, P673, DOI 10.1002/nau.21078; Boehm BJ, 2012, PROSTATE, V72, P307, DOI 10.1002/pros.21433; Burris MB, 2014, UROLOGY, V83, P186, DOI 10.1016/j.urology.2013.07.080; BUZARD JA, 1961, J PHARMACOL EXP THER, V131, P38; CERVERO F, 1994, PHYSIOL REV, V74, P95, DOI 10.1152/physrev.1994.74.1.95; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; Christianson JA, 2007, PAIN, V128, P235, DOI 10.1016/j.pain.2006.09.023; CUNHA BA, 1988, UROLOGY, V32, P67, DOI 10.1016/0090-4295(88)90460-8; de Groat William C, 2009, Handb Exp Pharmacol, P91, DOI 10.1007/978-3-540-79090-7_4; De Wachter SG, 2011, NEUROUROL URODYNAM, V30, P1220, DOI 10.1002/nau.21038; Delongchamps NB, 2008, J UROLOGY, V179, P1736, DOI 10.1016/j.juro.2008.01.034; Dmochowski Roger, 2006, Curr Urol Rep, V7, P462, DOI 10.1007/s11934-006-0055-4; Elkahwaji JE, 2007, PROSTATE, V67, P14, DOI 10.1002/pros.20445; Guerios SD, 2006, NEUROSCI LETT, V392, P193, DOI 10.1016/j.neulet.2005.09.026; Guerios SD, 2008, AM J PHYSIOL-REG I, V295, pR111, DOI 10.1152/ajpregu.00728.2007; Hochreiter WW, 2000, J UROLOGY, V163, P127, DOI 10.1016/S0022-5347(05)67987-6; Jerde TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000338; Kanasaki K, 2013, FASEB J, V27, P1950, DOI 10.1096/fj.12-223404; KEAST JR, 1992, J COMP NEUROL, V319, P615, DOI 10.1002/cne.903190411; KIRBY RS, 1982, BRIT J UROL, V54, P729, DOI 10.1111/j.1464-410X.1982.tb13635.x; Knutson T, 2001, NEUROUROL URODYNAM, V20, P237, DOI 10.1002/nau.1001; Krieger JN, 2002, INT J ANTIMICROB AG, V19, P475, DOI 10.1016/S0924-8579(02)00086-9; Levine M, 1943, J BACTERIOL, V45, P471, DOI 10.1128/JB.45.5.471-475.1943; Malykhina AP, 2006, NEUROGASTROENT MOTIL, V18, P936, DOI 10.1111/j.1365-2982.2006.00807.x; Malykhina AP, 2004, NEUROREPORT, V15, P2601, DOI 10.1097/00001756-200412030-00008; Mirone V, 2007, EUR UROL, V51, P57, DOI 10.1016/j.eururo.2006.07.050; Nazif O, 2007, UROLOGY, V69, P24, DOI 10.1016/j.urology.2006.08.1108; Nickel JC, 2008, EUR UROL, V54, P1379, DOI 10.1016/j.eururo.2007.11.026; Nomiya M, 2012, NEUROUROL URODYNAM, V31, P195, DOI 10.1002/nau.21073; Pan XQ, 2010, EXP NEUROL, V225, P262, DOI 10.1016/j.expneurol.2010.05.012; PANG X, 1995, BRIT J UROL, V75, P744, DOI 10.1111/j.1464-410X.1995.tb07384.x; Pezzone MA, 2005, GASTROENTEROLOGY, V128, P1953, DOI 10.1053/j.gastro.2005.03.008; Qin C, 2005, GASTROENTEROLOGY, V129, P1967, DOI 10.1053/j.gastro.2005.09.013; Rudick CN, 2007, AM J PHYSIOL-REG I, V293, pR1191, DOI 10.1152/ajpregu.00411.2007; Sauver JLS, 2008, UROLOGY, V71, P475, DOI 10.1016/j.urology.2007.11.155; Schnegelsberg B, 2010, AM J PHYSIOL-REG I, V298, pR534, DOI 10.1152/ajpregu.00367.2009; Smith AL, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.06.041; Sugino Y, 2008, NEUROUROL URODYNAM, V27, P548, DOI 10.1002/nau.20552; Ustinova EE, 2006, AM J PHYSIOL-RENAL, V290, pF1478, DOI 10.1152/ajprenal.00395.2005; Ustinova EE, 2007, AM J PHYSIOL-RENAL, V292, pF123, DOI 10.1152/ajprenal.00162.2006; WEISS J, 1983, J UROLOGY, V130, P479, DOI 10.1016/S0022-5347(17)51258-6; Wong L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100770	47	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116827	10.1371/journal.pone.0116827	http://dx.doi.org/10.1371/journal.pone.0116827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647072	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600039
J	Scumaci, D; Trimboli, F; Dell'Aquila, L; Concolino, A; Pappaianni, G; Tamme, L; Vignola, G; Luciani, A; Morelli, D; Cuda, G; Boari, A; Britti, D				Scumaci, Domenica; Trimboli, Francesca; Dell'Aquila, Ludovica; Concolino, Antonio; Pappaianni, Giusi; Tamme, Laura; Vignola, Giorgio; Luciani, Alessia; Morelli, Daniela; Cuda, Giovanni; Boari, Andrea; Britti, Domenico			Proteomics-Driven Analysis of Ovine Whey Colostrum	PLOS ONE			English	Article							PASSIVE TRANSFER STATUS; HEAT-SHOCK PROTEINS; MILK-FAT GLOBULE; MASS-SPECTROMETRY; NEONATAL LAMB; BOVINE WHEY; IDENTIFICATION; SHEEP; IMMUNOGLOBULINS; SECRETION	The aim of this study was to shed light in to the complexity of the ovine colostrum proteome, with a specific focus on the low abundance proteins. The ovine colostrum is characterized by a few dominating proteins, as the immunoglobulins, but it also contains less represented protein species, equally important for the correct development of neonates. Ovine colostrum, collected immediately after lambing, was separated by 1D SDS-PAGE. Proteins bands were digested with trypsin and the resulting peptides were analyzed by LC-MS/MS. On the basis of the Swiss-Prot database, a total of 343 unique proteins were identified. To our knowledge, this study represents the most comprehensive analysis of ovine colostrum proteome.	[Scumaci, Domenica; Concolino, Antonio; Pappaianni, Giusi; Tamme, Laura; Cuda, Giovanni] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Trimboli, Francesca; Britti, Domenico] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Dell'Aquila, Ludovica; Vignola, Giorgio; Luciani, Alessia; Boari, Andrea] Univ Teramo, Fac Vet Med, Teramo, Italy; [Morelli, Daniela] Ist Zooprofilatt Sperimentale Abruzzo & Molise IZ, Teramo, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; University of Teramo; IZS Dell'abruzzo E Del Molise Giuseppe Caporale	Cuda, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy.	cuda@unicz.it	Scumaci, Domenica/AAH-1493-2019; Cuda, Giovanni/F-5359-2012; Trimboli, Francesca/Y-1143-2019; Cuda, Giovanni/AAC-2821-2019; Britti, Domenico/O-3275-2015	Cuda, Giovanni/0000-0001-6313-1866; Trimboli, Francesca/0000-0002-1766-9179; Cuda, Giovanni/0000-0001-6313-1866; Scumaci, Domenica/0000-0002-8117-834X; LUCIANI, ALESSIA/0000-0002-0536-0916; Britti, Domenico/0000-0001-7355-8791	progetto special "ricerca di eccellenza anno 2011" Fondazione cassa di risparmio della provincial di Teramo	progetto special "ricerca di eccellenza anno 2011" Fondazione cassa di risparmio della provincial di Teramo	This work was supported by progetto special "ricerca di eccellenza anno 2011" Fondazione cassa di risparmio della provincial di Teramo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis MF, 2011, INFECT IMMUN, V79, P3833, DOI 10.1128/IAI.00040-11; Andrews MH, 2000, BRAIN RES, V878, P174, DOI 10.1016/S0006-8993(00)02735-9; Bauman DE, 2006, J DAIRY SCI, V89, P1235, DOI 10.3168/jds.S0022-0302(06)72192-0; Britti D, 2005, JAVMA-J AM VET MED A, V226, P951, DOI 10.2460/javma.2005.226.951; CAMPBELL SG, 1977, NEW ZEAL VET J, V25, P361, DOI 10.1080/00480169.1977.34458; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chen JX, 2013, MOL ENDOCRINOL, V27, P1065, DOI 10.1210/me.2012-1277; Chiaradia E, 2013, J PROTEOMICS, V83, P144, DOI 10.1016/j.jprot.2013.03.017; Delana R, 2007, MATRIX BIOL, V26, P508; Galvani M, 2001, RAPID COMMUN MASS SP, V15, P258, DOI 10.1002/rcm.220; Gu HM, 2013, BBA-MOL CELL BIOL L, V1831, P1067, DOI 10.1016/j.bbalip.2013.01.019; HALLIDAY R, 1974, ANIM PROD, V19, P301, DOI 10.1017/S000335610002287X; HALLIDAY R, 1978, VET REC, V103, P489, DOI 10.1136/vr.103.22.489; Hernandez-Castellano LE, 2014, CURR PROTEIN PEPT SC, V15, P64, DOI 10.2174/1389203715666140221124622; Hogarth CJ, 2004, PROTEOMICS, V4, P2094, DOI 10.1002/pmic.200300723; HUNTER AG, 1977, J ANIM SCI, V45, P1146, DOI 10.2527/jas1977.4551146x; Kelly D, 2000, LIVEST PROD SCI, V66, P161, DOI 10.1016/S0301-6226(00)00223-2; Korhonen H, 2007, CURR PHARM DESIGN, V13, P829, DOI 10.2174/138161207780363112; Korhonen H, 2000, BRIT J NUTR, V84, pS75; Kramer BW, 2002, AM J PHYSIOL-LUNG C, V283, pL452, DOI 10.1152/ajplung.00407.2001; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lahov E, 1996, FOOD CHEM TOXICOL, V34, P131, DOI 10.1016/0278-6915(95)00097-6; Leibundgut M, 2008, CURR OPIN STRUC BIOL, V18, P714, DOI 10.1016/j.sbi.2008.09.008; LEVIEUX D, 1982, PHYSL PATHOLOGIE PER, P345, DOI DOI 10.1016/J.EJVS.2014.10.022; Liao YL, 2011, J PROTEOME RES, V10, P1746, DOI 10.1021/pr101028k; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Massimini G, 2007, JAVMA-J AM VET MED A, V231, P1873, DOI 10.2460/javma.231.12.1873; McManaman L, 2002, J PHYSL, V545, P567; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Morelli M, 2014, INT J GYNECOL CANCER, V103, P550; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; Napolitano F, 2014, SMALL RUMINANT RES, V116, P21, DOI 10.1016/j.smallrumres.2013.10.007; Natale M, 2004, MOL NUTR FOOD RES, V48, P363, DOI 10.1002/mnfr.200400011; Nissen A, 2012, PROTEOMICS, V12, P2866, DOI 10.1002/pmic.201200231; Ogawa S, 2014, ANIM SCI J, V85, P440, DOI 10.1111/asj.12165; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Oshima K, 2002, EUR J BIOCHEM, V269, P1209, DOI 10.1046/j.1432-1033.2002.02758.x; Palmer DJ, 2006, PROTEOMICS, V6, P2208, DOI 10.1002/pmic.200500558; Parodi PW, 2007, CURR PHARM DESIGN, V13, P813, DOI 10.2174/138161207780363059; PATUREAU MIRAND P, 1990, BIOL NEONATE, V57, P30, DOI 10.1159/000243156; Pecka E, 2012, ANIM SCI J, V83, P162, DOI 10.1111/j.1740-0929.2011.00930.x; Petrof Elaine O, 2004, Chin J Dig Dis, V5, P45, DOI 10.1111/j.1443-9573.2004.00154.x; Picariello G, 2008, PROTEOMICS, V8, P3833, DOI 10.1002/pmic.200701057; Pujia A, 2010, INT J NANOMED, V5, P1005, DOI 10.2147/IJN.S12865; Robenek H, 2006, P NATL ACAD SCI USA, V103, P10385, DOI 10.1073/pnas.0600795103; SAWYER M, 1977, J AM VET MED ASSOC, V171, P1255; Scharte M, 2001, J NUTR, V131, P1433, DOI 10.1093/jn/131.5.1433; Senda A, 2011, ANIM SCI J, V82, P698, DOI 10.1111/j.1740-0929.2011.00886.x; Sozmen M, 2012, J COMP PATHOL, V147, P441, DOI 10.1016/j.jcpa.2012.04.004; Stelwagen K, 2009, J ANIM SCI, V87, P3, DOI 10.2527/jas.2008-1377; Welch WJ, 1990, STRESS PROTEINS BIOL, P223; Wu CC, 2000, TRAFFIC, V1, P769, DOI 10.1034/j.1600-0854.2000.011004.x; Wu WX, 1996, ENDOCRINOLOGY, V137, P5685, DOI 10.1210/en.137.12.5685; Yamada M, 2002, ELECTROPHORESIS, V23, P1153, DOI 10.1002/1522-2683(200204)23:7/8&lt;1153::AID-ELPS1153&gt;3.0.CO;2-Y; Yekta MA, 2011, VET MICROBIOL, V150, P373, DOI 10.1016/j.vetmic.2011.02.052	56	17	18	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117433	10.1371/journal.pone.0117433	http://dx.doi.org/10.1371/journal.pone.0117433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643159	Green Published, gold, Green Submitted			2022-12-27	WOS:000348821200037
J	Stein, GY; Alon, D; Korenfeld, R; Fuchs, S				Stein, Gideon Y.; Alon, Danny; Korenfeld, Roman; Fuchs, Shmuel			Clinical Implications of High-Sensitivity Cardiac Troponin Measurements in Hospitalized Medical Patients	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; MYOCARDIAL-INFARCTION; HEART-FAILURE; MORTALITY; ASSAY; ASSOCIATION; POPULATION; RISK; AGE	Background The increased use of high sensitivity cardiac troponins (hs-cTn), have made the diagnosis of non-ST elevation myocardial infarction (MI) challenging, especially in complex medical patients, in whom the clinical presentation of MI is nonspecific and multiple comorbidities as well as non-ischemic acute conditions may account for elevated hs-cTn levels. The aim of this study was to assess the frequency of both elevated hs-cTn levels and dynamic changes in hospitalized patients. Methods and Findings We conducted a retrospective study identifying all patients hospitalized in the Internal Medicine Division of Rabin Medical Center, Israel between January 2011 to December 2011, for whom at least one hs-cTn T (hs-cTnT) measurement was obtained. Collected data included patient demographics, acute and chronic diagnosis, hs-cTnT and creatinine levels and date of death. Hs-cTnT levels were obtained in 5,696 admissions and was above the 99th percentile (> = 13 ng/L) in 61.6% of the measurements. A relative change of 50% or higher was observed in 24% of the admissions. Among those with elevated hs-cTnT levels, acute coronary syndromes (ACS) accounted for only 6.1% of acute diagnoses. Maximal hs-cTnT levels above 100 ng/L but not dynamic changes discriminated between ACS and non-ACS conditions (positive and negative predictive values of 12% and 96% respectively). The frequency of elevated hs-cTnT levels was age-dependent and over 75% of patients aged >70 yearsold had levels above the 99th percentile. Multivariate analysis identified hs-cTnT levels higher than the 99th percentile, as an independent, strong predictor for 30-day mortality (OR 4.58 [2.8, 7.49], p<0.0001). Conclusions Elevated hs-cTnT levels together with dynamic changes are frequent findings among hospitalized patients and in most cases, are not related to the ACS diagnosis. These findings highlight the diagnostic challenge of ACS in this complex population. Further studies are needed in order to optimize the use of hs-cTnT measurements in hospitalized patients.	[Fuchs, Shmuel] Beilinson Med Ctr, Rabin Med Ctr, Dept Internal Med B, Petah Tiqwa, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Fuchs, S (corresponding author), Beilinson Med Ctr, Rabin Med Ctr, Dept Internal Med B, Petah Tiqwa, Israel.	shmuelf@clalit.org.il						Baron JM, 2014, AM J CLIN PATHOL, V141, P488, DOI 10.1309/AJCPLVQQY35XTFVN; de Lemos JA, 2011, CLIN CHEM, V57, P826, DOI 10.1373/clinchem.2011.163758; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; Eggers KM, 2013, J AM COLL CARDIOL, V61, P1906, DOI 10.1016/j.jacc.2012.12.048; Gore MO, 2014, J AM COLL CARDIOL, V63, P1441, DOI 10.1016/j.jacc.2013.12.032; Haaf P, 2012, CIRCULATION, V126, P31, DOI 10.1161/CIRCULATIONAHA.112.100867; Hammarsten O, 2012, CLIN CHEM, V58, P628, DOI 10.1373/clinchem.2011.171496; Hijazi Z, 2013, CIRCULATION, DOI [10.1161/CIRCULATIONAHA.113.007747, DOI 10.1161/CIRCULATIONAHA.113.007747]; Irfan A, 2012, AM J MED, V125, P491, DOI 10.1016/j.amjmed.2011.10.031; Kelley WE, 2009, CLIN CHEM, V55, P2098, DOI 10.1373/clinchem.2009.130799; Korley FK, 2013, J AM COLL CARDIOL, V61, P1753, DOI 10.1016/j.jacc.2012.09.069; Masson S, 2013, J INTERN MED, V273, P306, DOI 10.1111/joim.12023; McFalls EO, 2011, AM J MED, V124, P630, DOI 10.1016/j.amjmed.2011.02.024; Mishra RK, 2013, AM J KIDNEY DIS, V61, P701, DOI 10.1053/j.ajkd.2012.11.034; Mueller M, 2012, CLIN CHEM, V58, P209, DOI 10.1373/clinchem.2011.171827; Newby LK, 2012, J AM COLL CARDIOL, V60, P2427, DOI 10.1016/j.jacc.2012.08.969; Normann J, 2012, AM HEART J, V164, P698, DOI 10.1016/j.ahj.2012.08.003; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Sandoval Y, 2014, J AM COLL CARDIOL, V63, P2079, DOI 10.1016/j.jacc.2014.02.541; Saunders JT, 2011, CIRCULATION, V123, P1367, DOI 10.1161/CIRCULATIONAHA.110.005264; Stein GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084285; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184	24	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117162	10.1371/journal.pone.0117162	http://dx.doi.org/10.1371/journal.pone.0117162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25636061	gold, Green Published, Green Submitted			2022-12-27	WOS:000350680700073
J	Betzer, C; Movius, AJ; Shi, M; Gai, WP; Zhang, J; Jensen, PH				Betzer, Cristine; Movius, A. James; Shi, Min; Gai, Wei-Ping; Zhang, Jing; Jensen, Poul Henning			Identification of Synaptosomal Proteins Binding to Monomeric and Oligomeric alpha-Synuclein	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; FAMILIAL PARKINSON DISEASE; LEWY BODY DISEASE; IN-VITRO; CEREBROSPINAL-FLUID; HUMAN BRAIN; PROTEOMICS; DEMENTIA; MUTATION; BODIES	Monomeric alpha-synuclein (alpha SN) species are abundant in nerve terminals where they are hypothesized to play a physiological role related to synaptic vesicle turn-over. In Parkinson's disease (PD) and dementia with Lewy body (DLB), alpha SN accumulates as aggregated soluble oligomers in terminals, axons and the somatodendritic compartment and insoluble filaments in Lewy inclusions and Lewy neurites. The autosomal dominant heritability associated to mutations in the alpha SN gene suggest a gain of function associated to aggregated alpha SN. We have conducted a proteomic screen to identify the alpha SN interactome in brain synaptosomes. Porcine brain synaptosomes were fractionated, solubilized in non-denaturing detergent and subjected to co-immunoprecipitation using purified recombinant human aSN monomers or oligomers as bait. The isolated alpha SN binding proteins were identified with LC-LTQ-orbitrap tandem mass spectrometry and quantified by peak area using Windows client application, Skyline Targeted Proteomic Environment. Data are available via ProteomeXchange with identifier PXD001462. To quantify the preferential binding an average fold increase was calculated by comparing binding to monomer and oligomer. We identified 10 proteins preferentially binding monomer, and 76 binding preferentially to oligomer and a group of 92 proteins not displaying any preferred conformation of alpha SN. The proteomic data were validated by immunoprecipitation in both human and porcine brain extracts using antibodies against monomer alpha SN interactors: Abl interactor 1, and myelin proteolipid protein, and oligomer interactors: glutamate decarboxylase 2, synapsin 1, glial fibrillary acidic protein, and VAMP-2. We demonstrate the existence of alpha SN conformation selective ligands and present lists of proteins, whose identity and functions will be useful for modeling normal and pathological alpha SN dependent processes.	[Betzer, Cristine; Jensen, Poul Henning] Univ Aarhus, DANDRITE Danish Res Inst Translat Neurosci, Aarhus, Denmark; [Betzer, Cristine; Jensen, Poul Henning] Univ Aarhus, Dept Biomed, Aarhus, Denmark; [Movius, A. James; Shi, Min; Zhang, Jing] Flinders Univ S Australia, Sch Med, Dept Human Physiol, Bedford Pk, SA 5042, Australia; [Movius, A. James; Shi, Min; Zhang, Jing] Flinders Univ S Australia, Sch Med, Ctr Neurosci, Bedford Pk, SA 5042, Australia; [Gai, Wei-Ping] Washington Sch Med, Dept Pathol, Seattle, WA USA	Aarhus University; Aarhus University; Flinders University South Australia; Flinders University South Australia; University of Washington	Jensen, PH (corresponding author), Univ Aarhus, DANDRITE Danish Res Inst Translat Neurosci, Aarhus, Denmark.	phj@biomed.au.dk	Gai, Wei-Ping/A-3700-2008; Shi, Min/G-6165-2012	Shi, Min/0000-0002-6901-2558; Jensen, Poul Henning/0000-0002-4439-9020; Betzer, Cristine/0000-0001-5429-3548	European Community's Seventh Framework Programme (FP7) [241791]; Michael J. Fox Foundation with a Rapid Response Innovation Award (RRIA); Lundbeck Foundation	European Community's Seventh Framework Programme (FP7)(European Commission); Michael J. Fox Foundation with a Rapid Response Innovation Award (RRIA); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 241791 (MEFOPA), cordis.europa.eu/fp7/home_en.html; the Michael J. Fox Foundation with a Rapid Response Innovation Award (RRIA), www.michaeljfox.org; and The Lundbeck Foundation, www.lundbeckfonden.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alim MA, 2004, J ALZHEIMERS DIS, V6, P435; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Anderson NL, 1998, ELECTROPHORESIS, V19, P1853, DOI 10.1002/elps.1150191103; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Blackstock WP, 1999, TRENDS BIOTECHNOL, V17, P121, DOI 10.1016/S0167-7799(98)01245-1; Braak H, 2007, ACTA NEUROPATHOL, V114, P231, DOI 10.1007/s00401-007-0244-3; Burre J, 2012, J NEUROSCI, V32, P15227, DOI 10.1523/JNEUROSCI.3545-12.2012; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cali T, 2012, J BIOL CHEM, V287, P18478, DOI [10.1074/jbc.M111.304733, 10.1074/jbc.M111.302794]; Chartier-Harlin MC, 2011, AM J HUM GENET, V89, P398, DOI 10.1016/j.ajhg.2011.08.009; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Colla E, 2012, J NEUROSCI, V32, P3301, DOI 10.1523/JNEUROSCI.5368-11.2012; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Ejlerskov P, 2013, J BIOL CHEM, V288, P17313, DOI 10.1074/jbc.M112.401174; Gai WP, 2003, EXP NEUROL, V181, P68, DOI 10.1016/S0014-4886(03)00004-9; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Goedert M, 1998, MOL PSYCHIATR, V3, P462, DOI 10.1038/sj.mp.4000458; Hansson O, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt255; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Hoffman-Zacharska D, 2013, PARKINSONISM RELAT D, V19, P1057, DOI 10.1016/j.parkreldis.2013.07.011; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a; Jensen PH, 2000, J BIOL CHEM, V275, P21500, DOI 10.1074/jbc.M000099200; Jin JH, 2007, MOL CELL PROTEOMICS, V6, P845, DOI 10.1074/mcp.M600182-MCP200; Kalia LV, 2013, ANN NEUROL, V73, P155, DOI 10.1002/ana.23746; Kim SS, 2011, ARCH PHARM RES, V34, P837, DOI 10.1007/s12272-011-0518-0; Kragh CL, 2009, J BIOL CHEM, V284, P10211, DOI 10.1074/jbc.M809671200; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kubo S, 2001, J NEUROCHEM, V78, P42, DOI 10.1046/j.1471-4159.2001.00364.x; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Lin XM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00954; Lindersson E, 2005, J BIOL CHEM, V280, P5703, DOI 10.1074/jbc.M410409200; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Liu L, 2012, J BIOL CHEM, V287, P32307, DOI 10.1074/jbc.C112.403048; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; McFarland MA, 2008, MOL CELL PROTEOMICS, V7, P2123, DOI 10.1074/mcp.M800116-MCP200; Michalski A, 2011, J PROTEOME RES, V10, P1785, DOI 10.1021/pr101060v; Mysling S, 2013, BIOCHEMISTRY-US, V52, P9097, DOI 10.1021/bi4009193; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Nuytemans K, 2013, NEUROLOGY, V80, P982, DOI 10.1212/WNL.0b013e31828727d4; Ohrfelt A, 2011, NEUROCHEM RES, V36, P2029, DOI 10.1007/s11064-011-0527-x; Olanow CW, 2013, MOVEMENT DISORD, V28, P31, DOI 10.1002/mds.25373; Otzen DE, 2005, PROTEIN SCI, V14, P1396, DOI 10.1110/ps.041285605; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Paleologou KE, 2009, BRAIN, V132, P1093, DOI 10.1093/brain/awn349; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Paslawski W, 2014, BIOCHEMISTRY-US, V53, P6252, DOI 10.1021/bi5007833; Pennington K, 2010, J PROTEOME RES, V9, P2390, DOI 10.1021/pr901102d; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; Rockenstein E, 2014, BRAIN, V137, P1496, DOI 10.1093/brain/awu057; Sarafian TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063557; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Sharrad DF, 2013, J COMP NEUROL, V521, P2523, DOI 10.1002/cne.23296; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1999, PARKINSONISM RELAT D, V5, P157, DOI 10.1016/S1353-8020(99)00031-0; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Xilouri M, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001803; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou Y, 2004, J BIOL CHEM, V279, P39155, DOI 10.1074/jbc.M405456200	72	46	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116473	10.1371/journal.pone.0116473	http://dx.doi.org/10.1371/journal.pone.0116473			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659148	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900042
J	Breslin, JW; Zhang, XE; Worthylake, RA; Souza-Smith, FM				Breslin, Jerome W.; Zhang, Xun E.; Worthylake, Rebecca A.; Souza-Smith, Flavia M.			Involvement of Local Lamellipodia in Endothelial Barrier Function	PLOS ONE			English	Article							LIGHT-CHAIN PHOSPHORYLATION; SPHINGOSINE 1-PHOSPHATE; STRESS FIBERS; RHO-KINASE; MYOSIN-II; IN-VIVO; MICROVASCULAR HYPERPERMEABILITY; MONOLAYER INTEGRITY; MESENTERIC VENULES; MAMMALIAN-CELLS	Recently we observed that endothelial cells cultured in tightly confluent monolayers display frequent local lamellipodia, and that thrombin, an agent that increases endothelial permeability, reduces lamellipodia protrusions. This led us to test the hypothesis that local lamellipodia contribute to endothelial barrier function. Movements of subcellular structures containing GFP-actin or VE-cadherin-GFP expressed in endothelial cells were recorded using time-lapse microscopy. Transendothelial electrical resistance (TER) served as an index of endothelial barrier function. Changes in both lamellipodia dynamics and TER were assessed during baseline and after cells were treated with either the barrier-disrupting agent thrombin, or the barrier-stabilizing agent sphingosine-1-phosphate (S1P). The myosin II inhibitor blebbistatin was used to selectively block lamellipodia formation, and was used to test their role in the barrier function of endothelial cell monolayers and isolated, perfused rat mesenteric venules. Myosin light chain (MLC) phosphorylation was assessed by immunofluorescence microscopy. Rac1 and RhoA activation were evaluated using G-LISA assays. The role of Rac1 was tested with the specific inhibitor NSC23766 or by expressing wild-type or dominant negative GFP-Rac1. The results show that thrombin rapidly decreased both TER and the lamellipodia protrusion frequency. S1P rapidly increased TER in association with increased protrusion frequency. Blebbistatin nearly abolished local lamellipodia protrusions while cortical actin fibers and stress fibers remained intact. Blebbistatin also significantly decreased TER of cultured endothelial cells and increased permeability of isolated rat mesenteric venules. Both thrombin and S1P increased MLC phosphorylation and activation of RhoA. However, thrombin and S1P had differential impacts on Rac1, correlating with the changes in TER and lamellipodia protrusion frequency. Overexpression of Rac1 elevated, while NSC23766 and dominant negative Rac1 reduced barrier function and lamellipodia activity. Combined, these data suggest that local lamellipodia, driven by myosin II and Rac1, are important for dynamic changes in endothelial barrier integrity.	[Breslin, Jerome W.; Zhang, Xun E.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33606 USA; [Worthylake, Rebecca A.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Pharmacol, New Orleans, LA USA; [Souza-Smith, Flavia M.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Physiol, New Orleans, LA USA	State University System of Florida; University of South Florida; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Breslin, JW (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33606 USA.	jbreslin@health.usf.edu			U.S. National Institutes of Health [R01HL098215, P20RR018766, F32AA021049]; American Heart Association [0835388N]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA021049] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by U.S. National Institutes of Health grants R01HL098215, P20RR018766, and F32AA021049, and American Heart Association grant 0835388N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Taha A, 2014, MOL BIOL CELL, V25, P245, DOI 10.1091/mbc.E13-07-0404; Adamson RH, 2008, AM J PHYSIOL-HEART C, V294, pH1188, DOI 10.1152/ajpheart.00937.2007; Adamson RH, 2010, CARDIOVASC RES, V88, P344, DOI 10.1093/cvr/cvq184; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Aramoto H, 2004, AM J PHYSIOL-HEART C, V287, pH1590, DOI 10.1152/ajpheart.00767.2003; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; BALDWIN AL, 1995, AM J PHYSIOL-HEART C, V269, pH1528, DOI 10.1152/ajpheart.1995.269.5.H1528; Ballestrem C, 1998, J CELL SCI, V111, P1649; Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P765, DOI 10.1007/s00418-008-0422-y; Baumer Y, 2009, J CELL PHYSIOL, V220, P716, DOI 10.1002/jcp.21819; Belvitch P, 2012, MICROVASC RES, V83, P22, DOI 10.1016/j.mvr.2011.08.012; Betapudi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008560; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2013, MOL BIOL CELL; Birukova AA, 2008, J CELL PHYSIOL, V215, P715, DOI 10.1002/jcp.21354; Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; Birukova AA, 2010, MICROVASC RES, V79, P128, DOI 10.1016/j.mvr.2009.11.007; Birukova AA, 2009, J APPL PHYSIOL, V107, P1900, DOI 10.1152/japplphysiol.00462.2009; Bogatcheva NV, 2008, MICROVASC RES, V76, P202, DOI 10.1016/j.mvr.2008.06.003; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Breslin JW, 2011, LYMPHAT RES BIOL, V9, P3, DOI 10.1089/lrb.2010.0016; Breslin Jerome W., 2009, Lymphatic Research and Biology, V7, P229, DOI 10.1089/lrb.2009.0015; Breslin JW, 2006, AM J PHYSIOL-HEART C, V290, pH741, DOI 10.1152/ajpheart.00238.2005; Breslin JW, 2004, AM J PHYSIOL-HEART C, V286, pH1057, DOI 10.1152/ajpheart.00841.2003; Carbajal JM, 2000, AM J PHYSIOL-CELL PH, V279, pC195; Choidas A, 1998, EUR J CELL BIOL, V77, P81, DOI 10.1016/S0171-9335(98)80075-7; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Curry FRE, 2013, ACTA PHYSIOL, V207, P628, DOI 10.1111/apha.12076; Dejana E, 2000, INT J DEV BIOL, V44, P743; Delanoe-Ayari H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108102; Delanoe-Ayari H, 2004, P NATL ACAD SCI USA, V101, P2229, DOI 10.1073/pnas.0304297101; Doggett TM, 2011, JOVE-J VIS EXP, V57, P3187, DOI [10.3791/3187, DOI 10.3791/3187]; Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200; Duran WN, 2008, HANDBOOK OF PHYSIOLOGY: MICROCIRCULATION, 2ND EDITION, P81; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Goeckeler ZM, 2008, AM J PHYSIOL-CELL PH, V295, pC994, DOI 10.1152/ajpcell.00318.2008; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Jonas O, 2010, CYTOSKELETON, V67, P555, DOI 10.1002/cm.20466; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Luo YZ, 2008, J BIOMECH, V41, P2379, DOI 10.1016/j.jbiomech.2008.05.026; Martinelli R, 2013, J CELL BIOL, V201, P449, DOI 10.1083/jcb.201209077; Minnear FL, 2005, AM J PHYSIOL-HEART C, V289, pH840, DOI 10.1152/ajpheart.00026.2005; MOY AB, 1993, J CLIN INVEST, V92, P1198, DOI 10.1172/JCI116690; Moy AB, 2002, AM J PHYSIOL-HEART C, V282, pH21, DOI 10.1152/ajpheart.2002.282.1.H21; Moy AB, 1996, J CLIN INVEST, V97, P1020, DOI 10.1172/JCI118493; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Reynoso R, 2007, SHOCK, V28, P589, DOI 10.1097/SHK.0b013c31804d415f; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlegel N, 2009, AM J PHYSIOL-CELL PH, V296, pC453, DOI 10.1152/ajpcell.00360.2008; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Shikata Y, 2003, FASEB J, V17, P2240, DOI 10.1096/fj.03-0198com; Spindler V, 2011, AM J PATHOL, V178, P2424, DOI 10.1016/j.ajpath.2011.01.014; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Srinivas SP, 2006, INVEST OPHTH VIS SCI, V47, P4011, DOI 10.1167/iovs.05-1127; Sun HR, 2006, MICROCIRCULATION, V13, P237, DOI 10.1080/10739680600556944; Szulcek R, 2013, CARDIOVASC RES, V99, P471, DOI 10.1093/cvr/cvt075; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Walsh TG, 2011, J CELL PHYSIOL, V226, P3053, DOI 10.1002/jcp.22655; Waschke J, 2004, AM J PHYSIOL-HEART C, V287, pH2427, DOI 10.1152/ajpheart.00556.2004; Waschke J, 2004, AM J PHYSIOL-HEART C, V287, pH704, DOI 10.1152/ajpheart.01076.2003; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Wong RK, 1999, AM J PHYSIOL-HEART C, V276, pH736; Xu M, 2007, AM J PHYSIOL-CELL PH, V293, pC1309, DOI 10.1152/ajpcell.00014.2007; Yuan SY, 2002, CIRC RES, V90, P1214, DOI 10.1161/01.RES.0000020402.73609.F1; Yuan Y, 1997, AM J PHYSIOL-HEART C, V272, pH1437, DOI 10.1152/ajpheart.1997.272.3.H1437; YUAN Y, 1993, AM J PHYSIOL, V265, pH543, DOI 10.1152/ajpheart.1993.265.2.H543	72	46	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117970	10.1371/journal.pone.0117970	http://dx.doi.org/10.1371/journal.pone.0117970			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658915	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900247
J	Greenhill, AR; Tsuji, H; Ogata, K; Natsuhara, K; Morita, A; Soli, K; Larkins, JA; Tadokoro, K; Odani, S; Baba, J; Naito, Y; Tomitsuka, E; Nomoto, K; Siba, PM; Horwood, PF; Umezaki, M				Greenhill, Andrew R.; Tsuji, Hirokazu; Ogata, Kiyohito; Natsuhara, Kazumi; Morita, Ayako; Soli, Kevin; Larkins, Jo-Ann; Tadokoro, Kiyoshi; Odani, Shingo; Baba, Jun; Naito, Yuichi; Tomitsuka, Eriko; Nomoto, Koji; Siba, Peter M.; Horwood, Paul F.; Umezaki, Masahiro			Characterization of the Gut Microbiota of Papua New Guineans Using Reverse Transcription Quantitative PCR	PLOS ONE			English	Article							GROUP-SPECIFIC PRIMERS; PREDOMINANT BACTERIA; FECAL MICROBIOTA; HUMAN FECES; OBESITY; ENERGY; DIET; ENTEROTYPES; POPULATIONS; MICROFLORA	There has been considerable interest in composition of gut microbiota in recent years, leading to a better understanding of the role the gut microbiota plays in health and disease. Most studies have been limited in their geographical and socioeconomic diversity to high-income settings, and have been conducted using small sample sizes. To date, few analyses have been conducted in low-income settings, where a better understanding of the gut microbiome could lead to the greatest return in terms of health benefits. Here, we have used quantitative real-time polymerase chain reaction targeting dominant and sub-dominant groups of microorganisms associated with human gut microbiome in 115 people living a subsistence lifestyle in rural areas of Papua New Guinea. Quantification of Clostridium coccoides group, C. leptum subgroup, C. perfringens, Bacteroides fragilis group, Bifidobacterium, Atopobium cluster, Prevotella, Enterobacteriaceae, Enterococcus, Staphylococcus, and Lactobacillus spp. was conducted. Principle coordinates analysis (PCoA) revealed two dimensions with Prevotella, clostridia, Atopobium, Enterobacteriaceae, Enterococcus and Staphylococcus grouping in one dimension, while B. fragilis, Bifidobacterium and Lactobacillus grouping in the second dimension. Highland people had higher numbers of most groups of bacteria detected, and this is likely a key factor for the differences revealed by PCoA between highland and lowland study participants. Age and sex were not major determinants in microbial population composition. The study demonstrates a gut microbial composition with some similarities to those observed in other low-income settings where traditional diets are consumed, which have previously been suggested to favor energy extraction from a carbohydrate rich diet.	[Greenhill, Andrew R.; Larkins, Jo-Ann] Federat Univ, Sch Appl & Biomed Sci, Churchill, Australia; [Greenhill, Andrew R.; Soli, Kevin; Siba, Peter M.; Horwood, Paul F.] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea; [Tsuji, Hirokazu; Ogata, Kiyohito; Nomoto, Koji] Yakult Cent Inst, Tokyo, Japan; [Natsuhara, Kazumi] Japanese Red Cross Akita Coll Nursing, Fac Nursing, Akita, Japan; [Morita, Ayako; Tadokoro, Kiyoshi; Tomitsuka, Eriko; Umezaki, Masahiro] Univ Tokyo, Dept Human Ecol, Tokyo, Japan; [Odani, Shingo] Chiba Univ, Fac Letter, Chiba, Japan; [Baba, Jun] Tokyo Univ Foreign Studies, Res Inst Languages & Cultures Asia & Africa, Tokyo, Japan; [Naito, Yuichi] Univ Tubingen, Tubingen, Germany	Federation University Australia; PNG Institute Of Medical Research; Yakult Honsha Company, Limited; University of Tokyo; Chiba University; Tokyo University of Foreign Studies; Eberhard Karls University of Tubingen	Greenhill, AR (corresponding author), Federat Univ, Sch Appl & Biomed Sci, Churchill, Australia.	andrew.greenhill@federation.edu.au	Larkins, Jo-ann/Q-9858-2019	Hirokazu, Tsuji/0000-0003-2856-6447; Horwood, Paul/0000-0001-9622-0742; Greenhill, Andrew/0000-0001-5831-8714; Larkins, Jo-ann/0000-0002-3436-9362	Funding Program for Next Generation World-Leading Researchers (NEXT program) [LS024]; Grants-in-Aid for Scientific Research [26560137, 26360004] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers (NEXT program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by Funding Program for Next Generation World-Leading Researchers (NEXT program): LS024 (Masahiro UMEZAKI, the University of Tokyo), http://www.jsps.go.jp/j-jisedai/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agans R, 2011, FEMS MICROBIOL ECOL, V77, P404, DOI 10.1111/j.1574-6941.2011.01120.x; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Festi D, 2011, DIGEST DIS, V29, P518, DOI 10.1159/000332975; Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Grzeskowiak L, 2012, J PEDIATR GASTR NUTR, V54, P812, DOI 10.1097/MPG.0b013e318249039c; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Lin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053838; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Mendez FL, 2012, MOL BIOL EVOL, V29, P1513, DOI 10.1093/molbev/msr301; Ming X, 2012, J PROTEOME RES, V11, P5856, DOI 10.1021/pr300910n; Morita A, 2015, AM J HUM BIOL, V27, P349, DOI 10.1002/ajhb.22647; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Natsuhara K, 1999, MAN CUL OCEANIA, V15, P91; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Alonso VR, 2013, BRIT J NUTR, V109, pS21, DOI 10.1017/S0007114512005235; Sen Gupta S, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-7; Serjeanston SW, 1992, HUMAN BIOL PAPUA NEW; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Temu P. I., 2001, Food security for Papua New Guinea. Proceedings of the Papua New Guinea Food and Nutrition 2000 Conference, PNG University of Technology, Lae, Papua New Guinea, 26-30 June 2000, P395; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Umezaki M, 1999, ECOL FOOD NUTR, V37, P409, DOI 10.1080/03670244.1998.9991558; Umezaki M, 2003, HUM ECOL, V31, P3, DOI 10.1023/A:1022881506510; Umezaki M, 1998, J BIOSOC SCI, V30, P411, DOI 10.1017/S0021932098004118; Venema K, 2010, CURR OPIN CLIN NUTR, V13, P432, DOI 10.1097/MCO.0b013e32833a8b60; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xu PR, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-283; Yamauchi T, 2001, BRIT J NUTR, V85, P65, DOI 10.1079/BJN2000208; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	40	15	17	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117427	10.1371/journal.pone.0117427	http://dx.doi.org/10.1371/journal.pone.0117427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658868	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900147
J	Humphreys, AF; Tan, J; Peng, RS; Benton, SM; Qin, X; Worley, KC; Mikulski, RL; Chow, DC; Palzkill, TG; Ling, PD				Humphreys, Alan F.; Tan, Jie; Peng, RongSheng; Benton, Susan M.; Qin, Xiang; Worley, Kim C.; Mikulski, Rose L.; Chow, Dar-Chone; Palzkill, Timothy G.; Ling, Paul D.			Generation and Characterization of Antibodies against Asian Elephant (Elephas maximus) IgG, IgM, and IgA	PLOS ONE			English	Article							NEWLY RECOGNIZED DISEASE; ENDOTHELIOTROPIC HERPESVIRUS; INFECTION	Asian elephant (Elephas maximus) immunity is poorly characterized and understood. This gap in knowledge is particularly concerning as Asian elephants are an endangered species threatened by a newly discovered herpesvirus known as elephant endotheliotropic herpesvirus (EEHV), which is the leading cause of death for captive Asian elephants born after 1980 in North America. While reliable diagnostic assays have been developed to detect EEHV DNA, serological assays to evaluate elephant anti-EEHV antibody responses are lacking and will be needed for surveillance and epidemiological studies and also for evaluating potential treatments or vaccines against lethal EEHV infection. Previous studies have shown that Asian elephants produce IgG in serum, but they failed to detect IgM and IgA, further hampering development of informative serological assays for this species. To begin to address this issue, we determined the constant region genomic sequence of Asian elephant IgM and obtained some limited protein sequence information for putative serum IgA. The information was used to generate or identify specific commercial antisera reactive against IgM and IgA isotypes. In addition, we generated a monoclonal antibody against Asian elephant IgG. These three reagents were used to demonstrate that all three immunoglobulin isotypes are found in Asian elephant serum and milk and to detect antibody responses following tetanus toxoid booster vaccination or antibodies against a putative EEHV structural protein. The results indicate that these new reagents will be useful for developing sensitive and specific assays to detect and characterize elephant antibody responses for any pathogen or vaccine, including EEHV.	[Humphreys, Alan F.] Baylor Coll Med, Ctr Comparat Med, Houston, TX 77030 USA; [Tan, Jie; Peng, RongSheng; Ling, Paul D.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Benton, Susan M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Qin, Xiang; Worley, Kim C.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Mikulski, Rose L.; Chow, Dar-Chone; Palzkill, Timothy G.] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Ling, PD (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	pling@bcm.edu		Benton, Susan/0000-0002-7694-2091; Worley, Kim/0000-0002-0282-1000	NIH [P30 CA125123]; Houston zoo; Institute of Museum and Library Services [MG-30-13-0086-13]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Houston zoo; Institute of Museum and Library Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for these services was provided by NIH grant P30 CA125123. Support for these studies was also provided by a grant from the Houston zoo to PDL and in part by the Institute of Museum and Library Services grant MG-30-13-0086-13.	Dona MG, 2011, J WILDLIFE DIS, V47, P673, DOI 10.7589/0090-3558-47.3.673; Fickel J, 2001, VET MICROBIOL, V82, P103, DOI 10.1016/S0378-1135(01)00363-7; Fowler, 2011, FOWLERS ZOO WILD ANI, P496; Garner MM, 2009, VET PATHOL, V46, P97, DOI 10.1354/vp.46-1-97; Guo YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016889; Kania S. A., 1997, Journal of Veterinary Allergy and Clinical Immunology, V5, P125; Kelly PJ, 1998, COMP IMMUNOL MICROB, V21, P65, DOI 10.1016/S0147-9571(97)80053-7; Lam FW, 2013, THROMB RES, V132, P69, DOI 10.1016/j.thromres.2013.04.018; Latimer E, 2011, VET MICROBIOL, V147, P28, DOI 10.1016/j.vetmic.2010.05.042; Lindsay WA, 2010, VET IMMUNOL IMMUNOP, V133, P287, DOI 10.1016/j.vetimm.2009.08.005; Ling PD, 2008, J VIROL, V82, P8000, DOI 10.1128/JVI.02752-07; Ling PD, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00106-13; Nofs SA, 2013, VET IMMUNOL IMMUNOP, V153, P308, DOI 10.1016/j.vetimm.2013.03.008; Pretorius A, 1997, ONDERSTEPOORT J VET, V64, P201; Reid CE, 2006, VET QUART, V28, P61, DOI 10.1080/01652176.2006.9695209; Richman LK, 2000, ZOO BIOL, V19, P383, DOI 10.1002/1098-2361(2000)19:5&lt;383::AID-ZOO8&gt;3.0.CO;2-X; Richman LK, 2000, J WILDLIFE DIS, V36, P1, DOI 10.7589/0090-3558-36.1.1; Sripiboon S, 2013, J ZOO WILDLIFE MED, V44, P100, DOI 10.1638/1042-7260-44.1.100; Stanton JJ, 2013, J ZOO WILDLIFE MED, V44, P42, DOI 10.1638/1042-7260-44.1.42; Zechariah A, 2013, J WILDLIFE DIS, V49, P381, DOI 10.7589/2012-07-193	20	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116318	10.1371/journal.pone.0116318	http://dx.doi.org/10.1371/journal.pone.0116318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658336	Green Published, gold			2022-12-27	WOS:000349444900035
J	Lei, Y; Li, B; Tong, SY; Qi, L; Hu, XH; Cui, YB; Li, ZB; He, W; Zu, XB; Wang, Z; Chen, MF				Lei, Ye; Li, Bin; Tong, Shiyu; Qi, Lin; Hu, Xiheng; Cui, Yunbo; Li, Zengbo; He, Wei; Zu, Xiongbing; Wang, Zhi; Chen, Minfeng			miR-101 Suppresses Vascular Endothelial Growth Factor C That Inhibits Migration and Invasion and Enhances Cisplatin Chemosensitivity of Bladder Cancer Cells	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; VEGF-C; HEPATOCELLULAR-CARCINOMA; RADICAL CYSTECTOMY; GASTRIC-CANCER; MOLECULAR-MECHANISMS; PROSTATE-CANCER; DOWN-REGULATION; IN-VIVO; EXPRESSION	Background The microRNA miR-101 is downregulated in several cancers, including bladder cancer. However, miR-101's role in the invasion, metastasis, and chemosensitivity of bladder cancer cells remains unclear. This study was conducted to determine miR-101's role on the lymphangiogenic molecule vascular endothelial growth factor C (VEGF-C) and their effects upon bladder cancer cell migration, invasion, and chemosensitivity to cisplatin. Methods Two bladder cancer cell lines (T24 and 5637) and the tool cell line 293T were employed here. Bladder cancer cells were transfected with either a miR-101 overexpression vector or a scrambled-sequence lentivirus, both of which exhibited a high transfection efficiency. Non-transfection was used as a mock negative control. Wound healing and Transwell assays were performed to measure cell migration and invasiveness. A luciferase reporter assay was performed to validate miR-101's interaction with VEGF-C's 3' untranslated region followed by RT-PCR and Western blot confirmation. An MTS assay was used to evaluate the cisplatin sensitivity of the cell lines. Results miR-101 overexpression significantly inhibited the migration and invasiveness while significantly enhancing cisplatin sensitivity. miR-101 negatively regulated VEGF-C protein expression, and VEGF-C overexpression rescued the effects of miR-101 overexpression, indicating that miR-101 negatively regulates VEGF-C protein expression post-transcriptionally. miR-101 and VEGF-C interference independently enhanced cisplatin cytotoxicity in bladder cancer cells. Conclusions miR-101 suppresses VEGF-C expression, inhibits cell migration and invasion, and increases cisplatin sensitivity in bladder cancer cells. This study provides new insight into miR-101's role in bladder cancer and shows miR-101's promise as a potential molecular target for bladder cancer.	[Lei, Ye; Tong, Shiyu; Qi, Lin; Hu, Xiheng; He, Wei; Zu, Xiongbing; Wang, Zhi; Chen, Minfeng] Cent S Univ, Dept Urol, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Li, Bin] Hebei Med Univ, Dept Biochem & Mol Biol, Coll Basic Med, Key Lab Med Biotechnol Hebei Prov, Shijiazhuang 050017, Hebei, Peoples R China; [Li, Zengbo] Cent S Univ, Dept Gen Surg, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Cui, Yunbo] Cent S Univ, Sch Life Sci, Changsha 410008, Hunan, Peoples R China	Central South University; Hebei Medical University; Central South University; Central South University	Chen, MF (corresponding author), Cent S Univ, Dept Urol, Xiangya Hosp, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	chenminfeng1999@tom.com	He, Wei/GQO-8968-2022	He, Wei/0000-0001-8909-9008; Hu, Xiheng/0000-0002-0454-8060	National Nature Science Foundation for the Youth of China [81202005]; Technology Plan Fund of Hunan Science [2013FJ4109]; Central South University Innovation Fund for Independent Graduate Exploration [72150050587]	National Nature Science Foundation for the Youth of China; Technology Plan Fund of Hunan Science; Central South University Innovation Fund for Independent Graduate Exploration	This work was supported by the National Nature Science Foundation for the Youth of China (No. 81202005), the Technology Plan Fund of Hunan Science (No. 2013FJ4109), and the Central South University Innovation Fund for Independent Graduate Exploration (No. 72150050587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi K, 2000, BRIT J CANCER, V83, P887, DOI 10.1054/bjoc.2000.1396; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Canter D, 2008, BJU INT, V102, P952, DOI 10.1111/j.1464-410X.2008.07732.x; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Cho HJ, 2014, INT J CANCER, V135, P1553, DOI 10.1002/ijc.28801; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dai YM, 2011, HEAD NECK-J SCI SPEC, V33, P786, DOI 10.1002/hed.21540; Drayton RM, 2012, EXPERT REV ANTICANC, V12, P271, DOI [10.1586/era.11.201, 10.1586/ERA.11.201]; Eggert A, 2000, CLIN CANCER RES, V6, P1900; Fellmer PT, 1999, SURGERY, V126, P1056, DOI 10.1067/msy.2099.101432; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Frank I, 2003, CANCER, V97, P2425, DOI 10.1002/cncr.11370; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Guo F, 2014, ONCOL REP, V31, P2021, DOI 10.3892/or.2014.3106; Hao YB, 2011, CANCER PREV RES, V4, P1073, DOI 10.1158/1940-6207.CAPR-10-0333; Herr HW, 2001, J CLIN ONCOL, V19, P89, DOI 10.1200/JCO.2001.19.1.89; Hu ZH, 2013, BIOCHEM BIOPH RES CO, V435, P82, DOI 10.1016/j.bbrc.2013.04.042; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Joukov V, 1996, EMBO J, V15, P290; Kassouf W, 2009, UROLOGY, V73, P147, DOI 10.1016/j.urology.2008.07.035; Kottakis F, 2011, MOL CELL, V43, P285, DOI 10.1016/j.molcel.2011.06.020; Leissner J, 2003, J UROLOGY, V169, P955, DOI 10.1097/01.ju.0000043639.55877.17; Leppanen VM, 2013, P NATL ACAD SCI USA, V110, P12960, DOI 10.1073/pnas.1301415110; Li D, 2014, CANCER LETT, V346, P45, DOI 10.1016/j.canlet.2013.12.004; Lim JJ, 2014, NEOPLASIA, V16, P343, DOI 10.1016/j.neo.2014.04.003; Lin XJ, 2014, BIOMED REP, V2, P122, DOI 10.3892/br.2013.192; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Luo CL, 2013, CANCER LETT, V341, P240, DOI 10.1016/j.canlet.2013.08.021; Luo L, 2012, MED ONCOL, V29, P1681, DOI 10.1007/s12032-011-0085-8; Nordentoft I, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-40; Ratert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039309; Rosenberg JE, 2005, J UROLOGY, V174, P14, DOI 10.1097/01.ju.0000162039.38023.5f; Salven P, 1998, AM J PATHOL, V153, P103, DOI 10.1016/S0002-9440(10)65550-2; Schee K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-505; Sonpavde G, 2010, LANCET ONCOL, V11, P861, DOI 10.1016/S1470-2045(10)70086-3; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Su JL, 2006, CANCER CELL, V9, P209, DOI 10.1016/j.ccr.2006.02.018; Suzuki K, 2005, INT J UROL, V12, P152, DOI 10.1111/j.1442-2042.2005.01010.x; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tanji N, 2010, INT J CLIN ONCOL, V15, P369, DOI 10.1007/s10147-010-0069-2; Trojan L, 2006, BJU INT, V98, P903, DOI 10.1111/j.1464-410X.2006.06403.x; Tsurusaki T, 1999, BRIT J CANCER, V80, P309, DOI 10.1038/sj.bjc.6690356; Walz J, 2008, BJU INT, V101, P1356, DOI 10.1111/j.1464-410X.2008.07524.x; Wang HJ, 2010, EUR J CANCER, V46, P2295, DOI 10.1016/j.ejca.2010.05.012; Wang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046173; Xu LB, 2014, J HEPATOL, V60, P590, DOI 10.1016/j.jhep.2013.10.028; Xu YH, 2013, ONCOL REP, V29, P2019, DOI 10.3892/or.2013.2338; Yafi Faysal A, 2009, Can Urol Assoc J, V3, pS206; Yonemura Y, 1999, CLIN CANCER RES, V5, P1823	49	25	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117809	10.1371/journal.pone.0117809	http://dx.doi.org/10.1371/journal.pone.0117809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658842	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900228
J	Rabes, A; Zimmermann, S; Reppe, K; Lang, R; Seeberger, PH; Suttorp, N; Witzenrath, M; Lepenies, B; Opitz, B				Rabes, Anne; Zimmermann, Stephanie; Reppe, Katrin; Lang, Roland; Seeberger, Peter H.; Suttorp, Norbert; Witzenrath, Martin; Lepenies, Bernd; Opitz, Bastian			The C-Type Lectin Receptor Mincle Binds to Streptococcus pneumoniae but Plays a Limited Role in the Anti-Pneumococcal Innate Immune Response	PLOS ONE			English	Article							ACTIVATING RECEPTOR; LIPOTEICHOIC ACID; VIRULENCE FACTORS; MARGINAL ZONE; HOST-DEFENSE; RECOGNITION; CAPSULE; CELLS; IDENTIFICATION; COLONIZATION	The innate immune system employs C-type lectin receptors (CLRs) to recognize carbohydrate structures on pathogens and self-antigens. The Macrophage-inducible C-type lectin (Mincle) is a FcR gamma-coupled CLR that was shown to bind to mycobacterial cord factor as well as certain fungal species. However, since CLR functions during bacterial infections have not yet been investigated thoroughly, we aimed to examine their function in Streptococcus pneumonia infection. Binding studies using a library of recombinantly expressed CLR-Fc fusion proteins indicated a specific, Ca2+-dependent, and serotype-specific binding of Mincle to Streptococcus pneumonia. Subsequent experiments with different Mincle-expressing cells as well as Mincle-deficient mice, however, revealed a limited role of this receptor in bacterial phagocytosis, neutrophil-mediated killing, cytokine production, and antibacterial immune response during pneumonia. Collectively, our results indicate that Mincle is able to recognize Streptococcus pneumonia but is not required for the anti-pneumococcal innate immune response.	[Rabes, Anne; Reppe, Katrin; Suttorp, Norbert; Witzenrath, Martin; Opitz, Bastian] Charite, Dept Internal Med Infect Dis & Pulm Med, D-13353 Berlin, Germany; [Zimmermann, Stephanie; Seeberger, Peter H.; Lepenies, Bernd] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Potsdam, Germany; [Zimmermann, Stephanie; Lepenies, Bernd] Free Univ Berlin, Inst Chem & Biochem, Dept Biol Chem & Pharm, Berlin, Germany; [Lang, Roland] Univ Hosp Erlangen, Inst Clin Microbiol Immunol & Hyg, Erlangen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Free University of Berlin; University of Erlangen Nuremberg	Lepenies, B (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Potsdam, Germany.	bernd.lepenies@mpikg.mpg.de; bastian.opitz@charite.de	Lepenies, Bernd/C-6509-2009	Suttorp, Norbert/0000-0002-3958-1151; Lepenies, Bernd/0000-0001-9033-5522; Rabes, Anne/0000-0003-0495-5931; Lang, Roland/0000-0003-0502-3677; Opitz, Bastian/0000-0003-1276-836X	Deutsche Forschungsgemeinschaft [GRK1673/B5, OP 86/7-2, SFB/TR84, C3/6, B1, A1/A5, SFB765, B8, SFB796, B6]; IMPRS on Multiscale Bio-Systems; German Federal Ministry of Education and Research (BMBF) [Fkz. 0315446, 01ZX1304B]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IMPRS on Multiscale Bio-Systems; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Deutsche Forschungsgemeinschaft (GRK1673/B5 to A.R., M.W. and B.O., OP 86/7-2 to M.W. and B.O., SFB/TR84 project C3/6 to M.W., project B1 to N.S., and project A1/A5 to B.O., SFB765 project B8 to P.H.S. and B.L., and SFB796 project B6 to R. L.). S.Z. and B.L. acknowledge funding by the IMPRS on Multiscale Bio-Systems. Funding by the German Federal Ministry of Education and Research (BMBF, Fkz. 0315446 to B.L. and 01ZX1304B to M.W.) is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyta M, 2003, INFECT IMMUN, V71, P218, DOI 10.1128/IAI.71.1.218-225.2003; Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Balch SG, 2002, EUR J IMMUNOGENET, V29, P61, DOI 10.1046/j.1365-2370.2002.00266.x; Bugarcic A, 2008, GLYCOBIOLOGY, V18, P679, DOI 10.1093/glycob/cwn046; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Eriksson M, 2014, CHEMBIOCHEM, V15, P844, DOI 10.1002/cbic.201300764; Fang RD, 2011, J IMMUNOL, V187, P4890, DOI 10.4049/jimmunol.1100381; Feinberg H, 2013, J BIOL CHEM, V288, P28457, DOI 10.1074/jbc.M113.497149; Flornes LM, 2004, IMMUNOGENETICS, V56, P506, DOI 10.1007/s00251-004-0714-x; Furukawa A, 2013, P NATL ACAD SCI USA, V110, P17438, DOI 10.1073/pnas.1312649110; Gisch N, 2013, J BIOL CHEM, V288, P15654, DOI 10.1074/jbc.M112.446963; Hoving JC, 2014, CELL MICROBIOL, V16, P185, DOI 10.1111/cmi.12249; Hutter J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103281; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Jegouzo SAF, 2014, GLYCOBIOLOGY, V24, P1291, DOI 10.1093/glycob/cwu072; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kang YS, 2004, P NATL ACAD SCI USA, V101, P215, DOI 10.1073/pnas.0307124101; Kerscher B, 2013, INT IMMUNOL, V25, P271, DOI 10.1093/intimm/dxt006; Knapp S, 2004, J IMMUNOL, V172, P3132, DOI 10.4049/jimmunol.172.5.3132; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Koppe U, 2012, J IMMUNOL, V188, P811, DOI 10.4049/jimmunol.1004143; Koppel EA, 2005, EUR J IMMUNOL, V35, P2962, DOI 10.1002/eji.200526216; Lanoue A, 2004, J EXP MED, V200, P1383, DOI 10.1084/jem.20040795; Lee WB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002614; Lepenies B, 2013, ADV DRUG DELIVER REV, V65, P1271, DOI 10.1016/j.addr.2013.05.007; Maglinao M, 2014, J CONTROL RELEASE, V175, P36, DOI 10.1016/j.jconrel.2013.12.011; Maglinao M, 2013, J IMMUNOL, V191, P2551, DOI 10.4049/jimmunol.1203451; Matsunaga I, 2009, J EXP MED, V206, P2865, DOI 10.1084/jem.20092533; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Neumann K, 2014, IMMUNITY, V40, P389, DOI 10.1016/j.immuni.2013.12.015; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Schlegel MK, 2011, CHEMBIOCHEM, V12, P2791, DOI 10.1002/cbic.201100511; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Sharma A, 2014, J INFECT DIS, V209, P1837, DOI 10.1093/infdis/jit820; Standish AJ, 2009, J IMMUNOL, V183, P2602, DOI 10.4049/jimmunol.0900688; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Wevers BA, 2014, CELL HOST MICROBE, V15, P494, DOI 10.1016/j.chom.2014.03.008; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yoshimura A, 1999, J IMMUNOL, V163, P1	50	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117022	10.1371/journal.pone.0117022	http://dx.doi.org/10.1371/journal.pone.0117022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658823	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900093
J	Sekandi, JN; Dobbin, K; Oloya, J; Okwera, A; Whalen, CC; Corso, PS				Sekandi, Juliet N.; Dobbin, Kevin; Oloya, James; Okwera, Alphonse; Whalen, Christopher C.; Corso, Phaedra S.			Cost-Effectiveness Analysis of Community Active Case Finding and Household Contact Investigation for Tuberculosis Case Detection in Urban Africa	PLOS ONE			English	Article							SMEAR-POSITIVE TUBERCULOSIS; MIDDLE-INCOME COUNTRIES; GAMMA RELEASE ASSAY; CHEST-X-RAY; PULMONARY TUBERCULOSIS; SOUTHERN ETHIOPIA; CLASSIC SYMPTOMS; CLOSE CONTACTS; STRATEGIES; KAMPALA	Introduction Case detection by passive case finding (PCF) strategy alone is inadequate for detecting all tuberculosis (TB) cases in high burden settings especially Sub-Saharan Africa. Alternative case detection strategies such as community Active Case Finding (ACF) and Household Contact Investigations (HCI) are effective but empirical evidence of their cost-effectiveness is sparse. The objective of this study was to determine whether adding ACF or HCI compared with standard PCF alone represent cost-effective alternative TB case detection strategies in urban Africa. Methods A static decision modeling framework was used to examine the costs and effectiveness of three TB case detection strategies: PCF alone, PCF+ACF, and PCF+HCI. Probability and cost estimates were obtained from National TB program data, primary studies conducted in Uganda, published literature and expert opinions. The analysis was performed from the societal and provider perspectives over a 1.5 year time-frame. The main effectiveness measure was the number of true TB cases detected and the outcome was incremental cost-effectiveness ratios (ICERs) expressed as cost in 2013 US$ per additional true TB case detected. Results Compared to PCF alone, the PCF+HCI strategy was cost-effective at US$443.62 per additional TB case detected. However, PCF+ACF was not cost-effective at US$1492.95 per additional TB case detected. Sensitivity analyses showed that PCF+ACF would be cost-effective if the prevalence of chronic cough in the population screened by ACF increased 10-fold from 4% to 40% and if the program costs for ACF were reduced by 50%. Conclusions Under our baseline assumptions, the addition of HCI to an existing PCF program presented a more cost-effective strategy than the addition of ACF in the context of an African city. Therefore, implementation of household contact investigations as a part of the recommended TB control strategy should be prioritized.	[Sekandi, Juliet N.; Dobbin, Kevin; Oloya, James; Whalen, Christopher C.] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Corso, Phaedra S.] Univ Georgia, Coll Publ Hlth, Dept Hlth Policy & Management, Athens, GA 30602 USA; [Sekandi, Juliet N.] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Okwera, Alphonse] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Makerere University; Makerere University	Sekandi, JN (corresponding author), Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.	Juliet.Sekandi@gmail.com	Sekandi, Juliet/AAO-4212-2020	Sekandi, Juliet/0000-0003-2430-1396	National Institutes of Health Office of the Director; Fogarty International Center; Office of AIDS Research; Operations Research on AIDS Care and Tuberculosis in Africa (ORACTA) grant; Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093856] Funding Source: NIH RePORTER	National Institutes of Health Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Operations Research on AIDS Care and Tuberculosis in Africa (ORACTA) grant; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research Partial funding support for primary data was obtained from the Operations Research on AIDS Care and Tuberculosis in Africa (ORACTA) grant, Doris Duke Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABER VR, 1980, TUBERCLE, V61, P123, DOI 10.1016/0041-3879(80)90001-X; Andrews JR, 2012, AIDS, V26, P987, DOI 10.1097/QAD.0b013e3283522d47; Ayles H, 2013, LANCET; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Azman AS, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0216-0; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Cohen R, 1996, CHEST, V109, P420, DOI 10.1378/chest.109.2.420; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Currie CSM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-130; Dasgupta K, 2000, AM J RESP CRIT CARE, V162, P2079, DOI 10.1164/ajrccm.162.6.2001111; Dasgupta K, 2005, EUR RESPIR J, V25, P1107, DOI 10.1183/09031936.05.00074004; Datiko DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009158; Dowdy DW, 2009, B WORLD HEALTH ORGAN, V87, P296, DOI 10.2471/BLT.08.054510; Drummond MF, 2015, METHODS EC EVALUATIO; Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469; Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000; Floyd K, 2003, INT J TUBERC LUNG D, V7, pS29; Floyd K, 2012, EUR RESPIR J, V40, P133, DOI 10.1183/09031936.00169411; Gold MR, 1996, COST EFFECTIVENESS H; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Government of Uganda, 2010, HLTH SECT STRAT PLAN; Guwatudde D, 2003, B WORLD HEALTH ORGAN, V81, P799; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Khan MA, 2002, HEALTH POLICY PLANN, V17, P178, DOI 10.1093/heapol/17.2.178; Kiwuwa MS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-122; Kowada A, 2008, MOL DIAGN THER, V12, P235, DOI 10.1007/BF03256289; Kowada A, 2010, MOL DIAGN THER, V14, P229, DOI 10.2165/11538610-000000000-00000; Laxminarayan R, 2007, EC BENEFIT TUBERCULO; LEVY H, 1989, CHEST, V95, P1193, DOI 10.1378/chest.95.6.1193; Lodi S, 2012, THORAX, DOI [10.1136/thoraxjnl-2012-202544, DOI 10.1136/THORAXJNL-2012-202544]; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039187; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Ministry of Health, 2010, MIN HLTH MAN NAT TB; Moalosi G, 2003, INT J TUBERC LUNG D, V7, pS80; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Mupere E, 2013, INT J TUBERC LUNG D, V17, P207, DOI 10.5588/ijtld.12.0160; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; Murray CJL, 1998, INT J TUBERC LUNG D, V2, pS9; Nakiyingi Lydia, 2012, BMC Res Notes, V5, P487, DOI 10.1186/1756-0500-5-487; Nienhaus A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-247; Nishikiori N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-97; Okello D, 2003, INT J TUBERC LUNG D, V7, pS72; Pooran A, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-7; Resch SC, 2006, PLOS MED, V3, P1048, DOI 10.1371/journal.pmed.0030241; Sekandi JN, 2014, INT J TUBERC LUNG D, V18, P13, DOI 10.5588/ijtld.13.0129; Sekandi JN, 2009, INT J TUBERC LUNG D, V13, P508; Shapiro A E, 2012, SYSTEMATIC REV ACTIV; Shapiro AE, 2012, AM J RESP CRIT CARE, V185, P1110, DOI 10.1164/rccm.201111-1941OC; Shargie EB, 2006, B WORLD HEALTH ORGAN, V84, P112, DOI 10.2471/BLT.05.024489; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Shrestha RK, 2006, INT J TUBERC LUNG D, V10, P656; Sinanovic E, 2003, INT J TUBERC LUNG D, V7, pS56; Tadesse T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028258; Tattevin P, 1999, CHEST, V115, P1248, DOI 10.1378/chest.115.5.1248; Uganda Bureau of Statistics (UBOS) and ICF, 2011, UG DEM HLTH SURV 201; Uganda Ministry of Health, 2010, NAT TB LEPR PROGR AN; van Cleeff MRA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-111; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Whalen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016137; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Bank, 2013, GDP PER CAP UG CURR; World Health Organization, 2011, GLOB TUB REP; World Health Organization, 2013, TUBERCULOSIS; Zarocostas J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6396	67	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117009	10.1371/journal.pone.0117009	http://dx.doi.org/10.1371/journal.pone.0117009			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658592	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900091
J	Skhosana, L; Steegen, K; Bronze, M; Lukhwareni, A; Letsoalo, E; Papathanasopoulos, MA; Carmona, SC; Stevens, WS				Skhosana, Lindiwe; Steegen, Kim; Bronze, Michelle; Lukhwareni, Azwidowi; Letsoalo, Esrom; Papathanasopoulos, Maria A.; Carmona, Sergio C.; Stevens, Wendy S.			High Prevalence of the K65R Mutation in HIV-1 Subtype C Infected Patients Failing Tenofovir-Based First-Line Regimens in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; DISOPROXIL FUMARATE; NAIVE PATIENTS; STAVUDINE; FAILURE; ACCUMULATION; GENOTYPE; ABACAVIR	Background Tenofovir (TDF) has replaced stavudine (d4T) as the preferred nucleoside reverse transcriptase inhibitor (NRTI) in first-line regimens in South Africa, but limited information is available on the resistance patterns that develop after the introduction of TDF. This study investigated the antiretroviral drug resistance patterns in South African HIV-1 subtype C-infected patients failing stavudine-(d4T) and tenofovir-(TDF) based first-line regimens and assess the suitability of TDF as the preferred first-line nucleotide reverse transcriptase inhibitor (NRTI). Methods Resistance patterns of HIV-1 from 160 adult patients virologically failing TDF- (n = 80) and d4T- (n = 80) based first-line regimens were retrospectively analyzed. The pol gene was sequenced using an in-house protocol and mutations were analysed using the IAS-USA 2014 Drug Resistance Mutation list. Results Compared to d4T-exposed patients (n = 7), patients failing on a TDF-containing regimen (n = 43) were almost 5 times more likely to present with a K65R mutation (aRR 4.86 95% CI 2.29 - 10.34). Y115F was absent in the d4T group, and detected in 13.8% (n = 11) of TDF-exposed patients, p = 0.0007. Virus from 9 of the 11 patients (82.0%) who developed the Y115F mutation also developed K65R. Intermediate or high-level resistance to most NRTIs was common in the TDF-treatment group, but these patients twice more likely to remain susceptible to AZT as compared to those exposed to d4T (aRR 2.09 95% CI 1.13 - 3.90). Conclusion The frequency of the TDF induced K65R mutation was higher in our setting compared to non-subtype C dominated countries. However, despite the higher frequency of cross-resistance to NRTIs, most patients remained susceptible to AZT, which is reflected in the South African treatment guidelines that recommend AZT as an essential component of second-line regimens.	[Skhosana, Lindiwe; Steegen, Kim; Bronze, Michelle; Letsoalo, Esrom; Papathanasopoulos, Maria A.; Carmona, Sergio C.; Stevens, Wendy S.] Univ Witwatersrand, Fac Hlth Sci, Dept Haematol & Mol Med, Johannesburg, South Africa; [Lukhwareni, Azwidowi; Carmona, Sergio C.; Stevens, Wendy S.] Charlotte Maxeke Johannesburg Acad Hosp, Natl Hlth Lab Serv, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand	Steegen, K (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Haematol & Mol Med, Johannesburg, South Africa.	kim.steegen@nhls.ac.za	Lukhwareni, Azwidowi/AAZ-8649-2021; Steegen, Kim/ABH-4471-2020; Steegen, K/AAF-6512-2020	Steegen, Kim/0000-0003-3226-7685; Lukhwareni, Azwidowi/0000-0002-4456-2270; Carmona, Sergio/0000-0002-6792-4748				Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; Coutsinos D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020208; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Etiebet MAA, 2013, AIDS, V27, P553, DOI 10.1097/QAD.0b013e32835b0f59; Fielding KL, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-93; Hamers RL, 2012, CLIN INFECT DIS, V54, P1660, DOI 10.1093/cid/cis254; Hoffmann CJ, 2013, ANTIVIR THER, V18, P915, DOI 10.3851/IMP2652; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Kuritzkes DR, 2004, JAIDS-J ACQ IMM DEF, V36, P600, DOI 10.1097/00126334-200405010-00008; Lukhwareni A, 2012, VALIDATION ROBUST IN; Margot NA, 2006, HIV MED, V7, P442, DOI 10.1111/j.1468-1293.2006.00404.x; Martinez-Cajas JL, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-11; Miller MD, 2004, J INFECT DIS, V189, P837, DOI 10.1086/381784; Miller V, 2000, AIDS, V14, P163, DOI 10.1097/00002030-200001280-00012; National Department of Health (NDOH), 2010, S AFR ANT TREATM GUI; NDoH, 2013, S AFR ANT TREATM GUI; NDoH, 2004, S AFR ANT TREATM GUI; Novitsky V, 2007, AIDS RES HUM RETROV, V23, P868, DOI 10.1089/aid.2006.0298; Parikh UM, 2006, J INFECT DIS, V194, P651, DOI 10.1086/505711; Sigaloff KCE, 2012, AIDS RES HUM RETROV, V28, P171, DOI 10.1089/aid.2011.0136; Stone C, 2004, ANTIMICROB AGENTS CH, V48, P1413, DOI 10.1128/AAC.48.4.1413-1415.2004; Sunpath H, 2012, AIDS, V26, P1679, DOI 10.1097/QAD.0b013e328356886d; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang MW, 2013, J INFECT DIS, V207, pS70, DOI 10.1093/infdis/jit114; Theys K, 2013, ANTIMICROB AGENTS CH, V57, P1053, DOI 10.1128/AAC.01668-12; Van Zyl GU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067188; Wallis C, 2009, AFFORDABLE IN HOUSE; Wallis CL, 2010, JAIDS-J ACQ IMM DEF, V53, P480, DOI 10.1097/QAI.0b013e3181bc478b; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642; WHO, 2013, GLOB UPD HIV TREATM	31	28	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118145	10.1371/journal.pone.0118145	http://dx.doi.org/10.1371/journal.pone.0118145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659108	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900266
J	Szulzewsky, F; Pelz, A; Feng, X; Synowitz, M; Markovic, D; Langmann, T; Holtman, IR; Wang, X; Eggen, BJL; Boddeke, HWGM; Hambardzumyan, D; Wolf, SA; Kettenmann, H				Szulzewsky, Frank; Pelz, Andreas; Feng, Xi; Synowitz, Michael; Markovic, Darko; Langmann, Thomas; Holtman, Inge R.; Wang, Xi; Eggen, Bart J. L.; Boddeke, Hendrikus W. G. M.; Hambardzumyan, Dolores; Wolf, Susanne A.; Kettenmann, Helmut			Glioma-Associated Microglia/Macrophages Display an Expression Profile Different from M1 and M2 Polarization and Highly Express Gpnmb and Spp1	PLOS ONE			English	Article							MELANOMA PROTEIN-B; MT1-MMP EXPRESSION; MALIGNANT GLIOMAS; AURISTATIN-E; IFN-GAMMA; DC-HIL; MACROPHAGES; GLIOBLASTOMA; GLYCOPROTEIN; MICROGLIA	Malignant glioma belong to the most aggressive neoplasms in humans with no successful treatment available. Patients suffering from glioblastoma multiforme (GBM), the highest-grade glioma, have an average survival time of only around one year after diagnosis. Both microglia and peripheral macrophages/monocytes accumulate within and around glioma, but fail to exert effective anti-tumor activity and even support tumor growth. Here we use microarray analysis to compare the expression profiles of glioma-associated microglia/macrophages and naive control cells. Samples were generated from CD11b(+) MACS-isolated cells from naive and GL261-implanted C57BL/6 mouse brains. Around 1000 genes were more than 2-fold up-or downregulated in glioma-associated microglia/macrophages when compared to control cells. A comparison with published data sets of M1, M2a,b,c-polarized macrophages revealed a gene expression pattern that has only partial overlap with any of the M1 or M2 gene expression patterns. Samples for the qRT-PCR validation of selected M1 and M2a,b,c-specific genes were generated from two different glioma mouse models and isolated by flow cytometry to distinguish between resident microglia and invading macrophages. We confirmed in both models the unique glioma-associated microglia/macrophage phenotype including a mixture of M1 and M2a,b,c-specific genes. To validate the expression of these genes in human we MACS-isolated CD11b(+) microglia/macrophages from GBM, lower grade brain tumors and control specimens. Apart from the M1/M2 gene analysis, we demonstrate that the expression of Gpnmb and Spp1 is highly upregulated in both murine and human glioma-associated microglia/macrophages. High expression of these genes has been associated with poor prognosis in human GBM, as indicated by patient survival data linked to gene expression data. We also show that microglia/macrophages are the predominant source of these transcripts in murine and human GBM. Our findings provide new potential targets for future anti-glioma therapy.	[Szulzewsky, Frank; Pelz, Andreas; Synowitz, Michael; Markovic, Darko; Wang, Xi; Wolf, Susanne A.; Kettenmann, Helmut] Max Delbruck Ctr Mol Med, Berlin, Germany; [Pelz, Andreas] Charite, Dept Expt Neurol, D-13353 Berlin, Germany; [Feng, Xi; Hambardzumyan, Dolores] Cleveland Clin, Dept Neurosci, Cleveland, OH 44106 USA; [Hambardzumyan, Dolores] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44106 USA; [Synowitz, Michael] Charite, Dept Neurosurg, D-13353 Berlin, Germany; [Markovic, Darko] Helios Clin, Dept Neurosurg, Berlin, Germany; [Langmann, Thomas] Univ Cologne, Dept Ophthalmol, D-50931 Cologne, Germany; [Holtman, Inge R.; Eggen, Bart J. L.; Boddeke, Hendrikus W. G. M.] Univ Groningen, Univ Med Ctr Groningen, Sect Med Physiol, Dept Neurosci, Groningen, Netherlands	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; University of Groningen	Kettenmann, H (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	Kettenmann@mdc-berlin.de	Langmann, Thomas/HHZ-9814-2022; Synowitz, Michael/G-2596-2012; Kettenmann, Helmut/AAJ-5142-2021; Feng, Xi/N-7160-2016; Szulzewsky, Frank/AAF-3906-2020; Wolf, Susanne/AAA-6598-2022; Holtman, Inge R./AAE-8655-2020; Wang, Xi/N-9527-2014	Langmann, Thomas/0000-0001-6826-529X; Feng, Xi/0000-0002-6920-1519; Wang, Xi/0000-0002-7572-6354; Kettenmann, Helmut/0000-0001-8208-0291; Holtman, Inge R./0000-0001-9752-4756; Szulzewsky, Frank/0000-0001-5710-9590; Pelz, Andreas/0000-0002-7111-6970; Wolf, Susanne/0000-0003-0922-8418	Deutsche Forschungsgemeinschaft [SFB-TRR43, KE 329/301]; NeuroCure; NIC [U01CA160882-01A1]; NATIONAL CANCER INSTITUTE [U01CA160882] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NeuroCure; NIC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB-TRR43, KE 329/301), NeuroCure and NIC Grant (U01CA160882-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; BROWN LF, 1994, AM J PATHOL, V145, P610; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Chung JS, 2007, J IMMUNOL, V179, P5778, DOI 10.4049/jimmunol.179.9.5778; Chung JS, 2007, BLOOD, V109, P4320, DOI 10.1182/blood-2006-11-053769; Chung JS, 2009, EUR J IMMUNOL, V39, P965, DOI 10.1002/eji.200838990; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Engler JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043339; Fong YC, 2009, LUNG CANCER, V64, P263, DOI 10.1016/j.lungcan.2008.09.003; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Huang JJ, 2012, BRAIN BEHAV, V2, P85, DOI 10.1002/brb3.39; Huang YJ, 2014, CANCER RES, V74, P1011, DOI 10.1158/0008-5472.CAN-13-1072; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jan HJ, 2010, NEURO-ONCOLOGY, V12, P58, DOI 10.1093/neuonc/nop013; Kees T, 2012, NEURO-ONCOLOGY, V14, P64, DOI 10.1093/neuonc/nor182; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kerber M, 2008, CANCER RES, V68, P7342, DOI 10.1158/0008-5472.CAN-07-6241; Kuan CT, 2011, INT J CANCER, V129, P111, DOI 10.1002/ijc.25645; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li A, 2013, MOGENE 10STTRANSCURP; Li W, 2012, NEURO-ONCOLOGY, V14, P958, DOI 10.1093/neuonc/nos116; Lu DY, 2012, NEURO-ONCOLOGY, V14, P1367, DOI 10.1093/neuonc/nos262; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Markovic DS, 2011, BRAIN BEHAV IMMUN, V25, P624, DOI 10.1016/j.bbi.2011.01.015; Markovic DS, 2009, P NATL ACAD SCI USA, V106, P12530, DOI 10.1073/pnas.0804273106; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; Naumovski L, 2010, CURR OPIN MOL THER, V12, P248; Olah M, 2012, GLIA, V60, P96, DOI 10.1002/glia.21251; Patel AP, 2014, SCIENCE; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Pong WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077571; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Riquelme P, 2013, MOL THER, V21, P409, DOI 10.1038/mt.2012.168; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Sarkar S, 2014, NAT NEUROSCI, V17, P46, DOI 10.1038/nn.3597; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sreekanthreddy P, 2010, CANCER EPIDEM BIOMAR, V19, P1409, DOI 10.1158/1055-9965.EPI-09-1077; Tse KF, 2006, CLIN CANCER RES, V12, P1373, DOI 10.1158/1078-0432.CCR-05-2018; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Vinnakota K, 2013, NEURO-ONCOLOGY, V15, P1457, DOI 10.1093/neuonc/not115; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Warnes GR, 2013, GPLOTS VARIOUS R PRO; Watters JJ, 2005, J NEUROSCI RES, V81, P447, DOI 10.1002/jnr.20485; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248; Young GR, 2012, NATURE, V491, P774, DOI 10.1038/nature11599; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang LY, 2009, GLIA, V57, P1458, DOI 10.1002/glia.20863; Zhou LT, 2012, NEOPLASMA, V59, P1, DOI 10.4149/neo_2012_001	65	244	247	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116644	10.1371/journal.pone.0116644	http://dx.doi.org/10.1371/journal.pone.0116644			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658639	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000349444900055
J	Tracy, CM; Kolesnikov, AV; Blake, DR; Chen, CK; Baehr, W; Kefalov, VJ; Willardson, BM				Tracy, Christopher M.; Kolesnikov, Alexander V.; Blake, Devon R.; Chen, Ching-Kang; Baehr, Wolfgang; Kefalov, Vladimir J.; Willardson, Barry M.			Retinal Cone Photoreceptors Require Phosducin-Like Protein 1 for G Protein Complex Assembly and Signaling	PLOS ONE			English	Article							GTPASE ACCELERATING PROTEIN; BETA-SUBUNIT; EXPRESSION LEVELS; GAMMA-SUBUNIT; RGS PROTEINS; MICE LACKING; MOUSE MODEL; ROD; TRANSDUCIN; LIGHT	G protein beta subunits (G beta) play essential roles in phototransduction as part of G protein beta gamma. (G beta gamma) and regulator of G protein signaling 9 (RGS9)-G beta(5) heterodimers. Both are obligate dimers that rely on the cytosolic chaperone CCT and its co-chaperone PhLP1 to form complexes from their nascent polypeptides. The importance of PhLP1 in the assembly process was recently demonstrated in vivo in a retinal rod-specific deletion of the Phlp1 gene. To test whether this is a general mechanism that also applies to other cell types, we disrupted the Phlp1 gene specifically in mouse cones and measured the effects on G protein expression and cone visual signal transduction. In PhLP1-deficient cones, expression of cone transducin (G(t2)) and RGS9-G beta(5) subunits was dramatically reduced, resulting in a 27-fold decrease in sensitivity and a 38-fold delay in cone photoresponse recovery. These results demonstrate the essential role of PhLP1 in cone G protein complex formation. Our findings reveal a common mechanism of G beta gamma and RGS9-G beta(5) assembly in rods and cones, highlighting the importance of PhLP1 and CCT-mediated G beta complex formation in G protein signaling.	[Tracy, Christopher M.; Blake, Devon R.; Willardson, Barry M.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; [Kolesnikov, Alexander V.; Kefalov, Vladimir J.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Chen, Ching-Kang] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Chen, Ching-Kang] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Brigham Young University; Washington University (WUSTL); Baylor College of Medicine; Baylor College of Medicine; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kefalov, VJ (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	kefalov@vision.wustl.edu; bmwillardson@chem.byu.edu	Kolesnikov, Alexander V/O-1840-2016	Kefalov, Vladimir/0000-0002-1659-008X; Willardson, Barry/0000-0002-8503-2268	United States National Institutes of Health [EY012287, EY019312, EY021126, EY08123, EY019298, EY014800-039003, EY013811, EY02228]; NATIONAL EYE INSTITUTE [R01EY019298, R01EY013811, R01EY019312, R24EY021126, R56EY013811, P30EY014800, R01EY008123, R01EY012287] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding provided by United States National Institutes of Health (www.nih.gov) grants EY012287 to BMW; EY019312 and EY021126 to VJK; EY08123, EY019298 and EY014800-039003 to WB; and EY013811 and EY02228 to CKC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshavsky VY, 2013, INVEST OPHTH VIS SCI, V54, P7725, DOI 10.1167/iovs.13-13281; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; BLANKS JC, 1984, INVEST OPHTH VIS SCI, V25, P546; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Chen FS, 2010, INVEST OPHTH VIS SCI, V51, P686, DOI 10.1167/iovs.09-4084; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; Dhingra A, 2012, J NEUROSCI, V32, P11343, DOI 10.1523/JNEUROSCI.1436-12.2012; FUNG BKK, 1983, J BIOL CHEM, V258, P495; Garzon J, 2002, NEUROPHARMACOLOGY, V42, P813, DOI 10.1016/S0028-3908(02)00027-8; HIGGINS JB, 1994, J BIOL CHEM, V269, P9067; Howlett AC, 2009, J BIOL CHEM, V284, P16386, DOI 10.1074/jbc.M900800200; Kefalov VJ, 2012, J BIOL CHEM, V287, P1635, DOI 10.1074/jbc.R111.303008; Kolesnikov AV, 2012, JOVE-J VIS EXP, DOI 10.3791/3424; Kolesnikov AV, 2011, J NEUROSCI, V31, P8067, DOI 10.1523/JNEUROSCI.0174-11.2011; Lai CWJ, 2013, J NEUROSCI, V33, P7941, DOI 10.1523/JNEUROSCI.5001-12.2013; Le YZ, 2006, ADV EXP MED BIOL, V572, P173; Le YZ, 2004, MOL VIS, V10, P1011; Lee BY, 2004, J BIOL CHEM, V279, P54008, DOI 10.1074/jbc.M405669200; LEE RH, 1992, J BIOL CHEM, V267, P24776; LEREA CL, 1986, SCIENCE, V234, P77, DOI 10.1126/science.3529395; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Lobanova ES, 2008, J NEUROSCI, V28, P3510, DOI 10.1523/JNEUROSCI.0338-08.2008; Lobanova ES, 2013, P NATL ACAD SCI USA, V110, P9986, DOI 10.1073/pnas.1305521110; Lobanova ES, 2010, J NEUROSCI, V30, P6815, DOI 10.1523/JNEUROSCI.0613-10.2010; Lyubarsky A, 2001, MOL VIS, V7, P71; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; Nikonov SS, 2013, J NEUROSCI, V33, P5182, DOI 10.1523/JNEUROSCI.5204-12.2013; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; ONG OC, 1995, J BIOL CHEM, V270, P8495, DOI 10.1074/jbc.270.15.8495; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Ritchey ER, 2010, NEUROSCIENCE, V169, P1376, DOI 10.1016/j.neuroscience.2010.05.081; SILLMAN AJ, 1969, VISION RES, V9, P1435, DOI 10.1016/0042-6989(69)90059-5; Thulin CD, 1999, MOL VIS, V5, pU13; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Wells CA, 2006, J BIOL CHEM, V281, P20221, DOI 10.1074/jbc.M602409200; Willardson Barry M, 2012, Subcell Biochem, V63, P131, DOI 10.1007/978-94-007-4765-4_8; Zhang T, 2012, INVEST OPHTH VIS SCI, V53, P3349, DOI 10.1167/iovs.12-9851; Zhang X, 2003, J NEUROSCI, V23, P1287, DOI 10.1523/JNEUROSCI.23-04-01287.2003	43	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117129	10.1371/journal.pone.0117129	http://dx.doi.org/10.1371/journal.pone.0117129			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659125	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900105
J	Wheeler, SE; Egloff, AM; Wang, L; James, CD; Hammerman, PS; Grandis, JR				Wheeler, Sarah E.; Egloff, Ann Marie; Wang, Lin; James, C. David; Hammerman, Peter S.; Grandis, Jennifer R.			Challenges in EGFRvIII Detection in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR-ALPHA; GENE-TRANSCRIPTION; PHASE-II; CANCER; EXPRESSION; BREAST; COMMON; TUMORIGENICITY; GLIOBLASTOMAS	Objective Head and neck squamous cell carcinoma (HNSCC) accounts for more than 5% of all cancers worldwide. The mortality rate of HNSCC has remained unchanged (approximately 50%) over the last few decades. Ubiquitous overexpression of wild type EGFR in many solid tumors has led to the development of EGFR targeted therapies. EGFR can be constitutively activated via several mechanisms including the truncated, EGFR variant III isoform (EGFRvIII). EGFRvIII lacks exons 2-7 and has been reported to be present in up to 20-40% of HNSCC. EGFRvIII has been shown to contribute to cetuximab resistance. The mechanisms leading to EGFRvIII expression in HNSCC are unknown. The present investigation was undertaken to determine the etiology of EGFRvIII in HNSCC. Materials and Methods Fixed HNSCC and glioma tissues were analyzed by fluorescence in situ hybridization for EGFR amplification. DNA and RNA from fresh frozen specimens were used to determine the presence of EGFRvIII transcripts and the mechanisms of expression via PCR, RT-PCR and RNA sequencing. Results Unlike glioma, EGFRvIII expression in HNSCC did not correlate with EGFR amplification. We found evidence of genomic deletion of the exon 2-7 in 6 of 7 HNSCC cases examined, however, the presence of genomic deletion did not always result in mRNA expression of EGFRvIII. RNA sequencing with automated alignment did not identify EGFRvIII due to microhomology between intron 1 and exon 8. RNA sequencing analyzed by manual alignment methods did not correlate well with RT-PCR and PCR findings. Conclusion These findings suggest that genomic deletion as well as additional regulatory mechanisms may contribute to EGFRvIII expression in HNSCC. Further, large scale automated alignment of sequencing are unlikely to identify EGFRvIII and an assay specifically designed to detect EGFRvIII may be necessary to detect this altered form of EGFR in HNSCC tumors.	[Wheeler, Sarah E.; Wang, Lin; Grandis, Jennifer R.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; [Egloff, Ann Marie; Grandis, Jennifer R.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA USA; [Egloff, Ann Marie; Grandis, Jennifer R.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [James, C. David] Northwestern Univ, Dept Neurol Surg, Chicago, IL 60611 USA; [Hammerman, Peter S.; Grandis, Jennifer R.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA USA; [Grandis, Jennifer R.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Grandis, JR (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	grandisjr@upmc.edu		Wheeler, Sarah/0000-0002-7851-9836	National Institutes of Health [P50CA097190, R01CA77308]; American Cancer Society [1F31DE020223]; NATIONAL CANCER INSTITUTE [P50CA097190, R01CA077308] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding for this study was provided by the following: Grant Support: (http://www.nih.gov/), National Institutes of Health: P50CA097190, R01CA77308, the American Cancer Society (JRG), 1F31DE020223 (SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldape KD, 2004, J NEUROPATH EXP NEUR, V63, P700, DOI 10.1093/jnen/63.7.700; Arteaga CL, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.35642; Belancio VP, 2010, SEMIN CANCER BIOL, V20, P200, DOI 10.1016/j.semcancer.2010.06.001; Brandt B, 2006, CLIN CANCER RES, V12, P7252, DOI 10.1158/1078-0432.CCR-06-0626; Bray F, 2012, INT J CANCER, DOI [10.1002/ijc.27983, DOI 10.1002/IJC.27983]; Chau NG, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-11; CHRYSOGELOS SA, 1993, NUCLEIC ACIDS RES, V21, P5736, DOI 10.1093/nar/21.24.5736; Del Vecchio CA, 2012, ONCOGENE, DOI [10.1038/onc.2012.584, DOI 10.1038/ONC.2012.584]; Dreyer JH, 2013, VIRCHOWS ARCH, V462, P381, DOI 10.1007/s00428-013-1393-5; EKSTRAND AJ, 1991, CANCER RES, V51, P2164; Frederick L, 2000, NEURO-ONCOLOGY, V2, P159, DOI 10.1093/neuonc/2.3.159; Gebhardt F, 1999, J BIOL CHEM, V274, P13176, DOI 10.1074/jbc.274.19.13176; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Grandis JR, 1996, CANCER-AM CANCER SOC, V78, P1284, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; GRANDIS JR, 1993, CANCER RES, V53, P3579; Haas-Kogan DA, 2005, JNCI-J NATL CANCER I, V97, P880, DOI 10.1093/jnci/dji161; Hegi ME, 2011, MOL CANCER THER, V10, P1102, DOI 10.1158/1535-7163.MCT-11-0048; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Ji HB, 2006, P NATL ACAD SCI USA, V103, P7817, DOI 10.1073/pnas.0510284103; Kastenhuber ER, 2014, ACTA NEUROPATHOL, V127, P747, DOI 10.1007/s00401-013-1217-3; Kim E, 2008, TRENDS GENET, V24, P7, DOI 10.1016/j.tig.2007.10.001; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Nagane M, 1996, CANCER RES, V56, P5079; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Smilek P, 2012, NEOPLASMA, V59, P508, DOI 10.4149/neo_2012_065; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; SUGAWA N, 1990, P NATL ACAD SCI USA, V87, P8602, DOI 10.1073/pnas.87.21.8602; Tang CK, 2000, CANCER RES, V60, P3081; Tinhofer I, 2011, CLIN CANCER RES, V17, P5197, DOI 10.1158/1078-0432.CCR-10-3338; Vermorken JB, 2007, J CLIN ONCOL, V25, P2171, DOI 10.1200/JCO.2006.06.7447; Wheeler SE, 2010, ONCOGENE, V29, P5135, DOI 10.1038/onc.2009.279; Wheeler S, 2012, CLIN CANCER RES, V18, P2278, DOI 10.1158/1078-0432.CCR-11-1593; Wheeler SE, 2012, CLIN CANCER RES, V18, P2850, DOI 10.1158/1078-0432.CCR-11-2486; WIKSTRAND CJ, 1995, CANCER RES, V55, P3140	41	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117781	10.1371/journal.pone.0117781	http://dx.doi.org/10.1371/journal.pone.0117781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658924	Green Published, Green Accepted, gold			2022-12-27	WOS:000349444900220
J	Zhou, ZY; Zhou, XX; Li, J; Zhong, ZJ; Li, W; Liu, XH; Liu, FR; Su, HY; Luo, YJ; Gu, WY; Wang, CD; Zhang, HM; Li, DS; He, TM; Fu, HL; Cao, SZ; Shi, JJ; Peng, GN				Zhou, Ziyao; Zhou, Xiaoxiao; Li, Jin; Zhong, Zhijun; Li, Wei; Liu, Xuehan; Liu, Furui; Su, Huaiyi; Luo, Yongjiu; Gu, Wuyang; Wang, Chengdong; Zhang, Hemin; Li, Desheng; He, Tingmei; Fu, Hualin; Cao, Suizhong; Shi, Jinjiang; Peng, Guangneng			Transcriptional Regulation and Adaptation to a High-Fiber Environment in Bacillus subtilis HH2 Isolated from Feces of the Giant Panda	PLOS ONE			English	Article							GENOME SEQUENCE; BACTERIA; SPORULATION; DIVERSITY; IDENTIFICATION; 2-COMPONENT; ARCHAEA; SYSTEMS; RNAS	In the giant panda, adaptation to a high-fiber environment is a first step for the adequate functioning of intestinal bacteria, as the high cellulose content of the gut due to the panda's vegetarian appetite results in a harsh environment. As an excellent producer of several enzymes and vitamins, Bacillus subtilis imparts various advantages to animals. In our previous study, we determined that several strains of B. subtilis isolated from pandas exhibited good cellulose decomposition ability, and we hypothesized that this bacterial species can survive in and adapt well to a high-fiber environment. To evaluate this hypothesis, we employed RNA-Seq technology to analyze the differentially expressed genes of the selected strain B. subtilis HH2, which demonstrates significant cellulose hydrolysis of different carbon sources (cellulose and glucose). In addition, we used bioinformatics software and resources to analyze the functions and pathways of differentially expressed genes. Interestingly, comparison of the cellulose and glucose groups revealed that the up-regulated genes were involved in amino acid and lipid metabolism or transmembrane transport, both of which are involved in cellulose utilization. Conversely, the down-regulated genes were involved in non-essential functions for bacterial life, such as toxin and bacteriocin secretion, possibly to conserve energy for environmental adaptation. The results indicate that B. subtilis HH2 triggered a series of adaptive mechanisms at the transcriptional level, which suggests that this bacterium could act as a probiotic for pandas fed a high-fiber diet, despite the fact that cellulose is not a very suitable carbon source for this bacterial species. In this study, we present a model to understand the dynamic organization of and interactions between various functional and regulatory networks for unicellular organisms in a high-fiber environment.	[Zhou, Ziyao; Li, Jin; Zhong, Zhijun; Li, Wei; Liu, Xuehan; Liu, Furui; Su, Huaiyi; Luo, Yongjiu; Gu, Wuyang; Fu, Hualin; Cao, Suizhong; Shi, Jinjiang; Peng, Guangneng] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Yaan 625014, Peoples R China; [Zhou, Xiaoxiao] Chengdu Ctr Anim Dis Prevent & Control, Chengdu 610041, Peoples R China; [Wang, Chengdong; Zhang, Hemin; Li, Desheng; He, Tingmei] China Conservat & Res Ctr Giant Panda, Yaan Bifengxia Base, Yaan 625007, Peoples R China	Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University	Peng, GN (corresponding author), Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Yaan 625014, Peoples R China.	pgn.sicau@163.com			National Natural Science Foundation of China [31272620]; Sichuan Provincial Department of Science and Technology Support Program [2011NZ0060]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0848]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Provincial Department of Science and Technology Support Program; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (number 31272620), Sichuan Provincial Department of Science and Technology Support Program (number 2011NZ0060) and the Program for Changjiang Scholars and Innovative Research Team in University (number IRT0848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriouel H, 2011, FEMS MICROBIOL REV, V35, P201, DOI 10.1111/j.1574-6976.2010.00244.x; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Chen ZT, 2011, METHODS MOL BIOL, V733, P93, DOI 10.1007/978-1-61779-089-8_7; COHEN SS, 1951, J BIOL CHEM, V189, P617; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; Dintner S, 2011, J BACTERIOL, V193, P3851, DOI 10.1128/JB.05175-11; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050312; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111; Higgins CF, 1992, ANN REV CELL BIOL, V8, P67; Hottes AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003617; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Jin CZ, 2007, P NATL ACAD SCI USA, V104, P10932, DOI 10.1073/pnas.0704198104; Jin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022602; Joseph P, 2002, J MOL MICROB BIOTECH, V4, P503; Kleijn RJ, 2010, J BIOL CHEM, V285, P1587, DOI 10.1074/jbc.M109.061747; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Konings WN, 2002, ANTON LEEUW INT J G, V81, P61, DOI 10.1023/A:1020573408652; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; MartinezHackert E, 1997, J MOL BIOL, V269, P301, DOI 10.1006/jmbi.1997.1065; Meyer M, 2010, COLD SPRING HARBOR P; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sadaie Y, 2008, FEMS MICROBIOL LETT, V279, P103, DOI 10.1111/j.1574-6968.2007.01018.x; Schallmey M, 2004, CAN J MICROBIOL, V50, P1, DOI 10.1139/W03-076; Schultz D, 2009, P NATL ACAD SCI USA, V106, P21027, DOI 10.1073/pnas.0912185106; Stephens C, 1998, CURR BIOL, V8, pR45, DOI 10.1016/S0960-9822(98)70031-4; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tun HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079902; Widner B, 2005, APPL ENVIRON MICROB, V71, P3747, DOI 10.1128/AEM.71.7.3747-3752.2005; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Yano K, 2013, MICROBIOL-SGM, V159, P2225, DOI 10.1099/mic.0.067025-0; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042; Zhou Xiao-xiao, 2013, Zhongguo Shouyi Kexue, V43, P1115; Zhou ZY, 2014, WORLD J MICROB BIOT, V30, P3129, DOI 10.1007/s11274-014-1740-y; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108	42	9	13	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116935	10.1371/journal.pone.0116935	http://dx.doi.org/10.1371/journal.pone.0116935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658435	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900081
J	Hansen, GJA; Carey, CC				Hansen, Gretchen J. A.; Carey, Cayelan C.			Fish and Phytoplankton Exhibit Contrasting Temporal Species Abundance Patterns in a Dynamic North Temperate Lake	PLOS ONE			English	Article							INTERANNUAL VARIABILITY; COMMUNITY; DIVERSITY; CORE; DISTRIBUTIONS; MACROECOLOGY; ZOOPLANKTON; ASSEMBLAGES; TURNOVER; INSIGHTS	Temporal patterns of species abundance, although less well-studied than spatial patterns, provide valuable insight to the processes governing community assembly. We compared temporal abundance distributions of two communities, phytoplankton and fish, in a north temperate lake. We used both 17 years of observed relative abundance data as well as resampled data from Monte Carlo simulations to account for the possible effects of non-detection of rare species. Similar to what has been found in other communities, phytoplankton and fish species that appeared more frequently were generally more abundant than rare species. However, neither community exhibited two distinct groups of "core" (common occurrence and high abundance) and "occasional" (rare occurrence and low abundance) species. Both observed and resampled data show that the phytoplankton community was dominated by occasional species appearing in only one year that exhibited large variation in their abundances, while the fish community was dominated by core species occurring in all 17 years at high abundances. We hypothesize that the life-history traits that enable phytoplankton to persist in highly dynamic environments may result in communities dominated by occasional species capable of reaching high abundances when conditions allow. Conversely, longer turnover times and broad environmental tolerances of fish may result in communities dominated by core species structured primarily by competitive interactions.	[Hansen, Gretchen J. A.] Wisconsin Dept Nat Resources, Sci Serv, Madison, WI USA; [Carey, Cayelan C.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Carey, CC (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	cayelan@vt.edu	Carey, Cayelan/D-4874-2016	Carey, Cayelan/0000-0001-8835-4476; Hansen, Gretchen/0000-0003-0241-7048	U.S. National Science Foundation through the Riparian Land, People, and Lakes Biocomplexity Project [DEB-083545]; North Temperate Lakes Long-Term Ecological Research Program [DEB-9632853]; NSF [CDI-0941510]; Virginia Tech Department of Biological Sciences; Virginia Tech's Open Access Subvention Fund	U.S. National Science Foundation through the Riparian Land, People, and Lakes Biocomplexity Project(National Science Foundation (NSF)); North Temperate Lakes Long-Term Ecological Research Program; NSF(National Science Foundation (NSF)); Virginia Tech Department of Biological Sciences; Virginia Tech's Open Access Subvention Fund	The data collection for this study was supported by the U.S. National Science Foundation through the Riparian Land, People, and Lakes Biocomplexity Project (DEB-083545) and the North Temperate Lakes Long-Term Ecological Research Program (DEB-9632853). CCC was funded by NSF CDI-0941510 and the Virginia Tech Department of Biological Sciences. Virginia Tech's Open Access Subvention Fund provided funds for publication. The funders had no role in the study design, analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, FOOD WEB MANAGEMENT; Arnott SE, 1999, CAN J FISH AQUAT SCI, V56, P162, DOI 10.1139/cjfas-56-1-162; Becker G. C., 1983, FISHES WISCONSIN; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; BENSON BJ, 1992, CAN J FISH AQUAT SCI, V49, P1493, DOI 10.1139/f92-165; Blackburn TM, 1998, ECOL LETT, V1, P47, DOI 10.1046/j.1461-0248.1998.00005.x; Brock T.D., 1985, EUTROPHIC LAKE LAKE; BROWN JH, 1989, SCIENCE, V243, P1145, DOI 10.1126/science.243.4895.1145; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Carey CC, 2008, J PLANKTON RES, V30, P893, DOI 10.1093/plankt/fbn055; Chesson PL., 1986, COMMUNITY ECOL; Collins SL, 2000, AM NAT, V155, P311, DOI 10.1086/303326; COLLINS SL, 1991, ECOLOGY, V72, P654, DOI 10.2307/2937205; Dakos V, 2009, P ROY SOC B-BIOL SCI, V276, P2871, DOI 10.1098/rspb.2009.0584; Dolan JR, 2009, J BIOGEOGR, V36, P887, DOI 10.1111/j.1365-2699.2008.02046.x; Fisher JAD, 2010, GLOBAL ECOL BIOGEOGR, V19, P1, DOI 10.1111/j.1466-8238.2009.00482.x; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; GAEDKE U, 1992, LIMNOL OCEANOGR, V37, P1202, DOI 10.4319/lo.1992.37.6.1202; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; GASTON KJ, 1989, AM NAT, V134, P761, DOI 10.1086/285010; Genner MJ, 2004, P ROY SOC B-BIOL SCI, V271, P655, DOI 10.1098/rspb.2003.2651; Gibson DJ, 1999, J ECOL, V87, P1064, DOI 10.1046/j.1365-2745.1999.00424.x; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Guo QF, 2000, J ECOL, V88, P551, DOI 10.1046/j.1365-2745.2000.00466.x; HANSKI I, 1982, OIKOS, V38, P210, DOI 10.2307/3544021; Hanski I, 1996, J ANIM ECOL, V65, P274, DOI 10.2307/5874; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Jackson DA, 2001, CAN J FISH AQUAT SCI, V58, P157, DOI 10.1139/f00-239; Karlsson-Elfgren I, 2003, J PHYCOL, V39, P1050, DOI 10.1111/j.0022-3646.2003.03-030.x; Kitchell JF, 1992, FOOD WEB MANAGEMENTS; LATHROP RC, 1992, FOOD WEB MANAGEMENT, P99; LYONS J, 1987, T AM FISH SOC, V116, P29, DOI 10.1577/1548-8659(1987)116<29:EOWPOT>2.0.CO;2; MACARTHUR RH, 1957, P NATL ACAD SCI USA, V43, P293, DOI 10.1073/pnas.43.3.293; MAGNUSON JJ, 1994, AM ZOOL, V34, P437; Magurran A., 2010, BIOL DIVERSITY FRONT, P85; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Magurran AE, 2007, ECOL LETT, V10, P347, DOI 10.1111/j.1461-0248.2007.01024.x; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; May R.M., 1975, P81; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; NEE S, 1991, P ROY SOC B-BIOL SCI, V243, P161, DOI 10.1098/rspb.1991.0026; Oksanen J., 2020, VEGAN COMMUNITY ECOL; PRESTON FW, 1960, ECOLOGY, V41, P611, DOI 10.2307/1931793; Raybaud V, 2008, BIOGEOSCIENCES, V5, P1765, DOI 10.5194/bg-5-1765-2008; Reynolds CS, 1995, NATO ADV SCI INST SE, V38, P115; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Rigosi A, 2014, LIMNOL OCEANOGR, V59, P99, DOI 10.4319/lo.2014.59.1.0099; Scheffer M, 2003, HYDROBIOLOGIA, V491, P9, DOI 10.1023/A:1024404804748; Scrosati RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018982; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; Ulrich W, 2004, DIVERS DISTRIB, V10, P263, DOI 10.1111/j.1366-9516.2004.00082.x; Uthermol H., 1958, MITTEILINGEN INTERNA, V9, P1, DOI [10.1080/0 5384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; Vergnon R, 2009, ECOL LETT, V12, P1079, DOI 10.1111/j.1461-0248.2009.01364.x; Waters T.F., 1977, Advances in Ecological Research, V10, P91, DOI 10.1016/S0065-2504(08)60235-4; WEAVER MJ, 1993, T AM FISH SOC, V122, P1111, DOI 10.1577/1548-8659(1993)122<1111:AFDLFA>2.3.CO;2; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Williams C. B., 1964, PATTERNS BALANCE NAT; WILLIAMS CB, 1953, J ANIM ECOL, V22, P14, DOI 10.2307/1687	59	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0115414	10.1371/journal.pone.0115414	http://dx.doi.org/10.1371/journal.pone.0115414			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25651399	Green Published, gold, Green Submitted			2022-12-27	WOS:000349250700001
J	Li, YQ; Yang, HZ; Liu, N; Luo, JX; Wang, Q; Wang, L				Li, Yongquan; Yang, Huizhen; Liu, Na; Luo, Jixian; Wang, Qian; Wang, Lan			Cadmium Accumulation and Metallothionein Biosynthesis in Cadmium-Treated Freshwater Mussel Anodonta woodiana	PLOS ONE			English	Article							TISSUE-SPECIFIC CADMIUM; DIGESTIVE GLAND; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; METAL EXPOSURE; MYTILUS-EDULIS; PROTEIN-LEVELS; INDUCTION; BIOMARKER; BIVALVES	This study investigated the distribution of cadmium (Cd) and the protein level of metallothionein (MT) and examined the relationship of Cd accumulation and the MT concentration in different tissues of freshwater mussel Anodonta woodiana following Cd treatment. The mussels were exposed to Cd (4.21, 8.43, 16.86, 33.72 and 67.45 mg L-1) for 24, 48, 72 and 96 h, respectively. After Cd treatment, the gills, mantle, foot, visceral mass and digestive gland tissues were collected for analysis. We found that, in the controls, Cd distributed in all tissues in the concentration order of gills>mantle>foot>visceral mass>digestive gland. Upon Cd treatment, Cd concentration significantly increased in all tissues. The highest Cd accumulation was found in the digestive gland, which was 0.142 mg g(-1) (P< 0.05). MT levels in the gills and mantle of the mussels increased significantly (P< 0.05), which were in positive correlation with Cd accumulation in the tissues (P< 0.05). In conclusion, our results demonstrated a correlation between Cd accumulation and MT up-regulation in gills and mantle of the mussels after Cd treatment. It is suggested that the protein level of MT in gills and mantle of Anodonta woodiana is a good biomarker for Cd contamination.	[Li, Yongquan; Yang, Huizhen; Liu, Na; Luo, Jixian; Wang, Qian; Wang, Lan] Shanxi Univ, Sch Life Sci, Taiyuan 030006, Peoples R China	Shanxi University	Wang, L (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan 030006, Peoples R China.	cnlanwang@sxu.edu.cn			Doctor Subject Foundation of the Ministry of Education of China [20111401110010]; Youth Science Foundation Project of Shanxi, China [2013021022-4]	Doctor Subject Foundation of the Ministry of Education of China(Ministry of Education, China); Youth Science Foundation Project of Shanxi, China	This research was supported by the Doctor Subject Foundation of the Ministry of Education of China (No. 20111401110010) and the Youth Science Foundation Project of Shanxi, China (No. 2013021022-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiard JC, 2006, AQUAT TOXICOL, V76, P160, DOI 10.1016/j.aquatox.2005.08.015; AMIARD JC, 1987, WATER RES, V21, P693, DOI 10.1016/0043-1354(87)90081-9; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Barka S, 2001, COMP BIOCHEM PHYS C, V128, P479, DOI 10.1016/S1532-0456(00)00198-8; BEBIANNO MJ, 1993, AQUAT TOXICOL, V27, P315, DOI 10.1016/0166-445X(93)90061-5; BEBIANNO MJ, 1991, MAR BIOL, V108, P91, DOI 10.1007/BF01313475; BEBIANNO MJ, 1992, COMP BIOCHEM PHYS C, V103, P79, DOI 10.1016/0742-8413(92)90231-U; Berthet B, 2003, ARCH ENVIRON CON TOX, V45, P468, DOI 10.1007/s00244-003-0135-0; Blaise C, 2002, ENVIRON TOXICOL, V17, P170, DOI 10.1002/tox.10048; Boening DW, 1999, ENVIRON MONIT ASSESS, V55, P459, DOI 10.1023/A:1005995217901; Bourdineaud JP, 2006, BIOCHIMIE, V88, P1787, DOI 10.1016/j.biochi.2006.07.021; Burger J, 2008, SCI TOTAL ENVIRON, V389, P37, DOI 10.1016/j.scitotenv.2007.08.037; Bustamante P, 2002, MAR ENVIRON RES, V53, P227, DOI 10.1016/S0141-1136(01)00108-8; Cajaraville MP, 2000, SCI TOTAL ENVIRON, V247, P295, DOI 10.1016/S0048-9697(99)00499-4; Campbell PGC, 2006, ENVIRON CHEM, V3, P387, DOI 10.1071/EN06075; Campbell PGC, 2005, AQUAT TOXICOL, V72, P83, DOI 10.1016/j.aquatox.2004.11.023; Clements William H., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P113, DOI 10.1023/A:1009927612391; Corsi I, 2007, COMP BIOCHEM PHYS C, V145, P413, DOI 10.1016/j.cbpc.2007.01.011; Cosson RP, 2000, CELL MOL BIOL, V46, P295; Cossu C, 1997, ECOTOX ENVIRON SAFE, V38, P122, DOI 10.1006/eesa.1997.1582; COUILLARD Y, 1993, LIMNOL OCEANOGR, V38, P299, DOI 10.4319/lo.1993.38.2.0299; Dallinger R, 1995, MECH METAL INCORPORA, P135; Dalton T, 1997, COMP BIOCHEM PHYS B, V116, P75, DOI 10.1016/S0305-0491(96)00224-6; DALTON T, 1994, NUCLEIC ACIDS RES, V22, P5016, DOI 10.1093/nar/22.23.5016; Enshaei M, 2010, IRAN J ENVIRON HEALT, V7, P287; Fingerman M, 1996, ZOOL STUD, V35, P1; Geffard A, 2001, BIOMARKERS, V6, P91, DOI 10.1080/13547500010000860; Geret F, 2000, OCEANOL ACTA, V23, P261, DOI 10.1016/S0399-1784(00)00118-3; Giamberini L, 2005, ENVIRON RES, V98, P210, DOI 10.1016/j.envres.2004.11.003; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; Haq F, 2003, MUTAT RES-FUND MOL M, V533, P211, DOI 10.1016/j.mrfmmm.2003.07.014; Isani G, 2000, CELL MOL BIOL, V46, P311; Kalman J, 2010, ECOTOX ENVIRON SAFE, V73, P306, DOI 10.1016/j.ecoenv.2009.10.013; Kim BH, 2011, ECOL ENG, V37, P1957, DOI 10.1016/j.ecoleng.2011.08.008; Ladhar-Chaabouni R, 2012, ENVIRON MONIT ASSESS, V184, P2177, DOI 10.1007/s10661-011-2108-5; Langston William J., 1998, Chapman & Hall Ecotoxicology Series, V7, P219; Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080475; Liu LY, 2009, GEN ZOOLOGY, P208, DOI [10.1016/j.mrgentox.2009.07.012, DOI 10.1016/J.MRGENTOX.2009.07.012]; Ma WL, 2009, ARCH ENVIRON CON TOX, V56, P747, DOI 10.1007/s00244-008-9224-4; Ma WL, 2008, ENVIRON TOXICOL, V23, P393, DOI 10.1002/tox.20339; Mao H, 2012, AQUAT TOXICOL, V110, P208, DOI 10.1016/j.aquatox.2012.01.018; Marie V, 2006, BIOMETALS, V19, P399, DOI 10.1007/s10534-005-4064-4; MOORE MN, 1990, HISTOCHEM J, V22, P187, DOI 10.1007/BF02386003; Novelli JLVB, 2000, INT J ENVIRON HEAL R, V10, P125, DOI 10.1080/09603120050021128; ONOSAKA S, 1982, TOXICOL APPL PHARM, V63, P270, DOI 10.1016/0041-008X(82)90049-7; PALMITER RD, 1994, P NATL ACAD SCI USA, V91, P1219, DOI 10.1073/pnas.91.4.1219; Pedersen SN, 1996, MAR ENVIRON RES, V42, P241, DOI 10.1016/0141-1136(96)00077-3; Pellerin J, 2009, COMP BIOCHEM PHYS C, V150, P186, DOI 10.1016/j.cbpc.2009.04.008; Perceval O, 2002, ENVIRON POLLUT, V118, P5, DOI 10.1016/S0269-7491(01)00282-2; Rajalakshmi S, 2005, ECOTOX ENVIRON SAFE, V62, P140, DOI 10.1016/j.ecoenv.2005.01.003; Roesijadi G, 1996, COMP BIOCHEM PHYS C, V113, P117, DOI 10.1016/0742-8413(95)02077-2; Siegel A., 2009, METAL IONS LIFE SCI, V5, P51; Silvestre F, 2005, COMP BIOCHEM PHYS C, V140, P39, DOI 10.1016/j.cca.2005.01.004; STUART GW, 1984, P NATL ACAD SCI-BIOL, V81, P7318, DOI 10.1073/pnas.81.23.7318; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; Viarengo A, 1997, MAR ENVIRON RES, V44, P69, DOI 10.1016/S0141-1136(96)00103-1; VIARENGO A, 1993, COMP BIOCHEM PHYS C, V104, P355, DOI 10.1016/0742-8413(93)90001-2; VIARENGO A, 1985, MAR ENVIRON RES, V16, P23, DOI 10.1016/0141-1136(85)90018-2; Wang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064020; Wu JP, 2005, COMP BIOCHEM PHYS C, V140, P383, DOI 10.1016/j.cca.2005.03.006; [邢慧芳 Xing Huifang], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P856; Zhou QF, 2003, ENVIRON POLLUT, V125, P301, DOI 10.1016/S0269-7491(03)00145-3; Zorita I, 2007, TOXICOL APPL PHARM, V220, P186, DOI 10.1016/j.taap.2007.01.003; Zorita I, 2005, BIOMARKERS, V10, P342, DOI 10.1080/13547500500264645	64	45	50	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117037	10.1371/journal.pone.0117037	http://dx.doi.org/10.1371/journal.pone.0117037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647043	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600050
J	Wiggers, N; Nauwelaerts, SLP; Hobbs, SJ; Bool, S; Wolschrijn, CF; Back, W				Wiggers, Nathan; Nauwelaerts, Sandra L. P.; Hobbs, Sarah Jane; Bool, Sophie; Wolschrijn, Claudia F.; Back, Willem			Functional Locomotor Consequences of Uneven Forefeet for Trot Symmetry in Individual Riding Horses	PLOS ONE			English	Article							GROUND REACTION FORCES; SWEDISH WARMBLOOD; 3D KINEMATICS; 3-DIMENSIONAL KINEMATICS; FOOT CONFORMATION; DISTAL FORELIMB; HOOF ANGLE; FRONT FEET; LAMENESS; PERFORMANCE	Left-right symmetrical distal limb conformation can be an important prerequisite for a successful performance, and it is often hypothesized that asymmetric or uneven feet are important enhancing factors for the development of lameness. On a population level, it has been demonstrated that uneven footed horses are retiring earlier from elite level competition, but the biomechanical consequences are not yet known. The objectives of this study were to compare the functional locomotor asymmetries of horses with uneven to those with even feet. Hoof kinetics and distal limb kinematics were collected from horses (n = 34) at trot. Dorsal hoof wall angle was used to classify horses as even or uneven (< 1.5 and > 1.5 degrees difference between forefeet respectively) and individual feet as flat (< 50 degrees), medium (between 50 degrees and 55 degrees) or upright (> 55 degrees). Functional kinetic parameters were compared between even and uneven forefeet using MANOVA followed by ANOVA. The relative influences of differences in hoof angle between the forefeet and of absolute hoof angle on functional parameters were analysed using multiple regression analysis (P<0.05). In horses with uneven feet, the side with the flatter foot showed a significantly larger maximal horizontal braking and vertical ground reaction force, a larger vertical fetlock displacement and a suppler fetlock spring. The foot with a steeper hoof angle was linearly correlated with an earlier braking-propulsion transition. The conformational differences between both forefeet were more important for loading characteristics than the individual foot conformation of each individual horse. The differences in vertical force and braking force between uneven forefeet could imply either an asymmetrical loading pattern without a pathological component or a subclinical lameness as a result of a pathological development in the steeper foot.	[Wiggers, Nathan; Bool, Sophie; Back, Willem] Univ Utrecht, Fac Vet Med, Dept Equine Sci, Utrecht, Netherlands; [Nauwelaerts, Sandra L. P.] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Hobbs, Sarah Jane] Univ Cent Lancashire, Ctr Appl Sport & Exercise Sci, Preston PR1 2HE, Lancs, England; [Wolschrijn, Claudia F.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Back, Willem] Univ Ghent, Fac Vet Med, Dept Surg & Anaesthesiol, Merelbeke, Belgium	Utrecht University; University of Antwerp; University of Central Lancashire; Utrecht University; Ghent University	Hobbs, SJ (corresponding author), Univ Cent Lancashire, Ctr Appl Sport & Exercise Sci, Preston PR1 2HE, Lancs, England.	sjhobbs1@uclan.ac.uk		Hobbs, Sarah Jane/0000-0002-1552-8647	University of Central Lancashire; Utrecht University; University of Antwerp	University of Central Lancashire; Utrecht University; University of Antwerp	This work was funded by the the University of Central Lancashire, Utrecht University and the University of Antwerp in relation to resources needed to undertake the study. In addition, Qualisys AB kindly provided 1000 pound towards costs and Kistler Instrument Corp loaned equipment FOC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TM, 2004, EQUINE VET J, V36, P571, DOI 10.2746/0425164044864462; Back W, 2007, J EQUINE VET SCI, V27, P123, DOI 10.1016/j.jevs.2007.01.007; Back W., 2013, EQUINE LOCOMOTION, P175; BALCH O, 1995, COMP CONT EDUC PRACT, V17, P1275; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Chateau H, 2006, EQUINE VET J, V38, P164, DOI 10.2746/042516406776563260; Chateau H, 2004, EQUINE VET J, V36, P649, DOI 10.2746/0425164044848217; Chateau H, 2013, VET J, V198, pE20, DOI 10.1016/j.tvjl.2013.09.028; Clayton HM, 2007, VET COMP ORTHOPAED, V20, P86, DOI 10.1160/VCOT-07-01-0011; Clayton HM, 2007, VET COMP ORTHOPAED, V20, P1; Clayton H M, 1990, Equine Vet J Suppl, P86; Clayton HM, 2000, AM J VET RES, V61, P191, DOI 10.2460/ajvr.2000.61.191; CLAYTON HM, 1988, PROC ANN CONV AM ASS, V33, P289; Ducro BJ, 2009, EQUINE VET J, V41, P139, DOI 10.2746/042516409X366130; Ducro BJ, 2009, EQUINE VET J, V41, P144, DOI 10.2746/042516408X363800; DYCE KM, 2009, TXB VET ANATOMY, P586; FARLEY CT, 1993, J EXP BIOL, V185, P71; Gustas P, 2001, Equine Vet J Suppl, P11; Hobbs SJ, 2006, AM J VET RES, V67, P1511, DOI 10.2460/ajvr.67.9.1511; Jonsson L, 2014, LIVEST SCI, V163, P12, DOI 10.1016/j.livsci.2014.02.010; Jonsson L, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-34; Kane AJ, 1998, AM J VET RES, V59, P1545; Kaneene JB, 1997, PREV VET MED, V29, P277, DOI 10.1016/S0167-5877(96)01080-X; Keegan KG, 2010, EQUINE VET J, V42, P92, DOI 10.2746/042516409X479568; KEELING LK, 2001, SOCIAL BEHAV FARM AN, P59; Kroekenstoel AM, 2006, EQUINE VET J, V38, P652, DOI 10.2746/042516406X159089; Kummer M, 2006, VET J, V172, P58, DOI 10.1016/j.tvjl.2005.03.008; McGuigan MP, 2003, J EXP BIOL, V206, P1325, DOI 10.1242/jeb.00254; MCMAHON TA, 1990, J BIOMECH, V23, P65, DOI 10.1016/0021-9290(90)90042-2; Moleman M, 2006, EQUINE VET J, V38, P170, DOI 10.2746/042516406776563242; Moleman M, 2005, EQUINE VET EDUC, V17, P319, DOI 10.1111/j.2042-3292.2005.tb00401.x; Morris E., 1987, EQUINE EXERC PHYSL, V2, P553; Parkes RSV, 2009, EQUINE VET J, V41, P112, DOI 10.2746/042516408X343000; Parks A.H., 2003, DIAGNOSIS MANAGEMENT, P250; Robertson DGE, 2003, J ELECTROMYOGR KINES, V13, P569, DOI 10.1016/S1050-6411(03)00080-4; Scheffer CJW, 2001, VET QUART, V23, P191, DOI 10.1080/01652176.2001.9695111; Starke SD, 2012, VET J, V193, P73, DOI 10.1016/j.tvjl.2011.10.019; Stashak TS, 2002, ADAMS LAMENESS HORSE, V6th, P1081; van Heel MCV, 2006, EQUINE VET J, V38, P646, DOI 10.2746/042516406X159070; van Heel MCV, 2010, EQUINE VET J, V42, P444, DOI 10.1111/j.2042-3306.2010.00064.x; VELLEMAN PF, 1981, APPL BASICS COMPUTIN, P48; Wallin L, 2000, LIVEST PROD SCI, V63, P275, DOI 10.1016/S0301-6226(99)00126-8; Wallin L, 2001, LIVEST PROD SCI, V68, P97, DOI 10.1016/S0301-6226(00)00244-X; Weishaupt MA, 2006, VET J, V171, P135, DOI 10.1016/j.tvjl.2004.09.004; Willemen MA, 1999, EQUINE VET J, V31, P25, DOI 10.1111/j.2042-3306.1999.tb03787.x; Wilson AM, 1998, EQUINE VET J, V30, P540, DOI 10.1111/j.2042-3306.1998.tb04531.x	47	23	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0114836	10.1371/journal.pone.0114836	http://dx.doi.org/10.1371/journal.pone.0114836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646752	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600007
J	Zhang, ZH; Yin, JY; Chen, JDZ				Zhang, Zhaohui; Yin, Jieyun; Chen, Jiande D. Z.			Ameliorating Effects of Auricular Electroacupuncture on Rectal Distention-Induced Gastric Dysrhythmias in Rats	PLOS ONE			English	Article							IMPROVES DYSPEPTIC SYMPTOMS; MYOELECTRICAL ACTIVITY; ELECTRICAL-STIMULATION; SLOW WAVES; ACUPUNCTURE; MECHANISMS; MOTILITY; IMPAIRMENT	Gastric slow waves (GSW) are known to regulate gastric motility and are impaired with rectal distention (RD). Electroacupuncture (EA) at body acupoints, such as ST 36, has been shown to improve gastric dysrhythmias; however, little is known about the possible effects of auricular electroacupuncture (AEA) on GSW. To study effects and possible mechanisms of AEA on RD-induced gastric dysrhythmias in rats, ten male Sprague-Dawley (SD) rats implanted with gastric serosal electrodes were studied in two different experiments in fed state. Four sessions were performed in experiment 1 as follows: control (RD, no stimulation), RD+AEA, RD+EA at body points and RD+sham AEA. Two sessions were included in experiment 2 to study mechanisms of AEA: RD + atropine and RD + atropine + AEA. It was found that 1) RD significantly decreased the percentage of normal GSW from 89.8 +/- 3.5% to 76.0 +/- 3.3% (P<0.05); 2) AEA increased the percentage of normal GSW during RD to 94.0 +/- 2.1% (P<0.05 vs. RD) via a reduction in the percentages of tachygastria and arrhythmia (P<0.05 vs. RD); 3) atropine blocked the ameliorating effect of AEA on RD-induced gastric dysrhythmias. Our results demonstrated that RD induces gastric dysrhythmias in fed state in rats. AEA improves RD-induced gastric dysrhythmias via the vagal pathway. AEA may have a therapeutic potential in treating gastric dysrhythmias.	[Zhang, Zhaohui; Yin, Jieyun; Chen, Jiande D. Z.] Nanjing Med Univ, Affiliated Hosp 1, Dept Acupuncture, Nanjing, Jiangsu, Peoples R China; [Chen, Jiande D. Z.] Ningbo Pace Translat Med Res Ctr, Ningbo, Zhejiang, Peoples R China	Nanjing Medical University	Chen, JDZ (corresponding author), Univ Texas Med Branch, Div Gastroenterol, Galveston, TX 77555 USA.	Jiandedzchen@gmail.com	zhang, zh/GWV-4677-2022		National Institutes of Health (NIH) Program [CA149956]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [JX10231801]; NATIONAL CANCER INSTITUTE [R21CA149956] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support was received from the National Institutes of Health (NIH) Program (CA149956) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (JX10231801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo M, 2000, DIGEST DIS SCI, V45, P1731, DOI 10.1023/A:1005590413490; Abramochkin DV, 2012, J COMP PHYSIOL B, V182, P101, DOI 10.1007/s00360-011-0602-2; Arrighi N, 2011, PHARMACOL RES, V64, P420, DOI 10.1016/j.phrs.2011.06.009; Browning KN, 2006, AUTON NEUROSCI-BASIC, V126, P2, DOI 10.1016/j.autneu.2006.01.019; Chang FY, 2005, J GASTROEN HEPATOL, V20, P502, DOI 10.1111/j.1440-1746.2004.03751.x; Chen DD, 2008, J GASTROEN HEPATOL, V23, P141, DOI 10.1111/j.1440-1746.2007.05123.x; Chen JDZ, 1998, DIGEST DIS SCI, V43, P80, DOI 10.1023/A:1018876021156; Chen JDZ, 1996, DIGEST DIS SCI, V41, P1538, DOI 10.1007/BF02087897; Chen JDZ, 2003, GASTROENTEROLOGY, V124, P401, DOI 10.1053/gast.2003.50048; Chen JDZ, 2000, ALIMENT PHARM THERAP, V14, P1041, DOI 10.1046/j.1365-2036.2000.00801.x; Chen J, 2008, AM J PHYSIOL-GASTR L, V295, pG614, DOI 10.1152/ajpgi.90322.2008; Choy DSJ, 1998, J ALTERN COMPLEM MED, V4, P399, DOI 10.1089/acm.1998.4.399; Gao XY, 2011, BRAIN RES, V1397, P19, DOI 10.1016/j.brainres.2011.04.034; Gao XY, 2008, AUTON NEUROSCI-BASIC, V138, P50, DOI 10.1016/j.autneu.2007.10.003; Gori L, 2007, EVID-BASED COMPL ALT, V4, P13, DOI 10.1093/ecam/nem106; Guzik Przemyslaw, 2002, Card Electrophysiol Rev, V6, P256, DOI 10.1023/A:1016333109829; Hirsch DP, 2002, ALIMENT PHARM THER, V16, P17, DOI 10.1046/j.1365-2036.2002.01153.x; Hirst GDS, 2004, J PHARMACOL SCI, V96, P1, DOI 10.1254/jphs.CRJ04002X; Inui A, 2004, FASEB J, V18, P439, DOI 10.1096/fj.03-0641rev; Iwa M, 2007, AUTON NEUROSCI-BASIC, V137, P67, DOI 10.1016/j.autneu.2007.08.001; Kima EH, 2001, NEUROSCI LETT, V307, P113, DOI 10.1016/S0304-3940(01)01948-6; Kraus T, 2007, J NEURAL TRANSM, V114, P1485, DOI 10.1007/s00702-007-0755-z; Li H, 2013, ACUPUNCT MED, V31, P57, DOI 10.1136/acupmed-2012-010173; Li MK, 2010, J ALTERN COMPLEM MED, V16, P435, DOI 10.1089/acm.2009.0348; Liu JS, 2012, AM J PHYSIOL-REG I, V303, pR209, DOI 10.1152/ajpregu.00301.2010; Liu S, 2008, NEUROGASTROENT MOTIL, V20, P1204, DOI 10.1111/j.1365-2982.2008.01164.x; Olsson C, 2011, AUTON NEUROSCI-BASIC, V165, P80, DOI 10.1016/j.autneu.2010.07.002; ORGAN AN, 2009, VOPR KURORTOL FIZIOT, V5, P12; Qian L, 2002, DIGEST DIS SCI, V47, P2473, DOI 10.1023/A:1020551824234; Qian LW, 2003, DIGEST DIS SCI, V48, P508, DOI 10.1023/A:1022532515172; Sallam HS, 2010, AM J PHYSIOL-REG I, V299, pR298, DOI 10.1152/ajpregu.00135.2010; Schukro RP, 2014, COMPLEMENT THER MED, V22, P21, DOI 10.1016/j.ctim.2013.10.002; Shi X., 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/894096; SHIRAISHI T, 1995, BRAIN RES BULL, V36, P141, DOI 10.1016/0361-9230(94)00179-5; Sima Lei, 2009, Zhongguo Zhen Jiu, V29, P3; Sun Y, 2010, NEUROGASTROENT MOTIL, V22, P1217, DOI 10.1111/j.1365-2982.2010.01565.x; Takahashi T, 2011, NEUROMODULATION, V14, P8, DOI 10.1111/j.1525-1403.2010.00295.x; Takahashi T, 2006, J GASTROENTEROL, V41, P408, DOI 10.1007/s00535-006-1773-6; Wang J, 2010, J CLIN GASTROENTEROL, V44, P335, DOI 10.1097/MCG.0b013e3181d34572; Wang Yan-Gang, 2007, Zhongguo Zhen Jiu, V27, P245; Xu SP, 2006, DIGEST DIS SCI, V51, P2154, DOI 10.1007/s10620-006-9412-x; Xu XH, 2002, DIGEST DIS SCI, V47, P365, DOI 10.1023/A:1013726223531; Xu XH, 2002, DIGEST DIS SCI, V47, P1746, DOI 10.1023/A:1016484226110; Yang AC, 2011, MED HYPOTHESES, V77, P244, DOI 10.1016/j.mehy.2011.04.021; Yin JY, 2011, AM J PHYSIOL-REG I, V301, pR465, DOI 10.1152/ajpregu.00271.2010; Yin JY, 2010, AM J PHYSIOL-GASTR L, V298, pG563, DOI 10.1152/ajpgi.00252.2009	46	12	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0114226	10.1371/journal.pone.0114226	http://dx.doi.org/10.1371/journal.pone.0114226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643282	gold, Green Submitted, Green Published			2022-12-27	WOS:000348821200003
J	Djami-Tchatchou, AT; Maake, MP; Piater, LA; Dubery, IA				Djami-Tchatchou, Arnaud T.; Maake, Mmapula P.; Piater, Lizelle A.; Dubery, Ian A.			Isonitrosoacetophenone Drives Transcriptional Reprogramming in Nicotiana tabacum Cells in Support of Innate Immunity and Defense	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; DISEASE RESISTANCE; LIGNIN BIOSYNTHESIS; FUNCTIONAL-ANALYSIS; ARABIDOPSIS; RESPONSES; EXPRESSION; TOBACCO; GENES; TRANSPORT	Plants respond to various stress stimuli by activating broad-spectrum defense responses both locally as well as systemically. As such, identification of expressed genes represents an important step towards understanding inducible defense responses and assists in designing appropriate intervention strategies for disease management. Genes differentially expressed in tobacco cell suspensions following elicitation with isonitrosoacetophenone (INAP) were identified using mRNA differential display and pyro-sequencing. Sequencing data produced 14579 reads, which resulted in 198 contigs and 1758 singletons. Following BLAST analyses, several inducible plant defense genes of interest were identified and classified into functional categories including signal transduction, transcription activation, transcription and protein synthesis, protein degradation and ubiquitination, stress-responsive, defense-related, metabolism and energy, regulation, transportation, cytoskeleton and cell wall-related. Quantitative PCR was used to investigate the expression of 17 selected target genes within these categories. Results indicate that INAP has a sensitising or priming effect through activation of salicylic acid-, jasmonic acid- and ethylene pathways that result in an altered transcriptome, with the expression of genes involved in perception of pathogens and associated cellular re-programming in support of defense. Furthermore, infection assays with the pathogen Pseudomonas syringae pv. tabaci confirmed the establishment of a functional anti-microbial environment in planta.	[Djami-Tchatchou, Arnaud T.; Maake, Mmapula P.; Piater, Lizelle A.; Dubery, Ian A.] Univ Johannesburg, Dept Biochem, Auckland Pk, South Africa	University of Johannesburg	Dubery, IA (corresponding author), Univ Johannesburg, Dept Biochem, Auckland Pk, South Africa.	idubery@uj.ac.za	Dubery, Ian/A-6346-2013; TCHATCHOU, ARNAUD THIERRY DJAMI/S-2039-2019	Dubery, Ian/0000-0002-9079-4769; TCHATCHOU, ARNAUD THIERRY DJAMI/0000-0002-7496-449X; Piater, Lizelle/0000-0002-9526-0109	National Research Foundation, South Africa [76523]; University of Johannesburg, South Africa	National Research Foundation, South Africa(National Research Foundation - South Africa); University of Johannesburg, South Africa	The authors acknowledge fellowship support (MM and AD) and financial support (ID, grant number 76523) from the National Research Foundation (www.nrf.ac.za), South Africa and the University of Johannesburg, South Africa (www.uj.ac.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Briceno Z, 2012, J PLANT PHYSIOL, V169, P1050, DOI 10.1016/j.jplph.2012.03.008; CASSAB GI, 1988, ANNU REV PLANT PHYS, V39, P321, DOI 10.1146/annurev.pp.39.060188.001541; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18-0511; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Djami-Tchatchou AT, 2012, J PHYTOPATHOL, V160, P449, DOI 10.1111/j.1439-0434.2012.01925.x; Dubery IA, 2007, BIOL PLANTARUM, V51, P327, DOI 10.1007/s10535-007-0063-3; Dubery IA, 1999, PHYTOCHEMISTRY, V50, P983, DOI 10.1016/S0031-9422(98)00247-7; Gerber IB, 2006, PLANT PHYSIOL BIOCH, V44, P369, DOI 10.1016/j.plaphy.2006.06.015; Gerber IB, 2008, BBA-PROTEINS PROTEOM, V1784, P1750, DOI 10.1016/j.bbapap.2008.06.012; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Gust AA, 2010, CURR OPIN BIOTECH, V21, P204, DOI 10.1016/j.copbio.2010.02.004; Kadota Y, 2010, TRENDS BIOCHEM SCI, V35, P199, DOI 10.1016/j.tibs.2009.12.005; Kawamura Y, 2009, PLANT CELL PHYSIOL, V50, P924, DOI 10.1093/pcp/pcp044; Kim JS, 2008, PLANT J, V55, P455, DOI 10.1111/j.1365-313X.2008.03518.x; Kobayashi Y, 1997, PLANT J, V11, P525, DOI 10.1046/j.1365-313X.1997.11030525.x; Kullertz G, 1999, PLANTA, V208, P599, DOI 10.1007/s004250050598; Kwon SI, 2013, PLANT PHYSIOL, V161, P1722, DOI 10.1104/pp.112.208108; Liu F, 2010, PHYSIOL MOL PLANT P, V74, P330, DOI 10.1016/j.pmpp.2010.05.002; Liu SM, 2012, NATURE, V492, P256, DOI 10.1038/nature11651; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Madala NE, 2013, PHYTOCHEMISTRY, V94, P82, DOI 10.1016/j.phytochem.2013.05.010; Madala NE, 2012, INNATE IMMUN-LONDON, V18, P140, DOI 10.1177/1753425910392609; MARIVET J, 1994, PLANT MOL BIOL, V26, P1181, DOI 10.1007/BF00040698; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; Mashayekhi F, 2007, ANAL BIOCHEM, V363, P275, DOI 10.1016/j.ab.2007.02.002; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Meyer Y, 2008, BBA-MOL CELL RES, V1783, P589, DOI 10.1016/j.bbamcr.2007.10.017; Mishina TE, 2006, PLANT PHYSIOL, V141, P1666, DOI 10.1104/pp.106.081257; Moeder W, 2005, MOL PLANT MICROBE IN, V18, P116, DOI 10.1094/MPMI-18-0116; Monaghan J, 2009, SIGNAL COMMUN PLANTS, P119, DOI 10.1007/978-3-540-89230-4_7; Moreno JI, 2005, PLANT J, V41, P451, DOI 10.1111/j.1365-313X.2004.02311.x; Nakayama A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-150; New SA, 2015, BIOL PLANT IN PRESS; NIDERMAN T, 1995, PLANT PHYSIOL, V108, P17, DOI 10.1104/pp.108.1.17; Ogawa T, 2005, PLANT PHYSIOL, V138, P1436, DOI 10.1104/pp.105.063586; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; Piater LA, 2004, MOL PLANT PATHOL, V5, P331, DOI 10.1111/j.1364-3703.2004.00234.x; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pruzinska A, 2003, P NATL ACAD SCI USA, V100, P15259, DOI 10.1073/pnas.2036571100; Qiu YJ, 2012, PLANT J, V69, P489, DOI 10.1111/j.1365-313X.2011.04807.x; Rasmussen MW, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00169; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Romano PGN, 2004, PLANT PHYSIOL, V134, P1268, DOI 10.1104/pp.103.022160; Rowland O, 2005, PLANT CELL, V17, P295, DOI 10.1105/tpc.104.026013; Sadanandom A, 2012, NEW PHYTOL, V196, P13, DOI 10.1111/j.1469-8137.2012.04266.x; Sambrook J, 2000, MOL CLONING LAB MANU; Sanabria N, 2008, NEW PHYTOL, V178, P503, DOI 10.1111/j.1469-8137.2008.02403.x; Sanabria NM, 2006, BIOCHEM BIOPH RES CO, V344, P1001, DOI 10.1016/j.bbrc.2006.03.216; Sanabria Natasha M, 2010, Self Nonself, V1, P40; Scheel D, 1998, CURR OPIN PLANT BIOL, V1, P305, DOI 10.1016/1369-5266(88)80051-7; Schreiber K, 2008, PLANT PATHOLOGY J, V24, P245, DOI 10.5423/PPJ.2008.24.3.245; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Seo NS, 2008, J PLANT BIOL, V51, P1; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Spoel SH, 2009, CELL, V137, P860, DOI 10.1016/j.cell.2009.03.038; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; Taguchi F, 2010, MICROBIOL-SGM, V156, P72, DOI 10.1099/mic.0.030700-0; Takahashi H, 2004, PLANT CELL PHYSIOL, V45, P803, DOI 10.1093/pcp/pch085; Takeuchi M, 2000, PLANT J, V23, P517, DOI 10.1046/j.1365-313x.2000.00823.x; Thomas CM, 2000, MOL PLANT MICROBE IN, V13, P465, DOI 10.1094/MPMI.2000.13.4.465; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Thompson AR, 2005, CURR OPIN PLANT BIOL, V8, P165, DOI 10.1016/j.pbi.2005.01.013; Tronchet M, 2010, MOL PLANT PATHOL, P1183; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Unver T, 2013, PLANT MOL BIOL REP, V31, P323, DOI 10.1007/s11105-012-0502-y; van der Merwe JA, 2006, J PLANT PHYSIOL, V163, P877, DOI 10.1016/j.jplph.2005.08.016; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vidhyasekaran P, 2014, SIGNALING COMMUNICAT, P1; Walling LL, 2009, ADV BOT RES, V51, P551, DOI 10.1016/S0065-2296(09)51013-0; Walters DR, 2013, J EXP BOT, V64, P1263, DOI 10.1093/jxb/ert026; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Widjaja I, 2010, PLANT J, V61, P249, DOI 10.1111/j.1365-313X.2009.04047.x; Zheng HY, 1999, MOL BIOL CELL, V10, P2251, DOI 10.1091/mbc.10.7.2251; Zhong RQ, 2000, PLANT PHYSIOL, V124, P563, DOI 10.1104/pp.124.2.563; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004	86	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117377	10.1371/journal.pone.0117377	http://dx.doi.org/10.1371/journal.pone.0117377			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658943	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900139
J	Gisder, S; Genersch, E				Gisder, Sebastian; Genersch, Elke			Identification of Candidate Agents Active against N. ceranae Infection in Honey Bees: Establishment of a Medium Throughput Screening Assay Based on N. ceranae Infected Cultured Cells	PLOS ONE			English	Article							ENCEPHALITOZOON SP MICROSPORIDIA; APIS-MELLIFERA-IBERIENSIS; NOSEMA-CERANAE; PARASITE; HYMENOPTERA; SURFACTIN; PATHOGEN; GERMINATION; POLLINATORS; VENTRICULUS	Many flowering plants in both natural ecosytems and agriculture are dependent on insect pollination for fruit set and seed production. Managed honey bees (Apis mellifera) and wild bees are key pollinators providing this indispensable eco- and agrosystem service. Like all other organisms, bees are attacked by numerous pathogens and parasites. Nosema apis is a honey bee pathogenic microsporidium which is widely distributed in honey bee populations without causing much harm. Its congener Nosema ceranae was originally described as pathogen of the Eastern honey bee (Apis cerana) but jumped host from A. cerana to A. mellifera about 20 years ago and spilled over from A. mellifera to Bombus spp. quite recently. N. ceranae is now considered a deadly emerging parasite of both Western honey bees and bumblebees. Hence, novel and sustainable treatment strategies against N. ceranae are urgently needed to protect honey and wild bees. We here present the development of an in vitro medium throughput screening assay for the identification of candidate agents active against N. ceranae infections. This novel assay is based on our recently developed cell culture model for N. ceranae and coupled with an RT-PCR-ELISA protocol for quantification of N. ceranae in infected cells. The assay has been adapted to the 96-well microplate format to allow automated analysis. Several substances with known (fumagillin) or presumed (surfactin) or no (paromomycin) activity against N. ceranae were tested as well as substances for which no data concerning N. ceranae inhibition existed. While fumagillin and two nitroimidazoles (metronidazole, tinidazole) totally inhibited N. ceranae proliferation, all other test substances were inactive. In summary, the assay proved suitable for substance screening and demonstrated the activity of two synthetic antibiotics against N. ceranae.	[Gisder, Sebastian; Genersch, Elke] Inst Bee Res, Dept Mol Microbiol & Bee Dis, Hohen Neuendorf, Germany		Genersch, E (corresponding author), Inst Bee Res, Dept Mol Microbiol & Bee Dis, Hohen Neuendorf, Germany.	elke.genersch@rz.hu-berlin.de	Gisder, Sebastian/AAF-2586-2021	Genersch, Elke/0000-0001-7906-4530	Ministries for Agriculture from the Federal States of Brandenburg (MIL), Germany; Ministries for Agriculture from the Federal States of Sachsen-Anhalt (MLU), Germany; German Ministry of Nutrition, Agriculture and Consumer Protection (BMELV) [511-06.01-28-1-34.007-07]	Ministries for Agriculture from the Federal States of Brandenburg (MIL), Germany; Ministries for Agriculture from the Federal States of Sachsen-Anhalt (MLU), Germany; German Ministry of Nutrition, Agriculture and Consumer Protection (BMELV)	This work was supported by grants from the Ministries for Agriculture from the Federal States of Brandenburg (MIL) and Sachsen-Anhalt (MLU), Germany. S.G. was supported by a grant (511-06.01-28-1-34.007-07) from the German Ministry of Nutrition, Agriculture and Consumer Protection (BMELV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; ANDERSON DL, 1992, J ECON ENTOMOL, V85, P47, DOI 10.1093/jee/85.1.47; BAILEY L, 1953, NATURE, V171, P212, DOI 10.1038/171212a0; BAILEY L, 1955, PARASITOLOGY, V45, P86, DOI 10.1017/S0031182000027451; Bailey L, 1955, ANN APPL BIOL, V43, P379, DOI 10.1111/j.1744-7348.1955.tb02488.x; BEAUVAIS B, 1994, ANTIMICROB AGENTS CH, V38, P2440, DOI 10.1128/AAC.38.10.2440; BHAT SA, 2012, J ENTOMOL NEMATOL, V4, P12, DOI DOI 10.5897/JEN11.021; Bigliardi E, 2001, MICROBES INFECT, V3, P373, DOI 10.1016/S1286-4579(01)01393-4; Botias C, 2013, RES VET SCI, V95, P1041, DOI 10.1016/j.rvsc.2013.09.012; Botias C, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-25; Cali Ann, 1999, P85; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Corradi Nicolas, 2009, Fungal Biology Reviews, V23, P1, DOI 10.1016/j.fbr.2009.05.001; Ding WQ, 2006, MOL CANCER THER, V5, P1864, DOI 10.1158/1535-7163.MCT-06-0067; Ding WQ, 2005, CANCER RES, V65, P3389, DOI 10.1158/0008-5472.CAN-04-3577; Fenoy S, 2009, APPL ENVIRON MICROB, V75, P6886, DOI 10.1128/AEM.01025-09; Ferroglio E, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.11; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Fries I, 2006, J APICULT RES, V45, P230; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; FRIES I, 1984, J APICULT RES, V23, P102, DOI 10.1080/00218839.1984.11100617; FRIES I, 1992, APIDOLOGIE, V23, P61, DOI 10.1051/apido:19920107; FRIES I, 1988, APIDOLOGIE, V19, P319, DOI 10.1051/apido:19880310; FRIES I, 1989, J APICULT RES, V28, P107; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gisder S, 2011, ENVIRON MICROBIOL, V13, P404, DOI 10.1111/j.1462-2920.2010.02346.x; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Grangemard I, 1997, J PEPT SCI, V3, P145, DOI 10.1002/(SICI)1099-1387(199703)3:2<145::AID-PSC96>3.0.CO;2-Y; Graystock P, 2013, J INVERTEBR PATHOL, V114, P114, DOI 10.1016/j.jip.2013.06.005; HAQUE MA, 1993, J INVERTEBR PATHOL, V62, P171, DOI 10.1006/jipa.1993.1092; He Q, 1996, ANTIMICROB AGENTS CH, V40, P179, DOI 10.1128/AAC.40.1.179; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Huang WF, 2007, APIDOLOGIE, V38, P30, DOI 10.1051/apido:2006054; Huang WF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003185; Johny S, 2009, PARASITOL RES, V104, P419, DOI 10.1007/s00436-008-1214-y; Johny S, 2008, PARASITOL INT, V57, P362, DOI 10.1016/j.parint.2008.03.002; Katiyar SK, 1997, ANTIMICROB AGENTS CH, V41, P2729, DOI 10.1128/AAC.41.12.2729; KATIYAR SK, 1995, GENE, V152, P27, DOI 10.1016/0378-1119(94)00677-K; KATZNELSON H, 1952, SCIENCE, V115, P70, DOI 10.1126/science.115.2977.70; Kim SD, 2006, J MICROBIOL BIOTECHN, V16, P1656; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kobets T, 2010, NAT PROTOC, V5, P1074, DOI 10.1038/nprot.2010.68; Kowall M, 1998, J COLLOID INTERF SCI, V204, P1, DOI 10.1006/jcis.1998.5558; Kralj J, 2010, APIDOLOGIE, V41, P21, DOI 10.1051/apido/2009046; Lee SC, 2008, CURR BIOL, V18, P1675, DOI 10.1016/j.cub.2008.09.030; Maistrello L, 2008, APIDOLOGIE, V39, P436, DOI 10.1051/apido:2008022; Fernandez JM, 2012, J INVERTEBR PATHOL, V111, P106, DOI 10.1016/j.jip.2012.06.008; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Martin-Hernandez R, 2009, APPL ENVIRON MICROB, V75, P2554, DOI 10.1128/AEM.02908-08; MOFFETT JO, 1969, J ECON ENTOMOL, V62, P886, DOI 10.1093/jee/62.4.886; OLSEN PE, 1986, J INVERTEBR PATHOL, V47, P65, DOI 10.1016/0022-2011(86)90164-3; Pajuelo AG, 2008, J APICULT RES, V47, P84, DOI 10.1080/00218839.2008.11101429; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Payne MA, 1999, J AM VET MED ASSOC, V215, P28; Peypoux F, 1999, APPL MICROBIOL BIOT, V51, P553, DOI 10.1007/s002530051432; Plischuk S, 2009, ENV MICROBIOL REP, V1, P131, DOI 10.1111/j.1758-2229.2009.00018.x; Porrini MP, 2010, PARASITOL RES, V107, P381, DOI 10.1007/s00436-010-1875-1; Seydlova G, 2008, CENT EUR J MED, V3, P123, DOI 10.2478/s11536-008-0002-5; Stevanovic J, 2013, APIDOLOGIE, V44, P522, DOI 10.1007/s13592-013-0203-z; Stevanovic J, 2011, APIDOLOGIE, V42, P49, DOI 10.1051/apido/2010034; Teixeira EW, 2013, J INVERTEBR PATHOL, V114, P250, DOI 10.1016/j.jip.2013.09.002; Underwood RM, 2004, J ECON ENTOMOL, V97, P177, DOI 10.1603/0022-0493-97.2.177; Vollenbroich D, 1997, APPL ENVIRON MICROB, V63, P44, DOI 10.1128/AEM.63.1.44-49.1997; WANG DI, 1970, J ECON ENTOMOL, V63, P1539, DOI 10.1093/jee/63.5.1539; WANG DI, 1969, J INVERTEBR PATHOL, V14, P135, DOI 10.1016/0022-2011(69)90098-6; Williams GR, 2008, J INVERTEBR PATHOL, V99, P342, DOI 10.1016/j.jip.2008.04.005; Williams GR, 2008, J INVERTEBR PATHOL, V97, P189, DOI 10.1016/j.jip.2007.08.005; Williams GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099465; Williams GR, 2011, APIDOLOGIE, V42, P15, DOI 10.1051/apido/2010030; Yoder JA, 2014, APIDOLOGIE, V45, P568, DOI 10.1007/s13592-014-0274-5; Zander E., 1909, M NCH BIENENZ, V31, P196, DOI DOI 10.1016/J.BBAGEN.2015.01.008	80	20	22	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117200	10.1371/journal.pone.0117200	http://dx.doi.org/10.1371/journal.pone.0117200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658121	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900115
J	Huang, SL; Zhou, SQ; Zhang, YW; Lv, ZQ; Li, SS; Xie, CH; Ke, YB; Deng, PJ; Geng, YJ; Zhang, Q; Chu, XF; Yi, ZH; Zhang, Y; Wu, TC; Cheng, JQ				Huang, Suli; Zhou, Shiquan; Zhang, Yanwei; Lv, Ziquan; Li, Shanshan; Xie, Changhui; Ke, Yuebin; Deng, Pingjian; Geng, Yijie; Zhang, Qian; Chu, Xiaofan; Yi, Zhaohui; Zhang, Ying; Wu, Tangchun; Cheng, Jinquan			Association of the Genetic Polymorphisms in Pre-MicroRNAs with Risk of Ischemic Stroke in a Chinese Population	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; EXPRESSION PROFILE; CANCER; VARIANT; MIRNA; MIR-146A; BURDEN; CARE	microRNA (miRNA) plays a role in the pathogenesis of ischemic stroke, and single nucleotide polymorphisms in miRNA genes may contribute to disease susceptibility. However, the effect of miR-146a, miR-196a2, and miR-499 polymorphisms on ischemic stroke susceptibility has been rarely reported. Using the TaqMan assay, we evaluated the association of hsa-miR-146a/rs2910164, hsa-miR-196a2/rs11614913, and hsa-miR-499/rs3746444 polymorphisms with the risk of ischemic stroke in a Chinese population with 531 ischemic stroke patients and 531 control subjects. Rs2910164 C/G genotypes were significantly associated with increased risk of ischemic stroke in different genetic model (homozygote comparison: OR = 2.00, 95% CI, 1.29-3.12, P = 0.002; additive model: OR = 1.35, 95% CI, 1.10-1.65, P = 0.004; dominant model: OR = 1.33, 95% CI, 1.00-1.75, P = 0.049; recessive model: OR = 1.82, 95% CI, 1.20-2.74, P = 0.004). Subjects with allele G of hsa-miR-146a/rs2910164 also showed increased risk of ischemic stroke (OR = 1.33, 95% CI, 1.09-1.62, P = 0.005). Stratification analysis showed that the association between rs2910164 and the risk of ischemic stroke was more pronounced in subjects over 60 years old, females, non-drinkers, subjects without hypertension or diabetes mellitus. There were significant combined effects between miR-146a/rs2910164 and fasting glucose/low-density lipoprotein cholesterol levels on ischemic stroke susceptibility. However, we failed to find any association between the alleles/genotypes of rs11614913 T/C and ischemic stroke, respectively (P > 0.05). In summary, this study provides evidence that miR-146a/rs2910164 might be associated with a significantly increased risk of ischemic stroke in a Chinese population, and the combined effects between miRNA polymorphism and fasting glucose /blood lipid levels may contribute to stroke pathogenesis.	[Huang, Suli; Zhang, Yanwei; Lv, Ziquan; Li, Shanshan; Xie, Changhui; Ke, Yuebin; Deng, Pingjian; Geng, Yijie; Zhang, Qian; Cheng, Jinquan] Shenzhen Ctr Dis Control & Prevent, Key Lab Mol Biol, Shenzhen, Peoples R China; [Zhou, Shiquan] LongHua New Dist Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Chu, Xiaofan; Yi, Zhaohui; Zhang, Ying] Peoples Hosp Shenzhen, Dept Neurol, Shenzhen, Peoples R China; [Wu, Tangchun] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Wu, Tangchun] Huazhong Univ Sci & Technol, Minist Environm Protect, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Wu, Tangchun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, State Key Lab Environm Hlth Incubating, Wuhan 430074, Hubei, Peoples R China	Shenzhen Center for Disease Control & Prevention (SZCDC); Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Cheng, JQ (corresponding author), Shenzhen Ctr Dis Control & Prevent, Key Lab Mol Biol, Shenzhen, Peoples R China.	cjinquan@szcdc.net			National Natural Science Foundation of China [30771852, 81402754]; China Postdoctoral Scientific Foundation [2014M562031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Scientific Foundation(China Postdoctoral Science Foundation)	This work was supported by the following sources: National Natural Science Foundation of China (no: 30771852, JQC), for study design, China Postdoctoral Scientific Foundation (no: 2014M562031, SLH) for data collection and analysis, and National Natural Science Foundation of China (no: 81402754, SLH) for preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Cheng HS, 2013, EMBO MOL MED, V5, P1017, DOI 10.1002/emmm.201202318; Cui GL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-235; El Gazzar M, 2011, J LEUKOCYTE BIOL, V90, P509, DOI 10.1189/jlb.0211074; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Goldstein LB, 2001, STROKE, V32, P280, DOI 10.1161/01.STR.32.1.280; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Holliday EG, 2012, NAT GENET, V44, P1147, DOI 10.1038/ng.2397; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Jeon YJ, 2013, ARTERIOSCL THROM VAS, V33, P420, DOI 10.1161/ATVBAHA.112.300251; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Liu Y, 2013, JIMD REP, V7, P89, DOI 10.1007/8904_2012_153; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Rink C, 2011, PHYSIOL GENOMICS, V43, P521, DOI 10.1152/physiolgenomics.00158.2010; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Solito E, 2008, TRENDS PHARMACOL SCI, V29, P135, DOI 10.1016/j.tips.2007.12.003; Tan JR, 2011, CURR MOL MED, V11, P76; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Tsai NW, 2012, CLIN CHIM ACTA, V413, P1861, DOI 10.1016/j.cca.2012.07.021; Wessel J, 2007, J HYPERTENS, V25, P329, DOI 10.1097/HJH.0b013e328011753e; Xiong XD, 2014, MUTAT RES-FUND MOL M, V761, P15, DOI 10.1016/j.mrfmmm.2014.01.001; Xu J, 2009, HUM MUTAT, V30, P1231, DOI 10.1002/humu.21044; Yang B, 2012, HUM IMMUNOL, V73, P101, DOI 10.1016/j.humimm.2011.10.005; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357	31	38	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117007	10.1371/journal.pone.0117007	http://dx.doi.org/10.1371/journal.pone.0117007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658319	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900089
J	Jacomet, C; Allavena, C; Peyrol, F; Pereira, B; Joubert, LM; Bagheri, H; Cotte, L; Garaffo, R; Gerbaud, L; Dellamonica, P				Jacomet, Christine; Allavena, Clotilde; Peyrol, Fleur; Pereira, Bruno; Joubert, Laurence Morand; Bagheri, Haleh; Cotte, Laurent; Garaffo, Rodolphe; Gerbaud, Laurent; Dellamonica, Pierre			Perception of Antiretroviral Generic Medicines: One-Day Survey of HIV-Infected Patients and Their Physicians in France	PLOS ONE			English	Article							PATIENTS ATTITUDES; DRUG SUBSTITUTION; PRESCRIPTION; EXPERIENCES; VIEWS	Background In the interest of cost effectiveness, switching antiretroviral brand name medications to generics is recommended in France since 2013. The study objective was to evaluate the perception of generics per se and antiretroviral generics in HIV-infected patients and their hospital physicians Methods and Findings 556 out of 703 (79%) adult HIV+ outpatients and 116 physicians in 33 clinics were included in a multicentric cross-sectional survey performed in September 2013. Patients completed a self-questionnaire on their perception and acceptability of generics. Physicians completed a questionnaire on their acceptability of switching antiretroviral to generic. Socio-demographic data, medical history and HIV history were collected. Among the 556 patients with a median HIV duration of 13 years, 77% were France native, 59% in active employment, 100% covered by social insurance, 95% on antiretroviral therapy. Seventy-six percent of the patients accepted generics and 55% trusted them overall. Antiretroviral generics were accepted by 44% of them but only by 17% if the pill burden was going to increase. The factor significantly associated with acceptability of antiretroviral generics was acceptance of generics per se (p<0.001). Among the 116 physicians following a median of 100 HIV-patients/year, 75% would prescribe generics, dropping to 26% if the combo had to be broken. Factors significantly associated with willingness to prescribe antiretroviral generics were the absence of concern regarding the chemical entity (OR = 0.33), being aware that the patient would accept generics for other pathologies (OR = 2.04) and would accept antiretroviral generics (OR = 1.94). No factor related to sociodemographic conditions, HIV status or comorbidities was associated with the acceptability of antiretroviral generics. Conclusions Acceptability of antiretroviral generics in this French population was mostly dictated by the patient's and physician's knowledge and use of generics overall. It should be improved with an efficient information of both patients and physicians.	[Jacomet, Christine] CHU Clermont Ferrand, Hop Gabriel Montpied, Serv Malad Infect & Trop, Clermont Ferrand, France; [Allavena, Clotilde] CHU Hotel Dieu, Serv Malad Infect & Trop, Nantes, France; [Peyrol, Fleur; Gerbaud, Laurent] CHU Clermont Ferrand, EA PEPRADE 4681, Clermont Ferrand, France; [Pereira, Bruno] CHU Clermont Ferrand, Serv Biostat, Clermont Ferrand, France; [Joubert, Laurence Morand] CHU St Antoine, INSERM, UMR S 1136, Virol Lab, Paris, France; [Bagheri, Haleh] CHU Toulouse, INSERM, U1027, Toulouse, France; [Cotte, Laurent] Hosp Civils Lyon, INSERM, U1052, Serv Malad Infect & Trop, Lyon, France; [Garaffo, Rodolphe] CHU Pasteur, Nice, France; [Dellamonica, Pierre] CHU Archet, Serv Malad Infect & Trop, Nice, France	CHU Clermont Ferrand; Nantes Universite; CHU de Nantes; CHU Clermont Ferrand; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Nice; CHU Nice	Jacomet, C (corresponding author), CHU Clermont Ferrand, Hop Gabriel Montpied, Serv Malad Infect & Trop, Clermont Ferrand, France.	cjacomet@chu-clermontferrand.fr	Allavena, Clotilde/AAH-4310-2019; GERBAUD, Laurent/ABY-4952-2022	Pereira, Bruno/0000-0003-3778-7161	Mylan	Mylan	This paper presents independent research by CHU Clermont-Ferrand, the promoter of the survey. Mylan provided funding for data capture. Funding sources were not involved in study design, data collection, analysis, interpretation, medical writing or submission, decision to publish, or preparation of the manuscript.	Agence Nationale de Securite du Medicament et des produits de sante (ANSM), 2012, MED GEN MED PART ENT; Allenet B, 1999, J EC MED, V17, P301; Allenet B, 2013, REV MED SUISSE, V9, P1005; [Anonymous], 2012, ACAD NATL PHARM RAPP; Barrett LL, 2005, PHYS ATTITUDES PRACT; Baudrant-Boga M, 2011, MED MALADIES METABOL, V5, pS73, DOI [10.1038/nutd.2014.45, DOI 10.1038/NUTD.2014.45]; Chong CP, 2011, HEALTH POLICY, V99, P139, DOI 10.1016/j.healthpol.2010.08.002; Collet JP, 2010, LETT CARDIOLOGUE, V341, P16; De Plazaola JP, 2014, TABLEAU EC FRANCAISE; Decollogny A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-17; Figueiras MJ, 2008, PHARM WORLD SCI, V30, P590, DOI 10.1007/s11096-008-9247-y; Granlund D, 2009, SOC SCI MED, V69, P1643, DOI 10.1016/j.socscimed.2009.09.016; Hakonsen H, 2009, CURR MED RES OPIN, V25, P2515, DOI 10.1185/03007990903192223; Hassali Mohamed A A, 2009, Int J Pharm Pract, V17, P79; Kjoenniksen I, 2006, PHARM WORLD SCI, V28, P284, DOI 10.1007/s11096-006-9043-5; Lagarce L, 2005, THERAPIE, V60, P67, DOI 10.2515/therapie:2005009; Menkes CJ, 2012, B ACAD NAT MED PARIS, V196, P521, DOI 10.1016/S0001-4079(19)31843-6; Ringuier R, 2008, THERAPIE, V63, P11, DOI 10.2515/therapie:2008006; Roos J., 2005, Journal de Pharmacie Clinique, V24, P217; Sarradon-Eck A, 2007, REV EPIDEMIOL SANTE, V55, P179, DOI 10.1016/j.respe.2007.01.026; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Shrank WH, 2007, J GEN INTERN MED, V22, P1298, DOI 10.1007/s11606-007-0284-3; Valles JA, 2003, HEALTH POLICY, V65, P269, DOI 10.1016/S0168-8510(03)00018-6; WHO, 2010, WOR HEALT REP, P1; Zucman D, 2014, AIDS, V28, P607, DOI 10.1097/QAD.0000000000000170	26	23	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117214	10.1371/journal.pone.0117214	http://dx.doi.org/10.1371/journal.pone.0117214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658627	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900118
J	Kim, H; Cha, GW; Jeong, YE; Lee, WG; Chang, KS; Roh, JY; Yang, SC; Park, MY; Park, C; Shin, EH				Kim, Hyunwoo; Cha, Go-Woon; Jeong, Young Eui; Lee, Wook-Gyo; Chang, Kyu Sik; Roh, Jong Yul; Yang, Sung Chan; Park, Mi Yeoun; Park, Chan; Shin, E-Hyun			Detection of Japanese Encephalitis Virus Genotype V in Culex orientalis and Culex pipiens (Diptera: Culicidae) in Korea	PLOS ONE			English	Article							WEST-NILE-VIRUS; SOUTH-KOREA; TRANSMISSION; MOSQUITOS	Japanese encephalitis virus (JEV) causes significant viral encephalitis and is distributed throughout the Asian countries. The virus is known to be transmitted by Culex tritaeniorhynchus, which mainly breeds in rice paddies in Korea. In this study, we investigated the presence of other mosquito species that can transmit JEV as a second or regional vector. We selected five cities where patients have experienced JE in the last 5 years as mosquito-collecting locations and subdivided them into four collection sites according to the mosquito habitats (cowshed, downtown area, forest, and swamp). Mosquitoes were caught using the BG-Sentinel trap, CDC black-light trap, Fay-Prince trap, and Gravid trap. A total of 993 pools from 22,774 mosquitoes were prepared according to their species, collection date, and site. We performed a SYBR Green 1-based real-time RT-PCR assay to detect JEV from the mosquito pools. A total of six JEV-positive pools were detected from Culex orientalis and Culex pipiens caught in the Gangwon-do and Gyeonngi-do provinces. All the detected JEVs were revealed as genotype V by phylogenetic analysis of the envelope gene. Our findings confirm that a new genotype of JEV was introduced in Korea and suggest that two mosquito species may play a role in JEV transmission.	[Kim, Hyunwoo; Lee, Wook-Gyo; Chang, Kyu Sik; Roh, Jong Yul; Yang, Sung Chan; Park, Mi Yeoun; Shin, E-Hyun] Korea Natl Inst Hlth, Ctr Immunol & Pathol, Div Med Entomol, Cheongju, South Korea; [Cha, Go-Woon; Jeong, Young Eui; Park, Chan] Korea Natl Inst Hlth, Div Arboviruses, Ctr Immunol & Pathol, Cheongju, South Korea; [Kim, Hyunwoo] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Jeong, Young Eui] Hallym Univ, Grad Sch, Dept Biomed Sci, Chunchon, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Seoul National University (SNU); Hallym University	Shin, EH (corresponding author), Korea Natl Inst Hlth, Ctr Immunol & Pathol, Div Med Entomol, Cheongju, South Korea.	ehshin@nih.go.kr	Chang, Kyu-Sik/R-6752-2019		Research of Korea Center for Disease Control and Prevention [2012-N55001-00]	Research of Korea Center for Disease Control and Prevention	This research was supported by funding (2012-N55001-00) from Research of Korea Center for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chen WJ, 2000, J MED ENTOMOL, V37, P108, DOI 10.1603/0022-2585-37.1.108; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Johansen CA, 2002, AM J TROP MED HYG, V67, P656, DOI 10.4269/ajtmh.2002.67.656; Lee DW, 2012, INT J INFECT DIS, V16, pE448, DOI 10.1016/j.ijid.2012.02.006; Li MH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001231; Mohammed MAF, 2011, INFECT GENET EVOL, V11, P855, DOI 10.1016/j.meegid.2011.01.020; Nga PT, 2004, J GEN VIROL, V85, P1625, DOI 10.1099/vir.0.79797-0; Ravanini P, 2012, EUROSURVEILLANCE, V17, P2; Ree Han-Il, 2003, Korean Journal of Entomology, V33, P39; Seo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055165; Sohn YM, 2000, EMERG INFECT DIS, V6, P17; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; Takhampunya R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-449; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka K, 1974, REVISION ADULT LARVA; Turell MJ, 2006, J MED ENTOMOL, V43, P1076, DOI 10.1603/0022-2585(2006)43[1076:LTOJEW]2.0.CO;2; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510; Yang CF, 2010, J VIROL METHODS, V168, P147, DOI 10.1016/j.jviromet.2010.05.006; Yun SM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-127	21	46	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116547	10.1371/journal.pone.0116547	http://dx.doi.org/10.1371/journal.pone.0116547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658839	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900048
J	Raizada, N; Sachdeva, KS; Sreenivas, A; Kulsange, S; Gupta, RS; Thakur, R; Dewan, P; Boehme, C; Paramsivan, CN				Raizada, Neeraj; Sachdeva, Kuldeep Singh; Sreenivas, Achuthan; Kulsange, Shubhangi; Gupta, Radhey Shyam; Thakur, Rahul; Dewan, Puneet; Boehme, Catharina; Paramsivan, Chinnambedu Nainarappan			Catching the Missing Million: Experiences in Enhancing TB & DR-TB Detection by Providing Upfront Xpert MTB/RIF Testing for People Living with HIV in India	PLOS ONE			English	Article							RESISTANT TUBERCULOSIS; DIAGNOSIS; ASSAY; PULMONARY	Background A critical challenge in providing TB care to People Living with HIV (PLHIV) is establishing an accurate bacteriological diagnosis. Xpert MTB/RIF, a highly sensitive and specific rapid tool, offers a promising solution in addressing these challenges. This study presents results from PLHIV taking part in a large demonstration study across India wherein upfront Xpert MTB/RIF testing was offered to all presumptive PTB cases in public health facilities. Method The study covered a population of 8.8 million across 18 sub-district level tuberculosis units (TU), with one Xpert MTB/RIF platform established at each TU. All HIV-infected patients suspected of TB (both TB and Drug Resistant TB (DR-TB)) accessing public health facilities in study area were prospectively enrolled and provided upfront Xpert MTB/RIF testing. Result 2,787 HIV-infected presumptive pulmonary TB cases were enrolled and 867 (31.1%, 95% Confidence Interval (CI) 29.4-32.8) HIV-infected TB cases were diagnosed under the study. Overall 27.6% (CI 25.9-29.3) of HIV-infected presumptive PTB cases were positive by Xpert MTB/RIF, compared with 12.9% (CI 11.6-14.1) who had positive sputum smears. Upfront Xpert MTB/RIF testing of presumptive PTB and DR-TB cases resulted in diagnosis of 73 (9.5%, CI 7.6-11.8) and 16 (11.2%, CI 6.7-17.1) rifampicin resistance cases, respectively. Positive predictive value (PPV) for rifampicin resistance detection was high 97.7% (CI 89.3-99.8), with no significant difference with or without prior history of TB treatment. Conclusion The study results strongly demonstrate limitations of using smear microscopy for TB diagnosis in PLHIV, leading to low TB and DR-TB detection which can potentially lead to either delayed or sub-optimal TB treatment. Our findings demonstrate the usefulness and feasibility of addressing this diagnostic gap with upfront of Xpert MTB/RIF testing, leading to overall strengthening of care and support package for PLHIV.	[Raizada, Neeraj; Kulsange, Shubhangi; Thakur, Rahul; Paramsivan, Chinnambedu Nainarappan] Fdn Innovat New Diagnost, New Delhi, India; [Sachdeva, Kuldeep Singh; Gupta, Radhey Shyam] Govt India, Cent TB Div, New Delhi, India; [Sreenivas, Achuthan; Dewan, Puneet] WHO, India Country Off, New Delhi, India; [Boehme, Catharina] Fdn Innovat New Diagnost, Geneva, Switzerland	Foundation For Innovative New Diagnostics; World Health Organization; Foundation For Innovative New Diagnostics	Raizada, N (corresponding author), Fdn Innovat New Diagnost, New Delhi, India.	drneerajraizada@gmail.com		Raizada, Neeraj/0000-0003-2116-332X; Nair, Sreenivas/0000-0002-2586-6797	United States Agency for International Development	United States Agency for International Development(United States Agency for International Development (USAID))	The study was funded by the United States Agency for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, TB HIV COINFECTION L; Anastasis D, 1997, INT J TUBERC LUNG D, V1, P220; [Anonymous], 2012, MORBIDITY MORTALITY, V61; [Anonymous], 2013, GLOBAL REPORT, P4; [Anonymous], 2012, GUID NAT PROGR OTH S; Balcha TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085478; Barnard M, 2012, J CLIN MICROBIOL, V50, P3712, DOI 10.1128/JCM.01958-12; Brewer TF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025861; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Central TB Division Ministry of Health and Family Welfare, MAN RNTCP YOUR AR TR; Central TB Division Ministry of Health and Family Welfare, 2014, REV NAT TUB PROGR AN; Central TB Division Ministry of Health and Family Welfare New Delhi India Revised National TB Control Programme, 2012, GUID PROGR MAN DRUG; Coovadia YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077712; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cox H, 2014, 20 INT AIDS C MELB; Dewan PK, 2010, INT J TUBERC LUNG D, V14, P247; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Hargreaves N, 2003, GUIDELINES IMPLEMENT, p[7, 9, 11, 13]; Kim CH, 2014, J THORACIC MED, V6; Kwak N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077456; Loannidis P, 2011, COPHEID GENEZPERT MT; Lukoye D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070763; Nwokeukwu HI, 2013, J COMMUNITY MED PRIM, V25, P58; ODonnell MR, 2013, TREATMENT OUTCOMES E, V19; Organization WH, 2009, PATHW BETT DIAGN TUB; Osman M, 2014, J CLIN MICROBIOL, V52, P635, DOI 10.1128/JCM.02517-13; Raizada N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089301; Rasaki SO, 2014, J INFECT DIS THER, V2, P139, DOI [10.4172/2332-0877.1000139, DOI 10.4172/2332-0877.1000139]; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Vijay S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021008; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2013, GLOB BRIEF HYP, P9; World health Organization Policy update, 2013, WHOHTMTB201316; Zeka AN, 2011, J CLIN MICROBIOL, V49, P4138, DOI 10.1128/JCM.05434-11	34	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116721	10.1371/journal.pone.0116721	http://dx.doi.org/10.1371/journal.pone.0116721			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658091	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900061
J	Sarkar, S; Pires, MM				Sarkar, Sourav; Pires, Marcos M.			d-Amino Acids Do Not Inhibit Biofilm Formation in Staphylococcus aureus	PLOS ONE			English	Article							BACILLUS-SUBTILIS; BACTERIAL BIOFILMS; MECHANISMS	Bacteria can either exist in the planktonic (free floating) state or in the biofilm (encased within an organic framework) state. Bacteria biofilms cause industrial concerns and medical complications and there has been a great deal of interest in the discovery of small molecule agents that can inhibit the formation of biofilms or disperse existing structures. Herein we show that, contrary to previously published reports, d-amino acids do not inhibit biofilm formation of Bacillus subtilis (B. subtilis), Staphylococcus aureus (S. aureus), and Staphylococcus epidermis (S. epidermis) at millimolar concentrations. We evaluated a diverse set of natural and unnatural d-amino acids and observed no activity from these compounds in inhibiting biofilm formation.	[Sarkar, Sourav; Pires, Marcos M.] Lehigh Univ, Dept Chem, Bethlehem, PA 18015 USA	Lehigh University	Pires, MM (corresponding author), Lehigh Univ, Dept Chem, Bethlehem, PA 18015 USA.	map311@lehigh.edu			Lehigh University start up	Lehigh University start up	This work was supported by: Lehigh University start up. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauregard PB, 2013, P NATL ACAD SCI USA, V110, pE1621, DOI 10.1073/pnas.1218984110; Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Burt SA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115916, DOI 10.1371/JOURNAL.PONE.0115916]; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; DUNNE WM, 1993, ANTIMICROB AGENTS CH, V37, P2522, DOI 10.1128/AAC.37.12.2522; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hobley L, 2013, P NATL ACAD SCI USA, V110, P13600, DOI 10.1073/pnas.1306390110; Hochbaum AI, 2011, J BACTERIOL, V193, P5616, DOI 10.1128/JB.05534-11; Hu JF, 2006, J NAT PROD, V69, P118, DOI 10.1021/np049600s; Huigens RW, 2007, J AM CHEM SOC, V129, P6966, DOI 10.1021/ja069017t; Kadam RU, 2011, ANGEW CHEM INT EDIT, V50, P10631, DOI 10.1002/anie.201104342; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Leiman SA, 2013, J BACTERIOL, V195, P5391, DOI 10.1128/JB.00975-13; Lemon KP, 2008, CURR TOP MICROBIOL, V322, P1; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582; Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103; Petrelli D, 2008, J MED MICROBIOL, V57, P364, DOI 10.1099/jmm.0.47621-0; Ramon-Perez ML, 2014, J MED MICROBIOLOGY; Romero D, 2011, MOL MICROBIOL, V80, P1155, DOI 10.1111/j.1365-2958.2011.07653.x; Sanchez CJ, 2013, BMC INFECT DIS, V13, DOI [10.1186/1471-2334-13-611, DOI 10.1186/1471-2334-13-611]; Simoes M, 2010, LWT-FOOD SCI TECHNOL, V43, P573, DOI 10.1016/j.lwt.2009.12.008; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Soutourina O, 2004, J BIOL CHEM, V279, P42560, DOI 10.1074/jbc.M402931200; Valle J, 2006, P NATL ACAD SCI USA, V103, P12558, DOI 10.1073/pnas.0605399103; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960	32	32	33	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117613	10.1371/journal.pone.0117613	http://dx.doi.org/10.1371/journal.pone.0117613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658642	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900190
J	Sun, HW; Wu, XL; Wu, F; Li, Y; Yu, ZP; Chen, XR; Chen, YZ; Yang, WJ				Sun, Hongwei; Wu, Xiaoli; Wu, Fang; Li, Ying; Yu, Zhengping; Chen, Xiangrong; Chen, Yunzhi; Yang, Wenjun			Associations of Genetic Variants in the PSCA, MUC1 and PLCE1 Genes with Stomach Cancer Susceptibility in a Chinese Population	PLOS ONE			English	Article							STEM-CELL ANTIGEN; GENOME-WIDE ASSOCIATION; PHOSPHOLIPASE-C EPSILON; GASTRIC-CANCER; RISK; POLYMORPHISMS; ESOPHAGEAL; CARCINOMA; LOCI; 10Q23	Background Several genetic variants including PSCA rs2294008 C>T and rs2976392 G>A, MUC1 rs4072037 T>C, and PLCE1 rs2274223 A>G have shown significant association with stomach cancer risk in the previous genome-wide association studies (GWASs). Methods To evaluate associations of these SNPs in the Han Chinese, an independent hospital based case-control study was performed by genotyping these four polymorphisms in a total of 692 stomach cancer cases and 774 healthy controls acquired by using frequency matching for age and gender. False-positive report probability (FPRP) analysis was also performed to validate all statistically significant findings. Results In the current study, significant association with stomach cancer susceptibility was observed for all the four polymorphisms of interest. Specifically, a significant increased stomach cancer risk was associated with PSCA rs2294008 (CT vs. CC: adjusted OR = 1.37, 95% CI = 1.07-1.74, and CT/TT vs. CC: adjusted OR = 1.30, 95% CI = 1.03-1.63), PSCA rs2976392 (AG vs. GG: adjusted OR = 1.30, 95% CI = 1.02-1.65, and AG/AA vs. GG: adjusted OR = 1.26, 95% CI = 1.00-1.59), or PLCE1 rs2274223 (AG vs. AA: adjusted OR = 1.48, 95% CI = 1.15-1.90, and AG/GG vs. AA: adjusted OR = 1.45, 95% CI = 1.14-1.84), respectively. In contrast, MUC1 rs4072037 was shown to decrease the cancer risk (CT vs. TT: adjusted OR = 0.77, 95% CI = 0.60-0.98). Patients with more than one risk genotypes had significant increased risk to develop stomach cancer (adjusted OR = 1.30, 95% CI = 1.03-1.64), when compared with those having 0-1 risk genotypes. Stratified analysis indicated that the increased risk was more pronounced in younger subjects, men, ever smokers, smokers with pack years <= 27, patients with high BMI, or non-cardia stomach cancer. Conclusions This study substantiated the associations between four previous reported genetic variants and stomach cancer susceptibility in an independent Han Chinese population. Further studies with larger sample size and different ethnicities are warranted to validate our findings.	[Sun, Hongwei; Yu, Zhengping; Chen, Yunzhi; Yang, Wenjun] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou 325000, Zhejiang, Peoples R China; [Wu, Xiaoli; Wu, Fang; Chen, Xiangrong] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Wenzhou 325000, Zhejiang, Peoples R China; [Li, Ying] Wenzhou Med Univ, Affiliated Hosp 1, Dept Operating Room, Wenzhou 325000, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Yang, WJ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou 325000, Zhejiang, Peoples R China.	mdyangwenjun@126.com			China National Natural Science Foundation [81370563]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents and a Provincial Administration of Traditional Chinese Medicine of Zhejiang Province, China [2011ZA072]; ministry of health of China-the major medicine science and technology project in Zhejiang province [WKJ2012-2-033]; science technology department of Zhejiang province [2012C23108]; Excellent Youth Foundation of Zhejiang Provincial Natural Science [LR14H030001]; science and technology of Wencheng county	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents and a Provincial Administration of Traditional Chinese Medicine of Zhejiang Province, China; ministry of health of China-the major medicine science and technology project in Zhejiang province; science technology department of Zhejiang province; Excellent Youth Foundation of Zhejiang Provincial Natural Science; science and technology of Wencheng county	The study was supported by China National Natural Science Foundation (No. 81370563) grant and Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents and a Provincial Administration of Traditional Chinese Medicine of Zhejiang Province, China (No. 2011ZA072) and Project supported by ministry of health of China-the major medicine science and technology project in Zhejiang province (No. WKJ2012-2-033) and Public welfare technology application research project supported by science technology department of Zhejiang province (No. 2012C23108) and Excellent Youth Foundation of Zhejiang Provincial Natural Science (No. LR14H030001) and project of science and technology of Wencheng county. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Bye H, 2012, CARCINOGENESIS, V33, P2155, DOI 10.1093/carcin/bgs262; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; Dura P, 2013, EUR J CANCER PREV, V22, P417, DOI 10.1097/CEJ.0b013e32835c7f53; Eshel R, 2002, INT J CANCER, V98, P803, DOI 10.1002/ijc.10301; Gu HY, 2012, MOL BIOL REP, V39, P9105, DOI 10.1007/s11033-012-1782-x; Gu XX, 2014, TUMOR BIOL, V35, P2167, DOI 10.1007/s13277-013-1287-9; Hao NB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067229; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; He J, 2013, MOL CARCINOGEN, V52, P70, DOI 10.1002/mc.22013; He J, 2012, HUM GENET, V131, P1235, DOI 10.1007/s00439-012-1152-8; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hu HC, 2012, ANN SURG ONCOL, V19, P2403, DOI 10.1245/s10434-011-2160-y; Hu Zhibin, 2007, Gastrointest Cancer Res, V1, P12; Hwang JY, 2013, J HUM GENET, V58, P233, DOI 10.1038/jhg.2012.158; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kelley JR, 2003, J CLIN EPIDEMIOL, V56, P1, DOI 10.1016/S0895-4356(02)00534-6; Li F, 2012, ASIAN PAC J CANCER P, V13, P2593, DOI 10.7314/APJCP.2012.13.6.2593; Li FX, 2012, MOL BIOL REP, V39, P9557, DOI 10.1007/s11033-012-1820-8; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; Lochhead P, 2011, GASTROENTEROLOGY, V140, P435, DOI 10.1053/j.gastro.2010.11.001; Lu Y, 2010, INT J CANCER, V127, P2183, DOI 10.1002/ijc.25228; Ma HX, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-258; Mai RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069214; Malik MA, 2014, ASIAN PAC J CANCER P, V15, P4319, DOI 10.7314/APJCP.2014.15.10.4319; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Matsuo K, 2009, INT J CANCER, V125, P1961, DOI 10.1002/ijc.24519; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Ou JF, 2010, DNA CELL BIOL, V29, P319, DOI 10.1089/dna.2009.0960; Palmer AJ, 2012, EUR J CANCER PREV, V21, P541, DOI 10.1097/CEJ.0b013e3283529b79; Qiao L, 2012, GENE, V493, P83, DOI 10.1016/j.gene.2011.11.017; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Rouissi K, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-101; Saeki N, 2011, GASTROENTEROLOGY, V140, P892, DOI 10.1053/j.gastro.2010.10.058; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Sala N, 2012, INT J CANCER, V130, P2417, DOI 10.1002/ijc.26243; Sharma Kiran Lata, 2013, J Gastrointest Cancer, V44, P436, DOI 10.1007/s12029-013-9537-z; Shi DN, 2012, J CANCER RES CLIN, V138, P1339, DOI 10.1007/s00432-012-1210-6; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Song HR, 2011, MOL CARCINOGEN, V50, P871, DOI 10.1002/mc.20796; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Umar M, 2014, TUMOR BIOL, V35, P11667, DOI 10.1007/s13277-014-2458-z; Umar M, 2013, TUMOR BIOL, V34, P3537, DOI 10.1007/s13277-013-0932-7; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031932; Wang T, 2012, CANCER EPIDEM BIOMAR, V21, P843, DOI 10.1158/1055-9965.EPI-11-1176; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Wu C, 2009, MOL CARCINOGEN, V48, P1131, DOI 10.1002/mc.20565; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Zeng ZR, 2011, MOL CARCINOGEN, V50, P353, DOI 10.1002/mc.20718; Zhang HZ, 2011, CARCINOGENESIS, V32, P848, DOI 10.1093/carcin/bgr051; Zhang QH, 2012, ASIAN PAC J CANCER P, V13, P2867, DOI 10.7314/APJCP.2012.13.6.2867; Zhang T, 2012, EXP THER MED, V4, P158, DOI 10.3892/etm.2012.563; Zhang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076425; Zheng LZ, 2013, MOL BIOL REP, V40, P5791, DOI 10.1007/s11033-013-2682-4; Zhou RM, 2012, ARCH MED RES, V43, P578, DOI 10.1016/j.arcmed.2012.09.006	61	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117576	10.1371/journal.pone.0117576	http://dx.doi.org/10.1371/journal.pone.0117576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658482	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900180
J	Sun, WC; Hsu, PI; Yu, HC; Lin, KH; Tsay, FW; Wang, HM; Tsai, TJ; Chen, WC; Lai, KH; Cheng, JS				Sun, Wei-Chih; Hsu, Ping-I; Yu, Hsien-Chung; Lin, Kung-Hung; Tsay, Feng-Woei; Wang, Huay-Min; Tsai, Tzung-Jiun; Chen, Wen-Chi; Lai, Kwok-Hung; Cheng, Jin-Shiung			The Compliance of Doctors with Viral Hepatitis B Screening and Antiviral Prophylaxis in Cancer Patients Receiving Cytotoxic Chemotherapy Using a Hospital-Based Screening Reminder System	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; VIRUS HBV REACTIVATION; LAMIVUDINE PROPHYLAXIS; ADJUVANT CHEMOTHERAPY; RISK-FACTORS; LYMPHOMA; INFECTION; CARRIERS; THERAPY; MANAGEMENT	Background and Aim Screenings for hepatitis B surface antigen (HBsAg) and antiviral prophylaxis are recommended for HBsAg-positive patients before the start of cytotoxic chemotherapy; however, compliance with these recommendations varies among doctors. We investigated the compliance of doctors with these recommendations using a reminder system and assessed the outcomes of HBsAg-positive patients receiving cytotoxic chemotherapy. Methods Using a computer-assisted reminder system, doctors were alerted of both HBsAg screening and antiviral prophylaxis prior to prescribing chemotherapy. The compliance between different doctors and outcomes of patients were investigated during the period of execution of this system. The rates of compliance with both recommendations were compared among various cancer types. Results A total of 1053 patients were enrolled, of which only 88 had previous data pertaining to HBsAg status. Using this reminder system, an overall screening rate of 85.5%(825/965) was achieved and did not significantly differ according to cancer type. However, the overall antiviral prophylactic rate was only 45.5% (61/134). The rates of antiviral prophylaxis were lower for doctors treating lung, breast and colorectal cancers than for those treating hematological malignancies (all p<0.05). Consequently, the rate of HBV reactivation was lower in patients who received antiviral prophylaxis than in those who did not (1.6% vs. 15.1%; p<0.01). Multivariate analysis revealed that male gender and antiviral prophylaxis were both related to reactivation of hepatitis B (p<0.05). Conclusions By using this reminder system, the overall screening rate for HBsAg was satisfactory, whereas the antiviral prophylaxis was inadequate in patients with solid tumors due to the varying compliance of the attending doctors. Further strategies to improve both screening and prophylaxis are needed to minimize HBV-related events during cytotoxic chemotherapy.	[Sun, Wei-Chih; Hsu, Ping-I; Yu, Hsien-Chung; Lin, Kung-Hung; Tsay, Feng-Woei; Wang, Huay-Min; Tsai, Tzung-Jiun; Chen, Wen-Chi; Lai, Kwok-Hung; Cheng, Jin-Shiung] Kaohsiung Vet Gen Hosp, Dept Med, Div Gastroenterol, Kaohsiung, Taiwan; [Sun, Wei-Chih; Hsu, Ping-I; Yu, Hsien-Chung; Lin, Kung-Hung; Tsay, Feng-Woei; Wang, Huay-Min; Tsai, Tzung-Jiun; Chen, Wen-Chi; Lai, Kwok-Hung; Cheng, Jin-Shiung] Natl Yang Ming Univ, Taipei 112, Taiwan; [Yu, Hsien-Chung] Meiho Inst Technol, Dept Nursing, Pingtung, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University	Yu, HC (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med, Div Gastroenterol, Kaohsiung, Taiwan.	hcyu@vghks.gov.tw		Lin, Kunghung/0000-0003-2020-3756				Alexopoulos CG, 1999, BRIT J CANCER, V81, P69, DOI 10.1038/sj.bjc.6690652; [Anonymous], 2010, J INTERN MED TAIWAN, V21, P350; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; Cheng AL, 2003, HEPATOLOGY, V37, P1320, DOI 10.1053/jhep.2003.50220; Dai MS, 2004, LIVER INT, V24, P540, DOI 10.1111/j.1478-3231.2004.0964.x; Day FL, 2011, J ONCOL PRACT, V7, P141, DOI 10.1200/JOP.2010.000133; GALBRAITH RM, 1975, LANCET, V2, P528; Grewal J, 2007, NEW ENGL J MED, V356, P1591, DOI 10.1056/NEJMc063696; Hsu C, 2008, HEPATOLOGY, V47, P844, DOI 10.1002/hep.22106; Hsu C, 2014, HEPATOLOGY, V59, P2092, DOI 10.1002/hep.26718; Huang YH, 2013, J CLIN ONCOL, V31, P2765, DOI 10.1200/JCO.2012.48.5938; Hwang JP, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-534; Hwang JP, 2012, J ONCOL PRACT, V8, pE32, DOI 10.1200/JOP.2011.000450; Katz LH, 2008, J VIRAL HEPATITIS, V15, P89, DOI 10.1111/j.1365-2893.2007.00902.x; Khokhar OS, 2009, CHEMOTHERAPY, V55, P69, DOI 10.1159/000183731; Kohrt HE, 2006, ALIMENT PHARM THERAP, V24, P1003, DOI 10.1111/j.1365-2036.2006.03081.x; Lau GKK, 1997, BONE MARROW TRANSPL, V19, P795, DOI 10.1038/sj.bmt.1700744; Lau GKK, 2003, GASTROENTEROLOGY, V125, P1742, DOI 10.1053/j.gastro.2003.09.026; Lee R, 2010, CURR ONCOL, V17, P32; Li YH, 2006, CANCER-AM CANCER SOC, V106, P1320, DOI 10.1002/cncr.21701; Liang R, 1999, J CLIN ONCOL, V17, P394, DOI 10.1200/JCO.1999.17.1.394; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Lim LL, 2002, ALIMENT PHARM THER, V16, P1939, DOI 10.1046/j.1365-2036.2002.01364.x; Liu CJ, 2013, HEPATOL INT, V7, P316, DOI 10.1007/s12072-011-9279-6; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; LOK ASF, 1991, GASTROENTEROLOGY, V100, P182, DOI 10.1016/0016-5085(91)90599-G; Long MJ, 2011, BREAST CANCER RES TR, V127, P705, DOI 10.1007/s10549-011-1455-9; Loomba R, 2008, ANN INTERN MED, V148, P519, DOI 10.7326/0003-4819-148-7-200804010-00008; Lubel JS, 2010, J GASTROEN HEPATOL, V25, P864, DOI 10.1111/j.1440-1746.2010.06243.x; Mok TSK, 2000, CANCER-AM CANCER SOC, V89, P543, DOI 10.1002/1097-0142(20000801)89:3<543::AID-CNCR9>3.0.CO;2-V; Nakamura Y, 1996, CANCER-AM CANCER SOC, V78, P2210, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2210::AID-CNCR24>3.0.CO;2-0; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Sohn BS, 2011, JPN J CLIN ONCOL, V41, P1059, DOI 10.1093/jjco/hyr106; Tran TT, 2010, ALIMENT PHARM THER, V31, P240, DOI 10.1111/j.1365-2036.2009.04158.x; Tsai SH, 2011, SUPPORT CARE CANCER, V19, P1779, DOI 10.1007/s00520-010-1019-2; WANDS JR, 1975, GASTROENTEROLOGY, V68, P105; Wang Y, 2013, WORLD J GASTROENTERO, V19, P923, DOI 10.3748/wjg.v19.i6.923; Yeo W, 2006, HEPATOLOGY, V43, P209, DOI 10.1002/hep.21051; Yeo W, 2004, BREAST CANCER RES TR, V88, P209, DOI 10.1007/s10549-004-0725-1; Yeo W, 2004, ANN ONCOL, V15, P1661, DOI 10.1093/annonc/mdh430; Yeo W, 2004, J CLIN ONCOL, V22, P927, DOI 10.1200/JCO.2004.05.161; Yeo W, 2004, BRIT J CANCER, V90, P1306, DOI 10.1038/sj.bjc.6601699; Yeo W, 2003, J MED VIROL, V70, P553, DOI 10.1002/jmv.10430; Yeo W, 2000, J MED VIROL, V62, P299, DOI 10.1002/1096-9071(200011)62:3&lt;299::AID-JMV1&gt;3.0.CO;2-0; Yun J, 2011, BRIT J CANCER, V104, P559, DOI 10.1038/bjc.2011.4; Zurawska U, 2012, J CLIN ONCOL, V30, P3167, DOI 10.1200/JCO.2011.40.7510	46	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116978	10.1371/journal.pone.0116978	http://dx.doi.org/10.1371/journal.pone.0116978			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658926	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900085
J	Tulapurkar, ME; Ramarathnam, A; Hasday, JD; Singh, IS				Tulapurkar, Mohan E.; Ramarathnam, Aparna; Hasday, Jeffrey D.; Singh, Ishwar S.			Bacterial Lipopolysaccharide Augments Febrile-Range Hyperthermia-Induced Heat Shock Protein 70 Expression and Extracellular Release in Human THP1 Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; NECROSIS-FACTOR-ALPHA; LPS-STIMULATED MACROPHAGES; BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION; ENDOTHELIAL-CELLS; CARCINOMA-CELLS; FACTOR-I; STRESS; HSP70	Sepsis, a devastating and often lethal complication of severe infection, is characterized by fever and dysregulated inflammation. While infections activate the inflammatory response in part through Toll-like receptors (TLRs), fever can partially activate the heat shock response with generation of heat shock proteins (HSPs). Since extracellular HSPs, especially HSP70 (eHSP70), are proinflammatory TLR agonists, we investigated how exposure to the TLR4 agonist, bacterial lipopolysaccharide (LPS) and febrile range hyperthermia (FRH; 39.5 degrees C) modify HSP70 expression and extracellular release. Using differentiated THP1 cells, we found that concurrent exposure to FRH and LPS as well as TLR2 and TLR3 agonists synergized to activate expression of inducible HSP72 (HSPA1A) mRNA and protein via a p38 MAP kinase-requiring mechanism. Treatment with LPS for 6 h stimulated eHSP70 release; levels of eHSP70 released at 39.5 degrees C were higher than at 37 degrees C roughly paralleling the increase in intracellular HSP72 in the 39.5 degrees C cells. By contrast, 6 h exposure to FRH in the absence of LPS failed to promote eHSP70 release. Release of eHSP70 by LPS-treated THP1 cells was inhibited by glibenclamide, but not brefeldin, indicating that eHSP70 secretion occurred via a non-classical protein secretory mechanism. Analysis of eHSP70 levels in exosomes and exosome-depleted culture supernatants from LPS-treated THP1 cells using ELISA demonstrated similar eHSP70 levels in unfractionated and exosome-depleted culture supernatants, indicating that LPS-stimulated eHSP70 release did not occur via the exosome pathway. Immunoblot analysis of the exosome fraction of culture supernatants from these cells showed constitutive HSC70 (HSPA8) to be the predominant HSP70 family member present in exosomes. In summary, we have shown that LPS stimulates macrophages to secrete inducible HSP72 via a non-classical non-exosomal pathway while synergizing with FRH exposure to increase both intracellular and secreted levels of inducible HSP72. The impact of increased macrophage intracellular HSP70 levels and augmented secretion of proinflammatory eHSP70 in the febrile, infected patient remains to be elucidated.	[Tulapurkar, Mohan E.; Ramarathnam, Aparna; Hasday, Jeffrey D.; Singh, Ishwar S.] Univ Maryland, Sch Med, Dept Med, Div Pulm & Crit Care, Baltimore, MD 21201 USA; [Hasday, Jeffrey D.] Univ Maryland, Sch Med, Cytokine Core Lab, Baltimore, MD 21201 USA; [Hasday, Jeffrey D.; Singh, Ishwar S.] Baltimore Vet Affairs Med Ctr, Res Serv, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Singh, IS (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Pulm & Crit Care, Baltimore, MD 21201 USA.	isingh@medicine.umaryland.edu	tulapurkar, mohan/F-1926-2015	tulapurkar, mohan/0000-0002-2476-5417	Department of Veteran Affairs Merit Review [IBX002143A]; National Institutes of Health [HL69057]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069057] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002143] Funding Source: NIH RePORTER	Department of Veteran Affairs Merit Review(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	Supported by Department of Veteran Affairs Merit Review award IBX002143A and National Institutes of Health grant HL69057 (JDH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2007, FEBS LETT, V581, P3723, DOI 10.1016/j.febslet.2007.03.074; Anand Paras K, 2010, Commun Integr Biol, V3, P405, DOI 10.4161/cib.3.5.12474; Anand PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010136; Aneja R, 2006, J IMMUNOL, V177, P7184, DOI 10.4049/jimmunol.177.10.7184; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; BAUMGARTNER RA, 1994, J IMMUNOL, V153, P2609; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; BROWN CR, 1993, J CELL BIOL, V120, P1101, DOI 10.1083/jcb.120.5.1101; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Cooper ZA, 2010, CELL STRESS CHAPERON, V15, P665, DOI 10.1007/s12192-010-0179-9; Cooper ZA, 2010, AM J PHYSIOL-CELL PH, V298, pC171, DOI 10.1152/ajpcell.00346.2009; De Maio A, 2011, CELL STRESS CHAPERON, V16, P235, DOI 10.1007/s12192-010-0236-4; Edelman DA, 2007, J SURG RES, V140, P171, DOI 10.1016/j.jss.2006.12.560; Evdonin AL, 2006, EUR J CELL BIOL, V85, P443, DOI 10.1016/j.ejcb.2006.02.008; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Ganter MT, 2006, AM J PHYSIOL-LUNG C, V291, pL354, DOI 10.1152/ajplung.00405.2005; Gastpar R, 2004, J IMMUNOL, V172, P972, DOI 10.4049/jimmunol.172.2.972; Gupta A, 2013, J BIOL CHEM, V288, P2756, DOI 10.1074/jbc.M112.427336; Hasday JD, 2000, CELL STRESS CHAPERON, V5, P471, DOI 10.1379/1466-1268(2000)005<0471:FATHSR>2.0.CO;2; Hasday JD, 2001, J APPL PHYSIOL, V90, P90, DOI 10.1152/jappl.2001.90.1.90; Hasday Jeffrey D, 2011, Trans Am Clin Climatol Assoc, V122, P34; Hashiguchi N, 2001, J TRAUMA, V51, P1104, DOI 10.1097/00005373-200112000-00015; Hopkins PM, 2011, BRIT J ANAESTH, V107, P48, DOI 10.1093/bja/aer132; Hunter-Lavin C, 2004, BIOCHEM BIOPH RES CO, V324, P511, DOI 10.1016/j.bbrc.2004.09.075; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Maity TK, 2011, CYTOKINE, V54, P61, DOI 10.1016/j.cyto.2010.12.017; Mambula SS, 2006, J IMMUNOL, V177, P7849, DOI 10.4049/jimmunol.177.11.7849; Mambula SS, 2006, INT J HYPERTHER, V22, P575, DOI 10.1080/02656730600976042; McClung JP, 2008, AM J PHYSIOL-REG I, V294, pR185, DOI 10.1152/ajpregu.00532.2007; Molvarec A, 2010, CELL STRESS CHAPERON, V15, P237, DOI 10.1007/s12192-009-0146-5; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Nagarsekar A, 2008, J IMMUNOL, V181, P2636, DOI 10.4049/jimmunol.181.4.2636; Nagarsekar A, 2012, AM J RESP CELL MOL, V47, P824, DOI 10.1165/rcmb.2012-0105OC; Nakano M, 1996, AM J PHYSIOL-HEART C, V270, pH1231, DOI 10.1152/ajpheart.1996.270.4.H1231; Njemini R, 2003, SCAND J IMMUNOL, V58, P664, DOI 10.1111/j.1365-3083.2003.01341.x; Njemini R, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-24; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Pittet JF, 2002, J TRAUMA, V52, P611, DOI 10.1097/00005373-200204000-00001; Schortgen F, 2012, AM J RESP CRIT CARE, V185, P1088, DOI 10.1164/rccm.201110-1820OC; Shah NG, 2012, INT J HYPERTHER, V28, P627, DOI 10.3109/02656736.2012.690547; Shah NG, 2010, PROSTAG OTH LIPID M, V93, P1, DOI 10.1016/j.prostaglandins.2010.03.006; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; Singh IS, 2004, J ENDOTOXIN RES, V10, P175, DOI 10.1179/096805104225004851; Singh IS, 2000, J BIOL CHEM, V275, P9841, DOI 10.1074/jbc.275.13.9841; Singh IS, 2008, AM J RESP CELL MOL, V39, P235, DOI 10.1165/rcmb.2007-0294OC; Singh IS, 2013, INT J HYPERTHER, V29, P423, DOI 10.3109/02656736.2013.808766; Stephanou A, 1997, BIOCHEM J, V321, P103, DOI 10.1042/bj3210103; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Theriault JR, 2006, J IMMUNOL, V177, P8604, DOI 10.4049/jimmunol.177.12.8604; Tulapurkar ME, 2012, AM J RESP CELL MOL, V46, P807, DOI 10.1165/rcmb.2011-0378OC; Tulapurkar ME, 2009, CELL STRESS CHAPERON, V14, P499, DOI 10.1007/s12192-009-0103-3; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Zhan R, 2009, BIOCHEM BIOPH RES CO, V387, P229, DOI 10.1016/j.bbrc.2009.06.095	60	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118010	10.1371/journal.pone.0118010	http://dx.doi.org/10.1371/journal.pone.0118010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659128	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900249
J	de Miranda, ML; Pereira, SJ; Santos, AOMT; Villela, NR; Kraemer-Aguiar, LG; Bouskela, E				de Miranda, Marcos Lopes; Pereira, Sandra J.; Santos, Ana O. M. T.; Villela, Nivaldo R.; Kraemer-Aguiar, Luiz Guilherme; Bouskela, Eliete			Milrinone Attenuates Arteriolar Vasoconstriction and Capillary Perfusion Deficits on Endotoxemic Hamsters	PLOS ONE			English	Article							MICROCIRCULATORY BLOOD-FLOW; ISCHEMIA-REPERFUSION INJURY; ACTIVATED PROTEIN-C; SEPTIC SHOCK; INTESTINAL MICROCIRCULATION; SEPSIS; NOREPINEPHRINE; LACTATE; NITROGLYCERIN; VASODILATORS	Background and Objective Apart from its inotropic property, milrinone has vasodilator, anti-inflammatory and antithrombotic effects that could assist in the reversal of septic microcirculatory changes. This paper investigates the effects of milrinone on endotoxemia-related microcirculatory changes and compares them to those observed with the use of norepinephrine. Materials and Methods After skinfold chamber implantation procedures and endotoxemia induction by intravenous Escherichia coli lipopolysaccharide administration (2 mg. kg-1), male golden Syrian hamsters were treated with two regimens of intravenous milrinone (0.25 or 0.5 mu g. kg-1. min-1). Intravital microscopy of skinfold chamber preparations allowed quantitative analysis of microvascular variables. Macro-hemodynamic, biochemical, and hematological parameters and survival rate were also analyzed. Endotoxemic non-treated animals, endotoxemic animals treated with norepinephrine (0.2 mu g. kg-1. min-1), and non-endotoxemic hamsters served as controls. Results Milrinone (0.5 mu g. kg-1. min-1) was effective in reducing lipopolysaccharide-induced arteriolar vasoconstriction, capillary perfusion deficits, and inflammatory response, and in increasing survival. Norepinephrine treated animals showed the best mean arterial pressure levels but the worst functional capillary density values among all endotoxemic groups. Conclusion Our data suggests that milrinone yielded protective effects on endotoxemic animals' microcirculation, showed anti-inflammatory properties, and improved survival. Norepinephrine did not recruit the microcirculation nor demonstrated anti-inflammatory effects.	[de Miranda, Marcos Lopes] Univ Estado Rio De Janeiro, Fac Med Sci, Dept Internal Med, Div Crit Care, Rio De Janeiro, RJ, Brazil; [Pereira, Sandra J.] Perinatal Barra, Pediat Cardiac Intens Care Unit, Rio De Janeiro, RJ, Brazil; [Santos, Ana O. M. T.] Oswaldo Cruz Fdn FIOCRUZ, Inst Fernandes Figueira, Rio De Janeiro, RJ, Brazil; [Villela, Nivaldo R.] Univ Estado Rio De Janeiro, Fac Med Sci, Dept Surg, Div Anesthesiol, Rio De Janeiro, RJ, Brazil; [Kraemer-Aguiar, Luiz Guilherme] Univ Estado Rio De Janeiro, Fac Med Sci, Dept Internal Med, Div Endocrinol, Rio De Janeiro, RJ, Brazil; [Bouskela, Eliete] Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol BioVasc, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	de Miranda, ML (corresponding author), Univ Estado Rio De Janeiro, Fac Med Sci, Dept Internal Med, Div Crit Care, Rio De Janeiro, RJ, Brazil.	marcoslmiranda@gmail.com		Kraemer-Aguiar, Luiz Guilherme/0000-0002-3528-5881	CNPq (National Council for Scientific and Technological Development, Brasilia, Brazil) [303836/2010-5]; FAPERJ (State of Rio de Janeiro Agency for Research Support, Rio de Janeiro, Brazil) [E26/110.754/2012]	CNPq (National Council for Scientific and Technological Development, Brasilia, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (State of Rio de Janeiro Agency for Research Support, Rio de Janeiro, Brazil)	This study was supported by grants from CNPq (National Council for Scientific and Technological Development, Brasilia, Brazil, http:// www.cnpq.br/; grant number 303836/2010-5) and FAPERJ (State of Rio de Janeiro Agency for Research Support, Rio de Janeiro, Brazil, http://www. faperj.br/; grant number E26/110.754/2012).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker J, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-12; Barton P, 1996, CHEST, V109, P1302, DOI 10.1378/chest.109.5.1302; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Buwalda M, 2002, INTENS CARE MED, V28, P1208, DOI 10.1007/s00134-002-1407-2; Cabrales P, 2005, AM J PHYSIOL-HEART C, V288, pH2146, DOI 10.1152/ajpheart.00749.2004; De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; De Backer D, 2010, CURR OPIN CRIT CARE, V16, P250, DOI 10.1097/MCC.0b013e3283383621; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Donati A, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/892710; Dubin A, 2009, CRIT CARE, V13, DOI 10.1186/cc7922; ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841; FINK MP, 1990, J SURG RES, V49, P186, DOI 10.1016/0022-4804(90)90260-9; Gunnerson KJ, 2006, CRIT CARE, V10, DOI 10.1186/cc3987; Hangai-Hoger N, 2007, CRIT CARE MED, V35, P1123, DOI 10.1097/01.CCM.0000259533.84180.C7; Hayashida N, 1999, ANN THORAC SURG, V68, P1661, DOI 10.1016/S0003-4975(99)00716-X; Hoffmann JN, 1999, SHOCK, V12, P355, DOI 10.1097/00024382-199911000-00005; Hoffmann JN, 2005, CRIT CARE, V9, pS33, DOI 10.1186/cc3758; Hoffmann JN, 2004, CRIT CARE MED, V32, P1011, DOI 10.1097/01.CCM.0000120058.88975.42; Hofstetter C, 2007, INT J MOL MED, V20, P597; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; JOHNSON PC, 1986, CIRC RES, V59, P483, DOI 10.1161/01.RES.59.5.483; Jung HS, 2014, KOREAN J ANESTHESIOL, V66, P136, DOI 10.4097/kjae.2014.66.2.136; Jutkowitz LA, 2005, VET CLIN N AM-SMALL, V35, P397, DOI 10.1016/j.cvsm.2004.10.006; Klyscz T, 1997, BIOMED TECH, V42, P168, DOI 10.1515/bmte.1997.42.6.168; Krejci V, 2006, CRIT CARE MED, V34, P1456, DOI 10.1097/01.CCM.0000215834.48023.57; Kume M, 2006, J SURG RES, V136, P209, DOI 10.1016/j.jss.2006.05.038; Laschke MW, 2011, EUR CELLS MATER, V22, P147, DOI 10.22203/eCM.v022a12; Lei HY, 2001, J BIOMED SCI, V8, P377, DOI 10.1007/BF02255946; Li X, 2004, BRIT J PHARMACOL, V141, P709, DOI 10.1038/sj.bjp.0705634; Liet Jean-Michel, 2005, Pediatr Crit Care Med, V6, P195, DOI 10.1097/01.PCC.0000155636.53455.96; Mariscalco MM, 2006, CRIT CARE MED, V34, P561, DOI 10.1097/01.CCM.0000199075.70631.B8; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mollhoff T, 1999, ANESTHESIOLOGY, V90, P72, DOI 10.1097/00000542-199901000-00012; Nacul FE, 2010, ANESTH ANALG, V110, P547, DOI 10.1213/ANE.0b013e3181c88af1; Nakajima Y, 2006, CRIT CARE MED, V34, P1752, DOI 10.1097/01.CCM.0000218812.73741.6C; Nishiki T, 2011, TRANSPL P, V43, P1489, DOI 10.1016/j.transproceed.2011.03.009; Preiser JC, 2003, LANCET, V361, P880, DOI 10.1016/S0140-6736(03)12691-8; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Rich Naomi, 2003, Pediatr Crit Care Med, V4, P394, DOI 10.1097/01.PCC.0000074278.30462.73; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F; Sales Júnior João Andrade L., 2006, Rev. bras. ter. intensiva, V18, P9, DOI 10.1590/S0103-507X2006000100003; Santos AOMT, 2011, CLIN HEMORHEOL MICRO, V47, P1, DOI 10.3233/CH-2010-1358; Schafer A, 2003, BIOCHEM PHARMACOL, V65, P397, DOI 10.1016/S0006-2952(02)01523-X; Shipley JB, 1996, AM J MED SCI, V311, P286, DOI 10.1097/00000441-199606000-00011; Spronk PE, 2002, LANCET, V360, P1395, DOI 10.1016/S0140-6736(02)11393-6; Trzeciak S, 2008, ACAD EMERG MED, V15, P399, DOI 10.1111/j.1553-2712.2008.00109.x; Tsai AG, 2003, AM J PHYSIOL-HEART C, V285, pH1537, DOI 10.1152/ajpheart.00176.2003; Wesley MC, 2009, ANESTH ANALG, V108, P1425, DOI 10.1213/ane.0b013e3181981fbe; Wettstein R, 2003, CRIT CARE MED, V31, P1824, DOI 10.1097/01.CCM.0000069340.16319.F2; Yeh YC, 2012, ANESTH ANALG, V115, P46, DOI 10.1213/ANE.0b013e318253631c; Young E, 2008, THROMB RES, V122, P743, DOI 10.1016/j.thromres.2006.10.026	52	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117004	10.1371/journal.pone.0117004	http://dx.doi.org/10.1371/journal.pone.0117004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646813	gold, Green Submitted, Green Published			2022-12-27	WOS:000348822600048
J	Korzeniewski, B				Korzeniewski, Bernard			'Idealized' State 4 and State 3 in Mitochondria vs. Rest and Work in Skeletal Muscle	PLOS ONE			English	Article							METABOLIC CONTROL-THEORY; TOP-DOWN APPROACH; OXIDATIVE-PHOSPHORYLATION; PROTON LEAK; INTENSITY EXERCISE; RESPIRATION RATE; HEART; MODEL; CALCIUM; CELLS	A computer model of oxidative phosphorylation (OXPHOS) in skeletal muscle is used to compare state 3, intermediate state and state 4 in mitochondria with rest and work in skeletal muscle. 'Idealized' state 4 and 3 in relation to various 'experimental' states 4 and 3 are defined. Theoretical simulations show, in accordance with experimental data, that oxygen consumption (V'O-2), ADP and P-i are higher, while ATP/ADP and Delta p are lower in rest than in state 4, because of the presence of basal ATP consuming reactions in the former. It is postulated that moderate and intensive work in skeletal muscle is very different from state 3 in isolated mitochondria. V'O-2, ATP/ADP, Delta p and the control of ATP usage over V'O-2 are much higher, while ADP and Pi are much lower in the former. The slope of the phenomenological V'O-2-ADP relationship is much steeper during the rest-work transition than during the state 4-state 3 transition. The work state in intact muscle is much more similar to intermediate state than to state 3 in isolated mitochondria in terms of ADP, ATP/ADP, Delta p and metabolic control pattern, but not in terms of V'O-2. The huge differences between intact muscle and isolated mitochondria are proposed to be caused by the presence of the eachstep activation (ESA) mechanism of the regulation of OXPHOS in intact skeletal muscle. Generally, the present study suggests that isolated mitochondria (at least in the absence of Ca2+) cannot serve as a good model of OXPHOS regulation in intact skeletal muscle.	Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland	Jagiellonian University	Korzeniewski, B (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	bernard.korzeniewski@gmail.com						ANDERSEN P, 1985, J PHYSIOL-LONDON, V366, P233, DOI 10.1113/jphysiol.1985.sp015794; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BROWN GC, 1990, EUR J BIOCHEM, V188, P321, DOI 10.1111/j.1432-1033.1990.tb15406.x; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; CHANCE B, 1955, J BIOL CHEM, V217, P383; CHANCE B, 1985, P NATL ACAD SCI USA, V82, P8384, DOI 10.1073/pnas.82.24.8384; CHANCE B, 1982, P NATL ACAD SCI-BIOL, V79, P7714, DOI 10.1073/pnas.79.24.7714; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; Cieslar JH, 2000, J BIOL CHEM, V275, P6129, DOI 10.1074/jbc.275.9.6129; Contreras L, 2009, J BIOL CHEM, V284, P7091, DOI 10.1074/jbc.M808066200; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; FELL DA, 1995, BIOCHEM J, V311, P35, DOI 10.1042/bj3110035; Fernstrom M, 2004, J PHYSIOL-LONDON, V554, P755, DOI 10.1113/jphysiol.2003.055202; Gellerich FN, 2012, BIOCHEM J, V443, P747, DOI 10.1042/BJ20110765; Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983; GROEN AK, 1982, J BIOL CHEM, V257, P2754; HAFNER RP, 1990, EUR J BIOCHEM, V188, P313, DOI 10.1111/j.1432-1033.1990.tb15405.x; Hansford R.G., 1980, CURR TOP BIOENERG, VVolume 10, P217, DOI 10.1016/B978-0-12-152510-1.50012-2; Hochachka P, 1994, MUSCLES METABOLIC ME; HOPPELER H, 1985, J EXP BIOL, V115, P355; HOPPELER H, 1973, PFLUG ARCH EUR J PHY, V344, P217, DOI 10.1007/BF00588462; Kavanagh NI, 2000, BBA-BIOENERGETICS, V1457, P57, DOI 10.1016/S0005-2728(00)00054-2; Korzeniewski B, 1998, BIOCHEM J, V330, P1189, DOI 10.1042/bj3301189; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; Korzeniewski B, 2004, BIOPHYS CHEM, V110, P147, DOI 10.1016/j.bpc.2004.01.011; Korzeniewski B, 1996, BIOCHEM J, V319, P143, DOI 10.1042/bj3190143; Korzeniewski B, 2007, BIOPHYS CHEM, V129, P93, DOI 10.1016/j.bpc.2007.05.013; Korzeniewski B, 2014, J APPL PHYSIOL, V116, P83, DOI 10.1152/japplphysiol.00759.2013; KUSHMERICK MJ, 1985, AM J PHYSIOL, V248, pC542, DOI 10.1152/ajpcell.1985.248.5.C542; LETELLIER T, 1993, BIOCHIM BIOPHYS ACTA, V1141, P58, DOI 10.1016/0005-2728(93)90189-M; Li YJ, 2012, CELL MOL BIOENG, V5, P92, DOI 10.1007/s12195-011-0210-y; Li YJ, 2009, AM J PHYSIOL-CELL PH, V296, pC25, DOI 10.1152/ajpcell.00094.2008; MEYER RA, 1988, AM J PHYSIOL, V254, pC548, DOI 10.1152/ajpcell.1988.254.4.C548; Mildaziene V, 1996, BIOCHEM J, V320, P329, DOI 10.1042/bj3200329; RICHARDSON RS, 1995, AM J PHYSIOL-HEART C, V268, pH1453, DOI 10.1152/ajpheart.1995.268.4.H1453; Rolfe DFS, 1996, BBA-BIOENERGETICS, V1276, P45, DOI 10.1016/0005-2728(96)00029-1; Rolfe DFS, 1999, AM J PHYSIOL-CELL PH, V276, pC692, DOI 10.1152/ajpcell.1999.276.3.C692; Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Schild L, 1988, EUR J BIOCHEM, V252, P508; SCHWERZMANN K, 1989, P NATL ACAD SCI USA, V86, P1583, DOI 10.1073/pnas.86.5.1583; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Tonkonogi M, 2000, J PHYSIOL-LONDON, V528, P379, DOI 10.1111/j.1469-7793.2000.00379.x; Tonkonogi M, 1997, ACTA PHYSIOL SCAND, V161, P345, DOI 10.1046/j.1365-201X.1997.00222.x; Vendelin M, 2000, AM J PHYSIOL-CELL PH, V278, pC747, DOI 10.1152/ajpcell.2000.278.4.C747; WANDERS RJA, 1984, EUR J BIOCHEM, V142, P417, DOI 10.1111/j.1432-1033.1984.tb08303.x; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732; Wu F, 2007, AM J PHYSIOL-CELL PH, V292, pC115, DOI 10.1152/ajpcell.00237.2006; Zoladz JA, 2010, J PHYSIOL SCI, V60, P331, DOI 10.1007/s12576-010-0101-3	50	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117145	10.1371/journal.pone.0117145	http://dx.doi.org/10.1371/journal.pone.0117145			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647747	gold, Green Published, Green Submitted			2022-12-27	WOS:000348822600057
J	Zeng, Q; Zhang, YM; Sun, GQ; Duo, HR; Wen, L; Lei, GC				Zeng, Qing; Zhang, Yamian; Sun, Gongqi; Duo, Hairui; Wen, Li; Lei, Guangchun			Using Species Distribution Model to Estimate the Wintering Population Size of the Endangered Scaly-Sided Merganser in China	PLOS ONE			English	Article							MERGUS-SQUAMATUS; PREDICTION; BIAS; DISTURBANCE; ACCURACY; RANGE; RISK	Scaly-sided Merganser is a globally endangered species restricted to eastern Asia. Estimating its population is difficult and considerable gap exists between populations at its breeding grounds and wintering sites. In this study, we built a species distribution model (SDM) using Maxent with presence-only data to predict the potential wintering habitat for Scaly-sided Merganser in China. Area under the receiver operating characteristic curve (AUC) method suggests high predictive power of the model (training and testing AUC were 0.97 and 0.96 respectively). The most significant environmental variables included annual mean temperature, mean temperature of coldest quarter, minimum temperature of coldest month and precipitation of driest quarter. Suitable conditions for Scaly-sided Merganser are predicted in the middle and lower reaches of the Yangtze River, especially in Jiangxi, Hunan and Hubei Provinces. The predicted suitable habitat embraces 6,984 km of river. Based on survey results from three consecutive winters (2010-2012) and previous studies, we estimated that the entire wintering population of Scaly-sided Merganser in China to be 3,561 +/- 478 individuals, which is consistent with estimate in its breeding ground.	[Zeng, Qing; Zhang, Yamian; Sun, Gongqi; Duo, Hairui; Wen, Li; Lei, Guangchun] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Wen, Li] Off Environm & Heritage, Sydney, NSW, Australia	Beijing Forestry University; Office of Environment & Heritage - New South Wales	Lei, GC (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	guangchun8099@gmail.com	ZENG, Qing/V-9563-2019; Guangchun, Lei/ABC-8081-2021	Zeng, Qing/0000-0002-7471-4941; WEN, LI/0000-0003-3783-3826	National Basic Research Program of China (973 Program) [2009CB421103]; National Basic Research Program of China [2012CB417005]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (973 Program) (No. 2009CB421103) http://www.973.gov.cn and National Basic Research Program of China (No. 2012CB417005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, WATERBIRD POPULATION; Barre N, 2010, J ORNITHOL, V151, P695, DOI 10.1007/s10336-010-0499-7; Barter M, 2014, BIRD CONSERV INT, V24, P406, DOI 10.1017/S0959270913000622; Beale CM, 2004, J APPL ECOL, V41, P335, DOI 10.1111/j.0021-8901.2004.00900.x; BirdLife International, 2013, SPEC FACTSH MERG SQU; BirdLife International, 2001, THREAT BIRDS AS BIRD; Birdskorea, 2013, SCAL SID MERG REP KO; Birtsas P, 2013, ITAL J ZOOL, V80, P392, DOI 10.1080/11250003.2013.805827; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Cumming GS, 2000, J BIOGEOGR, V27, P425, DOI 10.1046/j.1365-2699.2000.00419.x; Dennis RLH, 2001, BIODIVERS CONSERV, V10, P483, DOI 10.1023/A:1016602309983; Duckworth J. W., 2005, Wildfowl, V55, P133; EAAFW, 2012, SCAL SID MERG; Elith J, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P39; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Frid A, 2002, CONSERV ECOL, V6; Funk VA, 2002, SYST BIOL, V51, P303, DOI 10.1080/10635150252899789; Gibson L, 2007, DIVERS DISTRIB, V13, P704, DOI 10.1111/j.1472-4642.2007.00365.x; *GLC, 2003, GLOB LAND COV 2000 D; Harcourt AH, 2005, SCIENCE, V310, P1276; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; He Fen-Qi, 2006, Chinese Journal of Zoology, V41, P52; He FQ, 2002, WATERBIRDS, V25, P462, DOI 10.1675/1524-4695(2002)025[0462:SOTSMW]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hochachka WM, 2000, CAN J ZOOL, V78, P521, DOI 10.1139/cjz-78-4-521; Hu JH, 2010, OECOLOGIA, V164, P555, DOI 10.1007/s00442-010-1732-z; Hughes B, 1994, THREATENED WATERFOWL; Jamieson IG, 2012, TRENDS ECOL EVOL, V27, P578, DOI 10.1016/j.tree.2012.07.001; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Katzner TE, 2011, ANIM CONSERV, V14, P328, DOI 10.1111/j.1469-1795.2011.00444.x; Kauffman MJ, 2003, ECOL APPL, V13, P1802, DOI 10.1890/01-5324; Legault A, 2013, BIOL CONSERV, V167, P149, DOI 10.1016/j.biocon.2013.07.041; Lisi PJ, 2013, GEOMORPHOLOGY, V185, P78, DOI 10.1016/j.geomorph.2012.12.013; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Liu Yu, 2008, Dongbei Shida Xuebao (Ziran Kexue Ban), V40, P111; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Manel S, 1999, ECOL MODEL, V120, P337, DOI 10.1016/S0304-3800(99)00113-1; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026784; Meffert PJ, 2012, BIOL CONSERV, V153, P87, DOI 10.1016/j.biocon.2012.04.018; Negro JJ, 2011, ANIM CONSERV, V14, P338, DOI 10.1111/j.1469-1795.2011.00484.x; Nilsson ALK, 2011, J ANIM ECOL, V80, P235, DOI 10.1111/j.1365-2656.2010.01755.x; Osborne PE, 2001, J APPL ECOL, V38, P458, DOI 10.1046/j.1365-2664.2001.00604.x; Pearce J, 2000, ECOL MODEL, V128, P127, DOI 10.1016/S0304-3800(99)00227-6; Penteriani V, 2011, ANIM CONSERV, V14, P233, DOI 10.1111/j.1469-1795.2010.00433.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Robertson M. P., 2001, Diversity and Distributions, V7, P15, DOI 10.1046/j.1472-4642.2001.00094.x; Robinet O, 1996, EMU, V96, P151, DOI 10.1071/MU9960151; Shao MQ, 2012, PAK J ZOOL, V44, P503; Shokhrin Valeri, 2003, TWSG News, V14, P43; Solberg KH, 2006, BIOL CONSERV, V128, P158, DOI 10.1016/j.biocon.2005.09.025; Solovieva Diana, 2006, TWSG News, V15, P60; Solovyeva DV, 2014, BIRD CONSERV INT, V24, P393, DOI 10.1017/S0959270913000610; Solovyeva Diana V., 2012, Endangered Species Research, V17, P217, DOI 10.3354/esr00429; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Underwood J, 2013, WILSON J ORNITHOL, V125, P159, DOI 10.1676/11-176.1; Vanagas Giedrius, 2004, Interact Cardiovasc Thorac Surg, V3, P319, DOI 10.1016/j.icvts.2004.01.008; Zhang J, 2012, J BIOGEOGRAPHY; Zhiru W, 2010, SICHUAN J ZOOLOGY, V29, P597	64	21	25	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117307	10.1371/journal.pone.0117307	http://dx.doi.org/10.1371/journal.pone.0117307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646969	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600064
J	Pham, N; Akonasu, H; Shishkin, R; Taghibiglou, C				Nam Pham; Akonasu, Hungbo; Shishkin, Rhonda; Taghibiglou, Changiz			Plasma Soluble Prion Protein, a Potential Biomarker for Sport-Related Concussions: A Pilot Study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; ENDOTHELIAL-CELLS; CELLULAR ISOFORM; EXPRESSION; EPIDEMIOLOGY; PRPC; PATHOPHYSIOLOGY; DIAGNOSIS; HEALTHY	Sport-related mild traumatic brain injury (mTBI) or concussion is a significant health concern to athletes with potential long-term consequences. The diagnosis of sport concussion and return to sport decision making is one of the greatest challenges facing health care clinicians working in sports. Blood biomarkers have recently demonstrated their potential in assisting the detection of brain injury particularly, in those cases with no obvious physical injury. We have recently discovered plasma soluble cellular prion protein (PrPC) as a potential reliable biomarker for blast induced TBI (bTBI) in a rodent animal model. In order to explore the application of this novel TBI biomarker to sport-related concussion, we conducted a pilot study at the University of Saskatchewan (U of S) by recruiting athlete and non-athlete 18 to 30 year-old students. Using a modified quantitative ELISA method, we first established normal values for the plasma soluble PrPC in male and female students. The measured plasma soluble PrPC in confirmed concussion cases demonstrated a significant elevation of this analyte in post-concussion samples. Data collected from our pilot study indicates that the plasma soluble PrPC is a potential biomarker for sport-related concussion, which may be further developed into a clinical diagnostic tool to assist clinicians in the assessment of sport concussion and return-to-play decision making.	[Nam Pham; Akonasu, Hungbo; Taghibiglou, Changiz] Univ Saskatchewan, Coll Med, Dept Pharmacol, Saskatoon, SK S7N 0W0, Canada; [Shishkin, Rhonda] Univ Saskatchewan, Coll Kinesiol & Huskies Athlet, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Taghibiglou, C (corresponding author), Univ Saskatchewan, Coll Med, Dept Pharmacol, Saskatoon, SK S7N 0W0, Canada.	changiz.taghibiglou@usask.ca	Taghibiglou, Changiz/H-4590-2019					Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Banks WA, 2009, EXP NEUROL, V218, P162, DOI 10.1016/j.expneurol.2009.04.025; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Breitling LP, 2012, EXP GERONTOL, V47, P919, DOI 10.1016/j.exger.2012.08.001; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Forde CT, 2014, BRIT J NEUROSURG, V28, P8, DOI 10.3109/02688697.2013.815317; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Guingab-Cagmat JD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00061; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Haddon DJ, 2009, J INFECT DIS, V200, P827, DOI 10.1086/605022; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Jeon Jae-Won, 2013, Immune Netw, V13, P148, DOI 10.4110/in.2013.13.4.148; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Krupinski J, 2008, ACTA NEUROPATHOL, V116, P537, DOI 10.1007/s00401-008-0427-6; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meehan WP, 2011, CLIN SPORT MED, V30, pXVII, DOI 10.1016/j.csm.2010.09.008; Megra B, 2013, J NEUROIMMUNE PHARM, V8, P1159, DOI 10.1007/s11481-013-9458-4; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Meyne F, 2009, J ALZHEIMERS DIS, V17, P863, DOI 10.3233/JAD-2009-1110; Mitsios N, 2007, J NEUROSCI RES, V85, P602, DOI 10.1002/jnr.21142; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Pham N, 2015, J NEUROTRAUM, V32, P58, DOI 10.1089/neu.2014.3471; Pham N, 2014, BIOCHEM BIOPH RES CO, V448, P151, DOI 10.1016/j.bbrc.2014.04.071; Picard-Hagen N, 2006, J GEN VIROL, V87, P3723, DOI 10.1099/vir.0.81859-0; Politopoulou G, 2000, HAEMATOLOGICA, V85, P580; Ritchie AJ, 2013, BRIT J HAEMATOL, V163, P678, DOI 10.1111/bjh.12543; Roberts TK, 2010, AM J PATHOL, V177, P1848, DOI 10.2353/ajpath.2010.091006; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Simak J, 2002, TRANSFUSION, V42, P334, DOI 10.1046/j.1537-2995.2002.00072.x; Starke R, 2002, BRIT J HAEMATOL, V119, P863, DOI 10.1046/j.1365-2141.2002.03847.x; Stewart TC, 2013, J TRAUMA ACUTE CARE, V76, P736; Strathmann FG, 2014, CLIN BIOCHEM, DOI [10.1016/j.clinbiochem.2014.12.017, DOI 10.1016/J.CLINBIOCHEM.2014.12.017]; Torres M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036159; Volkel D, 2001, TRANSFUSION, V41, P441, DOI 10.1046/j.1537-2995.2001.41040441.x; Wang Kevin K W, 2012, Front Neurol, V3, P147, DOI 10.3389/fneur.2012.00147; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Yusa S, 2012, VIRUSES-BASEL, V4, P3109, DOI 10.3390/v4113109; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	48	30	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117286	10.1371/journal.pone.0117286	http://dx.doi.org/10.1371/journal.pone.0117286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643046	Green Submitted, Green Published, gold			2022-12-27	WOS:000348821200036
J	Schwarting, T; Lechler, P; Struewer, J; Ambrock, M; Frangen, TM; Ruchholtz, S; Ziring, E; Frink, M				Schwarting, Tim; Lechler, Philipp; Struewer, Johannes; Ambrock, Marius; Frangen, Thomas Manfred; Ruchholtz, Steffen; Ziring, Ewgeni; Frink, Michael			Bone Morphogenetic Protein 7 (BMP-7) Influences Tendon-Bone Integration In Vitro	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; OSTEOGENIC PROTEIN-1; DIFFERENTIATION; RECONSTRUCTION; ANTAGONISTS; FIBROBLAST; EXPRESSION	Introduction Successful graft ingrowth following reconstruction of the anterior cruciate ligament is governed by complex biological processes at the tendon-bone interface. The aim of this study was to investigate in an in vitro study the effects of bone morphogenetic protein 7 (BMP-7) on tendon-bone integration. Materials and Methods To study the biological effects of BMP-7 on the process of tendon-bone-integration, two independent in vitro models were used. The first model involved the mono-and coculture of bovine tendon specimens and primary bovine osteoblasts with and without BMP-7 exposure. The second model comprised the mono-and coculture of primary bovine osteoblasts and fibroblasts. Alkaline phosphatase (ALP), lactate dehydrogenase (LDH), lactate and osteocalcin (OCN) were analyzed by ELISA. Histological analysis and electron microscopy of the tendon specimens were performed. Results In both models, positive effects of BMP-7 on ALP enzyme activity were observed (p<0.001). Additionally, similar results were noted for LDH activity and lactate concentration. BMP-7 stimulation led to a significant increase in OCN expression. Whereas the effects of BMP-7 on tendon monoculture peaked during an early phase of the experiment (p<0.001), the cocultures showed a maximal increase during the later stages (p<0.001). The histological analysis showed a stimulating effect of BMP-7 on extracellular matrix formation. Organized ossification zones and calcium carbonate-like structures were only observed in the BMP-stimulated cell cultures. Discussion This study showed the positive effects of BMP-7 on the biological process of tendon-bone integration in vitro. Histological signs of improved mineralization were paralleled by increased rates of osteoblast-specific protein levels in primary bovine osteoblasts and fibroblasts. Conclusion Our findings indicated a role for BMP-7 as an adjuvant therapeutic agent in the treatment of ligamentous injuries, and they emphasized the importance of the transdifferentiation process of tendinous fibroblasts at the tendon-bone interface.	[Schwarting, Tim; Lechler, Philipp; Ambrock, Marius; Frangen, Thomas Manfred; Ruchholtz, Steffen; Ziring, Ewgeni; Frink, Michael] Univ Hosp Giessen & Marburg, Dept Trauma Hand & Reconstruct Surg, Marburg, Germany; [Struewer, Johannes] Univ Hosp Giessen & Marburg, Dept Orthopaed & Rheumatol, Marburg, Germany	University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg	Frink, M (corresponding author), Univ Hosp Giessen & Marburg, Dept Trauma Hand & Reconstruct Surg, Marburg, Germany.	frink@med.uni-marburg.de						Ali IHA, 2014, BRIT J PHARMACOL, V171, P3620, DOI 10.1111/bph.12724; AMIEL D, 1986, J ORTHOPAED RES, V4, P162, DOI 10.1002/jor.1100040204; Aspenberg P, 2001, J BONE MINER RES, V16, P497, DOI 10.1359/jbmr.2001.16.3.497; Biau DJ, 2009, AM J SPORT MED, V37, P2470, DOI 10.1177/0363546509333006; Bishop GB, 2007, INT ORTHOP, V31, P721, DOI 10.1007/s00264-007-0424-8; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Chen D, 2004, FRONT BIOSCI-LANDMRK, V9, P349, DOI 10.2741/1090; Cook SD, 1996, CLIN ORTHOP RELAT R, P29, DOI 10.1097/00003086-199603000-00005; Cox S, 2004, BRAIN RES, V1010, P55, DOI 10.1016/j.brainres.2004.02.068; Curtze S, 2004, J CELL SCI, V117, P2721, DOI 10.1242/jcs.01119; de Jong DS, 2004, J BONE MINER RES, V19, P947, DOI 10.1359/JBMR.040216; Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151; Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x; Griffin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072978; Hashimoto Y, 2007, J ORTHOP RES, V25, P1415, DOI 10.1002/jor.20447; Jang WG, 2012, J BIOL CHEM, V287, P905, DOI 10.1074/jbc.M111.253187; JONES DB, 1991, CELL MATER, V1, P329; Lavery K, 2009, BONE, V45, P27, DOI 10.1016/j.bone.2009.03.656; Lovric V, 2012, AM J SPORT MED, V40, P2365, DOI 10.1177/0363546512457648; Martinek V, 2002, J BONE JOINT SURG AM, V84A, P1123, DOI 10.2106/00004623-200207000-00005; Menetrey J, 2008, KNEE SURG SPORT TR A, V16, P224, DOI 10.1007/s00167-007-0474-x; Mihelic R, 2004, AM J SPORT MED, V32, P1619, DOI 10.1177/0363546504263703; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Moon JS, 2014, J BONE MINER RES, V29, P1586, DOI 10.1002/jbmr.2197; Myllyla RM, 2014, CELL TISSUE RES, V355, P463, DOI 10.1007/s00441-013-1745-0; NICKLIN S, 2000, T ORTHOP RES SOC, V25, P155; Rodeo SA, 2007, J BONE JOINT SURG AM, V89A, P2250, DOI 10.2106/JBJS.F.00409; Salkeld SL, 2001, J BONE JOINT SURG AM, V83A, P803, DOI 10.2106/00004623-200106000-00001; Scheffler SU, 2008, KNEE SURG SPORT TR A, V16, P834, DOI 10.1007/s00167-008-0560-8; Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678; Shi ZL, 2009, BIOMACROMOLECULES, V10, P1603, DOI 10.1021/bm900203w; Spector JA, 2001, AM J PHYSIOL-CELL PH, V280, pC72, DOI 10.1152/ajpcell.2001.280.1.C72; Struewer J, 2013, ORTHOPEDICS, V36, pE200, DOI 10.3928/01477447-20130122-23; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Umehara K, 2012, ANAT REC, V295, P1327, DOI 10.1002/ar.22510; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Wang INE, 2007, J ORTHOP RES, V25, P1609, DOI 10.1002/jor.20475; Zhu W, 2006, BONE, V39, P61, DOI 10.1016/j.bone.2005.12.018	38	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116833	10.1371/journal.pone.0116833	http://dx.doi.org/10.1371/journal.pone.0116833			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643349	Green Published, gold, Green Submitted			2022-12-27	WOS:000348821200025
J	Oba, Y; Ohira, H; Murase, Y; Moriyama, A; Kumazawa, Y				Oba, Yuichi; Ohira, Hitoo; Murase, Yukio; Moriyama, Akihiko; Kumazawa, Yoshinori			DNA Barcoding of Japanese Click Beetles (Coleoptera, Elateridae)	PLOS ONE			English	Article								Click beetles (Coleoptera: Elateridae) represent one of the largest groups of beetle insects. Some click beetles in larval form, known as wireworms, are destructive agricultural pests. Morphological identification of click beetles is generally difficult and requires taxonomic expertise. This study reports on the DNA barcoding of Japanese click beetles to enable their rapid and accurate identification. We collected and assembled 762 cytochrome oxidase subunit I barcode sequences from 275 species, which cover approximately 75% of the common species found on the Japanese main island, Honshu. This barcode library also contains 20 out of the 21 potential pest species recorded in Japan. Our analysis shows that most morphologically identified species form distinct phylogenetic clusters separated from each other by large molecular distances. This supports the general usefulness of the DNA barcoding approach for quick and reliable identification of Japanese elaterid species for environmental impact assessment, agricultural pest control, and biodiversity analysis. On the other hand, the taxonomic boundary in dozens of species did not agree with the boundary of barcode index numbers (a criterion for sequence-based species delimitation). These findings urge taxonomic reinvestigation of these mismatched taxa.	[Oba, Yuichi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Ohira, Hitoo] Kitsuneyama, Okazaki, Aichi 4443511, Japan; [Murase, Yukio; Moriyama, Akihiko; Kumazawa, Yoshinori] Nagoya City Univ, Grad Sch Nat Sci, Res Ctr Biol Divers, Nagoya, Aichi 4678501, Japan	Nagoya University; Nagoya City University	Oba, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	oba@agr.nagoya-u.ac.jp; kuma@nsc.nagoya-cu.ac.jp	Oba, Yuichi/AAZ-7796-2021		Nagoya City University [42]; Japan Society for the Promotion of Science [258041]	Nagoya City University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Research in Nagoya City University (no. 42) and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (258041). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki N, 2008, J ECON ENTOMOL, V101, P1568, DOI 10.1603/0022-0493(2008)101[1568:MDFCOM]2.0.CO;2; Asahida T, 1996, FISHERIES SCI, V62, P727, DOI 10.2331/fishsci.62.727; Azuma S, 2002, CHECK LIST INSECT RY, P203; Chujo M, 1973, MEMOIRS FACULTY LIBE, P17; Costa C, 2010, HBK ZOOL, P75; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hayakawa H, 1987, ANN REPT PLANT PROT, V38, P107; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HIRAI Y, 1991, JARQ-JPN AGR RES Q, V25, P12; Hirano Y., 2004, INSECT FAUNA KANAGAW, VII, P335; Inaizumi M, 2003, INSECTS TOCHIGI PREF, P177; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Jinnouchi Hiroaki, 1997, Proceedings of the Association for Plant Protection of Kyushu, V43, P91; Johnson PJ, 2001, AM BEETLES, V2, P160; Kishii T, 1996, B HEIAN HIGH SCH KYO, V39, P1; Kishii T., 1999, B HEIAN HIGH SCH KYO, V42, P1; Kishii T, 1966, ELATERIDAE KYOTO ITS, P1; MATSUI M, 1980, J FOREST, V78, P96; Mendel H, 2012, CHECKLIST BEETLES BR, P62; Mittermeier RA, 2005, HOTSPOTS REVISITED; Oba Yuichi, 2007, Coleopterists' News, V157, P7; Ohira H., 1986, New Entomologist, V35, P17; Ohira H., 1989, Gekkan-Mushi, P23; Ohira H., 1988, Edaphologia, P27; Ohira H, 1988, T ESSA ENT SOC NIIGA, V65, P19; Ohira H, 2004, MISC REPT HIWA MUS N, V43; Ohira H., 1962, MORPHOLOGICAL TAXONO; Ohira H, 1999, B SOUNKYO MUS NAT HI, V19, P1; Ohira H, 2001, ANN REPT AOMORI PREF, V25, P77; Ohira H, 2002, THREATENED WILDLIFE; Ohira H, 1993, HIBAKAGAKU, V154, P11; Ohira H, 1984, B SOUNKYO MUS NAT HI, V4, P13; Ohira H, 1989, T ESSA ENT SOC NIIGA, V68, P59; Ohira H, 1968, KONCHU SHIZEN, V3, P30; Ohira H, 1989, GEKKAN MUSHI, V217, P9; Ohira H, 1990, INSECTS IN AICHI, V1, P367; Ohira H, 2013, ILLUSTRATED GUIDE ID, P227; Ohira H, 1985, COLEOPTERA JAPAN COL, VIII, P53; Ohira H, 1969, KONCHU SHIZEN, V4, P22; Ohira H, 1996, ENT J FUKUI, V19, P33; Ohira Hitoo, 1997, Miscellaneous Reports of the Hiwa Museum for Natural History, V35, P1; Ohira Hitoo, 1992, Transactions Essa Entomological Society Niigata, V74, P23; Pentinsaari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108651; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Sagegami-Oba R, 2008, ELYTRA, V36, P79; Sagegami-Oba R, 2007, MOL PHYLOGENET EVOL, V42, P410, DOI 10.1016/j.ympev.2006.07.017; Sakurai K, 1942, KONCHU, V16, P1; Sasaji H, 1998, INSECT FAUNA FUKUI P; Staudacher K, 2011, B ENTOMOL RES, V101, P201, DOI 10.1017/S0007485310000337; SUZUKI W, 1985, Transactions of the Shikoku Entomological Society, V17, P79; Suzuki W, 1989, CHECK LIST JAPANESE, P327; Taira A, 1989, EVOLUTION PACIFIC OC, P100; Tarnawski Dariusz, 2001, Genus (Wroclaw), V12, P277; The Association for Geological Collaboration of Japan, 1965, GEOL DEV JAP ISL; Vernon RS, 2007, J CHEM ECOL, V33, P345, DOI 10.1007/s10886-006-9217-6; Watanabe T, 1989, COLEOPTERA MIYAGI PR; Yamaji O, 2012, LIST COLEOPTERA OKAY; YOSHIDA M., 1951, OYO KONTYU, V7, P145	59	32	33	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116612	10.1371/journal.pone.0116612	http://dx.doi.org/10.1371/journal.pone.0116612			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25636000	Green Submitted, Green Published, gold			2022-12-27	WOS:000350680700049
J	Hoffmann, CJ; Hoffmann, JD; Kensler, C; van der Watt, M; Omar, T; Chaisson, RE; Martinson, NA; Variava, E				Hoffmann, Christopher J.; Hoffmann, Jennifer D.; Kensler, Caroline; van der Watt, Martin; Omar, Tanvier; Chaisson, Richard E.; Martinson, Neil A.; Variava, Ebrahim			Tuberculosis and Hepatic Steatosis Are Prevalent Liver Pathology Findings among HIV-Infected Patients in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HEPATOTOXICITY; DISEASE; BURDEN; ANTITUBERCULOSIS; INJURY; ADULTS; RISK	Liver disease epidemiology in sub-Saharan Africa has shifted as a result of HIV and the increased use of antiretroviral therapy leading to a need for updated data on common causes of liver disease. We retrospectively reviewed records from all hospitalized patients who had liver biopsy at a single hospital in South Africa from 2001 to 2009 and compared diagnosis by HIV status. During the period of study 262 patients had liver biopsy, 108 (41%) were HIV-infected, 25 (10%) were HIV-sero-negative, and 129 (49%) had unknown or unrecorded HIV status. Overall 81% of biopsies provided additional diagnostic data. Malignancy was the most common finding reported on 56 (21%) biopsies followed by granuloma or TB, hepatic steatosis, and fibrosis or cirrhosis. HIV-infected patients were more likely to have granulomas and steatosis. Half of patients with granulomas were already on TB treatment, suggesting paradoxical reactions or drug induced liver injury may have been important causes of liver inflammation among these patients. We note that TB, paradoxical reactions during TB treatment, possible drug induced liver injury, and hepatic steatosis are important causes of liver pathology among HIV-infected hospitalized patients with unclear etiology of liver disease after initial assessment. Among HIV sero-negative patients, malignancy was the major cause of liver disease. Our findings re-enforce the importance of TB as a diagnosis among HIV-infected individuals.	[Hoffmann, Christopher J.; Hoffmann, Jennifer D.; Chaisson, Richard E.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Kensler, Caroline] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [van der Watt, Martin; Martinson, Neil A.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Omar, Tanvier] Univ Witwatersrand, Dept Anat Pathol, Johannesburg, South Africa; [Omar, Tanvier] Natl Hlth Lab Serv, Johannesburg, South Africa; [Variava, Ebrahim] Klerksdorp Tshepong Hosp Complex, Dept Med, Klerksdorp, South Africa; [Variava, Ebrahim] Univ Witwatersrand, Klerksdorp, South Africa	Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand	Hoffmann, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	choffmann@jhmi.edu	Variava, Ebrahim/AAO-5717-2020	Variava, Ebrahim/0000-0003-2888-789X; Hoffmann, Christopher/0000-0002-9422-0519	National Institutes of Health [AI083099]; SATBAT a Fogarty International Center [5U2RTW007370/3]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI083099, P30AI094189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SATBAT a Fogarty International Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CJH is supported by a National Institutes of Health research grant [AI083099]. EV received research training from SATBAT a Fogarty International Center funded program [5U2RTW007370/3]. The funders had no role in study design, data collection, analysis, or manuscript preparation.	Alvarez SZ, 1998, J GASTROEN HEPATOL, V13, P833, DOI 10.1111/j.1440-1746.1998.tb00743.x; Barr DA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-257; Cho HJ, 2013, PEDIATR GASTROENTERO, V16, P273, DOI 10.5223/pghn.2013.16.4.273; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Crum-Cianflone N, 2009, JAIDS-J ACQ IMM DEF, V50, P464, DOI 10.1097/QAI.0b013e318198a88a; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Kleiner DE, 2014, HEPATOLOGY, V59, P661, DOI 10.1002/hep.26709; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; Martinson Neil A, 2011, Proc Am Thorac Soc, V8, P288, DOI 10.1513/pats.201010-064WR; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mugusi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040180; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nunez M, 2010, HEPATOLOGY, V52, P1143, DOI 10.1002/hep.23716; O'Brien CB, 2009, CLIN LIVER DIS, V13, P179, DOI 10.1016/j.cld.2009.02.010; Ouyang DW, 2009, AIDS, V23, P2425, DOI 10.1097/QAD.0b013e32832e34b1; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; Reddy SP, 2012, AM J PUBLIC HEALTH, V102, P262, DOI 10.2105/AJPH.2011.300222; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Schneider M, 2007, SAMJ S AFR MED J, V97, P664; Schutz C, 2012, SAMJ S AFR MED J, V102, P506, DOI 10.7196/SAMJ.5650; Shapiro AE, 2012, AM J RESP CRIT CARE, V185, P1110, DOI 10.1164/rccm.201111-1941OC; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Yao F, 1997, AM J GASTROENTEROL, V92, P167	26	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117813	10.1371/journal.pone.0117813	http://dx.doi.org/10.1371/journal.pone.0117813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668620	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000349493000026
J	Flass, T; Tong, SH; Frank, DN; Wagner, BD; Robertson, CE; Kotter, CV; Sokol, RJ; Zemanick, E; Accurso, F; Hoffenberg, EJ; Narkewicz, MR				Flass, Thomas; Tong, Suhong; Frank, Daniel N.; Wagner, Brandie D.; Robertson, Charles E.; Kotter, Cassandra Vogel; Sokol, Ronald J.; Zemanick, Edith; Accurso, Frank; Hoffenberg, Edward J.; Narkewicz, Michael R.			Intestinal Lesions Are Associated with Altered Intestinal Microbiome and Are More Frequent in Children and Young Adults with Cystic Fibrosis and Cirrhosis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; FATTY LIVER-DISEASE; FECAL CALPROTECTIN; TRANSIT-TIME; CAPSULE ENDOSCOPY; GUT MICROBIOTA; NONALCOHOLIC STEATOHEPATITIS; RISK-FACTORS; PERMEABILITY; LACTULOSE	Background and Aims Cirrhosis (CIR) occurs in 5-7% of cystic fibrosis (CF) patients. We hypothesized that alterations in intestinal function in CF contribute to the development of CIR. Aims: Determine the frequency of macroscopic intestinal lesions, intestinal inflammation, intestinal permeability and characterize fecal microbiome in CF CIR subjects and CF subjects with no liver disease (CFnoLIV). Methods 11 subjects with CFCIR (6 M, 12.8 yrs +/- 3.8) and 19 matched with CFnoLIV (10 M, 12.6 yrs +/- 3.4) underwent small bowel capsule endoscopy, intestinal permeability testing by urinary lactulose: mannitol excretion ratio, fecal calprotectin determination and fecal microbiome characterization. Results CFCIR and CFnoLIV did not differ in key demographics or CF complications. CFCIR had higher GGT (59 +/- 51 U/L vs 17 +/- 4 p = 0.02) and lower platelet count (187 +/- 126 vs 283 +/- 60 p = 0.04) and weight (-0.86 +/- 1.0 vs 0.30 +/- 0.9 p = 0.002) z scores. CFCIR had more severe intestinal mucosal lesions on capsule endoscopy (score >= 4, 4/11 vs 0/19 p = 0.01). Fecal calprotectin was similar between CFCIR and CFnoLIV (166 mu g/g +/- 175 vs 136 +/- 193 p = 0.58, nl < 120). Lactulose: mannitol ratio was elevated in 27/28 subjects and was slightly lower in CFCIR vs CFnoLIV (0.08 +/- 0.02 vs 0.11 +/- 0.05, p = 0.04, nl <= 0.03). Small bowel transit time was longer in CFCIR vs CFnoLIV (195 +/- 42 min vs 167 +/- 68 p < 0.001, nl 274 +/- 41). Bacteroides were decreased in relative abundance in CFCIR and were associated with lower capsule endoscopy score whereas Clostridium were more abundant in CFCIR and associated with higher capsule endoscopy score. Conclusions CFCIR is associated with increased intestinal mucosal lesions, slower small bowel transit time and alterations in fecal microbiome. Abnormal intestinal permeability and elevated fecal calprotectin are common in all CF subjects. Disturbances in intestinal function in CF combined with changes in the microbiome may contribute to the development of hepatic fibrosis and intestinal lesions.	[Flass, Thomas; Sokol, Ronald J.; Hoffenberg, Edward J.; Narkewicz, Michael R.] Univ Colorado, Sch Med, Sect Pediat Gastroenterol Hepatol & Nutr, Dept Pediat, Aurora, CO 80045 USA; [Flass, Thomas; Sokol, Ronald J.; Zemanick, Edith; Accurso, Frank; Hoffenberg, Edward J.; Narkewicz, Michael R.] Childrens Hosp Colorado, Aurora, CO USA; [Zemanick, Edith; Accurso, Frank] Univ Colorado, Sect Pediat Pulm Med, Dept Pediat, Sch Med, Aurora, CO USA; [Tong, Suhong; Wagner, Brandie D.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Tong, Suhong; Wagner, Brandie D.] Childrens Hosp, Aurora, CO USA; [Sokol, Ronald J.] Univ Colorado, Colorado Clin & Translat Sci Inst, Sch Med, Aurora, CO USA; [Frank, Daniel N.; Kotter, Cassandra Vogel] Univ Colorado Denver, Dept Infect Dis, Aurora, CO USA; [Wagner, Brandie D.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Robertson, Charles E.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	Narkewicz, MR (corresponding author), Univ Colorado, Sch Med, Sect Pediat Gastroenterol Hepatol & Nutr, Dept Pediat, Aurora, CO 80045 USA.	michael.narkewicz@childrenscolorado.org	Zemanick, Edith T/ABF-9455-2020; Zemanick, Edith/D-5260-2017	Zemanick, Edith T/0000-0002-7507-9337; Zemanick, Edith/0000-0002-7507-9337; Wagner, brandie/0000-0002-2745-0103; Hoffenberg, Edward/0000-0001-5179-489X; ROBERTSON, CHARLES/0000-0002-4136-4121	NIH/NCATS Colorado CTSI Grant [UL1 TR000154/UTR001082, UO1 DK62453, T32 DK067009]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000154, UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL114883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK067009, U01DK062453] Funding Source: NIH RePORTER	NIH/NCATS Colorado CTSI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by NIH/NCATS Colorado CTSI Grant Number UL1 TR000154/UTR001082, UO1 DK62453, and T32 DK067009. Given Imaging PLC provided the video capsules. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkanani AK, 2014, DIABETES, V63, P619, DOI 10.2337/db13-1007; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aoyama T, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/192543; Aron-Wisnewsky J, 2013, CLIN MICROBIOL INFEC, V19, P338, DOI 10.1111/1469-0691.12140; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012; Bartlett JR, 2009, JAMA-J AM MED ASSOC, V302, P1076, DOI 10.1001/jama.2009.1295; Blanco PG, 2004, AM J PHYSIOL-GASTR L, V287, pG491, DOI 10.1152/ajpgi.00452.2003; Bruzzese E, 2004, ALIMENT PHARM THER, V20, P813, DOI 10.1111/j.1365-2036.2004.02174.x; Caddy GR, 2006, GASTROINTEST ENDOSC, V63, P262, DOI 10.1016/j.gie.2005.07.043; Canani RB, 2008, DIGEST LIVER DIS, V40, P547, DOI 10.1016/j.dld.2008.01.017; Cariello R, 2010, DIGEST LIVER DIS, V42, P200, DOI 10.1016/j.dld.2009.05.001; COLOMBO C, 1994, J PEDIATR-US, V124, P393, DOI 10.1016/S0022-3476(94)70361-2; Colombo C, 2007, CURR OPIN PULM MED, V13, P529, DOI 10.1097/MCP.0b013e3282f10a16; Corey M, 1997, J PEDIATR-US, V131, P809, DOI 10.1016/S0022-3476(97)70025-8; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; Cox LM, 2013, FASEB J, V27, P692, DOI 10.1096/fj.12-219477; Croft NM, 1996, POSTGRAD MED J, V72, pS32; DALZELL AM, 1990, ARCH DIS CHILD, V65, P585, DOI 10.1136/adc.65.6.585; Davis JJ, 2013, INT J SYST EVOL MICR, V63, P2727, DOI 10.1099/ijs.0.048983-0; Delzenne NM, 2011, ANNU REV NUTR, V31, P15, DOI 10.1146/annurev-nutr-072610-145146; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Efrati O, 2003, EUR J GASTROEN HEPAT, V15, P1073, DOI 10.1097/00042737-200310000-00002; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fagerberg UL, 2007, J PEDIATR GASTR NUTR, V45, P414, DOI 10.1097/MPG.0b013e31810e75a9; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gisbert JP, 2009, DIGEST LIVER DIS, V41, P56, DOI 10.1016/j.dld.2008.05.008; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hallberg K, 1997, J PEDIATR GASTR NUTR, V25, P290, DOI 10.1097/00005176-199709000-00008; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Ho GT, 2009, AM J GASTROENTEROL, V104, P673, DOI 10.1038/ajg.2008.119; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Infante Pina D, 2008, An Pediatr (Barc), V69, P501; Kalantzis C, 2007, SCAND J GASTROENTERO, V42, P1120, DOI 10.1080/00365520701251601; Kelly CJ, 2012, NUTR CLIN PRACT, V27, P215, DOI 10.1177/0884533611434934; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; Lamireau T, 2004, J HEPATOL, V41, P920, DOI 10.1016/j.jhep.2004.08.006; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Langhorst J, 2008, AM J GASTROENTEROL, V103, P162, DOI 10.1111/j.1572-0241.2007.01556.x; LECLERCQFOUCART J, 1987, J PEDIATR GASTR NUTR, V6, P66, DOI 10.1097/00005176-198701000-00012; Lisowska A, 2009, ACTA BIOCHIM POL, V56, P631; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Maiden L, 2009, J GASTROENTEROL, V44, P64, DOI 10.1007/s00535-008-2248-8; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Marsilio R, 1998, CLIN CHEM, V44, P1685; Martin CR, 2012, AM J PHYSIOL-GASTR L, V303, pG474, DOI 10.1152/ajpgi.00055.2012; Martinez I, 2013, APPL ENVIRON MICROB, V79, P516, DOI 10.1128/AEM.03046-12; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Moschen AR, 2013, TRENDS ENDOCRIN MET, V24, P537, DOI 10.1016/j.tem.2013.05.009; Mouzaki M, 2013, HEPATOLOGY, V58, P120, DOI 10.1002/hep.26319; Niv E, 2008, WORLD J GASTROENTERO, V14, P2561, DOI 10.3748/wjg.14.2561; Norman K, 2008, CURR OPIN CLIN NUTR, V11, P613, DOI 10.1097/MCO.0b013e32830a70bc; Ogawa Y, 2011, J BACTERIOL, V193, P2959, DOI 10.1128/JB.01500-10; Oksanen J., 2008, R PACKAGE VERSION 1; Pradere JP, 2010, SEMIN LIVER DIS, V30, P232, DOI 10.1055/s-0030-1255353; Pruesse E, 2007, NUCL ACIDS RES; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Raman M, 2013, CLIN GASTROENTEROL H, V11, P868, DOI 10.1016/j.cgh.2013.02.015; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; ROSETH AG, 1992, SCAND J GASTROENTERO, V27, P793, DOI 10.3109/00365529209011186; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Slieker MG, 2003, HEPATOLOGY, V38, P775, DOI 10.1053/jhep.2003.50403; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; Vajro P, 2013, J PEDIATR GASTR NUTR, V56, P461, DOI 10.1097/MPG.0b013e318284abb5; VANELBURG RM, 1992, SCAND J GASTROENTERO, V27, P19, DOI 10.3109/00365529209096021; VANELBURG RM, 1995, J PEDIATR GASTR NUTR, V20, P184, DOI 10.1097/00005176-199502000-00008; vanElburg RM, 1996, PEDIATR RES, V39, P985, DOI 10.1203/00006450-199606000-00010; Vawter G F, 1979, Pathol Annu, V14 Pt 2, P357; von Roon AC, 2007, AM J GASTROENTEROL, V102, P803, DOI 10.1111/j.1572-0241.2007.01126.x; Werlin SL, 2010, J PEDIATR GASTR NUTR, V51, P304, DOI 10.1097/MPG.0b013e3181d1b013; Wilschanski Michael, 2008, Curr Gastroenterol Rep, V10, P316, DOI 10.1007/s11894-008-0062-3; Yagmur E, 2006, DEUT MED WOCHENSCHR, V131, P1930, DOI 10.1055/s-2006-949189; Zeuzem S, 2000, INT J COLORECTAL DIS, V15, P59, DOI 10.1007/s003840050236; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093	79	48	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116967	10.1371/journal.pone.0116967	http://dx.doi.org/10.1371/journal.pone.0116967			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658710	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900083
J	Lazzarotto, V; Corraze, G; Leprevost, A; Quillet, E; Dupont-Nivet, M; Medale, F				Lazzarotto, Viviana; Corraze, Genevieve; Leprevost, Amandine; Quillet, Edwige; Dupont-Nivet, Mathilde; Medale, Francoise			Three-Year Breeding Cycle of Rainbow Trout (Oncorhynchus mykiss) Fed a Plant-Based Diet, Totally Free of Marine Resources: Consequences for Reproduction, Fatty Acid Composition and Progeny Survival	PLOS ONE			English	Article							BREAM SPARUS-AURATA; SALMON SALMO-SALAR; EUROPEAN SEA-BASS; BODY/FILLET QUALITY TRAITS; FISH-MEAL REPLACEMENT; EGG QUALITY; VEGETABLE-OILS; DICENTRARCHUS-LABRAX; GROWTH-PERFORMANCE; GILTHEAD SEABREAM	Terrestrial plant resources are increasingly used as substitutes for fish meal and fish oil in fish feed in order to reduce the reliance of aquaculture on marine fishery resources. Although many studies have been conducted to assess the effects of such nutritional transition, no whole breeding cycles of fish fed diets free from marine resources has been reported to date. We therefore studied the reproductive performance of trout after a complete cycle of breeding while consuming a diet totally devoid of marine ingredients and thus of n-3 long chain polyunsaturated fatty acids (n-3 LC-PUFAs) that play a major role in the formation of ova. Two groups of female rainbow trout were fed from first feeding either a commercial diet (C, marine and plant ingredients), or a 100% plant-based diet (V, blend of plant proteins and vegetable oils). Livers, viscera, carcasses and ova were sampled at spawning and analyzed for lipids and fatty acids. Although the V-diet was devoid of n-3 LCPUFAs, significant amounts of EPA and DHA were found in livers and ova, demonstrating efficient bioconversion of linolenic acid and selective orientation towards the ova. Some ova were fertilized to assess the reproductive performance and offspring survival. We observed for the first time that trout fed a 100% plant-based diet over a 3-year breeding cycle were able to produce ova and viable alevins, although the ova were smaller. The survival of offspring from V-fed females was lower (-22%) at first spawning, but not at the second. Our study showed that, in addition to being able to grow on a plant-based diet, rainbow trout reared entirely on such a diet can successfully produce ova in which neo-synthesized n-3 LC-PUFAs are accumulated, leading to viable offspring. However, further adjustment of the feed formula is still needed to optimize reproductive performance.	[Lazzarotto, Viviana; Corraze, Genevieve; Leprevost, Amandine; Medale, Francoise] INRA, UR Nutr Metab Aquaculture 1067, F-64310 St Pee Sur Nivelle, France; [Quillet, Edwige; Dupont-Nivet, Mathilde; Medale, Francoise] INRA, UMR Genet Anim & Biol Integrat 1313, F-78352 Jouy En Josas, France	INRAE; Universite de Pau et des Pays de l'Adour; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Medale, F (corresponding author), INRA, UR Nutr Metab Aquaculture 1067, F-64310 St Pee Sur Nivelle, France.	medale@st-pee.inra.fr	, Dupont-Nivet/J-2850-2019	Medale, Francoise/0000-0002-8083-1298; Dupont-Nivet, Mathilde/0000-0002-9299-0560	FP7 European project ARRAINA [288925]; FUI progect VegeAqua	FP7 European project ARRAINA; FUI progect VegeAqua	This work was supported by the FP7 European project ARRAINA (no 288925) and by the FUI progect VegeAqua. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Ayad A, 1997, AQUACULT INT, V5; BELL JG, 1994, BBA-LIPID LIPID MET, V1211, P335, DOI 10.1016/0005-2760(94)90158-9; Bell JG, 2003, AQUACULTURE, V218, P515, DOI 10.1016/S0044-8486(02)00462-3; Benedito-Palos L, 2008, BRIT J NUTR, V100, P992, DOI 10.1017/S0007114508966071; BROMAGE N, 1992, AQUACULTURE, V100, P141, DOI 10.1016/0044-8486(92)90355-O; Bromage NR., 1995, BROODSTOCK MANAGEMEN; Brooks S, 1997, REV FISH BIOL FISHER, V7, P387, DOI 10.1023/A:1018400130692; Cerda J, 1995, ENDOCRINOLOGY, V111, P83; Corraze G, 1999, OCL-OL CORPS GRAS LI, V6, P111; Corraze G, 2009, CAH AGRIC, V18, P112, DOI 10.1684/agr.2009.0276; De Francesco M, 2007, AQUACULT NUTR, V13, P361, DOI 10.1111/j.1365-2095.2007.00485.x; de Francesco M, 2004, AQUACULTURE, V236, P413, DOI 10.1016/j.aquaculture.2004.01.006; Drew MD, 2007, AQUACULTURE, V267, P260, DOI 10.1016/j.aquaculture.2007.01.002; Enes P, 2011, REV FISH SCI, V19, P201, DOI 10.1080/10641262.2011.579363; FAO, 2009, STAT WORLD FISH AQ 2; FAO Aquaculture Department, 2013, GLOB AQ PROD STAT YE; FERNANDEZPALACIOS H, 1995, AQUACULTURE, V132, P325, DOI 10.1016/0044-8486(94)00345-O; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis G, 2001, AQUACULTURE, V199, P197, DOI 10.1016/S0044-8486(01)00526-9; Furuita H, 2002, AQUACULTURE, V210, P323, DOI 10.1016/S0044-8486(01)00855-9; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Gomez-Requeni P, 2004, AQUACULTURE, V232, P493, DOI 10.1016/S0044-8486(03)00532-5; Hamre K, 2013, REV AQUACULT, V5, pS26, DOI 10.1111/j.1753-5131.2012.01086.x; HARDY RW, 1987, AQUACULTURE, V65, P267, DOI 10.1016/0044-8486(87)90240-7; HAREL M, 1994, BRIT J NUTR, V72, P45, DOI 10.1079/BJN19940008; Izquierdo MS, 1996, AQUACULT NUTR, V2, P183, DOI 10.1111/j.1365-2095.1996.tb00058.x; Izquierdo MS, 2001, AQUACULTURE, V197, P25, DOI 10.1016/S0044-8486(01)00581-6; JUANEDA P, 1985, LIPIDS, V20, P40, DOI 10.1007/BF02534360; Kaushik SJ, 2004, AQUACULTURE, V230, P391, DOI 10.1016/S0044-8486(03)00422-8; KAUSHIK SJ, 1995, AQUACULTURE, V133, P257, DOI 10.1016/0044-8486(94)00403-B; Le Boucher R, 2011, AQUACULTURE, V321, P41, DOI 10.1016/j.aquaculture.2011.08.010; LERAY C, 1985, REPROD NUTR DEV, V25, P567, DOI 10.1051/rnd:19850409; Lim C., 2008, ALTERNATIVE PROTEIN; Manor ML, 2014, AQUACULTURE, V418, P17, DOI 10.1016/j.aquaculture.2013.09.023; Manor ML, 2012, AQUACULTURE, V364, P312, DOI 10.1016/j.aquaculture.2012.08.012; Matos E, 2012, AQUACULTURE, V358, P205, DOI 10.1016/j.aquaculture.2012.07.009; Medale F, 2009, CAH AGRIC, V18, P103, DOI 10.1684/agr.2009.0279; Mustafa T., 1989, ADV COMP ENV PHYSL, P157, DOI [10.1007/978-3-642-74510-2_6, DOI 10.1007/978-3-642-74510-2_6]; Nassour I, 1988, THESIS U PARIS DIDER; Nassour I., 1989, AQUAT LIVING RESOUR, V2, P153, DOI [10.1051/alr:1989018, DOI 10.1051/ALR:1989018, DOI 10.1016/j.ygcen.2009.05.004]; Navas JM, 1997, J FISH BIOL, V51, P760, DOI 10.1006/jfbi.1997.0484; Panserat S, 2009, AQUACULTURE, V294, P123, DOI 10.1016/j.aquaculture.2009.05.013; Panserat S, 2008, BRIT J NUTR, V100, P953, DOI 10.1017/S0007114508981411; Patino R, 2002, FISH PHYSIOL BIOCHEM, V26, P57, DOI 10.1023/A:1023311613987; Peragen J, 2000, MOL CELL BIOCHEM, V209, P97, DOI 10.1023/A:1007130906365; Pereira JOB, 1998, AQUAC RES, V29, P751, DOI 10.1046/j.1365-2109.1998.29100751.x; Richard N, 2006, BRIT J NUTR, V96, P299, DOI 10.1079/BJN20061821; Rodriguez C, 1998, FISH PHYSIOL BIOCHEM, V18, P177, DOI 10.1023/A:1007750218840; Ronnestad I, 1998, AQUACULTURE, V162, P157, DOI 10.1016/S0044-8486(98)00203-8; Rosenlund G., 2011, FISH OIL REPLACEMENT, P487; Salze G, 2005, AQUAC RES, V36, P1488, DOI 10.1111/j.1365-2109.2005.01367.x; Sargent J, 1999, AQUACULTURE, V179, P217, DOI 10.1016/S0044-8486(99)00191-X; Sargent J, 1995, BROODSTOCK MANAGEMEN, P353, DOI DOI 10.1016/S0044-8486(97)00122-1; Sargent John R., 2002, P181; SARGENT RC, 1987, AM NAT, V129, P32, DOI 10.1086/284621; SHANTHA NC, 1990, J CHROMATOGR-BIOMED, V533, P1, DOI 10.1016/S0378-4347(00)82182-9; Spoden K, 2013, AQUACULTURE TRIES FI, P57; Stottrup JG, 2013, AQUACULT NUTR, V19, P172, DOI 10.1111/j.1365-2095.2012.00967.x; Takeuchi Toshio, 1997, Reviews in Fisheries Science, V5, P1; Tocher DR, 2000, FISH PHYSIOL BIOCHEM, V23, P59, DOI 10.1023/A:1007807201093; Tocher DR, 2001, COMP BIOCHEM PHYS B, V130, P257, DOI 10.1016/S1096-4959(01)00429-8; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Tocher DR, 1997, LIPIDS, V32, P1237, DOI 10.1007/s11745-006-0159-0; TOCHER DR, 1984, LIPIDS, V19, P492, DOI 10.1007/BF02534481; Torstensen BE, 2011, BRIT J NUTR, V106, P633, DOI 10.1017/S0007114511000729; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Tyler CR, 1996, REV FISH BIOL FISHER, V6, P287, DOI 10.1007/BF00122584; Watanabe T., 1985, P395	69	58	58	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117609	10.1371/journal.pone.0117609	http://dx.doi.org/10.1371/journal.pone.0117609			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658483	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900189
J	Lienard, J; Florescu, I; Strigul, N				Lienard, Jean; Florescu, Ionut; Strigul, Nikolay			An Appraisal of the Classic Forest Succession Paradigm with the Shade Tolerance Index	PLOS ONE			English	Article							COMMUNITY STABILITY; CONTINUUM CONCEPT; MARKOV-MODELS; DISTURBANCE; GROWTH; TREES; DYNAMICS; ECOLOGY; SIZE; ARCHITECTURE	In this paper we revisit the classic theory of forest succession that relates shade tolerance and species replacement and assess its validity to understand patch-mosaic patterns of forested ecosystems of the USA. We introduce a macroscopic parameter called the "shade tolerance index" and compare it to the classic continuum index in southern Wisconsin forests. We exemplify shade tolerance driven succession in White Pine-Eastern Hemlock forests using computer simulations and analyzing approximated chronosequence data from the USDA FIA forest inventory. We describe this parameter across the last 50 years in the ecoregions of mainland USA, and demonstrate that it does not correlate with the usual macroscopic characteristics of stand age, biomass, basal area, and biodiversity measures. We characterize the dynamics of shade tolerance index using transition matrices and delimit geographical areas based on the relevance of shade tolerance to explain forest succession. We conclude that shade tolerance driven succession is linked to climatic variables and can be considered as a primary driving factor of forest dynamics mostly in central-north and northeastern areas in the USA. Overall, the shade tolerance index constitutes a new quantitative approach that can be used to understand and predict succession of forested ecosystems and biogeographic patterns.	[Lienard, Jean; Strigul, Nikolay] Washington State Univ, Dept Math, Vancouver, WA 98686 USA; [Lienard, Jean; Strigul, Nikolay] Washington State Univ Vancouver, Sch Art & Sci, Washington, DC USA; [Florescu, Ionut] Stevens Inst Technol, Financial Engn Div, Hoboken, NJ 07030 USA; [Florescu, Ionut] Stevens Inst Technol, Hanlon Financial Syst Lab, Hoboken, NJ 07030 USA	Washington State University; Washington State University; Stevens Institute of Technology; Stevens Institute of Technology	Strigul, N (corresponding author), Washington State Univ, Dept Math, Vancouver, WA 98686 USA.	nick.strigul@wsu.edu	Strigul, Nick/C-3987-2016; Florescu, Ionut/Y-7008-2018	Florescu, Ionut/0000-0002-4225-9008; Lienard, Jean/0000-0003-4279-4980	Simons Foundation [283770]; Washington State University New Faculty SEED grant	Simons Foundation; Washington State University New Faculty SEED grant	This work was partially supported by a grant from the Simons Foundation, simonsfoundation.org (283770 to NS) and a Washington State University New Faculty SEED grant (to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEVEDO MF, 1995, ECOL APPL, V5, P1040, DOI 10.2307/2269353; Ashton MPS, 1992, ECOLOGY SILVICULTURE, P101; Ashton MS, 2001, FOREST ECOL MANAG, V154, P409, DOI 10.1016/S0378-1127(01)00512-6; AUSTIN MP, 1985, ANNU REV ECOL SYST, V16, P39, DOI 10.1146/annurev.es.16.110185.000351; AUSTIN MP, 1977, VEGETATIO, V35, P165, DOI 10.1007/BF02097067; Bailey R.G., 1995, DESCRIPTION ECOREGIO; Bailey RG, 2004, ENVIRON MANAGE, V34, pS14, DOI 10.1007/s00267-003-0163-6; BAKER F. S., 1949, JOUR FOREST, V47, P179; BAZZAZ FA, 1979, ANNU REV ECOL SYST, V10, P351, DOI 10.1146/annurev.es.10.110179.002031; BORMANN FH, 1979, AM SCI, V67, P660; Bostock J., 1855, NAT HIST; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Bromley S.W., 1935, ECOL MONOGR, V5, P61, DOI DOI 10.2307/1943098; BUELL MF, 1966, ECOLOGY, V47, P416, DOI 10.2307/1932981; Bugmann H, 2001, CLIMATIC CHANGE, V51, P259, DOI 10.1023/A:1012525626267; Burns R. M., 1990, SILVICS N AM, V2; Burns RM., 1990, SILVICS N AM; Busing RT, 2004, J VEG SCI, V15, P831, DOI 10.1111/j.1654-1103.2004.tb02326.x; BUSING RT, 1991, VEGETATIO, V92, P167; CANHAM CD, 1988, ECOLOGY, V69, P786, DOI 10.2307/1941027; Chen HYH, 2012, GLOBAL ECOL BIOGEOGR, V21, P441, DOI 10.1111/j.1466-8238.2011.00689.x; Clements F.E, 1916, PLANT SUCCESSION ANA, DOI [10.5962/bhl.title.56234, DOI 10.5962/BHL.TITLE.56234]; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Cowles HC, 1911, ANN ASSOC AM GEOGR, V1, P3, DOI 10.2307/2560843; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; Deutschman DH, 1999, ECOLOGY, V80, P1927, DOI 10.2307/176669; Dube P, 2001, ECOL MODEL, V142, P39, DOI 10.1016/S0304-3800(01)00238-1; Franklin JF, 2007, NRS19 USDA FOR SERV; Frelich LE, 1999, ECOSYSTEMS, V2, P151, DOI 10.1007/s100219900066; FRELICH LE, 1988, FOREST SCI, V34, P530; GALE MR, 1987, CAN J FOREST RES, V17, P829, DOI 10.1139/x87-131; Hallik L, 2009, NEW PHYTOL, V184, P257, DOI 10.1111/j.1469-8137.2009.02918.x; Hewitt N, 1998, OECOLOGIA, V114, P432, DOI 10.1007/s004420050467; Heyer G, 1852, VERHALTEN WALDBAUME; Horn H. S., 1974, Annual Review of Ecology and Systematics, V5, P25, DOI 10.1146/annurev.es.05.110174.000325; Horn H. S., 1981, FOREST SUCCESSION CO, P24; Humbert L, 2007, ECOL INDIC, V7, P195, DOI 10.1016/j.ecolind.2005.12.002; HUSTON M, 1987, AM NAT, V130, P168, DOI 10.1086/284704; Johnstone JF, 2006, ECOSYSTEMS, V9, P268, DOI 10.1007/s10021-005-0061-2; KESSELL SR, 1980, ENVIRON MANAGE, V4, P227, DOI 10.1007/BF01866456; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; KOBE RK, 1995, ECOL APPL, V5, P517, DOI 10.2307/1942040; KOHYAMA T, 1993, J ECOL, V81, P131, DOI 10.2307/2261230; Kohyama T, 2006, ECOL RES, V21, P346, DOI 10.1007/s11284-006-0168-8; Korotkov VN, 2001, ECOL MODEL, V142, P25, DOI 10.1016/S0304-3800(01)00247-2; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; Laska G, 2001, PLANT ECOL, V157, P77, DOI 10.1023/A:1013760320805; LEPS J, 1988, FOLIA GEOBOT PHYTOTX, V23, P79, DOI 10.1007/BF02853297; LEVIN D. A., 2009, MARKOV CHAINS MIXING; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Lienard J, 2014, DATA INTENSIVE MULTI; Lin J, 2001, CAN J FOREST RES, V31, P345, DOI 10.1139/cjfr-31-2-345; Logofet DO, 2000, ECOL MODEL, V126, P285, DOI 10.1016/S0304-3800(00)00269-6; LORIMER CG, 1983, CAN J BOT, V61, P1595, DOI 10.1139/b83-172; McCarthy John, 2001, Environmental Reviews, V9, P1, DOI 10.1139/a00-012; MCINTOSH RP, 1967, BOT REV, V33, P130, DOI 10.1007/BF02858667; Messier C, 1999, CAN J FOREST RES, V29, P812, DOI 10.1139/cjfr-29-6-812; Morozov GF, 1908, ENCY RUSSIAN FORESTR, P1286; Morozov GF, 1912, THEORY OF FOREST; NAKAMURA T, 1985, VEGETATIO, V64, P15, DOI 10.1007/BF00033450; Nichols GE, 1935, ECOLOGY, V16, P403, DOI 10.2307/1930077; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; Oliver C.D., 1996, FOREST STAND DYNAMIC; PACALA SW, 1993, CAN J FOREST RES, V23, P1980, DOI 10.1139/x93-249; Pacala SW, 1995, OIKOS, V74, P357, DOI 10.2307/3545980; PARRISH JAD, 1982, B TORREY BOT CLUB, V109, P451, DOI 10.2307/2996486; PICKETT STA, 1987, BOT REV, V53, P335, DOI 10.1007/BF02858321; PICKETT STA, 1989, OIKOS, V54, P129, DOI 10.2307/3565258; Platt WJ, 2003, ECOL MONOGR, V73, P507, DOI 10.1890/01-0552; Purves DW, 2008, P NATL ACAD SCI USA, V105, P17018, DOI 10.1073/pnas.0807754105; Rogers DA, 2008, ECOLOGY, V89, P2482, DOI 10.1890/07-1129.1; RUNKLE JR, 1982, ECOLOGY, V63, P1533, DOI 10.2307/1938878; Shirley Hardy L., 1943, JOUR FOREST, V41, P339; Shugart H.H., 1984, THEORY FOREST DYNAMI; Smith D.M., 1997, PRACTICE SILVICULTUR; Spurr S.H., 1980, FOREST ECOLOGY; Stephens GR, 1980, B CONNECTICUT AGR EX; Strigul, 2012, SUSTAINABLE FOREST M, DOI DOI 10.5772/29590; Strigul N, 2008, ECOL MONOGR, V78, P523, DOI 10.1890/08-0082.1; Strigul N, 2012, ENVIRON MODELL SOFTW, V31, P64, DOI 10.1016/j.envsoft.2011.12.004; Sukatschew W, 1928, PLANT COMMUNITIES IN; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Thoreau HD, 1992, MASTERWORKS LIT SERI, P164; Turner MG, 2005, ANNU REV ECOL EVOL S, V36, P319, DOI 10.1146/annurev.ecolsys.36.102003.152614; USHER MB, 1979, J ANIM ECOL, V48, P413, DOI 10.2307/4170; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; WAGGONER PE, 1970, NATURE, V225, P1160, DOI 10.1038/2251160a0; Walters MB, 1996, ECOLOGY, V77, P841, DOI 10.2307/2265505; WHITE PS, 1979, BOT REV, V45, P229, DOI 10.1007/BF02860857; WHITTAKER RH, 1967, BIOL REV, V42, P207, DOI 10.1111/j.1469-185X.1967.tb01419.x; Wu JG, 1995, Q REV BIOL, V70, P439, DOI 10.1086/419172; Yamamoto S.I., 2000, J FORESTRY RES, V5, P223, DOI DOI 10.1007/BF02767114; Zon R, 1911, LIGHT RELATION TREE, DOI [10.5962/bhl.title.66218, DOI 10.5962/BHL.TITLE.66218]	93	32	33	7	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117138	10.1371/journal.pone.0117138	http://dx.doi.org/10.1371/journal.pone.0117138			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658092	gold, Green Submitted, Green Published			2022-12-27	WOS:000349444900106
J	Lin, CJ; Lin, HJ; Chen, TH; Hsu, YA; Liu, CS; Hwang, GY; Wan, L				Lin, Chao-Jen; Lin, Hui-Ju; Chen, Ter-Hsin; Hsu, Yu-An; Liu, Chin-San; Hwang, Guang-Yuh; Wan, Lei			Polygonum cuspidatum and Its Active Components Inhibit Replication of the Influenza Virus through Toll-Like Receptor 9-Induced Interferon Beta Expression	PLOS ONE			English	Article							A VIRUS; H1N1 VIRUS; ACTIVATION; HEMAGGLUTININ; INDUCTION; LACKING; HUMANS; DNA	Influenza virus infection is a global public health issue. The effectiveness of antiviral therapies for influenza has been limited by the emergence of drug-resistant viral strains. Therefore, there is an urgent need to identify novel antiviral therapies. Here we tested the effects of 300 traditional Chinese medicines on the replication of various influenza virus strains in a lung cell line, A549, using an influenza-specific luciferase reporter assay. Of the traditional medicines tested, Polygonum cuspidatum (PC) and its active components, resveratrol and emodin, were found to attenuate influenza viral replication in A549 cells. Furthermore, they preferentially inhibited the replication of influenza A virus, including clinical strains isolated in 2009 and 2011 in Taiwan and the laboratory strain A/WSN/33 (H1N1). In addition to inhibiting the expression of hemagglutinin and neuraminidase, PC, emodin, and resveratrol also increased the expression of interferon beta (IFN-beta) through Toll-like receptor 9 (TLR9). Moreover, the anti-viral activity of IFN-beta or resveratrol was reduced when the A549 cells were treated with neutralizing anti-IFN-beta antibodies or a TLR9 inhibitor, suggesting that IFN-beta likely acts synergistically with resveratrol to inhibit H1N1 replication. This potential antiviral mechanism, involving direct inhibition of virus replication and simultaneous activation of the host immune response, has not been previously described for a single antiviral molecule. In conclusion, our data support the use of PC, resveratrol or emodin for inhibiting influenza virus replication directly and via TLR-9-induced IFN-beta production.	[Lin, Chao-Jen] Changhua Christian Childrens Hosp, Dept Pediat, Changhua, Taiwan; [Lin, Chao-Jen; Hwang, Guang-Yuh] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Lin, Chao-Jen] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lin, Hui-Ju] China Med Univ Hosp, Dept Ophthalmol, Taichung, Taiwan; [Lin, Hui-Ju; Wan, Lei] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Chen, Ter-Hsin] Natl Chung Hsing Univ, Grad Inst Vet Pathobiol, Taichung 40227, Taiwan; [Hsu, Yu-An] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Liu, Chin-San] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Wan, Lei] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Wan, Lei] China Med Univ Hosp, Dept Gynecol, Taichung, Taiwan	Tunghai University; Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Chung Hsing University; National Tsing Hua University; Changhua Christian Hospital; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Hwang, GY (corresponding author), Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan.	gyhwang@thu.edu.tw; leiwan@mail.cmu.edu.tw	Wan, Lei/F-4719-2010	Wan, Lei/0000-0002-9525-3232	Ministry of Science and Technology, Taiwan, R.O.C. (MOST) [101-2320-B-039-038, 102-2320-B-039-043-MY3, 102-2632-B-039-001-MY3]; China Medical University Hospital, Taichung, Taiwan [DMR-103-064]; Changhua Christian Children's Hospital, Changhua, Taiwan [103-CCH-IRP-081]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [DOH102-TDB-111004]	Ministry of Science and Technology, Taiwan, R.O.C. (MOST); China Medical University Hospital, Taichung, Taiwan; Changhua Christian Children's Hospital, Changhua, Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was supported by Ministry of Science and Technology, Taiwan, R.O.C. (MOST 101-2320-B-039-038, 102-2320-B-039-043-MY3 and 102-2632-B-039-001-MY3), China Medical University Hospital, Taichung, Taiwan (DMR-103-064), Changhua Christian Children's Hospital, Changhua, Taiwan (103-CCH-IRP-081) and in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (DOH102-TDB-111004). The funders had no role in study design, data	Aluyen Julia Khristine, 2012, Journal of Dietary Supplements, V9, P45, DOI 10.3109/19390211.2011.650842; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Dapat C, 2013, ANTIVIR RES, V99, P261, DOI 10.1016/j.antiviral.2013.06.003; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Ghanim H, 2010, J CLIN ENDOCR METAB, V95, pE1, DOI 10.1210/jc.2010-0482; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Han JH, 2012, IMMUNOPHARM IMMUNOT, V34, P191, DOI 10.3109/08923973.2011.590499; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Jackson RJ, 2011, J INFECTION, V62, P14, DOI 10.1016/j.jinf.2010.10.003; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Naikin A. N., 2013, Voprosy Virusologii, V58, P38; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Park S, 2013, BIOCHEM BIOPH RES CO, V440, P14, DOI 10.1016/j.bbrc.2013.08.090; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; Sohail MN, 2011, ASIAN J ANIM VET ADV, V6, P1125, DOI 10.3923/ajava.2011.1125.1152; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; Trost BM, 2011, CHEM-EUR J, V17, P3630, DOI 10.1002/chem.201003454; Valarcher JF, 2003, J VIROL, V77, P8426, DOI 10.1128/JVI.77.15.8426-8439.2003; van der Vries E, 2013, ADV PHARMACOL, V67, P217, DOI 10.1016/B978-0-12-405880-4.00006-8; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053	32	59	63	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117602	10.1371/journal.pone.0117602	http://dx.doi.org/10.1371/journal.pone.0117602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658356	gold, Green Submitted, Green Published			2022-12-27	WOS:000349444900188
J	Moretti, D; Del Bello, B; Allavena, G; Corti, A; Signorini, C; Maellaro, E				Moretti, Daniele; Del Bello, Barbara; Allavena, Giulia; Corti, Alessandro; Signorini, Cinzia; Maellaro, Emilia			Calpain-3 Impairs Cell Proliferation and Stimulates Oxidative Stress-Mediated Cell Death in Melanoma Cells	PLOS ONE			English	Article							MUSCLE-SPECIFIC CALPAIN; DYSTROPHY TYPE 2A; GLUTATHIONE TRANSFERASES; REDOX REGULATION; COMET ASSAY; DNA-DAMAGE; P53; EXPRESSION; GENE; IDENTIFICATION	Calpain-3 is an intracellular cysteine protease, belonging to Calpain superfamily and predominantly expressed in skeletal muscle. In human melanoma cell lines and biopsies, we previously identified two novel splicing variants (hMp78 and hMp84) of Calpain-3 gene (CAPN3), which have a significant lower expression in vertical growth phase melanomas and, even lower, in metastases, compared to benign nevi. In the present study, in order to investigate the pathophysiological role played by the longer Calpain-3 variant, hMp84, in melanoma cells, we over-expressed it in A375 and HT-144 cells. In A375 cells, the enforced expression of hMp84 induces p53 stabilization, and modulates the expression of a few p53-and oxidative stress-related genes. Consistently, hMp84 increases the intracellular production of ROS (Reactive Oxygen Species), which lead to oxidative modification of phospholipids (formation of F-2-isoprostanes) and DNA damage. Such events culminate in an adverse cell fate, as indicated by the decrease of cell proliferation and by cell death. To a different extent, either the antioxidant N-acetyl-cysteine or the p53 inhibitor, Pifithrin-alpha, recover cell viability and decrease ROS formation. Similarly to A375 cells, hMp84 over-expression causes inhibition of cell proliferation, cell death, and increase of both ROS levels and F-2-iso-prostanes also in HT-144 cells. However, in these cells no p53 accumulation occurs. In both cell lines, no significant change of cell proliferation and cell damage is observed in cells over-expressing the mutant hMp84(C42S) devoid of its enzymatic activity, suggesting that the catalytic activity of hMp84 is required for its detrimental effects. Since a more aggressive phenotype is expected to benefit from down-regulation of mechanisms impairing cell growth and survival, we envisage that Calpain-3 down-regulation can be regarded as a novel mechanism contributing to melanoma progression.	[Moretti, Daniele; Del Bello, Barbara; Allavena, Giulia; Signorini, Cinzia; Maellaro, Emilia] Univ Siena, Dept Mol & Dev Med, I-53100 Siena, Italy; [Corti, Alessandro] Univ Pisa, Sch Med, Dept Translat Res & New Technol Med & Surg, I-56100 Pisa, Italy; [Moretti, Daniele; Del Bello, Barbara; Allavena, Giulia; Corti, Alessandro; Maellaro, Emilia] ITT, Florence, Italy	University of Siena; University of Pisa	Maellaro, E (corresponding author), Univ Siena, Dept Mol & Dev Med, Via Laterina 8, I-53100 Siena, Italy.	emilia.maellaro@unisi.it		Allavena, Giulia/0000-0003-3267-175X	Istituto Toscano Tumori (ITT)	Istituto Toscano Tumori (ITT)	This work was supported by the Istituto Toscano Tumori (ITT) (grant Research Project to EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma M, 2000, CURR EYE RES, V21, P710, DOI 10.1076/0271-3683(200009)21:3;1-R;FT710; Baghdiguian S, 1999, NAT MED, V5, P503, DOI 10.1038/8385; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Blackburn AC, 2006, MOL PHARMACOL, V69, P650, DOI 10.1124/mol.105.018911; Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; Comporti M, 2008, FREE RADICAL BIO MED, V44, P247, DOI 10.1016/j.freeradbiomed.2007.10.004; Corti A, 2009, MUTAT RES-FUND MOL M, V669, P112, DOI 10.1016/j.mrfmmm.2009.05.010; De Tullio R, 2003, BIOCHEM J, V375, P689, DOI 10.1042/BJ20030706; Del Bello B, 2007, ONCOGENE, V26, P2717, DOI 10.1038/sj.onc.1210079; Del Bello B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057236; Deneke SM, 2000, CURR TOP CELL REGUL, V36, P151; Diaz BG, 2004, J BIOL CHEM, V279, P27656, DOI 10.1074/jbc.M313290200; Gollob JA, 2005, CANCER RES, V65, P8869, DOI 10.1158/0008-5472.CAN-05-1387; GOPALAKRISHNA P, 1995, J BIOCHEM BIOPH METH, V30, P69, DOI 10.1016/0165-022X(94)00056-J; Guyon JR, 2003, MUSCLE NERVE, V28, P472, DOI 10.1002/mus.10465; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Holley AK, 2010, ANN NY ACAD SCI, V1201, P72, DOI 10.1111/j.1749-6632.2010.05612.x; Hong M, 2011, CANCER RES, V71, P6997, DOI 10.1158/0008-5472.CAN-11-1466; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Huynh KM, 2009, GENE, V433, P32, DOI 10.1016/j.gene.2008.11.013; Italiano D, 2012, CELL CYCLE, V11, P4589, DOI 10.4161/cc.22853; Kawabata Y, 2003, FEBS LETT, V555, P623, DOI 10.1016/S0014-5793(03)01324-3; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Konig N, 2003, J CHEM NEUROANAT, V25, P129, DOI 10.1016/S0891-0618(02)00102-3; Kramerova I, 2006, MOL CELL BIOL, V26, P8437, DOI 10.1128/MCB.01296-06; Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma H, 2000, CURR EYE RES, V20, P183, DOI 10.1076/0271-3683(200003)20:3;1-9;FT183; Maillet A, 2012, ANTIOXID REDOX SIGN, V16, P1285, DOI 10.1089/ars.2011.4434; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Meyskens FL, 2001, PIGM CELL RES, V14, P148, DOI 10.1034/j.1600-0749.2001.140303.x; Moretti D, 2009, CARCINOGENESIS, V30, P960, DOI 10.1093/carcin/bgp098; Ojima K, 2011, J MOL BIOL, V407, P439, DOI 10.1016/j.jmb.2011.01.057; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Ono Yasuko, 2007, Biotechnology Journal, V2, P565, DOI 10.1002/biot.200700018; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Ramsay J, 1998, BRIT J CANCER, V77, P11, DOI 10.1038/bjc.1998.2; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Roperto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010299; Ruffini F, 2013, ONCOL REP, V30, P2887, DOI 10.3892/or.2013.2791; Sander CS, 2003, BRIT J DERMATOL, V148, P913, DOI 10.1046/j.1365-2133.2003.05303.x; Signorini C, 2003, J MASS SPECTROM, V38, P1067, DOI 10.1002/jms.520; Soengas MS, 2012, PIGM CELL MELANOMA R, V25, P721, DOI 10.1111/pcmr.12021; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Weeraratna AT, 2004, ONCOGENE, V23, P2264, DOI 10.1038/sj.onc.1207337; Welm AL, 2002, J BIOL CHEM, V277, P33848, DOI 10.1074/jbc.M204096200; Wittgen HGM, 2007, MELANOMA RES, V17, P400, DOI 10.1097/CMR.0b013e3282f1d312; Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745	55	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117258	10.1371/journal.pone.0117258	http://dx.doi.org/10.1371/journal.pone.0117258			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658320	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900125
J	Shen, TC; Lin, CL; Wei, CC; Chen, CH; Tu, CY; Hsia, TC; Shih, CM; Hsu, WH; Sung, FC				Shen, Te-Chun; Lin, Cheng-Li; Wei, Chang-Ching; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei; Sung, Fung-Chang			The Risk of Asthma in Patients with Ankylosing Spondylitis: A Population-Based Cohort Study	PLOS ONE			English	Article							COLLAGEN VASCULAR DISEASES; RHEUMATOID-ARTHRITIS; PULMONARY INVOLVEMENT; PERIPHERAL SPONDYLOARTHRITIS; CLASSIFICATION CRITERIA; RETROSPECTIVE COHORT; PREVALENCE; MANIFESTATIONS; COMORBIDITIES; ATOPY	Background The relationship between asthma and ankylosing spondylitis (AS) is controversial. We examined the risk of asthma among AS patients in a nationwide population. Methods We conducted a retrospective cohort study using data from the National Health Insurance (NHI) system of Taiwan. The cohort included 5,974 patients newly diagnosed with AS from 2000 to 2010. The date of diagnosis was defined as the index date. A 4-fold of general population without AS was randomly selected frequency matched by age, gender and the index year. The occurrence and hazard ratio (HR) of asthma were estimated by the end of 2011. Results The overall incidence of asthma was 1.74 folds greater in the AS cohort than in the non-AS cohort (8.26 versus 4.74 per 1000 person-years) with a multivariable Cox method measured adjusted HR of 1.54 (95% confidence interval (CI), 1.34-1.76). The adjusted HR of asthma associated with AS was higher in women (1.59; 95% CI, 1.33-1.90), those aged 50-64 years (1.66; 95% CI, 1.31-2.09), or those without comorbidities (1.82; 95% CI, 1.54-2.13). Conclusion Patients with AS are at a higher risk of developing asthma than the general population, regardless of gender and age. The pathophysiology needs further investigation.	[Shen, Te-Chun; Chen, Chia-Hung; Sung, Fung-Chang] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Shen, Te-Chun; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei] China Med Univ, China Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Taichung, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ, China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wei, Chang-Ching] China Med Univ, China Med Univ Hosp, Dept Pediat, Div Nephrol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tu, CY (corresponding author), China Med Univ, China Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Taichung, Taiwan.	chesttu@gmail.com; fcsung.tw@gmail.com		Shen, Te-Chun/0000-0002-9427-1068	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project [BM103010096]; NRPB Stroke Clinical Trial Consortium (MOST) [103-2325-B-039-006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium (MOST); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002), China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM103010096), NRPB Stroke Clinical Trial Consortium (MOST w103-2325-B-039-006), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulet LP, 2011, EXPERT REV RESP MED, V5, P377, DOI [10.1586/ERS.11.34, 10.1586/ers.11.34]; Bulwark DW, 1985, CLIN REV ALLERG, V3, P249; Chou CH, 2014, SCAND J RHEUMATOL, V43, P132, DOI 10.3109/03009742.2013.822097; de Nijs SB, 2013, EUR RESPIR REV, V22, P44, DOI 10.1183/09059180.00007112; Dean LE, 2014, RHEUMATOLOGY, V53, P650, DOI 10.1093/rheumatology/ket387; Dincer U, 2007, TOHOKU J EXP MED, V212, P423, DOI 10.1620/tjem.212.423; GUPTA SM, 1978, NEW ZEAL MED J, V88, P186; Hajdarbegovic E, 2014, RHEUMATOL INT, V34, P847, DOI 10.1007/s00296-013-2785-1; HUNNINGHAKE GW, 1979, AM REV RESPIR DIS, V119, P471; Kaptanoglu E, 2004, RHEUMATOL INT, V24, P267, DOI 10.1007/s00296-003-0369-1; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; Mercieca C, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0434-7; Papaiwannou A, 2014, J THORAC DIS, V6, pS146, DOI 10.3978/j.issn.2072-1439.2014.03.04; Perez-Fernandez OM, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/736384; Pham T, 2008, JOINT BONE SPINE, V75, P656, DOI 10.1016/j.jbspin.2008.09.003; Reveille JD, 2005, AM J MED, V118, P592, DOI 10.1016/j.amjmed.2005.01.001; Reveille JD, 2012, ARTHRIT CARE RES, V64, P905, DOI 10.1002/acr.21621; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; Rudwaleit M, 2002, ANN RHEUM DIS, V61, P968, DOI 10.1136/ard.61.11.968; RUMANCIK WM, 1984, CT-J COMPUT TOMOGR, V8, P225, DOI 10.1016/0149-936X(84)90066-3; Shen TC, 2014, QJM-INT J MED, V107, P435, DOI 10.1093/qjmed/hcu008; Shen TC, 2014, AM J RESP CRIT CARE, V189, P496, DOI 10.1164/rccm.201310-1792LE; Sun LM, 2014, SCAND J RHEUMATOL, V43, P301, DOI 10.3109/03009742.2013.863969; TANOUE LT, 1992, J THORAC IMAG, V7, P62, DOI 10.1097/00005382-199203000-00008; WIEDEMANN HP, 1989, CLIN CHEST MED, V10, P677; WOLSON AH, 1975, AM J ROENTGENOL, V124, P466, DOI 10.2214/ajr.124.3.466; Yuksekkaya R, 2014, POL J RADIOL, V79, P156, DOI 10.12659/PJR.889850; Zeidler H, 2011, ANN RHEUM DIS, V70, P1, DOI 10.1136/ard.2010.135889	28	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116608	10.1371/journal.pone.0116608	http://dx.doi.org/10.1371/journal.pone.0116608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658339	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900053
J	Solc, P; Kitajima, TS; Yoshida, S; Brzakova, A; Kaido, M; Baran, V; Mayer, A; Samalova, P; Motlik, J; Ellenberg, J				Solc, Petr; Kitajima, Tomoya S.; Yoshida, Shuhei; Brzakova, Adela; Kaido, Masako; Baran, Vladimir; Mayer, Alexandra; Samalova, Pavlina; Motlik, Jan; Ellenberg, Jan			Multiple Requirements of PLK1 during Mouse Oocyte Maturation	PLOS ONE			English	Article							POLO-LIKE KINASE-1; ANAPHASE-PROMOTING COMPLEX; NUCLEAR-ENVELOPE BREAKDOWN; PROPHASE-I ARREST; SCF-BETA-TRCP; MEIOSIS-I; CHROMOSOME BIORIENTATION; MITOTIC CENTROSOMES; SPINDLE CHECKPOINT; MEIOTIC MATURATION	Polo-like kinase 1 (PLK1) orchestrates multiple events of cell division. Although PLK1 function has been intensively studied in centriole-containing and rapidly cycling somatic cells, much less is known about its function in the meiotic divisions of mammalian oocytes, which arrest for a long period of time in prophase before meiotic resumption and lack centrioles for spindle assembly. Here, using specific small molecule inhibition combined with live mouse oocyte imaging, we comprehensively characterize meiotic PLK1's functions. We show that PLK1 becomes activated at meiotic resumption on microtubule organizing centers (MTOCs) and later at kinetochores. PLK1 is required for efficient meiotic resumption by promoting nuclear envelope breakdown. PLK1 is also needed to recruit centrosomal proteins to acentriolar MTOCs to promote normal spindle formation, as well as for stable kineto-chore-microtubule attachment. Consequently, PLK1 inhibition leads to metaphase I arrest with misaligned chromosomes activating the spindle assembly checkpoint (SAC). Unlike in mitosis, the metaphase I arrest is not bypassed by the inactivation of the SAC. We show that PLK1 is required for the full activation of the anaphase promoting complex/cyclosome (APC/C) by promoting the degradation of the APC/C inhibitor EMI1 and is therefore essential for entry into anaphase I. Moreover, our data suggest that PLK1 is required for proper chromosome segregation and the maintenance of chromosome condensation during the meiosis I-II transition, independently of the APC/C. Thus, our results define the meiotic roles of PLK1 in oocytes and reveal interesting differential requirements of PLK1 between mitosis and oocyte meiosis in mammals.	[Solc, Petr; Brzakova, Adela; Mayer, Alexandra; Samalova, Pavlina; Motlik, Jan] Inst Anim Physiol & Genet, Libechov, Czech Republic; [Kitajima, Tomoya S.; Ellenberg, Jan] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69012 Heidelberg, Germany; [Baran, Vladimir] Inst Anim Physiol, Kosice, Slovakia; [Kitajima, Tomoya S.; Yoshida, Shuhei; Kaido, Masako] RIKEN Ctr Dev Biol, Lab Chromosome Segregat, Kobe, Hyogo, Japan	Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; European Molecular Biology Laboratory (EMBL); Slovak Academy of Sciences; RIKEN	Solc, P (corresponding author), Inst Anim Physiol & Genet, Libechov, Czech Republic.	solc@iapg.cas.cz; tkitajima@cdb.riken.jp	Šolc, Petr/G-7154-2014; Ellenberg, Jan/I-4688-2014; Kitajima, Tomoya/A-7049-2016; Baran, Vladimír/GXM-7406-2022	Šolc, Petr/0000-0003-4571-3891; Ellenberg, Jan/0000-0001-5909-701X; Kitajima, Tomoya/0000-0002-6486-7143; Baran, Vladimír/0000-0002-1686-2145; Yoshida, Shuhei/0000-0002-5640-6128	Ministry of Education, Youth and Sports of the Czech Republic [LH12057]; Grant Agency of the Czech Republic [P301-11-P081, 301-09-J036, P502/11/0593]; Japan Society for the Promotion of Science KAKENH [00376641]; Nakajima Foundation; Uehara Memorial Foundation; European Community [241548]; German Research Foundation DFG [EL246/4-1, EL246/4-2]; Human Frontier Science Program; Slovak Research and Development Agency [APVV-0237-10]; Institutional Research Concept [67985904]; European Regional Development Fund [CZ.1.05/2.1.00/03.0124]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Japan Society for the Promotion of Science KAKENH; Nakajima Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); European Community(European Commission); German Research Foundation DFG(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); Slovak Research and Development Agency(Slovak Research and Development Agency); Institutional Research Concept; European Regional Development Fund(European Commission)	This work was supported by the research grants from Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz, LH12057) and from Grant Agency of the Czech Republic (http://www.gacr.cz, P301-11-P081) to P. S.; Japan Society for the Promotion of Science KAKENHI (https://www.jsps.go.jp, 00376641), Nakajima Foundation (http://www.nakajimafound.or.jp), Uehara Memorial Foundation (http://www.ueharazaidan.or.jp) to T. S. K.; Grant Agency of the Czech Republic (http://www.gacr.cz, 301-09-J036) to J. M.; European Community's Seventh Framework Programme [FP7/2007-2013] (http://cordis.europa.eu/fp7/home_en.html) under grant agreement no [241548] "Mitosys" and the German Research Foundation DFG (http://www.dfg.de/en/, EL246/4-1,2) within the SPP 1384 "Mechanisms of Genome Haploidization" to J. E. T. S. K. was partly supported by the long-term fellowship from Human Frontier Science Program (http://www.hfsp.org/). A. B. and A. M. were partly supported by Grant Agency of the Czech Republic (http://www.gacr.cz, P502/11/0593). V. B. was supported by Slovak Research and Development Agency (http://www.apvv.sk, APVV-0237-10). Work at IAPG was supported by Institutional Research Concept 67985904 (IAPG AS CR, v.v.i.,http://www.iapg.cas.cz/). This work significantly benefited from European Regional Development Fund (http://ec.europa.eu/regional policy/thefunds/regional/index_en.cfm, ExAM CZ.1.05/2.1.00/03.0124) to J. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2011, GENE DEV, V25, P863, DOI 10.1101/gad.2016411; Anger M, 2004, MOL REPROD DEV, V69, P11, DOI 10.1002/mrd.20151; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Arnaud L, 1998, CHROMOSOMA, V107, P424, DOI 10.1007/s004120050326; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Burkard ME, 2012, ACS CHEM BIOL, V7, P978, DOI 10.1021/cb200551p; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Golan A, 2002, J BIOL CHEM, V277, P15552, DOI 10.1074/jbc.M111476200; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Hached K, 2011, DEVELOPMENT, V138, P2261, DOI 10.1242/dev.061317; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; Ito J, 2008, DEV BIOL, V320, P402, DOI 10.1016/j.ydbio.2008.05.548; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jaffe LA, 2004, METHOD CELL BIOL, V74, P219; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Kudo NR, 2009, J CELL SCI, V122, P2686, DOI 10.1242/jcs.035287; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Lenart P, 2003, CURR OPIN CELL BIOL, V15, P88, DOI 10.1016/S0955-0674(02)00011-X; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li HC, 2010, P NATL ACAD SCI USA, V107, P14633, DOI 10.1073/pnas.1006615107; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Liu D, 2012, J CELL BIOL, V198, P491, DOI 10.1083/jcb.201205090; Liu JJ, 2004, J BIOL CHEM, V279, P21367, DOI 10.1074/jbc.M400482200; Lobjois V, 2009, BBA-MOL CELL RES, V1793, P462, DOI 10.1016/j.bbamcr.2008.12.015; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Marangos P, 2007, J CELL BIOL, V176, P65, DOI 10.1083/jcb.200607070; Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Pahlavan G, 2000, DEV BIOL, V220, P392, DOI 10.1006/dbio.2000.9656; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Pomerantz Y, 2012, FASEB J, V26, P4495, DOI 10.1096/fj.12-209866; Potapova TA, 2011, MOL BIOL CELL, V22, P1191, DOI 10.1091/mbc.E10-07-0599; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Reis A, 2006, NAT CELL BIOL, V8, P539, DOI 10.1038/ncb1406; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Scutt PJ, 2009, J BIOL CHEM, V284, P15880, DOI 10.1074/jbc.M109.005694; Sdelci S, 2012, CURR BIOL, V22, P1516, DOI 10.1016/j.cub.2012.06.027; Solc P, 2008, DEV BIOL, V317, P260, DOI 10.1016/j.ydbio.2008.02.028; Solc P, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101014; Solc P, 2010, MOL HUM REPROD, V16, P654, DOI 10.1093/molehr/gaq034; Suijkerbuijk SJE, 2012, DEV CELL, V23, P745, DOI 10.1016/j.devcel.2012.09.005; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Swain JE, 2008, MOL HUM REPROD, V14, P291, DOI 10.1093/molehr/gan015; Tong C, 2002, BIOL REPROD, V67, P546, DOI 10.1095/biolreprod67.2.546; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Vanderheyden V, 2009, CELL CALCIUM, V46, P56, DOI 10.1016/j.ceca.2009.04.004; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wianny F, 1998, CHROMOSOMA, V107, P430, DOI 10.1007/s004120050327; Xiong B, 2008, CELL CYCLE, V7, P1804, DOI 10.4161/cc.7.12.6019; Zhang XY, 2009, J CELL SCI, V122, P2240, DOI 10.1242/jcs.042747; Zhou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068964	76	55	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116783	10.1371/journal.pone.0116783	http://dx.doi.org/10.1371/journal.pone.0116783			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658810	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900066
J	Wilson, MM; Anderson, DE; Bernstein, HD				Wilson, Marlena M.; Anderson, D. Eric; Bernstein, Harris D.			Analysis of the Outer Membrane Proteome and Secretome of Bacteroides fragilis Reveals a Multiplicity of Secretion Mechanisms	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; BINDING-PROTEIN; DEMYELINATING DISEASE; SURFACE-PROTEINS; SIGNAL PEPTIDES; DNA INVERSIONS; GENE SEQUENCE; CELL-ENVELOPE; IDENTIFICATION; EXPRESSION	Bacteroides fragilis is a widely distributed member of the human gut microbiome and an opportunistic pathogen. Cell surface molecules produced by this organism likely play important roles in colonization, communication with other microbes, and pathogenicity, but the protein composition of the outer membrane (OM) and the mechanisms used to transport polypeptides into the extracellular space are poorly characterized. Here we used LC-MS/MS to analyze the OM proteome and secretome of B. fragilis NCTC 9343 grown under laboratory conditions. Of the 229 OM proteins that we identified, 108 are predicted to be lipoproteins, and 61 are predicted to be TonB-dependent transporters. Based on their proximity to genes encoding TonB-dependent transporters, many of the lipoprotein genes likely encode proteins involved in nutrient or small molecule uptake. Interestingly, protease accessibility and biotinylation experiments indicated that an unusually large fraction of the lipoproteins are cell-surface exposed. We also identified three proteins that are members of a novel family of autotransporters, multiple potential type I protein secretion systems, and proteins that appear to be components of a type VI secretion apparatus. The secretome consisted of lipoproteins and other proteins that might be substrates of the putative type I or type VI secretion systems. Our proteomic studies show that B. fragilis differs considerably from well-studied Gram-negative bacteria such as Escherichia coli in both the spectrum of OM proteins that it produces and the range of secretion strategies that it utilizes.	[Wilson, Marlena M.; Bernstein, Harris D.] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA; [Anderson, D. Eric] NIDDK, Adv Mass Spectrometry Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bernstein, HD (corresponding author), NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA.	harris_bernstein@nih.gov			National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK062009, ZIADK075086] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arambula D, 2013, P NATL ACAD SCI USA, V110, P8212, DOI 10.1073/pnas.1301366110; Avelar KES, 1999, LETT APPL MICROBIOL, V29, P264, DOI 10.1046/j.1365-2672.1999.00603.x; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Bacic MK, 2008, CURR PROTOC MICROBIO, DOI DOI 10.1002/9780471729259.MC13C01S9; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Bendtsen JD, 2005, MICROBIOL-SGM, V151, P1725, DOI 10.1099/mic.0.28029-0; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Coulthurst SJ, 2013, RES MICROBIOL, V164, P640, DOI 10.1016/j.resmic.2013.03.017; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Coyne MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01305-14; Ferreira ED, 2006, RES MICROBIOL, V157, P960, DOI 10.1016/j.resmic.2006.09.005; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; DeRocco AJ, 2007, INFECT IMMUN, V75, P3220, DOI 10.1128/IAI.00072-07; Durand E, 2014, TRENDS MICROBIOL, V22, P498, DOI 10.1016/j.tim.2014.06.004; Elhenawy W, 2014, MBIO, V5, DOI 10.1128/mBio.00909-14; Ferreira ED, 2011, ANAEROBE, V17, P4, DOI 10.1016/j.anaerobe.2010.09.004; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Flores-Ramirez G, 2014, PROTEOMICS, V14, P1868, DOI 10.1002/pmic.201300338; Ge Y, 2007, INFECT IMMUN, V75, P3833, DOI 10.1128/IAI.00188-07; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; GUZMAN CA, 1990, FEMS MICROBIOL LETT, V71, P187; Houston S, 2010, MICROBIOL-SGM, V156, P2516, DOI 10.1099/mic.0.038588-0; Huang JY, 2011, ANAEROBE, V17, P137, DOI 10.1016/j.anaerobe.2011.05.017; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jose J, 2007, MICROBIOL MOL BIOL R, V71, P600, DOI 10.1128/MMBR.00011-07; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kenedy MR, 2012, FEMS IMMUNOL MED MIC, V66, P1, DOI 10.1111/j.1574-695X.2012.00980.x; KOTARSKI SF, 1984, J BACTERIOL, V158, P102, DOI 10.1128/JB.158.1.102-109.1984; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Okuda S, 2011, ANNU REV MICROBIOL, V65, P239, DOI 10.1146/annurev-micro-090110-102859; Olczak T, 2008, ARCH MICROBIOL, V189, P197, DOI 10.1007/s00203-007-0309-7; ONDERDONK AB, 1978, INFECT IMMUN, V19, P1083, DOI 10.1128/IAI.19.3.1083-1087.1978; OTTO BR, 1988, MICROB PATHOGENESIS, V4, P279, DOI 10.1016/0882-4010(88)90088-5; Papastathopoulou A, 1997, ANAEROBE, V3, P203, DOI 10.1006/anae.1997.0106; Patrick S, 2011, MICROBIOL-SGM, V157, P3071, DOI 10.1099/mic.0.049940-0; Pauer H, 2009, FEMS IMMUNOL MED MIC, V55, P388, DOI 10.1111/j.1574-695X.2009.00532.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Phansopa C, 2014, BIOCHEM J, V458, P499, DOI 10.1042/BJ20131415; Pumbwe L, 2006, ANAEROBE, V12, P211, DOI 10.1016/j.anaerobe.2006.09.004; Raghavan V, 2014, MOL MICROBIOL, V93, P1010, DOI 10.1111/mmi.12714; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rigel NW, 2012, CURR OPIN MICROBIOL, V15, P189, DOI 10.1016/j.mib.2011.12.007; ROGEMOND V, 1986, INFECT IMMUN, V53, P99, DOI 10.1128/IAI.53.1.99-102.1986; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Russell AB, 2014, CELL HOST MICROBE, V16, P227, DOI 10.1016/j.chom.2014.07.007; Salacha R, 2010, ENVIRON MICROBIOL, V12, P1498, DOI 10.1111/j.1462-2920.2010.02174.x; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Schulze RJ, 2006, MOL MICROBIOL, V59, P1473, DOI 10.1111/j.1365-2958.2006.05039.x; Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08; Sears KT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002856; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sijbrandi R, 2008, MICROBES INFECT, V10, P514, DOI 10.1016/j.micinf.2008.01.015; Ueda O, 2005, ANTIMICROB AGENTS CH, V49, P2807, DOI 10.1128/AAC.49.7.2807-2815.2005; Veith PD, 2009, J PROTEOME RES, V8, P4279, DOI 10.1021/pr900372c; Weinacht KG, 2004, MOL MICROBIOL, V53, P1319, DOI 10.1111/j.1365-2958.2004.04219.x; Weiner JH, 2008, BBA-BIOMEMBRANES, V1778, P1698, DOI 10.1016/j.bbamem.2007.07.020; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wexler HM, 2012, ANAEROBE, V18, P200, DOI 10.1016/j.anaerobe.2011.12.017; Wexler HM, 2009, MICROBIOL-SGM, V155, P2694, DOI 10.1099/mic.0.025858-0; Wexler HM, 2002, ANAEROBE, V8, P180, DOI 10.1006/anae.2002.0427; Wexler HM, 2002, GENE, V283, P95, DOI 10.1016/S0378-1119(01)00835-6; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yamanaka H, 2008, J BACTERIOL, V190, P7693, DOI 10.1128/JB.00853-08; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zischka H, 2004, PROTEOMICS, V4, P3776, DOI 10.1002/pmic.200400851	81	50	50	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117732	10.1371/journal.pone.0117732	http://dx.doi.org/10.1371/journal.pone.0117732			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658944	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900211
J	Dongiovanni, P; Lanti, C; Gatti, S; Rametta, R; Recalcati, S; Maggioni, M; Fracanzani, AL; Riso, P; Cairo, G; Fargion, S; Valenti, L				Dongiovanni, Paola; Lanti, Claudia; Gatti, Stefano; Rametta, Raffaela; Recalcati, Stefania; Maggioni, Marco; Fracanzani, Anna Ludovica; Riso, Patrizia; Cairo, Gaetano; Fargion, Silvia; Valenti, Luca			High Fat Diet Subverts Hepatocellular Iron Uptake Determining Dysmetabolic Iron Overload	PLOS ONE			English	Article							INSULIN-RESISTANCE; LIVER-DISEASE; METABOLIC SYNDROME; SERUM FERRITIN; HEPCIDIN; RISK; HYPERFERRITINEMIA; MACROPHAGES; DEPLETION	Increased serum ferritin associated with mild hepatic iron accumulation, despite preserved upregulation of the iron hormone hepcidin, is frequently observed in patients with dysmetabolic overload syndrome (DIOS). Genetic factors and Western diet represent predisposing conditions, but the mechanisms favoring iron accumulation in DIOS are still unclear. Aims of this study were to assess the effect a high-fat diet (HFD) on hepatic iron metabolismin an experimental model in rats, to further characterize the effect of free fatty acids on iron metabolismin HepG2 hepatocytes in vitro, and to assess the translational relevance in patients with fatty liver with and without iron accumulation. Despite decreased uptake of dietary iron, rats fed HFD accumulated more hepatic iron than those fed regular diet, which was associated with steatosis development. Hepatic iron accumulation was paralleled by induction of ferritin, in the presence of preserved upregulation of hepcidin, recapitulating the features of DIOS. HFD was associated with increased expression of the major iron uptake protein Transferrin receptor-1 (TfR-1), consistently with upregulation of the intracellular iron sensor Iron regulated protein-1 (IRP1). Supplementation with fatty acids induced TfR-1 and IRP1 in HepG2 hepatocytes, favoring intracellular iron accumulation following exposure to iron salts. IRP1 silencing completely abrogated TfR-1 induction and the facilitation of intracellular iron accumulation induced by fatty acids. Hepatic TfR-1 mRNA levels were upregulated in patients with fatty liver and DIOS, whereas they were not associated with liver fat nor with inflammation. In conclusion, increased exposure to fatty acids subverts hepatic iron metabolism, favoring the induction of an iron uptake program despite hepatocellular iron accumulation.	[Dongiovanni, Paola; Maggioni, Marco; Fracanzani, Anna Ludovica; Fargion, Silvia; Valenti, Luca] Fdn IRCCS Ca Granda, Osped Policlin, Milan, Italy; [Lanti, Claudia; Riso, Patrizia] Univ Milan, Dept Food Environm & Nutrit Sci, Milan, Italy; [Gatti, Stefano] Fdn IRCCS Ca Granda, Osped Policlin, Preclin Surg Res Ctr & Surg, Milan, Italy; [Rametta, Raffaela; Fracanzani, Anna Ludovica; Fargion, Silvia; Valenti, Luca] Univ Milan, Metab Liver Dis Res Ctr, Dept Pathophysiol & Transplantat, Milan, Italy; [Recalcati, Stefania; Cairo, Gaetano] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan	Dongiovanni, P (corresponding author), Fdn IRCCS Ca Granda, Osped Policlin, Milan, Italy.	paola.dongiovanni@policlinico.mi.it; luca.valenti@unimi.it	Gatti, Stefano/M-1780-2015; Dongiovanni, Paola/AAC-9965-2019; Gatti, Stefano/AAE-3281-2022; Fracanzani, Anna Ludovica/J-8986-2018; Maggioni, Marco/AAC-4617-2022; Riso, Patrizia/AAC-2072-2019; Valenti, Luca/B-3695-2009; Cairo, Gaetano/M-5104-2016; recalcati, stefania/M-5045-2016	Gatti, Stefano/0000-0003-2209-4338; Dongiovanni, Paola/0000-0003-4343-7213; Gatti, Stefano/0000-0003-2209-4338; Fracanzani, Anna Ludovica/0000-0001-5918-0171; Maggioni, Marco/0000-0001-8603-8998; Riso, Patrizia/0000-0002-9204-7257; Valenti, Luca/0000-0001-8909-0345; Cairo, Gaetano/0000-0002-8147-4720; recalcati, stefania/0000-0002-2115-8283; rametta, raffaela/0000-0003-0091-9394	Bando Giovani Ricercatori Ricerca Finalizzata; Ministero della Salute e delle Politiche Sociali (Italian ministry of Health grant) [GR-2007-683265]	Bando Giovani Ricercatori Ricerca Finalizzata; Ministero della Salute e delle Politiche Sociali (Italian ministry of Health grant)	This paper was supported by the following grants: Bando Giovani Ricercatori Ricerca Finalizzata 2007, Ministero della Salute e delle Politiche Sociali (Italian ministry of Health grant; GR-2007-683265) to LV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed U, 2013, NUTR RES, V33, P126, DOI 10.1016/j.nutres.2012.11.012; Aigner E, 2008, GASTROENTEROLOGY, V135, P680, DOI 10.1053/j.gastro.2008.04.007; Aigner E, 2008, AM J CLIN NUTR, V87, P1374, DOI 10.1093/ajcn/87.5.1374; Barisani D, 2008, J HEPATOL, V49, P123, DOI 10.1016/j.jhep.2008.03.011; BARRY M, 1971, LANCET, V1, P100; Bu WM, 2012, FASEB J, V26, P2394, DOI 10.1096/fj.11-198853; Cairo G, 2000, BIOCHEM J, V352, P241, DOI 10.1042/0264-6021:3520241; CAIRO G, 1995, J BIOL CHEM, V270, P700, DOI 10.1074/jbc.270.2.700; Camaschella C, 2011, THESCIENTIFICWORLDJO, V11, P1357, DOI 10.1100/tsw.2011.130; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Dongiovanni P, 2011, J HEPATOL, V54, pS505, DOI 10.1016/S0168-8278(11)61282-8; Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008; Dongiovanni P, 2010, AM J PATHOL, V176, P1006, DOI 10.2353/ajpath.2010.090249; Edgren G, 2008, J NATL CANCER I, V100, P572, DOI 10.1093/jnci/djn084; Facchini FS, 2002, GASTROENTEROLOGY, V122, P931, DOI 10.1053/gast.2002.32403; Fargion S, 2001, AM J GASTROENTEROL, V96, P2448, DOI 10.1111/j.1572-0241.2001.04052.x; Fernandez-Real JM, 1998, DIABETES CARE, V21, P62, DOI 10.2337/diacare.21.1.62; Gabrielsen JS, 2012, J CLIN INVEST, V122, P3529, DOI 10.1172/JCI44421; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kohgo Y, 2005, ALCOHOL CLIN EXP RES, V29, p189S, DOI 10.1097/01.alc.0000189274.00479.62; Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Martinelli N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048250; Meli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066570; Montosi G, 2005, HEPATOLOGY, V41, P545, DOI 10.1002/hep.20620; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Ramos P, 2011, BLOOD, V117, P1379, DOI 10.1182/blood-2010-09-307462; Riva A, 2008, WORLD J GASTROENTERO, V14, P4745, DOI 10.3748/wjg.14.4745; SCHEUER PJ, 1962, J PATHOL BACTERIOL, V84, P53, DOI 10.1002/path.1700840107; Sonnweber T, 2012, J NUTR BIOCHEM, V23, P1600, DOI 10.1016/j.jnutbio.2011.10.013; Svegliati-Baroni G, 2006, AM J PATHOL, V169, P846, DOI 10.2353/ajpath.2006.050953; VALENTI L, 2010, NUTR METAB IN PRESS; Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x; Valenti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048804; Valenti L, 2011, ARTERIOSCL THROM VAS, V31, P683, DOI 10.1161/ATVBAHA.110.214858; Valenti L, 2010, J HEPATOL, V53, P927, DOI 10.1016/j.jhep.2010.05.023; Valenti L, 2010, GASTROENTEROLOGY, V138, P905, DOI 10.1053/j.gastro.2009.11.013; WLAZLO N, 2012, DIABETES CARE, P28669	40	32	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116855	10.1371/journal.pone.0116855	http://dx.doi.org/10.1371/journal.pone.0116855			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647178	Green Published, gold			2022-12-27	WOS:000348822600040
J	Maier, IL; Karch, A; Mikolajczyk, R; Bahr, M; Liman, J				Maier, Ilko L.; Karch, Andre; Mikolajczyk, Rafael; Bahr, Mathias; Liman, Jan			Effect of Beta-Blocker Therapy on the Risk of Infections and Death after Acute Stroke - A Historical Cohort Study	PLOS ONE			English	Article							IMMUNE; IMMUNODEPRESSION; INFLAMMATION; IMMUNOLOGY; ACTIVATION; MORTALITY; STATINS; SEPSIS; INJURY; CELLS	Background Infections are a frequent cause for prolonged hospitalization and increased mortality after stroke. Recent studies revealed a stroke-induced depression of the peripheral immune system associated with an increased susceptibility for infections. In a mice model for stroke, this immunosuppressive effect was reversible after beta-blocker administration. The aim of our study was to investigate the effect of beta-blocker therapy on the risk of infections and death after stroke in humans. Methods 625 consecutive patients with ischemic or hemorrhagic stroke, admitted to a university hospital stroke unit, were included in this historical cohort study. The effect of beta-blocker therapy on post-stroke pneumonia, urinary tract infections and death was investigated using multivariable Poisson and Cox regression models. Results 553 (88.3%) patients were admitted with ischemic stroke, the remaining 72 (11.7%) had a hemorrhagic stroke. Median baseline NIHSS was 8 (IQR 5-16) points. 301 (48.2%) patients received beta-blocker therapy. There was no difference in the risk of post-stroke pneumonia between patients with and without beta-blocker therapy (Rate Ratio = 1.00, 95% CI 0.77-1.30, p = 0.995). Patients with beta-blocker therapy showed a decreased risk for urinary tract infections (RR = 0.65, 95% CI 0.43-0.98, p = 0.040). 7-days mortality did not differ between groups (Hazard Ratio = 1.36, 95% CI 0.65-2.77, p = 0.425), while patients with beta-blocker therapy showed a higher 30-days mortality (HR = 1.93, 95% CI 1.20-3.10, p = 0.006). Conclusions Beta-blocker therapy did not reduce the risk for post-stroke pneumonia, but significantly reduced the risk for urinary tract infections. Different immune mechanisms underlying both diseases might explain these findings that need to be confirmed in future studies.	[Maier, Ilko L.; Bahr, Mathias; Liman, Jan] Univ Med Gottingen, Dept Neurol, Gottingen, Germany; [Karch, Andre; Mikolajczyk, Rafael] Helmholtz Ctr Infect Res, Dept Epidemiol, Res Grp Epidemiol & Stat Methods ESME, Braunschweig, Germany; [Karch, Andre; Mikolajczyk, Rafael] German Ctr Infect Res DZIF, Braunschweig, Germany; [Mikolajczyk, Rafael] Hannover Med Sch, Hannover, Germany	University of Gottingen; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research; Hannover Medical School	Maier, IL (corresponding author), Univ Med Gottingen, Dept Neurol, Gottingen, Germany.	ilko.maier@med.uni-goettingen.de	Karch, André/D-6973-2017; Mikolajczyk, Rafael/ABB-5259-2021; Baehr, Mathias/K-2188-2014	Karch, André/0000-0003-3014-8543; Mikolajczyk, Rafael/0000-0003-1271-7204	German Research Foundation; Open Access Publication Funds of the Gottingen University	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the Gottingen University	The authors acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland GL, 2010, CRIT CARE MED, V38, P388, DOI 10.1097/CCM.0b013e3181c03dfa; Ay H, 2006, NEUROLOGY, V66, P1325, DOI 10.1212/01.wnl.0000206077.13705.6d; BARER DH, 1988, BRIT MED J, V296, P737, DOI 10.1136/bmj.296.6624.737; Brossay L, 1998, J IMMUNOL, V161, P5124; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Dziedzic T, 2007, J NEUROL SCI, V252, P53, DOI 10.1016/j.jns.2006.10.007; Fehr T, 2004, ATHEROSCLEROSIS, V175, P83, DOI 10.1016/j.atherosclerosis.2004.02.016; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Harms H, 2011, CEREBROVASC DIS, V32, P552, DOI 10.1159/000331922; Herz J, 2014, NEUROBIOL DIS, V62, P456, DOI 10.1016/j.nbd.2013.10.022; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Klehmet J, 2009, NEUROSCIENCE, V158, P1184, DOI 10.1016/j.neuroscience.2008.07.044; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Laowattana S, 2007, NEUROLOGY, V68, P509, DOI 10.1212/01.wnl.0000253186.23949.fd; Macchia A, 2012, CRIT CARE MED, V40, P2768, DOI 10.1097/CCM.0b013e31825b9509; Miida Takashi, 2004, J Atheroscler Thromb, V11, P253; Muthu K, 2009, J BURN CARE RES, V30, P8, DOI 10.1097/BCR.0b013e3181921f22; Oberbeck R, 2009, CURR MED CHEM, V16, P1082, DOI 10.2174/092986709787581770; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Platzer C, 2000, J NEUROIMMUNOL, V105, P31, DOI 10.1016/S0165-5728(00)00205-8; SCHROETER M, 1994, J NEUROIMMUNOL, V55, P195, DOI 10.1016/0165-5728(94)90010-8; Seki Y, 2010, J CLIN NEUROSCI, V17, P187, DOI 10.1016/j.jocn.2009.04.020; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Terblanche M, 2007, LANCET INFECT DIS, V7, P358, DOI 10.1016/S1473-3099(07)70111-1; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Weber MS, 2005, NAT CLIN PRACT NEURO, V1, P106, DOI 10.1038/ncpneuro0047; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301	31	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116836	10.1371/journal.pone.0116836	http://dx.doi.org/10.1371/journal.pone.0116836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643360	Green Published, gold, Green Submitted			2022-12-27	WOS:000348821200026
J	Silva, LFCE; Valadares, SD; Engle, TE; Rotta, PP; Marcondes, MI; Silva, FAS; Martins, EC; Tokunaga, AT				Costa e Silva, Luiz Fernando; Valadares Filho, Sebastiao de Campos; Engle, Terry Eugene; Rotta, Polyana Pizzi; Marcondes, Marcos Inacio; Sales Silva, Flavia Adriane; Martins, Edilane Costa; Tokunaga, Arnaldo Taishi			Macrominerals and Trace Element Requirements for Beef Cattle	PLOS ONE			English	Article							BIOLOGICAL AVAILABILITY; GLUTATHIONE-PEROXIDASE; ZINC SUPPLEMENTATION; CORN-SILAGE; COPPER; METABOLISM; MANGANESE; SELENIUM; CALCIUM; PERFORMANCE	Eighty-seven Nellore animals were utilized in this study to estimate net requirements for the maintenance and growth of beef cattle as well as the retention coefficients of 13 minerals: macrominerals (Ca, P, Mg, K, Na, and S) and trace elements (Cu, Fe, Mn, Se, Zn, Co, and Cr). The net requirements for maintenance and the true retention coefficient were estimated by using the regression between apparent retention and intake for each mineral. The net requirement for maintenance (mu g/kg BW) and retention coefficients (%) were 163 and 85 for Cu, 2,097 and 53 for Fe, 32.3 and 24 for Mn, 3.72 and 48 for Se, 669 and 0.80 for Zn, 18.4 and 86 for Co, and 22.9 and 78 for Cr. The dietary requirements of macrominerals (g/kg DMI) were 5.12 for Ca, 2.38 for P, 0.96 for Mg, 2.40 for K, 0.79 for Na, and 1.47 for S. This is the first study using Nellore cattle to estimate mineral requirements; considering that Nellore cattle are the most common breed in Brazil and that Brazil is a major beef producer globally, this knowledge can help producers to improve animal performance by supplying the correct amount of minerals.	[Costa e Silva, Luiz Fernando; Valadares Filho, Sebastiao de Campos; Rotta, Polyana Pizzi; Marcondes, Marcos Inacio; Sales Silva, Flavia Adriane; Martins, Edilane Costa; Tokunaga, Arnaldo Taishi] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Engle, Terry Eugene] Colorado State Univ, Dept Anim Sci, Ft Collins, CO 80523 USA	Universidade Federal de Vicosa; Colorado State University	Silva, LFCE (corresponding author), Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil.	lfcostasilva@yahoo.com.br	Hasui, Erica/AAF-5580-2019; Rotta, Polyana P/L-4722-2016; Rotta, Polyana/AAT-8719-2020; da Cunha, Rogério Grassetto Teixeira/AAS-6530-2020; Costa e Silva, Luiz Fernando/T-6073-2019; Silva, Flávia/AAQ-6163-2021; da Cunha, Rogério Grassetto Teixeira/J-1738-2012; Marcondes, Marcos/AAH-7553-2020	Hasui, Erica/0000-0002-9938-9284; Rotta, Polyana/0000-0002-1185-8120; da Cunha, Rogério Grassetto Teixeira/0000-0002-2368-3540; Silva, Flávia/0000-0001-5819-5638; da Cunha, Rogério Grassetto Teixeira/0000-0002-2368-3540; Marcondes, Marcos/0000-0003-4843-2809	FAPEMIG (BRAZIL) [CVZ-APQ-00655-12]	FAPEMIG (BRAZIL)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by FAPEMIG (BRAZIL) - CVZ-APQ-00655-12.	AFRC, 1993, ENERGY PROTEIN REQUI; Agricultural Research Council (ARC), 1980, NUTR REQ RUM LIV; Bankir L, 2010, AM J PHYSIOL-RENAL, V299, pF917, DOI 10.1152/ajprenal.00413.2010; BEHNE D, 1983, J NUTR, V113, P456, DOI 10.1093/jn/113.2.456; BENTLEY OG, 1951, J DAIRY SCI, V34, P396, DOI 10.3168/jds.S0022-0302(51)91727-4; Bernhard BC, 2012, J ANIM SCI, V90, P3879, DOI 10.2527/jas.2011-4981; BERNIER JF, 1984, J DAIRY SCI, V67, P2369, DOI 10.3168/jds.S0022-0302(84)81585-4; Bodansky M, 1920, J BIOL CHEM, V44, P399; BOUCHARD R, 1973, J DAIRY SCI, V56, P1276, DOI 10.3168/jds.S0022-0302(73)85347-0; Braselton WE, 1997, J VET DIAGN INVEST, V9, P395, DOI 10.1177/104063879700900409; BREMNER I, 1973, BRIT J NUTR, V30, P61, DOI 10.1079/BJN19730008; Brody S., 1945, BIOENERGETICS GROWTH; BUNTING LD, 1994, J ANIM SCI, V72, P1591, DOI 10.2527/1994.7261591x; CLAWSON WJ, 1972, J ANIM SCI, V34, P516; Commonwealth Scientific and Industrial Research Organization (CSIRO), 2007, NUTR REQUIREMENTS DO; COTZIAS GC, 1958, PHYSIOL REV, V38, P503, DOI 10.1152/physrev.1958.38.3.503; Delezenne C, 1919, ANN I PASTEUR, V33, P68; DOWE TW, 1957, J ANIM SCI, V16, P811, DOI 10.2527/jas1957.164811x; Erickson GE, 2002, J ANIM SCI, V80, P1690; Hambridge KM., 1986, TRACE ELEMENTS HUM A, P1; HANSARD SL, 1968, J ANIM SCI, V27, P1097, DOI 10.2527/jas1968.2741097x; HANSARD SL, 1968, J NUTR, V96, P247, DOI 10.1093/jn/96.2.247; Hartmans J., 1974, Trace element metabolism in animals-2,, P261; Hurley L., 1987, TRACE ELEMENTS HUMAN, V11, P185, DOI DOI 10.1016/B978-0-08-092468-7.50010-7; KEGLEY EB, 1995, J ANIM SCI, V73, P2721; Korn KT, 2013, J ANIM SCI, V91, P3332, DOI 10.2527/jas.2012-5962; LOONEY JW, 1976, J ANIM SCI, V42, P693, DOI 10.2527/jas1976.423693x; MILLER JK, 1965, J DAIRY SCI, V48, P370, DOI 10.3168/jds.S0022-0302(65)88231-5; MILLER WJ, 1966, J DAIRY SCI, V49, P1012, DOI 10.3168/jds.S0022-0302(66)88003-7; MILLS CF, 1976, BRIT J NUTR, V35, P309, DOI 10.1079/BJN19760039; MONROE RA, 1952, P SOC EXP BIOL MED, V80, P250, DOI 10.3181/00379727-80-19586; Mullis LA, 2003, J ANIM SCI, V81, P865; National Research Council (NRC), 2001, NUTR REQ DAIR CATTL; NRC, 1970, NUTR REQ BEEF CATTL, DOI DOI 10.17226/9791; OH SH, 1976, J ANIM SCI, V42, P977, DOI 10.2527/jas1976.424977x; PEELER HT, 1972, J ANIM SCI, V35, P695; PERRY TW, 1968, J ANIM SCI, V27, P1674; POND WG, 1988, NUTR REP INT, V38, P737; Rotta PP, 2014, J ANIM SCI, V92, P2996, DOI 10.2527/jas.2013-7364; SANSOM BF, 1978, RES VET SCI, V24, P366, DOI 10.1016/S0034-5288(18)33049-2; SCHROEDER HA, 1966, J CHRON DIS, V19, P545, DOI 10.1016/0021-9681(66)90094-4; Schwarz W A, 1975, Arch Tierernahr, V25, P597; Smith RM, 1987, TRACE ELEMENTS HUMAN, P185; Standing Committee on Agriculture (SCA), 1990, FEED STAND AUSTR LIV; STOMER VVE, 1967, CAN J ANIM SCI, V47, P39, DOI 10.4141/cjas67-006; SULLIVAN JF, 1979, J NUTR, V109, P1432, DOI 10.1093/jn/109.8.1432; Suttle N, 2010, MINERAL NUTRITION OF LIVESTOCK, 4TH EDITION, P306, DOI 10.1079/9781845934729.0306; SUTTLE NF, 1974, BRIT J NUTR, V32, P395, DOI 10.1079/BJN19740091; Teixeira IAMA, 2015, J ANIM SCI, V93, P2349, DOI 10.2527/jas.2014-8588; THOMAS JW, 1970, J DAIRY SCI, V53, P1107, DOI 10.3168/jds.S0022-0302(70)86354-8; Valadares S.C., 2010, NUTR REQUIREMENTS ZE, V2nd; VANBRUWAENE R, 1984, HEALTH PHYS, V46, P1069, DOI 10.1097/00004032-198405000-00007; WARD GM, 1966, J DAIRY SCI, V49, P268, DOI 10.3168/jds.S0022-0302(66)87848-7; WEIGAND E, 1982, Z TIERPHYSIOL TIERER, V47, P1, DOI 10.1111/j.1439-0396.1982.tb01228.x; WEITZEL G, 1954, H-S Z PHYSIOL CHEM, V296, P19, DOI 10.1515/bchm2.1954.296.1.19; WISE MB, 1963, J NUTR, V79, P79, DOI 10.1093/jn/79.1.79; WRIGHT PL, 1966, AM J PHYSIOL, V211, P6, DOI 10.1152/ajplegacy.1966.211.1.6	57	47	49	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144464	10.1371/journal.pone.0144464	http://dx.doi.org/10.1371/journal.pone.0144464			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	25658108	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900053
J	Kuwabara, WMT; Zhang, L; Schuiki, I; Curi, R; Volchuk, A; Alba-Loureiro, TC				Tatagiba Kuwabara, Wilson Mitsuo; Zhang, Liling; Schuiki, Irmgard; Curi, Rui; Volchuk, Allen; Alba-Loureiro, Tatiana Carolina			NADPH Oxidase-Dependent Production of Reactive Oxygen Species Induces Endoplasmatic Reticulum Stress in Neutrophil-Like HL60 Cells	PLOS ONE			English	Article							BIOLOGICAL DEFENSE-MECHANISMS; RESPIRATORY BURST OXIDASE; MESSENGER-RNA; BIOCHEMICAL ASPECTS; ACTIVATION DOMAIN; OXIDATIVE STRESS; GENE-EXPRESSION; ER STRESS; PROTEIN; DIFFERENTIATION	Reactive oxygen species (ROS) primarily produced via NADPH oxidase play an important role for killing microorganisms in neutrophils. In this study we examined if ROS production in Human promyelocytic leukemia cells (HL60) differentiated into neutrophil-like cells (dHL60) induces ER stress and activates the unfolded protein response (UPR). To cause ROS production cells were treated with PMA or by chronic hyperglycemia. Chronic hyperglycemia failed to induce ROS production and did not cause activation of the UPR in dHL60 cells. PMA, a pharmacologic NADPH oxidase activator, induced ER stress in dHL60 cells as monitored by IRE-1 and PERK pathway activation, and this was independent of calcium signaling. The NADPH oxidase inhibitor, DPI, abolished both ROS production and UPR activation. These results show that ROS produced by NADPH oxidase induces ER stress and suggests a close association between the redox state of the cell and the activation of the UPR in neutrophil-like HL60 cells.	[Tatagiba Kuwabara, Wilson Mitsuo; Curi, Rui; Volchuk, Allen] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Zhang, Liling; Schuiki, Irmgard; Volchuk, Allen] Univ Toronto, Dept Physiol, Toronto, ON, Canada	Universidade de Sao Paulo; University of Toronto	Kuwabara, WMT (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.	wilsonk@icb.usp.br	Loureiro, Tatiana C Alba/U-9436-2018; Curi, Rui/C-9351-2012; Loureiro, Tatiana/C-6712-2012; Kuwabara, Wilson MT/H-9492-2017	Kuwabara, Wilson MT/0000-0001-5307-6218	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/05349-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)- 2012/05349-9, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agner K., 1972, STRUCTURE FUNCTION O, P329; Ahmed N, 1999, LEUKEMIA RES, V23, P395, DOI 10.1016/S0145-2126(98)00179-9; BABIOR BM, 1991, AM J HEMATOL, V37, P263, DOI 10.1002/ajh.2830370410; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; BABIOR BM, 1975, J LAB CLIN MED, V85, P235; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Brechard S, 2005, CELL CALCIUM, V37, P531, DOI 10.1016/j.ceca.2005.01.019; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cassatella MA, 1999, ADV IMMUNOL, V73, P369, DOI 10.1016/S0065-2776(08)60791-9; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; COLLINS SJ, 1987, BLOOD, V70, P1233; DAVIS RC, 1987, DEV BIOL, V119, P164, DOI 10.1016/0012-1606(87)90218-1; DOMIGAN NM, 1995, J BIOL CHEM, V270, P16542, DOI 10.1074/jbc.270.28.16542; ELLIS JA, 1988, BIOCHEM J, V251, P887, DOI 10.1042/bj2510887; FANTONE JC, 1982, AM J PATHOL, V107, P397; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; HENDERSON LM, 1995, J BIOL CHEM, V270, P5909, DOI 10.1074/jbc.270.11.5909; IMLAY JA, 1986, J BACTERIOL, V166, P519, DOI 10.1128/jb.166.2.519-527.1986; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; IYER GY, 1961, NATURE, V192, P535, DOI 10.1038/192535a0; Kass GEN, 1999, ENVIRON HEALTH PERSP, V107, P25, DOI 10.2307/3434469; Kettle AJ, 1997, REDOX REP, V3, P3, DOI 10.1080/13510002.1997.11747085; KLEBANOFF SJ, 1968, J BACTERIOL, V95, P2131, DOI 10.1128/JB.95.6.2131-2138.1968; Klebanoff SJ, 1992, INFLAMMATION BASIC P, P451; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lakshmanan AP, 2013, INT J BIOCHEM CELL B, V45, P438, DOI 10.1016/j.biocel.2012.09.017; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li G, 2010, J CELL BIOL, V191, P1113, DOI 10.1083/jcb.201006121; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; Lin CJ, 2012, CELL BIOL INT, V36, P391, DOI 10.1042/CBI20110290; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu W, 2013, EXP THER MED, V5, P1289, DOI 10.3892/etm.2013.978; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Garcia P, 2006, BIOESSAYS, V28, P525, DOI 10.1002/bies.20413; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MACDOUGALL SL, 1988, J CLIN INVEST, V81, P449, DOI 10.1172/JCI113340; McGehee AM, 2009, J IMMUNOL, V183, P3690, DOI 10.4049/jimmunol.0900953; Miyake H, 2000, J CELL BIOCHEM, V77, P396, DOI 10.1002/(SICI)1097-4644(20000601)77:3<396::AID-JCB5>3.0.CO;2-5; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Paclet MH, 2004, BIOCHEM J, V382, P981, DOI 10.1042/BJ20040954; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Riganti C, 2004, J BIOL CHEM, V279, P47726, DOI 10.1074/jbc.M406314200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; ROSSI F, 1964, EXPERIENTIA, V20, P21, DOI 10.1007/BF02146019; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Sage AT, 2012, OBESITY, V20, P748, DOI 10.1038/oby.2011.144; Samali Afshin, 2010, Int J Cell Biol, V2010, P830307, DOI 10.1155/2010/830307; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Santos CX, 2013, ANTIOXID RE IN PRESS; SAVILL J, 1995, SEMIN CELL BIOL, V6, P385, DOI 10.1016/S1043-4682(05)80009-1; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schuster DP, 2007, AM J PHYSIOL-LUNG C, V292, pL845, DOI 10.1152/ajplung.00350.2006; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shimizu Y, 2009, ANTIOXID REDOX SIGN, V11, P2317, DOI [10.1089/ars.2009.2501, 10.1089/ARS.2009.2501]; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Teng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.24; Thorens B, 2010, AM J PHYSIOLENDOCRIN, V298; UNGER RH, 1991, SCIENCE, V251, P1200, DOI 10.1126/science.2006409; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walrand S, 2003, CLIN CHIM ACTA, V331, P103, DOI 10.1016/S0009-8981(03)00086-X; Wiseman RL, 2010, CELL, V140, P590, DOI 10.1016/j.cell.2010.02.006; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhai YP, 2013, ACTA PHARMACOL SIN, V34, P507, DOI 10.1038/aps.2012.207	75	39	39	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0116410	10.1371/journal.pone.0116410	http://dx.doi.org/10.1371/journal.pone.0116410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668518	Green Published, Green Submitted, gold			2022-12-27	WOS:000349493000007
J	Behar, RZ; Hua, M; Talbot, P				Behar, Rachel Z.; Hua, My; Talbot, Prue			Puffing Topography and Nicotine Intake of Electronic Cigarette Users	PLOS ONE			English	Article							SMOKING TOPOGRAPHY; DELIVERY-SYSTEMS; IN-VITRO; YIELDS; CONSUMPTION; CARTRIDGES; EXPOSURE; TAR	Background Prior electronic cigarette (EC) topography data are based on two video analyses with limited parameters. Alternate methods for measuring topography are needed to understand EC use and nicotine intake. Objectives This study evaluated EC topography with a CReSS Pocket device and quantified nicotine intake. Methods Validation tests on pressure drop, flow rate, and volume confirmed reliable performance of the CReSS Pocket device. Twenty participants used Blu Cigs and V2 Cigs for 10 minute intervals with a 10-15 minute break between brands. Brand order was reversed and repeated within 7 days Data were analyzed to determine puff duration, puff count, volume, flow rate, peak flow, and inter-puff interval. Nicotine intake was estimated from cartomizer fluid consumption and topography data. Results Nine patterns of EC use were identified. The average puff count and inter-puff interval were 32 puffs and 17.9 seconds. All participants, except one, took more than 20 puffs/10 minutes. The averages for puff duration (2.65 seconds/puff), volume/puff (51ml/puff), total puff volume (1,579 ml), EC fluid consumption (79.6 mg), flow rate (20 ml/s), and peak flow rate (27 ml/s) were determined for 10-minute sessions. All parameters except total puff count were significantly different for Blu versus V2 EC. Total volume for Blu versus V2 was four-times higher than for conventional cigarettes. Average nicotine intake for Blu and V2 across both sessions was 1.2 +/- 0.5 mg and 1.4 +/- 0.7 mg, respectively, which is similar to conventional smokers. Conclusions EC puffing topography was variable among participants in the study, but often similar within an individual between brands or days. Puff duration, inter-puff interval, and puff volume varied from conventional cigarette standards. Data on total puff volume and nicotine intake are consistent with compensatory usage of EC. These data can contribute to the development of a standard protocol for laboratory testing of EC products.	[Behar, Rachel Z.] Univ Calif Riverside, Cell Mol & Dev Biol Grad Program, Riverside, CA 92521 USA; [Behar, Rachel Z.; Hua, My; Talbot, Prue] Univ Calif Riverside, Dept Neurosci & Cell Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Talbot, P (corresponding author), Univ Calif Riverside, Dept Neurosci & Cell Biol, Riverside, CA 92521 USA.	talbot@ucr.edu	Talbot, Prue/AAY-3896-2021		University of California Tobacco-Related Disease Research Program [22RT-0127]; National Institutes of Health Predoctoral Fellowship [F32HL116121]; University of California Chancellors Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL116121] Funding Source: NIH RePORTER	University of California Tobacco-Related Disease Research Program(University of California System); National Institutes of Health Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Chancellors Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the University of California Tobacco-Related Disease Research Program Grant #22RT-0127 awarded to PT; National Institutes of Health Predoctoral Fellowship grant #F32HL116121 awarded to RB; University of California Chancellors Research Fellowship awarded to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 1997, J ORAL PATHOL MED, V26, P117, DOI 10.1111/j.1600-0714.1997.tb00033.x; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; Bahl V, 2012, REPROD TOXICOL, V34, P529, DOI 10.1016/j.reprotox.2012.08.001; Behar RZ, 2014, TOXICOL IN VITRO, V28, P198, DOI 10.1016/j.tiv.2013.10.006; Blank MD, 2009, NICOTINE TOB RES, V11, P896, DOI 10.1093/ntr/ntp083; BRIDGES RB, 1990, PHARMACOL BIOCHEM BE, V37, P29, DOI 10.1016/0091-3057(90)90037-I; Cameron JM, 2014, TOB CONTROL, V23, P77, DOI 10.1136/tobaccocontrol-2012-050604; Chen IL, 2014, TOB CONTROL, V23, P1, DOI 10.1136/tobaccocontrol-2013-051504; Chen IL, 2013, NICOTINE TOB RES, V15, P615, DOI 10.1093/ntr/nts145; Cheng TR, 2014, TOB CONTROL, V23, P11, DOI 10.1136/tobaccocontrol-2013-051482; Davis B, 2015, NICOTINE TOB RES, V17, P134, DOI 10.1093/ntr/ntu080; De Jesus S, 2015, J SMOK CESS, V10, P12, DOI 10.1017/jsc.2013.31; Dutra LM, 2014, JAMA PEDIATR, V168, P684, DOI 10.1001/jamapediatrics.2013.5488; Evans SE, 2014, TOB CONTROL, V23, P23, DOI 10.1136/tobaccocontrol-2013-051489; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P2500, DOI 10.3390/ijerph10062500; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Goniewicz ML, 2012, PEDIATRICS, V130, pE879, DOI 10.1542/peds.2011-3448; Grana RA, 2013, J ADOLESCENT HEALTH, V52, P135, DOI 10.1016/j.jadohealth.2012.11.007; Hammond D, 2005, CANCER EPIDEM BIOMAR, V14, P1370, DOI 10.1158/1055-9965.EPI-04-0498; Hammond D, 2006, CANCER EPIDEM BIOMAR, V15, P1495, DOI 10.1158/1055-9965.EPI-06-0047; Hua M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2324; Hua M, 2013, TOB CONTROL, V22, P103, DOI 10.1136/tobaccocontrol-2011-050226; Knoll M, 1998, REPROD TOXICOL, V12, P57, DOI 10.1016/S0890-6238(97)00100-7; KNOLL M, 1995, BIOL REPROD, V53, P29, DOI 10.1095/biolreprod53.1.29; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; Kozlowski LT, 2002, TOB CONTROL, V11, pI40, DOI 10.1136/tc.11.suppl_1.i40; Kozlowski LT, 1998, AM J PREV MED, V15, P9, DOI 10.1016/S0749-3797(98)00004-X; Lee EM, 2003, NICOTINE TOB RES, V5, P673, DOI 10.1080/1462220031000158645; Lee S, 2014, J ADOLESCENT HEALTH, V54, P684, DOI 10.1016/j.jadohealth.2013.11.003; McCauley L, 2012, CHEST, V141, P1110, DOI 10.1378/chest.11-1334; Siegel MB, 2011, AM J PREV MED, V40, P472, DOI 10.1016/j.amepre.2010.12.006; SUTTON SR, 1982, BRIT MED J, V285, P600, DOI 10.1136/bmj.285.6342.600; Trehy ML, 2011, J LIQ CHROMATOGR R T, V34, P1442, DOI 10.1080/10826076.2011.572213; Trtchounian A, 2011, TOB CONTROL, V20, P47, DOI 10.1136/tc.2010.037259; Trtchounian A, 2010, NICOTINE TOB RES, V12, P905, DOI 10.1093/ntr/ntq114; Uchiyama S, 2013, ANAL SCI, V29, P1219, DOI 10.2116/analsci.29.1219; Vardavas CI, 2012, CHEST, V141, P1400, DOI 10.1378/chest.11-2443; Williams M, 2015, NICOTINE TOB RES, V17, P201, DOI 10.1093/ntr/ntu118; Williams M, 2011, NICOTINE TOB RES, V13, P1276, DOI 10.1093/ntr/ntr164; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987	40	130	138	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117222	10.1371/journal.pone.0117222	http://dx.doi.org/10.1371/journal.pone.0117222			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664463	gold, Green Published			2022-12-27	WOS:000349123100021
J	Malhotra, A; Gundel, M; Rajput, AM; Mevissen, HT; Saiz, A; Pastor, X; Lozano-Rubi, R; Martinez-Lapsicina, EH; Zubizarreta, I; Mueller, B; Kotelnikova, E; Toldo, L; Hofmann-Apitius, M; Villoslada, P				Malhotra, Ashutosh; Guendel, Michaela; Rajput, Abdul Mateen; Mevissen, Heinz-Theodor; Saiz, Albert; Pastor, Xavier; Lozano-Rubi, Raimundo; Martinez-Lapsicina, Elena H.; Zubizarreta, Irati; Mueller, Bernd; Kotelnikova, Ekaterina; Toldo, Luca; Hofmann-Apitius, Martin; Villoslada, Pablo			Knowledge Retrieval from PubMed Abstracts and Electronic Medical Records with the Multiple Sclerosis Ontology	PLOS ONE			English	Article							HEALTH RECORDS; DECISION-SUPPORT; COMORBIDITIES; DIAGNOSIS; PATTERNS; THERAPY; MS	Background In order to retrieve useful information from scientific literature and electronic medical records (EMR) we developed an ontology specific for Multiple Sclerosis (MS). Methods The MS Ontology was created using scientific literature and expert review under the Protege OWL environment. We developed a dictionary with semantic synonyms and translations to different languages for mining EMR. The MS Ontology was integrated with other ontologies and dictionaries (diseases/comorbidities, gene/protein, pathways, drug) into the text-mining tool SCAIView. We analyzed the EMRs from 624 patients with MS using the MS ontology dictionary in order to identify drug usage and comorbidities in MS. Testing competency questions and functional evaluation using F statistics further validated the usefulness of MS ontology. Results Validation of the lexicalized ontology by means of named entity recognition-based methods showed an adequate performance (F score = 0.73). The MS Ontology retrieved 80% of the genes associated with MS from scientific abstracts and identified additional pathways targeted by approved disease-modifying drugs (e.g. apoptosis pathways associated with mitoxantrone, rituximab and fingolimod). The analysis of the EMR from patients with MS identified current usage of disease modifying drugs and symptomatic therapy as well as comorbidities, which are in agreement with recent reports. Conclusion The MS Ontology provides a semantic framework that is able to automatically extract information from both scientific literature and EMR from patients with MS, revealing new pathogenesis insights as well as new clinical information.	[Malhotra, Ashutosh; Guendel, Michaela; Mevissen, Heinz-Theodor; Mueller, Bernd; Hofmann-Apitius, Martin] Fraunhofer Inst Algorithms & Sci Comp, Dept Bioinformat, D-53754 St Augustin, Germany; [Rajput, Abdul Mateen; Toldo, Luca] Merck KGaA, Darmstadt, Germany; [Saiz, Albert] Hosp Clin Barcelona, Dept Neurol, MS Ctr, Barcelona, Spain; [Saiz, Albert; Martinez-Lapsicina, Elena H.; Zubizarreta, Irati; Kotelnikova, Ekaterina; Villoslada, Pablo] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Ctr Neuroimmunol, Barcelona, Spain; [Pastor, Xavier; Lozano-Rubi, Raimundo] Univ Barcelona, Hosp Clin Barcelona, Dept Med Informat, Barcelona, Spain	Fraunhofer Gesellschaft; Merck KGaA; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona	Villoslada, P (corresponding author), Inst Invest Biomed August Pi i Sunyer IDIBAPS, Ctr Neuroimmunol, Barcelona, Spain.	pvilloslada@clinic.ub.es	Martínez-Lapiscina, Elena H/L-1161-2014; Müller, Bernd/AFE-4930-2022; Villoslada, Pablo/AAF-9547-2019; Kotelnikova, Elena/N-8496-2013; Hofmann-Apitius, Martin/E-6123-2018	Martínez-Lapiscina, Elena H/0000-0003-4272-0826; Müller, Bernd/0000-0003-3062-8192; Zubizarreta Nafarrate, Irati/0000-0001-7637-7830; Hofmann-Apitius, Martin/0000-0001-9012-6720; Lozano-Rubi, Raimundo/0000-0002-7912-721X	Instituto de Salud Carlos III, Spain [PS09/00259, RD12/0032/0001]	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	Funded by the Instituto de Salud Carlos III, Spain (FIS program PS09/00259 and RETICS program RD12/0032/0001), www.isciii.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejarano B, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-67; Bodenreider O, 2008, Yearb Med Inform, P67; Davis MF, 2013, J AM MED INFORM ASSN, V20, pE334, DOI 10.1136/amiajnl-2013-001999; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Esposito M, 2011, ENG APPL ARTIF INTEL, V24, P1340, DOI 10.1016/j.engappai.2011.02.002; Frohman Teresa C, 2011, Ther Adv Neurol Disord, V4, P83, DOI 10.1177/1756285611400658; Fromont A, 2013, J NEUROL, V260, P2629, DOI 10.1007/s00415-013-7041-9; Hanisch D, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S14; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Kang JH, 2010, EUR J NEUROL, V17, P1215, DOI 10.1111/j.1468-1331.2010.02971.x; Katzan IL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004583; Lafata JE, 2008, J AM PHARM ASSOC, V48, P752, DOI 10.1331/JAPhA.2008.07116; LePendu P, 2013, CLIN PHARMACOL THER, V93, P547, DOI 10.1038/clpt.2013.47; Mahurkar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057655; Malhotra A, 2013, ALZHEIMERS DEMENT, P238; Markowitz Clyde, 2010, Continuum (Minneap Minn), V16, P90, DOI 10.1212/01.CON.0000389936.61789.04; Marrie RA, 2009, NEUROLOGY, V72, P117, DOI 10.1212/01.wnl.0000333252.78173.5f; Marriott JJ, 2013, CAN J NEUROL SCI, V40, P67, DOI 10.1017/S031716710001297X; Miller DM, 2011, TELEMED E-HEALTH, V17, P5, DOI 10.1089/tmj.2010.0133; Morrie RA, 2010, LANCET NEUROL, V9, P820, DOI 10.1016/S1474-4422(10)70135-6; Musen MA, 2012, J AM MED INFORM ASSN, V19, P190, DOI 10.1136/amiajnl-2011-000523; Obrst L, 2007, EVALUATION ONTOLOGIE, P139, DOI DOI 10.1007/978-0-387-48438-9_8; Oleen-Burkey MerriKay, 2013, J Med Econ, V16, P397, DOI 10.3111/13696998.2013.764309; Park J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.16; Rothman B, 2012, MT SINAI J MED, V79, P757, DOI 10.1002/msj.21351; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sethi NK, 2013, NEUROLOGY, V81, P1558, DOI 10.1212/WNL.0b013e3182a9f1ea; Solaro C, 2011, EUR J NEUROL, V18, P1113, DOI 10.1111/j.1468-1331.2011.03425.x; Torkildsen O, 2007, ACTA NEUROL SCAND, V115, P46, DOI 10.1111/j.1600-0404.2007.00846.x; Villoslada P, 2012, J NEUROIMMUNOL, V248, P58, DOI 10.1016/j.jneuroim.2012.01.001; Villoslada P, 2009, ANN NEUROL, V65, P124, DOI 10.1002/ana.21634; Wild F, 2013, NERVENARZT, V84, P202, DOI 10.1007/s00115-012-3683-6; Windt R, 2013, INT J CLIN PHARM-NET, V35, P1229, DOI 10.1007/s11096-013-9857-x; Zhao S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006548	35	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0116718	10.1371/journal.pone.0116718	http://dx.doi.org/10.1371/journal.pone.0116718			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25665127	Green Published, gold, Green Submitted			2022-12-27	WOS:000349123100012
J	Cha, YL; Li, PD; Yuan, LJ; Zhang, MY; Zhang, YJ; Rao, HL; Zhang, HZ; Zheng, XFS; Wang, HY				Cha, Yin-Lian; Li, Pin-Dong; Yuan, Lin-Jing; Zhang, Mei-Yin; Zhang, Yao-Jun; Rao, Hui-Lan; Zhang, Hui-Zhong; Zheng, X. F. Steven; Wang, Hui-Yun			EIF4EBP1 Overexpression Is Associated with Poor Survival and Disease Progression in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							BREAST-CANCER; 4E-BINDING PROTEIN-1; INITIATION-FACTORS; TRANSLATION; MTOR; EXPRESSION; P150; PHENOTYPE; EFFECTORS; HALLMARK	Objective EIF4EBP1 acts as a crucial effector in mTOR signaling pathway. Studies have suggested that EIF4EBP1 plays a critical role in carcinogenesis. However, the clinical significance and biological role of EIF4EBP1 in hepatocellular carcinoma (HCC) have not been elucidated. Therefore, we aimed to investigate the clinical significance of EIF4EBP1 in HCC. Methods Total 128 cases of HCCs were included in this study. EIF4EBP1 expression in HCC tissues was detected by qRT-PCR, Western blot and immunohistochemistry, respectively. Then the relationships between EIF4EBP1 expression and clinical features as well as survival were analyzed. Results The expression level of EIF4EBP1 mRNA is significantly higher in 60% (24/40) of fresh HCC tissues than that in the matched adjacent nontumor liver (NCL) tissues (P = 0.044). Similarly, EIF4EBP1 protein is notably upregulated in 8 HCC tissues (randomly selected from the 40 HCCs) measured by Western blot and is significantly increased in another 88 paraffin-embedded HCCs (53%, 47/88) by immunohistochemistry compared with the matched NCLs (P < 0.001). EIF4EBP1 protein expression in HCC tissues is significantly correlated with serum AFP (P = 0.003) and marginally significantly associated with pathological grade (P = 0.085), tumor number (P = 0.084), tumor embolus (P = 0.084) and capsulation (P = 0.073). Patients with higher EIF4EBP1 protein expression have a much worse 5-year overall survival (40.3% vs 73.6%) and 5-year disease-free survival (33.0% vs 49.0%) than those with low expression. Furthermore, Cox regression analysis shows that EIF4EBP1 protein is an independent prognostic factor for overall survival (HR, 2.285; 95% CI, 1.154-4.527; P = 0.018) and disease-free survival (HR, 1.901; 95% CI, 1.067-3.386; P = 0.029) in HCC patients. Conclusions Our results demonstrate for the first time that EIF4EBP1 mRNA and protein are markedly up-regulated in HCC tissues, and the protein overexpression is significantly associated with poor survival and progression, which provide a potential new prognostic marker and therapeutic target for HCC patients.	[Cha, Yin-Lian; Li, Pin-Dong; Yuan, Lin-Jing; Zhang, Mei-Yin; Wang, Hui-Yun] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Cha, Yin-Lian; Li, Pin-Dong; Yuan, Lin-Jing; Zhang, Mei-Yin; Wang, Hui-Yun] Sun Yat Sen Univ, Natl Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yao-Jun] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Rao, Hui-Lan; Zhang, Hui-Zhong] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, X. F. Steven] Rutgers State Univ, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Wang, HY (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China.	wanghyun@mail.sysu.edu.cn	Zhang, Yaojun/U-2965-2019; YANG, YANG/U-3889-2017	Zhang, Yaojun/0000-0002-9752-4729	National Natural Science Foundation of China [81171891]; Research Fund of National Key Laboratory of Oncology in South China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund of National Key Laboratory of Oncology in South China	This work was supported by a grant (No: 81171891) from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) and partly supported by the Research Fund of National Key Laboratory of Oncology in South China (http://skl.sysucc.org.cn/). The grants were awarded to HYW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi M, 2010, P NATL ACAD SCI USA, V107, P2640, DOI 10.1073/pnas.0914856107; Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Cai WJ, 2014, ONCOTARGET, V5, P6015, DOI 10.18632/oncotarget.2109; Castellvi J, 2006, CANCER-AM CANCER SOC, V107, P1801, DOI 10.1002/cncr.22195; Chen GP, 1999, INT J CANCER, V84, P95, DOI 10.1002/(SICI)1097-0215(19990420)84:2<95::AID-IJC1>3.0.CO;2-N; Dellas A, 1998, CANCER, V83, P1376, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Garcia-Maceira P, 2009, ONCOGENE, V28, P313, DOI 10.1038/onc.2008.398; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Grzmil M, 2014, J CLIN INVEST, V124, P742, DOI 10.1172/JCI70198; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Haybaeck J, 2010, ANTICANCER RES, V30, P1047; Heikkinen T, 2013, BREAST CANCER RES TR, V141, P79, DOI 10.1007/s10549-013-2671-2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karlsson E, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3557; Karlsson E, 2011, GENE CHROMOSOME CANC, V50, P775, DOI 10.1002/gcc.20900; Li M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086371; Li X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.331; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Martineau Y, 2013, ONCOGENE, V32, P671, DOI 10.1038/onc.2012.116; No JH, 2011, GYNECOL ONCOL, V121, P8, DOI 10.1016/j.ygyno.2010.12.364; Rojo F, 2007, CLIN CANCER RES, V13, P81, DOI 10.1158/1078-0432.CCR-06-1560; Scheper GC, 1997, J BIOL CHEM, V272, P26850, DOI 10.1074/jbc.272.43.26850; Spilka R, 2014, CELL ONCOL, V37, P253, DOI 10.1007/s13402-014-0181-9; Spilka R, 2012, J ONCOL, V2012, DOI 10.1155/2012/901956; Spilka R, 2013, CANCER LETT, V340, P9, DOI 10.1016/j.canlet.2013.06.019; Thoreen CC, 2013, BIOCHEM SOC T, V41, P913, DOI 10.1042/BST20130082; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Wang CM, 2013, CELL CYCLE, V12, P1999, DOI 10.4161/cc.25099; Weng QJ, 2011, INVEST NEW DRUG, V29, P1177, DOI 10.1007/s10637-010-9462-y; Zender L, 2010, J HEPATOL, V52, P921, DOI 10.1016/j.jhep.2009.12.034	31	19	19	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117493	10.1371/journal.pone.0117493	http://dx.doi.org/10.1371/journal.pone.0117493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658620	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900163
J	Chen, L; Qin, BC; Du, MQ; Zhong, HZ; Xu, QA; Li, YH; Zhang, P; Fan, MW				Chen, Lin; Qin, Bingcai; Du, Minquan; Zhong, Huanzi; Xu, Qingan; Li, Yuhong; Zhang, Ping; Fan, Mingwen			Extensive Description and Comparison of Human Supra-Gingival Microbiome in Root Caries and Health	PLOS ONE			English	Article							SURFACE CARIES; STREPTOCOCCUS-MUTANS; BACTERIAL; FLORA	Knowledge of the polymicrobial etiology of root caries is limited. To conduct a comprehensive research study on root caries, we utilized 454-pyrosequencing of 16S rRNA gene libraries and quantitative PCR to compare supra-gingival bacterial communities from healthy sites and carious sites of 21 patients with root caries (Patient-controls and Patient-cases) and the sites of 21 healthy individuals (Healthy-controls) from two nursing homes. Healthy-controls and Patient-cases showed no significant differences in terms of biomass, species richness, and species diversity. However, as for beta diversity based on either community membership metric (unweighted UniFrac) or community structure metric (weighted UniFrac), Healthy-controls and Patient-cases were clearly distinguished from each other, appearing more variable in the community membership and structure in root caries microbiome but relatively conserved in the health microbiome. The Patient-controls group was at an intermediate stage between Healthy-controls and Patient-cases, but was more inclined to the former. Demonstrated in both relative abundance and prevalence of species in health and root caries, Propionibacterium acidifaciens, Streptococcus mutans, Olsenella profusa, Prevotella multisaccharivorax, and Lactobacillus crispatus were found to be most associated with root caries, whereas Delftia acidovorans, Bacteroidetes[G-2] sp., Lachnospiraceae[G-3] sp., and Prevotella intermedia are most associated with health. Our study provides a basis for further elucidating the microbial etiology of root caries in the elderly.	[Chen, Lin; Du, Minquan; Xu, Qingan; Li, Yuhong; Fan, Mingwen] Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Sch & Hosp Stomatol, Minist Educ, Wuhan 430072, Peoples R China; [Chen, Lin; Du, Minquan; Xu, Qingan; Li, Yuhong; Fan, Mingwen] Wuhan Univ, Key Lab Oral Microbiol, Sch & Hosp Stomatol, Minist Educ, Wuhan 430072, Peoples R China; [Chen, Lin] Southern Med Univ, Guangdong Prov Stomatol Hosp, Dept Endodont, Guangzhou, Guangdong, Peoples R China; [Qin, Bingcai; Zhong, Huanzi] BGI Shenzhen, Shenzhen, Peoples R China; [Du, Minquan] Wuhan Univ, Sch & Hosp Stomatol, Dept Prevent, Wuhan 430072, Peoples R China; [Xu, Qingan] Wuhan Univ, Sch & Hosp Stomatol, Dept Endodont, Wuhan 430072, Peoples R China; [Zhang, Ping] Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL 35233 USA	Wuhan University; Wuhan University; Southern Medical University - China; Beijing Genomics Institute (BGI); Wuhan University; Wuhan University; University of Alabama System; University of Alabama Birmingham	Zhang, P (corresponding author), Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL 35233 USA.	pingz@uab.edu; fmw@whuss.com	Li, yu/HHZ-5236-2022; li, yu/HGL-9518-2022; Du, Min Quan/V-7359-2018; li, Yu/HCI-9086-2022	Du, Min Quan/0000-0002-5043-9981; Zhang, Ping/0000-0002-4585-9893	Department of Public Heath, P. R. China [201002017]; Research Fund for the Doctoral Program of Higher Education of China [30973312, 20110141130008]; MOST Program of International ST Cooperation [2011DFA33220]; Shenzhen Engineering Laboratory for Clinical Molecular Diagnostic	Department of Public Heath, P. R. China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); MOST Program of International ST Cooperation; Shenzhen Engineering Laboratory for Clinical Molecular Diagnostic	This research was supported financially by Grant No. 201002017 from Department of Public Heath, P. R. China, Grant No. 30973312 from Grant No. 20110141130008 from Research Fund for the Doctoral Program of Higher Education of China, and the MOST Program of International S&T Cooperation (2011DFA33220), Shenzhen Engineering Laboratory for Clinical Molecular Diagnostic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Beighton D, 2005, COMMUNITY DENT ORAL, V33, P248, DOI 10.1111/j.1600-0528.2005.00232.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Du MQ, 2009, COMMUNITY DENT ORAL, V37, P260, DOI 10.1111/j.1600-0528.2009.00461.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ELLEN RP, 1985, J DENT RES, V64, P1245, DOI 10.1177/00220345850640101301; ELLEN RP, 1985, J DENT RES, V64, P1377, DOI 10.1177/00220345850640121001; Li Y, 2005, J DENT RES, V84, P559, DOI 10.1177/154405910508400614; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Marsh P D, 1994, Adv Dent Res, V8, P263; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Marsh PD, 2009, ORAL MICROBIOLOGY TE; Marsh Philip D, 2006, BMC Oral Health, V6 Suppl 1, pS14, DOI 10.1186/1472-6831-6-S1-S14; Papone Yorio V, 1989, Odontoestomatologia, V2, P47; Preza D, 2008, J CLIN MICROBIOL, V46, P2015, DOI 10.1128/JCM.02411-07; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rocas IN, 2009, J ENDODONT, V35, P1359, DOI 10.1016/j.joen.2009.05.033; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schupbach P, 1996, CARIES RES, V30, P52, DOI 10.1159/000262137; Shen S, 2002, ORAL DIS, V8, P207, DOI 10.1034/j.1601-0825.2002.01796.x; VANHOUTE J, 1994, J DENT RES, V73, P1727, DOI 10.1177/00220345940730110801; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; WHO (World Health Organization), 1997, DET AIRB FIB NUMB CO, P53; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71	24	40	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117064	10.1371/journal.pone.0117064	http://dx.doi.org/10.1371/journal.pone.0117064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658087	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900097
J	Hegde, A; Strachan, RT; Walker, JKL				Hegde, Akhil; Strachan, Ryan T.; Walker, Julia K. L.			Quantification of Beta Adrenergic Receptor Subtypes in Beta-Arrestin Knockout Mouse Airways	PLOS ONE			English	Article							SMOOTH-MUSCLE; GUINEA-PIG; AUTORADIOGRAPHIC LOCALIZATION; I-125 IODOCYANOPINDOLOL; ADRENOCEPTOR SUBTYPES; RADIOLIGAND BINDING; ASTHMA PHENOTYPE; ISOLATED TRACHEA; MURINE MODEL; HUMAN-LUNG	In allergic asthma Beta 2 adrenergic receptors (beta(2)ARs) are important mediators of bronch-orelaxation and, paradoxically, asthma development. This contradiction is likely due to the activation of dual signaling pathways that are downstream of G proteins or beta-arrestins. Our group has recently shown that beta-arrestin-2 acts in its classical role to desensitize and constrain beta(2)AR-induced relaxation of both human and murine airway smooth muscle. To assess the role of beta-arrestins in regulating beta(2)AR function in asthma, we and others have utilized beta-arrestin-1 and -2 knockout mice. However, it is unknown if genetic deletion of beta-arrestins in these mice influences beta(2)AR expression in the airways. Furthermore, there is lack of data on compensatory expression of beta AR subtypes when either of the beta-arrestins is genetically deleted, thus necessitating a detailed beta AR subtype expression study in these beta-arrestin knockout mice. Here we standardized a radioligand binding methodology to characterize and quantitate beta AR subtype distribution in the airway smooth muscle of wild-type C57BL/6J and beta-arrestin-1 and beta-arrestin-2 knockout mice. Using complementary competition and single-point saturation binding assays we found that beta(2)ARs predominate over beta(1)ARs in the whole lung and epithelium-denuded tracheobronchial smooth muscle of C57BL/6J mice. Quantification of beta AR subtypes in beta-arrestin-1 and beta-arrestin-2 knockout mouse lung and epithelium-denuded tracheobronchial tissue showed that, similar to the C57BL/6J mice, both knockouts display a predominance of beta(2)AR expression. These data provide further evidence that beta(2)ARs are expressed in greater abundance than beta(1)ARs in the tracheobronchial smooth muscle and that loss of either beta-arrestin does not significantly affect the expression or relative proportions of beta(2)AR subtypes. As beta-arrestins are known to modulate beta(2)AR function, our analysis of beta AR subtype expression in beta-arrestin knockout mice airways sets a reference point for future studies exploiting these knockout mice in various disease models including asthma.	[Hegde, Akhil; Walker, Julia K. L.] Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC 27708 USA; [Strachan, Ryan T.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Strachan, Ryan T.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University	Walker, JKL (corresponding author), Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC 27708 USA.	walke082@mc.duke.edu			National Institutes of Health (NIH) [HL084123, HL093103]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084123, R01HL093103] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) grants HL084123 and HL093103 to JKLW. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abisheganaden J, 1998, AM J MED, V104, P494; Abraham G, 2003, BIOCHEM PHARMACOL, V66, P1067, DOI 10.1016/S0006-2952(03)00460-X; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; BARNES PJ, 1983, J PHARMACOL EXP THER, V225, P456; Black JL, 2009, CLIN EXP ALLERGY, V39, P962, DOI 10.1111/j.1365-2222.2009.03270.x; CARSTAIRS JR, 1985, AM REV RESPIR DIS, V132, P541; CARSWELL H, 1983, BRIT J PHARMACOL, V79, P965, DOI 10.1111/j.1476-5381.1983.tb10542.x; Davenport A.P., 1996, CURRENT DIRECTIONS R, P169, DOI DOI 10.1007/978-94-009-1768-2_11; DELEAN A, 1982, MOL PHARMACOL, V21, P5; Deng HY, 2012, PHARMACOLOGY, V89, P211, DOI 10.1159/000337184; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; ENGEL G, 1981, POSTGRAD MED J, V57, P77; FINKEL MS, 1984, PHARMACOLOGY, V29, P247, DOI 10.1159/000138020; GOLDIE RG, 1986, EUR J PHARMACOL, V124, P179, DOI 10.1016/0014-2999(86)90141-X; GOLDIE RG, 1986, BRIT J PHARMACOL, V87, P5, DOI 10.1111/j.1476-5381.1986.tb10150.x; GOLDIE RG, 1986, BRIT J PHARMACOL, V88, P621, DOI 10.1111/j.1476-5381.1986.tb10243.x; HENRY PJ, 1990, BRIT J PHARMACOL, V99, P136, DOI 10.1111/j.1476-5381.1990.tb14667.x; HENRY PJ, 1990, BRIT J PHARMACOL, V99, P131, DOI 10.1111/j.1476-5381.1990.tb14666.x; Ikeda T, 2012, BRIT J PHARMACOL, V166, P1804, DOI 10.1111/j.1476-5381.2012.01881.x; Kenakin T, 2009, PHARMACOLOGY PRIMER: THEORY, APPLICATIONS, AND METHODS, 3RD EDITION, pXV, DOI 10.1016/B978-0-12-374585-9.00017-7; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lin R, 2012, BRIT J PHARMACOL, V165, P2365, DOI 10.1111/j.1476-5381.2011.01725.x; Luttrell LM, 2002, J CELL SCI, V115, P455; MINNEMAN KP, 1979, MOL PHARMACOL, V16, P34; Nguyen LP, 2009, P NATL ACAD SCI USA, V106, P2435, DOI 10.1073/pnas.0810902106; OTA A, 1993, NEUROSCI LETT, V160, P96, DOI 10.1016/0304-3940(93)90922-8; Penn Raymond B, 2014, Handb Exp Pharmacol, V219, P387, DOI 10.1007/978-3-642-41199-1_20; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Spina D, 2014, CURR OPIN PULM MED, V20, P73, DOI 10.1097/MCP.0000000000000012; Thanawala VJ, 2013, AM J RESP CELL MOL, V48, P220, DOI 10.1165/rcmb.2012-0364OC; Walker JKL, 2011, BRIT J PHARMACOL, V163, P18, DOI 10.1111/j.1476-5381.2010.01178.x; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; Zuyderduyn S, 2008, EUR RESPIR J, V32, P265, DOI 10.1183/09031936.00051407	35	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116458	10.1371/journal.pone.0116458	http://dx.doi.org/10.1371/journal.pone.0116458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658948	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900040
J	Huang, MG; Sannaningaiah, D; Zhao, N; Gong, YQ; Grondolsky, J; Hoover-Plow, J				Huang, Menggui; Sannaningaiah, Devaraja; Zhao, Nan; Gong, Yanqing; Grondolsky, Jessica; Hoover-Plow, Jane			EMILIN2 Regulates Platelet Activation, Thrombus Formation, and Clot Retraction	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; ELASTIC FIBERS; BLOOD-PRESSURE; HEART-FAILURE; MOUSE MODELS; DOMAIN; INTEGRIN; MICE; ALPHA-IIB-BETA-3; HEMOSTASIS	Thrombosis, like other cardiovascular diseases, has a strong genetic component, with largely unknown determinants. EMILIN2, Elastin Microfibril Interface Located Protein2, was identified as a candidate gene for thrombosis in mouse and human quantitative trait loci studies. EMILIN2 is expressed during cardiovascular development, on cardiac stem cells, and in heart tissue in animal models of heart disease. In humans, the EMILIN2 gene is located on the short arm of Chromosome 18, and patients with partial and complete deletion of this chromosome region have cardiac malformations. To understand the basis for the thrombotic risk associated with EMILIN2, EMILIN2 deficient mice were generated. The findings of this study indicate that EMILIN2 influences platelet aggregation induced by adenosine diphosphate, collagen, and thrombin with both EMILIN2-deficient platelets and EMILIN2-deficient plasma contributing to the impaired aggregation response. Purified EMILIN2 added to platelets accelerated platelet aggregation and reduced clotting time when added to EMILIN2-deficient mouse and human plasma. Carotid occlusion time was 2-fold longer in mice with platelet-specific EMILIN2 deficiency, but stability of the clot was reduced in mice with both global EMILIN2 deficiency and with platelet-specific EMILIN2 deficiency. In vitro clot retraction was markedly decreased in EMILIN2 deficient mice, indicating that platelet outside-in signaling was dependent on EMILIN2. EMILIN1 deficient mice and EMILIN2: EMILIN1 double deficient mice had suppressed platelet aggregation and delayed clot retraction similar to EMILIN2 mice, but EMILIN2 and EMILIN1 had opposing affects on clot retraction, suggesting that EMILIN1 may attenuate the effects of EMILIN2 on platelet aggregation and thrombosis. In conclusion, these studies identify multiple influences of EMILIN2 in pathophysiology and suggest that its role as a prothrombotic risk factor may arise from its effects on platelet aggregation and platelet mediated clot retraction.	[Huang, Menggui; Sannaningaiah, Devaraja; Zhao, Nan; Gong, Yanqing; Grondolsky, Jessica; Hoover-Plow, Jane] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Hoover-Plow, J (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA.	hooverj@ccf.org		, Menggui/0000-0002-4942-5558	National Institutes of Health, National Heart, Lung, and Blood Institute [R01HL065204, R01HL17964]; University Grants Commission, Bahadur Shah Zafar Marg, New Delhi, India; American Heart Association [09BGIA2050157, 12SDG9050018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, R01HL065204, R01HL017964] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University Grants Commission, Bahadur Shah Zafar Marg, New Delhi, India(University Grants Commission, India); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by grants from the National Institutes of Health, National Heart, Lung, and Blood Institute, R01HL065204 and R01HL17964, (JHP), University Grants Commission, Bahadur Shah Zafar Marg, New Delhi-110 002, India, DS, and American Heart Association (09BGIA2050157 and 12SDG9050018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmeier W, 2014, THROMB RES, V133, pS3, DOI 10.1016/j.thromres.2014.03.002; BRESSAN GM, 1993, J CELL BIOL, V121, P201, DOI 10.1083/jcb.121.1.201; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Colombatti A, 2000, MATRIX BIOL, V19, P289, DOI 10.1016/S0945-053X(00)00074-3; Colombatti A, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00093; Doliana R, 2001, J BIOL CHEM, V276, P12003, DOI 10.1074/jbc.M011591200; Doliana R, 2000, FEBS LETT, V484, P164, DOI 10.1016/S0014-5793(00)02140-2; Flierl U, 2013, PHARMACOL RES, V74, P49, DOI 10.1016/j.phrs.2013.05.002; Godyna S, 1996, BLOOD, V88, P2569, DOI 10.1182/blood.V88.7.2569.bloodjournal8872569; Guthikonda S, 2008, THROMB HAEMOSTASIS, V100, P83, DOI 10.1160/TH07-10-0590; Hamirani YS, 2012, CIRCULATION, V126, P1121, DOI 10.1161/CIRCULATIONAHA.112.113993; HAYWARD CPM, 1993, J CLIN INVEST, V91, P2630, DOI 10.1172/JCI116502; Hildemann SK, 2014, THROMB HAEMOSTASIS, V111, P725, DOI 10.1160/TH13-08-0640; Hoover-Plow Jane, 2006, BMC Blood Disord, V6, P6, DOI 10.1186/1471-2326-6-6; Hubmacher D, 2013, CURR OPIN RHEUMATOL, V25, P65, DOI 10.1097/BOR.0b013e32835b137b; Jug B, 2009, INT HEART J, V50, P591, DOI 10.1536/ihj.50.591; Kauskot A, 2012, BLOOD, V119, P4056, DOI 10.1182/blood-2011-11-392787; Kielty CM, 2002, J CELL SCI, V115, P2817; Litteri G, 2012, ARTERIOSCL THROM VAS, V32, P2178, DOI 10.1161/ATVBAHA.112.254664; Nieswandt B, 2005, J THROMB HAEMOST, V3, P1725, DOI 10.1111/j.1538-7836.2005.01488.x; Ninivaggi M, 2014, THROMB HAEMOSTASIS, V111, P447, DOI 10.1160/TH13-06-0493; Robertson I, 2011, BIOCHEM J, V433, P263, DOI 10.1042/BJ20101320; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Sa Q, 2008, MAMM GENOME, V19, P406, DOI 10.1007/s00335-008-9122-0; Sa Q, 2011, THROMB J, V9, DOI 10.1186/1477-9560-9-9; Sa Q, 2010, MAMM GENOME, V21, P337, DOI 10.1007/s00335-010-9274-6; Soria JM, 2003, BLOOD, V101, P163, DOI 10.1182/blood-2002-06-1792; Spessotto P, 2003, J BIOL CHEM, V278, P6160, DOI 10.1074/jbc.M208322200; Stissing T, 2011, CLIN APPL THROMB-HEM, V17, pE211, DOI 10.1177/1076029610397183; TRAN H, 1995, J BIOL CHEM, V270, P19458, DOI 10.1074/jbc.270.33.19458; Tymvios C, 2008, THROMB HAEMOSTASIS, V99, P435, DOI 10.1160/TH07-07-0479; Verdone G, 2008, J BIOL CHEM, V283, P18947, DOI 10.1074/jbc.M801085200; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; Werneck CC, 2008, BLOOD, V111, P4137, DOI 10.1182/blood-2007-07-101733; Xu Z, 2014, ARTERIOSCL THROM VAS, V34, P1961, DOI 10.1161/ATVBAHA.114.303851; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035; Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004	39	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115284	10.1371/journal.pone.0115284	http://dx.doi.org/10.1371/journal.pone.0115284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658937	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900013
J	Joosten, H; Visser, ST; van Eersel, ME; Gansevoort, RT; Bilo, HJG				Joosten, H.; Visser, S. T.; van Eersel, M. E.; Gansevoort, R. T.; Bilo, H. J. G.			Statin Use and Cognitive Function: Population-Based Observational Study with Long-Term Follow-Up (vol 9, e115755, 2014)	PLOS ONE			English	Correction													Izaks, Gerbrand/F-5089-2014	Izaks, Gerbrand/0000-0003-3213-7637				Joosten H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115755	1	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118045	10.1371/journal.pone.0118045	http://dx.doi.org/10.1371/journal.pone.0118045			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658695	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900254
J	Li, GB; Shan, CY; Liu, L; Zhou, T; Zhou, J; Hu, XY; Chen, YB; Cui, HJ; Gao, N				Li, Guobing; Shan, Changyu; Liu, Lei; Zhou, Ting; Zhou, Jing; Hu, Xiaoye; Chen, Yibiao; Cui, Hongjuan; Gao, Ning			Tanshinone IIA Inhibits HIF-1 alpha and VEGF Expression in Breast Cancer Cells via mTOR/p70S6K/RPS6/4E-BP1 Signaling Pathway	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ENDOTHELIAL GROWTH-FACTOR; UNFAVORABLE PROGNOSIS; GENE-EXPRESSION; ANGIOGENESIS; OVEREXPRESSION; PROGRESSION; MECHANISMS; BIOLOGY; MTOR	Hypoxia-inducible factor 1 alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF) play important roles in angiogenesis and tumor growth. Tanshinone IIA (T2A) is a novel antiangiogenic agent with promising antitumor effects; however, the molecular mechanism underlying the antiangiogenic effects of T2A remains unclear. In the present study, we provided evidence showing that T2A inhibited angiogenesis and breast cancer growth by down-regulating VEGF expression. Specifically, T2A repressed HIF-1 alpha expression at the translational level and inhibited the transcriptional activity of HIF-1 alpha, which led to the down-regulation of VEGF expression. Suppression of HIF-1 alpha synthesis by T2A correlated with strong dephosphorylation of mammalian target of rapamycin (mTOR) and its effectors ribosomal protein S6 kinase (p70S6K) and eukaryotic initiation factor 4E-binding protein-1 (4E-BP1), a pathway regulating HIF-1 alpha expression at the translational level. In addition, we also found that T2A inhibited the angiogenesis and growth of human breast cancer xenografts in nude mice through suppression of HIF-1 alpha and VEGF. Our study provides novel perspectives and potential targets for the treatment of human breast cancer.	[Li, Guobing; Shan, Changyu; Liu, Lei; Zhou, Ting; Zhou, Jing; Hu, Xiaoye; Gao, Ning] Third Mil Med Univ, Coll Pharm, Chongqing, Peoples R China; [Chen, Yibiao; Cui, Hongjuan] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Army Medical University; Southwest University - China	Gao, N (corresponding author), Third Mil Med Univ, Coll Pharm, Chongqing, Peoples R China.	gaoning59@163.com			Chongqing Natural Science Foundation [CSTC2013jjB10007]; National Natural Science Foundation of China [81402970]; State Key Laboratory of Silkworm Genome Biology, Southwest University [2013024]	Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Silkworm Genome Biology, Southwest University	This work was supported by Chongqing Natural Science Foundation (CSTC2013jjB10007), the National Natural Science Foundation of China (No. 81402970), and the Open Project Program of State Key Laboratory of Silkworm Genome Biology, Southwest University (2013024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Boudreau N, 2003, BREAST CANCER RES, V5, P140, DOI 10.1186/bcr589; Chakraborty G, 2006, J BIOL CHEM, V281, P11322, DOI 10.1074/jbc.M512546200; Chekhonin VP, 2013, CURR CANCER DRUG TAR, V13, P423, DOI 10.2174/15680096113139990074; Chen CT, 2012, MOL CANCER THER, V11, P2212, DOI 10.1158/1535-7163.MCT-12-0180; Duong MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002538; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gao S, 2012, ATHEROSCLEROSIS, V220, P3, DOI 10.1016/j.atherosclerosis.2011.06.041; Garcia-Maceira P, 2009, ONCOGENE, V28, P313, DOI 10.1038/onc.2008.398; GOLDBERG MA, 1994, J BIOL CHEM, V269, P4355; Gong Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033656; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kakeya Hideaki, 2004, Nihon Rinsho, V62, P1264; Li G, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.7; Li XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043918; Longo Flavia, 2006, Tumori, V92, P1; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Maxwell PH, 2002, SEMIN CELL DEV BIOL, V13, P29, DOI 10.1006/scdb.2001.0287; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Miller KD, 2004, HEMATOL ONCOL CLIN N, V18, P1071, DOI 10.1016/j.hoc.2004.06.010; Montero JC, 2014, ONCOGENE, V33, P148, DOI 10.1038/onc.2012.572; Rankin EB, 2012, CELL, V149, P63, DOI 10.1016/j.cell.2012.01.051; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schwarzlose-Schwarck S, 2012, ANTICANCER RES, V32, P3435; Shibaji T, 2003, ANTICANCER RES, V23, P4721; Su CC, 2008, INT J MOL MED, V22, P357, DOI 10.3892/ijmm_00000030; Sumiyoshi Y, 2006, CLIN CANCER RES, V12, P5112, DOI 10.1158/1078-0432.CCR-05-2382; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Tsai MY, 2011, CANCER LETT, V310, P198, DOI 10.1016/j.canlet.2011.06.031; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; Van den Eynden GG, 2008, CLIN CANCER RES, V14, P2944, DOI 10.1158/1078-0432.CCR-07-4397; Vaupel P, 2005, ADV EXP MED BIOL, V566, P333; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang XH, 2007, MED RES REV, V27, P133, DOI 10.1002/med.20077; Wang XJ, 2005, INT J CANCER, V116, P799, DOI 10.1002/ijc.20880; Zhong Q, 2012, STEM CELLS DEV, V21, P2703, DOI 10.1089/scd.2011.0604	42	76	87	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117440	10.1371/journal.pone.0117440	http://dx.doi.org/10.1371/journal.pone.0117440			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659153	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900150
J	Verloop, WL; Beeftink, MMA; Santema, BT; Bots, ML; Blankestijn, PJ; Cramer, MJ; Doevendans, PA; Voskuil, M				Verloop, Willemien L.; Beeftink, Martine M. A.; Santema, Bernadet T.; Bots, Michiel L.; Blankestijn, Peter J.; Cramer, Maarten J.; Doevendans, Pieter A.; Voskuil, Michiel			A Systematic Review Concerning the Relation between the Sympathetic Nervous System and Heart Failure with Preserved Left Ventricular Ejection Fraction	PLOS ONE			English	Review							BETA-ADRENERGIC STIMULATION; DIASTOLIC DYSFUNCTION; EXERCISE CAPACITY; CARDIOVASCULAR CONTROL; CARDIAC-HYPERTROPHY; EUROPEAN-SOCIETY; TASK-FORCE; DIAGNOSIS; HYPERTENSION; SPIRONOLACTONE	Background Heart failure with preserved left ventricular ejection fraction (HFPEF) affects about half of all patients diagnosed with heart failure. The pathophysiological aspect of this complex disease state has been extensively explored, yet it is still not fully understood. Since the sympathetic nervous system is related to the development of systolic HF, we hypothesized that an increased sympathetic nerve activation (SNA) is also related to the development of HFPEF. This review summarizes the available literature regarding the relation between HFPEF and SNA. Methods and Results Electronic databases and reference lists through April 2014 were searched resulting in 7722 unique articles. Three authors independently evaluated citation titles and abstracts, resulting in 77 articles reporting about the role of the sympathetic nervous system and HFPEF. Of these 77 articles, 15 were included for critical appraisal: 6 animal and 9 human studies. Based on the critical appraisal, we selected 9 articles (3 animal, 6 human) for further analysis. In all the animal studies, isoproterenol was administered to mimic an increased sympathetic activity. In human studies, different modalities for assessment of sympathetic activity were used. The studies selected for further evaluation reported a clear relation between HFPEF and SNA. Conclusion Current literature confirms a relation between increased SNA and HFPEF. However, current literature is not able to distinguish whether enhanced SNA results in HFPEF, or HFPEF results in enhanced SNA. The most likely setting is a vicious circle in which HFPEF and SNA sustain each other.	[Verloop, Willemien L.; Beeftink, Martine M. A.; Santema, Bernadet T.; Cramer, Maarten J.; Doevendans, Pieter A.; Voskuil, Michiel] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Blankestijn, Peter J.] Univ Med Ctr Utrecht, Dept Nephrol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Voskuil, M (corresponding author), Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands.	m.voskuil@umcutrecht.nl						Arora R, 2004, PACE, V27, P299, DOI 10.1111/j.1540-8159.2004.00431.x; Borlaug BA, 2006, CIRCULATION, V114, P2138, DOI 10.1161/CIRCULATIONAHA.106.632745; Borlaug BA, 2011, CIRCULATION, V123, P2006, DOI 10.1161/CIRCULATIONAHA.110.954388; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Brandt MC, 2012, J AM COLL CARDIOL, V59, P901, DOI 10.1016/j.jacc.2011.11.034; Bronzwaer Jean G F, 2009, Curr Heart Fail Rep, V6, P281; Brooks WW, 2009, COMPARATIVE MED, V59, P339; Buss SJ, 2006, ENDOCRINOLOGY, V147, P2526, DOI 10.1210/en.2005-1167; Cacciapuoti F, 2011, J AM SOC HYPERTENS, V5, P449, DOI 10.1016/j.jash.2011.08.006; de Souza SBC, 2013, AM J HYPERTENS, V26, P912, DOI 10.1093/ajh/hpt032; Conraads VM, 2012, EUR J HEART FAIL, V14, P219, DOI 10.1093/eurjhf/hfr161; Daniel Kurt R, 2009, Congest Heart Fail, V15, P68, DOI 10.1111/j.1751-7133.2009.00056.x; de la Sierra A, 2014, J HUM HYPERTENS, V28, P416, DOI 10.1038/jhh.2013.135; Edelmann F, 2013, JAMA-J AM MED ASSOC, V309, P781, DOI 10.1001/jama.2013.905; Edelmann F, 2011, J AM COLL CARDIOL, V58, P1780, DOI 10.1016/j.jacc.2011.06.054; Eisenhofer G, 1996, CIRCULATION, V93, P1667, DOI 10.1161/01.CIR.93.9.1667; ESLER M, 1990, PHYSIOL REV, V70, P963, DOI 10.1152/physrev.1990.70.4.963; Fagius J, 1993, Clin Auton Res, V3, P201; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Grande MT, 2011, FREE RADICAL BIO MED, V51, P1831, DOI 10.1016/j.freeradbiomed.2011.08.014; GRASSI G, 1995, CIRCULATION, V92, P3206, DOI 10.1161/01.CIR.92.11.3206; Grassi G, 2009, HYPERTENSION, V53, P205, DOI 10.1161/HYPERTENSIONAHA.108.121467; Grimm D, 1998, CARDIOVASC RES, V37, P91, DOI 10.1016/S0008-6363(97)00212-5; Hilz MJ, 2006, MUSCLE NERVE, V33, P6, DOI 10.1002/mus.20365; Hirono O, 2001, Am Heart J, V142, pE11, DOI 10.1067/mhj.2001.118117; Hogg K, 2005, PROG CARDIOVASC DIS, V47, P357, DOI 10.1016/j.pcad.2005.02.001; Hubens LEG, 2013, CURR HYPERTENS REP, V15, P313, DOI 10.1007/s11906-013-0367-y; Kelm M, 1996, J HYPERTENS, V14, P1357, DOI 10.1097/00004872-199611000-00015; Klein IHHT, 2003, J AM SOC NEPHROL, V14, P425, DOI 10.1097/01.ASN.0000045049.72965.B7; Krishnamurthy P, 2007, HYPERTENSION, V49, P865, DOI 10.1161/01.HYP.0000258703.36986.13; LaCroix C, 2008, AM J PHYSIOL-HEART C, V294, pH810, DOI 10.1152/ajpheart.00724.2007; Leite-Moreira AF, 2006, HEART, V92, P712, DOI 10.1136/hrt.2005.062950; Levick SP, 2010, HYPERTENSION, V55, P270, DOI 10.1161/HYPERTENSIONAHA.109.142042; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Ma XW, 2011, SCI CHINA LIFE SCI, V54, P493, DOI 10.1007/s11427-011-4183-9; Mahadevan G, 2012, EUR J HEART FAIL, V14, P106, DOI 10.1093/eurjhf/hfr153; Malpas SC, 2010, PHYSIOL REV, V90, P513, DOI 10.1152/physrev.00007.2009; Mandinov L, 2000, CARDIOVASC RES, V45, P813, DOI 10.1016/S0008-6363(99)00399-5; MARMOR A, 1989, AM J MED, V87, pS61; Martin-Fernandez B, 2012, EXP PHYSIOL, V97, P710, DOI 10.1113/expphysiol.2011.063230; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Miyoshi T, 2012, EUR HEART J, V33, P117; Murray DR, 2000, CIRCULATION, V101, P2338, DOI 10.1161/01.CIR.101.20.2338; Nakata T, 2013, JACC-CARDIOVASC IMAG, V6, P772, DOI 10.1016/j.jcmg.2013.02.007; Nixdorff U, 1997, J CARDIOVASC PHARM, V29, P476, DOI 10.1097/00005344-199704000-00008; Patel AD, 2002, J NUCL CARDIOL, V9, P75, DOI 10.1067/mnc.2002.121471; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Persson H, 2007, J AM COLL CARDIOL, V49, P687, DOI 10.1016/j.jacc.2006.08.062; Piccirillo G, 2006, INT J CARDIOL, V110, P160, DOI 10.1016/j.ijcard.2005.06.041; Rosendorff C, 2009, HYPERTENSION, V53, P108, DOI 10.1161/HYPERTENSIONAHA.108.126177; Rutten Frans H, 2012, Ned Tijdschr Geneeskd, V156, pA5315; Seeland U, 2007, BASIC RES CARDIOL, V102, P183, DOI 10.1007/s00395-006-0635-y; Shah RV, 2010, J CARD FAIL, V16, P260, DOI 10.1016/j.cardfail.2009.11.007; Spyrou N, 2002, J AM COLL CARDIOL, V40, P1216, DOI 10.1016/S0735-1097(02)02162-9; Sugiura M, 2006, INT J CARDIOL, V113, P223, DOI 10.1016/j.ijcard.2005.11.017; Tsuchida Takaya, 2007, Journal of Nippon Medical School, V74, P114, DOI 10.1272/jnms.74.114; van Kraaij DJW, 2002, EUR J HEART FAIL, V4, P419, DOI 10.1016/S1388-9842(02)00020-X; van Veldhuisen DJ, 2009, J AM COLL CARDIOL, V53, P2150, DOI 10.1016/j.jacc.2009.02.046; Verschure DO, 2014, EUR HEART J-CARD IMG, V15, P996, DOI 10.1093/ehjci/jeu044; Vinch CS, 2003, AM J CARDIOL, V91, P1140, DOI 10.1016/S0002-9149(03)00170-X; Vink EE, 2013, CURR HYPERTENS REP, V15, P95, DOI 10.1007/s11906-013-0328-5; Wachter R, 2009, EUR HEART J, V30, P3027, DOI 10.1093/eurheartj/ehp341; Wright JW, 2008, HEART FAIL REV, V13, P367, DOI 10.1007/s10741-007-9060-z; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yoshikawa WS, 2013, CIRC J, V77, P741, DOI 10.1253/circj.CJ-12-0779; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Yuyama R, 2005, CLIN PHYSIOL FUNCT I, V25, P34, DOI 10.1111/j.1475-097X.2004.00571.x; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566; Zile MR, 2002, CIRCULATION, V105, P1503, DOI 10.1161/hc1202.105290	70	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117332	10.1371/journal.pone.0117332	http://dx.doi.org/10.1371/journal.pone.0117332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658630	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900136
J	Wen, JL; Wen, XF; Li, RB; Jin, YC; Wang, XL; Zhou, L; Chen, HX				Wen, Ji Ling; Wen, Xiao Fei; Li, Rong Bing; Jin, Yong Chao; Wang, Xue Lei; Zhou, Lan; Chen, Hui Xing			UBE3C Promotes Growth and Metastasis of Renal Cell Carcinoma via Activating Wnt/beta- Catenin Pathway	PLOS ONE			English	Article							E3 UBIQUITIN LIGASES; CANCER STATISTICS; BETA-CATENIN; HECT FAMILY; WNT; EXPRESSION; KIDNEY; DISEASE; GENE	Renal cell carcinoma (RCC) is the most common primary malignancy of the kidney and one of the most lethal genitourinary malignancies. Clear-cell renal cell carcinoma (ccRCC) has an extremely poor prognosis because of a high potential for tumor growth, vascular invasion, metastasis and recurrence. Unfortunately, the mechanism of RCC growth and metastasis is not well understood. In this report, we for the first time demonstrated ubiquitin protein ligase E3C (UBE3C) as a driving factor for RCC growth and metastasis. UBE3C expression was increased in ccRCC tissues compared with adjacent normal tissues. ccRCC patients with high UBE3C protein expression in tumors were associated with significantly worse postoperative survival. Knockdown of UBE3C expression in ACHN cells inhibited cell proliferation, migrations and invasiveness in vitro while overexpression of UBE3C in 786-O cells exerted the opposite effects. UBE3C up-regulated beta-catenin protein levels and promoted beta-catenin nuclear accumulation, leading to the activation of the Wnt/beta-catenin signal pathway in RCC cells. Collectively, these observations suggest that UBE3C plays an important role in RCC development and progression, and UBE3C may be a novel target for prevention and treatment of ccRCC.	[Wen, Ji Ling; Wen, Xiao Fei; Li, Rong Bing; Jin, Yong Chao; Wang, Xue Lei; Zhou, Lan; Chen, Hui Xing] Tongji Univ, Dept Urol, East Hosp, Sch Med, Shanghai 200120, Peoples R China	Tongji University	Wen, XF (corresponding author), Tongji Univ, Dept Urol, East Hosp, Sch Med, Shanghai 200120, Peoples R China.	wenxiaofei20140415@163.com						Anglesio MS, 2004, HUM MOL GENET, V13, P2061, DOI 10.1093/hmg/ddh215; Banumathy G, 2010, CANCER BIOL THER, V10, P658, DOI 10.4161/cbt.10.7.13247; Basel-Vanagaite L, 2012, AM J HUM GENET, V91, P998, DOI 10.1016/j.ajhg.2012.10.011; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bilim V, 2000, CLIN CANCER RES, V6, P460; Bruder E, 2007, MODERN PATHOL, V20, P1217, DOI 10.1038/modpathol.3800957; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Guillen-Ahlers H, 2008, CURR DRUG TARGETS, V9, P591, DOI 10.2174/138945008784911813; HERZLINGER D, 1994, DEV BIOL, V166, P815, DOI 10.1006/dbio.1994.1360; Janzen NK, 2003, UROL CLIN N AM, V30, P843, DOI 10.1016/S0094-0143(03)00056-9; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jiang JH, 2014, HEPATOLOGY, V59, P2216, DOI 10.1002/hep.27012; Katoh M, 2003, INT J ONCOL, V22, P209; Kim YS, 2000, PATHOL INT, V50, P725, DOI 10.1046/j.1440-1827.2000.01111.x; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Martinez-Salamanca JI, 2011, EUR UROL, V59, P120, DOI 10.1016/j.eururo.2010.10.001; Mashimo T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000784; Mccoy KE, 2011, DEV DYNAM, V240, P1558, DOI 10.1002/dvdy.22626; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Roberts DM, 2007, NAT STRUCT MOL BIOL, V14, P463, DOI 10.1038/nsmb0607-463; ROLFE M, 1995, P NATL ACAD SCI USA, V92, P3264, DOI 10.1073/pnas.92.8.3264; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Siegel R, 2012, CA-CANCER J CLIN, V62, DOI 10.3322/caac.21153; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Thevenod F, 2010, CURR MOL MED, V10, P387, DOI 10.2174/156652410791316986; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150	32	32	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115622	10.1371/journal.pone.0115622	http://dx.doi.org/10.1371/journal.pone.0115622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658088	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900025
J	Wu, HY; Han, Y; Yang, X; Chase, GG; Tang, Q; Lee, CJ; Cao, B; Zhe, J; Cheng, G				Wu, Haiyan; Han, Yu; Yang, Xi; Chase, George G.; Tang, Qiong; Lee, Chen-Jung; Cao, Bin; Zhe, Jiang; Cheng, Gang			A Versatile Microparticle-Based Immunoaggregation Assay for Macromolecular Biomarker Detection and Quantification	PLOS ONE			English	Article							IMMUNOSORBENT-ASSAY; BLOOD-PLASMA; BIOSENSOR; IMMUNOASSAY; PROTEIN; ENHANCEMENT; DISEASE; POINT	The rapid, sensitive and low-cost detection of macromolecular biomarkers is critical in clinical diagnostics, environmental monitoring, research, etc. Conventional assay methods usually require bulky, expensive and designated instruments and relative long assay time. For hospitals and laboratories that lack immediate access to analytical instruments, fast and low-cost assay methods for the detection of macromolecular biomarkers are urgently needed. In this work, we developed a versatile microparticle (MP)-based immunoaggregation method for the detection and quantification of macromolecular biomarkers. Antibodies (Abs) were firstly conjugated to MP through streptavidin-biotin interaction; the addition of macromolecular biomarkers caused the aggregation of Ab-MPs, which were subsequently detected by an optical microscope or optical particle sizer. The invisible nanometer-scale macromolecular biomarkers caused detectable change of micrometer-scale particle size distributions. Goat anti-rabbit immunoglobulin and human ferritin were used as model biomarkers to demonstrate MP-based immunoaggregation assay in PBS and 10% FBS to mimic real biomarker assay in the complex medium. It was found that both the number ratio and the volume ratio of Ab-MP aggregates caused by biomarker to all particles were directly correlated to the biomarker concentration. In addition, we found that the detection range could be tuned by adjusting the Ab-MP concentration. We envision that this novel MP-based immunoaggregation assay can be combined with multiple detection methods to detect and quantify macromolecular biomarkers at the nanogram per milliliter level.	[Wu, Haiyan; Yang, Xi; Chase, George G.; Tang, Qiong; Lee, Chen-Jung; Cao, Bin; Cheng, Gang] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA; [Han, Yu; Zhe, Jiang] Univ Akron, Dept Mech Engn, Akron, OH 44325 USA	University System of Ohio; University of Akron; University System of Ohio; University of Akron	Zhe, J (corresponding author), Univ Akron, Dept Mech Engn, Akron, OH 44325 USA.	jzhe@uakron.edu; gc@uakron.edu			National Science Foundation (NSF) [CMMI-1129727]; Directorate For Engineering [1129727] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The work was supported by the National Science Foundation (NSF CMMI-1129727).	Cao C, 2007, BIOSENS BIOELECTRON, V22, P1874, DOI 10.1016/j.bios.2006.07.021; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; Cui XQ, 2003, TALANTA, V60, P53, DOI 10.1016/S0039-9140(03)00043-2; Daniels JS, 2007, ELECTROANAL, V19, P1239, DOI 10.1002/elan.200603855; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Gubala V, 2012, ANAL CHEM, V84, P487, DOI 10.1021/ac2030199; Jebrail MJ, 2010, CURR OPIN CHEM BIOL, V14, P574, DOI 10.1016/j.cbpa.2010.06.187; Jokerst JV, 2009, BIOSENS BIOELECTRON, V24, P3622, DOI 10.1016/j.bios.2009.05.026; LEE MH, 1995, AM J MED, V98, P566, DOI 10.1016/S0002-9343(99)80015-1; Lequin RM, 2005, CLIN CHEM, V51, P2415, DOI 10.1373/clinchem.2005.051532; Moyo M, 2014, SENSOR ACTUAT B-CHEM, V193, P515, DOI 10.1016/j.snb.2013.11.086; Soper SA, 2006, BIOSENS BIOELECTRON, V21, P1932, DOI 10.1016/j.bios.2006.01.006; Su XD, 2001, CHEM COMMUN, P755, DOI 10.1039/b009768n; SUN S, 1992, J BIOL CHEM, V267, P25160; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Vaisocherova H, 2008, ANAL CHEM, V80, P7894, DOI 10.1021/ac8015888; Vaisocherova H, 2009, BIOSENS BIOELECTRON, V24, P1924, DOI 10.1016/j.bios.2008.09.035; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Yang W, 2011, BIOSENS BIOELECTRON, V26, P2454, DOI 10.1016/j.bios.2010.10.031; Zhang WY, 2014, TRAC-TREND ANAL CHEM, V54, P1, DOI 10.1016/j.trac.2013.10.007	20	39	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115046	10.1371/journal.pone.0115046	http://dx.doi.org/10.1371/journal.pone.0115046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658837	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900012
J	Wu, ZQ; Tembrock, LR; Ge, S				Wu, Zhiqiang; Tembrock, Luke R.; Ge, Song			Are Differences in Genomic Data Sets due to True Biological Variants or Errors in Genome Assembly: An Example from Two Chloroplast Genomes	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; GENE ORGANIZATION; DNA; SEQUENCE; INDELS; DIVERSIFICATION; IDENTIFICATION; TRANSFORMATION; CHALLENGES; EVOLUTION	DNA sequencing has been revolutionized by the development of high-throughput sequencing technologies. Plummeting costs and the massive throughput capacities of second and third generation sequencing platforms have transformed many fields of biological research. Concurrently, new data processing pipelines made rapid de novo genome assemblies possible. However, high quality data are critically important for all investigations in the genomic era. We used chloroplast genomes of one Oryza species (O. australiensis) to compare differences in sequence quality: one genome (GU592209) was obtained through Illumina sequencing and reference-guided assembly and the other genome (KJ830774) was obtained via target enrichment libraries and shotgun sequencing. Based on the whole genome alignment, GU592209 was more similar to the reference genome (O. sativa: AY522330) with 99.2% sequence identity (SI value) compared with the 98.8% SI values in the KJ830774 genome; whereas the opposite result was obtained when the SI values in coding and noncoding regions of GU592209 and KJ830774 were compared. Additionally, the junctions of two single copies and repeat copies in the chloroplast genome exhibited differences. Phylogenetic analyses were conducted using these sequences, and the different data sets yielded dissimilar topologies: phylogenetic replacements of the two individuals were remarkably different based on whole genome sequencing or SNP data and insertions and deletions (indels) data. Thus, we concluded that the genomic composition of GU592209 was heterogeneous in coding and non-coding regions. These findings should impel biologists to carefully consider the quality of sequencing and assembly when working with next-generation data.	[Wu, Zhiqiang; Ge, Song] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Wu, Zhiqiang; Tembrock, Luke R.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Colorado State University	Wu, ZQ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	wu.zhiqiang.1020@gmail.com	Wu, Zhiqiang/CAG-6688-2022; , wuzhiqiang/C-7843-2017	Wu, Zhiqiang/0000-0002-4238-7317; , wuzhiqiang/0000-0002-4238-7317	National Natural Science Foundation of China [30990240]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30990240). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Ball EV, 2005, HUM MUTAT, V26, P205, DOI 10.1002/humu.20212; Bayly MJ, 2013, MOL PHYLOGENET EVOL, V69, P704, DOI 10.1016/j.ympev.2013.07.006; Bock R, 2007, CURR OPIN BIOTECH, V18, P100, DOI 10.1016/j.copbio.2006.12.001; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Cheng L, 2010, PLANT CELL REP, V29, P371, DOI 10.1007/s00299-010-0828-6; COLLINS FS, 1987, SCIENCE, V235, P1046, DOI 10.1126/science.2950591; Cui CJ, 2011, ACTA BIOCH BIOPH SIN, V43, P284, DOI 10.1093/abbs/gmr008; Day A, 2011, PLANT BIOTECHNOL J, V9, P540, DOI 10.1111/j.1467-7652.2011.00604.x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Graham SW, 2000, INT J PLANT SCI, V161, pS83, DOI 10.1086/317583; Grimm D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-132; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Ingvarsson PK, 2003, MOL BIOL EVOL, V20, P1737, DOI 10.1093/molbev/msg163; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kelchner SA, 2000, ANN MO BOT GARD, V87, P482, DOI 10.2307/2666142; Krawitz P, 2010, BIOINFORMATICS, V26, P722, DOI 10.1093/bioinformatics/btq027; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Ledford H, 2008, NATURE, V451, P616, DOI 10.1038/451616b; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li ST, 2013, GENOME RES, V23, P195, DOI 10.1101/gr.132480.111; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lu BR, 2009, PROG NAT SCI-MATER, V19, P1241, DOI 10.1016/j.pnsc.2009.01.011; Lunter G, 2006, PLOS COMPUT BIOL, V2, P2, DOI 10.1371/journal.pcbi.0020005; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mahmud MP, 2012, BIOINFORMATICS, V28, pI325, DOI 10.1093/bioinformatics/bts380; Masood MS, 2004, GENE, V340, P133, DOI 10.1016/j.gene.2004.06.008; Meader S, 2010, GENOME RES, V20, P675, DOI 10.1101/gr.096966.109; Meyers B, 2010, BIOTECHNOL ADV, V28, P747, DOI 10.1016/j.biotechadv.2010.05.022; Middleton CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085761; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Nock CJ, 2011, PLANT BIOTECHNOL J, V9, P328, DOI 10.1111/j.1467-7652.2010.00558.x; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; PALMER JD, 1985, ANNU REV GENET, V19, P325, DOI 10.1146/annurev.ge.19.120185.001545; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schatz MC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-243; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Steele PR, 2012, AM J BOT, V99, P330, DOI 10.3732/ajb.1100491; Sugiura M, 2003, PHOTOSYNTH RES, V76, P371, DOI 10.1023/A:1024913304263; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Vali U, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-8; Wang L, 2010, MOL PHYLOGENET EVOL, V54, P211, DOI 10.1016/j.ympev.2009.08.032; Wang L, 2010, BOT J LINN SOC, V162, P28, DOI 10.1111/j.1095-8339.2009.01018.x; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Waters DLE, 2012, ECOL EVOL, V2, P211, DOI 10.1002/ece3.66; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wu ZQ, 2012, MOL PHYLOGENET EVOL, V62, P573, DOI 10.1016/j.ympev.2011.10.019; Wu ZQ, 2016, MITOCHONDRIAL DNA A, V27, P1062, DOI 10.3109/19401736.2014.928868; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835; Zou XH, 2013, NEW PHYTOL, V198, P1155, DOI 10.1111/nph.12230; Zou XH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r49	72	39	42	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118019	10.1371/journal.pone.0118019	http://dx.doi.org/10.1371/journal.pone.0118019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658309	gold, Green Submitted, Green Published			2022-12-27	WOS:000349444900251
J	Eisenberger, T; Decker, C; Hiersche, M; Hamann, RC; Decker, E; Neuber, S; Frank, V; Bolz, HJ; Fehrenbach, H; Pape, L; Toenshoff, B; Mache, C; Latta, K; Bergmann, C				Eisenberger, Tobias; Decker, Christian; Hiersche, Milan; Hamann, Ruben C.; Decker, Eva; Neuber, Steffen; Frank, Valeska; Bolz, Hanno J.; Fehrenbach, Henry; Pape, Lars; Toenshoff, Burkhard; Mache, Christoph; Latta, Kay; Bergmann, Carsten			An Efficient and Comprehensive Strategy for Genetic Diagnostics of Polycystic Kidney Disease	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT; PRIMARY CILIUM; MUTATIONS; CILIOPATHIES; ALIGNMENT; PKD1; NEK8	Renal cysts are clinically and genetically heterogeneous conditions. Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent life-threatening genetic disease and mainly caused by mutations in PKD1. The presence of six PKD1 pseudogenes and tremendous allelic heterogeneity make molecular genetic testing challenging requiring laborious locus-specific amplification. Increasing evidence suggests a major role for PKD1 in early and severe cases of ADPKD and some patients with a recessive form. Furthermore it is becoming obvious that clinical manifestations can be mimicked by mutations in a number of other genes with the necessity for broader genetic testing. We established and validated a sequence capture based NGS testing approach for all genes known for cystic and polycystic kidney disease including PKD1. Thereby, we demonstrate that the applied standard mapping algorithm specifically aligns reads to the PKD1 locus and overcomes the complication of unspecific capture of pseudogenes. Employing careful and experienced assessment of NGS data, the method is shown to be very specific and equally sensitive as established methods. An additional advantage over conventional Sanger sequencing is the detection of copy number variations (CNVs). Sophisticated bioinformatic read simulation increased the high analytical depth of the validation study and further demonstrated the strength of the approach. We further raise some awareness of limitations and pitfalls of common NGS work-flows when applied in complex regions like PKD1 demonstrating that quality of NGS needs more than high coverage of the target region. By this, we propose a time- and cost-efficient diagnostic strategy for comprehensive molecular genetic testing of polycystic kidney disease which is highly automatable and will be of particular value when therapeutic options for PKD emerge and genetic testing is needed for larger numbers of patients.	[Eisenberger, Tobias; Decker, Christian; Hiersche, Milan; Hamann, Ruben C.; Decker, Eva; Neuber, Steffen; Frank, Valeska; Bolz, Hanno J.; Bergmann, Carsten] Bioscientia Ctr Human Genet, Ingelheim, Germany; [Fehrenbach, Henry] Childrens Hosp Memmingen, Dept Pediat, Memmingen, Germany; [Pape, Lars] MHH Hannover, Clin Pediat Kidney Liver & Metab Dis, Hannover, Germany; [Toenshoff, Burkhard] Univ Childrens Hosp Heidelberg, Dept Pediat 1, Heidelberg, Germany; [Mache, Christoph] Med Univ Graz, Dept Pediat, Graz, Austria; [Latta, Kay] Clementine Childrens Hosp, Frankfurt, Germany; [Bergmann, Carsten] Univ Freiburg, Med Ctr, Dept Med, Div Renal, D-79106 Freiburg, Germany	Hannover Medical School; Ruprecht Karls University Heidelberg; Medical University of Graz; University of Freiburg	Bergmann, C (corresponding author), Bioscientia Ctr Human Genet, Ingelheim, Germany.	carsten.bergmann@bioscientia.de	Pape, Lars/AAF-1477-2021	Pape, Lars/0000-0002-3635-6418				Arts HH, 2013, PEDIATR NEPHROL, V28, P863, DOI 10.1007/s00467-012-2259-9; Audrezet MP, 2012, HUM MUTAT, V33, P1239, DOI 10.1002/humu.22103; Bergmann C, 2014, AUTOSOMAL RECESSIVE; Bergmann C., 2014, PEDIAT NEPHROL; Bergmann C, 2008, NEW ENGL J MED, V359, P318, DOI 10.1056/NEJMc0801868; Bergmann C, 2011, J AM SOC NEPHROL, V22, P2047, DOI 10.1681/ASN.2010101080; Bogdanova N, 2001, GENOMICS, V74, P333, DOI 10.1006/geno.2001.6568; Consugar MB, 2008, KIDNEY INT, V74, P1468, DOI 10.1038/ki.2008.485; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Eisenberger T, 2014, HUM MUTAT, V35, P565, DOI 10.1002/humu.22532; Eisenberger T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078496; Fehrenbach H., 2014, PEDIAT NEPHROL; Frank V, 2013, HUM MOL GENET, V22, P2177, DOI 10.1093/hmg/ddt070; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Landsverk ML, 2012, GENET MED, V14, P877, DOI 10.1038/gim.2012.58; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nix DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-9; OTT E, 2014, J MED GENET, P91; Rossetti S, 2002, KIDNEY INT, V61, P1588, DOI 10.1046/j.1523-1755.2002.00326.x; Rossetti S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387; Rossetti S, 2007, J AM SOC NEPHROL, V18, P1374, DOI 10.1681/ASN.2007010125; Rossetti S, 2012, J AM SOC NEPHROL, V23, P915, DOI 10.1681/ASN.2011101032; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Salomon R, 2009, PEDIATR NEPHROL, V24, P2333, DOI 10.1007/s00467-008-0840-z; Schmidts M, 2013, HUM MUTAT, V34, P714, DOI 10.1002/humu.22294; Suzuki S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S7; Symmons O, 2008, MOL BIOL EVOL, V25, P2601, DOI 10.1093/molbev/msn202; TRUJILLANO D, 2014, MOL GENETIC GENETIC, V5, P28669, DOI DOI 10.1093/BRAIN/AWQ331; Turner EH, 2009, ANNU REV GENOM HUM G, V10, P263, DOI 10.1146/annurev-genom-082908-150112; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789	35	51	52	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116680	10.1371/journal.pone.0116680	http://dx.doi.org/10.1371/journal.pone.0116680			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646624	Green Submitted, gold, Green Published			2022-12-27	WOS:000348822600032
J	Pasqualim, G; Baldo, G; de Carvalho, TG; Tavares, AMV; Giugliani, R; Matte, U				Pasqualim, Gabriela; Baldo, Guilherme; de Carvalho, Talita Giacomet; Tavares, Angela Maria Vicente; Giugliani, Roberto; Matte, Ursula			Effects of Enzyme Replacement Therapy Started Late in a Murine Model of Mucopolysaccharidosis Type I	PLOS ONE			English	Article							RECOMBINANT ENCAPSULATED CELLS; MPS-I; AORTIC DILATATION; UP-REGULATION; TRANSPLANTATION; LARONIDASE; EFFICACY; IMPROVES; GUIDELINES; MANAGEMENT	Mucopolysaccharidosis type I (MPS I) is a progressive disorder caused by deficiency of alpha L- iduronidase (IDUA), which leads to storage of heparan and dermatan sulphate. It is suggested that early enzyme replacement therapy (ERT) leads to better outcomes, although many patients are diagnosed late and don't receive immediate treatment. This study aims to evaluate the effects of late onset ERT in a MPS I murine model. MPS I mice received treatment from 6 to 8 months of age (ERT 6-8mo) with 1.2mg laronidase/kg every 2 weeks and were compared to 8 months-old wild-type (Normal) and untreated animals (MPS I). ERT was effective in reducing urinary and visceral GAG to normal levels. Heart GAG levels and left ventricular (LV) shortening fraction were normalized but cardiac function was not completely improved. While no significant improvements were found on aortic wall width, treatment was able to significantly reduce heart valves thickening. High variability was found in behavior tests, with treated animals presenting intermediate results between normal and affected mice, without correlation with cerebral cortex GAG levels. Cathepsin D activity in cerebral cortex also did not correlate with behavior heterogeneity. All treated animals developed anti-laronidase antibodies but no correlation was found with any parameters analyzed. However, intermediary results from locomotion parameters analyzed are in accordance with intermediary levels of heart function, cathepsin D, activated glia and reduction of TNF-alpha expression in the cerebral cortex. In conclusion, even if started late, ERT can have beneficial effects on many aspects of the disease and should be considered whenever possible.	[Pasqualim, Gabriela; de Carvalho, Talita Giacomet; Giugliani, Roberto; Matte, Ursula] Univ Fed Rio Grande do Sul, Postgrad Program Genet & Mol Biol PPGBM, Porto Alegre, RS, Brazil; [Pasqualim, Gabriela; Baldo, Guilherme; de Carvalho, Talita Giacomet; Giugliani, Roberto; Matte, Ursula] Hosp Clin Porto Alegre, Expt Res Ctr, Gene Therapy Ctr, Porto Alegre, RS, Brazil; [Baldo, Guilherme] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Physiol, Porto Alegre, RS, Brazil; [Tavares, Angela Maria Vicente] Uniritter Laureate Int Univ, Dept Hlth Sci, Porto Alegre, RS, Brazil; [Giugliani, Roberto] Hosp Clin Porto Alegre, Med Genet Serv, Porto Alegre, RS, Brazil; [Giugliani, Roberto; Matte, Ursula] INAGEMP, Porto Alegre, RS, Brazil; [Giugliani, Roberto; Matte, Ursula] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Matte, U (corresponding author), Univ Fed Rio Grande do Sul, Postgrad Program Genet & Mol Biol PPGBM, Porto Alegre, RS, Brazil.	umatte@hcpa.ufrgs.br	Baldo, Guilherme/U-9104-2019; Da Silveira Matte umatte, Ursula/U-3912-2019; Pasqualim, Gabriela/E-5219-2018; Baldo, Guilherme/AAR-5677-2020; Giugliani, Roberto/G-4790-2015; Tavares, Angela Maria Vicente/F-6539-2010	Baldo, Guilherme/0000-0003-1598-5861; Da Silveira Matte umatte, Ursula/0000-0003-4977-6662; Pasqualim, Gabriela/0000-0002-6250-9609; Giugliani, Roberto/0000-0001-9655-3686; Vicente Tavares, Angela Maria/0000-0002-3402-0523	Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE-HCPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)/Ministerio da Saude (MS)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/Secretaria de Estado da Saude do RS [1151-2551/13-3]	Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE-HCPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)/Ministerio da Saude (MS)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/Secretaria de Estado da Saude do RS	This work was supported by Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE-HCPA) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)/Ministerio da Saude (MS)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/Secretaria de Estado da Saude do RS (process #1151-2551/13-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer LD, 2014, J INHERIT METAB DIS, V37, P1, DOI 10.1007/s10545-013-9613-3; Arfi A, 2011, MOL GENET METAB, V103, P18, DOI 10.1016/j.ymgme.2011.01.015; Baldo G, 2014, MED HYPOTHESES, V82, P478, DOI 10.1016/j.mehy.2014.01.029; Baldo G, 2013, MOL GENET METAB, V109, P33, DOI 10.1016/j.ymgme.2013.03.005; Baldo G, 2012, CYTOTHERAPY, V14, P860, DOI 10.3109/14653249.2012.672730; Baldo G, 2012, BEHAV BRAIN RES, V233, P169, DOI 10.1016/j.bbr.2012.04.051; Baldo G, 2012, CELLS TISSUES ORGANS, V195, P323, DOI 10.1159/000327532; Baldo G, 2011, MOL GENET METAB, V104, P608, DOI 10.1016/j.ymgme.2011.08.018; Beck M, 2014, GENET MED, V16, P759, DOI 10.1038/gim.2014.25; Boelens JJ, 2010, PEDIATR CLIN N AM, V57, P123, DOI 10.1016/j.pcl.2009.11.004; Brands MMMG, 2013, J INHERIT METAB DIS, V36, P227, DOI 10.1007/s10545-011-9444-z; Braunlin EA, 2003, AM J CARDIOL, V92, P882, DOI 10.1016/S0002-9149(03)00909-3; Braunlin EA, 2006, AM J CARDIOL, V98, P416, DOI 10.1016/j.amjcard.2006.02.047; Clarke LA, 2009, PEDIATRICS, V123, P229, DOI 10.1542/peds.2007-3847; D'Aco K, 2012, EUR J PEDIATR, V171, P911, DOI 10.1007/s00431-011-1644-x; de Ru MH, 2013, J INHERIT METAB DIS, V36, P247, DOI 10.1007/s10545-012-9538-2; de Ru MH, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-22; de Ru MH, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-55; Dickson P, 2008, J CLIN INVEST, V118, P2868, DOI 10.1172/JCI34676; Dierenfeld AD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001380; Gabrielli O, 2010, PEDIATRICS, V125, pE183, DOI 10.1542/peds.2009-1728; Giugliani R, 2009, MOL GENET METAB, V96, P13, DOI 10.1016/j.ymgme.2008.10.009; Giugliani R, 2012, J INHERIT METAB DIS, V35, P871, DOI 10.1007/s10545-011-9436-z; Giugliani R, 2010, GENET MOL BIOL, V33, P589, DOI 10.1590/S1415-47572010005000093; Harada H, 2011, MOL GENET METAB, V103, P215, DOI 10.1016/j.ymgme.2011.03.016; Jones JE, 2002, AM J PHYSIOL-HEART C, V283, pH364, DOI 10.1152/ajpheart.00979.2001; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Lyons JA, 2011, LAB INVEST, V91, P665, DOI 10.1038/labinvest.2011.7; Ma X, 2008, MOL GENET METAB, V94, P298, DOI 10.1016/j.ymgme.2008.03.018; Martins AM, 2009, J PEDIATR-US, V155, pS32, DOI 10.1016/j.jpeds.2009.07.005; Matthes F, 2012, HUM MOL GENET, V21, P2599, DOI 10.1093/hmg/dds086; Metcalf JA, 2010, MOL GENET METAB, V99, P396, DOI 10.1016/j.ymgme.2009.12.003; Muenzer J, 2011, RHEUMATOLOGY, V50, pV4, DOI 10.1093/rheumatology/ker394; Muenzer J, 2009, PEDIATRICS, V123, P19, DOI 10.1542/peds.2008-0416; Munoz-Rojas MV, 2011, J INHERIT METAB DIS, V34, P1029, DOI 10.1007/s10545-011-9336-2; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Ou L, 2014, MOL GENET METAB, V111, P116, DOI 10.1016/j.ymgme.2013.09.008; Pan D, 2008, BRAIN RES, V1188, P241, DOI 10.1016/j.brainres.2007.10.036; Sifuentes M, 2007, MOL GENET METAB, V90, P171, DOI 10.1016/j.ymgme.2006.08.007; Tokic V, 2007, EUR J PEDIATR, V166, P727, DOI 10.1007/s00431-006-0316-8; Valayannopoulos V, 2011, RHEUMATOLOGY, V50, pV49, DOI 10.1093/rheumatology/ker396; Vieira T, 2008, AM J MED GENET A, V146A, P1741, DOI 10.1002/ajmg.a.32320; Wilkinson FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035787; Wolf DA, 2012, BONE MARROW TRANSPL, V47, P1235, DOI 10.1038/bmt.2011.239; Wraith JE, 2007, PEDIATRICS, V120, pE37, DOI 10.1542/peds.2006-2156; Wraith JE, 2004, J PEDIATR-US, V144, P581, DOI 10.1016/j.jpeds.2004.01.046	47	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117271	10.1371/journal.pone.0117271	http://dx.doi.org/10.1371/journal.pone.0117271			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646802	gold, Green Submitted, Green Published			2022-12-27	WOS:000348822600062
J	Zhang, H; Huang, PF; Meng, E; Li, WY; Zhou, L; Zhu, LY; Wu, L; Li, MJ; Liang, SP; Zhang, DY				Zhang, Hui; Huang, Peng-Fei; Meng, Er; Li, Wen-Ying; Zhou, Lu; Zhu, Ling-Yun; Wu, Lei; Li, Meng-Jie; Liang, Song-Ping; Zhang, Dong-Yi			An Efficient Strategy for Heterologous Expression and Purification of Active Peptide Hainantoxin-IV	PLOS ONE			English	Article							SPIDER-VENOM PEPTIDES; GATED SODIUM-CHANNEL; TOXINS; PROTEINS	Hainantoxin-IV (HNTX-IV) from the venom of the spider Selenocosmia hainana is a potent antagonist that specifically inhibits the tetrodotoxin-sensitive (TTX-S) sodium channels. The toxin peptide consists of 35 amino acids and adopts a typical inhibitory cystine knot (ICK) motif. To obtain adequate HNTX-IV peptides for further insight into the structure-activity relationships of the toxin, a novel strategy including cloning, expression and purification was developed in an E. coli expression system. For this purpose, a seamless restriction-free (RF) cloning method was employed for the construction of an expression vector to avoid introducing unwanted sequences into the target gene. Furthermore, the solubility of recombinant HNTX-IV could be promoted efficiently by the combination of a glutathione S-transferase (GST) tag and a small ubiquitin-related modifier (SUMO) tag. Finally, an affinity-chromatography-free purification strategy was developed by cut-off dialysis tubing combined with trichloroacetic acid (TCA) extraction. Further HPLC purification yielded recombinant, tag-free HNTX-IV with high yield and purity. The molecular weight of recombinant HNTX-IV (rHNTX-IV) is identical to its theoretical value according to Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF-MS) analysis. The recombinant toxin has similar activity (IC50 value of 120 nM) on the tetrodotoxin-sensitive (TTX-S) sodium channels in adult rat dorsal root ganglion (DRG) neurons to native toxins. In the report, an efficient and cost-effective strategy for producing rHNTX-IV was developed, which paved the way for the further study of structure-activity relationships of rHNTX-IV and its pharmaceutical applications.	[Zhang, Hui; Huang, Peng-Fei; Zhou, Lu; Li, Meng-Jie; Liang, Song-Ping] Hunan Normal Univ, Coll Life Sci, Key Lab Prot Chem & Dev Biol, Minist Educ, Changsha 410081, Hunan, Peoples R China; [Meng, Er; Zhu, Ling-Yun; Wu, Lei; Zhang, Dong-Yi] Natl Univ Def Technol, Res Ctr Biol Informat, Coll Sci, Changsha 410073, Hunan, Peoples R China	Hunan Normal University; National University of Defense Technology - China	Liang, SP (corresponding author), Hunan Normal Univ, Coll Life Sci, Key Lab Prot Chem & Dev Biol, Minist Educ, Changsha 410081, Hunan, Peoples R China.	liangsp@hunnu.edu.cn; dongyizhang@nudt.edu.cn	li, mengjie/GRS-3931-2022	/0000-0002-0420-4508; zhang, hui/0000-0003-4513-5606	Ministry of Science and Technology of China "973" Project [2010CB529800]; National University of Defense Technology Project [JC2006-02-01, JC13-02-16]; National Natural Science Foundation of China [31100609]	Ministry of Science and Technology of China "973" Project(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National University of Defense Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China "973" Project, No. 2010CB529800 to Prof. S.P. Liang; National University of Defense Technology Project, No. JC2006-02-01 to Prof. D.Y. Zhang, and JC13-02-16 to Dr. Lei Wu; and National Natural Science Foundation of China, No. 31100609 to Dr. L.Y. Zhu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051516; Bommarius B, 2010, PEPTIDES, V31, P1957, DOI 10.1016/j.peptides.2010.08.008; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Cain CC, 1997, PLANT MOL BIOL, V35, P377, DOI 10.1023/A:1005846620791; de Marco A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-26; Escoubas P, 2006, MOL DIVERS, V10, P545, DOI 10.1007/s11030-006-9050-4; Garcia F, 2013, J ANTIBIOT, V66, P3, DOI 10.1038/ja.2012.87; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; Kumar P, 2014, PROTEIN EXPRES PURIF, V95, P129, DOI 10.1016/j.pep.2013.12.004; Li DL, 2004, J BIOL CHEM, V279, P37734, DOI 10.1074/jbc.M405765200; Liang S, 1998, LIFE SCI RES HUMAN N, V3, P299; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Liu XJ, 2012, APPL MICROBIOL BIOT, V96, P103, DOI 10.1007/s00253-011-3864-4; Liu Z, 2003, CELL MOL LIFE SCI, V60, P972, DOI 10.1007/s00018-003-2354-x; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Prakash A, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-92; Rabhi-Essafi I, 2007, PROTEIN ENG DES SEL, V20, P201, DOI 10.1093/protein/gzm012; Rowe AH, 2013, SCIENCE, V342, P441, DOI 10.1126/science.1236451; Sermadiras I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083202; Tang X, 2010, J PROTEOME RES, V9, P2550, DOI 10.1021/pr1000016; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Windley MJ, 2012, TOXINS, V4, P191, DOI 10.3390/toxins4030191	24	7	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117099	10.1371/journal.pone.0117099	http://dx.doi.org/10.1371/journal.pone.0117099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647561	gold, Green Submitted, Green Published			2022-12-27	WOS:000348822600055
J	Seferian, AM; Moraux, A; Annoussamy, M; Canal, A; Decostre, V; Diebate, O; Le Moing, AG; Gidaro, T; Deconinck, N; Van Parys, F; Vereecke, W; Wittevrongel, S; Mayer, M; Maincent, K; Desguerre, I; Themar-Noel, C; Cuisset, JM; Tiffreau, V; Denis, S; Jousten, V; Quijano-Roy, S; Voit, T; Hogrel, JY; Servais, L				Seferian, Andreea Mihaela; Moraux, Amelie; Annoussamy, Melanie; Canal, Aurelie; Decostre, Valerie; Diebate, Oumar; Le Moing, Anne-Gaelle; Gidaro, Teresa; Deconinck, Nicolas; Van Parys, Frauke; Vereecke, Wendy; Wittevrongel, Sylvia; Mayer, Michele; Maincent, Kim; Desguerre, Isabelle; Themar-Noel, Christine; Cuisset, Jean-Marie; Tiffreau, Vincent; Denis, Severine; Jousten, Virginie; Quijano-Roy, Susana; Voit, Thomas; Hogrel, Jean-Yves; Servais, Laurent			Upper Limb Strength and Function Changes during a One-Year Follow-Up in Non-Ambulant Patients with Duchenne Muscular Dystrophy: An Observational Multicenter Trial	PLOS ONE			English	Article							HETEROGENEITY; CHILDREN; MOTOR	Introduction Upper limb evaluation of patients with Duchenne Muscular Dystrophy is crucially important to evaluations of efficacy of new treatments in non-ambulant patients. In patients who have lost ambulation, there are few validated and informative outcome measures. In addition, longitudinal data demonstrating sensitivity to clinical evolution of outcome measures over short-term periods are lacking. Patients and Methods We report here the results of a one-year multicenter study using specifically designed tools to assess grip, pinch strength, and hand function in wheelchair-bound patients. Our study assessed 53 non-ambulant patients with Duchenne muscular dystrophy aged 17.1 +/- 4.8 years (range: 9 - 28.1 years). The average Brooke functional score of these patients was 4.6 +/- 1.1. The average forced vital capacity was 44.5% predicted and 19 patients used non-invasive ventilation. Patients were assessed at baseline, 6 months, and one year using the Motor Function Measure and innovative devices (namely the MyoSet composed of Myo-Grip, MyoPinch, and MoviPlate). Results Our study confirmed preliminary data previously reported regarding feasibility of use and of reliability of the MyoSet and the correlation at baseline between distal strength and clinical outcomes such as FVC, Brooke score, age, and duration since loss of ambulation. A significant correlation was observed between the distal upper limb strength and clinical variables. The sensitive dynamometers (MyoGrip and MyoPinch) and MoviPlate captured a 12-month change in non-ambulant Duchenne muscular dystrophy patients of all ages.	[Seferian, Andreea Mihaela; Moraux, Amelie; Annoussamy, Melanie; Canal, Aurelie; Decostre, Valerie; Diebate, Oumar; Le Moing, Anne-Gaelle; Gidaro, Teresa; Themar-Noel, Christine; Voit, Thomas; Hogrel, Jean-Yves; Servais, Laurent] Inst Myol, Paris, France; [Le Moing, Anne-Gaelle] Ctr Hosp Univ Amiens, Dept Child Neurol, Grp Rech Anal Multimodale Fonct Cerebrale, Amiens, France; [Deconinck, Nicolas; Van Parys, Frauke; Vereecke, Wendy; Wittevrongel, Sylvia] Univ Ziekenhuis Gent, Neuromuscular Reference Ctr, Dept Pediat, Div Pediat Neurol & Metab, Ghent, Belgium; [Mayer, Michele; Maincent, Kim] Hop Trousseau, AP HP, Dept Child Neurol, F-75571 Paris, France; [Desguerre, Isabelle] Hop Necker Enfants Malad, AP HP, Dept Child Neurol, Paris, France; [Cuisset, Jean-Marie] Ctr Hosp Reg Univ Lille, Hop Roger Salengro, Dept Child Neurol, Lille, France; [Tiffreau, Vincent] Ctr Hosp Reg Univ Lille, Hop Pierre Swynghedauw, Dept Phys Med & Rehabil, Lille, France; [Denis, Severine; Jousten, Virginie; Servais, Laurent] Ctr Hosp Reg Citadelle, Reference Ctr Neuromuscular Dis, Liege, Belgium; [Quijano-Roy, Susana] Univ Versailles St Quentin En Yvelines, Hop Raymond Poincare, AP HP,Dept Pediat, Malad Neuromusculaires Garches Necker Mondor Hend, Garches, France; [Voit, Thomas] Univ Paris 06, CNRS, Inst Natl Sante & Rech Med, Inst Myol,Unite Mixte Rech S 974, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Ghent University; Ghent University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Seferian, AM (corresponding author), Inst Myol, Paris, France.	a.totoescu@institut-myologie.org	Quijano-Roy, Susana/GRF-6829-2022; Servais, Laurent/AAL-7384-2020	Hogrel, Jean-Yves/0000-0003-0045-7505; Servais, Laurent/0000-0001-9270-4061	ADNA (Advanced Diagnostics for New Therapeutic Approaches)	ADNA (Advanced Diagnostics for New Therapeutic Approaches)	The ULENAP study was funded by ADNA (Advanced Diagnostics for New Therapeutic Approaches, http://www.institut-merieux.com/projetssante adna.php), a program dedicated to personalized medicine, coordinated by Institut Merieux and supported by research and innovation aid from the French public agency, OSEO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels B, 2011, J REHABIL MED, V43, P770, DOI 10.2340/16501977-0841; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Buyse GM, 2011, NEUROMUSCULAR DISORD, V21, P396, DOI 10.1016/j.nmd.2011.02.016; CHOW SC, 2008, SAMPLE SIZE CALCULAT, V14; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Daoud F, 2009, HUM MOL GENET, V18, P3779, DOI 10.1093/hmg/ddp320; Desguerre I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004347; Dooley JM, 2010, PEDIATR NEUROL, V43, P173, DOI 10.1016/j.pediatrneurol.2010.04.013; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Henricson EK, 2013, MUSCLE NERVE, V48, P55, DOI 10.1002/mus.23808; Humbertclaude V, 2012, EUR J PAEDIATR NEURO, V16, P149, DOI 10.1016/j.ejpn.2011.07.001; Kurillo G, 2013, NEUROMUSCULAR DISORD, V23, P749, DOI 10.1016/j.nmd.2013.06.409; Kurillo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045341; Lerario A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-91; LOWES LP, 2013, PLOS CURR, V5; Mattar FL, 2008, NEUROMUSCULAR DISORD, V18, P193, DOI 10.1016/j.nmd.2007.11.004; MAYHEW A, 2013, DEV MED CHILD NEUROL; Mayhew JE, 2007, MUSCLE NERVE, V35, P36, DOI 10.1002/mus.20654; Mazzone E, 2011, NEUROMUSCULAR DISORD, V21, P406, DOI 10.1016/j.nmd.2011.02.014; Mazzone ES, 2012, DEV MED CHILD NEUROL, V54, P879, DOI 10.1111/j.1469-8749.2012.04345.x; MCDONALD CM, 2013, MUSCLE NERVE; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; MENDELL J, 2013, ANN NEUROL; Mercuri E, 2008, Neuromuscul Disord, V18, P894, DOI 10.1016/j.nmd.2008.07.003; Mercuri E, 2013, LANCET, V381, P845, DOI 10.1016/S0140-6736(12)61897-2; Mercuri E, 2012, NEUROMUSCULAR DISORD, V22, P1105, DOI [10.1016/j.nmd.2012.11.001, 10.1016/j.nmd.2012.06.006]; PANE M, 2013, NEUROMUSCUL DISORD; Pane M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083400, 10.1371/journal.pone.0108205]; Roberto R, 2011, SPINE, V36, pE1009, DOI 10.1097/BRS.0b013e3181fea1ed; SCOTT OM, 1982, MUSCLE NERVE, V5, P291, DOI 10.1002/mus.880050405; Servais L, 2013, NEUROMUSCULAR DISORD, V23, P139, DOI 10.1016/j.nmd.2012.10.022; STUBERG WA, 1988, PHYS THER, V68, P977, DOI 10.1093/ptj/68.6.977; Vuillerot C, 2012, ARCH PHYS MED REHAB, V93, P2251, DOI 10.1016/j.apmr.2012.05.025; WAGNER MB, 1993, ARCH PHYS MED REHAB, V74, P801, DOI 10.1016/0003-9993(93)90004-T	36	49	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0113999	10.1371/journal.pone.0113999	http://dx.doi.org/10.1371/journal.pone.0113999			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643053	Green Submitted, Green Published, gold			2022-12-27	WOS:000348821200001
J	Ha, S; Hong, SH; Paeng, JC; Lee, DY; Cheon, GJ; Arya, A; Chung, JK; Lee, DS; Kang, KW				Ha, Seunggyun; Hong, Sung Hwan; Paeng, Jin Chul; Lee, Dong Yeon; Cheon, Gi Jeong; Arya, Amitabh; Chung, June-Key; Lee, Dong Soo; Kang, Keon Wook			Comparison of SPECT/CT and MRI in Diagnosing Symptomatic Lesions in Ankle and Foot Pain Patients: Diagnostic Performance and Relation to Lesion Type	PLOS ONE			English	Article							EMISSION COMPUTED-TOMOGRAPHY; ANTERIOR CRUCIATE LIGAMENT; FACET JOINT INJECTION; TC-99M-METHYLENE DIPHOSPHONATE; OSTEOCHONDRAL LESIONS; BONE-SCINTIGRAPHY; CLINICAL-VALUE; BACK-PAIN; OSTEOARTHRITIS; KNEE	Purpose The purpose of this study was to compare the diagnostic performance of SPECT/CT and MRI in patients with ankle and foot pain, with regard to the lesion types. Materials and Methods Fifty consecutive patients with ankle and foot pain, who underwent Tc-99m-MDP SPECT/CT and MRI, were retrospectively enrolled in this study. Symptomatic lesions were determined based on clinical examination and response to treatment. On MRI and SPECT/CT, detected lesions were classified as bone, ligament/tendon, and joint lesions. Uptake on SPECT/CT was assessed using a 4-grade system. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of SPECT/CT and MRI were evaluated in all detected lesions and each lesion type. Diagnostic value of uptake grade was analyzed using receiver-operating characteristics (ROC) curve analysis, and diagnostic performance was compared using Chi-square or McNemar tests. Results In overall lesions, the sensitivity, PPV and NPV of SPECT/CT for symptomatic lesions were 93%, 56%, 91%, and they were 98%, 48%, 95% for MRI. There was no significant difference between SPECT/CT and MRI. However, the specificity of SPECT/CT was significantly higher than that of MRI (48% versus 24%, P = 0.016). Uptake grade on SPECT/CT was significantly higher in symptomatic lesions (P < 0.001), and its area under curve on ROC analysis was 0.787. In the analysis of each lesion type, the specificity of SPECT/CT was poor in joint lesions compared with other lesion types and MRI (P < 0.001, respectively). MRI exhibited lower specificity than SPECT/CT in bone lesions (P = 0.004) and ligament/tendon lesions (P < 0.001). Conclusions SPECT/CT has MRI-comparable diagnostic performance for symptomatic lesions in ankle and foot pain patients. SPECT/CT and MRI exhibit different diagnostic specificity in different lesion types. SPECT/CT may be used as a complementary imaging method to MRI for enhancing diagnostic specificity.	[Ha, Seunggyun; Paeng, Jin Chul; Cheon, Gi Jeong; Chung, June-Key; Lee, Dong Soo; Kang, Keon Wook] Seoul Natl Univ Hosp, Dept Nucl Med, Seoul 110744, South Korea; [Hong, Sung Hwan] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Lee, Dong Yeon] Seoul Natl Univ Hosp, Dept Orthoped Surg, Seoul 110744, South Korea; [Arya, Amitabh] Sanjay Gandhi Postgrad Inst Med Sci, Dept Nucl Med, Lucknow, Uttar Pradesh, India	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Paeng, JC (corresponding author), Seoul Natl Univ Hosp, Dept Nucl Med, Seoul 110744, South Korea.	paengjc@snu.ac.kr; leedy@snu.ac.kr	Kang, Keon Wook/J-1385-2012; Cheon, Gi Jeong/AAA-5702-2020; Cheon, Gi Jeong/G-6064-2018	Kang, Keon Wook/0000-0003-2622-9017; Cheon, Gi Jeong/0000-0002-1360-5186	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1277]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number : HI14C1277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas D, 2009, J BONE JOINT SURG AM, V91A, P1882, DOI 10.2106/JBJS.H.01199; Buchbender C, 2013, EUR J RADIOL, V82, P374, DOI 10.1016/j.ejrad.2012.10.011; Chicklore S, 2013, NUCL MED COMMUN, V34, P130, DOI 10.1097/MNM.0b013e32835c0964; CHRISTENSEN SB, 1983, SCAND J RHEUMATOL, V12, P343, DOI 10.3109/03009748309099738; Chung HW, 2000, NUCL MED COMMUN, V21, P651, DOI 10.1097/00006231-200007000-00009; DeSmet A A, 2000, Radiology, V215 Suppl, P321; Dolan AL, 1996, BRIT J RHEUMATOL, V35, P1269; Hart AJ, 2005, J BONE JOINT SURG BR, V87B, P1483, DOI 10.1302/0301-620X.87B11.16138; Hirschmann MT, 2011, SPORTS MED ARTHROSC, V19, P174, DOI 10.1097/JSA.0b013e3181ec8707; HOLDER LE, 1995, J NUCL MED, V36, P37; Huellner MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085359; Huellner MW, 2012, EUR J NUCL MED MOL I, V39, P750, DOI 10.1007/s00259-011-2034-3; Khan KM, 1998, CLIN J SPORT MED, V8, P1, DOI 10.1097/00042752-199801000-00001; Kim HR, 2008, OSTEOARTHR CARTILAGE, V16, P212, DOI 10.1016/j.joca.2007.05.025; Knupp M, 2009, J ORTHOP RES, V27, P1461, DOI 10.1002/jor.20922; Koike Y, 2013, AM J SPORT MED, V41, P2028, DOI 10.1177/0363546513494741; Kretzschmar M, 2011, EUR J RADIOL, V80, pE410, DOI 10.1016/j.ejrad.2010.09.013; Lee JW, 2007, NUCL MED MOL IMAGING, V41, P350; Leumann A, 2011, AM J SPORT MED, V39, P1095, DOI 10.1177/0363546510392709; Linke R, 2010, AM J ROENTGENOL, V194, pW329, DOI 10.2214/AJR.09.3288; Mariani G, 2010, EUR J NUCL MED MOL I, V37, P1959, DOI 10.1007/s00259-010-1390-8; Meftah M, 2011, FOOT ANKLE INT, V32, P233, DOI 10.3113/FAI.2011.0233; Mohan HK, 2010, SEMIN NUCL MED, V40, P41, DOI 10.1053/j.semnuclmed.2009.08.004; Nathan M, 2012, NUCL MED COMMUN, V33, P799, DOI 10.1097/MNM.0b013e328355880b; Pagenstert GI, 2009, J BONE JOINT SURG BR, V91B, P1191, DOI [10.1302/0301-620X.91B9, 10.1302/0301-620X.91B9.22570]; Papathanassiou D, 2009, JOINT BONE SPINE, V76, P474, DOI 10.1016/j.jbspin.2009.01.016; Pneumaticos SG, 2006, RADIOLOGY, V238, P693, DOI 10.1148/radiol.2382041930; Schleich FS, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-53; SCHWARTZ Z, 1993, J NUCL MED, V34, P104; Sormaala MJ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-128; Wiewiorski Martin, 2011, Foot Ankle Spec, V4, P92, DOI 10.1177/1938640010395749; Yildirim M, 2004, BRIT J SPORT MED, V38, P15, DOI 10.1136/bjsm.2002.000695; Zhang YQ, 2011, NUCL MED COMMUN, V32, P1194, DOI 10.1097/MNM.0b013e32834bd82e	33	23	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117583	10.1371/journal.pone.0117583	http://dx.doi.org/10.1371/journal.pone.0117583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668182	Green Submitted, Green Published, gold			2022-12-27	WOS:000349493000020
J	Suzuki, T; Kikuchi, H; Ogura, M; Homma, MK; Oshima, Y; Homma, Y				Suzuki, Toshiyuki; Kikuchi, Haruhisa; Ogura, Masato; Homma, Miwako K.; Oshima, Yoshiteru; Homma, Yoshimi			Weight Loss by Ppc-1, a Novel Small Molecule Mitochondrial Uncoupler Derived from Slime Mold	PLOS ONE			English	Article							DIFFERENTIATION-INDUCING FACTOR; SUPPRESSES CELL-GROWTH; DICTYOSTELIUM-DISCOIDEUM; RESPIRATORY-CHAIN; OXIDATIVE-PHOSPHORYLATION; 3T3-L1 ADIPOCYTES; CYCLIN D1; C-SRC; PROLIFERATION; INHIBITION	Mitochondria play a key role in diverse processes including ATP synthesis and apoptosis. Mitochondrial function can be studied using inhibitors of respiration, and new agents are valuable for discovering novel mechanisms involved in mitochondrial regulation. Here, we screened small molecules derived from slime molds and other microorganisms for their effects on mitochondrial oxygen consumption. We identified Ppc-1 as a novel molecule which stimulates oxygen consumption without adverse effects on ATP production. The kinetic behavior of Ppc-1 suggests its function as a mitochondrial uncoupler. Serial administration of Ppc-1 into mice suppressed weight gain with no abnormal effects on liver or kidney tissues, and no evidence of tumor formation. Serum fatty acid levels were significantly elevated in mice treated with Ppc-1, while body fat content remained low. After a single administration, Ppc-1 distributes into various tissues of individual animals at low levels. Ppc-1 stimulates adipocytes in culture to release fatty acids, which might explain the elevated serum fatty acids in Ppc-1-treated mice. The results suggest that Ppc-1 is a unique mitochondrial regulator which will be a valuable tool for mitochondrial research as well as the development of new drugs to treat obesity.	[Suzuki, Toshiyuki; Ogura, Masato; Homma, Miwako K.; Homma, Yoshimi] Fukushima Med Univ, Sch Med, Fukushima 9601295, Japan; [Kikuchi, Haruhisa; Oshima, Yoshiteru] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808678, Japan	Fukushima Medical University; Tohoku University	Homma, Y (corresponding author), Fukushima Med Univ, Sch Med, Fukushima 9601295, Japan.	yoshihom@fmu.ac.jp	Kikuchi, Haruhisa/AAC-3758-2019; Ogura, Masato/AAK-1619-2020	Kikuchi, Haruhisa/0000-0001-6938-0185; Ogura, Masato/0000-0001-9557-5023	Japan Society for the Promotion of Science [24590110, 23710247]; Fukushima Medical University [H2401]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fukushima Medical University	Funding: This work was supported in part by a Grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (to YO: No. 24590110, and to HK: No. 23710247) and a grant from Fukushima Medical University (to YH: No. H2401). The funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	ASAHI KI, 1995, BIOCHEM BIOPH RES CO, V208, P1036, DOI 10.1006/bbrc.1995.1438; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; Goldgof M, 2014, J BIOL CHEM, V289, P19341, DOI 10.1074/jbc.M114.568204; Grundlingh J, 2011, J MED TOXICOL, V7, P205, DOI 10.1007/s13181-011-0162-6; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; HEKMAN C, 1988, BIOCHEMISTRY-US, V27, P7559, DOI 10.1021/bi00419a057; Heytler P G, 1979, Methods Enzymol, V55, P462; HEYTLER PG, 1963, BIOCHEMISTRY-US, V2, P357, DOI 10.1021/bi00902a031; HORGAN DJ, 1968, J BIOL CHEM, V243, P834; Kabuyama Y, 2010, AM J PHYSIOL-CELL PH, V298, pC107, DOI 10.1152/ajpcell.00231.2009; Kanai M, 2003, ONCOGENE, V22, P548, DOI 10.1038/sj.onc.1206109; Katou Y, 2014, LIFE SCI, V103, P1, DOI 10.1016/j.lfs.2014.03.023; Kikuchi H, 2005, J ORG CHEM, V70, P8854, DOI 10.1021/jo051352x; Kikuchi H, 2002, TETRAHEDRON LETT, V43, P1477, DOI 10.1016/S0040-4039(02)00038-2; Kikuchi H, 2001, J ORG CHEM, V66, P6982, DOI 10.1021/jo015657x; Kikuchi H, 2007, TETRAHEDRON LETT, V48, P5905, DOI 10.1016/j.tetlet.2007.06.040; Kikuchi H, 2010, TETRAHEDRON, V66, P6000, DOI 10.1016/j.tet.2010.06.029; KUBOHARA Y, 1995, FEBS LETT, V359, P119, DOI 10.1016/0014-5793(95)00022-2; Kubohara Y, 1999, EUR J PHARMACOL, V381, P57, DOI 10.1016/S0014-2999(99)00548-8; Kubohara Y, 1997, BIOCHEM BIOPH RES CO, V236, P418, DOI 10.1006/bbrc.1997.6964; Kubohara Y, 2014, BIOL OPEN, V3, P289, DOI 10.1242/bio.20146585; Kubohara Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072118; Kudoh A, 2011, LIFE SCI, V88, P1055, DOI 10.1016/j.lfs.2011.04.001; LOOMIS WF, 1948, J BIOL CHEM, V173, P807; MATSUNOYAGI A, 1986, J BIOL CHEM, V261, P14031; MORRIS HR, 1988, BIOCHEM J, V249, P903, DOI 10.1042/bj2490903; MORRIS HR, 1987, NATURE, V328, P811, DOI 10.1038/328811a0; Ogura M, 2014, FEBS LETT, V588, P2837, DOI 10.1016/j.febslet.2014.06.044; Ogura M, 2012, BIOCHEM J, V447, P281, DOI 10.1042/BJ20120509; Ohira H, 2013, J ATHEROSCLER THROMB, V20, P425, DOI 10.5551/jat.15065; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Poole F, 1934, J AMER MED ASSOC, V102, P1141, DOI 10.1001/jama.1934.02750140027011; POTTER VR, 1952, J BIOL CHEM, V194, P287; Rigoulet M, 1996, EUR J BIOCHEM, V241, P280; Singer T P, 1979, Methods Enzymol, V55, P454; Tainter ML, 1934, J AMER MED ASSOC, V102, P1147, DOI 10.1001/jama.1934.02750140033012; Takahashi-Yanaga F, 2003, J BIOL CHEM, V278, P9663, DOI 10.1074/jbc.M205768200; Takahashi-Yanaga F, 2006, J BIOL CHEM, V281, P38489, DOI 10.1074/jbc.M605205200; Takaya Y, 2000, J ORG CHEM, V65, P985, DOI 10.1021/jo991338i; Thrush AB, 2013, FEBS J, V280, P5015, DOI 10.1111/febs.12399; Worrall DS, 2002, MOL ENDOCRINOL, V16, P378, DOI 10.1210/me.16.2.378; Yamada T, 2013, J CHROMATOGR A, V1292, P211, DOI 10.1016/j.chroma.2013.01.078	45	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117088	10.1371/journal.pone.0117088	http://dx.doi.org/10.1371/journal.pone.0117088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668511	Green Published, gold, Green Submitted			2022-12-27	WOS:000349493000015
J	Chen, JH; Ke, KF; Lu, JH; Qiu, YH; Peng, YP				Chen, Jia-Hui; Ke, Kai-Fu; Lu, Jian-Hua; Qiu, Yi-Hua; Peng, Yu-Ping			Protection of TGF-beta 1 against Neuroinflammation and Neurodegeneration in A beta(1-42)-Induced Alzheimer's Disease Model Rats	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BLOOD-BRAIN-BARRIER; T-CELLS; MOUSE MODEL; FACTOR-I; MICROGLIAL ACTIVATION; PLAQUE BURDEN; ANIMAL-MODEL; EXPRESSION; ALPHA	Neuroinflammation has been reported to be associated with Alzheimer's disease (AD) pathogenesis. Neuroinflammation is generally considered as an outcome of glial activation; however, we recently demonstrated that T helper (Th) 17 cells, a subpopulation of proinflammatory CD4+ T cells, are also involved in AD pathogenesis. Transforming growth factor (TGF)-beta 1, a cytokine that can be expressed in the brain, can be immunosuppressive, but its effects on lymphocyte-mediated neuroinflammation in AD pathogenesis have not been well addressed. In the current study we administered TGF-beta 1 via intracerebroventricle (ICV) and intranasal (IN) routes in AD model rats to investigate its antiinflammatory and neuroprotective effects. The AD rat model was prepared by bilateral hippocampal injection of amyloid- beta (A beta)(1-42). TGF-beta 1 was administered via ICV one hour prior to A beta(1-42) injection or via both nares seven days after A beta(1-42) injection. ICV administration of TGF-beta 1 before A beta(1-42) injection remarkably ameliorated A beta(1-42)-induced neurodegeneration and prevented A beta(1-42) induced increases in glia-derived proinflammatory mediators (TNF-alpha, IL-1 beta and iNOS), as well as T cell-derived proinflammatory cytokines (IFN-gamma, IL-2, IL-17 and IL-22), in the hypothalamus, serum or cerebrospinal fluid (CSF) in a concentration-dependent manner. TGF beta 1 pretreatment also prevented A beta(1-42)-induced decreases in the neurotrophic factors, IGF1, GDNF and BDNF, and in the antiinflammatory cytokine, IL-10. Similarly, IN administration of TGF-beta 1 after A beta(1-42) injection reduced neurodegeneration, elevation of proinflammatory mediators and cytokines, and reduction of neurotrophic and antiinflammatory factors, in the hypothalamus, serum or CSF. These findings suggest that TGF-beta 1 suppresses glial and T cell-mediated neuroinflammation and thereby alleviates AD-related neurodegeneration. The effectiveness of IN administered TGF-beta 1 in reducing A beta(1-42) neurotoxicity suggests a possible therapeutic approach in patients with AD.	[Chen, Jia-Hui; Lu, Jian-Hua; Qiu, Yi-Hua; Peng, Yu-Ping] Nantong Univ, Sch Med, Dept Physiol, Nantong, Peoples R China; [Chen, Jia-Hui; Lu, Jian-Hua; Qiu, Yi-Hua; Peng, Yu-Ping] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China; [Chen, Jia-Hui; Ke, Kai-Fu] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong, Peoples R China	Nantong University; Nantong University; Nantong University	Qiu, YH (corresponding author), Nantong Univ, Sch Med, Dept Physiol, Nantong, Peoples R China.	yhqiu@ntu.edu.cn; yppeng@ntu.edu.cn	peng, yu/GXW-2071-2022		National Natural Science Foundation of China [81271323, 31371182]; Natural Science Foundation of Jiangsu Province of China; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	The authors wish to thank Dr. M. Kerry O'Banion, University of Rochester, for editing this manuscript. This work was supported by grants 81271323 and 31371182 from the National Natural Science Foundation of China, BK2011386 from the Natural Science Foundation of Jiangsu Province of China, and a project funded by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biscaro B, 2012, NEURODEGENER DIS, V9, P187, DOI 10.1159/000330363; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bosco P, 2013, CURR GENOMICS, V14, P147, DOI 10.2174/1389202911314020007; Browne TC, 2013, J IMMUNOL, V190, P2241, DOI 10.4049/jimmunol.1200947; Caraci F, 2008, NEUROBIOL DIS, V30, P234, DOI 10.1016/j.nbd.2008.01.007; Caraci F, 2012, CELL TISSUE RES, V347, P291, DOI 10.1007/s00441-011-1230-6; Caraci F, 2011, CNS NEUROSCI THER, V17, P237, DOI 10.1111/j.1755-5949.2009.00115.x; Carare RO, 2014, BRAIN BEHAV IMMUN, V36, P9, DOI 10.1016/j.bbi.2013.10.012; Dhandapani KM, 2003, J BIOL CHEM, V278, P43329, DOI 10.1074/jbc.M305835200; Giuffrida ML, 2007, J NEUROSCI RES, V85, P623, DOI 10.1002/jnr.21135; Heath VL, 2000, EUR J IMMUNOL, V30, P2639, DOI 10.1002/1521-4141(200009)30:9<2639::AID-IMMU2639>3.0.CO;2-7; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; HenrichNoack P, 1996, STROKE, V27, P1609, DOI 10.1161/01.STR.27.9.1609; Jantaratnotai Nattinee, 2011, Int J Alzheimers Dis, V2011, P918280, DOI 10.4061/2011/918280; Juraskova B, 2010, J NUTR HEALTH AGING, V14, P758, DOI 10.1007/s12603-010-0325-1; Le YY, 2005, INT IMMUNOPHARMACOL, V5, P1771, DOI 10.1016/j.intimp.2005.07.006; Li M, 2009, J IMMUNOL, V182, P5778, DOI 10.4049/jimmunol.0803013; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liu XF, 2001, J NEUROL SCI, V187, P91, DOI 10.1016/S0022-510X(01)00532-9; Liu XF, 2001, NEUROSCI LETT, V308, P91, DOI 10.1016/S0304-3940(01)01982-6; Liu YJ, 2010, NEUROBIOL AGING, V31, P175, DOI 10.1016/j.neurobiolaging.2008.03.024; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardi VRM, 1999, J NEUROIMMUNOL, V97, P163, DOI 10.1016/S0165-5728(99)00046-6; Luppi C, 2009, ARCH GERONTOL GERIAT, V49, P173, DOI 10.1016/j.archger.2009.09.027; Lynch MA, 2014, IMMUNOLOGY, V141, P292, DOI 10.1111/imm.12156; Ma MM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-117; Ma YP, 2007, BRAIN RES BULL, V74, P271, DOI 10.1016/j.brainresbull.2007.06.021; McLarnon JG, 2008, CURR ALZHEIMER RES, V5, P475, DOI 10.2174/156720508785908874; Meraz-Rios MA, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00059; Metcalfe MJ, 2010, MT SINAI J MED, V77, P50, DOI 10.1002/msj.20163; Rubio-Perez JM, 2012, SCI WORLD J, DOI 10.1100/2012/756357; Morales I, 2010, NEUROIMMUNOMODULAT, V17, P202, DOI 10.1159/000258724; Paxinos G, 2005, THE RAT BRAIN IN STE; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Rojo LE, 2008, ARCH MED RES, V39, P1, DOI 10.1016/j.arcmed.2007.10.001; Ryu JK, 2008, NEUROBIOL DIS, V29, P254, DOI 10.1016/j.nbd.2007.08.019; Ryu JK, 2009, J CELL MOL MED, V13, P2911, DOI 10.1111/j.1582-4934.2008.00434.x; Saresella M, 2011, BRAIN BEHAV IMMUN, V25, P539, DOI 10.1016/j.bbi.2010.12.004; Schindowski K, 2007, NEUROMOL MED, V9, P340, DOI 10.1007/s12017-007-8015-9; Schwab C, 2008, J ALZHEIMERS DIS, V13, P359; Subramanian S, 2010, J ALZHEIMERS DIS, V22, P619, DOI 10.3233/JAD-2010-100852; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Togo T, 2002, J NEUROIMMUNOL, V124, P83, DOI 10.1016/S0165-5728(01)00496-9; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009; Vivien D, 2006, CYTOKINE GROWTH F R, V17, P121, DOI 10.1016/j.cytogfr.2005.09.011; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Wyss-Coray Tony, 2006, Current Alzheimer Research, V3, P191, DOI 10.2174/156720506777632916; Yang YM, 2013, NEUROCHEM RES, V38, P2295, DOI 10.1007/s11064-013-1138-5; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075786	53	153	159	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116549	10.1371/journal.pone.0116549	http://dx.doi.org/10.1371/journal.pone.0116549			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658940	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900049
J	Gabery, S; Georgiou-Karistianis, N; Lundh, SH; Cheong, RY; Churchyard, A; Chua, P; Stout, JC; Egan, GF; Kirik, D; Petersen, A				Gabery, Sanaz; Georgiou-Karistianis, Nellie; Lundh, Sofia Hult; Cheong, Rachel Y.; Churchyard, Andrew; Chua, Phyllis; Stout, Julie C.; Egan, Gary F.; Kirik, Deniz; Petersen, Asa			Volumetric Analysis of the Hypothalamus in Huntington Disease Using 3T MRI: The IMAGE-HD Study	PLOS ONE			English	Article							BASAL GANGLIA; SUPRACHIASMATIC NUCLEUS; MAMMILLARY BODY; MOOD DISORDERS; WHITE-MATTER; HUMAN-BRAIN; ATROPHY; SEX; DIAGNOSIS; SCHIZOPHRENIA	Huntington disease (HD) is a fatal neurodegenerative disorder caused by an expanded CAG repeat in the huntingtin gene. Non-motor symptoms and signs such as psychiatric disturbances, sleep problems and metabolic dysfunction are part of the disease manifestation. These aspects may relate to changes in the hypothalamus, an area of the brain involved in the regulation of emotion, sleep and metabolism. Neuropathological and imaging studies using both voxel-based morphometry (VBM) of magnetic resonance imaging (MRI) as well as positron emission tomography (PET) have demonstrated pathological changes in the hypothalamic region during early stages in symptomatic HD. In this investigation, we aimed to establish a robust method for measurements of the hypothalamic volume in MRI in order to determine whether the hypothalamic dysfunction in HD is associated with the volume of this region. Using T1-weighted imaging, we describe a reproducible delineation procedure to estimate the hypothalamic volume which was based on the same landmarks used in histologically processed postmortem hypothalamic tissue. Participants included 36 prodromal HD (pre-HD), 33 symptomatic HD (symp-HD) and 33 control participants who underwent MRI scanning at baseline and 18 months follow-up as part of the IMAGE-HD study. We found no evidence of cross-sectional or longitudinal changes between groups in hypothalamic volume. Our results suggest that hypothalamic pathology in HD is not associated with volume changes.	[Gabery, Sanaz; Lundh, Sofia Hult; Cheong, Rachel Y.; Petersen, Asa] Lund Univ, Dept Expt Med Sci, Translat Neuroendocrine Res Unit, Lund, Sweden; [Georgiou-Karistianis, Nellie; Churchyard, Andrew; Stout, Julie C.; Egan, Gary F.] Monash Univ, Sch Psychol Sci, Clayton, Vic 3180, Australia; [Churchyard, Andrew; Chua, Phyllis] Bethlehem Hosp, Huntingtons Dis Unit, Caulfield, Vic 3162, Australia; [Chua, Phyllis] Monash Univ, Sch Clin Sci Monash Hlth, Dept Psychiat, Clayton, Vic 3168, Australia; [Egan, Gary F.] Monash Univ, Monash Biomed Imaging, Clayton, Vic 3180, Australia; [Egan, Gary F.] Victorian Life Sci Computat Initiat, Life Sci Computat Ctr, Melbourne, Vic, Australia; [Kirik, Deniz] Lund Univ, Dept Expt Med Sci, Brain Repair & Imaging Neural Syst BRAINS Unit, Lund, Sweden; [Kirik, Deniz] Lund Univ, Bioimaging Ctr, Lund, Sweden	Lund University; Monash University; Monash University; Monash University; Lund University; Lund University	Gabery, S (corresponding author), Lund Univ, Dept Expt Med Sci, Translat Neuroendocrine Res Unit, Lund, Sweden.	sanaz.gabery@med.lu.se	Egan, Gary F./A-1381-2013; Georgiou-Karistianis, Nellie/ABC-5623-2020; Chua, Phyllis ML/I-2109-2014	Georgiou-Karistianis, Nellie/0000-0003-0718-6760; Chua, Phyllis ML/0000-0001-6503-6678; Egan, Gary/0000-0002-3186-4026; Cheong, Rachel/0000-0003-0264-7636; Stout, Julie/0000-0001-9637-8590	Swedish Research Council [20083092, 2010-4500, 2012-5854, 2013-3537]; Bagadilico network; province of Skane ALF; Ragnar Soderberg Foundation; CHDI Foundation Inc. New York (USA) [A - 3433]; National Health and Medical Research Council (NHMRC, Australia) [606650]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Bagadilico network; province of Skane ALF; Ragnar Soderberg Foundation; CHDI Foundation Inc. New York (USA); National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Swedish Research Council (grant numbers 20083092, 2010-4500, 2012-5854 and 2013-3537), the Bagadilico network, the province of Skane ALF, the Ragnar Soderberg Foundation, the CHDI Foundation Inc. New York (USA) (grant number A - 3433) and the National Health and Medical Research Council (NHMRC, Australia) (grant number 606650). The funders had no role in study design, data collection	Arnulf I, 2008, ARCH NEUROL-CHICAGO, V65, P482, DOI 10.1001/archneur.65.4.482; Aylward EH, 2004, NEUROLOGY, V63, P66, DOI 10.1212/01.WNL.0000132965.14653.D1; Aylward EH, 2000, MOVEMENT DISORD, V15, P552, DOI 10.1002/1531-8257(200005)15:3<552::AID-MDS1020>3.0.CO;2-P; AYLWARD EH, 1994, NEUROLOGY, V44, P823, DOI 10.1212/WNL.44.5.823; Aziz A, 2008, BRAIN PATHOL, V18, P474, DOI 10.1111/j.1750-3639.2008.00135.x; Bielau H, 2005, EUR ARCH PSY CLIN N, V255, P401, DOI 10.1007/s00406-005-0581-y; Callen DJA, 2001, NEUROLOGY, V57, P1669, DOI 10.1212/WNL.57.9.1669; Dominguez JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074131; DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004; Douaud G, 2006, NEUROIMAGE, V32, P1562, DOI 10.1016/j.neuroimage.2006.05.057; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; DUPONT RM, 1995, ARCH GEN PSYCHIAT, V52, P747; Epping EA, 2011, NEURODEGENER DIS MAN, V1, P407, DOI 10.2217/NMT.11.45; Gabery S, 2010, ACTA NEUROPATHOL; Georgiou-Karistianis N, 2013, NEUROBIOL DIS, V51, P82, DOI 10.1016/j.nbd.2012.10.001; Georgiou-Karistianis N, 2013, HUMAN BRAIN MAPPING; Georgiou-Karistianis N, 2013, BRAIN COGNITION, V83, P80, DOI 10.1016/j.bandc.2013.07.004; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Gray MA, 2013, EXP NEUROL, V239, P218, DOI 10.1016/j.expneurol.2012.10.020; Ha J, 2013, DIS MARKERS, V2013, P249, DOI 10.1155/2013/531736; Hulshoff HE, 2002, AM J PSYCHIAT, V159, P244, DOI 10.1176/appi.ajp.159.2.244; Hult S, 2011, CELL METAB, V13, P428, DOI 10.1016/j.cmet.2011.02.013; Kassubek J, 2004, J NEUROL NEUROSUR PS, V75, P213; Klomp A, 2012, INT J NEUROPSYCHOPH, V15, P281, DOI 10.1017/S1461145711000794; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Lundh SH, 2013, HUM MOL GENET, V22, P3485, DOI 10.1093/hmg/ddt203; Koolschijn PCMP, 2008, EUR NEUROPSYCHOPHARM, V18, P312, DOI 10.1016/j.euroneuro.2007.12.004; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mai JK., 2008, ATLAS HUMAN BRAIN, V3rd ed; Majid DSA, 2011, MOVEMENT DISORD, V26, P2544, DOI 10.1002/mds.23912; Makris N, 2013, NEUROIMAGE, V69, P1, DOI 10.1016/j.neuroimage.2012.12.008; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Nelson H., 1991, NATL ADULT READING T; Nopoulos PC, 2004, NEUROPSYCHOPHARMACOL, V29, pS142; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; Paulsen JS, 2010, BRAIN RES BULL, V82, P201, DOI 10.1016/j.brainresbull.2010.04.003; Petersen A, 2005, HUM MOL GENET, V14, P39, DOI 10.1093/hmg/ddi004; Petersen A, 2006, EUR J NEUROSCI, V24, P961, DOI 10.1111/j.1460-9568.2006.04985.x; Petersen A, 2012, J HUNTINGTONS DIS, V1, P5, DOI 10.3233/JHD-2012-120006; Piguet O, 2011, ANN NEUROL, V69, P312, DOI 10.1002/ana.22244; Politis M, 2008, BRAIN, V131, P2860, DOI 10.1093/brain/awn244; Politis M, 2011, HUM BRAIN MAPP, V32, P258, DOI 10.1002/hbm.21008; Poudel GR, 2014, J PSYCHIATR NEUROSCI, V39, P87, DOI 10.1503/jpn.120226; Poudel GR, 2013, BRAIN STRUCTURE FUNC; Sanchez-Castaneda C, 2013, HUM BRAIN MAPP, V34, P1625, DOI 10.1002/hbm.22019; Schindler S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066394; Schindler S, 2012, PSYCHIAT RES-NEUROIM, V201, P1, DOI 10.1016/j.pscychresns.2011.06.005; Shear PK, 1996, ALCOHOL CLIN EXP RES, V20, P1489, DOI 10.1111/j.1530-0277.1996.tb01153.x; Smith A, 2002, SYMBOL DIGIT MODALIT; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Soneson C, 2010, NEUROBIOL DIS; Stoffers D, 2010, NEUROLOGY, V74, P1208, DOI 10.1212/WNL.0b013e3181d8c20a; Sullivan EV, 1999, ALCOHOL CLIN EXP RES, V23, P1629, DOI 10.1097/00000374-199910000-00010; Swaab DF, 2004, INT REV CYTOL, V240, P305, DOI 10.1016/S0074-7696(04)40003-5; SWAAB DF, 1985, BRAIN RES, V342, P37, DOI 10.1016/0006-8993(85)91350-2; SWAAB DF, 1985, SCIENCE, V228, P1112, DOI 10.1126/science.3992248; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Terlevic R, 2013, J AFFECT DISORDERS, V146, P390, DOI 10.1016/j.jad.2012.09.024; Thieben MJ, 2002, BRAIN, V125, P1815, DOI 10.1093/brain/awf179; Tognin S, 2012, PSYCHIAT RES-NEUROIM, V204, P75, DOI 10.1016/j.pscychresns.2012.10.006; Trejo A, 2004, NUTRITION, V20, P192, DOI 10.1016/j.nut.2003.10.007; van Duijn E, 2007, J NEUROPSYCH CLIN N, V19, P441, DOI 10.1176/appi.neuropsych.19.4.441; van Wamelen DJ, 2013, SLEEP, V36, P117, DOI 10.5665/sleep.2314; van Wamelen DJ, 2011, BRAIN PATHOL, V21, P419, DOI 10.1111/j.1750-3639.2010.00465.x; van Wamelen DJ, 2012, J NEUROENDOCRINOLOGY; van Wamelen DJ, 2012, BRAIN PATHOLOGY; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Watson D, 2005, ASSESSMENT, V12, P50, DOI 10.1177/1073191104271483; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	72	24	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117593	10.1371/journal.pone.0117593	http://dx.doi.org/10.1371/journal.pone.0117593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659157	Green Published, gold			2022-12-27	WOS:000349444900186
J	Wang, HN; Bai, YH; Chen, YC; Zhang, RG; Wang, HH; Zhang, YH; Gan, JL; Peng, ZW; Tan, QR				Wang, Hua-ning; Bai, Yuan-han; Chen, Yun-chun; Zhang, Rui-guo; Wang, Huai-hai; Zhang, Ya-hong; Gan, Jing-li; Peng, Zheng-wu; Tan, Qing-rong			Repetitive Transcranial Magnetic Stimulation Ameliorates Anxiety-Like Behavior and Impaired Sensorimotor Gating in a Rat Model of Post-Traumatic Stress Disorder	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; ACOUSTIC STARTLE REFLEX; PREPULSE INHIBITION; NUCLEUS-ACCUMBENS; GENE-EXPRESSION; MESSENGER-RNA; DOUBLE-BLIND; PLACEBO; HIPPOCAMPAL; ATTENTION	Background Repetitive transcranial magnetic stimulation (rTMS) has been employed for decades as a non-pharmacologic treatment for post-traumatic stress disorder (PTSD). Although a link has been suggested between PTSD and impaired sensorimotor gating (SG), studies assessing the effects of rTMS against PTSD or PTSD with impaired SG are scarce. Aim To assess the benefit of rTMS in a rat model of PTSD. Methods Using a modified single prolonged stress (SPS&S) rat model of PTSD, behavioral parameters were acquired using open field test (OFT), elevated plus maze test (EPMT), and prepulse inhibition trial (PPI), with or without 7 days of high frequency (10Hz) rTMS treatment of SPS&S rats. Results Anxiety-like behavior, impaired SG and increased plasma level of cortisol were observed in SPS&S animals after stress for a prolonged time. Interestingly, rTMS administered immediately after stress prevented those impairment. Conclusion Stress-induced anxiety-like behavior, increased plasma level of cortisol and impaired PPI occur after stress and high-frequency rTMS has the potential to ameliorate this behavior, suggesting that high frequency rTMS should be further evaluated for its use as a method for preventing PTSD.	[Wang, Hua-ning; Bai, Yuan-han; Chen, Yun-chun; Zhang, Rui-guo; Wang, Huai-hai; Zhang, Ya-hong; Peng, Zheng-wu; Tan, Qing-rong] Fourth Mil Med Univ, Xijing Hosp, Dept Psychiat, Xian 710032, Peoples R China; [Gan, Jing-li] 91 Hosp PLA, Dept Psychiat, Jiaozuo 454150, Peoples R China	Air Force Military Medical University	Peng, ZW (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Psychiat, Xian 710032, Peoples R China.	pengzhengwu1446@163.com; tanqingr@fmmu.edu.cn	Peng, Zheng-wu/ABA-5838-2021	Peng, Zheng-wu/0000-0002-8185-0538; Bai, Yuanhan/0000-0003-3574-1346; Wang, Hua-Ning/0000-0003-1981-4293	National Key Technology R & D Program of China [2009BA177B09]; Natural Science Foundation of China [81201041, 81371478, 81401109]	National Key Technology R & D Program of China(National Key Technology R&D Program); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Technology R & D Program of China (No. 2009BA177B09) and the Natural Science Foundation of China (No. 81201041, 81371478 and 81401109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2007, SCIENCE, V317, P1918, DOI 10.1126/science.1146426; Baek K, 2012, NEUROSCIENCE, V200, P159, DOI 10.1016/j.neuroscience.2011.09.050; Baisley SK, 2011, PHYSIOL BEHAV, V104, P796, DOI 10.1016/j.physbeh.2011.08.001; Bitsios P, 2005, INT J PSYCHOPHYSIOL, V55, P229, DOI 10.1016/j.ijpsycho.2004.08.002; Boggio PS, 2010, J CLIN PSYCHIAT, V71, P992, DOI 10.4088/JCP.08m04638blu; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cohen H, 2004, AM J PSYCHIAT, V161, P515, DOI 10.1176/appi.ajp.161.3.515; Conrad KL, 2011, PHYSIOL BEHAV, V104, P248, DOI 10.1016/j.physbeh.2011.03.001; Feng SF, 2012, BEHAV BRAIN RES, V232, P245, DOI 10.1016/j.bbr.2012.04.019; Ferguson SA, 2001, NEUROTOXICOL TERATOL, V23, P57, DOI 10.1016/S0892-0362(00)00115-X; Filion DL, 2003, BIOL PSYCHOL, V64, P283, DOI 10.1016/S0301-0511(03)00077-2; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Friedman MJ, 2007, J CLIN PSYCHIAT, V68, P711, DOI 10.4088/JCP.v68n0508; George MS, 1996, J NEUROPSYCH CLIN N, V8, P373; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Ghisolfi ES, 2004, INT J PSYCHOPHYSIOL, V51, P209, DOI 10.1016/j.ijpsycho.2003.09.002; Gillette GM, 1997, LIFE SCI, V61, P1421, DOI 10.1016/S0024-3205(97)00688-7; Grillon C, 1996, PSYCHIAT RES, V64, P169, DOI 10.1016/S0165-1781(96)02942-3; HERBERT H, 1991, J COMP NEUROL, V304, P103, DOI 10.1002/cne.903040108; Horger BA, 1996, CRIT REV NEUROBIOL, V10, P395; Imanaka A, 2006, BEHAV BRAIN RES, V173, P129, DOI 10.1016/j.bbr.2006.06.012; Iwamoto Y, 2007, PROG NEURO-PSYCHOPH, V31, P642, DOI 10.1016/j.pnpbp.2006.12.010; JACKSON G, 1991, BRIT MED J, V303, P533, DOI 10.1136/bmj.303.6802.533; Jia M, 2012, JOVE-J VIS EXP, DOI 10.3791/3361; Kanno M, 2003, J NEUROL SCI, V211, P5, DOI 10.1016/S0022-510X(03)00030-3; Keck ME, 2000, EUR J NEUROSCI, V12, P3713, DOI 10.1046/j.1460-9568.2000.00243.x; Khan S, 2004, PSYCHOPHARMACOLOGY, V172, P225, DOI 10.1007/s00213-003-1634-4; Kumari V, 2003, PSYCHIAT RES-NEUROIM, V122, P99, DOI 10.1016/s0925-4927(02)00123-3; Li YN, 2013, J MOL NEUROSCI, V51, P127, DOI 10.1007/s12031-013-9965-z; Liberzon I, 1999, J NEUROENDOCRINOL, V11, P11; Liberzon I, 1997, PSYCHONEUROENDOCRINO, V22, P443, DOI 10.1016/S0306-4530(97)00044-9; Marshall RD, 2001, AM J PSYCHIAT, V158, P1982, DOI 10.1176/appi.ajp.158.12.1982; McAuliffe JJ, 2009, ANESTHESIOLOGY, V111, P533, DOI 10.1097/ALN.0b013e3181b060d3; Meloni EG, 2000, J NEUROSCI, V20, P5374, DOI 10.1523/JNEUROSCI.20-14-05374.2000; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Neylan TC, 1999, BIOL PSYCHIAT, V46, P1656, DOI 10.1016/S0006-3223(99)00047-5; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Sailer U, 2008, NEUROPSYCHOLOGIA, V46, P2836, DOI 10.1016/j.neuropsychologia.2008.05.022; Sallinen J, 1998, J NEUROSCI, V18, P3035; Seo JH, 2013, MOL MED REP, V7, P389, DOI 10.3892/mmr.2012.1197; Stewart LP, 2008, DEPRESS ANXIETY, V25, P38, DOI 10.1002/da.20255; Swerdlow NR, 2013, NEUROPHARMACOLOGY, V75, P38, DOI 10.1016/j.neuropharm.2013.06.003; Swerdlow NR, 2013, BEHAV BRAIN RES, V257, P118, DOI 10.1016/j.bbr.2013.09.005; SWERDLOW NR, 1991, J PHARMACOL EXP THER, V256, P530; Takahashi K, 2007, BIOL PSYCHIAT, V62, P148, DOI 10.1016/j.biopsych.2006.06.035; Thorne GL, 2005, INT J PSYCHOPHYSIOL, V56, P121, DOI 10.1016/j.ijpsycho.2004.11.006; Tucker P, 2001, J CLIN PSYCHIAT, V62, P860, DOI 10.4088/JCP.v62n1105; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Wang HN, 2010, PHYSIOL RES, V59, P263, DOI 10.33549/physiolres.931756; Wang HY, 2011, J NEUROSCI, V31, P11044, DOI 10.1523/JNEUROSCI.2125-11.2011; Wang HN, 2014, J PSYCHIATR RES, V51, P79, DOI 10.1016/j.jpsychires.2014.01.004; Wang HN, 2009, PROG NEURO-PSYCHOPH, V33, P1458, DOI 10.1016/j.pnpbp.2009.07.031; Wang W, 2008, NEUROSCI LETT, V441, P237, DOI 10.1016/j.neulet.2008.06.031; Weiss SJ, 2007, PERSPECT PSYCHIATR C, V43, P114, DOI 10.1111/j.1744-6163.2007.00120.x; Wen L, 2014, J MOL NEUROSCI; Yamamoto S, 2009, DEPRESS ANXIETY, V26, P1110, DOI 10.1002/da.20629; Yeomans JS, 1995, BRAIN RES REV, V21, P301, DOI 10.1016/0165-0173(96)00004-5; Yue L, 2009, BRAIN RES, V1260, P94, DOI 10.1016/j.brainres.2009.01.009; Zelikowsky M, 2014, J NEUROSCI, V34, P8462, DOI 10.1523/JNEUROSCI.3624-13.2014; Zhao DM, 2014, J MOL NEUROSCI, V54, P147, DOI 10.1007/s12031-014-0263-1	61	17	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117189	10.1371/journal.pone.0117189	http://dx.doi.org/10.1371/journal.pone.0117189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659132	gold, Green Published			2022-12-27	WOS:000349444900114
J	Yamaji, M; Mahmoud, M; Evans, IM; Zachary, IC				Yamaji, Maiko; Mahmoud, Marwa; Evans, Ian M.; Zachary, Ian C.			Neuropilin 1 Is Essential for Gastrointestinal Smooth Muscle Contractility and Motility in Aged Mice	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; INTESTINAL PSEUDOOBSTRUCTION; URINARY-BLADDER; GENE-EXPRESSION; SEMAPHORIN-III; CELL MIGRATION; GROWTH-FACTOR; TUMOR-CELLS; MYOSIN; RECEPTOR	Background and Aims Neuropilin 1 (NRP1) is a non-tyrosine kinase receptor for vascular endothelial growth factor (VEGF) and class 3 semaphorins, playing a role in angiogenesis and neuronal axon guidance, respectively. NRP1 is expressed in smooth muscle cells (SMC) but the functional role of NRP1 in SMC has not been elucidated. We therefore investigated the biological relevance of NRP1 in SMC in vivo by generating mice with SMC-specific Nrp1 deficiency. Methods Conditional gene targeting generated SMC-specific Nrp1 knockout mice (Nrp1(SMKO)) in which Cre recombinase is driven by the smooth muscle-specific myosin heavy chain (smMHC) promoter. Results SMC-specific Nrp1 deficiency resulted in a significant reduction in intestinal length by 6 months, and, by 18 months, in severe constipation, and enlargement of the intestine consistent with chronic intestinal pseudo-obstruction. These effects were associated with significant thinning of the intestinal smooth muscle, and decreased intestinal contractility. Expression of contractile proteins was reduced in Nrp1(SMKO) mice, including the smMHC isoform, SMB, whereas we observed a significant increase in the expression of the small-conductance calcium-activated potassium channel 3 (SK3/KCa2.3), implicated in negative regulation of smooth muscle contraction. Conclusions Nrp1 deficiency in visceral SMC results in adult-onset defects in gastrointestinal contractility and motility and causes a shift to a less contractile SMC phenotype. These findings indicate a new role for Nrp1 in the maintenance of the visceral SMC contractile phenotype required for normal GI motility in aged mice.	[Yamaji, Maiko; Mahmoud, Marwa; Evans, Ian M.; Zachary, Ian C.] UCL, Div Med, Ctr Cardiovasc Biol & Med, London WC1E 6JJ, England	University of London; University College London	Zachary, IC (corresponding author), UCL, Div Med, Ctr Cardiovasc Biol & Med, Rayne Bldg, London WC1E 6JJ, England.	I.Zachary@ucl.ac.uk	Evans, Ian/C-8533-2009	Evans, Ian/0000-0002-0468-8274; Mahmoud, Marwa/0000-0003-4382-1725	British Heart Foundation [RG/06/003]; British Heart Foundation [RG/06/003/21131, RG/11/11/29050] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation programme grant RG/06/003 to I.Z. (M.Y., M.M., I.M.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Babu GJ, 2000, MICROSC RES TECHNIQ, V50, P532, DOI 10.1002/1097-0029(20000915)50:6<532::AID-JEMT10>3.0.CO;2-E; Bielenberg DR, 2012, AM J PATHOL, V181, P548, DOI 10.1016/j.ajpath.2012.04.013; Burn Sally F, 2012, Methods Mol Biol, V886, P241, DOI 10.1007/978-1-61779-851-1_21; de Lange WJ, 2008, PHYSIOL GENOMICS, V35, P1, DOI 10.1152/physiolgenomics.90284.2008; Evans IM, 2011, MOL CELL BIOL, V31, P1174, DOI 10.1128/MCB.00903-10; Fantin A, 2014, DEVELOPMENT, V141, P556, DOI 10.1242/dev.103028; Frankel P, 2008, EMBO REP, V9, P983, DOI 10.1038/embor.2008.151; Fujita A, 2001, AM J PHYSIOL-CELL PH, V281, pC1727, DOI 10.1152/ajpcell.2001.281.5.C1727; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; HAMADA Y, 1990, BIOCHEM BIOPH RES CO, V170, P53, DOI 10.1016/0006-291X(90)91239-O; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; HENNING SJ, 1973, ENZYME, V15, P3, DOI 10.1159/000481051; Herrera GM, 2000, AM J PHYSIOL-REG I, V279, pR60, DOI 10.1152/ajpregu.2000.279.1.R60; Hoggatt AM, 2013, J BIOL CHEM, V288, P28477, DOI 10.1074/jbc.M113.478974; Jubb AM, 2012, J PATHOL, V226, P50, DOI 10.1002/path.2989; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; KELLEY CA, 1993, J BIOL CHEM, V268, P12848; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; KLEIN RM, 1983, J PEDIATR GASTR NUTR, V2, P204, DOI 10.1097/00005176-198305000-00002; Knowles CH, 2004, GUT, V53, P1583, DOI 10.1136/gut.2003.037275; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Lauzon AM, 1998, J MUSCLE RES CELL M, V19, P825, DOI 10.1023/A:1005489501357; Li F, 2008, BIOCHEM BIOPH RES CO, V370, P317, DOI 10.1016/j.bbrc.2008.03.096; Li ZS, 2006, J NEUROSCI, V26, P2798, DOI 10.1523/JNEUROSCI.4720-05.2006; Liu WB, 2005, CYTOKINE, V32, P206, DOI 10.1016/j.cyto.2005.09.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mann SD, 1997, GUT, V41, P675, DOI 10.1136/gut.41.5.675; McHugh KM, 1996, J PEDIATR GASTR NUTR, V23, P379, DOI 10.1097/00005176-199611000-00001; Mericskay M, 2007, GASTROENTEROLOGY, V133, P1960, DOI 10.1053/j.gastro.2007.09.010; Niessen P, 2005, GASTROENTEROLOGY, V129, P1592, DOI 10.1053/j.gastro.2005.08.018; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Park C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018628; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Pellet-Many C, 2011, BIOCHEM J, V435, P609, DOI 10.1042/BJ20100580; Ro S, 2001, AM J PHYSIOL-GASTR L, V281, pG964, DOI 10.1152/ajpgi.2001.281.4.G964; Rovner AS, 1997, J MUSCLE RES CELL M, V18, P103, DOI 10.1023/A:1018689102122; SCHUFFLER MD, 1977, GASTROENTEROLOGY, V73, P327; Shintani Y, 2006, EMBO J, V25, P3045, DOI 10.1038/sj.emboj.7601188; Siegman MJ, 1997, AM J PHYSIOL-GASTR L, V272, pG1571, DOI 10.1152/ajpgi.1997.272.6.G1571; Sjuve R, 1996, J CELL BIOCHEM, V63, P86; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Taylor MS, 2003, CIRC RES, V93, P124, DOI 10.1161/01.RES.0000081980.63146.69; Taylor TN, 2010, BEHAV BRAIN RES, V211, P1, DOI 10.1016/j.bbr.2010.03.004; Vohra BPS, 2006, DEV BIOL, V298, P259, DOI 10.1016/j.ydbio.2006.06.033; Wright-Jin EC, 2013, DEV BIOL, V381, P28, DOI 10.1016/j.ydbio.2013.06.021; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Zhang M, 2011, MOL CELL BIOL, V31, P2618, DOI 10.1128/MCB.01338-10	52	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115563	10.1371/journal.pone.0115563	http://dx.doi.org/10.1371/journal.pone.0115563			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659123	Green Published, gold			2022-12-27	WOS:000349444900023
J	Zhang, XT; Ni, ZH; Duan, ZP; Xin, ZY; Wang, HD; Tan, JY; Wang, GQ; Li, F				Zhang, XiaoTian; Ni, ZhaoHui; Duan, ZiPeng; Xin, ZhuoYuan; Wang, HuaiDong; Tan, JiaYi; Wang, GuoQing; Li, Fan			Overexpression of E2F mRNAs Associated with Gastric Cancer Progression Identified by the Transcription Factor and miRNA Co-Regulatory Network Analysis	PLOS ONE			English	Article							MICRORNA TARGET PREDICTION; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; EXPRESSION; CELL; PROLIFERATION; ACTIVATION; RESISTANCE; PATTERNS; BIOLOGY	Gene expression is regulated at the transcription and translation levels; thus, both transcription factors (TFs) and microRNAs (miRNA) play roles in regulation of gene expression. This study profiled differentially expressed mRNAs and miRNAs in gastric cancer tissues to construct a TF and miRNA co-regulatory network in order to identify altered genes in gastric cancer progression. A total of 70 cases gastric cancer and paired adjacent normal tissues were subjected to cDNA and miRNA microarray analyses. We obtained 887 up-regulated and 93 down-regulated genes and 41 down-regulated and 4 up-regulated miRNAs in gastric cancer tissues. Using the Transcriptional Regulatory Element Database, we obtained 105 genes that are regulated by the E2F family of genes and using Targetscan, miRanda, miRDB and miRWalk tools, we predicted potential targeting genes of these 45 miRNAs. We then built up the E2F-related TF and miRNA co-regulatory gene network and identified 9 hub-genes. Furthermore, we found that levels of E2F1, 2, 3, 4, 5, and 7 mRNAs associated with gastric cancer cell invasion capacity, and has associated with tumor differentiation. These data showed Overexpression of E2F mRNAs associated with gastric cancer progression.	[Zhang, XiaoTian; Ni, ZhaoHui; Duan, ZiPeng; Xin, ZhuoYuan; Wang, HuaiDong; Tan, JiaYi; Wang, GuoQing; Li, Fan] Jilin Univ, Coll Basic Med, Dept Pathogenobiol, Key Lab Zoonosis,Chinese Minist Educ, Changchun 130023, Jilin, Peoples R China	Jilin University	Wang, GQ (corresponding author), Jilin Univ, Coll Basic Med, Dept Pathogenobiol, Key Lab Zoonosis,Chinese Minist Educ, Changchun 130023, Jilin, Peoples R China.	qing@jlu.edu.cn; lifan@jlu.edu.cn		Tan, Jiayi/0000-0001-5938-7471	National Natural Science Foundation of China [81320108025, 81472662]; Foundation of Jilin Province Science and Technology Department [20130522013JH, 20140414048GH]; Norman Bethune Program of Jilin University [2012219]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Jilin Province Science and Technology Department; Norman Bethune Program of Jilin University	This work was supported in part by grants from National Natural Science Foundation of China (#81320108025 and #81472662), Foundation of Jilin Province Science and Technology Department (#20130522013JH and #20140414048GH) and the Norman Bethune Program of Jilin University (#2012219). The authors also thank the Medjaden Bioscience Limited (Hong Kong, China) for editing and proofreading this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Emmrich S, 2010, CELL CYCLE, V9, P2555, DOI 10.4161/cc.9.13.12061; Gao CP, 2010, CANCER-AM CANCER SOC, V116, P41, DOI 10.1002/cncr.24743; Golan T, 2014, BRIT J CANCER, DOI [10.1038/bjc.2014.626, DOI 10.1038/BJC.2014.626]; Greten FR, 2014, CELL, V158, P11, DOI 10.1016/j.cell.2014.06.021; Guo XB, 2010, BIOCHEM BIOPH RES CO, V398, P1, DOI 10.1016/j.bbrc.2010.05.082; Hsu KW, 2012, CARCINOGENESIS, V33, P1459, DOI 10.1093/carcin/bgs165; Huang SL, 2012, CANCER LETT, V315, P198, DOI 10.1016/j.canlet.2011.10.011; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jiang DF, 2014, BLOOD, V123, P86, DOI 10.1182/blood-2013-07-515254; Kubota E, 2014, CELL CYCLE, V13, P2129, DOI 10.4161/cc.29212; Lee JS, 2010, J CLIN ONCOL, V28, P2660, DOI 10.1200/JCO.2009.25.0977; Li GJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp491; Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045; Miller TW, 2011, CANCER DISCOV, V1, P338, DOI 10.1158/2159-8290.CD-11-0101; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Okamoto W, 2011, BRIT J CANCER, V105, P407, DOI 10.1038/bjc.2011.246; Park D, 2014, PATHOL INT, V64, P309, DOI 10.1111/pin.12178; Peterson SM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00023; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Reimer D, 2011, ONCOGENE, V30, P4038, DOI 10.1038/onc.2011.119; Ren ZJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.327; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Vauhkonen M, 2006, BEST PRACT RES CL GA, V20, P651, DOI 10.1016/j.bpg.2006.03.016; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wei J, 2011, J NATL CANCER I, V103, P1552, DOI 10.1093/jnci/djr326; Wilting SM, 2013, ONCOGENE, V32, P106, DOI 10.1038/onc.2012.20; Wong HL, 2011, CANCER SCI, V102, P1911, DOI 10.1111/j.1349-7006.2011.02033.x; Wu Q, 2013, J CELL SCI, V126, P4220, DOI 10.1242/jcs.127944; Wu Q, 2010, BIOCHEM BIOPH RES CO, V392, P340, DOI 10.1016/j.bbrc.2009.12.182; Xu YJ, 2014, MOL MED REP, V10, P2601, DOI 10.3892/mmr.2014.2567; Yao YL, 2013, ASIAN PAC J CANCER P, V14, P2839, DOI 10.7314/APJCP.2013.14.5.2839; Zhang YY, 2010, MED ONCOL, V27, P685, DOI 10.1007/s12032-009-9269-x; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	47	29	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116979	10.1371/journal.pone.0116979	http://dx.doi.org/10.1371/journal.pone.0116979			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646628	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600045
J	Kellar, NM; Catelani, KN; Robbins, MN; Trego, ML; Allen, CD; Danil, K; Chivers, SJ				Kellar, Nicholas M.; Catelani, Krista N.; Robbins, Michelle N.; Trego, Marisa L.; Allen, Camryn D.; Danil, Kerri; Chivers, Susan J.			Blubber Cortisol: A Potential Tool for Assessing Stress Response in Free-Ranging Dolphins without Effects due to Sampling	PLOS ONE			English	Article							FECAL GLUCOCORTICOIDS; TURSIOPS-TRUNCATUS; THYROID-HORMONES; SEASONAL-CHANGES; BIOPSY SYSTEM; BLOOD-OXYGEN; PREGNANCY; CAPTURE; INDICATORS; CALIFORNIA	When paired with dart biopsying, quantifying cortisol in blubber tissue may provide an index of relative stress levels (i.e., activation of the hypothalamus-pituitary-adrenal axis) in free-ranging cetacean populations while minimizing the effects of the act of sampling. To validate this approach, cortisol was extracted from blubber samples collected from beach-stranded and bycaught short-beaked common dolphins using a modified blubber steroid isolation technique and measured via commercially available enzyme immunoassays. The measurements exhibited appropriate quality characteristics when analyzed via a bootstraped stepwise parallelism analysis (observed/expected = 1.03, 95%CI: 99.6-1.08) and showed no evidence of matrix interference with increasing sample size across typical biopsy tissue masses (75-150mg; r(2) = 0.012, p = 0.78, slope = 0.022ng(cortisol) (deviation)/ul(tissue) (extract added)). The relationships between blubber cortisol and eight potential cofactors namely, 1) fatality type (e.g., stranded or bycaught), 2) specimen condition (state of decomposition), 3) total body length, 4) sex, 5) sexual maturity state, 6) pregnancy status, 7) lactation state, and 8) adrenal mass, were assessed using a Bayesian generalized linear model averaging technique. Fatality type was the only factor correlated with blubber cortisol, and the magnitude of the effect size was substantial: beach-stranded individuals had on average 6.1-fold higher cortisol levels than those of bycaught individuals. Because of the difference in conditions surrounding these two fatality types, we interpret this relationship as evidence that blubber cortisol is indicative of stress response. We found no evidence of seasonal variation or a relationship between cortisol and the remaining cofactors.	[Kellar, Nicholas M.; Catelani, Krista N.; Robbins, Michelle N.; Trego, Marisa L.; Allen, Camryn D.; Danil, Kerri; Chivers, Susan J.] Natl Marine Fisheries Serv, Natl Ocean & Atmospher Adm, Southwest Fisheries Sci Ctr, Protected Resources Div, La Jolla, CA 92038 USA; [Catelani, Krista N.; Robbins, Michelle N.; Trego, Marisa L.] Ocean Associates Inc, Arlington, VA USA	National Oceanic Atmospheric Admin (NOAA) - USA	Kellar, NM (corresponding author), Natl Marine Fisheries Serv, Natl Ocean & Atmospher Adm, Southwest Fisheries Sci Ctr, Protected Resources Div, La Jolla, CA 92038 USA.	Nick.Kellar@noaa.gov	Kellar, Nicholas/AAA-4606-2021	Danil, Kerri/0000-0001-6985-4678	Office of Naval Research [N0001411IP20080]; National Marine Fisheries Service	Office of Naval Research(Office of Naval Research); National Marine Fisheries Service	The Office of Naval Research, award N0001411IP20080, was the primary funding source for this research with additional support from the National Marine Fisheries Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON HC, 1995, ENDOCRINOLOGY, V136, P512, DOI 10.1210/en.136.2.512; BarrettLennard LG, 1996, MAR MAMMAL SCI, V12, P14, DOI 10.1111/j.1748-7692.1996.tb00302.x; Bennett KA, 2012, COMP BIOCHEM PHYS A, V161, P69, DOI 10.1016/j.cbpa.2011.09.003; Blas J, 2007, P NATL ACAD SCI USA, V104, P8880, DOI 10.1073/pnas.0700232104; Blasius ME, 2008, MAR POLLUT BULL, V56, P1973, DOI 10.1016/j.marpolbul.2008.08.011; Boonstra R, 2001, CAN J ZOOL, V79, P49, DOI 10.1139/cjz-79-1-49; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; Caretta J.V., 2004, MAR FISH REV, V66, P21; CARLIN BP, 1995, J ROY STAT SOC B MET, V57, P473; Cash WB, 1997, GEN COMP ENDOCR, V108, P427, DOI 10.1006/gcen.1997.6999; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Danil Kerri, 2010, Journal of Cetacean Research and Management, V11, P163; Delehanty B, 2009, GEN COMP ENDOCR, V160, P176, DOI 10.1016/j.ygcen.2008.11.011; DESLYPERE JP, 1985, J CLIN ENDOCR METAB, V61, P564, DOI 10.1210/jcem-61-3-564; Douyon L, 2002, ENDOCRIN METAB CLIN, V31, P173, DOI 10.1016/S0889-8529(01)00023-8; du Dot TJ, 2009, COMP BIOCHEM PHYS A, V152, P524, DOI 10.1016/j.cbpa.2008.12.010; Fair PA, 2014, GEN COMP ENDOCR, V206, P203, DOI 10.1016/j.ygcen.2014.07.002; Falk RT, 2008, CANCER EPIDEM BIOMAR, V17, P1891, DOI 10.1158/1055-9965.EPI-08-0119; Ferin M, 1999, J CLIN ENDOCR METAB, V84, P1768, DOI 10.1210/jc.84.6.1768; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; Heyning John E., 1994, Contributions in Science (Los Angeles), V442, P1; Hunt KE, 2006, GEN COMP ENDOCR, V148, P260, DOI 10.1016/j.ygcen.2006.03.012; Hunt KE, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot006; JOHNSON EO, 1992, NEUROSCI BIOBEHAV R, V16, P115, DOI 10.1016/S0149-7634(05)80175-7; Keay JM, 2006, J ZOO WILDLIFE MED, V37, P234, DOI 10.1638/05-050.1; Kellar NM, 2013, ENDANGER SPECIES RES, V22, P61, DOI 10.3354/esr00537; Kellar NM, 2013, MAR BIOL, V160, P3113, DOI 10.1007/s00227-013-2299-0; Kellar NM, 2013, MAR MAMMAL SCI, V29, pE366, DOI 10.1111/mms.12014; Kellar NM, 2009, MAR MAMMAL SCI, V25, P507, DOI 10.1111/j.1748-7692.2009.00291.x; Kellar NM, 2006, MAR MAMMAL SCI, V22, P1, DOI 10.1111/j.1748-7692.2006.00001.x; Knieriem A., 2001, Aquatic Mammals, V27, P73; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Le Boeuf Burney J, 2002, BMC Ecol, V2, P11, DOI 10.1186/1472-6785-2-11; LOCKYER C, 1976, J CONSEIL, V36, P259, DOI 10.1093/icesjms/36.3.259; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; Mansour AAH, 2002, MAR MAMMAL SCI, V18, P112, DOI 10.1111/j.1748-7692.2002.tb01022.x; Martin P. A., 2003, McDonald's veterinary endocrinology and reproduction, P165; Mashburn KL, 2004, GEN COMP ENDOCR, V136, P371, DOI 10.1016/j.ygcen.2004.01.016; Mead J. F., 1986, LIPIDS CHEM BIOCH NU; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; Noren DP, 2012, MAR MAMMAL SCI, V28, P154, DOI 10.1111/j.1748-7692.2011.00469.x; Noren SR, 2002, J ZOOL, V258, P105, DOI 10.1017/S0952836902001243; Ortiz RM, 2000, COMP BIOCHEM PHYS A, V125, P317, DOI 10.1016/S1095-6433(00)00158-6; PEARN J, 1985, MED J AUSTRALIA, V142, P586, DOI 10.5694/j.1326-5377.1985.tb113523.x; Perez S, 2011, MAR BIOL, V158, P1677, DOI 10.1007/s00227-011-1676-9; PROTHERO JW, 1980, COMP BIOCHEM PHYS A, V67, P649, DOI 10.1016/0300-9629(80)90255-8; Reeder DM, 2005, J MAMMAL, V86, P225, DOI 10.1644/BHE-003.1; RIDGWAY SH, 1966, SCIENCE, V151, P456, DOI 10.1126/science.151.3709.456; Rolland RM, 2012, P ROY SOC B-BIOL SCI, V279, P2363, DOI 10.1098/rspb.2011.2429; Romero LM, 2008, AM J PHYSIOL-REG I, V294, pR614, DOI 10.1152/ajpregu.00752.2007; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Ryan C, 2013, MAR MAMMAL SCI, V29, P542, DOI 10.1111/j.1748-7692.2012.00578.x; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schwacke LH, 2014, ENVIRON SCI TECHNOL, V48, P93, DOI 10.1021/es403610f; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Southall BL, 2012, MAR TECHNOL SOC J, V46, P48, DOI 10.4031/MTSJ.46.4.1; Szymczak J, 1998, STEROIDS, V63, P319, DOI 10.1016/S0039-128X(98)00019-1; TAYLOR KM, 1978, J THORAC CARDIOV SUR, V75, P574; Trego ML, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082806, DOI 10.1371/JOURNAL.PONE.0082806]; Wingfield J.C., 2001, HANDBK PHYSL, P211, DOI [10.1002/cphy.cp070411, DOI 10.1002/CPHY.CP070411]	64	51	52	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0115257	10.1371/journal.pone.0115257	http://dx.doi.org/10.1371/journal.pone.0115257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643144	Green Published, gold, Green Submitted			2022-12-27	WOS:000348821200009
J	Barker, JW; Han, PK; Choi, SH; Bae, KT; Park, SH				Barker, Jeffrey W.; Han, Paul Kyu; Choi, Seung Hong; Bae, Kyongtae Ty; Park, Sung-Hong			Investigation of Inter-Slice Magnetization Transfer Effects as a New Method for MTR Imaging of the Human Brain	PLOS ONE			English	Article							TRANSFER CONTRAST; TRANSFER RATIO; TISSUE; RELAXATION; RESONANCE; CARTILAGE; TUMOR	We present a new method for magnetization transfer (MT) ratio imaging in the brain that requires no separate saturation pulse. Interslice MT effects that are inherent to multi-slice balanced steady-state free precession (bSSFP) imaging were controlled via an interslice delay time to generate MT-weighted (0 s delay) and reference images (5-8 s delay) for MT ratio (MTR) imaging of the brain. The effects of varying flip angle and phase encoding (PE) order were investigated experimentally in normal, healthy subjects. Values of up to similar to 50% and similar to 40% were observed for white and gray matter MTR. Centric PE showed larger MTR, higher SNR, and better contrast between white and gray matter than linear PE. Simulations of a two-pool model of MT agreed well with in vivo MTR values. Simulations were also used to investigate the effects of varying acquisition parameters, and the effects of varying flip angle, PE steps, and interslice delay are discussed. Lastly, we demonstrated reduced banding with a non-balanced SSFP-FID sequence and showed preliminary results of interslice MTR imaging of meningioma.	[Barker, Jeffrey W.; Bae, Kyongtae Ty; Park, Sung-Hong] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Barker, Jeffrey W.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Han, Paul Kyu; Park, Sung-Hong] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU)	Park, SH (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.	sunghongpark@kaist.ac.kr	Park, Sung-Hong/B-3393-2012	Park, Sung-Hong/0000-0002-1731-0668; Choi, Seung Hong/0000-0002-0412-2270	National Research Foundation of Korea [NRF-2013R1A1A1061759]; Competitive Medical Research Fund of the UPMC Health System	National Research Foundation of Korea(National Research Foundation of Korea); Competitive Medical Research Fund of the UPMC Health System	This study was supported by a grant from National Research Foundation of Korea (NRF-2013R1A1A1061759) and a grant from Competitive Medical Research Fund of the UPMC Health System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieri O, 2007, MAGN RESON MED, V58, P511, DOI 10.1002/mrm.21326; Bieri O, 2006, MAGN RESON MED, V56, P1067, DOI 10.1002/mrm.21056; Bieri O, 2008, MAGN RESON MED, V60, P1261, DOI 10.1002/mrm.21781; DIXON WT, 1990, MAGN RESON IMAGING, V8, P417, DOI 10.1016/0730-725X(90)90050-C; Garcia M, 2011, NEURORADIOLOGY, V53, P159, DOI 10.1007/s00234-010-0714-5; Gloor M, 2008, MAGN RESON MED, V60, P691, DOI 10.1002/mrm.21705; Graham SJ, 1997, JMRI-J MAGN RESON IM, V7, P903, DOI 10.1002/jmri.1880070520; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Hua J, 2007, MAGN RESON MED, V58, P786, DOI 10.1002/mrm.21387; Laurent D, 2001, MAGN RESON IMAGING, V19, P1279, DOI 10.1016/S0730-725X(01)00433-7; MELKI PS, 1992, MAGNET RESON MED, V24, P189, DOI 10.1002/mrm.1910240122; MORRISON C, 1995, J MAGN RESON SER B, V108, P103, DOI 10.1006/jmrb.1995.1111; Okumura A, 1999, NEUROL RES, V21, P250, DOI 10.1080/01616412.1999.11740927; Park SH, 2012, MAGN RESON MED, V68, P1600, DOI 10.1002/mrm.24169; Park SH, 2011, MAGN RESON MED, V65, P1578, DOI 10.1002/mrm.22580; Park SH, 2011, MAGN RESON MED, V65, P1702, DOI 10.1002/mrm.22568; Pui MH, 2000, J MAGN RESON IMAGING, V12, P395, DOI 10.1002/1522-2586(200009)12:3<395::AID-JMRI4>3.0.CO;2-L; SANTYR GE, 1993, MAGN RESON IMAGING, V11, P521, DOI 10.1016/0730-725X(93)90471-O; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Wang CY, 2010, MAGN RESON MED, V64, P1520, DOI 10.1002/mrm.22533; Weigel M, 2010, MAGN RESON MED, V63, P230, DOI 10.1002/mrm.22145; Welsch GH, 2008, J MAGN RESON IMAGING, V28, P979, DOI 10.1002/jmri.21516; WOLFF SD, 1991, RADIOLOGY, V179, P623, DOI 10.1148/radiology.179.3.2027963; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113	25	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117101	10.1371/journal.pone.0117101	http://dx.doi.org/10.1371/journal.pone.0117101			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664938	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000349123100018
J	Yao, FY; Chen, YH; Yan, ZB; Li, P; Han, WX; Fang, JY				Yao, Fanyun; Chen, Yahan; Yan, Zhengbing; Li, Peng; Han, Wenxuan; Fang, Jingyun			Biogeographic Patterns of Structural Traits and C:N:P Stoichiometry of Tree Twigs in China's Forests	PLOS ONE			English	Article							LEAF NITROGEN; PHOSPHORUS STOICHIOMETRY; FUNCTIONAL TRAITS; GROWTH FORM; SOIL; PLANTS; EVOLUTION; CLIMATE; BIOMASS; STRATEGIES	There have been a number of studies on biogeographic patterns of plant leaf functional traits; however, the variations in traits of other plant organs such as twigs are rarely investigated. In this study, we sampled current-year twigs of 335 tree species from 12 forest sites across a latitudinal span of 32 degrees in China, and measured twig specific density (TSD), twig dry matter content (TDMC), and carbon (C), nitrogen (N) and phosphorous (P) contents, to explore the latitudinal and environmental patterns of these twig traits. The overall mean of TSD and TDMC was 0.37 g cm(-3) and 41%, respectively; mean twig C, N and P was 472 mg g(-1), 9.8 mg g(-1) and 1.15 mg g(-1), respectively, and mean N:P mass ratio was 10.6. TSD was positively correlated with TDMC which was positively associated with twig C but negatively with twig N and P. There were no significant differences in TSD between conifer, deciduous-broadleaf and evergreen-broadleaf plants, but evergreen-broadleaf plants had the lowest and conifers the highest TDMC. Conifer twigs were lowest in C, N, P and N:P, whereas deciduous-plant twigs were highest in N and P and evergreen-plant twigs were highest in C and N:P. As latitude increased or temperature/precipitation dropped, TDMC and P increased, but N:P ratio decreased. Our results also showed that the patterns of twig P and N:P stoichiometry were consistent with those reported for leaves, but no significant trends in twig N were observed along the gradient of latitude, climate and soils. This study provides the first large-scale patterns of the twig traits and will improve our understanding of the biogeochemistry of carbon and other key nutrients in forest ecosystems.	[Yao, Fanyun; Chen, Yahan; Yan, Zhengbing; Li, Peng; Fang, Jingyun] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Key Lab Earth Surface Proc,Minist Educ, Beijing 100871, Peoples R China; [Han, Wenxuan] China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China	Peking University; China Agricultural University	Fang, JY (corresponding author), Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Key Lab Earth Surface Proc,Minist Educ, Beijing 100871, Peoples R China.	jyfang@urban.pku.edu.cn	Han, Wenxuan/B-8791-2016	Han, Wenxuan/0000-0001-8678-7147	National Natural Science Foundation of China [31321061, 31330012, 41173083]; National Basic Research Program of China on Global Change [2010CB950600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China on Global Change(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (# 31321061 and 31330012, 41173083) and the National Basic Research Program of China on Global Change (2010CB950600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2000, BIOSCIENCE, V50, P979, DOI 10.1641/0006-3568(2000)050[0979:TEOPET]2.0.CO;2; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Bazzaz FA., 1997, PLANT RESOURCE ALLOC; Boerner R, 1984, J APPL ECOL, P1029; Chen YH, 2013, ECOGRAPHY, V36, P178, DOI 10.1111/j.1600-0587.2011.06833.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; GROVE TS, 1990, PLANT SOIL, V126, P265, DOI 10.1007/BF00012829; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; HAUKIOJA E, 1991, PHILOS T R SOC B, V333, P241, DOI 10.1098/rstb.1991.0073; He JS, 2006, OECOLOGIA, V149, P115, DOI 10.1007/s00442-006-0425-0; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; John A, 1950, GRASS FORAGE SCI, V5, P93; JOHN MK, 1970, SOIL SCI, V109, P214, DOI 10.1097/00010694-197004000-00002; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; Liu C, 2006, GLOBAL ECOL BIOGEOGR, V15, P438, DOI 10.1111/j.1466-822x.2006.00251.x; Ma SB, 2001, CHINESE J ECOL, V21, P65; Martin JG, 1998, CAN J FOREST RES, V28, P1648, DOI 10.1139/cjfr-28-11-1648; McIntyre S, 1999, J VEG SCI, V10, P621, DOI 10.2307/3237077; Mooney H. A., 1972, Annual Review of Ecology and Systematics, V3, P315, DOI 10.1146/annurev.es.03.110172.001531; Osada N, 2006, NEW PHYTOL, V172, P667, DOI 10.1111/j.1469-8137.2006.01857.x; RADULOVICH R, 1991, BIOTROPICA, V23, P84, DOI 10.2307/2388691; Reich P. B., 2003, International Journal of Plant Sciences, V164, pS143, DOI 10.1086/374368; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Ren Shu-jie, 2007, Huanjing Kexue, V28, P2665; RYAN MG, 1991, ECOL APPL, V1, P157, DOI 10.2307/1941808; Santiago LS, 2007, ECOLOGY, V88, P1126, DOI 10.1890/06-1841; Sardans J, 2011, FOREST ECOL MANAG, V262, P2024, DOI 10.1016/j.foreco.2011.08.019; Sardans J, 2013, GLOBAL ECOL BIOGEOGR, V22, P494, DOI 10.1111/geb.12015; Schreeg LA, 2014, ECOLOGY, V95, P2062, DOI 10.1890/13-1671.1; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sun SC, 2000, ACTA PHYTO SINI, V25, P76; VANDENDRIESSCHE R, 1974, BOT REV, V40, P347, DOI 10.1007/BF02860066; WILSON BF, 1989, CAN J BOT, V67, P434, DOI 10.1139/b89-060; Xiang SA, 2009, TREES-STRUCT FUNCT, V23, P637, DOI 10.1007/s00468-008-0308-6; Yan En-Rong, 2010, Chinese Journal of Plant Ecology, V34, P48, DOI 10.3773/j.issn.1005-264x.2010.01.008; Yang X, 2014, SCI REP-UK, V4, DOI 10.1038/srep05448; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x; Zechmeister-Boltenstern S, 2002, SOIL BIOL BIOCHEM, V34, P823, DOI 10.1016/S0038-0717(02)00012-3	40	22	26	10	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0116391	10.1371/journal.pone.0116391	http://dx.doi.org/10.1371/journal.pone.0116391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664764	Green Submitted, Green Published, gold			2022-12-27	WOS:000349123100008
J	Bannon, MJ; Savonen, CL; Hartley, ZJ; Johnson, MM; Schmidt, CJ				Bannon, Michael J.; Savonen, Candace L.; Hartley, Zachary J.; Johnson, Magen M.; Schmidt, Carl J.			Investigating the Potential Influence of Cause of Death and Cocaine Levels on the Differential Expression of Genes Associated with Cocaine Abuse	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; PROFILE; BRAINS	The development of new therapeutic strategies for the treatment of complex brain disorders such as drug addiction is likely to be advanced by a more complete understanding of the underlying molecular pathophysiology. Although the study of postmortem human brain represents a unique resource in this regard, it can be challenging to disentangle the relative contribution of chronic pathological processes versus perimortem events to the observed changes in gene expression. To begin to unravel this issue, we analyzed by quantitative PCR the midbrain expression of numerous candidate genes previously associated with cocaine abuse. Data obtained from chronic cocaine abusers (and matched control subjects) dying of gunshot wounds were compared with a prior study of subjects with deaths directly attributable to cocaine abuse. Most of the genes studied (i.e., tyrosine hydroxylase, dopamine transporter, forkhead box A2, histone variant H3 family 3B, nuclear factor kappa B inhibitor alpha, growth arrest and DNA damage-inducible beta) were found to be differentially expressed in chronic cocaine abusers irrespective of immediate cause of death or perimortem levels of cocaine, suggesting that these may represent core pathophysiological changes arising with chronic drug abuse. On the other hand, chemokine C-C motif ligand 2 and jun proto-oncogene expression were unaffected in cocaine-abusing subjects dying of gunshot wounds, in contrast to the differential expression previously reported in cocaine-related fatalities. The possible influence of cause of death and other factors on the cocaine-responsiveness of these genes is discussed.	[Bannon, Michael J.; Savonen, Candace L.; Hartley, Zachary J.; Johnson, Magen M.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Schmidt, Carl J.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	Wayne State University; University of Michigan System; University of Michigan	Bannon, MJ (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.	mbannon@med.wayne.edu		Savonen, Candace/0000-0001-6331-7070	National Institutes of Health [DA006470, DA032222]; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA032222, R01DA006470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants DA006470 (MJB) and DA032222 (MMJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Albertson DN, 2006, NEUROPSYCHOPHARMACOL, V31, P2304, DOI 10.1038/sj.npp.1301089; Albertson DN, 2004, J NEUROCHEM, V88, P1211, DOI 10.1046/j.1471-4159.2003.02247.x; Bannon MJ, 2014, NEUROPSYCHOPHARMACOL, V39, P2191, DOI 10.1038/npp.2014.70; Bannon MJ, 2005, ADDICT BIOL, V10, P119, DOI 10.1080/13556210412331308921; Bannon MJ, 2012, DOPAMINE; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Dowling GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P209, DOI 10.1038/sj.npp.1301412; Feng J, 2013, CURR OPIN NEUROBIOL, V23, P521, DOI 10.1016/j.conb.2013.01.001; Johnson MM, 2012, J FORENSIC SCI, V57, P1519, DOI 10.1111/j.1556-4029.2012.02212.x; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; McCullumsmith RE, 2014, NEUROPSYCHOPHARMACOL, V39, P65, DOI 10.1038/npp.2013.239; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Ploski JE, 2006, J NEUROCHEM, V99, P1122, DOI 10.1111/j.1471-4159.2006.04156.x; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Volkow ND, 2011, P NATL ACAD SCI USA, V108, P15037, DOI 10.1073/pnas.1010654108; Zhou YH, 2014, ADDICT BIOL, V19, P122, DOI 10.1111/j.1369-1600.2011.00391.x	20	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117580	10.1371/journal.pone.0117580	http://dx.doi.org/10.1371/journal.pone.0117580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658879	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900183
J	Cui, DZ; Wu, DD; Liu, J; Li, DT; Xu, CY; Li, S; Li, P; Zhang, H; Liu, X; Jiang, C; Wang, LW; Chen, TT; Chen, HB; Zhao, L				Cui, Dezhou; Wu, Dandan; Liu, Jie; Li, Detao; Xu, Chunyan; Li, Song; Li, Peng; Zhang, Hua; Liu, Xu; Jiang, Chuan; Wang, Liwen; Chen, Tingting; Chen, Huabang; Zhao, Li			Proteomic Analysis of Seedling Roots of Two Maize Inbred Lines That Differ Significantly in the Salt Stress Response	PLOS ONE			English	Article							SALINITY TOLERANCE; ARABIDOPSIS ROOTS; PROTEINS; MECHANISMS; GENOTYPES; GROWTH; PLANTS; HOMEOSTASIS; ADJUSTMENT; DROUGHT	Salinity is a major abiotic stress that limits plant productivity and quality throughout the world. Roots are the sites of salt uptake. To better understand salt stress responses in maize, we performed a comparative proteomic analysis of seedling roots from the salt-tolerant genotype F63 and the salt-sensitive genotype F35 under 160 mM NaCl treatment for 2 days. Under salinity conditions, the shoot fresh weight and relative water content were significantly higher in F63 than in F35, while the osmotic potential was significantly lower and the reduction of the K+/Na+ ratio was significantly less pronounced in F63 than in F35. Using an iTRAQ approach, twenty-eight proteins showed more than 2.0-fold changes in abundance and were regarded as salt-responsive proteins. Among them, twenty-two were specifically regulated in F63 but remained constant in F35. These proteins were mainly involved in signal processing, water conservation, protein synthesis and biotic cross-tolerance, and could be the major contributors to the tolerant genotype of F63. Functional analysis of a salt-responsive protein was performed in yeast as a case study to confirm the salt-related functions of detected proteins. Taken together, the results of this study may be helpful for further elucidating salt tolerance mechanisms in maize.	[Cui, Dezhou; Liu, Jie; Zhang, Hua; Chen, Huabang; Zhao, Li] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Cui, Dezhou] Shandong Acad Agr Sci, Inst Crops Sci, Jinan, Shandong, Peoples R China; [Wu, Dandan] Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Li, Detao; Xu, Chunyan; Li, Song; Li, Peng; Liu, Xu; Jiang, Chuan; Wang, Liwen; Chen, Tingting] Shandong Agr Univ, Coll Agr, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Shandong Academy of Agricultural Sciences; Shandong University; Shandong Agricultural University	Chen, HB (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.	hbchen@genetics.ac.cn; zhaoli@genetics.ac.cn			China National Science Foundation [31201214]; National Sci-Tech Support program [2013BAD05B01]	China National Science Foundation(National Natural Science Foundation of China (NSFC)); National Sci-Tech Support program	This work was funded by grant support from the China National Science Foundation (Grant No. 31201214, http://www.nsfc.gov.cn/publish/portal1/) and the National Sci-Tech Support program (Grant No. 2013BAD05B01, http://program.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, SCI C P, P781; Ashraf M, 2004, PLANT SCI, V166, P3, DOI 10.1016/j.plantsci.2003.10.024; BLUM A, 1989, CROP SCI, V29, P230, DOI 10.2135/cropsci1989.0011183X002900010052x; Canovas FM, 2004, PROTEOMICS, V4, P285, DOI 10.1002/pmic.200300602; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Cheng YW, 2009, PROTEOMICS, V9, P3100, DOI 10.1002/pmic.200800340; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Gao CQ, 2011, MOL BIOL REP, V38, P957, DOI 10.1007/s11033-010-0189-9; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; Khan MH, 2008, ACTA PHYSIOL PLANT, V30, P81, DOI 10.1007/s11738-007-0093-7; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; Lippuner V, 1996, J BIOL CHEM, V271, P12859, DOI 10.1074/jbc.271.22.12859; Liu YM, 2012, J PLANT PHYSIOL, V169, P117, DOI 10.1016/j.jplph.2011.08.019; Lopez L, 2007, PLANTA, V226, P517, DOI 10.1007/s00425-007-0501-7; Munns R, 2002, PLANT SOIL, V247, P93, DOI 10.1023/A:1021119414799; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pang QY, 2010, J PROTEOME RES, V9, P2584, DOI 10.1021/pr100034f; Parida AK, 2004, TREES-STRUCT FUNCT, V18, P167, DOI 10.1007/s00468-003-0293-8; Pechan T, 2000, PLANT CELL, V12, P1031, DOI 10.1105/tpc.12.7.1031; Sairam RK, 2002, PLANT SCI, V163, P1037, DOI 10.1016/S0168-9452(02)00278-9; Schweppe RE, 2003, ACCOUNTS CHEM RES, V36, P453, DOI 10.1021/ar020143l; Shin D, 2004, BIOCHEM BIOPH RES CO, V323, P534, DOI 10.1016/j.bbrc.2004.08.127; Steppuhn H, 2005, CAN J PLANT SCI, V85, P863, DOI 10.4141/P04-014; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Wang MC, 2008, PROTEOMICS, V8, P1470, DOI 10.1002/pmic.200700569; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853; Yang L, 2012, J PLANT PHYSIOL, V169, P839, DOI 10.1016/j.jplph.2012.01.023; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhao Q, 2013, J PROTEOMICS, V82, P230, DOI 10.1016/j.jprot.2013.01.024; Zhou HP, 2014, PLANT CELL, V26, P1166, DOI 10.1105/tpc.113.117069; Zhu CF, 2005, J EXP BOT, V56, P2971, DOI 10.1093/jxb/eri294; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zorb C, 2010, PROTEOMICS, V10, P4441, DOI 10.1002/pmic.201000231	36	38	42	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116697	10.1371/journal.pone.0116697	http://dx.doi.org/10.1371/journal.pone.0116697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659111	gold, Green Submitted, Green Published			2022-12-27	WOS:000349444900059
J	Hsu, WC; Nenov, MN; Shavkunov, A; Panova, N; Zhan, M; Laezza, F				Hsu, Wei-Chun; Nenov, Miroslav N.; Shavkunov, Alexander; Panova, Neli; Zhan, Ming; Laezza, Fernanda			Identifying a Kinase Network Regulating FGF14:Nav1.6 Complex Assembly Using Split-Luciferase Complementation	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; BIPOLAR AFFECTIVE-DISORDER; NERVOUS-SYSTEM DISEASE; AXON INITIAL SEGMENT; NA+ CHANNELS; C ACTIVITY; INHIBITORS; ACTIVATION; BRAIN; EXPRESSION	Kinases play fundamental roles in the brain. Through complex signaling pathways, kinases regulate the strength of protein: protein interactions (PPI) influencing cell cycle, signal transduction, and electrical activity of neurons. Changes induced by kinases on neuronal excitability, synaptic plasticity and brain connectivity are linked to complex brain disorders, but the molecular mechanisms underlying these cellular events remain for the most part elusive. To further our understanding of brain disease, new methods for rapidly surveying kinase pathways in the cellular context are needed. The bioluminescence-based luciferase complementation assay (LCA) is a powerful, versatile toolkit for the exploration of PPI. LCA relies on the complementation of two firefly luciferase protein fragments that are functionally reconstituted into the full luciferase enzyme by two interacting binding partners. Here, we applied LCA in live cells to assay 12 kinase pathways as regulators of the PPI complex formed by the voltage-gated sodium channel, Nav1.6, a transmembrane ion channel that elicits the action potential in neurons and mediates synaptic transmission, and its multivalent accessory protein, the fibroblast growth factor 14 (FGF14). Through extensive dose-dependent validations of structurally-diverse kinase inhibitors and hierarchical clustering, we identified the PI3K/Akt pathway, the cell-cycle regulator Wee1 kinase, and protein kinase C (PKC) as prospective regulatory nodes of neuronal excitability through modulation of the FGF14: Nav1.6 complex. Ingenuity Pathway Analysis shows convergence of these pathways on glycogen synthase kinase 3 (GSK3) and functional assays demonstrate that inhibition of GSK3 impairs excitability of hippocampal neurons. This combined approach provides a versatile toolkit for rapidly surveying PPI signaling, allowing the discovery of new modular pathways centered on GSK3 that might be the basis for functional alterations between the normal and diseased brain.	[Hsu, Wei-Chun; Nenov, Miroslav N.; Shavkunov, Alexander; Panova, Neli; Laezza, Fernanda] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Hsu, Wei-Chun] Univ Texas Med Branch, MD PhD Combined Degree Program, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Addict Res Ctr, Galveston, TX 77555 USA; [Zhan, Ming] Methodist Hosp, Res Inst, Weill Cornell Med Coll, Dept Syst Med & Bioengn, Houston, TX 77030 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Laezza, F (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.	felaezza@utmb.edu	Laezza, Fernanda/L-6019-2016; Nenov, Miroslav/C-5252-2008; Laezza, Fernanda/X-4076-2019	Laezza, Fernanda/0000-0003-1141-1852; Nenov, Miroslav/0000-0001-6000-2372; Laezza, Fernanda/0000-0003-1141-1852	Sealy Center for Molecular Medicine, University of Texas Medical Branch; National Institutes of Health [R01MH095995]; National Institute of Mental Health, Florida; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095995] Funding Source: NIH RePORTER	Sealy Center for Molecular Medicine, University of Texas Medical Branch; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health, Florida; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	WJH was supported by the Sealy Center for Molecular Medicine, University of Texas Medical Branch. FL received grant support from the National Institutes of Health (Grant R01MH095995) from the National Institute of Mental Health, Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Baek H, 2011, SEMIN CELL DEV BIOL, V22, P153, DOI 10.1016/j.semcdb.2010.09.009; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bandyopadhyay RS, 1997, ENDOTHELIUM-J ENDOTH, V5, P95, DOI 10.3109/10623329709079867; Battaini F, 2001, PHARMACOL RES, V44, P353, DOI 10.1006/phrs.2001.0893; Berendt FJ, 2010, J PROTEOME RES, V9, P1976, DOI 10.1021/pr901171q; Brusse E, 2006, MOVEMENT DISORD, V21, P396, DOI 10.1002/mds.20708; Budni J, 2012, J PSYCHOPHARMACOL, V26, P714, DOI 10.1177/0269881111424456; Buffington SA, 2011, EUR J NEUROSCI, V34, P1609, DOI 10.1111/j.1460-9568.2011.07875.x; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Cen L, 2012, NEURO-ONCOLOGY, V14, P870, DOI 10.1093/neuonc/nos114; Chiu CT, 2010, PHARMACOL THERAPEUT, V128, P281, DOI 10.1016/j.pharmthera.2010.07.006; Clay JR, 2005, PROG BIOPHYS MOL BIO, V88, P59, DOI 10.1016/j.pbiomolbio.2003.12.004; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Frey RS, 2006, J BIOL CHEM, V281, P16128, DOI 10.1074/jbc.M508810200; FRIEDMAN E, 1993, BIOL PSYCHIAT, V33, P520, DOI 10.1016/0006-3223(93)90006-Y; Gildish I, 2012, LEARN MEMORY, V19, P116, DOI 10.1101/lm.023937.111; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; GOODE N, 1992, J BIOL CHEM, V267, P16878; Gould TD, 2004, INT J NEUROPSYCHOPH, V7, P387, DOI 10.1017/S1461145704004535; Hsu WCJ, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00109; Insel TR, 2013, NEUROSCI BIOBEHAV R, V37, P2438, DOI 10.1016/j.neubiorev.2013.03.022; Insel TR, 2014, AM J PSYCHIAT, V171, P395, DOI 10.1176/appi.ajp.2014.14020138; Insel TR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004873; Jacinto E, 1998, IMMUNITY, V8, P31, DOI 10.1016/S1074-7613(00)80456-2; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kamb A, 2007, NAT REV DRUG DISCOV, V6, P115, DOI 10.1038/nrd2155; Karyo R, 2010, MOL CELL NEUROSCI, V45, P449, DOI 10.1016/j.mcn.2010.08.004; Konig HG, 2012, J CELL SCI, V125, P6058, DOI 10.1242/jcs.111880; Kramer T, 2012, ACS CHEM NEUROSCI, V3, P151, DOI 10.1021/cn200117j; Laezza F, 2007, J NEUROSCI, V27, P12033, DOI 10.1523/JNEUROSCI.2282-07.2007; Laezza F, 2009, MOL CELL NEUROSCI, V42, P90, DOI 10.1016/j.mcn.2009.05.007; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Li XH, 2012, NEUROPSYCHOPHARMACOL, V37, P77, DOI 10.1038/npp.2011.198; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Malhi GS, 2013, CNS DRUGS, V27, P135, DOI 10.1007/s40263-013-0039-0; Manji HK, 1999, BIOL PSYCHIAT, V46, P1328, DOI 10.1016/S0006-3223(99)00235-8; Miah SMS, 2004, MOL CELL BIOL, V24, P71, DOI 10.1128/MCB.24.1.71-83.2004; Michnick SW, 2011, METHODS MOL BIOL, V756, P395, DOI 10.1007/978-1-61779-160-4_25; Miller JS, 2010, BRAIN RES BULL, V82, P184, DOI 10.1016/j.brainresbull.2010.03.005; Miller JS, 2009, NEUROPHARMACOLOGY, V56, P1116, DOI 10.1016/j.neuropharm.2009.03.006; Muller M, 2010, J CELL SCI, V123, P286, DOI 10.1242/jcs.058230; Nakamura Y, 2003, NEUROSCIENCE, V116, P477, DOI 10.1016/S0306-4522(02)00658-9; Pan JQ, 2011, NEUROPSYCHOPHARMACOL, V36, P1397, DOI 10.1038/npp.2011.24; Rodriguez-Murillo L, 2014, NEUROPSYCHOPHARMACOL, V39, P934, DOI 10.1038/npp.2013.293; Rosa AO, 2008, PROG NEURO-PSYCHOPH, V32, P1549, DOI 10.1016/j.pnpbp.2008.05.020; Scheuer T, 2011, SEMIN CELL DEV BIOL, V22, P160, DOI 10.1016/j.semcdb.2010.10.002; Schultz C, 2006, MOL CELL NEUROSCI, V33, P68, DOI 10.1016/j.mcn.2006.06.008; Shavkunov A, 2012, ASSAY DRUG DEV TECHN, V10, P148, DOI 10.1089/adt.2011.413; Shavkunov AS, 2013, J BIOL CHEM, V288, P19370, DOI 10.1074/jbc.M112.445924; Smith B, 2012, ACS CHEM NEUROSCI, V3, P857, DOI 10.1021/cn300094k; Tomashevski A, 2001, J ALZHEIMERS DIS, V3, P195; Verbeek EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037384; Verpelli C, 2010, J NEUROSCI, V30, P5830, DOI 10.1523/JNEUROSCI.0119-10.2010; Wang HY, 1996, BIOL PSYCHIAT, V40, P568, DOI 10.1016/0006-3223(95)00611-7; Wang Q, 2000, MECH DEVELOP, V90, P283, DOI 10.1016/S0925-4773(99)00241-5; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wittmack EK, 2005, J NEUROSCI, V25, P6621, DOI 10.1523/JNEUROSCI.0541-05.2005; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014; Xiao ML, 2007, MOL CELL NEUROSCI, V34, P366, DOI 10.1016/j.mcn.2006.11.020; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Zhang H, 2004, J PHYSIOL-LONDON, V561, P133, DOI 10.1113/jphysiol.2004.071241; Zhang JY, 2005, J CELL BIOL, V168, P561, DOI 10.1083/jcb.200411060	72	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117246	10.1371/journal.pone.0117246	http://dx.doi.org/10.1371/journal.pone.0117246			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659151	gold, Green Submitted, Green Published			2022-12-27	WOS:000349444900123
J	Li, WW; Yuan, FS; Lv, PJ; Wang, Y; Sun, YC				Li, Weiwei; Yuan, Fusong; Lv, Peijun; Wang, Yong; Sun, Yuchun			Evaluation of the Quantitative Accuracy of 3D Reconstruction of Edentulous Jaw Models with Jaw Relation Based on Reference Point System Alignment	PLOS ONE			English	Article							3-D OBJECT RETRIEVAL; RECOGNITION	Objectives To apply contact measurement and reference point system (RPS) alignment techniques to establish a method for 3D reconstruction of the edentulous jaw models with centric relation and to quantitatively evaluate its accuracy. Methods Upper and lower edentulous jaw models were clinically prepared, 10 pairs of resin cylinders with same size were adhered to axial surfaces of upper and lower models. The occlusal bases and the upper and lower jaw models were installed in the centric relation position. Faro Edge 1.8m was used to directly obtain center points of the base surface of the cylinders (contact method). Activity 880 dental scanner was used to obtain 3D data of the cylinders and the center points were fitted (fitting method). 3 pairs of center points were used to align the virtual model to centric relation. An observation coordinate system was interactively established. The straight-line distances in the X (horizontal left/right), Y (horizontal anterior/posterior), and Z (vertical) between the remaining 7 pairs of center points derived from contact method and fitting method were measured respectively and analyzed using a paired t-test. Results The differences of the straight-line distances of the remaining 7 pairs of center points between the two methods were X: 0.074 +/- 0.107 mm, Y: 0.168 +/- 0.176 mm, and Z: -0.003 +/- 0.155 mm. The results of paired t-test were X and Z: p >0.05, Y: p <0.05. Conclusion By using contact measurement and the reference point system alignment technique, highly accurate reconstruction of the vertical distance and centric relation of a digital edentulous jaw model can be achieved, which meets the design and manufacturing requirements of the complete dentures. The error of horizontal anterior/posterior jaw relation was relatively large.	[Li, Weiwei; Yuan, Fusong; Lv, Peijun; Wang, Yong; Sun, Yuchun] Peking Univ, Sch & Hosp Stomatol, Ctr Digital Dent, Beijing 100871, Peoples R China; [Li, Weiwei; Yuan, Fusong; Lv, Peijun; Wang, Yong; Sun, Yuchun] Peking Univ, Sch & Hosp Stomatol, Fac Prosthodont, Beijing 100871, Peoples R China; [Li, Weiwei; Yuan, Fusong; Lv, Peijun; Wang, Yong; Sun, Yuchun] Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China; [Li, Weiwei; Yuan, Fusong; Lv, Peijun; Wang, Yong; Sun, Yuchun] Minist Hlth, Res Ctr Engn & Technol Digital Dent, Beijing, Peoples R China	Peking University; Peking University	Wang, Y (corresponding author), Peking Univ, Sch & Hosp Stomatol, Ctr Digital Dent, Beijing 100871, Peoples R China.	kqcadc@bjmu.edu.cn; polarshining@163.com	, 孙玉春/AAX-5280-2020		National Natural Science Foundation of China [81271181]; National High Technology Research and Development Program [2013AA040802]; Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Peking University School and Hospital of Stomatology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program(National High Technology Research and Development Program of China); Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Peking University School and Hospital of Stomatology	This study was supported by the National Natural Science Foundation of China (grant no. 81271181), National High Technology Research and Development Program (grant no. 2013AA040802) and Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Peking University School and Hospital of Stomatology(2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Busch M, 2006, Int J Comput Dent, V9, P113; Feng HL, 2005, PROSTHODONTICS, P298, DOI [10.1016/j.talanta.2005.08.055, DOI 10.1016/J.TALANTA.2005.08.055]; Gao Y, 2014, IEEE T IND ELECTRON, V61, P2088, DOI 10.1109/TIE.2013.2262760; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P4290, DOI 10.1109/TIP.2012.2199502; Guan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098806; Guan T, 2014, IEEE MULTIMEDIA, V21, P32, DOI 10.1109/MMUL.2013.31; Guan T, 2013, IEEE T MULTIMEDIA, V15, P1688, DOI 10.1109/TMM.2013.2265674; Guan T, 2011, IEEE COMPUT GRAPH, V31, P56, DOI 10.1109/MCG.2010.23; Ji RR, 2012, INT J COMPUT VISION, V96, P290, DOI 10.1007/s11263-011-0472-9; Ji RR, 2013, IEEE T MULTIMEDIA, V15, P153, DOI 10.1109/TMM.2012.2225035; Ji RR, 2011, ACM T MULTIM COMPUT, V7, DOI 10.1145/2037676.2037688; Li H, 2014, CHINE J PROSTHODONTI, V15, P65; Lu P, 2001, Zhonghua Kou Qiang Yi Xue Za Zhi, V36, P139; Maeda Y, 1994, Int J Prosthodont, V7, P17; Sun YC, 2014, BIO-MED MATER ENG, V24, P1275, DOI 10.3233/BME-130930; Wei BC, 2014, IEEE MULTIMEDIA, V21, P41, DOI 10.1109/MMUL.2013.65; Wu J, 2010, CHINESE J AESTHETIC, V19, P1838; Yuan FS, 2013, INT J ORAL SCI, V5, P155, DOI 10.1038/ijos.2013.49; Zhang YD, 2002, IEEE-ASME T MECH, V7, P392, DOI 10.1109/TMECH.2002.802718	20	7	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117320	10.1371/journal.pone.0117320	http://dx.doi.org/10.1371/journal.pone.0117320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659133	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900132
J	Marshall, AT; Kirkpatrick, K				Marshall, Andrew T.; Kirkpatrick, Kimberly			Relative Gains, Losses, and Reference Points in Probabilistic Choice in Rats	PLOS ONE			English	Article							DECISION-MAKING; INDIVIDUAL-DIFFERENCES; IMPULSIVE CHOICE; FORAGING PREFERENCES; UNITED-STATES; RISK-TAKING; HOT HAND; BEHAVIOR; DOPAMINE; OUTCOMES	Theoretical reference points have been proposed to differentiate probabilistic gains from probabilistic losses in humans, but such a phenomenon in non-human animals has yet to be thoroughly elucidated. Three experiments evaluated the effect of reward magnitude on probabilistic choice in rats, seeking to determine reference point use by examining the effect of previous outcome magnitude(s) on subsequent choice behavior. Rats were trained to choose between an outcome that always delivered reward (low-uncertainty choice) and one that probabilistically delivered reward (high-uncertainty). The probability of high-uncertainty outcome receipt and the magnitudes of low-uncertainty and high-uncertainty outcomes were manipulated within and between experiments. Both the low- and high-uncertainty outcomes involved variable reward magnitudes, so that either a smaller or larger magnitude was probabilistically delivered, as well as reward omission following high-uncertainty choices. In Experiments 1 and 2, the between groups factor was the magnitude of the high-uncertainty-smaller (H-S) and high-uncertainty-larger (H-L) outcome, respectively. The H-S magnitude manipulation differentiated the groups, while the H-L magnitude manipulation did not. Experiment 3 showed that manipulating the probability of differential losses as well as the expected value of the low-uncertainty choice produced systematic effects on choice behavior. The results suggest that the reference point for probabilistic gains and losses was the expected value of the low-uncertainty choice. Current theories of probabilistic choice behavior have difficulty accounting for the present results, so an integrated theoretical framework is proposed. Overall, the present results have implications for understanding individual differences and corresponding underlying mechanisms of probabilistic choice behavior.	[Marshall, Andrew T.; Kirkpatrick, Kimberly] Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA	Kansas State University	Marshall, AT (corresponding author), Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA.	atmarsh@ksu.edu		Marshall, Andrew/0000-0002-0068-8138	National Institute of Mental Health [085739]; Kansas State University; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085739] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Kansas State University; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institute of Mental Health Grant 085739 awarded to Kimberly Kirkpatrick and Kansas State University (http://www.nimh.nih.gov). Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL A, 1952, J EXP PSYCHOL, V43, P363, DOI 10.1037/h0059393; Ayton P, 2004, MEM COGNITION, V32, P1369, DOI 10.3758/BF03206327; BACOTTI AV, 1976, ANIM LEARN BEHAV, V4, P41, DOI 10.3758/BF03211983; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bhatti M, 2014, BEHAV BRAIN RES; BOLES TL, 1995, ORGAN BEHAV HUM DEC, V61, P262, DOI 10.1006/obhd.1995.1021; BRUE SL, 1993, J ECON PERSPECT, V7, P185, DOI 10.1257/jep.7.3.185; CARACO T, 1983, BEHAV ECOL SOCIOBIOL, V12, P63, DOI 10.1007/BF00296934; CARACO T, 1981, BEHAV ECOL SOCIOBIOL, V8, P213, DOI 10.1007/BF00299833; Cardinal R.N., 2005, BIOMED CTR NEUROSCI, V28, P37; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; Connolly T, 2002, CURR DIR PSYCHOL SCI, V11, P212, DOI 10.1111/1467-8721.00203; COWIE RJ, 1977, NATURE, V268, P137, DOI 10.1038/268137a0; Crossman E, 1983, Behav Anal, V6, P109; Dai ZJ, 2009, LEARN BEHAV, V37, P281, DOI 10.3758/LB.37.3.281; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Demaree HA, 2012, EMOTION, V12, P495, DOI 10.1037/a0025780; Dixon MJ, 2010, ADDICTION, V105, P1819, DOI 10.1111/j.1360-0443.2010.03050.x; Dixon MR, 1998, PSYCHOL REP, V82, P1047, DOI 10.2466/PR0.82.3.1047-1050; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; DUKAS R, 1993, OECOLOGIA, V94, P244, DOI 10.1007/BF00341323; EVENDEN JL, 1984, Q J EXP PSYCHOL-B, V36, P1, DOI 10.1080/14640748408402190; Floresco SB, 2008, COGN AFFECT BEHAV NE, V8, P375, DOI 10.3758/CABN.8.4.375; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Friedman M, 1948, J POLIT ECON, V56, P279, DOI 10.1086/256692; Fulop A, 2000, ANIM BEHAV, V60, P657, DOI 10.1006/anbe.2000.1492; Galtress T, 2012, J EXP ANAL BEHAV, V98, P65, DOI 10.1901/jeab.2012.98-65; Garcia A, 2013, BEHAV BRAIN RES, V238, P10, DOI 10.1016/j.bbr.2012.10.017; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; GILOVICH T, 1985, COGNITIVE PSYCHOL, V17, P295, DOI 10.1016/0010-0285(85)90010-6; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; Goyer JP, 2008, J COGNITIVE NEUROSCI, V20, P2058, DOI 10.1162/jocn.2008.20134; GREGGERS U, 1993, BEHAV ECOL SOCIOBIOL, V32, P17, DOI 10.1007/BF00172219; HALDANE JBS, 1956, ANN HUM GENET, V20, P309; HAMM SL, 1987, J EXP PSYCHOL-ANIM B, V13, P376, DOI 10.1037/0097-7403.13.4.376; Hastie R., 2010, RATIONAL CHOICE UNCE; Hayden BY, 2009, ANIM COGN, V12, P201, DOI 10.1007/s10071-008-0186-8; Heilbronner SR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00007; HOLLENBECK JR, 1994, J APPL PSYCHOL, V79, P592, DOI 10.1037/0021-9010.79.4.592; Holt DD, 2003, BEHAV PROCESS, V64, P355, DOI 10.1016/S0376-6357(03)00141-4; HOUSTON A, 1982, ANIM BEHAV, V30, P1260, DOI 10.1016/S0003-3472(82)80225-X; Kacelnik A, 2011, BEHAV ECOL SOCIOBIOL, V65, P547, DOI 10.1007/s00265-010-1101-2; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kalenscher T, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00082; KEREN G, 1987, J EXP PSYCHOL LEARN, V13, P387, DOI 10.1037/0278-7393.13.3.387; Kirkpatrick K, 2014, BEHAV BRAIN RES, V269, P115, DOI 10.1016/j.bbr.2014.04.024; Lakshminarayanan VR, 2011, J EXP SOC PSYCHOL, V47, P689, DOI 10.1016/j.jesp.2010.12.011; Levin IP, 1998, ORGAN BEHAV HUM DEC, V76, P149, DOI 10.1006/obhd.1998.2804; Levin IP, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00015; Madden GJ, 2007, J GAMBL STUD, V23, P63, DOI 10.1007/s10899-006-9041-5; Marsh B, 2002, P NATL ACAD SCI USA, V99, P3352, DOI 10.1073/pnas.042491999; Marshall AT, 2014, J EXP ANAL BEHAV, V102, P86, DOI 10.1002/jeab.88; Marshall AT, 2013, J EXP PSYCHOL-ANIM B, V39, P24, DOI 10.1037/a0030765; MAZUR JE, 1988, ANIM LEARN BEHAV, V16, P199, DOI 10.3758/BF03209066; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; MCGLOTHLIN WH, 1956, AM J PSYCHOL, V69, P604, DOI 10.2307/1419083; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; MONTAGUE PR, 1995, NATURE, V377, P725, DOI 10.1038/377725a0; Myerson J, 2003, J ECON PSYCHOL, V24, P619, DOI 10.1016/S0167-4870(03)00005-9; Niv Y, 2012, J NEUROSCI, V32, P551, DOI 10.1523/JNEUROSCI.5498-10.2012; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Potenza MN, 2009, NEUROPSYCHOPHARMACOL, V34, P2623, DOI 10.1038/npp.2009.152; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; Rasmussen EB, 2010, BEHAV PROCESS, V83, P23, DOI 10.1016/j.beproc.2009.09.001; Reynolds B, 2004, BEHAV PROCESS, V65, P35, DOI 10.1016/S0376-6357(03)00109-8; Riba J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002479; Rode C, 1999, COGNITION, V72, P269, DOI 10.1016/S0010-0277(99)00041-4; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Shaffer HJ, 1999, AM J PUBLIC HEALTH, V89, P1369, DOI 10.2105/AJPH.89.9.1369; Shaffer HJ, 2002, ANNU REV PUBL HEALTH, V23, P171, DOI 10.1146/annurev.publhealth.23.100901.140532; SHELLEY MK, 1993, MANAGE SCI, V39, P806, DOI 10.1287/mnsc.39.7.806; Slattery JP, 2002, J MANAGE, V28, P89, DOI 10.1177/014920630202800106; Smethells JR, 2012, J EXP ANAL BEHAV, V97, P203, DOI 10.1901/jeab.2012.97-203; St Onge JR, 2012, J NEUROSCI, V32, P2886, DOI 10.1523/JNEUROSCI.5625-11.2012; Staddon JER, 1966, PSYCHON SCI, V4, P287; Stauffer WR, 2014, CURR BIOL, V24, P2491, DOI 10.1016/j.cub.2014.08.064; Steiner AP, 2012, FRONTIERS NEUROSCIEN, V6, P1, DOI [10.3389/fnins.2012.00001, DOI 10.3389/FNINS.2012.00001]; Steiner AP, 2014, NATURE NEUROSCIENCE; Stephens D.W., 1986, pi; STEPHENS DW, 1981, ANIM BEHAV, V29, P628, DOI 10.1016/S0003-3472(81)80128-5; Stopper CM, 2012, CEREBRAL CORTEX; Stopper CM, 2011, COGN AFFECT BEHAV NE, V11, P97, DOI 10.3758/s13415-010-0015-9; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; TATHAM TA, 1989, BEHAV RES METH INSTR, V21, P294, DOI 10.3758/BF03205598; THALER R, 1981, ECON LETT, V8, P201, DOI 10.1016/0165-1765(81)90067-7; THALER RH, 1990, MANAGE SCI, V36, P643, DOI 10.1287/mnsc.36.6.643; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; Vasconcelos M, 2010, BEHAV PROCESS, V84, P435, DOI 10.1016/j.beproc.2009.11.010; Wang XT, 2012, J EXP PSYCHOL GEN, V141, P743, DOI 10.1037/a0027415; Weatherly JN, 2007, ANAL GAMBLING BEHAV, V1, P79; Weber EU, 2004, PSYCHOL REV, V111, P430, DOI 10.1037/0033-295X.111.2.430; Winstanley CA, 2011, NEUROPSYCHOPHARMACOL, V36, P359, DOI 10.1038/npp.2010.136	95	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117697	10.1371/journal.pone.0117697	http://dx.doi.org/10.1371/journal.pone.0117697			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658448	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900207
J	Okuda, M; Hijikuro, I; Fujita, Y; Wu, XF; Nakayama, S; Sakata, Y; Noguchi, Y; Ogo, M; Akasofu, S; Ito, Y; Soeda, Y; Tsuchiya, N; Tanaka, N; Takahashi, T; Sugimoto, H				Okuda, Michiaki; Hijikuro, Ichiro; Fujita, Yuki; Wu, Xiaofeng; Nakayama, Shinichi; Sakata, Yoko; Noguchi, Yuji; Ogo, Makoto; Akasofu, Shigeru; Ito, Yoshimasa; Soeda, Yoshiyuki; Tsuchiya, Nobuhiko; Tanaka, Naoki; Takahashi, Takashi; Sugimoto, Hachiro			PE859, a Novel Tau Aggregation Inhibitor, Reduces Aggregated Tau and Prevents Onset and Progression of Neural Dysfunction In Vivo	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; NEUROFIBRILLARY TANGLES; PROTEIN-TAU; P301L TAU; OLIGOMERS; PATHOLOGY; BINDING; NEURODEGENERATION; PHOSPHORYLATION; DEGENERATION	In tauopathies, a neural microtubule-associated protein tau (MAPT) is abnormally aggregated and forms neurofibrillary tangle. Therefore, inhibition of the tau aggregation is one of the key approaches for the treatment of these diseases. Here, we have identified a novel tau aggregation inhibitor, PE859. An oral administration of PE859 resulted in the significant reduction of sarkosyl-insoluble aggregated tau along with the prevention of onset and progression of the motor dysfunction in JNPL3 P301L-mutated human tau transgenic mice. These results suggest that PE859 is useful for the treatment of tauopathies.	[Okuda, Michiaki; Wu, Xiaofeng; Nakayama, Shinichi; Sakata, Yoko; Noguchi, Yuji; Sugimoto, Hachiro] Pharma Eight Co Ltd, Kyoto, Japan; [Okuda, Michiaki; Fujita, Yuki; Sugimoto, Hachiro] Doshisha Univ, Grad Sch Brain Sci, Kyoto 602, Japan; [Hijikuro, Ichiro] ChemGenesis Inc, Tokyo, Japan; [Wu, Xiaofeng] Chinese Acad Sci, Key Lab Reprod Biol, Inst Zool, Beijing, Peoples R China; [Ogo, Makoto; Akasofu, Shigeru; Ito, Yoshimasa] Eisai & Co Ltd, Tsukuba Res Labs, Tsukuba, Ibaraki, Japan; [Soeda, Yoshiyuki] Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Dept Aging Neurobiol, Obu, Japan; [Tsuchiya, Nobuhiko; Tanaka, Naoki] Kyoto Inst Technol, Dept Biomol Engn, Kyoto 606, Japan; [Takahashi, Takashi] Yokohama Coll Pharm, Nat Prod Chem & Pharmaceut Res Ctr, Yokohama, Kanagawa, Japan	Doshisha University; Chinese Academy of Sciences; Institute of Zoology, CAS; Eisai Co Ltd; National Center for Geriatrics & Gerontology; Kyoto Institute of Technology	Okuda, M (corresponding author), Pharma Eight Co Ltd, Kyoto, Japan.	jt-liaay@mail.doshisha.ac.jp		Okuda, Michiaki/0000-0002-0211-7144	Pharma Eight Co., Ltd.; ChemGenesis Inc.; Eisai Co., Ltd.	Pharma Eight Co., Ltd.; ChemGenesis Inc.; Eisai Co., Ltd.(Eisai Co Ltd)	The authors received no specific funding for this work. Pharma Eight Co., Ltd., ChemGenesis Inc. and Eisai Co., Ltd. provided support in the form of salaries for authors M Okuda, YF, SN, YS, YN, HS, IH, M. Ogo, SA and YI but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akoury E, 2013, ANGEW CHEM INT EDIT, V52, P3511, DOI 10.1002/anie.201208290; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; Blair LJ, 2013, J CLIN INVEST, V123, P4158, DOI 10.1172/JCI69003; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buee L, 1999, BRAIN PATHOL, V9, P681; Castillo-Carranza DL, 2014, J ALZHEIMERS DIS, V40, pS97, DOI 10.3233/JAD-132477; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Congdon EE, 2012, AUTOPHAGY, V8, P609, DOI 10.4161/auto.19048; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickson D, 2011, J MOL NEUROSCI, V45, P384, DOI 10.1007/s12031-011-9589-0; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Ferreira A, 2011, MOL MED, V17, P676, DOI 10.2119/molmed.2010.00220; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Guzman-Martinez L, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00167; Hosokawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052389; IQBAL K, 1994, FEBS LETT, V349, P104, DOI 10.1016/0014-5793(94)00650-4; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lee G, 2012, PROG MOL BIOL TRANSL, V107, P263, DOI 10.1016/B978-0-12-385883-2.00004-7; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Martin L, 2011, NEUROCHEM INT, V58, P458, DOI 10.1016/j.neuint.2010.12.023; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; Morsch R, 1999, J NEUROPATH EXP NEUR, V58, P188, DOI 10.1097/00005072-199902000-00008; NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x; O'Leary JC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-45; Okuyama K, 2008, FEBS J, V275, P1529, DOI 10.1111/j.1742-4658.2008.06312.x; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Sahara N, 2002, J NEUROCHEM, V83, P1498, DOI 10.1046/j.1471-4159.2002.01241.x; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; Sugino E, 2009, BIOCHEM BIOPH RES CO, V385, P236, DOI 10.1016/j.bbrc.2009.05.047; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Vana L, 2011, AM J PATHOL, V179, P2533, DOI 10.1016/j.ajpath.2011.07.044; Ward SM, 2012, BIOCHEM SOC T, V40, P667, DOI 10.1042/BST20120134; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wischik C, 2009, J NUTR HEALTH AGING, V13, P367, DOI 10.1007/s12603-009-0046-5; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Yuzwa SA, 2011, AMINO ACIDS, V40, P857, DOI 10.1007/s00726-010-0705-1; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102	46	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117511	10.1371/journal.pone.0117511	http://dx.doi.org/10.1371/journal.pone.0117511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659102	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900167
J	Scambi, C; Ugolini, S; Jokiranta, TS; De Franceschi, L; Bortolami, O; La Verde, V; Guarini, P; Caramaschi, P; Ravagnani, V; Martignoni, G; Colato, C; Pedron, S; Benedetti, F; Sorio, M; Poli, F; Biasi, D				Scambi, Cinzia; Ugolini, Sara; Jokiranta, T. Sakari; De Franceschi, Lucia; Bortolami, Oscar; La Verde, Valentina; Guarini, Patrizia; Caramaschi, Paola; Ravagnani, Viviana; Martignoni, Guido; Colato, Chiara; Pedron, Serena; Benedetti, Fabio; Sorio, Marco; Poli, Fabio; Biasi, Domenico			The Local Complement Activation on Vascular Bed of Patients with Systemic Sclerosis: A Hypothesis-Generating Study	PLOS ONE			English	Article							MEMBRANE COFACTOR PROTEIN; HEMOLYTIC-UREMIC SYNDROME; DECAY-ACCELERATING FACTOR; FACTOR-H; MACULAR DEGENERATION; TERMINAL COMPLEMENT; ABERRANT EXPRESSION; ENDOTHELIAL-CELLS; FACTOR-I; DISEASE	Objective The role of complement system in the pathogenesis of systemic sclerosis (SSc) has been debated during the last decade but an evident implication in this disease has never been found. We carried out an explorative study on SSc patients to evaluate the expression of soluble and local C5b-9 complement complex and its relation with a complement regulator, the Membrane Cofactor Protein (MCP, CD46) on skin vascular bed as target distinctive of SSc disease. We also analyzed two polymorphic variants in the complement activation gene cluster involving the MCP region. Methods C5b-9 plasma levels of SSc patients and healthy subjects were analyzed by ELISA assay. Archival skin biopsies of SSc patients and controls were subjected to immunofluorescence analysis to detect C5b-9 and MCP on vascular endothelial cells. The expression of MCP was validated by immunoblot analysis with specific antibody. Polymorphic variants in the MCP gene promoter were tested by a quantitative PCR technique-based allelic discrimination method. Results Even though circulating levels of C5b-9 did not differ between SSc and controls, C5b-9 deposition was detected in skin biopsies of SSc patients but not in healthy subjects. MCP was significantly lower in skin vessels of SSc patients than in healthy controls and was associated with the over-expression of two polymorphic variants in the MCP gene promoter, which has been related to more aggressive phenotypes in other immune-mediated diseases. Conclusions Our results firsty document the local complement activation with an abnormal expression of MCP in skin vessels of SSc patients, suggesting that a subset of SSc patients might be exposed to more severe organ complications and clinical evolution due to abnormal local complement activation.	[Scambi, Cinzia; Ugolini, Sara; De Franceschi, Lucia; La Verde, Valentina; Guarini, Patrizia; Caramaschi, Paola; Ravagnani, Viviana; Benedetti, Fabio; Sorio, Marco; Poli, Fabio; Biasi, Domenico] Univ Verona, Dept Med, I-37100 Verona, Italy; [Ugolini, Sara] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Jokiranta, T. Sakari] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Martignoni, Guido; Colato, Chiara; Pedron, Serena] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Bortolami, Oscar] Verona Univ Hosp, Res Support Unit, Verona, Italy	University of Verona; University of Helsinki; University of Helsinki; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Scambi, C (corresponding author), Univ Verona, Dept Med, I-37100 Verona, Italy.	cinzia.scambi@univr.it	DE FRANCESCHI, Lucia/AAB-8652-2022; Bortolami, Oscar/H-6559-2019; Bortolami, Oscar/E-9219-2016	DE FRANCESCHI, Lucia/0000-0001-7093-777X; Bortolami, Oscar/0000-0002-4346-9672; Bortolami, Oscar/0000-0002-4346-9672	research grant from Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR)	research grant from Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR)	This study was funded by a research grant from the Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson A, 2003, CLIN EXP RHEUMATOL, V21, pS5; Arason GJ, 2002, ANN RHEUM DIS, V61, P257, DOI 10.1136/ard.61.3.257; Asgari E, 2010, CURR OPIN ORGAN TRAN, V15, P486, DOI 10.1097/MOT.0b013e32833b9cb7; Barilla-LaBarca ML, 2002, J IMMUNOL, V168, P6298, DOI 10.4049/jimmunol.168.12.6298; Batal I, 2009, HUM PATHOL, V40, P332, DOI 10.1016/j.humpath.2008.08.001; BENZAQUEN LR, 1994, J EXP MED, V179, P985, DOI 10.1084/jem.179.3.985; Caccavo D, 2008, INT J IMMUNOPATH PH, V21, P659, DOI 10.1177/039463200802100320; Chizzolini C, 2011, AUTOIMMUN REV, V10, P276, DOI 10.1016/j.autrev.2010.09.016; Commereuc M, 2013, TRANSPLANTATION, V96, pE58, DOI 10.1097/TP.0b013e3182a7fccd; Cuomo G, 2008, REUMATISMO, V60, P268, DOI 10.4081/reumatismo.2008.268; Cutolo M, 2000, J RHEUMATOL, V27, P155; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Devaux P, 1999, EUR J IMMUNOL, V29, P815; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Esparza-Gordillo J, 2006, MOL IMMUNOL, V43, P1769, DOI 10.1016/j.molimm.2005.11.008; Esparza-Gordillo J, 2005, HUM MOL GENET, V14, P703, DOI 10.1093/hmg/ddi066; EVANS DJ, 1987, LANCET, V1, P480; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Fischetti F, 2011, ATHEROSCLEROSIS, V216, P83, DOI 10.1016/j.atherosclerosis.2011.01.050; Fremeaux-Bacchi V, 2005, J MED GENET, V42, P852, DOI 10.1136/jmg.2005.030783; Guilpain P, 2008, CLIN REV ALLERG IMMU, V35, P59, DOI 10.1007/s12016-007-8069-3; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hudson M, 2007, J RHEUMATOL, V34, P2218; Johnson PT, 2006, P NATL ACAD SCI USA, V103, P17456, DOI 10.1073/pnas.0606234103; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Katsumoto TR, 2011, ANNU REV PATHOL-MECH, V6, P509, DOI 10.1146/annurev-pathol-011110-130312; LEROY EC, 1988, J RHEUMATOL, V15, P202; Magro CM, 2007, AM J CLIN PATHOL, V127, P237, DOI 10.1309/CNQDMHLH2WGKL32T; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Medsger TA, 1999, J RHEUMATOL, V26, P2159; Mihai C, 2010, ANN RHEUM DIS, V69, P319, DOI 10.1136/ard.2008.102400; Mold C, 1999, MICROBES INFECT, V1, P633, DOI 10.1016/S1286-4579(99)80063-X; Muller-Ladner U, 2009, AUTOIMMUNITY, V42, P587, DOI 10.1080/08916930903002487; Neumann E, 2002, ARTHRITIS RHEUM, V46, P934, DOI 10.1002/art.10183; PASSWELL J, 1988, J CLIN INVEST, V82, P1676, DOI 10.1172/JCI113780; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Sakkas LI, 2006, NAT CLIN PRACT RHEUM, V2, P679, DOI 10.1038/ncprheum0346; Sanchez-Corral P, 2004, MOL IMMUNOL, V41, P81, DOI 10.1016/j.molimm.2004.01.003; Saunders RE, 2007, HUM MUTAT, V28, P222, DOI 10.1002/humu.20435; Scambi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012162; SENALDI G, 1989, ARTHRITIS RHEUM, V32, P1262, DOI 10.1002/anr.1780321011; SENALDI G, 1987, LANCET, V1, P1143; SEYA T, 1991, MOL IMMUNOL, V28, P1137; Shapira I, 2012, ARTHRITIS RHEUM-US, V64, P2719, DOI 10.1002/art.34440; Sprott H, 2000, J RHEUMATOL, V27, P402; VENNEKER GT, 1994, LAB INVEST, V70, P830; VENNEKER GT, 1994, BRIT J DERMATOL, V131, P237; Wills-Karp M, 2005, CURR ALLERGY ASTHM R, V5, P362, DOI 10.1007/s11882-005-0007-y; Xiang Y, 2007, ARTHRITIS RHEUM-US, V56, P2018, DOI 10.1002/art.22645; Xie L, 2012, TRANSPL P, V44, P3037, DOI 10.1016/j.transproceed.2012.07.141; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	51	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0114856	10.1371/journal.pone.0114856	http://dx.doi.org/10.1371/journal.pone.0114856			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658605	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000349444900010
J	Zhang, HX; Shao, B; Zhuge, QC; Wang, P; Zheng, CC; Huang, WL; Yang, CQ; Wang, B; Su, DM; Jin, KL				Zhang, Hongxia; Shao, Bei; Zhuge, Qichuan; Wang, Peng; Zheng, Chengcai; Huang, Weilong; Yang, Chenqi; Wang, Brian; Su, Dong-Ming; Jin, Kunlin			Cross-Talk between Human Neural Stem/Progenitor Cells and Peripheral Blood Mononuclear Cells in an Allogeneic Co-Culture Model	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; VERSUS-HOST-DISEASE; DELTA-T-CELLS; PRECURSOR CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; NEURONAL DIFFERENTIATION; FUNCTIONAL RECOVERY; BRAIN-INJURY; GLIAL-CELLS; RAT MODEL	Transplantation of human neural stem/progenitor cells (hNSCs) as a regenerative cell replacement therapy holds great promise. However, the underlying mechanisms remain unclear. We, here, focused on the interaction between hNSCs and allogeneic peripheral blood mononuclear cells (PBMCs) in a co-culture model. We found that hNSCs significantly decrease the CD3(+) and CD8(+) T cells, reduce the gamma delta T cells and increase the regulatory T cells, along with reduced pro-inflammatory cytokines and increased anti-inflammatory cytokines after co-culture. We also found that PBMCs, in turn, significantly promote the proliferation and differentiation of hNSCs. Our data suggest that hNSCs cross-talk with immune cells.	[Zhang, Hongxia; Shao, Bei; Zhuge, Qichuan; Wang, Peng; Zheng, Chengcai; Huang, Weilong; Su, Dong-Ming; Jin, Kunlin] Wenzhou Med Univ, Affiliated Hosp 1, Zhejiang Prov Key Lab Aging & Neurol Disorder Res, Wenzhou 35000, Peoples R China; [Yang, Chenqi; Wang, Brian; Su, Dong-Ming; Jin, Kunlin] Univ North Texas Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA	Wenzhou Medical University	Shao, B (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Zhejiang Prov Key Lab Aging & Neurol Disorder Res, Wenzhou 35000, Peoples R China.	shao_bei@yahoo.com.cn; kunlin.jin@unthsc.edu	Wang, Brian/HGA-9535-2022	zhang, Hongxia/0000-0003-1594-6707	Foundation of Zhejiang Provincial Top Key Discipline of Surgery; National Natural Science Foundation of China [81371396]; Educational Commission of Zhenjiang Province, China [Z201016125]; US Public Health Service Grants [NS57186, AG21980]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021980] Funding Source: NIH RePORTER	Foundation of Zhejiang Provincial Top Key Discipline of Surgery; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Educational Commission of Zhenjiang Province, China; US Public Health Service Grants(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was partially supported by the Foundation of Zhejiang Provincial Top Key Discipline of Surgery, National Natural Science Foundation of China (81371396 to QCZG), the Educational Commission of Zhenjiang Province, China (Z201016125 to BS), and the US Public Health Service Grants NS57186 and AG21980 (to KJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson E, 2009, STEM CELL RES, V2, P56, DOI 10.1016/j.scr.2008.06.002; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Fainstein N, 2008, MOL CELL NEUROSCI, V39, P335, DOI 10.1016/j.mcn.2008.07.007; Felix NJ, 2007, NAT REV IMMUNOL, V7, P942, DOI 10.1038/nri2200; GASQUE P, 1995, J IMMUNOL, V154, P4726; Gomi M, 2011, J NEUROSCI RES, V89, P1388, DOI 10.1002/jnr.22667; Grinnemo KH, 2006, REPROD BIOMED ONLINE, V13, P712, DOI 10.1016/S1472-6483(10)60663-3; Ideguchi M, 2008, J NEUROSCI RES, V86, P1936, DOI 10.1002/jnr.21652; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Kim SJ, 2007, NEUROCHEM RES, V32, P1399, DOI 10.1007/s11064-007-9323-z; Kim SY, 2009, J NEUROSCI RES, V87, P2264, DOI 10.1002/jnr.22050; Kleinschnitz C, 2010, BLOOD, V115, P3835, DOI 10.1182/blood-2009-10-249078; Knight J, 2011, J NEUROL SCI, V306, P121, DOI 10.1016/j.jns.2011.03.030; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; Lee ST, 2005, NEUROSCI RES, V52, P243, DOI 10.1016/j.neures.2005.03.016; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Liu J, 2013, J CELL MOL MED, V17, P1434, DOI 10.1111/jcmm.12123; Liu J, 2013, STEM CELL RES, V10, P325, DOI 10.1016/j.scr.2013.01.001; Liu MY, 2013, J NEUROIMMUNOL, V255, P32, DOI 10.1016/j.jneuroim.2012.10.013; Mariani S, 2005, LEUKEMIA, V19, P664, DOI 10.1038/sj.leu.2403693; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Martino G, 2011, PHYSIOL REV, V91, P1281, DOI 10.1152/physrev.00032.2010; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Michel ML, 2012, P NATL ACAD SCI USA, V109, P17549, DOI 10.1073/pnas.1204327109; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Odeberg J, 2005, J NEUROIMMUNOL, V161, P1, DOI 10.1016/j.jneuroim.2004.11.016; Okano H, 2008, PHILOS T R SOC B, V363, P2111, DOI 10.1098/rstb.2008.2264; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Piao JH, 2006, J NEUROSCI RES, V84, P471, DOI 10.1002/jnr.20955; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Pluchino S, 2009, ANN NEUROL, V66, P343, DOI 10.1002/ana.21745; Preynat-Seauve O, 2009, J CELL MOL MED, V13, P3556, DOI 10.1111/j.1582-4934.2009.00746.x; SATOH JI, 1995, J NEUROSCI RES, V41, P805, DOI 10.1002/jnr.490410611; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Spahn TW, 1999, EUR J IMMUNOL, V29, P4060, DOI 10.1002/(SICI)1521-4141(199912)29:12<4060::AID-IMMU4060>3.0.CO;2-S; Ubiali F, 2007, INT IMMUNOL, V19, P1063, DOI 10.1093/intimm/dxm079; Wang LQ, 2014, CNS NEUROSCI THER, V20, P317, DOI 10.1111/cns.12216; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006; Yin L, 2008, STEM CELLS DEV, V17, P53, DOI 10.1089/scd.2007.0063; Zhang Hui, 2011, Front Biosci (Schol Ed), V3, P869; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	51	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117432	10.1371/journal.pone.0117432	http://dx.doi.org/10.1371/journal.pone.0117432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658950	gold, Green Submitted, Green Published			2022-12-27	WOS:000349444900148
J	Sakurai, A; Takayama, K; Nomura, N; Kajiwara, N; Okamatsu, MS; Yamamoto, N; Tamura, T; Yamada, J; Hashimoto, M; Sakoda, Y; Suda, Y; Kobayashi, Y; Kida, H; Shibasaki, F				Sakurai, Akira; Takayama, Katsuyoshi; Nomura, Namiko; Kajiwara, Naoki; Okamatsu, Masatoshi; Yamamoto, Naoki; Tamura, Tsuruki; Yamada, Jitsuho; Hashimoto, Masako; Sakoda, Yoshihiro; Suda, Yoshihiko; Kobayashi, Yukuharu; Kida, Hiroshi; Shibasaki, Futoshi			Fluorescent Immunochromatography for Rapid and Sensitive Typing of Seasonal Influenza Viruses	PLOS ONE			English	Article							A H7N9 VIRUS; HUMAN INFECTION; H5N1 VIRUS; EVOLUTIONARY PATTERN; UNITED-STATES; B VIRUS; ORIGIN; LINEAGES; HUMANS; TRANSMISSION	Lateral flow tests also known as Immunochromatography (IC) is an antigen-detection method conducted on a nitrocellulose membrane that can be completed in less than 20 min. IC has been used as an important rapid test for clinical diagnosis and surveillance of influenza viruses, but the IC sensitivity is relatively low (approximately 60%) and the limit of detection (LOD) is as low as 10(3) pfu per reaction. Recently, we reported an improved IC assay using antibodies conjugated with fluorescent beads (fluorescent immunochromatography; FLIC) for subtyping H5 influenza viruses (FLIC-H5). Although the FLIC strip must be scanned using a fluorescent reader, the sensitivity (LOD) is significantly improved over that of conventional IC methods. In addition, the antibodies which are specific against the subtypes of influenza viruses cannot be available for the detection of other subtypes when the major antigenicity will be changed. In this study, we established the use of FLIC to type seasonal influenza A and B viruses (FLIC-AB). This method has improved sensitivity to 100-fold higher than that of conventional IC methods when we used several strains of influenza viruses. In addition, FLIC-AB demonstrated the ability to detect influenza type A and influenza type B viruses from clinical samples with high sensitivity and specificity (Type A: sensitivity 98.7% (74/75), specificity 100% (54/54), Type B: sensitivity 100% (90/90), specificity 98.2% (54/55) in nasal swab samples) in comparison to the results of qRT-PCR. And furthermore, FLIC-AB performs better in the detection of early stage infection (under 13h) than other conventional IC methods. Our results provide new strategies to prevent the early-stage transmission of influenza viruses in humans during both seasonal outbreaks and pandemics.	[Sakurai, Akira; Nomura, Namiko; Kajiwara, Naoki; Hashimoto, Masako; Kobayashi, Yukuharu; Shibasaki, Futoshi] Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Setagaya Ku, Tokyo 113, Japan; [Takayama, Katsuyoshi; Kobayashi, Yukuharu] ADTEC Co LTD, Oita, Japan; [Okamatsu, Masatoshi; Yamamoto, Naoki; Sakoda, Yoshihiro; Kida, Hiroshi] Hokkaido Univ, Microbiol Lab, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Yamamoto, Naoki] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 113, Japan; [Tamura, Tsuruki; Yamada, Jitsuho; Suda, Yoshihiko] Konica Minolta Inc, Tokyo, Japan; [Sakoda, Yoshihiro; Kida, Hiroshi] Hokkaido Univ, Global Stn Zoonosis Control, Global Inst Collaborat Res & Educ GI CoRE, Sapporo, Hokkaido, Japan	Tokyo Metropolitan Institute of Medical Science; Hokkaido University; Tokyo Metropolitan Institute of Medical Science; Konica Minolta Inc.; Hokkaido University	Shibasaki, F (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 113, Japan.	shibasaki-ft@igakuken.or.jp			Ministry of Economy, Trade, and Industry, Japan [2010FY]; Japan Society for the Promotion of Science KAKENHI [23659069, 23659314, 25860420]; Ministry of Education, Culture, Sports, Science; Tokyo Metropolitan Government	Ministry of Economy, Trade, and Industry, Japan; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Metropolitan Government(Tokyo Metropolitan Government)	This work was supported by grants from Ministry of Economy, Trade, and Industry, Japan as a part of "Program to support collaboration between hospitals and businesses for development and improvement of medical equipment and devices to solve unmet medical needs" (supplementary budget, 2010FY), Japan Society for the Promotion of Science KAKENHI (Grant Numbers 23659069 [FS], 23659314 [AS] and 25860420 [AS]), a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and by some part of the special grant from Tokyo Metropolitan Government (FS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Bowman AS, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.33; Centers for Disease Control and Preventation, 2013, 1 H3N2V OUTBR 2013 R; Chan KH, 2007, J CLIN VIROL, V38, P169, DOI 10.1016/j.jcv.2006.11.010; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Cruz AT, 2006, ANN EMERG MED, V47, P250, DOI 10.1016/j.annemergmed.2005.10.019; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; DiOrio Mary, 2012, Morbidity and Mortality Weekly Report, V61, P764; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Indiana State Department of Health, 2013, HLTH OFF ENC HOOS PR; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Kamigaki T, 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1139; KANEGAE Y, 1990, J VIROL, V64, P2860, DOI 10.1128/JVI.64.6.2860-2865.1990; Keitel K, 2011, EUR J PEDIATR, V170, P511, DOI 10.1007/s00431-010-1326-0; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Mok C. K., 2013, MBIO, V4, P4, DOI DOI 10.1128/MBIO.01006-13; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Sakai-Tagawa Y, 2010, J CLIN MICROBIOL, V48, P2872, DOI 10.1128/JCM.00439-10; Sakurai A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076753; Sakurai A, 2012, VIRUSES-BASEL, V4, P1235, DOI 10.3390/v4081235; Sakurai A, 2011, J VIROL METHODS, V178, P75, DOI 10.1016/j.jviromet.2011.08.015; Sasaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050670; Shichinohe S, 2013, VET MICROBIOL, V164, P39, DOI 10.1016/j.vetmic.2013.01.041; Shu B, 2012, VIROLOGY, V422, P151, DOI 10.1016/j.virol.2011.10.016; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Wada A, 2011, J VIROL METHODS, V178, P82, DOI 10.1016/j.jviromet.2011.08.017; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Webster RG, 1997, ARCH VIROL, P105; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; WHO, 2013, CUM NUMB CONF HUM CA; WHO, 2020, PAND INFL RISK MAN W; World Health Organization, 2010, H1N1 IN POSTP PER; World Health Organization, 2010, PAND H1N1 2009 UPD 1; World Health Organization, 2013, 9 WHO, V14, P45; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; YAMASHITA M, 1988, VIROLOGY, V163, P112, DOI 10.1016/0042-6822(88)90238-3	44	13	14	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0116715	10.1371/journal.pone.0116715	http://dx.doi.org/10.1371/journal.pone.0116715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25650570	Green Published, Green Submitted, gold			2022-12-27	WOS:000349250700005
J	Sussan, TE; Gajghate, S; Thimmulappa, RK; Ma, JF; Kim, JH; Sudini, K; Consolini, N; Cormier, SA; Lomnicki, S; Hasan, F; Pekosz, A; Biswal, S				Sussan, Thomas E.; Gajghate, Sachin; Thimmulappa, Rajesh K.; Ma, Jinfang; Kim, Jung-Hyun; Sudini, Kuladeep; Consolini, Nicola; Cormier, Stephania A.; Lomnicki, Slawo; Hasan, Farhana; Pekosz, Andrew; Biswal, Shyam			Exposure to Electronic Cigarettes Impairs Pulmonary Anti-Bacterial and Anti-Viral Defenses in a Mouse Model	PLOS ONE			English	Article							SMOKE-INDUCED EMPHYSEMA; VIRUS M2 PROTEIN; ACETYLCHOLINE-RECEPTORS; ALVEOLAR MACROPHAGES; INFLUENZA-VIRUS; CELL RESPONSE; IMPACT; SUSCEPTIBILITY; PHAGOCYTOSIS; INFLAMMATION	Electronic cigarettes (E-cigs) have experienced sharp increases in popularity over the past five years due to many factors, including aggressive marketing, increased restrictions on conventional cigarettes, and a perception that E-cigs are healthy alternatives to cigarettes. Despite this perception, studies on health effects in humans are extremely limited and in vivo animal models have not been generated. Presently, we determined that E-cig vapor contains 7x10(11) free radicals per puff. To determine whether E-cig exposure impacts pulmonary responses in mice, we developed an inhalation chamber for E-cig exposure. Mice that were exposed to E-cig vapor contained serum cotinine concentrations that are comparable to human E-cig users. E-cig exposure for 2 weeks produced a significant increase in oxidative stress and moderate macrophage-mediated inflammation. Since, COPD patients are susceptible to bacterial and viral infections, we tested effects of E-cigs on immune response. Mice that were exposed to E-cig vapor showed significantly impaired pulmonary bacterial clearance, compared to air-exposed mice, following an intranasal infection with Streptococcus pneumonia. This defective bacterial clearance was partially due to reduced phagocytosis by alveolar macrophages from E-cig exposed mice. In response to Influenza A virus infection, E-cig exposed mice displayed increased lung viral titers and enhanced virus-induced illness and mortality. In summary, this study reports a murine model of E-cig exposure and demonstrates that E-cig exposure elicits impaired pulmonary anti-microbial defenses. Hence, E-cig exposure as an alternative to cigarette smoking must be rigorously tested in users for their effects on immune response and susceptibility to bacterial and viral infections.	[Sussan, Thomas E.; Gajghate, Sachin; Thimmulappa, Rajesh K.; Ma, Jinfang; Kim, Jung-Hyun; Sudini, Kuladeep; Consolini, Nicola] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Cormier, Stephania A.] Univ Tennessee, Childrens Res Fdn Inst, Hlth Sci Ctr, Memphis, TN 37996 USA; [Lomnicki, Slawo] Louisiana State Univ, Dept Environm Sci, Baton Rouge, LA 70803 USA; [Hasan, Farhana] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA; [Pekosz, Andrew] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Tennessee System; University of Tennessee Health Science Center; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sussan, TE (corresponding author), Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	tsussan1@jhu.edu; sbiswal@jhu.edu	Thimmulappa, Rajesh/AAW-5013-2021; Cormier, Stephania A/I-7382-2017	Thimmulappa, Rajesh/0000-0001-6050-1323; Cormier, Stephania A/0000-0002-6050-6172; Pekosz, Andrew/0000-0003-3248-1761; Sussan, Thomas/0000-0002-5240-4299	Young Clinical Scientist Awards from Flight Attendant Medical Research Institute (FAMRI); Clinical Innovator Award from FAMRI; National Institutes of Health (NIH) [R01CA140492, P50CA058184]; NATIONAL CANCER INSTITUTE [R01CA140492, P50CA058184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015050] Funding Source: NIH RePORTER	Young Clinical Scientist Awards from Flight Attendant Medical Research Institute (FAMRI); Clinical Innovator Award from FAMRI; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	TES and RKTare supported in part by Young Clinical Scientist Awards from Flight Attendant Medical Research Institute (FAMRI). SB is supported by a Clinical Innovator Award from FAMRI and National Institutes of Health (NIH) grants R01CA140492 and P50CA058184. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl V, 2012, REPROD TOXICOL, V34, P529, DOI 10.1016/j.reprotox.2012.08.001; Benowitz NL, 2004, J PHARMACOL EXP THER, V310, P1208, DOI 10.1124/jpet.104.066902; Berenson CS, 2006, J INFECT DIS, V194, P1375, DOI 10.1086/508428; Bertholon JF, 2013, RESPIRATION, V86, P433, DOI 10.1159/000353253; Drannik AG, 2004, AM J RESP CRIT CARE, V170, P1164, DOI 10.1164/rccm.200311-1521OC; Etter JF, 2014, ADDICTION, V109, P825, DOI 10.1111/add.12475; Feng Y, 2011, INFECT IMMUN, V79, P229, DOI 10.1128/IAI.00709-10; Flouris AD, 2013, INHAL TOXICOL, V25, P91, DOI 10.3109/08958378.2012.758197; Giebelen IAJ, 2009, EUR RESPIR J, V33, P375, DOI 10.1183/09031936.00103408; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Grantham ML, 2010, J VIROL, V84, P8765, DOI 10.1128/JVI.00853-10; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042; Kim HJ, 2013, J CHROMATOGR A, V1291, P48, DOI 10.1016/j.chroma.2013.03.035; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; Mahapatra SK, 2011, INT IMMUNOPHARMACOL, V11, P485, DOI 10.1016/j.intimp.2010.12.020; Manani Madhu, 2013, Perm J, V17, P8, DOI 10.7812/TPP/12-130; Matsunaga K, 2001, J IMMUNOL, V167, P6518, DOI 10.4049/jimmunol.167.11.6518; Matt U, 2013, J CLIN INVEST, V123, P3014, DOI 10.1172/JCI60681; McAuley TR, 2012, INHAL TOXICOL, V24, P850, DOI 10.3109/08958378.2012.724728; McCauley L, 2012, CHEST, V141, P1110, DOI 10.1378/chest.11-1334; Park S, 2014, THE EFFECT OF E CIGA, pB16; Pearson JL, 2012, AM J PUBLIC HEALTH, V102, P1758, DOI 10.2105/AJPH.2011.300526; PRYOR WA, 1976, ENVIRON HEALTH PERSP, V16, P161, DOI 10.2307/3428597; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Radek KA, 2010, CELL HOST MICROBE, V7, P277, DOI 10.1016/j.chom.2010.03.009; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Razani-Boroujerdi S, 2004, CELL IMMUNOL, V230, P1, DOI 10.1016/j.cellimm.2004.07.007; Regan AK, 2013, TOB CONTROL, V22, P19, DOI 10.1136/tobaccocontrol-2011-050044; Robbins CS, 2006, AM J RESP CRIT CARE, V174, P1342, DOI 10.1164/rccm.200604-561OC; Romagna G, 2013, INHAL TOXICOL, V25, P354, DOI 10.3109/08958378.2013.793439; Saini A, 2013, INDIAN J MED RES, V137, P1193; Schober W, 2014, INT J HYG ENVIR HEAL, V217, P628, DOI 10.1016/j.ijheh.2013.11.003; Schripp T, 2013, INDOOR AIR, V23, P25, DOI 10.1111/j.1600-0668.2012.00792.x; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Stewart SM, 2010, VIROLOGY, V405, P530, DOI 10.1016/j.virol.2010.06.035; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Taut K, 2008, AM J RESP CELL MOL, V38, P105, DOI 10.1165/rcmb.2007-0132OC; Thimmulappa RK, 2012, BIOCHEM BIOPH RES CO, V426, P253, DOI 10.1016/j.bbrc.2012.08.076; Vardavas CI, 2012, CHEST, V141, P1400, DOI 10.1378/chest.11-2443; Varughese S, 2005, AM J IND MED, V47, P411, DOI 10.1002/ajim.20151; Wang XH, 2011, CELL MOL IMMUNOL, V8, P462, DOI 10.1038/cmi.2011.38; Wieslander G, 2001, OCCUP ENVIRON MED, V58, P649, DOI 10.1136/oem.58.10.649; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Wongtrakool C, 2012, PEDIATR RES, V72, P147, DOI 10.1038/pr.2012.55	45	258	266	4	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0116861	10.1371/journal.pone.0116861	http://dx.doi.org/10.1371/journal.pone.0116861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25651083	Green Submitted, Green Published, gold			2022-12-27	WOS:000349250700008
J	Barn, R; Waaijman, R; Nollet, F; Woodburn, J; Bus, SA				Barn, Ruth; Waaijman, Roelof; Nollet, Frans; Woodburn, James; Bus, Sicco A.			Predictors of Barefoot Plantar Pressure during Walking in Patients with Diabetes, Peripheral Neuropathy and a History of Ulceration	PLOS ONE			English	Article							LIMITED JOINT MOBILITY; FOOT ULCERATION; HIGH-RISK; TOE DEFORMITY; ULCERS; PEOPLE; MELLITUS; TRIAL; DETERMINANTS; RECURRENCE	Objective Elevated dynamic plantar foot pressures significantly increase the risk of foot ulceration in diabetes mellitus. The aim was to determine which factors predict plantar pressures in a population of diabetic patients who are at high-risk of foot ulceration. Methods Patients with diabetes, peripheral neuropathy and a history of ulceration were eligible for inclusion in this cross sectional study. Demographic data, foot structure and function, and disease-related factors were recorded and used as potential predictor variables in the analyses. Barefoot peak pressures during walking were calculated for the heel, midfoot, forefoot, lesser toes, and hallux regions. Potential predictors were investigated using multivariate linear regression analyses. 167 participants with mean age of 63 years contributed 329 feet to the analyses. Results The regression models were able to predict between 6% (heel) and 41% (midfoot) of the variation in peak plantar pressures. The largest contributing factor in the heel model was glycosylated haemoglobin concentration, in the midfoot Charcot deformity, in the forefoot prominent metatarsal heads, in the lesser toes hammer toe deformity and in the hallux previous ulceration. Variables with local effects (e.g. foot deformity) were stronger predictors of plantar pressure than global features (e.g. body mass, age, gender, or diabetes duration). Conclusion The presence of local deformity was the largest contributing factor to barefoot dynamic plantar pressure in high-risk diabetic patients and should therefore be adequately managed to reduce plantar pressure and ulcer risk. However, a significant amount of variance is unexplained by the models, which advocates the quantitative measurement of plantar pressures in the clinical risk assessment of the patient.	[Barn, Ruth; Waaijman, Roelof; Nollet, Frans; Bus, Sicco A.] Univ Amsterdam, Acad Med Ctr, Dept Rehabil, NL-1105 AZ Amsterdam, Netherlands; [Barn, Ruth; Woodburn, James] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Inst Appl Hlth Res, Glasgow G4 0BA, Lanark, Scotland	University of Amsterdam; Academic Medical Center Amsterdam; Glasgow Caledonian University	Bus, SA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Rehabil, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.a.bus@amc.uva.nl		Bus, Sicco/0000-0002-8357-9163; Woodburn, James/0000-0002-5497-8739	Dutch Diabetes Research Foundation [2007.00.067]; Dutch Foundation for the Development of Orthopaedic Footwear; Dutch Organization for Health Research and Development [14350054]	Dutch Diabetes Research Foundation; Dutch Foundation for the Development of Orthopaedic Footwear; Dutch Organization for Health Research and Development	The study was supported by project grants from the Dutch Diabetes Research Foundation project 2007.00.067) www.diabetesfonds.nl; the Dutch Foundation for the Development of Orthopaedic Footwear, and the Dutch Organization for Health Research and Development (project 14350054) www.zonmw.nl/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouaesha F, 2001, DIABETES CARE, V24, P1270, DOI 10.2337/diacare.24.7.1270; Ahroni JH, 1999, DIABETES CARE, V22, P965, DOI 10.2337/diacare.22.6.965; Armstrong D G, 1998, J Foot Ankle Surg, V37, P303; Arts MLJ, 2012, DIABETIC MED, V29, P1534, DOI 10.1111/j.1464-5491.2012.03770.x; Bus SA, 2005, CLIN BIOMECH, V20, P892, DOI 10.1016/j.clinbiomech.2005.05.004; Bus SA, 2005, J BIOMECH, V38, P1918, DOI 10.1016/j.jbiomech.2004.07.034; Bus SA, 2002, DIABETES CARE, V25, P1444, DOI 10.2337/diacare.25.8.1444; Bus SA, 2013, DIABETES CARE, V36, P4109, DOI 10.2337/dc13-0996; Bus SA, 2012, DIABETES-METAB RES, V28, P54, DOI 10.1002/dmrr.2240; CAVANAGH PR, 1991, DIABETES CARE, V14, P750, DOI 10.2337/diacare.14.8.750; Cavanagh PR, 2005, LANCET, V366, P1725, DOI 10.1016/S0140-6736(05)67699-4; Crawford F, 2007, QJM-INT J MED, V100, P65; FERNANDO DJS, 1991, DIABETES CARE, V14, P8, DOI 10.2337/diacare.14.1.8; Frykberg RG, 1998, DIABETES CARE, V21, P1714, DOI 10.2337/diacare.21.10.1714; GRIMSTON SK, 1993, FOOT ANKLE, V14, P215, DOI 10.1177/107110079301400407; Guldemond Nick A, 2008, BMC Endocr Disord, V8, P16, DOI 10.1186/1472-6823-8-16; HAMILL J, 1989, CLIN BIOMECH, V4, P217, DOI 10.1016/0268-0033(89)90006-5; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Kastenbauer T, 2001, J AM PODIAT MED ASSN, V91, P343; Kwan RLC, 2010, CLIN BIOMECH, V25, P601, DOI 10.1016/j.clinbiomech.2010.04.003; Lavery LA, 2003, DIABETES CARE, V26, P1069, DOI 10.2337/diacare.26.4.1069; Melai T, 2013, HUM MOVEMENT SCI, V32, P785, DOI 10.1016/j.humov.2013.05.001; Menz HB, 2006, GAIT POSTURE, V24, P229, DOI 10.1016/j.gaitpost.2005.09.002; Monteiro-Soares M, 2012, DIABETES-METAB RES, V28, P574, DOI 10.1002/dmrr.2319; Morag E, 1999, J BIOMECH, V32, P359, DOI 10.1016/S0021-9290(98)00188-2; Mueller MJ, 2003, J BONE JOINT SURG AM, V85A, P1436, DOI 10.2106/00004623-200308000-00003; Mueller MJ, 2003, J BIOMECH, V36, P1009, DOI 10.1016/S0021-9290(03)00078-2; MUELLER MJ, 1989, PHYS THER, V69, P453, DOI 10.1093/ptj/69.6.453; Payne C, 2002, J DIABETES COMPLICAT, V16, P277, DOI 10.1016/S1056-8727(01)00187-8; Pham H, 2000, DIABETES CARE, V23, P606, DOI 10.2337/diacare.23.5.606; Pound N, 2005, DIABETIC MED, V22, P1306, DOI 10.1111/j.1464-5491.2005.01640.x; Rasmussen A, 2013, J TISSUE VIABILITY, V22, P68, DOI 10.1016/j.jtv.2013.04.001; Rosenbloom AL, 1996, ENDOCRIN METAB CLIN, V25, P473, DOI 10.1016/S0889-8529(05)70335-2; Segal A, 2004, FOOT ANKLE INT, V25, P926, DOI 10.1177/107110070402501215; Turner DE, 2007, DIABETIC MED, V24, P1240, DOI 10.1111/j.1464-5491.2007.02233.x; VEVES A, 1992, DIABETOLOGIA, V35, P660, DOI 10.1007/BF00400259; Waaijman R, 2014, DIABETES CARE, V37, P1697, DOI 10.2337/dc13-2470; Wrobel JS, 2003, J AM PODIAT MED ASSN, V93, P367, DOI 10.7547/87507315-93-5-367; Zimny S, 2004, DIABETES CARE, V27, P942, DOI 10.2337/diacare.27.4.942	39	40	40	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117443	10.1371/journal.pone.0117443	http://dx.doi.org/10.1371/journal.pone.0117443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647421	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600068
J	Hart, CE; Blanco, GS; Coyne, MS; Delgado-Trejo, C; Godley, BJ; Jones, TT; Resendiz, A; Seminoff, JA; Witt, MJ; Nichols, WJ				Hart, Catherine E.; Blanco, Gabriela S.; Coyne, Michael S.; Delgado-Trejo, Carlos; Godley, Brendan J.; Jones, T. Todd; Resendiz, Antonio; Seminoff, Jeffrey A.; Witt, Matthew J.; Nichols, Wallace J.			Multinational Tagging Efforts Illustrate Regional Scale of Distribution and Threats for East Pacific Green Turtles (Chelonia mydas agassizii)	PLOS ONE			English	Article							POST-NESTING MIGRATIONS; GULF-OF-CALIFORNIA; SATELLITE TRACKING; SEA-TURTLES; LEATHERBACK TURTLES; DERMOCHELYS-CORIACEA; FORAGING AREA; NATIONAL-PARK; GLOBAL PATTERNS; MOVEMENTS	To further describe movement patterns and distribution of East Pacific green turtles (Chelonia mydas agassizii) and to determine threat levels for this species within the Eastern Pacific. In order to do this we combined published data from existing flipper tagging and early satellite tracking studies with data from an additional 12 satellite tracked green turtles (1996-2006). Three of these were tracked from their foraging grounds in the Gulf of California along the east coast of the Baja California peninsula to their breeding grounds in Michoacan (1337-2928 km). In addition, three post-nesting females were satellite tracked from Colola beach, Michoacan to their foraging grounds in southern Mexico and Central America (941.3-3020 km). A further six turtles were tracked in the Gulf of California within their foraging grounds giving insights into the scale of ranging behaviour. Turtles undertaking long-distance migrations showed a tendency to follow the coastline. Turtles tracked within foraging grounds showed that foraging individuals typically ranged up to 691.6 km (maximum) from release site location. Additionally, we carried out threat analysis (using the cumulative global human impact in the Eastern Pacific) clustering pre-existing satellite tracking studies from Galapagos, Costa Rica, and data obtained from this study; this indicated that turtles foraging and nesting in Central American waters are subject to the highest anthropogenic impact. Considering that turtles from all three rookeries were found to migrate towards Central America, it is highly important to implement conservation plans in Central American coastal areas to ensure the survival of the remaining green turtles in the Eastern Pacific. Finally, by combining satellite tracking data from this and previous studies, and data of tag returns we created the best available distributional patterns for this particular sea turtle species, which emphasized that conservation measures in key areas may have positive consequences on a regional scale.	[Hart, Catherine E.; Coyne, Michael S.; Godley, Brendan J.; Witt, Matthew J.] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Blanco, Gabriela S.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Coyne, Michael S.] SEATURTLE Org, Durham, NC USA; [Delgado-Trejo, Carlos] Univ Michoacana, Inst Invest Recursos Nat, Morelia, Michoacan, Mexico; [Jones, T. Todd] NOAA Fisheries, Pacific Islands Fisheries Sci Ctr, Honolulu, HI USA; [Resendiz, Antonio] Inst Nacl Ecol, Direcc Gen Vida Silvestre, Secretaria Medio Ambiente Recursos Natur, Ensenada, Baja California, Mexico; [Seminoff, Jeffrey A.] NOAA, Southwest Fisheries Sci Ctr, La Jolla, CA USA; [Nichols, Wallace J.] Calif Acad Sci, San Francisco, CA 94118 USA	University of Exeter; Drexel University; Universidad Michoacana de San Nicolas de Hidalgo; National Oceanic Atmospheric Admin (NOAA) - USA; Instituto de Ecologia - Mexico; National Oceanic Atmospheric Admin (NOAA) - USA; California Academy of Sciences	Nichols, WJ (corresponding author), Calif Acad Sci, Golden Gate Pk, San Francisco, CA 94118 USA.	wallacejnichols@me.com	Hart, Catherine E./AAD-5944-2022; godley, brendan j/A-6139-2009; Witt, Matthew/V-3318-2018; godley, brendan/O-1959-2019	Hart, Catherine E./0000-0002-0833-2523; godley, brendan j/0000-0003-3845-0034; Witt, Matthew/0000-0002-9498-5378; godley, brendan/0000-0003-3845-0034; Blanco, Gabriela S./0000-0001-6794-4207	Earthwatch Institute; David and Lucile Packard Foundation; Wallace Research Foundation; PADI Foundation; Arizona-Sonora Desert Museum; Unversity of Exeter; European Social Fund; Consejo Nacional de Ciencia y Tecnologia (iMexico); Fulbright Fellowship; Marshall Fellowship; Darwin Initiative; Natural Environment Research Council	Earthwatch Institute; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Wallace Research Foundation; PADI Foundation; Arizona-Sonora Desert Museum; Unversity of Exeter; European Social Fund(European Social Fund (ESF)); Consejo Nacional de Ciencia y Tecnologia (iMexico); Fulbright Fellowship; Marshall Fellowship; Darwin Initiative; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was supported by Earthwatch Institute, David and Lucile Packard Foundation, Wallace Research Foundation, PADI Foundation and the Arizona-Sonora Desert Museum. C. E. H. received a Masters degree bursary from the Unversity of Exeter and the European Social Fund and would like to thank Consejo Nacional de Ciencia y Tecnologia (iMexico) for support through a PhD scholarship. W. J. N. was supported by a Fulbright Fellowship and a Marshall Fellowship during the period field research in Baja California was conducted. B. J. G. is supported by the Darwin Initiative, European Social Fund and The Natural Environment Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVARADO J, 1992, BIOTROPICA, V24, P560, DOI 10.2307/2389020; Alvarado-Diaz J, 2003, P 22 ANN S SEA TURTL, P69; Alvarado-Diaz Javier, 2001, Marine Turtle Newsletter, V92, P4; Amorocho Diego F., 2007, Endangered Species Research, V3, P43, DOI 10.3354/esr003043; Amorocho DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031486; Arthur KE, 2008, PAC SCI, V62, P205, DOI 10.2984/1534-6188(2008)62[205:ACOIGT]2.0.CO;2; AWBREY F T, 1984, Bulletin Southern California Academy of Sciences, V83, P69; Balazs G.H., 1996, P 15 ANN S SEA TURTL, P21; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Benson SR, 2007, CHELONIAN CONSERV BI, V6, P150, DOI 10.2744/1071-8443(2007)6[150:PMOLTD]2.0.CO;2; BJORNDAL K.A, 2003, BIOL SEA TURTLES, V2; Blanco Gabriela S., 2012, Endangered Species Research, V18, P233, DOI 10.3354/esr00451; Blanco GS, 2012, J WILDLIFE MANAGE, V76, P841, DOI 10.1002/jwmg.304; Blanco GS, 2010, THESIS DREXEL U PHIL; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Blumenthal Janice M., 2006, Endangered Species Research, V7, P1; Broderick AC, 2007, P ROY SOC B-BIOL SCI, V274, P1533, DOI 10.1098/rspb.2007.0211; Brooks LB, 2009, MAR ECOL PROG SER, V386, P263, DOI 10.3354/meps08061; Byles R, 1995, P 12 ANN WORKSH SEA, P12; Cardona L, 2009, MAR BIOL, V156, P2621, DOI 10.1007/s00227-009-1288-9; Cheng IJ, 2000, MAR BIOL, V137, P747, DOI 10.1007/s002270000375; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; Dutton PH, 2014, ECOL EVOL, V4, P4317, DOI 10.1002/ece3.1269; Eguchi T, 2010, MAR BIOL, V157, P1869, DOI 10.1007/s00227-010-1458-9; Ferraroli S, 2004, NATURE, V429, P521, DOI 10.1038/429521a; Finkelstein M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002480; Fonseca LG, 2014, ANIDACION TORTUGAS M; Fuentes MMPB, 2011, GLOBAL CHANGE BIOL, V17, P140, DOI 10.1111/j.1365-2486.2010.02192.x; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Godley BJ, 2003, MAR ECOL PROG SER, V253, P279, DOI 10.3354/meps253279; Godley BJ, 2002, ECOGRAPHY, V25, P352, DOI 10.1034/j.1600-0587.2002.250312.x; GREEN D, 1984, J HERPETOL, V18, P121, DOI 10.2307/1563739; Guerra-Correa C, 2008, NOAA TECH MEMO NMFS, P211; Guerra-Correa C, 2007, SEA TURTLES SI UNPUB; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hart KA, 2013, MAR POLICY, V42, P236, DOI 10.1016/j.marpol.2013.03.008; Hays GC, 2007, J EXP MAR BIOL ECOL, V349, P52, DOI 10.1016/j.jembe.2007.04.016; Holroyd GL, 2010, CHELONIAN CONSERV BI, V9, P305, DOI 10.2744/CCB-0831.1; Hueter R, 2007, HIGHLY MIGRATORY SHA, P91; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Inter-American Tropical Tuna Commission, 2003, WORK GROUP BYC 4 M K; James MC, 2005, P ROY SOC B-BIOL SCI, V272, P1547, DOI 10.1098/rspb.2005.3110; Jones TT, 2013, METHODS ECOL EVOL, V4, P1178, DOI 10.1111/2041-210X.12109; Jones TT, 2011, NMFSSWFSC480 NOAA; Juarez-Ceron JA, 2002, P 22 ANN S SEA TURTL, P70; Kelez S, 2011, THESIS DUKE U; Keller JM, 2014, ENVIRON SCI TECHNOL, V48, P7807, DOI 10.1021/es5014054; Koch V, 2006, BIOL CONSERV, V128, P327, DOI 10.1016/j.biocon.2005.09.038; Koch V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056776; Lewison RL, 2014, P NATL ACAD SCI USA, V111, P5271, DOI 10.1073/pnas.1318960111; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Lopez E, 2002, P 22 ANN S SEA TURTL, P84; MacDonald BD, 2012, MAR ECOL PROG SER, V461, P211, DOI 10.3354/meps09820; Marquez-Millan, 2002, P 22 ANN S SEA TURTL, P80; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; McCarthy AL, 2010, PROG OCEANOGR, V86, P224, DOI 10.1016/j.pocean.2010.04.009; Nichols WJ, 2003, THESIS U ARIZONA MEX; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Pritchard PCH, 1999, CONSERV BIOL, V13, P1000, DOI 10.1046/j.1523-1739.1999.98432.x; Quinones J, 2010, DEV HYDROBIOL, V212, P69, DOI 10.1007/s10750-010-0225-8; Raygadas-Torres BS, 2008, THESIS U MICHOACANA, DOI [10.1038/tp.2014.91, DOI 10.1038/TP.2014.91]; Tomillo PS, 2015, MAR ECOL-EVOL PERSP, V36, P506, DOI 10.1111/maec.12159; Santos RG, 2011, MAR POLLUT BULL, V62, P1297, DOI 10.1016/j.marpolbul.2011.03.004; Scott R, 2014, ECOLOGY, V95, P2840, DOI 10.1890/13-2164.1; Scott R, 2012, GLOBAL ECOL BIOGEOGR, V21, P1053, DOI 10.1111/j.1466-8238.2011.00757.x; Seminoff JA, 2002, SOUTHWEST NAT, V47, P314, DOI 10.2307/3672922; Seminoff JA, 2002, MAR ECOL PROG SER, V242, P253, DOI 10.3354/meps242253; Seminoff JA, 2002, J HERPETOL, V36, P447, DOI 10.2307/1566189; Seminoff JA, 2007, GREEN SEA TURTLE CHE; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; Seminoff JA, 2006, HERPETOL CONSERV BIO, V1, P81; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Southall EJ, 2006, BIOL CONSERV, V132, P33, DOI 10.1016/j.biocon.2006.03.011; Tomillo PS, 2008, CONSERV BIOL, V22, P1216, DOI 10.1111/j.1523-1739.2008.00987.x; Tomillo PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037602; Troeng S, 2005, BIOL CONSERV, V121, P111, DOI 10.1016/j.biocon.2004.04.014; Wallace BP, 2010, CONSERV LETT, V3, P131, DOI 10.1111/j.1755-263X.2010.00105.x; Watson KP, 1998, J EXP BIOL, V201, P2497; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022; Witt MJ, 2008, ORYX, V42, P296, DOI 10.1017/S0030605308006947; Zarate P, 2002, P 22 ANN S SEA TURTL, P70	83	15	16	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116225	10.1371/journal.pone.0116225	http://dx.doi.org/10.1371/journal.pone.0116225			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646803	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600023
J	Kim, SC; Kim, S; Lee, DH; Choi, SR; Kim, JS				Kim, Seong Chun; Kim, Sunjoo; Lee, Dong-Hyun; Choi, Sae-Rom; Kim, Jeong-Sook			Effect of Blood Volume in Standard Anaerobic Blood Culture Bottles of the BacT/ALERT 3D System Used for the Detection of Pathogens and Time to Detection	PLOS ONE			English	Article								Background Blood volume may profoundly affect the isolation of microorganisms in blood cultures. The effect of blood volume in standard anaerobic bottles of the BacT/ALERT 3D system was investigated. Methods Adult patients who visited the emergency department and referred for blood culture (n = 824) were enrolled from June to September 2013. Two sets of blood cultures were obtained from each patient. One set consisted of 5 mL that was collected in a standard aerobic bottle (SA5), 5 mL that was collected in a standard anaerobic bottle (SN5), and 10 mL that was collected in a standard anaerobic bottle (SN10). The growth of clinically significant pathogens and the time to detection (TTD) were compared between the SN5 and SN10 samples. Results Increasing the volume of blood collected from 5 to 10 mL yielded a 14.7% improvement in the isolation of microorganisms. There was a statistically significant difference in the isolation of pathogens (14 vs. 30, P = 0.023) between the SN5 and SN10 samples. Gram-positive microorganisms were detected earlier in the SN10 samples than the SN5 samples (P = 0.052). The mean TTD of all pathogens was 13.5 h for the SN5 samples and 12.9 h for the SN10 samples (P = 0.099). Conclusion Increased blood volume in the SN bottle yielded a significantly higher pathogen detection rate. However, there was no difference in the frequency of earlier detection or TTD between the SN5 and SN10 samples.	[Kim, Seong Chun] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Dept Emergency Med, Jinju, South Korea; [Kim, Sunjoo; Lee, Dong-Hyun; Choi, Sae-Rom] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Dept Lab Med, Jinju, South Korea; [Kim, Jeong-Sook] Jinju Hlth Coll, Dept Nursing, Jinju, South Korea	Gyeongsang National University; Gyeongsang National University	Kim, S (corresponding author), Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Dept Lab Med, Jinju, South Korea.	sjkim8239@hanmail.net		Kim, Sunjoo/0000-0001-8099-8891; Lee, Donghyun/0000-0001-5880-4528	National Research Foundation (NRF) of Korea - Ministry of Education, Science, and Technology [2011-0008757]	National Research Foundation (NRF) of Korea - Ministry of Education, Science, and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science, and Technology (2011-0008757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFA M, 1995, J CLIN MICROBIOL, V33, P1185, DOI 10.1128/JCM.33.5.1185-1191.1995; Bouza E, 2007, J CLIN MICROBIOL, V45, P2765, DOI 10.1128/JCM.00140-07; BROWN DFJ, 1990, J CLIN PATHOL, V43, P777, DOI 10.1136/jcp.43.9.777; Clinical and Laboratory Standards Institute, 2007, M47A CLSI; Kellogg JA, 2000, J CLIN MICROBIOL, V38, P2181; LI J, 1994, J CLIN MICROBIOL, V32, P2829, DOI 10.1128/JCM.32.11.2829-2831.1994; Riedel S, 2010, J INFECT CHEMOTHER, V16, P301, DOI 10.1007/s10156-010-0069-1; Shin JH, 2011, KOREAN J CLIN MICROB, V14, P91; Vitrat-Hincky V, 2011, EUR J CLIN MICROBIOL, V30, P533, DOI 10.1007/s10096-010-1115-8; WEINSTEIN MP, 1994, J CLIN MICROBIOL, V32, P2103, DOI 10.1128/JCM.32.9.2103-2106.1994; Weinstein MP, 2003, J CLIN MICROBIOL, V41, P2275, DOI 10.1128/JCM.41.6.2275-2278.2003	11	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116728	10.1371/journal.pone.0116728	http://dx.doi.org/10.1371/journal.pone.0116728			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646758	Green Submitted, Green Published, gold			2022-12-27	WOS:000348822600033
J	Noda, T; Murakami, K; Etoh, Y; Okamoto, F; Yatsuyanagi, J; Sera, N; Furuta, M; Onozuka, D; Oda, T; Asai, T; Fujimoto, S				Noda, Tamie; Murakami, Koichi; Etoh, Yoshiki; Okamoto, Fuyuki; Yatsuyanagi, Jun; Sera, Nobuyuki; Furuta, Munenori; Onozuka, Daisuke; Oda, Takahiro; Asai, Tetsuo; Fujimoto, Shuji			Increase in Resistance to Extended-Spectrum Cephalosporins in Salmonella Isolated from Retail Chicken Products in Japan	PLOS ONE			English	Article							AMPC BETA-LACTAMASES; FOOD-PRODUCING ANIMALS; ESCHERICHIA-COLI; CTX-M; SEROVAR INFANTIS; MOLECULAR CHARACTERIZATION; KLEBSIELLA-PNEUMONIAE; SOUTHERN TAIWAN; FARM-ANIMALS; ENTERICA	Extended-spectrum beta-lactamase (ESBL)-producing Salmonella are one of the most important public health problems in developed countries. ESBL-producing Salmonella strains have been isolated from humans in Asian countries neighboring Japan, along with strains harboring the plasmid-mediated extended-spectrum cephalosporin (ESC)-resistance gene, ampC (pAmpC). However, only a few studies have investigated the prevalence of ESC-resistant Salmonella in chicken products in Japan, which are the main vehicle of Salmonella transmission. The aim of this study was to investigate the prevalence of ESBL-producing, pAmpC-harboring, or carbapenem-resistant Salmonella in chicken products in Japan. In total, 355 out of 779 (45.6%) chicken product samples collected from 1996-2010 contained Salmonella, resulting in 378 distinct isolates. Of these isolates, 373 were tested for resistance to ESCs, cephamycins, or carbapenems. Isolates that showed resistance to one or more of these antimicrobials were then examined by PCR and DNA sequence analysis for the presence of the bla(CMY), bla(CTX-M), bla(TEM), and bla(SHV) resistance genes. Thirty-five resistant isolates were detected, including 26 isolates that contained pAmpC (bla(CMY-2)), and nine ESBL-producing isolates harboring bla(CTX-M) (n = 4, consisting of two bla(CTX-M-2) and two bla(CTX-M-15) genes), bla(TEM) (n = 4, consisting of one bla(TEM-20) and three bla(TEM-52) genes), and bla(SHV) (n = 1, bla(SHV-12)). All pAmpC-harboring and ESBL-producing Salmonella isolates were obtained from samples collected after 2005, and the percentage of resistant isolates increased significantly from 0% in 2004 to 27.9% in 2010 (P for trend = 0.006). This increase was caused in part by an increase in the number of Salmonella enterica subsp. enterica serovar Infantis strains harboring an approximately 280-kb plasmid containing bla(CMY-2) in proximity to ISEcp1. The dissemination of ESC-resistant Salmonella containing plasmid-mediated bla(CMY-2) in chicken products indicates the need for the development of continuous monitoring strategies in the interests of public health.	[Noda, Tamie; Fujimoto, Shuji] Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Higashi Ku, Fukuoka 8128582, Japan; [Noda, Tamie; Murakami, Koichi; Etoh, Yoshiki; Okamoto, Fuyuki; Sera, Nobuyuki] Fukuoka Inst Hlth & Environm Sci, Dept Hlth Sci, Div Pathol & Bacteriol, Dazaifu, Fukuoka 8180135, Japan; [Yatsuyanagi, Jun] Akita Prefectural Inst Publ Hlth, Akita 0100874, Japan; [Furuta, Munenori; Oda, Takahiro] Nakamura Gakuen Univ, Jr Coll, Jonan Ku, Fukuoka 8140198, Japan; [Onozuka, Daisuke] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Higashi Ku, Fukuoka 8128582, Japan; [Asai, Tetsuo] Gifu Univ, United Grad Sch Vet Sci, Anim Infect Dis Control, Gifu 5011193, Japan	Kyushu University; Kyushu University; Gifu University	Murakami, K (corresponding author), Fukuoka Inst Hlth & Environm Sci, Dept Hlth Sci, Div Pathol & Bacteriol, 39 Mukaizano, Dazaifu, Fukuoka 8180135, Japan.	murakami@fihes.pref.fukuoka.jp	Asai, Tetsuo/F-3402-2014; Onozuka, Daisuke/F-5067-2014	Asai, Tetsuo/0000-0002-6556-9674; Onozuka, Daisuke/0000-0001-9596-9188	Japan Society for the Promotion of Sciences [24590846]; Daido Life Welfare Foundation, Osaka, Japan	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Daido Life Welfare Foundation, Osaka, Japan	This work was supported by the Japan Society for the Promotion of Sciences KAKENHI, Grant No. 24590846 and the Daido Life Welfare Foundation, Osaka, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2009, J FOOD SCI, V74, pM405, DOI 10.1111/j.1750-3841.2009.01291.x; Allen KJ, 2002, CAN J VET RES, V66, P137; Aviv G, 2014, ENVIRON MICROBIOL, V16, P977, DOI 10.1111/1462-2920.12351; Clinical and Laboratory Standards Institute, 2009, M02A10 CLSI; Clinical and Laboratory Standards Institute, 2014, M100S24 CLSI; CLSI, 2012, PERFORMANCE STANDARD, V7th; Colom K, 2003, FEMS MICROBIOL LETT, V223, P147, DOI 10.1016/S0378-1097(03)00306-9; Fernandez-Alarcon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023415; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; Fujita Takuji, 2011, Kansenshogaku Zasshi, V85, P355; Furuta M, 2010, JPN J FOOD MICROBIOL, V27, P200; Giles WP, 2004, ANTIMICROB AGENTS CH, V48, P2845, DOI 10.1128/AAC.48.8.2845-2852.2004; Hamidian M, 2009, JPN J INFECT DIS, V62, P368; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Hiki M, 2013, FOODBORNE PATHOG DIS, V10, P243, DOI 10.1089/fpd.2012.1306; Hiroi M, 2011, JPN J INFECT DIS, V64, P153; Ishihara K, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-35; Izumiya H, 2005, ANTIMICROB AGENTS CH, V49, P2568, DOI 10.1128/AAC.49.6.2568-2570.2005; Jacoby G, 2014, BETA LACTAMASE CLASS; Leinberger DM, 2010, J CLIN MICROBIOL, V48, P460, DOI 10.1128/JCM.00765-09; Li Y, 2008, J CLIN MICROBIOL, V46, P1317, DOI 10.1128/JCM.00073-07; Liu JH, 2007, INT J ANTIMICROB AG, V29, P576, DOI 10.1016/j.ijantimicag.2006.12.015; Mataseje LE, 2009, J ANTIMICROB CHEMOTH, V64, P723, DOI 10.1093/jac/dkp249; Matsumoto Y, 2007, JPN J INFECT DIS, V60, P236; Morita M, 2010, ANTIMICROB AGENTS CH, V54, P3991, DOI 10.1128/AAC.00225-10; Murakami K, 2001, EPIDEMIOL INFECT, V126, P159, DOI 10.1017/S0950268801005283; Murakami Koichi, 2013, Int J Microbiol, V2013, P463095, DOI 10.1155/2013/463095; Murakami K, 2014, J MICROBIOL METH, V101, P67, DOI 10.1016/j.mimet.2014.04.001; Nakaya H, 2001, Kansenshogaku Zasshi, V75, P815; National Institute of Genetics, 2014, DNA DAT BANK JAP; Noda T, 2010, FOODBORNE PATHOG DIS, V7, P727, DOI 10.1089/fpd.2009.0438; Pagani L, 2003, J CLIN MICROBIOL, V41, P4264, DOI 10.1128/JCM.41.9.4264-4269.2003; Perilli M, 2002, J CLIN MICROBIOL, V40, P611, DOI 10.1128/JCM.40.2.611-614.2002; Riano I, 2006, J ANTIMICROB CHEMOTH, V58, P844, DOI 10.1093/jac/dkl337; Rodriguez I, 2009, J ANTIMICROB CHEMOTH, V64, P301, DOI 10.1093/jac/dkp195; Shahada F, 2013, POULTRY SCI, V92, P1641, DOI 10.3382/ps.2012-02934; Shahada F, 2011, ANTIMICROB AGENTS CH, V55, P4114, DOI 10.1128/AAC.00560-11; Su LH, 2006, J ANTIMICROB CHEMOTH, V57, P424, DOI 10.1093/jac/dki478; Su LH, 2005, J ANTIMICROB CHEMOTH, V55, P846, DOI 10.1093/jac/dki116; Sun Y, 2010, CLIN MICROBIOL INFEC, V16, P1475, DOI 10.1111/j.1469-0691.2010.03127.x; Taguchi M, 2006, JPN J INFECT DIS, V59, P144; Tamang MD, 2011, J CLIN MICROBIOL, V49, P2671, DOI 10.1128/JCM.00754-11; Xia SL, 2009, J CLIN MICROBIOL, V47, P401, DOI 10.1128/JCM.01099-08; Yamasaki K, 2010, J CLIN MICROBIOL, V48, P3267, DOI 10.1128/JCM.02111-09; Yan JJ, 2003, EMERG INFECT DIS, V9, P323; Yan JJ, 2004, J CLIN MICROBIOL, V42, P5337, DOI 10.1128/JCM.42.11.5337-5340.2004; Yan JJ, 2004, ANTIMICROB AGENTS CH, V48, P1353, DOI 10.1128/AAC.48.4.1353-1356.2004; Yan JJ, 2000, J CLIN MICROBIOL, V38, P4320, DOI 10.1128/JCM.38.12.4320-4325.2000; Yum JH, 2005, J KOREAN MED SCI, V20, P961, DOI 10.3346/jkms.2005.20.6.961; Zhao S, 2003, J CLIN MICROBIOL, V41, P5366, DOI 10.1128/JCM.41.12.5366-5371.2003	50	38	39	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116927	10.1371/journal.pone.0116927	http://dx.doi.org/10.1371/journal.pone.0116927			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642944	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000348821200028
J	Bryan, BA; Huai, J; Connor, J; Gao, L; King, D; Kandulu, J; Zhao, G				Bryan, Brett A.; Huai, Jianjun; Connor, Jeff; Gao, Lei; King, Darran; Kandulu, John; Zhao, Gang			What Actually Confers Adaptive Capacity? Insights from Agro-Climatic Vulnerability of Australian Wheat	PLOS ONE			English	Article							CLIMATE-CHANGE; LIVELIHOOD DIVERSIFICATION; EMPIRICAL-ANALYSIS; SPATIAL-ANALYSIS; LARGE-SCALE; MODEL; VARIABILITY; DROUGHT; STRATEGIES; IMPACT	Vulnerability assessments have often invoked sustainable livelihoods theory to support the quantification of adaptive capacity based on the availability of capital-social, human, physical, natural, and financial. However, the assumption that increased availability of these capitals confers greater adaptive capacity remains largely untested. We quantified the relationship between commonly used capital indicators and an empirical index of adaptive capacity (ACI) in the context of vulnerability of Australian wheat production to climate variability and change. We calculated ACI by comparing actual yields from farm survey data to climate-driven expected yields estimated by a crop model for 12 regions in Australia's wheat-sheep zone from 1991-2010. We then compiled data for 24 typical indicators used in vulnerability analyses, spanning the five capitals. We analyzed the ACI and used regression techniques to identify related capital indicators. Between regions, mean ACI was not significantly different but variance over time was. ACI was higher in dry years and lower in wet years suggesting that farm adaptive strategies are geared towards mitigating losses rather than capitalizing on opportunity. Only six of the 24 capital indicators were significantly related to adaptive capacity in a way predicted by theory. Another four indicators were significantly related to adaptive capacity but of the opposite sign, countering our theory-driven expectation. We conclude that the deductive, theory-based use of capitals to define adaptive capacity and vulnerability should be more circumspect. Assessments need to be more evidence-based, first testing the relevance and influence of capital metrics on adaptive capacity for the specific system of interest. This will more effectively direct policy and targeting of investment to mitigate agro-climatic vulnerability.	[Bryan, Brett A.; Huai, Jianjun; Connor, Jeff; Gao, Lei; King, Darran; Kandulu, John; Zhao, Gang] CSIRO, Land & Water Flagship & Agr Flagship, Urrbrae, SA, Australia; [Bryan, Brett A.; Huai, Jianjun; Connor, Jeff; Gao, Lei; King, Darran; Kandulu, John; Zhao, Gang] Northwest A&F Univ, Coll Econ & Management, Yangling, Shaanxi, Peoples R China; [Zhao, Gang] Univ Bonn, Inst Crop Sci & Resource Conservat, Crop Sci Grp, Bonn, Germany	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Northwest A&F University - China; University of Bonn	Bryan, BA (corresponding author), CSIRO, Land & Water Flagship & Agr Flagship, Waite Campus, Urrbrae, SA, Australia.	brett.bryan@csiro.au	King, Darran A/G-3996-2011; Gao, Lei/F-9698-2010; kandulu, john M/G-3521-2011; Bryan, Brett Anthony/F-8949-2010; Kandulu, John/AAC-6448-2020; Connor, Jeff/T-7345-2019; connor, jeffery/G-5466-2010; KANDULU, JOHN/AAL-6208-2020	Gao, Lei/0000-0003-4272-9417; kandulu, john M/0000-0002-1871-4429; Bryan, Brett Anthony/0000-0003-4834-5641; Kandulu, John/0000-0002-1871-4429; connor, jeffery/0000-0002-2313-8630; Huai, Jianjun/0000-0003-4175-2260	Social Science Special Program of Northwest AF University [2011RWZXX3]; CSIRO's Sustainable Agriculture Flagship; Australian National Outlook initiative; Chinese Scholarship Council; Program of the National Natural Science Foundation of China [71473196]	Social Science Special Program of Northwest AF University; CSIRO's Sustainable Agriculture Flagship; Australian National Outlook initiative; Chinese Scholarship Council(China Scholarship Council); Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Social Science Special Program of Northwest A&F University Grant No. 2011RWZXX3, CSIRO's Sustainable Agriculture Flagship and Australian National Outlook initiative, the Chinese Scholarship Council, and the Program of the National Natural Science Foundation of China Grant No. 71473196. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARES, 2010, US GUID CAV LAND US; ABARES, 2011, SURV METH DEF; Adger WN., 2004, TYNDALL CTR CLIMATE; Antwi-Agyei P, 2012, APPL GEOGR, V32, P324, DOI 10.1016/j.apgeog.2011.06.010; Asseng S, 2013, NAT CLIM CHANGE, V3, P827, DOI [10.1038/nclimate1916, 10.1038/NCLIMATE1916]; Asseng S, 1998, FIELD CROP RES, V57, P163, DOI 10.1016/S0378-4290(97)00117-2; Asseng S, 2013, CLIMATIC CHANGE, V118, P167, DOI 10.1007/s10584-012-0623-1; Asseng S, 2011, GLOBAL CHANGE BIOL, V17, P997, DOI 10.1111/j.1365-2486.2010.02262.x; Babulo B, 2008, AGR SYST, V98, P147, DOI 10.1016/j.agsy.2008.06.001; Bartos S., 2006, GRAIN AWB SCANDAL WH; Bell LW, 2012, AGR SYST, V111, P1, DOI 10.1016/j.agsy.2012.04.003; Block S, 2001, FOOD POLICY, V26, P333, DOI 10.1016/S0306-9192(01)00015-X; Brenkert AL, 2005, CLIMATIC CHANGE, V72, P57, DOI 10.1007/s10584-005-5930-3; BREUSCH TS, 1979, ECONOMETRICA, V47, P1287, DOI 10.2307/1911963; Bryan BA, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/4/044005; Bryan BA, 2008, LAND USE POLICY, V25, P533, DOI 10.1016/j.landusepol.2007.11.003; Bryan BA, 2010, GCB BIOENERGY, V2, P330, DOI 10.1111/j.1757-1707.2010.01056.x; Bryan BA, 2010, LAND USE POLICY, V27, P713, DOI 10.1016/j.landusepol.2009.09.012; Challinor AJ, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/034012; Chambers R., 1992, SUSTAINABLE RURAL LI; Chen CC, 2004, CLIMATIC CHANGE, V66, P239, DOI 10.1023/B:CLIM.0000043159.33816.e5; CSIRO, 2010, CLIM VAR CHANG SE AU; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Dong ZQ, 2015, ECOL INDIC, V48, P49, DOI 10.1016/j.ecolind.2014.07.032; Dougill AJ, 2010, ECOL SOC, V15; Ellis F, 1998, J DEV STUD, V35, P1, DOI 10.1080/00220389808422553; Ellis F, 2000, J AGR ECON, V51, P289, DOI 10.1111/j.1477-9552.2000.tb01229.x; Ellis Frank, 2000, RURAL LIVELIHOODS DI; Fang YP, 2014, ECOL INDIC, V38, P225, DOI 10.1016/j.ecolind.2013.11.007; Fraser EDG, 2008, CR GEOSCI, V340, P679, DOI 10.1016/j.crte.2008.07.004; Fraser EDG, 2013, AGR FOREST METEOROL, V170, P195, DOI 10.1016/j.agrformet.2012.04.008; Gbetibouo GA, 2010, NAT RESOUR FORUM, V34, P175, DOI 10.1111/j.1477-8947.2010.01302.x; Goklany I. M., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P755, DOI 10.1007/s11027-007-9098-1; Hahn MB, 2009, GLOBAL ENVIRON CHANG, V19, P74, DOI 10.1016/j.gloenvcha.2008.11.002; HERBEL CH, 1972, ECOLOGY, V53, P1084, DOI 10.2307/1935420; Hinkel J, 2011, GLOBAL ENVIRON CHANG, V21, P198, DOI 10.1016/j.gloenvcha.2010.08.002; Jeffrey SJ, 2001, ENVIRON MODELL SOFTW, V16, P309, DOI 10.1016/S1364-8152(01)00008-1; Kandulu JM, 2012, ECOL ECON, V79, P105, DOI 10.1016/j.ecolecon.2012.04.025; Keating BA, 2003, EUR J AGRON, V18, P267, DOI 10.1016/S1161-0301(02)00108-9; Kirono DGC, 2011, J ARID ENVIRON, V75, P566, DOI 10.1016/j.jaridenv.2010.12.012; Krishnamurthy PK, 2014, GLOBAL ENVIRON CHANG, V25, P121, DOI 10.1016/j.gloenvcha.2013.11.004; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Luo QY, 2005, AGR FOREST METEOROL, V132, P273, DOI 10.1016/j.agrformet.2005.08.003; Luo QY, 2005, CLIMATIC CHANGE, V72, P213, DOI 10.1007/s10584-005-5361-1; Marshall NA, 2014, AGR ECOSYST ENVIRON, V186, P86, DOI 10.1016/j.agee.2014.01.004; McCarl BA, 2008, AM J AGR ECON, V90, P1241, DOI 10.1111/j.1467-8276.2008.01211.x; McKernan M, 2005, DROUGHT RED MARAUDER; Meinke H, 1998, EUR J AGRON, V8, P101, DOI 10.1016/S1161-0301(97)00015-4; Monjardino M, 2013, AGR SYST, V116, P37, DOI 10.1016/j.agsy.2012.12.007; Moss R. H., 2001, PNNLSA33642 US DEP E; Murphy BF, 2008, INT J CLIMATOL, V28, P859, DOI 10.1002/joc.1627; Nelson R, 2010, ENVIRON SCI POLICY, V13, P8, DOI 10.1016/j.envsci.2009.09.006; Nelson R, 2010, ENVIRON SCI POLICY, V13, P18, DOI 10.1016/j.envsci.2009.09.007; Parry M. L., 2007, CONTRIBUTION WORKING, P976; Potgieter A, 2013, CLIMATIC CHANGE, V117, P163, DOI 10.1007/s10584-012-0543-0; RAMSEY JB, 1969, J ROY STAT SOC B, V31, P350; Sanchez PA, 2005, SCIENCE, V307, P357, DOI 10.1126/science.1109057; Scoones I., 1998, SUSTAINABLE RURAL LI; Sheng Y., 2011, TURNING POINT AGR PR; Simelton E, 2012, FOOD SECUR, V4, P163, DOI 10.1007/s12571-012-0173-4; Simelton E, 2009, ENVIRON SCI POLICY, V12, P438, DOI 10.1016/j.envsci.2008.11.005; Solomon S., 2007, PHYS SCI BASIS WORKI; Thomas RJ, 2008, AGR ECOSYST ENVIRON, V126, P36, DOI 10.1016/j.agee.2008.01.011; Tukey JW, 1977, EXPLORATORY DATA ANA; Valdivia C, 2010, ANN ASSOC AM GEOGR, V100, P818, DOI 10.1080/00045608.2010.500198; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; Zhang Y, 2012, CAN J PLANT SCI, V92, P937, DOI [10.4141/CJPS2011-266, 10.4141/cjps2011-266]; Zhao G, 2014, ECOL MODEL, V279, P1, DOI 10.1016/j.ecolmodel.2014.02.003; Zhao G, 2013, GLOBAL CHANGE BIOL, V19, P1585, DOI 10.1111/gcb.12145; Zhao G, 2013, ENVIRON MODELL SOFTW, V41, P231, DOI 10.1016/j.envsoft.2012.08.007; Zhao G, 2012, COMPUT ELECTRON AGR, V89, P94, DOI 10.1016/j.compag.2012.08.007	71	21	21	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117600	10.1371/journal.pone.0117600	http://dx.doi.org/10.1371/journal.pone.0117600			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2XY	25668192	Green Submitted, Green Published, gold			2022-12-27	WOS:000349493000021
J	Nguyen, DN; Jiang, PP; Jacobsen, S; Sangild, PT; Bendixen, E; Chatterton, DEW				Duc Ninh Nguyen; Jiang, Pingping; Jacobsen, Susanne; Sangild, Per T.; Bendixen, Emoke; Chatterton, Dereck E. W.			Protective Effects of Transforming Growth Factor beta 2 in Intestinal Epithelial Cells by Regulation of Proteins Associated with Stress and Endotoxin Responses	PLOS ONE			English	Article							IN-VITRO; BACTERIAL-COLONIZATION; TISSUE INHIBITOR; BREAST-MILK; EXPRESSION; APOPTOSIS; PROTEOME; HSP27; DEATH; FORMULA	Transforming growth factor (TGF)-beta 2 is an important anti-inflammatory protein in milk and colostrum. TGF-beta 2 supplementation appears to reduce gut inflammatory diseases in early life, such as necrotizing enterocolitis (NEC) in young mice. However, the molecular mechanisms by which TGF-beta 2 protects immature intestinal epithelial cells (IECs) remain to be more clearly elucidated before interventions in infants can be considered. Porcine IECs PsIc1 were treated with TGF-beta 2 and/or lipopolysaccharide (LPS), and changes in the cellular proteome were subsequently analyzed using two-dimensional gel electrophoresis-MS and LC-MS-based proteomics. TGF-beta 2 alone induced the differential expression of 13 proteins and the majority of the identified proteins were associated with stress responses, TGF-alpha and Toll-like receptor 4 signaling cascades. In particular, a series of heat shock proteins had similar differential trends as previously shown in the intestine of NEC-resistant preterm pigs and young mice. Furthermore, LC-MS-based proteomics and Western blot analyses revealed 20 differentially expressed proteins following treatment with TGF-beta 2 in LPS-challenged IECs. Thirteen of these proteins were associated with stress response pathways, among which five proteins were altered by LPS and restored by TGF-beta 2, whereas six were differentially expressed only by TGF-beta 2 in LPS-challenged IECs. Based on previously reported biological functions, these patterns indicate the anti-stress and anti-inflammatory effects of TGF-beta 2 in IECs. We conclude that TGF-beta 2 of dietary or endogenous origin may regulate the IEC responses against LPS stimuli, thereby supporting cellular homeostasis and innate immunity in response to bacterial colonization, and the first enteral feeding in early life.	[Duc Ninh Nguyen; Chatterton, Dereck E. W.] Univ Copenhagen, Fac Sci, Dept Food Sci, Frederiksberg, Denmark; [Jiang, Pingping; Sangild, Per T.; Chatterton, Dereck E. W.] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Frederiksberg, Denmark; [Jacobsen, Susanne] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Bendixen, Emoke] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	University of Copenhagen; University of Copenhagen; Technical University of Denmark; Aarhus University	Chatterton, DEW (corresponding author), Univ Copenhagen, Fac Sci, Dept Food Sci, Frederiksberg, Denmark.	dcha@food.ku.dk	Nguyen, Duc Ninh/AAX-1131-2020; Chatterton, Dereck/G-6827-2015	Nguyen, Duc Ninh/0000-0002-4997-555X; Chatterton, Dereck/0000-0002-8417-3210; Jiang, Pingping/0000-0002-7393-9719; Nguyen, Duc Ninh/0000-0002-6296-8450	Danish Dairy Research Foundation	Danish Dairy Research Foundation	The study was supported by a grant from the Danish Dairy Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Argon Y, 1999, SEMIN CELL DEV BIOL, V10, P495, DOI 10.1006/scdb.1999.0320; Bitar KN, 2002, AM J PHYSIOL-GASTR L, V282, pG894, DOI 10.1152/ajpgi.00141.2001; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Boyd CA, 2007, ARCH DIS CHILD-FETAL, V92, pF169, DOI 10.1136/adc.2005.089490; Burguillos MA, 2011, NEUROBIOL DIS, V41, P177, DOI 10.1016/j.nbd.2010.09.005; Chatterton DEW, 2013, INT J BIOCHEM CELL B, V45, P1730, DOI 10.1016/j.biocel.2013.04.028; Chatterton DEW, 2004, TRENDS FOOD SCI TECH, V15, P373, DOI 10.1016/j.tifs.2003.12.004; Chen SH, 2008, MOL BIOL CELL, V19, P3909, DOI 10.1091/mbc.E08-04-0433; Chiang CW, 2011, BIOCHEM J, V433, P187, DOI 10.1042/BJ20100247; Danielsen M, 2007, J PROTEOME RES, V6, P2596, DOI 10.1021/pr070038b; Das A, 2013, BIOCHIP J, V7, P75, DOI 10.1007/s13206-013-7112-0; Dokladny K, 2010, CELL STRESS CHAPERON, V15, P153, DOI 10.1007/s12192-009-0129-6; Nguyen DN, 2014, AM J PHYSIOL-GASTR L, V307, pG689, DOI 10.1152/ajpgi.00193.2014; Farhadi A, 2006, J PHARMACOL EXP THER, V316, P1, DOI 10.1124/jpet.105.085449; Gadgil HS, 2003, PROTEOMICS, V3, P1767, DOI 10.1002/pmic.200300532; Gauthier SF, 2006, LAIT, V86, P99, DOI 10.1051/lait:2005048; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Hackam David J, 2005, Semin Pediatr Surg, V14, P49, DOI 10.1053/j.sempedsurg.2004.10.025; Hackam DJ, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/475415; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hu L, 2013, ONCOL LETT, V6, P49, DOI 10.3892/ol.2013.1318; Im E, 2009, J NUTR, V139, P1848, DOI 10.3945/jn.109.108613; Jiang PP, 2008, J NUTR, V138, P1895, DOI 10.1093/jn/138.10.1895; Jiang PP, 2014, PROTEOM CLIN APPL, V8, P700, DOI 10.1002/prca.201300097; Jiang PP, 2013, J PEDIATR GASTR NUTR, V56, P615, DOI 10.1097/MPG.0b013e318288cf71; Jiang PP, 2013, PEDIATR RES, V73, P268, DOI 10.1038/pr.2012.182; Jiang PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044929; Jiang PP, 2011, NEONATOLOGY, V99, P280, DOI 10.1159/000317807; Jin YH, 2009, BIOSCI BIOTECH BIOCH, V73, P1318, DOI 10.1271/bbb.80841; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee JK, 2008, NEUROBIOL DIS, V30, P174, DOI 10.1016/j.nbd.2008.01.004; Lee J, 2010, ARCH PHARM RES, V33, P181, DOI 10.1007/s12272-010-0200-y; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Maheshwari A, 2011, GASTROENTEROLOGY, V140, P242, DOI 10.1053/j.gastro.2010.09.043; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Nissen L, 2009, INT J FOOD MICROBIOL, V135, P288, DOI 10.1016/j.ijfoodmicro.2009.08.027; Nunez MT, 2001, J CELL BIOCHEM, V82, P660, DOI 10.1002/jcb.1194; Osterloh A, 2007, J BIOL CHEM, V282, P4669, DOI 10.1074/jbc.M608666200; Oz HS, 2004, J AM COLL NUTR, V23, P220, DOI 10.1080/07315724.2004.10719364; Paduch R, 2009, J BIOSCIENCES, V34, P927, DOI 10.1007/s12038-009-0107-2; Perrotti D, 2007, CLIN CANCER RES, V13, P1638, DOI 10.1158/1078-0432.CCR-06-2320; Quarmby L, 2000, J CELL SCI, V113, P2821; Rankin CR, 2013, J BIOL CHEM, V288, P15229, DOI 10.1074/jbc.M112.440909; Rautava S, 2011, NEONATOLOGY, V99, P192, DOI 10.1159/000314109; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Sangild PT, 2013, J ANIM SCI, V91, P4713, DOI 10.2527/jas.2013-6359; Sangild PT, 2009, AM J PHYSIOL-REG I, V296, pR1053, DOI 10.1152/ajpregu.90790.2008; Smith MR, 1997, CYTOKINE, V9, P770, DOI 10.1006/cyto.1997.0233; Somara S, 2004, AM J PHYSIOL-CELL PH, V286, pC1290, DOI 10.1152/ajpcell.00458.2003; TAKENAKA IM, 1993, J CELL PHYSIOL, V155, P54, DOI 10.1002/jcp.1041550108; TAKENAKA IM, 1992, J CELL PHYSIOL, V152, P568, DOI 10.1002/jcp.1041520317; Wang SA, 2011, J BIOL CHEM, V286, P43816, DOI 10.1074/jbc.M111.310979; Wang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038221; Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095; Xing XM, 2011, ACTA HISTOCHEM, V113, P777, DOI 10.1016/j.acthis.2010.11.006; Yahata T, 2000, J BIOL CHEM, V275, P8825, DOI 10.1074/jbc.275.12.8825; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	59	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117608	10.1371/journal.pone.0117608	http://dx.doi.org/10.1371/journal.pone.0117608			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668313	Green Published, Green Submitted, gold			2022-12-27	WOS:000349493000023
J	Bougerol, M; Aurade, F; Lambert, FM; Le Ray, D; Combes, D; Thoby-Brisson, M; Relaix, F; Pollet, N; Tostivint, H				Bougerol, Marion; Aurade, Frederic; Lambert, Francois M.; Le Ray, Didier; Combes, Denis; Thoby-Brisson, Muriel; Relaix, Frederic; Pollet, Nicolas; Tostivint, Herve			Generation of BAC Transgenic Tadpoles Enabling Live Imaging of Motoneurons by Using the Urotensin II-Related Peptide (ust2b) Gene as a Driver	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; SPINAL-CORD; XENOPUS-LAEVIS; BRAIN-STEM; MESSENGER-RNAS; MOTOR-NEURONS; CLAWED FROG; RAT-BRAIN; ZEBRAFISH; MOUSE	Xenopus is an excellent tetrapod model for studying normal and pathological motoneuron ontogeny due to its developmental morpho-physiological advantages. In mammals, the urotensin II-related peptide (UTS2B) gene is primarily expressed in motoneurons of the brainstem and the spinal cord. Here, we show that this expression pattern was conserved in Xenopus and established during the early embryonic development, starting at the early tailbud stage. In late tadpole stage, uts2b mRNA was detected both in the hindbrain and in the spinal cord. Spinal uts2b(+) cells were identified as axial motoneurons. In adult, however, the uts2b expression was only detected in the hindbrain. We assessed the ability of the uts2b promoter to drive the expression of a fluorescent reporter in motoneurons by recombineering a green fluorescent protein (GFP) into a bacterial artificial chromosome (BAC) clone containing the entire X. tropicalis uts2b locus. After injection of this construction in one-cell stage embryos, a transient GFP expression was observed in the spinal cord of about a quarter of the resulting animals from the early tailbud stage and up to juveniles. The GFP expression pattern was globally consistent with that of the endogenous uts2b in the spinal cord but no fluorescence was observed in the brainstem. A combination of histological and electrophysiological approaches was employed to further characterize the GFP(+) cells in the larvae. More than 98% of the GFP(+) cells expressed choline acetyltransferase, while their projections were co-localized with alpha-bungarotoxin labeling. When tail myotomes were injected with rhodamine dextran amine crystals, numerous double-stained GFP(+) cells were observed. In addition, intracellular electrophysiological recordings of GFP(+) neurons revealed locomotion-related rhythmic discharge patterns during fictive swimming. Taken together our results provide evidence that uts2b is an appropriate driver to express reporter genes in larval motoneurons of the Xenopus spinal cord.	[Bougerol, Marion; Tostivint, Herve] Museum Natl Hist Nat, CNRS, UMR 7221, Paris, France; [Aurade, Frederic; Relaix, Frederic] UPMC, INSERM, UMRS 974, CNRS,AIM,FRE 3617, Paris, France; [Aurade, Frederic; Relaix, Frederic] INSERM, Avenir Team, Paris, France; [Lambert, Francois M.; Le Ray, Didier; Combes, Denis; Thoby-Brisson, Muriel] Univ Bordeaux, CNRS, UMR 5287, INCIA, Bordeaux, France; [Pollet, Nicolas] Univ Evry Val dEssonne, CNRS, Inst Syst & Synthet Biol, Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Tostivint, H (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7221, Paris, France.	htostivi@mnhn.fr	Lambert, François/AAG-1626-2021; Tostivint, Hervé/P-8524-2019; Le Ray, Didier/C-2625-2008; Pollet, Nicolas/A-4746-2013; Thoby-Brisson, Muriel/E-1167-2014	Tostivint, Hervé/0000-0002-0719-0922; Le Ray, Didier/0000-0003-2089-9861; Pollet, Nicolas/0000-0002-9975-9644; Thoby-Brisson, Muriel/0000-0003-3214-1724; Relaix, Frederic/0000-0003-1270-1472	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Association Francaise contre les Myopathies (AFM); AFM; Association Institut de Myologie (AIM); Labex REVIVE; Fondation pour la Recherche Medicale FRM [ARF20140128968]; PEPS IdEx de Bordeaux-CNRS [101SG/1024R]; Genopole; AFM (Amphigentools); French Ministry of Research and the Legs Prevost (MNHN)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Museum National d'Histoire Naturelle (MNHN); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); AFM(Association Francaise contre les Myopathies); Association Institut de Myologie (AIM); Labex REVIVE; Fondation pour la Recherche Medicale FRM(Fondation pour la Recherche Medicale); PEPS IdEx de Bordeaux-CNRS; Genopole; AFM (Amphigentools); French Ministry of Research and the Legs Prevost (MNHN)	This research was supported by funding obtained from the Centre National de la Recherche Scientifique (CNRS; http://www.cnrs.fr), the Museum National d'Histoire Naturelle (MNHN; http://www.mnhn. fr) and the Association Francaise contre les Myopathies (AFM; http://www.afm-telethon.fr; Amphigentools) to HT, from the AFM, Association Institut de Myologie (AIM; http://www.institutmyologie.org/), and Labex REVIVE to FA and FR, from the Fondation pour la Recherche Medicale FRM ARF20140128968; http://www.frm.org) to FML, from the PEPS IdEx de Bordeaux-CNRS (101SG/1024R) to DLR, and from Genopole and the AFM (Amphigentools) to NP. MB was the recipient of Ph.D grants from the French Ministry of Research and the Legs Prevost (MNHN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2013, DEV GROWTH DIFFER, V55, P390, DOI 10.1111/dgd.12062; Ampatzis K, 2013, J NEUROSCI, V33, P10875, DOI 10.1523/JNEUROSCI.0896-13.2013; Babin PJ, 2014, PROG NEUROBIOL, V118, P36, DOI 10.1016/j.pneurobio.2014.03.001; Becker TS, 2012, DEV NEUROBIOL, V72, P415, DOI 10.1002/dneu.20888; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Coulouarn Y, 1999, FEBS LETT, V457, P28, DOI 10.1016/S0014-5793(99)01003-0; Coulouarn Y, 1998, P NATL ACAD SCI USA, V95, P15803, DOI 10.1073/pnas.95.26.15803; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Detrich HW, 2011, METHOD CELL BIOL, V104, P1; Djenoune L, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00026; Douglas SA, 2004, TRENDS PHARMACOL SCI, V25, P76, DOI 10.1016/j.tips.2003.12.005; Dubessy C, 2008, J NEUROCHEM, V107, P361, DOI 10.1111/j.1471-4159.2008.05624.x; Dun SL, 2001, NEUROSCI LETT, V305, P9, DOI 10.1016/S0304-3940(01)01804-3; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Farfsing A, 2009, LEUKEMIA, V23, P2018, DOI 10.1038/leu.2009.144; Fish MB, 2012, GENESIS, V50, P307, DOI 10.1002/dvg.20819; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; FOREHAND CJ, 1982, J COMP NEUROL, V209, P386, DOI 10.1002/cne.902090408; Gabriel JP, 2011, NAT NEUROSCI, V14, P93, DOI 10.1038/nn.2704; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; HARTENSTEIN V, 1993, J COMP NEUROL, V328, P213, DOI 10.1002/cne.903280205; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; HUGHES A, 1961, J EMBRYOL EXP MORPH, V9, P269; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kelly LE, 2005, GENESIS, V41, P185, DOI 10.1002/gene.20113; Konno N, 2013, GEN COMP ENDOCR, V185, P44, DOI 10.1016/j.ygcen.2013.01.015; KORZH V, 1993, DEVELOPMENT, V118, P417; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; Lihrmann I, 2013, HDB BIOL ACTIVE PEPT, P957; Long XC, 2007, J BIOL CHEM, V282, P15941, DOI 10.1074/jbc.R700010200; Lopez JM, 2002, J COMP NEUROL, V453, P418, DOI 10.1002/cne.10419; Marsh-Armstrong N, 2004, P NATL ACAD SCI USA, V101, P165, DOI 10.1073/pnas.2136755100; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Park HC, 2004, DEVELOPMENT, V131, P5959, DOI 10.1242/dev.01456; Parmentier C, 2008, PEPTIDES, V29, P820, DOI 10.1016/j.peptides.2008.01.023; Pelletier G, 2005, NEUROSCIENCE, V132, P689, DOI 10.1016/j.neuroscience.2004.12.045; Pelletier G, 2002, NEUROSCIENCE, V115, P525, DOI 10.1016/S0306-4522(02)00413-X; Pelzer D, 2014, 15 INT XEN C PAC GRO; Pratt KG, 2013, DIS MODEL MECH, V6, P1057, DOI 10.1242/dmm.012138; PRESTIGE MC, 1967, J EMBRYOL EXP MORPH, V18, P359; Roberts A, 1999, J COMP NEUROL, V411, P472, DOI 10.1002/(SICI)1096-9861(19990830)411:3<472::AID-CNE9>3.0.CO;2-B; SCHEDL A, 1993, NUCLEIC ACIDS RES, V21, P4783, DOI 10.1093/nar/21.20.4783; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlosser G, 2002, DEV DYNAM, V225, P485, DOI 10.1002/dvdy.10179; Schmitt SM, 2014, ADV DRUG DELIVER REV, V69, P225, DOI 10.1016/j.addr.2014.02.004; Seredick SD, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-35; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Sive HL, 2007, INDUCING OVULATION X; Straka H, 1998, BIOL BULL, V195, P220, DOI 10.2307/1542849; Sugo T, 2003, BIOCHEM BIOPH RES CO, V310, P860, DOI 10.1016/j.bbrc.2003.09.102; Suster ML, 2011, NAT PROTOC, V6, P1998, DOI 10.1038/nprot.2011.416; Tostivint H, 2014, J MOL ENDOCRINOL, V52, pT61, DOI 10.1530/JME-13-0274; Tostivint H, 2013, GEN COMP ENDOCR, V188, P110, DOI 10.1016/j.ygcen.2012.12.015; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; VANMIER P, 1986, INT J DEV NEUROSCI, V4, P465, DOI 10.1016/0736-5748(86)90028-6; VANMIER P, 1985, ANAT EMBRYOL, V172, P311; Vaudry H, 2014, PHARMACOL REV IN PRE; Vaudry H, 2010, ANN NY ACAD SCI, V1200, P53, DOI 10.1111/j.1749-6632.2010.05514.x; Vouillot L, 2014, XENOPUS DEVELOPMENT, P383; Ymlahi-Ouazzani Q, 2010, NEUROGENETICS, V11, P27, DOI 10.1007/s10048-009-0200-6; Zhang GH, 1996, BIOCHEM BIOPH RES CO, V227, P707, DOI 10.1006/bbrc.1996.1573; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P11674, DOI 10.1073/pnas.1018512108	68	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117370	10.1371/journal.pone.0117370	http://dx.doi.org/10.1371/journal.pone.0117370			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658845	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900138
J	Loh, PY; Muraki, S				Loh, Ping Yeap; Muraki, Satoshi			Effect of Wrist Angle on Median Nerve Appearance at the Proximal Carpal Tunnel	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; GENDER-DIFFERENCES; PATHOPHYSIOLOGY; DIAGNOSIS; WORK	This study investigated the effects of wrist angle, sex, and handedness on the changes in the median nerve cross-sectional area (MNCSA) and median nerve diameters, namely longitudinal diameter (D1) and vertical diameter (D2). Ultrasound examination was conducted to examine the median nerve at the proximal carpal tunnel in both dominant and nondominant hands of men (n = 27) and women (n = 26). A total of seven wrist angles were examined: neutral; 15 degrees, 30 degrees, and 45 degrees extension; and 15 degrees, 30 degrees, and 45 degrees flexion. Our results indicated sexual dimorphism and bilateral asymmetry of MNCSA, D1 and D2 measurements. MNCSA was significantly reduced when the wrist angle changed from neutral to flexion or extension positions. At flexion positions, D1 was significantly smaller than that at neutral. In contrast, at extension positions, D2 was significantly smaller than that at neutral. In conclusion, this study showed that MNCSA decreased as the wrist angle changed from neutral to flexion or extension positions in both dominant and nondominant hands of both sexes, whereas deformation of the median nerve differed between wrist flexion and extension.	[Loh, Ping Yeap] Kyushu Univ, Grad Sch Design, Dept Human Sci, Minami Ku, Fukuoka 812, Japan; [Muraki, Satoshi] Kyushu Univ, Fac Design, Dept Human Sci, Minami Ku, Fukuoka 812, Japan	Kyushu University; Kyushu University	Loh, PY (corresponding author), Kyushu Univ, Grad Sch Design, Dept Human Sci, Minami Ku, Fukuoka 812, Japan.	lohpingyeap@gmail.com		Loh, Ping Yeap/0000-0003-3821-3039				[Anonymous], 2011, J STAT MODELING ANAL, DOI DOI 10.1515/BILE-2015-0008; Baker NA, 2007, CLIN BIOMECH, V22, P34, DOI 10.1016/j.clinbiomech.2006.08.008; Bakhsh H, 2012, Ortop Traumatol Rehabil, V14, P335, DOI 10.5604/15093492.1005085; Bonfiglioli R, 2007, INT ARCH OCC ENV HEA, V80, P248, DOI 10.1007/s00420-006-0129-0; Brasseur JL, 2004, EUR RADIOL, V14, P1770, DOI 10.1007/s00330-004-2401-6; Cramer D., 2004, SAGE DICT STAT; Cramer D., 1998, FUNDAMENTAL STAT SOC; Doane DP, 2011, J STAT EDUC, V19, DOI 10.1080/10691898.2011.11889611; Donoghue MF, 2013, APPL ERGON, V44, P42, DOI 10.1016/j.apergo.2012.04.009; Duncan I, 1999, AM J ROENTGENOL, V173, P681, DOI 10.2214/ajr.173.3.10470903; Duymus M, 2013, J NEUROL SCI-TURK, V30, P59; Fragala MS, 2012, GENDER MED, V9, P445, DOI 10.1016/j.genm.2012.10.004; Jarvik JG, 2004, NEUROIMAG CLIN N AM, V14, P93, DOI 10.1016/j.nic.2004.02.002; Jarvik JG, 2002, NEUROLOGY, V58, P1597, DOI 10.1212/WNL.58.11.1597; Keir Peter J, 2005, J Hand Ther, V18, P259, DOI 10.1197/j.jht.2005.02.001; Kele H., 2012, PERSPECTIVES MED, V1, P417, DOI [DOI 10.1016/J.PERMED.2012.02.047, 10.1016/j.permed.2012.02.047.]; Klauser AS, 2009, RADIOLOGY, V250, P171, DOI 10.1148/radiol.2501080397; LaJoie AS, 2005, PLAST RECONSTR SURG, V116, P502, DOI 10.1097/01.prs.0000172894.21006.e2; Loh PY, 2015, BRIDGING RESEARCH AND GOOD PRACTICES TOWARDS PATIENT WELFARE: HEALTHCARE SYSTEMS ERGONOMICS AND PATIENT SAFETY 2014, P149; Lopes MM, 2011, CLIN BIOMECH, V26, P930, DOI 10.1016/j.clinbiomech.2011.03.014; MILLESI H, 1995, CLIN ORTHOP RELAT R, P76; Mogk JPM, 2007, J BIOMECH, V40, P2222, DOI 10.1016/j.jbiomech.2006.10.033; Mogk JPM, 2009, CLIN BIOMECH, V24, P708, DOI 10.1016/j.clinbiomech.2009.05.012; Lopez PM, 2011, J BIOSOC SCI, V43, P597, DOI 10.1017/S0021932011000228; Moriyama H, 2013, SEXUAL DIMORPHISM, DOI [10.5772/56080, DOI 10.5772/56080]; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pasternack II, 2003, SCAND J WORK ENV HEA, V29, P189, DOI 10.5271/sjweh.721; Perissinotto E, 2002, BRIT J NUTR, V87, P177, DOI 10.1079/BJN2001487; Pratt NE, 2011, REHABILITATION HAND; Presazzi A, 2011, J Ultrasound, V14, P40, DOI 10.1016/j.jus.2011.01.006; ROY TA, 1994, AM J PHYS ANTHROPOL, V94, P203, DOI 10.1002/ajpa.1330940205; Sakurai M, 2006, HYPERTENS RES, V29, P75, DOI 10.1291/hypres.29.75; Sambandam SN, 2008, INT ORTHOP, V32, P497, DOI 10.1007/s00264-007-0344-7; SARRAFIAN SK, 1977, CLIN ORTHOP RELAT R, P153; SAUTER SL, 1991, HUM FACTORS, V33, P151, DOI 10.1177/001872089103300203; SAVELBERG HHCM, 1991, J ORTHOPAED RES, V9, P693, DOI 10.1002/jor.1100090509; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Toosi KK, 2011, AM J IND MED, V54, P826, DOI 10.1002/ajim.20983; Topp KS, 2012, J HAND THER, V25, P142, DOI 10.1016/j.jht.2011.09.002; Topp KS, 2006, PHYS THER, V86, P92, DOI 10.1093/ptj/86.1.92; Uchiyama S, 2010, J ORTHOP SCI, V15, P1, DOI 10.1007/s00776-009-1416-x; van Doesburg MHM, 2010, J ORTHOP RES, V28, P1387, DOI 10.1002/jor.21131; Viera AJ, 2003, AM FAM PHYSICIAN, V68, P265; Werner RA, 2002, CLIN NEUROPHYSIOL, V113, P1373, DOI 10.1016/S1388-2457(02)00169-4; Yao L, 2009, SKELETAL RADIOL, V38, P355, DOI 10.1007/s00256-008-0626-1	46	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117930	10.1371/journal.pone.0117930	http://dx.doi.org/10.1371/journal.pone.0117930			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658422	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900243
J	Pourhoseini, S; Seth, RK; Das, S; Dattaroy, D; Kadiiska, MB; Xie, G; Michelotti, GA; Nagarkatti, M; Diehl, AM; Chatterjee, S				Pourhoseini, Sahar; Seth, Ratanesh Kumar; Das, Suvarthi; Dattaroy, Diptadip; Kadiiska, Maria B.; Xie, Guanhua; Michelotti, Gregory A.; Nagarkatti, Mitzi; Diehl, Anna Mae; Chatterjee, Saurabh			Upregulation of miR21 and Repression of Grhl3 by Leptin Mediates Sinusoidal Endothelial Injury in Experimental Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							DISEASE PROGRESSION; STELLATE CELLS; MICRORNAS; DYSFUNCTION; EXPRESSION; MECHANISMS; FIBROSIS; MICROCIRCULATION; INFLAMMATION; METABOLISM	Sinusoidal endothelial dysfunction (SED) has been found to be an early event in nonalcoholic steatohepatitis (NASH) progression but the molecular mechanisms underlying its causation remains elusive. We hypothesized that adipokine leptin worsens sinusoidal injury by decreasing functionally active nitric oxide synthase 3 (NOS) 3 via miR21. Using rodent models of NASH, and transgenic mice lacking leptin and leptin receptor, results showed that hyperleptinemia caused a 4-5 fold upregulation of hepatic miR21 as assessed by qRTPCR. The upregulation of miR21 led to a time-dependent repression of its target protein Grhl3 levels as shown by western blot analyses. NOS3-p/NOS3 ratio which is controlled by Grhl3 was significantly decreased in NASH models. SED markers ICAM-1, VEGFR-2, and E-selectin as assessed by immunofluorescence microscopy were significantly up regulated in the progressive phases of NASH. Lack of leptin or its receptor in vivo, reversed the upregulation of miR21 and restored the levels of Grhl3 and NOS3-p/NOS3 ratio coupled with decreased SED dysfunction markers. Interestingly, leptin supplementation in mice lacking leptin, significantly enhanced miR21 levels, decreased Grhl3 repression and NOS3 phosphorylation. Leptin supplementation in isolated primary endothelial cells, Kupffer cells and stellate cells showed increased mir21 expression in stellate cells while sinusoidal injury was significantly higher in all cell types. Finally miR21 KO mice showed increased NOS3-p/NOS3 ratio and reversed SED markers in the rodent models of NASH. The experimental results described here show a close association of leptin-induced miR21 in aiding sinusoidal injury in NASH.	[Pourhoseini, Sahar; Seth, Ratanesh Kumar; Das, Suvarthi; Dattaroy, Diptadip; Chatterjee, Saurabh] Univ S Carolina, Dept Environm Hlth Sci, Environm Hlth & Dis Lab, Columbia, SC 29208 USA; [Kadiiska, Maria B.] Inst Environm Hlth Sci, Free Rad Metab Grp, Res Triangle Pk, NC 27709 USA; [Xie, Guanhua; Michelotti, Gregory A.; Diehl, Anna Mae] Duke Univ, Div Gastroenterol, Durham, NC 27707 USA; [Nagarkatti, Mitzi] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29209 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Chatterjee, S (corresponding author), Univ S Carolina, Dept Environm Hlth Sci, Environm Hlth & Dis Lab, Columbia, SC 29208 USA.	schatt@mailbox.sc.edu	Das, Suvarthi/AAK-2589-2020; Das, Suvarthi/AAA-4364-2020; Kadiiska, Maria B./AAC-9981-2019; Seth, Ratanesh/M-3700-2016	Seth, Ratanesh/0000-0002-7078-0052; , Gregory/0000-0002-3936-4675; Nagarkatti, Mitzi/0000-0002-5977-5615	NIH [4R00ES019875-02, R01DK053792, P20GM103641, R01AT006888, R01ES019313]; Intramural Research Program of the National Institutes of Health; National Institute of Environmental Health Sciences; National Center for Complementary & Integrative Health [R01AT006888, P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053792, T32DK007568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES019875, R01ES019313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by NIH pathway to Independence Award (4R00ES019875-02 to Saurabh Chatterjee), NIH R01 (R01DK053792 to Anna Mae Diehl) NIH grants (P20GM103641, R01AT006888, R01ES019313 to Mitzi Nagarkatti) and the Intramural Research Program of the National Institutes of Health and the National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisi A, 2011, LAB INVEST, V91, P283, DOI 10.1038/labinvest.2010.166; Bohinc BN, 2012, CLIN LIVER DIS, V16, P549, DOI 10.1016/j.cld.2012.05.002; Bosch J, 2010, J HEPATOL, V53, P558, DOI 10.1016/j.jhep.2010.03.021; Cayon A, 2006, LIVER INT, V26, P1065, DOI 10.1111/j.1478-3231.2006.01337.x; Ceccarelli S, 2013, INT J MOL SCI, V14, P8437, DOI 10.3390/ijms14048437; Chatterjee S, 2012, J HEPATOL; Cheung O, 2010, CURR PHARM DESIGN, V16, P1952, DOI 10.2174/138161210791208866; Copaci Ionel, 2006, J Gastrointestin Liver Dis, V15, P363; Darido C, 2011, CANCER CELL, V20, P635, DOI 10.1016/j.ccr.2011.10.014; Das S, 2013, TOXICOL APPL PHARM; De Minicis S, 2008, HEPATOLOGY, V48, P2016, DOI 10.1002/hep.22560; Farrell GC, 2008, ANAT REC, V291, P684, DOI 10.1002/ar.20715; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Ikejima K, 2005, HEPATOL RES, V33, P151, DOI 10.1016/j.hepres.2005.09.024; Ikejima K, 2001, HEPATOLOGY, V34, P288, DOI 10.1053/jhep.2001.26518; Imajo K, 2012, CELL METAB, V16, P44, DOI 10.1016/j.cmet.2012.05.012; Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; Iwakiri Y, 2012, LIVER INT, V32, P199, DOI 10.1111/j.1478-3231.2011.02579.x; Jou J, 2008, SEMIN LIVER DIS, V28, P370, DOI 10.1055/s-0028-1091981; Kerr TA, 2011, TRANSL RES, V157, P241, DOI 10.1016/j.trsl.2011.01.008; Kida K, 2011, PHARM RES-DORDR, V28, P2467, DOI 10.1007/s11095-011-0473-y; Kitade M, 2006, HEPATOLOGY, V44, P983, DOI 10.1002/hep.21338; Korda M, 2008, AM J PHYSIOL-HEART C, V295, pH1514, DOI 10.1152/ajpheart.00479.2008; Krawczyk K, 2009, J PHYSIOL PHARMACOL, V60, P71; Lawrie CH, 2013, BLOOD REV, V27, P143, DOI 10.1016/j.blre.2013.04.002; Li ZP, 2002, GASTROENTEROLOGY, V123, P1304, DOI 10.1053/gast.2002.35997; Lukosz M, 2011, BIOCHEM BIOPH RES CO, V412, P648, DOI 10.1016/j.bbrc.2011.08.018; Matsuda Satoru, 2013, ISRN Endocrinol, V2013, P472432, DOI 10.1155/2013/472432; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Mukhopadhyay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015705; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Musso G, 2010, ANNU REV MED, V61, P375, DOI 10.1146/annurev.med.60.101107.134820; Nakagawa T, 2007, AM J PHYSIOL-RENAL, V292, pF1665, DOI 10.1152/ajprenal.00495.2006; Ng R, 2012, J CLIN INVEST, V122, P1097, DOI 10.1172/JCI46039; Noetel A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00049; Pasarin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032785; Pasarin M, 2011, J HEPATOL, V55, P1095, DOI 10.1016/j.jhep.2011.01.053; Paulus P, 2011, BIOMARKERS, V16, pS11, DOI 10.3109/1354750X.2011.587893; Pogribny IP, 2013, EXPERT OPIN DRUG MET, V9, P713, DOI 10.1517/17425255.2013.783817; Procaccini C, 2010, CURR PHARM DESIGN, V16, P1902, DOI 10.2174/138161210791208884; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; Radisavljevic Z, 2000, J BIOL CHEM, V275, P20770, DOI 10.1074/jbc.M002448200; Rafiee P, 2010, AM J PHYSIOL-GASTR L, V298, pG167, DOI 10.1152/ajpgi.00385.2009; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje; Saxena NK, 2003, J CELL BIOCHEM, V89, P311, DOI 10.1002/jcb.10494; Saxena NK, 2002, HEPATOLOGY, V35, P762, DOI 10.1053/jhep.2002.32029; Seth RK, 2014, TOXICOL APPL PHARM, V274, P42, DOI 10.1016/j.taap.2013.10.029; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Wang JH, 2009, GASTROENTEROLOGY, V137, P713, DOI 10.1053/j.gastro.2009.04.011; Xie GH, 2013, GUT, V62, P299, DOI 10.1136/gutjnl-2011-301494; Yamada H, 2013, CLIN CHIM ACTA, V424, P99, DOI 10.1016/j.cca.2013.05.021; Zhang Y, 2006, PHYSIOL BEHAV, V88, P249, DOI 10.1016/j.physbeh.2006.05.038	55	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116780	10.1371/journal.pone.0116780	http://dx.doi.org/10.1371/journal.pone.0116780			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658689	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900065
J	Quintero-Hernandez, V; Ramirez-Carreto, S; Romero-Gutierrez, MT; Valdez-Velazquez, LL; Becerril, B; Possani, LD; Ortiz, E				Quintero-Hernandez, Veronica; Ramirez-Carreto, Santos; Romero-Gutierrez, Maria Teresa; Valdez-Velazquez, Laura L.; Becerril, Baltazar; Possani, Lourival D.; Ortiz, Ernesto			Transcriptome Analysis of Scorpion Species Belonging to the Vaejovis Genus	PLOS ONE			English	Article							KV1.3 POTASSIUM CHANNELS; VENOM PEPTIDES; FUNCTIONAL-CHARACTERIZATION; SARCOPLASMIC-RETICULUM; MOLECULAR DIVERSITY; RYANODINE RECEPTOR; CHEMICAL-SYNTHESIS; DISULFIDE BRIDGES; CDNA SEQUENCES; CLONING	Scorpions belonging to the Buthidae family have traditionally drawn much of the biochemist's attention due to the strong toxicity of their venoms. Scorpions not toxic to mammals, however, also have complex venoms. They have been shown to be an important source of bioactive peptides, some of them identified as potential drug candidates for the treatment of several emerging diseases and conditions. It is therefore important to characterize the large diversity of components found in the non-Buthidae venoms. As a contribution to this goal, this manuscript reports the construction and characterization of cDNA libraries from four scorpion species belonging to the Vaejovis genus of the Vaejovidae family: Vaejovis mexicanus, V. intrepidus, V. subcristatus and V. punctatus. Some sequences coding for channel-acting toxins were found, as expected, but the main transcribed genes in the glands actively producing venom were those coding for non disulfide-bridged peptides. The ESTs coding for putative channel-acting toxins, corresponded to sodium channel beta toxins, to members of the potassium channel-acting a or. families, and to calcium channel-acting toxins of the calcin family. Transcripts for scorpine-like peptides of two different lengths were found, with some of the species coding for the two kinds. One sequence coding for La1-like peptides, of yet unknown function, was found for each species. Finally, the most abundant transcripts corresponded to peptides belonging to the long chain multifunctional NDBP-2 family and to the short antimicrobials of the NDBP-4 family. This apparent venom composition is in correspondence with the data obtained to date for other non-Buthidae species. Our study constitutes the first approach to the characterization of the venom gland transcriptome for scorpion species belonging to the Vaejovidae family.	[Quintero-Hernandez, Veronica; Ramirez-Carreto, Santos; Romero-Gutierrez, Maria Teresa; Becerril, Baltazar; Possani, Lourival D.; Ortiz, Ernesto] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico; [Valdez-Velazquez, Laura L.] Univ Colima, Fac Ciencias Quim, Colima, Mexico; [Valdez-Velazquez, Laura L.] Univ Colima, Fac Med, Colima, Mexico	Universidad Nacional Autonoma de Mexico; Universidad de Colima; Universidad de Colima	Possani, LD (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico.	possani@ibt.unam.mx; erne@ibt.unam.mx	Valdez-Velazquez, Laura L/AAM-1280-2021; Ortiz, Ernesto/E-4592-2013	Valdez-Velazquez, Laura L/0000-0001-8474-1495; Romero-Gutierrez, Teresa/0000-0002-4882-7491; Quintero-Hernandez, Veronica/0000-0002-1856-8134; Ortiz, Ernesto/0000-0002-8713-0224; RAMIREZ-CARRETO, SANTOS/0000-0002-8052-9793	Consejo Nacional de Ciencia y Tecnologia (CONACyT) of the Mexican Government (SEP-CONACyT) [153496)]; Direccion General de Asuntos del Personal Academico (DGAPA) of the National Autonomous University of Mexico [200113]	Consejo Nacional de Ciencia y Tecnologia (CONACyT) of the Mexican Government (SEP-CONACyT); Direccion General de Asuntos del Personal Academico (DGAPA) of the National Autonomous University of Mexico	The work described here was partially financed by grants from the Consejo Nacional de Ciencia y Tecnologia (CONACyT) of the Mexican Government (SEP-CONACyT #153496) and Direccion General de Asuntos del Personal Academico (DGAPA) of the National Autonomous University of Mexico (grant #200113) to LDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman MA, 2013, TOXICON, V74, P193, DOI 10.1016/j.toxicon.2013.08.064; Almaaytah A, 2014, PEPTIDES, V51, P35, DOI 10.1016/j.peptides.2013.10.021; BECERRIL B, 1993, GENE, V128, P165, DOI 10.1016/0378-1119(93)90559-L; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Cao LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040135; Chen TB, 2005, PEPTIDES, V26, P731, DOI 10.1016/j.peptides.2004.12.002; Chen TB, 2003, REGUL PEPTIDES, V115, P115, DOI 10.1016/S0167-0115(03)00146-0; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Chippaux JP, 2012, DRUG DES DEV THER, V6, P165, DOI 10.2147/DDDT.S24754; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Dai C, 2008, ANTIMICROB AGENTS CH, V52, P3967, DOI 10.1128/AAC.00542-08; Dai L, 2001, BIOCHEM BIOPH RES CO, V286, P820, DOI 10.1006/bbrc.2001.5472; Darbon H, 1999, J Soc Biol, V193, P445; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; DEHESADAVILA M, 1994, TOXICON, V32, P1015, DOI 10.1016/0041-0101(94)90383-2; Diego-Garcia E, 2008, CELL MOL LIFE SCI, V65, P187, DOI 10.1007/s00018-007-7370-x; Diego-Garcia E, 2012, PROTEOMICS, V12, P313, DOI 10.1002/pmic.201100409; Dunlop JA, 2009, EXP APPL ACAROL, V48, P183, DOI 10.1007/s10493-009-9247-1; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fajloun Z, 2000, FEBS LETT, V469, P179, DOI 10.1016/S0014-5793(00)01239-4; FERREIRA LAF, 1993, TOXICON, V31, P941, DOI 10.1016/0041-0101(93)90253-F; Fet V., 2000, Catalog of the scorpions of the world (1758-1998); Fletcher PL, 2010, J BIOL CHEM, V285, P7405, DOI 10.1074/jbc.M109.028365; Gao B, 2009, FASEB J, V23, P1230, DOI 10.1096/fj.08-122317; Garcia F, 2013, J ANTIBIOT, V66, P3, DOI 10.1038/ja.2012.87; Gurrola GB, 2012, BIOCHEMISTRY-US, V51, P4049, DOI 10.1021/bi300060n; Hernandez-Aponte CA, 2011, TOXICON, V57, P84, DOI 10.1016/j.toxicon.2010.10.008; Hoffmann CC, 1931, MONOGRAFIA ANAL I BI, V2, P117; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P1, DOI 10.1007/s10493-008-9203-5; Ji YH, 1997, CHINESE SCI BULL, V42, P952, DOI 10.1007/BF02882556; Kamachi S, 2014, ACTA CRYSTALLOGR F, V70, P915, DOI 10.1107/S2053230X14010589; Kozminsky-Atias A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-333; Kuhn-Nentwig L, 2003, CELL MOL LIFE SCI, V60, P2651, DOI 10.1007/s00018-003-3106-8; Lazo GR, 2001, BIOTECHNIQUES, V30, P1300, DOI 10.2144/01306bc03; Luna-Ramirez K, 2013, TOXICON, V63, P44, DOI 10.1016/j.toxicon.2012.11.017; Ma YB, 2012, J PROTEOMICS, V75, P1563, DOI 10.1016/j.jprot.2011.11.029; Ma YB, 2010, PROTEOMICS, V10, P2471, DOI 10.1002/pmic.200900763; Ma YB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-290; Matsushita N, 2007, TOXICON, V50, P861, DOI 10.1016/j.toxicon.2007.06.014; Miyashita M, 2007, TOXICON, V50, P428, DOI 10.1016/j.toxicon.2007.04.012; Moerman L, 2002, EUR J BIOCHEM, V269, P4799, DOI 10.1046/j.1432-1033.2002.03177.x; Morrissette J, 1996, BIOPHYS J, V71, P707, DOI 10.1016/S0006-3495(96)79270-6; Nascimento DG, 2006, TOXICON, V47, P628, DOI 10.1016/j.toxicon.2006.01.015; Ortiz E, 2015, TOXICON, V93, P125, DOI 10.1016/j.toxicon.2014.11.233; Ortiz E, 2014, BBA-GEN SUBJECTS, V1840, P1738, DOI 10.1016/j.bbagen.2013.12.012; Panyi G, 2006, CURR PHARM DESIGN, V12, P2199, DOI 10.2174/138161206777585120; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Quintero-Hernandez V, 2013, TOXICON, V76, P328, DOI 10.1016/j.toxicon.2013.07.012; Quintero-Hernandez V, 2011, TOXICON, V58, P644, DOI 10.1016/j.toxicon.2011.09.015; Ramirez-Carreto S, 2012, PEPTIDES, V34, P290, DOI 10.1016/j.peptides.2012.02.002; Rendon-Anaya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043331; de la Vega RCR, 2010, TOXICON, V56, P1155, DOI 10.1016/j.toxicon.2009.11.010; Roeding F, 2009, MOL PHYLOGENET EVOL, V53, P826, DOI 10.1016/j.ympev.2009.08.014; Sambrook J., 2001, MOL CLONING LAB MANU; Lopez CS, 2010, ZOOTAXA, P49; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; Schwartz EF, 2009, BRIT J PHARMACOL, V157, P392, DOI 10.1111/j.1476-5381.2009.00147.x; Sheldon TJ, 2007, FEBS LETT, V581, P5268, DOI 10.1016/j.febslet.2007.10.016; Silva ECN, 2009, TOXICON, V54, P252, DOI 10.1016/j.toxicon.2009.04.010; Sissom WD, 2010, CATALOG SCORPIONS WO, P503; Smith JJ, 2013, P NATL ACAD SCI USA, V110, P8906, DOI 10.1073/pnas.1214062110; Smith Jennifer J, 2012, J Venom Res, V3, P7; Soleglad ME, 2003, EUSCORPIUS, V11, P1, DOI DOI 10.18590/euscorpius.2003.vol2003.iss11.1; Sollod BL, 2005, PEPTIDES, V26, P131, DOI 10.1016/j.peptides.2004.07.016; Soudani N, 2005, Arch Inst Pasteur Tunis, V82, P39; Stahnke HL, 1974, J ARACHNOL, V1, P35; Sunagar K, 2013, TOXINS, V5, P2456, DOI 10.3390/toxins5122456; Torres-Larios A, 2000, EUR J BIOCHEM, V267, P5023, DOI 10.1046/j.1432-1327.2000.01556.x; Tuuri RE, 2011, PEDIATR EMERG CARE, V27, P667, DOI 10.1097/PEC.0b013e3182228dfa; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Uawonggul N, 2007, TOXICON, V49, P19, DOI 10.1016/j.toxicon.2006.09.003; Valdez-Velazquez LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066486; VALDIVIA HH, 1991, J BIOL CHEM, V266, P19135; VALDIVIA HH, 1992, P NATL ACAD SCI USA, V89, P12185, DOI 10.1073/pnas.89.24.12185; Varga Z, 2012, MOL PHARMACOL, V82, P372, DOI 10.1124/mol.112.078006; Zeng XC, 2005, IUBMB LIFE, V57, P13, DOI 10.1080/15216540500058899; Zeng XC, 2004, PEPTIDES, V25, P143, DOI 10.1016/j.peptides.2003.12.003; Zeng XC, 2000, IUBMB LIFE, V49, P207, DOI 10.1080/713803610; Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200; Zhu S, 2004, CELL MOL LIFE SCI, V61, P1751, DOI 10.1007/s00018-004-4149-1	82	46	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117188	10.1371/journal.pone.0117188	http://dx.doi.org/10.1371/journal.pone.0117188			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659089	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900113
J	Yaya, I; Saka, B; Landoh, DE; Patchali, PM; Patassi, AA; Aboubakari, AS; Makawa, MS; N'Dri, MK; Senanou, S; Lamboni, B; Idrissou, D; Salaka, KT; Pitche, P				Yaya, Issifou; Saka, Bayaki; Landoh, Dadja Essoya; Patchali, P'Niwe Massoubayo; Patassi, Akouda Akessiwe; Aboubakari, Abdoul-Samadou; Makawa, Makawa-Sy; N'Dri, Mathias Kouame; Senanou, Sekande; Lamboni, Bassan; Idrissou, Daoudou; Salaka, Kao Tanang; Pitche, Palokinam			HIV Status Disclosure to Sexual Partners, among People Living with HIV and AIDS on Antiretroviral Therapy at Sokode Regional Hospital, Togo	PLOS ONE			English	Article							SEROSTATUS DISCLOSURE; HIV/AIDS; UGANDA; TANZANIA; PREDICTORS; WOMEN; RISK; CARE	Background Many studies have reported factors associated with HIV status disclosure among People Living With HIV and AIDS (PLWHA) but very few were conducted among PLWHA receiving ART. In Togo, no study on HIV status disclosure to sexual partners has been conducted among PLWHA on ART yet. We sought to document factors associated with HIV status disclosure among PLWHA receiving ART at Sokode regional hospital in Togo. Method This was a cross-sectional study conducted from May to July 2013 at the regional hospital of Sokode among 291 PLWHA who had been on ART for at least three months. Results A total of 291 PLWHA on ART were enrolled in this study. Their mean age (+/- SD) was 37.3 +/- 9.3 years and the sex ratio (Male/Female) was 0.4. Among them, 215 (74.6%) completed the questionnaire on HIV sero-status disclosure. We found that 131 PLWHA (60.9%) had disclosed their HIV sero-status to their sexual partners; 130 (60.5%) were aware of the HIV status of their sexual partners. In the multivariate analysis, the factors associated with HIV status disclosure to sexual partners were: adherence to ART (aOR = 4.89; 95%CI = [1.52; 15.78]), sexual partner awareness of HIV sero-status (aOR = 52.73; 95%CI = [14.76; 188.36]) and marital status of PLWHA (aOR = 6.10; 95%CI = [1.74; 21.37]). Conclusion This study allowed us to note that the disclosure of HIV status to sexual partners is relatively low and to document the associated factors such as adherence to ART, sexual partner awareness of HIV sero-status and marital status.	[Yaya, Issifou; N'Dri, Mathias Kouame] Aix Marseille Univ, Lab Sante Publ, EA 3279, Marseille, France; [Saka, Bayaki; Pitche, Palokinam] Univ Lome, CHU Sylvanus Olympio, Serv Dermatol & IST, Lome, Togo; [Landoh, Dadja Essoya] Minist Sante, Div Epidemiol, Lome, Togo; [Patchali, P'Niwe Massoubayo; Senanou, Sekande] Ctr Hosp Reg CHR Sokode, Serv Dispensat Antiretroviraux ARV, Sokode, Togo; [Patassi, Akouda Akessiwe] Univ Lome, CHU Sylvanus Olympio, Serv Malad Infect, Lome, Togo; [Aboubakari, Abdoul-Samadou] CHU Kara, Serv Gynecoobstet, Kara, Togo; [Makawa, Makawa-Sy] Direct Prefectorale Sante Tone, Dapaong, Togo; [Lamboni, Bassan] Minist Sante, Programme Natl Lutte Malad Non Transmissibles, Lome, Togo; [Idrissou, Daoudou] Minist Sante, Div Sante Familiale, Lome, Togo; [Salaka, Kao Tanang] Minist Sante, Div Sante Communautaire, Lome, Togo; [Pitche, Palokinam] Conseil Natl Lutte IST VIH Sida, Lome, Togo	UDICE-French Research Universities; Aix-Marseille Universite	Saka, B (corresponding author), Univ Lome, CHU Sylvanus Olympio, Serv Dermatol & IST, Lome, Togo.	barthelemysaka@yahoo.fr	YAYA, Issifou/J-3662-2017	YAYA, Issifou/0000-0002-2554-6515; N'DRI, KOUAME MATHIAS/0000-0001-8620-0457				Amoran OE, 2012, NIGER J CLIN PRACT, V15, P385, DOI 10.4103/1119-3077.104507; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Coutherut J, 2014, B SOC PATHOL EXOT; Deribe K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-81; Erku TA, 2012, PAN AFR MED J, V13, P87; Kangwende R A, 2009, Cent Afr J Med, V55, P1; King R, 2008, AIDS BEHAV, V12, P232, DOI 10.1007/s10461-007-9307-7; Kiula ES, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-433; Kouanda S, 2012, REV EPIDEMIOL SANTE, V60, P221, DOI 10.1016/j.respe.2011.12.135; Kyaddondo D, 2013, SAHARA J-J SOC ASP H, V10, pS37, DOI 10.1080/02664763.2012.755323; Ministere de la sante, 2012, PLAN NAT DEV SAN 201; Ndiaye C, 2008, World Health Popul, V10, P43; ONUSIDA, 2001, EP VIH SIDA PARL OUV, P43; Osinde MO, 2012, INT J GYNECOL OBSTET, V118, P61, DOI 10.1016/j.ijgo.2012.02.008; Pinkerton SD, 2007, AIDS BEHAV, V11, P698, DOI 10.1007/s10461-006-9187-2; Programme National de Lutte contre le Sida et les IST au Togo, 2013, RAPP ACT 2012; Roura M, 2009, AIDS PATIENT CARE ST, V23, P203, DOI 10.1089/apc.2008.0129; Seid Mohammed, 2012, Afr J Reprod Health, V16, P97; Simbayi LC, 2007, SEX TRANSM INFECT, V83, P29, DOI 10.1136/sti.2006.019893; Sow K, 2013, SAHARA J-J SOC ASP H, V10, pS28, DOI 10.1080/02664763.2012.755322; Ssali SN, 2010, AIDS PATIENT CARE ST, V24, P675, DOI 10.1089/apc.2010.0062; Stirratt MJ, 2006, AIDS BEHAV, V10, P483, DOI 10.1007/s10461-006-9106-6; Yonah G, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-5	24	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118157	10.1371/journal.pone.0118157	http://dx.doi.org/10.1371/journal.pone.0118157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658105	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900268
J	Graf, P; Yu, M				Graf, Peter; Yu, Martin			Valenced Cues and Contexts Have Different Effects on Event-Based Prospective Memory	PLOS ONE			English	Article							POSITIVE AFFECT; BRAIN POTENTIALS; AFFECTIVE STATE; EMOTION; ATTENTION; BROADEN	This study examined the separate influence and joint influences on event-based prospective memory task performance due to the valence of cues and the valence of contexts. We manipulated the valence of cues and contexts with pictures from the International Affective Picture System. The participants, undergraduate students, showed higher performance when neutral compared to valenced pictures were used for cueing prospective memory. In addition, neutral pictures were more effective as cues when they occurred in a valenced context than in the context of neutral pictures, but the effectiveness of valenced cues did not vary across contexts that differed in valence. The finding of an interaction between cue and context valence indicates that their respective influence on event-based prospective memory task performance cannot be understood in isolation from each other. Our findings are not consistent with by the prevailing view which holds that the scope of attention is broadened and narrowed, respectively, by positively and negatively valenced stimuli. Instead, our findings are more supportive of the recent proposal that the scope of attention is determined by the motivational intensity associated with valenced stimuli. Consistent with this proposal, we speculate that the motivational intensity associated with different retrieval cues determines the scope of attention, that contexts with different valence values determine participants' task engagement, and that prospective memory task performance is determined jointly by attention scope and task engagement.	[Graf, Peter; Yu, Martin] Univ British Columbia, Dept Psychol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Graf, P (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC V5Z 1M9, Canada.	pgraf@psych.ubc.ca			Natural Sciences and Research Council of Canada [RGPIN-2014-04835]	Natural Sciences and Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a Discovery Grant (RGPIN-2014-04835) to Peter Graf from the Natural Sciences and Research Council of Canada (http://www.nserc-crsng.gc.ca/ index_eng.asp). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J, 2010, NEUROIMAGE, V49, P914, DOI 10.1016/j.neuroimage.2009.08.045; Altgassen M, 2011, J CLIN EXP NEUROPSYC, V33, P910, DOI 10.1080/13803395.2011.574607; Altgassen M, 2010, Q J EXP PSYCHOL, V63, P1057, DOI 10.1080/17470211003770920; Bradley MM, 1996, PSYCHOPHYSIOLOGY, V33, P662, DOI 10.1111/j.1469-8986.1996.tb02362.x; Clark-Foos A, 2009, AM J PSYCHOL, V122, P89; Codispoti M, 2001, PSYCHOPHYSIOLOGY, V38, P474, DOI 10.1111/1469-8986.3830474; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa, 1989, NEO PI NEO FFI MANUA; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Derryberry D., 1994, HEARTS EYE EMOTIONAL, P167, DOI [10.1016/B978-0-12-410560-7.50014-4, DOI 10.1016/B978-0-12-410560-7.50014-4]; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Fiske ST., 2008, SOCIAL COGNITION BRA; Fredrickson BL, 2004, PHILOS T R SOC B, V359, P1367, DOI 10.1098/rstb.2004.1512; Friedman RS, 2010, PSYCHOL BULL, V136, P875, DOI 10.1037/a0020495; Gable P.A., 2008, NETHERLANDS J PSYCHO, V64, P132, DOI [10.1007/BF03076416, DOI 10.1007/BF03076416]; Garrett AS, 2001, PSYCHIAT RES-NEUROIM, V108, P39, DOI 10.1016/S0925-4927(01)00110-X; Hajcak G, 2008, EMOTION, V8, P250, DOI 10.1037/1528-3542.8.2.250; Harmon-Jones E, 2013, CURR DIR PSYCHOL SCI, V22, P301, DOI 10.1177/0963721413481353; Huntsinger JR, 2013, CURR DIR PSYCHOL SCI, V22, P265, DOI 10.1177/0963721413480364; Isen A.M., 2008, HDB EMOTIONS, V3, P548; ISEN AM, 1984, J PERS SOC PSYCHOL, V47, P1206, DOI 10.1037/0022-3514.47.6.1206; ISEN AM, 1985, J PERS SOC PSYCHOL, V48, P1413, DOI 10.1037/0022-3514.48.6.1413; Kvavilashvili L, 1998, APPL COGNITIVE PSYCH, V12, P533, DOI 10.1002/(SICI)1099-0720(1998120)12:6<533::AID-ACP538>3.0.CO;2-1; Lang P.J., 2008, INT AFFECTIVE PICTUR; Meinhardt J, 2003, COGNITION EMOTION, V17, P477, DOI 10.1080/02699930244000039; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Rendell PG, 2011, COGNITION EMOTION, V25, P916, DOI 10.1080/02699931.2010.508610; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Rummel J, 2012, COGNITION EMOTION, V26, P351, DOI 10.1080/02699931.2011.574873; Schneider W., 2002, E PRIME USERS GUIDE; Schnitzspahn KM, 2012, PSYCHOL AGING, V27, P498, DOI 10.1037/a0025021; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Schwarz N., 2007, SOCIAL PSYCHOL HDB B, V(2nd), P385, DOI DOI 10.1023/A:1021223113233; Sutton SK, 1997, PSYCHOPHYSIOLOGY, V34, P217, DOI 10.1111/j.1469-8986.1997.tb02135.x; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed	35	3	3	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116953	10.1371/journal.pone.0116953	http://dx.doi.org/10.1371/journal.pone.0116953			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3QZ	25647484	gold, Green Published, Green Submitted			2022-12-27	WOS:000348822600043
J	Kenerson, HL; Subramanian, S; McIntyre, R; Kazami, M; Yeung, RS				Kenerson, Heidi L.; Subramanian, Savitha; McIntyre, Rebecca; Kazami, Machiko; Yeung, Raymond S.			Livers with Constitutive mTORC1 Activity Resist Steatosis Independent of Feedback Suppression of Akt	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; CELL-SURVIVAL; FATTY LIVER; LIPOGENESIS; COMPLEX; NRF2; INHIBITION; ACTIVATION; SUBSTRATE; SREBP-1C	Insulin resistance is an important contributing factor in non-alcoholic fatty liver disease. AKT and mTORC1 are key components of the insulin pathway, and play a role in promoting de novo lipogenesis. However, mTORC1 hyperactivity per se does not induce steatosis in mouse livers, but instead, protects against high-fat diet induced steatosis. Here, we investigate the in vivo mechanism of steatosis-resistance secondary to mTORC1 activation, with emphasis on the role of S6K1-mediated feedback inhibition of AKT. Mice with single or double deletion of Tsc1 and/ or S6k1 in a liver-specific or whole-body manner were generated to study glucose and hepatic lipid metabolism between the ages of 6-14 weeks. Following 8 weeks of high- fat diet, the Tsc1-/-; S6k1-/- mice had lower body weights but higher liver TG levels compared to that of the Tsc1-/- mice. However, the loss of S6k1 did not relieve feedback inhibition of Akt activity in the Tsc1-/- livers. To overcome Akt suppression, Pten was deleted in Tsc1-/- livers, and the resultant mice showed improved glucose tolerance compared with the Tsc1-/- mice. However, liver TG levels were significantly reduced in the Tsc1-/-; Pten-/- mice compared to the Pten-/- mice, which was restored with rapamycin. We found no correlation between liver TG and serum NEFA levels. Expression of lipogenic genes (Srebp1c, Fasn) were elevated in the Tsc1-/-; Pten-/- livers, but this was counterbalanced by an up-regulation of Cpt1a involved in fatty acid oxidation and the anti-oxidant protein, Nrf2. In summary, our in vivo models showed that mTORC1-induced resistance to steatosis was dependent on S6K1 activity, but not secondary to AKT suppression. These findings confirm that AKT and mTORC1 have opposing effects on hepatic lipid metabolism in vivo.	[Kenerson, Heidi L.; McIntyre, Rebecca; Kazami, Machiko; Yeung, Raymond S.] Univ Washington, Dept Surg, Northwest Liver Res Program, Seattle, WA 98195 USA; [Subramanian, Savitha] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Yeung, RS (corresponding author), Univ Washington, Dept Surg, Northwest Liver Res Program, Seattle, WA 98195 USA.	ryeung@uw.edu		Subramanian, Savitha/0000-0002-4866-2009; McIntyre, Rebecca L./0000-0002-2863-8132	National Institutes of Health [CA102662]; University of Washington Department of Surgery Reinvestment Fund; NATIONAL CANCER INSTITUTE [R01CA102662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Department of Surgery Reinvestment Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health CA102662 (RSY), University of Washington Department of Surgery Reinvestment Fund (RSY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Dagon Y, 2012, CELL METAB, V16, P104, DOI 10.1016/j.cmet.2012.05.010; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kay HY, 2011, ANTIOXID REDOX SIGN, V15, P2135, DOI 10.1089/ars.2010.3834; Kenerson HL, 2013, GASTROENTEROLOGY, V144, P1055, DOI 10.1053/j.gastro.2013.01.053; Kenerson HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018075; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lamle J, 2008, GASTROENTEROLOGY, V134, P1159, DOI 10.1053/j.gastro.2008.01.011; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; McCullough AJ, 2011, J DIGEST DIS, V12, P333, DOI 10.1111/j.1751-2980.2010.00469.x; Miyake T, 2012, INTERNAL MED, V51, P2151, DOI 10.2169/internalmedicine.51.7578; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Quinn WJ, 2012, P NATL ACAD SCI USA, V109, P15974, DOI 10.1073/pnas.1214113109; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schieren G, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-22; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Umemura A, 2014, CELL METAB, V20, P133, DOI 10.1016/j.cmet.2014.05.001; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	36	29	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117000	10.1371/journal.pone.0117000	http://dx.doi.org/10.1371/journal.pone.0117000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646773	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600047
J	Tark, D; Kim, H; Neale, MH; Kim, M; Sohn, H; Lee, Y; Cho, I; Joo, Y; Windl, O				Tark, Dongseob; Kim, Hyojin; Neale, Michael H.; Kim, Minjeong; Sohn, Hyunjoo; Lee, Yoonhee; Cho, Insoo; Joo, Yiseok; Windl, Otto			Generation of a Persistently Infected MDBK Cell Line with Natural Bovine Spongiform Encephalopathy (BSE)	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; ENDOGENOUS PROTEOLYTIC CLEAVAGE; PRION PROTEIN-FORMATION; NEUROBLASTOMA-CELLS; SCRAPIE STRAINS; PRP; TISSUES; TRANSMISSION; PROPAGATION; EXPRESSION	Bovine spongiform encephalopathy (BSE) is a zoonotic transmissible spongiform encephalopathy (TSE) thought to be caused by the same prion strain as variant Creutzfeldt-Jakob disease (vCJD). Unlike scrapie and chronic wasting disease there is no cell culture model allowing the replication of proteinase K resistant BSE (PrPBSE) and the further in vitro study of this disease. We have generated a cell line based on the Madin-Darby Bovine Kidney (MDBK) cell line over-expressing the bovine prion protein. After exposure to naturally BSE infected bovine brain homogenate this cell line has shown to replicate and accumulate Pr-PBSE and maintain infection up to passage 83 after initial challenge. Collectively, we demonstrate, for the first time, that the BSE agent can infect cell lines over-expressing the bovine prion protein similar to other prion diseases. These BSE infected cells will provide a useful tool to facilitate the study of potential therapeutic agents and the diagnosis of BSE.	[Tark, Dongseob; Kim, Minjeong; Sohn, Hyunjoo; Lee, Yoonhee; Cho, Insoo] Anim & Plant Quarantine Agcy, Dept Anim & Plant Hlth Res, Anyang Si, Gyeonggi Do, South Korea; [Kim, Hyojin; Joo, Yiseok] Anim & Plant Quarantine Agcy, Dept Anim Dis Control & Quarantine, Anyang Si, Gyeonggi Do, South Korea; [Neale, Michael H.; Windl, Otto] Anim Hlth & Vet Labs Agcy, Pathol & Host Susceptibil Dept, Addlestone KT15 3NB, Surrey, England	Animal & Plant Quarantine Agency; Animal & Plant Quarantine Agency; Veterinary Laboratories Agency	Tark, D (corresponding author), Anim & Plant Quarantine Agcy, Dept Anim & Plant Hlth Res, 175 Anyang Ro, Anyang Si, Gyeonggi Do, South Korea.	tarkds@korea.kr			Veterinary Science Technical Development project of the Animal, Plant and Fisheries Quarantine and Inspection Agency [M-AD16-2006-09-09]	Veterinary Science Technical Development project of the Animal, Plant and Fisheries Quarantine and Inspection Agency	This work was supported by a fund of the Veterinary Science Technical Development project of the Animal, Plant and Fisheries Quarantine and Inspection Agency (project no. M-AD16-2006-09-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonia F, 2000, NAT GENET, V25, P217; Arima K, 2005, J VIROL, V79, P7104, DOI 10.1128/JVI.79.11.7104-7112.2005; Baron T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015839; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; Birkett CR, 2001, EMBO J, V20, P3351, DOI 10.1093/emboj/20.13.3351; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Dron M, 2010, J BIOL CHEM, V285, P10252, DOI 10.1074/jbc.M109.083857; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; HADLOW WJ, 1987, J VIROL, V61, P3235, DOI 10.1128/JVI.61.10.3235-3240.1987; Heinig L, 2010, PROTEIN EXPRES PURIF, V70, P129, DOI 10.1016/j.pep.2009.09.015; Iwamaru Y, 2008, J NEUROCHEM, V107, P636, DOI 10.1111/j.1471-4159.2008.05628.x; Iwamaru Y, 2007, J VIROL, V81, P1524, DOI 10.1128/JVI.01379-06; Jha KK, 1998, EXP CELL RES, V245, P1, DOI 10.1006/excr.1998.4272; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Kim HJ, 2012, J VET MED SCI, V74, P1377, DOI 10.1292/jvms.12-0061; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; LADOGANA A, 1995, LANCET, V345, P594, DOI 10.1016/S0140-6736(95)90508-1; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Manuelidis L, 2007, P NATL ACAD SCI USA, V104, P1965, DOI 10.1073/pnas.0610999104; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Paquet S, 2007, J VIROL, V81, P10786, DOI 10.1128/JVI.01137-07; Peralta OA, 2009, PRION, V3, P161, DOI 10.4161/pri.3.3.9772; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; Raymond GJ, 2006, J VIROL, V80, P596, DOI 10.1128/JVI.80.2.596-604.2006; Ryder SJ, 2001, VET REC, V148, P437, DOI 10.1136/vr.148.14.437; Stack MJ, 2011, J COMP PATHOL, V145, P289, DOI 10.1016/j.jcpa.2011.01.010; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vilette D, 2008, VET RES, V39, DOI 10.1051/vetres:2007049; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	38	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0115939	10.1371/journal.pone.0115939	http://dx.doi.org/10.1371/journal.pone.0115939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647616	gold, Green Submitted, Green Published			2022-12-27	WOS:000348822600017
J	Yang, QC; Chen, LN; Hu, XL; Zhao, L; Yin, PH; Li, Q				Yang, Qiuchan; Chen, Lina; Hu, Xiaoli; Zhao, Ling; Yin, Pinghe; Li, Qiang			Toxic Effect of a Marine Bacterium on Aquatic Organisms and Its Algicidal Substances against Phaeocystis globosa	PLOS ONE			English	Article							RED TIDE; HYPOXANTHINE; BLOOMS; DINOFLAGELLATE; COMPOUND; EXTRACTS; INOSINE; OXIDASE	Harmful algal blooms have caused enormous damage to the marine ecosystem and the coastal economy in China. In this paper, a bacterial strain B1, which had strong algicidal activity against Phaeocystis globosa, was isolated from the coastal waters of Zhuhai in China. The strain B1 was identified as Bacillus sp. on the basis of 16S rDNA gene sequence and morphological characteristics. To evaluate the ecological safety of the algicidal substances produced by strain B1, their toxic effects on marine organisms were tested. Results showed that there were no adverse effects observed in the growth of Chlorella vulgaris, Chaetoceros muelleri, and Isochrystis galbana after exposure to the algicidal substances at a concentration of 1.0% (v/v) for 96 h. The 48h LC50 values for Brachionus plicatilis, Moina mongolica Daday and Paralichthys olivaceus were 5.7, 9.0 and 12.1%(v/v), respectively. Subsequently, the algicidal substances from strain B1 culture were isolated and purified by silica gel column, Sephadex G-15 column and high-performance liquid chromatography. Based on quadrupole time-of-flight mass spectrometry and PeakView Software, the purified substances were identified as prolyl-methionine and hypoxanthine. Algicidal mechanism indicated that prolyl-methionine and hypoxanthine inhibited the growth of P. globosa by disrupting the antioxidant systems. In the acute toxicity assessment using M. mongolica, 24h LC50 values of prolyl-methionine and hypoxanthine were 7.0 and 13.8 g/L, respectively. The active substances produced by strain B1 can be considered as ecologically and environmentally biological agents for controlling harmful algal blooms.	[Yang, Qiuchan; Chen, Lina; Zhao, Ling] Jinan Univ, Key Lab Water Soil Tox Pollutants Control & Biore, Guangdong Higher Educ Inst, Sch Environm, Guangzhou 510632, Guangdong, Peoples R China; [Hu, Xiaoli; Yin, Pinghe; Li, Qiang] Jinan Univ, Dept Chem, Guangzhou 510632, Guangdong, Peoples R China	Jinan University; Jinan University	Zhao, L (corresponding author), Jinan Univ, Key Lab Water Soil Tox Pollutants Control & Biore, Guangdong Higher Educ Inst, Sch Environm, Guangzhou 510632, Guangdong, Peoples R China.	zhaoling@jnu.edu.cn; tyinph@jnu.edu.cn			National Natural Science Foundation of China [41076068]; United Fund Project of National Natural Science Foundation of China-Guangdong [U1133003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); United Fund Project of National Natural Science Foundation of China-Guangdong	This research was supported by the National Natural Science Foundation of China (No. 41076068) and the United Fund Project of National Natural Science Foundation of China-Guangdong (No. U1133003)(http://www.nsfc.gov.cn/publish/portal0/default.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CY, 2003, BIOTECHNOL LETT, V25, P1137, DOI 10.1023/A:1024508927361; Alamri SA, 2013, SAUDI J BIOL SCI, V20, P357, DOI 10.1016/j.sjbs.2013.04.002; Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Balladin DA, 1997, APPL BIOCHEM BIOTECH, V62, P317, DOI 10.1007/BF02788006; Banin E, 2001, APPL ENVIRON MICROB, V67, P1536, DOI 10.1128/AEM.67.4.1536-1541.2001; Beauchamp Charles, ANAL BIOCHEM, V44, P276, DOI [10.1016/0003-2697(71)90370-8, DOI 10.1016/0003-2697(71)90370-8]; Blauw AN, 2010, J MARINE SYST, V83, P115, DOI 10.1016/j.jmarsys.2010.05.003; Chen WM, 2011, ENZYME MICROB TECH, V49, P372, DOI 10.1016/j.enzmictec.2011.06.016; Cho JY, 2012, BIOSCI BIOTECH BIOCH, V76, P1452, DOI 10.1271/bbb.120102; Farthing D, 2007, J CHROMATOGR B, V854, P158, DOI 10.1016/j.jchromb.2007.04.013; Farthing DE, 2011, LUMINESCENCE, V26, P65, DOI 10.1002/bio.1187; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gillespie KM, 2011, J EXP BOT, V62, P2667, DOI 10.1093/jxb/erq435; Imamura N, 2000, J ANTIBIOT, V53, P1317, DOI 10.7164/antibiotics.53.1317; Jancula D, 2007, ENVIRON TOXICOL, V22, P480, DOI 10.1002/tox.20290; Jeong SY, 2003, TETRAHEDRON LETT, V44, P8005, DOI 10.1016/j.tetlet.2003.08.115; Kim MJ, 2008, J APPL PHYCOL, V20, P1069, DOI 10.1007/s10811-008-9312-x; Kim SJ, 2011, ENVIRON TOXICOL CHEM, V30, P2810, DOI 10.1002/etc.691; Lee SO, 2002, BIOSCI BIOTECH BIOCH, V66, P1366, DOI 10.1271/bbb.66.1366; Li HS, 2006, EXPT PRINCIPLES TECH; Lovejoy C, 1998, APPL ENVIRON MICROB, V64, P2806; Luo JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076444, 10.1371/journal.pone.0049231]; Mayali X, 2002, HARMFUL ALGAE, V1, P277, DOI 10.1016/S1568-9883(02)00032-X; Nakashima T, 2006, APPL MICROBIOL BIOT, V73, P684, DOI 10.1007/s00253-006-0507-2; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Pierce RH, 2008, ECOTOXICOLOGY, V17, P623, DOI 10.1007/s10646-008-0241-x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schoemann V, 2005, J SEA RES, V53, P43, DOI 10.1016/j.seares.2004.01.008; Shao J, 2014, INT J ENVIRON SCI TE, V11, P469, DOI 10.1007/s13762-013-0205-4; Shao JH, 2013, J ENVIRON MANAGE, V125, P149, DOI 10.1016/j.jenvman.2013.04.001; Somdee T, 2013, J APPL PHYCOL, V25, P1587, DOI 10.1007/s10811-013-9999-1; Su RQ, 2007, HARMFUL ALGAE, V6, P799, DOI 10.1016/j.hal.2007.04.004; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Valentine JS, 1998, CURR OPIN CHEM BIOL, V2, P253, DOI 10.1016/S1367-5931(98)80067-7; van Rijssel M, 2000, J SEA RES, V43, P297, DOI 10.1016/S1385-1101(00)00013-7; VANHAECKE P, 1981, ECOTOX ENVIRON SAFE, V5, P382, DOI 10.1016/0147-6513(81)90012-9; Wang BX, 2010, LETT APPL MICROBIOL, V51, P552, DOI 10.1111/j.1472-765X.2010.02936.x; Wang XL, 2005, HARMFUL ALGAE, V4, P433, DOI 10.1016/j.hal.2004.06.001; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; Yang L, 2012, BIOCONTROL SCI, V17, P107, DOI 10.4265/bio.17.107; Yoshikawa K, 2000, APPL ENVIRON MICROB, V66, P718, DOI 10.1128/AEM.66.2.718-722.2000; Zhang HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065277, 10.1371/journal.pone.0054510, 10.1371/journal.pone.0068634, 10.1371/journal.pone.0079454]; Zheng XW, 2013, APPL MICROBIOL BIOT, V97, P9207, DOI 10.1007/s00253-012-4617-8; Zhou LH, 2010, J APPL PHYCOL, V22, P803, DOI 10.1007/s10811-010-9522-x	45	47	52	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0114933	10.1371/journal.pone.0114933	http://dx.doi.org/10.1371/journal.pone.0114933			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646807	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600009
J	Gerber, M; Fischer, A; Jagannathan, V; Drogemuller, M; Drogemuller, C; Schmidt, MJ; Bernardino, F; Manz, E; Matiasek, K; Rentmeister, K; Leeb, T				Gerber, Martina; Fischer, Andrea; Jagannathan, Vidhya; Droegemueller, Michaela; Droegemueller, Cord; Schmidt, Martin J.; Bernardino, Filipa; Manz, Eberhard; Matiasek, Kaspar; Rentmeister, Kai; Leeb, Tosso			A Deletion in the VLDLR Gene in Eurasier Dogs with Cerebellar Hypoplasia Resembling a Dandy-Walker-Like Malformation (DWLM)	PLOS ONE			English	Article							LIPOPROTEIN RECEPTOR GENE; DYSEQUILIBRIUM SYNDROME; QUADRUPEDAL LOCOMOTION; MUTATIONS; GENOME; IDENTIFICATION; ASSOCIATION	Dandy-Walker-like malformation (DWLM) is the result of aberrant brain development and mainly characterized by cerebellar hypoplasia. DWLM affected dogs display a non-progressive cerebellar ataxia. Several DWLM cases were recently observed in the Eurasier dog breed, which strongly suggested a monogenic autosomal recessive inheritance in this breed. We performed a genome-wide association study (GWAS) with 9 cases and 11 controls and found the best association of DWLM with markers on chromosome 1. Subsequent homozygosity mapping confirmed that all 9 cases were homozygous for a shared haplotype in this region, which delineated a critical interval of 3.35 Mb. We sequenced the genome of an affected Eurasier and compared it with the Boxer reference genome and 47 control genomes of dogs from other breeds. This analysis revealed 4 private non-synonymous variants in the critical interval of the affected Eurasier. We genotyped these variants in additional dogs and found perfect association for only one of these variants, a single base deletion in the VLDLR gene encoding the very low density lipoprotein receptor. This variant, VLDLR:c.1713delC is predicted to cause a frameshift and premature stop codon (p.W572Gfs*10). Variants in the VLDLR gene have been shown to cause congenital cerebellar ataxia and mental retardation in human patients and Vldlr knockout mice also display an ataxia phenotype. Our combined genetic data together with the functional knowledge on the VLDLR gene from other species thus strongly suggest that VLDLR:c.1713delC is indeed causing DWLM in Eurasier dogs.	[Gerber, Martina; Jagannathan, Vidhya; Droegemueller, Michaela; Droegemueller, Cord; Leeb, Tosso] Univ Bern, Vetsuisse Fac, Inst Genet, CH-3001 Bern, Switzerland; [Fischer, Andrea; Bernardino, Filipa] Univ Munich, Clin Small Anim Med, Neurol Sect, D-80539 Munich, Germany; [Schmidt, Martin J.] Univ Giessen, Small Anim Clin, Dept Vet Clin Sci, D-35392 Giessen, Germany; [Manz, Eberhard] Generatio Sol GmbH, D-69115 Heidelberg, Germany; [Matiasek, Kaspar] Univ Munich, Ctr Clin Vet Med, Inst Vet Pathol, Sect Clin & Comparat Neuropathol, D-80539 Munich, Germany; [Rentmeister, Kai] Tierarztliche Praxis Neurol, D-97337 Dettelbach, Germany	University of Bern; University of Munich; Justus Liebig University Giessen; University of Munich	Leeb, T (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, CH-3001 Bern, Switzerland.	tosso.leeb@vetsuisse.unibe.ch	Leeb, Tosso/G-3187-2014; Fischer, Andrea/AFV-0155-2022; Jagannathan, Vidhya/P-1055-2019	Leeb, Tosso/0000-0003-0553-4880; Jagannathan, Vidhya/0000-0002-8155-0041; Matiasek, Kaspar/0000-0001-5021-3280; Fischer, Andrea/0000-0001-7094-1947; Drogemuller, Cord/0000-0001-9773-522X	Albert-Heim Foundation; Alexander von Humboldt Foundation	Albert-Heim Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This study was funded in part by a grant from the Albert-Heim Foundation. T. Leeb received a Humboldt Research Award from the Alexander von Humboldt Foundation. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BR, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-80; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bernardino F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117670; Boycott KM, 2005, AM J HUM GENET, V77, P477, DOI 10.1086/444400; Boycott KM, 2009, J CHILD NEUROL, V24, P1310, DOI 10.1177/0883073809332696; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Drogemuller C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001079; Forster E, 2010, EUR J NEUROSCI, V31, P1511, DOI 10.1111/j.1460-9568.2010.07222.x; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; KNECHT CD, 1979, J AM ANIM HOSP ASSOC, V15, P51; Kolb LE, 2010, NEUROGENETICS, V11, P319, DOI 10.1007/s10048-009-0232-y; KORNEGAY JN, 1986, VET PATHOL, V23, P374, DOI 10.1177/030098588602300405; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moheb LA, 2008, EUR J HUM GENET, V16, P270, DOI 10.1038/sj.ejhg.5201967; Ozcelik T, 2008, P NATL ACAD SCI USA, V105, P4232, DOI 10.1073/pnas.0804078105; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schlotawa L, 2013, J NEUROL, V260, P1678, DOI 10.1007/s00415-013-6941-z; SCHMID V, 1992, J AM ANIM HOSP ASSOC, V28, P355; Sonmez FM, 2013, J CHILD NEUROL, V28, P379, DOI 10.1177/0883073812441065; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Turkmen S, 2008, EUR J HUM GENET, V16, P1070, DOI 10.1038/ejhg.2008.73	24	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0108917	10.1371/journal.pone.0108917	http://dx.doi.org/10.1371/journal.pone.0108917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668033	Green Published, gold, Green Submitted			2022-12-27	WOS:000349493000001
J	Lachmandas, E; Vrieling, F; Wilson, LG; Joosten, SA; Netea, MG; Ottenhoff, TH; Van Crevel, R				Lachmandas, Ekta; Vrieling, Frank; Wilson, Louis G.; Joosten, Simone A.; Netea, Mihai G.; Ottenhoff, Tom H.; Van Crevel, Reinout			The Effect of Hyperglycaemia on In Vitro Cytokine Production and Macrophage Infection with Mycobacterium tuberculosis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; TYPE-2 MACROPHAGES; INTERFERON-GAMMA; SUSCEPTIBILITY; DEFICIENCY; MONOCYTES; RESPONSES; IMMUNITY; BLOOD; MICE	Type 2 diabetes mellitus is an established risk factor for tuberculosis but the underlying mechanisms are largely unknown. We examined the effects of hyperglycaemia, a hallmark of diabetes, on the cytokine response to and macrophage infection with Mycobacterium tuberculosis. Increasing in vitro glucose concentrations from 5 to 25 mmol/L had marginal effects on cytokine production following stimulation of peripheral blood mononuclear cells (PBMCs) with Mycobacterium. tuberculosis lysate, LPS or Candida albicans, while 40 mmol/L glucose increased production of TNF-alpha, IL-1 beta, IL-6 and IL-10, but not of IFN-gamma, IL-17A and IL-22. Macrophage differentiation under hyperglycaemic conditions of 25 mmol/L glucose was also associated with increased cytokine production upon stimulation with Mycobacterium. tuberculosis lysate and LPS but in infection experiments no differences in Mycobacterium. tuberculosis killing or outgrowth was observed. The phagocytic capacity of these hyperglycaemic macrophages also remained unaltered. The fact that only very high glucose concentrations were able to significantly influence cytokine production by macrophages suggests that hyperglycaemia alone cannot fully explain the increased susceptibility of diabetes mellitus patients to tuberculosis.	[Lachmandas, Ekta; Netea, Mihai G.; Van Crevel, Reinout] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Lachmandas, Ekta; Netea, Mihai G.; Van Crevel, Reinout] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Vrieling, Frank; Wilson, Louis G.; Joosten, Simone A.; Ottenhoff, Tom H.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Van Crevel, R (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.	Ekta.Lachmandas@rabdboudumc.nl	Joosten, Simone/E-4731-2011; Vrieling, Frank/AAC-7489-2022; Joosten, Simone A/F-1357-2011; Netea, Mihai/N-5155-2014; Lachmandas, Ekta/G-6682-2016; van Crevel, reinout/A-6636-2010	Joosten, Simone A/0000-0002-9878-0863; van Crevel, reinout/0000-0002-6233-6410; Vrieling, Frank/0000-0002-8064-672X	TANDEM (Tuberculosis and Diabetes Mellitus) Grant of the EC-FP7 (European Union's Seventh Framework Programme) [305279]; ERC (European Research Council) Starting Grant (ERC) [310372]; Vidi grant of NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek) [91710310]; EC-FP7 EURIPRED INFRASTRUCTURES (European Research Infrastructures for Poverty Related Diseases) [2012.1 312661]; EC-FP7 ADITEC (Advanced Immunization Technologies) [280873]; LUMC (Leiden University Medical Center) Profiling area grant	TANDEM (Tuberculosis and Diabetes Mellitus) Grant of the EC-FP7 (European Union's Seventh Framework Programme); ERC (European Research Council) Starting Grant (ERC); Vidi grant of NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek); EC-FP7 EURIPRED INFRASTRUCTURES (European Research Infrastructures for Poverty Related Diseases); EC-FP7 ADITEC (Advanced Immunization Technologies); LUMC (Leiden University Medical Center) Profiling area grant	This study was supported by the TANDEM (Tuberculosis and Diabetes Mellitus) Grant of the EC-FP7 (European Union's Seventh Framework Programme) under Grant Agreement No. 305279. MGN was supported by an ERC (European Research Council) Starting Grant (ERC#310372). RvC was supported by a Vidi grant of NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek) (No. 91710310). SAJ and THO were supported by EC-FP7 EURIPRED INFRASTRUCTURES (European Research Infrastructures for Poverty Related Diseases), contract no. 2012.1 312661, EC-FP7 ADITEC (Advanced Immunization Technologies) Grant agreement no. 280873 and LUMC (Leiden University Medical Center) Profiling area grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsma F, 2011, TRANSFUSION, V51, P412, DOI 10.1111/j.1537-2995.2010.02867.x; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Devaraj S, 2005, DIABETES, V54, P85, DOI 10.2337/diabetes.54.1.85; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Gomez DI, 2013, TUBERCULOSIS, V93, P192, DOI 10.1016/j.tube.2012.10.003; Han JM, 2014, J IMMUNOL, V192, P623, DOI 10.4049/jimmunol.1302181; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Komura T, 2010, DIABETES, V59, P634, DOI 10.2337/db09-0659; Kumar Nathella Pavan, 2013, Ann Am Thorac Soc, V10, P441, DOI 10.1513/AnnalsATS.201305-112OC; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Leclerc L, 2010, INHAL TOXICOL, V22, P1091, DOI 10.3109/08958378.2010.522781; Lecube A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023366; Liu HF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/867023; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; MARHOFFER W, 1992, DIABETES CARE, V15, P256, DOI 10.2337/diacare.15.2.256; Martens GW, 2007, AM J RESP CELL MOL, V37, P518, DOI 10.1165/rcmb.2006-0478OC; Martinez N, 2014, EUR J IMMUNOL, V44, P617, DOI 10.1002/eji.201344301; Mo YQ, 2009, TOXICOLOGY, V262, P130, DOI 10.1016/j.tox.2009.05.019; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Ottenhoff THM, 2012, TRENDS MICROBIOL, V20, P419, DOI 10.1016/j.tim.2012.06.002; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Restrepo BI, 2008, CLIN INFECT DIS, V47, P634, DOI 10.1086/590565; Restrepo BI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092977; Restrepo BI, 2013, TUBERCULOSIS, V93, pS10, DOI 10.1016/S1472-9792(13)70004-0; Ruslami R, 2010, TROP MED INT HEALTH, V15, P1289, DOI 10.1111/j.1365-3156.2010.02625.x; Stalenhoef JE, 2008, EUR J CLIN MICROBIOL, V27, P97, DOI 10.1007/s10096-007-0395-0; Statistics Netherlands, 2010, HLTH LIF US MED FAC; Sugawara I, 2004, TOHOKU J EXP MED, V204, P135, DOI 10.1620/tjem.204.135; Sugawara I, 2008, TOHOKU J EXP MED, V216, P363, DOI 10.1620/tjem.216.363; Sun CM, 2012, J CELL PHYSIOL, V227, P1670, DOI 10.1002/jcp.22891; Tan KS, 2012, J CLIN INVEST, V122, P2289, DOI 10.1172/JCI57817; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; van Crevel R, 2014, LANCET DIABETES ENDO, V2, P270, DOI 10.1016/S2213-8587(14)70011-7; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015	38	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117941	10.1371/journal.pone.0117941	http://dx.doi.org/10.1371/journal.pone.0117941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664765	Green Published, Green Submitted, gold			2022-12-27	WOS:000349123100024
J	Gallerano, D; Ndlovu, P; Makupe, I; Focke-Tejkl, M; Fauland, K; Wollmann, E; Puchhammer-Stockl, E; Keller, W; Sibanda, E; Valenta, R				Gallerano, Daniela; Ndlovu, Portia; Makupe, Ian; Focke-Tejkl, Margarete; Fauland, Kerstin; Wollmann, Eva; Puchhammer-Stoeckl, Elisabeth; Keller, Walter; Sibanda, Elopy; Valenta, Rudolf			Comparison of the Specificities of IgG, IgG-Subclass, IgA and IgM Reactivities in African and European HIV-Infected Individuals with an HIV-1 Clade C Proteome-Based Array	PLOS ONE			English	Article							PNEUMOCYSTIS-CARINII-PNEUMONIA; VIRUS TYPE-1 ENVELOPE; B-CELL EPITOPES; NEUTRALIZING ANTIBODIES; GLYCOPROTEIN; ALLERGY; GAMMA; RESPONSES; DOMAIN; MODEL	A comprehensive set of recombinant proteins and peptides of the proteome of HIV-1 clade C was prepared and purified and used to measure IgG, IgG-subclass, IgA and IgM responses in HIV-infected patients from Sub-Saharan Africa, where clade C is predominant. As a comparison group, HIV-infected patients from Europe were tested. African and European patients showed an almost identical antibody reactivity profile in terms of epitope specificity and involvement of IgG, IgG subclass, IgA and IgM responses. A V3-peptide of gp120 was identified as major epitope recognized by IgG(1) > IgG(2) = IgG(4) > IgG(3), IgA > IgM antibodies and a C-terminal peptide represented another major peptide epitope for the four IgG subclasses. By contrast, gp41-derived-peptides were mainly recognized by IgG1 but not by the other IgG subclasses, IgA or IgM. Among the non-surface proteins, protease, reverse transcriptase+RNAseH, integrase, as well as the capsid and matrix proteins were the most frequently and strongly recognized antigens which showed broad IgG subclass and IgA reactivity. Specificities and magnitudes of antibody responses in African patients were stable during disease and antiretroviral treatment, and persisted despite severe T cell loss. Using a comprehensive panel of gp120, gp41 peptides and recombinant non-surface proteins of HIV-1 clade C we found an almost identical antibody recognition profile in African and European patients regarding epitopes and involved IgG-sublass, IgA- and IgM-responses. Immune recognition of gp120 peptides and non-surface proteins involved all four IgG subclasses and was indicative of a mixed Th1/Th2 immune response. The HIV-1 clade C proteome-based test allowed diagnosis and monitoring of antibody responses in the course of HIV-infections and assessment of isotype and subclass responses.	[Gallerano, Daniela; Focke-Tejkl, Margarete; Wollmann, Eva; Valenta, Rudolf] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria; [Ndlovu, Portia; Makupe, Ian] Gamma City Lab, Harare, Zimbabwe; [Fauland, Kerstin; Keller, Walter] Karl Franzens Univ Graz, Inst Mol Biosci Struct Biol, Graz, Austria; [Puchhammer-Stoeckl, Elisabeth] Med Univ Vienna, Dept Virol, Vienna, Austria; [Sibanda, Elopy] Parirenyatwa Univ, Teaching Hosp, Asthma Allergy & Immune Dysfunct Clin, Harare, Zimbabwe	Medical University of Vienna; University of Graz; Medical University of Vienna	Valenta, R (corresponding author), Med Univ Vienna, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria.	rudolf.valenta@meduniwien.ac.at	Keller, Walter/AAW-1501-2021	Keller, Walter/0000-0002-2261-958X; Rigler, Eva/0000-0002-3596-3937; Valenta, Rudolf/0000-0001-5944-3365	Biomay AG, Vienna, Austria [KP00085OFF]; Austrian Science Fund (PhD Program "Inflammation and Immunity") [KPW01212FW]	Biomay AG, Vienna, Austria; Austrian Science Fund (PhD Program "Inflammation and Immunity")(Austrian Science Fund (FWF))	This study was supported by Biomay AG, Vienna, Austria (www.biomay.com, Nr. KP00085OFF) and in part by a research grant from the Austrian Science Fund (PhD Program "Inflammation and Immunity", Nr. KPW01212FW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bjorndal A, 1997, J VIROL, V71, P7478; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; Douglas SD, 2003, CLIN DIAGN LAB IMMUN, V10, P399, DOI 10.1128/CDLI.10.3.399-404.2003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Focke M, 2001, FASEB J, V15, P2042, DOI 10.1096/fj.01-0016fje; Gallerano D, 2011, AMINO ACIDS, V40, P981, DOI 10.1007/s00726-010-0725-x; GNANN JW, 1987, J VIROL, V61, P2639, DOI 10.1128/JVI.61.8.2639-2641.1987; GNANN JW, 1987, SCIENCE, V237, P1346, DOI 10.1126/science.2888192; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; GOUDSMIT J, 1990, INTERVIROLOGY, V31, P327, DOI 10.1159/000150169; GRAZIOSI C, 1994, SCIENCE, V265, P248, DOI 10.1126/science.8023143; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; HAFFAR OK, 1988, J CELL BIOL, V107, P1677, DOI 10.1083/jcb.107.5.1677; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hill M, 2005, CURR HIV RES, V3, P73, DOI 10.2174/1570162052772942; Hiller R, 2002, FASEB J, V16, P414, DOI 10.1096/fj.01-0711fje; Huang A, 2012, FUTURE VIROL, V7, P505, DOI 10.2217/FVL.12.37; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KAWANO Y, 1994, J IMMUNOL, V153, P4948; KITANI A, 1993, J IMMUNOL, V151, P3478; KLASSE PJ, 1988, P NATL ACAD SCI USA, V85, P5225, DOI 10.1073/pnas.85.14.5225; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; KOWALSKI M, 1987, SCIENCE, V237, P1351, DOI 10.1126/science.3629244; LECLERC C, 1995, EUR J IMMUNOL, V25, P2533, DOI 10.1002/eji.1830250919; Linhart B, 2007, J IMMUNOL, V178, P3924, DOI 10.4049/jimmunol.178.6.3924; LIU HM, 1995, J VIROL, V69, P7630, DOI 10.1128/JVI.69.12.7630-7638.1995; Loomis-Price LD, 1998, J INFECT DIS, V178, P1306, DOI 10.1086/314436; Lupinek C, 2014, METHODS, V66, P106, DOI 10.1016/j.ymeth.2013.10.008; Marth K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097893; MASUR H, 1981, NEW ENGL J MED, V305, P1431, DOI 10.1056/NEJM198112103052402; McCoy LE, 2013, J EXP MED, V210, P209, DOI 10.1084/jem.20121827; Munier ML, 2007, IMMUNOL CELL BIOL, V85, P6, DOI 10.1038/sj.icb.7100015; NUSSLEIN HG, 1990, J CLIN LAB ANAL, V4, P414, DOI 10.1002/jcla.1860040605; PALKER TJ, 1987, P NATL ACAD SCI USA, V84, P2479, DOI 10.1073/pnas.84.8.2479; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Postler TS, 2013, J VIROL, V87, P2, DOI 10.1128/JVI.02053-12; RATNER L, 1985, NATURE, V313, P636, DOI 10.1038/313636c0; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Roux KH, 2007, CURR OPIN STRUC BIOL, V17, P244, DOI 10.1016/j.sbi.2007.03.008; Rowland-Jones SL, 2003, NAT REV IMMUNOL, V3, P343, DOI 10.1038/nri1058; Sarih M, 1996, IMMUNOL LETT, V50, P125, DOI 10.1016/0165-2478(96)02509-6; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Wan YY, 2009, J MOL CELL BIOL, V1, P20, DOI 10.1093/jmcb/mjp001; Welker R, 1996, VIROLOGY, V219, P228, DOI 10.1006/viro.1996.0240; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	57	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117204	10.1371/journal.pone.0117204	http://dx.doi.org/10.1371/journal.pone.0117204			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658330	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900116
J	Kitamura, J; Uemura, M; Kurozumi, M; Sonobe, M; Manabe, T; Hiai, H; Date, H; Kinoshita, K				Kitamura, Jiro; Uemura, Munehiro; Kurozumi, Mafumi; Sonobe, Makoto; Manabe, Toshiaki; Hiai, Hiroshi; Date, Hiroshi; Kinoshita, Kazuo			Chronic Lung Injury by Constitutive Expression of Activation-Induced Cytidine Deaminase Leads to Focal Mucous Cell Metaplasia and Cancer	PLOS ONE			English	Article							ATYPICAL ADENOMATOUS HYPERPLASIA; STEM-CELLS; BRONCHIOLOALVEOLAR CARCINOMA; EPITHELIAL-CELLS; GENE; DEDIFFERENTIATION; MUTATION; DNA	Activation-induced cytidine deaminase (AID) is an enzyme required for antibody diversification, and it causes DNA mutations and strand breaks. Constitutive AID expression in mice invariably caused lung lesions morphologically similar to human atypical adenomatous hyperplasia (AAH), which can be a precursor of bronchioloalveolar carcinoma. Similar to AAH, mouse AAH-like lesion (MALL) exhibited signs of alveolar differentiation, judging from the expression of alveolar type II (AT2) cell marker surfactant protein C (SP-C). However, electron microscopy indicated that MALL, which possessed certain features of a mucous cell, is distinct from an AAH or AT2 cell. Although MALL developed in all individuals within 30 weeks after birth, lung tumors occurred in only 10%; this suggests that the vast majority of MALLs fail to grow into visible tumors. MALL expressed several recently described markers of lung alveolar regeneration such as p63, keratin 5, keratin 14, leucine-rich repeat containing G protein-coupled receptor 5 (Lgr5), and Lgr6. Increased cell death was observed in the lungs of AID transgenic mice compared with wild-type mice. Based on these observations, we speculate that MALL is a regenerating tissue compensating for cellular loss caused by AID cytotoxicity. AID expression in such regenerating tissue should predispose cells to malignant transformation via its mutagenic activity.	[Kitamura, Jiro; Sonobe, Makoto; Date, Hiroshi] Kyoto Univ, Fac Med, Dept Thorac Surg, Kyoto, Japan; [Kitamura, Jiro] Nagahama City Hosp, Dept Thorac Surg, Nagahama, Japan; [Uemura, Munehiro; Kurozumi, Mafumi; Manabe, Toshiaki; Kinoshita, Kazuo] Shiga Med Ctr Res Inst, Moriyama Ku, Shiga, Japan; [Hiai, Hiroshi] Kyoto Univ, Grad Sch Med, Kyoto, Japan	Kyoto University; Kyoto University	Kinoshita, K (corresponding author), Shiga Med Ctr Res Inst, Moriyama Ku, Shiga, Japan.	kkinoshi.shigamed@mac.com			Ministry of Education, Culture, Sports, Science and Technology in Japan (KAKENHI) [23390097]	Ministry of Education, Culture, Sports, Science and Technology in Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Grant-in-Aid for Scientific Research by Ministry of Education, Culture, Sports, Science and Technology in Japan (KAKENHI 23390097). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alimam MZ, 2000, AM J RESP CELL MOL, V22, P253, DOI 10.1165/ajrcmb.22.3.3768; Brenner DR, 2012, AM J EPIDEMIOL, V176, P573, DOI 10.1093/aje/kws151; Cooper CA, 1997, J PATHOL, V181, P401, DOI 10.1002/(SICI)1096-9896(199704)181:4<401::AID-PATH799>3.0.CO;2-Y; Endo Y, 2008, GASTROENTEROLOGY, V135, P889, DOI 10.1053/j.gastro.2008.06.091; Fehrenbach H, 1999, EUR RESPIR J, V14, P534, DOI 10.1034/j.1399-3003.1999.14c10.x; Hasham MG, 2010, NAT IMMUNOL, V11, P820, DOI 10.1038/ni.1909; Henry M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004277; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kinoshita K, 2006, INT J HEMATOL, V83, P201, DOI 10.1532/IJH97.06011; Kitamura H, 1997, VIRCHOWS ARCH, V431, P415, DOI 10.1007/s004280050118; Kou T, 2007, INT J CANCER, V120, P469, DOI 10.1002/ijc.22292; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Larijani M, 2007, MOL CELL BIOL, V27, P8038, DOI 10.1128/MCB.01046-07; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Malvezzi M, 2011, ANN ONCOL, V22, P947, DOI 10.1093/annonc/mdq774; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Morisawa T, 2008, INT J CANCER, V123, P2735, DOI 10.1002/ijc.23853; Muto T, 2006, P NATL ACAD SCI USA, V103, P2752, DOI 10.1073/pnas.0510970103; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Oeztuerk-Winder F, 2012, EMBO J, V31, P3431, DOI 10.1038/emboj.2012.192; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Olivier M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04482; Reader JR, 2003, AM J PATHOL, V162, P2069, DOI 10.1016/S0002-9440(10)64338-6; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; ROGERS DF, 1994, EUR RESPIR J, V7, P1690; Sakamoto H, 2007, J PATHOL, V212, P287, DOI 10.1002/path.2165; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shinmura K, 2011, ANN SURG ONCOL, V18, P2084, DOI 10.1245/s10434-011-1568-8; SHORTER RG, 1964, DIS CHEST, V46, P138; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slebos RJC, 1998, HUM PATHOL, V29, P801, DOI 10.1016/S0046-8177(98)90448-8; Takai A, 2009, ONCOGENE, V28, P469, DOI 10.1038/onc.2008.415; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Uhal BD, 1997, AM J PHYSIOL-LUNG C, V272, pL1031, DOI 10.1152/ajplung.1997.272.6.L1031; Westra WH, 1996, CANCER RES, V56, P2224; Yamasaki M, 2000, PATHOL INT, V50, P778, DOI 10.1046/j.1440-1827.2000.01123.x; Yoo SB, 2010, J THORAC ONCOL, V5, P964, DOI 10.1097/JTO.0b013e3181dd15c0; Yoshida Y, 2005, LUNG CANCER, V50, P1, DOI 10.1016/j.lungcan.2005.04.012; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556	44	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117986	10.1371/journal.pone.0117986	http://dx.doi.org/10.1371/journal.pone.0117986			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659078	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900248
J	Kull, S; Schulz, KM; Strotmeier, JWN; Kirchner, S; Schreiber, T; Bollenbach, A; Dabrowski, PW; Nitsche, A; Kalb, SR; Dorner, MB; Barr, JR; Rummel, A; Dorner, BG				Kull, Skadi; Schulz, K. Melanie; Strotmeier, Jasmin Weisemann Nee; Kirchner, Sebastian; Schreiber, Tanja; Bollenbach, Alexander; Dabrowski, P. Wojtek; Nitsche, Andreas; Kalb, Suzanne R.; Dorner, Martin B.; Barr, John R.; Rummel, Andreas; Dorner, Brigitte G.			Isolation and Functional Characterization of the Novel Clostridium botulinum Neurotoxin A8 Subtype	PLOS ONE			English	Article							ANTIBODY-BASED IMMUNOASSAY; NEUROTRANSMITTER RELEASE; NUCLEOTIDE-SEQUENCE; ENZYMATIC-ACTIVITY; GENETIC DIVERSITY; CRYSTAL-STRUCTURE; INFANT BOTULISM; COMPLEX GENES; PURE CULTURE; SEROTYPE-A	Botulism is a severe neurological disease caused by the complex family of botulinum neuro-toxins (BoNT). Based on the different serotypes known today, a classification of serotype variants termed subtypes has been proposed according to sequence diversity and immunological properties. However, the relevance of BoNT subtypes is currently not well understood. Here we describe the isolation of a novel Clostridium botulinum strain from a foodborne botulism outbreak near Chemnitz, Germany. Comparison of its botulinum neurotoxin gene sequence with published sequences identified it to be a novel subtype within the BoNT/A serotype designated BoNT/A8. The neurotoxin gene is located within an ha-orfX+ cluster and showed highest homology to BoNT/A1, A2, A5, and A6. Unexpectedly, we found an arginine insertion located in the HC domain of the heavy chain, which is unique compared to all other BoNT/A subtypes known so far. Functional characterization revealed that the binding characteristics to its main neuronal protein receptor SV2C seemed unaffected, whereas binding to membrane-incorporated gangliosides was reduced in comparison to BoNT/A1. Moreover, we found significantly lower enzymatic activity of the natural, full-length neurotoxin and the recombinant light chain of BoNT/A8 compared to BoNT/A1 in different endopeptidase assays. Both reduced ganglioside binding and enzymatic activity may contribute to the considerably lower biological activity of BoNT/A8 as measured in a mouse phrenic nerve hemidiaphragm assay. Despite its reduced activity the novel BoNT/A8 subtype caused severe botulism in a 63-year-old male. To our knowledge, this is the first description and a comprehensive characterization of a novel BoNT/A subtype which combines genetic information on the neurotoxin gene cluster with an in-depth functional analysis using different technical approaches. Our results show that subtyping of BoNT is highly relevant and that understanding of the detailed toxin function might pave the way for the development of novel therapeutics and tailor-made antitoxins.	[Kull, Skadi; Schulz, K. Melanie; Kirchner, Sebastian; Schreiber, Tanja; Dorner, Martin B.; Dorner, Brigitte G.] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Biol Toxins ZBS3, Berlin, Germany; [Strotmeier, Jasmin Weisemann Nee; Bollenbach, Alexander; Rummel, Andreas] Hannover Med Sch, Inst Toxikol, D-30623 Hannover, Germany; [Dabrowski, P. Wojtek; Nitsche, Andreas] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Highly Pathogen Viruses ZBS1, Berlin, Germany; [Kalb, Suzanne R.; Barr, John R.] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA USA	Robert Koch Institute; Hannover Medical School; Robert Koch Institute; Centers for Disease Control & Prevention - USA	Dorner, BG (corresponding author), Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Biol Toxins ZBS3, Berlin, Germany.	DornerB@rki.de	Kirchner, Sebastian/AAF-6646-2019; Dorner, Martin B/C-5703-2013; Dabrowski, Piotr Wojtek/L-1423-2015	Kirchner, Sebastian/0000-0003-0415-5352; Dorner, Martin B/0000-0002-8176-797X; Dabrowski, Piotr Wojtek/0000-0003-4893-805X; Weisemann, Jasmin/0000-0002-6299-9257; Dorner, Brigitte/0000-0002-5100-2546; Rummel, Andreas/0000-0002-0645-1641; Nitsche, Andreas/0000-0001-8185-3176; Kalb, Suzanne/0000-0002-8067-136X	German Federal Ministry of Education and Research (BiGRUDI project) [13N9601]; Swiss Federal Department of Defence, Civil Protection and Sport, Spiez Laboratory [353003364/Stm]; Robert Koch-Institut [1362/I-979]	German Federal Ministry of Education and Research (BiGRUDI project); Swiss Federal Department of Defence, Civil Protection and Sport, Spiez Laboratory; Robert Koch-Institut	This work was supported by grants from the German Federal Ministry of Education and Research (BiGRUDI project, 13N9601; http://www.bmbf.de) and by the Swiss Federal Department of Defence, Civil Protection and Sport, Spiez Laboratory (353003364/Stm; http://www.labor-spiez.ch) to BGD. AR was supported by the Robert Koch-Institut (1362/I-979; http://www.rki.de). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arndt JW, 2006, J MOL BIOL, V362, P733, DOI 10.1016/j.jmb.2006.07.040; Barash JR, 2014, J INFECT DIS, V209, P183, DOI 10.1093/infdis/jit449; Benoit RM, 2014, NATURE, V505, P108, DOI 10.1038/nature12732; Binz T, 2002, BIOCHEMISTRY-US, V41, P1717, DOI 10.1021/bi0157969; BINZ T, 1994, J BIOL CHEM, V269, P1617; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; Bollenbach A, 2013, IDENTIFIZIERUNG DER; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Carter AT, 2011, J BACTERIOL, V193, P2351, DOI 10.1128/JB.00072-11; Carter AT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-115; Chevreux B, 2005, MIRA AN AUTOMATED GE; Dineen SS, 2004, FEMS MICROBIOL LETT, V235, P9, DOI 10.1016/j.femsle.2004.04.002; DOLMAN CLAUDE E., 1960, ARCTIC, V13, P230; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dorner MB, 2013, CURR TOP MICROBIOL, V364, P219, DOI 10.1007/978-3-642-33570-9_11; Dover N, 2014, J INFECT DIS, V209, P192, DOI 10.1093/infdis/jit450; Dover N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061205; Dover N, 2009, J CLIN MICROBIOL, V47, P2349, DOI 10.1128/JCM.00799-09; Foran P, 1996, BIOCHEMISTRY-US, V35, P2630, DOI 10.1021/bi9519009; Garcia-Rodriguez C, 2011, PROTEIN ENG DES SEL, V24, P321, DOI 10.1093/protein/gzq111; GIBSON AM, 1987, J APPL BACTERIOL, V63, P217, DOI 10.1111/j.1365-2672.1987.tb04939.x; GIBSON AM, 1988, J APPL BACTERIOL, V64, P285, DOI 10.1111/j.1365-2672.1988.tb01873.x; GIMENEZ DF, 1978, ZBL BAKT-INT J MED M, V240, P215; GIMENEZ DF, 1970, ZENTBL BAKTERIOLOG P, V215, P212; Gu SY, 2012, SCIENCE, V335, P977, DOI 10.1126/science.1214270; Hall IC, 1928, SCIENCE, V68, P141, DOI 10.1126/science.68.1754.141; HATHEWAY CL, 1981, J CLIN MICROBIOL, V14, P607, DOI 10.1128/JCM.14.6.607-611.1981; Henkel JS, 2009, BIOCHEMISTRY-US, V48, P2522, DOI 10.1021/bi801686b; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hill KK, 2013, CURR TOP MICROBIOL, V364, P1, DOI 10.1007/978-3-642-33570-9_1; Hill KK, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-66; Kalb SR, 2014, ANAL CHEM, V86, P3254, DOI 10.1021/ac5001509; Kalb SR, 2012, ANAL BIOANAL CHEM, V403, P215, DOI 10.1007/s00216-012-5767-3; Kalb SR, 2012, FEBS LETT, V586, P109, DOI 10.1016/j.febslet.2011.11.033; Kalb SR, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-58; Kalb SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012237; Kalb SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005355; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kirchner S, 2010, APPL ENVIRON MICROB, V76, P4387, DOI 10.1128/AEM.02490-09; KRIEGLSTEIN KG, 1994, J PROTEIN CHEM, V13, P49, DOI 10.1007/BF01891992; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lee K, 2014, SCIENCE, V344, P1405, DOI 10.1126/science.1253823; Leuchs J, 1910, Z HYG INFEKT, V76, P55; Lmann G., 1904, HYG RUNDSCHAU, V14, P449; Luo S, 2014, ANAL BIOCHEM, V463, P75, DOI 10.1016/j.ab.2013.06.019; Luquez C, 2009, APPL ENVIRON MICROB, V75, P6094, DOI 10.1128/AEM.01009-09; Macdonald TE, 2011, APPL ENVIRON MICROB, V77, P8625, DOI 10.1128/AEM.05155-11; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; Mazuet C, 2012, J CLIN MICROBIOL, V50, P4091, DOI 10.1128/JCM.02392-12; Mizanur RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095188; MOLLER VAGN, 1960, ACTA PATHOL ET MICROBIOL SCAND, V48, P80; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Moriishi K, 1996, BBA-GENE STRUCT EXPR, V1307, P123, DOI 10.1016/0167-4781(96)00006-1; Muraro L, 2009, BIOCHEM BIOPH RES CO, V380, P76, DOI 10.1016/j.bbrc.2009.01.037; Pantano S, 2014, CELL MOL LIFE SCI, V71, P793, DOI 10.1007/s00018-013-1380-7; Parks BA, 2011, ANAL CHEM, V83, P9047, DOI 10.1021/ac201910q; Pauly D, 2009, POULTRY SCI, V88, P281, DOI 10.3382/ps.2008-00323; Pauly D, 2009, ANALYST, V134, P2028, DOI 10.1039/b911525k; Peck MW, 2011, FOOD MICROBIOL, V28, P183, DOI 10.1016/j.fm.2010.03.005; Peck MW, 2009, ADV MICROB PHYSIOL, V55, P183, DOI 10.1016/S0065-2911(09)05503-9; Pier CL, 2008, INFECT IMMUN, V76, P437, DOI 10.1128/IAI.00843-07; Pier CL, 2011, FEBS LETT, V585, P199, DOI 10.1016/j.febslet.2010.11.045; Popoff MR, 2014, J INFECT DIS, V209, P168, DOI 10.1093/infdis/jit505; Popoff MR, 2009, FUTURE MICROBIOL, V4, P1021, DOI 10.2217/FMB.09.72; Raphael BH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-245; Raphael BH, 2010, APPL ENVIRON MICROB, V76, P4805, DOI 10.1128/AEM.03109-09; Raphael BH, 2010, MOL CELL PROBE, V24, P146, DOI 10.1016/j.mcp.2009.12.003; Rossetto O, 2013, TOXICON, V67, P31, DOI 10.1016/j.toxicon.2013.01.017; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Rummel A, 2013, CURR TOP MICROBIOL, V364, P61, DOI 10.1007/978-3-642-33570-9_4; SAKAGUCHI G, 1990, INT J FOOD MICROBIOL, V11, P231, DOI 10.1016/0168-1605(90)90016-X; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Segelke B, 2004, P NATL ACAD SCI USA, V101, P6888, DOI 10.1073/pnas.0400584101; Smith TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001271; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Smith TJ, 2014, RES MICROBIOL, DOI [10.1016/j.resmic.2014.12.010, DOI 10.1016/J.RESMIC.2014.12.010]; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Stevens GB, 2013, ANALYST, V138, P6154, DOI 10.1039/c3an00525a; Strotmeier J, 2014, FEBS LETT; THOMPSON DE, 1990, EUR J BIOCHEM, V189, P73, DOI 10.1111/j.1432-1033.1990.tb15461.x; Torii Y, 2013, TOXICON, V73, P9, DOI 10.1016/j.toxicon.2013.06.020; Torii Y, 2011, J PHARMACOL SCI, V117, P275, DOI 10.1254/jphs.11121FP; Torii Y, 2011, TOXICON, V57, P93, DOI 10.1016/j.toxicon.2010.10.009; Umeda K, 2009, J CLIN MICROBIOL, V47, P2720, DOI 10.1128/JCM.00077-09; van Ermengem E., 1897, Z HYG INFEKTIONSKR, V26, P1, DOI [10.1007/BF02220526, DOI 10.1007/BF02220526]; Wang DX, 2013, BBA-PROTEINS PROTEOM, V1834, P2722, DOI 10.1016/j.bbapap.2013.09.007; Wangroongsarb P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077792; Weedmark KA, 2014, APPL ENVIRON MICROB, V80, P6334, DOI 10.1128/AEM.01573-14; White PB, 1923, REPORT ON THE CIRCUM; Whitemarsh RCM, 2013, INFECT IMMUN, V81, P3894, DOI 10.1128/IAI.00536-13; Whitemarsh RCM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090252; YAMASAKI S, 1994, BIOCHEM BIOPH RES CO, V200, P829, DOI 10.1006/bbrc.1994.1526	96	48	51	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116381	10.1371/journal.pone.0116381	http://dx.doi.org/10.1371/journal.pone.0116381			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658638	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900037
J	Liu, YZ; Zhou, Y; Zhang, L; Li, J; Tian, Q; Zhang, JG; Deng, HW				Liu, Yao-Zhong; Zhou, Yu; Zhang, Lei; Li, Jian; Tian, Qing; Zhang, Ji-Gang; Deng, Hong-Wen			Attenuated Monocyte Apoptosis, a New Mechanism for Osteoporosis Suggested by a Transcriptome-Wide Expression Study of Monocytes	PLOS ONE			English	Article							BONE-MINERAL DENSITY; CIRCULATING MONOCYTES; GENETIC-DETERMINANTS; PRINCIPAL-COMPONENTS; RANK LIGAND; ASSOCIATION; ESTROGEN; PROTEIN; FAMILY; CELLS	Background Osteoporosis is caused by excessive bone resorption (by osteoclasts) over bone formation (by osteoblasts). Monocytes are important to osteoporosis by serving as progenitors of osteoclasts and produce cytokines for osteoclastogenesis. Aim To identify osteoporosis-related genes, we performed microarray analyses of monocytes using Affymetrix 1.0 ST arrays in 42 (including 16 pre- and 26 postmenopausal) high hip BMD (bone mineral density) vs. 31 (including 15 pre- and 16 postmenopausal) low hip BMD Caucasian female subjects. Here, high vs. low BMD is defined as belonging to top vs. bottom 30% of BMD values in population. Method Differential gene expression analysis in high vs. low BMD subjects was conducted in the total cohort as well as pre- and post-menopausal subjects. Focusing on the top differentially expressed genes identified in the total, the pre- and the postmenopausal subjects (with a p <5E-03), we performed replication of the findings in 3 independent datasets of microarray analyses of monocytes (total N = 125). Results We identified (in the 73 subjects) and successfully replicated in all the 3 independent datasets 2 genes, DAXX and PLK3. Interestingly, both genes are apoptosis induction genes and both down-regulated in the low BMD subjects. Moreover, using the top 200 genes identified in the meta-analysis across all of the 4 microarray datasets, GO term enrichment analysis identified a number of terms related to induction of apoptosis, for which the majority of component genes are also down-regulated in the low BMD subjects. Overall, our result may suggest that there might be a decreased apoptosis activity of monocytes in the low BMD subjects. Conclusion Our study for the first time suggested a decreased apoptosis rate (hence an increased survival) of monocytes, an important osteoclastogenic cell, as a novel mechanism for osteoporosis.	[Liu, Yao-Zhong; Zhou, Yu; Zhang, Lei; Li, Jian; Tian, Qing; Zhang, Ji-Gang; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA; [Zhang, Lei; Deng, Hong-Wen] Univ Shanghai Sci & Technol, Ctr Syst Biomed Sci, Shanghai, Peoples R China	Tulane University; University of Shanghai for Science & Technology	Deng, HW (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA.	hdeng2@tulane.edu	Li, Jian/G-4445-2015; Liu, Yaozhong/ABD-5544-2020; Zhang, Lei/L-1016-2016	Zhang, Lei/0000-0002-1007-4834; Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221]; National Natural Science Foundation of China [31100902]; Endowments of University of Missouri-Kansas City (the Franklin D. Dickson/Missouri Endowment); Tulane University (Edward G. Schlieder Endowment); FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004790, U01HG004801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050066, P50AR055081, R01AR041398, R01AR059781, R01AR050496, R01AR057049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, P01AG018397] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH022110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Endowments of University of Missouri-Kansas City (the Franklin D. Dickson/Missouri Endowment); Tulane University (Edward G. Schlieder Endowment); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the National Institutes of Health (for YZL, YZ, LZ, JL, QT, JGZ, HWD) through grants P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, and R03TW008221, by the National Natural Science Foundation of China (for LZ) through project 31100902 and by Endowments of University of Missouri-Kansas City (the Franklin D. Dickson/Missouri Endowment) and Tulane University (Edward G. Schlieder Endowment) (for HWD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Bell NH, 2003, J CLIN INVEST, V111, P1120, DOI 10.1172/JCI200318358; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chen XD, 2009, J BONE MINER RES; Chen YY, 2001, FEBS LETT, V509, P191, DOI 10.1016/S0014-5793(01)03062-9; Conn CW, 2000, CANCER RES, V60, P6826; Deng FY, 2008, PROTEOMICS, V8, P4259, DOI 10.1002/pmic.200700480; Deng FY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011700; DEQUEKER J, 1987, BONE, V8, P207, DOI 10.1016/8756-3282(87)90166-9; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058; Golsteyn R M, 1996, Prog Cell Cycle Res, V2, P107; Hider SL, 2005, RHEUMATOLOGY, V44, P138, DOI 10.1093/rheumatology/keh430; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higuchi S, 1998, J BONE MINER RES, V13, P44, DOI 10.1359/jbmr.1998.13.1.44; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiang N, 2006, J BIOL CHEM, V281, P10577, DOI 10.1074/jbc.M513156200; Kalathur RKR, 2014, NUCLEIC ACIDS RES, V42, pD408, DOI 10.1093/nar/gkt1100; Kameda T, 1997, J EXP MED, V186, P489, DOI 10.1084/jem.186.4.489; Kawai T, 2003, MOL CELL BIOL, V23, P6174, DOI 10.1128/MCB.23.17.6174-6186.2003; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kiewe P, 2009, ANN HEMATOL, V88, P1177, DOI 10.1007/s00277-009-0751-5; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; Kooperberg C, 2005, STAT MED, V24, P2281, DOI 10.1002/sim.2109; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Lei SF, 2009, BONE, V44, P1010, DOI 10.1016/j.bone.2008.05.016; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu HT, 1999, BIOCHEM BIOPH RES CO, V254, P203, DOI 10.1006/bbrc.1998.9893; Liu YJ, 2013, J CLIN ENDOCR METAB, V98, pE1278, DOI 10.1210/jc.2013-1637; Liu YZ, 2005, J BIOL CHEM, V280, P29011, DOI 10.1074/jbc.M501164200; Mackey DC, 2007, JAMA-J AM MED ASSOC, V298, P2381, DOI 10.1001/jama.298.20.2381; Matayoshi A, 1996, P NATL ACAD SCI USA, V93, P10785, DOI 10.1073/pnas.93.20.10785; Pacifici R, 1996, J BONE MINER RES, V11, P1043; Peng Bo, 2007, BMC Proc, V1 Suppl 1, pS156; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; POCOCK NA, 1987, J CLIN INVEST, V80, P706, DOI 10.1172/JCI113125; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purton LE, 1996, BLOOD, V87, P1802; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Schoppet M, 2002, ARTERIOSCL THROM VAS, V22, P549, DOI 10.1161/01.ATV.0000012303.37971.DA; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; SMITH DM, 1973, J CLIN INVEST, V52, P2800, DOI 10.1172/JCI107476; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002; Weinstein RS, 2002, J CLIN INVEST, V109, P1041, DOI 10.1172/JCI200214538; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025; Xu XH, 2010, ENDOCR REV, V31, P447, DOI 10.1210/er.2009-0032; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhang L, 2009, ANN HUM GENET, V73, P601, DOI 10.1111/j.1469-1809.2009.00539.x	64	44	49	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116792	10.1371/journal.pone.0116792	http://dx.doi.org/10.1371/journal.pone.0116792			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659073	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900068
J	Rezende, TJR; de Albuquerque, M; Lamas, GM; Martinez, ARM; Campos, BM; Casseb, RF; Silva, CB; Branco, LMT; D'Abreu, A; Lopes-Cendes, I; Cendes, F; Franca, MC				Rezende, Thiago J. R.; de Albuquerque, Milena; Lamas, Gustavo M.; Martinez, Alberto R. M.; Campos, Brunno M.; Casseb, Raphael F.; Silva, Cynthia B.; Branco, Lucas M. T.; D'Abreu, Anelyssa; Lopes-Cendes, Iscia; Cendes, Fernando; Franca, Marcondes C., Jr.			Multimodal MRI-Based Study in Patients with SPG4 Mutations	PLOS ONE			English	Article							HEREDITARY SPASTIC PARAPARESIS; HUMAN CEREBRAL-CORTEX; BRAIN; PURE; SEGMENTATION; ATROPHY	Mutations in the SPG4 gene (SPG4-HSP) are the most frequent cause of hereditary spastic paraplegia, but the extent of the neurodegeneration related to the disease is not yet known. Therefore, our objective is to identify regions of the central nervous system damaged in patients with SPG4-HSP using a multi-modal neuroimaging approach. In addition, we aimed to identify possible clinical correlates of such damage. Eleven patients (mean age 46.0 +/- 15.0 years, 8 men) with molecular confirmation of hereditary spastic paraplegia, and 23 matched healthy controls (mean age 51.4 +/- 14.1years, 17 men) underwent MRI scans in a 3T scanner. We used 3D T1 images to perform volumetric measurements of the brain and spinal cord. We then performed tract-based spatial statistics and tractography analyses of diffusion tensor images to assess microstructural integrity of white matter tracts. Disease severity was quantified with the Spastic Paraplegia Rating Scale. Correlations were then carried out between MRI metrics and clinical data. Volumetric analyses did not identify macroscopic abnormalities in the brain of hereditary spastic paraplegia patients. In contrast, we found extensive fractional anisotropy reduction in the corticospinal tracts, cingulate gyri and splenium of the corpus callosum. Spinal cord morphometry identified atrophy without flattening in the group of patients with hereditary spastic paraplegia. Fractional anisotropy of the corpus callosum and pyramidal tracts did correlate with disease severity. Hereditary spastic paraplegia is characterized by relative sparing of the cortical mantle and remarkable damage to the distal portions of the corticospinal tracts, extending into the spinal cord.	[Rezende, Thiago J. R.; de Albuquerque, Milena; Lamas, Gustavo M.; Martinez, Alberto R. M.; Campos, Brunno M.; Casseb, Raphael F.; Silva, Cynthia B.; Branco, Lucas M. T.; D'Abreu, Anelyssa; Cendes, Fernando; Franca, Marcondes C., Jr.] Univ Estadual Campinas, Dept Neurol, UNICAMP, Sao Paulo, Brazil; [Lopes-Cendes, Iscia] Univ Estadual Campinas, Dept Med Genet, UNICAMP, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Franca, MC (corresponding author), Univ Estadual Campinas, Dept Neurol, Sao Paulo, Brazil.	mcfrancajr@uol.com.br	Casseb, Raphael F/K-3731-2017; Rezende, Thiago/B-9673-2017; Lopes-Cendes, Iscia/B-9416-2013; de Campos, Brunno Machado/L-8423-2013; Cendes, Fernando/C-1301-2012; Abreu, Anelyssa D'/AAK-4535-2021	Casseb, Raphael F/0000-0002-0643-7110; Lopes-Cendes, Iscia/0000-0002-6221-6822; de Campos, Brunno Machado/0000-0003-1261-8257; Cendes, Fernando/0000-0001-9336-9568; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/21521-3]; CAPES (Coordenacao de Aperfeicoamento de Pessoal - Brazil)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordenacao de Aperfeicoamento de Pessoal - Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grant #2011/21521-3 for MCF Jr. Dr Albuquerque received a PhD scholarship from FAPESP and Dr Rezende received a Msc scholarship from CAPES (Coordenacao de Aperfeicoamento de Pessoal - Brazil). Both agencies are governmental institutions and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghakhanyan G, 2014, AM J NEURORADIOL, V35, P1533, DOI 10.3174/ajnr.A3897; Bergo FPG, 2012, CISTI 2012 7 C IB SI, P400; Branco LMT, 2014, AMYOTROPH LAT SCL FR, V15, P93, DOI 10.3109/21678421.2013.852589; Charvin D, 2003, HUM MOL GENET, V12, P71, DOI 10.1093/hmg/ddg004; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Depienne C, 2007, J MED GENET, V44, P281, DOI 10.1136/jmg.2006.046425; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Duning T, 2010, MOVEMENT DISORD, V25, P1986, DOI 10.1002/mds.23211; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fitzgibbon A, 1999, IEEE T PATTERN ANAL, V21, P476, DOI 10.1109/34.765658; Franca MC, 2014, CLIN GENET, V86, P194, DOI 10.1111/cge.12252; Franca MC, 2012, J NEUROL NEUROSUR PS, V83, P828, DOI 10.1136/jnnp-2011-300129; Garaci F, 2014, INT J NEUROSCI, V124, P261, DOI 10.3109/00207454.2013.836705; Hedera P, 2005, NEURORADIOLOGY, V47, P730, DOI 10.1007/s00234-005-1415-3; Karle KN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-158; Kassubek J, 2006, EUR J NEUROL, V13, P880, DOI 10.1111/j.1468-1331.2006.01380.x; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; McDermott CJ, 2000, J NEUROL NEUROSUR PS, V69, P150, DOI 10.1136/jnnp.69.2.150; Murphy S, 2009, NEUROLOGY, V73, P378, DOI 10.1212/WNL.0b013e3181b04c6c; Salinas S, 2007, J NEUROSCI RES, V85, P2778, DOI 10.1002/jnr.21238; Schule R, 2006, NEUROLOGY, V67, P430, DOI 10.1212/01.wnl.0000228242.53336.90; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sun SW, 2008, NEUROIMAGE, V40, P1, DOI 10.1016/j.neuroimage.2007.11.049; Uttner I, 2007, NEUROSCI LETT, V419, P158, DOI 10.1016/j.neulet.2007.04.031; Verstraete E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013664; White KD, 2000, NEUROLOGY, V55, P89, DOI 10.1212/WNL.55.1.89	30	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117666	10.1371/journal.pone.0117666	http://dx.doi.org/10.1371/journal.pone.0117666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658484	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900198
J	Wang, Y; Barbeau, X; Bilimoria, A; Lague, P; Couture, M; Tang, JKH				Wang, Yaya; Barbeau, Xavier; Bilimoria, Astha; Laguee, Patrick; Couture, Manon; Tang, Joseph Kuo-Hsiang			Peroxidase Activity and Involvement in the Oxidative Stress Response of Roseobacter denitrificans Truncated Hemoglobin	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS HEMOGLOBIN; MULTIPLE SEQUENCE ALIGNMENT; NITRIC-OXIDE-REDUCTASE; HEME DISTAL SITE; FUNCTIONAL-PROPERTIES; LIGAND-BINDING; BACILLUS-SUBTILIS; SINGLE-DOMAIN; GEN. NOV.; BACTERIA	Roseobacter denitrificans is a member of the widespread marine Roseobacter genus. We report the first characterization of a truncated hemoglobin from R. denitrificans (Rd. trHb) that was purified in the heme-bound form from heterologous expression of the protein in Escherichia coli. Rd. trHb exhibits predominantly alpha-helical secondary structure and absorbs light at 412, 538 and 572 nm. The phylogenetic classification suggests that Rd. trHb falls into group II trHbs, whereas sequence alignments indicate that it shares certain important heme pocket residues with group I trHbs in addition to those of group II trHbs. The resonance Raman spectra indicate that the isolated Rd. trHb contains a ferric heme that is mostly 6-coordinate low-spin and that the heme of the ferrous form displays a mixture of 5- and 6-coordinate states. Two Fe-His stretching modes were detected, notably one at 248 cm(-1), which has been reported in peroxidases and some flavohemoglobins that contain an Fe-His-Asp (or Glu) catalytic triad, but was never reported before in a trHb. We show that Rd. trHb exhibits a significant peroxidase activity with a (k(cat)/K-m) value three orders of magnitude higher than that of bovine Hb and only one order lower than that of horseradish peroxidase. This enzymatic activity is pH-dependent with a pK(a) value similar to 6.8. Homology modeling suggests that residues known to be important for interactions with heme-bound ligands in group II trHbs from Mycobacterium tuberculosis and Bacillus subtilis are pointing toward to heme in Rd. trHb. Genomic organization and gene expression profiles imply possible functions for detoxification of reactive oxygen and nitrogen species in vivo. Altogether, Rd. trHb exhibits some distinctive features and appears equipped to help the bacterium to cope with reactive oxygen/nitrogen species and/or to operate redox biochemistry.	[Wang, Yaya; Bilimoria, Astha; Tang, Joseph Kuo-Hsiang] Clark Univ, Dept Chem & Biochem, Worcester, MA 01610 USA; [Barbeau, Xavier; Laguee, Patrick; Couture, Manon] Univ Laval, Dept Biochem Microbiol & Bioinformat, Quebec City, PQ, Canada; [Barbeau, Xavier; Laguee, Patrick; Couture, Manon] Univ Laval, PROTEO, Quebec City, PQ, Canada	Clark University; Laval University; Laval University	Tang, JKH (corresponding author), Clark Univ, Dept Chem & Biochem, Worcester, MA 01610 USA.	manon.couture@bcm.ulaval.ca; jtang@clarku.edu	Couture, Manon/F-8326-2015	Couture, Manon/0000-0001-8296-8055; Lague, Patrick/0000-0002-5236-4979	Clark University; National Sciences and Engineering Research Council [250073]; Les Fonds de recherche du Quebec-Nature et technologies	Clark University; National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Les Fonds de recherche du Quebec-Nature et technologies	JKT is supported by the start-up funds from Clark University. MC acknowledges support by National Sciences and Engineering Research Council grant 250073. XB was supported from Les Fonds de recherche du Quebec-Nature et technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascenzi P, 2008, BIOCHEM BIOPH RES CO, V373, P197, DOI 10.1016/j.bbrc.2008.05.168; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brinkhoff T, 2004, APPL ENVIRON MICROB, V70, P2560, DOI 10.1128/AEM.70.4.2560-2565.2003; Bruhn JB, 2007, APPL ENVIRON MICROB, V73, P442, DOI 10.1128/AEM.02238-06; Chartier FJM, 2004, BIOPHYS J, V87, P1939, DOI 10.1529/biophysj.104.042119; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZC, 2004, BIOCHEMISTRY-US, V43, P1798, DOI 10.1021/bi034920g; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; COUTURE M, 1994, MOL GEN GENET, V243, P185, DOI 10.1007/BF00280316; Couture M, 1999, J BIOL CHEM, V274, P6898, DOI 10.1074/jbc.274.11.6898; Couture M, 2001, J BIOL CHEM, V276, P36377, DOI 10.1074/jbc.M103907200; Couture M, 2000, EUR J BIOCHEM, V267, P4770, DOI 10.1046/j.1432-1327.2000.01531.x; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Dai X, 2006, INT J SYST EVOL MICR, V56, P529, DOI 10.1099/ijs.0.64013-0; Das TK, 1999, BIOCHEMISTRY-US, V38, P15360, DOI 10.1021/bi991237e; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; Diaz JM, 2013, SCIENCE, V340, P1223, DOI 10.1126/science.1237331; DOI M, 1991, PLANT CELL PHYSIOL, V32, P365, DOI 10.1093/oxfordjournals.pcp.a078089; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egawa T, 2005, J INORG BIOCHEM, V99, P72, DOI 10.1016/j.jinorgbio.2004.10.017; Elvers KT, 2005, MOL MICROBIOL, V57, P735, DOI 10.1111/j.1365-2958.2005.04723.x; Ermler U, 1995, EMBO J, V14, P6067, DOI 10.1002/j.1460-2075.1995.tb00297.x; EVERSE J, 1994, METHOD ENZYMOL, V231, P547; Falzone CJ, 2002, J MOL BIOL, V324, P1015, DOI 10.1016/S0022-2836(02)01093-8; Faulkner DJ, 2000, NAT PROD REP, V17, P7, DOI 10.1039/a809395d; Feehily C, 2013, J APPL MICROBIOL, V114, P11, DOI 10.1111/j.1365-2672.2012.05434.x; Feis A, 2008, BIOCHEMISTRY-US, V47, P902, DOI 10.1021/bi701297f; GARCIA D, 1994, BIOCHIMIE, V76, P666, DOI 10.1016/0300-9084(94)90143-0; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Giangiacomo L, 2005, J BIOL CHEM, V280, P9192, DOI 10.1074/jbc.M407267200; GOODIN DB, 1993, BIOCHEMISTRY-US, V32, P3313, DOI 10.1021/bi00064a014; Haghighi AZ, 1996, J NEUROSCI RES, V43, P107, DOI 10.1002/jnr.490430114; Hemschemeier A, 2013, P NATL ACAD SCI USA, V110, P10854, DOI 10.1073/pnas.1302592110; Hill DR, 1996, J BACTERIOL, V178, P6587, DOI 10.1128/jb.178.22.6587-6598.1996; Hvitved AN, 2001, J BIOL CHEM, V276, P34714, DOI 10.1074/jbc.M105175200; Igamberdiev A, 2006, PLANTA, V223, P1041, DOI 10.1007/s00425-005-0145-4; Johnson EA, 2014, BIOCHEMISTRY-US, V53, P4573, DOI 10.1021/bi5005206; Kimura M, 2012, BIOSCI BIOTECH BIOCH, V76, P1984, DOI 10.1271/bbb.120406; Kitagawa T, 1987, STRUCT BONDING BERLI, V64, P71, DOI DOI 10.1007/BFB0036788; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; LAFAY B, 1995, INT J SYST BACTERIOL, V45, P290, DOI 10.1099/00207713-45-2-290; Lu CY, 2007, J BIOL CHEM, V282, P25917, DOI 10.1074/jbc.M704415200; Lu CY, 2007, J BIOL CHEM, V282, P13627, DOI 10.1074/jbc.M609397200; Manac'h-Little N, 2005, PLANT PHYSIOL BIOCH, V43, P485, DOI 10.1016/j.plaphy.2005.03.012; Matsuda Y, 2002, J BIOCHEM, V131, P791, DOI 10.1093/oxfordjournals.jbchem.a003167; Milani M, 2004, J BIOL CHEM, V279, P21520, DOI 10.1074/jbc.M401320200; Milani M, 2003, IUBMB LIFE, V55, P623, DOI 10.1080/15216540310001628708; Milani M, 2003, P NATL ACAD SCI USA, V100, P5766, DOI 10.1073/pnas.1037676100; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; Mukai M, 2002, BIOCHEMISTRY-US, V41, P3897, DOI 10.1021/bi0156409; Mukai M, 2001, J BIOL CHEM, V276, P7272, DOI 10.1074/jbc.M009280200; Nie XZ, 2006, PLANTA, V223, P542, DOI 10.1007/s00425-005-0094-y; Ouellet H, 2003, BIOCHEMISTRY-US, V42, P5764, DOI 10.1021/bi0270337; Ouellet H, 2007, BIOCHEMISTRY-US, V46, P11440, DOI 10.1021/bi7010288; Ouellet H, 2007, J BIOL CHEM, V282, P7491, DOI 10.1074/jbc.M609155200; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Pesce A, 2000, EMBO J, V19, P2424, DOI 10.1093/emboj/19.11.2424; Pesce A, 2001, J MOL BIOL, V309, P1153, DOI 10.1006/jmbi.2001.4731; Pesce A, 2013, ADV MICROB PHYSIOL, V63, P49, DOI 10.1016/B978-0-12-407693-8.00002-9; Pesce A, 2011, BBA-PROTEINS PROTEOM, V1814, P810, DOI 10.1016/j.bbapap.2010.11.001; Ramond E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003893; Reeder BJ, 2014, ACTA CRYSTALLOGR D, V70, P1411, DOI 10.1107/S1399004714004878; ROUSSEAU DL, 1983, ANNU REV BIOPHYS BIO, V12, P357, DOI 10.1146/annurev.bb.12.060183.002041; Ruiz-Ponte C, 1998, INT J SYST BACTERIOL, V48, P537, DOI 10.1099/00207713-48-2-537; Saikin SK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05057; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samuni U, 2004, J AM CHEM SOC, V126, P2682, DOI 10.1021/ja038093i; Schwarze C, 2000, EUR J BIOCHEM, V267, P422, DOI 10.1046/j.1432-1327.2000.01018.x; SCHWEIZER M, 1994, BIOCHEM BIOPH RES CO, V204, P169, DOI 10.1006/bbrc.1994.2441; Scott NL, 2002, BIOCHEMISTRY-US, V41, P6902, DOI 10.1021/bi025609m; Selje N, 2004, NATURE, V427, P445, DOI 10.1038/nature02272; Shapleigh JP, 2011, BIOCHEM SOC T, V39, P179, DOI 10.1042/BST0390179; SHIBA T, 1991, SYST APPL MICROBIOL, V14, P140, DOI 10.1016/S0723-2020(11)80292-4; SHIBA T, 1979, APPL ENVIRON MICROB, V38, P43, DOI 10.1128/AEM.38.1.43-45.1979; Spiro TG, 1988, BIOL APPL RAMAN SPEC, P39; Swingley WD, 2007, J BACTERIOL, V189, P683, DOI 10.1128/JB.01390-06; TAKAMIYA K, 1993, PLANT CELL PHYSIOL, V34, P985; TAKAMIYA K, 1993, ARCH MICROBIOL, V159, P51, DOI 10.1007/BF00244264; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang KH, 2002, BIOCHEMISTRY-US, V41, P8767, DOI 10.1021/bi020255k; Tang KH, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00165; Tang KH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-150; Tang KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007233; Tang KH, 2009, J BACTERIOL, V191, P3580, DOI 10.1128/JB.00110-09; Thiel V, 2010, ORG BIOMOL CHEM, V8, P234, DOI 10.1039/b909133e; Tomasch J, 2011, ISME J, V5, P1957, DOI 10.1038/ismej.2011.68; Torge R, 2009, J MOL CATAL B-ENZYM, V61, P303, DOI 10.1016/j.molcatb.2009.08.010; Vinogradov SN, 2008, J BIOL CHEM, V283, P8773, DOI 10.1074/jbc.R700029200; Vinogradov SN, 2013, ADV MICROB PHYSIOL, V63, P391, DOI 10.1016/B978-0-12-407693-8.00009-1; Wagner-Dobler I, 2004, INT J SYST EVOL MICR, V54, P1177, DOI 10.1099/ijs.0.02850-0; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Watts RA, 2001, P NATL ACAD SCI USA, V98, P10119, DOI 10.1073/pnas.191349198; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; Yeh SR, 2004, J PHYS CHEM B, V108, P1478, DOI 10.1021/jp037054q; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	99	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117768	10.1371/journal.pone.0117768	http://dx.doi.org/10.1371/journal.pone.0117768			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658318	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900215
J	Willet, CE; Makara, M; Reppas, G; Tsoukalas, G; Malik, R; Haase, B; Wade, CM				Willet, Cali E.; Makara, Mariano; Reppas, George; Tsoukalas, George; Malik, Richard; Haase, Bianca; Wade, Claire M.			Canine Disorder Mirrors Human Disease: Exonic Deletion in HES7 Causes Autosomal Recessive Spondylocostal Dysostosis in Miniature Schnauzer Dogs	PLOS ONE			English	Article							MYOTONIA-CONGENITA; NATURAL-HISTORY; MUTATION; GENE; SEGMENTATION; HAIRY-AND-ENHANCER-OF-SPLIT-7; CLASSIFICATION; HEMIVERTEBRA; MECHANISM; SEQUENCE	Spondylocostal dysostosis is a congenital disorder of the axial skeleton documented in human families from diverse racial backgrounds. The condition is characterised by truncal shortening, extensive hemivertebrae and rib anomalies including malalignment, fusion and reduction in number. Mutations in the Notch signalling pathway genes DLL3, MESP2, LFNG, HES7 and TBX6 have been associated with this defect. In this study, spondylocostal dysostosis in an outbred family of miniature schnauzer dogs is described. Computed tomography demonstrated that the condition mirrors the skeletal defects observed in human cases, but unlike most human cases, the affected dogs were stillborn or died shortly after birth. Through gene mapping and whole genome sequencing, we identified a single-base deletion in the coding region of HES7. The frameshift mutation causes loss of functional domains essential for the oscillatory transcriptional autorepression of HES7 during somitogenesis. A restriction fragment length polymorphism test was applied within the immediate family and supported a highly penetrant autosomal recessive mode of inheritance. The mutation was not observed in wider testing of 117 randomly sampled adult miniature schnauzer and six adult standard schnauzer dogs; providing a significance of association of P-raw = 4.759e(-36) (genome-wide significant). Despite this apparently low frequency in the Australian population, the allele may be globally distributed based on its presence in two unrelated sires from geographically distant locations. While isolated hemivertebrae have been observed in a small number of other dog breeds, this is the first clinical and genetic diagnosis of spontaneously occurring spondylocostal dysostosis in a non-human mammal and offers an excellent model in which to study this devastating human disorder. The genetic test can be utilized by dog breeders to select away from the disease and avoid unnecessary neonatal losses.	[Willet, Cali E.; Makara, Mariano; Tsoukalas, George; Haase, Bianca; Wade, Claire M.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Reppas, George] Vetnostics, N Ryde, NSW, Australia; [Malik, Richard] Univ Sydney, Ctr Vet Educ, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Willet, CE (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	cali.willet@sydney.edu.au; claire.wade@sydney.edu.au	Malik, Richard/I-2009-2019	Willet, Cali/0000-0001-8449-1502; Waud, Bianca/0000-0001-6493-9808; Wade, Claire/0000-0003-3413-4771	Australian Postgraduate Award; Val Street Scholarship; National Institutes of Health [NIH/NIDCR1R01DE022532-01A1]; Vetnostics; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022532] Funding Source: NIH RePORTER	Australian Postgraduate Award(Australian Government); Val Street Scholarship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vetnostics; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Research conducted by CEW was funded by the Australian Postgraduate Award and Val Street Scholarship. Four of the samples used in the authors' study were genotyped and sequenced as part of an unrelated project funded by the National Institutes of Health (http://www.nih.gov/) grant NIH/NIDCR1R01DE022532-01A1. NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Vetnostics provided support in the form of salaries for authors GR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Australian National Kennel Council Ltd, 2012, NAT REG STAT; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Besalti O, 2005, IRISH VET J, V58, P688, DOI 10.1186/2046-0481-58-12-688; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Bhalerao DR, 2002, AM J VET RES, V63, P1443, DOI 10.2460/ajvr.2002.63.1443; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Cornier AS, 2008, AM J HUM GENET, V82, P1334, DOI 10.1016/j.ajhg.2008.04.014; Cornier AS, 2004, AM J MED GENET A, V128A, P120, DOI 10.1002/ajmg.a.30011; Cornier AS, 2003, CURR OPIN PEDIATR, V15, P614, DOI 10.1097/00008480-200312000-00012; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Ghebranious N, 2006, AM J MED GENET A, V140A, P1346, DOI 10.1002/ajmg.a.31307; Gracis M, 2000, J VET DENT, V17, P119, DOI 10.1177/089875640001700301; Gutierrez-Quintana R, 2014, VET RADIOL ULTRASOUN, V55, P585, DOI 10.1111/vru.12172; Hirata H, 2004, NAT GENET, V36, P750, DOI 10.1038/ng1372; KRAMER JW, 1982, J AM VET MED ASSOC, V181, P814; Lewis J, 2009, J BIOL, V8, pe44; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; MARTINEZFRIAS ML, 1994, AM J MED GENET, V51, P203, DOI 10.1002/ajmg.1320510306; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramirez N, 2007, J BONE JOINT SURG AM, V89A, P2663, DOI 10.2106/JBJS.F.01085; Rozen S, 2000, Methods Mol Biol, V132, P365; Schlensker E, 2013, EUR J COMP ANIM PRAC, V23, P119; Shearin AL, 2010, DIS MODEL MECH, V3, P27, DOI 10.1242/dmm.004358; Sparrow DB, 2006, AM J HUM GENET, V78, P28, DOI 10.1086/498879; Sparrow DB, 2008, HUM MOL GENET, V17, P3761, DOI 10.1093/hmg/ddn272; Sparrow DB, 2013, AM J MED GENET A, V161, P2244, DOI 10.1002/ajmg.a.36073; Sparrow DB, 2013, HUM MOL GENET, V22, P1625, DOI 10.1093/hmg/ddt012; Sparrow DB, 2012, CELL, V149, P295, DOI 10.1016/j.cell.2012.02.054; Sparrow DB, 2010, EUR J HUM GENET, V18, P674, DOI 10.1038/ejhg.2009.241; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506; Tsai KL, 2007, MAMM GENOME, V18, P444, DOI 10.1007/s00335-007-9037-1; Turnpenny PD, 2007, DEV DYNAM, V236, P1456, DOI 10.1002/dvdy.21182; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Whittock NV, 2004, AM J HUM GENET, V74, P1249, DOI 10.1086/421053	38	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117055	10.1371/journal.pone.0117055	http://dx.doi.org/10.1371/journal.pone.0117055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659135	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900096
J	Damgaard, AL; Hansen, BM; Mathiasen, R; Buchvald, F; Lange, T; Greisen, G				Damgaard, Anne Louise; Hansen, Bo Molholm; Mathiasen, Rene; Buchvald, Frederik; Lange, Theis; Greisen, Gorm			Prematurity and Prescription Asthma Medication from Childhood to Young Adulthood: A Danish National Cohort Study	PLOS ONE			English	Article							BRONCHOPULMONARY DYSPLASIA; LUNG-FUNCTION; PRETERM BIRTH; CHILDREN BORN; DISEASE; INFANTS; ASSOCIATION; PATHOLOGY; REGISTERS; PATTERNS	Introduction Preterm birth is associated with increased risk of asthma-like symptoms and purchase of prescription asthma medication in childhood. We investigated whether this association persists into adulthood and whether it is affected by accounting for neonatal respiratory morbidity (acute respiratory disease and bronchopulmonary dysplasia). Methods A national cohort of all infants born in Denmark in the period 1980-2009 was included in this register study. Data on purchase of asthma medication (combination of inhaled beta-2 agonists and other drugs for obstructive airway disease) in 2010-2011 were obtained from the Danish National Prescription Registry. Associations between gestational age (GA), neonatal respiratory morbidity and a cross-sectional evaluation of asthma medication purchase were explored by multivariate logistic regressions. Results A full dataset was obtained on 1,790,241 individuals, 84.6% of all infants born in the period. Odds-ratios (95% CI) for the association between GA and purchase of asthma medication during infancy were: 3.86 (2.46-6.04) in GA 23-27 weeks, 2.37 (1.84-3.04) in GA 28-31 weeks and 1.59 (1.43-1.77) in GA 32-36 weeks compared to term infants with GA 37-42 weeks. Associations weakened in older age groups and became insignificant in young adults born extremely and very preterm with odds-ratios: 1.41 (0.63-3.19) and 1.15 (0.83-1.60) in GA 23-27 and 28-31 respectively. When adjusting for neonatal respiratory morbidity, the associations weakened but persisted both in childhood and adolescence. Conclusion There was a strong dose-response association between gestational age and the purchase of prescription asthma medication in infancy and childhood. This association weakened during adolescence and was mostly non-significant in young adulthood. The increased risk of prescription asthma medication purchase in ex-preterm children could only partly be explained by neonatal respiratory morbidity.	[Damgaard, Anne Louise; Hansen, Bo Molholm; Greisen, Gorm] Rigshosp, Copenhagen Univ Hosp, Dept Neonatol, DK-2100 Copenhagen, Denmark; [Mathiasen, Rene] Rigshosp, Copenhagen Univ Hosp, Dept Pediat & Adolescent Med, DK-2100 Copenhagen, Denmark; [Buchvald, Frederik] Rigshosp, Copenhagen Univ Hosp, Dept Pediat & Adolescent Med, Pulm Serv, DK-2100 Copenhagen, Denmark; [Lange, Theis] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Damgaard, AL (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Neonatol, DK-2100 Copenhagen, Denmark.	aldamgaard@me.com	Greisen, Gorm/AAA-6463-2022; de Barros Garioud, Anne Louise/AAQ-3868-2021	Greisen, Gorm/0000-0001-8042-3262; de Barros Garioud, Anne Louise/0000-0003-1149-9946; Hansen, Bo Molholm/0000-0002-3087-3983; Lange, Theis/0000-0001-6807-8347	Rigshospitalet Research Funds	Rigshospitalet Research Funds	The study was funded by Rigshospitalet Research Funds and internal funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2012, CLIN EXP ALLERGY, V42, P1369, DOI 10.1111/j.1365-2222.2012.04021.x; Bancalari E, 2006, SEMIN PERINATOL, V30, P164, DOI 10.1053/j.semperi.2006.05.002; Baraldi E, 2005, AM J RESP CRIT CARE, V171, P68, DOI 10.1164/rccm.200403-298Oc; Bhatia Jatinder, 2009, Neonatology, V95, P362, DOI 10.1159/000209302; Bonnelykke Klaus, 2013, Ugeskr Laeger, V175, P1863; Brostrom EB, 2010, RESP MED, V104, P362, DOI 10.1016/j.rmed.2009.10.008; Crump C, 2011, PEDIATRICS, V127, pE913, DOI 10.1542/peds.2010-2603; Dishop MK, 2010, PEDIAT ALLER IMM PUL, V23, P69, DOI 10.1089/ped.2010.0007; Doyle LW, 2006, PEDIATRICS, V118, P108, DOI 10.1542/peds.2005-2522; Fakhoury KF, 2010, PEDIATRICS, V125, pE1441, DOI 10.1542/peds.2009-0668; Fawke J, 2010, AM J RESP CRIT CARE, V182, P237, DOI 10.1164/rccm.200912-1806OC; Filippone M, 2010, EUR RESPIR J, V35, P1419, DOI 10.1183/09031936.00013310; Goyal NK, 2011, PEDIATRICS, V128, pE830, DOI 10.1542/peds.2011-0809; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Hjalmarson O, 2002, AM J RESP CRIT CARE, V165, P83, DOI 10.1164/ajrccm.165.1.2107093; Jensen KE, 2008, ACTA OBSTET GYN SCAN, V87, P760, DOI 10.1080/00016340802179814; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Kallen B, 2012, ARCH DIS CHILD; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kindlund K, 2010, THORAX, V65, P146, DOI 10.1136/thx.2009.117101; Larsen CG, 2013, CLIN RESPIR J, V7, P354, DOI 10.1111/crj.12015; Laughon M, 2009, PEDIATRICS, V123, P1124, DOI 10.1542/peds.2008-0862; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McEvoy C, 2013, J PEDIATR-US, V162, P464, DOI 10.1016/j.jpeds.2012.09.042; Moth G, 2007, EUR J CLIN PHARMACOL, V63, P605, DOI 10.1007/s00228-007-0286-4; Narang I, 2006, PEDIATR PULM, V41, P497, DOI 10.1002/ppul.20385; Narayanan M, 2013, AM J RESP CRIT CARE, V187, P1104, DOI 10.1164/rccm.201210-1850OC; NORTHWAY WH, 1990, NEW ENGL J MED, V323, P1793, DOI 10.1056/NEJM199012273232603; Ortqvist AK, 2009, PEDIATRICS, V124, pE737, DOI 10.1542/peds.2009-0305; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pelkonen AS, 1997, AM J RESP CRIT CARE, V156, P1178, DOI 10.1164/ajrccm.156.4.9610028; Porsbjerg C, 2009, ASTMA BEHANDLING, P1; Rogvi RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016668; Stensballe LG, 2012, J PEDIAT; THURLBECK WM, 1982, THORAX, V37, P564, DOI 10.1136/thx.37.8.564; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; Tollanes MC, 2008, J PEDIATR-US, V153, P112, DOI 10.1016/j.jpeds.2008.01.029; Vinding GR, 2013, ACTA DERMATO VENEREO; Vogt H, 2011, PEDIATRICS, V127, P1052, DOI 10.1542/peds.2010-3083; Vrijlandt EJLE, 2007, J PEDIATR-US, V150, P256, DOI 10.1016/j.jpeds.2006.12.007; Wang Lei, 2008, Birth Defects Research, V84, P54, DOI 10.1002/bdrc.20114; Zilmer M, 2011, ACTA PAEDIATR, V100, P385, DOI 10.1111/j.1651-2227.2010.02036.x	43	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0117253	10.1371/journal.pone.0117253	http://dx.doi.org/10.1371/journal.pone.0117253			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25651521	Green Published, Green Submitted, gold			2022-12-27	WOS:000349250700011
J	Starlard-Davenport, A; Orloff, MS; Dhakal, I; Penney, RB; Kadlubar, SA				Starlard-Davenport, Athena; Orloff, Mohammed S.; Dhakal, Ishwori; Penney, Rosalind B.; Kadlubar, Susan A.			Genotypic and Allelic Variability in CYP19A1 among Populations of African and European Ancestry	PLOS ONE			English	Article							BREAST-CANCER RISK; ENDOMETRIAL CANCER; GENETIC-VARIATION; LINKAGE DISEQUILIBRIUM; HORMONE-LEVELS; AROMATASE; POLYMORPHISMS; ASSOCIATION; VARIANTS	CYP19A1 facilitates the bioconversion of estrogens from androgens. CYP19A1 intron single nucleotide polymorphisms (SNPs) may alter mRNA splicing, resulting in altered CYP19A1 activity, and potentially influencing disease susceptibility. Genetic studies of CYP19A1 SNPs have been well documented in populations of European ancestry; however, studies in populations of African ancestry are limited. In the present study, ten 'candidate' intronic SNPs in CYP19A1 from 125 African Americans (AA) and 277 European Americans (EA) were genotyped and their frequencies compared. Allele frequencies were also compared with HapMap and ASW 1000 Genomes populations. We observed significant differences in the minor allele frequencies between AA and EA in six of the ten SNPs including rs10459592 (p < 0.0001), rs12908960 (p < 0.0001), rs1902584 (p = 0.016), rs2470144 (p < 0.0001), rs1961177 (p < 0.0001), and rs6493497 (p = 0.003). While there were no significant differences in allele frequencies between EA and CEU in the HapMap population, a 1.2- to 19-fold difference in allele frequency for rs10459592 (p = 0.004), rs12908960 (p = 0.0006), rs1902584 (p < 0.0001), rs2470144 (p = 0.0006), rs1961177 (p < 0.0001), and rs6493497 (p = 0.0092) was observed between AA and the Yoruba (YRI) population. Linkage disequilibrium (LD) blocks and haplotype clusters that is unique to the EA population but not AA was also observed. In summary, we demonstrate that differences in the allele frequencies of CYP19A1 intron SNPs are not consistent between populations of African and European ancestry. Thus, investigations into whether CYP19A1 intron SNPs contribute to variations in cancer incidence, outcomes and pharmacological response seen in populations of different ancestry may prove beneficial.	[Starlard-Davenport, Athena; Kadlubar, Susan A.] Univ Arkansas Med Sci, Dept Med Genet, Little Rock, AR 72205 USA; [Orloff, Mohammed S.] Univ Arkansas Med Sci, Coll Publ Hlth, Dept Epidemiol, Little Rock, AR 72205 USA; [Dhakal, Ishwori] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Penney, Rosalind B.] Univ Arkansas Med Sci, Coll Publ Hlth, Dept Environm & Occupat Hlth, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Kadlubar, SA (corresponding author), Univ Arkansas Med Sci, Dept Med Genet, Little Rock, AR 72205 USA.	SAKadlubar@uams.edu	Starlard-Davenport, Athena/Q-3866-2017	Starlard-Davenport, Athena/0000-0002-8938-237X	UAMS Winthrop P. Rockefeller Cancer Institute; Arkansas Breast Cancer Research Program (ABCRP)	UAMS Winthrop P. Rockefeller Cancer Institute; Arkansas Breast Cancer Research Program (ABCRP)	This work was supported by generous funds from the UAMS Winthrop P. Rockefeller Cancer Institute to AS-D and funding from the Arkansas Breast Cancer Research Program (ABCRP) to MSO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai QY, 2008, CANCER EPIDEM BIOMAR, V17, P27, DOI 10.1158/1055-9965.EPI-07-0688; Chace C, 2012, J ALZHEIMERS DIS, V28, P601, DOI 10.3233/JAD-2011-110860; Chattopadhyay S., 2014, TUMOUR BIOL; Choudhury A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-437; Cooper David N, 2010, Hum Genomics, V4, P284; Czajka-Oraniec I, 2010, ENDOKRYNOL POL, V61, P126; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Garringer JA, 2013, J NEUROTRAUM, V30, P1415, DOI 10.1089/neu.2012.2565; Gingeras TR, 2009, NATURE, V461, P206, DOI 10.1038/nature08452; Golledge J, 2011, EUR J HUM GENET, V19, P363, DOI 10.1038/ejhg.2010.182; Haiman CA, 2003, HUM MOL GENET, V12, P2679, DOI 10.1093/hmg/ddg294; Haiman CA, 2007, CANCER RES, V67, P1893, DOI 10.1158/0008-5472.CAN-06-4123; He SS, 2012, AM J ORTHOD DENTOFAC, V142, P662, DOI 10.1016/j.ajodo.2012.06.014; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Ikeda K, 2014, ANN SURG ONCOL, V21, P939, DOI 10.1245/s10434-013-3362-2; Kado N, 2002, HUM REPROD, V17, P897, DOI 10.1093/humrep/17.4.897; Kohno T, 2010, CARCINOGENESIS, V31, P1794, DOI 10.1093/carcin/bgq159; Lee SJ, 2010, J HUM GENET, V55, P189, DOI 10.1038/jhg.2010.6; Lin JH, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-78; Lonjou C, 2003, P NATL ACAD SCI USA, V100, P6069, DOI 10.1073/pnas.1031521100; Millar David S., 2010, Human Genomics, V4, P289; Olson SH, 2007, AM J EPIDEMIOL, V165, P235, DOI 10.1093/aje/kwk015; Park IH, 2011, CANCER CHEMOTH PHARM, V68, P1263, DOI 10.1007/s00280-011-1615-y; Paynter RA, 2005, INT J CANCER, V116, P267, DOI 10.1002/ijc.21041; Pietranera L, 2011, NEUROSCIENCE, V174, P151, DOI 10.1016/j.neuroscience.2010.11.044; Setiawan VW, 2009, CANCER EPIDEM BIOMAR, V18, P242, DOI 10.1158/1055-9965.EPI-08-0689; Shifman S, 2003, HUM MOL GENET, V12, P771, DOI 10.1093/hmg/ddg088; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; Slattery ML, 2011, CANCER CAUSE CONTROL, V22, P955, DOI 10.1007/s10552-011-9768-x; Travis RC, 2009, CANCER EPIDEM BIOMAR, V18, P2734, DOI 10.1158/1055-9965.EPI-09-0496; Umamaheswaran G, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0665-x; Wang LW, 2010, CANCER RES, V70, P319, DOI 10.1158/0008-5472.CAN-09-3224; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Zhang XL, 2012, MOL MED REP, V5, P245, DOI 10.3892/mmr.2011.616	34	3	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117347	10.1371/journal.pone.0117347	http://dx.doi.org/10.1371/journal.pone.0117347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647083	gold, Green Published, Green Submitted			2022-12-27	WOS:000348822600065
J	Li, YY; Ma, XL; Zhao, JL; Xu, JJ; Shi, JF; Zhu, XG; Zhao, YX; Zhang, H				Li, Yuanyuan; Ma, Xiuling; Zhao, Jialei; Xu, Jiajia; Shi, Junfeng; Zhu, Xin-Guang; Zhao, Yanxiu; Zhang, Hui			Developmental Genetic Mechanisms of C-4 Syndrome Based on Transcriptome Analysis of C-3 Cotyledons and C-4 Assimilating Shoots in Haloxylon ammodendron	PLOS ONE			English	Article							AMPHIBIOUS PLANT; LEAF DEVELOPMENT; KRANZ ANATOMY; PHOTOSYNTHESIS; EVOLUTION; DIFFERENTIATION; EXPRESSION; RECRUITMENT; CO2; DISCRIMINATION	It is believed that transferring the C-4 engine into C-3 crops will greatly increase the yields of major C-3 crops. Many efforts have been made since the 1960s, but relatively little success has been achieved because C(4)plant traits, referred to collectively as C-4 syndrome, are very complex, and little is known about the genetic mechanisms involved. Unfortunately, there exists no ideal genetic model system to study C-4 syndrome. It was previously reported that the Haloxylon species have different photosynthetic pathways in different photosynthetic organs, cotyledons and assimilating shoots. Here, we took advantage of the developmental switch from the C-3 to the C-4 pathway to study the genetic mechanisms behind this natural transition. We compared the transcriptomes of cotyledons and assimilating shoots using mRNA-Seq to gain insight into the molecular and cellular events associated with C-4 syndrome. A total of 2959 differentially expressed genes [FDR <= 0.001 and abs (vertical bar log2(Fold change)vertical bar >= 1)] were identified, revealing that the transcriptomes of cotyledons and assimilating shoots are considerably different. We further identified a set of putative regulators of C-4 syndrome. This study expands our understanding of the development of C-4 syndrome and provides a new model system for future studies on the C-3-to- C-4 switch mechanism.	[Li, Yuanyuan] Shandong Normal Univ, Key Lab Syst Biol, Jinan, Shandong, Peoples R China; [Ma, Xiuling; Zhao, Jialei; Shi, Junfeng; Zhao, Yanxiu; Zhang, Hui] Shandong Normal Univ, Key Lab Plant Stress Res, Jinan, Shandong, Peoples R China; [Li, Yuanyuan; Xu, Jiajia; Zhu, Xin-Guang] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Computat Biol, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China	Shandong Normal University; Shandong Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Li, YY (corresponding author), Shandong Normal Univ, Key Lab Syst Biol, Jinan, Shandong, Peoples R China.	yuanyuan_li@outlook.com	xu, jia/GSD-6347-2022	Zhang, Hui/0000-0002-4819-6482; LI, YUANYUAN/0000-0003-3332-8128	China Postdoctoral Science Foundation [2013T60468]; National Basic Research Program of China [2012CB114204]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the China Postdoctoral Science Foundation (Grant No. 2013T60468) and the National Basic Research Program of China (Grant No. 2012CB114204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004365; Aubry S, 2011, J EXP BOT, V62, P3049, DOI 10.1093/jxb/err012; BENDER MM, 1971, PHYTOCHEMISTRY, V10, P1239, DOI 10.1016/S0031-9422(00)84324-1; BENDER MM, 1968, RADIOCARBON, V10, P468, DOI 10.1017/S0033822200011103; BJORKMAN O, 1970, YEAR B CARNEGIE I WA, V69, P640; BJORKMAN O, 1971, YEAR B CARNEGIE I WA, V70, P507; Bju┬rkman O., 1969, YB CARNEGIE I WASHIN, V68, P620; BOYNTON JE, 1970, YEAR B CARNEGIE I WA, V69, P629; Brautigam A, 2011, PLANT PHYSIOL, V155, P142, DOI 10.1104/pp.110.159442; Brown NJ, 2011, SCIENCE, V331, P1436, DOI 10.1126/science.1201248; BROWN RH, 1993, ANNU REV PLANT PHYS, V44, P435, DOI 10.1146/annurev.pp.44.060193.002251; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Christin PA, 2008, CURR BIOL, V18, P37, DOI 10.1016/j.cub.2007.11.058; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Gowik U, 2011, PLANT CELL, V23, P2087, DOI 10.1105/tpc.111.086264; Hatch MD, 1976, TRANSPORT PLANTS 3 E, V3, P144, DOI DOI 10.1007/978-3-642-66417-5_5; Hibberd JM, 2008, CURR OPIN PLANT BIOL, V11, P228, DOI 10.1016/j.pbi.2007.11.002; John CR, 2014, PLANT PHYSIOL, V165, P62, DOI 10.1104/pp.114.238667; Kajala K, 2012, PLANT J, V69, P47, DOI 10.1111/j.1365-313X.2011.04769.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kulahoglu C, 2014, PLANT CELL, V26, P3243, DOI 10.1105/tpc.114.123752; LAETSCH WM, 1974, ANNU REV PLANT PHYS, V25, P27, DOI 10.1146/annurev.pp.25.060174.000331; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li YY, 2014, J EXP BOT, V65, P3657, DOI 10.1093/jxb/eru193; LLOYD J, 1994, OECOLOGIA, V99, P201, DOI 10.1007/BF00627732; Majeran W, 2010, PLANT CELL, V22, P3509, DOI 10.1105/tpc.110.079764; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; NOBS MA, 1970, YEAR B CARNEGIE I WA, V69, P625; Osborne CP, 2006, PHILOS T R SOC B, V361, P173, DOI 10.1098/rstb.2005.1737; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; PEARCY RW, 1970, YEAR B CARNEGIE I WA, V69, P632; Pyankov VI, 1999, PLANT CELL PHYSIOL, V40, P125, DOI 10.1093/oxfordjournals.pcp.a029519; Pyankov VI, 2000, PHOTOSYNTH RES, V63, P69, DOI 10.1023/A:1006377708156; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sage RF, 2012, ANNU REV PLANT BIOL, V63, P19, DOI 10.1146/annurev-arplant-042811-105511; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; Sawers RJH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-12; Slewinski TL, 2012, PLANT CELL PHYSIOL, V53, P2030, DOI 10.1093/pcp/pcs147; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Su PX, 2010, DESERT PLANTS: BIOLOGY AND BIOTECHNOLOGY, P243, DOI 10.1007/978-3-642-02550-1_12; Tolley BJ, 2012, PLANT PHYSIOL, V159, P1418, DOI 10.1104/pp.112.200584; Ueno O, 2001, PLANT PHYSIOL, V127, P1524, DOI 10.1104/pp.010704; Ueno O, 1998, PLANT CELL, V10, P571; UENO O, 1988, P NATL ACAD SCI USA, V85, P6733, DOI 10.1073/pnas.85.18.6733; von Caemmerer S, 2012, SCIENCE, V336, P1671, DOI 10.1126/science.1220177; Wang P, 2013, PLANT J, V75, P656, DOI 10.1111/tpj.12229; Westhoff P, 2010, PLANT PHYSIOL, V154, P598, DOI 10.1104/pp.110.161729; Xu JJ, 2013, PLANT MOL BIOL, V83, P77, DOI 10.1007/s11103-013-0025-4	53	27	28	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117175	10.1371/journal.pone.0117175	http://dx.doi.org/10.1371/journal.pone.0117175			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643361	gold, Green Published, Green Submitted			2022-12-27	WOS:000348821200033
J	Shen, YG; Sun, ZH; Xu, L; Li, Y; Zhang, N; Yan, ZX; Fan, ZM				Shen, Yanguang; Sun, Zhonghua; Xu, Lei; Li, Yu; Zhang, Nan; Yan, Zixu; Fan, Zhanming			High-Pitch, Low-Voltage and Low-Iodine-Concentration CT Angiography of Aorta: Assessment of Image Quality and Radiation Dose with Iterative Reconstruction	PLOS ONE			English	Article							FILTERED BACK-PROJECTION; LOW-TUBE-VOLTAGE; CORONARY-ANGIOGRAPHY; CONTRAST MATERIAL; INDUCED NEPHROPATHY; ABDOMINAL-AORTA; ENHANCEMENT; REPAIR; SEGMENTATION; ULTRASOUND	Objective To assess the image quality of aorta obtained by dual-source computed tomography angiography (DSCTA), performed with high pitch, low tube voltage, and low iodine concentration contrast medium (CM) with images reconstructed using iterative reconstruction (IR). Methods One hundred patients randomly allocated to receive one of two types of CM underwent DSCTA with the electrocardiogram-triggered Flash protocol. In the low-iodine group, 50 patients received CM containing 270 mg I/mL and were scanned at low tube voltage (100 kVp). In the high-iodine CMgroup, 50 patients received CMcontaining 370 mg I/mL and were scanned at the tube voltage (120 kVp). The filtered back projection (FBP) algorithm was used for reconstruction in both groups. In addition, the IR algorithmwas used in the low-iodine group. Image quality of the aorta was analyzed subjectively by a 3-point grading scale and objectively by measuring the CT attenuation in terms of the signal-and contrast-to-noise ratios (SNR and CNR, respectively). Radiation and CM doses were compared. Results The CT attenuation, subjective image quality assessment, SNR, and CNR of various aortic regions of interest did not differ significantly between two groups. In the low-iodine group, images reconstructed by FBP and IR demonstrated significant differences in image noise, SNR, and CNR (p<0.05). The low-iodine group resulted in 34.3% less radiation (4.4 +/- 0.5mSv) than the high-iodine group (6.7 +/- 0.6mSv), and 27.3% less iodine weight (20.36 +/- 2.65 g) than the high-iodine group (28 +/- 1.98 g). Observers exhibited excellent agreement on the aortic image quality scores (kappa = 0.904). Conclusions CT images of aorta could be obtained within 2 s by using a DSCT Flash protocol with low tube voltage, IR, and low-iodine-concentration CM. Appropriate contrast enhancement was achieved while maintaining good image quality and decreasing the radiation and iodine doses.	[Shen, Yanguang; Xu, Lei; Li, Yu; Zhang, Nan; Yan, Zixu; Fan, Zhanming] Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Shen, Yanguang] Hosp Affiliated Hainan Med Coll, Dept Radiol, Haikou, Hainan Province, Peoples R China; [Sun, Zhonghua] Curtin Univ, Discipline Med Imaging, Dept Imaging & Appl Phys, Perth, WA 6845, Australia	Capital Medical University; Curtin University	Fan, ZM (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China.	302643187@qq.com	Sun, Zhonghua/B-3125-2010; Sun, Zhonghua/N-1648-2019	Sun, Zhonghua/0000-0002-7538-4761; Sun, Zhonghua/0000-0002-7538-4761; , Nan/0000-0002-8309-4262	Beijing Municipal Natural Science Foundation [7132086]; National Science Fund for Distinguished Young Scholars [81401375]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by grants from the Beijing Municipal Natural Science Foundation (No. 7132086) and the National Science Fund for Distinguished Young Scholars (No. 81401375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfaltrer P, 2012, AM J ROENTGENOL, V199, P1402, DOI 10.2214/AJR.12.8652; Bazalova M, 2008, PHYS MED BIOL, V53, P2439, DOI 10.1088/0031-9155/53/9/015; Bolen MA, 2012, AM J ROENTGENOL, V198, P931, DOI 10.2214/AJR.11.6921; BUFFA V, 2014, RADIOL MED, P13897; Cademartiri F, 2005, RADIOLOGY, V236, P661, DOI 10.1148/radiol.2362040468; Cody D, 2008, MANAGEMENT RAD DOSE; Duquette AA, 2012, COMPUT MED IMAG GRAP, V36, P294, DOI 10.1016/j.compmedimag.2011.12.001; Fleischmann D, 2010, RADIOL CLIN N AM, V48, P237, DOI 10.1016/j.rcl.2010.02.002; Fujioka C, 2009, AM J ROENTGENOL, V193, P227, DOI 10.2214/AJR.08.1722; Goetti R, 2010, AM J ROENTGENOL, V194, P938, DOI 10.2214/AJR.09.3482; Hansen NJ, 2014, AM J ROENTGENOL, V202, P648, DOI 10.2214/AJR.13.11286; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Herman S, 2004, J COMPUT ASSIST TOMO, V28, pS7, DOI 10.1097/01.rct.0000120855.80935.2f; Hou Y, 2012, AM J ROENTGENOL, V199, P588, DOI 10.2214/AJR.11.7557; Hu ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073093; Karlo C, 2011, EUR RADIOL, V21, P205, DOI 10.1007/s00330-010-1907-3; Katzberg RW, 2007, RADIOLOGY, V243, P622, DOI 10.1148/radiol.2433061411; Khan Nouman U, 2009, Interact Cardiovasc Thorac Surg, V9, P119, DOI 10.1510/icvts.2008.189506; Kim EY, 2010, ACTA RADIOL, V51, P982, DOI 10.3109/02841851.2010.509740; Koike Y, 2014, J VASC INTERV RADIOL, V25, P1172, DOI 10.1016/j.jvir.2014.03.019; Li Y, 2012, EUR RADIOL, V22, P2432, DOI 10.1007/s00330-012-2497-z; Liu Y, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-228; Lu MH, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-15; Macari M, 2001, RADIOLOGY, V220, P519, DOI 10.1148/radiology.220.2.r01au35519; Marin D, 2010, RADIOLOGY, V256, P450, DOI 10.1148/radiol.10091819; Michaels JA, 2005, BRIT J SURG, V92, P960, DOI 10.1002/bjs.5119; Mitsumori LM, 2012, EUR RADIOL, V22, P138, DOI 10.1007/s00330-011-2186-3; Nakayama Yoshiharu, 2006, AJR Am J Roentgenol, V187, pW490; Nayeemuddin M, 2012, CLIN RADIOL, V67, P802, DOI 10.1016/j.crad.2011.12.005; Nyman U, 2005, ACTA RADIOL, V46, P830, DOI 10.1080/02841850500335051; Prakash P, 2010, INVEST RADIOL, V45, P202, DOI 10.1097/RLI.ob013e3181dzfeec; Puippe GD, 2012, EUR J RADIOL, V81, P2592, DOI 10.1016/j.ejrad.2011.12.021; Qi L, 2014, ACTA RADIOL; Rubin GD, 2000, RADIOLOGY, V215, P670, DOI 10.1148/radiology.215.3.r00jn18670; Rubin GD, 2001, RADIOLOGY, V221, P146, DOI 10.1148/radiol.2211001325; Rutten A, 2010, EUR RADIOL, V20, P1917, DOI 10.1007/s00330-010-1752-4; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Sun ZH, 2006, J VASC INTERV RADIOL, V17, P759, DOI 10.1097/01.RVI.0000217944.36738.02; Sun ZH, 2012, J ENDOVASC THER, V19, P656, DOI 10.1583/JEVT-12-3909C.1; Wang R, 2012, EUR J RADIOL, V81, P3141, DOI 10.1016/j.ejrad.2012.04.012; Weerakkody RA, 2008, BRIT J SURG, V95, P699, DOI 10.1002/bjs.6229; Winklehner A, 2011, EUR RADIOL, V21, P2521, DOI 10.1007/s00330-011-2227-y; Worasuwannarak Surapong, 2010, J Med Assoc Thai, V93 Suppl 1, pS29; Zhang WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081486; Zheng MW, 2014, EUR J RADIOL, V83, pE92, DOI 10.1016/j.ejrad.2013.11.006	45	26	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117469	10.1371/journal.pone.0117469	http://dx.doi.org/10.1371/journal.pone.0117469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643353	Green Submitted, Green Published, gold			2022-12-27	WOS:000348821200039
J	Zhu, LX; Di, PYP; Wu, R; Pinkerton, KE; Chen, Y				Zhu, Lingxiang; Di, Peter Y. P.; Wu, Reen; Pinkerton, Kent E.; Chen, Yin			Repression of CC16 by Cigarette Smoke (CS) Exposure	PLOS ONE			English	Article							CELL SECRETORY PROTEIN; OBSTRUCTIVE PULMONARY-DISEASE; RETINOIC ACID; SYSTEMIC INFLAMMATION; ALVEOLAR REGENERATION; LUNG EPITHELIUM; VIRUS-INFECTION; 10-KD PROTEIN; CLARA CELLS; UTEROGLOBIN	Club (Clara) Cell Secretory Protein (CCSP, or CC16) is produced mainly by non-ciliated airway epithelial cells including bronchiolar club cells and the change of its expression has been shown to associate with the progress and severity of Chronic Obstructive Pulmonary Disease (COPD). In an animal model, the lack of CC16 renders the animal susceptible to the tumorigenic effect of a major CS carcinogen. A recent population-based Tucson Epidemiological Study of Airway Obstructive Diseases (TESAOD) has indicated that the low serum CC16 concentration is closely linked with the smoke-related mortality, particularly that driven by the lung cancer. However, the study of CC16 expression in well-defined smoke exposure models has been lacking, and there is no experimental support for the potential causal link between CC16 and CS-induced pathophysiological changes in the lung. In the present study, we have found that airway CC16 expression was significantly repressed in COPD patients, in monkey CS exposure model, and in CS-induced mouse model of COPD. Additionally, the lack of CC16 exacerbated airway inflammation and alveolar loss in the mouse model. Therefore, CC16 may play an important protective role in CS-related diseases.	[Zhu, Lingxiang; Chen, Yin] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Di, Peter Y. P.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Wu, Reen] Univ Calif Davis, Ctr Comparat Resp Biol & Med, Davis, CA 95616 USA; [Pinkerton, Kent E.] Univ Calif Davis, Dept Pediat, Davis, CA 95616 USA	University of Arizona; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis; University of California System; University of California Davis	Chen, Y (corresponding author), Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA.	ychen@pharmacy.arizona.edu	Di, Yuanpu Peter/H-4191-2016	Di, Yuanpu Peter/0000-0003-2028-2087	Flight Attendant Medical Research Institute [123055_CIA]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091938] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by a grant (123055_CIA) from Flight Attendant Medical Research Institute (http://www.famri.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif ME, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008308.pub2; Antico G, 2006, J CELL PHYSIOL, V207, P553, DOI 10.1002/jcp.20604; Belloni PN, 2000, CHEST, V117, p235S, DOI 10.1378/chest.117.5_suppl_1.235S; BERNARD A, 1992, EUR RESPIR J, V5, P1231; Boers JE, 1999, AM J RESP CRIT CARE, V159, P1585, DOI 10.1164/ajrccm.159.5.9806044; Braido F, 2007, RESP MED, V101, P2119, DOI 10.1016/j.rmed.2007.05.023; Broeckaert F, 2000, CLIN EXP ALLERGY, V30, P469; Buro-Auriemma LJ, 2013, HUM MOL GENET, V22, P4726, DOI 10.1093/hmg/ddt326; Coppens JT, 2007, AM J PHYSIOL-LUNG C, V292, pL1155, DOI 10.1152/ajplung.00454.2006; DIERYNCK I, 1995, AM J RESP CELL MOL, V12, P205, DOI 10.1165/ajrcmb.12.2.7865218; ENGELHARDT JF, 1994, J CLIN INVEST, V93, P737, DOI 10.1172/JCI117028; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Ganesan S, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24997; Geerts L, 2001, CRIT CARE MED, V29, P1920, DOI 10.1097/00003246-200110000-00012; Guerra S, 2013, LANCET RESP MED, V1, P779, DOI 10.1016/S2213-2600(13)70220-0; Harrod KS, 1998, AM J PHYSIOL-LUNG C, V275, pL924, DOI 10.1152/ajplung.1998.275.5.L924; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hermans C, 1999, AM J RESP CRIT CARE, V159, P646, DOI 10.1164/ajrccm.159.2.9806064; Hind M, 2004, EUR RESPIR J, V23, P20, DOI 10.1183/09031936.03.00119103; Hung CH, 2004, J ALLERGY CLIN IMMUN, V114, P664, DOI 10.1016/j.jaci.2004.05.042; Johnston CJ, 1997, AM J RESP CELL MOL, V17, P147, DOI 10.1165/ajrcmb.17.2.2676; Lakind JS, 2007, BIOMARKERS, V12, P445, DOI 10.1080/13547500701359327; LESUR O, 1995, AM J RESP CRIT CARE, V152, P290, DOI 10.1164/ajrccm.152.1.7541278; LEVIN SW, 1986, LIFE SCI, V38, P1813, DOI 10.1016/0024-3205(86)90135-9; Levine CR, 2005, PEDIATR RES, V58, P15, DOI 10.1203/01.PDR.0000156371.89952.35; Lomas DA, 2008, THORAX, V63, P1058, DOI 10.1136/thx.2008.102574; Mandal AK, 2005, J BIOL CHEM, V280, P32897, DOI 10.1074/jbc.M502375200; Mandal AK, 2004, J EXP MED, V199, P1317, DOI 10.1084/jem.20031666; Mango GW, 1998, AM J PHYSIOL-LUNG C, V275, pL348, DOI 10.1152/ajplung.1998.275.2.L348; Massaro GD, 1997, NAT MED, V3, P675, DOI 10.1038/nm0697-675; Massaro GD, 2000, AM J PHYSIOL-LUNG C, V278, pL955, DOI 10.1152/ajplung.2000.278.5.L955; Mossman BT, 2006, AM J RESP CELL MOL, V34, P666, DOI 10.1165/rcmb.2006-0047SF; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Park HY, 2013, AM J RESP CRIT CARE, V188, P1413, DOI 10.1164/rccm.201305-0892OC; Pilette C, 2001, AM J RESP CRIT CARE, V163, P185, DOI 10.1164/ajrccm.163.1.9912137; Pilon AL, 2000, ANN NY ACAD SCI, V923, P280; Plopper CG, 2006, TOXICOL APPL PHARM, V213, P74, DOI 10.1016/j.taap.2005.09.003; Ray R, 2006, FEBS LETT, V580, P6022, DOI 10.1016/j.febslet.2006.09.059; Sin Don D, 2007, BMC Pulm Med, V7, P13, DOI 10.1186/1471-2466-7-13; Sin DD, 2007, CAN J PHYSIOL PHARM, V85, P141, DOI 10.1139/Y06-093; SINGH G, 1988, J HISTOCHEM CYTOCHEM, V36, P73, DOI 10.1177/36.1.3275712; Singh G, 1992, COMP BIOL NORMAL LUN, P93; Snyder JC, 2010, AM J RESP CELL MOL, V42, P161, DOI 10.1165/rcmb.2008-0353OC; Stinchcombe SV, 2008, AM J RESP CELL MOL, V38, P185, DOI 10.1165/rcmb.2007-0252OC; Stripp BR, 1996, AM J PHYSIOL-LUNG C, V271, pL656, DOI 10.1152/ajplung.1996.271.4.L656; Tepper J, 2000, CHEST, V117, p242S, DOI 10.1378/chest.117.5_suppl_1.242S; Tsoumakidou M, 2010, EXP LUNG RES, V36, P373, DOI 10.3109/01902141003690389; VASANTHAKUMAR G, 1988, BIOCHEM PHARMACOL, V37, P389, DOI 10.1016/0006-2952(88)90204-3; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Wang L, 2008, J ALLERGY CLIN IMMUN, V122, P400, DOI 10.1016/j.jaci.2008.04.011; Wang SZ, 2003, J IMMUNOL, V171, P1051, DOI 10.4049/jimmunol.171.2.1051; Wang SZ, 2001, AM J PHYSIOL-LUNG C, V281, pL1303, DOI 10.1152/ajplung.2001.281.5.L1303; Wendt CH, 2013, AM J PHYSIOL LUNG CE; Widegren H, 2009, ANN ALLERG ASTHMA IM, V102, P51, DOI 10.1016/S1081-1206(10)60108-1; Yang YP, 2004, J BIOL CHEM, V279, P29336, DOI 10.1074/jbc.C400162200; Ye Q, 2004, RESPIRATION, V71, P505, DOI 10.1159/000080636	56	37	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116159	10.1371/journal.pone.0116159	http://dx.doi.org/10.1371/journal.pone.0116159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635997	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000350680700025
J	Steel, MM; Papsin, BC; Gordon, KA				Steel, Morrison M.; Papsin, Blake C.; Gordon, Karen A.			Binaural Fusion and Listening Effort in Children Who Use Bilateral Cochlear Implants: A Psychoacoustic and Pupillometric Study	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; INTERAURAL TIME DIFFERENCES; CROSS-MODAL PLASTICITY; PLACE-OF-STIMULATION; SPEECH-PERCEPTION; PUPILLARY RESPONSES; SOUND LOCALIZATION; LEVEL DIFFERENCES; EVOKED-POTENTIALS; SPATIAL UNMASKING	Bilateral cochlear implants aim to provide hearing to both ears for children who are deaf and promote binaural/spatial hearing. Benefits are limited by mismatched devices and unilaterally-driven development which could compromise the normal integration of left and right ear input. We thus asked whether children hear a fused image (ie. 1 vs 2 sounds) from their bilateral implants and if this "binaural fusion" reduces listening effort. Binaural fusion was assessed by asking 25 deaf children with cochlear implants and 24 peers with normal hearing whether they heard one or two sounds when listening to bilaterally presented acoustic click-trains/electric pulses (250 Hz trains of 36 ms presented at 1 Hz). Reaction times and pupillary changes were recorded simultaneously to measure listening effort. Bilaterally implanted children heard one image of bilateral input less frequently than normal hearing peers, particularly when intensity levels on each side were balanced. Binaural fusion declined as brainstem asymmetries increased and age at implantation decreased. Children implanted later had access to acoustic input prior to implantation due to progressive deterioration of hearing. Increases in both pupil diameter and reaction time occurred as perception of binaural fusion decreased. Results indicate that, without binaural level cues, children have difficulty fusing input from their bilateral implants to perceive one sound which costs them increased listening effort. Brainstem asymmetries exacerbate this issue. By contrast, later implantation, reflecting longer access to bilateral acoustic hearing, may have supported development of auditory pathways underlying binaural fusion. Improved integration of bilateral cochlear implant signals for children is required to improve their binaural hearing.	[Steel, Morrison M.] Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA; [Steel, Morrison M.; Papsin, Blake C.; Gordon, Karen A.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Papsin, Blake C.; Gordon, Karen A.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Papsin, Blake C.; Gordon, Karen A.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Steel, Morrison M.; Papsin, Blake C.; Gordon, Karen A.] Hosp Sick Children, Dept Otolaryngol, Toronto, ON M5G 1X8, Canada; [Gordon, Karen A.] Hosp Sick Children, Dept Commun Disorders, Toronto, ON M5G 1X8, Canada	Central Michigan University; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Steel, MM (corresponding author), Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA.	mosteel47@gmail.com			Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	K.A.G. received funding from the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonson V, 2001, J ACOUST SOC AM, V109, P2840, DOI 10.1121/1.1371756; Aronoff JM, 2010, J ACOUST SOC AM, V127, pEL87, DOI 10.1121/1.3298451; BABKOFF H, 1966, J ACOUST SOC AM, V39, P87, DOI 10.1121/1.1909878; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Baskent D, 2012, JARO-J ASSOC RES OTO, V13, P683, DOI 10.1007/s10162-012-0334-3; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; BEATTY J, 1982, PSYCHOPHYSIOLOGY, V19, P167, DOI 10.1111/j.1469-8986.1982.tb02540.x; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Breebaart J, 2001, J ACOUST SOC AM, V110, P1074, DOI 10.1121/1.1383297; Burkholder RA, 2003, J EXP CHILD PSYCHOL, V85, P63, DOI 10.1016/S0022-0965(03)00033-X; CARR CE, 1990, J NEUROSCI, V10, P3227; Casey BJ, 2005, CURR OPIN NEUROBIOL, V15, P239, DOI 10.1016/j.conb.2005.03.012; Casey BJ, 2002, DEV PSYCHOBIOL, V40, P237, DOI 10.1002/dev.10030; Chadha NK, 2011, OTOL NEUROTOL, V32, P1057, DOI 10.1097/MAO.0b013e3182267de7; Cheng AK, 1999, ANN OTO RHINOL LARYN, V108, P124; Chermak Gail D, 2005, J Am Acad Audiol, V16, P554, DOI 10.3766/jaaa.16.8.4; Colburn HS, 2006, INT J AUDIOL, V45, pS34, DOI 10.1080/14992020600782642; COLBURN HS, 1977, J ACOUST SOC AM, V61, P525, DOI 10.1121/1.381294; D'Elia A, 2012, OTOL NEUROTOL, V33, P343, DOI 10.1097/MAO.0b013e3182487dbb; Darwin C., 1965, EXPRESS EMOT MAN; DOBIE RA, 1980, ELECTROEN CLIN NEURO, V49, P303, DOI 10.1016/0013-4694(80)90224-2; Eggermont JJ, 2003, ACTA OTO-LARYNGOL, V123, P249, DOI 10.1080/0036554021000028098; Eisenberg LS, 2007, EAR HEARING, V28, P766, DOI 10.1097/AUD.0b013e318157f01f; Fiedler A, 2011, COGN AFFECT BEHAV NE, V11, P68, DOI 10.3758/s13415-010-0013-y; Finley CC, 2008, OTOL NEUROTOL, V29, P920, DOI 10.1097/MAO.0b013e318184f492; FURST M, 1985, J ACOUST SOC AM, V78, P1644, DOI 10.1121/1.392802; Galvin KL, 2007, EAR HEARING, V28, P470, DOI 10.1097/AUD.0b013e31806dc194; GIOLAS TG, 1967, J SPEECH HEAR DISORD, V32, P336, DOI 10.1044/jshd.3204.336; Gordon K A, 2011, Cochlear Implants Int, V12 Suppl 2, pS8, DOI 10.1179/146701011X13074645127199; Gordon KA, 2005, NEUROREPORT, V16, P2041, DOI 10.1097/00001756-200512190-00015; Gordon KA, 2006, AUDIOL NEURO-OTOL, V11, P7, DOI 10.1159/000088851; Gordon KA, 2004, EAR HEARING, V25, P447, DOI 10.1097/01.aud.0000146178.84065.b3; Gordon KA, 2001, J OTOLARYNGOL, V30, P216, DOI 10.2310/7070.2001.20157; Gordon KA, PLOS ONE IN PRESS, DOI [10.1371/journal.pone.0116463, DOI 10.1371/JOURNAL.PONE.0116463]; Gordon KA, 2008, OTOL NEUROTOL, V29, P193, DOI 10.1097/mao.0b013e318162514c; Gordon KA, 2007, NEUROREPORT, V18, P613, DOI 10.1097/WNR.0b013e3280b10c15; Gordon KA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00719; Gordon KA, 2013, BRAIN, V136, P1609, DOI 10.1093/brain/awt052; Gordon KA, 2012, J NEUROSCI, V32, P4212, DOI 10.1523/JNEUROSCI.5741-11.2012; Gordon KA, 2010, OTOL NEUROTOL, V31, P1293, DOI 10.1097/MAO.0b013e3181e8f965; Gordon KA, 2009, OTOL NEUROTOL, V30, P319, DOI 10.1097/MAO.0b013e31819a8f4c; Goupell MJ, 2013, J ACOUST SOC AM, V133, P2272, DOI 10.1121/1.4792936; Grantham DW, 2007, EAR HEARING, V28, P524, DOI 10.1097/AUD.0b013e31806dc21a; Grieco-Calub TM, 2008, OTOL NEUROTOL, V29, P235, DOI 10.1097/mao.0b013e31816250fe; Grieco-Calub TM, 2010, EAR HEARING, V31, P645, DOI 10.1097/AUD.0b013e3181e50a1d; Hancock KE, 2010, J NEUROSCI, V30, P14068, DOI 10.1523/JNEUROSCI.3213-10.2010; Harrison RV, 2005, DEV PSYCHOBIOL, V46, P252, DOI 10.1002/dev.20052; Hartmann WM, 2002, J ACOUST SOC AM, V112, P1037, DOI 10.1121/1.1500759; HESS EH, 1964, SCIENCE, V143, P1190, DOI 10.1126/science.143.3611.1190; Hicks CB, 2002, J SPEECH LANG HEAR R, V45, P573, DOI 10.1044/1092-4388(2002/046); Hopyan T, 2011, Cochlear Implants Int, V12, P21, DOI 10.1179/146701010X12677899497399; Hopyan T, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00425; Hughes Kathryn C, 2013, Cochlear Implants Int, V14, P121, DOI 10.1179/1754762812Y.0000000009; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Jiwani S, 2013, CLIN NEUROPHYSIOL, V124, P1868, DOI 10.1016/j.clinph.2013.03.023; Jung KH, 2012, AUDIOL NEURO-OTOL, V17, P189, DOI 10.1159/000336407; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; KAHNEMAN D, 1969, J EXP PSYCHOL, V79, P164, DOI 10.1037/h0026952; KAHNEMAN D, 1967, PERCEPT PSYCHOPHYS, V2, P101; Kan A, 2013, J ACOUST SOC AM, V134, P2923, DOI 10.1121/1.4820889; Kirk K I, 1985, Ear Hear, V6, p36S, DOI 10.1097/00003446-198505001-00008; Kral A, 2007, INT J AUDIOL, V46, P479, DOI 10.1080/14992020701383027; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Krumbholz K, 2005, EUR J NEUROSCI, V21, P230, DOI 10.1111/j.1460-9568.2004.03836.x; Lee DS, 2001, NATURE, V409, P149, DOI 10.1038/35051653; Lieu JEC, 2004, ARCH OTOLARYNGOL, V130, P524, DOI 10.1001/archotol.130.5.524; Limb CJ, 2010, JARO-J ASSOC RES OTO, V11, P133, DOI 10.1007/s10162-009-0184-9; Litovsky RY, 2012, J AM ACAD AUDIOL, V23, P476, DOI 10.3766/jaaa.23.6.9; Litovsky RY, 2010, J ACOUST SOC AM, V127, P400, DOI 10.1121/1.3257546; Litovsky RY, 2006, EAR HEARING, V27, P43, DOI 10.1097/01.aud.0000194515.28023.4b; Litovsky RY, 1999, J ACOUST SOC AM, V106, P1633, DOI 10.1121/1.427914; Litovsky RY, 2004, ARCH OTOLARYNGOL, V130, P648, DOI 10.1001/archotol.130.5.648; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; Long CJ, 2003, J ACOUST SOC AM, V114, P1565, DOI 10.1121/1.1603765; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; MCPHERSON DL, 1995, HEARING RES, V89, P162, DOI 10.1016/0378-5955(95)00134-1; Meredith MA, 2011, HEARING RES, V280, P38, DOI 10.1016/j.heares.2011.02.004; Mickey BJ, 2001, J NEUROPHYSIOL, V86, P1333, DOI 10.1152/jn.2001.86.3.1333; Miyamoto RT, 1996, ACTA OTO-LARYNGOL, V116, P240, DOI 10.3109/00016489609137832; Mok M, 2007, AUDIOL NEURO-OTOL, V12, P295, DOI 10.1159/000103210; MOORE MJ, 1983, J NEUROSCI, V3, P237; Nadol JB, 1997, OTOLARYNG HEAD NECK, V117, P220, DOI 10.1016/S0194-5998(97)70178-5; Naito Y, 2000, HEARING RES, V143, P139, DOI 10.1016/S0378-5955(00)00035-6; Pals C, 2013, J SPEECH LANG HEAR R, V56, P1075, DOI 10.1044/1092-4388(2012/12-0074); Papesh MH, 2012, INT J PSYCHOPHYSIOL, V83, P56, DOI 10.1016/j.ijpsycho.2011.10.002; Papsin BC, 2008, CURR OPIN OTOLARYNGO, V16, P69, DOI 10.1097/MOO.0b013e3282f5e97c; Ponton CW, 2000, CLIN NEUROPHYSIOL, V111, P220, DOI 10.1016/S1388-2457(99)00236-9; Poon BB, 2009, J ACOUST SOC AM, V126, P806, DOI 10.1121/1.3158821; Privitera CM, 2010, J VISION, V10, DOI 10.1167/10.10.3; Rauschecker JP, 1999, TRENDS NEUROSCI, V22, P74, DOI 10.1016/S0166-2236(98)01303-4; Riedel H, 2006, HEARING RES, V218, P5, DOI 10.1016/j.heares.2006.03.018; Rubinstein Jay T, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P444, DOI 10.1097/01.moo.0000134452.24819.c0; Rubinstein JT, 2003, ANN OTO RHINOL LARYN, V112, P14; Rubinstein JT, 1999, AM J OTOL, V20, P445; Salloum CAM, 2010, EAR HEARING, V31, P441, DOI 10.1097/AUD.0b013e3181d4f228; SAYERS BM, 1957, J ACOUST SOC AM, V29, P973, DOI 10.1121/1.1914990; SCHWARTZ IR, 1982, ACTA OTO-LARYNGOL, V93, P9, DOI 10.3109/00016488209130847; Seeber BU, 2008, J ACOUST SOC AM, V123, P1030, DOI 10.1121/1.2821965; Shepherd RK, 2001, AUDIOL NEURO-OTOL, V6, P305, DOI 10.1159/000046843; Smith ZM, 2007, JARO-J ASSOC RES OTO, V8, P134, DOI 10.1007/s10162-006-0069-0; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; Steel MM, EAR HEAR IN PRESS; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; Takeuchi T, 2011, PLOS ONE, V6, P1; TERAYAMA Y, 1977, ACTA OTO-LARYNGOL, V83, P291, DOI 10.3109/00016487709128848; Tillein J, 2010, CEREB CORTEX, V20, P492, DOI 10.1093/cercor/bhp222; Tirko NN, 2012, J COMP NEUROL, V520, P2202, DOI 10.1002/cne.23038; Tremblay KL, 2009, CLIN NEUROPHYSIOL, V120, P128, DOI 10.1016/j.clinph.2008.10.005; Van Deun L, 2010, EAR HEARING, V31, P702, DOI 10.1097/AUD.0b013e3181e40dfe; Van Deun L, 2010, AUDIOL NEURO-OTOL, V15, P7, DOI 10.1159/000218358; Van Deun L, 2009, AUDIOL NEURO-OTOL, V14, P240, DOI 10.1159/000190402; Van Deun L, 2009, EAR HEARING, V30, P178, DOI 10.1097/AUD.0b013e318194256b; van Hoesel RJM, 2007, J ACOUST SOC AM, V121, P2192, DOI 10.1121/1.2537300; van Hoesel RJM, 2004, AUDIOL NEURO-OTOL, V9, P234, DOI 10.1159/000078393; van Hoesel RJM, 2003, J ACOUST SOC AM, V113, P1617, DOI 10.1121/1.1539520; WADA SI, 1989, ELECTROEN CLIN NEURO, V72, P535, DOI 10.1016/0013-4694(89)90231-9; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; Yulek F, 2008, CURR EYE RES, V33, P263, DOI 10.1080/02713680801915284; Zekveld AA, 2010, EAR HEARING, V31, P480, DOI 10.1097/AUD.0b013e3181d4f251; Zhou JX, 2003, J ACOUST SOC AM, V114, P1508, DOI 10.1121/1.1600718	120	41	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117611	10.1371/journal.pone.0117611	http://dx.doi.org/10.1371/journal.pone.0117611			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2XY	25668423	Green Published, gold			2022-12-27	WOS:000349493000024
J	Lerner, CA; Sundar, IK; Yao, HW; Gerloff, J; Ossip, DJ; McIntosh, S; Robinson, R; Rahman, I				Lerner, Chad A.; Sundar, Isaac K.; Yao, Hongwei; Gerloff, Janice; Ossip, Deborah J.; McIntosh, Scott; Robinson, Risa; Rahman, Irfan			Vapors Produced by Electronic Cigarettes and E-Juices with Flavorings Induce Toxicity, Oxidative Stress, and Inflammatory Response in Lung Epithelial Cells and in Mouse Lung	PLOS ONE			English	Article							PROINFLAMMATORY CYTOKINE RELEASE; NF-KAPPA-B; CARBONYL-COMPOUNDS; SMOKE EXTRACT; MAINSTREAM; EXPOSURE; COTININE; NICOTINE; ACTIVATION; EMPHYSEMA	Oxidative stress and inflammatory response are the key events in the pathogenesis of chronic airway diseases. The consumption of electronic cigarettes (e-cigs) with a variety of e-liquids/e-juices is alarmingly increasing without the unrealized potential harmful health effects. We hypothesized that electronic nicotine delivery systems (ENDS)/e-cigs pose health concerns due to oxidative toxicity and inflammatory response in lung cells exposed to their aerosols. The aerosols produced by vaporizing ENDS e-liquids exhibit oxidant reactivity suggesting oxidants or reactive oxygen species (OX/ROS) may be inhaled directly into the lung during a "vaping" session. These OX/ROS are generated through activation of the heating element which is affected by heating element status (new versus used), and occurs during the process of e-liquid vaporization. Unvaporized e-liquids were oxidative in a manner dependent on flavor additives, while flavors containing sweet or fruit flavors were stronger oxidizers than tobacco flavors. In light of OX/ROS generated in ENDS e-liquids and aerosols, the effects of ENDS aerosols on tissues and cells of the lung were measured. Exposure of human airway epithelial cells (H292) in an air-liquid interface to ENDS aerosols from a popular device resulted in increased secretion of inflammatory cytokines, such as IL-6 and IL-8. Furthermore, human lung fibroblasts exhibited stress and morphological change in response to treatment with ENDS/e-liquids. These cells also secrete increased IL-8 in response to a cinnamon flavored e-liquid and are susceptible to loss of cell viability by ENDS e-liquids. Finally, exposure of wild type C57BL/6J mice to aerosols produced from a popular e-cig increase pro-inflammatory cytokines and diminished lung glutathione levels which are critical in maintaining cellular redox balance. Thus, exposure to e-cig aerosols/juices incurs measurable oxidative and inflammatory responses in lung cells and tissues that could lead to unrealized health consequences.	[Lerner, Chad A.; Sundar, Isaac K.; Yao, Hongwei; Gerloff, Janice; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA; [Ossip, Deborah J.; McIntosh, Scott] Univ Rochester, Med Ctr, Dept Publ Hlth Sci, Rochester, NY 14642 USA; [Robinson, Risa] Rochester Inst Technol, Dept Mech Engn, Rochester, NY 14623 USA	University of Rochester; University of Rochester; Rochester Institute of Technology	Rahman, I (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA.	irfan_rahman@urmc.rochester.edu	Yao, Hongwei/G-6444-2010; Sundar, Isaac K/F-8764-2012	Sundar, Isaac K/0000-0001-6742-3460; McIntosh, Scott/0000-0002-5776-9617	National Institute of Drug Abuse at the National Institutes of Health, NIH [R21DA036057, 2R01 HL085613, 1R01HL092842]; National Cancer Institute, NCI at the NIH [R01CA132950, R01CA152093]; University of Rochester Clinical Translational Research Institute, CTSI incubator project [5UL1RR024160];  [T32 HL066988]; NATIONAL CANCER INSTITUTE [R01CA152093, R01CA132950] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085613, T32HL066988, R01HL092842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA036057] Funding Source: NIH RePORTER	National Institute of Drug Abuse at the National Institutes of Health, NIH; National Cancer Institute, NCI at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Rochester Clinical Translational Research Institute, CTSI incubator project; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Drug Abuse at the National Institutes of Health, NIH (R21DA036057 to RR and IR), NIH 2R01 HL085613 (IR), 1R01HL092842 (IR), and by the National Cancer Institute, NCI at the NIH (R01CA132950 to DJO, and R01CA152093 to SM), pulmonary training grant T32 HL066988, and by the University of Rochester Clinical Translational Research Institute, CTSI 5UL1RR024160 incubator project (IR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson J, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-50; Alpar B, 1998, Clin Oral Investig, V2, P40, DOI 10.1007/s007840050042; Arnold C, 2014, ENVIRON HEALTH PERSP, V122, pA244, DOI 10.1289/ehp.122-A244; Baglole CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL19, DOI 10.1152/ajplung.00306.2005; Bahl V, 2012, REPROD TOXICOL, V34, P529, DOI 10.1016/j.reprotox.2012.08.001; Bakand S, 2012, INHAL TOXICOL, V24, P125, DOI 10.3109/08958378.2010.642021; Behar RZ, 2014, TOXICOL IN VITRO, V28, P198, DOI 10.1016/j.tiv.2013.10.006; BLACK MJ, 1974, ANAL BIOCHEM, V58, P246, DOI 10.1016/0003-2697(74)90464-3; Brown CJ, 2014, TOB CONTROL, V23, P4, DOI 10.1136/tobaccocontrol-2013-051476; Burstyn I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-18; Cervellati F, 2014, TOXICOL IN VITRO, V28, P999, DOI 10.1016/j.tiv.2014.04.012; Cheng TR, 2014, TOB CONTROL, V23, P11, DOI 10.1136/tobaccocontrol-2013-051482; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P5146, DOI 10.3390/ijerph10105146; Fuoco FC, 2014, ENVIRON POLLUT, V184, P523, DOI 10.1016/j.envpol.2013.10.010; Goniewicz ML, 2013, DRUG ALCOHOL REV, V32, P133, DOI 10.1111/j.1465-3362.2012.00512.x; Goniewicz ML, 2013, NICOTINE TOB RES, V15, P158, DOI 10.1093/ntr/nts103; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Goniewicz ML, 2011, NICOTINE TOB RES, V13, P202, DOI 10.1093/ntr/ntq237; Horn KH, 2008, REPROD TOXICOL, V26, P203, DOI 10.1016/j.reprotox.2008.09.013; Hua M, 2013, TOB CONTROL, V22, P103, DOI 10.1136/tobaccocontrol-2011-050226; Huang MF, 2005, INDOOR AIR, V15, P135, DOI 10.1111/j.1600-0668.2005.00330.x; Hung HF, 2001, J AEROSOL SCI, V32, P1201, DOI 10.1016/S0021-8502(01)00051-9; Hwang JW, 2014, FASEB J, V28, P176, DOI 10.1096/fj.13-232629; Jarvis MJ, 2001, TOB CONTROL, V10, P368, DOI 10.1136/tc.10.4.368; Jiang J, 2008, NANOTOXICOLOGY, V2, P33, DOI 10.1080/17435390701882478; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; Kosno K, 2012, FREE RADICAL REACTIO, P20; Lane ME, 2013, INT J PHARMACEUT, V447, P12, DOI 10.1016/j.ijpharm.2013.02.040; Laytragoon-Lewin N, 2011, ANTICANCER RES, V31, P1527; Lim HH, 2013, B KOREAN CHEM SOC, V34, P2691, DOI 10.5012/bkcs.2013.34.9.2691; Manke A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/942916; Maunders H, 2007, AM J PHYSIOL-LUNG C, V292, pL1248, DOI 10.1152/ajplung.00290.2006; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Nelson N, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju101; Paschke A, 2002, TOBACCO RES, P20; Pepper JK, 2014, CHEM RES TOXICOL, V27, P1336, DOI 10.1021/tx500200j; Phillips J, 2005, ATLA-ALTERN LAB ANIM, V33, P239, DOI 10.1177/026119290503300310; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Romagna G, 2013, INHAL TOXICOL, V25, P354, DOI 10.3109/08958378.2013.793439; Ruprecht Ario Alberto, 2014, Tumori, V100, pe24, DOI 10.1700/1430.15833; Schober W, 2014, INT J HYG ENVIR HEAL, V217, P628, DOI 10.1016/j.ijheh.2013.11.003; Schraufnagel DE, 2014, AM J RESP CRIT CARE, V190, P611, DOI 10.1164/rccm.201407-1198PP; Schripp T, 2013, INDOOR AIR, V23, P25, DOI 10.1111/j.1600-0668.2012.00792.x; Sitzwohl C, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5943; Sundar IK, 2013, ANTIOXID REDOX SIGN, V18, P1956, DOI 10.1089/ars.2012.4863; Thorne D, 2009, MUTAT RES-GEN TOX EN, V673, P3, DOI 10.1016/j.mrgentox.2008.11.008; Uchiyama S, 2013, ANAL SCI, V29, P1219, DOI 10.2116/analsci.29.1219; Weaver M, 2014, J ADDICT MED, V8, P234, DOI 10.1097/ADM.0000000000000043; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Winterbourn CC, 2014, BBA-GEN SUBJECTS, V1840, P730, DOI 10.1016/j.bbagen.2013.05.004; Xu X, 2014, SCI REP-UK, V4, DOI 10.1038/srep03864; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Yao HW, 2011, TOXICOL APPL PHARM, V254, P72, DOI 10.1016/j.taap.2009.10.022	59	393	402	6	169	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116732	10.1371/journal.pone.0116732	http://dx.doi.org/10.1371/journal.pone.0116732			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658421	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900063
J	Mao, LY; Zhang, Y; Mo, WJ; Yu, Y; Lu, H				Mao, Langyong; Zhang, Yan; Mo, Wenjuan; Yu, Yao; Lu, Hong			BANF1 Is Downregulated by IRF1-Regulated MicroRNA-203 in Cervical Cancer	PLOS ONE			English	Article							SUPPRESSES TUMOR-GROWTH; HUMAN-PAPILLOMAVIRUS; MIR-203; EXPRESSION; PROTEIN; ROLES; IRF-1; EPIGENETICS; BIOGENESIS; MECHANISM	MicroRNAs (miRNAs) play important roles in various biological processes and are closely associated with the development of cancer. In fact, aberrant expression of miRNAs has been implicated in numerous cancers. In cervical cancer, miR-203 levels are decreased, although the cause of this aberrant expression remains unclear. In this study, we investigate the molecular mechanisms regulating miR-203 gene transcription. We identify the miR-203 transcription start site by 5' rapid amplification of cDNA ends and subsequently identify the miR-203 promoter region. Promoter analysis revealed that IRF1, a transcription factor, regulates miR-203 transcription by binding to the miR-203 promoter. We also demonstrate that miR-203 targets the 3' untranslated region of BANF1, thus downregulating its expression, whereas miR-203 expression is driven by IRF1. MiR-203 is involved in cell cycle regulation and overexpression of miR-203 suppresses cervical cancer cell proliferation, colony formation, migration and invasion. The inhibitory effect of miR-203 on the cancer cells is partially mediated by downregulating its target, BANF1, since knockdown of BANF1 also suppresses colony formation, migration and invasion.	[Mao, Langyong; Mo, Wenjuan; Yu, Yao; Lu, Hong] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Yan] Changhai Hosp, Dept Gynecol & Obstet, Shanghai, Peoples R China; [Yu, Yao; Lu, Hong] Shanghai Engn Res Ctr Ind Microorganisms, Shanghai, Peoples R China; [Lu, Hong] Shanghai Collaborat Innovat Ctr Biomfg Technol, Shanghai, Peoples R China	Fudan University; Naval Medical University	Lu, H (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	honglu0211@yahoo.com		Yu, Yao/0000-0003-0090-8193				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Chen HM, 1998, P NATL ACAD SCI USA, V95, P15270, DOI 10.1073/pnas.95.26.15270; Davalos V, 2010, CURR OPIN ONCOL, V22, P35, DOI 10.1097/CCO.0b013e328333dcbb; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Hata A, 2009, CYTOKINE GROWTH F R, V20, P517, DOI 10.1016/j.cytogfr.2009.10.004; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Manikandan J, 2008, BIOINFORMATION, V2, P330, DOI 10.6026/97320630002330; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Park JS, 2000, J BIOL CHEM, V275, P6764, DOI 10.1074/jbc.275.10.6764; Pereira PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011780; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Qian JJ, 2011, GENOMICS, V97, P294, DOI 10.1016/j.ygeno.2011.02.004; Rao QX, 2012, MED ONCOL, V29, P1242, DOI 10.1007/s12032-011-9830-2; Romeo G, 2002, J INTERF CYTOK RES, V22, P39, DOI 10.1089/107999002753452647; Rouhi A, 2008, MAMM GENOME, V19, P517, DOI 10.1007/s00335-008-9133-x; Saini HK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-564; Saito Y, 2006, CELL CYCLE, V5, P2220, DOI 10.4161/cc.5.19.3340; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Segura-Totten M, 2004, TRENDS CELL BIOL, V14, P261, DOI 10.1016/j.tcb.2004.03.004; Takama H, 2013, J DERMATOL SCI, V71, P100, DOI 10.1016/j.jdermsci.2013.04.007; Takaoka A, 2008, CANCER SCI, V99, P467, DOI 10.1111/j.1349-7006.2007.00720.x; Taniguchi T, 1997, BBA-REV CANCER, V1333, pM9, DOI 10.1016/S0304-419X(97)00014-0; Torres A, 2011, MED RES REV, V31, P895, DOI 10.1002/med.20205; Um SJ, 2002, CANCER LETT, V179, P205, DOI 10.1016/S0304-3835(01)00871-0; Van Maele B, 2006, TRENDS BIOCHEM SCI, V31, P98, DOI 10.1016/j.tibs.2005.12.002; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073985; Wang GZ, 2010, REPRODUCTIVE HEALTH AND GENDER EQUALITY: METHOD, MEASUREMENT, AND IMPLICATIONS, P1; Wang XH, 2014, P NATL ACAD SCI USA, V111, P4262, DOI 10.1073/pnas.1401430111; Wiklund ED, 2010, EPIGENOMICS-UK, V2, P823, DOI 10.2217/EPI.10.51; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088745; Zhang F, 2014, CANCER LETT, V342, P121, DOI 10.1016/j.canlet.2013.08.037; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhou YF, 2014, MOL ONCOL, V8, P83, DOI 10.1016/j.molonc.2013.09.004; Zhu XY, 2013, CELL PHYSIOL BIOCHEM, V32, P64, DOI 10.1159/000350125	43	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117035	10.1371/journal.pone.0117035	http://dx.doi.org/10.1371/journal.pone.0117035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658920	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900094
J	Poulin-Dubois, D; Crivello, C; Wright, K				Poulin-Dubois, Diane; Crivello, Cristina; Wright, Kristyn			Biological Motion Primes the Animate/Inanimate Distinction in Infancy	PLOS ONE			English	Article							SEQUENTIAL-TOUCHING TASK; YOUNG-CHILDREN; CATEGORIZATION; PERCEPTION; PREFERENCE; DISPLAYS; ANIMALS; LEVEL; RECOGNITION; HABITUATION	Given that biological motion is both detected and preferred early in life, we tested the hypothesis that biological motion might be instrumental to infants' differentiation of animate and inanimate categories. Infants were primed with either point-light displays of realistic biological motion, random motion, or schematic biological motion of an unfamiliar shape. After being habituated to these displays, 12-month-old infants categorized animals and vehicles as well as furniture and vehicles with the sequential touching task. The findings indicated that infants primed with point-light displays of realistic biological motion showed better categorization of animates than those exposed to random or schematic biological motion. These results suggest that human biological motion might be one of the motion cues that provide the building blocks for infants' concept of animacy.	[Poulin-Dubois, Diane; Crivello, Cristina; Wright, Kristyn] Concordia Univ, Dept Psychol, Ctr Res Human Dev, Montreal, PQ H3G 1M8, Canada	Concordia University - Canada	Poulin-Dubois, D (corresponding author), Concordia Univ, Dept Psychol, Ctr Res Human Dev, Montreal, PQ H3G 1M8, Canada.	diane.poulindubois@concordia.ca			Natural Sciences and Engineering Research Council of Canada [2003-2013]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was funded by the Natural Sciences and Engineering Research Council of Canada (grant # 2003-2013) to Diane Poulin-Dubois. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arterberry ME, 2002, COGNITION, V86, P1, DOI 10.1016/S0010-0277(02)00108-7; Barr R, 2002, MEM COGNITION, V30, P246, DOI 10.3758/BF03195285; BERTENTHAL B. I., 1993, VISUAL PERCEPTION CO, V21, P175; Bidet-Ildei C, 2014, DEV PSYCHOL, V50, P113, DOI 10.1037/a0032956; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Bornstein MH, 2010, DEV PSYCHOL, V46, P350, DOI 10.1037/a0018411; Cohen LB, 2004, INFANT CHILD DEV, V13, P349, DOI 10.1002/icd.355; Cohen LB, 2000, INFANCY, V1, P1, DOI 10.1207/S15327078IN0101_01; Dixon WE, 2007, BEHAV RES METHODS, V39, P407, DOI 10.3758/BF03193010; Dixon WE, 1998, BEHAV RES METH INS C, V30, P592, DOI 10.3758/BF03209476; Elsner B, 2013, DEV COGN NEUROS-NETH, V3, P53, DOI 10.1016/j.dcn.2012.09.002; FOX R, 1982, SCIENCE, V218, P486, DOI 10.1126/science.7123249; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Grossman ED, 2001, VISION RES, V41, P1475, DOI 10.1016/S0042-6989(00)00317-5; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kline RB, 2009, PRACTICAL DATA ANALY, P225; Kosugi D, 2002, JPN PSYCHOL RES, V44, P66, DOI 10.1111/1468-5884.00008; LESLIE AM, 1984, BRIT J DEV PSYCHOL, V2, P19, DOI 10.1111/j.2044-835X.1984.tb00531.x; Luo Y, 2005, PSYCHOL SCI, V16, P601, DOI 10.1111/j.1467-9280.2005.01582.x; Mandler JM, 2012, COGNITIVE SCI, V36, P421, DOI 10.1111/j.1551-6709.2012.01241.x; MANDLER JM, 1991, COGNITIVE PSYCHOL, V23, P263, DOI 10.1016/0010-0285(91)90011-C; MANDLER JM, 1988, COGNITIVE DEV, V3, P247, DOI 10.1016/0885-2014(88)90011-1; MANDLER JM, 1993, COGNITIVE DEV, V8, P291, DOI 10.1016/S0885-2014(93)80003-C; MANDLER JM, 1992, PSYCHOL REV, V99, P587, DOI 10.1037/0033-295X.99.4.587; Mandler JM, 1998, DEV PSYCHOL, V34, P1274, DOI 10.1037/0012-1649.34.6.1274; MANDLER JM, 1987, COGNITIVE DEV, V2, P339, DOI 10.1016/S0885-2014(87)80012-6; Mandler JM., 2004, FDN MIND ORIGINS CON; Mareschal D, 2001, TRENDS COGN SCI, V5, P443, DOI 10.1016/S1364-6613(00)01752-6; Mareschal D, 2008, INFANCY, V13, P620, DOI 10.1080/15250000802458658; Markson L, 2006, INFANCY, V9, P45, DOI 10.1207/s15327078in0901_3; Michotte A. E, 1963, PERCEPTION CAUSALITY; Moore DG, 2007, COGNITION, V104, P377, DOI 10.1016/j.cognition.2006.07.007; Oakes LM, 2002, INFANT BEHAV DEV, V25, P529, DOI 10.1016/S0163-6383(02)00149-2; Opfer J. E., 2011, WILEY BLACKWELL HDB, P213; Over H, 2009, PSYCHOL SCI, V20, P1189, DOI 10.1111/j.1467-9280.2009.02419.x; Pauen S, 2002, INT J BEHAV DEV, V26, P492, DOI 10.1080/01650250143000445; Pauen S, 2009, COGNITIVE PSYCHOL, V59, P275, DOI 10.1016/j.cogpsych.2009.06.001; Pavlova M, 2001, PERCEPTION, V30, P925, DOI 10.1068/p3157; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Poulin-Dubois D, 2006, J COGN DEV, V7, P431, DOI 10.1207/s15327647jcd0704_1; PoulinDubois D, 1996, COGNITIVE DEV, V11, P19, DOI 10.1016/S0885-2014(96)90026-X; Rakison DH, 2001, PSYCHOL BULL, V127, P209, DOI 10.1037//0033-2909.127.2.209; Rostad K, 2012, INFANT BEHAV DEV, V35, P584, DOI 10.1016/j.infbeh.2012.05.005; Saxe R, 2005, PSYCHOL SCI, V16, P995, DOI 10.1111/j.1467-9280.2005.01649.x; Saxe R, 2007, DEV PSYCHOL, V43, P149, DOI 10.1037/0012-1649.43.1.149; Schlottmann A, 1999, PERCEPTION, V28, P1105, DOI 10.1068/p2767; Schlottmann A, 2002, CHILD DEV, V73, P1656, DOI 10.1111/1467-8624.00497; Schlottmann A, 2010, DEVELOPMENTAL SCI, V13, P1, DOI 10.1111/j.1467-7687.2009.00854.x; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; SPELKE ES, 1995, BRIT J DEV PSYCHOL, V13, P113, DOI 10.1111/j.2044-835X.1995.tb00669.x; STARKEY D, 1981, CHILD DEV, V52, P489, DOI 10.2307/1129166; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; WOODWARD AL, 1993, PROCEEDINGS OF THE FIFTEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P1087; Yoon JMD, 2009, CHILD DEV, V80, P1069, DOI 10.1111/j.1467-8624.2009.01317.x; Younger BA, 2000, INFANCY, V1, P47, DOI 10.1207/S15327078IN0101_05	57	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116910	10.1371/journal.pone.0116910	http://dx.doi.org/10.1371/journal.pone.0116910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25659077	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000349444900077
J	Yip, W; Sabanayagam, C; Teo, BW; Tay, WT; Ikram, MK; Tai, ES; Chow, KY; Wong, TY; Cheung, CY				Yip, WanFen; Sabanayagam, Charumathi; Teo, Boon Wee; Tay, Wan Ting; Ikram, M. Kamran; Tai, E. Shyong; Chow, Khuan Yew; Wong, Tien Y.; Cheung, Carol Y.			Retinal Microvascular Abnormalities and Risk of Renal Failure in Asian Populations	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; VESSEL DIAMETERS; FRACTAL ANALYSIS; SINGAPORE; PROGRESSION; PREVALENCE; NEPHROPATHY; METHODOLOGY	Background Retinal microvascular signs may provide insights into the structure and function of small vessels that are associated with renal disease. We examined the relationship of retinal microvascular signs with both prevalent and incident end-stage renal disease (ESRD) in a multi-ethnic Asian population. Methods A total of 5763 subjects (aged >= 40 years) from two prospective population-based studies (the Singapore Malay Eye Study and the Singapore Prospective Study) were included for the current analysis. Retinopathy was graded using the modified Airlie House classification system. Retinal vascular parameters were measured using computer-assisted programs to quantify the retinal vessel widths (arteriolar and venular caliber) and retinal vascular network (fractal dimension). Data on ESRD was obtained by record linkage with the ESRD cases registered by National Registry of Diseases Office, Singapore. Multi-variable adjusted regression analyses were performed to assess the associations of baseline retinal vascular parameters and prevalent and incident ESRD. Results At baseline, 21(0.36%) persons had prevalent ESRD. During a median follow-up of 4.3 years, 33 (0.57%) subjects developed ESRD. In our analyses, retinopathy was associated with prevalent ESRD (multi-variable adjusted odds ratio [OR], 3.21, 95% confidence interval [CI]: 1.28-8.05) and incident ESRD (multi-variable adjusted hazard ratio [HR], 2.51, 95% CI: 1.14-5.54). This association was largely seen in person with diabetes (HR, 2.60, 95% CI: 1.01-6.66) and not present in persons without diabetes (HR, 1.65, 95% CI: 0.14-18.98). Retinal arteriolar caliber, retinal venular caliber and retinal vascular fractal dimension were not associated with ESRD. Conclusion Retinopathy signs in persons with diabetes are related to an increased risk of ESRD; however, other microvascular changes in the retina are not associated with ESRD.	[Yip, WanFen; Sabanayagam, Charumathi; Tay, Wan Ting; Ikram, M. Kamran; Wong, Tien Y.; Cheung, Carol Y.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Yip, WanFen; Sabanayagam, Charumathi; Wong, Tien Y.; Cheung, Carol Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Yip, WanFen; Sabanayagam, Charumathi; Teo, Boon Wee; Tai, E. Shyong; Wong, Tien Y.; Cheung, Carol Y.] Natl Univ Hlth Syst, Singapore, Singapore; [Sabanayagam, Charumathi; Ikram, M. Kamran; Wong, Tien Y.; Cheung, Carol Y.] Duke NUS Grad Med Sch, Off Clin Sci, Singapore, Singapore; [Teo, Boon Wee; Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Ikram, M. Kamran] Natl Univ Hlth Syst, Memory Aging & Cognit Ctr, Singapore, Singapore; [Chow, Khuan Yew] Natl Registry Dis Off, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Cheung, CY (corresponding author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore.	carol.cheung.y.l@seri.com.sg	Cheung, Carol Y./G-7895-2016; Cheung, Carol/AAF-1101-2020; Sabanayagam, Charumathi/C-1294-2011; Wong, Tien Yin/AAC-9724-2020	Cheung, Carol/0000-0002-9672-1819; Sabanayagam, Charumathi/0000-0002-4042-4719; Wong, Tien Yin/0000-0002-8448-1264; Tai, E Shyong/0000-0003-2929-8966; Ikram, Mohammad Kamran/0000-0003-0173-9571; Cheung, Carol/0000-0003-0869-859X	National Medical Research Council (NMRC) [R607/28/2008]	National Medical Research Council (NMRC)(National Medical Research Council, Singapore)	This work was supported by National Medical Research Council (NMRC) R607/28/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexei V, 2002, J RENIN-ANGIO-ALDO S, V3, P16; Amann K, 2000, J AM SOC NEPHROL, V11, P1702, DOI 10.1681/ASN.V1191702; [Anonymous], 2013, SYST USRD USRDS 2013; Awua-Larbi S, 2011, NEPHROL DIAL TRANSPL, V26, P3523, DOI 10.1093/ndt/gfr095; Board HP, 2012, DROP; Board HP, 2012, 8 BOARD HP; Cheung CYL, 2012, HYPERTENSION, V60, P1094, DOI 10.1161/HYPERTENSIONAHA.111.189142; Chew EY, 1996, ARCH OPHTHALMOL-CHIC, V114, P1079, DOI 10.1001/archopht.1996.01100140281004; Cutter J, 2001, B WORLD HEALTH ORGAN, V79, P908; Earle KA, 2001, NEPHROL DIAL TRANSPL, V16, P286, DOI 10.1093/ndt/16.2.286; Edwards MS, 2005, AM J KIDNEY DIS, V46, P214, DOI 10.1053/j.ajkd.2005.05.005; El-Asrar A M, 2001, Int Ophthalmol, V24, P1, DOI 10.1023/A:1014409829614; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; FREEDMAN BI, 1995, AM J KIDNEY DIS, V25, P207, DOI 10.1016/0272-6386(95)90001-2; Grunwald JE, 2014, CLIN J AM SOC NEPHRO, V9, P1217, DOI 10.2215/CJN.11761113; He F, 2013, DIABETOLOGIA, V56, P457, DOI 10.1007/s00125-012-2796-6; Hoffmann F, 2011, NEPHROL DIAL TRANSPL, V26, P1634, DOI 10.1093/ndt/gfq609; Hughes K, 1997, J EPIDEMIOL COMMUN H, V51, P394, DOI 10.1136/jech.51.4.394; HUGHES K, 1990, J EPIDEMIOL COMMUN H, V44, P29, DOI 10.1136/jech.44.1.29; Ikram MK, 2013, OPHTHALMOLOGICA, V229, P125, DOI 10.1159/000342158; JACOBSON HR, 1991, LANCET, V338, P419, DOI 10.1016/0140-6736(91)91042-S; Jennette JC OJ, 1998, DIABETES MELLITUS HE, P41, DOI [10.1148/radiol.14144045, DOI 10.1148/RADIOL.14144045]; JENSEN T, 1992, HORM METAB RES, V26, P68; Klein BEK, 2009, ARCH OPHTHALMOL-CHIC, V127, P1175, DOI 10.1001/archophthalmol.2009.172; Klein R, 2005, DIABETES, V54, P527, DOI 10.2337/diabetes.54.2.527; KLEIN R, 1986, OPHTHALMOLOGY, V93, P1183; Klein R, 2000, ARTERIOSCL THROM VAS, V20, P1644, DOI 10.1161/01.ATV.20.6.1644; Klein R, 1999, DIABETES CARE, V22, P743, DOI 10.2337/diacare.22.5.743; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Liew G, 2008, OPHTHALMOLOGY, V115, P1951, DOI 10.1016/j.ophtha.2008.05.029; Liew G, 2007, INVEST OPHTH VIS SCI, V48, P52, DOI 10.1167/iovs.06-0672; Liew G, 2006, HYPERTENSION, V48, pE10, DOI 10.1161/01.HYP.0000231652.97173.4c; Lim LS, 2013, INVEST OPHTH VIS SCI, V54, P2970, DOI 10.1167/iovs.13-11941; London GM, 1997, KIDNEY INT, V51, P1678, DOI 10.1038/ki.1997.233; MacGillivray TJ, 2007, P ANN INT IEEE EMBS, P6456; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Roderick PJ, 1996, J EPIDEMIOL COMMUN H, V50, P334, DOI 10.1136/jech.50.3.334; Sabanayagam C, 2011, AM J KIDNEY DIS, V57, P682, DOI 10.1053/j.ajkd.2010.11.025; Sabanayagam C, 2009, J HYPERTENS, V27, P2209, DOI 10.1097/HJH.0b013e328330141d; Schwartz MM, 1998, NEPHROL DIAL TRANSPL, V13, P2547, DOI 10.1093/ndt/13.10.2547; Skyler JS, 2001, ENDOCRIN METAB CLIN, V30, P833, DOI 10.1016/S0889-8529(05)70218-8; Sng CCA, 2010, NEPHROL DIAL TRANSPL, V25, P2252, DOI 10.1093/ndt/gfq007; Stenvinkel P, 2006, NEPHROLOGY, V11, P36, DOI 10.1111/j.1440-1797.2006.00541.x; Tan CE, 1999, DIABETES CARE, V22, P241, DOI 10.2337/diacare.22.2.241; Tornig J, 1996, J AM SOC NEPHROL, V7, P667; Weiner DE, 2010, AM J KIDNEY DIS, V55, P5, DOI 10.1053/j.ajkd.2009.11.004; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Wong TY, 2008, ARCH OPHTHALMOL-CHIC, V126, P1091, DOI 10.1001/archopht.126.8.1091; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Wong TY, 2004, J AM SOC NEPHROL, V15, P2469, DOI 10.1097/01.ASN.0000136133.28194.E4; Wong TY, 2004, OPHTHALMOLOGY, V111, P1183, DOI 10.1016/j.ophtha.2003.09.039; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X; Yau JWY, 2011, AM J KIDNEY DIS, V58, P39, DOI 10.1053/j.ajkd.2011.02.382	54	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118076	10.1371/journal.pone.0118076	http://dx.doi.org/10.1371/journal.pone.0118076			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658337	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900260
J	Adrion, ER; Aucott, J; Lemke, KW; Weiner, JP				Adrion, Emily R.; Aucott, John; Lemke, Klaus W.; Weiner, Jonathan P.			Health Care Costs, Utilization and Patterns of Care following Lyme Disease	PLOS ONE			English	Article							BORRELIA-BURGDORFERI; UNITED-STATES; PREVENTION; IMPACT	Background Lyme disease is the most frequently reported vector borne infection in the United States. The Centers for Disease Control have estimated that approximately 10% to 20% of individuals may experience Post-Treatment Lyme Disease Syndrome - a set of symptoms including fatigue, musculoskeletal pain, and neurocognitive complaints that persist after initial antibiotic treatment of Lyme disease. Little is known about the impact of Lyme disease or post-treatment Lyme disease symptoms (PTLDS) on health care costs and utilization in the United States. Objectives 1) to examine the impact of Lyme disease on health care costs and utilization, 2) to understand the relationship between Lyme disease and the probability of developing PTLDS, 3) to understand how PTLDS may impact health care costs and utilization. Methods This study utilizes retrospective data on medical claims and member enrollment for persons aged 0-64 years who were enrolled in commercial health insurance plans in the United States between 2006-2010. 52,795 individuals treated for Lyme disease were compared to 263,975 matched controls with no evidence of Lyme disease exposure. Results Lyme disease is associated with $2,968 higher total health care costs (95% CI: 2,8073,128, p<.001) and 87% more outpatient visits (95% CI: 86%-89%, p<.001) over a 12-month period, and is associated with 4.77 times greater odds of having any PTLDS-related diagnosis, as compared to controls (95% CI: 4.67-4.87, p<.001). Among those with Lyme disease, having one or more PTLDS-related diagnosis is associated with $3,798 higher total health care costs (95% CI: 3,542-4,055, p<.001) and 66% more outpatient visits ( 95% CI: 64%-69%, p<.001) over a 12-month period, relative to those with no PTLDS-related diagnoses. Conclusions Lyme disease is associated with increased costs above what would be expected for an easy to treat infection. The presence of PTLDS-related diagnoses after treatment is associated with significant health care costs and utilization.	[Adrion, Emily R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MA USA; [Aucott, John] Johns Hopkins Univ, Div Rheumatol, Johns Hopkins Greenspring Stn, Sch Med, Baltimore, MD 21218 USA; [Adrion, Emily R.] Johns Hopkins Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Weiner, Jonathan P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Aucott, J (corresponding author), Johns Hopkins Univ, Div Rheumatol, Johns Hopkins Greenspring Stn, Sch Med, 10755 Falls Rd,Suite 200, Baltimore, MD 21218 USA.	Jaucott2@jhmi.edu	DeHaas, Keith/I-4957-2017	Lemke, Klaus/0000-0001-6936-5946	Lyme Disease Research Foundation	Lyme Disease Research Foundation	The acquisition and analysis of the data was funded by a grant from the Lyme Disease Research Foundation. The Lyme Disease Research Foundation was not involved in the design and conduct of the study, the statistical analysis or in any publication decisions.	AgueroRosenfeld ME, 1996, J CLIN MICROBIOL, V34, P1; Aucott JN, 2013, QUAL LIFE RES, V22, P75, DOI 10.1007/s11136-012-0126-6; Aucott JN, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-173; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Centers for Disease Control and Prevention, 2013, POST TREATM LYM DIS; Centers for Disease Control and Prevention, 2012, REP CAS LYM DIS YEAR; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P669; Fallon BA, 2008, NEUROLOGY, V70, P992, DOI 10.1212/01.WNL.0000284604.61160.2d; Feder HM, 2007, NEW ENGL J MED, V357, P1422, DOI 10.1056/NEJMra072023; Henningsson AJ, 2010, CLIN MICROBIOL INFEC, V16, P1245, DOI 10.1111/j.1469-0691.2009.03059.x; Hinckley AF, 2014, CLIN INFECT DIS, V59, P676, DOI 10.1093/cid/ciu397; Johns Hopkins School of Public Health, J HOPK ACG R SYST VE; Johnson L, 2011, HEALTH POLICY, V102, P64, DOI 10.1016/j.healthpol.2011.05.007; Joss AWL, 2003, PUBLIC HEALTH, V117, P264, DOI 10.1016/S0033-3506(03)00067-2; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Krupp LB, 2003, NEUROLOGY, V60, P1923, DOI 10.1212/01.WNL.0000071227.23769.9E; LEY C, 1994, JAMA-J AM MED ASSOC, V271, P460, DOI 10.1001/jama.271.6.460; Maes E, 1998, CLIN THER, V20, P993, DOI 10.1016/S0149-2918(98)80081-7; MAGID D, 1992, NEW ENGL J MED, V327, P534, DOI 10.1056/NEJM199208203270806; Muller I, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/595427; Shadick NA, 1999, ANN INTERN MED, V131, P919, DOI 10.7326/0003-4819-131-12-199912210-00003; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Vanderhoof IT, 1993, CONTINGENCIES    JAN, P42; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Zhang XZ, 2006, EMERG INFECT DIS, V12, P653, DOI 10.3201/eid1204.050602	26	121	124	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0116767	10.1371/journal.pone.0116767	http://dx.doi.org/10.1371/journal.pone.0116767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA9NG	25650808	Green Submitted, gold, Green Published			2022-12-27	WOS:000349250700006
J	Li, G; Hu, HH; Dong, Z; Xie, J; Zhou, Y				Li, Gang; Hu, Huanhuan; Dong, Zhong; Xie, Jin; Zhou, Ying			Urban and Suburban Differences in Hypertension Trends and Self-Care: Three Population-Based Cross-Sectional Studies from 2005-2011	PLOS ONE			English	Article							PREVALENCE; AWARENESS; ASSOCIATION; BEHAVIORS; ADULTS; RATES; CHINA	Objectives This study aimed to compare hypertension trends in the urban and suburban population, and to examine the use of several self-care behaviors among patients who were aware of their hypertension. Methods We examined the data from three cross-sectional adult populations obtained in 2005, 2008, and 2011, in Beijing. Results Our analyses indicated that from 2005 to 2011 the standardized rate of hypertension increased from 31.9% to 36.0% (P <0.001) among urban adults, and was relatively stable (40.8% -40.2%) among suburban adults (P = 0.02). About 10% of the patients reported having taken measures to control their weight for hypertension management. As compared to the other patients, the female patients in the urban areas reported the highest rate of regular BP measurement (52.6%). In addition, the patients who reported taking medication regularly increased among the males and females. Most of the women reported nonsmoking (>= 95%) and alcohol abstinence (>= 90%). The trend of nonsmoking decreased among the urban males. In contrast, the prevalence of nonsmoking increased among the suburban males, though the trend was not statistically significant (P = 0.055). Further, the patient-reported alcohol abstinence was found to exhibit a decreasing trend among the males. Conclusions We observed an increase in the hypertension prevalence from 2005 to 2011. The rates remained higher for suburban adults than for urban adults. Females generally had better self-care ability as compared to male patients. Further research is needed to promote self-care behaviors in hypertensive patients, especially for male patients.	[Li, Gang; Dong, Zhong; Xie, Jin; Zhou, Ying] Beijing Ctr Dis Control & Prevent, Inst Chron Dis Control & Prevent, Beijing, Peoples R China; [Hu, Huanhuan] Waseda Univ, Grad Sch Sport Sci, Lab Exercise Epidemiol, Saitama, Japan	Waseda University	Li, G (corresponding author), Beijing Ctr Dis Control & Prevent, Inst Chron Dis Control & Prevent, Beijing, Peoples R China.	ligangcn@126.com			Beijing Health Bureau	Beijing Health Bureau	This work was supported by Beijing Health Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2013, FRONT PUBLIC HEALTH, DOI [10.3389/fpubh.2013.00074, DOI 10.3389/FPUBH.2013.00074]; Bogner HR, 2008, ANN FAM MED, V6, P295, DOI 10.1370/afm.843; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065938; Gupta R, 2010, INDIAN J MED RES, V132, P531; Hou XH, 2008, ASIA-PAC J PUBLIC HE, V20, P159, DOI 10.1177/1010539507312306; Hu HH, 2013, ISRN PUBLIC HLTH; Hu HH, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/526949; Hu SS, 2012, BIOMED ENVIRON SCI, V25, P251, DOI 10.3967/0895-3988.2012.03.001; Lee JE, 2010, INT J NURS STUD, V47, P411, DOI 10.1016/j.ijnurstu.2009.09.011; Ma WJ, 2012, AM J HYPERTENS, V25, P590, DOI 10.1038/ajh.2012.11; Ma YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058302; MarquesVidal P, 1997, J HUM HYPERTENS, V11, P213, DOI 10.1038/sj.jhh.1000426; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; Modesti PA, 2014, J HYPERTENS, V32, P951, DOI 10.1097/HJH.0000000000000125; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; Peters RM, 2008, RES NURS HEALTH, V31, P543, DOI 10.1002/nur.20287; Trivedi RB, 2008, J BEHAV MED, V31, P489, DOI 10.1007/s10865-008-9173-4; Wang TJ, 1999, CIRCULATION, V99, P2055, DOI 10.1161/01.CIR.99.15.2055; Wang X, 2014, J HYPERTENS, V32, P1919, DOI 10.1097/HJH.0000000000000252; Warren-Findlow J, 2012, J COMMUN HEALTH, V37, P15, DOI 10.1007/s10900-011-9410-6; Warren-Findlow J, 2011, J NATL MED ASSOC, V103, P503, DOI 10.1016/S0027-9684(15)30365-5; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yoon Sung Sug, 2012, NCHS Data Brief, P1	25	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117999	10.1371/journal.pone.0117999	http://dx.doi.org/10.1371/journal.pone.0117999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UO	25665069	Green Published, gold, Green Submitted			2022-12-27	WOS:000349123100027
J	Minami, H; Isomoto, H; Miuma, S; Kobayashi, Y; Yamaguchi, N; Urabe, S; Matsushima, K; Akazawa, Y; Ohnita, K; Takeshima, F; Inoue, H; Nakao, K				Minami, Hitomi; Isomoto, Hajime; Miuma, Satoshi; Kobayashi, Yasutoshi; Yamaguchi, Naoyuki; Urabe, Shigetoshi; Matsushima, Kayoko; Akazawa, Yuko; Ohnita, Ken; Takeshima, Fuminao; Inoue, Haruhiro; Nakao, Kazuhiko			New Endoscopic Indicator of Esophageal Achalasia: "Pinstripe Pattern"	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; EOSINOPHILIC ESOPHAGITIS; PNEUMATIC DILATION; CANCER	Background and Study Aims Endoscopic diagnosis of esophageal achalasia lacking typical endoscopic features can be extremely difficult. The aim of this study was to identify simple and reliable early indicator of esophageal achalasia. Patients and Methods This single-center retrospective study included 56 cases of esophageal achalasia without previous treatment. As a control, 60 non-achalasia subjects including reflux esophagitis and superficial esophageal cancer were also included in this study. Endoscopic findings were evaluated according to Descriptive Rules for Achalasia of the Esophagus as follows: (1) esophageal dilatation, (2) abnormal retention of liquid and/or food, (3) whitish change of the mucosal surface, (4) functional stenosis of the esophago-gastric junction, and (5) abnormal contraction. Additionally, the presence of the longitudinal superficial wrinkles of esophageal mucosa, "pinstripe pattern (PSP)" was evaluated endoscopically. Then, inter-observer diagnostic agreement was assessed for each finding. Results The prevalence rates of the above-mentioned findings (1-5) were 41.1%, 41.1%, 16.1%, 94.6%, and 43.9%, respectively. PSP was observed in 60.7% of achalasia, while none of the control showed positivity for PSP. PSP was observed in 26 (62.5%) of 35 cases with shorter history < 10 years, which usually lacks typical findings such as severe esophageal dilation and tortuosity. Inter-observer agreement level was substantial for food/liquid remnant (k = 0.6861) and PSP (k = 0.6098), and was fair for abnormal contraction and white change. The accuracy, sensitivity, and specificity for achalasia were 83.8%, 64.7%, and 100%, respectively. Conclusion "Pinstripe pattern" could be a reliable indicator for early discrimination of primary esophageal achalasia.	[Minami, Hitomi; Isomoto, Hajime; Miuma, Satoshi; Yamaguchi, Naoyuki; Urabe, Shigetoshi; Matsushima, Kayoko; Akazawa, Yuko; Ohnita, Ken; Takeshima, Fuminao; Nakao, Kazuhiko] Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Nagasaki, Japan; [Kobayashi, Yasutoshi] Kobayashi Internal Med Clin, Kobe, Hyogo, Japan; [Inoue, Haruhiro] Showa Univ, Northern Yokohama Hosp, Ctr Digest Dis, Yokohama, Kanagawa, Japan	Nagasaki University; Showa University	Isomoto, H (corresponding author), Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Nagasaki, Japan.	hajimei2002@yahoo.co.jp						Bassett J, 2009, DIS ESOPHAGUS, V22, P543, DOI 10.1111/j.1442-2050.2009.00949.x; Dellon ES, 2013, GASTROENTEROL CLIN N, V42, P133, DOI 10.1016/j.gtc.2012.11.008; Dunaway Peter M., 2001, Curr Treat Options Gastroenterol, V4, P89, DOI 10.1007/s11938-001-0051-1; ECKARDT VF, 1992, GASTROENTEROLOGY, V103, P1732, DOI 10.1016/0016-5085(92)91428-7; Heller, 1913, MITT GRENZGEB MED CH, V27, P141; HOWARD PJ, 1992, GUT, V33, P1011, DOI 10.1136/gut.33.8.1011; Inoue H, 2010, ENDOSCOPY, V42, P265, DOI 10.1055/s-0029-1244080; Iwakiri K, 2010, J GASTROENTEROL, V45, P422, DOI 10.1007/s00535-009-0179-7; Junginger T, 2002, LONG TERM OUTCOME MY; Leeuwenburgh I, 2010, AM J GASTROENTEROL, V105, P2144, DOI 10.1038/ajg.2010.263; Leeuwenburgh I, 2010, DIS ESOPHAGUS, V23, P506, DOI 10.1111/j.1442-2050.2009.01040.x; Loviscek L F, 1998, Dis Esophagus, V11, P239; PORSCHEN R, 1995, GASTROENTEROLOGY, V108, P545, DOI 10.1016/0016-5085(95)90084-5; Spiess AE, 1998, JAMA-J AM MED ASSOC, V280, P638, DOI 10.1001/jama.280.7.638; STREITZ JM, 1995, ANN THORAC SURG, V59, P1604, DOI 10.1016/0003-4975(94)00997-L; West RL, 2002, AM J GASTROENTEROL, V97, P1346, DOI 10.1016/S0002-9270(02)04127-8	16	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0101833	10.1371/journal.pone.0101833	http://dx.doi.org/10.1371/journal.pone.0101833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664812	gold, Green Published, Green Submitted			2022-12-27	WOS:000349123100001
J	Ardal, C; Rottingen, JA				Ardal, Christine; Rottingen, John-Arne			An Open Source Business Model for Malaria	PLOS ONE			English	Article							ERADICATION	Greater investment is required in developing new drugs and vaccines against malaria in order to eradicate malaria. These precious funds must be carefully managed to achieve the greatest impact. We evaluate existing efforts to discover and develop new drugs and vaccines for malaria to determine how best malaria R&D can benefit from an enhanced open source approach and how such a business model may operate. We assess research articles, patents, clinical trials and conducted a smaller survey among malaria researchers. Our results demonstrate that the public and philanthropic sectors are financing and performing the majority of malaria drug/vaccine discovery and development, but are then restricting access through patents, 'closed' publications and hidden away physical specimens. This makes little sense since it is also the public and philanthropic sector that purchases the drugs and vaccines. We recommend that a more "open source" approach is taken by making the entire value chain more efficient through greater transparency which may lead to more extensive collaborations. This can, for example, be achieved by empowering an existing organization like the Medicines for Malaria Venture (MMV) to act as a clearing house for malaria-related data. The malaria researchers that we surveyed indicated that they would utilize such registry data to increase collaboration. Finally, we question the utility of publicly or philanthropically funded patents for malaria medicines, where little to no profits are available. Malaria R&D benefits from a publicly and philanthropically funded architecture, which starts with academic research institutions, product development partnerships, commercialization assistance through UNITAID and finally procurement through mechanisms like The Global Fund to Fight AIDS, Tuberculosis and Malaria and the U.S.' President's Malaria Initiative. We believe that a fresh look should be taken at the cost/benefit of patents particularly related to new malaria medicines and consider alternative incentives, like WHO prequalification.	[Ardal, Christine] Norwegian Inst Publ Hlth, Dept Int Publ Hlth, Oslo, Norway; [Ardal, Christine] Norwegian Knowledge Ctr Hlth Serv, Sect Global Hlth, Oslo, Norway; [Rottingen, John-Arne] Norwegian Inst Publ Hlth, Div Infect Dis Control, Oslo, Norway; [Rottingen, John-Arne] Univ Oslo, Inst Hlth & Soc, Dept Hlth Management & Hlth Econ, Oslo, Norway; [Rottingen, John-Arne] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Norwegian Institute of Public Health (NIPH); Norwegian Knowledge Centre for Health Services; Norwegian Institute of Public Health (NIPH); University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health	Ardal, C (corresponding author), Norwegian Inst Publ Hlth, Dept Int Publ Hlth, Oslo, Norway.	christine.ardal@fhi.no			Norwegian Research Council [192465]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This research was made possible through the generous financing of the Norwegian Research Council (grant number 192465). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CP, 2006, HEALTH AFFAIR, V25, P420, DOI 10.1377/hlthaff.25.2.420; Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; Barrett S, 2010, WHY COOPERATIVE INCE; Burrows J, 2013, GUARDIAN; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Chesbrough H, 2002, IND CORP CHANGE, V11, P529, DOI 10.1093/icc/11.3.529; Dilaforette, 2012, AB US; Institute for Health Metrics and Evaluation, 2013, GLOB BURD DIS GEN EV; Kar S, 2010, NAT REV DRUG DISCOV, V9, P511, DOI 10.1038/nrd3207; Liu J, 2013, LANCET GLOB HEALTH, V1, pE2, DOI 10.1016/S2214-109X(13)70002-0; Malaria Vaccine Initiative, 2013, MAL VACC CAND RED DI; Masum H., 2011, OPEN SOURCE NEGLECTE; Maurer S, 2005, RIGHT TOOLS DESIGNIN; Medicines for Malaria Venture, 2013, MMV PROV PROM COMP S; Medicines for Malaria Venture, 2013, GLOB MAL PORTF; Medicines for Malaria Venture, 2013, ANN REP 2012; Mendis K, 2009, TROP MED INT HEALTH, V14, P802, DOI 10.1111/j.1365-3156.2009.02287.x; Moran M, 2012, G FINDER NEGLECTED D; Moran M, 2013, G FINDER NEGLECTED D; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Patentstyret, 2013, KOSTN INT PAT, DOI [10.1016/j.mgene.2013.11.003, DOI 10.1016/J.MGENE.2013.11.003]; Pecoul B, 2011, COMMUNICATION; PLOS, 2014, PUBL FEES; Robertson M, 2013, PARASITOLOGY; The Global Fund to Fight AIDS TaM, 2013, ACT PRIC AFF MED FAC; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2012, ANN REP 2012; The President's Malaria Initiative, 2013, 7 PRES MAL IN; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2012, RES DEV MEET HLTH NE; Wikipedia, 2013, BUS MOD; World Health Organization, 2013, PUBL BRIEF HELD WHO; World Health Organization Roll Back Malaria Partnership, 2011, EL MAL LEARN LOOK AH; World Health Organization Roll Back Malaria Partnership, 2013, FOC S AFR	34	7	7	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117150	10.1371/journal.pone.0117150	http://dx.doi.org/10.1371/journal.pone.0117150			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658590	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900109
J	Bao, LD; Fu, XD; Si, MW; Wang, Y; Ma, RL; Ren, XH; Lv, HJ				Bao, Lidao; Fu, Xudong; Si, Mingwen; Wang, Yi; Ma, Ruilian; Ren, Xianhua; Lv, Haijun			MicroRNA-185 Targets SOCS3 to Inhibit Beta-Cell Dysfunction in Diabetes	PLOS ONE			English	Article							LEPTIN RECEPTOR; EXPRESSION; GLUCOSE; PROGRESSION; SUPPRESSOR; COMPONENTS; MIR-185; CANCER	Diabetes is the most common and complex metabolic disorder, and one of the most important health threats now. MicroRNAs (miRNAs) are a group of small non-coding RNAs that have been suggested to play a vital role in a variety of physiological processes, including glucose homeostasis. In this study, we investigated the role of miR-185 in diabetes. MiR-85 was significantly downregulated in diabetic patients and mice, and the low level was correlated to blood glucose concentration. Overexpression of miR-185 enhanced insulin secretion of pancreatic beta-cells, promoted cell proliferation and protected cells from apoptosis. Further experiments using in silico prediction, luciferase reporter assay and western blot assay demonstrated that miR-185 directly targeted SOCS3 by binding to its 3'-UTR. On the contrary to miR-185's protective effects, SOCS3 significantly suppressed functions of beta-cell and inactivated Stat3 pathway. When treating cells with miR-185 mimics in combination with SOCS3 overexpression plasmid, the inhibitory effects of SOCS3 were reversed. While combined treatment of miR-185 mimics and SOCS3 siRNA induced synergistically promotive effects compared to either miR-185 mimics or SOCS3 siRNA treatment alone. Moreover, we observed that miR-185 level was inversely correlated with SOCS3 expression in diabetes patients. In conclusion, this study revealed a functional and mechanistic link between miR-185 and SOCS3 in the pathogenesis of diabetes. MIR-185 plays an important role in the regulation of insulin secretion and beta-cell growth in diabetes. Restoration of miR-185 expression may serve a potentially promising and efficient therapeutic approach for diabetes.	[Bao, Lidao; Wang, Yi; Ma, Ruilian; Ren, Xianhua] Inner Mongolia Med Univ, Affiliated Hosp, Dept Pharm, Hohhot, Inner Mongolia, Peoples R China; [Fu, Xudong] Liaocheng Peoples Hosp, Dept Endocrinol, Liaocheng, Shandong, Peoples R China; [Si, Mingwen] Liaocheng Peoples Hosp, Dept Gen Surg, Liaocheng, Shandong, Peoples R China; [Lv, Haijun] Inner Mongolia Med Univ, Affiliated Hosp, Res Dept, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia Medical University; Inner Mongolia Medical University	Ren, XH (corresponding author), Inner Mongolia Med Univ, Affiliated Hosp, Dept Pharm, Hohhot, Inner Mongolia, Peoples R China.	xhr197702@126.com; haijun_lv13@126.com			Nature Science Foundation of Inner Mongolia Autonomous Region [2013MS1224]; Scientific Project of Affiliated Hospital of Inner Mongolia Medical University [NYFY2010YB006]; Youth Innovation Fund of Inner Mongolia Medical University [NY2010QN002]; Key Scientific Fund of Affiliated Hospital of Inner Mongolia Medical University [NYFYZD20130158]	Nature Science Foundation of Inner Mongolia Autonomous Region; Scientific Project of Affiliated Hospital of Inner Mongolia Medical University; Youth Innovation Fund of Inner Mongolia Medical University; Key Scientific Fund of Affiliated Hospital of Inner Mongolia Medical University	This study was financially supported by the Nature Science Foundation of Inner Mongolia Autonomous Region (2013MS1224, for LDB, http://nsbr.nmkjt.gov.cn/index.aspx), Scientific Project of Affiliated Hospital of Inner Mongolia Medical University (NYFY2010YB006, for LDB, http://www.nmgfy.com/), Youth Innovation Fund of Inner Mongolia Medical University (NY2010QN002, for LDB, http://www.nmgfy.com/), and Key Scientific Fund of Affiliated Hospital of Inner Mongolia Medical University (NYFYZD20130158, for LDB, http://www. nmgfy.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Babon JJ, 2012, GROWTH FACTORS, V30, P207, DOI 10.3109/08977194.2012.687375; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Han X, 2001, DIABETES, V50, P1047, DOI 10.2337/diabetes.50.5.1047; Holman RR, 2014, LANCET, V383, P2008, DOI 10.1016/S0140-6736(14)60794-7; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ilonen J, 1999, Diabetes Technol Ther, V1, P205, DOI 10.1089/152091599317440; Imam JS, 2010, ONCOGENE, V29, P4971, DOI 10.1038/onc.2010.233; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kato M, 2013, FREE RADICAL BIO MED, V64, P85, DOI 10.1016/j.freeradbiomed.2013.06.009; Kloek C, 2002, J BIOL CHEM, V277, P41547, DOI 10.1074/jbc.M205148200; Ley SH, 2014, LANCET, V383, P1999, DOI 10.1016/S0140-6736(14)60613-9; Li Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.148; Liu M, 2011, CANCER LETT, V301, P151, DOI 10.1016/j.canlet.2010.11.009; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Meyer JM, 2013, CURR OPIN LIPIDOL, V24, P386, DOI 10.1097/MOL.0b013e3283638042; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rochette L, 2014, BIOCHIM BIOPHYS ACTA; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sands WA, 2006, MOL CELL BIOL, V26, P6333, DOI 10.1128/MCB.00207-06; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shantikumar S, 2012, CARDIOVASC RES, V93, P583, DOI 10.1093/cvr/cvr300; Staedel C, 2013, CELL MICROBIOL, V15, P1496, DOI 10.1111/cmi.12159; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Takahashi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006677; Tomita S, 2011, CANCER SCI, V102, P57, DOI 10.1111/j.1349-7006.2010.01751.x; van de Bunt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055272; Wang C, 2014, FEBS J, V281, P2136, DOI 10.1111/febs.12767; Wang J, 2014, J MOL MED BERL; Xie J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108559; Yang MH, 2014, J LIPID RES, V55, P226, DOI 10.1194/jlr.M041335; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357	36	57	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116067	10.1371/journal.pone.0116067	http://dx.doi.org/10.1371/journal.pone.0116067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658748	gold, Green Submitted, Green Published			2022-12-27	WOS:000349444900029
J	Castorina, A; Waschek, JA; Marzagalli, R; Cardile, V; Drago, F				Castorina, Alessandro; Waschek, James A.; Marzagalli, Rubina; Cardile, Venera; Drago, Filippo			PACAP Interacts with PAC(1) Receptors to Induce Tissue Plasminogen Activator (tPA) Expression and Activity in Schwann Cell-Like Cultures	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; PERIPHERAL-NERVE INJURY; TUMOR MPNST CELLS; SIGNALING PATHWAYS; NEURITE OUTGROWTH; GENE-EXPRESSION; UP-REGULATION; VIP; NEURONS; MICE	Regeneration of peripheral nerves depends on the abilities of rejuvenating axons to migrate at the injury site through cellular debris and altered extracellular matrix, and then grow along the residual distal nerve sheath conduit and reinnervate synaptic targets. Considerable evidence suggest that glial cells participate in this process, although the mechanisms remain to be clarified. In cell culture, regenerating neurites secrete PACAP, a peptide shown to induce the expression of the protease tissue plasminogen activator (tPA) in neural cell types. In the present studies, we tested the hypothesis that PACAP can stimulate peripheral glial cells to produce tPA. More specifically, we addressed whether or not PACAP promoted the expression and activity of tPA in the Schwann cell line RT4-D6P2T, which shares biochemical and physical properties with Schwann cells. We found that PACAP dose- and time-dependently stimulated tPA expression both at the mRNA and protein level. Such effect was mimicked by maxadilan, a potent PAC1 receptor agonist, but not by the PACAP-related homolog VIP, suggesting a PAC1-mediated function. These actions appeared to be mediated at least in part by the Akt/CREB signaling cascade because wortmannin, a PI3K inhibitor, prevented peptide-driven CREB phosphorylation and tPA increase. Interestingly, treatment with BDNF mimicked PACAP actions on tPA, but acted through both the Akt and MAPK signaling pathways, while causing a robust increase in PACAP and PAC1 expression. PACAP6-38 totally blocked PACAP-driven tPA expression and in part hampered BDNF-mediated effects. We conclude that PACAP, acting through PAC1 receptors, stimulates tPA expression and activity in a Akt/CREB-dependent manner to promote proteolytic activity in Schwann-cell like cultures.	[Castorina, Alessandro; Marzagalli, Rubina] Univ Catania, Dept Biomed Sci & Biotechnol, Sect Human Anat & Histol, Catania, Italy; [Waschek, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Semel Inst, Los Angeles, CA USA; [Cardile, Venera] Univ Catania, Dept Biomed Sci & Biotechnol, Physiol Sect, Catania, Italy; [Drago, Filippo] Univ Catania, Dept Biomed Sci & Biotechnol, Pharmacol Sect, Catania, Italy	University of Catania; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Catania; University of Catania	Castorina, A (corresponding author), Univ Catania, Dept Biomed Sci & Biotechnol, Sect Human Anat & Histol, Catania, Italy.	alecasto@unict.it	Drago, Francesco/H-7563-2019; Drago, Filippo/AAC-5090-2022; loreto, carla/AAC-2711-2019; Castorina, Alessandro/C-5495-2013; Drago, Filippo/K-5619-2018	Castorina, Alessandro/0000-0001-7037-759X; Drago, Filippo/0000-0003-2887-5223; CARDILE, Venera/0000-0001-9902-3736; Marzagalli, Rubina/0000-0002-2165-8632	National grant [PON01-00110]	National grant	This work was supported by a National grant PON01-00110. Part of these experiments were accomplished using scientific equipment provided through a convention with Catania City Hall in the context of the ICT-E1 project. The authors would like to thank Mr P. Asero for his technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2006, CURR TOP MED CHEM, V6, P151, DOI 10.2174/156802606775270288; Akassoglou K, 2000, J CELL BIOL, V149, P1157, DOI 10.1083/jcb.149.5.1157; Akassoglou K, 2003, NEUROSCI LETT, V338, P185, DOI 10.1016/S0304-3940(02)01387-3; Akassoglou K, 2002, NEURON, V33, P861, DOI 10.1016/S0896-6273(02)00617-7; Armstrong BD, 2008, NEUROSCIENCE, V151, P63, DOI 10.1016/j.neuroscience.2007.09.084; Armstrong BD, 2004, NEUROREPORT, V15, P2647, DOI 10.1097/00001756-200412030-00018; Armstrong BD, 2003, J NEUROSCI RES, V74, P240, DOI 10.1002/jnr.10750; Castorina A, 2013, NEUROSCIENCE, V250, P546, DOI 10.1016/j.neuroscience.2013.07.053; Castorina A, 2014, EXP CELL RES, V322, P108, DOI 10.1016/j.yexcr.2013.11.003; Castorina A, 2012, J MOL NEUROSCI, V48, P674, DOI 10.1007/s12031-012-9755-z; Castorina A, 2010, PEPTIDES, V31, P2276, DOI 10.1016/j.peptides.2010.08.013; Castorina A, 2008, BRAIN RES, V1241, P29, DOI 10.1016/j.brainres.2008.09.035; Chan JR, 2006, SCIENCE, V314, P832, DOI 10.1126/science.1134069; CLARK MB, 1991, GLIA, V4, P514, DOI 10.1002/glia.440040511; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Endo A, 1998, NEUROSCI LETT, V246, P37, DOI 10.1016/S0304-3940(98)00204-3; Giunta S, 2012, PEPTIDES, V37, P32, DOI 10.1016/j.peptides.2012.06.004; Giunta S, 2010, NEUROPEPTIDES, V44, P45, DOI 10.1016/j.npep.2009.10.003; Godinho MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069987; GOLD LI, 1992, J CELL BIOCHEM, V50, P441, DOI 10.1002/jcb.240500412; Hai M, 2002, J NEUROSCI RES, V69, P497, DOI 10.1002/jnr.10327; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Jamen F, 2002, J NEUROCHEM, V82, P1199, DOI 10.1046/j.1471-4159.2002.01124.x; KRYSTOSEK A, 1984, J CELL BIOL, V98, P773, DOI 10.1083/jcb.98.2.773; Kwinter DM, 2009, NEUROSCIENCE, V162, P1001, DOI 10.1016/j.neuroscience.2009.05.038; Lee H, 2009, J NEUROSCI RES, V87, P171, DOI 10.1002/jnr.21820; MARS WM, 1993, AM J PATHOL, V143, P949; MCGUIRE PG, 1990, NEURON, V4, P633, DOI 10.1016/0896-6273(90)90121-U; Moody TW, 2003, PEPTIDES, V24, P163, DOI 10.1016/S0196-9781(02)00290-5; MURPHY G, 1992, ANN NY ACAD SCI, V667, P1, DOI 10.1111/j.1749-6632.1992.tb51590.x; Nakajima E, 2013, MOL VIS, V19, P174; OHLSSON M, 1993, MOL CELL BIOL, V13, P266, DOI 10.1128/MCB.13.1.266; Parmer RJ, 1997, J BIOL CHEM, V272, P1976, DOI 10.1074/jbc.272.3.1976; Pettersson LME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100730; Raoult E, 2011, J NEUROCHEM, V119, P920, DOI 10.1111/j.1471-4159.2011.07486.x; Richner M, 2014, MOL NEUROBIOL, V50, P945, DOI 10.1007/s12035-014-8706-9; Sasagasako N, 1996, J NEUROCHEM, V66, P1432; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scuderi S, 2013, PEPTIDES, V39, P119, DOI 10.1016/j.peptides.2012.11.015; Tamas A, 2012, INT J MOL SCI, V13, P8430, DOI 10.3390/ijms13078430; Tan YV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061200; Tan YV, 2011, ASN NEURO, V3, P195, DOI 10.1042/AN20110024; Tan YV, 2009, P NATL ACAD SCI USA, V106, P2012, DOI 10.1073/pnas.0812257106; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Waschek JA, 2013, BRIT J PHARMACOL, V169, P512, DOI 10.1111/bph.12181; Waschek JA, 1995, REGUL PEPTIDES, V60, P149, DOI 10.1016/0167-0115(95)00124-7; Watson MB, 2013, NEUROSCIENCE, V240, P277, DOI 10.1016/j.neuroscience.2013.03.002; Xiao JH, 2009, J NEUROSCI, V29, P4016, DOI 10.1523/JNEUROSCI.3811-08.2009; Zhang YZ, 1996, NEUROSCIENCE, V74, P1099, DOI 10.1016/S0306-4522(96)00168-6; Zhou CJ, 2002, CURR PROTEIN PEPT SC, V3, P423, DOI 10.2174/1389203023380576; Zou T, 2006, J NEUROPATH EXP NEUR, V65, P78, DOI 10.1097/01.jnen.0000195942.25163.f5	51	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117799	10.1371/journal.pone.0117799	http://dx.doi.org/10.1371/journal.pone.0117799			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658447	Green Published, gold			2022-12-27	WOS:000349444900225
J	Ding, F; Zhang, QR; Ung, COL; Wang, YT; Han, YF; Hu, YJ; Qi, J				Ding, Fan; Zhang, Qianru; Ung, Carolina Oi Lam; Wang, Yitao; Han, Yifan; Hu, Yuanjia; Qi, Jin			An Analysis of Chemical Ingredients Network of Chinese Herbal Formulae for the Treatment of Coronary Heart Disease	PLOS ONE			English	Article							MEDICINE; PHARMACOLOGY; TARGETS	As a complex system, the complicated interactions between chemical ingredients, as well as the potential rules of interactive associations among chemical ingredients of traditional Chinese herbal formulae are not yet fully understood by modern science. On the other hand, network analysis is emerging as a powerful approach focusing on processing complex interactive data. By employing network approach in selected Chinese herbal formulae for the treatment of coronary heart disease (CHD), this article aims to construct and analyze chemical ingredients network of herbal formulae, and provide candidate herbs, chemical constituents, and ingredient groups for further investigation. As a result, chemical ingredients network composed of 1588 ingredients from 36 herbs used in 8 core formulae for the treatment of CHD was produced based on combination associations in herbal formulae. In this network, 9 communities with relative dense internal connections are significantly associated with 14 kinds of chemical structures with P < 0.001. Moreover, chemical structural fingerprints of network communities were detected, while specific centralities of chemical ingredients indicating different levels of importance in the network were also measured. Finally, several distinct herbs, chemical ingredients, and ingredient groups with essential position in the network or high centrality value are recommended for further pharmacology study in the context of new drug development.	[Ding, Fan; Zhang, Qianru; Ung, Carolina Oi Lam; Wang, Yitao; Hu, Yuanjia] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa 999078, Peoples R China; [Zhang, Qianru] Zunyi Med Univ, Sch Pharm, Zunyi 563003, Peoples R China; [Han, Yifan] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon 999077, Hong Kong, Peoples R China; [Qi, Jin] China Pharmaceut Univ, Dept Complex Prescript Tradit Chinese Med, Nanjing 211198, Jiangsu, Peoples R China	University of Macau; Zunyi Medical University; Hong Kong Polytechnic University; China Pharmaceutical University	Hu, YJ (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Ave Padre Tomas Pereira SJ, Taipa 999078, Peoples R China.	yuanjiahu@umac.mo; yaoyuelingxing@163.com	Hu, Yuanjia/AAW-7721-2021; Ung, Carolina Oi Lam/AAR-2672-2020; Wang, Yitao/O-5184-2016	yuanjia, Hu/0000-0001-5244-8577; Han, Yifan/0000-0002-5833-069X; Ung, Carolina Oi Lam/0000-0003-1915-5099	University of Macau [MYRG119 (Y1-L3)-ICMS12-HYJ, MYRG208 (Y2-L4)-ICMS11-WYT]	University of Macau	The University of Macau provided financial support for this research by the projects MYRG119 (Y1-L3)-ICMS12-HYJ and MYRG208 (Y2-L4)-ICMS11-WYT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abugessaisa I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104382; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Bi YF, 2013, WORLD SCI TECHNOL MO, V15, P804; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Cheng KF, 2011, J CANC THER, V2, P91; Chu Y, 2011, J ETHNOPHARMACOL, V137, P1457, DOI 10.1016/j.jep.2011.08.035; Dzubak P, 2006, NAT PROD REP, V23, P394, DOI 10.1039/b515312n; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Hu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077247; Janga SC, 2009, MOL BIOSYST, V5, P1536, DOI [10.1039/b908147j, 10.1039/B908147j]; Jiang M, 2011, PLANTA MED, V77, P873, DOI 10.1055/s-0030-1270983; Konkimalla VB, 2008, J ETHNOPHARMACOL, V116, P207, DOI 10.1016/j.jep.2007.12.009; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Li S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S6; Li S, 2009, CURR BIOINFORM, V4, P188, DOI 10.2174/157489309789071129; Li XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043918; Li ZJ, 2011, MOD J INTEGR TRADIT, V20, P933; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Noack A, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026102; Owens J, 2006, NAT REV DRUG DISCOV, V5, P1474; Pei LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057414; Porter MA., 2009, NOT AM MATH SOC, V56, P1082, DOI DOI 10.1103/PHYSREVE.69.066133; Qin LP, 2008, J ETHNOPHARMACOL, V118, P271, DOI 10.1016/j.jep.2008.04.009; Shi Q, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/697028; Smith Mary Elizabeth, 2012, Semin Oncol Nurs, V28, P64, DOI 10.1016/j.soncn.2011.11.007; Tao WY, 2013, J ETHNOPHARMACOL, V145, P1, DOI 10.1016/j.jep.2012.09.051; van der Greef J, 2011, NATURE, V480, pS87, DOI 10.1038/480S87a; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang P, 2010, FITOTERAPIA, V81, P793, DOI 10.1016/j.fitote.2010.04.007; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; Yang M, 2012, MOD TRADIT CHIN MED, V14, P1376; Yang M, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/971272; Zhang AH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-20; Zhang AH, 2011, FITOTERAPIA, V82, P1160, DOI 10.1016/j.fitote.2011.07.014; [张兰凤 Zhang Lanfeng], 2005, [中华中医药杂志, China Journal of Traditional Chinese Medicine and Pharmacy], V20, P8; Zhao J, 2010, BRIEF BIOINFORM, V11, P417, DOI 10.1093/bib/bbp063; Zhou XZ, 2009, FIRST INTERNATIONAL WORKSHOP ON DATABASE TECHNOLOGY AND APPLICATIONS, PROCEEDINGS, P188, DOI 10.1109/DBTA.2009.65; Zhu Hui, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P474	42	12	12	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116441	10.1371/journal.pone.0116441	http://dx.doi.org/10.1371/journal.pone.0116441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658855	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900039
J	Doyon, A; Fischer, DC; Bayazit, AK; Canpolat, N; Duzova, A; Sozeri, B; Bacchetta, J; Balat, A; Busher, A; Candan, C; Cakar, N; Donmez, O; Dusek, J; Heckel, M; Klaus, G; Mir, S; Ozcelik, G; Sever, L; Shroff, R; Vidal, E; Wuhl, E; Gondan, M; Melk, A; Querfeld, U; Haffner, D; Schaefer, F				Doyon, Anke; Fischer, Dagmar-Christiane; Bayazit, Aysun Karabay; Canpolat, Nur; Duzova, Ali; Sozeri, Betul; Bacchetta, Justine; Balat, Ayse; Buesher, Anja; Candan, Cengiz; Cakar, Nilgun; Donmez, Osman; Dusek, Jiri; Heckel, Martina; Klaus, Guenter; Mir, Sevgi; Ozcelik, Gul; Sever, Lale; Shroff, Rukshana; Vidal, Enrico; Wuehl, Elke; Gondan, Matthias; Melk, Anette; Querfeld, Uwe; Haffner, Dieter; Schaefer, Franz		4C Study Consortium	Markers of Bone Metabolism Are Affected by Renal Function and Growth Hormone Therapy in Children with Chronic Kidney Disease	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE; HEMODIALYSIS-PATIENTS; SERUM-LEVELS; SCLEROSTIN; FGF23; CLASSIFICATION; OSTEODYSTROPHY; CONSEQUENCES; OSTEOCYTES; DISORDER	Objectives The extent and relevance of altered bone metabolism for statural growth in children with chronic kidney disease is controversial. We analyzed the impact of renal dysfunction and recombinant growth hormone therapy on a panel of serum markers of bone metabolism in a large pediatric chronic kidney disease cohort. Methods Bone alkaline phosphatase (BAP), tartrate-resistant acid phosphatase 5b (TRAP5b), sclerostin and C-terminal FGF-23 (cFGF23) normalized for age and sex were analyzed in 556 children aged 6-18 years with an estimated glomerular filtration rate (eGFR) of 10-60 ml/min/1.73m(2). 41 children receiving recombinant growth hormone therapy were compared to an untreated matched control group. Results Standardized levels of BAP, TRAP5b and cFGF-23 were increased whereas sclerostin was reduced. BAP was correlated positively and cFGF-23 inversely with eGFR. Intact serum parathormone was an independent positive predictor of BAP and TRAP5b and negatively associated with sclerostin. BAP and TRAP5B were negatively affected by increased C-reactive protein levels. In children receiving recombinant growth hormone, BAP was higher and TRAP5b lower than in untreated controls. Sclerostin levels were in the normal range and higher than in untreated controls. Serum sclerostin and cFGF-23 independently predicted height standard deviation score, and BAP and TRAP5b the prospective change in height standard deviation score. Conclusion Markers of bone metabolism indicate a high-bone turnover state in children with chronic kidney disease. Growth hormone induces an osteoanabolic pattern and normalizes osteocyte activity. The osteocyte markers cFGF23 and sclerostin are associated with standardized height, and the markers of bone turnover predict height velocity.	[Doyon, Anke; Wuehl, Elke; Schaefer, Franz] Ctr Pediat & Adolescent Med, Div Pediat Nephrol, Heidelberg, Germany; [Fischer, Dagmar-Christiane] Univ Hosp Rostock, Dept Pediat, Rostock, Germany; [Bayazit, Aysun Karabay] Cukurova Univ, Sch Med, Div Pediat Nephrol, Adana, Turkey; [Canpolat, Nur; Sever, Lale] Istanbul Univ, Cerrahpasa Fac Med, Div Pediat Nephrol, Istanbul, Turkey; [Duzova, Ali] Hacettepe Univ, Fac Med, Dept Pediat, Div Pediat Nephrol, TR-06100 Ankara, Turkey; [Sozeri, Betul; Mir, Sevgi] Ege Univ, Fac Med, Div Pediat Nephrol, Izmir, Turkey; [Bacchetta, Justine] Hosp Civils Lyon, Hop Femme Mere Enfant, Ctr Reference Malad Renales Rares, Bron, France; [Balat, Ayse] Gaziantep Univ, Dept Pediat Nephrol, Gaziantep, Turkey; [Buesher, Anja] Univ Childrens Hosp, Div Pediat Nephrol, Essen, Germany; [Candan, Cengiz] Istanbul Medeniyet Univ, Goztepe Training & Res Hosp, Div Pediat Nephrol, Istanbul, Turkey; [Cakar, Nilgun] Diskapi Childrens Hosp, Ankara, Turkey; [Donmez, Osman] Uludag Univ, Fac Med, Div Pediat Nephrol, Bursa, Turkey; [Dusek, Jiri] Univ Hosp Motol, Pediat Hosp, Prague, Czech Republic; [Heckel, Martina] Univ Childrens Hosp, Hamburg, Germany; [Klaus, Guenter] KfH Kidney Ctr Children, Marburg, Germany; [Ozcelik, Gul] Sisli Educ & Res Hosp, Dept Pediat Nephrol, Istanbul, Turkey; [Shroff, Rukshana] Great Ormond St Hosp Sick Children, Div Pediat Nephrol, London, England; [Vidal, Enrico] Dialysis & Transplantat Dept Pediat, Padua, Italy; [Gondan, Matthias] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Melk, Anette; Haffner, Dieter] Hannover Med Sch, Dept Pediat Kidney Liver & Metab Dis, Hannover, Germany; [Melk, Anette] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany; [Querfeld, Uwe] Charite Childrens Hosp, Clin Pediat Nephrol, Berlin, Germany	University of Rostock; Cukurova University; Istanbul University; Istanbul University - Cerrahpasa; Hacettepe University; Ege University; CHU Lyon; Gaziantep University; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Istanbul Goztepe Training and Research Hospital; Istanbul Medeniyet University; Ankara Children's Hematology Oncology Training & Research Hospital; Uludag University; Motol University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Istanbul Sisli Hamidiye Etfal Training & Research Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Copenhagen; Hannover Medical School; Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Doyon, A (corresponding author), Ctr Pediat & Adolescent Med, Div Pediat Nephrol, Heidelberg, Germany.	anke.doyon@med.uni-heidelberg.de	BAYAZIT, AYSUN K/E-8696-2018; Duzova, Ali/AAB-7692-2021; Harambat, Jérôme/T-1371-2019; Vidal, Enrico/AAL-9105-2021; DÜZOVA, ALI/AAB-7679-2021; Cakar, Nilgun/AAI-1121-2020; BALAT, AYSE/AAC-5793-2021; Candan, Cengiz/ABC-6193-2021; Canpolat, Nur/AHE-2082-2022; Shroff, Rukshana/AAG-5383-2019; Querfeld, Uwe/AAF-6330-2020; Urasinski, Tomasz F./O-7155-2014; Shroff, Rukshana C/C-7347-2008; DÖNMEZ, OSMAN/AAA-8778-2021; CANPOLAT, NUR/GVS-8683-2022; Canpolat, Nur/V-6807-2017; Tkaczyk, Marcin/S-9468-2016; Bacchetta, Justine/B-3842-2016	BAYAZIT, AYSUN K/0000-0002-2644-5628; Vidal, Enrico/0000-0003-3963-0803; DÜZOVA, ALI/0000-0002-4365-2995; Cakar, Nilgun/0000-0002-1853-0101; BALAT, AYSE/0000-0002-8904-1348; Canpolat, Nur/0000-0002-3420-9756; Shroff, Rukshana/0000-0001-8501-1072; Urasinski, Tomasz F./0000-0003-3107-8575; Shroff, Rukshana C/0000-0001-8501-1072; Canpolat, Nur/0000-0002-3420-9756; Szczepanska, Maria/0000-0002-6772-1983; Querfeld, Uwe/0000-0001-6783-3822; Gimpel, Charlotte/0000-0003-1296-9081; Tkaczyk, Marcin/0000-0003-1753-7560; Gondan, Matthias/0000-0001-9974-0057; Bacchetta, Justine/0000-0002-0578-2529	KfH Foundation for Preventive Medicine; European Renal Association-European Dialysis and Transplant Association; German Federal Ministry of Education and Research [01EO0802]; Pfizer Deutschland GmbH; Kidney Research UK [RP39/2013] Funding Source: researchfish	KfH Foundation for Preventive Medicine; European Renal Association-European Dialysis and Transplant Association; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Pfizer Deutschland GmbH; Kidney Research UK(Kidney Research UK (KRUK))	This study has been made possible by grants of the KfH Foundation for Preventive Medicine, the European Renal Association-European Dialysis and Transplant Association (www.era-edta.org), the German Federal Ministry of Education and Research (reference number: 01EO0802) and Pfizer Deutschland GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2003, J BONE MINER RES, V18, P1912, DOI 10.1359/jbmr.2003.18.10.1912; Bacchetta J, 2013, CLIN J AM SOC NEPHRO, V8, P824, DOI 10.2215/CJN.00330112; Bacchetta J, 2012, NEPHROL DIAL TRANSPL, V27, P3063, DOI 10.1093/ndt/gfs299; Bacchetta J, 2010, J CLIN ENDOCR METAB, V95, P1741, DOI 10.1210/jc.2009-1576; Behnke B, 1998, NEPHROL DIAL TRANSPL, V13, P662, DOI 10.1093/ndt/13.3.662; Borzych D, 2010, KIDNEY INT, V78, P1295, DOI 10.1038/ki.2010.316; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P877, DOI 10.2215/CJN.06550810; Drake MT, 2010, J CLIN ENDOCR METAB, V95, P5056, DOI 10.1210/jc.2010-0720; Drueke TB, 2011, CLIN J AM SOC NEPHRO, V6, P700, DOI 10.2215/CJN.01370211; Fischer DC, 2012, ANN CLIN BIOCHEM, V49, P546, DOI 10.1258/acb.2012.011274; Galli C, 2010, J DENT RES, V89, P331, DOI 10.1177/0022034510363963; Gardner J, 2011, J PEDIATR ENDOCR MET, V24, P645, DOI 10.1515/JPEM.2011.301; Hogg RJ, 2003, PEDIATRICS, V111, P1416, DOI 10.1542/peds.111.6.1416; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Kirmani S, 2012, OSTEOPOROSIS INT, V23, P1123, DOI 10.1007/s00198-011-1669-z; Kramer I, 2010, TRENDS ENDOCRIN MET, V21, P237, DOI 10.1016/j.tem.2009.12.002; Lu Yongbo, 2011, Curr Osteoporos Rep, V9, P103, DOI 10.1007/s11914-011-0053-4; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Pelletier S, 2013, CLIN J AM SOC NEPHRO, V8, P819, DOI 10.2215/CJN.07670712; Pereira RC, 2009, BONE, V45, P1161, DOI 10.1016/j.bone.2009.08.008; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Querfeld U, 2010, CLIN J AM SOC NEPHRO, V5, P1642, DOI 10.2215/CJN.08791209; Riminucci M, 2003, J CLIN INVEST, V112, P683, DOI 10.1172/JC120031899; Ryan ZC, 2013, P NATL ACAD SCI USA, V110, P6199, DOI 10.1073/pnas.1221255110; Sabbagh Y, 2012, J BONE MINER RES, V27, P1757, DOI 10.1002/jbmr.1630; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Shidara K, 2008, CALCIFIED TISSUE INT, V82, P278, DOI 10.1007/s00223-008-9127-4; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Siomou E, 2011, PEDIATR NEPHROL, V26, P1105, DOI 10.1007/s00467-011-1870-5; Tobiume H, 1997, J CLIN ENDOCR METAB, V82, P2056, DOI 10.1210/jc.82.7.2056; Urena P, 1996, J AM SOC NEPHROL, V7, P506; Urena P, 1999, KIDNEY INT, V55, P2141, DOI 10.1046/j.1523-1755.1999.00461.x; Wesseling-Perry K, 2013, SEMIN NEPHROL, V33, P169, DOI 10.1016/j.semnephrol.2012.12.017; Wesseling-Perry K, 2012, CLIN J AM SOC NEPHRO, V7, P146, DOI 10.2215/CJN.05940611; Wesseling-Perry K, 2010, PEDIATR NEPHROL, V25, P603, DOI 10.1007/s00467-009-1384-6; Wesseling-Perry K, 2009, J CLIN ENDOCR METAB, V94, P511, DOI 10.1210/jc.2008-0326; Yoshiko Y, 2007, BONE, V40, P1565, DOI 10.1016/j.bone.2007.01.017	37	25	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0113482	10.1371/journal.pone.0113482	http://dx.doi.org/10.1371/journal.pone.0113482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659076	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900005
J	Gaudin, ACM; Tolhurst, TN; Ker, AP; Janovicek, K; Tortora, C; Martin, RC; Deen, W				Gaudin, Amelie C. M.; Tolhurst, Tor N.; Ker, Alan P.; Janovicek, Ken; Tortora, Cristina; Martin, Ralph C.; Deen, William			Increasing Crop Diversity Mitigates Weather Variations and Improves Yield Stability	PLOS ONE			English	Article							ORGANIC-MATTER; CORN YIELD; RED-CLOVER; SOIL-STRUCTURE; CLIMATE-CHANGE; HYDRAULIC CONDUCTIVITY; STRUCTURAL STABILITY; CONSERVATION TILLAGE; MIXTURE-MODELS; WATER-CONTENT	Cropping sequence diversification provides a systems approach to reduce yield variations and improve resilience to multiple environmental stresses. Yield advantages of more diverse crop rotations and their synergistic effects with reduced tillage are well documented, but few studies have quantified the impact of these management practices on yields and their stability when soil moisture is limiting or in excess. Using yield and weather data obtained from a 31-year long term rotation and tillage trial in Ontario, we tested whether crop rotation diversity is associated with greater yield stability when abnormal weather conditions occur. We used parametric and non-parametric approaches to quantify the impact of rotation diversity (monocrop, 2-crops, 3-crops without or with one or two legume cover crops) and tillage (conventional or reduced tillage) on yield probabilities and the benefits of crop diversity under different soil moisture and temperature scenarios. Although the magnitude of rotation benefits varied with crops, weather patterns and tillage, yield stability significantly increased when corn and soybean were integrated into more diverse rotations. Introducing small grains into short corn-soybean rotation was enough to provide substantial benefits on long-term soybean yields and their stability while the effects on corn were mostly associated with the temporal niche provided by small grains for underseeded red clover or alfalfa. Crop diversification strategies increased the probability of harnessing favorable growing conditions while decreasing the risk of crop failure. In hot and dry years, diversification of corn-soybean rotations and reduced tillage increased yield by 7% and 22% for corn and soybean respectively. Given the additional advantages associated with cropping system diversification, such a strategy provides a more comprehensive approach to lowering yield variability and improving the resilience of cropping systems to multiple environmental stresses. This could help to sustain future yield levels in challenging production environments.	[Gaudin, Amelie C. M.; Janovicek, Ken; Martin, Ralph C.; Deen, William] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada; [Tolhurst, Tor N.; Ker, Alan P.] Univ Guelph, Dept Food Agr & Resources Econ, Guelph, ON N1G 2W1, Canada; [Tortora, Cristina] McMaster Univ, Dept Math & Stat, Hamilton, ON L8S 4L8, Canada	University of Guelph; University of Guelph; McMaster University	Gaudin, ACM (corresponding author), Univ Guelph, Dept Plant Agr, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	agaudind@uoguelph.ca		Tortora, Cristina/0000-0001-8351-3730	Ontario Ministry of Agriculture and Food; Grain Farmers of Ontario	Ontario Ministry of Agriculture and Food; Grain Farmers of Ontario	Funding was provided by the Ontario Ministry of Agriculture and Food and Grain Farmers of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Karaki GN, 1998, J PLANT NUTR, V21, P263, DOI 10.1080/01904169809365401; Almaraz JJ, 2008, CLIMATIC CHANGE, V88, P187, DOI 10.1007/s10584-008-9408-y; Altieri MA, 2017, CLIMATIC CHANGE, V140, P33, DOI 10.1007/s10584-013-0909-y; Angers D.A., 1993, SOIL SAMPLING METHOD, P651; Baxter S, 2007, WORLD SOIL RESOURCES, V43, P264, DOI [10.1017/s0014479706394902, DOI 10.1017/S0014479706394902]; Benson MH, 2014, SOC NATUR RESOUR, V27, P777, DOI 10.1080/08941920.2014.901467; Biggs R, 2012, ANNU REV ENV RESOUR, V37, P421, DOI 10.1146/annurev-environ-051211-123836; BLEVINS RL, 1983, J SOIL WATER CONSERV, V38, P301; Bohning D, 2014, COMPUT STAT DATA AN, V71, P1, DOI 10.1016/j.csda.2013.10.010; Bukowski R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033047, 10.1371/journal.pone.0047149]; Canadian Agricultural Services Coordinating Committee, 1998, CAN SYST SOIL CLASS; Carpenter SR, 2012, SUSTAINABILITY-BASEL, V4, P3248, DOI 10.3390/su4123248; CARTER MR, 1993, AGR ECOSYST ENVIRON, V43, P245, DOI 10.1016/0167-8809(93)90089-8; Carter MR, 2002, AGRON J, V94, P38, DOI 10.2134/agronj2002.0038; Chen JH, 2009, ANN STAT, V37, P2523, DOI 10.1214/08-AOS651; Cote IM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000438; Dapaah HK, 1998, COMMUN SOIL SCI PLAN, V29, P2557, DOI 10.1080/00103629809370134; de Mendiburu F., 2014, STAT PROCEDURES AGR; DeFelice M. S., 2006, Crop Management, P1; Deguchi S, 2007, PLANT SOIL, V291, P291, DOI 10.1007/s11104-007-9194-8; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Di Falco S, 2008, LAND ECON, V84, P83, DOI 10.3368/le.84.1.83; Di Falco S, 2006, EUR REV AGRIC ECON, V33, P289, DOI 10.1093/eurrag/jbl016; DIXON BL, 1994, J AGR RESOUR ECON, V19, P58; Drury CF, 1999, AGRON J, V91, P101, DOI 10.2134/agronj1999.00021962009100010016x; Drury CF, 2003, SOIL SCI SOC AM J, V67, P867, DOI 10.2136/sssaj2003.0867; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Everitt B.S., 2011, CLUSTER ANAL, P71, DOI DOI 10.1002/9780470977811.CH4; FEDDES RA, 1978, J HYDROL, V37, P393, DOI 10.1016/0022-1694(78)90030-6; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P197, DOI 10.1016/S0167-1987(02)00027-2; Fujikoshi Y, 2010, WILEY SER PROBAB ST, P283; Gaudin ACM, 2013, AGRONOMY-BASEL, V3, P148, DOI 10.3390/agronomy3010148; Gentry LF, 2013, AGRON J, V105, P295, DOI 10.2134/agronj2012.0246; Givens GH, 2012, COMPUTATION STAT, P287; Goodwin BK, 2000, J AGR RESOUR ECON, V25, P195; GRIFFITH DR, 1988, AGRON J, V80, P599, DOI 10.2134/agronj1988.00021962008000040011x; Grover KK, 2009, AGRON J, V101, P940, DOI 10.2134/agronj2008.0221x; Harri A, 2011, AM J AGR ECON, V93, P703, DOI 10.1093/ajae/aar009; HARRISON GW, 1979, AM NAT, V113, P659, DOI 10.1086/283424; Hatfield JL, 2013, MAR FRESHWATER RES, V64, P423, DOI 10.1071/MF12164; Hatfield JL, 2011, AGRON J, V103, P351, DOI 10.2134/agronj2010.0303; HAYNES RJ, 1991, SOIL TILL RES, V19, P77, DOI 10.1016/0167-1987(91)90111-A; Helmers GA, 2001, AGRON J, V93, P1337, DOI 10.2134/agronj2001.1337; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hooyer M, 2012, THESIS U GUELPH; Horton R, 1996, THEOR APPL CLIMATOL, V54, P27, DOI 10.1007/BF00863556; Hu Q, 2003, J APPL METEOROL, V42, P1626, DOI 10.1175/1520-0450(2003)042&lt;1626:CEOCYI&gt;2.0.CO;2; HUDSON BD, 1994, J SOIL WATER CONSERV, V49, P189; Intergovernmental Panel on Climate Change, 2013, WORKING GROUP 1 CONT; Jansa J, 2002, MYCORRHIZA, V12, P225, DOI [10.1007/s005572-002-0163-z, 10.1007/s00572-002-0163-z]; JOHNSON MD, 1985, SOIL SCI SOC AM J, V49, P1547, DOI 10.2136/sssaj1985.03615995004900060043x; KARLEN DL, 1991, COMMUN SOIL SCI PLAN, V22, P1985, DOI 10.1080/00103629109368552; Katsvairo T, 2002, AGRON J, V94, P299, DOI 10.2134/agronj2002.0299; Katsvairo TW, 2000, AGRON J, V92, P493, DOI 10.2134/agronj2000.923493x; Kucharik CJ, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034003; Lazcano C, 2014, SOIL BIOL BIOCHEM, V74, P184, DOI 10.1016/j.soilbio.2014.03.010; Lehman R. M., 2012, Applied Soil Ecology, V61, P300, DOI 10.1016/j.apsoil.2011.11.008; Liebman M, 2013, RENEW AGR FOOD SYST, V28, P115, DOI 10.1017/S1742170512000300; Lin BB, 2011, BIOSCIENCE, V61, P183, DOI 10.1525/bio.2011.61.3.4; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Lobell DB, 2014, SCIENCE, V344, P516, DOI 10.1126/science.1251423; LOCKERETZ W, 1981, SCIENCE, V211, P540, DOI 10.1126/science.211.4482.540; Lotter DW, 2000, AM J ALTER AGR, V18, P1; MCNAUGHTON SJ, 1978, NATURE, V274, P251, DOI 10.1038/274251a0; Meyer-Aurich A, 2006, AGR ECOSYST ENVIRON, V117, P119, DOI 10.1016/j.agee.2006.03.023; Meyer-Aurich A, 2006, AGRON J, V98, P1204, DOI 10.2134/agronj2005.0262; Mitchell JP, 2012, CALIF AGR, V66, P55, DOI 10.3733/ca.v066n02p55; MORIN J, 1981, J HYDROL, V52, P321, DOI 10.1016/0022-1694(81)90178-5; MUALEM Y, 1976, WATER RESOUR RES, V12, P513, DOI 10.1029/WR012i003p00513; Mueller L, 2009, SOIL TILL RES, V103, P188, DOI 10.1016/j.still.2008.09.010; Munkholm LJ, 2013, SOIL TILL RES, V127, P85, DOI 10.1016/j.still.2012.02.007; Naeem S, 2002, NATURE, V416, P23, DOI 10.1038/416023a; OMAFRA, 2013, AGR GUID FIELD CROPS; OMAFRA, 2013, FIELD CROPS STAT; PETERSON TA, 1989, AGRON J, V81, P735, DOI 10.2134/agronj1989.00021962008100050007x; Pimentel D, 2005, BIOSCIENCE, V55, P573, DOI 10.1641/0006-3568(2005)055[0573:EEAECO]2.0.CO;2; Porter JR, 2005, PHILOS T R SOC B, V360, P2021, DOI 10.1098/rstb.2005.1752; Porter PM, 1997, AGRON J, V89, P442, DOI 10.2134/agronj1997.00021962008900030012x; RAIMBAULT BA, 1991, AGRON J, V83, P979, DOI 10.2134/agronj1991.00021962008300060011x; Richards RA, 2000, J EXP BOT, V51, P447, DOI 10.1093/jexbot/51.suppl_1.447; RUNGE ECA, 1960, AGRON J, V52, P245, DOI 10.2134/agronj1960.00021962005200050001x; RUNGE ECA, 1968, AGRON J, V60, P503, DOI 10.2134/agronj1968.00021962006000050018x; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; SETA AK, 1993, J ENVIRON QUAL, V22, P661, DOI 10.2134/jeq1993.00472425002200040004x; Singer JW, 1998, CROP SCI, V38, P996, DOI 10.2135/cropsci1998.0011183X003800040019x; Six J, 1999, SOIL SCI SOC AM J, V63, P1350, DOI 10.2136/sssaj1999.6351350x; Smith RG, 2008, ECOSYSTEMS, V11, P355, DOI 10.1007/s10021-008-9124-5; Smolik J. D., 1995, American Journal of Alternative Agriculture, V10, P25, DOI 10.1017/S0889189300006081; Southworth J, 2000, AGR ECOSYST ENVIRON, V82, P139, DOI 10.1016/S0167-8809(00)00223-1; Stanger TF, 2008, AGRON J, V100, P643, DOI 10.2134/agronj2007.0280; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; TISDALL JM, 1979, AUST J SOIL RES, V17, P429, DOI 10.1071/SR9790429; TOBAR RM, 1994, MYCORRHIZA, V4, P105, DOI 10.1007/BF00203769; Toliver DK, 2012, AGRON J, V104, P530, DOI 10.2134/agronj2011.0291; Urban D, 2012, CLIMATIC CHANGE, V112, P525, DOI 10.1007/s10584-012-0428-2; VandenBygaart AJ, 1999, CAN J SOIL SCI, V79, P149, DOI 10.4141/S98-034; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Varvel GE, 2000, AGRON J, V92, P938, DOI 10.2134/agronj2000.925938x; VARVEL GE, 1994, AGRON J, V86, P204, DOI 10.2134/agronj1994.00021962008600010036x; WALKER B, 1995, CONSERV BIOL, V9, P747, DOI 10.1046/j.1523-1739.1995.09040747.x; Wesseling J.G., 1991, SWATRE INSTRUCTIONS; Wilhelm WW, 2004, AGRON J, V96, P1, DOI 10.2134/agronj2004.0001; Woodard JD, 2011, AM J AGR ECON, V93, P968, DOI 10.1093/ajae/aar034; YAACOB O, 1981, PLANT SOIL, V60, P11, DOI 10.1007/BF02377108; Yamoah CF, 1998, J PROD AGRIC, V11, P219, DOI 10.2134/jpa1998.0219; Zentner RP, 2002, SOIL TILL RES, V67, P9, DOI 10.1016/S0167-1987(02)00028-4	106	208	211	13	188	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0113261	10.1371/journal.pone.0113261	http://dx.doi.org/10.1371/journal.pone.0113261			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658914	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900004
J	Kawano, M; Sawada, K; Shimodera, S; Ogawa, Y; Kariya, S; Lang, DJ; Inoue, S; Honer, WG				Kawano, Mitsuhiko; Sawada, Ken; Shimodera, Shinji; Ogawa, Yasuhiro; Kariya, Shinji; Lang, Donna J.; Inoue, Shimpei; Honer, William G.			Hippocampal Subfield Volumes in First Episode and Chronic Schizophrenia	PLOS ONE			English	Article							COGNITION RATING-SCALE; 1ST-EPISODE SCHIZOPHRENIA; ALZHEIMERS-DISEASE; WHITE-MATTER; 3 T; AMYGDALA; SEGMENTATION; METAANALYSIS; PLASTICITY; CIRCUITRY	Background Reduced hippocampal volume in schizophrenia is a well-replicated finding. New imaging techniques allow delineation of hippocampal subfield volumes. Studies including predominantly chronic patients demonstrate differences between subfields in sensitivity to illness, and in associations with clinical features. We carried out a cross-sectional and longitudinal study of first episode, sub-chronic, and chronic patients, using an imaging strategy that allows for the assessment of multiple hippocampal subfields. Methods Hippocampal subfield volumes were measured in 34 patients with schizophrenia (19 first episode, 6 sub-chronic, 9 chronic) and 15 healthy comparison participants. A subset of 10 first episode and 12 healthy participants were rescanned after six months. Results Total left hippocampal volume was smaller in sub-chronic (p = 0.04, effect size 1.12) and chronic (p = 0.009, effect size 1.42) patients compared with healthy volunteers. The CA2-3 subfield volume of chronic patients was significantly decreased (p = 0.009, effect size 1.42) compared to healthy volunteers. The CA4-DG volume was significantly reduced in all three patient groups compared to healthy group (all p < 0.005). The two affected subfield volumes were inversely correlated with severity of negative symptoms (p < 0.05). There was a small, but statistically significant decline in left CA4-DG volume over the first six months of illness (p = 0.01). Conclusions Imaging strategies defining the subfields of the hippocampus may be informative in linking symptoms and structural abnormalities, and in understanding more about progression during the early phases of illness in schizophrenia.	[Kawano, Mitsuhiko; Sawada, Ken; Shimodera, Shinji] Kochi Med Sch, Dept Neuropsychiat, Kochi, Japan; [Sawada, Ken] Aki Gen Hosp, Dept Psychiat, Kochi, Japan; [Ogawa, Yasuhiro] Hyogo Prefectural Kakogawa Hosp, Dept Radiol, Kobe, Hyogo, Japan; [Kariya, Shinji] Kochi Med Sch, Dept Diagnost Radiol & Radiat Oncol, Kochi, Japan; [Lang, Donna J.] Univ British Columbia, Dept Radiol, Vancouver, BC V5Z 1M9, Canada; [Inoue, Shimpei] Fukushima Med Univ, Aizu Med Ctr, Dept Neuropsychiat, Fukushima, Japan; [Honer, William G.] Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada	Kochi University; Kochi University; University of British Columbia; Fukushima Medical University; University of British Columbia	Sawada, K (corresponding author), Kochi Med Sch, Dept Neuropsychiat, Kochi, Japan.	kensawadaster@gmail.com	Lang, Donna/GVR-9040-2022	Lang, Donna/0000-0001-9373-1555	Japan Society for the Promotion of Science [16790691]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science: Grant-in-Aid for Scientific Research (Grant Number 16790691 to KS, URL: http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, JPN J BIOL PSYCHIAT; Benes FM, 1999, BIOL PSYCHIAT, V46, P589, DOI 10.1016/S0006-3223(99)00136-5; Blakesley RE, 2009, NEUROPSYCHOLOGY, V23, P255, DOI 10.1037/a0012850; Brambilla P, 2013, BRIT J PSYCHIAT, V202, P50, DOI 10.1192/bjp.bp.111.105700; Csernansky JG, 1998, P NATL ACAD SCI USA, V95, P11406, DOI 10.1073/pnas.95.19.11406; Csernansky JG, 2002, AM J PSYCHIAT, V159, P2000, DOI 10.1176/appi.ajp.159.12.2000; Das SR, 2012, NEUROIMAGE, V60, P1266, DOI 10.1016/j.neuroimage.2012.01.098; Driessen M, 2000, ARCH GEN PSYCHIAT, V57, P1115, DOI 10.1001/archpsyc.57.12.1115; Francis AN, 2013, SCHIZOPHR RES, V151, P154, DOI 10.1016/j.schres.2013.10.002; Guy W, 2000, HANDBOOK OF PSYCHIAT; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Herz MI, 1997, AM J PSYCHIAT, V154, P1; Ho AJ, 2010, HUM BRAIN MAPP, V31, P499, DOI 10.1002/hbm.20882; Huang YF, 2007, BIOMETRIKA, V94, P965, DOI 10.1093/biomet/asm067; Inagaki A., 2006, JAPANESE J CLIN PSYC, V9, P1443; Kaneda Yasuhiro, 2011, JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, V31, P259; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keefe RSE, 2006, AM J PSYCHIAT, V163, P426, DOI 10.1176/appi.ajp.163.3.426; Kuhn S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.51; Li YD, 2013, AM J ALZHEIMERS DIS, V28, P627, DOI 10.1177/1533317513494452; Makris N, 1999, NEUROIMAGE, V9, P18, DOI 10.1006/nimg.1998.0384; Mamah Daniel, 2012, Front Psychiatry, V3, P96, DOI 10.3389/fpsyt.2012.00096; Mathew I, 2014, JAMA PSYCHIATRY; Narr KL, 2004, NEUROIMAGE, V21, P1563, DOI 10.1016/j.neuroimage.2003.11.011; Pajonk FG, 2010, ARCH GEN PSYCHIAT, V67, P133, DOI 10.1001/archgenpsychiatry.2009.193; Panenka WJ, 2007, SCHIZOPHR RES, V94, P288, DOI 10.1016/j.schres.2007.05.002; Pereira JB, 2013, HIPPOCAMPUS, V23, P720, DOI 10.1002/hipo.22131; Pluta J, 2012, J ALZHEIMERS DIS, V31, P85, DOI 10.3233/JAD-2012-111931; Qiu AQ, 2010, NEUROIMAGE, V52, P1181, DOI 10.1016/j.neuroimage.2010.05.046; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Sawada K, 2005, ARCH GEN PSYCHIAT, V62, P263, DOI 10.1001/archpsyc.62.3.263; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Sheng GQ, 2012, ARCH GEN PSYCHIAT, V69, P550, DOI 10.1001/archgenpsychiatry.2011.1882; Shenton ME, 2002, PSYCHIAT RES-NEUROIM, V115, P15, DOI 10.1016/S0925-4927(02)00025-2; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Tamminga CA, 2012, SCHIZOPHR BULL; Tamminga CA, 2010, AM J PSYCHIAT, V167, P1178, DOI 10.1176/appi.ajp.2010.09081187; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Van Leemput K, 2009, HIPPOCAMPUS, V19, P549, DOI 10.1002/hipo.20615; Vermetten E, 2006, AM J PSYCHIAT, V163, P630, DOI 10.1176/appi.ajp.163.4.630; Vita A, 2006, SCHIZOPHR RES, V82, P75, DOI 10.1016/j.schres.2005.11.004; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Wang L, 2008, BIOL PSYCHIAT, V64, P1060, DOI 10.1016/j.biopsych.2008.08.007; Winterburn JL, 2013, NEUROIMAGE, V74, P254, DOI 10.1016/j.neuroimage.2013.02.003; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Zierhut KC, 2013, BRAIN, V136, P804, DOI 10.1093/brain/aws335	47	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117785	10.1371/journal.pone.0117785	http://dx.doi.org/10.1371/journal.pone.0117785			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658118	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900223
J	Mariapun, S; Li, JM; Yip, CH; Taib, NAM; Teo, SH				Mariapun, Shivaani; Li, Jingmei; Yip, Cheng Har; Taib, Nur Aishah Mohd; Teo, Soo-Hwang			Ethnic Differences in Mammographic Densities: An Asian Cross-Sectional Study	PLOS ONE			English	Article							BREAST-CANCER RISK; HORMONE REPLACEMENT THERAPY; PARENCHYMAL PATTERNS; CHINESE WOMEN; METAANALYSIS; KNOWLEDGE; MORTALITY; SINGAPORE; TRENDS	Background Mammographic density is a strong risk factor for breast cancer and is highly variable, but, to date, few studies have examined density in Asian women, particularly those in low and middleincome Asian countries where genetic and lifestyle determinants may be significantly different. Methods A total of 1,240 women who attended an opportunistic mammogram screening programme were eligible for analysis. Mammographic density was estimated using a fully-automated thresholding method and differences across ethnic groups were examined using linear regression in 205 randomly selected Chinese women, 138 Malay and 199 Indian women. Results Percent density was significantly higher in Chinese women (28.5%; 95% CI 27.0%, 30.0%) compared to Malay (24.2%; 95% CI 22.5%, 26.0%) and Indian (24.3%; 95% CI 22.8%, 25.7%) women (p<0.001), after adjustment for age, BMI, menopausal status, parity and age at first full term pregnancy. Correspondingly, adjusted nondense area was significantly lower in Chinese (72.2cm(2); 95% CI 67.9cm(2), 76.5cm(2)) women compared to Malay (92.1cm(2); 95% CI 86.9cm(2,) 97.2cm(2)) and Indian (97.7cm(2); 95% CI 93.4cm(2), 101.9cm(2)) women (p<0.001), but dense area did not differ across the three ethnic groups. Conclusions Our study shows that higher percent density and lower nondense area reflect the higher incidence of breast cancer in Chinese compared to Malay and Indian women in Malaysia. Known lifestyle determinants of mammographic density do not fully account for the ethnic variations observed in mammographic density in this Asian cohort.	[Mariapun, Shivaani; Teo, Soo-Hwang] Canc Res Initiat Fdn, Sime Darby Med Ctr, Subang Jaya 47500, Selangor, Malaysia; [Mariapun, Shivaani; Taib, Nur Aishah Mohd; Teo, Soo-Hwang] Univ Malaya, Fac Med, Canc Res Inst, Breast Canc Res Unit, Kuala Lumpur 50603, Malaysia; [Li, Jingmei] Genome Inst Singapore, Singapore 138672, Singapore; [Yip, Cheng Har] Sime Darby Med Ctr, Subang Jaya 47500, Selangor, Malaysia	Universiti Malaya; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Teo, SH (corresponding author), Canc Res Initiat Fdn, Sime Darby Med Ctr, 1 Jalan SS12-1A, Subang Jaya 47500, Selangor, Malaysia.	soohwang.teo@carif.com.my	Li, Jingmei/I-2904-2012; Teo, Soo-hwang/H-2353-2014; Taib, Nur Aishah Mohd/B-2370-2010; Yip, Cheng-Har/B-1909-2010	Li, Jingmei/0000-0001-8587-7511; Taib, Nur Aishah Mohd/0000-0001-8419-0478; 	Cancer Research Initiatives Foundation; Agency for Science, Technology and Research (A-STAR), Singapore under the 2nd Joint Council Office (JCO) Career Development [13302EG065]	Cancer Research Initiatives Foundation; Agency for Science, Technology and Research (A-STAR), Singapore under the 2nd Joint Council Office (JCO) Career Development(Agency for Science Technology & Research (A*STAR))	This work is supported by the donors of Cancer Research Initiatives Foundation, particularly funds raised through the Sime Darby LPGA Tournament Malaysia. Work on the automated thresholding method was supported by the Agency for Science, Technology and Research (A-STAR), Singapore under the 2nd Joint Council Office (JCO) Career Development Grant (13302EG065). Jingmei Li is a UNESCO-L'OREAL International Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken Z, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-35; Althuis MD, 2005, INT J EPIDEMIOL, V34, P405, DOI 10.1093/ije/dyh414; [Anonymous], 2011, QUICK FACTS 2011 MAL, P39; [Anonymous], 2004, CANC INCIDENCE MALAY; [Anonymous], 2012, STAT YB MALAYSIA 201; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; Carmona-Sanchez E, 2013, GYNECOL ENDOCRINOL, V29, P1067, DOI 10.3109/09513590.2013.831831; Chen ZJ, 2004, AM J EPIDEMIOL, V159, P140, DOI 10.1093/aje/kwh028; Colacurci N, 2001, MATURITAS, V40, P159, DOI 10.1016/S0378-5122(01)00232-8; Dai H, 2014, INT J EPIDEMIOL; Heng D, 2004, CANCER EPIDEM BIOMAR, V13, P1751; Li JM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3238; Malaysia DoS, 2012, HOUS INC BAS AM SURV; Maskarinec G, 2005, AM J EPIDEMIOL, V162, P743, DOI 10.1093/aje/kwi270; Maskarinec G, 2001, INT J EPIDEMIOL, V30, P959, DOI 10.1093/ije/30.5.959; Maskarinec G, 2007, BREAST CANCER RES TR, V104, P47, DOI 10.1007/s10549-006-9387-5; McCormack VA, 2008, AM J EPIDEMIOL, V168, P412, DOI 10.1093/aje/kwn169; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; OZA AM, 1993, EPIDEMIOL REV, V15, P196, DOI 10.1093/oxfordjournals.epirev.a036105; Parsa P, 2008, ASIAN PAC J CANCER P, V9, P221; Persson I, 1997, J CLIN ONCOL, V15, P3201, DOI 10.1200/JCO.1997.15.10.3201; Pettersson A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3041; SAFTLAS AF, 1987, EPIDEMIOL REV, V9, P146, DOI 10.1093/oxfordjournals.epirev.a036300; Shin HR, 2010, CANCER SCI, V101, P1241, DOI 10.1111/j.1349-7006.2010.01519.x; Sim HL, 2009, SINGAP MED J, V50, P132; WARNER E, 1992, CANCER DETECT PREV, V16, P67; Wu AH, 2008, CANCER EPIDEM BIOMAR, V17, P3358, DOI 10.1158/1055-9965.EPI-08-0132; Yip Cheng Har, 2006, Asian Pac J Cancer Prev, V7, P369	28	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117568	10.1371/journal.pone.0117568	http://dx.doi.org/10.1371/journal.pone.0117568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659139	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900177
J	Rao, S; Larroque-Lombard, AL; Peyrard, L; Thauvin, C; Rachid, Z; Williams, C; Jean-Claude, BJ				Rao, Suman; Larroque-Lombard, Anne-Laure; Peyrard, Lisa; Thauvin, Cedric; Rachid, Zakaria; Williams, Christopher; Jean-Claude, Bertrand J.			Target Modulation by a Kinase Inhibitor Engineered to Induce a Tandem Blockade of the Epidermal Growth Factor Receptor (EGFR) and c-Src: The Concept of Type III Combi-Targeting	PLOS ONE			English	Article							BREAST-CANCER CELLS; TYROSINE KINASE; ACTIVATION; EXPRESSION; POLYPHARMACOLOGY; MOLECULES; DISCOVERY; CARCINOMA; GEFITINIB; OVERCOME	Cancer cells are characterized by a complex network of interrelated and compensatory signaling driven by multiple kinases that reduce their sensitivity to targeted therapy. Therefore, strategies directed at inhibiting two or more kinases are required to robustly block the growth of refractory tumour cells. Here we report on a novel strategy to promote sustained inhibition of two oncogenic kinases (Kin-1 and Kin-2) by designing a molecule K1-K2, termed "combi-molecule", to induce a tandem blockade of Kin-1 and Kin-2, as an intact structure and to be further hydrolyzed to two inhibitors K1 and K2 directed at Kin-1 and Kin-2, respectively. We chose to target EGFR (Kin-1) and c-Src (Kin-2), two tyrosine kinases known to synergize to promote tumour growth and progression. Variation of K1-K2 linkers led to AL776, our first optimized EGFR-c-Src targeting prototype. Here we showed that: (a) AL776 blocked EGFR and c-Src as an intact structure using an in vitro kinase assay (IC50 EGFR = 0.12 mu M and IC50 c-Src = 3 nM), (b) it could release K1 (AL621, a nanomolar EGFR inhibitor) and K2 (dasatinib, a clinically approved Abl/c-Src inhibitor) by hydrolytic cleavage both in vitro and in vivo, (c) it could robustly inhibit phosphorylation of EGFR and c-Src (0.25-1 mu M) in cells, (d) it induced 2-4 fold stronger growth inhibition than gefitinib or dasatinib and apoptosis at concentrations as low as 1 mu M, and, (e) blocked motility and invasion at sub-micromolar doses in the highly invasive 4T1 and MDA-MB-231 cells. Despite its size (MW = 1032), AL776 blocked phosphorylation of EGFR and c-Src in 4T1 tumours in vivo. We now term this new targeting model consisting of designing a kinase inhibitor K1-K2 to target Kin-1 and Kin-2, and to further release two inhibitors K1 and K2 of the latter kinases, "type III combi-targeting".	[Rao, Suman; Larroque-Lombard, Anne-Laure; Peyrard, Lisa; Thauvin, Cedric; Rachid, Zakaria; Jean-Claude, Bertrand J.] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Canc Drug Res Lab,Dept Med,Div Med Oncol, Montreal, PQ H3A 1A1, Canada; [Williams, Christopher] Chem Comp Grp Inc, Montreal, PQ H3A 2R7, Canada	McGill University; Royal Victoria Hospital; Chemical Computing Group	Jean-Claude, BJ (corresponding author), McGill Univ, Ctr Hlth, Royal Victoria Hosp, Canc Drug Res Lab,Dept Med,Div Med Oncol, 687 Pine Ave West Rm M7-19, Montreal, PQ H3A 1A1, Canada.	bertrandj.jean-claude@mcgill.ca		Rao, Suman/0000-0002-5046-0852	Canadian Institutes of Health Research (CIHR) team grant; Canadian Institutes of Health Research (CIHR)-Frederick Banting and Charles Best award (Canadian Graduate Scholarship); McGill-CIHR Drug Development Training Program [TGF-96110]; McGill University Health Center (MUHC) scholarship; postdoctoral fellowship-training award	Canadian Institutes of Health Research (CIHR) team grant(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research (CIHR)-Frederick Banting and Charles Best award (Canadian Graduate Scholarship)(Canadian Institutes of Health Research (CIHR)); McGill-CIHR Drug Development Training Program(Canadian Institutes of Health Research (CIHR)); McGill University Health Center (MUHC) scholarship; postdoctoral fellowship-training award	This work was supported by the following sources of funding: Canadian Institutes of Health Research (CIHR) team grant (http://www.cihr-irsc.gc.ca/; BJC), Canadian Institutes of Health Research (CIHR)-Frederick Banting and Charles Best award (Canadian Graduate Scholarship; SR), McGill-CIHR Drug Development Training Program, TGF-96110 (http://www.medicine.mcgill.ca/trainingindrugdev/, postdoctoral fellowship-training award; SR ALL LP CT), and McGill University Health Center (MUHC) scholarship (http://muhc.ca/; SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar FG, 2012, J PHARM SCI-US, V101, P3979, DOI 10.1002/jps.23258; Banerjee R, 2003, J MED CHEM, V46, P5546, DOI 10.1021/jm030423m; Banerjee R, 2011, CELL SIGNAL, V23, P630, DOI 10.1016/j.cellsig.2010.11.014; Banerjee R, 2010, J PHARMACOL EXP THER, V334, P9, DOI 10.1124/jpet.109.160085; Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; Barchechath S, 2009, CHEM BIOL DRUG DES, V73, P380, DOI 10.1111/j.1747-0285.2009.00786.x; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Brahimi F, 2005, BIOCHEM PHARMACOL, V70, P511, DOI 10.1016/j.bcp.2005.04.037; Brahimi F, 2002, J PHARMACOL EXP THER, V303, P238, DOI 10.1124/jpet.102.039099; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Dar AC, 2012, NATURE, V486, P80, DOI 10.1038/nature11127; Fortin S, 2013, EXPERT OPIN DRUG DIS, V8, P1029, DOI 10.1517/17460441.2013.798296; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Getlik M, 2009, J MED CHEM, V52, P3915, DOI 10.1021/jm9002928; Heppner GH, 2000, BREAST CANCER RES, V2, P331; HUNTER RL, 1961, ANN NY ACAD SCI, V94, P861; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irwin ME, 2011, CANCER BIOL THER, V12, P718, DOI 10.4161/cbt.12.8.16907; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Koppikar P, 2008, CLIN CANCER RES, V14, P4284, DOI 10.1158/1078-0432.CCR-07-5226; Larroque AL, 2008, CHEM BIOL DRUG DES, V71, P374, DOI 10.1111/j.1747-0285.2008.00638.x; Larroque-Lombard AL, 2012, CHEM BIOL DRUG DES, V80, P981, DOI 10.1111/cbdd.12043; Larroque-Lombard AL, 2011, CHEM BIOL DRUG DES, V77, P309, DOI 10.1111/j.1747-0285.2011.01098.x; Larroque-Lombard AL, 2010, J MED CHEM, V53, P2104, DOI 10.1021/jm9016043; Li H, 2011, ADV MED SCI-POLAND, V56, P275, DOI 10.2478/v10039-011-0043-x; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; MODJTAHEDI H, 1994, INT J ONCOL, V4, P277; Nautiyal J, 2009, CANCER LETT, V283, P143, DOI 10.1016/j.canlet.2009.03.035; Neto C, 2012, NUCL MED BIOL, V39, P247, DOI 10.1016/j.nucmedbio.2011.09.001; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Rachid Z, 2005, BIOORG MED CHEM LETT, V15, P1135, DOI 10.1016/j.bmcl.2004.12.015; Reddy AS, 2013, EXPERT REV CLIN PHAR, V6, P41, DOI [10.1586/ECP.12.74, 10.1586/ecp.12.74]; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Solca F, 2012, J PHARMACOL EXP THER, V343, P342, DOI 10.1124/jpet.112.197756; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Tanjoni I, 2010, CANCER BIOL THER, V9, P764, DOI 10.4161/cbt.9.10.11434; Todorova MI, 2010, MOL CANCER THER, V9, P869, DOI 10.1158/1535-7163.MCT-09-0673; Tryfonopoulos D, 2011, ANN ONCOL, V22, P2234, DOI 10.1093/annonc/mdq757; Walker I, 2009, NAT REV DRUG DISCOV, V8, P15, DOI 10.1038/nrd2758; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	47	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117215	10.1371/journal.pone.0117215	http://dx.doi.org/10.1371/journal.pone.0117215			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658745	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900119
J	Verret-Chalifour, J; Giguere, Y; Forest, JC; Croteau, J; Zhang, PY; Marc, I				Verret-Chalifour, Julie; Giguere, Yves; Forest, Jean-Claude; Croteau, Jordie; Zhang, Peiyin; Marc, Isabelle			Breastfeeding Initiation: Impact of Obesity in a Large Canadian Perinatal Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; MATERNAL OBESITY; DURATION; ASSOCIATION; PREGNANCY; INTERVENTIONS; CESSATION; INTENTION; WOMEN	Objective To evaluate incidence of breastfeeding initiation according to maternal pre-pregnancy body mass index (BMI) in "Grossesse en Sante" a large prospective birth cohort in Quebec City. Methods Breastfeeding initiation in the post-partum period, pre-pregnancy BMI, sociodemographic determinants and obstetrical and neonatal factors were collected from years 2005 to 2010 in 6592 women with single pregnancies. Prenatal non-intention to breastfeed was documented in a subgroup of the cohort (years 2009-2010). Log-binomial regression analyses were performed to assess relative risk (RR) of non-initiation of breastfeeding between maternal BMI categories in models including pre- and post-natal determinants, after exclusion of variables with a mediating effect. Results Twenty percent (20%) of obese women did not initiate breastfeeding in the post-natal period at hospital compared to 12% for normal weight women. Compared with those having a normal pre-pregnancy BMI, obese women had a higher risk of non-initiation of breastfeeding (RRunadj 1.69, 95% CI 1.44-1.98), even after adjustment for prenatal and sociodemographic factors (RRadj 1.26, 95% CI 1.08-1.46). Furthermore, the risk of non-initiation of breastfeeding in obese women still remained higher after introduction of per-and post-natal factors (RR 1.22, 95% CI 1.04-1.42). The prenatal non-intention to breastfeed was strongly associated with the non-initiation of breastfeeding for all categories of BMI. Maternal obesity is associated with a two-fold rate of non-initiation of breastfeeding. Considering the benefits of breastfeeding and the increasing obesity rate, adapted interventions and specialized support should target both pre- and immediate post-natal periods in this population.	[Verret-Chalifour, Julie; Zhang, Peiyin; Marc, Isabelle] Ctr Hosp Univ CHU Quebec, Dept Pediat, Quebec City, PQ, Canada; [Giguere, Yves; Forest, Jean-Claude] Ctr Hosp Univ CHU Quebec, Dept Med Biol, Quebec City, PQ, Canada; [Croteau, Jordie] Univ Laval, Lab Biostat, Ctr Rech, Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Marc, I (corresponding author), Ctr Hosp Univ CHU Quebec, Dept Pediat, Quebec City, PQ, Canada.	isabelle.marc@crchudequebec.ulaval.ca		Marc, Isabelle/0000-0001-6060-8550	Canadian Institutes of Health Research (CIHR); Fonds de Recherche Quebec-Sante (FRQ-S), Canada; Universite Laval; Fondations des Etoiles; Canadian Institutes of Health Research (CIHR), Healthy Pregnancy Initiative from the Institute for Human Development, Child and Youth Health	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche Quebec-Sante (FRQ-S), Canada; Universite Laval; Fondations des Etoiles; Canadian Institutes of Health Research (CIHR), Healthy Pregnancy Initiative from the Institute for Human Development, Child and Youth Health(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) (http://www.cihrirsc.gc.ca/). Isabelle Marc and Yves Giguere were supported by a clinician researcher award from the Fonds de Recherche Quebec-Sante (FRQ-S) http://www.frsq.gouv.qc.ca), Canada. Julie Verret-Chalifour was supported by social leadership scholarship from Universite Laval. Peiyin Zhang summer bursary was supported by Fondations des Etoiles (http://www.fondationdesetoiles.ca/fr). Authors (Giguere, Forest) of the original cohort were supported by the Canadian Institutes of Health Research (CIHR), Healthy Pregnancy Initiative from the Institute for Human Development, Child and Youth Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo KB, 2012, INT J ENV RES PUB HE, V9, P1263, DOI 10.3390/ijerph9041263; Amir Lisa H, 2007, BMC Pregnancy Childbirth, V7, P9, DOI 10.1186/1471-2393-7-9; Baillargeon D, 2004, QUEBEC MAL ENFANTS M, DOI [10.1016/j.chemosphere.2014.04.039, DOI 10.1016/J.CHEMOSPHERE.2014.04.039]; Berger H, 2002, J OBS GYN CAN, V24; Buschur E, 2012, INT J GYNECOL OBSTET, V119, P6, DOI 10.1016/j.ijgo.2012.04.025; Davies GAL, 2010, INT J GYNECOL OBSTET, V110, P167, DOI 10.1016/j.ijgo.2010.03.008; Donald B. Rubin, 1987, MULTIPLE IMPUTATION; Donath SM, 2008, MATERN CHILD NUTR, V4, P163, DOI 10.1111/j.1740-8709.2008.00134.x; Feldman-Winter L, 2013, PEDIATR CLIN N AM, V60, P169, DOI 10.1016/j.pcl.2012.09.007; Gale C, 2012, AM J CLIN NUTR, V95, P656, DOI 10.3945/ajcn.111.027284; Galtier-Dereure F, 2000, AM J CLIN NUTR, V71, p1242S, DOI 10.1093/ajcn/71.5.1242s; Gaudet L, 2012, J MATERN-FETAL NEO M, V25, P2281, DOI 10.3109/14767058.2012.688080; Gubler T, 2013, J PERINAT MED, V41, P331, DOI 10.1515/jpm-2012-0102; Guelinckx I, 2012, PUBLIC HEALTH NUTR, V15, P840, DOI 10.1017/S1368980011002667; Hales CN, 2013, INT J EPIDEMIOL, V42, P1215, DOI 10.1093/ije/dyt133; Hauff LE, 2014, AM J CLIN NUTR, V99, P524, DOI 10.3945/ajcn.113.071191; Hauff LE, 2012, AM J HUM BIOL, V24, P339, DOI 10.1002/ajhb.22238; Heslehurst N, 2007, BJOG-INT J OBSTET GY, V114, P334, DOI 10.1111/j.1471-0528.2006.01230.x; Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Horta BL, 2013, LONG TERM EFFECTS BR, DOI [10.1002/jobm.201300173, DOI 10.1002/JOBM.201300173]; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; Howel D, 2013, J HUM LACT, V29, P579, DOI 10.1177/0890334413492908; Kehler HL, 2009, CAN J PUBLIC HEALTH, V100, P376, DOI 10.1007/BF03405274; Knol MJ, 2012, CAN MED ASSOC J, V184, P895, DOI 10.1503/cmaj.101715; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Kronborg H, 2013, EUR J PUBLIC HEALTH, V23, P316, DOI 10.1093/eurpub/cks135; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; Mehta UJ, 2011, BREASTFEED MED, V6, P369, DOI 10.1089/bfm.2010.0052; Meyerink Rachael O, 2002, J Hum Lact, V18, P38, DOI 10.1177/089033440201800106; Ministere de la sante et des services sociaux, 2008, POLITIQUE DE PERINAT; Organisation mondiale de la sante, 2003, OB PREV PRIS CHARG E, DOI [10.1371/journal.pone.0116506, DOI 10.1371/JOURNAL.PONE.0116506]; Organisation mondiale de la sante Unicef, 2003, STRAT MOND AL NOURR, DOI [10.1016/j.syapm.2014.12.003, DOI 10.1016/J.SYAPM.2014.12.003]; Riordan J., 2005, BREASTFEEDING HUMAN; Sante Canada, 2004, DUR ALL MAT EXCL REC, DOI [10.3389/fnhum.2014.01019, DOI 10.3389/FNHUM.2014.01019]; Statistics Canada Canadian Community Health Survey, 2010, BREASTF IN CAN KEY S; Theriault S, 2013, OBSTET GYNECOL, V122, P345, DOI 10.1097/AOG.0b013e31829b2f7c; Thompson LA, 2013, MATERN CHILD HLTH J, V17, P1842, DOI 10.1007/s10995-012-1204-7; Turcksin R, 2014, MATERN CHILD NUTR, V10, P166, DOI 10.1111/j.1740-8709.2012.00439.x; Wojcicki JM, 2011, J WOMENS HEALTH, V20, P341, DOI 10.1089/jwh.2010.2248; Yu C.Y., 2002, EVALUATING CUTOFF CR	40	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117512	10.1371/journal.pone.0117512	http://dx.doi.org/10.1371/journal.pone.0117512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659144	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900168
J	Xue, F; Li, X; Zhao, XQ; Wang, LQ; Liu, M; Shi, RF; Zheng, J				Xue, Feng; Li, Xia; Zhao, Xiaoqing; Wang, Lanqi; Liu, Min; Shi, Ruofei; Zheng, Jie			SRSF1 Facilitates Cytosolic DNA-Induced Production of Type I Interferons Recognized by RIG-I	PLOS ONE			English	Article							SPLICING FACTOR SF2/ASF; INNATE IMMUNE SENSOR; SR PROTEINS; RNA; EXPRESSION; PSORIASIS; HELICASE; PHOSPHORYLATION; PROLIFERATION; INFLAMMASOME	Background Evidence has shown that psoriasis is closely associated with infection; however, the mechanism of this association remains unclear. In mammalian cells, viral or bacterial infection is accompanied by the release of cytosolic DNA, which in turn triggers the production of type-I interferons (IFNs). Type I IFNs and their associated genes are significantly upregulated in psoriatic lesions. RIG-I is also highly upregulated in psoriatic lesions and is responsible for IFN production. However, RIG-I mediated regulatory signaling in psoriasis is poorly understood. Methods We screened a cDNA library and identified potential RIG-I interacting partners that may play a role in psoriasis. Results We found that serine/arginine-rich splicing factor 1 (SRSF1) could specifically interact with RIG-I to facilitate RIG-I mediated production of type-I IFN that is triggered by cytosolic DNA. We found SRSF1 associates with RNA polymerase III and RIG-I in a DNA-dependent manner. In addition, treatment with a TNF alpha inhibitor downregulated SRSF1 expression in peripheral blood mononuclear cells (PBMCs) from psoriasis vulgaris patients. Discussion Based on the abundance of pathogenic cytosolic DNA that is detected in psoriatic lesions, our finding that RIG-I interacts with SRSF1 to regulate type-I IFN production reveals acritical link regarding how cytosolic DNA specifically activates aberrant IFN expression. These data may provide new therapeutic targets for the treatment of psoriasis.	[Xue, Feng; Zheng, Jie] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dermatol Lab, Shanghai 200030, Peoples R China; [Li, Xia; Zhao, Xiaoqing; Wang, Lanqi; Liu, Min; Shi, Ruofei; Zheng, Jie] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Dermatol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zheng, J (corresponding author), Ruijin Hosp, Dept Dermatol, Shanghai, Peoples R China.	jie-zheng2001@126.com			National Natural Science Foundation of China [81171500]; Science and Technology Commission Foundation of Shanghai [11JC1407500]; National Bureau of Health, China [2011Y076]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission Foundation of Shanghai; National Bureau of Health, China	This work was supported by grants (81171500) from the National Natural Science Foundation of China, (11JC1407500) from the Science and Technology Commission Foundation of Shanghai, 2011 and (No. 2011Y076) from National Bureau of Health, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Baran W, 2005, ACTA DERMATOVEN ALP, V14, P79; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Buerger C, 2013, THE BRITISH JOURNAL; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cai YH, 2009, J INVEST DERMATOL, V129, P2653, DOI 10.1038/jid.2009.153; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cui J, 2014, CELL RES, V24, P400, DOI 10.1038/cr.2013.170; Das S, 2012, CELL REP, V1, P110, DOI 10.1016/j.celrep.2011.12.001; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fregoso OI, 2013, MOL CELL, V50, P56, DOI 10.1016/j.molcel.2013.02.001; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Karni R, 2008, P NATL ACAD SCI USA, V105, P15323, DOI 10.1073/pnas.0801376105; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Kitamura H, 2007, J DERMATOL SCI, V45, P127, DOI 10.1016/j.jdermsci.2006.11.003; Krueger JG, 2002, J AM ACAD DERMATOL, V46, P1, DOI 10.1067/mjd.2002.120568; Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6; Leva V, 2012, NUCLEIC ACIDS RES, V40, P1106, DOI 10.1093/nar/gkr837; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Moulton VR, 2013, P NATL ACAD SCI USA, V110, P1845, DOI 10.1073/pnas.1214207110; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Prens EP, 2008, J INVEST DERMATOL, V128, P932, DOI 10.1038/sj.jid.5701087; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; SCHMID P, 1994, J INTERFERON RES, V14, P229, DOI 10.1089/jir.1994.14.229; Sun L, 2012, SCIENCE; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Tlaskalova-Hogenova H, 2005, ANN NY ACAD SCI, V1051, P787, DOI 10.1196/annals.1361.122; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Van der Fits L, 2004, J INVEST DERMATOL, V122, P51, DOI 10.1046/j.0022-202X.2003.22113.x; Wu J, 2012, SCIENCE; Xiao TS, 2013, MOL CELL, V51, P135, DOI 10.1016/j.molcel.2013.07.004; Xiong Z, 2006, J CLIN PATHOL, V59, P855, DOI 10.1136/jcp.2005.032961; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2007, NAT IMMUNOL, V8, P907, DOI 10.1038/ni0907-907; Zhang Z, 2004, MOL CELL, V16, P597, DOI 10.1016/j.molcel.2004.10.031; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016	57	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115354	10.1371/journal.pone.0115354	http://dx.doi.org/10.1371/journal.pone.0115354			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658361	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900017
J	Liu, XS; Weidle, K; Schrock, K; Tonjes, A; Schleinitz, D; Breitfeld, J; Stumvoll, M; Bottcher, Y; Schoneberg, T; Kovacs, P				Liu, Xuanshi; Weidle, Kerstin; Schroeck, Kristin; Toenjes, Anke; Schleinitz, Dorit; Breitfeld, Jana; Stumvoll, Michael; Boettcher, Yvonne; Schoeneberg, Torsten; Kovacs, Peter			Signatures of Natural Selection at the FTO (Fat Mass and Obesity Associated) Locus in Human Populations	PLOS ONE			English	Article							AMINO-ACID SITES; POSITIVE SELECTION; BODY-MASS; PHYLOGENETIC ANALYSIS; STATISTICAL-METHODS; CODON-SUBSTITUTION; GENE-EXPRESSION; VARIANTS; MODELS; GENOME	Background and aims Polymorphisms in the first intron of FTO have been robustly replicated for associations with obesity. In the Sorbs, a Slavic population resident in Germany, the strongest effect on body mass index (BMI) was found for a variant in the third intron of FTO (rs17818902). Since this may indicate population specific effects of FTO variants, we initiated studies testing FTO for signatures of selection in vertebrate species and human populations. Methods First, we analyzed the coding region of 35 vertebrate FTO orthologs with Phylogenetic Analysis by Maximum Likelihood (PAML, omega = dN/dS) to screen for signatures of selection among species. Second, we investigated human population (Europeans/CEU, Yoruba/YRI, Chinese/CHB, Japanese/JPT, Sorbs) SNP data for footprints of selection using DnaSP version 4.5 and the Haplotter/PhaseII. Finally, using ConSite we compared transcription factor (TF) binding sites at sequences harbouring FTO SNPs in intron three. Results PAML analyses revealed strong conservation in coding region of FTO (omega<1). Sliding-window results from population genetic analyses provided highly significant (p<0.001) signatures for balancing selection specifically in the third intron (e.g. Tajima's D in Sorbs = 2.77). We observed several alterations in TF binding sites, e.g. TCF3 binding site introduced by the rs17818902 minor allele. Conclusion Population genetic analysis revealed signatures of balancing selection at the FTO locus with a prominent signal in intron three, a genomic region with strong association with BMI in the Sorbs. Our data support the hypothesis that genes associated with obesity may have been under evolutionary selective pressure.	[Liu, Xuanshi; Breitfeld, Jana; Stumvoll, Michael; Boettcher, Yvonne; Kovacs, Peter] Univ Leipzig, IFB Adipos Dis, D-04109 Leipzig, Germany; [Liu, Xuanshi] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04109 Leipzig, Germany; [Weidle, Kerstin; Toenjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany; [Schroeck, Kristin; Schoeneberg, Torsten] Univ Leipzig, Inst Biochem, Dept Med, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Kovacs, P (corresponding author), Univ Leipzig, IFB Adipos Dis, D-04109 Leipzig, Germany.	peter.kovacs@medizin.uni-leipzig.de	Stumvoll, Michael/ABE-1121-2021	Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423	Boehringer Ingelheim Foundation; IFB AdiposityDiseases [ADI-K50D, ADI-K7-45, ADI-K60E]; Collaborative Research Center (CRC) [1052, B03]; German Research Foundation [BO 3147/4-1]; Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001]	Boehringer Ingelheim Foundation(Boehringer Ingelheim); IFB AdiposityDiseases; Collaborative Research Center (CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	This project was supported by grants from the Boehringer Ingelheim Foundation to P.K., from the IFB AdiposityDiseases (ADI-K50D and ADI-K7-45 to Y.B. and ADI-K60E to P. K.), and from the Collaborative Research Center granted by the DFG (CRC 1052; B03). The work was further funded by the German Research Foundation (BO 3147/4-1 to Y.B.). IFB AdiposityDiseases is supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Ayub Q, 2014, AM J HUM GENET, V94, P176, DOI 10.1016/j.ajhg.2013.12.010; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friese RS, 2013, HUM MOL GENET, V22, P3624, DOI 10.1093/hmg/ddt213; FU YX, 1993, GENETICS, V133, P693; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gorkin DU, 2014, NATURE, V507, P309, DOI 10.1038/nature13212; Hennig BJ, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-21; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Kulzer JR, 2014, AM J HUM GENET, V94, P186, DOI 10.1016/j.ajhg.2013.12.011; LEWONTIN RC, 1973, ANNU REV GENET, V7, P1, DOI 10.1146/annurev.ge.07.120173.000245; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Loos RJF, 2014, NAT REV ENDOCRINOL, V10, P51, DOI 10.1038/nrendo.2013.227; Ma YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094911; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Melas PA, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.31; Metzger KJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-139; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; NEEL JV, 1962, AM J HUM GENET, V14, P353; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Nielsen R, 1998, GENETICS, V148, P929; Ohashi J, 2007, J HUM GENET, V52, P1031, DOI 10.1007/s10038-007-0198-2; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pybus M, 2014, NUCLEIC ACIDS RES, V42, pD903, DOI 10.1093/nar/gkt1188; Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Southam L, 2009, DIABETOLOGIA, V52, P1846, DOI 10.1007/s00125-009-1419-3; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tonjes A, 2010, EUR J HUM GENET, V18, P104, DOI 10.1038/ejhg.2009.107; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yajnik CS, 2009, DIABETOLOGIA, V52, P247, DOI 10.1007/s00125-008-1186-6; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283	57	9	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117093	10.1371/journal.pone.0117093	http://dx.doi.org/10.1371/journal.pone.0117093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647475	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600054
J	Yang, YQ; Dong, C; Yang, SH; Li, X; Sun, XD; Yang, YP				Yang, Yunqiang; Dong, Chao; Yang, Shihai; Li, Xiong; Sun, Xudong; Yang, Yongping			Physiological and Proteomic Adaptation of the Alpine Grass Stipa purpurea to a Drought Gradient	PLOS ONE			English	Article							OSMOTIC ADJUSTMENT; TIBETAN PLATEAU; HEAT-STRESS; ARABIDOPSIS; RESPONSES; PLANT; ABA; GROWTH; ROOT; CELL	Stipa purpurea, an endemic forage species on the Tibetan Plateau, is highly resistant to cold and drought, but the mechanisms underlying its responses to drought stress remain elusive. An understanding of such mechanisms may be useful for developing cultivars that are adaptable to water deficit. In this study, we analyzed the physiological and proteomic responses of S. purpurea under increasing drought stress. Seedlings of S. purpurea were subjected to a drought gradient in a controlled experiment, and proteins showing changes in abundance under these conditions were identified by two-dimensional electrophoresis followed by mass spectrometry analysis. A western blotting analysis was conducted to confirm the increased abundance of a heat-shock protein, NCED2, and a dehydrin in S. purpurea seedlings under drought conditions. We detected carbonylated proteins to identify oxidation-sensitive proteins in S. purpurea seedlings, and found that ribulose-1, 5-bisphosphate carboxylase oxygenase (RuBisCO) was one of the oxidation-sensitive proteins under drought. Together, these results indicated drought stress might inhibit photosynthesis in S. purpurea by oxidizing RuBisCO, but the plants were able to maintain photosynthetic efficiency by a compensatory upregulation of unoxidized RuBisCO and other photosynthesis-related proteins. Further analyses confirmed that increased abundance of antioxidant enzymes could balance the redox status of the plants to mitigate drought induced oxidative damage.	[Yang, Yunqiang; Dong, Chao; Li, Xiong; Sun, Xudong; Yang, Yongping] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Peoples R China; [Yang, Yunqiang; Dong, Chao; Li, Xiong; Sun, Xudong; Yang, Yongping] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Kunming, Peoples R China; [Yang, Yunqiang; Dong, Chao; Li, Xiong; Sun, Xudong; Yang, Yongping] Chinese Acad Sci, Kunming Inst Bot, Inst Tibetan Plateau Res Kunming, Kunming, Peoples R China; [Yang, Shihai] Chinese Acad Sci, Key Lab Tibetan Environm Changes & Land Surface P, Inst Tibetan Plateau Res, Beijing, Peoples R China; [Dong, Chao; Yang, Shihai; Li, Xiong] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, XD (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Peoples R China.	sunxudong@mail.kib.ac.cn; yangyp@mail.kib.ac.cn	Sun, Xudong/HHN-3905-2022; Yang, Shihai/J-1593-2012	Yang, Shihai/0000-0002-6497-968X	National Natural Science Foundation of China (NSFC) [41271058]; Major State Basic Research Development Program of China [2010CB951704]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China)	This work was financially supported by the National Natural Science Foundation of China (NSFC) (No. 41271058) and the Major State Basic Research Development Program of China ( No. 2010CB951704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GM, 2006, J PROTEOME RES, V5, P396, DOI 10.1021/pr050291g; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Austin AT, 2004, OECOLOGIA, V141, P221, DOI 10.1007/s00442-004-1519-1; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Bernstein N, 2010, FREE RADICAL BIO MED, V49, P1161, DOI 10.1016/j.freeradbiomed.2010.06.032; Bonhomme L, 2009, PROTEOMICS, V9, P4121, DOI 10.1002/pmic.200900047; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Broin M, 2002, PLANT CELL, V14, P1417, DOI 10.1105/tpc.001644; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costa MA, 2010, TREES-STRUCT FUNCT, V24, P275, DOI 10.1007/s00468-009-0397-x; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Ding SH, 2009, PLANT MOL BIOL, V69, P577, DOI 10.1007/s11103-008-9440-3; Duan BL, 2005, PHYSIOL PLANTARUM, V124, P476, DOI 10.1111/j.1399-3054.2005.00535.x; Gou XH, 2007, INT J CLIMATOL, V27, P1497, DOI 10.1002/joc.1480; GRENECHE M, 1991, SEED SCI TECHNOL, V19, P147; Grigorova B, 2011, BIOL PLANTARUM, V55, P105, DOI 10.1007/s10535-011-0014-x; He CM, 2011, EUPHYTICA, V177, P151, DOI 10.1007/s10681-010-0263-3; Jiang SL, 2012, J EXP BOT, V63, P2693, DOI 10.1093/jxb/err452; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; Kang Y, 2012, PLANT SIGNAL BEHAV, V7, P539, DOI 10.4161/psb.19780; Kim K, 2005, PLANT CELL PHYSIOL, V46, P522, DOI 10.1093/pcp/pci052; KOCHERT G, 1978, P95; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Lippert DN, 2009, PROTEOMICS, V9, P350, DOI 10.1002/pmic.200800252; Liu FL, 2003, FUNCT PLANT BIOL, V30, P65, DOI 10.1071/FP02170; Lounifi I, 2013, PROTEOMICS, V13, P568, DOI 10.1002/pmic.201200304; Lu SY, 2009, PLANT CELL REP, V28, P517, DOI 10.1007/s00299-008-0649-z; LUDLOW MM, 1990, AUST J AGR RES, V41, P67, DOI 10.1071/AR9900067; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; MITTLER R, 1994, PLANT J, V5, P397, DOI 10.1111/j.1365-313X.1994.00397.x; Ni J, 2000, MT RES DEV, V20, P80, DOI 10.1659/0276-4741(2000)020[0080:ASOBOT]2.0.CO;2; Ozkur O, 2009, ENVIRON EXP BOT, V66, P487, DOI 10.1016/j.envexpbot.2009.04.003; Pandey A, 2008, MOL CELL PROTEOMICS, V7, P88, DOI 10.1074/mcp.M700314-MCP200; Plomion C, 2006, PROTEOMICS, V6, P6509, DOI 10.1002/pmic.200600362; Raven EL, 2002, ENZYME CATALYZED ELE, P317, DOI DOI 10.1007/0-306-46828-X_; Riccardi F, 1998, PLANT PHYSIOL, V117, P1253, DOI 10.1104/pp.117.4.1253; Sanchez FJ, 1998, FIELD CROP RES, V59, P225, DOI 10.1016/S0378-4290(98)00125-7; Sandalio LM, 2001, J EXP BOT, V52, P2115, DOI 10.1093/jexbot/52.364.2115; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sung DY, 2003, PLANT PHYSIOL, V132, P979, DOI 10.1104/pp.102.019398; Taiz L., 1998, PLANT PHYSIOL, P725; Wang XQ, 2009, PLANT PHYSIOL, V149, P1739, DOI 10.1104/pp.108.131714; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Windhof A, 2011, THESIS LMU; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395; Xu CP, 2008, J EXP BOT, V59, P4183, DOI 10.1093/jxb/ern258; Xu LX, 2013, ENVIRON EXP BOT, V89, P28, DOI 10.1016/j.envexpbot.2012.12.001; Yamasaki Simone, 1999, Revista Brasileira de Fisiologia Vegetal, V11, P69; Yue PP, 2011, RUSS J ECOL+, V42, P50, DOI 10.1134/S1067413611010140; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhang MH, 2010, PROTEOMICS, V10, P3117, DOI 10.1002/pmic.200900637; Zhu JM, 2007, PLANT PHYSIOL, V145, P1533, DOI 10.1104/pp.107.107250; Zhuang Q, 2010, GLOBAL ECOL BIOGEOGR, V19, P649, DOI 10.1111/j.1466-8238.2010.00559.x	55	25	29	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117475	10.1371/journal.pone.0117475	http://dx.doi.org/10.1371/journal.pone.0117475			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646623	Green Submitted, gold, Green Published			2022-12-27	WOS:000348822600071
J	Berland, A; Gaillard, P; Guidetti, M; Barone, P				Berland, Aurore; Gaillard, Pascal; Guidetti, Michele; Barone, Pascal			Perception of Everyday Sounds: A Developmental Study of a Free Sorting Task	PLOS ONE			English	Article							CATEGORIZATION; INFANTS; SPEECH; IDENTIFICATION; VOICE; ACQUISITION; INHIBITION; SIMILARITY; CHILDREN; OBJECT	Objectives The analysis of categorization of everyday sounds is a crucial aspect of the perception of our surrounding world. However, it constitutes a poorly explored domain in developmental studies. The aim of our study was to understand the nature and the logic of the construction of auditory cognitive categories for natural sounds during development. We have developed an original approach based on a free sorting task (FST). Indeed, categorization is fundamental for structuring the world and cognitive skills related to, without having any need of the use of language. Our project explored the ability of children to structure their acoustic world, and to investigate how such structuration matures during normal development. We hypothesized that age affects the listening strategy and the category decision, as well as the number and the content of individual categories. Design Eighty-two French children (6-9 years), 20 teenagers (12-13 years), and 24 young adults participated in the study. Perception and categorization of everyday sounds was assessed based on a FST composed of 18 different sounds belonging to three a priori categories: non-linguistic human vocalizations, environmental sounds, and musical instruments. Results Children listened to the sounds more times than older participants, built significantly more classes than adults, and used a different strategy of classification. We can thus conclude that there is an age effect on how the participants accomplished the task. Analysis of the auditory categorization performed by 6-year-old children showed that this age constitutes a pivotal stage, in agreement with the progressive change from a non-logical reasoning based mainly on perceptive representations to the logical reasoning used by older children. In conclusion, our results suggest that the processing of auditory object categorization develops through different stages, while the intrinsic basis of the classification of sounds is already present in childhood.	[Berland, Aurore; Gaillard, Pascal; Guidetti, Michele] Univ Toulouse Jean Jaures, Lab Cognit Commun & Dev, EA4156, Unite Rech Interdisciplinaire Octogone, Toulouse, France; [Berland, Aurore; Barone, Pascal] Univ Toulouse UPS, Ctr Rech Cerveau & Cognit, CNRS UMR 5549, Toulouse, France	Universite de Toulouse; Universite de Toulouse - Jean Jaures; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE)	Barone, P (corresponding author), Univ Toulouse UPS, Ctr Rech Cerveau & Cognit, CNRS UMR 5549, Toulouse, France.	barone@cerco.ups-tlse.fr	Barone, Pascal/A-4008-2009; BARONE, Pascal/AHE-2323-2022; Gaillard, Pascal/H-7048-2018	BARONE, Pascal/0000-0003-0125-7468; Gaillard, Pascal/0000-0003-0389-1593; Guidetti, Michele/0000-0002-1678-946X	Center of Research and Higher Education of Toulouse; CNRS; Octogone-ECCD	Center of Research and Higher Education of Toulouse; CNRS(Centre National de la Recherche Scientifique (CNRS)); Octogone-ECCD	Support provided by the Center of Research and Higher Education of Toulouse (http://www.univ-toulouse.fr) and the recurrent funding of the CNRS, and of Octogone-ECCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 1990, Lecture Notes in Biomathematics, V84, P43; Aldrich KM, 2009, Q J EXP PSYCHOL, V62, P63, DOI 10.1080/17470210701814451; BALLAS JA, 1993, J EXP PSYCHOL HUMAN, V19, P250, DOI 10.1037/0096-1523.19.2.250; Ballas JA, 1991, HUM PERFORM, V4, P199, DOI DOI 10.1207/S15327043HUP0403_3; Barthelemy J-P, 1991, SEMANTIQUE COGNITION, P205, DOI [10.1167/15.1.18, DOI 10.1167/15.1.18]; Barthelemy JP, 1991, TREES PROXIMITY REPR; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belin P, 2010, NEURON, V65, P733, DOI 10.1016/j.neuron.2010.03.018; Bergelson E, 2012, P NATL ACAD SCI USA, V109, P3253, DOI 10.1073/pnas.1113380109; BERTONCINI J, 1988, J EXP PSYCHOL GEN, V117, P21, DOI 10.1037/0096-3445.117.1.21; Bertoncini J, 2011, J ACOUST SOC AM, V129, P2761, DOI 10.1121/1.3571424; Blaye A, 2006, EUR J DEV PSYCHOL, V3, P163, DOI 10.1080/17405620500412267; Bonthoux F, 2004, NAISSANCE DEV CONCEP; Brenac T, 2002, CONTRIBUTION METHODE; BURNHAM DK, 1991, J CHILD LANG, V18, P231, DOI 10.1017/S0305000900011041; Cabrera L, 2013, J SPEECH LANG HEAR R, V56, P1733, DOI 10.1044/1092-4388(2013/12-0169); CECI SJ, 1991, DEV PSYCHOL, V27, P703, DOI 10.1037/0012-1649.27.5.703; Chanquoy L, 2007, CHARGE COGNITIVE THE, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Coulet JC, 1998, ANN PSYCHOL, V98, P9; DAEHLER MW, 1979, CHILD DEV, V50, P170, DOI 10.1111/j.1467-8624.1979.tb02991.x; David S, 2002, CAHIERS LCPE CNRS AR, V6, P29; Demany Laurent, 2008, V29, P77; Dowling WJ, 1999, PSYCHOL MUSIC, P603, DOI DOI 10.1016/B978-012213564-4/50016-0; Dubois D, 1991, SEMANTIQUE COGNITION; DUBOIS D., 2000, COGNITIVE SCI Q, V1, P35; Dubois D., 1997, CATEGORISATION COGNI; DURLACH NI, 1969, J ACOUST SOC AM, V46, P372, DOI 10.1121/1.1911699; Eisenberg Daniel, 2015, J MENT HEALTH, V20, P222, DOI [10.3109/10673229.2012.712839, DOI 10.3109/09638237.2014.954693, 10.3109/08039481003777484]; FAYE P., 2011, REV MODULAD, V43, P1; FENSON L, 1988, CHILD DEV, V59, P897, DOI 10.1111/j.1467-8624.1988.tb03243.x; Gaillard P, 2009, SENTIR DIRE CONCEPTS, P189; Garner W. R., 1974, PROCESSING INFORM ST; GAVER WW, 1993, ECOL PSYCHOL, V5, P1, DOI 10.1207/s15326969eco0501_1; GAVER WW, 1993, ECOL PSYCHOL, V5, P285, DOI 10.1207/s15326969eco0504_2; Gentner D, 1999, COGNITIVE DEV, V14, P487, DOI 10.1016/S0885-2014(99)00016-7; Gentner D, 2006, CURR DIR PSYCHOL SCI, V15, P297, DOI 10.1111/j.1467-8721.2006.00456.x; Giordano BL, 2011, MULTIVAR BEHAV RES, V46, P779, DOI 10.1080/00273171.2011.606748; Giordano BL, 2010, BRAIN COGNITION, V73, P7, DOI 10.1016/j.bandc.2010.01.005; Gooding L., 2011, UPDATE APPL RES MUSI, V30, P32, DOI [DOI 10.1177/8755123311418481, 10.1177/8755123311418481]; GOPNIK A, 1987, CHILD DEV, V58, P1523, DOI 10.2307/1130692; Goudbeek M, 2005, HDB CATEGORIZATION C, P497; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; Guastavino C, 2007, CAN J EXP PSYCHOL, V61, P54, DOI 10.1037/cjep2007006; Guenoche A, 2000, LECT NOTES COMPUTER, V2066, P45; Guenoche A, 2012, MATH SCI HUMAINES, V197, P65, DOI [10.1016/j.ejmp.2014.12.008, DOI 10.1016/J.EJMP.2014.12.008]; Guenoche A, 2011, ADV DATA ANAL CLASSI, V5, P215, DOI 10.1007/s11634-011-0087-6; Guyot F, 1996, THESIS U MAINE, P41; Guyot F, 1997, CATEGORISATION COGNI, P41, DOI [10.3855/jidc.5778, DOI 10.3855/JIDC.5778]; Gygi B, 2001, THESIS INDIANA U IND; Gygi B, 2007, PERCEPT PSYCHOPHYS, V69, P839, DOI 10.3758/BF03193921; Hailstone JC, 2010, NEUROPSYCHOLOGIA, V48, P1104, DOI 10.1016/j.neuropsychologia.2009.12.011; Houde O, 1996, REV NEUROPSYCHOL, V6, P329; Houde O, 2000, COGNITIVE DEV, V15, P63, DOI 10.1016/S0885-2014(00)00015-0; HOUDE O, 1995, REV NEUROPSYCHOL, V5, P281; Houde O, 1992, CATEGORISATION DEV C; Houde O, 1995, RATINOALITE DEV INHI; Houix O, 2012, J EXP PSYCHOL-APPL, V18, P52, DOI 10.1037/a0026240; Inverso Y, 2009, PERSPECTIVES HEARING, V19, P43; Inverso Y, 2010, EAR HEARING, V31, P505, DOI 10.1097/AUD.0b013e3181d99a52; JUSCZYK PW, 1995, COGNITIVE PSYCHOL, V29, P1, DOI 10.1006/cogp.1995.1010; Kail M, 2000, ACQUISITION LANGAGE, DOI [10.1016/j.arcped.2014.10.027, DOI 10.1016/J.ARCPED.2014.10.027]; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; KUHL PK, 1983, INFANT BEHAV DEV, V6, P263, DOI 10.1016/S0163-6383(83)80036-8; KUHL PK, 1979, J ACOUST SOC AM, V66, P1668, DOI 10.1121/1.383639; Kuhl PK, 2009, PERCEPTION SPEECH SO, P103; Lautrey J, 1998, PIAG APR PIAG PIAG P; LAWSON AE, 1993, J RES SCI TEACH, V30, P1029, DOI 10.1002/tea.3660300904; Lemaitre G, 2010, J EXP PSYCHOL-APPL, V16, P16, DOI 10.1037/a0018762; LUCARIELLO J, 1992, CHILD DEV, V63, P978; Marcell ME, 2000, J CLIN EXP NEUROPSYC, V22, P830, DOI 10.1076/jcen.22.6.830.949; MARKMAN EM, 1981, DEV PSYCHOL, V17, P115, DOI 10.1037/0012-1649.17.1.115; Markman EM, 1991, CATEGORIZATION NAMIN; McAdams S, 1993, THINKING IN SOUND; Moon C, 2013, ACTA PAEDIATR, V102, P156, DOI 10.1111/apa.12098; Mounoud P, 1994, ENFANCE, V47, P5; Namy LL, 2002, J EXP PSYCHOL GEN, V131, P5, DOI 10.1037//0096-3445.131.1.5; NELSON K., 1985, MAKING SENSE ACQUISI; Parizet E, 2012, APPL ACOUST, V73, P61, DOI 10.1016/j.apacoust.2011.07.007; Piaget J, 1959, GENESE STRUCTURES LO; Poitevineau J, 2002, ARBRES CLASSES DISTA; Poitevineau J, 2009, PRENDRE SES DISTANCE, P255; Polka L, 2013, P M ACOUSTICS, V19; Pothos EM, 2011, COGNITION, V121, P83, DOI 10.1016/j.cognition.2011.06.002; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Rosch E, 1976, B PSYCHOL, P242; Rosch E., 1978, COGNITION CATEGORIZA, P27, DOI DOI 10.1037/0012-1649.16.5.391; ROSCH EH, 1973, COGNITIVE PSYCHOL, V4, P328, DOI 10.1016/0010-0285(73)90017-0; Sattah A, 1977, PSYCHOMETRIKA, V42, P19; SCOTT MS, 1982, INT J BEHAV DEV, V5, P243, DOI 10.1177/016502548200500206; Seifert KL, 2006, HDB RES ED YOUNG CHI; Shafiro V, 2008, EAR HEARING, V29, P401, DOI 10.1097/AUD.0b013e31816a0cf1; SMILEY SS, 1979, J EXP CHILD PSYCHOL, V28, P249, DOI 10.1016/0022-0965(79)90087-0; Swingley D, 2000, COGNITION, V76, P147, DOI 10.1016/S0010-0277(00)00081-0; Trawick-Smith J, 2003, EARLY CHILDHOOD DEV; Trehub SE, 2006, COGNITION, V100, P73, DOI 10.1016/j.cognition.2005.11.006; Valentin D, 2012, J EXP CHILD PSYCHOL, V113, P337, DOI 10.1016/j.jecp.2012.05.007; Vanderveer NJ, 1979, ECOLOGICAL ACOUSTICS; Weinberger NM, 1999, PSYCHOL MUSIC, P47; Werner L, 2007, WHAT DO CHILDREN HEA; WERNEROLSHO L, 1988, J ACOUST SOC AM, V84, P1316, DOI 10.1121/1.396630; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	104	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0115557	10.1371/journal.pone.0115557	http://dx.doi.org/10.1371/journal.pone.0115557			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3QK	25643286	Green Submitted, Green Published, gold			2022-12-27	WOS:000348821200011
J	George, BJ; Reif, DM; Gallagher, JE; Williams-DeVane, CR; Heidenfelder, BL; Hudgens, EE; Jones, W; Neas, L; Hubal, EAC; Edwards, SW				George, Barbara Jane; Reif, David M.; Gallagher, Jane E.; Williams-DeVane, ClarLynda R.; Heidenfelder, Brooke L.; Hudgens, Edward E.; Jones, Wendell; Neas, Lucas; Hubal, Elaine A. Cohen; Edwards, Stephen W.			Data-Driven Asthma Endotypes Defined from Blood Biomarker and Gene Expression Data	PLOS ONE			English	Article							EXHALED NITRIC-OXIDE; OBESE INDIVIDUALS; PHENOTYPES; ASSOCIATION; IDENTIFICATION; ADIPONECTIN; CHILDREN; DISEASE	The diagnosis and treatment of childhood asthma is complicated by its mechanistically distinct subtypes (endotypes) driven by genetic susceptibility and modulating environmental factors. Clinical biomarkers and blood gene expression were collected from a stratified, cross-sectional study of asthmatic and non-asthmatic children from Detroit, MI. This study describes four distinct asthma endotypes identified via a purely data-driven method. Our method was specifically designed to integrate blood gene expression and clinical biomarkers in a way that provides new mechanistic insights regarding the different asthma endotypes. For example, we describe metabolic syndrome-induced systemic inflammation as an associated factor in three of the four asthma endotypes. Context provided by the clinical biomarker data was essential in interpreting gene expression patterns and identifying putative endotypes, which emphasizes the importance of integrated approaches when studying complex disease etiologies. These synthesized patterns of gene expression and clinical markers from our research may lead to development of novel serum-based biomarker panels.	[George, Barbara Jane] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA; [Reif, David M.] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA; [Gallagher, Jane E.; Heidenfelder, Brooke L.; Hudgens, Edward E.; Neas, Lucas] US EPA, Natl Hlth & Environm Effects Res Lab, Environm Publ Hlth Div, Res Triangle Pk, NC 27711 USA; [Williams-DeVane, ClarLynda R.; Edwards, Stephen W.] US EPA, Natl Hlth & Environm Effects Res Lab, Integrated Syst Toxicol Div, Res Triangle Pk, NC 27711 USA; [Jones, Wendell] Quintiles Co, Dept Bioinformat, Express Anal, Durham, NC USA; [Hubal, Elaine A. Cohen] US EPA, Off Res & Dev, Res Triangle Pk, NC 27711 USA	United States Environmental Protection Agency; United States Environmental Protection Agency; United States Environmental Protection Agency; United States Environmental Protection Agency; IQVIA; United States Environmental Protection Agency	Edwards, SW (corresponding author), US EPA, Natl Hlth & Environm Effects Res Lab, Integrated Syst Toxicol Div, Res Triangle Pk, NC 27711 USA.	edwards.stephen@epa.gov	Jones, Wendell/AAM-4831-2021	Neas, Lucas/0000-0002-9377-8334; Williams-DeVane, ClarLynda/0000-0002-1013-5545; Edwards, Stephen/0000-0002-7985-111X; Jones, Wendell/0000-0002-9676-5387; Reif, David/0000-0001-7815-6767	National Health and Environmental Effects Research Laboratory; National Center for Computational Toxicology within the U.S. Environmental Protection Agency (EPA) Office of Research and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043446] Funding Source: NIH RePORTER	National Health and Environmental Effects Research Laboratory; National Center for Computational Toxicology within the U.S. Environmental Protection Agency (EPA) Office of Research and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by the National Health and Environmental Effects Research Laboratory and the National Center for Computational Toxicology within the U.S. Environmental Protection Agency (EPA) Office of Research and Development. This manuscript has been subjected to review by the US Environmental Protection Agency, National Health and Environmental Effects Research Laboratory and approved for publication. Approval does not signify that the contents reflect the views of the Agency, nor does the mention of trade names or commercial products constitute endorsement or recommendation for use. Except as noted above, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami Lara J, 2011, Natl Health Stat Report, P1; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Assad N, 2013, AM J RESP CRIT CARE, V188, P319, DOI 10.1164/rccm.201303-0457OC; Baines KJ, 2011, J ALLERGY CLIN IMMUN, V127, P153, DOI 10.1016/j.jaci.2010.10.024; Barnes Kathleen C, 2007, Proc Am Thorac Soc, V4, P58, DOI 10.1513/pats.200607-146JG; Bhakta NR, 2011, IMMUNOL REV, V242, P220, DOI 10.1111/j.1600-065X.2011.01032.x; Bjornsdottir US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021902; Borrell LN, 2013, AM J RESP CRIT CARE, V187, P697, DOI 10.1164/rccm.201211-2116OC; Boudier A, 2013, AM J RESP CRIT CARE, V188, P550, DOI 10.1164/rccm.201301-0156OC; Bryborn M, 2010, ALLERGY, V65, P220, DOI 10.1111/j.1398-9995.2009.02141.x; Carolan BJ, 2013, AM J RESP CRIT CARE, V188, P561, DOI 10.1164/rccm.201212-2299OC; Chawes BLK, 2011, AM J RESP CRIT CARE, V184, P656, DOI 10.1164/rccm.201101-0111OC; Choy DF, 2011, J IMMUNOL, V186, P1861, DOI 10.4049/jimmunol.1002568; Desai D, 2013, AM J RESP CRIT CARE, V188, P657, DOI 10.1164/rccm.201208-1470OC; Dixon AE, 2012, AM J RESP CRIT CARE, V186, P395, DOI 10.1164/rccm.201206-1092ED; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; FAJANS SS, 1989, DIABETES METAB REV, V5, P579, DOI 10.1002/dmr.5610050705; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P382, DOI 10.1016/j.jaci.2010.11.015; Fogg DK, 2002, BIOCHEMISTRY-US, V41, P4953, DOI 10.1021/bi012045y; Gallagher J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-344; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; GUIGNARD F, 1995, BIOCHEM J, V309, P395, DOI 10.1042/bj3090395; Holguin F, 2013, AM J RESP CRIT CARE, V187, P153, DOI 10.1164/rccm.201207-1270OC; Juel CTB, 2012, J ASTHMA ALLERGY, V5, P21, DOI 10.2147/JAA.S32232; Just J, 2012, J ALLERGY CLIN IMMUN, V130, P103, DOI 10.1016/j.jaci.2012.02.041; Li Q, 2007, ARTERIOSCL THROM VAS, V27, P1383, DOI 10.1161/ATVBAHA.107.142901; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Lugogo NL, 2012, AM J RESP CRIT CARE, V186, P404, DOI 10.1164/rccm.201109-1671OC; Lugogo NL, 2010, J APPL PHYSIOL, V108, P729, DOI 10.1152/japplphysiol.00845.2009; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; McNicholl DM, 2012, AM J RESP CRIT CARE, V186, P1102, DOI 10.1164/rccm.201204-0587OC; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Mullane K, 2011, BIOCHEM PHARMACOL, V82, P586, DOI 10.1016/j.bcp.2011.06.033; Nakanishi K, 2011, AM J RESP CRIT CARE, V183, P1164, DOI 10.1164/rccm.201007-1091OC; Naqvi M, 2007, J ALLERGY CLIN IMMUN, V120, P137, DOI 10.1016/j.jaci.2007.02.045; Paraskakis E, 2006, AM J RESP CRIT CARE, V174, P260, DOI 10.1164/rccm.200506-962OC; Pendharkar S, 2008, CAN RESPIR J, V15, P99, DOI 10.1155/2008/463762; Peters MC, 2013, AM J RESP CRIT CARE, V188, P633, DOI 10.1164/rccm.201307-1360ED; Potapov Viktor A, 2008, Rev Diabet Stud, V5, P28, DOI 10.1900/RDS.2008.5.28; Research Triangle Institute, 2012, SUDAAN LANG MAN, V2; Research Triangle Institute, 2012, SUDAAN LANG MAN, V1; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; *SAS I INC, 2010, SAS 9 2 LANG REF DIC, P13897; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; Sideleva O, 2012, AM J RESP CRIT CARE, V186, P598, DOI 10.1164/rccm.201203-0573OC; Siroux V, 2011, EUR RESPIR J, V38, P310, DOI 10.1183/09031936.00120810; Sood A, 2012, AM J RESP CRIT CARE, V186, P41, DOI 10.1164/rccm.201110-1767OC; Sutherland ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036631; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, pS9, DOI 10.1016/j.jaci.2011.12.979; Tahvanainen J, 2009, BLOOD, V113, P1268, DOI 10.1182/blood-2008-07-166553; Verrills NM, 2011, AM J RESP CRIT CARE, V183, P1633, DOI 10.1164/rccm.201010-1623OC; von Mutius E, 2013, AM J RESP CRIT CARE, V188, P150, DOI 10.1164/rccm.201303-0468UP; Welsch R, 1980, REGRESSION DIAGNOSTI; Wenzel S, 2012, CLIN EXP ALLERGY, V42, P650, DOI 10.1111/j.1365-2222.2011.03929.x; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Williams-DeVane CR, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-119; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Yang LL, 2011, INT ARCH ALLERGY IMM, V156, P373, DOI 10.1159/000324448	59	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117445	10.1371/journal.pone.0117445	http://dx.doi.org/10.1371/journal.pone.0117445			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643280	Green Submitted, gold, Green Published			2022-12-27	WOS:000348821200038
J	Almonte, M; Ferreccio, C; Luciani, S; Gonzales, M; Delgado, JM; Santos, C; Alvarez, M; Cuzick, J; Sasieni, P				Almonte, Maribel; Ferreccio, Catterina; Luciani, Silvana; Gonzales, Miguel; Delgado, Jose M.; Santos, Carlos; Alvarez, Manuel; Cuzick, Jack; Sasieni, Peter			Visual Inspection after Acetic Acid (VIA) Is Highly Heterogeneous in Primary Cervical Screening in Amazonian Peru	PLOS ONE			English	Article							CANCER PREVENTION; ACCURACY; CYTOLOGY; TESTS; WOMEN	Background Conventional cytology (Pap) and visual inspection after the application of acetic acid (VIA) are currently used in primary screening in Peru. Studies suggest that the quality of VIA is highly variable. Over 36 000 women were screened with Pap and VIA in the TATI (Tamizaje y Tratamiento Inmediato de Lesiones Cervico-uterinas) project conducted in Amazonian Peru. Within a nested study to compare several screening techniques (C-TATI), a total of 5435 women were additionally screened with liquid-based cytology (LBC) and high-risk human papillomavirus testing (HR-HPV). We investigate the variation of positivity rates of VIA, Pap, LBC and HR-HPV in C-TATI and of VIA in the full TATI intervention. Methods At the screening visit, midwives collected three cervical samples for Pap, LBC and HC2 before performing VIA. The dispersion factor "D" (D = Pearson chi-square value/degrees-of-freedom) was used to measure the variability of tests results. Within C-TATI, the variability of positivity rates of VIA, Pap, LBC and HR-HPV was also graphically assessed with box- and scatter plots by midwife and month of screening. Funnel plots and smoothed scatter plots were used to correlate the variation of VIA by the number of examinations performed by each midwife over the full TATI intervention. Results Consistently over TATI, VIA results were highly variable, independently of the examiner, the time when the test was performed and the number of tests the examiner performed (D>6, p-values<0.001). In C-TATI, VIA results varied the most while those of HR-HPV varied the least (Ds>25, p-values<0.001 for VIA, Ds<1.6, p-values>0.05 for HR-HPV). No evidence for correlation between the number of VIAs done per midwife and the variability of VIA results was observed. Conclusion The lack of over-dispersion for HR-HPV detection suggests that the variable VIA results do not reflect true variation in underlying disease, but a lack of consistency in human judgement.	[Almonte, Maribel] Int Agcy Res Canc, F-69372 Lyon, France; [Almonte, Maribel; Cuzick, Jack; Sasieni, Peter] Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Canc Prevent, London, England; [Ferreccio, Catterina] Pontificia Univ Catolica Chile, Fac Med, Adv Ctr Chron Dis, ACCDIS FONDAP, Santiago, Chile; [Luciani, Silvana] Pan Amer Hlth Org, Washington, DC USA; [Gonzales, Miguel; Delgado, Jose M.] Direcc Reg Salud San Martin, San Martin, Peru; [Santos, Carlos; Alvarez, Manuel] Inst Nacl Enfermedades Neoplasicas, Lima, Peru	World Health Organization; International Agency for Research on Cancer (IARC); University of London; Queen Mary University London; Pontificia Universidad Catolica de Chile; Pan American Health Organization; Instituto Nacional de Enfermedades Neoplasicas	Almonte, M (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	AlmonteM@iarc.fr	Bardales, José Manuel Delgado/AAL-1882-2021; Almonte, Maribel/O-3286-2016	Bardales, José Manuel Delgado/0000-0001-6574-2759; ferreccio, catterina/0000-0001-6331-5534; Sasieni, Peter/0000-0003-1509-8744	Bill & Melinda Gates Foundation through the Alliance for Cervical Cancer Prevention; Cancer Research UK; Cancer Research UK [16892, 16893, 16891] Funding Source: researchfish	Bill & Melinda Gates Foundation through the Alliance for Cervical Cancer Prevention(Bill & Melinda Gates Foundation); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	The TATI project was conducted with the generous support of the Bill & Melinda Gates Foundation to the Pan American Health Organization through the Alliance for Cervical Cancer Prevention. Cancer Research UK provided financial support for the additional work involved in this study including the cost of HPV and LBC testing.	Ajenifuja KO, 2013, INT J GYNECOL CANCER, V23, P507, DOI 10.1097/IGC.0b013e318280f395; Almonte M, 2007, INT J CANCER, V121, P796, DOI 10.1002/ijc.22757; [Anonymous], 2005, IARC HANDBOOKS OF CA, V10; Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; Belinson J, 2001, GYNECOL ONCOL, V83, P439, DOI 10.1006/gyno.2001.6370; CECCHINI S, 1993, TUMORI, V79, P22, DOI 10.1177/030089169307900104; Chirenje Z. M., 1999, Central African Journal of Medicine, V45, P30; Chirenje ZM, 1999, CENT AFR J MED, V45, P79; Denny L, 2002, CANCER-AM CANCER SOC, V94, P1699, DOI 10.1002/cncr.10381; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Luciani S, 2006, CERVICAL CANCER PREV; Murillo R, 2010, INT J GYNECOL OBSTET, V109, P230, DOI 10.1016/j.ijgo.2010.01.019; Perez-Cruz E, 2005, SALUD PUBLICA MEXICO, V47, P39, DOI 10.1590/S0036-36342005000100007; Robles SC, 2009, REV PANAM SALUD PUBL, V25, P189, DOI 10.1590/S1020-49892009000300001; Sankaranarayanan R, 2004, INT J CANCER, V110, P907, DOI 10.1002/ijc.20190; Sankaranarayanan R, 2012, BEST PRACT RES CL OB, V26, P221, DOI 10.1016/j.bpobgyn.2011.08.003; Sarian LO, 2005, J MED SCREEN, V12, P142, DOI 10.1258/0969141054855328; Sasieni P, 1999, BRIT MED J, V318, P1244; Sauvaget C, 2011, INT J GYNECOL OBSTET, V113, P14, DOI 10.1016/j.ijgo.2010.10.012; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; Vedantham H, 2010, CANCER EPIDEM BIOMAR, V19, P1373, DOI 10.1158/1055-9965.EPI-09-1282; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; World Health Organization, 2013, WHO GUIDELINES FOR S	24	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115355	10.1371/journal.pone.0115355	http://dx.doi.org/10.1371/journal.pone.0115355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635965	gold, Green Published, Green Submitted			2022-12-27	WOS:000350680700009
J	Lin, HH; Chuang, YF; Weng, JL; Lo, LJ				Lin, Hsiu-Hsia; Chuang, Ya-Fang; Weng, Jing-Ling; Lo, Lun-Jou			Comparative Validity and Reproducibility Study of Various Landmark-Oriented Reference Planes in 3-Dimensional Computed Tomographic Analysis for Patients Receiving Orthognathic Surgery	PLOS ONE			English	Article							CEPHALOMETRIC ANALYSIS; ORIENTATION; DEVIATION; LIP	Background Three-dimensional computed tomographic imaging has become popular in clinical evaluation, treatment planning, surgical simulation, and outcome assessment for maxillofacial intervention. The purposes of this study were to investigate whether there is any correlation among landmark-based horizontal reference planes and to validate the reproducibility and reliability of landmark identification. Materials and Methods Preoperative and postoperative cone-beam computed tomographic images of patients who had undergone orthognathic surgery were collected. Landmark-oriented reference planes including the Frankfort horizontal plane (FHP) and the lateral semicircular canal plane (LSP) were established. Four FHPs were defined by selecting 3 points from the orbitale, porion, or midpoint of paired points. The LSP passed through both the lateral semicircular canal points and nasion. The distances between the maxillary or mandibular teeth and the reference planes were measured, and the differences between the 2 sides were calculated and compared. The precision in locating the landmarks was evaluated by performing repeated tests, and the intraobserver reproducibility and interobserver reliability were assessed. Results A total of 30 patients with facial deformity and malocclusion-10 patients with facial symmetry, 10 patients with facial asymmetry, and 10 patients with cleft lip and palate-were recruited. Comparing the differences among the 5 reference planes showed no statistically significant difference among all patient groups. Regarding intraobserver reproducibility, the mean differences in the 3 coordinates varied from 0 to 0.35 mm, with correlation coefficients between 0.96 and 1.0, showing high correlation between repeated tests. Regarding interobserver reliability, the mean differences among the 3 coordinates varied from 0 to 0.47 mm, with correlation coefficients between 0.88 and 1.0, exhibiting high correlation between the different examiners. Conclusions The 5 horizontal reference planes were reliable and comparable for 3D craniomaxillofacial analysis. These reference planes were useful in standardizing the orientation of 3D skull models.	[Lin, Hsiu-Hsia] Chang Gung Univ, Chang Gung Mem Hosp, Craniofacial Res Ctr, Taoyuan, Taiwan; [Chuang, Ya-Fang; Weng, Jing-Ling; Lo, Lun-Jou] Chang Gung Univ, Chang Gung Mem Hosp, Craniofacial Res Ctr, Taoyuan, Taiwan; [Lo, Lun-Jou] Chang Gung Univ, Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lo, LJ (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Taoyuan, Taiwan.	lunjoulo@cgmh.org.tw		Lin, Hsiu-Hsia/0000-0002-4252-4182	Chang Gung Memorial Hospital [CMRPG381601-3, CMRPG3B0291-3]; Ministry of Science and Technology (Taiwan) [MOST 103-2221-E-182A-002]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan)	This research was supported by Chang Gung Memorial Hospital Grants CMRPG381601-3 and CMRPG3B0291-3, and by the Ministry of Science and Technology (Taiwan) Grant MOST 103-2221-E-182A-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung LK, 2011, ORAL SURG ORAL MED O, V112, pE56, DOI 10.1016/j.tripleo.2011.02.045; Damstra J, 2011, AM J ORTHOD DENTOFAC, V140, pE107, DOI 10.1016/j.ajodo.2011.02.020; FINLAY LM, 1980, ANGLE ORTHOD, V50, P312; Gateno J, 2011, J ORAL MAXIL SURG, V69, P606, DOI 10.1016/j.joms.2010.09.010; Hwang HS, 2006, AM J ORTHOD DENTOFAC, V130, P779, DOI 10.1016/j.ajodo.2005.02.021; Kim EJ, 2011, ANGLE ORTHOD, V81, P988, DOI 10.2319/112210-681.1; Kim YI, 2011, ORAL SURG ORAL MED O, V111, P681, DOI 10.1016/j.tripleo.2010.08.001; Kim YH, 2010, J ORAL MAXIL SURG, V68, P1106, DOI 10.1016/j.joms.2009.07.030; Lagravere MO, 2006, AM J ORTHOD DENTOFAC, V129, P601, DOI 10.1016/j.ajodo.2005.11.031; Lagravere MO, 2005, AM J ORTHOD DENTOFAC, V129, P601; McIntyre GT, 2003, CLEFT PALATE-CRAN J, V40, P416, DOI 10.1597/1545-1569(2003)040<0416:PCAOTP>2.0.CO;2; Moro A, 2009, J CRANIOFAC SURG, V20, P417, DOI 10.1097/SCS.0b013e31819b96a5; Oh S, 2013, J KOR ASSOC ORAL MAX, V39, P71, DOI 10.5125/jkaoms.2013.39.2.71; Olszewski R, 2006, NEURORADIOLOGY, V48, P853, DOI 10.1007/s00234-006-0140-x; Park SB, 2013, J CRANIO MAXILL SURG, V41, P119, DOI 10.1016/j.jcms.2012.05.017; Park SH, 2006, AM J ORTHOD DENTOFAC, V129, DOI 10.1016/j.ajodo.2005.11.032; Pellerin P., 1995, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V96, P214; Pelo S, 2009, J CRANIOFAC SURG, V20, P41, DOI 10.1097/SCS.0b013e318190ddd3; Pertuzon B., 1995, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V96, P209; Reyneke JP, 2010, ESSENTIALS OF ORTHOGNATHIC SURGERY, SECOND EDITION, P1; Song WW, 2013, J ORAL MAXIL SURG, V71, P752, DOI 10.1016/j.joms.2012.07.043; Suri S, 2008, AM J ORTHOD DENTOFAC, V134, P418, DOI 10.1016/j.ajodo.2006.09.065; Terajima M, 2009, AM J ORTHOD DENTOFAC, V136, P857, DOI 10.1016/j.ajodo.2008.01.019; Trpkova B, 2003, AM J ORTHOD DENTOFAC, V123, P512, DOI 10.1016/S0889-5406(02)57034-7; Vinchon M, 2007, CHILD NERV SYST, V23, P1403, DOI 10.1007/s00381-007-0471-x; Wong RWK, 2011, INT J ORAL MAX SURG, V40, P920, DOI 10.1016/j.ijom.2011.03.011; Xia J, 2000, Int J Adult Orthodon Orthognath Surg, V15, P265	27	21	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117604	10.1371/journal.pone.0117604	http://dx.doi.org/10.1371/journal.pone.0117604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668209	Green Published, Green Submitted, gold			2022-12-27	WOS:000349493000022
J	Anchisi, D; Zanon, M				Anchisi, Davide; Zanon, Marco			A Bayesian Perspective on Sensory and Cognitive Integration in Pain Perception and Placebo Analgesia	PLOS ONE			English	Article							NEUROBIOLOGICAL MECHANISMS; CAPSULE COLOR; ILLUSIONS; RESPONSES; MONKEY; EXPECTATIONS; INFORMATION; MODULATION; INFERENCE; MODELS	The placebo effect is a component of any response to a treatment (effective or inert), but we still ignore why it exists. We propose that placebo analgesia is a facet of pain perception, others being the modulating effects of emotions, cognition and past experience, and we suggest that a computational understanding of pain may provide a unifying explanation of these phenomena. Here we show how Bayesian decision theory can account for such features and we describe a model of pain that we tested against experimental data. Our model not only agrees with placebo analgesia, but also predicts that learning can affect pain perception in other unexpected ways, which experimental evidence supports. Finally, the model can also reflect the strategies used by pain perception, showing that modulation by disparate factors is intrinsic to the pain process.	[Anchisi, Davide; Zanon, Marco] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy	University of Udine	Anchisi, D (corresponding author), Univ Bologna, Ctr Studi & Ric Neurosci Cognit, Campus Cesena, Cesena, Italy.	davide.anchisi@uniud.it	Zanon, Marco/T-7343-2018; Anchisi, Davide/AAK-1902-2021	Zanon, Marco/0000-0003-1295-1420				Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; BEECHER HK, 1956, JAMA-J AM MED ASSOC, V161, P1609, DOI 10.1001/jama.1956.02970170005002; Benedetti F, 2005, J NEUROSCI, V25, P10390, DOI 10.1523/JNEUROSCI.3458-05.2005; Berger J.O., 1995, STAT DECISION THEORY, V2nd ed; Berkeley, 1709, ESSAY NEW THEORY VIS; Brown H, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00043; BUCKALEW LW, 1982, J CLIN PSYCHOPHARM, V2, P245; Colloca L, 2008, PAIN, V139, P306, DOI 10.1016/j.pain.2008.04.021; Colloca L, 2008, EUR J APPL PHYSIOL, V102, P371, DOI 10.1007/s00421-007-0593-6; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1; DARIANSMITH I, 1979, J NEUROPHYSIOL, V42, P1297, DOI 10.1152/jn.1979.42.5.1297; Dolan, 2013, WALL MELZACKS TXB PA, P248; Duda R.O., 2001, PATTERN CLASSIFICATI, p[36, 174, 517, 20]; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Fischer BJ, 2011, NAT NEUROSCI, V14, P1061, DOI 10.1038/nn.2872; Flor H, 1999, EUR J PAIN-LONDON, V3, P317, DOI 10.1016/S1090-3801(99)90013-7; Friston KJ, 2003, NEURAL NETWORKS, V16, P1325, DOI 10.1016/j.neunet.2003.06.005; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Geisler WS, 2002, NAT NEUROSCI, V5, P508, DOI 10.1038/nn0602-508; Gracely RH, 1994, TXB PAIN, P315; Green AM, 2010, CURR OPIN NEUROBIOL, V20, P353, DOI 10.1016/j.conb.2010.04.009; Hahn RA, 1997, PREV MED, V26, P607, DOI 10.1006/pmed.1996.0124; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Jaynes E., 2003, PROBABILITY THEORY L, DOI [10.1017/CBO9780511790423, DOI 10.1017/CBO9780511790423]; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jones A, 2013, PLACEBO AND PAIN: FROM BENCH TO BEDSIDE, P37, DOI 10.1016/B978-0-12-397928-5.00005-2; Kaptchuk TJ, 2008, CONTEMP CLIN TRIALS, V29, P587, DOI 10.1016/j.cct.2008.02.002; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P817, DOI 10.7326/0003-4819-136-11-200206040-00011; KENNEDY W P, 1961, Med World, V95, P203; Knill DC, 1996, PERCEPTION BAYESIAN; KOLTZENBURG M, 1994, J NEUROSCI, V14, P1756, DOI 10.1523/JNEUROSCI.14-03-01756.1994; Kong J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067485; LAMOTTE RH, 1978, J NEUROPHYSIOL, V41, P509, DOI 10.1152/jn.1978.41.2.509; LEVINE JD, 1978, LANCET, V2, P654, DOI 10.1016/S0140-6736(78)92762-9; Lui F, 2010, PAIN, V151, P816, DOI 10.1016/j.pain.2010.09.021; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Maloney LT, 2010, VISION RES, V50, P2362, DOI 10.1016/j.visres.2010.09.031; Mehta R, 2009, SCIENCE, V323, P1226, DOI 10.1126/science.1169144; MELZACK R, 1982, PAIN, V14, P33, DOI 10.1016/0304-3959(82)90078-1; Merleau-Ponty M, 2009, PHENOMENOLOGIE PERCE; Montgomery G, 1996, PSYCHOL SCI, V7, P174, DOI 10.1111/j.1467-9280.1996.tb00352.x; Montgomery GH, 1997, PAIN, V72, P107, DOI 10.1016/S0304-3959(97)00016-X; Morton DL, 2010, BRAIN RES, V1359, P137, DOI 10.1016/j.brainres.2010.08.046; Pacheco-Lopez G, 2006, BRAIN BEHAV IMMUN, V20, P430, DOI 10.1016/j.bbi.2006.05.003; Pecina M, 2014, SOC COGN AFFECT NEUR, V9, P1013, DOI 10.1093/scan/nst079; Pollo A, 2001, PAIN, V93, P77, DOI 10.1016/S0304-3959(01)00296-2; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Purves D, 1999, J NEUROSCI, V19, P8542; Purves D, 2001, PHILOS T ROY SOC B, V356, P285, DOI 10.1098/rstb.2000.0772; R Core Team, 2021, R LANGUAGE ENV STAT; Rahnev D, 2011, J NEUROSCI, V31, P10741, DOI 10.1523/JNEUROSCI.1478-11.2011; Rao RPN, 2004, NEURAL COMPUT, V16, P1, DOI 10.1162/08997660460733976; Rao RPN, 1999, VISION RES, V39, P1963, DOI 10.1016/S0042-6989(98)00279-X; Rhudy JL, 2000, PAIN, V84, P65, DOI 10.1016/S0304-3959(99)00183-9; Ryan JD, 2008, J COGNITIVE NEUROSCI, V20, P1030, DOI 10.1162/jocn.2008.20075; SALLIS RE, 1984, PERCEPT MOTOR SKILL, V58, P897, DOI 10.2466/pms.1984.58.3.897; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Shimojo S, 2001, CURR OPIN NEUROBIOL, V11, P505, DOI 10.1016/S0959-4388(00)00241-5; Sinha P, 1996, NATURE, V384, P460, DOI 10.1038/384460a0; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; TOMKO GJ, 1974, BRAIN RES, V79, P405, DOI 10.1016/0006-8993(74)90438-7; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Wiech K, 2014, CURR BIOL, V24, pR679, DOI 10.1016/j.cub.2014.06.022; Wolpert DM, 2007, HUM MOVEMENT SCI, V26, P511, DOI 10.1016/j.humov.2007.05.005; Wunsch A, 2003, PAIN, V102, P27, DOI 10.1016/S0304-3959(02)00331-7; Yoshida W, 2013, J NEUROSCI, V33, P5638, DOI 10.1523/JNEUROSCI.4984-12.2013; Zubieta JK, 2009, ANN NY ACAD SCI, V1156, P198, DOI 10.1111/j.1749-6632.2009.04424.x; Zwislocki JJ, 2008, SENSORY NEUROSCIENCE	76	36	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117270	10.1371/journal.pone.0117270	http://dx.doi.org/10.1371/journal.pone.0117270			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664586	gold, Green Submitted, Green Published			2022-12-27	WOS:000349123100022
J	Okruszek, L; Haman, M; Kalinowski, K; Talarowska, M; Becchio, C; Manera, V				Okruszek, Lukasz; Haman, Maciej; Kalinowski, Kasper; Talarowska, Monika; Becchio, Cristina; Manera, Valeria			Impaired Recognition of Communicative Interactions from Biological Motion in Schizophrenia	PLOS ONE			English	Article							POINT-LIGHT; STIMULUS SET; PART 1; PERCEPTION; SELECTION; EMOTION; PEOPLE	Background Patients with schizophrenia are deficient in multiple aspects of social cognition, including biological motion perception. In the present study we investigated the ability to read social information from point-light stimuli in schizophrenia. Methodology/Principal Findings Participants with paranoid schizophrenia and healthy controls were presented with a biological motion task depicting point-light actions of two agents either engaged in a communicative interaction, or acting independently of each other. For each stimulus, participants were asked to decide whether the two agents were communicating vs. acting independently of each other (task A), and to select the correct action description among five response alternatives (task B). Participants were also presented with a mental rotation task to assess their visuospatial abilities, and with a facial emotion recognition task tapping social cognition. Results revealed that participants with schizophrenia performed overall worse than controls both in discriminating communicative from non-communicative actions (task A) and in selecting which of the 5 response alternatives best described the observed actions (task B). Interestingly, the impaired performance of schizophrenic participants was mainly due to misclassification of non-communicative stimuli as communicative actions. Correlation analysis revealed that visuospatial abilities predicted performance in task A but not in task B, while facial emotion recognition abilities was correlated with performance in both task A and task B. Conclusions/Significance These findings are consistent with theories of "overmentalizing" (excessive attribution of intentionality) in schizophrenia, and suggest that processing social information from biological motion does rely on social cognition abilities.	[Okruszek, Lukasz; Haman, Maciej; Kalinowski, Kasper] Univ Warsaw, Fac Psychol, Warsaw, Poland; [Talarowska, Monika] Med Univ Lodz, Dept Adult Psychiat, Lodz, Poland; [Becchio, Cristina] Univ Turin, Dept Psychol, Turin, Italy; [Becchio, Cristina] Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy; [Manera, Valeria] Univ Nice Sophia Antipolis, CoBtek Lab, F-06189 Nice, France	University of Warsaw; Medical University Lodz; University of Turin; Istituto Italiano di Tecnologia - IIT; UDICE-French Research Universities; Universite Cote d'Azur	Okruszek, L (corresponding author), Univ Warsaw, Fac Psychol, Warsaw, Poland.	lukasz.okruszek@psych.uw.edu.pl	Manera, Valeria/O-3498-2016; Talarowska, Monika/S-9729-2016	Manera, Valeria/0000-0003-4490-4485; Haman, Maciej/0000-0002-3621-1630; Okruszek, Lukasz/0000-0002-7136-2864	University of Warsaw	University of Warsaw	Publication fees were provided by the University of Warsaw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Akel A, 2013, SOC COGN SCHIZOPHR E, P196, DOI [10.1093/med:psych/9780199777587.003.0008, DOI 10.1093/MED:PSYCH/9780199777587.003.0008]; AMBADY N, 1995, J PERS SOC PSYCHOL, V69, P518, DOI 10.1037/0022-3514.69.3.518; Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Backasch B, 2013, SOC NEUROSCI-UK, V8, P489, DOI 10.1080/17470919.2013.820666; Becchio C, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00117; Billeke Pablo, 2013, Front Psychiatry, V4, P4, DOI 10.3389/fpsyt.2013.00004; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Brooks A, 2008, CURR BIOL, V18, pR728, DOI 10.1016/j.cub.2008.06.054; Carter CS, 2009, SCHIZOPHRENIA BULL, V35, P153, DOI 10.1093/schbul/sbn157; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; Frith CD, 2004, PSYCHOL MED, V34, P385, DOI 10.1017/S0033291703001326; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Green MF, 2013, SCHIZOPHRENIA BULL, V39, P1192, DOI 10.1093/schbul/sbt131; Hastings CNM, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00436; Heberlein AS, 2004, J COGNITIVE NEUROSCI, V16, P1143, DOI 10.1162/0898929041920423; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kim J., 2011, PLOS ONE; KIM J, 2008, THESIS GRADUATE SCH; Kim J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00391; Kim JJ, 2005, SCHIZOPHR RES, V77, P299, DOI 10.1016/j.schres.2005.04.006; Loula F, 2005, J EXP PSYCHOL HUMAN, V31, P210, DOI 10.1037/0096-1523.31.1.210; Manera V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014594; Manera V, 2010, BEHAV RES METHODS, V42, P168, DOI 10.3758/BRM.42.1.168; Matczak A., 2005, EMOTIONAL INTELLIGEN; Miller LE, 2013, COGNITION, V128, P140, DOI 10.1016/j.cognition.2013.03.013; MONTEPARE JM, 1988, J PERS SOC PSYCHOL, V55, P547, DOI 10.1037/0022-3514.55.4.547; Mueller S. T., 2012, PEBL PSYCHOL EXPT BU; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Russell TA, 2006, SCHIZOPHR RES, V81, P101, DOI 10.1016/j.schres.2005.10.002; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Spencer J. M. Y., 2013, J VIS, V13, P189, DOI [10.1167/13.9.189, DOI 10.1167/13.9.189]; Spencer JMY, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00507; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tandon R, 2008, SCHIZOPHR RES, V100, P4, DOI 10.1016/j.schres.2008.01.022; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Vanrie J, 2004, BEHAV RES METH INS C, V36, P625, DOI 10.3758/BF03206542; Walter H, 2009, SOC COGN AFFECT NEUR, V4, P166, DOI 10.1093/scan/nsn047	42	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0116793	10.1371/journal.pone.0116793	http://dx.doi.org/10.1371/journal.pone.0116793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UO	25664584	Green Submitted, Green Published, gold			2022-12-27	WOS:000349123100014
J	Koutangni, T; Mainassara, HB; Mueller, JE				Koutangni, Thibaut; Mainassara, Halima Boubacar; Mueller, Judith E.			Incidence, Carriage and Case-Carrier Ratios for Meningococcal Meningitis in the African Meningitis Belt: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SUB-SAHARAN AFRICA; BURKINA-FASO; NEISSERIA-MENINGITIDIS; SEROGROUP; EPIDEMIC; IMMUNITY; DISEASE; VACCINATION; IMPACT; MODEL	Background To facilitate the interpretation of meningococcal meningitis epidemiology in the "African meningitis belt", we aimed at obtaining serogroup-specific pooled estimates of incidence, carriage and case-carrier ratios for meningococcal meningitis in the African meningitis belt and describe their variations across the endemic, hyperendemic and epidemic context. Methods We conducted a systematic review and meta-analysis of studies reporting serogroup-specific meningococcal meningitis monthly incidence and carriage in the same population and time period. Epidemiological contexts were defined as endemic (wet season, no epidemic), hyperendemic (dry season, no epidemic), and epidemic (dry season, epidemic). Findings Eight studies reporting a total of eighty pairs of serogroup-specific meningococcal meningitis incidence and carriage estimates were included in this review. For serogroup A, changes associated with the transition from endemic to hyperendemic incidence and from hyperendemic to epidemic incidence were 15-fold and 120-fold respectively. Changes in carriage prevalence associated with both transitions were 1-fold and 30-fold respectively. For serogroup Wand X, the transition from endemic to hyperendemic incidence involved a 4-fold and 1 center dot 1-fold increase respectively. Increases in carriage prevalence for the later transition were 7-fold and 1 center dot 7-fold respectively. No data were available for the hyperendemic-epidemic transition for these serogroups. Our findings suggested that the regular seasonal variation in serogroup A meningococcal meningitis incidence between the rainy and the dry season could be mainly driven by seasonal change in the ratio of clinical cases to subclinical infections. In contrast appearance of epidemic incidences is related to a substantial increase in transmission and colonisation and to lesser extent with changes in the case-carrier ratio. Conclusion Seasonal change in the rate of progression to disease given carriage together with variations in frequency of carriage transmission should be considered in models attempting to capture the epidemiology of meningococcal meningitis and mainly to predict meningitis epidemics in the African meningitis belt.	[Koutangni, Thibaut; Mueller, Judith E.] Sorbonne Paris Cite, EHESP French Sch Publ Hlth, Rennes, France; [Mainassara, Halima Boubacar] Ctr Rech Med & Sanit CERMES, Niamey, Niger; [Koutangni, Thibaut; Mueller, Judith E.] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Koutangni, T (corresponding author), Sorbonne Paris Cite, EHESP French Sch Publ Hlth, Rennes, France.	thibautkoutangni@gmail.com	Koutangni, Thibaut/ABB-5227-2021	Koutangni, Thibaut/0000-0002-1892-9112	EHESP School of Public Health; Universite Pierre et Marie Curie	EHESP School of Public Health; Universite Pierre et Marie Curie	TK was financially supported by EHESP School of Public Health during a Master internship and by Universite Pierre et Marie Curie (Paris 6) through a doctoral contract. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Boisier P, 2006, EMERG INFECT DIS, V12, P1421, DOI 10.3201/eid1209.051518; Delrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019513; Djibo S, 2004, Med Trop (Mars), V64, P363; Emele FE, 1999, ACTA PAEDIATR, V88, P265, DOI 10.1080/08035259950170006; GHIPPONI P, 1971, B WORLD HEALTH ORGAN, V45, P95; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; GREENWOOD BM, 1985, LANCET, V2, P829, DOI 10.1016/S0140-6736(85)90812-8; Greenwood B, 2013, VACCINE, V31, P1453, DOI 10.1016/j.vaccine.2012.12.035; HALDANE JBS, 1956, ANN HUM GENET, V20, P309; Hamidou AA, 2006, MICROBES INFECT, V8, P2098, DOI 10.1016/j.micinf.2006.03.006; HASSANKING MKA, 1988, J INFECTION, V16, P55, DOI 10.1016/S0163-4453(88)96117-8; HOLLIS DG, 1969, APPL MICROBIOL, V17, P71, DOI 10.1128/AEM.17.1.71-77.1969; Hosmer DWJ., 2008, APPL SURVIVAL ANAL; Irving TJ, 2012, EPIDEMIOL INFECT, V140, P897, DOI 10.1017/S0950268811001385; Kristiansen PA, 2011, CLIN VACCINE IMMUNOL, V18, P435, DOI 10.1128/CVI.00479-10; Lapeyssonnie L., 1963, B WHO              S, V28, P3; Leimkugel J, 2007, PLOS MED, V4, P535, DOI 10.1371/journal.pmed.0040101; Martiny N, 2013, ATMOS ENVIRON, V70, P245, DOI 10.1016/j.atmosenv.2013.01.016; Molesworth AM, 2002, T ROY SOC TROP MED H, V96, P242, DOI 10.1016/S0035-9203(02)90089-1; MOORE PS, 1992, CLIN INFECT DIS, V14, P515, DOI 10.1093/clinids/14.2.515; MOORE PS, 1990, JAMA-J AM MED ASSOC, V264, P1271, DOI 10.1001/jama.264.10.1271; Mueller JE, 2006, J INFECT DIS, V193, P812, DOI 10.1086/500511; Mueller JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052464; Mueller JE, 2011, J INFECT DIS, V204, P1787, DOI 10.1093/infdis/jir623; Mueller JE, 2010, INT J INFECT DIS, V14, pE553, DOI 10.1016/j.ijid.2009.08.013; Mueller JE, 2008, TROP MED INT HEALTH, V13, P1543, DOI 10.1111/j.1365-3156.2008.02165.x; Palmgren H, 2009, GLOB HLTH ACTION, V2, P1; Perilla MJ, 2002, MANUAL LAB IDENTITIF; Raghunathan PL, 2006, J INFECT DIS, V193, P607, DOI 10.1086/499822; Rameix-Welti MA, 2009, INFECT IMMUN, V77, P3588, DOI 10.1128/IAI.00155-09; Sie A, 2008, TROP MED INT HEALTH, V13, P861, DOI 10.1111/j.1365-3156.2008.02056.x; Sjolinder H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014034; Tall H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-2; Trotter CL, 2007, LANCET INFECT DIS, V7, P797, DOI 10.1016/S1473-3099(07)70288-8; Trotter CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055486; World Health Organisation, 2000, WKLY EPIDEMIOL REC, V75, P306; World Health Organization Regional Office for Africa, 2009, STAND OP PROC ENH ME; Yaka P, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-34	38	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116725	10.1371/journal.pone.0116725	http://dx.doi.org/10.1371/journal.pone.0116725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658307	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900062
J	Kumar, KJS; Vani, MG; Chueh, PJ; Mau, JL; Wang, SY				Kumar, K. J. Senthil; Vani, M. Gokila; Chueh, Pin-Ju; Mau, Jeng-Leun; Wang, Sheng-Yang			Antrodin C Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Suppression of Smad2/3 and beta-Catenin Signaling Pathways	PLOS ONE			English	Article							DERIVATIVES; ACTIVATION; CAMPHORATA	Epithelial-to-mesenchymal transition (EMT) is a crucial event involved metastasis of certain tumors. Thus, identifying chemical agents that can block EMT is highly warranted for the development of anti-cancer chemoprevention/chemotherapies. In this study, we found that Antrodin C (ADC), a maleimide derivative isolated from Antrodia cinnamomea health food product inhibits TGF-beta 1-induced EMT and breast cancer cell metastasis in vitro. Pretreatment of MCF-7 cells with ADC significantly blocked TGF-beta 1-induced phenotypic changes and actin cytoskeleton remodeling. In addition, ADC was able to up-regulate epithelial markers such as E-cadherin and occludin, whereas mesenchymal markers including N-cadherin and vimentin were significantly inhibited, possibly through the modulation of transcriptional regulators Smad/Smad3. ADC blocked TGF-beta 1-induced migration and invasion of MCF-7 cells through the down-regulation of matrix-metalloproteinases (MMP-2, -9) and urokinase plasminogen activator (uPA). The inhibition of MMPs and uPA activity by ADC was reasoned by suppression of its corresponding transcription factor beta-catenin. Taken together, our data suggested that ADC attenuates the TGF-beta 1-induced EMT, migration and invasion of human breast carcinoma through the suppression of Smad2/3 and beta-catenin signaling pathways.	[Kumar, K. J. Senthil; Vani, M. Gokila; Wang, Sheng-Yang] Natl Chung Hsing Univ, Dept Forestry, Taichung 40227, Taiwan; [Chueh, Pin-Ju] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Chueh, Pin-Ju] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Mau, Jeng-Leun] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan; [Mau, Jeng-Leun; Wang, Sheng-Yang] Natl Chung Hsing Univ, Univ Calif Davis, Plant & Food Biotechnol Ctr, Taichung 40227, Taiwan; [Wang, Sheng-Yang] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan	National Chung Hsing University; National Chung Hsing University; Asia University Taiwan; National Chung Hsing University; National Chung Hsing University; Academia Sinica - Taiwan	Wang, SY (corresponding author), Natl Chung Hsing Univ, Dept Forestry, Taichung 40227, Taiwan.	taiwanfir@dragon.nchu.edu.tw	Wang, Sheng-Yang/M-9656-2019; K.J., Senthil Kumar/F-5309-2011	Wang, Sheng-Yang/0000-0002-8579-3569; Chueh, Pin Ju/0000-0002-3200-7552; K.J., Senthil Kumar/0000-0002-8310-0546	National Science Council, Republic of China [NSC-102-2911-I-005-301, NSC-103-2911-I-005-301]; Ministry of Education, Taiwan, ROC, under the ATU plan	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, ROC, under the ATU plan(Ministry of Education, Taiwan)	This study was supported by the National Science Council, Republic of China (NSC-102-2911-I-005-301, NSC-103-2911-I-005-301), and the Ministry of Education, Taiwan, ROC, under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao ZH, 2009, J ETHNOPHARMACOL, V121, P194, DOI 10.1016/j.jep.2008.10.039; Asuthkar S, 2012, J BIOL CHEM, V287, P20576, DOI 10.1074/jbc.M112.348888; Caraci F, 2008, PHARMACOL RES, V57, P274, DOI 10.1016/j.phrs.2008.02.001; Chen Y, 2011, J BIOL CHEM, V286, P42575, DOI 10.1074/jbc.M111.294595; Cheng J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030088, 10.1371/journal.pone.0042436]; Chien SC, 2008, J AGR FOOD CHEM, V56, P7017, DOI 10.1021/jf801171x; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Krstic Jelena, 2014, ScientificWorldJournal, V2014, P521754, DOI 10.1155/2014/521754; Lambrechts A, 2004, INT J BIOCHEM CELL B, V36, P1890, DOI 10.1016/j.biocel.2004.01.024; Lu MC, 2013, PHARMACOL THERAPEUT, V139, P124, DOI 10.1016/j.pharmthera.2013.04.001; Lv ZD, 2013, ONCOL REP, V29, P219, DOI 10.3892/or.2012.2111; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; Moustakas A, 2001, J CELL SCI, V114, P4359; Mukherjee N, 2012, CANCER SCI, V103, P210, DOI 10.1111/j.1349-7006.2011.02131.x; Nakamura N, 2004, J NAT PROD, V67, P46, DOI 10.1021/np030293k; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Scully OJ, 2012, CANCER GENOM PROTEOM, V9, P311; Sundqvist A, 2013, ONCOGENE, V32, P3606, DOI 10.1038/onc.2012.370; Tang LL, 2013, BIOMED PHARMACOTHER, V67, P179, DOI 10.1016/j.biopha.2012.10.003; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Verheyen EM, 2010, DEV DYNAM, V239, P34, DOI 10.1002/dvdy.22019; Walsh LA, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-10; Wiercinska E, 2011, BREAST CANCER RES TR, V128, P657, DOI 10.1007/s10549-010-1147-x; Wu MD, 2008, J NAT PROD, V71, P1258, DOI 10.1021/np070634k; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yao DB, 2011, MOL CANCER RES, V9, P1608, DOI 10.1158/1541-7786.MCR-10-0568; Zarzynska JM, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/141747; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058719	33	38	46	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117111	10.1371/journal.pone.0117111	http://dx.doi.org/10.1371/journal.pone.0117111			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658913	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900103
J	Peess, C; von Proff, L; Goller, S; Andersson, K; Gerg, M; Malmqvist, M; Bossenmaier, B; Schraml, M				Peess, Carmen; von Proff, Leopold; Goller, Sabine; Andersson, Karl; Gerg, Michael; Malmqvist, Magnus; Bossenmaier, Birgit; Schraeml, Michael			Deciphering the Stepwise Binding Mode of HRG1 beta to HER3 by Surface Plasmon Resonance and Interaction Map	PLOS ONE			English	Article							OPTICAL BIOSENSOR LITERATURE; EXTRACELLULAR REGION; TYROSINE KINASES; RECEPTOR; ERBB4; HEREGULIN; CONFORMATION; COMPLEX; ABSENCE; TETHER	For the development of efficient anti-cancer therapeutics against the HER receptor family it is indispensable to understand the mechanistic model of the HER receptor activation upon ligand binding. Due to its high complexity the binding mode of Heregulin 1 beta (HRG1 beta) with its receptor HER3 is so far not understood. Analysis of the interaction of HRG1 beta with surface immobilized HER3 extracellular domain by time-resolved Surface Plasmon Resonance (SPR) was so far not interpretable using any regular analysis method as the interaction was highly complex. Here, we show that Interaction Map (IM) made it possible to shed light on this interaction. IM allowed deciphering the rate limiting kinetic contributions from complex SPR sensorgrams and thereby enabling the extraction of discrete kinetic rate components from the apparently heterogeneous interactions. We could resolve details from the complex avidity-driven binding mode of HRG1 beta with HER3 by using a combination of SPR and IM data. Our findings contribute to the general understanding that a major conformational change of HER3 during its activation is induced by a complex sequential HRG1 beta docking mode.	[Peess, Carmen; von Proff, Leopold; Goller, Sabine; Gerg, Michael; Schraeml, Michael] Roche Diagnost GmbH, Penzberg, Germany; [Bossenmaier, Birgit] Roche Innovat Ctr, Penzberg, Germany; [Andersson, Karl; Malmqvist, Magnus] Ridgeview Diagnost AB, Uppsala, Sweden	Roche Holding	Peess, C (corresponding author), Roche Diagnost GmbH, Penzberg, Germany.	carmen.peess@roche.com	Bossenmaier, Birgit/AAN-7075-2020					Altschuh D, 2012, BIOCHEM BIOPH RES CO, V428, P74, DOI 10.1016/j.bbrc.2012.10.008; Andersson K, 2010, GOOGLE PATENTS; BAUMGARTEN H, 1989, J IMMUNOL METHODS, V122, P1, DOI 10.1016/0022-1759(89)90327-X; Bjorkelund H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024739; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Cooper MA, 2009, LABEL-FREE BIOSENSORS: TECHNIQUES AND APPLICATIONS, P1, DOI 10.1017/CBO9780511626531; Danielson UH, 2009, FUTURE MED CHEM, V1, P1399, DOI [10.4155/fmc.09.100, 10.4155/FMC.09.100]; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; Du Y, 2012, J AM CHEM SOC, V134, P6720, DOI 10.1021/ja211941d; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Jacobsen NE, 1996, BIOCHEMISTRY-US, V35, P3402, DOI 10.1021/bi952626l; Liu P, 2012, PROTEIN SCI, V21, P152, DOI 10.1002/pro.753; Luo C, 2005, PROTEINS, V59, P742, DOI 10.1002/prot.20443; Nilvebrant J, 2012, BIOTECHNOL APPL BIOC, V59, P367, DOI 10.1002/bab.1033; Rich RL, 2011, J MOL RECOGNIT, V24, P892, DOI 10.1002/jmr.1138; Rich RL, 2008, J MOL RECOGNIT, V21, P355, DOI 10.1002/jmr.928; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Singer E, 2001, J BIOL CHEM, V276, P44266, DOI 10.1074/jbc.M105428200; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; Zhang K, 1996, J BIOL CHEM, V271, P3884	26	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116870	10.1371/journal.pone.0116870	http://dx.doi.org/10.1371/journal.pone.0116870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658697	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900074
J	Sherwin, JS; Gaston, JR				Sherwin, Jason Samuel; Gaston, Jeremy Rodney			Experience Does Not Equal Expertise in Recognizing Infrequent Incoming Gunfire: Neural Markers for Experience and Task Expertise at Peak Behavioral Performance	PLOS ONE			English	Article							PERCEPTUAL DECISION-MAKING; ELECTROMAGNETIC TOMOGRAPHY LORETA; BRAIN; FMRI; EEG; NEGATIVITY; ERP	For a soldier, decisions to use force can happen rapidly and sometimes lead to undesired consequences. In many of these situations, there is a rapid assessment by the shooter that recognizes a threat and responds to it with return fire. But the neural processes underlying these rapid decisions are largely unknown, especially amongst those with extensive weapons experience and expertise. In this paper, we investigate differences in weapons experts and non-experts during an incoming gunfire detection task. Specifically, we analyzed the electroencephalography (EEG) of eleven expert marksmen/soldiers and eleven non-experts while they listened to an audio scene consisting of a sequence of incoming and non-incoming gunfire events. Subjects were tasked with identifying each event as quickly as possible and committing their choice via a motor response. Contrary to our hypothesis, experts did not have significantly better behavioral performance or faster response time than novices. Rather, novices indicated trends of better behavioral performance than experts. These group differences were more dramatic in the EEG correlates of incoming gunfire detection. Using machine learning, we found condition-discriminating EEG activity among novices showing greater magnitude and covering longer periods than those found in experts. We also compared group-level source reconstruction on the maximum discriminating neural correlates and found that each group uses different neural structures to perform the task. From condition-discriminating EEG and source localization, we found that experts perceive more categorical overlap between incoming and non-incoming gunfire. Consequently, the experts did not perform as well behaviorally as the novices. We explain these unexpected group differences as a consequence of experience with gunfire not being equivalent to expertise in recognizing incoming gunfire.	[Sherwin, Jason Samuel] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; [Sherwin, Jason Samuel; Gaston, Jeremy Rodney] US Army Res Lab, Human Res & Engn Directorate, Aberdeen Proving Ground, MD USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL)	Sherwin, JS (corresponding author), Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA.	jason.sherwin@downstate.edu			U.S. Army Research Office [W911NF-11-1-0219]; U.S. Army Research Laboratory	U.S. Army Research Office; U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL))	This work was supported by a grant from the U.S. Army Research Office (W911NF-11-1-0219) and in part by an appointment to the U.S. Army Research Laboratory Postdoctoral Fellowship Program administered by the Oak Ridge Associated Universities through a contract with the U.S. Army Research Laboratory.	Abramson ASaL L, 1968, J ACOUSTICAL SOC AM, V44; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bledowski C, 2004, NEUROIMAGE, V22, P530, DOI 10.1016/j.neuroimage.2003.12.034; Conroy Bryan, 2012, JMLR Workshop Conf Proc, V22, P246; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; Gandour J, 2003, HUM BRAIN MAPP, V18, P149, DOI 10.1002/hbm.10088; Garinther GR, 1966, ACOUSTICAL CONSIDERA; Goldman RI, 2009, NEUROIMAGE, V47, P136, DOI 10.1016/j.neuroimage.2009.03.062; JORDAN MI, 1994, NEURAL COMPUT, V6, P181, DOI 10.1162/neco.1994.6.2.181; Just MA, 2008, BRAIN RES, V1205, P70, DOI 10.1016/j.brainres.2007.12.075; Kida N, 2005, COGNITIVE BRAIN RES, V22, P257, DOI 10.1016/j.cogbrainres.2004.09.003; Koelsch S, 2002, PSYCHOPHYSIOLOGY, V39, P657, DOI 10.1017/S0048577202010508; Maher RC, 2006, MODELING SIGNAL PROC, P257; Maidhof C, 2010, J COGNITIVE NEUROSCI, V22, P2401, DOI 10.1162/jocn.2009.21332; Mashal N, 2007, BRAIN LANG, V100, P115, DOI 10.1016/j.bandl.2005.10.005; Miller BL, 2007, HUMAN FRONTAL LOBES; Parra L, 2002, NEUROIMAGE, V17, P223, DOI 10.1006/nimg.2002.1212; Parra LC, 2005, NEUROIMAGE, V28, P326, DOI 10.1016/j.neuroimage.2005.05.032; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; Philiastides MG, 2006, CEREB CORTEX, V16, P509, DOI 10.1093/cercor/bhi130; Radlo SJ, 2001, RES Q EXERCISE SPORT, V72, P22, DOI 10.1080/02701367.2001.10608928; Ratcliff R, 2009, P NATL ACAD SCI USA, V106, P6539, DOI 10.1073/pnas.0812589106; Rea Duda, 2001, PATTERN CLASSIFICATI; Sajda Paul, 2009, IEEE Rev Biomed Eng, V2, P97, DOI 10.1109/RBME.2009.2034535; Sherwin J, 2013, BRAIN COGNITION, V83, P190, DOI 10.1016/j.bandc.2013.07.002; Sherwin J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00067	31	1	1	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115629	10.1371/journal.pone.0115629	http://dx.doi.org/10.1371/journal.pone.0115629			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658335	Green Published, gold			2022-12-27	WOS:000349444900026
J	Tiezzi, F; Parker-Gaddis, KL; Cole, JB; Clay, JS; Maltecca, C				Tiezzi, Francesco; Parker-Gaddis, Kristen L.; Cole, John B.; Clay, John S.; Maltecca, Christian			A Genome-Wide Association Study for Clinical Mastitis in First Parity US Holstein Cows Using Single-Step Approach and Genomic Matrix Re-Weighting Procedure	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MAMMARY EPITHELIAL-CELLS; MAPPING INCLUDING PHENOTYPES; FACTOR-KAPPA-B; STAPHYLOCOCCUS-AUREUS; GENE-EXPRESSION; CANDIDATE GENES; DAIRY-CATTLE; TUMOR-SUPPRESSOR; MILK-PRODUCTION	Clinical mastitis (CM) is one of the health disorders with large impacts on dairy farming profitability and animal welfare. The objective of this study was to perform a genome-wide association study (GWAS) for CM in first-lactation Holstein. Producer-recorded mastitis event information for 103,585 first-lactation cows were used, together with genotype information on 1,361 bulls from the Illumina BovineSNP50 BeadChip. Single-step genomic-BLUP methodology was used to incorporate genomic data into a threshold-liability model. Association analysis confirmed that CM follows a highly polygenic mode of inheritance. However, 10-adjacent-SNP windows showed that regions on chromosomes 2, 14 and 20 have impacts on genetic variation for CM. Some of the genes located on chromosome 14 (LY6K, LY6D, LYNX1, LYPD2, SLURP1, PSCA) are part of the lymphocyte-antigen-6 complex (LY6) known for its neutrophil regulation function linked to the major histocompatibility complex. Other genes on chromosome 2 were also involved in regulating immune response (IFIH1, LY75, and DPP4), or are themselves regulated in the presence of specific pathogens (ITGB6, NR4A2). Other genes annotated on chromosome 20 are involved in mammary gland metabolism (GHR, OXCT1), antibody production and phagocytosis of bacterial cells (C6, C7, C9, C1QTNF3), tumor suppression (DAB2), involution of mammary epithelium (OSMR) and cytokine regulation (PRLR). DAVID enrichment analysis revealed 5 KEGG pathways. The JAK-STAT signaling pathway (cell proliferation and apoptosis) and the 'Cytokine-cytokine receptor interaction' (cytokine and interleukines response to infectious agents) are co-regulated and linked to the 'ABC transporters' pathway also found here. Gene network analysis performed using GeneMania revealed a co-expression network where 665 interactions existed among 145 of the genes reported above. Clinical mastitis is a complex trait and the different genes regulating immune response are known to be pathogen-specific. Despite the lack of information in this study, candidate QTL for CM were identified in the US Holstein population.	[Tiezzi, Francesco; Parker-Gaddis, Kristen L.; Maltecca, Christian] N Carolina State Univ, Dept Anim Sci, Raleigh, NC 27695 USA; [Parker-Gaddis, Kristen L.; Cole, John B.] ARS, Anim Genom & Improvement Lab, USDA, Beltsville, MD 20705 USA; [Clay, John S.] Dairy Records Management Syst, Raleigh, NC 27603 USA	University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA)	Tiezzi, F (corresponding author), N Carolina State Univ, Dept Anim Sci, Box 7621, Raleigh, NC 27695 USA.	ftmaestr@ncsu.edu	Cole, John B./J-8571-2014; Tiezzi, Francesco/L-6411-2016	Cole, John B./0000-0003-1242-4401; Tiezzi, Francesco/0000-0002-4358-9236; maltecca, christian/0000-0002-9996-4680; Clay, John/0000-0001-7273-225X	Select Sires [2010-1714]; ARS [ARS-0423282] Funding Source: Federal RePORTER	Select Sires; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by project 2010-1714 from Select Sires - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adermann K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/ps.8.4.810; Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Aguilar I., 2014, P 10 WORLD C GENETIC; Bahrenberg G, 2000, BIOCHEM BIOPH RES CO, V275, P783, DOI 10.1006/bbrc.2000.3393; Beecher C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-99; Bionaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033268; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Bishop SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008940; Bonnefont CMD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-208; Boutet P, 2004, J DAIRY SCI, V87, P4104, DOI 10.3168/jds.S0022-0302(04)73553-5; Boutet P, 2007, J DAIRY SCI, V90, P155, DOI 10.3168/jds.S0022-0302(07)72617-6; Brenaut P, 2012, J DAIRY SCI, V95, P6130, DOI 10.3168/jds.2012-5604; Buitenhuis B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-130; CDCB, 2014, TREND SOM CELL SCOR; Christensen OF, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-2; Connor EE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-362; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; Detilleux JC, 2009, VET MICROBIOL, V134, P157, DOI 10.1016/j.vetmic.2008.09.023; DETILLEUX JC, 1994, J DAIRY SCI, V77, P2640, DOI 10.3168/jds.S0022-0302(94)77205-2; Dikmen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069202; Eshraghi HR, 1999, LIFE SCI, V64, P1675, DOI 10.1016/S0024-3205(99)00105-8; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gaddis KLP, 2014, J DAIRY SCI, V97, P3190, DOI 10.3168/jds.2013-7543; Gaddis KLP, 2012, J DAIRY SCI, V95, P5422, DOI 10.3168/jds.2012-5572; Galvao KN, 2011, J DAIRY SCI, V94, P2083, DOI 10.3168/jds.2010-3636; Glass EJ, 2007, VET IMMUNOL IMMUNOP, V120, P20, DOI 10.1016/j.vetimm.2007.07.013; Griesbeck-Zilch B, 2009, J DAIRY SCI, V92, P4621, DOI 10.3168/jds.2008-1954; Gutierrez-Barroso A, 2008, VET IMMUNOL IMMUNOP, V121, P113, DOI 10.1016/j.vetimm.2007.09.007; He YH, 2011, J DAIRY RES, V78, P242, DOI 10.1017/S0022029911000148; Heringstad B, 2003, J DAIRY SCI, V86, P369, DOI 10.3168/jds.S0022-0302(03)73615-7; Heringstad B, 2000, LIVEST PROD SCI, V64, P95, DOI 10.1016/S0301-6226(99)00128-1; Holmberg M, 2004, J DAIRY SCI, V87, P2653, DOI 10.3168/jds.S0022-0302(04)73391-3; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Huang C, 2006, J ANIM SCI, V84, P275; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Jiang L, 2012, PHYSIOL GENOMICS, V44, P305, DOI 10.1152/physiolgenomics.00047.2011; Jiang L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-443; Kandasamy S, 2012, J DAIRY SCI, V95, P3852, DOI 10.3168/jds.2011-5251; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Klungland H, 2001, MAMM GENOME, V12, P837, DOI 10.1007/s00335001-2081-3; Lad SP, 2005, J IMMUNOL, V174, P7186, DOI 10.4049/jimmunol.174.11.7186; Lahouassa H, 2007, CYTOKINE, V38, P12, DOI 10.1016/j.cyto.2007.04.006; Lara-Zarate L, 2011, MICROB PATHOGENESIS, V51, P313, DOI 10.1016/j.micpath.2011.07.010; Lavon Y, 2011, THERIOGENOLOGY, V76, P942, DOI 10.1016/j.theriogenology.2011.05.001; Lee JW, 2006, VET RES, V37, P219, DOI 10.1051/vetres:2005051; Lee SU, 2001, INFECT IMMUN, V69, P7190, DOI 10.1128/IAI.69.11.7190-7193.2001; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Lund MS, 2008, J DAIRY SCI, V91, P4028, DOI 10.3168/jds.2007-0290; Mallya M, 2002, GENOMICS, V80, P113, DOI 10.1006/geno.2002.6794; Meredith Brian K., 2013, Frontiers in Genetics, V4, P229, DOI 10.3389/fgene.2013.00229; Meredith BK, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-21; Misztal I., 2002, Proceedings of the 7th World Congress on Genetics Applied to Livestock Production, Montpellier, France, August, 2002. Session 18, P1; Misztal I, 2013, POULTRY SCI, V92, P2530, DOI 10.3382/ps.2012-02739; Moreilhon C, 2005, PHYSIOL GENOMICS, V20, P244, DOI 10.1152/physiolgenomics.00135.2004; Moyes KM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-542; Mrode R, 2012, J DAIRY SCI, V95, P4618, DOI 10.3168/jds.2011-4971; Naeem A, 2012, J DAIRY SCI, V95, P6397, DOI 10.3168/jds.2011-5173; Neerhof HJ, 2000, J DAIRY SCI, V83, P1064, DOI 10.3168/jds.S0022-0302(00)74970-8; Nguyen TTT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000229; Ogorevc J, 2009, ANIM GENET, V40, P832, DOI 10.1111/j.1365-2052.2009.01921.x; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; PHILIPSSON J, 1995, LIVEST PROD SCI, V41, P195, DOI 10.1016/0301-6226(94)00067-H; Pighetti GM, 2011, J MAMMARY GLAND BIOL, V16, P421, DOI 10.1007/s10911-011-9238-9; Pimentel ECG, 2011, ANIM GENET, V42, P251, DOI 10.1111/j.1365-2052.2010.02148.x; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Rainard P, 2003, VET RES, V34, P647, DOI 10.1051/vetres:2003025; Rambeaud M, 2003, VET IMMUNOL IMMUNOP, V96, P193, DOI 10.1016/j.vetimm.2003.08.008; Rinaldi M, 2010, VET IMMUNOL IMMUNOP, V138, P267, DOI 10.1016/j.vetimm.2010.10.005; Rupp R, 2003, VET RES, V34, P671, DOI 10.1051/vetres:2003020; Schulman NF, 2004, J DAIRY SCI, V87, P443, DOI 10.3168/jds.S0022-0302(04)73183-5; Schwerin M, 2003, GENET SEL EVOL, V35, pS19, DOI 10.1051/gse:2003014; Sellar GC, 2003, NAT GENET, V34, P337, DOI 10.1038/ng1183; Sigl T, 2014, J ANIM PHYSIOL AN N, V98, P84, DOI 10.1111/jpn.12039; Sodeland M, 2011, ANIM GENET, V42, P457, DOI 10.1111/j.1365-2052.2010.02165.x; Sorensen LP, 2008, J DAIRY SCI, V91, P2493, DOI 10.3168/jds.2007-0583; Stanford JC, 2013, APOPTOSIS CLEARANCE; Swanson KM, 2009, J DAIRY SCI, V92, P117, DOI 10.3168/jds.2008-1382; Thacker JD, 2012, ANTIMICROB AGENTS CH, V56, P1921, DOI 10.1128/AAC.06372-11; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; Wang HY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00134; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Youngerman SM, 2004, J DAIRY SCI, V87, P2442, DOI 10.3168/jds.S0022-0302(04)73367-6; Zarrin M, 2014, J DAIRY SCI, V97, P3531, DOI 10.3168/jds.2013-7480	87	61	65	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0114919	10.1371/journal.pone.0114919	http://dx.doi.org/10.1371/journal.pone.0114919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658712	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900011
J	Whiteford, HA; Ferrari, AJ; Degenhardt, L; Feigin, V; Vos, T				Whiteford, Harvey A.; Ferrari, Alize J.; Degenhardt, Louisa; Feigin, Valery; Vos, Theo			The Global Burden of Mental, Neurological and Substance Use Disorders: An Analysis from the Global Burden of Disease Study 2010	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SYSTEMATIC ANALYSIS; CONDUCT DISORDER; 187 COUNTRIES; 21 REGIONS; MORTALITY; INJURIES	Background The Global Burden of Disease Study 2010 (GBD 2010), estimated that a substantial proportion of the world's disease burden came from mental, neurological and substance use disorders. In this paper, we used GBD 2010 data to investigate time, year, region and age specific trends in burden due to mental, neurological and substance use disorders. Method For each disorder, prevalence data were assembled from systematic literature reviews. DisMod-MR, a Bayesian meta-regression tool, was used to model prevalence by country, region, age, sex and year. Prevalence data were combined with disability weights derived from survey data to estimate years lived with disability (YLDs). Years lost to premature mortality (YLLs) were estimated by multiplying deaths occurring as a result of a given disorder by the reference standard life expectancy at the age death occurred. Disability-adjusted life years (DALYs) were computed as the sum of YLDs and YLLs. Results In 2010, mental, neurological and substance use disorders accounted for 10.4% of global DALYs, 2.3% of global YLLs and, 28.5% of global YLDs, making them the leading cause of YLDs. Mental disorders accounted for the largest proportion of DALYs (56.7%), followed by neurological disorders (28.6%) and substance use disorders (14.7%). DALYs peaked in early adulthood for mental and substance use disorders but were more consistent across age for neurological disorders. Females accounted for more DALYs in all mental and neurological disorders, except for mental disorders occurring in childhood, schizophrenia, substance use disorders, Parkinson's disease and epilepsy where males accounted for more DALYs. Overall DALYs were highest in Eastern Europe/Central Asia and lowest in East Asia/the Pacific. Conclusion Mental, neurological and substance use disorders contribute to a significant proportion of disease burden. Health systems can respond by implementing established, cost effective interventions, or by supporting the research necessary to develop better prevention and treatment options.	[Whiteford, Harvey A.; Ferrari, Alize J.] Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia; [Whiteford, Harvey A.; Ferrari, Alize J.] Queensland Ctr Mental Hlth Res, Wacol, Qld, Australia; [Whiteford, Harvey A.; Ferrari, Alize J.; Degenhardt, Louisa; Vos, Theo] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Degenhardt, Louisa] UNSW Australia, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Degenhardt, Louisa] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia; [Feigin, Valery] AUT Univ, Fac Hlth & Environm Studies, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand	University of Queensland; Queensland Centre for Mental Health Research; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of New South Wales Sydney; University of Melbourne; Auckland University of Technology	Whiteford, HA (corresponding author), Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia.	h.whiteford@uq.edu.au	Degenhardt, Louisa J/D-4515-2012; Whiteford, Harvey A/A-4840-2009; Feigin, Valery/AAF-2313-2019; Ferrari, Alize J/G-1746-2011	Degenhardt, Louisa J/0000-0002-8513-2218; Whiteford, Harvey A/0000-0003-4667-6623; Ferrari, Alize J/0000-0002-7863-9117; Feigin, Valery L./0000-0002-6372-1740	Queensland Centre for Mental Health Research; Australian National Health and Medical Research Council (NHMRC) Principal Research Fellowship [1041742]; Australian National Health and Medical Research Council Principal Research Fellowship; Australian Government under the Substance Misuse Prevention and Service Improvements Grants Fund; Queensland Department of Health; Bill and Melinda Gates Foundation	Queensland Centre for Mental Health Research; Australian National Health and Medical Research Council (NHMRC) Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Government under the Substance Misuse Prevention and Service Improvements Grants Fund(Australian Government); Queensland Department of Health; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	HAW and AJF are supported by the Queensland Centre for Mental Health Research which receives its funding from the Queensland Department of Health. LD is supported by an Australian National Health and Medical Research Council (NHMRC) Principal Research Fellowship (#1041742). The National Drug and Alcohol Research Centre at UNSW Australia is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grants Fund and an Australian National Health and Medical Research Council Principal Research Fellowship. TV receives funding from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Baxter AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065514; Cheng ATA, 2001, BRIT J PSYCHIAT, V179, P1, DOI 10.1192/bjp.179.1.1; Crump C, 2013, AM J PSYCHIAT, V170, P324, DOI 10.1176/appi.ajp.2012.12050599; Degenhardt L, 2014, ADDICTION, V109, P1320, DOI 10.1111/add.12551; Degenhardt L, 2014, DRUG ALCOHOL DEPEN, V137, P36, DOI 10.1016/j.drugalcdep.2013.12.025; Degenhardt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076635; Degenhardt L, 2011, DRUG ALCOHOL DEPEN, V117, P85, DOI 10.1016/j.drugalcdep.2010.11.032; Diop AG, 2005, EPILEPSIA, V46, P33, DOI 10.1111/j.1528-1167.2005.00405.x; Erskine HE, 2014, J CHILD PSYCHOL PSYC, V55, P328, DOI 10.1111/jcpp.12186; Erskine HE, 2013, J CHILD PSYCHOL PSYC, V54, P1263, DOI 10.1111/jcpp.12144; Ferrari AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091936; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Ferrari AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069637; Ferrari AJ, 2011, J AFFECT DISORDERS, V134, P1, DOI 10.1016/j.jad.2010.11.007; Jorm AF, 2012, AM PSYCHOL, V67, P231, DOI 10.1037/a0025957; Lawrence D, 2013, BRIT MED J, V346, DOI [10.1136/bmj.f4242, DOI 10.1136/BMJ.F4242]; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; United Nations, 2011, WORLD POP PROSP 2010, DOI [10.4414/smw.2014.14059, DOI 10.4414/SMW.2014.14059]; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Wang PS, 2007, WORLD PSYCHIATRY, V6, P177; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Whiteford HA, 2013, CURR OPIN PSYCHIATR, V26, P376, DOI 10.1097/YCO.0b013e328361e60f; World Health Organization, 1992, ICD 10 CLASSIFICATIO; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yang LH, 2009, LANCET, V373, P2002, DOI 10.1016/S0140-6736(09)61091-6	35	669	680	6	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116820	10.1371/journal.pone.0116820	http://dx.doi.org/10.1371/journal.pone.0116820			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658103	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900070
J	Xiao, JP; Zang, J; Pei, JJ; Xu, F; Zhu, Y; Liao, XP				Xiao, Jian-Ping; Zang, Jia; Pei, Jing-Jing; Xu, Fei; Zhu, Yan; Liao, Xiang-Peng			Low Maternal Vitamin D Status during the Second Trimester of Pregnancy: A Cross-Sectional Study in Wuxi, China	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; D DEFICIENCY; RACIAL-DIFFERENCES; WOMEN; INSUFFICIENCY; ASSOCIATION; AGE	Background Vitamin D deficiency is common in pregnant women, but an optimal serum vitamin D level during pregnancy has not been determined and remains an area of active research. Vitamin D data from large populations of pregnant Chinese women are still limited. Objective To evaluate the vitamin D status of women in Eastern China during the second trimester of pregnancy. Methods A hospital-based, cross-sectional, observational study. Serum 25-hydroxyvitamin D [25(OH)D] concentration was measured in samples from 5823 pregnant women in Wuxi City, China (latitude: 31.5o N), from January 2011 to June 2012. Results The median serum 25(OH)D concentration was 34.0 nmol/L [2.5 nmol/L 25(OH)D = 1 ng/mL 25(OH)D]. Vitamin D deficiency [defined as 25(OH)D < 30 nmol/L according to the Institute of Medicine (National Academy of Sciences, Washington, D.C., USA)] or inadequacy [25(OH)D of 30-49.9 nmol/L] was identified in 40.7% and 38.0% of the women, respectively. Only 0.9% had a 25(OH)D level >= 80.0 nmol/L, which is the concentration recommended as adequate by the Endocrine Society (Washington, D.C., USA). Compared with older women, younger women were more likely to be deficient in vitamin D. There were significant differences in the 25(OH)D levels according to season. The 25(OH)D levels reached peak values in September and were correlated with (r = 0.337, P < 0.001), and fluctuated with, average monthly air temperatures. Conclusions There is a high prevalence of Vitamin D deficiency among pregnant Chinese women, and 25(OH)D levels varied according to season and air temperature. The results of this study also suggest that currently there is a big gap between the levels of Vitamin D detected in pregnant Chinese women and the levels recommended by the Endocrine Society.	[Xiao, Jian-Ping; Zhu, Yan] Nanjing Med Univ, Wuxi Matern & Child Hlth Hosp, Dept Obstet, Nanjing, Jiangsu, Peoples R China; [Zang, Jia; Xu, Fei] Nanjing Med Univ, Wuxi Matern & Child Hlth Hosp, Cent Lab, Nanjing, Jiangsu, Peoples R China; [Pei, Jing-Jing] Nanjing Med Univ, Wuxi Matern & Child Hlth Hosp, Dept Hlth Care, Nanjing, Jiangsu, Peoples R China; [Liao, Xiang-Peng] Nanjing Med Univ, Wuxi Matern & Child Hlth Hosp, Dept Newborn, Nanjing, Jiangsu, Peoples R China; [Xiao, Jian-Ping] Soochow Univ, Sch Med, Perinatal Biol Ctr, Suzhou, Jiangsu, Peoples R China; [Liao, Xiang-Peng] Univ Sherbrooke, Ctr Hosp, Dept Obstet & Gynecol, Sherbrooke, PQ J1K 2R1, Canada	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Soochow University - China; University of Sherbrooke	Liao, XP (corresponding author), Nanjing Med Univ, Wuxi Matern & Child Hlth Hosp, Dept Newborn, Nanjing, Jiangsu, Peoples R China.	lxp4848@aliyun.com	Liao, Xiangpeng/GNP-2312-2022; Xiao, Jian/GYU-4351-2022		Science and Technology Department of Jiangsu Province [BL2014025]; Jiangsu Province Department of Health [F201305]; Wuxi Municipal Hospital Management Center in China [YGZZ1107, YGZXL1317]	Science and Technology Department of Jiangsu Province; Jiangsu Province Department of Health; Wuxi Municipal Hospital Management Center in China	The present study was supported by grants: BL2014025 from Science and Technology Department of Jiangsu Province, F201305 from Jiangsu Province Department of Health, YGZZ1107 and YGZXL1317 from Wuxi Municipal Hospital Management Center in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia JF, 2011, J CLIN ENDOCR METAB, V96, P2987, DOI 10.1210/jc.2011-0090; [Anonymous], 2011, Obstet Gynecol, V118, P197, DOI 10.1097/AOG.0b013e318227f06b; Brannon PM, 2011, ANNU REV NUTR, V31, P89, DOI 10.1146/annurev.nutr.012809.104807; Dror DK, 2011, CURR OPIN OBSTET GYN, V23, P422, DOI 10.1097/GCO.0b013e32834cb791; Du XQ, 2001, AM J CLIN NUTR, V74, P494; Francis R, 2013, VITAMIN D BONE HLTH; Ginde AA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.036; Gutierrez OM, 2011, OSTEOPOROSIS INT, V22, P1745, DOI 10.1007/s00198-010-1383-2; Haddow JE, 2011, CLIN ENDOCRINOL, V75, P309, DOI 10.1111/j.1365-2265.2011.04066.x; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Holmes VA, 2009, BRIT J NUTR, V102, P876, DOI 10.1017/S0007114509297236; Kasahara AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065785; Lawlor DA, 2013, LANCET, V381, P2176, DOI 10.1016/S0140-6736(12)62203-X; Looker Anne C, 2011, NCHS Data Brief, P1; [毛宇清 Mao Yuqing], 2010, [气象科学, Scientia Meteorologlca Sinica], V30, P516; Norris KC, 2013, JAMA-J AM MED ASSOC, V310, P153, DOI 10.1001/jama.2013.7229; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Robinson-Cohen C, 2013, JAMA-J AM MED ASSOC, V310, P179, DOI 10.1001/jama.2013.7228; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Tao MF, 2012, J MATERN-FETAL NEO M, V25, P237, DOI 10.3109/14767058.2011.569613; Urrutia RP, 2012, CURR OPIN OBSTET GYN, V24, P57, DOI 10.1097/GCO.0b013e3283505ab3; Vandevijvere S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043868; Wei SQ, 2012, BJOG-INT J OBSTET GY, V119, P832, DOI 10.1111/j.1471-0528.2012.03307.x; Woo J, 2008, BRIT J NUTR, V99, P1330, DOI 10.1017/S0007114507844382; Xiang F, 2013, J ENDOCRINOL INVEST, V36, P503, DOI 10.3275/8814; Zhu K, 2014, J BONE MINER RES, V29, P1088, DOI 10.1002/jbmr.2138; Zhu ZW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-126	28	32	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117748	10.1371/journal.pone.0117748	http://dx.doi.org/10.1371/journal.pone.0117748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659105	gold, Green Submitted, Green Published			2022-12-27	WOS:000349444900212
J	Yuasa, M; Yamada, T; Taniyama, T; Masaoka, T; Wei, XT; Yoshii, T; Horie, M; Yasuda, H; Uemura, T; Okawa, A; Sotome, S				Yuasa, Masato; Yamada, Tsuyoshi; Taniyama, Takashi; Masaoka, Tomokazu; Wei Xuetao; Yoshii, Toshitaka; Horie, Masaki; Yasuda, Hiroaki; Uemura, Toshimasa; Okawa, Atsushi; Sotome, Shinichi			Dexamethasone Enhances Osteogenic Differentiation of Bone Marrow- and Muscle-Derived Stromal Cells and Augments Ectopic Bone Formation Induced by Bone Morphogenetic Protein-2	PLOS ONE			English	Article							LUMBAR INTERBODY FUSION; MESENCHYMAL STEM-CELLS; PROGENITOR CELLS; EXPRESSION; CULTURES; MATRIX; COMPLICATIONS; C3H10T1/2; DELIVERY; SUBPOPULATION	We evaluated whether dexamethasone augments the osteogenic capability of bone marrow-derived stromal cells (BMSCs) and muscle tissue-derived stromal cells (MuSCs), both of which are thought to contribute to ectopic bone formation induced by bone morphogenetic protein-2 (BMP-2), and determined the underlying mechanisms. Rat BMSCs and MuSCs were cultured in growth media with or without 10-7 M dexamethasone and then differentiated under osteogenic conditions with dexamethasone and BMP-2. The effects of dexamethasone on cell proliferation and osteogenic differentiation, and also on ectopic bone formation induced by BMP-2, were analyzed. Dexamethasone affected not only the proliferation rate but also the subpopulation composition of BMSCs and MuSCs, and subsequently augmented their osteogenic capacity during osteogenic differentiation. During osteogenic induction by BMP-2, dexamethasone also markedly affected cell proliferation in both BMSCs and MuSCs. In an in vivo ectopic bone formation model, bone formation in muscle-implanted scaffolds containing dexamethasone and BMP-2 was more than two fold higher than that in scaffolds containing BMP-2 alone. Our results suggest that dexamethasone potently enhances the osteogenic capability of BMP-2 and may thus decrease the quantity of BMP-2 required for clinical application, thereby reducing the complications caused by excessive doses of BMP-2. Highlights: 1. Dexamethasone induced selective proliferation of bone marrow-and muscle- derived cells with higher differentiation potential. 2. Dexamethasone enhanced the osteogenic capability of bone marrow-and muscle-derived cells by altering the subpopulation composition. 3. Dexamethasone augmented ectopic bone formation induced by bone morphogenetic protein-2.	[Yuasa, Masato; Yamada, Tsuyoshi; Taniyama, Takashi; Masaoka, Tomokazu; Wei Xuetao; Yoshii, Toshitaka; Yasuda, Hiroaki; Okawa, Atsushi; Sotome, Shinichi] Tokyo Med & Dent Univ, Grad Sch, Dept Orthopaed & Spinal Surg, Tokyo, Japan; [Yuasa, Masato; Yamada, Tsuyoshi; Okawa, Atsushi] Tokyo Med & Dent Univ, Global Ctr Excellence GCOE Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo, Japan; [Horie, Masaki] Tokyo Med & Dent Univ, Univ Hosp Med, Hyperbar Med Ctr, Tokyo, Japan; [Uemura, Toshimasa] Natl Inst Adv Ind Sci & Technol, Tsukuba, Japan; [Sotome, Shinichi] Tokyo Med & Dent Univ, Grad Sch, Dept Orthopaed Res & Dev, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Institute of Advanced Industrial Science & Technology (AIST); Tokyo Medical & Dental University (TMDU)	Sotome, S (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Orthopaed & Spinal Surg, Tokyo, Japan.	sotome.orth@tmd.ac.jp			Japanese Ministry of Health, Labor and Welfare; Olympus Corporation	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Olympus Corporation	This study was partially supported by grants from the Japanese Ministry of Health, Labor and Welfare and by Olympus Corporation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahlstrom M, 2005, BIOCHEM PHARMACOL, V69, P267, DOI 10.1016/j.bcp.2004.09.012; AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; Akamaru T, 2003, SPINE, V28, P429, DOI 10.1097/00007632-200303010-00004; Alm JJ, 2012, TISSUE ENG PART C-ME, V18, P658, DOI [10.1089/ten.tec.2011.0675, 10.1089/ten.TEC.2011.0675]; Arrington ED, 1996, CLIN ORTHOP RELAT R, P300, DOI 10.1097/00003086-199608000-00037; Aubin JE, 1999, J CELL BIOCHEM, V72, P396, DOI 10.1002/(SICI)1097-4644(19990301)72:3<396::AID-JCB9>3.3.CO;2-Y; BELLOWS CG, 1994, ENDOCRINOLOGY, V134, P2221, DOI 10.1210/en.134.5.2221; BELLOWS CG, 1989, CELL TISSUE RES, V256, P145; BELLOWS CG, 1990, DEV BIOL, V140, P132, DOI 10.1016/0012-1606(90)90060-V; Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005; Boraiah S, 2009, CLIN ORTHOP RELAT R, V467, P3257, DOI 10.1007/s11999-009-1039-8; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Chen NF, 2010, J NEUROSURG-SPINE, V12, P40, DOI 10.3171/2009.4.SPINE0876; Cole BJ, 1997, CLIN ORTHOP RELAT R, P219; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Derfoul A, 2006, STEM CELLS, V24, P1487, DOI 10.1634/stemcells.2005-0415; Diefenderfer DL, 2003, J BONE JOINT SURG AM, V85A, P19, DOI 10.2106/00004623-200300003-00005; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; Haramoto N, 2007, ORAL DIS, V13, P23, DOI 10.1111/j.1601-0825.2006.01234.x; Hayashi K, 2009, BIOCHEM BIOPH RES CO, V379, P261, DOI 10.1016/j.bbrc.2008.12.035; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; HERBERTSON A, 1995, J BONE MINER RES, V10, P285; Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbrc.2004.06.029; Iu MF, 2005, J BONE MINER METAB, V23, P450, DOI 10.1007/s00774-005-0627-2; Iu MF, 2005, J ENDOCRINOL, V185, P131, DOI 10.1677/joe.1.05962; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kamolratanakul P, 2011, ARTHRITIS RHEUM-US, V63, P1021, DOI 10.1002/art.30151; Kandziora F, 2002, J NEUROSURG, V97, P40, DOI 10.3171/spi.2002.97.1.0040; Kaul Z, 2007, ANN NY ACAD SCI, V1100, P368, DOI 10.1196/annals.1395.040; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kuhn LT, 2013, J GERONTOL A-BIOL, V68, P1170, DOI 10.1093/gerona/glt018; Lewandrowski KU, 2007, SPINE J, V7, P609, DOI 10.1016/j.spinee.2007.01.011; Lounev VY, 2009, J BONE JOINT SURG AM, V91A, P652, DOI 10.2106/JBJS.H.01177; MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317; Matsumoto Y, 2010, MOL CELL ENDOCRINOL, V325, P118, DOI 10.1016/j.mce.2010.05.004; McClellan JW, 2006, J SPINAL DISORD TECH, V19, P483, DOI 10.1097/01.bsd.0000211231.83716.4b; McDonald MM, 2013, J BONE MINER RES, V28, P1550, DOI 10.1002/jbmr.1889; Mikami Y, 2007, BIOCHEM BIOPH RES CO, V362, P368, DOI 10.1016/j.bbrc.2007.07.192; Mikami Y, 2010, J CELL PHYSIOL, V223, P123, DOI 10.1002/jcp.22017; Mindea SA, 2009, SPINE, V34, P1480, DOI 10.1097/BRS.0b013e3181a396a1; Nakagawa K, 2007, BONE, V41, P543, DOI 10.1016/j.bone.2007.06.013; Nottmeier EW, 2010, SPINE J, V10, P595, DOI [10.1016/j.spinee.2010.04.013, 10.1016/j.spinee.2010.03.023]; Oliveira JM, 2010, BONE, V46, P1424, DOI 10.1016/j.bone.2010.02.007; Oliveira JM, 2009, BIOMATERIALS, V30, P804, DOI 10.1016/j.biomaterials.2008.10.024; Oshina H, 2007, BONE, V41, P575, DOI 10.1016/j.bone.2007.06.022; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; OZKAYNAK E, 1992, J BIOL CHEM, V267, P25220; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rihn JA, 2009, SPINE J, V9, P623, DOI 10.1016/j.spinee.2009.04.004; Robin BN, 2010, SPINE, V35, pE1350, DOI 10.1097/BRS.0b013e3181e85756; Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83; Sekiya I, 2001, BIOCHEM BIOPH RES CO, V284, P411, DOI 10.1006/bbrc.2001.4898; Spiro AS, 2010, J TRAUMA, V69, P1473, DOI 10.1097/TA.0b013e3181dc59e4; Suh DY, 2002, SPINE, V27, P353, DOI 10.1097/00007632-200202150-00006; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Vaidya R, 2007, EUR SPINE J, V16, P1257, DOI 10.1007/s00586-007-0351-9; Vaidya R, 2008, J SPINAL DISORD TECH, V21, P557, DOI 10.1097/BSD.0b013e31815ea897; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Wong DA, 2008, SPINE J, V8, P1011, DOI 10.1016/j.spinee.2007.06.014; Wosczyna MN, 2012, J BONE MINER RES, V27, P1004, DOI 10.1002/jbmr.1562; Yoshii T, 2009, J ORTHOP RES, V27, P1, DOI 10.1002/jor.20630; Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002	64	52	58	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116462	10.1371/journal.pone.0116462	http://dx.doi.org/10.1371/journal.pone.0116462			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659106	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900041
J	Chaudhary, N; Sharma, AK; Agarwal, P; Gupta, A; Sharma, VK				Chaudhary, Nikhil; Sharma, Ashok K.; Agarwal, Piyush; Gupta, Ankit; Sharma, Vineet K.			16S Classifier: A Tool for Fast and Accurate Taxonomic Classification of 16S rRNA Hypervariable Regions in Metagenomic Datasets	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; IDENTIFICATION; SEQUENCES; RESOURCE; DATABASE; SEARCH	The diversity of microbial species in a metagenomic study is commonly assessed using 16S rRNA gene sequencing. With the rapid developments in genome sequencing technologies, the focus has shifted towards the sequencing of hypervariable regions of 16S rRNA gene instead of full length gene sequencing. Therefore, 16S Classifier is developed using a machine learning method, Random Forest, for faster and accurate taxonomic classification of short hypervariable regions of 16S rRNA sequence. It displayed precision values of up to 0.91 on training datasets and the precision values of up to 0.98 on the test dataset. On real metagenomic datasets, it showed up to 99.7% accuracy at the phylum level and up to 99.0% accuracy at the genus level. 16S Classifier is available freely at http://metagenomics.iiserb.ac.in/16Sclassifier and http://metabiosys.iiserb.ac.in/16Sclassifier.	[Chaudhary, Nikhil; Sharma, Ashok K.; Agarwal, Piyush; Gupta, Ankit; Sharma, Vineet K.] Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Metagen & Syst Biol Grp, MetaInformat Lab, Bhopal, Madhya Pradesh, India; [Agarwal, Piyush] Indian Inst Sci Educ & Res Bhopal, Dept Phys, Bhopal, Madhya Pradesh, India	Indian Institute of Science Education & Research (IISER) - Bhopal; Indian Institute of Science Education & Research (IISER) - Bhopal	Sharma, VK (corresponding author), Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Metagen & Syst Biol Grp, MetaInformat Lab, Bhopal, Madhya Pradesh, India.	vineetks@iiserb.ac.in	Agarwal, Piyush/B-7443-2017; Sharma, Ashok K/X-1149-2018; Sharma, Ashok Kumar/AAU-7623-2020	Agarwal, Piyush/0000-0001-7485-7531; Sharma, Ashok K/0000-0002-2264-7628; Sharma, Ashok Kumar/0000-0002-2264-7628; K. Sharma, Vineet/0000-0002-2958-6215	intramural funding received from Indian Institute of Science Education and Research Bhopal (IISER Bhopal)	intramural funding received from Indian Institute of Science Education and Research Bhopal (IISER Bhopal)	This work was supported by the intramural funding received from Indian Institute of Science Education and Research Bhopal (IISER Bhopal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Aravindraja C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076724; Biau G, 2012, J MACH LEARN RES, V13, P1063; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Claesson Marcus J, 2010, Nucleic Acids Res, V38, pe200, DOI 10.1093/nar/gkq873; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; D'Argenio V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/325340; Desai A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060204; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fuhrman Jed A, 2012, F1000 Biol Rep, V4, P15, DOI 10.3410/B4-15; Gupta A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093907; Hao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049785; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Jonasson J, 2002, APMIS, V110, P263, DOI 10.1034/j.1600-0463.2002.100309.x; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mitra S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S17; Mizrahi-Man O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053608; Mullan Lisa J, 2002, Brief Bioinform, V3, P92, DOI 10.1093/bib/3.1.92; Panov P., 2007, COMBINING BAGGING RA; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; QUNFENG D, 2012, METAGENOMICS; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; ZHANG J, 2006, IEEE; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	42	45	47	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116106	10.1371/journal.pone.0116106	http://dx.doi.org/10.1371/journal.pone.0116106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646627	Green Submitted, gold, Green Published			2022-12-27	WOS:000348822600019
J	Garay, T; Kenessey, I; Molnar, E; Juhasz, E; Reti, A; Laszlo, V; Rozsas, A; Dobos, J; Dome, B; Berger, W; Klepetko, W; Tovari, J; Timar, J; Hegedus, B				Garay, Tamas; Kenessey, Istvan; Molnar, Eszter; Juhasz, Eva; Reti, Andrea; Laszlo, Viktoria; Rozsas, Anita; Dobos, Judit; Doeme, Balazs; Berger, Walter; Klepetko, Walter; Tovari, Jozsef; Timar, Jozsef; Hegedus, Balazs			Prenylation Inhibition-Induced Cell Death in Melanoma: Reduced Sensitivity in BRAF Mutant/PTEN Wild-Type Melanoma Cells	PLOS ONE			English	Article							ZOLEDRONIC ACID; IN-VITRO; SIGNALING PATHWAYS; CANCER-CELLS; N-RAS; BISPHOSPHONATE PAMIDRONATE; METASTATIC MELANOMA; GENETIC ALTERATIONS; INDUCED APOPTOSIS; POTENT INHIBITOR	While targeted therapy brought a new era in the treatment of BRAF mutant melanoma, therapeutic options for non-BRAF mutant cases are still limited. In order to explore the antitumor activity of prenylation inhibition we investigated the response to zoledronic acid treatment in thirteen human melanoma cell lines with known BRAF, NRAS and PTEN mutational status. Effect of zoledronic acid on proliferation, clonogenic potential, apoptosis and migration of melanoma cells as well as the activation of downstream elements of the RAS/RAF pathway were investigated in vitro with SRB, TUNEL and PARP cleavage assays and videomicroscopy and immunoblot measurements, respectively. Subcutaneous and spleen-to-liver colonization xenograft mouse models were used to evaluate the influence of zoledronic acid treatment on primary and disseminated tumor growth of melanoma cells in vivo. Zoledronic acidmore efficiently decreased short-term in vitro viability in NRAS mutant cells when compared to BRAF mutant and BRAF/NRAS wild-type cells. In line with this finding, following treatment decreased activation of ribosomal protein S6 was found in NRAS mutant cells. Zoledronic acid demonstrated no significant synergism in cell viability inhibition or apoptosis induction with cisplatin or DTIC treatment in vitro. Importantly, zoledronic acid could inhibit clonogenic growth in the majority of melanoma cell lines except in the three BRAFmutant but PTEN wild-type melanoma lines. A similar pattern was observed in apoptosis induction experiments. In vivo zoledronic acid did not inhibit the subcutaneous growth or spleen-to-liver colonization of melanoma cells. Altogether our data demonstrates that prenylation inhibition may be a novel therapeutic approach in NRASmutant melanoma. Nevertheless, we also demonstrated that therapeutic sensitivity might be influenced by the PTEN status of BRAF mutant melanoma cells. However, further investigations are needed to identify drugs that have appropriate pharmacological properties to efficiently target prenylation in melanoma cells.	[Garay, Tamas; Kenessey, Istvan; Molnar, Eszter; Juhasz, Eva; Reti, Andrea; Timar, Jozsef] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary; [Garay, Tamas; Rozsas, Anita; Doeme, Balazs] Natl Koranyi Inst TB & Pulmonol, Budapest, Hungary; [Garay, Tamas] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Laszlo, Viktoria; Rozsas, Anita; Doeme, Balazs; Klepetko, Walter; Hegedus, Balazs] Med Univ Vienna, Dept Thorac Surg, Vienna, Austria; [Dobos, Judit; Tovari, Jozsef] Natl Inst Oncol, Dept Expt Pharmacol, Budapest, Hungary; [Doeme, Balazs] Semmelweis Univ, Natl Inst Oncol, Dept Thorac Surg, H-1085 Budapest, Hungary; [Berger, Walter] Med Univ Vienna, Inst Canc Res, Vienna, Austria; [Berger, Walter] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria; [Timar, Jozsef; Hegedus, Balazs] Hungarian Acad Sci, MTA SE Mol Oncol Res Grp, Budapest, Hungary	Semmelweis University; Eotvos Lorand University; Medical University of Vienna; National Institute of Oncology Hungary; National Institute of Oncology Hungary; Semmelweis University; Medical University of Vienna; Medical University of Vienna; Hungarian Academy of Sciences	Hegedus, B (corresponding author), Med Univ Vienna, Dept Thorac Surg, Vienna, Austria.	balazs.hegedus@meduniwien.ac.at	laszlo, viktoria/A-4667-2017; Hegedus, Balazs/B-6076-2008	laszlo, viktoria/0000-0002-6567-3965; Hegedus, Balazs/0000-0002-4341-4153; Dome, Balazs/0000-0001-8799-8624; Berger, Walter/0000-0003-0014-1658	TAMOP [4.2.1/B-09/1/MKR-2010-0001]; National Innovation Office INNO [08-3-2009-0248]; Hungarian Science Foundation (OTKA) MOB [80325, PD109580]; OTKA [CNK77649, K84173]; National Development Agency-NFU KTIA AIK [12-12013-0041]; Herzfelder'schen Familienstiftung, Vienna; Osterreichischer Austauschdienst; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	TAMOP; National Innovation Office INNO; Hungarian Science Foundation (OTKA) MOB; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency-NFU KTIA AIK; Herzfelder'schen Familienstiftung, Vienna; Osterreichischer Austauschdienst; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was financially supported by TAMOP 4.2.1/B-09/1/MKR-2010-0001, the National Innovation Office INNO 08-3-2009-0248, the Hungarian Science Foundation (OTKA) MOB 80325, PD109580, OTKA CNK77649, K84173 and the National Development Agency-NFU KTIA AIK 12-12013-0041 research grants and by the Herzfelder'schen Familienstiftung, Vienna. BH was a Magyary Zoltan postdoctoral fellow. GT acknowledges the Ernst Mach fellowship from the Osterreichischer Austauschdienst. IK is a recipient of Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN D, 1992, J LIPID RES, V33, P1657; Aparicio A, 1998, LEUKEMIA, V12, P220, DOI 10.1038/sj.leu.2400892; Appels NMGM, 2005, ONCOLOGIST, V10, P565, DOI 10.1634/theoncologist.10-8-565; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Berger W, 1997, INT J CANCER, V71, P108, DOI 10.1002/(SICI)1097-0215(19970328)71:1<108::AID-IJC18>3.0.CO;2-E; Blum R, 2005, DRUG RESIST UPDATE, V8, P369, DOI 10.1016/j.drup.2005.11.002; Blum R, 2008, RECENT PAT ANTI-CANC, V3, P31; Blum R, 2007, CANCER RES, V67, P3320, DOI 10.1158/0008-5472.CAN-06-4287; Budman DR, 2006, ONCOLOGY-BASEL, V70, P147, DOI 10.1159/000093006; Buzzeo R, 2005, CLIN CANCER RES, V11, P6057, DOI 10.1158/1078-0432.CCR-04-2685; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Chen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042598; Collisson EA, 2003, CANCER RES, V63, P5669; Corey E, 2003, CLIN CANCER RES, V9, P295; Cremers SCLM, 2005, CLIN PHARMACOKINET, V44, P551, DOI 10.2165/00003088-200544060-00001; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Demunter A, 2001, J INVEST DERMATOL, V117, P1483, DOI 10.1046/j.0022-202x.2001.01601.x; Derenne S, 1999, J BONE MINER RES, V14, P2048, DOI 10.1359/jbmr.1999.14.12.2048; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Egozi Y, 1999, INT J CANCER, V80, P911, DOI 10.1002/(SICI)1097-0215(19990315)80:6<911::AID-IJC18>3.0.CO;2-4; Fabbri F, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-43; Forsea AM, 2004, BRIT J CANCER, V91, P803, DOI 10.1038/sj.bjc.6602052; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Garay T, 2013, EXP CELL RES, V319, P3094, DOI 10.1016/j.yexcr.2013.08.018; Goel VK, 2006, J INVEST DERMATOL, V126, P154, DOI 10.1038/sj.jid.5700026; Guenther A, 2010, INT J CANCER, V126, P239, DOI 10.1002/ijc.24758; Haapajarvi T, 1999, CELL GROWTH DIFFER, V10, P163; Haluska FG, 2006, CLIN CANCER RES, V12, p2301S, DOI 10.1158/1078-0432.CCR-05-2518; Hegedus B, 2004, J NEURO-ONCOL, V67, P147, DOI 10.1023/B:NEON.0000021826.73020.f3; Hegedus B, 2000, J NEUROSURG, V92, P428, DOI 10.3171/jns.2000.92.3.0428; Houben Roland, 2004, J Carcinog, V3, P6, DOI 10.1186/1477-3163-3-6; Iguchi T, 2003, CELL SIGNAL, V15, P719, DOI 10.1016/S0898-6568(03)00007-X; Jagdev SP, 2001, BRIT J CANCER, V84, P1126, DOI 10.1054/bjoc.2001.1727; Ji ZY, 2012, TRENDS MOL MED, V18, P27, DOI 10.1016/j.molmed.2011.08.001; Kloog Y, 2004, SEMIN CANCER BIOL, V14, P253, DOI 10.1016/j.semcancer.2004.04.004; Kumar R, 2003, CLIN CANCER RES, V9, P3362; LADANYI A, 1990, INT J CANCER, V46, P456, DOI 10.1002/ijc.2910460322; Ladanyi Andrea, 2001, Pathology and Oncology Research, V7, P260; Lazar V, 2009, MODERN PATHOL, V22, P1367, DOI 10.1038/modpathol.2009.109; Lee MV, 2001, CANCER RES, V61, P2602; Lerner EC, 1997, ONCOGENE, V15, P1283, DOI 10.1038/sj.onc.1201296; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Mathieu V, 2009, J CELL MOL MED, V13, P3960, DOI 10.1111/j.1582-4934.2009.00708.x; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; MUELLER BM, 1991, CANCER RES, V51, P2193; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Neville-Webbe HL, 2005, INT J CANCER, V113, P364, DOI 10.1002/ijc.20602; Niessner H, 2011, J INVEST DERMATOL, V131, P468, DOI 10.1038/jid.2010.297; Nikolaou VA, 2012, J INVEST DERMATOL, V132, P854, DOI 10.1038/jid.2011.421; Nissan MH, 2014, CANCER RES, V74, P2340, DOI 10.1158/0008-5472.CAN-13-2625; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Peng HJ, 2007, CANCER RES, V67, P9346, DOI 10.1158/0008-5472.CAN-06-4508; Posch C, 2013, P NATL ACAD SCI USA, V110, P4015, DOI 10.1073/pnas.1216013110; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Raz T, 2007, BLOOD, V110, P2102, DOI 10.1182/blood-2006-12-064907; Riebeling C, 2002, BRIT J CANCER, V87, P366, DOI 10.1038/sj.bjc.6600476; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Sebti SM, 2000, ONCOGENE, V19, P6584, DOI 10.1038/sj.onc.1204146; Senaratne SG, 2000, BRIT J CANCER, V82, P1459, DOI 10.1054/bjoc.1999.1131; Shipman CM, 1997, BRIT J HAEMATOL, V98, P665, DOI 10.1046/j.1365-2141.1997.2713086.x; Smalley KSM, 2003, INT J CANCER, V105, P165, DOI 10.1002/ijc.11064; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Sonnemann J, 2001, ANTI-CANCER DRUG, V12, P459, DOI 10.1097/00001813-200106000-00007; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Srinivasan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008283; Stachnik A, 2014, P NATL ACAD SCI USA, DOI [10.1073/pnas.1421566112, DOI 10.1073/PNAS.1421566112]; Tassone P, 2003, BRIT J CANCER, V88, P1971, DOI 10.1038/sj.bjc.6600986; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; van Beek E, 1999, BIOCHEM BIOPH RES CO, V264, P108, DOI 10.1006/bbrc.1999.1499; Weiss HM, 2008, DRUG METAB DISPOS, V36, P2043, DOI 10.1124/dmd.108.021071; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Yuen T, 2014, P NATL ACAD SCI USA, DOI [10.1073/pnas.1421566112, DOI 10.1073/PNAS.1421566112]	77	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117021	10.1371/journal.pone.0117021	http://dx.doi.org/10.1371/journal.pone.0117021			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646931	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000348822600049
J	Tsai, HC; Lin, YC; Ko, CL; Lou, HY; Chen, TL; Tam, KW; Chen, CY				Tsai, Hsiao-Chien; Lin, Yu-Cih; Ko, Ching-Lung; Lou, Horng-Yuan; Chen, Ta-Liang; Tam, Ka-Wai; Chen, Chien-Yu			Propofol versus Midazolam for Upper Gastrointestinal Endoscopy in Cirrhotic Patients: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							TRADITIONAL SEDATIVE AGENTS; NURSE-ADMINISTERED PROPOFOL; OUTPATIENT COLONOSCOPY; COMPARING PROPOFOL; PROTEIN-BINDING; PHARMACOKINETICS; ENCEPHALOPATHY; MEPERIDINE; QUALITY	Background Sedation during gastrointestinal endoscopy is often achieved using propofol or midazolam in general population. However, impaired protein synthesis, altered drug metabolism, and compromised hepatic blood flow in patients with liver cirrhosis might affect the pharmacokinetics of sedatives, placing cirrhotic patients undergoing endoscopy at a greater risk of adverse events. The objective of this study was to assess comparative efficacies and safety of propofol and midazolam in cirrhotic patients undergoing endoscopy. Methods Randomized, controlled trials comparing propofol with midazolam in cirrhotic patients undergoing gastrointestinal endoscopy were selected. We performed the meta-analysis, using a random-effect model, the Review Manager, Version 5.2, statistical software package (Cochrane Collaboration, Oxford, UK) according to the PRISMA guidelines. Results Five studies between 2003 and 2012, including 433 patients, were included. Propofol provided a shorter time to sedation (weight mean difference: -2.76 min, 95% confidence interval: -3.00 to -2.51) and a shorter recovery time (weight mean difference -6.17 min, 95% confidence interval: -6.81 to -5.54) than midazolam did. No intergroup difference in the incidence of hypotension, bradycardia, or hypoxemia was observed. Midazolam was associated with the deterioration of psychometric scores for a longer period than propofol. Conclusion This meta-analysis suggests that Propofol sedation for endoscopy provides more rapid sedation and recovery than midazolam does. The risk of sedation-related side effects for propofol does not differ significantly from that of midazolam. The efficacy of propofol in cirrhotic patients undergoing endoscopy is superior to those of midazolam.	[Tsai, Hsiao-Chien; Lin, Yu-Cih; Ko, Ching-Lung; Chen, Ta-Liang; Chen, Chien-Yu] Taipei Med Univ, Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Lin, Yu-Cih] Taipei Med Univ, Coll Nursing, Grad Inst Nursing, Taipei, Taiwan; [Lou, Horng-Yuan] Taipei Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Chen, Ta-Liang] Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Tam, Ka-Wai] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Gen Surg, New Taipei City, Taiwan; [Tam, Ka-Wai] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan; [Tam, Ka-Wai] Taipei Med Univ, Ctr Evidence Based Med, Taipei, Taiwan; [Tam, Ka-Wai] Taipei Med Univ, Shuang Ho Hosp, Ctr Evidence Based Hlth Care, New Taipei City, Taiwan; [Chen, Chien-Yu] Taipei Med Univ, Grad Inst Human Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University	Tam, KW (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Gen Surg, New Taipei City, Taiwan.	kelvintam@h.tmu.edu.tw; jonathan630514@yahoo.com.tw	Chen, Chien-Yu/AAR-8724-2021	Chen, Chien-Yu/0000-0001-5895-9941; Ko, Ching-Lung/0000-0003-0057-5616				Agrawal A, 2012, J GASTROEN HEPATOL, V27, P1726, DOI 10.1111/j.1440-1746.2012.07231.x; ALLONEN H, 1981, CLIN PHARMACOL THER, V30, P653, DOI 10.1038/clpt.1981.217; CARLSSON U, 1995, ENDOSCOPY, V27, P240, DOI 10.1055/s-2007-1005678; CHERNIK DA, 1990, J CLIN PSYCHOPHARM, V10, P244; Chin N. M., 1992, Singapore Medical Journal, V33, P478; Cohen LB, 2006, AM J GASTROENTEROL, V101, P967, DOI 10.1111/j.1572-0241.2006.00500.x; Correia LM, 2011, GASTROINTEST ENDOSC, V73, P45, DOI 10.1016/j.gie.2010.09.025; Costela JL, 1996, ACTA ANAESTH SCAND, V40, P741, DOI 10.1111/j.1399-6576.1996.tb04521.x; DANESHMEND TK, 1991, GUT, V32, P12, DOI 10.1136/gut.32.1.12; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DeWitt J, 2008, GASTROINTEST ENDOSC, V68, P499, DOI 10.1016/j.gie.2008.02.092; Froehlich F, 2006, ENDOSCOPY, V38, P461, DOI 10.1055/s-2006-925368; Higgins JPT, 2008, COCHRANE HDB SYSTEMA, Vxxi, DOI [10.1002/14651858.CD004741.pub2, DOI 10.1002/14651858.CD004741.PUB2]; Khamaysi I, 2011, J HEPATOL, V54, P72, DOI 10.1016/j.jhep.2010.06.023; Kiriyama S, 2010, J GASTROENTEROL, V45, P831, DOI 10.1007/s00535-010-0222-8; Meining A, 2007, ENDOSCOPY, V39, P345, DOI 10.1055/s-2006-945195; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Oei-Lim VLB, 1998, EUR J ANAESTH, V15, P535, DOI 10.1046/j.1365-2346.1998.00349.x; PATTERSON KW, 1991, BRIT J ANAESTH, V67, P108, DOI 10.1093/bja/67.1.108; Qadeer MA, 2005, CLIN GASTROENTEROL H, V3, P1049, DOI 10.1016/S1542-3565(05)00742-1; Riphaus A, 2009, SCAND J GASTROENTERO, V44, P1244, DOI 10.1080/00365520903194591; SERVIN F, 1990, BRIT J ANAESTH, V65, P177, DOI 10.1093/bja/65.2.177; Servin F, 1988, Anaesthesia, V43 Suppl, P23, DOI 10.1111/j.1365-2044.1988.tb09063.x; SERVIN F, 1988, ANESTHESIOLOGY, V69, P887, DOI 10.1097/00000542-198812000-00014; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Sipe BW, 2002, GASTROINTEST ENDOSC, V55, P815, DOI 10.1067/mge.2002.124636; SMITH MT, 1981, EUR J CLIN PHARMACOL, V19, P271, DOI 10.1007/BF00562804; Suh SJ, 2014, KOREAN J INTERN MED, V29, P57, DOI 10.3904/kjim.2014.29.1.57; Ulmer BJ, 2003, CLIN GASTROENTEROL H, V1, P425, DOI 10.1016/S1542-3565(03)00226-X; Wang DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053311; Wang DR, 2013, SCAND J GASTROENTERO, V48, P101, DOI 10.3109/00365521.2012.737360; Weston BR, 2003, AM J GASTROENTEROL, V98, P2440, DOI 10.1016/S0002-9270(03)01701-5; Wu J, 2013, YONSEI MED J, V54, P231, DOI 10.3349/ymj.2013.54.1.231	33	29	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117585	10.1371/journal.pone.0117585	http://dx.doi.org/10.1371/journal.pone.0117585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646815	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600075
J	Knudsen, ML; Ljungberg, K; Tatoud, R; Weber, J; Esteban, M; Liljestrom, P				Knudsen, Maria L.; Ljungberg, Karl; Tatoud, Roger; Weber, Jonathan; Esteban, Mariano; Liljestrom, Peter			Alphavirus Replicon DNA Expressing HIV Antigens Is an Excellent Prime for Boosting with Recombinant Modified Vaccinia Ankara (MVA) or with HIV gp140 Protein Antigen	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; T-CELL RESPONSES; CLADE-C; DENDRITIC CELLS; IMMUNOGENICITY; IMMUNIZATION; INTERFERON; INDUCTION; ELECTROPORATION; IMMUNODOMINANCE	Vaccination with DNA is an attractive strategy for induction of pathogen-specific T cells and antibodies. Studies in humans have shown that DNA vaccines are safe, but their immunogenicity needs further improvement. As a step towards this goal, we have previously demonstrated that immunogenicity is increased with the use of an alphavirus DNA-launched replicon (DREP) vector compared to conventional DNA vaccines. In this study, we investigated the effect of varying the dose and number of administrations of DREP when given as a prime prior to a heterologous boost with poxvirus vector (MVA) and/or HIV gp140 protein formulated in glucopyranosyl lipid A (GLA-AF) adjuvant. The DREP and MVA vaccine constructs encoded Env and a Gag-Pol-Nef fusion protein from HIV clade C. One to three administrations of 0.2 mu g DREP induced lower HIV-specific T cell and IgG responses than the equivalent number of immunizations with 10 mu g DREP. However, the two doses were equally efficient as a priming component in a heterologous prime-boost regimen. The magnitude of immune responses depended on the number of priming immunizations rather than the dose. A single low dose of DREP prior to a heterologous boost resulted in greatly increased immune responses compared to MVA or protein antigen alone, demonstrating that a mere 0.2 mu g DREP was sufficient for priming immune responses. Following a DREP prime, T cell responses were expanded greatly by an MVA boost, and IgG responses were also expanded when boosted with protein antigen. When MVA and protein were administered simultaneously following multiple DREP primes, responses were slightly compromised compared to administering them sequentially. In conclusion, we have demonstrated efficient priming of HIV-specific T cell and IgG responses with a low dose of DREP, and shown that the priming effect depends on number of primes administered rather than dose.	[Knudsen, Maria L.; Ljungberg, Karl; Liljestrom, Peter] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Tatoud, Roger; Weber, Jonathan] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, Div Med, London, England; [Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain	Karolinska Institutet; Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Knudsen, ML (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	maria.knudsen@ki.se; peter.liljestrom@ki.se	Esteban, Mariano/ABG-5375-2020	Esteban, Mariano/0000-0003-0846-2827; TATOUD, Roger/0000-0002-3999-8264; Ljungberg, Karl/0000-0001-7192-6204; Liljestrom, Peter/0000-0002-2132-0981	Swedish Research Council; UK HIV Vaccine Consortium (HVC) Programme; Wellcome. GENEART AG (Regensburg, Germany) [EP1240333B1]; National Institute for Health Research [NF-SI-0513-10093] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); UK HIV Vaccine Consortium (HVC) Programme; Wellcome. GENEART AG (Regensburg, Germany); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Swedish Research Council (www.vr.se) and by the UK HIV Vaccine Consortium (HVC; www.ukhvc.org) Programme. The CN54 env and ZM96 gag-pol-nef (DNA-C) plasmids were developed as part of the UK HVC. The UK HVC is funded by an award from the Wellcome. GENEART AG (Regensburg, Germany) owns a European Patent EP1240333B1 covering the complete clade C/B' HIV-1 97CN54 coding sequence and codon optimized genes used for the creation of the DREP-C CN54. The 96ZM651-8 clone construct used as a template to build the DREP-C ZM96 candidate vaccine is the property of the University of Alabama at Birmingham Research Foundation (UABRF; www.uab.edu/uabrf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA Y, 1984, CANCER RES, V44, P5127; Akram A, 2012, CLIN IMMUNOL, V143, P99, DOI 10.1016/j.clim.2012.01.015; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Arias MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041144; Barry G, 2010, J VIROL, V84, P7369, DOI 10.1128/JVI.02310-09; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Berglund P, 1998, NAT BIOTECHNOL, V16, P562, DOI 10.1038/nbt0698-562; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Brave A, 2006, VACCINE, V24, P4524, DOI 10.1016/j.vaccine.2005.08.018; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; De Filette M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087837; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Excler JL, 2014, CLIN VACCINE IMMUNOL, V21, P1023, DOI 10.1128/CVI.00230-14; Excler JL, 2014, HUM VACC IMMUNOTHER, V10, P1734, DOI 10.4161/hv.28462; Glasgow GM, 1997, J GEN VIROL, V78, P1559, DOI 10.1099/0022-1317-78-7-1559; Graw F, 2014, J VIROL, V88, P10134, DOI 10.1128/JVI.00647-14; Hallengard D, 2014, J VIROL, V88, P13333, DOI 10.1128/JVI.01926-14; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Hanke T, 1998, VACCINE, V16, P439, DOI 10.1016/S0264-410X(97)00226-0; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Hariharan MJ, 1998, J VIROL, V72, P950, DOI 10.1128/JVI.72.2.950-958.1998; Hidmark AS, 2005, J VIROL, V79, P10376, DOI 10.1128/JVI.79.16.10376-10385.2005; Hidmark AS, 2006, J VIROL, V80, P7100, DOI 10.1128/JVI.02579-05; Johansson DX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029732; Knudsen ML, 2014, METHODS MOL BIOL, V1121, P147, DOI 10.1007/978-1-4614-9632-8_13; Knudsen ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065964; Knudsen ML, 2012, J VIROL, V86, P4082, DOI 10.1128/JVI.06535-11; Knudsen ML, 2014, J VIROL, V88, P12438, DOI 10.1128/JVI.02223-14; Littel-van den Hurk SV, 2010, EXPERT REV VACCINES, V9, P503, DOI [10.1586/erv.10.42, 10.1586/ERV.10.42]; Liu JY, 2006, J VIROL, V80, P11991, DOI 10.1128/JVI.01348-06; Ljungberg K, 2014, EXPERT REV VACCINES, P1; Ljungberg K, 2007, J VIROL, V81, P13412, DOI 10.1128/JVI.01799-07; Lux A, 2010, ANN RHEUM DIS, V69, P92, DOI 10.1136/ard.2009.117101; McKay PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084707; Muthumani K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084234; Naslund TI, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-36; Nkolola JP, 2014, VACCINE, V32, P2109, DOI 10.1016/j.vaccine.2014.02.001; Nordstrom EKL, 2005, J GEN VIROL, V86, P349, DOI 10.1099/vir.0.80481-0; Paris RM, 2010, EXPERT REV VACCINES, V9, P1055, DOI 10.1586/ERV.10.106; Pattacini L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042163; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Wang SX, 2006, VIROLOGY, V350, P34, DOI 10.1016/j.virol.2006.02.032; Wijesundara DK, 2011, IMMUNOL CELL BIOL, V89, P367, DOI 10.1038/icb.2010.118; Wild J, 2009, VIRAL IMMUNOL, V22, P309, DOI 10.1089/vim.2009.0038	51	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117042	10.1371/journal.pone.0117042	http://dx.doi.org/10.1371/journal.pone.0117042			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643354	Green Published, gold, Green Submitted			2022-12-27	WOS:000348821200032
J	Ramesh, BP; Sethi, RJ; Yu, H				Ramesh, Balaji Polepalli; Sethi, Ricky J.; Yu, Hong			Figure-Associated Text Summarization and Evaluation	PLOS ONE			English	Article							BIOMEDICAL LITERATURE; FULL-TEXT; RETRIEVAL; DATABASE; IMAGES	Biomedical literature incorporates millions of figures, which are a rich and important knowledge resource for biomedical researchers. Scientists need access to the figures and the knowledge they represent in order to validate research findings and to generate new hypotheses. By themselves, these figures are nearly always incomprehensible to both humans and machines and their associated texts are therefore essential for full comprehension. The associated text of a figure, however, is scattered throughout its full-text article and contains redundant information content. In this paper, we report the continued development and evaluation of several figure summarization systems, the FigSum+ systems, that automatically identify associated texts, remove redundant information, and generate a text summary for every figure in an article. Using a set of 94 annotated figures selected from 19 different journals, we conducted an intrinsic evaluation of FigSum+. We evaluate the performance by precision, recall, F1, and ROUGE scores. The best FigSum+ system is based on an unsupervised method, achieving F1 score of 0.66 and ROUGE-1 score of 0.97. The annotated data is available at figshare.com (http://figshare.com/articles/Figure_Associated_Text_Summarization_and_Evaluation/858903).	[Ramesh, Balaji Polepalli; Sethi, Ricky J.; Yu, Hong] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01655 USA; [Yu, Hong] Univ Massachusetts, Sch Comp Sci, Amherst, MA 01003 USA; [Yu, Hong] VA Cent Western Massachusetts, Leeds, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Amherst	Yu, H (corresponding author), Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01655 USA.	Hong.Yu@umassmed.edu	PADAMATI, RameshBabu/AAI-4589-2020; Sethi, Ricky J/B-5229-2013	PADAMATI, RameshBabu/0000-0003-0102-0049; Sethi, Ricky J/0000-0001-5254-3750	start-up fund from University of Massachusetts Medical School; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000161];  [1R01GM095476]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095476] Funding Source: NIH RePORTER	start-up fund from University of Massachusetts Medical School; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported in part by 1R01GM095476 to Hong Yu, by a start-up fund from University of Massachusetts Medical School to Hong Yu, and by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR000161. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, BIOINFORMATICS, V27, P1723, DOI 10.1093/bioinformatics/btr194; Agarwal Shashank, 2009, AMIA Annu Symp Proc, V2009, P6; Agarwal S, 2009, BIOINFORMATICS, V25, P3174, DOI 10.1093/bioinformatics/btp548; Alegre E, 2009, ELMAR PROC, P65; Aone C, 1999, ADVANCES IN AUTOMATIC TEXT SUMMARIZATION, P71; Bhatia S, 2012, ACM T INFORM SYST, V30, DOI 10.1145/2094072.2094075; Bhattacharya S, 2011, BIOINFORMATICS, V27, pI120, DOI 10.1093/bioinformatics/btr223; Brunn M., 2001, P DOC UND C, P135; Chiang JH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-392; Collobert R, 2011, J MACH LEARN RES, V12, P2493; CONROY JM, 2001, P 24 ANN INT ACM SIG, P406; Conroy John M, 2006, P COLING ACL MAIN C, P152; Demner-Fushman D, 2009, INT J MED INFORM, V78, pE59, DOI 10.1016/j.ijmedinf.2009.05.003; DONAWAY R. L., 2000, P 2000 NAACL ANLPWOR, P69, DOI DOI 10.3115/1117575.1117583; *DUC TASK, 2007, DOCUMENTS FOR SUMMAR, P13897; EDMUNDSON HP, 1969, J ACM, V16, P264, DOI 10.1145/321510.321519; Erkan G, 2004, J ARTIF INTELL RES, V22, P457, DOI 10.1613/jair.1523; FILATOVA E, 2004, PROCEEDINGS OF THE 2, P13897; Fiszman M., 2004, P HLT NAACL WORKSH C, P76, DOI DOI 10.3115/1596431.1596442; Futrelle R.P., 2004, P WORKSH ANN M ASS C, P61; Futrelle RP, 1999, ADVANCES IN AUTOMATIC TEXT SUMMARIZATION, P403; GONG Y, 2001, PROCEEDINGS OF THE 2, P13897; Guglielmo EJ, 1996, ACM T INFORM SYST, V14, P237, DOI 10.1145/230538.230539; Gupta  S., 2007, P 45 ANN M ACL INT P, P193; HAMMOND T, 2008, CHI 08, P3027; HIRAO T, 2002, P 19 INT C COMP LING, P1; Hovy E, 1999, ADVANCES IN AUTOMATIC TEXT SUMMARIZATION, P81; Humphreys BL, 1998, J AM MED INFORM ASSN, V5, P1; Japkowicz N, 2001, MACH LEARN, V42, P97, DOI 10.1023/A:1007660820062; Jeon J., 2003, P ACM SIGIR C RES DE, P119; Jin F, 2009, P WORKSH CURR TRENDS, P97, DOI DOI 10.3115/1572364.1572377; Kekre H. B., 2010, ICGST INT J GRAPHICS, V10, P9; Kupiec Julian, 1995, 18 ANN INT ACM SIGIR, P68, DOI 10.1145/215206.215333; Leskovec J., 2004, LINKKDD WORKSHOP, P133; Lin Chin-Yew, 2004, P ACL TEXT SUMM BRAN, P74, DOI DOI 10.3115/V1/D14-1020; Ling X, 2007, INFORM PROCESS MANAG, V43, P1777, DOI 10.1016/j.ipm.2007.01.018; Lipinski RJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-49; LUHN HP, 1958, IBM J RES DEV, V2, P159, DOI 10.1147/rd.22.0159; MANI I, 2001, AUTOMATIC SUMMARIZAT, V3, P13897, DOI DOI 10.1075/NLP.3; MANI I, 2001, PROCEEDINGS OF THE N, V2, P13897; MIHALCEA R, 2004, PROCEEDINGS OF THE A, P13897; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Muller H, 2004, INT J MED INFORM, V73, P1, DOI 10.1016/j.ijmedinf.2003.11.024; Myaeng SH, 1999, ADVANCES IN AUTOMATIC TEXT SUMMARIZATION, P61; NAKOV PI, 2004, PROCEEDINGS OF THE S, P13897; NENKOVA A, 2011, TUTORIAL ABSTRACTS O, P3; Nenkova A., 2007, ACM T SPEECH LANGUAG, V4, P4, DOI DOI 10.1145/1233912.1233913; NOMOTO T, 1997, PROCEEDINGS OF THE F, P13897; Papineni K, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P311, DOI 10.3115/1073083.1073135; Pastra K, 2003, PROC 2003 EACL WORKS, P35, DOI [10.3115/1641396.1641402, DOI 10.3115/1641396.1641402]; Paulson Brandon, 2008, 13th International Conference on Intelligent User Interfaces. IUI 2008, P1, DOI 10.1145/1378773.1378775; Plaza L, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-71; Plaza L, 2011, ARTIF INTELL MED, V53, P1, DOI 10.1016/j.artmed.2011.06.005; Prasad R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-188; Prochaska JJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2856; Radev D.R., 2003, INT C INF KNOWL MANA, P508; Radev DR, 2003, 41ST ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P375; Radev DR, 2004, INFORM PROCESS MANAG, V40, P919, DOI 10.1016/j.ipm.2003.10.006; REEVE L, 2006, P 21 ANN ACM S APPL, P180; Rowe NC, 1999, LIBR TRENDS, V48, P475; ROWE NC, 1993, EFFICIENT CAPTION BA, P13897; Rui Y, 1998, IEEE T CIRC SYST VID, V8, P644, DOI 10.1109/76.718510; SAGGION H, 2002, PROCEEDINGS OF THE 1, V1, P1, DOI DOI 10.3115/1072228.1072301; Salton G, 1997, INFORM PROCESS MANAG, V33, P193, DOI 10.1016/S0306-4573(96)00062-3; Shang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023862; Smith J. R., 1996, Proceedings ACM Multimedia 96, P87, DOI 10.1145/244130.244151; Swets DL, 1996, IEEE T PATTERN ANAL, V18, P831, DOI 10.1109/34.531802; Tufte E. R., 1991, OPTOMETRY VISION SCI, V68, P322, DOI DOI 10.1097/00006324-199104000-00013; Wang C, 2007, IEEE DECIS CONTR P, P55; Workman TE, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-6; Workman TE, 2010, J MED LIBR ASSOC, V98, P273, DOI 10.3163/1536-5050.98.4.003; Wu P., 2011, P WORKSH TEXT SUMM C, P53; Yarowsky D, 1995, P ACL, P189, DOI [10.3115/981658.981684, DOI 10.3115/981658.981684]; Yeh JY, 2005, INFORM PROCESS MANAG, V41, P75, DOI 10.1016/j.ipm.2004.04.003; Yoo I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S9-S4; Yu Hong, 2006, AMIA Annu Symp Proc, P834; Yu Hong, 2009, J Biomed Discov Collab, V4, P1, DOI 10.1186/1747-5333-4-1; [No title captured]	78	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0115671	10.1371/journal.pone.0115671	http://dx.doi.org/10.1371/journal.pone.0115671			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3QK	25643357	Green Published, gold			2022-12-27	WOS:000348821200012
J	Lion, M; Raimondi, I; Donati, S; Jousson, O; Ciribilli, Y; Inga, A				Lion, Mattia; Raimondi, Ivan; Donati, Stefano; Jousson, Olivier; Ciribilli, Yari; Inga, Alberto			Evolution of p53 Transactivation Specificity through the Lens of a Yeast-Based Functional Assay	PLOS ONE			English	Article							DNA-BINDING DOMAIN; TUMOR-SUPPRESSOR; TRANSCRIPTION FACTOR; STRUCTURAL EVOLUTION; CRYSTAL-STRUCTURES; TARGET; RECOGNITION; MECHANISMS; DIVERSITY; HOMOLOG	Co-evolution of transcription factors (TFs) with their respective cis-regulatory network enhances functional diversity in the course of evolution. We present a new approach to investigate transactivation capacity of sequence-specific TFs in evolutionary studies. Saccharomyces cerevisiae was used as an in vivo test tube and p53 proteins derived from human and five commonly used animal models were chosen as proof of concept. p53 is a highly conserved master regulator of environmental stress responses. Previous reports indicated conserved p53 DNA binding specificity in vitro, even for evolutionary distant species. We used isogenic yeast strains where p53-dependent transactivation was measured towards chromosomally integrated p53 response elements (REs). Ten REs were chosen to sample a wide range of DNA binding affinity and transactivation capacity for human p53 and proteins were expressed at two levels using an inducible expression system. We showed that the assay is amenable to study thermo-sensitivity of frog p53, and that chimeric constructs containing an ectopic transactivation domain could be rapidly developed to enhance the activity of proteins, such as fruit fly p53, that are poorly effective in engaging the yeast transcriptional machinery. Changes in the profile of relative transactivation towards the ten REs were measured for each p53 protein and compared to the profile obtained with human p53. These results, which are largely independent from relative p53 protein levels, revealed widespread evolutionary divergence of p53 transactivation specificity, even between human and mouse p53. Fruit fly and human p53 exhibited the largest discrimination among REs while zebrafish p53 was the least selective.	[Lion, Mattia; Raimondi, Ivan; Donati, Stefano; Ciribilli, Yari; Inga, Alberto] Univ Trento, Ctr Integrat Biol CIBIO, Lab Transcript Networks, Mattarello, Trento, Italy; [Jousson, Olivier] Univ Trento, Ctr Integrat Biol CIBIO, Lab Microbial Genom, Mattarello, Trento, Italy	University of Trento; University of Trento	Inga, A (corresponding author), Univ Trento, Ctr Integrat Biol CIBIO, Lab Transcript Networks, Mattarello, Trento, Italy.	inga@science.unitn.it	Ciribilli, Yari/K-2751-2018; Inga, Alberto/AAC-3815-2022; Jousson, Olivier/S-4397-2019	Ciribilli, Yari/0000-0001-9231-379X; Inga, Alberto/0000-0002-8767-1637; Jousson, Olivier/0000-0003-3344-7194; Raimondi, Ivan/0000-0002-9522-2794; Donati, Stefano/0000-0001-9946-0346	Italian Association for Cancer Research, AIRC [12869]; Pezcoller Foundation Fellowship	Italian Association for Cancer Research, AIRC(Fondazione AIRC per la ricerca sul cancro); Pezcoller Foundation Fellowship	This work was partially supported by the Italian Association for Cancer Research, AIRC (IG #12869 to AI) (www.airc.it/). IR is supported by a Pezcoller Foundation Fellowship (http://www.pezcoller.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Andreotti V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020643; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Beno I, 2011, NUCLEIC ACIDS RES, V39, P1919, DOI 10.1093/nar/gkq1044; Bensaad K, 2003, J BIOL CHEM, V278, P10546, DOI 10.1074/jbc.M208233200; Besaratinia A, 2010, FASEB J, V24, P2612, DOI 10.1096/fj.10-157263; Bisio A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-552; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brandt T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047889; Brandt T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-628; Ciribilli Y, 2013, NUCLEIC ACIDS RES, V41, P8637, DOI 10.1093/nar/gkt657; Cui F, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-2; D'Erchia AM, 2006, CELL CYCLE, V5, P750, DOI 10.4161/cc.5.7.2622; Deutsch GB, 2011, CELL, V144, P566, DOI 10.1016/j.cell.2011.01.013; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Dowell RD, 2010, TRENDS GENET, V26, P468, DOI 10.1016/j.tig.2010.08.005; Espinosa JM, 2008, ONCOGENE, V27, P4013, DOI 10.1038/onc.2008.37; Ethayathulla AS, 2013, J BIOL CHEM, V288, P4744, DOI 10.1074/jbc.M112.408039; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gordon KL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002432; Herzog G, 2012, J BIOL CHEM, V287, P44330, DOI 10.1074/jbc.M112.417980; Horvath MM, 2007, PLOS GENET, V3, P1284, DOI 10.1371/journal.pgen.0030127; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Huyen Y, 2004, STRUCTURE, V12, P1237, DOI 10.1016/j.str.2004.05.007; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; James RS, 2012, J EXP BIOL, V215, P552, DOI 10.1242/jeb.063396; Jegga AG, 2008, P NATL ACAD SCI USA, V105, P944, DOI 10.1073/pnas.0704694105; Joerger AC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000919; Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106; Jordan JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000104; Kennedy BK, 2002, NAT REV MOL CELL BIO, V3, P41, DOI 10.1038/nrm704; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; Lang L, 2000, CELL STRESS CHAPERON, V5, P36, DOI 10.1379/1466-1268(2000)005<0036:SITSEO>2.0.CO;2; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lion M, 2013, CELL CYCLE, V12, P1211, DOI 10.4161/cc.24309; Lozano G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001115; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Maeso I, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0020; Marcel V, 2011, CELL DEATH DIFFER, V18, P1815, DOI 10.1038/cdd.2011.120; Menendez D, 2013, NUCLEIC ACIDS RES, V41, P7286, DOI 10.1093/nar/gkt504; Menendez D, 2010, DISCOV MED, V10, P94; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Mercier PA, 1997, J BIOL CHEM, V272, P14147, DOI 10.1074/jbc.272.22.14147; Micale L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046642; Monti P, 2014, ONCOTARGET, V5, P2116, DOI 10.18632/oncotarget.1845; Nagasawa K, 2013, BIOL OPEN, V2, P1057, DOI 10.1242/bio.20136106; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Ou HD, 2007, EMBO J, V26, P3463, DOI 10.1038/sj.emboj.7601764; Pagano B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076014; Pan YP, 2006, BIOCHEMISTRY-US, V45, P3925, DOI 10.1021/bi052242n; Raimondi I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069152; Reamon-Buettner SM, 2008, HUM MOL GENET, V17, P1397, DOI 10.1093/hmg/ddn027; Resnick MA, 2003, P NATL ACAD SCI USA, V100, P9934, DOI 10.1073/pnas.1633803100; Rubinstein M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0017; Rutkowski R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001131; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIKORSKI RS, 1989, GENETICS, V122, P19; Simeonova I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002731; Storer NY, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001123; Sullivan KD, 2012, BBA-REV CANCER, V1825, P229, DOI 10.1016/j.bbcan.2012.01.004; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Veprintsev DB, 2008, NUCLEIC ACIDS RES, V36, P1589, DOI 10.1093/nar/gkm1040; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wagner GP, 2008, TRENDS ECOL EVOL, V23, P377, DOI 10.1016/j.tree.2008.03.006; Wang B, 2009, P NATL ACAD SCI USA, V106, P14373, DOI 10.1073/pnas.0903284106; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095	74	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0116177	10.1371/journal.pone.0116177	http://dx.doi.org/10.1371/journal.pone.0116177			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668429	Green Published, gold, Green Submitted			2022-12-27	WOS:000349493000006
J	An, YH; Guo, WJ; Li, LN; Xu, CW; Yang, DX; Wang, SS; Lu, YX; Zhang, Q; Zhai, JD; Fan, HX; Qiu, CJ; Qi, J; Chen, Y; Yuan, SJ				An, Yinghong; Guo, Wanjun; Li, Linna; Xu, Chengwang; Yang, Dexuan; Wang, Shanshan; Lu, Yaxin; Zhang, Quan; Zhai, Jiadai; Fan, Hongxia; Qiu, Chuanjiang; Qi, Jie; Chen, Yue; Yuan, Shoujun			Micheliolide Derivative DMAMCL Inhibits Glioma Cell Growth In Vitro and In Vivo	PLOS ONE			English	Article							ADJUVANT TEMOZOLOMIDE; GLIOBLASTOMA CELLS; EFFICACY; TUMOR; PROLIFERATION; RADIOTHERAPY; TEMSIROLIMUS; CONCOMITANT; MODULATION; EXPRESSION	Background There is no highly effective chemotherapy for malignant gliomas to date. We found that dimethylaminomicheliolide (DMAMCL), a selective inhibitor of acute myeloid leukemia (AML) stem/progenitor cells, inhibited the growth of glioma cells. Methods The distribution of DMAMCL in brain was analyzed by an ultraperformance liquid chromatography-mass spectrometry (UPLC-MS/MS) system. The anti-tumor evaluations of DMAMCL in vitro were performed by MTT, FACS and RT-PCR. In vivo, the mixture of C6 cells and matrigel was injected into caudatum, and the anti-tumor activity of DMAMCL was evaluated by tumor growth and rat survival. The toxicity of DMAMCL was evaluated by body weight, daily food intake, hematological or serum biochemical analyses, and histological appearance of tissues. Results The IC50 values of DMAMCL against the C6 and U-87MG cell lines in vitro were 27.18 +/- 1.89 mu M and 20.58 +/- 1.61 mu M, respectively. DAMMCL down-regulated the anti-apoptosis gene Bcl-2 and increased apoptosis in C6 and U-87MG cells in a dose-dependent manner. In a C6 rat tumor model, daily administration of DMAMCL for 21 days reduced the burden of C6 tumors by 60% to 88% compared to controls, and more than doubled the mean lifespan of tumor-bearing rats. Distribution analysis showed that the DMAMCL concentration was higher in the brain than in plasma. Evaluations for toxicity revealed that oral administration of DMAMCL at 200 or 300 mg/kg once a day for 21 days did not result in toxicity. Conclusions These results suggest that DMAMCL is highly promising for the treatment of glioma.	[An, Yinghong] Chinese PLA Air Force Gen Hosp, Clin Lab Ctr, Beijing 100142, Peoples R China; [Guo, Wanjun; Li, Linna; Xu, Chengwang; Yang, Dexuan; Wang, Shanshan; Yuan, Shoujun] Beijing Inst Radiat Med, Dept Pharmacol & Toxicol, Beijing 100850, Peoples R China; [Lu, Yaxin; Zhang, Quan; Zhai, Jiadai; Fan, Hongxia] Nankai Univ, Coll Pharm, State Key Lab Elementoorgan Chem, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300071, Peoples R China; [Lu, Yaxin; Zhang, Quan; Zhai, Jiadai; Fan, Hongxia] Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin 300071, Peoples R China; [Qiu, Chuanjiang; Qi, Jie; Chen, Yue] Accendatech Co Ltd, Tianjin 300384, Peoples R China	Air Force General Hospital PLA; Academy of Military Medical Sciences - China; Nankai University; Nankai University	Chen, Y (corresponding author), Accendatech Co Ltd, Tianjin 300384, Peoples R China.	yuechenayh@163.com; yuansj@nic.bmi.ac.cn	li, li/HII-4157-2022; zhai, jiadai/GZB-1710-2022		National Natural Science Foundation of China (NSFC) [21072106, 21372129, 81001377, 81370086]; Fok Ying Tong Education Foundation [122037]; National Program on Key Basic Research Project [2013CB967200]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fok Ying Tong Education Foundation(Fok Ying Tung Education Foundation); National Program on Key Basic Research Project(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (NSFC) (NO. 21072106 and NO. 21372129 to Y.C., NO. 81001377 and NO. 81370086 to Q.Z.), Fok Ying Tong Education Foundation (No. 122037), and National Program on Key Basic Research Project (No. 2013CB967200).	Abbott N Joan, 2004, Drug Discov Today Technol, V1, P407, DOI 10.1016/j.ddtec.2004.11.014; Anderson KN, 2008, J PHARMACOL SCI, V106, P318, DOI 10.1254/jphs.SC0060164; [Anonymous], 2010, BRAIN SPIN CORD TUM; Carlisi D, 2011, J CELL PHYSIOL, V226, P1632, DOI 10.1002/jcp.22494; Chan S, 2005, J CLIN ONCOL, V23, P5314, DOI 10.1200/JCO.2005.66.130; Chen Y., 2010, [No title captured], Patent No. [201,010,153,701.0, 2010101537010]; Colpo A, 2012, ONCOLOGY-BASEL, V82, P165, DOI 10.1159/000336602; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Dell'Agli M, 2009, BIOORG MED CHEM LETT, V19, P1858, DOI 10.1016/j.bmcl.2009.02.080; Feng MR, 2002, CURR DRUG METAB, V3, P647, DOI 10.2174/1389200023337063; Guo M, 2006, J PHARMACOL EXP THER, V317, P97, DOI 10.1124/jpet.105.097782; Guzman ML, 2007, BLOOD, V110, P4427, DOI 10.1182/blood-2007-05-090621; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Jin P, 2007, AAPS PHARMSCITECH, V8, DOI 10.1208/pt0804105; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Li D, 2012, INT J NANOMED, V7, P6105, DOI 10.2147/IJN.S38927; Mrugala MM, 2013, DISCOV MED, V15, P221; Murphy S, 2007, J NEURO-ONCOL, V85, P181, DOI 10.1007/s11060-007-9406-3; Nagane M, 1998, P NATL ACAD SCI USA, V95, P5724, DOI 10.1073/pnas.95.10.5724; National Cancer Institute, 2010, FDA APPR TEM; Newlands ES, 1997, CANCER TREAT REV, V23, P35, DOI 10.1016/S0305-7372(97)90019-0; Nieto-Sampedro M, 2011, CLIN MED INSIGHTS-ON, V5, P265, DOI 10.4137/CMO.S7685; Sampson JH, 2011, NEURO-ONCOLOGY, V13, P324, DOI 10.1093/neuonc/noq157; Sengupta S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/831090; Strik H, 1999, J NEUROL NEUROSUR PS, V67, P763, DOI 10.1136/jnnp.67.6.763; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun J, 2014, ASIAN PAC J CANCER P, V15, P4897, DOI 10.7314/APJCP.2014.15.12.4897; Tyler B, 2011, NEURO-ONCOLOGY, V13, P700, DOI 10.1093/neuonc/nor050; von Eckardstein K, 2005, J NEURO-ONCOL, V72, P209, DOI 10.1007/s11060-004-3010-6; Wang XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018490; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Zhai JD, 2012, J ORG CHEM, V77, P7103, DOI 10.1021/jo300888s; Zhang Q, 2012, J MED CHEM, V55, P8757, DOI 10.1021/jm301064b	35	41	42	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116202	10.1371/journal.pone.0116202	http://dx.doi.org/10.1371/journal.pone.0116202			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658946	gold, Green Submitted, Green Published			2022-12-27	WOS:000349444900031
J	Cetz-Navarro, NP; Carpizo-Ituarte, EJ; Espinoza-Avalos, J; Chee-Barragan, G				Cetz-Navarro, Neidy P.; Carpizo-Ituarte, Eugenio J.; Espinoza-Avalos, Julio; Chee-Barragan, Guillermina			The Effect of Filamentous Turf Algal Removal on the Development of Gametes of the Coral Orbicella annularis	PLOS ONE			English	Article							GREAT-BARRIER-REEF; REGION-WIDE DECLINES; LONG-TERM DECLINE; MONTASTRAEA-ANNULARIS; SCLERACTINIAN CORALS; SEXUAL REPRODUCTION; CARIBBEAN CORALS; PHASE-SHIFTS; COMPETITION; MACROALGAE	Macroalgae and filamentous turf algae (FTA) are abundant on degraded coral reefs, and the reproductive responses of corals may indicate sub-lethal stress under these conditions. The percentage of gametogenic stages (PGS) and the maximum diameter of eggs (MDE; or egg size) of Orbicella annularis were used to evaluate the effect of long-(7-10 months) and short-term (2.5 months) FTA removal (treatments T1 and T2, respectively) at both the beginning (May) and the end (August) of gametogenesis. Ramets (individual lobes of a colony) surrounded by FTA (T3) or crustose coralline algae (CCA; T4) were used as controls. The removal of FTA enhanced the development of gametes (i.e., a larger and higher percentage of mature gametes (PMG)) of O. annularis for T1 vs. T3 ramets in May and T1 and T2 vs. T3 ramets in August. Similar values of PGS and MDE between gametes from T3 and T4 in both May and August were unexpected because a previous study had shown that the same ramets of T4 (with higher tissue thickness, chlorophyll a cm(-2) and zooxanthellae density and lower mitotic index values) were less stressed than ramets of T3. Evaluating coral stress through reproduction can reveal more sensitive responses than other biological parameters; within reproductive metrics, PGS can be a better stress indicator than egg size. The presence of turf algae strongly impacted the development of gametes and egg size (e.g., PMG in ramets with FTA removal increased almost twofold in comparison with ramets surrounded by FTA in August), most likely exerting negative chronic effects in the long run due to the ubiquity and permanence of turf algae in the Caribbean. These algae can be considered a stressor that affects coral sexual reproduction. Although the effects of turf algae on O. annularis are apparently less severe than those of other stressors, the future of this species is uncertain because of the combined impacts of these effects, the decline of O. annularis populations and the almost complete lack of recruitment.	[Cetz-Navarro, Neidy P.; Espinoza-Avalos, Julio] El Colegio Frontera Sur, Chetmal, Quintana Roo, Mexico; [Cetz-Navarro, Neidy P.] Univ Autonoma Baja California, Fac Ciencias Marinas, Inst Invest Oceanol, Ensenada, Baja California, Mexico; [Carpizo-Ituarte, Eugenio J.; Chee-Barragan, Guillermina] Univ Autonoma Baja California, Inst Invest Oceanol, Ensenada, Baja California, Mexico	El Colegio de la Frontera Sur (ECOSUR); Universidad Autonoma de Baja California; Universidad Autonoma de Baja California	Espinoza-Avalos, J (corresponding author), El Colegio Frontera Sur, Chetmal, Quintana Roo, Mexico.	jespino@ecosur.mx	Espinoza-Avalos, Julio/H-9189-2013	Espinoza-Avalos, Julio/0000-0001-5697-446X; Carpizo-Ituarte, Eugenio/0000-0002-3253-2357	PADI Foundation; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [32985]; ECOES; EI Colegio de la Frontera Sur; Universidad Autonoma de Baja California	PADI Foundation; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ECOES; EI Colegio de la Frontera Sur; Universidad Autonoma de Baja California	NPCN was supported by PADI Foundation (register number 64, 2009), the Consejo Nacional de Ciencia y Tecnologia (CONACYT, PhD Fellowship 32985), and ECOES (a study mobility grant). JEA was supported by federal funds from EI Colegio de la Frontera Sur. ECI was supported by federal funds from the Universidad Autonoma de Baja California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Antonius A, 2001, CORAL REEFS, V19, P418, DOI 10.1007/s003380000126; Armoza-Zvuloni R, 2012, MAR POLLUT BULL, V64, P1556, DOI 10.1016/j.marpolbul.2012.05.020; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; BAK RPM, 1995, B MAR SCI, V56, P609; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Barott KL, 2012, MAR ECOL PROG SER, V460, P1, DOI 10.3354/meps09874; Benzoni F, 2011, MAR BIOL, V158, P2419, DOI 10.1007/s00227-011-1743-2; Blackwood JC, 2012, THEOR ECOL-NETH, V5, P105, DOI 10.1007/s12080-010-0102-0; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Bruckner A. W, 2006, Rev. biol. trop, V54, P45; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Buenau KE, 2012, ECOL MODEL, V237, P23, DOI 10.1016/j.ecolmodel.2012.04.013; Buenau KE, 2011, OIKOS, V120, P941, DOI 10.1111/j.1600-0706.2010.18972.x; Cetz-Navarro NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054810; Cox EF, 2002, MAR POLLUT BULL, V44, P1230, DOI 10.1016/S0025-326X(02)00213-8; Cramer KL, 2012, ECOL LETT, V15, P561, DOI 10.1111/j.1461-0248.2012.01768.x; Cvitanovic C, 2009, CORAL REEFS, V28, P127, DOI 10.1007/s00338-008-0433-0; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DUSTAN P, 1987, CORAL REEFS, V6, P91, DOI 10.1007/BF00301378; Edmunds PJ, 2011, CORAL REEFS, V30, P123, DOI 10.1007/s00338-010-0676-4; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Fong P, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P241, DOI 10.1007/978-94-007-0114-4_17; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Hauri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012685; Hongo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060952; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Humphrey C, 2008, CORAL REEFS, V27, P837, DOI 10.1007/s00338-008-0408-1; Jokiel P. L, 1985, P 5 INT CORAL REEF C, V4, P307; Jompa J, 2003, MAR ECOL PROG SER, V258, P79, DOI 10.3354/meps258079; Jompa J, 2002, J EXP MAR BIOL ECOL, V271, P25, DOI 10.1016/S0022-0981(02)00040-0; KOJIS BL, 1984, CORAL REEFS, V3, P165, DOI 10.1007/BF00301961; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Mendes JM, 2002, MAR ECOL PROG SER, V235, P93, DOI 10.3354/meps235093; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Oren U, 2001, ECOLOGY, V82, P802, DOI 10.2307/2680199; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pante E, 2008, HYDROBIOLOGIA, V596, P121, DOI 10.1007/s10750-007-9062-9; PORTER JW, 1992, AM ZOOL, V32, P625; Quan-Young LI, 2006, LIMNOL OCEANOGR, V51, P1159, DOI 10.4319/lo.2006.51.2.1159; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; River GF, 2001, J EXP MAR BIOL ECOL, V261, P159, DOI 10.1016/S0022-0981(01)00266-0; Rodriguez-Troncoso AP, 2011, MAR BIOL, V158, P2673, DOI 10.1007/s00227-011-1765-9; Rogers CS, 2008, P 11 INT COR REEF S, V7, P226; Sudek M, 2012, CORAL REEFS, V31, P351, DOI 10.1007/s00338-011-0844-1; Szmant AM, 1997, MAR BIOL, V129, P561, DOI 10.1007/s002270050197; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; SZMANT AM, 1991, MAR ECOL PROG SER, V74, P13, DOI 10.3354/meps074013; Szmant-Froelich A, 1985, P 5 INT COR REEF S, V4, P295; SZMANTFROELICH A, 1985, B MAR SCI, V37, P880; TANNER JE, 1995, J EXP MAR BIOL ECOL, V190, P151, DOI 10.1016/0022-0981(95)00027-O; TOMASCIK T, 1987, MAR BIOL, V94, P77, DOI 10.1007/BF00392901; VANVEGHEL MLJ, 1994, MAR ECOL PROG SER, V109, P209, DOI 10.3354/meps109209; Vermeij MJA, 2008, ECOLOGY, V89, P1994, DOI 10.1890/07-1296.1; Ward S, 2000, J EXP MAR BIOL ECOL, V246, P179, DOI 10.1016/S0022-0981(99)00182-3; Ward S, 2002, P 9 INT COR REEF S, V2, P1123; Weil E, 2009, DIS AQUAT ORGAN, V87, P45, DOI 10.3354/dao02103; Wilkinson C, 2013, MAR POLLUT BULL, V70, P7, DOI 10.1016/j.marpolbul.2013.02.040	71	5	6	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117936	10.1371/journal.pone.0117936	http://dx.doi.org/10.1371/journal.pone.0117936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658586	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900244
J	Chen, H; Zheng, DH; Ambadapadi, S; Davids, J; Ryden, S; Samy, H; Bartee, M; Sobel, E; Dai, EB; Liu, LY; Macaulay, C; Yachnis, A; Weyand, C; Thoburn, R; Lucas, A				Chen, Hao; Zheng, Donghang; Ambadapadi, Sriram; Davids, Jennifer; Ryden, Sally; Samy, Hazem; Bartee, Mee; Sobel, Eric; Dai, Erbin; Liu, Liying; Macaulay, Colin; Yachnis, Anthony; Weyand, Cornelia; Thoburn, Robert; Lucas, Alexandra			Serpin Treatment Suppresses Inflammatory Vascular Lesions in Temporal Artery Implants (TAI) from Patients with Giant Cell Arteritis	PLOS ONE			English	Article							FACTOR-XA; RESPONSES; INJURY; COAGULATION; EXPRESSION; INHIBITOR; ADHESION; DISEASE; VESSEL; PAR-2	Giant cell arteritis (GCA) and Takayasu's disease are inflammatory vasculitic syndromes (IVS) causing sudden blindness and widespread arterial obstruction and aneurysm formation. Glucocorticoids and aspirin are mainstays of treatment, predominantly targeting T cells. Serp-1, a Myxomavirus-derived serpin, blocks macrophage and T cells in a wide range of animal models. Serp-1 also reduced markers of myocardial injury in a Phase IIa clinical trial for unstable coronary disease. In recent work, we detected improved survival and decreased arterial inflammation in a mouse Herpesvirus model of IVS. Here we examine Serp-1 treatment of human temporal artery (TA) biopsies from patients with suspected TA GCA arteritis after implant (TAI) into the aorta of immunodeficient SCID (severe combined immunodeficiency) mice. TAI positive for arteritis (GCA(pos)) had significantly increased inflammation and plaque when compared to negative TAI (GCA(neg)). Serp-1 significantly reduced intimal inflammation and CD11b(+) cell infiltrates in TAI, with reduced splenocyte Th1, Th17, and Treg. Splenocytes from mice with GCApos grafts had increased gene expression for interleukin-1beta (IL-1 beta), IL-17, and CD25 and decreased Factor II. Serp-1 decreased IL-1 beta expression. In conclusion, GCA(pos) TAI xenografts in mice provide a viable disease model and have increased intimal inflammation as expected and Serp-1 significantly reduces vascular inflammatory lesions with reduced IL-1 beta.	[Chen, Hao; Zheng, Donghang; Ambadapadi, Sriram; Davids, Jennifer; Ryden, Sally; Bartee, Mee; Sobel, Eric; Dai, Erbin; Liu, Liying; Thoburn, Robert; Lucas, Alexandra] Univ Florida, Dept Med, Gainesville, FL 32611 USA; [Chen, Hao; Zheng, Donghang] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Samy, Hazem; Lucas, Alexandra] Univ Florida, Dept Ophthalmol, Gainesville, FL USA; [Yachnis, Anthony] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Macaulay, Colin; Lucas, Alexandra] Viron Therapeut, London, ON, Canada; [Weyand, Cornelia] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Stanford University	Lucas, A (corresponding author), Univ Florida, Dept Med, Gainesville, FL 32611 USA.	alexandra.lucas@medicine.ufl.edu	Weyand, Cornelia/AAH-3343-2021	Yachnis, Anthony/0000-0002-6971-0698; Chen, Hao/0000-0003-0018-480X; Ambadapadi, Sriram/0000-0001-6542-4259	Ethel Smith Endowed Vasculitis Research Chair [F008570]; National Institutes of Health [1RC1HL100202]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100202, P01HL058000, R01HL117913] Funding Source: NIH RePORTER	Ethel Smith Endowed Vasculitis Research Chair; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the F008570 Ethel Smith Endowed Vasculitis Research Chair and a National Institutes of Health 1RC1HL100202 award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard ELR, 2006, TRANSPLANTATION, V81, P908, DOI 10.1097/01.tp.0000203141.02725.8a; Brack A, 1997, MOL MED, V3, P530, DOI 10.1007/BF03401699; Brack A, 1997, J CLIN INVEST, V99, P2842, DOI 10.1172/JCI119477; Cantini F, 2008, DRUG AGING, V25, P281, DOI 10.2165/00002512-200825040-00002; Chen H, 2013, ANTIMICROB AGENTS CH, V57, P4114, DOI 10.1128/AAC.02594-12; Dai E, 2003, J BIOL CHEM, V278, P18563, DOI 10.1074/jbc.M209683200; Dai EB, 2006, J BIOL CHEM, V281, P8041, DOI 10.1074/jbc.M509454200; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; Deng JS, 2010, CIRCULATION, V121, P906, DOI 10.1161/CIRCULATIONAHA.109.872903; Feinberg HL, 1996, J RHEUMATOL, V23, P1550; Gonzalez-Gay MA, 2001, RHEUM DIS CLIN N AM, V27, P729, DOI 10.1016/S0889-857X(05)70232-5; Guo M, 2011, BLOOD, V117, P936, DOI 10.1182/blood-2010-06-288506; Hoffman GS, 2007, ANN INTERN MED, V146, P621, DOI 10.7326/0003-4819-146-9-200705010-00004; Kaiser B, 2003, CARDIOVASC DRUG REV, V21, P91; Kawasaki A, 2009, ACTA OPHTHALMOL, V87, P13, DOI 10.1111/j.1755-3768.2008.01314.x; Krupa WM, 2002, AM J PATHOL, V161, P1815, DOI 10.1016/S0002-9440(10)64458-6; Krupiczojc MA, 2008, INT J BIOCHEM CELL B, V40, P1228, DOI 10.1016/j.biocel.2008.02.026; Levi M, 2005, TRENDS CARDIOVAS MED, V15, P254, DOI 10.1016/j.tcm.2005.07.004; Munuswamy-Ramanujam G, 2010, THROMB HAEMOSTASIS, V103, P545, DOI 10.1160/TH09-07-0441; Napoli C, 2004, J CLIN PATHOL, V57, P513, DOI 10.1136/jcp.2003.015156; Pryshchep O, 2008, CIRCULATION, V118, P1276, DOI 10.1161/CIRCULATIONAHA.108.789172; Rauch BH, 2004, CIRC RES, V94, P340, DOI 10.1161/01.RES.0000111805.09592.D8; Senden NHM, 1998, J IMMUNOL, V161, P4318; Tardif JC, 2010, CIRC-CARDIOVASC INTE, V3, P543, DOI 10.1161/CIRCINTERVENTIONS.110.953885; Tennant GM, 2008, ATHEROSCLEROSIS, V198, P57, DOI 10.1016/j.atherosclerosis.2007.09.043; vanderVeen, 1996, ANN RHEUM DIS, V55, P490; Weyand CM, 2003, NEW ENGL J MED, V349, P160, DOI 10.1056/NEJMra022694; Weyand CM, 2002, ARTHRITIS RHEUM, V46, P457, DOI 10.1002/art.10071; Weyand CM, 1999, ARTHRITIS RHEUM-US, V42, P844, DOI 10.1002/1529-0131(199905)42:5<844::AID-ANR2>3.0.CO;2-M; Weyand CM, 2008, CURR OPIN LIPIDOL, V19, P469, DOI 10.1097/MOL.0b013e32830bfdc2	30	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115482	10.1371/journal.pone.0115482	http://dx.doi.org/10.1371/journal.pone.0115482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658487	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900018
J	Diouf, F; Diouf, D; Klonowska, A; Le Quere, A; Bakhoum, N; Fall, D; Neyra, M; Parrinello, H; Diouf, M; Ndoye, I; Moulin, L				Diouf, Fatou; Diouf, Diegane; Klonowska, Agnieszka; Le Quere, Antoine; Bakhoum, Niokhor; Fall, Dioumacor; Neyra, Marc; Parrinello, Hugues; Diouf, Mayecor; Ndoye, Ibrahima; Moulin, Lionel			Genetic and Genomic Diversity Studies of Acacia Symbionts in Senegal Reveal New Species of Mesorhizobium with a Putative Geographical Pattern	PLOS ONE			English	Article							RHIZOBIAL POPULATIONS; PHYLOGENETIC ANALYSES; NITROGEN-FIXATION; HOST-RANGE; SALT; SALINITY; STRAINS; SOILS; L.; STRESS	Acacia senegal (L) Willd. and Acacia seyal Del. are highly nitrogen-fixing and moderately salt tolerant species. In this study we focused on the genetic and genomic diversity of Acacia mesorhizobia symbionts from diverse origins in Senegal and investigated possible correlations between the genetic diversity of the strains, their soil of origin, and their tolerance to salinity. We first performed a multi-locus sequence analysis on five markers gene fragments on a collection of 47 mesorhizobia strains of A. senegal and A. seyal from 8 localities. Most of the strains (60%) clustered with the M. plurifarium type strain ORS 1032(T), while the others form four new clades (MSP1 to MSP4). We sequenced and assembled seven draft genomes: four in the M. plurifarium clade (ORS3356, ORS3365, STM8773 and ORS1032T), one in MSP1 (STM8789), MSP2 (ORS3359) and MSP3 (ORS3324). The average nucleotide identities between these genomes together with the MLSA analysis reveal three new species of Mesorhizobium. A great variability of salt tolerance was found among the strains with a lack of correlation between the genetic diversity of mesorhizobia, their salt tolerance and the soils samples characteristics. A putative geographical pattern of A. senegal symbionts between the dryland north part and the center of Senegal was found, reflecting adaptations to specific local conditions such as the water regime. However, the presence of salt does not seem to be an important structuring factor of Mesorhizobiumspecies.	[Diouf, Fatou; Diouf, Diegane; Bakhoum, Niokhor; Fall, Dioumacor; Ndoye, Ibrahima] Univ Cheikh Anta DIOP Dakar, Ctr Rech Bel Air, Fac Sci & Tech, Dept Biol Vegetal,Lab Commun Microbiol IRD ISRA U, Dakar, Senegal; [Diouf, Fatou; Diouf, Diegane; Bakhoum, Niokhor; Ndoye, Ibrahima; Moulin, Lionel] Lab Mixte Int Adaptat Plantes & Microorganismes A, Dakar, Senegal; [Diouf, Fatou; Klonowska, Agnieszka; Moulin, Lionel] IRD, Lab Symbioses Trop & Mediterraneennes, Montpellier, France; [Le Quere, Antoine] Lab Mixte Int Biotechnol Microbienne & Vegetale L, Rabat, Morocco; [Fall, Dioumacor; Diouf, Mayecor] Inst Senegalais Rech Agr, Dakar, Senegal; [Neyra, Marc] Irstea, UR MALY, Ctr Lyon Villeurbanne, Villeurbanne, France; [Parrinello, Hugues] MGX Montpellier GenomiX, Inst Genom Fonct, Montpellier, France	University Cheikh Anta Diop Dakar; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; Universite de Montpellier	Moulin, L (corresponding author), Lab Mixte Int Adaptat Plantes & Microorganismes A, Dakar, Senegal.	lionel.moulin@ird.fr	Le Quere, antoine/GOH-0137-2022; Moulin, Lionel/C-2921-2008	Le Quere, antoine/0000-0001-7470-5730; Moulin, Lionel/0000-0001-9068-6912; Klonowska, Agnieszka/0000-0003-3325-7980	Institute of Research for Development (IRD); IRD (PEERS grant "RhizAdap"); Joint International Laboratory on adaptation of plants and associated microorganisms to environmental stresses (LMI LAPSE); Institute of Agronomic Research in Senegal (ISRA)	Institute of Research for Development (IRD); IRD (PEERS grant "RhizAdap"); Joint International Laboratory on adaptation of plants and associated microorganisms to environmental stresses (LMI LAPSE); Institute of Agronomic Research in Senegal (ISRA)	FD was funded by PhD grant from Institute of Research for Development (IRD, www.ird.fr). The study was funded by IRD (PEERS grant "RhizAdap") and the Joint International Laboratory on adaptation of plants and associated microorganisms to environmental stresses (LMI LAPSE, http://en.lapse.ird.fr/) and the Institute of Agronomic Research in Senegal (ISRA, www.isra.sn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Assaf S, 2007, FOOD HYDROCOLLOID, V21, P319, DOI 10.1016/j.foodhyd.2006.04.011; Alexandre A, 2008, INT J SYST EVOL MICR, V58, P2839, DOI 10.1099/ijs.0.2008/001636-0; Arora NK, 2006, WORLD J MICROB BIOT, V22, P603, DOI 10.1007/s11274-005-9077-1; Ba S, 2002, SYST APPL MICROBIOL, V25, P130, DOI 10.1078/0723-2020-00091; Bakhoum N, 2012, WORLD J MICROB BIOT, V28, P2567, DOI 10.1007/s11274-012-1066-6; Barbiero L, 2004, CATENA, V58, P101, DOI 10.1016/j.catena.2004.03.003; Chen WM, 2011, INT J SYST EVOL MICR, V61, P574, DOI 10.1099/ijs.0.022947-0; de la Pena TC, 2012, AGRON SUSTAIN DEV, V32, P65, DOI 10.1007/s13593-011-0024-2; de Lacerda CF, 2005, ENVIRON EXP BOT, V54, P69, DOI 10.1016/j.envexpbot.2004.06.004; de Lajudie P, 1998, INT J SYST BACTERIOL, V48, P369, DOI 10.1099/00207713-48-2-369; Deloger M, 2009, J BACTERIOL, V191, P91, DOI 10.1128/JB.01202-08; Diouf D, 2005, FUNCT PLANT BIOL, V32, P1143, DOI 10.1071/FP04069; Diouf D, 2010, J APPL MICROBIOL, V108, P818, DOI 10.1111/j.1365-2672.2009.04500.x; Diouf D, 2007, MICROB ECOL, V54, P553, DOI 10.1007/s00248-007-9243-0; Dommergues YR, 1995, FERT RES, V42, P215, DOI 10.1007/BF00750516; Elboutahiri N, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-15; Fall D, 2008, LETT APPL MICROBIOL, V47, P85, DOI 10.1111/j.1472-765X.2008.02389.x; Fernandez-Aunion C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-192; Gaunt MW, 2001, INT J SYST EVOL MICR, V51, P2037, DOI 10.1099/00207713-51-6-2037; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Hoque MS, 2011, INT J SYST EVOL MICR, V61, P299, DOI 10.1099/ijs.0.021014-0; Lorite MJ, 2010, SYST APPL MICROBIOL, V33, P282, DOI 10.1016/j.syapm.2010.03.006; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; LAL B, 1994, WORLD J MICROB BIOT, V10, P637, DOI 10.1007/BF00327949; Laranjo M, 2008, FEMS MICROBIOL ECOL, V66, P391, DOI 10.1111/j.1574-6941.2008.00584.x; Laranjo M, 2014, MICROBIOL RES, V169, P2, DOI 10.1016/j.micres.2013.09.012; Laranjo M, 2011, ANTON LEEUW INT J G, V99, P651, DOI 10.1007/s10482-010-9539-9; Lorite MJ, 2010, APPL ENVIRON MICROB, V76, P4019, DOI 10.1128/AEM.02555-09; Lortet G, 1996, MOL PLANT MICROBE IN, V9, P736, DOI 10.1094/MPMI-9-0736; Lu YL, 2009, INT J SYST EVOL MICR, V59, P3012, DOI 10.1099/ijs.0.007393-0; Martens M, 2007, INT J SYST EVOL MICR, V57, P489, DOI 10.1099/ijs.0.64344-0; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Midgley JJ, 2001, J TROP ECOL, V17, P871, DOI 10.1017/S026646740100164X; Mishra RPN, 2012, FEMS MICROBIOL ECOL, V79, P487, DOI 10.1111/j.1574-6941.2011.01235.x; Motlagh S, 2006, FOOD HYDROCOLLOID, V20, P848, DOI 10.1016/j.foodhyd.2005.08.007; Moulin L, 2004, MOL PHYLOGENET EVOL, V30, P720, DOI 10.1016/S1055-7903(03)00255-0; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Nandasena KG, 2009, INT J SYST EVOL MICR, V59, P2140, DOI 10.1099/ijs.0.005728-0; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; NORMAND P, 1992, GENE, V111, P119, DOI 10.1016/0378-1119(92)90612-S; Odee DW, 2002, SOIL BIOL BIOCHEM, V34, P801, DOI 10.1016/S0038-0717(02)00009-3; Op den Camp RHM, 2012, MOL PLANT MICROBE IN, V25, P954, DOI 10.1094/MPMI-11-11-0304; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Qadir M, 2002, LAND DEGRAD DEV, V13, P275, DOI 10.1002/ldr.504; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Sarr A, 2005, MICROB ECOL, V50, P152, DOI 10.1007/s00248-004-0077-8; Shamseldin A, 2005, CURR MICROBIOL, V50, P11, DOI 10.1007/s00284-004-4391-7; Singh G, 2009, LAND DEGRAD DEV, V20, P367, DOI 10.1002/ldr.933; Stepkowski T, 2003, SYST APPL MICROBIOL, V26, P483, DOI 10.1078/072320203770865765; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047677; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thrall PH, 2008, J ECOL, V96, P746, DOI 10.1111/j.1365-2745.2008.01381.x; Thrall PH, 2009, AUSTRAL ECOL, V34, P950, DOI 10.1111/j.1442-9993.2009.01998.x; Thrall PH, 2005, J APPL ECOL, V42, P740, DOI 10.1111/j.1365-2664.2005.01058.x; Turner SL, 2002, FEMS MICROBIOL ECOL, V42, P227, DOI 10.1111/j.1574-6941.2002.tb01012.x; Turner SL, 2000, MOL BIOL EVOL, V17, P309, DOI 10.1093/oxfordjournals.molbev.a026311; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; van Asten PJA, 2003, AGR WATER MANAGE, V60, P13, DOI 10.1016/S0378-3774(02)00155-5; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Vincent JM., 1970, MANUAL PRATICAL STUD; Vinuesa P, 2005, SYST APPL MICROBIOL, V28, P702, DOI 10.1016/j.syapm.2005.05.007; Vriezen JAC, 2007, APPL ENVIRON MICROB, V73, P3451, DOI 10.1128/AEM.02991-06; Wade TK, 2014, SYST APPL MICROBIOL, V37, P129, DOI 10.1016/j.syapm.2013.10.002; Wang ET, 2003, ARCH MICROBIOL, V180, P444, DOI 10.1007/s00203-003-0610-z; Wang SM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-440; Wei GH, 2008, PEDOSPHERE, V18, P102, DOI 10.1016/S1002-0160(07)60108-8; Wei GH, 2007, CHEM BIODIVERS, V4, P893, DOI 10.1002/cbdv.200790077; Weir BS, 2004, APPL ENVIRON MICROB, V70, P5980, DOI 10.1128/AEM.70.10.5980-5987.2004; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999; ZOU N, 1995, SOIL BIOL BIOCHEM, V27, P409, DOI 10.1016/0038-0717(95)98611-Q	75	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117667	10.1371/journal.pone.0117667	http://dx.doi.org/10.1371/journal.pone.0117667			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658650	Green Published, gold			2022-12-27	WOS:000349444900199
J	Karblane, K; Gerassimenko, J; Nigul, L; Piirsoo, A; Smialowska, A; Vinkel, K; Kylsten, P; Ekwall, K; Swoboda, P; Truve, E; Sarmiento, C				Kaerblane, Kairi; Gerassimenko, Jelena; Nigul, Lenne; Piirsoo, Alla; Smialowska, Agata; Vinkel, Kadri; Kylsten, Per; Ekwall, Karl; Swoboda, Peter; Truve, Erkki; Sarmiento, Cecilia			ABCE1 Is a Highly Conserved RNA Silencing Suppressor	PLOS ONE			English	Article							L INHIBITOR; C-ELEGANS; CAENORHABDITIS-ELEGANS; PROTEIN INTERACTS; INTERFERING RNA; RISC ACTIVATION; GENE; TRANSLATION; PATHWAY; BIOGENESIS	ATP-binding cassette sub-family E member 1 (ABCE1) is a highly conserved protein among eukaryotes and archaea. Recent studies have identified ABCE1 as a ribosome-recycling factor important for translation termination in mammalian cells, yeast and also archaea. Here we report another conserved function of ABCE1. We have previously described AtRLI2, the homolog of ABCE1 in the plant Arabidopsis thaliana, as an endogenous suppressor of RNA silencing. In this study we show that this function is conserved: human ABCE1 is able to suppress RNA silencing in Nicotiana benthamiana plants, in mammalian HEK293 cells and in the worm Caenorhabditis elegans. Using co-immunoprecipitation and mass spectrometry, we found a number of potential ABCE1-interacting proteins that might support its function as an endogenous suppressor of RNA interference. The interactor candidates are associated with epigenetic regulation, transcription, RNA processing and mRNA surveillance. In addition, one of the identified proteins is translin, which together with its binding partner TRAX supports RNA interference.	[Kaerblane, Kairi; Gerassimenko, Jelena; Nigul, Lenne; Piirsoo, Alla; Vinkel, Kadri; Truve, Erkki; Sarmiento, Cecilia] Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia; [Kaerblane, Kairi; Gerassimenko, Jelena; Truve, Erkki; Sarmiento, Cecilia] Competence Ctr Canc Res, Tallinn, Estonia; [Smialowska, Agata; Kylsten, Per; Ekwall, Karl] Sodertorn Univ Coll, Sch Life Sci, S-14189 Huddinge, Sweden; [Smialowska, Agata; Ekwall, Karl; Swoboda, Peter] Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden	Tallinn University of Technology; Competence Centre for Cancer Research; Sodertorn University; Karolinska Institutet	Sarmiento, C (corresponding author), Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia.	cecilia.sarmiento@ttu.ee	Mõttus, Jelena/AAC-9357-2020; SARMIENTO, Cecilia/G-6291-2016; Piirsoo, Alla/G-5890-2017	Mõttus, Jelena/0000-0001-5573-0623; SARMIENTO, Cecilia/0000-0002-8011-1370; Swoboda, Peter/0000-0001-6416-8572; Ekwall, Karl/0000-0002-3029-4041; Karblane, Kairi/0000-0002-1418-2760	EU through the European Regional Development Fund [EU30013]; Estonian Ministry of Education and Research [IUT 193]; Swedish Foundation for Baltic and East European Studies [300501]	EU through the European Regional Development Fund; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Swedish Foundation for Baltic and East European Studies	This work was supported by the EU through the European Regional Development Fund (to Centre of Excellence ENVIRON and to Competence Center for Cancer Research via Enterprise Estonia grant EU30013) and by institutional research funding IUT 193 of the Estonian Ministry of Education and Research and by the Swedish Foundation for Baltic and East European Studies (grant 300501 to PK, PS and KE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandalakshmi R, 2000, SCIENCE, V290, P142, DOI 10.1126/science.290.5489.142; Andersen DS, 2007, J BIOL CHEM, V282, P14752, DOI 10.1074/jbc.M701361200; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Barthelme D, 2011, P NATL ACAD SCI USA, V108, P3228, DOI 10.1073/pnas.1015953108; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Becker T, 2012, NATURE, V482, P501, DOI 10.1038/nature10829; Bendahmane A, 2002, PLANT J, V32, P195, DOI 10.1046/j.1365-313X.2002.01413.x; BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; Bisbal C, 2007, BIOCHIMIE, V89, P789, DOI 10.1016/j.biochi.2007.02.006; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chen WX, 2008, VIRUS RES, V133, P250, DOI 10.1016/j.virusres.2008.01.011; Chen ZQ, 2006, J BIOL CHEM, V281, P7452, DOI 10.1074/jbc.M510603200; Christie M, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00099; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Dumesic PA, 2013, RNA BIOL, V10, P1653, DOI 10.4161/rna.26800; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Estevez AM, 2004, MOL BIOCHEM PARASIT, V133, P137, DOI 10.1016/j.molbiopara.2003.09.009; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gy I, 2007, PLANT CELL, V19, P3451, DOI 10.1105/tpc.107.055319; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hamilton CM, 1996, P NATL ACAD SCI USA, V93, P9975, DOI 10.1073/pnas.93.18.9975; Hopfner KP, 2012, BIOL CHEM, V393, P1079, DOI 10.1515/hsz-2012-0196; Incarbone M, 2013, TRENDS PLANT SCI, V18, P382, DOI 10.1016/j.tplants.2013.04.001; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kerr ID, 2004, BIOCHEM BIOPH RES CO, V315, P166, DOI 10.1016/j.bbrc.2004.01.044; Khoshnevis S, 2010, EMBO REP, V11, P214, DOI 10.1038/embor.2009.272; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Maloverjan A, 2010, J BIOL CHEM, V285, P30079, DOI 10.1074/jbc.M110.133991; Maloverjan A, 2010, EXP CELL RES, V316, P627, DOI 10.1016/j.yexcr.2009.10.018; Maloveryan A, 2007, J CELL COMMUN SIGNAL, V1, P165, DOI 10.1007/s12079-007-0014-y; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Melnyk CW, 2011, CURR BIOL, V21, P1678, DOI 10.1016/j.cub.2011.08.065; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Nurenberg E, 2013, TRENDS BIOCHEM SCI, V38, P64, DOI 10.1016/j.tibs.2012.11.003; Olspert A, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-19; Olspert A, 2011, J GEN VIROL, V92, P445, DOI 10.1099/vir.0.026476-0; Pisarev AV, 2010, MOL CELL, V37, P196, DOI 10.1016/j.molcel.2009.12.034; Popova B, 2006, NUCLEIC ACIDS RES, V34, P773, DOI 10.1093/nar/gkj465; R Core Team, 2018, R LANG ENV STAT COMP; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Sarmiento C, 2006, PLANT MOL BIOL, V61, P153, DOI 10.1007/s11103-005-0001-8; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuetz S, 2006, VIROLOGY, V344, P151, DOI 10.1016/j.virol.2005.09.034; Shoemaker CJ, 2011, P NATL ACAD SCI USA, V108, pE1392, DOI 10.1073/pnas.1113956108; Szittya G, 2002, PLANT CELL, V14, P359, DOI 10.1105/tpc.010366; Szittya G, 2003, EMBO J, V22, P633, DOI 10.1093/emboj/cdg74; Thomas MF, 2014, TRENDS GENET, V30, P298, DOI 10.1016/j.tig.2014.05.003; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xu S KW, 1997, FIRELAB 1997 VECTOR; Yarunin A, 2005, EMBO J, V24, P580, DOI 10.1038/sj.emboj.7600540; Ye XC, 2011, NAT STRUCT MOL BIOL, V18, P650, DOI 10.1038/nsmb.2032; Zhuang JJ, 2012, PARASITOLOGY, V139, P560, DOI 10.1017/S0031182011001788	59	11	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116702	10.1371/journal.pone.0116702	http://dx.doi.org/10.1371/journal.pone.0116702			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659154	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900060
J	Moilanen, LJ; Hamalainen, M; Lehtimaki, L; Nieminen, RM; Moilanen, E				Moilanen, Lauri J.; Hamalainen, Mari; Lehtimaki, Lauri; Nieminen, Riina M.; Moilanen, Eeva			Urate Crystal Induced Inflammation and Joint Pain Are Reduced in Transient Receptor Potential Ankyrin 1 Deficient Mice - Potential Role for Transient Receptor Potential Ankyrin 1 in Gout	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; ANKLE JOINT; A1 TRPA1; MODEL; HYPERALGESIA; EXPRESSION; CALCIUM; STIMULATION; MECHANISMS; ARTHRITIS	Introduction In gout, monosodium urate (MSU) crystals deposit intra-articularly and cause painful arthritis. In the present study we tested the hypothesis that Transient Receptor Poten-tial Ankyrin 1 (TRPA1), an ion channel mediating nociceptive signals and neurogenic in-flammation, is involved in MSU crystal-induced responses in gout by utilizing three experi-mental murine models. Methods The effects of selective pharmacological inhibition (by HC-030031) and genetic depletion of TRPA1 were studied in MSU crystal-induced inflammation and pain by using 1) spontaneous weight-bearing test to assess MSU crystal-induced joint pain, 2) subcutaneous air-pouch model resembling joint inflammation to measure MSU crystal-induced cytokine production and inflammatory cell accumulation, and 3) MSU crystal-induced paw edema to assess acute vascular inflammatory responses and swelling. Results Intra-articularly injected MSU crystals provoked spontaneous weight shift off from the affected limb in wild type but not in TRPA1 knock-out mice referring alleviated joint pain in TRPA1 deficient animals. MSU crystal-induced inflammatory cell infiltration and accumulation of cytokines MCP-1, IL-6, IL-1beta, MPO, MIP-1alpha and MIP-2 into subcu-taneous air-pouch (resembling joint cavity) was attenuated in TRPA1 deficient mice and in mice treated with the selective TRPA1 inhibitor HC-030031 as compared to control animals. Further, HC-030031 treated and TRPA1 deficient mice developed tempered inflammatory edema when MSU crystals were injected into the paw. Conclusions TRPA1 mediates MSU crystal-induced inflammation and pain in experimental models supporting the role of TRPA1 as a potential mediator and a drug target in gout flare.	[Moilanen, Eeva] Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland	Tampere University; Tampere University; Tampere University Hospital	Moilanen, E (corresponding author), Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland.	eeva.moilanen@uta.fi		Lehtimaki, Lauri/0000-0003-1586-4998; Hamalainen, Mari/0000-0002-6409-3758	Medical Research Fund of Tampere University Hospital, Tampere, Finland; Tampere Tuberculosis Foundation, Tampere, Finland; Finnish Medical Society Duodecim, Finland; Tampereen Reumayhdistys Patient Organization for Rheumatoid Arthritis, Tampere, Finland	Medical Research Fund of Tampere University Hospital, Tampere, Finland; Tampere Tuberculosis Foundation, Tampere, Finland; Finnish Medical Society Duodecim, Finland; Tampereen Reumayhdistys Patient Organization for Rheumatoid Arthritis, Tampere, Finland	The study was supported by grants from Medical Research Fund of Tampere University Hospital, Tampere, Finland; Tampere Tuberculosis Foundation, Tampere, Finland; The Finnish Medical Society Duodecim, Finland and Tampereen Reumayhdistys Patient Organization for Rheumatoid Arthritis, Tampere, Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andrade EL, 2012, PHARMACOL THERAPEUT, V133, P189, DOI 10.1016/j.pharmthera.2011.10.008; [Anonymous], 2003, ASSAY INTRACELLULAR; Atoyan R, 2009, J INVEST DERMATOL, V129, P2312, DOI 10.1038/jid.2009.58; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Capasso R, 2012, BRIT J PHARMACOL, V165, P1966, DOI 10.1111/j.1476-5381.2011.01703.x; CODERRE TJ, 1987, PAIN, V28, P379, DOI 10.1016/0304-3959(87)90072-8; de Oliveira C, 2014, J NEUROSCI, V34, P4445, DOI 10.1523/JNEUROSCI.5387-13.2014; DeBerry JJ, 2014, PAIN, V155, P1280, DOI 10.1016/j.pain.2014.03.023; del Camino D, 2010, J NEUROSCI, V30, P15165, DOI 10.1523/JNEUROSCI.2580-10.2010; DENKO CW, 1976, J RHEUMATOL, V3, P54; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Fernandes ES, 2012, BRIT J PHARMACOL, V166, P510, DOI 10.1111/j.1476-5381.2012.01851.x; Forrest MJ, 1988, HDB ANIMAL MODELS RH, P125; Graepel R, 2011, J PHARMACOL EXP THER, V337, P117, DOI 10.1124/jpet.110.172403; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hatano N, 2012, J BIOL CHEM, V287, P31962, DOI 10.1074/jbc.M112.361139; Jain A, 2011, PAIN, V152, P2765, DOI 10.1016/j.pain.2011.08.025; Jakobsson PJ, 2010, NAT REV RHEUMATOL, V6, P679, DOI 10.1038/nrrheum.2010.175; Jaquemar D, 1999, J BIOL CHEM, V274, P7325, DOI 10.1074/jbc.274.11.7325; Kim MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089062; Koivisto A, 2014, BASIC CLIN PHARMACOL, V114, P50, DOI 10.1111/bcpt.12138; Korhonen R, 2001, BIOCHEM J, V354, P351, DOI 10.1042/0264-6021:3540351; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Lunam CA, 2004, NEUROSCI LETT, V354, P87, DOI 10.1016/S0304-3940(03)00575-5; Moilanen LJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00380; Nassini R, 2014, REV PHYSL BIOCH PHAR; Nilius B, 2012, PFLUG ARCH EUR J PHY, V464, P425, DOI 10.1007/s00424-012-1158-z; OTSUKI T, 1986, BRAIN RES, V365, P235, DOI 10.1016/0006-8993(86)91634-3; Perin-Martins A, 2013, J PERIPHER NERV SYST, V18, P62, DOI 10.1111/jns5.12010; Punzi L, 2012, AUTOIMMUN REV, V12, P66, DOI 10.1016/j.autrev.2012.07.024; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Shi Y, 2010, IMMUNOL REV, V233, P203, DOI 10.1111/j.0105-2896.2009.00851.x; Taylor-Clark TE, 2008, MOL PHARMACOL, V73, P274, DOI 10.1124/mol.107.040832; Torres R, 2009, ANN RHEUM DIS, V68, P1602, DOI 10.1136/ard.2009.109355; Trevisan G, 2014, FREE RADICAL BIO MED, V72, P200, DOI 10.1016/j.freeradbiomed.2014.04.021; Trevisan G, 2013, ARTHRITIS RHEUM-US, V65, P2984, DOI 10.1002/art.38112; Trevisan G, 2013, CANCER RES, V73, P3120, DOI 10.1158/0008-5472.CAN-12-4370; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Zygmunt PM, 2014, HANDB EXP PHARMACOL, V222, P583, DOI 10.1007/978-3-642-54215-2_23	41	36	38	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117770	10.1371/journal.pone.0117770	http://dx.doi.org/10.1371/journal.pone.0117770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658427	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900216
J	Oh, IH; Park, JH; Lee, CH; Park, JS				Oh, Il Hwan; Park, Jung Hwan; Lee, Chang Hwa; Park, Joon-Sung			The Association of Normal Range Glycated Hemoglobin with Restrictive Lung Pattern in the General Population	PLOS ONE			English	Article							VASCULAR COMPLICATIONS; SYSTEMIC INFLAMMATION; PULMONARY-FUNCTION; GAS-EXCHANGE; PREVALENCE; MECHANISMS; MARKER	Glycated hemoglobin (HbA1c) is an important diagnostic indicator of diabetes mellitus, and some authors have argued that it is related to impaired lung function in the diabetic population. However, there was rare study for association between lung function and HbA1c in the non-diabetic population. We investigated whether HbA1c below the diagnostic threshold is related to deficits in lung function. We analyzed biochemical and spirometry data from a nation-wide, population-based, case-control study (the KNHANES IV and V). Eligible as cases were all native Koreans aged 40 years or more with no medical illness. A total of 3670 participants were divided into 4 groups according to HbA1c (%) as follows: Group I (n = 842), >= 4.0 and <= 5.3; Group II (n = 833), >5.3 and <= 5.5; Group III (n = 898), >5.5 and <= 5.7; and Group IV (n = 1097), >5.7 and <= 6.4. Group I had the greatest forced vital capacity (FVC, 96.3 +/- 0.5% pred, P < 0.0001), forced expiratory volume per second (FEV1, 93.8 +/- 0.5% pred, P < 0.0001) and FEV1/FVC (0.792 +/- 0.003, P < 0.0001) compared with the other groups. Linear regression showed that HbA1c was closely related to FVC (beta = -6.972154, P < 0.0001) and FEV1 (beta = -5.591589, P < 0.0001), but not to FEV1/FVC. Logistic regression analysis revealed a significant association between HbA1c and a restrictive spirometric pattern (FVC < 80% pred., FEV1/FVC >= 0.70; OR = 3.772, 95% CI = 1.234-11.53), indicating that elevated HbA1c is closely associated with lung impairment in the non-diabetic population. In the healthy population, relatively high HbA1c level is associated with decrements of FVC and FEV1 and may be a reliable predictor of poor lung function, especially the restrictive pattern.	[Oh, Il Hwan; Park, Jung Hwan; Lee, Chang Hwa; Park, Joon-Sung] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea	Hanyang University	Lee, CH (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea.	changhwa@hanyang.ac.kr; sjpjoon@hanyang.ac.kr	Park, Jung Hwan/AAA-1951-2022	Park, Jung Hwan/0000-0003-3941-4836	fund of Hanyang University [HY-2014-N]	fund of Hanyang University	This work was supported by the research fund of Hanyang University (HY-2014-N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Anandhalakshmi S, 2013, J CLIN DIAGN RES, V7, P1874, DOI 10.7860/JCDR/2013/6550.3339; ASANUMA Y, 1985, Diabetes Research and Clinical Practice, V1, P95, DOI 10.1016/S0168-8227(85)80034-6; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Chung JH, 2014, COPD IN PRESS; Davis TME, 2000, DIABETES RES CLIN PR, V50, P153, DOI 10.1016/S0168-8227(00)00166-2; Ehrlich SF, 2010, DIABETES CARE, V33, P55, DOI 10.2337/dc09-0880; Fogarty AW, 2007, THORAX, V62, P515, DOI 10.1136/thx.2006.066969; Furuya A, 2014, CLIN CHIM ACTA, V436, P93, DOI 10.1016/j.cca.2014.05.005; Ghosh A, 2007, EUR J CLIN NUTR, V61, P412, DOI 10.1038/sj.ejcn.1602534; Goldman MD, 2003, DIABETES CARE, V26, P1915, DOI 10.2337/diacare.26.6.1915; Hancox RJ, 2007, THORAX, V62, P1064, DOI 10.1136/thx.2006.076877; Kalhan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011431; Khaw KT, 2006, CURR OPIN LIPIDOL, V17, P637, DOI 10.1097/MOL.0b013e3280106b95; Kitada M, 2010, J DIABETES INVEST, V1, P77, DOI 10.1111/j.2040-1124.2010.00018.x; Klein OL, 2010, DIABETIC MED, V27, P977, DOI 10.1111/j.1464-5491.2010.03073.x; Lee YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076244; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; McKeever TM, 2005, AM J EPIDEMIOL, V161, P546, DOI 10.1093/aje/kwi076; Milman S, 2011, MED CLIN N AM, V95, P309, DOI 10.1016/j.mcna.2010.11.004; OFULUE AF, 1988, AM REV RESPIR DIS, V138, P284, DOI 10.1164/ajrccm/138.2.284; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pereira LMP, 2013, J THORAC DIS, V5, P289, DOI 10.3978/j.issn.2072-1439.2012.07.06; Sokolov EI, 2008, TERAPEVT ARKH, V80, P63; Steele AM, 2014, JAMA-J AM MED ASSOC, V311, P279, DOI 10.1001/jama.2013.283980; van den Borst B, 2010, CHEST, V138, P393, DOI 10.1378/chest.09-2622; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; VRACKO R, 1979, AM REV RESPIR DIS, V120, P973; Wannamethee SG, 2010, DIABETES CARE, V33, P1990, DOI 10.2337/dc10-0324; Watanabe K, 1997, RESP MED, V91, P406, DOI 10.1016/S0954-6111(97)90254-7; Weynand B, 1999, RESPIRATION, V66, P14, DOI 10.1159/000029331; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yoon JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094125	33	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117725	10.1371/journal.pone.0117725	http://dx.doi.org/10.1371/journal.pone.0117725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658743	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900209
J	Orikiriza, P; Tibenderana, B; Siedner, MJ; Mueller, Y; Byarugaba, F; Moore, CC; Evans, EE; Bonnet, M; Page, AL; Bazira, J; Boum, Y				Orikiriza, Patrick; Tibenderana, Becky; Siedner, Mark J.; Mueller, Yolanda; Byarugaba, Frederick; Moore, Christopher C.; Evans, Emily E.; Bonnet, Maryline; Page, Anne-Laure; Bazira, Joel; Boum, Yap, II			Low Resistance to First and Second Line Anti-Tuberculosis Drugs among Treatment Naive Pulmonary Tuberculosis Patients in Southwestern Uganda	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS	Background There are limited data on region-specific drug susceptibility of tuberculosis (TB) in Uganda. We performed resistance testing on specimens collected from treatment-naive patients with pulmonary TB in Southwestern Uganda for first and second line anti-TB drugs. We sought to provide data to guide regional recommendations for empiric TB therapy. Methods Archived isolates, obtained from patients at Mbarara Regional Referral Hospital from February 2009 to February 2013, were tested for resistance to isoniazid and rifampicin using the MTBDRplus and Xpert MTB/RIF assays. A subset of randomly selected isolates was tested for second line agents, including fluoroquinolones (FQs), aminoglycosides, cyclic peptides, and ethambutol using the MTBDRs/assay. We performed confirmatory testing for FQ resistance using repeated MTBDRs/, the Mycobacteria growth indicator tube (MGIT) assay, and sequencing of the gyrA and gyrB genes. Results We tested isolates from 190 patients. The cohort had a median age of 33 years (IQR 2643), 69% (131/190) were male, and the HIV prevalence was 42% (80/190). No isolates (0/190) were rifampicin-resistant and only 1/190 (0.5%) was isoniazid-resistant. Among 92 isolates tested for second-line drug resistance, 71 (77%) had interpretable results, of which none were resistant to aminoglycosides, cyclic peptides or ethambutol. Although 7 (10%) initially tested as resistant to FQs by the MTBDRs/assay, they were confirmed as susceptible by repeat MTBDRs/testing as well as by MGIT and gyrase gene sequencing. Conclusion We found no MDR-TB and no resistance to ethambutol, FQs, or injectable anti-TB drugs in treatment naive patients with pulmonary TB in Southwestern Uganda. Standard treatment guidelines for susceptible TB should be adequate for most patients with TB in this population. Where possible, molecular susceptibility testing methods should be routinely validated by culture methods.	[Orikiriza, Patrick; Mueller, Yolanda; Boum, Yap, II] Epictr Mbarara Res Ctr, Mbarara, Uganda; [Orikiriza, Patrick; Byarugaba, Frederick; Bazira, Joel; Boum, Yap, II] Mbarara Univ Sci & Technol, Dept Microbiol, Mbarara, Uganda; [Tibenderana, Becky; Moore, Christopher C.] Mbarara Univ Sci & Technol, Dept Med, Mbarara, Uganda; [Siedner, Mark J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Siedner, Mark J.] Harvard Univ, Sch Med, Boston, MA USA; [Moore, Christopher C.; Evans, Emily E.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA; [Bonnet, Maryline; Page, Anne-Laure] Epictr Paris, Paris, France	Mbarara University of Science & Technology; Mbarara University of Science & Technology; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Virginia	Boum, Y (corresponding author), Epictr Mbarara Res Ctr, Mbarara, Uganda.	yap.boum@epicentre.msf.org	Mueller, Yolanda/AAH-3571-2019	Mueller, Yolanda/0000-0002-8861-4538	Office of Global AIDS Coordinator [5R24TW008886]; U.S. Department of Health and Human Services; Health Resources and Services Administration; National Institutes of Health; Pfizer Initiative in International Health; Center for Global Health at the University of Virginia; Pfizer, Inc.; National Institutes of Health [K23 MH099916]; MSF; FOGARTY INTERNATIONAL CENTER [R24TW008886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH099916] Funding Source: NIH RePORTER	Office of Global AIDS Coordinator; U.S. Department of Health and Human Services; Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Initiative in International Health; Center for Global Health at the University of Virginia; Pfizer, Inc.(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSF; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was made possible by Medical Education for Equitable Services to All Ugandans a Medical Education Partnership Initiative grant number 5R24TW008886 from the Office of Global AIDS Coordinator and the U.S. Department of Health and Human Services, Health Resources and Services Administration and National Institutes of Health. Funding for the study was also provided in part by the Pfizer Initiative in International Health and the Center for Global Health at the University of Virginia. This initiative was conceived to fund global infectious disease research and exchange programs between post-doctoral fellows and students from the University of Virginia and several international partners to conduct research on global health issues. The major purpose of this program is to foster and enhance bidirectional research training. An independent board at the University of Virginia determines which research proposals are funded. Pfizer, Inc. provided funds to promote the Initiative but has no role in the planning or execution of research protocols, including the study described in the article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MJS receives support from National Institutes of Health K23 MH099916. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the government. The authors appreciate MSF for funding the studies from which isolates were collected for this sub-study and Uganda Research Student Support Fund (URSSF) for linking the study team.	Bazira J, 2010, BMC CLIN PATHOL, V10, DOI 10.1186/1472-6890-10-5; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Kaswa MK, 2014, J CLIN MICROBIOL, V52, P2876, DOI 10.1128/JCM.00398-14; Lukoye D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070763; Maruri F, 2012, J ANTIMICROB CHEMOTH, V67, P819, DOI 10.1093/jac/dkr566; Ongaya VA, 2012, AFR J HLTH SCI, V20, P77; Organization WH, 2012, WHOHTMTB2012, V6; Uganda MOH, 2010, NAT GUID MAN COMM CO; Umubyeyi A, 2008, INT J INFECT DIS, V12, P152, DOI 10.1016/j.ijid.2007.05.003; van den Boogaard J, 2011, J ANTIMICROB CHEMOTH, V66, P1810, DOI 10.1093/jac/dkr205; Van Deun A, 2013, J CLIN MICROBIOL, DOI [10.1128/JCM.02925-13, DOI 10.1128/JCM.02925-13]; World Health Organization, 2008, MOL LIN PROB ASS RAP	12	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118191	10.1371/journal.pone.0118191	http://dx.doi.org/10.1371/journal.pone.0118191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658921	gold, Green Submitted, Green Published			2022-12-27	WOS:000349444900274
J	Salemi, LM; Loureiro, SO; Schild-Poulter, C				Salemi, Louisa M.; Loureiro, Sandra O.; Schild-Poulter, Caroline			Characterization of RanBPM Molecular Determinants that Control Its Subcellular Localization	PLOS ONE			English	Article							PROLYL ISOMERASE PIN1; NUCLEAR-LOCALIZATION; BINDING-PROTEIN; GID COMPLEX; MICROTUBULE DYNAMICS; CELL-MIGRATION; INTERACTS; TRANSPORT; SIGNALS; HDAC6	RanBPM/RanBP9 is a ubiquitous, nucleocytoplasmic protein that is part of an evolutionary conserved E3 ubiquitin ligase complex whose function and targets in mammals are still unknown. RanBPM itself has been implicated in various cellular processes that involve both nuclear and cytoplasmic functions. However, to date, little is known about how RanBPM subcellular localization is regulated. We have conducted a systematic analysis of RanBPM regions that control its subcellular localization using RanBPM shRNA cells to examine ectopic RanBPM mutant subcellular localization without interference from the endogenously expressed protein. We show that several domains and motifs regulate RanBPM nuclear and cytoplasmic localization. In particular, RanBPM comprises two motifs that can confer nuclear localization, one proline/glutamine-rich motif in the extreme N-terminus which has a dominant effect on RanBPM localization, and a second motif in the C-terminus which minimally contributes to RanBPM nuclear targeting. We also identified a nuclear export signal (NES) which mutation prevented RanBPM accumulation in the cytoplasm. Likewise, deletion of the central RanBPM conserved domains (SPRY and LisH/CTLH) resulted in the relocalization of RanBPM to the nucleus, suggesting that RanBPM cytoplasmic localization is also conferred by protein-protein interactions that promote its cytoplasmic retention. Indeed we found that in the cytoplasm, RanBPM partially colocalizes with microtubules and associates with a-tubulin. Finally, in the nucleus, a significant fraction of RanBPM is associated with chromatin. Altogether, these analyses reveal that RanBPM subcellular localization results from the combined effects of several elements that either confer direct transport through the nucleocytoplasmic transport machinery or regulate it indirectly, likely through interactions with other proteins and by intramolecular folding.	[Schild-Poulter, Caroline] Univ Western Ontario, Robarts Res Inst, Schulich Sch Med & Dent, London, ON, Canada; Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Schild-Poulter, C (corresponding author), Univ Western Ontario, Robarts Res Inst, Schulich Sch Med & Dent, London, ON, Canada.	cschild-poulter@robarts.ca	Schild-Poulter, Caroline/K-4476-2013		Canadian Institutes for Health Research (CIHR) [MOP-114958]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by operating grant [MOP-114958] from the Canadian Institutes for Health Research (CIHR) to CSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atabakhsh E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047803; Atabakhsh E, 2012, AM J CANCER RES, V2, P549; Atabakhsh E, 2009, MOL CANCER RES, V7, P1962, DOI 10.1158/1541-7786.MCR-09-0098; Bala S, 2006, BIOCHEM BIOPH RES CO, V342, P1040, DOI 10.1016/j.bbrc.2006.02.060; Barry DM, 2000, ESSAYS BIOCHEM, V36, P89, DOI 10.1042/bse0360089; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Braun B, 2011, FEBS LETT, V585, P3856, DOI 10.1016/j.febslet.2011.10.038; Brunkhorst A, 2005, MOL CELL NEUROSCI, V29, P250, DOI 10.1016/j.mcn.2005.02.015; Chang LK, 2008, J MOL BIOL, V379, P231, DOI 10.1016/j.jmb.2008.04.011; Cheng L, 2005, J NEUROCHEM, V94, P1102, DOI 10.1111/j.1471-4159.2005.03254.x; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; d'Ydewalle C, 2012, TRAFFIC, V13, P771, DOI 10.1111/j.1600-0854.2012.01347.x; Dansereau DA, 2008, J CELL BIOL, V182, P963, DOI 10.1083/jcb.200711046; de Forges H, 2012, INT J BIOCHEM CELL B, V44, P266, DOI 10.1016/j.biocel.2011.11.009; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; DePristo MA, 2006, GENE, V378, P19, DOI 10.1016/j.gene.2006.03.023; Emes RD, 2001, HUM MOL GENET, V10, P2813, DOI 10.1093/hmg/10.24.2813; Fan G, 2009, CANCER RES, V69, P4589, DOI 10.1158/0008-5472.CAN-08-4117; Fernandez-Montalvan A, 2007, FEBS J, V274, P4256, DOI 10.1111/j.1742-4658.2007.05952.x; Francis O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075217; Gerlitz G, 2005, CELL CYCLE, V4, P1632, DOI 10.4161/cc.4.11.2151; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hosono K, 2010, GENOMICS, V96, P102, DOI 10.1016/j.ygeno.2010.05.003; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ideguchi H, 2002, BIOCHEM J, V367, P87, DOI 10.1042/BJ20011851; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032; Korlimarla A, 2013, CELL MOL BIOL LETT, V18, P284, DOI 10.2478/s11658-013-0088-x; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lakshmana MK, 2010, FASEB J, V24, P119, DOI 10.1096/fj.09-136457; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Marcucci R, 2011, EMBO J, V30, P4211, DOI 10.1038/emboj.2011.303; Mateja A, 2006, J MOL BIOL, V357, P621, DOI 10.1016/j.jmb.2006.01.002; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; Menssen R, 2012, J BIOL CHEM, V287, P25602, DOI 10.1074/jbc.M112.363762; Mikolajczyk M, 2003, BIOCHEM BIOPH RES CO, V310, P14, DOI 10.1016/j.bbrc.2003.08.116; Nishitani H, 2001, GENE, V272, P25, DOI 10.1016/S0378-1119(01)00553-4; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Poirier MB, 2006, J MOL ENDOCRINOL, V36, P313, DOI 10.1677/jme.1.01891; Rao MA, 2002, J BIOL CHEM, V277, P48020, DOI 10.1074/jbc.M209741200; Rowland RRR, 2003, VIRUS RES, V95, P23, DOI 10.1016/S0168-1702(03)00161-8; Salemi LM, 2014, BIOL OPEN, V3, P418, DOI 10.1242/bio.20147021; Santt O, 2008, MOL BIOL CELL, V19, P3323, DOI 10.1091/mbc.E08-03-0328; Sarkari F, 2010, J MOL BIOL, V402, P825, DOI 10.1016/j.jmb.2010.08.017; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Sorg G, 1999, BIOTECHNIQUES, V26, P858, DOI 10.2144/99265bm12; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Torisawa T, 2011, J BIOL CHEM, V286, P1959, DOI 10.1074/jbc.M110.169847; Umeda M, 2003, GENE, V303, P47, DOI 10.1016/S0378-1119(02)01153-8; Valiyaveettil M, 2008, J CELL BIOL, V182, P727, DOI 10.1083/jcb.200801133; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Wang L, 2012, MOL CELL BIOCHEM, V359, P83, DOI 10.1007/s11010-011-1002-3; Wei JD, 2013, J BIOL CHEM, V288, P26753, DOI 10.1074/jbc.M113.470260; Woo JA, 2012, FASEB J, V26, P1672, DOI 10.1096/fj.11-194423; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Yuan Y, 2006, NEUROSCI LETT, V407, P26, DOI 10.1016/j.neulet.2006.06.059; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zou YL, 2003, J BIOL CHEM, V278, P49573, DOI 10.1074/jbc.M307556200; Zuccotti P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052867	67	18	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117655	10.1371/journal.pone.0117655	http://dx.doi.org/10.1371/journal.pone.0117655			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659156	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900195
J	Sharfi, K; Rosenblum, S				Sharfi, Kineret; Rosenblum, Sara			Sensory Modulation and Sleep Quality among Adults with Learning Disabilities: A Quasi-Experimental Case-Control Design Study	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; POOR SLEEP; CHILDREN; DISORDERS; ANXIETY; DEFICIT; LIFE; DIFFICULTIES; DEFINITION; PREVALENCE	Purpose Following the International Classification of Functioning, Disability and Health (ICF) concepts, this study examines body functions such as sensory modulation and sleep quality among adults with learning disabilities (LD). Methods One hundred and ten participants, 55 adults with LD and 55 matched controls (mean age 30 years) filled in a socio-demographic questionnaire, the Adults/Adolescents Sensory Profile (AASP), and the Mini Sleep Questionnaire (MSQ). Chi-tests, Mann-Whitney tests, and Kolmogorov-Smirnov tests were conducted to examine group differences related to socio-demographic characteristics and body functions. Correlation and regression analyses were conducted to examine relationships between body functions. Results Significant differences were found between the groups in: (a) unique socio-demographic variables: high-schools attended, family status and number of children; (b) body functions: low registration and sensory sensitivity (p < .001), sensory avoiding (p = .002), sensory seeking (p = .021) and sleep quality (p < .001). Significant correlations were found between AASP subscale scores and the MSQ final score in each group. Regression analysis revealed that for the entire sample (N = 108), low registration accounted for 10.2% of the variance of sleep quality above group membership (p < .001), while in a separate examination of adults with LD (n = 53), low registration accounted for 19.9% of the variance of sleep quality (p < .001). Conclusions Adults with LD need to be studied through a health-related perspective such as the ICF model to gain further understanding of their unique characteristics and daily needs. Sensory and sleep functions of adults with LD should be further studied in the context of health related quality of life.	[Sharfi, Kineret; Rosenblum, Sara] Univ Haifa, Dept Occupat Therapy, Lab Complex Human Act & Participat, IL-31999 Haifa, Israel	University of Haifa	Sharfi, K (corresponding author), Univ Haifa, Dept Occupat Therapy, Lab Complex Human Act & Participat, IL-31999 Haifa, Israel.	kineretsharfi@gmail.com			Israeli Ministry of Science and Technology	Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel)	This study is funded by the Israeli Ministry of Science and Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn RR, 2004, AM J OCCUP THER, V58, P287, DOI 10.5014/ajot.58.3.287; Alapin I, 2000, J PSYCHOSOM RES, V49, P381, DOI 10.1016/S0022-3999(00)00194-X; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, DOI [10.1016/j.amsu.2013.12.001, DOI 10.1016/J.AMSU.2013.12.001]; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bar-Shalita T, 2008, DEV MED CHILD NEUROL, V50, P932, DOI 10.1111/j.1469-8749.2008.03095.x; Barkley R.A., 1994, ADHD REPORT, V2, P1; Benitez A, 2012, CLIN NEUROPSYCHOL, V26, P214, DOI 10.1080/13854046.2012.658439; Bolge SC, 2009, QUAL LIFE RES, V18, P415, DOI 10.1007/s11136-009-9462-6; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Brown C., 2002, ADULT SENSORY PROFIL; Bruni O, 2009, SLEEP, V32, P1333, DOI 10.1093/sleep/32.10.1333; Bryan T, 2004, LEARN DISABILITY Q, V27, P45, DOI 10.2307/1593631; Cavendish W, 2013, J LEARN DISABIL-US, V46, P52, DOI 10.1177/0022219412464352; Dunn W, 1997, INFANT YOUNG CHILD, V9, P23, DOI 10.1097/00001163-199704000-00005; Dunn W, 2001, AM J OCCUP THER, V55, P608, DOI 10.5014/ajot.55.6.608; Engel-Yeger B, 2012, CAN J OCCUP THER, V79, P134, DOI 10.2182/cjot.2012.79.3.2; Engel-Yeger B, 2011, BRIT J OCCUP THER, V74, P210, DOI 10.4276/030802211X13046730116407; Engel-Yeger B, 2011, RES DEV DISABIL, V32, P1154, DOI 10.1016/j.ridd.2011.01.008; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fisher AG, 1991, SENSORY INTEGRATION, P3; Fortier-Brochu E, 2010, J PSYCHOSOM RES, V69, P475, DOI 10.1016/j.jpsychores.2010.05.005; Gerber PJ, 2012, J LEARN DISABIL-US, V45, P31, DOI 10.1177/0022219411426858; Gilger JW, 2001, DEV NEUROPSYCHOL, V20, P465, DOI 10.1207/S15326942DN2002_2; Grant AC, 1999, NEUROPSYCHOLOGIA, V37, P1201, DOI 10.1016/S0028-3932(99)00013-5; Hari R, 2001, TRENDS COGN SCI, V5, P525, DOI 10.1016/S1364-6613(00)01801-5; Hering-Hanit R, 2000, HEADACHE, V40, P809, DOI 10.1046/j.1526-4610.2000.00146.x; Jongmans MJ, 2003, J LEARN DISABIL-US, V36, P528, DOI 10.1177/00222194030360060401; Kavale KA, 2000, J LEARN DISABIL-US, V33, P239, DOI 10.1177/002221940003300303; Kavale KA, 1996, J LEARN DISABIL, V29, P226, DOI 10.1177/002221949602900301; Kavale KA, 2009, LEARN DISABILITY Q, V32, P39, DOI 10.2307/25474661; Koren D, 2002, AM J PSYCHIAT, V159, P855, DOI 10.1176/appi.ajp.159.5.855; Kyle SD, 2010, SLEEP MED REV, V14, P69, DOI 10.1016/j.smrv.2009.07.004; Leger D, 2000, J SLEEP RES, V9, P35, DOI 10.1046/j.1365-2869.2000.00178.x; Lopez N, 2012, J APPL RES MEM COGN, V1, P27, DOI 10.1016/j.jarmac.2011.10.002; Madaus JW, 2008, J LEARN DISABIL-US, V41, P291, DOI 10.1177/0022219407313805; MALCOLM CB, 1990, J LEARN DISABIL, V23, P518, DOI 10.1177/002221949002300811; Mangeot SD, 2001, DEV MED CHILD NEUROL, V43, P399, DOI 10.1017/S0012162201000743; McIntosh DN, 1999, DEV MED CHILD NEUROL, V41, P608, DOI 10.1017/S0012162299001267; Nicolson RI, 2007, TRENDS NEUROSCI, V30, P135, DOI 10.1016/j.tins.2007.02.003; Novak M, 2004, J PSYCHOSOM RES, V56, P527, DOI 10.1016/j.jpsychores.2004.02.007; Parush S, 2007, PHYSIOL BEHAV, V90, P553, DOI 10.1016/j.physbeh.2006.11.004; Parush S, 1997, DEV MED CHILD NEUROL, V39, P464, DOI 10.1111/j.1469-8749.1997.tb07466.x; Peleg O, 2009, LEARN DISABILITY Q, V32, P11, DOI 10.2307/25474659; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; Roffman AJ, 2000, M CHALLENGES LEARNIN; Scanlon D, 2013, J LEARN DISABIL-US, V46, P26, DOI 10.1177/0022219412464342; Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011; Tzischinsky O, 2012, J ATTEN DISORD; VanWijk CMTG, 1997, SOC SCI MED, V45, P231, DOI 10.1016/S0277-9536(96)00340-1; Velluti RA, 1997, J SLEEP RES, V6, P61, DOI 10.1046/j.1365-2869.1997.00031.x; Walsh JK, 2004, J CLIN PSYCHIAT, V65, P13; WHO, 2001, WHO INT CLASS FUNCT; Wilson AM, 2009, J LEARN DISABIL-US, V42, P24, DOI 10.1177/0022219408326216; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn; Yoon SYR, 2012, SLEEP MED REV, V16, P371, DOI 10.1016/j.smrv.2011.07.001; Zomer J., 1985, SLEEP 84, P467	56	7	7	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115518	10.1371/journal.pone.0115518	http://dx.doi.org/10.1371/journal.pone.0115518			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658647	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900019
J	Tuulari, JJ; Karlsson, HK; Hirvonen, J; Salminen, P; Nuutila, P; Nummenmaa, L				Tuulari, Jetro J.; Karlsson, Henry K.; Hirvonen, Jussi; Salminen, Paulina; Nuutila, Pirjo; Nummenmaa, Lauri			Neural Circuits for Cognitive Appetite Control in Healthy and Obese Individuals: An fMRI Study	PLOS ONE			English	Article							GO/NO-GO TASKS; RESPONSE-INHIBITION; NORMAL-WEIGHT; BRAIN ACTIVATION; FOOD; METAANALYSIS; REAPPRAISAL; ADDICTION; CORTEX	The mere sight of foods may activate the brain's reward circuitry, and humans often experience difficulties in inhibiting urges to eat upon encountering visual food signals. Imbalance between the reward circuit and those supporting inhibitory control may underlie obesity, yet brain circuits supporting volitional control of appetite and their possible dysfunction that can lead to obesity remain poorly specified. Here we delineated the brain basis of volitional appetite control in healthy and obese individuals with functional magnetic resonance imaging (fMRI). Twenty-seven morbidly obese women (mean BMI = 41.4) and fourteen age-matched normal-weight women (mean BMI = 22.6) were scanned with 1.5 Tesla fMRI while viewing food pictures. They were instructed to inhibit their urge to eat the foods, view the stimuli passively or imagine eating the foods. Across all subjects, a frontal cortical control circuit was activated during appetite inhibition versus passive viewing of the foods. Inhibition minus imagined eating (appetite control) activated bilateral precunei and parietal cortices and frontal regions spanning anterior cingulate and superior medial frontal cortices. During appetite control, obese subjects had lower responses in the medial frontal, middle cingulate and dorsal caudate nuclei. Functional connectivity of the control circuit was increased in morbidly obese versus control subjects during appetite control, which might reflect impaired integrative and executive function in obesity.	[Tuulari, Jetro J.; Karlsson, Henry K.; Hirvonen, Jussi; Nuutila, Pirjo; Nummenmaa, Lauri] Univ Turku, Turku PET Ctr, Turku, Finland; [Hirvonen, Jussi] Turku Univ Hosp, Dept Radiol, FIN-20520 Turku, Finland; [Salminen, Paulina] Turku Univ Hosp, Dept Surg, FIN-20520 Turku, Finland; [Nuutila, Pirjo] Turku Univ Hosp, Dept Endocrinol, FIN-20520 Turku, Finland; [Nummenmaa, Lauri] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, Aalto, Finland; [Nummenmaa, Lauri] Aalto Univ, Sch Sci, OV Lounasmaa Lab, Brain Res Unit, Aalto, Finland	University of Turku; University of Turku; University of Turku; University of Turku; Aalto University; Aalto University	Tuulari, JJ (corresponding author), Univ Turku, Turku PET Ctr, Turku, Finland.	jetro.tuulari@utu.fi	Hirvonen, Jussi/H-2521-2012; Salminen, Paulina Taru Pipsa (T.P.)/ABB-8883-2020; Hirvonen, Jussi/AAC-1864-2020; Nummenmaa, Lauri/G-6910-2012; Tuulari, Jetro/ABB-8747-2020	Salminen, Paulina Taru Pipsa (T.P.)/0000-0001-6435-9264; Nummenmaa, Lauri/0000-0002-2497-9757; Tuulari, Jetro/0000-0002-1797-8000; Nuutila, Pirjo/0000-0001-9597-338X	Academy of Finland [256147, 251125]; Sigrid Juselius Foundation; University Hospital of Turku; University of Turku [10463]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); University Hospital of Turku; University of Turku	This study was financially supported by the Academy of Finland (grants #256147 and #251125 to LN), the Sigrid Juselius Foundation, the University Hospital of Turku and the University of Turku (grant 10463 to JJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan RAH, 2013, TRENDS NEUROSCI, V36, P133, DOI 10.1016/j.tins.2012.12.001; Batterink L, 2010, NEUROIMAGE, V52, P1696, DOI 10.1016/j.neuroimage.2010.05.059; Buchsbaum BR, 2005, HUM BRAIN MAPP, V25, P35, DOI 10.1002/hbm.20128; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Criaud M, 2013, NEUROSCI BIOBEHAV R, V37, P11, DOI 10.1016/j.neubiorev.2012.11.003; de Araujo IE, 2009, INT J OBESITY, V33, pS34, DOI 10.1038/ijo.2009.70; Diekhof EK, 2008, BRAIN RES REV, V59, P164, DOI 10.1016/j.brainresrev.2008.07.004; Flint A, 2007, BRIT J NUTR, V98, P17, DOI 10.1017/S000711450768297X; Frank TC, 2010, BRAIN RES, V1363, P81, DOI 10.1016/j.brainres.2010.09.071; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koziol LF, 2012, CEREBELLUM, V11, P505, DOI 10.1007/s12311-011-0321-y; Laird AR, 2013, NEUROIMAGE, V80, P505, DOI 10.1016/j.neuroimage.2013.04.073; Liddle PF, 2001, HUM BRAIN MAPP, V12, P100, DOI 10.1002/1097-0193(200102)12:2<100::AID-HBM1007>3.0.CO;2-6; Loeber S, 2013, APPETITE, V71, P32, DOI 10.1016/j.appet.2013.07.008; Mostofsky SH, 2003, COGNITIVE BRAIN RES, V17, P419, DOI 10.1016/S0926-6410(03)00144-7; Nummenmaa L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031089; Passamonti L, 2008, NEUROIMAGE, V43, P562, DOI 10.1016/j.neuroimage.2008.07.045; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Scharmuller W, 2012, NEUROSCI LETT, V518, P106, DOI 10.1016/j.neulet.2012.04.063; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Staudinger MR, 2011, CEREB CORTEX, V21, P2578, DOI 10.1093/cercor/bhr041; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Volkow ND, 2013, BIOL PSYCHIAT, V73, P811, DOI 10.1016/j.biopsych.2012.12.020; Wang GJ, 2014, INT J OBESITY, V38, P682, DOI 10.1038/ijo.2013.145; Wang GJ, 2009, P NATL ACAD SCI USA, V106, P1249, DOI 10.1073/pnas.0807423106; Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866; Yokum S, 2013, INT J OBESITY, V37, P1565, DOI 10.1038/ijo.2013.39; Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212	32	55	56	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116640	10.1371/journal.pone.0116640	http://dx.doi.org/10.1371/journal.pone.0116640			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658479	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900054
J	Weng, HC; Endo, K; Li, JW; Kito, N; Iwai, N				Weng, Huachun; Endo, Kosuke; Li, Jiawei; Kito, Naoko; Iwai, Naoharu			Induction of Peroxisomes by Butyrate-Producing Probiotics	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; PPAR-ALPHA; HEPATIC STEATOSIS; INULIN; DIET; PROLIFERATION; PEX11-ALPHA; DEFICIENCY; ELONGATION; DIVISION	We previously found that peroxisomal biogenesis factor 11a (Pex11a) deficiency is associated with a reduction in peroxisome abundance and impaired fatty acid metabolism in hepatocytes, and results in steatosis. In the present study, we investigated whether butyrate induces Pex11a expression and peroxisome proliferation, and studied its effect on lipid metabolism. C57BL/ 6 mice fed standard chow or a high-fat diet (HFD) were treated with tributyrin, 4-phelybutyrate acid (4-PBA), or the butyrate-producing probiotics (Clostridium butyricum MIYAIRI 588 [CBM]) plus inulin (dietary fiber), and the body weight, white adipose tissue, serum triglycerides, mRNA expression, and peroxisome abundance were evaluated. Tributyrin or 4-PBA treatment significantly decreased body weight and increased hepatic mRNA expression of peroxisome proliferator-activated receptor-alpha (PPAR alpha) and Pex11a. In addition, 4-PBA treatment increased peroxisome abundance and the expression of genes involved in peroxisomal fatty acid beta-oxidation (acyl-coenzyme A oxidase 1 and hydroxysteroid [17-beta] dehydrogenase 4). CBM and inulin administration reduced adipose tissue mass and serum triglycerides, induced Pex11a, acyl-coenzyme A oxidase 1, and hydroxysteroid (17-beta) dehydrogenase 4 genes, and increased peroxisome abundance in mice fed standard chow or an HFD. In conclusion, elevation of butyrate availability (directly through administration of butyrate or indirectly via administration of butyrate-producing probiotics plus fiber) induces PPAR alpha and Pex11a and the genes involved in peroxisomal fatty acid beta-oxidation, increases peroxisome abundance, and improves lipid metabolism. These results may provide a new therapeutic strategy against hyperlipidemia and obesity.	[Weng, Huachun; Endo, Kosuke; Li, Jiawei; Kito, Naoko; Iwai, Naoharu] Natl Cerebral & Cardiovasc Ctr, Dept Genom Med, Res Inst, Suita, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan	Weng, HC (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Genom Med, Res Inst, Suita, Osaka, Japan.	weng@ncvc.go.jp; iwai@ncvc.go.jp	Endo, Kosuke/C-6038-2015; Kito, Naoko/D-3077-2018; Li, Jiawei/GXM-4151-2022	Kito, Naoko/0000-0002-6926-5053; 	Adaptable and Seamless Technology Transfer Program through Target-driven RD, Japan [AS251Z00329Q]	Adaptable and Seamless Technology Transfer Program through Target-driven RD, Japan	This research was supported by Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan (AS251Z00329Q). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Endo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063388; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Galisteo M, 2008, J NUTR BIOCHEM, V19, P71, DOI 10.1016/j.jnutbio.2007.02.009; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jakobsdottir G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080476; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kaur N, 2002, J BIOSCIENCES, V27, P703, DOI 10.1007/BF02708379; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Kumar A, 2009, J IMMUNOL, V182, P538, DOI 10.4049/jimmunol.182.1.538; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Li XL, 2002, MOL CELL BIOL, V22, P8226, DOI 10.1128/MCB.22.23.8226-8240.2002; Li XL, 2002, J CELL BIOL, V156, P643, DOI 10.1083/jcb.200112028; Okamoto T, 2000, J GASTROENTEROL, V35, P341, DOI 10.1007/s005350050358; Vinolo MAR, 2012, AM J PHYSIOL-ENDOC M, V303, pE272, DOI 10.1152/ajpendo.00053.2012; Reitman ML, 2013, CELL METAB, V18, P307, DOI 10.1016/j.cmet.2013.08.014; Seo M, 2013, DIGEST DIS SCI, V58, P3534, DOI 10.1007/s10620-013-2879-3; Sugatani J, 2006, DRUG METAB DISPOS, V34, P1677, DOI 10.1124/dmd.106.010645; Tarini J, 2010, APPL PHYSIOL NUTR ME, V35, P9, DOI 10.1139/H09-119; Wanders RJA, 1998, MOL ASPECTS MED, V19, P71, DOI 10.1016/S0098-2997(98)00003-X; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Weng HC, 2014, HYPERTENSION, V64, P1054, DOI 10.1161/HYPERTENSIONAHA.114.04094; Weng HC, 2013, AM J PHYSIOL-ENDOC M, V304, pE187, DOI 10.1152/ajpendo.00425.2012; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392	26	22	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117851	10.1371/journal.pone.0117851	http://dx.doi.org/10.1371/journal.pone.0117851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659146	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900231
J	Zou, JM; Dai, W; Gong, SX; Ma, ZY				Zou, Jianmei; Dai, Wei; Gong, Shengxuan; Ma, Zeyu			Analysis of Spatial Variations and Sources of Heavy Metals in Farmland Soils of Beijing Suburbs	PLOS ONE			English	Article							MERCURY	To understand the effect of intense human activities in suburbs on environmental quality, we obtained 758 measurements of the heavy metals in certain farmland soils of the Beijing suburbs. Multivariate statistical analysis and geostatistical analysis were used to conduct a basic analysis of the heavy metal concentrations, the distribution characteristics and the sources of pollution of the farmland soils in these suburbs. The results showed the presence of eight heavy metals in the agricultural soils at levels exceeding the background values for As, Cd, Cr, Cu, Hg, Ni, Pb, and Zn. In particular, all the measured Cr concentrations exceeded the background value, while As, Cd, Cr, Cu, Hg, Ni, Pb, and Zn were present at 1.13, 1.68, 1.95, 1.43, 1.63, 0.79, 0.92 and 1.36 times their background values, respectively. The results of correlation, factor and spatial structure analyses showed that Cd, Cu, Pb and Zn were strongly homologous, whereas Cr and Hg showed a degree of heterogeneity. The analysis further indicated that in addition to natural factors, Cd, Cu, Pb and Zn in the soil were mainly associated with distribution from road traffic and land use status. Different agricultural production measures in the various areas were also important factors that affected the spatial distribution of the soil Cr concentration. The major sources of Hg pollution were landfills for industrial waste and urban domestic garbage, while the spatial distribution of As was more likely to be a result of composite pollution. The regional distribution of the heavy metals indicated that except for Cr and Hg, the high heavy metal levels occurred in districts and counties with higher organic matter concentrations, such as the northwestern and southeastern suburbs of Beijing. There was no significant Ni pollution in the agricultural soils of the Beijing suburbs.	[Zou, Jianmei; Dai, Wei; Gong, Shengxuan; Ma, Zeyu] Beijing Forestry Univ, Coll Forestry, Beijing 100083, Peoples R China	Beijing Forestry University	Dai, W (corresponding author), Beijing Forestry Univ, Coll Forestry, 35 Qing Hua East Rd, Beijing 100083, Peoples R China.	daiwei1@bjfu.edu.cn			Fundamental Research Funds for Central University [BLYJ201308]; Major Project of Science and Technology of Beijing [D09040903780801]	Fundamental Research Funds for Central University; Major Project of Science and Technology of Beijing	The research was sponsored by the Fundamental Research Funds for Central University (Grant No. BLYJ201308) and the Major Project of Science and Technology of Beijing (Grant NO. D09040903780801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caceres DD, 2005, ENVIRON RES, V98, P151, DOI 10.1016/j.envres.2005.02.007; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; Chen Tong-bin, 2004, Huanjing Kexue, V25, P117; Cheng JZ, 2005, J ENVIRON SCI, V42, P149; Facchinelli A, 2001, ENVIRON POLLUT, V114, P313, DOI 10.1016/S0269-7491(00)00243-8; Goovaerts P, 1999, GEODERMA, V89, P1, DOI 10.1016/S0016-7061(98)00078-0; Goovaerts P, 1997, GEOSTATISTICS NATURA, P19; Huo XiaoNi, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P223; Kelly J, 1996, APPL GEOCHEM, V11, P363, DOI 10.1016/0883-2927(95)00084-4; Kitagishi K, 1981, HEAVY METAL POLLUTIO, P3; Kocher B, 2005, PEDOSPHERE, V15, P746; Li J, 1989, DATA MANUAL ENV BACK; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039690; Lin YP, 2002, LANDSCAPE URBAN PLAN, V62, P19, DOI 10.1016/S0169-2046(02)00094-4; Lindstrom M, 2001, WATER AIR SOIL POLL, V126, P363, DOI 10.1023/A:1005291611702; Lu JY, 1998, ANAL CHEM, V70, P2403, DOI 10.1021/ac971278l; Nicholson FA, 2003, SCI TOTAL ENVIRON, V311, P205, DOI 10.1016/S0048-9697(03)00139-6; PETERSEN G, 1995, ATMOS ENVIRON, V29, P47, DOI 10.1016/1352-2310(94)00223-8; Sutherland RA, 2000, ARCH ENVIRON CON TOX, V38, P428, DOI 10.1007/s002449910057; TRANGMAR BB, 1985, ADV AGRON, V38, P45; Wu WenYong, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P165; [姚荣江 Yao Rongjiang], 2011, [生态环境学报, Ecology and Environmental Sciences], V20, P1912; Zhang JL, 2012, ELECTROCATALYSIS-US, V3, P161, DOI 10.1007/s12678-012-0116-z; [郑袁明 Zheng Yuanming], 2003, [地理学报, Acta Geographica Sinica], V58, P470; Zhong XiaoLan, 2007, Acta Pedologica Sinica, V44, P33; Zhu XF, 2010, J ENVIRON SCI, V30, P2553; Zou JianMei, 2013, Journal of Beijing Forestry University, V35, P132	27	28	30	4	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118082	10.1371/journal.pone.0118082	http://dx.doi.org/10.1371/journal.pone.0118082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658749	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900263
J	Federau, C; O'Brien, K; Birbaumer, A; Meuli, R; Hagmann, P; Maeder, P				Federau, Christian; O'Brien, Kieran; Birbaumer, Adrien; Meuli, Reto; Hagmann, Patric; Maeder, Philippe			Functional Mapping of the Human Visual Cortex with Intravoxel Incoherent Motion MRI	PLOS ONE			English	Article							APPARENT-DIFFUSION-COEFFICIENT; CEREBRAL-BLOOD-FLOW; MATTER FMRI ACTIVATION; HUMAN BRAIN; WHITE-MATTER; SPATIAL LOCALIZATION; NEURONAL ACTIVATION; GRADIENT-ECHO; OXYGENATION; CONTRAST	Functional imaging with intravoxel incoherent motion (IVIM) magnetic resonance imaging (MRI) is demonstrated. Images were acquired at 3 Tesla using a standard Stejskal-Tanner diffusion-weighted echo-planar imaging sequence with multiple b-values. Cerebro-spinal fluid signal, which is highly incoherent, was suppressed with an inversion recovery preparation pulse. IVIM microvascular perfusion parameters were calculated according to a two-compartment (vascular and non-vascular) diffusion model. The results obtained in 8 healthy human volunteers during visual stimulation are presented. The IVIM blood flow related parameter fD* increased 170% during stimulation in the visual cortex, and 70% in the underlying white matter.	[Federau, Christian; Birbaumer, Adrien; Meuli, Reto; Hagmann, Patric; Maeder, Philippe] CHU Vaudois, Dept Diagnost & Intervent Radiol, Lausanne, Switzerland; [Federau, Christian; Birbaumer, Adrien; Meuli, Reto; Hagmann, Patric; Maeder, Philippe] Univ Lausanne, Lausanne, Switzerland; [O'Brien, Kieran] Univ Geneva, Ctr Biomed Imaging CIBM, Geneva, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Geneva	Federau, C (corresponding author), CHU Vaudois, Dept Diagnost & Intervent Radiol, Lausanne, Switzerland.	christian.federau@gmail.com	O'Brien, Kieran/B-7276-2016	O'Brien, Kieran/0000-0003-1996-3563	Centre d'Imagerie BioMedicale (CIBM) of the UNIL; UNIGE; HUG; CHUV; EPFL; Leenaards Foundation; Jeantet Foundation; Faculte de biologie et de medecine of the University of Lausanne	Centre d'Imagerie BioMedicale (CIBM) of the UNIL; UNIGE; HUG; CHUV; EPFL; Leenaards Foundation; Jeantet Foundation; Faculte de biologie et de medecine of the University of Lausanne	This work was supported by the Centre d'Imagerie BioMedicale (CIBM) of the UNIL, UNIGE, HUG, CHUV, EPFL and the Leenaards and Jeantet Foundations. CF was supported by the Faculte de biologie et de medecine of the University of Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso T, 2012, NEUROIMAGE, V67C, P25; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P4, DOI 10.1002/mrm.1910340103; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; CHRISTIANSEN P, 1994, MAGN RESON IMAGING, V12, P1237, DOI 10.1016/0730-725X(94)90088-9; COX SB, 1993, J CEREBR BLOOD F MET, V13, P899, DOI 10.1038/jcbfm.1993.113; D'Arcy RCN, 2006, MAGN RESON MED, V55, P952, DOI 10.1002/mrm.20839; Darquie A, 2001, P NATL ACAD SCI USA, V98, P9391, DOI 10.1073/pnas.151125698; Donahue MJ, 2006, MAGN RESON MED, V56, P1261, DOI 10.1002/mrm.21072; Federau C, 2012, RADIOLOGY, V265, P874, DOI 10.1148/radiol.12120584; Feng CM, 2004, NEUROIMAGE, V22, P443, DOI 10.1016/j.neuroimage.2004.01.017; Gangstead SL, 2002, MAGNET RESON MED, V48, P385, DOI 10.1002/mrm.10189; Ito H, 2005, ANN NUCL MED, V19, P65, DOI 10.1007/BF03027383; Jin T, 2008, NEUROIMAGE, V41, P801, DOI 10.1016/j.neuroimage.2008.03.014; Jin T, 2010, NEUROIMAGE, V51, P1378, DOI 10.1016/j.neuroimage.2010.03.047; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LASSEN NA, 1985, J CEREBR BLOOD F MET, V5, P347, DOI 10.1038/jcbfm.1985.48; Le Bihan D, 2006, P NATL ACAD SCI USA, V103, P8263, DOI 10.1073/pnas.0600644103; Le Bihan D, 2012, NEUROIMAGE, V62, P1131, DOI 10.1016/j.neuroimage.2011.09.058; LEBIHAN D, 1992, MAGNET RESON MED, V27, P171, DOI 10.1002/mrm.1910270116; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lee SP, 1999, MAGNET RESON MED, V42, P919, DOI 10.1002/(SICI)1522-2594(199911)42:5<919::AID-MRM12>3.0.CO;2-8; Liang CL, 2013, NEUROIMAGE, V64, P104, DOI 10.1016/j.neuroimage.2012.08.077; LINDAUER U, 1993, AM J PHYSIOL, V264, pH1223, DOI 10.1152/ajpheart.1993.264.4.H1223; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; Mazerolle EL, 2010, NEUROIMAGE, V50, P616, DOI 10.1016/j.neuroimage.2009.12.102; McWhinney SR, 2012, J NEUROSCI METH, V209, P351, DOI 10.1016/j.jneumeth.2012.06.014; Michelich CR, 2006, NMR BIOMED, V19, P566, DOI 10.1002/nbm.1035; Miller KL, 2007, P NATL ACAD SCI USA, V104, P20967, DOI 10.1073/pnas.0707257105; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Pauling L, 1936, P NATL ACAD SCI USA, V22, P210, DOI 10.1073/pnas.22.4.210; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Piechnik SK, 2009, MAGN RESON MED, V61, P579, DOI 10.1002/mrm.21897; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Roy C S, 1890, J Physiol, V11, P85; Scouten A, 2008, MAGN RESON MED, V59, P308, DOI 10.1002/mrm.21427; Seber G. A. F., 2003, NONLINEAR REGRESSION; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Song AW, 2012, NEUROIMAGE, V62, P949, DOI 10.1016/j.neuroimage.2012.01.001; Song AW, 2003, NEUROIMAGE, V20, P955, DOI 10.1016/S1053-8119(03)00292-1; Song AW, 2002, NEUROIMAGE, V17, P742, DOI 10.1006/nimg.2002.1217; Song AW, 1996, MAGNET RESON MED, V35, P155, DOI 10.1002/mrm.1910350204; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; THULBORN KR, 1982, BIOCHIM BIOPHYS ACTA, V714, P265, DOI 10.1016/0304-4165(82)90333-6; TURNER R, 1990, RADIOLOGY, V177, P407, DOI 10.1148/radiology.177.2.2217777; Turner R, 2002, NEUROIMAGE, V16, P1062, DOI 10.1006/nimg.2002.1082; van Zijl PCM, 1998, NAT MED, V4, P159, DOI 10.1038/nm0298-159; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259; Wirestam R, 2001, ACTA RADIOL, V42, P123, DOI 10.1080/028418501127346459; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257	58	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117706	10.1371/journal.pone.0117706	http://dx.doi.org/10.1371/journal.pone.0117706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647423	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600081
J	Lopez, A; Vera, M; Planas, M; Bouza, C				Lopez, Almudena; Vera, Manuel; Planas, Miquel; Bouza, Carmen			Conservation Genetics of Threatened Hippocampus guttulatus in Vulnerable Habitats in NW Spain: Temporal and Spatial Stability of Wild Populations with Flexible Polygamous Mating System in Captivity	PLOS ONE			English	Article							ENDANGERED KNYSNA SEAHORSE; COMPUTER-PROGRAM; LIFE-HISTORY; MICROSATELLITE MARKERS; GEOGRAPHICAL VARIATION; MULTIPLE PATERNITY; SOCIAL PROMISCUITY; SEXUAL SELECTION; SOFTWARE; SIZE	This study was focused on conservation genetics of threatened Hippocampus guttulatus on the Atlantic coast of NW Iberian Peninsula. Information about spatial structure and temporal stability of wild populations was obtained based on microsatellite markers, and used for monitoring a captive breeding program firstly initiated in this zone at the facilities of the Institute of Marine Research (Vigo, Spain). No significant major genetic structure was observed regarding the biogeographical barrier of Cape Finisterre. However, two management units under continuous gene flow are proposed based on the allelic differentiation between South-Atlantic and Cantabrian subpopulations, with small to moderate contemporary effective size based on single-sample methods. Temporal stability was observed in South-Atlantic population samples of H. guttulatus for the six-year period studied, suggesting large enough effective population size to buffer the effects of genetic drift within the time frame of three generations. Genetic analysis of wild breeders and offspring in captivity since 2009 allowed us to monitor the breeding program founded in 2006 in NW Spain for this species. Similar genetic diversity in the renewed and founder broodstock, regarding the wild population of origin, supports suitable renewal and rearing processes to maintain genetic variation in captivity. Genetic parentage proved single-brood monogamy in the wild and in captivity, but flexible short- and long-term mating system under captive conditions, from strict monogamy to polygamy within and/or among breeding seasons. Family analysis showed high reproductive success in captivity under genetic management assisted by molecular relatedness estimates to avoid inbreeding. This study provides genetic information about H. guttulatus in the wild and captivity within an uncovered geographical range for this data deficient species, to be taken into account for management and conservation purposes.	[Lopez, Almudena; Bouza, Carmen] Univ Santiago de Compostela, Fac Vet Sci, Dept Genet, Lugo, Spain; [Vera, Manuel] Univ Girona, Fac Sci, Dept Biol, Lab Ictiol Genet, Girona, Spain; [Planas, Miquel] Inst Invest Marinas CSIC, Dept Ecol & Marine Resources, Vigo, Spain	Universidade de Santiago de Compostela; Universitat de Girona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Bouza, C (corresponding author), Univ Santiago de Compostela, Fac Vet Sci, Dept Genet, Campus Lugo, Lugo, Spain.	mcarmen.bouza@usc.es	Vera, Manuel/B-7429-2012; Bouza, Carmen/K-9322-2014; Planas, Miquel/A-8780-2008; Gómez, ACUIGEN/ABD-5337-2020	Vera, Manuel/0000-0003-1584-6140; Bouza, Carmen/0000-0002-9501-4506; Planas, Miquel/0000-0003-1217-5716; 	Spanish Government [CGL2005-05927-C03-01/-03, CGL2009-08386]; Regional Government of Galicia [09MDS022402PR]	Spanish Government(Spanish GovernmentEuropean Commission); Regional Government of Galicia	This work was supported by the Spanish Government (CGL2005-05927-C03-01/-03; CGL2009-08386) and the Regional Government of Galicia (09MDS022402PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaunza P, 2008, FISH RES, V89, P196, DOI 10.1016/j.fishres.2007.09.022; Allendorf FW, 2007, CONSERV GENET, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; Avise JC, 2011, P NATL ACAD SCI USA, V108, P7091, DOI 10.1073/pnas.1103329108; Blanco A, 2014, AQUACULTURE, V433, P214, DOI 10.1016/j.aquaculture.2014.06.019; Caballero A, 2010, CONSERV GENET, V11, P409, DOI 10.1007/s10592-009-0020-0; Caballero A, 2013, GENETICS, V195, P1373, DOI 10.1534/genetics.113.158410; CITES, 2002, 12 M C PART SANT CHI; CITES, 2004, 13 M C PART BANGK TH; Clynick BG, 2008, AQUAT CONSERV, V18, P483, DOI 10.1002/aqc.856; Correia M, 2013, J EXP MAR BIOL ECOL, V448, P258, DOI 10.1016/j.jembe.2013.08.001; Curtis JMR, 2006, J FISH BIOL, V68, P707, DOI 10.1111/j.0022-1112.2006.00952.x; Curtis JMR, 2004, PROJECT SEAHORSE TEC, V8; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Diekmann OE, 2005, MAR ECOL PROG SER, V290, P89, DOI 10.3354/meps290089; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Estoup A, 1996, MOL MAR BIOL BIOTECH, V5, P295; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Fiumera AC, 2004, CONSERV BIOL, V18, P94, DOI 10.1111/j.1523-1739.2004.00521.x; Foster SJ, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00429.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Fraser DJ, 2008, EVOL APPL, V1, P501, DOI 10.1111/j.1752-4571.2008.00037.x; Galbusera PHA, 2007, MOL ECOL NOTES, V7, P638, DOI 10.1111/j.1471-8286.2007.01688.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guinand B, 2003, P ROY SOC B-BIOL SCI, V270, P425, DOI 10.1098/rspb.2002.2250; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Hedrick P.W., 2011, GENETICS POPULATIONS; Hellyer CB, 2011, AQUAT CONSERV, V21, P582, DOI 10.1002/aqc.1217; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; IUCN, 2011, CBSG NEWS        JAN; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jones AG, 2003, P NATL ACAD SCI USA, V100, P6598, DOI 10.1073/pnas.1131969100; Jones AG, 2001, J HERED, V92, P150, DOI 10.1093/jhered/92.2.150; Jones AG, 1998, MOL ECOL, V7, P1497, DOI 10.1046/j.1365-294x.1998.00481.x; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kaiser MJ, 2002, FISH FISH, V3, P114, DOI 10.1046/j.1467-2979.2002.00079.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kelly CD, 1999, P ROY SOC B-BIOL SCI, V266, P2403, DOI 10.1098/rspb.1999.0938; Kvarnemo C, 2000, J EVOLUTION BIOL, V13, P882, DOI 10.1046/j.1420-9101.2000.00228.x; Larsson LC, 2010, HEREDITY, V104, P40, DOI 10.1038/hdy.2009.98; Lopez A, 2012, AQUACULTURE, V356, P153, DOI 10.1016/j.aquaculture.2012.05.021; Lopez A, 2010, CONSERV GENET, V11, P2431, DOI 10.1007/s10592-010-0116-6; LOPEZJAMAR E, 1992, J MAR RES, V50, P465, DOI 10.1357/002224092784797584; Lourie SA, 2005, MOL ECOL, V14, P1073, DOI 10.1111/j.1365-294X.2005.02464.x; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Lundy CJ, 1999, MOL ECOL, V8, P1889, DOI 10.1046/j.1365-294x.1999.00789.x; Martin-Smith KM, 2004, OCEAN COAST MANAGE, V47, P165, DOI 10.1016/j.ocecoaman.2004.02.002; Martinez P, 2008, ESTIMATING PARENTAGE; Mobley KB, 2007, MOL ECOL, V16, P2596, DOI 10.1111/j.1365-294X.2007.03337.x; Mobley KB, 2009, MOL ECOL, V18, P1476, DOI 10.1111/j.1365-294X.2009.04104.x; Montgomery ME, 1997, ZOO BIOL, V16, P377, DOI 10.1002/(SICI)1098-2361(1997)16:5<377::AID-ZOO1>3.0.CO;2-7; Muthusamy Thangaraj, 2012, Notulae Scientia Biologicae, V4, P7; Naud MJ, 2009, BEHAV ECOL, V20, P160, DOI 10.1093/beheco/arn128; Nei M., 1987, MOL EVOLUTIONARY GEN; Nickel J, 2012, NEW ZEAL J MAR FRESH, V46, P207, DOI 10.1080/00288330.2011.632014; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Olivotto I, 2011, J WORLD AQUACULT SOC, V42, P135, DOI 10.1111/j.1749-7345.2011.00453.x; OSPAR Commission, 2008, CAS REP OSPAR LIST T; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Panithanarak T, 2010, ZOOL STUD, V49, P564; Pascoal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007268; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pearse DE, 2009, MOL ECOL, V18, P3124, DOI 10.1111/j.1365-294X.2009.04268.x; Peel D., 2004, NEESTIMATOR SOFTWARE; Perez-Figueroa A, 2009, CONSERV GENET, V10, P1097, DOI 10.1007/s10592-008-9718-7; Pineira J, 2008, MAR ECOL PROG SER, V357, P175, DOI 10.3354/meps07278; Pino-Querido A, 2010, AQUAC RES, V41, P528, DOI 10.1111/j.1365-2109.2009.02344.x; Planas M, 2012, J EXP MAR BIOL ECOL, V438, P154, DOI 10.1016/j.jembe.2012.10.003; Planas M, 2010, ANIM REPROD SCI, V122, P66, DOI 10.1016/j.anireprosci.2010.07.008; Planas M, 2013, AQUACULTURE, V388, P147, DOI 10.1016/j.aquaculture.2013.01.030; Plesnar-Bielak A, 2013, P R SOC B, V279, P4661; Pritchard JK, 2000, GENETICS, V155, P945; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; Riccioni G, 2010, P NATL ACAD SCI USA, V107, P2102, DOI 10.1073/pnas.0908281107; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saarman NP, 2010, CONSERV GENET, V11, P1989, DOI 10.1007/s10592-010-0092-x; Sogabe A, 2007, ETHOLOGY, V113, P764, DOI 10.1111/j.1439-0310.2007.01370.x; Taggart JB, 2007, MOL ECOL NOTES, V7, P412, DOI 10.1111/j.1471-8286.2006.01616.x; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Teske PR, 2005, MAR ECOL PROG SER, V286, P249, DOI 10.3354/meps286249; Teske PR, 2003, MOL ECOL, V12, P1703, DOI 10.1046/j.1365-294X.2003.01852.x; Valladares S, 2011, 1 SYNGN BIOL INT S F; van de Vliet MS, 2009, CONSERV GENET RESOUR, V1, P93, DOI 10.1007/s12686-009-9022-y; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vincent ACJ, 2011, J FISH BIOL, V78, P1681, DOI 10.1111/j.1095-8649.2011.03003.x; Wang JL, 2002, GENETICS, V160, P1203; Waples RS, 2007, CONSERV BIOL, V21, P964, DOI 10.1111/j.1523-1739.2007.00730.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Wedekind C, 2002, CONSERV BIOL, V16, P1204, DOI 10.1046/j.1523-1739.2002.01217.x; Wilson AB, 2007, MOL ECOL, V16, P2345, DOI 10.1111/j.1365-294X.2007.03243.x; Woodall L., 2009, THESIS U LONDON UK; Woodall LC, 2011, J FISH BIOL, V78, P1738, DOI 10.1111/j.1095-8649.2011.02974.x; Woodall LC, 2011, CONSERV GENET, V12, P1645, DOI 10.1007/s10592-011-0253-6; Zarraonaindia I, 2009, ICES J MAR SCI, V66, P2176, DOI 10.1093/icesjms/fsp187	105	14	14	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117538	10.1371/journal.pone.0117538	http://dx.doi.org/10.1371/journal.pone.0117538			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646777	Green Published, gold			2022-12-27	WOS:000348822600073
J	Shi, M; Sun, WL; Hua, YY; Han, B; Shi, L				Shi, Ming; Sun, Wan-Li; Hua, Yan-Yan; Han, Bo; Shi, Long			Effects of Entecavir on Hepatitis B Virus Covalently Closed Circular DNA in Hepatitis B e Antigen-Positive Patients with Hepatitis B	PLOS ONE			English	Article							REAL-TIME PCR; LAMIVUDINE THERAPY; NUCLEIC-ACIDS; HBV CCCDNA; PEGINTERFERON ALPHA-2B; COMBINATION THERAPY; ANTIVIRAL THERAPY; SERUM; SUPPRESSION; INFECTION	The aim of this study was to assess the effect of 48-week entecavir therapy on serum and intrahepatic hepatitis B virus, covalently closed circular DNA (HBV cccDNA) levels in hepatitis B e antigen (HBeAg)-positive patients. A total of 120 patients with HBeAg-positive chronic hepatitis were treated with entecavir for 48 weeks. Serum HBV markers, total HBV DNA, and HBV cccDNA levels were measured at baseline and week 48. Biopsies from 20 patients were available for both intrahepatic total HBV DNA and cccDNA testing at these timepoints. HBV cccDNA levels were decreased from a median level of 5.1x10(6) copies/mL at baseline to a median level of 2.4x10(3) copies/mL at week 48. Reduction magnitudes of HBV cccDNA in patients with normalized alanine aminotransferase levels and those undergoing HBeAg seroconversion were significantly greater than those in alanine aminotransferase-abnormal and HBeAg positive patients. Intrahepatic HBV cccDNA was decreased significantly after 48 weeks of treatment, but could not be eradicated. In conclusion, treatment of HBeAg-positive hepatitis B patients with entecavir for 48 weeks decreased serum and intrahepatic HBV cccDNA significantly, and the magnitude of HBV cccDNA reduction was related to total HBV DNA decrease, alanine aminotransferase normalization, and HBeAg seroconversion.	[Shi, Ming; Sun, Wan-Li; Hua, Yan-Yan; Han, Bo; Shi, Long] 6 Hosp Dalian, Dept Lab Med, Dalian, Peoples R China		Shi, M (corresponding author), 6 Hosp Dalian, Dept Lab Med, Dalian, Peoples R China.	zhsh6655@sohu.com						Bourne EJ, 2007, J VIRAL HEPATITIS, V14, P55, DOI 10.1111/j.1365-2893.2006.00775.x; Breitkreutz R, 2001, ANN NY ACAD SCI, V945, P195; Caruntu Florin Alexandru, 2005, Rom J Gastroenterol, V14, P373; Chen Y, 2004, WORLD J GASTROENTERO, V10, P82; Hagiwara S, 2013, J MED VIROL, V85, P987, DOI 10.1002/jmv.23564; He ML, 2002, BIOCHEM BIOPH RES CO, V295, P1102, DOI 10.1016/S0006-291X(02)00813-6; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Loustaud-Ratti V, 2013, CLIN RES HEPATOL GAS, V37, P373, DOI 10.1016/j.clinre.2012.11.002; Mazet-Wagner AA, 2006, J VIROL METHODS, V138, P70, DOI 10.1016/j.jviromet.2006.07.019; Moraleda G, 1997, J VIROL, V71, P9392, DOI 10.1128/JVI.71.12.9392-9399.1997; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shi M, 2006, J ANTIMICROB CHEMOTH, V58, P1031, DOI 10.1093/jac/dkl385; Su Q, 2001, CLIN CANCER RES, V7, P2005; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wong DKH, 2006, ANTIVIR THER, V11, P909; Wong DKH, 2004, HEPATOLOGY, V40, P727, DOI 10.1002/hep.20353; Wursthorn K, 2006, HEPATOLOGY, V44, P675, DOI 10.1002/hep.21282; YOKOSUKA O, 1985, HEPATOLOGY, V5, P728, DOI 10.1002/hep.1840050505; Yuen MF, 2005, AM J GASTROENTEROL, V100, P1099, DOI 10.1111/j.1572-0241.2005.41530.x; Zhang W, 2003, J MED VIROL, V71, P24, DOI 10.1002/jmv.10464; Zhou TL, 2000, J VIROL, V74, P11754, DOI 10.1128/JVI.74.24.11754-11763.2000	23	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117741	10.1371/journal.pone.0117741	http://dx.doi.org/10.1371/journal.pone.0117741			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647607	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600083
J	Clouse, MD; Shikiya, RA; Bartz, JC; Kincaid, AE				Clouse, Melissa D.; Shikiya, Ronald A.; Bartz, Jason C.; Kincaid, Anthony E.			Nasal Associated Lymphoid Tissue of the Syrian Golden Hamster Expresses High Levels of PrPC	PLOS ONE			English	Article							TRANSMISSIBLE MINK ENCEPHALOPATHY; PRION PROTEIN PRPC; SCRAPIE AGENT; MICE; PATHOGENESIS; INFECTION; DISEASE; NEUROINVASION; VIRUS; ROUTE	The key event in the pathogenesis of the transmissible spongiform encephalopathies is a template-dependent misfolding event where an infectious isoform of the prion protein (PrPSc) comes into contact with native prion protein (PrPC) and changes its conformation to PrPSc. In many extraneurally inoculated models of prion disease this PrPC misfolding event occurs in lymphoid tissues prior to neuroinvasion. The primary objective of this study was to compare levels of total PrPC in hamster lymphoid tissues involved in the early pathogenesis of prion disease. Lymphoid tissues were collected from golden Syrian hamsters and Western blot analysis was performed to quantify PrPC levels. PrPC immunohistochemistry (IHC) of paraffin embedded tissue sections was performed to identify PrPC distribution in tissues of the lymphoreticular system. Nasal associated lymphoid tissue contained the highest amount of total PrPC followed by Peyer's patches, mesenteric and submandibular lymph nodes, and spleen. The relative levels of PrPC expression in IHC processed tissue correlated strongly with the Western blot data, with high levels of PrPC corresponding with a higher percentage of PrPC positive B cell follicles. High levels of PrPC in lymphoid tissues closely associated with the nasal cavity could contribute to the relative increased efficiency of the nasal route of entry of prions, compared to other routes of infection.	[Clouse, Melissa D.; Kincaid, Anthony E.] Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA; [Shikiya, Ronald A.; Bartz, Jason C.; Kincaid, Anthony E.] Creighton Univ, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA; [Kincaid, Anthony E.] Creighton Univ, Dept Pharm Sci, Omaha, NE 68178 USA	Creighton University; Creighton University; Creighton University	Kincaid, AE (corresponding author), Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA.	akincaid@creighton.edu		Bartz, Jason/0000-0003-4081-7886; Kincaid, Anthony/0000-0002-5700-5887	National Institute for Neurological Disorders and Stroke [RO1 NS061994, RO1 NS061994-03S1]; National Center for Research Resources [CO6 RR17417-01, G20 RR024001]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR024001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061994] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute for Neurological Disorders and Stroke (RO1 NS061994 and RO1 NS061994-03S1 to AEK) and the National Center for Research Resources (CO6 RR17417-01 and G20 RR024001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartz JC, 2005, J VIROL, V79, P11858, DOI 10.1128/JVI.79.18.11858-11863.2005; Bartz JC, 2003, J VIROL, V77, P583, DOI 10.1128/JVI.77.1.583-591.2003; Bartz JC, 2002, J VIROL, V76, P5759, DOI 10.1128/JVI.76.11.5759-5768.2002; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Brown KL, 2009, J IMMUNOL, V183, P5199, DOI 10.4049/jimmunol.0802695; BRUCE ME, 1985, J GEN VIROL, V66, P2517, DOI 10.1099/0022-1317-66-12-2517; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CHEN LL, 1978, J CELL BIOL, V77, P148, DOI 10.1083/jcb.77.1.148; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Denkers ND, 2013, J VIROL, V87, P1890, DOI 10.1128/JVI.02852-12; Dron M, 2010, J BIOL CHEM, V285, P10252, DOI 10.1074/jbc.M109.083857; EKLUND CM, 1967, J INFECT DIS, V117, P15, DOI 10.1093/infdis/117.1.15; Ford MJ, 2002, NEUROSCIENCE, V113, P177, DOI 10.1016/S0306-4522(02)00155-0; Fournier JG, 1998, CELL TISSUE RES, V292, P77, DOI 10.1007/s004410051036; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; HADLOW WJ, 1987, J VIROL, V61, P3235, DOI 10.1128/JVI.61.10.3235-3240.1987; Hamir AN, 2008, VET PATHOL, V45, P7, DOI 10.1354/vp.45-1-7; Haybaeck J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001257; Heritage PL, 1997, AM J RESP CRIT CARE, V156, P1256, DOI 10.1164/ajrccm.156.4.97-03017; HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; KIMBERLIN RH, 1978, J COMP PATHOL, V88, P39, DOI 10.1016/0021-9975(78)90059-2; Kincaid AE, 2007, J VIROL, V81, P4482, DOI 10.1128/JVI.02649-06; Kincaid AE, 2012, J VIROL, V86, P12731, DOI 10.1128/JVI.01930-12; LEAVITT R, 1977, J BIOL CHEM, V252, P9018; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Maignien T, 1999, J GEN VIROL, V80, P3035, DOI 10.1099/0022-1317-80-11-3035; Mays CE, 2009, BIOCHEM BIOPH RES CO, V388, P306, DOI 10.1016/j.bbrc.2009.07.163; McDonald AJ, 2014, J BIOL CHEM, V289, P803, DOI 10.1074/jbc.M113.502351; Nishina KA, 2006, BIOCHEMISTRY-US, V45, P14129, DOI 10.1021/bi061526k; Pan T, 2002, J NEUROCHEM, V81, P1092, DOI 10.1046/j.1471-4159.2002.00909.x; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; SAKAGUCHI S, 1995, J VIROL, V69, P7586, DOI 10.1128/JVI.69.12.7586-7592.1995; Sbriccoli M, 2009, ACTA NEUROPATHOL, V117, P175, DOI 10.1007/s00401-008-0474-z; Shikiya RA, 2010, J VIROL, V84, P5706, DOI 10.1128/JVI.00243-10; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4	38	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117935	10.1371/journal.pone.0117935	http://dx.doi.org/10.1371/journal.pone.0117935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642714	Green Published, gold, Green Submitted			2022-12-27	WOS:000348821200041
J	Arauz, MJ; Ridde, V; Hernandez, LM; Charris, Y; Carabali, M; Villar, LA				Arauz, Mara Jose; Ridde, Valery; Hernandez, Libia Milena; Charris, Yaneth; Carabali, Mabel; Villar, Luis Angel			Developing a Social Autopsy Tool for Dengue Mortality: A Pilot Study	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; AEDES-AEGYPTI; HEALTH-CARE; DETERMINANTS; SURVEILLANCE; QUALITY; AMERICA; ACCESS; BRAZIL; DELAYS	Background Dengue fever is a public health problem in the tropical and sub-tropical world. Dengue cases have grown dramatically in recent years as well as dengue mortality. Colombia has experienced periodic dengue outbreaks with numerous dengue related-deaths, where the Santander department has been particularly affected. Although social determinants of health (SDH) shape health outcomes, including mortality, it is not yet understood how these affect dengue mortality. The aim of this pilot study was to develop and pre-test a social autopsy (SA) tool for dengue mortality. Methods and Findings The tool was developed and pre-tested in three steps. First, dengue fatal cases and 'near misses' (those who recovered from dengue complications) definitions were elaborated. Second, a conceptual framework on determinants of dengue mortality was developed to guide the construction of the tool. Lastly, the tool was designed and pre-tested among three relatives of fatal cases and six near misses in 2013 in the metropolitan zone of Bucaramanga. The tool turned out to be practical in the context of dengue mortality in Colombia after some modifications. The tool aims to study the social, individual, and health systems determinants of dengue mortality. The tool is focused on studying the socioeconomic position and the intermediary SDH rather than the socioeconomic and political context. Conclusions The SA tool is based on the scientific literature, a validated conceptual framework, researchers' and health professionals' expertise, and a pilot study. It is the first time that a SA tool has been created for the dengue mortality context. Our work furthers the study on SDH and how these are applied to neglected tropical diseases, like dengue. This tool could be integrated in surveillance systems to provide complementary information on the modifiable and avoidable death- related factors and therefore, be able to formulate interventions for dengue mortality reduction.	[Arauz, Mara Jose; Ridde, Valery] Univ Montreal, Univ Montreal Hosp Res Ctr CRCHUM, Sch Publ Hlth ESPUM, Montreal, PQ, Canada; [Hernandez, Libia Milena; Charris, Yaneth] Ctr Atenc Diagnost Enfermedades Infecciosas CDI A, Bucaramanga, Colombia; [Carabali, Mabel] Int Vaccines Inst, Dengue Vaccines Initiat, Seoul, South Korea; [Villar, Luis Angel] Univ Ind Santander, Bucaramanga, Colombia	Universite de Montreal; Universidad Industrial de Santander	Arauz, MJ (corresponding author), Univ Montreal, Univ Montreal Hosp Res Ctr CRCHUM, Sch Publ Hlth ESPUM, Montreal, PQ, Canada.	mariajarauz@gmail.com	ridde, valery/AAV-1016-2020; Ridde, Valery/AAD-2736-2019	Ridde, Valery/0000-0001-9299-8266; Carabali, Mabel/0000-0002-9171-0483	Canadian Institutes of Health Research; Ministere de l'Education, du Loisir et du Sport of Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministere de l'Education, du Loisir et du Sport of Quebec	MJA received a James Rossiter (MSc) scholarship from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/) and a Visiting Fellowship from the Ministere de l'Education, du Loisir et du Sport of Quebec (http://www.mels.gouv.qc.ca/). The Centro de atencion y diagnostico de enfermedades infecciosas (http://www.cdi.net.co/) and the Info Vida Foundation from Bucaramanga, Colombia (no URL) contributed to the logistics of the pilot study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard-Hansen J, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P135; Albert M, 2008, SOC SCI MED, V66, P2520, DOI 10.1016/j.socscimed.2008.01.052; Alvarez Perez A, 2010, REV CUBANA HIGIENE E, V48; Cafferata Maria Luisa, 2013, Value Health Reg Issues, V2, P347, DOI 10.1016/j.vhri.2013.10.002; Carabali JM, 2012, GLOB HEALTH PROMOT, V19, P45, DOI 10.1177/1757975912464250; Cascio W.F., 2011, APPL PSYCHOL HUMAN R, V7 ed.; Castañeda Oneida, 2011, Rev. salud pública, V13, P514; Child Health Epidemiology Reference Group CHERG Verbal and Social Autopsy Survey Tools and Information, FAIL PATHW SURV; CSDH, 2008, CLOS GAP GEN HLTH EQ; Diaz-Quijano FA, 2012, AM J TROP MED HYG, V86, P328, DOI 10.4269/ajtmh.2012.11-0074; Figueiro AC, 2011, CAD SAUDE PUBLICA, V27, P2373, DOI 10.1590/S0102-311X2011001200009; Gabrysch S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000394; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gruenais ME, 2012, ANTHROPOL ACTION, V19, P27, DOI 10.3167/aia.2012.190204; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guha-Sapir D, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-1; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI [10.1371/journal.pntd.0000352, DOI 10.1371/J0URNAL.PNTD.0000352]; Instituto Nacional de Salud, 2013, B EP DENG COL SEM; Instituto Nacional de Salud, 2013, INF EV DENG PER EP D; Kallander K, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-44; Kalter Henry D, 2011, Popul Health Metr, V9, P45, DOI 10.1186/1478-7954-9-45; Kouri G, 2007, REV CUBA MED TROP, V59; Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774; Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412; Pacagnella RC, 2012, REPROD HEALTH MATTER, V20, P155, DOI 10.1016/S0968-8080(12)39601-8; Padilla J.C., 2012, DENGUE COLOMBIA EPID; Pattinson RC, 2003, BRIT MED BULL, V67, P231, DOI 10.1093/bmb/ldg007; Quintero J, 2009, CAD SAUDE PUBLICA, V25, pS93, DOI 10.1590/S0102-311X2009001300009; Reidpath DD, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-1; Ronsmans C, 2004, NUMBERS REV MATERNAL; Sam SS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002194; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Solar O, 2010, 2 WHO; Spiegel JM, 2007, TROP MED INT HEALTH, V12, P503, DOI 10.1111/j.1365-3156.2007.01818.x; Alvarez LS, 2011, INT J HEALTH SERV, V41, P355, DOI 10.2190/HS.41.2.i; Suarez R, 2009, CAD SAUDE PUBLICA, V25, pS104, DOI 10.1590/S0102-311X2009001300010; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Theiss-Nyland K, 2013, PARTNERSHIP MATERNAL; van Teijlingen Edwin, 2002, Nurs Stand, V16, P33; Vargas J Julián, 2009, Rev. Fac. Nac. Salud Pública, V27, P121; Waiswa P, 2012, B WORLD HEALTH ORGAN, V90, P403, DOI 10.2471/BLT.12.105718; Waiswa P, 2010, TROP MED INT HEALTH, V15, P964, DOI 10.1111/j.1365-3156.2010.02557.x; WHO, 2013, DENG SEV DENG; Wilder-Smith A, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.17273; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2004, NUMB REV MAT DEATHS; World Health Organization, 2013, VERB AUT STAND ASC A; World Health Organization, 2012, GLOB STRAT DENG PREV, DOI [10.1093/trstmh/tru209, DOI 10.1093/TRSTMH/TRU209]	52	9	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117455	10.1371/journal.pone.0117455	http://dx.doi.org/10.1371/journal.pone.0117455			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658485	gold, Green Submitted, Green Published			2022-12-27	WOS:000349444900153
J	Fernandez-Marino, AI; Cidad, P; Zafra, D; Nocito, L; Dominguez, J; Olivan-Viguera, A; Kohler, R; Lopez-Lopez, JR; Perez-Garcia, MT; Valverde, MA; Guinovart, JJ; Fernandez-Fernandez, JM				Isabel Fernandez-Marino, Ana; Cidad, Pilar; Zafra, Delia; Nocito, Laura; Dominguez, Jorge; Olivan-Viguera, Aida; Koehler, Ralf; Lopez-Lopez, Jose R.; Perez-Garcia, Maria Teresa; Valverde, Miguel Angel; Guinovart, Joan J.; Fernandez-Fernandez, Jose M.			Tungstate-Targeting of BK alpha beta(1) Channels Tunes ERK Phosphorylation and Cell Proliferation in Human Vascular Smooth Muscle	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; INDUCED DIABETIC-RATS; SODIUM TUNGSTATE; HIGH-CONDUCTANCE; BETA-1 SUBUNIT; ANTIDIABETIC AGENT; GLYCOGEN-SYNTHESIS; VOLTAGE SENSOR; BLOOD-PRESSURE; MAXIK-CHANNEL	Despite the substantial knowledge on the antidiabetic, antiobesity and antihypertensive actions of tungstate, information on its primary target/s is scarce. Tungstate activates both the ERK1/2 pathway and the vascular voltage-and Ca2+-dependent large-conductance BK alpha beta(1) potassium channel, which modulates vascular smooth muscle cell (VSMC) proliferation and function, respectively. Here, we have assessed the possible involvement of BK alpha beta(1) channels in the tungstate-induced ERK phosphorylation and its relevance for VSMC proliferation. Western blot analysis in HEK cell lines showed that expression of vascular BK alpha beta(1) channels potentiates the tungstate-induced ERK1/2 phosphorylation in a G(i/o) protein-dependent manner. Tungstate activated BK alpha beta(1) channels upstream of G proteins as channel activation was not altered by the inhibition of G proteins with GDP beta S or pertussis toxin. Moreover, analysis of Gi/o protein activation measuring the FRET among heterologously expressed G(i) protein subunits suggested that tungstate-targeting of BK alpha beta(1) channels promotes G protein activation. Single channel recordings on VSMCs from wild-type and beta(1)-knockout mice indicated that the presence of the regulatory beta(1) subunit was essential for the tungstate-mediated activation of BK channels in VSMCs. Moreover, the specific BK channel blocker iberiotoxin lowered tungstate-induced ERK phosphorylation by 55% and partially reverted (by 51%) the tungstate-produced reduction of platelet-derived growth factor (PDGF)induced proliferation in human VSMCs. Our observations indicate that tungstate-targeting of BK alpha beta(1) channels promotes activation of PTX-sensitive G(i) proteins to enhance the tungstate-induced phosphorylation of ERK, and inhibits PDGF-stimulated cell proliferation in human vascular smooth muscle.	[Isabel Fernandez-Marino, Ana; Valverde, Miguel Angel; Fernandez-Fernandez, Jose M.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Lab Fisiol Mol & Canalopaties, Barcelona, Spain; [Cidad, Pilar; Lopez-Lopez, Jose R.; Perez-Garcia, Maria Teresa] Univ Valladolid, Dept Bioquim & Biol Mol & Fisiol, Valladolid, Spain; [Cidad, Pilar; Lopez-Lopez, Jose R.; Perez-Garcia, Maria Teresa] Univ Valladolid, IBGM, Valladolid, Spain; [Cidad, Pilar; Lopez-Lopez, Jose R.; Perez-Garcia, Maria Teresa] CSIC, Valladolid, Spain; [Zafra, Delia; Nocito, Laura; Dominguez, Jorge; Guinovart, Joan J.] Univ Barcelona, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Zafra, Delia; Nocito, Laura; Dominguez, Jorge; Guinovart, Joan J.] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain; [Zafra, Delia; Nocito, Laura; Dominguez, Jorge; Guinovart, Joan J.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Olivan-Viguera, Aida; Koehler, Ralf] Aragon Inst Hlth Sci I CS IIS, Zaragoza, Spain; [Olivan-Viguera, Aida; Koehler, Ralf] Fdn Agencia Aragonesa Invest & Desarrollo ARAID, Zaragoza, Spain	Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Fernandez-Fernandez, JM (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Lab Fisiol Mol & Canalopaties, Barcelona, Spain.	jmanuel.fernandez@upf.edu	López, José Ramón López/A-5541-2009; Fernández-Fernández, José Manuel M/M-8157-2015; Oliván-Viguera, Aida/ABG-4048-2020; Cidad, Pilar/G-1904-2016; Perez-Garcia, M. Teresa/F-5173-2015; Oliván-Viguera, Aida/I-4260-2015	López, José Ramón López/0000-0002-3870-421X; Fernández-Fernández, José Manuel M/0000-0003-2330-8449; Oliván-Viguera, Aida/0000-0001-5348-924X; Cidad, Pilar/0000-0002-6338-7738; Perez-Garcia, M. Teresa/0000-0001-8540-8117; Oliván-Viguera, Aida/0000-0001-5348-924X; Valverde, Miguel A./0000-0002-6961-3361; Zafra, Delia/0000-0003-4143-0659; Fernandez-Marino, Ana/0000-0002-6995-4529	Spanish Ministry of Economy and Competitiveness [SAF2012-31089, SAF2012-38140, BFU2013-45867-R]; FEDER Funds, Ministry of Science and Innovation [BFU 2008-00769, BFU2010-15898]; Instituto de Salud Carlos III [RIC RD12/0042/0006, RD12/0042/0014, Red HERACLES]; Junta de Castilla y Leon [VA094A11-2]; European Community [FP7-People-CIG-321721]	Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER Funds, Ministry of Science and Innovation; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Junta de Castilla y Leon(Junta de Castilla y Leon); European Community(European Commission)	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF2012-31089 to JMFF, SAF2012-38140 to MAV, BFU2013-45867-R to JRLL), FEDER Funds, Ministry of Science and Innovation (BFU 2008-00769 to JG, BFU2010-15898 to MTPG), Instituto de Salud Carlos III (RIC RD12/0042/0006, RD12/0042/0014, Red HERACLES) and Junta de Castilla y Leon (VA094A11-2 to JRLL) and European Community (FP7-People-CIG-321721 to RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigo-Correig M, 2011, DIABETES OBES METAB, V13, P235, DOI 10.1111/j.1463-1326.2010.01339.x; Ballester J, 2005, J ANDROL, V26, P706, DOI 10.2164/jandrol.04156; Banerjee A, 2013, ELIFE, V2, DOI 10.7554/eLife.00594; Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; BARBERA A, 1994, J BIOL CHEM, V269, P20047; Barbera A, 1997, DIABETOLOGIA, V40, P143, DOI 10.1007/s001250050655; Barbera A, 2001, DIABETOLOGIA, V44, P507, DOI 10.1007/s001250100479; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Bukiya AN, 2007, MOL PHARMACOL, V72, P359, DOI 10.1124/mol.107.034330; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Chen XX, 2011, J GEN PHYSIOL, V138, P137, DOI 10.1085/jgp.201110632; Cidad P, 2015, PFLUG ARCH EUR J PHY, V467, P1711, DOI 10.1007/s00424-014-1607-y; Cidad P, 2010, ARTERIOSCL THROM VAS, V30, P1203, DOI 10.1161/ATVBAHA.110.205187; Claret M, 2005, ENDOCRINOLOGY, V146, P4362, DOI 10.1210/en.2005-0385; Contreras GF, 2012, P NATL ACAD SCI USA, V109, P18991, DOI 10.1073/pnas.1216953109; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Dick GM, 2001, J BIOL CHEM, V276, P44835, DOI 10.1074/jbc.M106851200; Dominguez JE, 2003, J BIOL CHEM, V278, P42785, DOI 10.1074/jbc.M308334200; Fernandez-Fernandez JM, 2004, J CLIN INVEST, V113, P1032, DOI 10.1172/JCI200420347; Fernandez-Marino AI, 2014, PFLUG ARCH EUR J PHY, V466, P1365, DOI 10.1007/s00424-013-1379-9; Fernandez-Marino AI, 2012, CARDIOVASC RES, V95, P29, DOI 10.1093/cvr/cvs139; GIANGIACOMO KM, 1992, BIOCHEMISTRY-US, V31, P6719, DOI 10.1021/bi00144a011; Giron MD, 2008, DIABETOLOGIA, V51, P1285, DOI 10.1007/s00125-008-1003-2; Gomez-Ramos A, 2006, J NEUROSCI RES, V83, P264, DOI 10.1002/jnr.20726; Gruslova A, 2012, J GEN PHYSIOL, V139, P57, DOI 10.1085/jgp.201110698; Guo TB, 2005, AM J PHYSIOL-CELL PH, V289, pC257, DOI 10.1152/ajpcell.00010.2005; Hanner M, 1998, J BIOL CHEM, V273, P16289, DOI 10.1074/jbc.273.26.16289; Hanner M, 1997, P NATL ACAD SCI USA, V94, P2853, DOI 10.1073/pnas.94.7.2853; Hanzu F, 2010, DIABETES OBES METAB, V12, P1013, DOI 10.1111/j.1463-1326.2010.01293.x; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kohler R, 2012, CARDIOVASC RES, V95, P3, DOI 10.1093/cvr/cvs169; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Li M, 2010, P NATL ACAD SCI USA, V107, P19096, DOI 10.1073/pnas.1002685107; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Miguel-Velado E, 2005, CIRC RES, V97, P1280, DOI 10.1161/01.RES.0000194322.91255.13; Millership JE, 2011, AM J PHYSIOL-CELL PH, V300, pC792, DOI 10.1152/ajpcell.00274.2010; Munoz MC, 2001, DIABETES, V50, P131, DOI 10.2337/diabetes.50.1.131; Olivan-Viguera A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058614; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Peredo HA, 2010, CLIN EXP HYPERTENS, V32, P453, DOI 10.3109/10641961003686443; Piskorowski RA, 2006, J GEN PHYSIOL, V127, P557, DOI 10.1085/jgp.200509482; Reusch HP, 2001, J BIOL CHEM, V276, P19540, DOI 10.1074/jbc.M101963200; Reusch HP, 2001, J BIOL CHEM, V276, P33630, DOI 10.1074/jbc.M105322200; Sankaranarayanan A, 2009, MOL PHARMACOL, V75, P281, DOI 10.1124/mol.108.051425; Schauwienold D, 2003, HYPERTENSION, V41, P546, DOI 10.1161/01.HYP.0000054213.37471.84; SCHWARTZ SM, 1984, PROG CARDIOVASC DIS, V26, P355, DOI 10.1016/0033-0620(84)90010-0; Suzuki H, 1998, P NATL ACAD SCI USA, V95, P4754, DOI 10.1073/pnas.95.8.4754; Swei A, 1999, MICROCIRCULATION, V6, P179, DOI 10.1038/sj.mn.7300070; Tanaka Y, 2004, J PHARMACOL SCI, V94, P339, DOI 10.1254/jphs.94.339; TWITCHELL WA, 1994, MOL PHARMACOL, V46, P793; Valverde MA, 1999, SCIENCE, V285, P1929, DOI 10.1126/science.285.5435.1929; Xu DZ, 1999, BLOOD, V94, P139, DOI 10.1182/blood.V94.1.139.413k11_139_145; Zafra D, 2013, FEBS LETT, V587, P291, DOI 10.1016/j.febslet.2012.11.034; Zhou XB, 2008, J BIOL CHEM, V283, P21036, DOI 10.1074/jbc.M800447200	57	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118148	10.1371/journal.pone.0118148	http://dx.doi.org/10.1371/journal.pone.0118148			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659150	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900267
J	Isobe, A; Sawada, K; Kinose, Y; Ohyagi-Hara, C; Nakatsuka, E; Makino, H; Ogura, T; Mizuno, T; Suzuki, N; Morii, E; Nakamura, K; Sawada, I; Toda, A; Hashimoto, K; Mabuchi, S; Ohta, T; Morishige, K; Kurachi, H; Kimura, T				Isobe, Aki; Sawada, Kenjiro K; Kinose, Yasuto; Ohyagi-Hara, Chifumi; Nakatsuka, Erika; Makino, Hiroshi; Ogura, Tomonori; Mizuno, Tomoko; Suzuki, Noriko; Morii, Eiichi; Nakamura, Koji; Sawada, Ikuko; Toda, Aska; Hashimoto, Kae; Mabuchi, Seiji; Ohta, Tsuyoshi; Morishige, Ken-ichirou; Kurachi, Hirohisa; Kimura, Tadashi			Interleukin 6 Receptor Is an Independent Prognostic Factor and a Potential Therapeutic Target of Ovarian Cancer	PLOS ONE			English	Article							TUMOR PROGRESSION; M2 MACROPHAGES; CELL CARCINOMA; IN-VIVO; EXPRESSION; ANTIBODY; TOCILIZUMAB; METASTASIS; ASCITES; PATHWAY	Ovarian cancer remains the most lethal gynecologic cancer and new targeted molecular therapies against this miserable disease continue to be challenging. In this study, we analyzed the expressional patterns of Interleukin-6 (IL-6) and its receptor (IL-6R) expression in ovarian cancer tissues, evaluated the impact of these expressions on clinical outcomes of patients, and found that a high-level of IL-6R expression but not IL-6 expression in cancer cells is an independent prognostic factor. In in vitro analyses using ovarian cell lines, while six (RMUG-S, RMG-1, OVISE, A2780, SKOV3ip1 and OVCAR-3) of seven overexpressed IL-6R compared with a primary normal ovarian surface epithelium, only two (RMG-1, OVISE) of seven cell lines overexpressed IL-6, suggesting that IL-6/IL-6R signaling exerts in a paracrine manner in certain types of ovarian cancer cells. Ovarian cancer ascites were collected from patients, and we found that primary CD11b(+)CD14(+) cells, which were predominantly M2-polarized macrophages, are the major source of IL-6 production in an ovarian cancer microenvironment. When CD11b(+)CD14(+) cells were co-cultured with cancer cells, both the invasion and the proliferation of cancer cells were robustly promoted and these promotions were almost completely inhibited by pretreatment with anti-IL-6R antibody (tocilizumab). The data presented herein suggest a rationale for anti-IL-6/IL-6R therapy to suppress the peritoneal spread of ovarian cancer, and represent evidence of the therapeutic potential of anti-IL-6R therapy for ovarian cancer treatment.	[Isobe, Aki; Sawada, Kenjiro K; Kinose, Yasuto; Ohyagi-Hara, Chifumi; Nakatsuka, Erika; Nakamura, Koji; Sawada, Ikuko; Toda, Aska; Hashimoto, Kae; Mabuchi, Seiji; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka, Japan; [Ohyagi-Hara, Chifumi] JCHO Osaka Hosp, Dept Obstet & Gynecol, Osaka, Japan; [Makino, Hiroshi; Ogura, Tomonori; Mizuno, Tomoko; Suzuki, Noriko; Morishige, Ken-ichirou] Gifu Univ, Grad Sch Med, Dept Obstet & Gynecol, Gifu, Japan; [Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka, Japan; [Ohta, Tsuyoshi; Kurachi, Hirohisa] Yamagata Univ, Fac Med, Dept Obstet & Gynecol, Yamagata 990, Japan	Osaka University; Gifu University; Osaka University; Yamagata University	Sawada, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka, Japan.	daasawada@gyne.med.osaka-u.ac.jp	Mabuchi, Seiji/AAX-1986-2020		Ministry of Education, Science, Sports and Culture of Japan [21791555, 23592447, 22390308, 23659779]; Osaka Medical Research Foundation for Intractable Diseases	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka Medical Research Foundation for Intractable Diseases	This work was supported by a Grant-in-Aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan (21791555 and 23592447 to KS, 22390308 to HK, and 23659779 to TK). This work was also partly supported by the Osaka Medical Research Foundation for Intractable Diseases (to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2013, J CLIN ONCOL, V31, pE69, DOI 10.1200/JCO.2012.44.2020; Ataie-Kachoie P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060817; Bak SP, 2007, CANCER RES, V67, P4783, DOI 10.1158/0008-5472.CAN-06-4410; Cai QC, 2012, FASEB J, V26, P3306, DOI 10.1096/fj.12-207597; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Dijkgraaf EM, 2013, CANCER RES, V73, P2480, DOI 10.1158/0008-5472.CAN-12-3542; Dijkgraaf EM, 2012, CURR PHARM DESIGN, V18, P3816; Duan ZF, 2006, CLIN CANCER RES, V12, P5055, DOI 10.1158/1078-0432.CCR-06-0861; ERROI A, 1989, INT J CANCER, V44, P795, DOI 10.1002/ijc.2910440508; Fulciniti M, 2009, CLIN CANCER RES, V15, P7144, DOI 10.1158/1078-0432.CCR-09-1483; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Hall M, 2013, BRIT J CANCER, V108, P250, DOI 10.1038/bjc.2012.541; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kawamura K, 2009, PATHOL INT, V59, P300, DOI 10.1111/j.1440-1827.2009.02369.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maccio A, 2012, CYTOKINE, V58, P133, DOI 10.1016/j.cyto.2012.01.015; Mihara M, 2005, INT IMMUNOPHARMACOL, V5, P1731, DOI 10.1016/j.intimp.2005.05.010; MORADI MM, 1993, CANCER, V72, P2433, DOI 10.1002/1097-0142(19931015)72:8<2433::AID-CNCR2820720822>3.0.CO;2-L; Nishimoto N, 2005, BLOOD, V106, P2627, DOI 10.1182/blood-2004-12-4602; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Oguro T, 2013, EUR J CANCER, V49, P1715, DOI 10.1016/j.ejca.2012.11.038; PLANTE M, 1994, CANCER, V73, P1882, DOI 10.1002/1097-0142(19940401)73:7<1882::AID-CNCR2820730718>3.0.CO;2-R; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rath KS, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.034; Reinartz S, 2014, INT J CANCER, V134, P32, DOI 10.1002/ijc.28335; Robinson-Smith TM, 2007, CANCER RES, V67, P5708, DOI 10.1158/0008-5472.CAN-06-4375; SCAMBIA G, 1995, BRIT J CANCER, V71, P354, DOI 10.1038/bjc.1995.71; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; Shinriki S, 2009, CLIN CANCER RES, V15, P5426, DOI 10.1158/1078-0432.CCR-09-0287; Stone RL, 2012, NEW ENGL J MED, V366, P610, DOI 10.1056/NEJMoa1110352; Wang Y, 2012, CYTOKINE, V59, P228, DOI 10.1016/j.cyto.2012.04.020; WATSON JM, 1990, CANCER RES, V50, P6959	33	51	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118080	10.1371/journal.pone.0118080	http://dx.doi.org/10.1371/journal.pone.0118080			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658637	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900262
J	Lombardi, A; Senese, R; De Matteis, R; Busiello, RA; Cioffi, F; Goglia, F; Lanni, A				Lombardi, Assunta; Senese, Rosalba; De Matteis, Rita; Busiello, Rosa Anna; Cioffi, Federica; Goglia, Fernando; Lanni, Antonia			3,5-Diiodo-L-Thyronine Activates Brown Adipose Tissue Thermogenesis in Hypothyroid Rats	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; DIET-INDUCED THERMOGENESIS; HORMONE RECEPTOR BETA-1; RESTING METABOLIC-RATE; CYTOCHROME-C-OXIDASE; FATTY-ACID OXIDATION; THYROID-HORMONE; SKELETAL-MUSCLE; LIVER-MITOCHONDRIA; RAPID STIMULATION	3,5-diiodo-l-thyronine (T2), a thyroid hormone derivative, is capable of increasing energy expenditure, as well as preventing high fat diet-induced overweight and related metabolic dysfunction. Most studies to date on T2 have been carried out on liver and skeletal muscle. Considering the role of brown adipose tissue (BAT) in energy and metabolic homeostasis, we explored whether T2 could activate BAT thermogenesis. Using euthyroid, hypothyroid, and T2-treated hypothyroid rats (all maintained at thermoneutrality) in morphological and functional studies, we found that hypothyroidism suppresses the maximal oxidative capacity of BAT and thermogenesis, as revealed by reduced mitochondrial content and respiration, enlarged cells and lipid droplets, and increased number of unilocular cells within the tissue. In vivo administration of T2 to hypothyroid rats activated BAT thermogenesis and increased the sympathetic innervation and vascularization of tissue. Likewise, T2 increased BAT oxidative capacity in vitro when added to BAT homogenates from hypothyroid rats. In vivo administration of T2 to hypothyroid rats enhanced mitochondrial respiration. Moreover, UCP1 seems to be a molecular determinant underlying the effect of T2 on mitochondrial thermogenesis. In fact, inhibition of mitochondrial respiration by GDP and its reactivation by fatty acids were greater in mitochondria from T2-treated hypothyroid rats than untreated hypothyroid rats. In vivo administration of T2 led to an increase in PGC-1 alpha protein levels in nuclei (transient) and mitochondria (longer lasting), suggesting a coordinate effect of T2 in these organelles that ultimately promotes net activation of mitochondrial biogenesis and BAT thermogenesis. The effect of T2 on PGC-1 alpha is similar to that elicited by triiodothyronine. As a whole, the data reported here indicate T2 is a thyroid hormone derivative able to activate BAT thermogenesis.	[Lombardi, Assunta] Univ Naples Federico II, Dipartimento Biol, Naples, Italy; [Senese, Rosalba; Lanni, Antonia] Univ Naples 2, Dipartimento Sci & Tecnol Ambientali, Caserta, Italy; [De Matteis, Rita] Univ Urbino Carlo Bo, Dipartimento Sci Biomol, Sez Sci Motorie & Salute, Urbino, Italy; [Busiello, Rosa Anna; Cioffi, Federica; Goglia, Fernando] Univ Sannio, Dipartimento Sci & Tecnol, Benevento, Italy	University of Naples Federico II; Universita della Campania Vanvitelli; University of Urbino; University of Sannio	Goglia, F (corresponding author), Univ Sannio, Dipartimento Sci & Tecnol, Benevento, Italy.	goglia@unisannio.it; antonia.lanni@unina2.it	cioffi, federica/AAB-8161-2019; De+Matteis, Rita/AAG-6904-2019	cioffi, federica/0000-0002-1530-8556; GOGLIA, Fernando/0000-0003-0468-9645; DE MATTEIS, Rita/0000-0003-4665-4547; SENESE, Rosalba/0000-0003-1571-0980	COFIN-MIUR [20089SRS2X]; POR Campania [FSE 2007/2013]	COFIN-MIUR(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); POR Campania(Regione Campania)	This work was partially supported by COFIN-MIUR 2008 Protocol No. 20089SRS2X. Rosa Anna Busiello received a grant from POR Campania FSE 2007/2013 project MODO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2011, J BIOL REG HOMEOS AG, V25, P655; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Arnold S, 1998, EUR J BIOCHEM, V252, P325, DOI 10.1046/j.1432-1327.1998.2520325.x; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Ball SG, 1997, J MOL ENDOCRINOL, V19, P137, DOI 10.1677/jme.0.0190137; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bartelt A., 2012, Journal of Molecular Medicine, V90, P887, DOI 10.1007/s00109-012-0858-3; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Baxter JD, 2009, NAT REV DRUG DISCOV, V8, P308, DOI 10.1038/nrd2830; Boss O, 2012, FRONT ENDOCRINOL LAU, V6, P14, DOI [10.1056/NEJMoa0808718, DOI 10.1056/NEJM0A0808718]; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2012, J CLIN INVEST, V122, P486, DOI 10.1172/JCI60941; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; Carvalho SD, 1996, ENDOCRINOLOGY, V137, P5519, DOI 10.1210/en.137.12.5519; Cavallo A, 2011, J BIOENERG BIOMEMBR, V43, P349, DOI 10.1007/s10863-011-9366-3; Cimmino M, 1996, J ENDOCRINOL, V149, P319, DOI 10.1677/joe.0.1490319; Cinti S, 1999, THE ADIPOSE ORGAN KU; Cioffi F, 2010, FASEB J, V24, P3451, DOI 10.1096/fj.10-157115; de Lange P, 2011, DIABETES, V60, P2730, DOI 10.2337/db11-0207; De Matteis R, 2013, NUTR METAB CARDIOVAS, V23, P582, DOI 10.1016/j.numecd.2012.01.013; De Matteis R, 1998, J NEUROCYTOL, V27, P877, DOI 10.1023/A:1006996922657; Doyle KP, 2007, STROKE, V38, P2569, DOI 10.1161/STROKEAHA.106.480277; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Figueiredo AS, 2014, J ENDOCRINOL, V221, P415, DOI [10.1530/JOE-13-0502, DOI 10.1530/JOE-13-0502]; Fredriksson JM, 2000, J BIOL CHEM, V275, P13802, DOI 10.1074/jbc.275.18.13802; GOGLIA F, 1994, FEBS LETT, V346, P295, DOI 10.1016/0014-5793(94)00476-5; Goglia F, 2005, BIOCHEMISTRY-MOSCOW+, V70, P164, DOI 10.1007/s10541-005-0097-0; Grasselli E, 2012, J ENDOCRINOL, V212, P149, DOI 10.1530/JOE-11-0288; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Jonas W, 2014, ENDOCRINOLOGY, V16; Klaus S, 2004, CURR DRUG TARGETS, V5, P241, DOI 10.2174/1389450043490523; Lanni A, 2005, FASEB J, V19, DOI 10.1096/fj.05.3977fje; LANNI A, 1993, J ENDOCRINOL, V136, P59, DOI 10.1677/joe.0.1360059; Lanni A, 1998, PFLUG ARCH EUR J PHY, V436, P407, DOI 10.1007/s004240050650; LANNI A, 1994, MOL CELL ENDOCRINOL, V99, P89, DOI 10.1016/0303-7207(94)90150-3; Lanni A, 1996, J PHYSIOL-LONDON, V494, P831, DOI 10.1113/jphysiol.1996.sp021536; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lombardi A, 2009, AM J PHYSIOL-ENDOC M, V296, pE497, DOI 10.1152/ajpendo.90642.2008; Lombardi A, 2007, FEBS LETT, V581, P5911, DOI 10.1016/j.febslet.2007.11.073; Lombardi A, 2012, AM J PHYSIOL-ENDOC M, V303, pE1222, DOI 10.1152/ajpendo.00037.2012; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Mendoza A, 2013, ENDOCRINOLOGY, V154, P2948, DOI 10.1210/en.2013-1030; Moreno M, 1997, J PHYSIOL-LONDON, V505, P529, DOI 10.1111/j.1469-7793.1997.529bb.x; Moreno M, 2002, ENDOCRINOLOGY, V143, P504, DOI 10.1210/en.143.2.504; Moreno M, 2008, THYROID, V18, P239, DOI 10.1089/thy.2007.0248; Moreno M, 2011, FASEB J, V25, P3312, DOI 10.1096/fj.11-181982; Navarrete-Ramirez P, 2014, J MOL ENDOCRINOL, V52, P1, DOI 10.1530/JME-13-0145; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nedergaard J, 2011, CELL METAB, V13, P238, DOI 10.1016/j.cmet.2011.02.009; OREILLY I, 1992, ACTA ENDOCRINOL-COP, V127, P542, DOI 10.1530/acta.0.1270542; Padron AS, 2014, J ENDOCRINOL, V221, P415, DOI 10.1530/JOE-13-0502; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Ribeiro MO, 2001, J CLIN INVEST, V108, P97, DOI 10.1172/JCI12584; ROTHWELL NJ, 1983, CLIN SCI, V64, P19, DOI 10.1042/cs0640019; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Scanlan TS, 2004, NAT MED, V10, P638, DOI 10.1038/nm1051; Shang GG, 2013, BBA-MOL BASIS DIS, V1832, P674, DOI 10.1016/j.bbadis.2013.01.023; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; SUNDIN U, 1984, METABOLISM, V33, P1028, DOI 10.1016/0026-0495(84)90232-4	62	33	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116498	10.1371/journal.pone.0116498	http://dx.doi.org/10.1371/journal.pone.0116498			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658324	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900044
J	Mengist, HM; Taye, B; Tsegaye, A				Mengist, Hylemariam Mihiretie; Taye, Bineyam; Tsegaye, Aster			Intestinal Parasitosis in Relation to CD4+T Cells Levels and Anemia among HAART Initiated and HAART Naive Pediatric HIV Patients in a Model ART Center in Addis Ababa, Ethiopia	PLOS ONE			English	Article							INFECTION; CHILDREN; PROFILE	Background Intestinal parasites (IPs) are major concerns in most developing countries where HIV/AIDS cases are concentrated and almost 80% of AIDS patients die of AIDS-related infections. In the absence of highly active antiretroviral therapy (HAART), HIV/AIDS patients in developing countries unfortunately continue to suffer from the consequences of opportunistic and other intestinal parasites. The aim of the study was to determine the prevalence of intestinal parasites in relation to CD4+T cells levels and anemia among HAART initiated and HAART naive pediatric HIV patients in a Model ART center in Addis Ababa, Ethiopia. Methods A prospective comparative cross-sectional study was conducted among HAART initiated and HAART naive pediatric HIV/AIDS patients attending a model ART center at Zewditu Memorial Hospital between August 05, 2013 and November 25, 2013. A total of 180 (79 HAART initiated and 101 HAART naive) children were included by using consecutive sampling. Stool specimen was collected and processed using direct wet mount, formol-ether concentration and modified Ziehl-Neelsen staining techniques. A structured questionnaire was used to collect data on socio-demographic and associated risk factors. CD4+T cells and complete blood counts were performed using BD FACScalibur and Cell-Dyn 1800, respectively. The data was analyzed by SPSS version 16 software. Logistic regressions were applied to assess any association between explanatory factors and outcome variables. P values < 0.05 were taken as statistically significant. Results The overall prevalence of IPs was 37.8% where 27.8% of HAART initiated and 45.5% of HAART naive pediatric HIV/AIDS patients were infected (p < 0.05). Cryptosporidium species, E. histolytica/dispar, Hook worm and Taenia species were IPs associated with CD4+T cell counts < 350 cells/mu mu L in HAART naive patients. The overall prevalence of anemia was 10% in HAART and 31.7% in non-HAART groups. Hook worm, S. stercoralis and H. nana were helminthes significantly associated with anemia in non-HAART patients [AOR, 95% CI: 4.5(1.3, 15.2), P<0.05]. The prevalence of IPs in non-HAART patients was significantly associated with eating unwashed/raw fruit [AOR, 95% CI: 6.3(1.2, 25.6), P<0.05], open field defecation [AOR, 95% CI: 9.3(1.6, 53.6), P<0.05] and diarrhea [AOR, 95% CI: 5.2(1.3, 21.3), P<0.05]. IPs significantly increased in rural residents [AOR, 95% CI: 0.4(0.1, 0.9, P<0.05)]. Conclusion The overall prevalence of intestinal parasites significantly differed by HAART status and cryptosporidium species were found only in HAART naive patients with low CD4+T cell counts. Anemia was also more prevalent and significantly associated with IPs in non-HAART patients. This study identified some environmental and associated risk factors for intestinal parasitic infections. Therefore, Public health measures should continue to emphasize the importance of environmental and personal hygiene to protect HIV/AIDS patients from infections with intestinal parasites and maximize the benefits of HAART.	[Mengist, Hylemariam Mihiretie] Wollega Univ, Fac Med & Hlth Sci, Dept Med Lab Sci, Nekemte, Ethiopia; [Mengist, Hylemariam Mihiretie; Taye, Bineyam; Tsegaye, Aster] Univ Addis Ababa, Coll Hlth Sci, Sch Allied Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia	Addis Ababa University	Mengist, HM (corresponding author), Wollega Univ, Fac Med & Hlth Sci, Dept Med Lab Sci, Nekemte, Ethiopia.	hylemariam@gmail.com	Mengist, Hylemariam Mihiretie/AAA-6133-2022; Tsegaye, Aster/AAH-7028-2020	Tsegaye, Aster/0000-0002-9026-4629; Mengist, Hylemariam Mihiretie/0000-0002-8467-6985	Addis Ababa University	Addis Ababa University	Addis Ababa University sponsored for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamu H, 2009, ETHIOP J HEALTH DEV, V23, P133; Adjei A, 2003, East Afr Med J, V80, P369; Akinbo F. O., 2011, Genomic Medicine, Biomarkers and Health Sciences, V3, P119; Akinbol AO, 2011, TANZANIA J HLTH RES, V13, P10; [Anonymous], 1987, B WORLD HEALTH ORGAN, V65, P575; Anteneh T, 2008, MANUAL INTESTINAL PA, P6; Asma L, 2011, TROP BIOMED, V28, P400; Awole M., 2003, ETHIOP J HEALTH DEV, V17, P71; Cheesbrough M, 1999, DISTRICT LAB PRACT 1, P193; Dufera M., 2008, ETHIOP J HLTH BIOMED, V1, P11; Farthing M, 2009, MANSONS TROPICAL DIS; Habib MK, 2001, I STAT MIMEO, V1840, P1; Huruy K, 2008, JPN J INFECT DIS, V61, P205; Idris NS, 2010, J INFECT DEV COUNTR, V4, P309, DOI 10.3855/jidc.275; Kassu A, 2003, CLIN EXP IMMUNOL, V132, P113, DOI 10.1046/j.1365-2249.2003.02106.x; Le HT, 2007, ASIA PAC J CLIN NUTR, V16, P716; Missaye A, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-7; Mohammed H, 2010, EHNRI, V11, P1; Rao VG, 2006, PUBLIC HEALTH NUTR, V9, P19, DOI 10.1079/PHN2005761; Bachur TPR, 2008, BRAZ J INFECT DIS, V12, P115, DOI 10.1590/S1413-86702008000200004; Telele NF, 2010, REV ANT INFEC DIS, V3, P7; Tian LG, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-36; WHO, 2011, HEM CONC DIAGN AN AS, P3; WHO, 2005, INT WHO CLIN STAG HI, P8; WHO, 1998, 749 WHO, V749, P1; Zeynudin A, 2013, EUR REV MED PHARMACO, V17, P513	26	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117715	10.1371/journal.pone.0117715	http://dx.doi.org/10.1371/journal.pone.0117715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658626	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900208
J	Michaelides, S; Cornish, N; Griffiths, R; Groombridge, J; Zajac, N; Walters, GJ; Aubret, F; While, GM; Uller, T				Michaelides, Sozos; Cornish, Nina; Griffiths, Richard; Groombridge, Jim; Zajac, Natalia; Walters, Graham J.; Aubret, Fabien; While, Geoffrey M.; Uller, Tobias			Phylogeography and Conservation Genetics of the Common Wall Lizard, Podarcis muralis, on Islands at Its Northern Range	PLOS ONE			English	Article							POPULATION-STRUCTURE; SPECIES RANGE; DIVERSITY; INFERENCE; SOFTWARE; REVEALS; REFUGIA; ORIGIN; ALIEN	Populations at range limits are often characterized by lower genetic diversity, increased genetic isolation and differentiation relative to populations at the core of geographical ranges. Furthermore, it is increasingly recognized that populations situated at range limits might be the result of human introductions rather than natural dispersal. It is therefore important to document the origin and genetic diversity of marginal populations to establish conservation priorities. In this study, we investigate the phylogeography and genetic structure of peripheral populations of the common European wall lizard, Podarcis muralis, on Jersey (Channel Islands, UK) and in the Chausey archipelago. We sequenced a fragment of the mitochondrial cytochrome b gene in 200 individuals of P. muralis to infer the phylogeography of the island populations using Bayesian approaches. We also genotyped 484 individuals from 21 populations at 10 polymorphic microsatellite loci to evaluate the genetic structure and diversity of island and mainland (Western France) populations. We detected four unique haplotypes in the island populations that formed a sub-clade within the Western France clade. There was a significant reduction in genetic diversity (H-O, H-E and A(R)) of the island populations in relation to the mainland. The small fragmented island populations at the northern range margin of the common wall lizard distribution are most likely native, with genetic differentiation reflecting isolation following sea level increase approximately 7000 BP. Genetic diversity is lower on islands than in marginal populations on the mainland, potentially as a result of early founder effects or long-term isolation. The combination of restriction to specific localities and an inability to expand their range into adjacent suitable locations might make the island populations more vulnerable to extinction.	[Michaelides, Sozos; Zajac, Natalia; While, Geoffrey M.; Uller, Tobias] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Cornish, Nina] States Jersey, Dept Environm, Trinity JE3 5JP, Jersey, England; [Griffiths, Richard; Groombridge, Jim] Univ Kent, DICE, Sch Anthropol & Conservat, Canterbury CT2 7NR, Kent, England; [Walters, Graham J.] London Metropolitan Univ, Int Inst Culture Tourism & Dev, London N7 8HN, England; [Aubret, Fabien] CNRS, Stn Ecol Expt Moulis, F-09200 St Girons, France; [While, Geoffrey M.] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia; [Uller, Tobias] Lund Univ, Dept Biol, SE-22362 Lund, Sweden	University of Oxford; University of Kent; London Metropolitan University; Centre National de la Recherche Scientifique (CNRS); University of Tasmania; Lund University	Michaelides, S (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England.	sozos.michaelides@zoo.ox.ac.uk; tobias.uller@zoo.ox.ac.uk	While, Geoffrey M/O-6306-2017; Michaelides, Sozos/G-3239-2011	While, Geoffrey M/0000-0001-8122-9322; Michaelides, Sozos/0000-0001-7636-5768	Royal Society of London; Knut Foundation; FP7 Marie Curie Fellowship; Biotechnology and Biological Sciences Research Council (BBSRC); AG Leventis Foundation Trust; Alice Wallenberg Foundation; Biotechnology and Biological Sciences Research Council [1091476] Funding Source: researchfish	Royal Society of London(Royal Society of London); Knut Foundation; FP7 Marie Curie Fellowship; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AG Leventis Foundation Trust; Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	TU is supported by the Royal Society of London and the Knut and Alice Wallenberg Foundations. GMW was supported by an FP7 Marie Curie Fellowship. SM is supported by the Biotechnology and Biological Sciences Research Council (BBSRC) and the AG Leventis Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansted DT, 1865, THE CHANNEL ISLANDS; AVERY RA, 1989, J ZOOL, V217, P73, DOI 10.1111/j.1469-7998.1989.tb02475.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beebee TJC, 2005, BIODIVERS CONSERV, V14, P1607, DOI 10.1007/s10531-004-0532-3; Bellati A, 2011, J ZOOL SYST EVOL RES, V49, P240, DOI 10.1111/j.1439-0469.2011.00619.x; Berry RJ, 2009, ISLANDS; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Buckley J, 2005, REINTRODUCTION STRAT; Bunnell FL, 2004, CAN J FOREST RES, V34, P2240, DOI [10.1139/x04-102, 10.1139/X04-102]; Cd Gibon, 1919, ANCRE MARINE, V541; Cornish N., 2011, GENETIC DIVERSITY CO; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Deichsel Guntram, 2004, Herpetological Review, V35, P289; Drummond A., 2011, GENEIOUS V6 1 7; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Gadeau de Kerville H, 1894, RECHERCHES FAUNES MA, P1; Gadeau de Kerville H, 1897, FAUNE NORMANDIE, P1; Gassert F, 2013, J BIOGEOGR, V40, P1475, DOI 10.1111/jbi.12109; Giovannotti M, 2010, ITAL J ZOOL, V77, P277, DOI 10.1080/11250000903143885; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gruschwitz M, 1986, HDB AMPHIBIEN REPTIL, P155; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Heathcote RJP, 2014, CONSERVATION GENETIC; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUNTER ML, 1994, CONSERV BIOL, V8, P1163, DOI 10.1046/j.1523-1739.1994.08041163.x; Jones RL, 1993, QUANERNARY JERSEY FI, P35; Joseph-Lafosse P, 1891, B SOC LINN NORMANDIE, V5, P169; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Le Sueur F, 1976, NATURAL HIST JERSEY; Leberg PL, 2008, MOL ECOL, V17, P334, DOI 10.1111/j.1365-294X.2007.03433.x; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Livory A, 1997, FLORE CHAUSEY ARCHIP, P87; Michaelides S, 2013, BIOL INVASIONS, V15, P1101, DOI 10.1007/s10530-012-0353-3; MILLAR CI, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P149; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Podnar M, 2004, ORG DIVERS EVOL, V4, P307, DOI 10.1016/j.ode.2004.04.004; Podnar M, 2007, J MOL EVOL, V64, P308, DOI 10.1007/s00239-005-0259-0; Pritchard JK, 2000, GENETICS, V155, P945; Quatrefages AD, 1842, REV DEUX MONDES, P1; R Development Core Team, 2011, R LANG ENV STAT COMP, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Richard M, 2012, MOL ECOLOGY RESOURCE, P1; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Salvi D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-147; Schulte U, 2008, DIE MAUEREIDECHSE; Schulte U, 2012, AMPHIBIA-REPTILIA, V33, P129, DOI 10.1163/156853812X626160; Schulte U, 2012, GLOBAL ECOL BIOGEOGR, V21, P198, DOI 10.1111/j.1466-8238.2011.00665.x; Schulte Ulrich, 2008, Zeitschrift fuer Feldherpetologie, V15, P139; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Sinel J, 1908, T SOC GUERNESIAISE, V4, P466; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Uller T, 2011, GLOBAL CHANGE BIOL, V17, P3478, DOI 10.1111/j.1365-2486.2011.02509.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; Walters GJ, 2006, B SOC ZOOLOGIQUE FRA, P131	60	10	11	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117113	10.1371/journal.pone.0117113	http://dx.doi.org/10.1371/journal.pone.0117113			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659074	Green Published, gold, Green Accepted			2022-12-27	WOS:000349444900104
J	Qin, T; Yin, YY; Yu, QH; Yang, Q				Qin, Tao; Yin, Yinyan; Yu, Qinghua; Yang, Qian			Bursopentin (BP5) Protects Dendritic Cells from Lipopolysaccharide-Induced Oxidative Stress for Immunosuppression	PLOS ONE			English	Article							NF-KAPPA-B; HEME OXYGENASE-1; NITRIC-OXIDE; CHICKEN BURSA; ANTIGEN PRESENTATION; FREE-RADICALS; ANTIBODY-PRODUCTION; ADAPTIVE IMMUNITY; GENE-EXPRESSION; CYTOCHROME-C	Dendritic cells (DCs) play a vital role in the regulation of immune-mediated inflammatory diseases. Thus, DCs have been regarded as a major target for the development of immuno-modulators. However, oxidative stress could disturb inflammatory regulation in DCs. Here, we examined the effect of bursopentine (BP5), a novel pentapeptide isolated from chicken bursa of fabricius, on the protection of DCs against oxidative stress for immunosuppression. BP5 showed potent protective effects against the lipopolysaccharide (LPS)-induced oxidative stress in DCs, including nitric oxide, reactive oxygen species and lipid peroxidation. Furthermore, BP5 elevated the level of cellular reductive status through increasing the reduced glutathione (GSH) and the GSH/GSSG ratio. Concomitant with these, the activities of several antioxidative redox enzymes, including glutathione peroxidase (GPx), catalase (CAT) and superoxide dismutase (SOD), were obviously enhanced. BP5 also suppressed submucosal DC maturation in the LPS-stimulated intestinal epithelial cells (ECs)/DCs coculture system. Finally, we found that heme oxygenase 1 (HO-1) was remarkably upregulated by BP5 in the LPS-induced DCs, and played an important role in the suppression of oxidative stress and DC maturation. These results suggested that BP5 could protect the LPS-activated DCs against oxidative stress and have potential applications in DC-related inflammatory responses.	[Qin, Tao; Yin, Yinyan; Yu, Qinghua; Yang, Qian] Nanjing Agr Univ, Coll Vet Med, Chinas Dept Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, Q (corresponding author), Nanjing Agr Univ, Coll Vet Med, Chinas Dept Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China.	zxbyq@njau.edu.cn	Qin, Tao/AAB-3778-2021; Yu, Qinghua/T-3261-2019; yu, qing/HGC-4611-2022; YIN, Yinyan/GPK-5820-2022	Qin, Tao/0000-0003-1596-2168; 	National Natural Science Foundation of China [31172302]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Natural Science Foundation of China (31172302) and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Huseini LMA, 2014, J BIOL CHEM, V289, P16442, DOI 10.1074/jbc.M113.532069; Almenier Hazem A, 2012, Front Biosci (Elite Ed), V4, P1335; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bai SK, 2005, EXP MOL MED, V37, P323, DOI 10.1038/emm.2005.42; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Biswas S, 2013, CURR MED CHEM, V20, P1496, DOI 10.2174/0929867311320120004; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; BRAND A, 1976, SCIENCE, V193, P319, DOI 10.1126/science.180600; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Carey IM, 1998, AM J RESP CRIT CARE, V158, P728, DOI 10.1164/ajrccm.158.3.9712065; Chan RCF, 2006, J ALLERGY CLIN IMMUN, V118, P455, DOI 10.1016/j.jaci.2006.06.006; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Chen DY, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/125643; Chernatynskaya AV, 2011, DIABETES-METAB RES, V27, P809, DOI 10.1002/dmrr.1232; Corinti S, 2003, J INTERF CYTOK RES, V23, P423, DOI 10.1089/107999003322277838; DEAKIN AM, 1995, CYTOKINE, V7, P408, DOI 10.1006/cyto.1995.0056; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; DiazSanchez D, 1997, J IMMUNOL, V158, P2406; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Feng XL, 2012, AMINO ACIDS, V43, P2443, DOI 10.1007/s00726-012-1323-x; Feng XL, 2012, PEPTIDES, V36, P292, DOI 10.1016/j.peptides.2012.04.015; Feng XL, 2013, VACCINE, V31, P1535, DOI 10.1016/j.vaccine.2012.09.022; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Hespel C, 2012, EUR J IMMUNOL, V42, P2535, DOI 10.1002/eji.201242480; Hildeman DA, 2003, J CLIN INVEST, V111, P575, DOI 10.1172/JCI200318007; Hussain SP, 2008, CANCER RES, V68, P7130, DOI 10.1158/0008-5472.CAN-08-0410; Im E, 2012, AM J PHYSIOL-GASTR L, V303, pG490, DOI 10.1152/ajpgi.00120.2012; Jeong GS, 2011, EUR J PHARMACOL, V654, P226, DOI 10.1016/j.ejphar.2010.12.027; Ji YB, 2011, EXP TOXICOL PATHOL, V63, P69, DOI 10.1016/j.etp.2009.09.010; Kantengwa S, 2003, AM J RESP CRIT CARE, V167, P431, DOI 10.1164/rccm.200205-425OC; Kim GY, 2004, IMMUNOLOGY, V113, P203, DOI 10.1111/j.1365-2567.2004.01945.x; Kuppner MC, 2003, BLOOD, V102, P3668, DOI 10.1182/blood-2003-05-1408; LASSILA O, 1989, CELL IMMUNOL, V122, P319, DOI 10.1016/0008-8749(89)90080-4; Li DY, 2011, AMINO ACIDS, V40, P505, DOI 10.1007/s00726-010-0663-7; Li DY, 2012, CELL PHYSIOL BIOCHEM, V29, P9, DOI 10.1159/000337581; Liu HY, 2012, J ETHNOPHARMACOL, V141, P982, DOI 10.1016/j.jep.2012.03.029; Liu SH, 2010, J AGR FOOD CHEM; Liu XD, 2013, REGUL PEPTIDES, V186, P57, DOI 10.1016/j.regpep.2013.07.007; Liu XD, 2012, PEPTIDES, V35, P107, DOI 10.1016/j.peptides.2012.03.003; Lushchak VI, 2012, AMINO ACIDS, V2012, DOI [10.1155/2012/736837, DOI 10.1155/2012/736837]; Maemura K, 2005, IMMUNOL CELL BIOL, V83, P336, DOI 10.1111/j.1440-1711.2005.01323.x; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; MASTELLER EL, 1995, J IMMUNOL, V155, P5550; Matsue H, 2003, J IMMUNOL, V171, P3010, DOI 10.4049/jimmunol.171.6.3010; Matsumoto H, 2006, MOL CELL BIOCHEM, V291, P21, DOI 10.1007/s11010-006-9190-y; McDaid J, 2005, FASEB J, V19, P458, DOI 10.1096/fj.04-2217fje; Mileti E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007056; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Miwa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052926; MUELLER AP, 1962, J IMMUNOL, V88, P354; Oh GS, 2006, FREE RADICAL BIO MED, V41, P106, DOI 10.1016/j.freeradbiomed.2006.03.021; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Park Y, 2014, INT IMMUNOPHARMACOL, V22, P400, DOI 10.1016/j.intimp.2014.07.023; Peterson JD, 1998, P NATL ACAD SCI USA, V95, P3071, DOI 10.1073/pnas.95.6.3071; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rimoldi M, 2004, ANN NY ACAD SCI, V1029, P66, DOI 10.1196/annals.1309.009; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416; Soares MP, 2009, CURR OPIN PHARMACOL, V9, P482, DOI 10.1016/j.coph.2009.05.008; Suzuki S, 1999, ONCOGENE, V18, P6380, DOI 10.1038/sj.onc.1203024; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Tan PH, 2005, J IMMUNOL, V174, P7633, DOI 10.4049/jimmunol.174.12.7633; Thamsen M, 2011, CURR OPIN CHEM BIOL, V15, P113, DOI 10.1016/j.cbpa.2010.11.013; Tobwala S, 2013, FREE RADICAL RES, V47, P740, DOI 10.3109/10715762.2013.819974; Victor VM, 2004, INT IMMUNOPHARMACOL, V4, P327, DOI 10.1016/j.intimp.2004.01.020; Victor VM, 2003, FREE RADICAL RES, V37, P19, DOI 10.1080/1071576021000038522; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Wu Q, 2013, ZHONGGUO ZHONGYAO ZA, V38, P2854; Yamada H, 2006, LIFE SCI, V78, P926, DOI 10.1016/j.lfs.2005.05.106; Yin YY, 2014, AMINO ACIDS, V46, P1763, DOI 10.1007/s00726-014-1735-x; Zeng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034830	76	21	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117477	10.1371/journal.pone.0117477	http://dx.doi.org/10.1371/journal.pone.0117477			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659113	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900158
J	Schokker, D; Zhang, J; Vastenhouw, SA; Heilig, HGHJ; Smidt, H; Rebel, JMJ; Smits, MA				Schokker, Dirkjan; Zhang, Jing; Vastenhouw, Stephanie A.; Heilig, Hans G. H. J.; Smidt, Hauke; Rebel, Johanna M. J.; Smits, Mari A.			Long-Lasting Effects of Early-Life Antibiotic Treatment and Routine Animal Handling on Gut Microbiota Composition and Immune System in Pigs	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; BACTERIAL; EXTRACTION; EXPRESSION; HEALTH; YOUNG; DIET; DNA	Background In intensive pig husbandry systems, antibiotics are frequently administrated during early life stages to prevent respiratory and gastro-intestinal tract infections, often in combination with stressful handlings. The immediate effects of these treatments on microbial colonization and immune development have been described recently. Here we studied whether the early life administration of antibiotics has long-lasting effects on the pig's intestinal microbial community and on gut functionality. Methodology/Principal Findings To investigate the long-lasting effect of early-life treatment, piglets were divided into three different groups receiving the following treatments: 1) no antibiotics and no stress, 2) antibiotics and no stress, and 3) antibiotics and stress. All treatments were applied at day four after birth. Sampling of jejunal content for community scale microbiota analysis, and jejunal and ileal tissue for genome-wide transcription profiling, was performed at day 55 (similar to 8 weeks) and day 176 (similar to 25 weeks) after birth. Antibiotic treatment in combination with or without exposure to stress was found to have long-lasting effects on host intestinal gene expression involved in a multitude of processes, including immune related processes. Conclusions/Significance The results obtained in this study indicate that early life (day 4 after birth) perturbations have long-lasting effects on the gut system, both in gene expression (day 55) as well as on microbiota composition (day 176). At day 55 high variance was observed in the microbiota data, but no significant differences between treatment groups, which is most probably due to the newly acquired microbiota during and right after weaning (day 28). Based on the observed difference in gene expression at day 55, it is hypothesized that due to the difference in immune programming during early life, the systems respond differently to the post-weaning newly acquired microbiota. As a consequence, the gut systems of the treatment groups develop into different homeostasis.	[Schokker, Dirkjan; Smits, Mari A.] Wageningen UR Livestock Res, NL-8200 AB Lelystad, Netherlands; [Zhang, Jing; Heilig, Hans G. H. J.; Smidt, Hauke] Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands; [Vastenhouw, Stephanie A.; Rebel, Johanna M. J.; Smits, Mari A.] Cent Vet Inst, NL-8200 AB Lelystad, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Schokker, D (corresponding author), Wageningen UR Livestock Res, POB 65, NL-8200 AB Lelystad, Netherlands.	dirkjan.schokker@wur.nl	Smidt, Hauke/D-7054-2014; Schokker, Dirkjan/M-6385-2014; smits, mari/J-4892-2013; Schokker, Dirkjan/AAB-2668-2020	Smidt, Hauke/0000-0002-6138-5026; Schokker, Dirkjan/0000-0001-6082-7227; smits, mari/0000-0002-3493-291X; Schokker, Dirkjan/0000-0001-6082-7227; Rebel, Annemarie/0000-0003-4765-4215	Dutch Ministry of Economic Affairs; Central Veterinary Institute; China Scholarship Programme; European Union through the Interplay project [227549]; Wageningen Livestock Research	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Central Veterinary Institute; China Scholarship Programme; European Union through the Interplay project; Wageningen Livestock Research	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DS, SAV, JMJR, and MAS were supported by the funding of Dutch Ministry of Economic Affairs, Central Veterinary Institute and Wageningen Livestock Research. JZ was supported by a fellowship of the China Scholarship Programme, and JZ, HGHJH and HS were supported by the European Union through the Interplay project, Grant agreement no. 227549).	Arnal ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087967; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bauer Eva, 2006, Current Issues in Intestinal Microbiology, V7, P35; Brook I, 1997, J ANTIMICROB CHEMOTH, V39, P763, DOI 10.1093/jac/39.6.763; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Geuking MB, 2011, GUT MICROBES, P2; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Hakansson A, 2011, NUTRIENTS, V3, P637, DOI 10.3390/nu3060637; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jalanka-Tuovinen J, 2013, GUT; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Konstantinov SR, 2006, ENVIRON MICROBIOL, V8, P1191, DOI 10.1111/j.1462-2920.2006.01009.x; Kozyrskyj AL, 2011, CURR OPIN ALLERGY CL, V11, P400, DOI 10.1097/ACI.0b013e328349b166; Lahti L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5344; Leps J, 2003, MULTIVARIATE ANAL EC; Lewis MC, 2012, PEDIAT ALLERGY IMMUN; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mulder IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028279; Ohnmacht C, 2011, CELL MICROBIOL, V13, P653, DOI 10.1111/j.1462-5822.2011.01577.x; Ou JH, 2013, AM J CLIN NUTR, V98, P111, DOI 10.3945/ajcn.112.056689; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Perez-Gutierrez O, 2010, UNRAVELING PIGLET GU; Pfefferle Petra Ina, 2014, F1000Prime Rep, V6, P11, DOI 10.12703/P6-11; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Russell SL, 2013, GUT MICROBES, V4, P158, DOI 10.4161/gmic.23567; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schokker D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100040; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Starke IC, 2013, FEMS MICROBIOL ECOL; Su Y, 2008, FEMS MICROBIOL ECOL, V66, P546, DOI 10.1111/j.1574-6941.2008.00529.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; ter Braak C., 1990, UPDATE NOTES CANOCO; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Wagner RD, 2008, ADV EXP MED BIOL, V635, P41, DOI 10.1007/978-0-387-09550-9_4; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Weng M, 2013, J DEV ORIG HLTH DIS, V4, DOI [10.1017/S2040174413000068, DOI 10.1017/S2040174413000068]; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhang QS, 2013, GUT MICROBES, V4, P193, DOI 10.4161/gmic.23867	46	74	80	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116523	10.1371/journal.pone.0116523	http://dx.doi.org/10.1371/journal.pone.0116523			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658611	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900046
J	Tivers, MS; Handel, I; Gow, AG; Lipscomb, VJ; Jalan, R; Mellanby, RJ				Tivers, Michael S.; Handel, Ian; Gow, Adam G.; Lipscomb, Victoria J.; Jalan, Rajiv; Mellanby, Richard J.			Attenuation of Congenital Portosystemic Shunt Reduces Inflammation in Dogs	PLOS ONE			English	Article							MINIMAL HEPATIC-ENCEPHALOPATHY; NECROSIS-FACTOR-ALPHA; SURGICAL ATTENUATION; LIVER-CIRRHOSIS; AMMONIA; ENDOTOXIN; BLOOD; INTERLEUKIN-6; ASSOCIATION; DIAGNOSIS	Liver disease is a major cause of morbidity and mortality. One of the most significant complications in patients with liver disease is the development of neurological disturbances, termed hepatic encephalopathy. The pathogenesis of hepatic encephalopathy is incompletely understood, which has resulted in the development of a wide range of experimental models. Congenital portosystemic shunt is one of the most common congenital disorders diagnosed in client owned dogs. Our recent studies have demonstrated that the pathophysiology of canine hepatic encephalopathy is very similar to human hepatic encephalopathy, which provides strong support for the use of dogs with a congenital portosystemic shunt as a naturally occurring model of human hepatic encephalopathy. Specifically, we have demonstrated an important role for ammonia and inflammation in the development of hepatic encephalopathy in dogs with a congenital portosystemic shunt. Despite the apparent importance of inflammation in driving hepatic encephalopathy in dogs, it is unclear whether inflammation resolves following the successful treatment of liver disease. We hypothesized that haematological and biochemical evidence of inflammation, as gauged by neutrophil, lymphocyte and monocyte concentrations together with C-reactive protein concentrations, would decrease following successful treatment of congenital portosystemic shunts in dogs. One hundred and forty dogs with a congenital portosystemic shunt were enrolled into the study. We found that the proportion of dogs with a monocyte concentration above the reference range was significantly greater in dogs with hepatic encephalopathy at time of initial diagnosis. Importantly, neutrophil and monocyte concentrations significantly decreased following surgical congenital portosystemic shunt attenuation. We also found a significant decrease in C-reactive protein concentrations following surgical attenuation of congenital portosystemic shunts. Our study demonstrates that haematological and biochemical indices of inflammation reduce following successful treatment of the underlying liver disorder.	[Tivers, Michael S.; Lipscomb, Victoria J.] Royal Vet Coll, Dept Vet Clin Sci, Hatfield, Herts, England; [Handel, Ian; Gow, Adam G.; Mellanby, Richard J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Handel, Ian; Gow, Adam G.; Mellanby, Richard J.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Jalan, Rajiv] UCL Med Sch, UCL Inst Liver & Digest Hlth, London, England; [Mellanby, Richard J.] Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland	University of London; University of London Royal Veterinary College; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of London; University College London; University of Edinburgh	Tivers, MS (corresponding author), Georges Farm, Nr Wellington, Somerset, England.	mtivers@cave-vet-specialists.co.uk	Gow, Adam/H-6623-2019	Gow, Adam/0000-0002-4297-8870; Tivers, Michael/0000-0001-7047-9334; Mellanby, Richard John/0000-0002-3467-7007	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	Richard Mellanby is supported by a Wellcome Trust Intermediate Clinical Fellowship.	Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; BRADFIELD JW, 1974, LANCET, V2, P883; Cariou MP, 2009, VET REC, V165, P226, DOI 10.1136/vr.165.8.226; Coltart I, 2013, ARCH BIOCHEM BIOPHYS, V536, P189, DOI 10.1016/j.abb.2013.03.016; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; Falls EL, 2013, VET SURG, V42, P951, DOI 10.1111/j.1532-950X.2013.12072.x; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Goral V, 2011, HEPATO-GASTROENTEROL, V58, P943; Gow AG, 2012, METAB BRAIN DIS, V27, P227, DOI 10.1007/s11011-012-9278-x; Gow AG, 2010, J VET INTERN MED, V24, P90, DOI 10.1111/j.1939-1676.2009.0408.x; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; Howe LM, 1997, AM J VET RES, V58, P83; Hu RH, 1999, J FORMOS MED ASSOC, V98, P85; Hunt GB, 1999, AUST VET J, V77, P303, DOI 10.1111/j.1751-0813.1999.tb10268.x; JACOB AI, 1977, GASTROENTEROLOGY, V72, P1268; Kaser A, 2002, LIVER, V22, P380, DOI 10.1034/j.1600-0676.2002.01666.x; Kilpatrick S, 2014, VET J, V200, P197, DOI 10.1016/j.tvjl.2014.01.007; Kummeling A, 2010, J VET INTERN MED, V24, P114, DOI 10.1111/j.1939-1676.2009.0439.x; Lawrence J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081288; Lee KCL, 2006, JAVMA-J AM VET MED A, V229, P1122, DOI 10.2460/javma.229.7.1122; LIN RS, 1995, J HEPATOL, V22, P165, DOI 10.1016/0168-8278(95)80424-2; LUMSDEN AB, 1988, HEPATOLOGY, V8, P232, DOI 10.1002/hep.1840080207; Luo M, 2013, CLIN RES HEPATOL GAS, V37, P384, DOI 10.1016/j.clinre.2012.08.007; Luo M, 2012, HEPATOL RES, V42, P1202, DOI 10.1111/j.1872-034X.2012.01047.x; Odeh M, 2005, ANN MED, V37, P603, DOI 10.1080/07853890500317414; Shawcross D, 2005, CELL MOL LIFE SCI, V62, P2295, DOI 10.1007/s00018-005-5089-0; Shawcross DL, 2007, METAB BRAIN DIS, V22, P125, DOI 10.1007/s11011-006-9042-1; Stieger SM, 2007, VET RADIOL ULTRASOUN, V48, P409, DOI 10.1111/j.1740-8261.2007.00268.x; Stringer MD, 2008, CLIN ANAT, V21, P147, DOI 10.1002/ca.20574; TACHIYAMA G, 1988, JPN J SURG, V18, P403, DOI 10.1007/BF02471464; Tivers MS, 2012, J SMALL ANIM PRACT, V53, P3, DOI 10.1111/j.1748-5827.2011.01144.x; Tivers MS, 2014, VET J, V200, P305, DOI 10.1016/j.tvjl.2014.02.027; Tivers MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082303; Tivers MS, 2013, VET SURG, V42, pE46; Tobias KM, 2003, J AM VET MED ASSOC, V223, P1636, DOI 10.2460/javma.2003.223.1636; ZLYDASZYK JC, 1976, INFECT IMMUN, V14, P100, DOI 10.1128/IAI.14.1.100-105.1976	36	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117557	10.1371/journal.pone.0117557	http://dx.doi.org/10.1371/journal.pone.0117557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658922	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000349444900175
J	Rising, JP; Moscovitch, B				Rising, Joshua P.; Moscovitch, Ben			Characteristics of Pivotal Trials and FDA Review of Innovative Devices	PLOS ONE			English	Review								When patients lack sufficient treatment options for serious medical conditions, they rely on the prompt approval and development of new therapeutic alternatives, such as medical devices. Understanding the development of innovative medical devices, including the characteristics of premarket clinical trials and length of Food and Drug Administration (FDA) review, can help identify ways to expedite patient access to novel technologies and inform recent efforts by FDA to more quickly get these products to patients and physicians. We analyzed publicly available information on clinical trials and premarket FDA review for innovative medical devices that fill an unmet medical need. In this first-of-its-kind study focusing on these products, we extracted data on the length of the pivotal trials, primary study endpoint and FDA review; number of patients enrolled in trials; and in what country the device was available first. We identified 27 approved priority review devices from January 2006 through August 2013. The median duration of pivotal clinical trials was 3 years, ranging from 3 months to approximately 7 years. Trials had a median primary outcome measure evaluation time of one year and a median enrollment of 297 patients. The median FDA review time was 1 year and 3 months. Most priority review devices were available abroad before they were approved in the United States. Our study indicates that addressing the length of clinical studies-and contributing factors, such as primary outcome measures and enrollment-could expedite patient access to innovative medical devices. FDA, manufacturers, Congress and other stakeholders should identify the contributing factors to the length of clinical development, and implement appropriate reforms to address those issues.	[Rising, Joshua P.; Moscovitch, Ben] Pew Charitable Trusts, Washington, DC 20004 USA		Rising, JP (corresponding author), Pew Charitable Trusts, Washington, DC 20004 USA.	jrising@pewtrusts.org						Buss Mary K, 2008, J Support Oncol, V6, P168; California Healthcare Institute, 2014, TAK PULS MED DEV REG, DOI 10.1016/j.leukres.2014.12.002; Center for Devices and Radiological Health (CDRH) U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Office of Device Evaluation Division of Anesthesiology General Hospital Infection Control and Dental Devices Anesthesiology and Respiratory Devices Branch, 2013, GUID IND FOOD DRUG A; Cohen D, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2748; European Commission, 2012, COMM COMM EUR PARL C; FDA, 2014, GUID IND FOOD DRUG A; FDA, 2012, MDUFA PERF GOALS PRO; FDA, 2014, CDRH ADV M MAT ARCH; FDA, 2014, PREM APPR; Gottlieb S, 2011, WALL STREET J; Hwang TJ, 2014, PEDIATRICS, V133, pE1197, DOI 10.1542/peds.2013-3348; Hwang TJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g217; Kaplan AV, 2004, CIRCULATION, V109, P3068, DOI 10.1161/01.CIR.0000134695.65733.64; Lievre M, 2001, BRIT MED J, V322, P603, DOI 10.1136/bmj.322.7286.603; Shields AM, 2010, J HOSP PALLIAT NURS, V12, P312, DOI 10.1097/NJH.0b013e3181ec9dd1; Sorenson C, 2014, MILBANK Q, V92, P114, DOI 10.1111/1468-0009.12043; Steinhauser KE, 2006, PALLIATIVE MED, V20, P745, DOI 10.1177/0269216306073112; US Government Accountability Office, 2012, MED DEV FDA HAS MET; Wolanski N, 2013, PRIORITY REV	19	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0117235	10.1371/journal.pone.0117235	http://dx.doi.org/10.1371/journal.pone.0117235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25651420	Green Submitted, Green Published, gold			2022-12-27	WOS:000349250700010
J	Sato, T; Kinoshita, M; Yamamoto, TS; Ito, M; Nishida, T; Takeuchi, M; Saitoh, DZ; Seki, SH; Mukai, YS				Sato, Tomohito; Kinoshita, Manabu; Yamamoto, Tetsuo; Ito, Masataka; Nishida, Takafumi; Takeuchi, Masaru; Saitoh, Daizoh; Seki, Shuhji; Mukai, Yasuo			Treatment of Irradiated Mice with High-Dose Ascorbic Acid Reduced Lethality	PLOS ONE			English	Article							ACUTE OXALATE NEPHROPATHY; IONIZING-RADIATION; VITAMIN-C; CELLS; DEFICIENCY; HEMOLYSIS; RADICALS; INJURY; DAMAGE; TUMOR	Ascorbic acid is an effective antioxidant and free radical scavenger. Therefore, it is expected that ascorbic acid should act as a radioprotectant. We investigated the effects of post-radiation treatment with ascorbic acid on mouse survival. Mice received whole body irradiation (WBI) followed by intraperitoneal administration of ascorbic acid. Administration of 3 g/kg of ascorbic acid immediately after exposure significantly increased mouse survival after WBI at 7 to 8 Gy. However, administration of less than 3 g/kg of ascorbic acid was ineffective, and 4 or more g/kg was harmful to the mice. Post-exposure treatment with 3 g/kg of ascorbic acid reduced radiation-induced apoptosis in bone marrow cells and restored hematopoietic function. Treatment with ascorbic acid (3 g/kg) up to 24 h (1, 6, 12, or 24 h) after WBI at 7.5 Gy effectively improved mouse survival; however, treatments beyond 36 h were ineffective. Two treatments with ascorbic acid (1.5 g/kg x 2, immediately and 24 h after radiation, 3 g/kg in total) also improved mouse survival after WBI at 7.5 Gy, accompanied with suppression of radiation-induced free radical metabolites. In conclusion, administration of high-dose ascorbic acid might reduce radiation lethality in mice even after exposure.	[Sato, Tomohito; Yamamoto, Tetsuo; Nishida, Takafumi; Mukai, Yasuo] Mil Med Res Unit, Tokyo, Setagaya, Japan; [Kinoshita, Manabu; Seki, Shuhji] Natl Def Med Coll, Dept Immunol Microbiol, Tokorozawa, Saitama 359, Japan; [Ito, Masataka] Natl Def Med Coll, Dept Dev Anat & Regenerat Biol, Tokorozawa, Saitama 359, Japan; [Takeuchi, Masaru] Natl Def Med Coll, Dept Ophthalmol, Tokorozawa, Saitama, Japan; [Saitoh, Daizoh] Natl Def Med Coll, Res Inst, Div Traumatol, Tokorozawa, Saitama 359, Japan	National Defense Medical College - Japan; National Defense Medical College - Japan; National Defense Medical College - Japan; National Defense Medical College - Japan	Kinoshita, M (corresponding author), Natl Def Med Coll, Dept Immunol Microbiol, Tokorozawa, Saitama 359, Japan.	manabu@ndmc.ac.jp			National Defense Medical College; Ministry of Defense	National Defense Medical College; Ministry of Defense	This work was supported by a grant-in-aid for Special Research Program (Host stress responses to internal and external factors) from the National Defense Medical College to M.K. and S.S. and a grant-in-aid for Promoted Research Program of Defense Medicine (Host defense against radiation) from the Ministry of Defense to M.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anscher MS, 2010, ONCOLOGIST, V15, P350, DOI 10.1634/theoncologist.2009-S101; Archambeau JO, 2013, REDOX BIOL, V1, P599, DOI 10.1016/j.redox.2013.10.002; Brown SL, 2010, RADIAT RES, V173, P462, DOI 10.1667/RR1716.1; Buonocore G, 2000, PEDIATR RES, V47, P221, DOI 10.1203/00006450-200002000-00012; CAMPBELL GD, 1975, ANN INTERN MED, V82, P810, DOI 10.7326/0003-4819-82-6-810_1; Cesarone MR, 1999, INT ANGIOL, V18, P127; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Cole A, 1965, CELLULAR RAD BIOL, P267; DiCarlo AL, 2011, DISASTER MED PUBLIC, V5, pS32, DOI 10.1001/dmp.2011.17; Dohi K, 2005, IN VIVO, V19, P855; FLOMENBERG N, 1992, BONE MARROW TRANSPL, V10, P115; Gridley DS, 2007, ANTICANCER RES, V27, P3101; Guelman LR, 2005, INT J DEV NEUROSCI, V23, P1, DOI 10.1016/j.ijdevneu.2004.10.001; Hensley ML, 1999, J CLIN ONCOL, V17, P3333, DOI 10.1200/JCO.1999.17.10.3333; Hoffer LJ, 2008, ANN ONCOL, V19, P1969, DOI 10.1093/annonc/mdn377; Hogan DE, 2002, AM J MED SCI, V323, P341, DOI 10.1097/00000441-200206000-00006; Ito Y, 2013, INT J MOL SCI, V14, P19618, DOI 10.3390/ijms141019618; Jia D, 2010, RADIAT RES, V173, P579, DOI 10.1667/RR2030.1; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Koenig KL, 2005, ANN EMERG MED, V45, P643, DOI 10.1016/j.annemergmed.2005.01.020; Koyama S, 1998, MUTAT RES-FUND MOL M, V421, P45, DOI 10.1016/S0027-5107(98)00153-5; LAWTON JM, 1985, ARCH INTERN MED, V145, P950, DOI 10.1001/archinte.145.5.950; MCALLISTER CJ, 1984, JAMA-J AM MED ASSOC, V252, P1684, DOI 10.1001/jama.1984.03350130016019; OKUNIEFF P, 1991, AM J CLIN NUTR, V54, pS1281; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; REES DC, 1993, BRIT MED J, V306, P841, DOI 10.1136/bmj.306.6881.841; ROOTS R, 1975, RADIAT RES, V64, P306, DOI 10.2307/3574267; Van der Meeren A, 2005, RADIAT RES, V163, P144, DOI 10.1667/RR3293; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Weiss JF, 2003, TOXICOLOGY, V189, P1, DOI 10.1016/S0300-483X(03)00149-5; WONG K, 1994, AUST NZ J MED, V24, P410, DOI 10.1111/j.1445-5994.1994.tb01477.x; Yamamoto T, 2010, J RADIAT RES, V51, P145, DOI 10.1269/jrr.09078	32	37	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0117020	10.1371/journal.pone.0117020	http://dx.doi.org/10.1371/journal.pone.0117020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25651298	gold, Green Published, Green Submitted			2022-12-27	WOS:000349250700009
J	Li, AS; Yong, X				Li, Angsheng; Yong, Xi			Emergence of Super Cooperation of Prisoner's Dilemma Games on Scale-Free Networks	PLOS ONE			English	Article							EVOLUTION; PROMOTES	Recently, the authors proposed a quantum prisoner's dilemma game based on the spatial game of Nowak and May, and showed that the game can be played classically. By using this idea, we proposed three generalized prisoner's dilemma (GPD, for short) games based on the weak Prisoner's dilemma game, the full prisoner's dilemma game and the normalized Prisoner's dilemma game, written by GPD(W), GPD(F) and GPD(N) respectively. Our games consist of two players, each of which has three strategies: cooperator (C), defector (D) and super cooperator (denoted by Q), and have a parameter. to measure the entangled relationship between the two players. We found that our generalised prisoner's dilemma games have new Nash equilibrium principles, that entanglement is the principle of emergence and convergence (i.e., guaranteed emergence) of super cooperation in evolutions of our generalised prisoner's dilemma games on scale-free networks, that entanglement provides a threshold for a phase transition of super cooperation in evolutions of our generalised prisoner's dilemma games on scale-free networks, that the role of heterogeneity of the scale-free networks in cooperations and super cooperations is very limited, and that well-defined structures of scale-free networks allow coexistence of cooperators and super cooperators in the evolutions of the weak version of our generalised prisoner's dilemma games.	[Li, Angsheng; Yong, Xi] Chinese Acad Sci, Inst Software, State Key Lab Comp Sci, Beijing, Peoples R China; [Yong, Xi] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Software, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, AS (corresponding author), Chinese Acad Sci, Inst Software, State Key Lab Comp Sci, Beijing, Peoples R China.	angsheng@ios.ac.cn			Institute of Software, Chinese Academy of Sciences; NSFC [61161130530]; High-Tech Program (863) [2012AA8113011]; 973 program [2014CB340302]	Institute of Software, Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC)); High-Tech Program (863)(National High Technology Research and Development Program of China); 973 program(National Basic Research Program of China)	The authors are partially supported by the Grand Project "Network Algorithms and Digital Information" of the Institute of Software, Chinese Academy of Sciences, by an NSFC grant No. 61161130530, by a High-Tech Program (863) Grant No. 2012AA8113011, and by a 973 program Grant No. 2014CB340302. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Chappell JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021623; Chen XJ, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/8/083016; Eisert J, 1999, PHYS REV LETT, V83, P3077, DOI 10.1103/PhysRevLett.83.3077; Follmer H, 1974, J MATH ECON, V1, P51, DOI [10.1016/0304-4068(74)90035-4, DOI 10.1016/0304-4068(74)90035-4]; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Li AS, 2014, SCI REP-UK, V4, DOI 10.1038/srep06286; Li Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep02949; Li Q, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/10/103034; Li Q, 2012, PHYSICA A, V391, P3316, DOI 10.1016/j.physa.2012.01.048; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pacheco JM, 2005, AIP CONF PROC, V776, P90, DOI 10.1063/1.1985380; Pawela L, 2013, PHYSICA A, V392, P910, DOI 10.1016/j.physa.2012.10.034; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Rong ZH, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/68005; Rong ZH, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/30001; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, J EVOLUTION BIOL, V19, P726, DOI 10.1111/j.1420-9101.2005.01063.x; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; Vukov J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026109; Wang Z, 2014, J THEOR BIOL, V349, P50, DOI 10.1016/j.jtbi.2014.01.037; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep02470; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu ZX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021107; Wu ZX, 2007, PHYSICA A, V379, P672, DOI 10.1016/j.physa.2007.02.085	32	33	34	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116429	10.1371/journal.pone.0116429	http://dx.doi.org/10.1371/journal.pone.0116429			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643279	Green Published, Green Submitted, gold			2022-12-27	WOS:000348821200017
J	Maiwulanjiang, M; Bi, CWC; Lee, PSC; Xin, G; Miernisha, A; Lau, KM; Xiong, A; Li, N; Dong, TTX; Aisa, HA; Tsim, KWK				Maiwulanjiang, Maitinuer; Bi, Cathy W. C.; Lee, Pinky S. C.; Xin, Guizhong; Miernisha, Abudureyimu; Lau, Kei M.; Xiong, Aizhen; Li, Ning; Dong, Tina T. X.; Aisa, Haji A.; Tsim, Karl W. K.			The Volatile Oil of Nardostachyos Radix et Rhizoma Induces Endothelial Nitric Oxide Synthase Activity in HUVEC Cells	PLOS ONE			English	Article							PHOSPHORYLATION; AKT; IDENTIFICATION; ACTIVATION; JATAMANSI; OXYGEN; ENOS	Nardostahyos Radix et Rhizoma (NRR; the root and rhizome of Nardostachys jatamansi DC.) is a widely used medicinal herb. Historically, NRR is being used for the treatment of cardiovascular and neurological diseases. To search for active ingredients of NRR, we investigated the vascular benefit of NRR volatile oil in (i) the vasodilation in rat aorta ring, and (ii) the release of nitric oxide (NO) and the phosphorylation of endothelial NO synthase (eNOS) in cultured human umbilical vein endothelial cells (HUVECs). By measuring the fluorescence signal in cultures, application of NRR volatile oil resulted in a rapid activation of NO release as well as the phosphorylation of eNOS: both inductions were markedly reduced by L-NAME. In parallel, the phosphorylation level of Akt kinase was markedly increased by the oil treatment, which was partially attenuated by PI3K/Akt inhibitor LY294002. This inhibitor also blocked the NRR-induced NO production and eNOS phosphorylation. In HUVECs, application of NRR volatile oil elevated the intracellular Ca2+ level, and BAPTA-AM, a Ca2+ chelator, reduced the Ca2+ surge: the blockage were also applied to NRR-induced eNOS phosphorylation and NO production. These findings suggested the volatile oil of NRR was the major ingredient in triggering the vascular dilatation, and which was mediated via the NO production.	[Maiwulanjiang, Maitinuer; Bi, Cathy W. C.; Lee, Pinky S. C.; Xin, Guizhong; Miernisha, Abudureyimu; Lau, Kei M.; Xiong, Aizhen; Li, Ning; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China; [Maiwulanjiang, Maitinuer; Bi, Cathy W. C.; Lee, Pinky S. C.; Xin, Guizhong; Miernisha, Abudureyimu; Lau, Kei M.; Xiong, Aizhen; Li, Ning; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Peoples R China; [Aisa, Haji A.] Chinese Acad Sci, Xinjiang Tech Inst Phys & Chem, Xinjiang Key Lab Plant Resources & Nat Prod Chem, Urumqi, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese Academy of Sciences; Xinjiang Technical Institute of Physics & Chemistry, CAS	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China.	BOTSIM@UST.HK	Li, Ning/D-6576-2015		Hong Kong Research Grants Council Theme-based Research Scheme [T13-607/12R]; GRF [661110, 662911, 660411, 663012, 662713]; Hong Kong Jockey Club Charities Trust [TUYF12SC03]; Foundation of The Awareness of Nature [TAON12SC01]	Hong Kong Research Grants Council Theme-based Research Scheme(Hong Kong Research Grants Council); GRF; Hong Kong Jockey Club Charities Trust; Foundation of The Awareness of Nature	This research was supported by Hong Kong Research Grants Council Theme-based Research Scheme (T13-607/12R), GRF (661110, 662911, 660411, 663012, 662713), TUYF12SC03, The Hong Kong Jockey Club Charities Trust and Foundation of The Awareness of Nature (TAON12SC01) to Karl Tsim. M. Maiwulanjiang received a Kanya Lee Scholarship from Lee's Pharmaceutical C. Ltd. The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airi S, 2000, CURR SCI INDIA, V79, P1467; Bi CWC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051670; Cai H, 2008, CARDIOVASC RES, V77, P30, DOI 10.1093/cvr/cvm010; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Choi Roy Chi-Yan, 2010, Chin Med, V5, P38, DOI 10.1186/1749-8546-5-38; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Guo AJY, 2011, J BIOL CHEM, V286, P27882, DOI 10.1074/jbc.M111.236281; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Kutala VK, 2007, ANTIOXID REDOX SIGN, V9, P1193, DOI 10.1089/ars.2007.1636; Lee JH, 2003, J BIOL CHEM, V278, P51360, DOI 10.1074/jbc.M302332200; Liang MJ, 2005, LIFE SCI, V78, P128, DOI 10.1016/j.lfs.2005.04.038; Lu J.N., 2003, J MED PHARM CHINESE, V9, P13; LUSCHER TF, 1991, EUR HEART J, V12, P2; Maiwulanjiang M, 2014, J ETHNOPHAR IN PRESS; Maiwulanjiang M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/687958; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Mikkelsen RB, 2003, ONCOGENE, V22, P5734, DOI 10.1038/sj.onc.1206663; MONCADA S, 1988, BIOCHEM PHARMACOL, V37, P2495, DOI 10.1016/0006-2952(88)90236-5; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Nautiyal B. P., 2003, Plant Genetic Resources Newsletter, P34; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; Subashini R, 2006, J PHARM PHARMACOL, V58, P257, DOI 10.1211/jpp.58.2.0014; Tuerhong E, 2009, TRADITIONAL UYGHUR M, DOI [10. 1016/j.ijid.2014.12.037, DOI 10.1016/J.IJID.2014.12.037]; Vanhoutte PM, 1997, EUR HEART J, V18, pE19, DOI 10.1016/S0195-668X(97)90005-1; Yasen T, 1999, DRUG STANDARD TRADIT; Yusup A, 2011, ECAM, V2011; ZEIHER AM, 1993, J CLIN INVEST, V92, P652, DOI 10.1172/JCI116634; Zhang Xu, 2007, Zhong Yao Cai, V30, P38	32	15	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116761	10.1371/journal.pone.0116761	http://dx.doi.org/10.1371/journal.pone.0116761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643147	Green Submitted, Green Published, gold			2022-12-27	WOS:000348821200023
J	Zhu, H; Zhao, ZJ; Xia, S; Hu, ZY; Liu, GX				Zhu, Huan; Zhao, Zhijuan; Xia, Shuang; Hu, Zhengyu; Liu, Guoxiang			Morphological Examination and Phylogenetic Analyses of Phycopeltis spp. (Trentepohliales, Ulvophyceae) from Tropical China	PLOS ONE			English	Article							PRINTZINA TRENTEPOHLIALES; SEQUENCE ALIGNMENT; CHLOROPHYTA; DIVERSITY; INTERFACE; EVOLUTION; TAXONOMY; ECOLOGY; ALGAE	During an investigation of Trentepohliales (Ulvophyceae) from tropical areas in China, four species of the genus Phycopeltis were identified: Phycopeltis aurea, P. epiphyton, P. flabellata and P. prostrata. The morphological characteristics of both young and adult thalli were observed and compared. Three species (P. flabellata, P. aurea and P. epiphyton) shared a symmetrical development with dichotomously branching vegetative cells during early stages; conversely, P. prostrata had dishevelled filaments with no dichotomously branching filaments and no symmetrical development. The adult thalli of the former three species shared common morphological characteristics, such as equally dichotomous filaments, absence of erect hair and gametangia formed in prostate vegetative filaments. Phylogenetic analyses based on SSU and ITS rDNA sequences showed that the three morphologically similar species were in a clade that was sister to a clade containing T. umbrina and T. abietina, thus confirming morphological monophyly. Conversely, Phycopeltis prostrata, a species with erect filaments, sessile gametangia on the basal erect hair, larger length/width ratio of vegetative cells and very loosely coalescent prostrate filaments, branched separately from the core Phycopeltis group and the T. umbrina and T. abietina clade. Based on morphological and molecular evidence, the genus Phycopeltis was paraphyletic. Furthermore, the traditional taxonomic criteria for Phycopeltis must be reassessed based on phylogeny using more species. A new circumscription of the Phycopeltis and the erection of new genera are recommended.	[Zhu, Huan; Zhao, Zhijuan; Xia, Shuang; Hu, Zhengyu; Liu, Guoxiang] Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Peoples R China; [Zhu, Huan; Zhao, Zhijuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xia, Shuang] South Cent Univ Nationalities, Coll Life Sci, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; South Central Minzu University	Liu, GX (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Peoples R China.	liugx@ihb.ac.cn	Liu, Guoxiang/L-7413-2019	Liu, Guoxiang/0000-0001-8565-2363				Allali HA, 2013, NOVA HEDWIGIA, V96, P309, DOI 10.1127/0029-5035/2013/0096; Boedeker C, 2013, PHYCOL RES, V61, P133, DOI 10.1111/pre.12011; CHAPMAN RL, 1984, SYSTEMATICS OF THE G; CHAPMAN RL, 1983, ALGAL SYMBIOSIS A CO; Cocquyt E, 2010, MOL BIOL EVOL, V27, P2052, DOI 10.1093/molbev/msq091; FRITZ L, 1985, J PHYCOL, V21, P662, DOI 10.1111/j.0022-3646.1985.00662.x; GOOD BH, 1978, J PHYCOL, V14, P374, DOI 10.1111/j.1529-8817.1978.tb00317.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hametner C, 2014, SYMBIOSIS, V63, P31, DOI 10.1007/s13199-014-0285-z; Hametner C, 2014, PHYCOL RES, V62, P170, DOI 10.1111/pre.12055; Hayakawa YI, 2012, PHYCOL RES, V60, P86, DOI 10.1111/j.1440-1835.2012.00641.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Liu GX, 2008, NOVA HEDWIGIA, V87, P487, DOI 10.1127/0029-5035/2008/0087-0487; Lopez-Bautista JM, 2003, INT J SYST EVOL MICR, V53, P1715, DOI 10.1099/ijs.0.02561-0; Lopez-Bautista JM, 2006, INT J SYST EVOL MICR, V56, P1709, DOI 10.1099/ijs.0.63990-0; LuEpez-Bautista J.M., 2002, CONSTANCEA, V83; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Nelsen MP, 2011, J PHYCOL, V47, P282, DOI 10.1111/j.1529-8817.2011.00962.x; Neustupa J, 2005, CRYPTOGAMIE ALGOL, V26, P229; Neustupa J, 2003, NOVA HEDWIGIA, V76, P487, DOI 10.1127/0029-5035/2003/0076-0487; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PRINTZ HENRIK, 1939, NYTT MAG NATURVIDENSK, V80, P137; Raven J.A., 1987, Prog Phycol Res, V5, P1; Rindi F, 2005, PHYCOLOGIA, V44, P270, DOI 10.2216/0031-8884(2005)44[270:TADOTA]2.0.CO;2; Rindi F, 2004, CRYPTOGAMIE ALGOL, V25, P3; Rindi F, 2003, CRYPTOGAMIE ALGOL, V24, P133; Rindi F, 2002, J PHYCOL, V38, P39, DOI 10.1046/j.1529-8817.2002.01193.x; Rindi F, 2002, PHYCOLOGIA, V41, P421, DOI 10.2216/i0031-8884-41-4-421.1; Rindi F, 2008, NOVA HEDWIGIA, V87, P421, DOI 10.1127/0029-5035/2008/0087-0421; Rindi F, 2008, CRYPTOGAMIE ALGOL, V29, P13; Rindi F, 2006, NOVA HEDWIGIA, V83, P431, DOI 10.1127/0029-5035/2006/0083-0431; Rindi F, 2009, MOL PHYLOGENET EVOL, V52, P329, DOI 10.1016/j.ympev.2009.01.009; Sarma P., 1986, NOVA HEDWIGIA, V58, P1; SCHMIDLE W, 1897, BER DEUT BOT GES, V15, P456; SCHMIDLE W, 1897, HEDWIGIA, V36, P277; SLUIMAN H J, 1989, Cryptogamic Botany, V1, P83; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suutari M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-86; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON RH, 1992, J PHYCOL, V28, P232, DOI 10.1111/j.0022-3646.1992.00232.x; THOMPSON RH, 1997, MORPHOLOGY TAXONOMY; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WILDEMAN DE, 1896, NOTRISIA, V11, P84	45	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0114936	10.1371/journal.pone.0114936	http://dx.doi.org/10.1371/journal.pone.0114936			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643363	Green Submitted, Green Published, gold			2022-12-27	WOS:000348821200005
J	Bach, AJE; Stewart, IB; Disher, AE; Costello, JT				Bach, Aaron J. E.; Stewart, Ian B.; Disher, Alice E.; Costello, Joseph T.			A Comparison between Conductive and Infrared Devices for Measuring Mean Skin Temperature at Rest, during Exercise in the Heat, and Recovery	PLOS ONE			English	Article							AMBIENT-TEMPERATURE; CONTACT THERMOMETRY; STATISTICAL-METHODS; BODY-TEMPERATURE; AGREEMENT; VALIDITY; THERMOCOUPLES; RELIABILITY; RESPONSES	Purpose Skin temperature assessment has historically been undertaken with conductive devices affixed to the skin. With the development of technology, infrared devices are increasingly utilised in the measurement of skin temperature. Therefore, our purpose was to evaluate the agreement between four skin temperature devices at rest, during exercise in the heat, and recovery. Methods Mean skin temperature ((T) over bar (sk)) was assessed in thirty healthy males during 30 min rest (24.0 +/- 1.2 degrees C, 56 +/- 8%), 30 min cycle in the heat (38.0 +/- 0.5 degrees C, 41 +/- 2%), and 45 min recovery (24.0 +/- 1.3 degrees C, 56 +/- 9%). (T) over bar (sk) was assessed at four sites using two conductive devices (thermistors, iButtons) and two infrared devices (infrared thermometer, infrared camera). Results Bland-Altman plots demonstrated mean bias +/- limits of agreement between the thermistors and iButtons as follows (rest, exercise, recovery): -0.01 +/- 0.04, 0.26 +/- 0.85, -0.37 +/- 0.98 degrees C; thermistors and infrared thermometer: 0.34 +/- 0.44, -0.44 +/- 1.23, -1.04 +/- 1.75 degrees C; thermistors and infrared camera (rest, recovery): 0.83 +/- 0.77, 1.88 +/- 1.87 degrees C. Pairwise comparisons of (T) over bar (sk) found significant differences (p < 0.05) between thermistors and both infrared devices during resting conditions, and significant differences between the thermistors and all other devices tested during exercise in the heat and recovery. Conclusions These results indicate poor agreement between conductive and infrared devices at rest, during exercise in the heat, and subsequent recovery. Infrared devices may not be suitablefor monitoring <(T)over bar>(sk) in the presence of, or following, metabolic and environmental induced heat stress.	[Bach, Aaron J. E.] Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia; Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Bach, AJE (corresponding author), Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia.	aj.bach@qut.edu.au	Costello, Joseph/AAW-8764-2020; Stewart, Ian B/I-9927-2012; Costello, Joseph/G-6294-2011; Costello, Joseph/J-1374-2012; Bach, Aaron/AAQ-2258-2020	Costello, Joseph/0000-0001-9510-7932; Costello, Joseph/0000-0001-9510-7932; Costello, Joseph/0000-0001-9510-7932; Bach, Aaron/0000-0002-5581-5018; Bach, Aaron/0000-0002-4551-0149; Stewart, Ian/0000-0003-1741-718X				Ammer K, 2006, MED DEVICES SYSTEMS, P321; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Belding H, 1955, HEATING PIPING AIR C, V27, P129; Bernard V, 2013, PHYS MEDICA, V29, P1, DOI [10.1016/j.ejmp.2013.08.141 PMID: 24055408, DOI 10.1016/J.EJMP.2013.08.141]; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Marins JCB, 2014, INFRARED PHYS TECHN, V65, P30, DOI 10.1016/j.infrared.2014.02.008; Buono MJ, 2007, PHYSIOL MEAS, V28, P855, DOI 10.1088/0967-3334/28/8/008; Buono MJ, 1998, PHYSIOL MEAS, V19, P297, DOI 10.1088/0967-3334/19/2/016; Burnham RS, 2006, AM J PHYS MED REHAB, V85, P553, DOI 10.1097/01.phm.0000223232.32653.7f; Cheung SS, 2000, SPORTS MED, V29, P329, DOI 10.2165/00007256-200029050-00004; COLIN J, 1971, J APPL PHYSIOL, V31, P484, DOI 10.1152/jappl.1971.31.3.484; Costello J., 2013, INT SPORTMED J, V14, P94, DOI DOI 10.10520/EJC138120; Costello J, 2012, PLOS ONE, V7, P1; Costello JT, 2012, J THERM BIOL, V37, P103, DOI 10.1016/j.jtherbio.2011.11.008; deDear RJ, 1997, INT J BIOMETEOROL, V40, P141, DOI 10.1007/s004840050035; Fernandes AD, 2014, PHYSIOL MEAS, V35, P189, DOI 10.1088/0967-3334/35/2/189; Foto JG, 2007, J AM PODIAT MED ASSN, V97, P360, DOI 10.7547/0970360; Fournet D, 2013, J THERM BIOL, V38, P339, DOI 10.1016/j.jtherbio.2013.04.005; FRIM J, 1990, J APPL PHYSIOL, V68, P540, DOI 10.1152/jappl.1990.68.2.540; Grgic G, 2011, INT J THERMOPHYS, V32, P237, DOI 10.1007/s10765-011-0932-z; International Organisation for Standardisation, 2004, 9886 ISO, DOI [10.1007/s00484-011-0516-4, DOI 10.1007/S00484-011-0516-4]; JOLY HR, 1969, CIRCULATION, V39, P131, DOI 10.1161/01.CIR.39.1.131; Kelechi TJ, 2006, J NURS MEAS, V14, P19, DOI 10.1891/jnum.14.1.19; Kelechi TJ, 2011, J NURS MEAS, V19, P55, DOI 10.1891/1061-3749.19.1.55; Long BC, 2010, J ATHL TRAINING, V45, P338, DOI 10.4085/1062-6050-45.4.338; Merla A, 2010, ANN BIOMED ENG, V38, P158, DOI 10.1007/s10439-009-9809-8; Mora-Rodriguez R, 2012, EXERC SPORT SCI REV, V40, P79, DOI 10.1097/JES.0b013e318246ee56; NADEL ER, 1971, J APPL PHYSIOL, V31, P80, DOI 10.1152/jappl.1971.31.1.80; Niu H H, 2001, Zhonghua Yi Xue Za Zhi (Taipei), V64, P459; Psikuta A, 2014, INT J BIOMETEOROL, V58, P877, DOI 10.1007/s00484-013-0669-4; Roy R, 2006, J MANIP PHYSIOL THER, V29, P150, DOI 10.1016/j.jmpt.2005.12.004; Ruopsa N, 2009, J HAND SURG-EUR VOL, V34E, P526, DOI 10.1177/1753193409102456; Sarabia JA, 2008, PHYSIOL BEHAV, V95, P570, DOI 10.1016/j.physbeh.2008.08.005; Schlader ZJ, 2011, EUR J APPL PHYSIOL, V111, P757, DOI 10.1007/s00421-010-1692-3; Selfe J, 2008, THERMOL INT, V18, P51; Smith ADH, 2010, PHYSIOL MEAS, V31, P95, DOI 10.1088/0967-3334/31/1/007; STEKETEE J, 1973, PHYS MED BIOL, V18, P686, DOI 10.1088/0031-9155/18/5/307; Stewart IB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083740; STOLWIJK JA, 1966, J APPL PHYSIOL, V21, P967, DOI 10.1152/jappl.1966.21.3.967; SUNDBERG S, 1984, SCAND J CLIN LAB INV, V44, P341, DOI 10.3109/00365518409083817; TOGAWA T, 1994, PHYSIOL MEAS, V15, P291, DOI 10.1088/0967-3334/15/3/007; Tyler CJ, 2011, PHYSIOL MEAS, V32, P1541, DOI 10.1088/0967-3334/32/10/003; van den Heuvel CJ, 2003, PHYSIOL MEAS, V24, P717, DOI 10.1088/0967-3334/24/3/308; Lichtenbelt WDV, 2006, PHYSIOL BEHAV, V88, P489, DOI 10.1016/j.physbeh.2006.04.026; Wasner G, 2002, PAIN, V98, P19, DOI 10.1016/S0304-3959(01)00470-5; WILMORE DW, 1975, J APPL PHYSIOL, V38, P593, DOI 10.1152/jappl.1975.38.4.593	47	37	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117907	10.1371/journal.pone.0117907	http://dx.doi.org/10.1371/journal.pone.0117907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659140	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900240
J	Chakraborty, S; Fernandes, VO; Dias, FMV; Prates, JAM; Ferreira, LMA; Fontes, CMGA; Goyal, A; Centeno, MSJ				Chakraborty, Soumyadeep; Fernandes, Vania O.; Dias, Fernando M. V.; Prates, Jose A. M.; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.; Goyal, Arun; Centeno, Maria S. J.			Role of Pectinolytic Enzymes Identified in Clostridium thermocellum Cellulosome	PLOS ONE			English	Article							CARBOHYDRATE-BINDING MODULES; PECTATE-LYASE-C; ERWINIA-CHRYSANTHEMI 3937; PLANT VIRULENCE FACTOR; RHAMNOGALACTURONAN LYASE; PECTIC POLYSACCHARIDE; BACILLUS-SUBTILIS; LIGAND-BINDING; CELL WALLS; FUNCTIONAL IMPLICATIONS	The cloning, expression and characterization of three cellulosomal pectinolytic enzymes viz., two variants of PL1 (PL1A and PL1B) and PL9 from Clostridium thermocellum was carried out. The comparison of the primary sequences of PL1A, PL1B and PL9 revealed that these proteins displayed considerable sequence similarities with family 1 and 9 polysaccharide lyases, respectively. PL1A, PL1B and PL9 are the putative catalytic domains of protein sequence ABN54148.1 and ABN53381.1 respectively. These two protein sequences also contain putative carbohydrate binding module (CBM) and type-I dockerin. The associated putative CBM of PL1A showed strong homology with family 6 CBMs while those of PL1B and PL9 showed homology with family 35 CBMs. Recombinant derivatives of these three enzymes showed molecular masses of approximately 34 kDa, 40 kDa and 32 kDa for PL1A, PL1B and PL9, respectively. PL1A, PL1B and PL9 displayed high activity toward polygalacturonic acid and pectin (up to 55% methyl-esterified) from citrus fruits. However, PL1B showed relatively higher activity towards 55% and 85% methyl-esterified pectin (citrus). PL1A and PL9 showed higher activity on rhamnogalacturonan than PL1B. Both PL1A and PL9 displayed maximum activity at pH 8.5 with optimum temperature of 50 degrees C and 60 degrees C respectively. PL1B achieved highest activity at pH 9.8, under an optimum temperature of 50 degrees C. PL1A, PL1B and PL9 all produced two or more unsaturated galacturonates from pectic substrates as displayed by TLC analysis confirming that they are endo-pectate lyase belonging to family 1 and 9, respectively. This report reveals that pectinolytic activity displayed by Clostridium thermocellum cellulosome is coordinated by a sub-set of at least three multi-modular enzymes.	[Chakraborty, Soumyadeep; Goyal, Arun] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India; [Fernandes, Vania O.; Dias, Fernando M. V.; Prates, Jose A. M.; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.; Centeno, Maria S. J.] Univ Lisbon, CIISA Fac Med Vet, P-1699 Lisbon, Portugal	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Universidade de Lisboa	Goyal, A (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India.	arungoyl@iitg.ernet.in; zecenteno@fmv.ulisboa.pt	Prates, José A M/K-9934-2013; Dias, Fernando/I-4861-2012	Prates, José A M/0000-0003-1032-5987; Dias, Fernando/0000-0001-8109-2063; Fontes, Carlos/0000-0002-1219-9753; Fernandes, Vania/0000-0002-9671-3923; Chakraborty, Soumyadeep/0000-0002-3882-7172	Department of Science and Technology, India; Fundacao para a Ciencia e a Tecnologia, Portugal; Ministry of Human Resource Development, Government of India through IIT Guwahati;  [SFRH/BDE/51101/2010]	Department of Science and Technology, India(Department of Science & Technology (India)); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Ministry of Human Resource Development, Government of India through IIT Guwahati; 	This research work was funded under a Indo-Portugal project grant from Department of Science and Technology, India and Fundacao para a Ciencia e a Tecnologia, Portugal. PhD scholarships to Soumyadeep Chakraborty was provided by Ministry of Human Resource Development, Government of India through IIT Guwahati. PhD Grant (SFRH/BDE/51101/2010) was provided to Vania O. Fernandes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson VE, 1998, COMPREHENSIVE BIOL C, V2, P115; BARRAS F, 1994, ANNU REV PHYTOPATHOL, V32, P201, DOI 10.1146/annurev.py.32.090194.001221; BAYER EA, 1983, J BACTERIOL, V156, P818, DOI 10.1128/JB.156.2.818-827.1983; Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; Blum DL, 2000, J BACTERIOL, V182, P1346, DOI 10.1128/JB.182.5.1346-1351.2000; Bolam DN, 2004, J BIOL CHEM, V279, P22953, DOI 10.1074/jbc.M313317200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brown IE, 2001, BIOCHEM J, V355, P155, DOI 10.1042/0264-6021:3550155; Bruhlmann F, 1997, GENE, V202, P45, DOI 10.1016/S0378-1119(97)00449-6; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; COLLMER A, 1988, METHOD ENZYMOL, V161, P329; Cote GL, 2005, J IND MICROBIOL BIOT, V32, P53, DOI 10.1007/s10295-004-0194-x; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; DARVILL AG, 1978, PLANT PHYSIOL, V62, P418, DOI 10.1104/pp.62.3.418; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Fernandes AC, 1999, BIOCHEM J, V342, P105, DOI 10.1042/0264-6021:3420105; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; FONTES CMGA, 1995, APPL MICROBIOL BIOT, V43, P52, DOI 10.1007/BF00170622; Halstead JR, 1999, MICROBIOL-SGM, V145, P3101, DOI 10.1099/00221287-145-11-3101; HASEGAWA S, 1966, J FOOD SCI, V31, P838, DOI 10.1111/j.1365-2621.1966.tb03259.x; HENRISSAT B, 1995, PLANT PHYSIOL, V107, P963, DOI 10.1104/pp.107.3.963; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Herron SR, 2003, J BIOL CHEM, V278, P12271, DOI 10.1074/jbc.M209306200; HINTON JCD, 1989, MOL MICROBIOL, V3, P1785, DOI 10.1111/j.1365-2958.1989.tb00164.x; Hugouvieux-Cotte-Pattat N., 1996, ANNU REV MICROBIOL, V50, P213; Jenkins J, 2004, J BIOL CHEM, V279, P9139, DOI 10.1074/jbc.M311390200; Jurnak F, 1996, PROGR BIOTECHNOL, V14, P295, DOI 10.1016/S0921-0423(96)80263-2; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; LIETZKE SE, 1994, PLANT PHYSIOL, V106, P849, DOI 10.1104/pp.106.3.849; LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135; LOJKOWSKA E, 1995, MOL MICROBIOL, V16, P1183, DOI 10.1111/j.1365-2958.1995.tb02341.x; McDonough MA, 2004, FEBS LETT, V565, P188, DOI 10.1016/j.febslet.2004.03.094; McKie VA, 2001, BIOCHEM J, V355, P167, DOI 10.1042/0264-6021:3550167; MCNEIL M, 1980, PLANT PHYSIOL, V66, P1128, DOI 10.1104/pp.66.6.1128; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; MORAN F, 1968, ARCH BIOCHEM BIOPHYS, V123, P298, DOI 10.1016/0003-9861(68)90138-0; Ochiai A, 2007, J BIOL CHEM, V282, P37134, DOI 10.1074/jbc.M704663200; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Pages S, 2003, J BACTERIOL, V185, P4727, DOI 10.1128/JB.185.16.4727-4733.2003; PICKERSGILL R, 1994, NAT STRUCT BIOL, V1, P717, DOI 10.1038/nsb1094-717; Pissavin C, 1996, J BACTERIOL, V178, P7187, DOI 10.1128/jb.178.24.7187-7196.1996; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scavetta RD, 1999, PLANT CELL, V11, P1081, DOI 10.1105/tpc.11.6.1081; Shevchik VE, 1997, J BACTERIOL, V179, P7321, DOI 10.1128/jb.179.23.7321-7330.1997; Shevchik VE, 1999, J BACTERIOL, V181, P1652, DOI 10.1128/JB.181.5.1652-1663.1999; Soriano M, 2006, MICROBIOL-SGM, V152, P617, DOI 10.1099/mic.0.28562-0; Soriano M, 2000, MICROBIOL-SGM, V146, P89, DOI 10.1099/00221287-146-1-89; SPINNLER HE, 1986, APPL MICROBIOL BIOT, V23, P434, DOI 10.1007/BF02346055; Sukhumsiirchart W, 2009, BIOSCI BIOTECH BIOCH, V73, P268; Tamaru Y, 2001, P NATL ACAD SCI USA, V98, P4125, DOI 10.1073/pnas.071045598; Tunnicliffe RB, 2005, J MOL BIOL, V347, P287, DOI 10.1016/j.jmb.2005.01.038; White GW, 1999, J PHARMACEUT BIOMED, V20, P905, DOI 10.1016/S0731-7085(99)00083-7; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994; Zverlov VV, 2002, APPL ENVIRON MICROB, V68, P3176, DOI 10.1128/AEM.68.6.3176-3179.2002; ZVERLOV VV, 1994, BIOTECHNOL LETT, V16, P29, DOI 10.1007/BF01022619	61	14	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116787	10.1371/journal.pone.0116787	http://dx.doi.org/10.1371/journal.pone.0116787			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658912	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900067
J	Cho, Y; Kim, JO; Lee, JH; Park, HM; Jeon, YJ; Oh, SH; Bae, J; Park, YS; Kim, OJ; Kim, NK				Cho, Yunkyung; Kim, Jung O.; Lee, Jeong Han; Park, Hye Mi; Jeon, Young Joo; Oh, Seung Hun; Bae, Jinkun; Park, Young Seok; Kim, Ok Joon; Kim, Nam Keun			Association of Reduced Folate Carrier-1 (RFC-1) Polymorphisms with Ischemic Stroke and Silent Brain Infarction	PLOS ONE			English	Article							TOTAL HOMOCYSTEINE CONCENTRATIONS; CARDIOVASCULAR-DISEASE; RISK-FACTOR; HEART-DISEASE; WHITE-MATTER; SERUM FOLATE; GENE; METAANALYSIS; HYPERHOMOCYSTEINEMIA; METHOTREXATE	Stroke is the second leading cause of death in the world and in South Korea. Ischemic stroke and silent brain infarction (SBI) are complex, multifactorial diseases influenced by multiple genetic and environmental factors. Moderately elevated plasma homocysteine levels are a major risk factor for vascular diseases, including stroke and SBI. Folate and vitamin B12 are important regulators of homocysteine metabolism. Reduced folate carrier (RFC), a bidirectional anion exchanger, mediates folate delivery to a variety of cells. We selected three known RFC-1 polymorphisms (-43C>T, 80A>G, 696T>C) and investigated their relationship to cerebral infarction in the Korean population. We used the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method to analyze associations between the three RFC-1 polymorphisms, disease status, and folate and homocysteine levels in 584 ischemic stroke patients, 353 SBI patients, and 505 control subjects. The frequencies of the RFC-1-43TT, 80GG, and 696CC genotypes differed significantly between the stroke and control groups. The RFC-1 80A>G substitution was also associated with small artery occlusion and SBI. In a gene-environment analysis, the RFC-1-43C>T, 80A>G, and 696T>C polymorphisms in the ischemic stroke group had combined effects with all environmental factors. In summary, we found that the RFC-1-43C>T, 80A>G, and 696T>C polymorphisms may be risk factors for ischemic stroke.	[Cho, Yunkyung] CHA Univ, CHA Gangnam Med Ctr, Sch Med, Dept Internal Med, Seoul 135081, South Korea; [Kim, Jung O.; Park, Hye Mi; Jeon, Young Joo; Kim, Nam Keun] CHA Univ, Sch Med, CHA Bundang Med Ctr, Inst Clin Res, Songnam 463712, South Korea; [Lee, Jeong Han; Bae, Jinkun] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Emergency Med, Songnam 463712, South Korea; [Oh, Seung Hun; Kim, Ok Joon] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Neurol, Songnam 463712, South Korea; [Park, Young Seok] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Dept Neurosurg, Chongju 361711, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University; Pochon Cha University; Chungbuk National University; Chungbuk National University Hospital	Kim, OJ (corresponding author), CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Neurol, Songnam 463712, South Korea.	okjun77@cha.ac.kr; nkkim@cha.ac.kr			National Research foundation, South Korea [NRF-2012R1A1A2007033, NRF-2013R1A1A2008177, NRF-2013R1A2A2A01067990]	National Research foundation, South Korea(National Research Foundation of Korea)	1. NRF-2012R1A1A2007033: National Research foundation, South Korea; NKK. 2. NRF-2013R1A1A2008177: National Research Foundation, South Korea; OJK. 3. NRF-2013R1A2A2A01067990: National Research Foundation, South Korea; YSP.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Ashfield-Watt PAL, 2001, BIOMED PHARMACOTHER, V55, P425, DOI 10.1016/S0753-3322(01)00125-1; Bazzano LA, 2002, STROKE, V33, P1183, DOI 10.1161/01.STR.0000014607.90464.88; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernick C, 2001, NEUROLOGY, V57, P1222, DOI 10.1212/WNL.57.7.1222; Casas JP, 2004, ARCH NEUROL-CHICAGO, V61, P1652, DOI 10.1001/archneur.61.11.1652; Chango A, 2000, MOL GENET METAB, V70, P310, DOI 10.1006/mgme.2000.3034; Chatzikyriakidou A, 2007, RHEUMATOL INT, V27, P1057, DOI 10.1007/s00296-007-0339-0; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Dasarathy J, 2010, AM J CLIN NUTR, V91, P357, DOI 10.3945/ajcn.2009.28457; De Marco P, 2001, EUR J PEDIATR SURG, V11, pS14, DOI 10.1055/s-2001-19739; Frederiksen J, 2004, BLOOD, V104, P3046, DOI 10.1182/blood-2004-03-0897; FREISHEIM JH, 1989, ADV ENZYME REGUL, V29, P13, DOI 10.1016/0065-2571(89)90091-5; Gellekink Henkjan, 2005, Semin Vasc Med, V5, P98, DOI 10.1055/s-2005-872396; GILES WH, 1995, STROKE, V26, P1166, DOI 10.1161/01.STR.26.7.1166; GOLDMAN ID, 1968, J BIOL CHEM, V243, P5007; Goldstein LB, 2001, STROKE, V32, P280, DOI 10.1161/01.STR.32.1.280; He K, 2004, STROKE, V35, P169, DOI 10.1161/01.STR.0000106762.55994.86; Ifergan I, 2008, J BIOL CHEM, V283, P20687, DOI 10.1074/jbc.M802812200; Iso H, 2004, CIRCULATION, V109, P2766, DOI 10.1161/01.CIR.0000131942.77635.2D; JACOB RA, 1994, J NUTR, V124, P1072, DOI 10.1093/jn/124.7.1072; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Jeon YJ, 2011, GENES GENOM, V33, P223, DOI 10.1007/s13258-011-0016-2; Khan U, 2008, STROKE, V39, P2943, DOI 10.1161/STROKEAHA.107.513416; Kim NK, 2003, NEUROLOGY, V61, P1595, DOI 10.1212/01.WNL.0000096010.98989.49; Kim OJ, 2011, STROKE, V42, P2393, DOI 10.1161/STROKEAHA.110.607739; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Kluijtmans LAJ, 2003, BLOOD, V101, P2483, DOI 10.1182/blood.V101.7.2483; Kobayashi S, 1997, STROKE, V28, P1932, DOI 10.1161/01.STR.28.10.1932; Lievers KJA, 2001, J MOL MED-JMM, V79, P522, DOI 10.1007/s001090100253; Matsui T, 2001, STROKE, V32, P1116, DOI 10.1161/01.STR.32.5.1116; Maxwell CJ, 2002, DEMENT GERIATR COGN, V13, P225, DOI 10.1159/000057701; MOSCOW JA, 1995, CANCER RES, V55, P3790; Murray RC, 1996, J BIOL CHEM, V271, P19174, DOI 10.1074/jbc.271.32.19174; Pei LJ, 2006, ANN EPIDEMIOL, V16, P352, DOI 10.1016/j.annepidem.2005.02.014; Rah H, 2012, REPROD SCI, V19, P513, DOI 10.1177/1933719111426604; Shen M, 2005, LUNG CANCER-J IASLC, V49, P299, DOI 10.1016/j.lungcan.2005.04.002; Sudlow C, 2006, STROKE, V37, P364, DOI 10.1161/01.STR.0000199065.12908.62; Szolnoki Z, 2007, NEUROMOL MED, V9, P21, DOI 10.1385/NMM:9:1:21; Szolnoki Z, 2007, CURR MED CHEM, V14, P1027, DOI 10.2174/092986707780362907; Uehara T, 1999, STROKE, V30, P378, DOI 10.1161/01.STR.30.2.378; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Vermeer SE, 2002, ANN NEUROL, V51, P285, DOI 10.1002/ana.10111; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wang LN, 2006, EUR J CANCER, V42, P3206, DOI 10.1016/j.ejca.2006.04.022; Warlow CP, 1998, LANCET, V352, pSIII1; World Health Organization, 2007, STEPWISE APPR STROK; Yates Z, 2005, LIFE SCI, V77, P2735, DOI 10.1016/j.lfs.2005.02.029	48	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115295	10.1371/journal.pone.0115295	http://dx.doi.org/10.1371/journal.pone.0115295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659099	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900014
J	Lavikainen, P; Korhonen, MJ; Huupponen, R; Helin-Salmivaara, A				Lavikainen, Piia; Korhonen, Maarit Jaana; Huupponen, Risto; Helin-Salmivaara, Arja			Accumulation of Cardiovascular and Diabetes Medication among Apparently Healthy Statin Initiators	PLOS ONE			English	Article							PRIMARY PREVENTION; EUROPEAN GUIDELINES; DISEASE PREVENTION; CLINICAL-PRACTICE; ROSUVASTATIN; POPULATION; COHORT	Purpose To characterize accumulation of drug-modifiable cardiovascular (CV) risk factors in statin initiators who had no prior medication or hospitalizations for CV disease or diabetes. Methods A cohort of 45-75-year-old statin initiators in Finland with no prior CV diseases, diabetes or medication for these conditions was followed up for 24 months after statin initiation for accumulation of CV and diabetes drugs. The number of drugs was measured semi-annually since the first statin purchase and analyzed by growth mixture modeling. Results Of the 11 948 apparently healthy statin initiators, 34% purchased at least one additional CV or diabetes drug during the subsequent 24 months. Of those, 20% redeemed no other CV or diabetes drugs at statin initiation but started to accumulate them after 18 months of follow-up, receiving on average 1.3 other drugs at 24 months. The majority, 59%, redeemed on average 0.5 drugs at statin initiation and accumulated 1.5 drugs by the end of 24-month follow-up. Seventeen percent received 1 additional drug at statin initiation, accumulating on average 3 drugs. The remaining 4% with an average of 2 CV or diabetes drugs at statin initiation redeemed 3.5 additional drugs during the follow-up. Conclusions Two years after statin initiation, 2 in 3 apparently healthy initiators could still be defined as such as reflected by CV and diabetes medication use.	[Lavikainen, Piia; Korhonen, Maarit Jaana; Huupponen, Risto; Helin-Salmivaara, Arja] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Lavikainen, Piia] Univ Turku, Drug Res Doctoral Programme, Turku, Finland; [Korhonen, Maarit Jaana] Univ Turku, Dept Publ Hlth, Turku, Finland; [Huupponen, Risto] Turku Univ Hosp, Dept Clin Pharmacol, FIN-20520 Turku, Finland; [Helin-Salmivaara, Arja] Hosp Dist Helsinki & Uusimaa, Unit Primary Hlth Care, Helsinki, Finland	University of Turku; University of Turku; University of Turku; University of Turku; University of Helsinki; Helsinki University Central Hospital	Lavikainen, P (corresponding author), Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland.	piia.lavikainen@utu.fi		Korhonen, Maarit/0000-0002-2953-4757; Lavikainen, Piia/0000-0003-3560-8860	Academy of Finland [138255]	Academy of Finland(Academy of Finland)	This study was funded by the Academy of Finland (www.aka.fi,decision number 138255). The Academy of Finland had no role in the design, analyses, interpretation of data, writing the report, or in the decision to submit the manuscript.	Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; [Anonymous], 2007, FINN STAT MED 2006; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Crouse JR, 2007, JAMA-J AM MED ASSOC, V297, P1344, DOI 10.1001/jama.297.12.1344; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Germano G, 2012, EUR HEART J, V33, P137; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Greving JP, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1672; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kildemoes HW, 2012, HEALTH POLICY, V108, P216, DOI 10.1016/j.healthpol.2012.08.008; Kildemoes HW, 2012, PHARMACOEPIDEM DR S, V21, P1027, DOI 10.1002/pds.2195; Lazar LD, 2011, CIRCULATION, V124, P146, DOI 10.1161/CIRCULATIONAHA.110.986349; Mitchell Aaron P, 2012, BMC Res Notes, V5, P373, DOI 10.1186/1756-0500-5-373; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Prasad V, 2014, ANN INTERN MED, V160, P867, DOI 10.7326/M13-2974; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Raymond CB, 2007, CLIN THER, V29, P2107, DOI 10.1016/j.clinthera.2007.09.022; Reinecke J, 2011, ASTA-ADV STAT ANAL, V95, P415, DOI 10.1007/s10182-011-0171-4; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Rikala M, 2013, BASIC CLIN PHARMACOL, V113, P173, DOI 10.1111/bcpt.12075; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Vartiainen E, 2013, FINRISKI TUTKIMUS 20; WHO, ATC DDD SYST	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117182	10.1371/journal.pone.0117182	http://dx.doi.org/10.1371/journal.pone.0117182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658919	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900112
J	Neves, CDC; Lacerda, ACR; Lage, VKS; Lima, LP; Fonseca, SF; de Avelar, NCP; Teixeira, MM; Mendonca, VA				Neves, Camila D. C.; Rodrigues Lacerda, Ana Cristina; Lage, Vanessa K. S.; Lima, Liliana P.; Fonseca, Sueli F.; de Avelar, Nubia C. P.; Teixeira, Mauro M.; Mendonca, Vanessa A.			Cardiorespiratory Responses and Prediction of Peak Oxygen Uptake during the Shuttle Walking Test in Healthy Sedentary Adult Men	PLOS ONE			English	Article							REFERENCE VALUES; HEART-RATE; EQUATIONS	Background The application of the Shuttle Walking Test (SWT) to assess cardiorespiratory fitness and the intensity of this test in healthy participants has rarely been studied. This study aimed to assess and correlate the cardiorespiratory responses of the SWT with the cardiopulmonary exercise testing (CEPT) and to develop a regression equation for the prediction of peak oxygen uptake (VO2 peak) in healthy sedentary adult men. Methods In the first stage of this study, 12 participants underwent the SWT and the CEPT on a treadmill. In the second stage, 53 participants underwent the SWT twice. In both phases, the VO2 peak, respiratory exchange ratio (R), and heart rate (HR) were evaluated. Results Similar results in VO2 peak (P>0.05), R peak (P>0.05) and predicted maximum HR (P>0.05) were obtained between the SWT and CEPT. Both tests showed strong and significant correlations of VO2 peak (r = 0.704, P = 0.01) and R peak (r = 0.737, P<0.01), as well as the agreement of these measurements by Bland-Altman analysis. Body mass index and gait speed were the variables that explained 40.6%(R2 = 0.406, P = 0.001) of the variance in VO2 peak. The results obtained by the equation were compared with the values obtained by the gas analyzer and no significant difference between them (P>0.05) was found. Conclusions The SWT produced maximal cardiorespiratory responses comparable to the CEPT, and the developed equation showed viability for the prediction of VO2 peak in healthy sedentary men.	[Neves, Camila D. C.; Rodrigues Lacerda, Ana Cristina; Fonseca, Sueli F.; Mendonca, Vanessa A.] Univ Fed Vales Jequitinhonha & Mucuri, Sociedade Brasileira Fisiol, Programa Multicentrico Posgrad Ciencias Fisiol, Diamantina, MG, Brazil; [Neves, Camila D. C.; Lage, Vanessa K. S.; Lima, Liliana P.; Mendonca, Vanessa A.] Univ Fed Vales Jequitinhonha & Mucuri, Labo Inflamacao & Metab, Diamantina, MG, Brazil; [de Avelar, Nubia C. P.] Univ Fed Santa Catarina, Dept Fisioterapia, Ararangua, SC, Brazil; [Teixeira, Mauro M.] Univ Fed Minas Gerais, Lab Imunofarmacol, Belo Horizonte, MG, Brazil	Sociedade Brasileira de Fisiologia; Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Minas Gerais	Neves, CDC (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, Sociedade Brasileira Fisiol, Programa Multicentrico Posgrad Ciencias Fisiol, Diamantina, MG, Brazil.	camilinhadcn@yahoo.com.br	Teixeira, Mauro M/A-4587-2008; Lage, Vanessa/AAE-6639-2019; Lacerda, Ana Cristina/J-2181-2012; Mendonça, Vanessa Amaral/T-7958-2019; FONSECA, SUELI/AAP-3800-2021	Teixeira, Mauro M/0000-0002-6944-3008; Lage, Vanessa/0000-0002-0381-5622; Lacerda, Ana Cristina/0000-0001-5366-3754; Mendonça, Vanessa Amaral/0000-0002-1696-6091; 	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) were financial supporters of this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2003, DIR ACSM TEST ESF SU; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Dourado VZ, 2013, BRAZ J MED BIOL RES, V46, P194, DOI 10.1590/1414-431X20122376; Dourado VZ, 2010, INT J SPORTS MED, V31, P698, DOI 10.1055/s-0030-1255110; Dourado VZ, 2013, J BRAS PNEUMOL, V39, P190, DOI 10.1590/S1806-37132013000200010; Dourado VZ, 2011, J BRAS PNEUMOL, V37, P607, DOI 10.1590/S1806-37132011000500007; Green DJ, 2001, J SCI MED SPORT, V4, P292, DOI 10.1016/S1440-2440(01)80038-4; Harrison SL, 2013, J CARDIOPULM REHABIL, V33, P309, DOI 10.1097/HCR.0b013e3182a0297e; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Jurgensen SP, 2011, RESPIRATION, V81, P223, DOI 10.1159/000319037; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; Loe H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064319; Moloney ED, 2003, RESP MED, V97, P682, DOI 10.1053/rmed.2003.1501; Morales FJ, 2000, INT J CARDIOL, V76, P101, DOI 10.1016/S0167-5273(00)00393-4; Nici L, 2006, AM J RESP CRIT CARE, V173, P1390, DOI 10.1164/rccm.200508-1211ST; Onorati P, 2003, EUR J APPL PHYSIOL, V89, P331, DOI 10.1007/s00421-003-0803-9; Palange P, 2007, EUR RESPIR J, V29, P185, DOI 10.1183/09031936.00046906; Probst VS, 2012, RESP MED, V106, P243, DOI 10.1016/j.rmed.2011.07.023; Robergs RA, 2010, SPORTS MED, V40, P95, DOI 10.2165/11319670-000000000-00000; Sawyer BJ, 2010, MED SCI SPORT EXER, V42, P2122, DOI 10.1249/MSS.0b013e3181de2da7; Seixas DM, 2013, J BRAS PNEUMOL, V39, P440, DOI 10.1590/S1806-37132013000400007; SINGH SJ, 1994, EUR RESPIR J, V7, P2016; SINGH SJ, 1992, THORAX, V47, P1019, DOI 10.1136/thx.47.12.1019; Siri WE, 1961, SCIENCE, P223	25	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117563	10.1371/journal.pone.0117563	http://dx.doi.org/10.1371/journal.pone.0117563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659094	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900176
J	Smiga, M; Bielecki, M; Olczak, M; Smalley, JW; Olczak, T				Smiga, Michal; Bielecki, Marcin; Olczak, Mariusz; Smalley, John W.; Olczak, Teresa			Anti-HmuY Antibodies Specifically Recognize Porphyromonas gingivalis HmuY Protein but Not Homologous Proteins in Other Periodontopathogens	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; SERUM ANTIBODY; CHECKERBOARD ASSESSMENTS; PERIODONTAL PATHOGENS; RHEUMATOID-ARTHRITIS; IMMUNOGLOBULIN-G; P. GINGIVALIS; ATHEROSCLEROSIS; HAEMOPHORE; MICROBIOTA	Given the emerging evidence of an association between periodontal infections and systemic conditions, the search for specific methods to detect the presence of P. gingivalis, a principal etiologic agent in chronic periodontitis, is of high importance. The aim of this study was to characterize antibodies raised against purified P. gingivalis HmuY protein and selected epitopes of the HmuY molecule. Since other periodontopathogens produce homologs of HmuY, we also aimed to characterize responses of antibodies raised against the HmuY protein or its epitopes to the closest homologous proteins from Prevotella intermedia and Tannerella forsythia. Rabbits were immunized with purified HmuY protein or three synthetic, KLH-conjugated peptides, derived from the P. gingivalis HmuY protein. The reactivity of anti-HmuY antibodies with purified proteins or bacteria was determined using Western blotting and ELISA assay. First, we found homologs of P. gingivalis HmuY in P. intermedia (PinO and PinA proteins) and T. forsythia (Tfo protein) and identified corrected nucleotide and amino acid sequences of Tfo. All proteins were overexpressed in E. coli and purified using ion-exchange chromatography, hydrophobic chromatography and gel filtration. We demonstrated that antibodies raised against P. gingivalis HmuY are highly specific to purified HmuY protein and HmuY attached to P. gingivalis cells. No reactivity between P. intermedia and T. forsythia or between purified HmuY homologs from these bacteria and antiHmuY antibodies was detected. The results obtained in this study demonstrate that P. gingivalis HmuY protein may serve as an antigen for specific determination of serum antibodies raised against this bacterium.	[Smiga, Michal; Bielecki, Marcin; Olczak, Mariusz; Olczak, Teresa] Univ Wroclaw, Fac Biotechnol, Biochem Lab, PL-50383 Wroclaw, Poland; [Smalley, John W.] Univ Liverpool, Sch Dent, Liverpool L69 3GN, Merseyside, England	University of Wroclaw; University of Liverpool	Olczak, T (corresponding author), Univ Wroclaw, Fac Biotechnol, Biochem Lab, 14A F Joliot Curie St, PL-50383 Wroclaw, Poland.	Teresa.Olczak@biotech.uni.wroc.pl	Śmiga, Michał/AAM-6190-2020	Śmiga, Michał/0000-0002-9236-4236	Wroclaw Research Center EIT+ - European Regional Development Fund (Operational Program Innovative Economy) [POIG 01.01.02-02-003/08/00, 1.1.2]; Wroclaw Center of Biotechnology program "The Leading National Research Center (KNOW)"	Wroclaw Research Center EIT+ - European Regional Development Fund (Operational Program Innovative Economy); Wroclaw Center of Biotechnology program "The Leading National Research Center (KNOW)"	This study was supported by Wroclaw Research Center EIT+ (www.eitplus.pl) under the project "Biotechnologies and advanced medical technologies - BioMed" (POIG 01.01.02-02-003/08/00) financed by the European Regional Development Fund (Operational Program Innovative Economy, 1.1.2). Publication costs were supported by Wroclaw Center of Biotechnology program "The Leading National Research Center (KNOW) for years 2014-2018". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko Y, 2010, J PERIODONTAL RES, V45, P389, DOI 10.1111/j.1600-0765.2009.01250.x; Albandar JM, 2001, J PERIODONTOL, V72, P1463, DOI 10.1902/jop.2001.72.11.1463; Arvikar SL, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4289; Bohnstedt S, 2010, J DENT RES, V89, P938, DOI 10.1177/0022034510370817; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Byrne DP, 2013, MOL ORAL MICROBIOL, V28, P219, DOI 10.1111/omi.12018; Byrne SJ, 2009, ORAL MICROBIOL IMMUN, V24, P469, DOI 10.1111/j.1399-302X.2009.00544.x; Carvalho PC, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-206; Choi J, 2011, J PERIODONTAL IMPLAN, V41, P54, DOI 10.5051/jpis.2011.41.2.54; Craig RG, 2003, J PERIODONTOL, V74, P1007, DOI 10.1902/jop.2003.74.7.1007; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dye BA, 2009, J PERIODONTOL, V80, P634, DOI 10.1902/jop.2009.080474; Ebersole JL, 2009, J PERIODONTOL, V80, P953, DOI 10.1902/jop.2009.080464; Franca M, 2007, J APPL ORAL SCI, V15, P213, DOI 10.1590/S1678-77572007000300011; Gmiterek A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067719; Graves DT, 2000, CURR OPIN INFECT DIS, V13, P227, DOI 10.1097/00001432-200006000-00005; Griffen AL, 1998, J CLIN MICROBIOL, V36, P3239, DOI 10.1128/JCM.36.11.3239-3242.1998; Guo SJ, 2000, J CLIN PERIODONTOL, V27, P769, DOI 10.1034/j.1600-051x.2000.027010769.x; Guyodo H, 2012, FEMS IMMUNOL MED MIC, V64, P175, DOI 10.1111/j.1574-695X.2011.00877.x; Haffajee AD, 1998, J CLIN PERIODONTOL, V25, P346, DOI 10.1111/j.1600-051X.1998.tb02454.x; Hajishengallis G, 2011, J ORAL BIOSCI, V53, P233, DOI 10.2330/joralbiosci.53.233; Hanaoka Y, 2013, HYPERTENS RES, V36, P829, DOI 10.1038/hr.2013.46; Hitchon CA, 2010, J RHEUMATOL, V37, P1105, DOI 10.3899/jrheum.091323; Holmlund A, 2011, INT J CARDIOL, V148, P148, DOI 10.1016/j.ijcard.2009.10.034; Honma Y, 2008, J PERIODONTAL RES, V43, P706, DOI 10.1111/j.1600-0765.2007.01078.x; Iida Y, 2004, BRIT J ORAL MAX SURG, V42, P180, DOI 10.1016/S0266-4356(03)00190-6; Kamaguchi A, 2003, MICROBIOL-SGM, V149, P1257, DOI 10.1099/mic.0.25997-0; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Kozarov E, 2006, MICROBES INFECT, V8, P687, DOI 10.1016/j.micinf.2005.09.004; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Leon R, 2007, J PERIODONTOL, V78, P1249, DOI 10.1902/jop.2007.060368; Meurman JH, 2004, CRIT REV ORAL BIOL M, V15, P403, DOI 10.1177/154411130401500606; Mikuls TR, 2009, INT IMMUNOPHARMACOL, V9, P38, DOI 10.1016/j.intimp.2008.09.008; Ogrendik Mesut, 2005, MedGenMed, V7, P2; Olczak T, 2005, FEMS MICROBIOL REV, V29, P119, DOI 10.1016/j.femsre.2004.09.001; Olczak T, 2008, ARCH MICROBIOL, V189, P197, DOI 10.1007/s00203-007-0309-7; Olczak T, 2012, ARCH MICROBIOL, V194, P719, DOI 10.1007/s00203-012-0804-3; Olczak T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-134; Papapanou PN, 2000, J PERIODONTOL, V71, P885, DOI 10.1902/jop.2000.71.6.885; Papapanou PN, 2001, J CLIN PERIODONTOL, V28, P103, DOI 10.1034/j.1600-051x.2001.280116.x; Rosenstein ED, 2004, INFLAMMATION, V28, P311, DOI 10.1007/s10753-004-6641-z; Roy S, 2010, J BACTERIOL, V192, P2285, DOI 10.1128/JB.00079-10; Skottrup PD, 2011, ANAL BIOCHEM, V415, P158, DOI 10.1016/j.ab.2011.04.015; Smalley JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017182; Trindade SC, 2012, J PERIODONTAL RES, V47, P27, DOI 10.1111/j.1600-0765.2011.01401.x; Trindade SC, 2012, ARCH ORAL BIOL, V57, P314, DOI 10.1016/j.archoralbio.2011.09.003; Trindade SC, 2013, J PERIODONTOL, V84, P650, DOI 10.1902/jop.2012.120230; Veith PD, 2014, J PROTEOME RES, V13, P2420, DOI 10.1021/pr401227e; Vitkov L, 2005, ORAL MICROBIOL IMMUN, V20, P317, DOI 10.1111/j.1399-302X.2005.00233.x; Wojaczynski J, 2011, BIOCHEM BIOPH RES CO, V411, P299, DOI 10.1016/j.bbrc.2011.06.129; Wojtowicz H, 2013, METALLOMICS, V5, P343, DOI 10.1039/c3mt20215a; Wojtowicz H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000419; Wojtowicz H, 2009, BIOCHEM BIOPH RES CO, V383, P178, DOI 10.1016/j.bbrc.2009.03.148; Yilmaz O, 2006, INFECT IMMUN, V74, P703, DOI 10.1128/IAI.74.1.703-710.2006	54	12	12	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117508	10.1371/journal.pone.0117508	http://dx.doi.org/10.1371/journal.pone.0117508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658942	Green Published, gold			2022-12-27	WOS:000349444900166
J	Wu, L; Rabe, KG; Petersen, GM				Wu, Lang; Rabe, Kari G.; Petersen, Gloria M.			Do Variants Associated with Susceptibility to Pancreatic Cancer and Type 2 Diabetes Reciprocally Affect Risk?	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC SUSCEPTIBILITY; LOCI; METAANALYSIS; GLUCOSE; MELLITUS; MTNR1B; KCNQ1	Objectives Although type 2 diabetes mellitus is a known risk factor for pancreatic cancer, the existence of shared genetic susceptibility is largely unknown. We evaluated whether any reported genetic risk variants of either disease found by genome-wide association studies reciprocally confer susceptibility. Methods Data that were generated in previous genome-wide association studies (GENEVA Type 2 Diabetes; PanScan) were obtained through the National Institutes of Health database of Genotypes and Phenotypes (dbGaP). Using the PanScan datasets, we tested for association of 38 variants within 37 genomic regions known to be susceptibility factors for type 2 diabetes. We further examined whether type 2 diabetes variants predispose to pancreatic cancer risk stratified by diabetes status. Correspondingly, we examined the association of fourteen pancreatic cancer susceptibility variants within eight genomic regions in the GENEVA Type 2 Diabetes dataset. Results Four plausible associations of diabetes variants and pancreatic cancer risk were detected at a significance threshold of p = 0.05, and one pancreatic cancer susceptibility variant was associated with diabetes risk at threshold of p = 0.05, but none remained significant after correction for multiple comparisons. Conclusion Currently identified GWAS susceptibility variants are unlikely to explain the potential shared genetic etiology between Type 2 diabetes and pancreatic cancer.	[Wu, Lang; Rabe, Kari G.; Petersen, Gloria M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55902 USA; [Wu, Lang] Mayo Clin, Ctr Clin & Translat Sci, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Petersen, GM (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55902 USA.	Petersen.Gloria@mayo.edu	Wu, Lang/M-4053-2017		National Cancer Institute [P50CA102701, R01CA97075]; National Center for Advancing Translational Sciences [TL1TR000137]; NATIONAL CANCER INSTITUTE [P50CA102701, R01CA097075] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000137, UL1TR000135] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Cancer Institute (P50CA102701) [www.cancer.gov/] to GMP, the National Cancer Institute (R01CA97075) [www.cancer.gov/] to GMP, and National Center for Advancing Translational Sciences (TL1TR000137) [www.ncats.nih.gov/] to LW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Austin MA, 2013, CANCER EPIDEM BIOMAR, V22, P1913, DOI 10.1158/1055-9965.EPI-13-0518; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; Benjamini Y, 2001, ANN STAT, V29, P1165; Bosetti C, 2014, ANN ONCOLOGY OFFICIA; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; EVERHART J, 1995, JAMA-J AM MED ASSOC, V273, P1605, DOI 10.1001/jama.273.20.1605; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113; Klein AP, 2012, MOL CARCINOGEN, V51, P14, DOI 10.1002/mc.20855; Lin YS, 2011, J EPIDEMIOL, V21, P2, DOI 10.2188/jea.JE20100090; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pierce BL, 2011, CANCER CAUSE CONTROL, V22, P877, DOI 10.1007/s10552-011-9760-5; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wolpin BM, 2014, NAT GENET, V46, P994, DOI 10.1038/ng.3052; Wu L, 2014, CANC EPIDEMIOLOGY BI; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	30	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117230	10.1371/journal.pone.0117230	http://dx.doi.org/10.1371/journal.pone.0117230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658847	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900120
J	Liu, N; Li, P; Zang, SL; Liu, Q; Ma, DX; Sun, XL; Ji, CY				Liu, Na; Li, Peng; Zang, Shaolei; Liu, Qiang; Ma, Daoxin; Sun, Xiulian; Ji, Chunyan			Novel Agent Nitidine Chloride Induces Erythroid Differentiation and Apoptosis in CML Cells through c-Myc-miRNAs Axis	PLOS ONE			English	Article							BCR-ABL; SIGNALING PATHWAY; IMATINIB; INHIBITION; MIR-17-92; MICRORNA; CLUSTER; PROLIFERATION; RESISTANCE; P21	The proto-oncogene c-Myc plays critical roles in human malignancies including chronic myeloid leukemia (CML), suggesting that the discovery of specific agents targeting c-Myc would be extremely valuable for CML treatment. Nitidine Chloride (NC), a natural bioactive alkaloid, is suggested to possess anti-tumor effects. However, the function of NC in leukemia and the underlying molecular mechanisms have not been established. In this study, we found that NC induced erythroid differentiation, accompanied by increased expression of erythroid differentiation markers, e. g. alpha-, epsilon-, gamma-globin, CD235a, CD71 and alpha-hemoglobin stabilizing protein (AHSP) in CML cells. We also observed that NC induced apoptosis and upregulated cleaved caspase-3 and Parp-1 in K562 cells. These effects were associated with concomitant attenuation of c-Myc. Our study showed that NC treatment in CML cells enhanced phosphorylation of Thr58 residue and subsequently accelerated degradation of c-Myc. A specific group of miRNAs, which had been reported to be activated by c-Myc, mediated biological functions of c-Myc. We found that most of these miRNAs, especially miR17 and miR-20a showed strong decrement after NC treatment or c-Myc interference. Furthermore, overexpression of c-Myc or miR-17/20a alleviated NC induced differentiation and apoptosis in K562 cells. More importantly, NC enhanced the effects of imatinib in K562 and primary CML cells. We further found that even imatinib resistant CML cell line (K562/G01) and CML primary cells exhibited high sensitivity to NC, which showed potential possibility to overcome imatinib resistance. Taken together, our results clearly suggested that NC promoted erythroid differentiation and apoptosis through c-Myc-miRNAs regulatory axis, providing potential possibility to overcome imatinib resistance.	[Liu, Na; Li, Peng; Zang, Shaolei; Ma, Daoxin; Ji, Chunyan] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China; [Liu, Qiang; Sun, Xiulian] Shandong Univ, Qilu Hosp, Key Lab Otolaryngol, Jinan 250100, Peoples R China	Shandong University; Shandong University	Ji, CY (corresponding author), Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China.	jichunyan@sdu.edu.cn			National Natural Science Foundation of China [81370662, 81000223]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China: 81370662(CJ), 81000223(SZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albajar M, 2011, MOL CANCER RES, V9, P564, DOI 10.1158/1541-7786.MCR-10-0356; An X, 2010, LEUKEMIA RES, V34, P1255, DOI 10.1016/j.leukres.2010.04.016; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; Bouquet J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-67; Breccia M, 2012, LEUKEMIA RES, V36, P1498, DOI 10.1016/j.leukres.2012.09.006; Chen J, 2012, MOL CANCER THER, V11, P277, DOI 10.1158/1535-7163.MCT-11-0648; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Dai BB, 2011, CANCER RES, V71, P3658, DOI 10.1158/0008-5472.CAN-10-3647; Del Poeta M, 1999, ANTIMICROB AGENTS CH, V43, P2862, DOI 10.1128/AAC.43.12.2862; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Fang ZQ, 2014, FOOD CHEM TOXICOL, V66, P210, DOI 10.1016/j.fct.2014.01.049; Fang ZQ, 2013, FOOD CHEM TOXICOL, V60, P246, DOI 10.1016/j.fct.2013.07.062; Feng M, 2011, ONCOGENE, V30, P2242, DOI 10.1038/onc.2010.602; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Frenquelli M, 2010, BLOOD, V115, P3949, DOI 10.1182/blood-2009-11-254656; Gocek E, 2011, CANCER RES, V71, P6230, DOI 10.1158/0008-5472.CAN-11-1717; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; HENRIKSSON M, 1993, ONCOGENE, V8, P3199; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; JACKSTADT R, 2014, BIOCH BIOPHYS ACTA, P28669; Kang M, 2014, J BUON, V19, P130; Kawano T, 2004, ANTICANCER RES, V24, P2705; Kim BY, 2010, FEBS LETT, V584, P4524, DOI 10.1016/j.febslet.2010.10.031; Kirito K, 1998, BLOOD, V92, P462, DOI 10.1182/blood.V92.2.462.414k15_462_471; Lamontanara AJ, 2013, BBA-PROTEINS PROTEOM, V1834, P1449, DOI 10.1016/j.bbapap.2012.12.009; Liao J, 2013, INT J MOL MED, V32, P79, DOI 10.3892/ijmm.2013.1358; Liu L, 2012, BIOCHEM BIOPH RES CO, V425, P368, DOI 10.1016/j.bbrc.2012.07.098; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Liu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097974; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; Mi SL, 2010, P NATL ACAD SCI USA, V107, P3710, DOI 10.1073/pnas.0914900107; Mitchell KO, 1999, CELL GROWTH DIFFER, V10, P223; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Nagel S, 2009, LEUKEMIA LYMPHOMA, V50, P101, DOI 10.1080/10428190802626632; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pan XN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105381; Pan XH, 2011, CANCER LETT, V313, P181, DOI 10.1016/j.canlet.2011.09.001; Porro A, 2011, MOL CANCER RES, V9, P1054, DOI 10.1158/1541-7786.MCR-10-0510; PULVERER BJ, 1994, ONCOGENE, V9, P59; Qi Jing, 2004, Zhonghua Xue Ye Xue Za Zhi, V25, P337; Qian J, 2013, LEUKEMIA RES, V37, P765, DOI 10.1016/j.leukres.2013.03.014; Redner RL, 2010, ONCOLOGIST, V15, P182, DOI 10.1634/theoncologist.2009-0297; Rinaldi A, 2007, LEUKEMIA LYMPHOMA, V48, P410, DOI 10.1080/10428190601059738; Sakoe Y, 2010, BLOOD, V115, P3787, DOI 10.1182/blood-2009-05-222976; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; SUN M, 2014, TUMOUR BIOL, P28669; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wall M, 2008, BLOOD, V112, P2305, DOI 10.1182/blood-2007-09-111856; Wang ZZ, 2010, INT J ONCOL, V37, P1315, DOI 10.3892/ijo_00000783; Wang ZQ, 2012, J ETHNOPHARMACOL, V144, P145, DOI 10.1016/j.jep.2012.08.041; Wong P, 2010, CANCER RES, V70, P3833, DOI 10.1158/0008-5472.CAN-09-3268; Xie SH, 2002, ONCOGENE, V21, P7137, DOI 10.1038/sj.onc.1205942; Yu Y, 2012, LEUKEMIA, V26, P1752, DOI 10.1038/leu.2012.65; Zhang QL, 2011, J CELL BIOCHEM, V112, P2910, DOI 10.1002/jcb.23207	65	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116880	10.1371/journal.pone.0116880	http://dx.doi.org/10.1371/journal.pone.0116880			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647305	Green Submitted, Green Published, gold			2022-12-27	WOS:000348822600041
J	Yang, XW; Zhu, JJ; Tung, CY; Gardiner, G; Wang, Q; Chang, HC; Zhou, BH				Yang, Xiaowei; Zhu, Jingjing; Tung, Chun-Yu; Gardiner, Gail; Wang, Qun; Chang, Hua-Chen; Zhou, Baohua			Lunasin Alleviates Allergic Airway Inflammation while Increases Antigen-Specific Tregs	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; SOYBEAN PEPTIDE LUNASIN; REGULATORY T-CELLS; FACTOR-KAPPA-B; ASTHMA; IMMUNOTHERAPY; RESPONSES; INDUCTION; BINDS	Lunasin is a naturally occurring peptide isolated from soybeans and has been explored in cancer treatment. Lunasin inhibits NF-kappa B activation and thus pro-inflammatory cytokine and mediator production in macrophages. In this study we demonstrate that lunasin can effectively suppress allergic airway inflammation in two murine models of asthma. In an OVA+Alum sensitization model, intranasal lunasin treatment at the time of OVA challenges significantly reduced total cells counts in bronchoalveolar lavage (BAL) fluid and eosinophilia, peribronchiolar inflammatory infiltration, goblet cell metaplasia and airway IL-4 production. In an OVA+LPS intranasal sensitization model, lunasin treatment either at the time of sensitization or challenge has similar effects in suppress allergic airway inflammation including significantly reduced total cell and eosinophil counts in BAL fluid, inflammatory gene Fizz1 expression in the lung, and IL-4 production by OVA re-stimulated cells from mediastinal lymph nodes. We further show that intranasal instillation of OVA+lunasin significantly increases OVA-specific regulatory T cell (Treg) accumulation in the lung comparing to OVA only treatment. Taken together, our results suggest lunasin as an anti-inflammatory agent can be potentially used in asthma therapy or as an adjuvant to enhance the induction of antigen-specific Tregs and thus boost the efficacy of allergy immunotherapy.	[Yang, Xiaowei; Zhu, Jingjing; Wang, Qun; Zhou, Baohua] Indiana Univ Sch Med, Dept Pediat, HB Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Gardiner, Gail; Zhou, Baohua] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Yang, Xiaowei] Southwest Univ Rongchang, Dept Vet Med, Rongchang, Peoples R China; [Tung, Chun-Yu; Chang, Hua-Chen] Indiana Univ Purdue Univ, Sch Sci, Dept Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Chang, HC (corresponding author), Indiana Univ Purdue Univ, Sch Sci, Dept Biol, Indianapolis, IN 46202 USA.	huchang@iupui.edu; zhoub@iu.edu			United States Public Health Service [RO1 AI085046]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085046] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United States Public Health Service Grant RO1 AI085046 to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250; Akdis CA, 2012, NAT MED, V18, P736, DOI 10.1038/nm.2754; Cam A, 2012, MOL NUTR FOOD RES, V56, P1569, DOI 10.1002/mnfr.201200301; Chang HC, 2014, CANCER IMMUNOL IMMUN, V63, P283, DOI 10.1007/s00262-013-1513-8; Comhair SAA, 2010, ANTIOXID REDOX SIGN, V12, P93, DOI [10.1089/ars.2008.2425, 10.1089/ARS.2008.2425]; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; de Mejia EG, 2009, PEPTIDES, V30, P2388, DOI 10.1016/j.peptides.2009.08.005; Dia VP, 2011, CANCER LETT, V313, P167, DOI 10.1016/j.canlet.2011.09.002; Dia VP, 2009, J AGR FOOD CHEM, V57, P1260, DOI 10.1021/jf803303k; Dong L, 2008, J ASTHMA, V45, P648, DOI 10.1080/02770900802126941; Donovan CE, 1999, J IMMUNOL, V163, P6827; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fujita Hiroyuki, 2012, Clin Transl Allergy, V2, P2, DOI 10.1186/2045-7022-2-2; Galvez AF, 2001, CANCER RES, V61, P7473; Galvez AF, 1999, NAT BIOTECHNOL, V17, P495, DOI 10.1038/8676; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Han SW, 2006, ONCOGENE, V25, P4341, DOI 10.1038/sj.onc.1209460; Hankin CS, 2014, CURR OPIN ALLERGY CL, V14, P363, DOI 10.1097/ACI.0000000000000084; Hernandez-Ledesma B, 2009, BIOCHEM BIOPH RES CO, V390, P803, DOI 10.1016/j.bbrc.2009.10.053; Hernandez-Ledesma B, 2009, PEPTIDES, V30, P426, DOI 10.1016/j.peptides.2008.11.002; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Hsieh CC, 2010, J FOOD SCI, V75, pH311, DOI 10.1111/j.1750-3841.2010.01861.x; Janssen-Heininger Yvonne M W, 2009, Proc Am Thorac Soc, V6, P249, DOI 10.1513/pats.200806-054RM; Garcia-Nebot MJ, 2014, FOOD CHEM TOXICOL, V65, P155, DOI 10.1016/j.fct.2013.12.021; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; Khare A, 2013, J IMMUNOL, V191, P25, DOI 10.4049/jimmunol.1300193; Lei LY, 2011, J IMMUNOL, V186, P2254, DOI 10.4049/jimmunol.1002503; Li XM, 2011, MT SINAI J MED, V78, P697, DOI 10.1002/msj.20294; Loubaki L, 2010, MOL IMMUNOL, V47, P2112, DOI 10.1016/j.molimm.2010.03.011; Nelson HS, 2014, CHEM IMMUNOL ALLERGY, V100, P333, DOI 10.1159/000360047; ODANI S, 1987, J BIOL CHEM, V262, P10502; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Radulovic S, 2008, J ALLERGY CLIN IMMUN, V121, P1467, DOI 10.1016/j.jaci.2008.03.013; Tai XG, 2012, BLOOD, V119, P5155, DOI 10.1182/blood-2011-11-388918; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739; Zhang YL, 2012, EUR J IMMUNOL, V42, P1735, DOI 10.1002/eji.201142123; Zhou BH, 2008, J IMMUNOL, V181, P6557, DOI 10.4049/jimmunol.181.9.6557; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	42	24	24	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0115330	10.1371/journal.pone.0115330	http://dx.doi.org/10.1371/journal.pone.0115330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646897	gold, Green Published			2022-12-27	WOS:000348822600011
J	Papoff, G; Trivieri, N; Marsilio, S; Crielesi, R; Lalli, C; Castellani, L; Balog, EM; Ruberti, G				Papoff, Giuliana; Trivieri, Nadia; Marsilio, Sonia; Crielesi, Roberta; Lalli, Cristiana; Castellani, Loriana; Balog, Edward M.; Ruberti, Giovina			N-Terminal and C-Terminal Domains of Calmodulin Mediate FADD and TRADD Interaction	PLOS ONE			English	Article							DEATH DOMAIN; OXIDIZED CALMODULIN; GLUTAMINE SUBSTITUTIONS; DEPENDENT ACTIVATION; METHIONINE RESIDUES; TARGET RECOGNITION; PYRIN DOMAIN; OXIDATION; PROTEIN; BINDING	FADD (Fas-associated death domain) and TRADD (Tumor Necrosis Factor Receptor 1-associated death domain) proteins are important regulators of cell fate in mammalian cells. They are both involved in death receptors mediated signaling pathways and have been linked to the Toll-like receptor family and innate immunity. Here we identify and characterize by database search analysis, mutagenesis and calmodulin (CaM) pull-down assays a calcium-dependent CaM binding site in the alpha-helices 1-2 of TRADD death domain. We also show that oxidation of CaM methionines drastically reduces CaM affinity for FADD and TRADD suggesting that oxidation might regulate CaM-FADD and CaM-TRADD interactions. Finally, using Met-to-Leu CaM mutants and binding assays we show that both the Nand C-terminal domains of CaM are important for binding.	[Papoff, Giuliana; Trivieri, Nadia; Marsilio, Sonia; Crielesi, Roberta; Lalli, Cristiana; Castellani, Loriana; Ruberti, Giovina] CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Castellani, Loriana] Univ Cassino, Dept Human Sci Soc & Hlth, I-03043 Cassino, Italy; [Balog, Edward M.] Georgia Inst Technol, Sch Appl Physiol, Atlanta, GA 30332 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); University of Cassino; University System of Georgia; Georgia Institute of Technology	Ruberti, G (corresponding author), CNR, Inst Cell Biol & Neurobiol, Campus Adriano Buzzati Traverso, Rome, Italy.	gruberti@ibc.cnr.it	PAPOFF, GIULIANA/AAX-9520-2020; trivieri, nadia/GVS-1410-2022	PAPOFF, GIULIANA/0000-0003-2251-8794; RUBERTI, Giovina/0000-0003-2367-9709; Castellani, Loriana/0000-0002-8519-3504	National Research Council Project RTL "FADD and TRADD non apoptotic functions"; National Research Council Project "FaReBio di Qualita" - Italian Ministry of Economy and Finance	National Research Council Project RTL "FADD and TRADD non apoptotic functions"; National Research Council Project "FaReBio di Qualita" - Italian Ministry of Economy and Finance	This work was supported by grants (to G.R.) from the National Research Council: i) Project RTL "FADD and TRADD non apoptotic functions"; ii) Project "FaReBio di Qualita" financed by the Italian Ministry of Economy and Finance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; Ahn EY, 2004, J BIOL CHEM, V279, P5661, DOI 10.1074/jbc.M311040200; Aravind L, 2001, SCIENCE, V291, P1279, DOI 10.1126/science.291.5507.1279; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Balog EM, 2009, BIOCHEMISTRY-US, V48, P3005, DOI 10.1021/bi802117k; Balog EM, 2006, AM J PHYSIOL-HEART C, V290, pH794, DOI 10.1152/ajpheart.00706.2005; Balog EM, 2003, J BIOL CHEM, V278, P15615, DOI 10.1074/jbc.M209180200; Bartlett RK, 2003, BIOCHEMISTRY-US, V42, P3231, DOI 10.1021/bi026956z; Bigelow DJ, 2005, BBA-PROTEINS PROTEOM, V1703, P121, DOI 10.1016/j.bbapap.2004.09.012; Boschek CB, 2008, BIOCHEMISTRY-US, V47, P131, DOI 10.1021/bi701352w; BROT N, 1983, ARCH BIOCHEM BIOPHYS, V223, P271, DOI 10.1016/0003-9861(83)90592-1; Chen BW, 2005, BIOCHEMISTRY-US, V44, P4737, DOI 10.1021/bi0474113; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chin D, 1996, J BIOL CHEM, V271, P30465, DOI 10.1074/jbc.271.48.30465; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; DAVIS TN, 1986, CELL, V47, P423, DOI 10.1016/0092-8674(86)90599-4; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Dickens LS, 2012, EXP CELL RES, V318, P1269, DOI 10.1016/j.yexcr.2012.04.005; Driscoll PC, 2014, METHOD ENZYMOL, V545, P201, DOI 10.1016/B978-0-12-801430-1.00009-3; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Esposito D, 2010, STRUCTURE, V18, P1378, DOI 10.1016/j.str.2010.08.006; Fairbrother WJ, 2001, PROTEIN SCI, V10, P1911, DOI 10.1110/ps.13801; Fernandez TF, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.471821; Ferrington DA, 2001, J BIOL CHEM, V276, P937, DOI 10.1074/jbc.M005356200; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Gao J, 1998, BIOCHEMISTRY-US, V37, P9536, DOI 10.1021/bi9803877; Gao J, 2001, BIOPHYS J, V80, P1791, DOI 10.1016/S0006-3495(01)76149-8; Genestra M, 2007, CELL SIGNAL, V19, P1807, DOI 10.1016/j.cellsig.2007.04.009; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hofmann K, 1999, CELL MOL LIFE SCI, V55, P1113, DOI 10.1007/s000180050361; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Jang TH, 2014, BIOCHEMISTRY-US, V53, P5424, DOI 10.1021/bi500585u; Jones EM, 2008, BIOPHYS J, V95, P5268, DOI 10.1529/biophysj.108.139634; Jung T, 2008, IUBMB LIFE, V60, P743, DOI 10.1002/iub.114; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lu JV, 2014, SEMIN CELL DEV BIOL, V35, P33, DOI 10.1016/j.semcdb.2014.07.003; Martinon F, 2001, CURR BIOL, V11, pR118, DOI 10.1016/S0960-9822(01)00056-2; Michaelis ML, 1996, LIFE SCI, V59, P405, DOI 10.1016/0024-3205(96)00319-0; Montgomery HJ, 2003, BIOCHEMISTRY-US, V42, P7759, DOI 10.1021/bi027097h; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Papoff G, 2010, BBA-MOL CELL RES, V1803, P898, DOI 10.1016/j.bbamcr.2010.04.006; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Park SM, 2005, CURR OPIN CELL BIOL, V17, P610, DOI 10.1016/j.ceb.2005.09.010; Pawar PS, 2008, BIOCHEM J, V412, P459, DOI 10.1042/BJ20071507; Robison AJ, 2007, BIOCHEM BIOPH RES CO, V356, P97, DOI 10.1016/j.bbrc.2007.02.087; Sacksteder CA, 2006, BIOPHYS J, V91, P1480, DOI 10.1529/biophysj.106.086033; Sandu C, 2005, J BIOL CHEM, V280, P31974, DOI 10.1074/jbc.M506938200; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; STRASBURG GM, 1988, J BIOL CHEM, V263, P542; Suever JD, 2008, BIOPHYS J, V95, P5913, DOI 10.1529/biophysj.108.130542; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Tsao DHH, 2007, J BIOMOL NMR, V39, P337, DOI 10.1007/s10858-007-9198-y; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Vougier S, 2004, J BIOL CHEM, V279, P30210, DOI 10.1074/jbc.M400604200; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yao YH, 1996, BIOCHEMISTRY-US, V35, P2767, DOI 10.1021/bi951712i; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	69	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116251	10.1371/journal.pone.0116251	http://dx.doi.org/10.1371/journal.pone.0116251			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643035	Green Submitted, Green Published, gold			2022-12-27	WOS:000348821200015
J	Sreekar, R; Zhang, K; Xu, JC; Harrison, RD				Sreekar, Rachakonda; Zhang, Kai; Xu, Jianchu; Harrison, Rhett D.			Yet Another Empty Forest: Considering the Conservation Value of a Recently Established Tropical Nature Reserve	PLOS ONE			English	Article							PROTECTED AREAS; CLIMATE-CHANGE; WESTERN-GHATS; BIODIVERSITY; BIRDS; DEFORESTATION; EXTINCTIONS; LANDSCAPE; DIVERSITY; CHINA	The primary approach used to conserve tropical biodiversity is in the establishment of protected areas. However, many tropical nature reserves are performing poorly and interventions in the broader landscape may be essential for conserving biodiversity both within reserves and at large. Between October 2010 and 2012, we conducted bird surveys in and around a recently established nature reserve in Xishuangbanna, China. We constructed a checklist of observed species, previously recorded species, and species inferred to have occurred in the area from their distributions and habitat requirements. In addition, we assessed variation in community composition and habitat specificity at a landscape-scale. Despite the fact that the landscape supports a large area of natural forest habitat (similar to 50,000 ha), we estimate that >40% of the bird fauna has been extirpated and abundant evidence suggests hunting is the primary cause. A large proportion (52%) of the bigger birds (>20 cm) were extirpated and for large birds there was a U-shaped relationship between habitat breadth and extirpation probability. Habitat specificity was low and bird communities were dominated by widespread species of limited conservation concern. We question whether extending tropical protected area networks will deliver desired conservation gains, unless much greater effort is channeled into addressing the hunting problem both within existing protected areas and in the broader landscape.	[Sreekar, Rachakonda] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Menglun, Peoples R China; [Zhang, Kai] Chinese Acad Sci, Ecol Conservat & Environm Ctr, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Sreekar, Rachakonda; Zhang, Kai] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xu, Jianchu; Harrison, Rhett D.] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China; [Xu, Jianchu; Harrison, Rhett D.] World Agroforestry Ctr, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Harrison, RD (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China.	r.harrison@cgiar.org	Xu, Jianchu/Y-2890-2019; Sreekar, Rachakonda/C-4377-2008	Sreekar, Rachakonda/0000-0001-5445-6589; Harrison, Rhett/0000-0001-9055-3546	German GIZ/BMZ Making the Mekong Connected through the World Agroforestry Centre, East Asia Node [08.7860.3- 001.00]	German GIZ/BMZ Making the Mekong Connected through the World Agroforestry Centre, East Asia Node	Funding for this work was generously provided by the German GIZ/BMZ Making the Mekong Connected, Project No. 08.7860.3- 001.00, through the World Agroforestry Centre, East Asia Node. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Athreya V, 2014, TROP CONSERV SCI, V7, P75, DOI 10.1177/194008291400700111; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Balaji D, 2014, J NAT CONSERV, V22, P337, DOI 10.1016/j.jnc.2014.03.004; Barlow J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009609; BECKSCHFER P, 2013, OPEN J FORESTRY, V0003; Benchimol M, 2013, DIVERS DISTRIB, V19, P1339, DOI 10.1111/ddi.12111; Bhupathy S, 2013, TROP CONSERV SCI, V6, P241, DOI 10.1177/194008291300600206; Brashares JS, 2010, SCIENCE, V329, P402, DOI 10.1126/science.1190095; Bregman TP, 2014, BIOL CONSERV, V169, P372, DOI 10.1016/j.biocon.2013.11.024; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Brooks TM, 2009, CONSERV BIOL, V23, P1448, DOI 10.1111/j.1523-1739.2009.01334.x; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Castelletta M, 2000, CONSERV BIOL, V14, P1870, DOI 10.1111/j.1523-1739.2000.99285.x; CHAO A, 1984, SCAND J STAT, V11, P265; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; Cheng T. h., 1961, Acta Zoologica Sinica, V13, P53; Corlett RT, 2013, TRENDS ECOL EVOL, V28, P482, DOI 10.1016/j.tree.2013.04.003; Corlett RT, 2013, BIOTROPICA, V45, P273, DOI 10.1111/btp.12028; Dalvi S, 2013, SCIENCE, V339, P270, DOI 10.1126/science.339.6117.270-a; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Fa JE, 2009, MAMMAL REV, V39, P231, DOI 10.1111/j.1365-2907.2009.00149.x; Fan PF, 2014, ORYX, V48, P52, DOI 10.1017/S0030605312001305; FAO (Food and Agricultural Organization of the United Nations), 2010, GLOB FOR RES ASS 201, DOI [10.1073/pnas.0913658107, DOI 10.1073/PNAS.0913658107]; Freeman BG, 2014, P NATL ACAD SCI USA, V111, P4490, DOI 10.1073/pnas.1318190111; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Galetti M, 2009, BIOL CONSERV, V142, P1229, DOI 10.1016/j.biocon.2009.01.023; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Hallingback T, 2006, APPL IUCN 2001 RED L; Harris JBC, 2014, DIVERS DISTRIB, V20, P773, DOI 10.1111/ddi.12180; Harris JBC, 2012, RAFFLES B ZOOL, P197; Harrison RD, 2013, ECOL LETT, V16, P687, DOI 10.1111/ele.12102; Harrison RD, 2011, BIOSCIENCE, V61, P919, DOI 10.1525/bio.2011.61.11.11; Ivanov Al, 1961, ACTA ZOOL SINCA, V13, P70; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Lenz J, 2011, P ROY SOC B-BIOL SCI, V278, P2257, DOI 10.1098/rspb.2010.2383; Li YM, 2005, BIOSCIENCE, V55, P147, DOI 10.1641/0006-3568(2005)055[0147:TTVSIC]2.0.CO;2; Liang W, 2013, BIRD CONSERV INT, V23, P45, DOI 10.1017/S0959270911000499; Liu JG, 2003, SCIENCE, V300, P1240, DOI 10.1126/science.1078868; MacKinnon J, 2000, FIELD GUIDE BIRDS CH; Mascia MB, 2014, BIOL CONSERV, V169, P355, DOI 10.1016/j.biocon.2013.11.021; McConkey KR, 2004, ORYX, V38, P439, DOI 10.1017/S0030605304000821; Mikusinski G, 2001, CONSERV BIOL, V15, P208, DOI 10.1046/j.1523-1739.2001.99236.x; Mikusinski G, 2006, ANN ZOOL FENN, V43, P86; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Palomo I, 2014, BIOSCIENCE, V64, P181, DOI 10.1093/biosci/bit033; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Raman TRS, 2006, BIODIVERS CONSERV, V15, P1577, DOI 10.1007/s10531-005-2352-5; Ranganathan J, 2008, P NATL ACAD SCI USA, V105, P17852, DOI 10.1073/pnas.0808874105; Rao M, 2002, CONSERV BIOL, V16, P360, DOI 10.1046/j.1523-1739.2002.00219.x; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Robinson JG, 2000, HUNTING SUSTAINABILI, DOI [10.1111/j.15231739.2009.01224.x, DOI 10.1111/J.1523-1739.2009.01224.X]; Robson C, 2000, NEW HOLLAND FIELD GU; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rodriguez JP, 2001, TRENDS ECOL EVOL, V16, P17, DOI 10.1016/S0169-5347(00)02050-4; Schmitt CB, 2009, BIOL CONSERV, V142, P2122, DOI 10.1016/j.biocon.2009.04.012; SCHONEWALDCOX C, 1992, ENVIRON MANAGE, V16, P273, DOI 10.1007/BF02393833; Sekercioglu CH, 2012, BIOL CONSERV, V148, P1, DOI 10.1016/j.biocon.2011.10.019; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Sodhi NS, 2010, CONSERV BIOL, V24, P1290, DOI 10.1111/j.1523-1739.2010.01495.x; Sodhi NS, 2004, ANNU REV ECOL EVOL S, V35, P323, DOI 10.1146/annurev.ecolsys.35.112202.130209; Sodhi NS, 2009, CAUSES CONSEQUENCES, DOI [10.1098/rstb.2008.0278, DOI 10.1098/RSTB.2008.0278]; Sreekar R, 2015, DIVERS DISTRIB, V21, P441, DOI 10.1111/ddi.12292; Sreekar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070379; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; Wade AA, 2010, CONSERV BIOL, V24, P151, DOI 10.1111/j.1523-1739.2009.01296.x; Wang ZJ, 2003, BIOL CONSERV, V110, P231, DOI 10.1016/S0006-3207(02)00222-7; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; Xi J, 2009, VALUATION ECOSYSTEM; Xu JC, 2007, CONSERV BIOL, V21, P318, DOI 10.1111/j.1523-1739.2006.00636.x; Xu JC, 2014, ECOL INDIC, V36, P749, DOI 10.1016/j.ecolind.2012.08.023; Xu JC, 2009, ECOL SOC, V14; Yang D. H., 1993, FAUNA XISHUANGBANNA; Yang L., 1995, AVIFAUNA YUNNAN CHIN, VI; Yang L., 2004, AVIFAUNA YUNNAN CHIN, VII; Zhang KX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085720, 10.1371/journal.pone.0086598]; Zheng Z., 1962, ACTA ZOOL SINICA, V14, P74; Zhu H, 2005, BIODIVERS CONSERV, V14, P2855, DOI 10.1007/s10531-004-8220-x	85	24	24	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117920	10.1371/journal.pone.0117920	http://dx.doi.org/10.1371/journal.pone.0117920			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668338	Green Published, Green Submitted, gold			2022-12-27	WOS:000349493000032
J	Di-Nizo, CB; Ventura, K; Ferguson-Smith, MA; O'Brien, PCM; Yonenaga-Yassuda, Y; Silva, MJD				Di-Nizo, Camilla Bruno; Ventura, Karen; Ferguson-Smith, Malcolm Andrew; Mary O'Brien, Patricia Caroline; Yonenaga-Yassuda, Yatiyo; Silva, Maria Jose de J.			Comparative Chromosome Painting in Six Species of Oligoryzomys (Rodentia, Sigmodontinae) and the Karyotype Evolution of the Genus	PLOS ONE			English	Article							TELOMERIC SEQUENCE; ZOO-FISH; CRICETIDAE; HYBRIDIZATION; MARSUPIALIA; PATTERNS	Oligoryzomys belongs to the tribe Oryzomyini, and contains about 22 species. Diploid numbers range from 2n = 44 in Oligoryzomys sp. 2 to 2n = 72 in O. utiaritensis and phylogenetic relationships are not well defined. The high morphological convergence leads to misidentification of taxonomic entities and the species are often identified by chromosomal characters. Until now, the genus has been studied only by classical cytogenetic approaches. To understand the chromosomal evolution of Oligoryzomys, we developed chromosome probes from a female of Oligoryzomys moojeni (OMO) with 2n = 70 and hybridized to other five Oligoryzomys species. The probes painted 31 segments on O. fornesi (OFO) with 2n = 62; 32 segments on O. microtis (OMI), 2n = 64; 33 segments on O. nigripes (ONI), 2n = 62 and on O. rupestris (ORU), 2n = 46; and 34 on Oligoryzomys sp. 2 (OSP), 2n = 44. OMO probes 4 and 5 showed a syntenic association in O. fornesi, O. microtis and O. nigripes and were also presented in the same pair, although disrupted, in O. rupestris and Oligoryzomys sp. 2. Concerning O. rupestris and Oligoryzomys sp. 2, species with the lowest diploid numbers of the genus, a total of 8 probes hybridized to 11 segments on the largest pair of ORU 1 and 9 probes hybridized to 12 segments on OSP 1. Also, OMO 6 painted three segments in ORU, corresponding to the proximal segment of ORU 2q, and the whole of ORU 19 and 20. In OSP, the segment corresponding to ORU 20 was homologous to OSP 1p. OMO X showed signals of hybridization in both X and Y chromosomes. Extensive chromosomal rearrangements, that could not be detected by classical cytogenetic techniques, such as pericentric inversions or repositioning of centromeres, Robertsonian rearrangements and tandem fusions/fissions, as well as gain/activation or loss/inactivation of centromeres and telomeric sequences have driven the huge genome reshuffling in these closely related species.	[Di-Nizo, Camilla Bruno; Silva, Maria Jose de J.] Inst Butantan, Lab Ecol & Evolucao, Sao Paulo, Brazil; [Ventura, Karen; Yonenaga-Yassuda, Yatiyo] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil; [Ventura, Karen; Ferguson-Smith, Malcolm Andrew; Mary O'Brien, Patricia Caroline] Univ Cambridge, Dept Vet Med, Cambridge Resource Ctr Comparat Genom, Cambridge, England; [Ventura, Karen] Univ Fed Itajuba, Inst Recursos Nat, Itajuba, MG, Brazil	Instituto Butantan; Universidade de Sao Paulo; University of Cambridge; Universidade Federal de Itajuba	Di-Nizo, CB (corresponding author), Inst Butantan, Lab Ecol & Evolucao, Sao Paulo, Brazil.	camilladinizo@gmail.com	Fapesp, Biota/F-8655-2017; Ventura, Karen/G-2566-2012; de J. Silva, Maria José/E-3035-2013; Di Nizo, Camilla/AAI-1848-2020	Fapesp, Biota/0000-0002-9887-8449; de J. Silva, Maria José/0000-0002-0841-8677; Di Nizo, Camilla/0000-0002-6995-5994	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/03432-0, 2009/54300-0, 2005/04557-3, 2011/50146-6]; Coordenacao de Aperfeicoamento de nivel superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [303477/2011-3]; Cambridge Resource Centre for Comparative Genomics (Wellcome Trust)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de nivel superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Cambridge Resource Centre for Comparative Genomics (Wellcome Trust)(Wellcome Trust)	The authors thank Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2010/03432-0 for CBDN, 2009/54300-0 for KV, "Jovem Pesquisador" 2005/04557-3 for MJJS and 2011/50146-6), Coordenacao de Aperfeicoamento de nivel superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 303477/2011-3) and Cambridge Resource Centre for Comparative Genomics (supported by a grant from the Wellcome Trust to MAFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta MJ, 2011, CYTOGENET GENOME RES, V132, P47, DOI 10.1159/000318012; Agrellos R, 2012, ZOOTAXA, P1; Andrades-Miranda J, 2001, J MAMMAL, V82, P1080, DOI 10.1644/1545-1542(2001)082<1080:CSOSSO>2.0.CO;2; Bonvicino CR, 1998, Z SAUGETIERKD, V63, P90; Carleton MD, 1989, B AM MUS NAT HIST, V191, P1; Carpenter J.W., 1996, EXOTIC ANIMAL FORMUL, V1st edn.; Chowdhary B. P., 2001, Methods in Cell Science, V23, P37, DOI 10.1023/A:1013185330114; D'Elía Guillermo, 2007, Gayana (Concepc.), V71, P187; Di-Nizo CB, 2013, THESIS U SAO PAULO S; DICKERMAN AW, 1995, J MAMMAL, V76, P172, DOI 10.2307/1382326; Palma RE, 2010, ZOOL J LINN SOC-LOND, V160, P551, DOI 10.1111/j.1096-3642.2009.00621.x; Fagundes V, 1997, CYTOGENET CELL GENET, V78, P224, DOI 10.1159/000134662; Ferguson-Smith Malcolm A., 1998, ILAR J, V39, P68; Hass I, 2008, CHROMOSOME RES, V16, P75, DOI 10.1007/s10577-007-1211-5; Hershkovitz P., 1966, Z SAUGETIERKD, V31, P81, DOI DOI 10.1177/0961203308089428; Metcalfe CJ, 1998, CHROMOSOME RES, V6, P603, DOI 10.1023/A:1009249325574; Miranda GB, 2009, J HERED, V100, P309, DOI 10.1093/jhered/esn099; Moreira CN, 2013, GENET MOL BIOL, V36, P201, DOI 10.1590/S1415-47572013000200010; Musser GG, 2005, MAMMAL SPECIES WORLD, P894; Myers P, 1995, MOL PHYLOGENET EVOL, V4, P372, DOI 10.1006/mpev.1995.1035; Nagamachi CY, 2013, CHROMOSOME RES, V21, P107, DOI 10.1007/s10577-013-9341-4; Pagnozzi JM, 2000, CHROMOSOME RES, V8, P585, DOI 10.1023/A:1009229806649; Paresque R, 2007, GENET MOL BIOL, V30, P43, DOI 10.1590/S1415-47572007000100010; Patton JL, 1976, OCCASIONAL PAPERS MU, V49, P1; REIG OA, 1980, J ZOOL, V192, P257; Ruiz-Herrera A, 2008, CYTOGENET GENOME RES, V122, P219, DOI 10.1159/000167807; SBALQUEIRO IJ, 1991, ACTA THERIOL, V36, P193, DOI 10.4098/AT.arch.91-18; Silva MJD, 1997, HEREDITAS, V127, P217, DOI 10.1111/j.1601-5223.1997.00217.x; Silva MJJ, 2004, CYTOGENET GENOME RES, V106, P257, DOI 10.1159/000079296; TELENIUS H, 1992, GENE CHROMOSOME CANC, V4, P257, DOI 10.1002/gcc.2870040311; Teta P, 2013, ZOOTAXA, V3641, P433, DOI 10.11646/zootaxa.3641.4.9; Ventura K, 2012, CHROMOSOME RES, V20, P427, DOI 10.1007/s10577-012-9286-z; Ventura K, 2009, CHROMOSOME RES, V17, P1063, DOI 10.1007/s10577-009-9083-5; Weksler M, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3537[1:TNGOOR]2.0.CO;2; WILEY JE, 1992, CYTOGENET CELL GENET, V61, P55, DOI 10.1159/000133368; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691	36	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117579	10.1371/journal.pone.0117579	http://dx.doi.org/10.1371/journal.pone.0117579			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658766	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900182
J	Guo, Y; Yang, TL; Dong, SS; Yan, H; Hao, RH; Chen, XF; Chen, JB; Tian, Q; Li, J; Shen, H; Deng, HW				Guo, Yan; Yang, Tie-Lin; Dong, Shan-Shan; Yan, Han; Hao, Ruo-Han; Chen, Xiao-Feng; Chen, Jia-Bin; Tian, Qing; Li, Jian; Shen, Hui; Deng, Hong-Wen			Genetic Analysis Identifies DDR2 as a Novel Gene Affecting Bone Mineral Density and Osteoporotic Fractures in Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RECEPTOR TYROSINE KINASES; RUNX2 ACTIVATION; HIP FRACTURE; EXPRESSION; COLLAGEN; DOMAIN; DIFFERENTIATION; DWARFISM; ALLELE	DDR2 gene, playing an essential role in regulating osteoblast differentiation and chondrocyte maturation, may influence bone mineral density (BMD) and osteoporosis, but the genetic variations actually leading to the association remain to be elucidated. Therefore, the aim of this study was to investigate whether the genetic variants in DDR2 are associated with BMD and fracture risk. This study was performed in three samples from two ethnicities, including 1,300 Chinese Han subjects, 700 Chinese Han subjects (350 with osteoporotic hip fractures and 350 healthy controls) and 2,286 US white subjects. Twenty-eight SNPs in DDR2 were genotyped and tested for associations with hip BMD and fractures. We identified 3 SNPs in DDR2 significantly associated with hip BMD in the Chinese population after multiple testing adjustments, which were rs7521233 (P = 1.06x10(-4), beta: -0.018 for allele C), rs7553831 (P = 1.30x10(-4), beta: -0.018 for allele T), and rs6697469 (P = 1.59x10(-3), beta: -0.015 for allele C), separately. These three SNPs were in high linkage disequilibrium. Haplotype analyses detected two significantly associated haplotypes, including one haplotype in block 2 (P = 9.54x10(-4), beta: -0.016) where these three SNPs located. SNP rs6697469 was also associated with hip fractures (P = 0.043, OR: 1.42) in the Chinese population. The effect on fracture risk was consistent with its association with lower BMD. However, in the white population, we didn't observe significant associations with hip BMD. eQTL analyses revealed that SNPs associated with BMD also affected DDR2 mRNA expression levels in Chinese. Our findings, together with the prior biological evidence, suggest that DDR2 could be a new candidate for osteoporosis in Chinese population. Our results also reveal an ethnic difference, which highlights the need for further genetic studies in each ethnic group.	[Guo, Yan; Yang, Tie-Lin; Dong, Shan-Shan; Yan, Han; Hao, Ruo-Han; Chen, Xiao-Feng; Chen, Jia-Bin] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Shaanxi, Peoples R China; [Guo, Yan; Yang, Tie-Lin; Dong, Shan-Shan; Yan, Han; Hao, Ruo-Han; Chen, Xiao-Feng; Chen, Jia-Bin] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Xian 710049, Shaanxi, Peoples R China; [Tian, Qing; Li, Jian; Shen, Hui; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA	Xi'an Jiaotong University; Xi'an Jiaotong University; Tulane University	Yang, TL (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Shaanxi, Peoples R China.	yangtielin@mail.xjtu.edu.cn; hdeng2@tulane.edu	Chen, Xiao-Feng/AAN-8808-2020; Li, Jian/G-4445-2015; Yang, Tie-Lin/G-8365-2014; Guo, Yan/G-8742-2014	Chen, Xiao-Feng/0000-0002-5886-6427; Yang, Tie-Lin/0000-0001-7062-3025; Guo, Yan/0000-0002-7364-2392; Deng, Hong-Wen/0000-0002-0387-8818	National Natural Science Foundation of China [31371278, 31471188]; NIH [P50AR055081, R01AG026564, R01AR050496, R01AR057049]; Fundamental Research Funds for the Central Universities; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057049, R01AR050496, R01AR059781, P50AR055081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Natural Science Foundation of China (31371278, 31471188), the grants from NIH (P50AR055081, R01AG026564, R01AR050496, and R01AR057049), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargal R, 2009, AM J HUM GENET, V84, P80, DOI 10.1016/j.ajhg.2008.12.004; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Dvornyk V, 2003, ANN HUM GENET, V67, P216, DOI 10.1046/j.1469-1809.2003.00037.x; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Guo Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000806; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kano K, 2008, MOL ENDOCRINOL, V22, P1866, DOI 10.1210/me.2007-0310; KARN T, 1993, ONCOGENE, V8, P3433; Kwan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000608; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; Lau EMC, 2001, OSTEOPOROSIS INT, V12, P239, DOI 10.1007/s001980170135; Lee JH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000718; Lin KL, 2010, J BONE MINER RES, V25, P2489, DOI 10.1002/jbmr.159; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Michaelsson K, 2005, ARCH INTERN MED, V165, P1825, DOI 10.1001/archinte.165.16.1825; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Xu L, 2007, ARTHRITIS RHEUM, V56, P2663, DOI 10.1002/art.22761; Yang TL, 2012, OSTEOPOROSIS INT, V23, P781, DOI 10.1007/s00198-011-1626-x; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357; Zhang Y, 2011, J BONE MINER RES, V26, P604, DOI 10.1002/jbmr.225	30	5	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117102	10.1371/journal.pone.0117102	http://dx.doi.org/10.1371/journal.pone.0117102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658585	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900100
J	Kanda, E; Muneyuki, T; Kanno, Y; Suwa, K; Nakajima, K				Kanda, Eiichiro; Muneyuki, Toshitaka; Kanno, Yoshihiko; Suwa, Kaname; Nakajima, Kei			Uric Acid Level Has a U-Shaped Association with Loss of Kidney Function in Healthy People: A Prospective Cohort Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; URATE EXCRETION; MOUSE KIDNEY; RISK-FACTOR; HYPOURICEMIA; EXERCISE; DISEASE; JAPAN; HYPERURICEMIA; HYPOURICAEMIA	Background The relationship between hyperuricemia and chronic kidney disease (CKD) has been found in various observational studies. Although hypouricemia is associated with cardiovascular events, it has not been established as a risk factor for CKD. We investigated the relationship between serum uric acid level and the loss of kidney function and incident CKD in healthy people. Materials and Methods Healthy people were enrolled in this community-based prospective cohort study, the Saitama Cardiometabolic Disease and Organ Impairment Study, Japan. The analysis was conducted on 4188 subjects followed up for at least 3 years, 3102 for 6 years and 1052 for 9 years. Their data including glomerular filtration rate (eGFR) decline were examined every three years. The outcome event was incident CKD or the decrease in eGFR by more than 25% in three years. Multivariate statistical models were adjusted for the baseline characteristics. Results The following data was obtained: mean +/- SD age, male, 39.6 +/- 10.4 years, female 38.4 +/- 10.8 years; eGFR, male, 81.9 +/- 16.4 ml/min/1.73m2, female, 82.1 +/- 17.5 ml/min/1.73m2; serum uric acid level, male, 5.8 +/- 1.2 mg/dl, female, 4.1 +/- 0.9 mg/dl. Both low and high serum uric acid levels were associated with the outcome and eGFR decline in males (multivariate logistic additional additive models, linear p = 0.0001, spline p = 0.043; generalized additive models, linear p = 0.0001, spline p = 0.012). In subjects with low serum uric acid levels (male, < 5 mg/dl; female, < 3.6 mg/dl), multivariate linear mixed models showed that low serum uric acid levels were associated with eGFR decline in a time-dependent manner (male, p = 0.0001; female, p = 0.045). Conclusion This study showed that low as well as high levels of uric acid are associated with the loss of kidney function. Hypouricemia is a candidate predictor of kidney function decline in healthy people.	[Kanda, Eiichiro] Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan; [Kanda, Eiichiro] Tokyo Med & Dent Univ, Ctr Life Sci & Bioeth, Bunkyo Ku, Tokyo, Japan; [Muneyuki, Toshitaka] Saitama Citizens Med Ctr, Saitama, Japan; [Kanno, Yoshihiko] Tokyo Med Univ, Dept Nephrol, Shinjuku Ku, Tokyo 1608402, Japan; Saitama Hlth Promotion Corp, Hikigun, Saitama, Japan; [Suwa, Kaname] Saitama Hlth Promot Corp, Saitama, Japan; [Nakajima, Kei] Josai Univ, Fac Pharmaceut Sci, Dept Med Dietet, Div Clin Nutr, Sakado, Saitama 35002, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical University; Josai University	Kanda, E (corresponding author), Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan.	tokyo.kyosai.kanda@gmail.com	Nakajima, Kei/AAF-2801-2019	Nakajima, Kei/0000-0002-1788-3896				AKIZUKI S, 1982, ANN RHEUM DIS, V41, P272, DOI 10.1136/ard.41.3.272; Bellomo G, 2010, AM J KIDNEY DIS, V56, P264, DOI 10.1053/j.ajkd.2010.01.019; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Hakoda M, 2005, J RHEUMATOL, V32, P906; Heiwe S, 2014, AM J KIDNEY DIS, V64, P383, DOI 10.1053/j.ajkd.2014.03.020; HISATOME I, 1989, NEPHRON, V51, P13, DOI 10.1159/000185233; Hosoyamada M, 2010, NUCLEOS NUCLEOT NUCL, V29, P574, DOI 10.1080/15257770.2010.494651; Ichida K, 2004, J AM SOC NEPHROL, V15, P164, DOI 10.1097/01.ASN.0000105320.04395.D0; Iseki K, 2004, AM J KIDNEY DIS, V44, P642, DOI 10.1016/S0272-6386(04)00934-5; Ishikawa I, 2002, NEPHRON, V91, P559, DOI 10.1159/000065013; Iwai N, 2004, KIDNEY INT, V66, P935, DOI 10.1111/j.1523-1755.2004.00839.x; Kawashima M, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-31; Maesaka JK, 1998, AM J KIDNEY DIS, V32, P917, DOI 10.1016/S0272-6386(98)70067-8; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Muneyuki T, 2013, OPEN J ENDOCRINE MET, V3; Muneyuki T, 2013, KIDNEY INT, V84, P1254, DOI 10.1038/ki.2013.222; MURAKAMI T, 1993, PEDIATR NEPHROL, V7, P772, DOI 10.1007/BF01213352; Neri L, 2011, AM J KIDNEY DIS, V58, P398, DOI 10.1053/j.ajkd.2011.04.025; Obermayr RP, 2008, J AM SOC NEPHROL, V19, P2407, DOI 10.1681/ASN.2008010080; Odden MC, 2014, AM J KIDNEY DIS; OGINO K, 1991, J MED, V22, P76; Ohta T, 2004, NEPHROL DIAL TRANSPL, V19, P1447, DOI 10.1093/ndt/gfh094; SHICHIRI M, 1987, NEPHRON, V45, P31, DOI 10.1159/000184067; Suliman ME, 2006, AM J KIDNEY DIS, V48, P761, DOI 10.1053/j.ajkd.2006.08.019; Takiue Y, 2011, NUCLEOS NUCLEOT NUCL, V30, P113, DOI 10.1080/15257770.2010.551645; Wang SF, 2011, NEPHROLOGY, V16, P767, DOI 10.1111/j.1440-1797.2011.01513.x	26	49	52	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118031	10.1371/journal.pone.0118031	http://dx.doi.org/10.1371/journal.pone.0118031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658588	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900253
J	Loying, P; Manhas, J; Sen, S; Bose, B				Loying, Pojul; Manhas, Janvie; Sen, Sudip; Bose, Biplab			Autoregulation and Heterogeneity in Expression of Human Cripto-1	PLOS ONE			English	Article							COLON-CANCER CELLS; GENE-EXPRESSION; POSITIVE FEEDBACK; STEM-CELLS; GROWTH; NOISE; TIME; STOCHASTICITY; ACTIVATION; CONVERSION	Cripto-1 (CR-1) is involved in various processes in embryonic development and cancer. Multiple pathways regulate CR-1 expression. Our present work demonstrates a possible positive feedback circuit where CR-1 induces its own expression. Using U-87 MG cells treated with exogenous CR-1, we show that such induction involves ALK4/SMAD2/3 pathway. Stochasticity in gene expression gives rise to heterogeneity in expression in genetically identical cells. Positive feedback increases such heterogeneity and often gives rise to two subpopulations of cells, having higher and lower expression of a gene. Using flow cytometry, we show that U-87 MG cells have a minuscule subpopulation with detectable expression of CR-1. Induction of CR-1 expression, by exogenous CR-1, increases the size of this CR-1 positive subpopulation. However, even at very high dose, most of the cells remain CR-1 negative. We show that population behavior of CR-1 induction has a signature similar to bimodal expression expected in a transcriptional circuit with positive feedback. We further show that treatment of U-87 MG cells with CR-1 leads to higher expression of drug efflux protein MDR-1 in the CR-1 positive subpopulation, indicating correlated induction of these two proteins. Positive feedback driven heterogeneity in expression of CR-1 may play crucial role in phenotypic diversification of cancer cells.	[Loying, Pojul; Bose, Biplab] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, India; [Manhas, Janvie; Sen, Sudip] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; All India Institute of Medical Sciences (AIIMS) New Delhi	Bose, B (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, India.	biplabbose@iitg.ernet.in	Bose, Biplab/C-8151-2009	Bose, Biplab/0000-0002-7616-6838; Manhas, Janvie/0000-0001-6004-8004; Sen, Sudip/0000-0003-0303-2836	Department of Biotechnology, India [BT/239/NE/TBP/2011]	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work has been funded by a research grant from Department of Biotechnology, India, project no. BT/239/NE/TBP/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Alon U., 2006, INTRO SYSTEMS BIOL D; Ariasi AM, 2011, CURR OPIN CELL BIOL, V23, P650, DOI 10.1016/j.ceb.2011.09.007; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bianco C, 2009, AM J PATHOL, V175, P2146, DOI 10.2353/ajpath.2009.090218; Birtwistle MR, 2012, MOL BIOSYST, V8, P3068, DOI 10.1039/c2mb25168j; Briones-Orta MA, 2013, CANCER RES, V73, P1800, DOI 10.1158/0008-5472.CAN-12-1916; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Castro NP, 2011, EMBRYONIC STEM CELLS, P347, DOI [10.1109/EMBC.2014.6945038, DOI 10.1109/EMBC.2014.6945038]; Chalancon G, 2012, TRENDS GENET, V28, P221, DOI 10.1016/j.tig.2012.01.006; Comerford KM, 2002, CANCER RES, V62, P3387; Das AB, 2012, CANCER LETT, V318, P189, DOI 10.1016/j.canlet.2011.12.013; Daschner PJ, 1999, BREAST CANCER RES TR, V53, P229, DOI 10.1023/A:1006138803392; Davidson E.H., 2006, REGULATORY GENOME; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Ebert AD, 1999, CANCER RES, V59, P4502; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Henness S, 2006, AM J PHYSIOL-LUNG C, V290, pL1283, DOI 10.1152/ajplung.00367.2005; Hentschke M, 2006, J BIOL CHEM, V281, P33497, DOI 10.1074/jbc.M606975200; Hermsen R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002265; Herreros-Villanueva M, 2014, WORLD J GASTROENTERO, V20, P2247, DOI 10.3748/wjg.v20.i9.2247; Hu XF, 2007, BRIT J CANCER, V96, P918, DOI 10.1038/sj.bjc.6603641; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Karmakar R, 2007, PHYS BIOL, V4, P29, DOI 10.1088/1478-3975/4/1/004; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Mancino M, 2008, J CELL PHYSIOL, V215, P192, DOI 10.1002/jcp.21301; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Nakahata Adriana M, 2010, J Stem Cells, V5, P103, DOI jsc.2010.5.3.103; Nakai E, 2009, CANCER INVEST, V27, P901, DOI 10.3109/07357900801946679; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; OVERTON WR, 1988, CYTOMETRY, V9, P619, DOI 10.1002/cyto.990090617; Palani S, 2012, CELL REP, V1, P215, DOI 10.1016/j.celrep.2012.01.007; Park BO, 2012, CELL REP, V2, P976, DOI 10.1016/j.celrep.2012.08.038; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruggieri P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047825; Shiou SR, 2007, CANCER RES, V67, P1571, DOI 10.1158/0008-5472.CAN-06-1680; Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918; Strizzi L, 2013, CELL CYCLE, V12, P1450, DOI 10.4161/cc.24601; Stroschein SL, 1999, J BIOL CHEM, V274, P9431, DOI 10.1074/jbc.274.14.9431; To TL, 2010, SCIENCE, V327, P1142, DOI 10.1126/science.1178962; Utsunomiya Y, 1997, LEUKEMIA, V11, P894, DOI 10.1038/sj.leu.2400663; Wang ML, 2013, ONCOTARGETS THER, V6, P1207, DOI 10.2147/OTT.S38114; Yamada T, 2000, CANCER RES, V60, P4761; Zechner C, 2012, P NATL ACAD SCI USA, V109, P8340, DOI 10.1073/pnas.1200161109; Zhang M, 2010, J BIOL CHEM, V285, P8703, DOI 10.1074/jbc.M109.093526	51	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116748	10.1371/journal.pone.0116748	http://dx.doi.org/10.1371/journal.pone.0116748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658584	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900064
J	Ohtani, M; Villumsen, KR; Koppang, EO; Raida, MK				Ohtani, Maki; Villumsen, Kasper Romer; Koppang, Erling Olaf; Raida, Martin Kristian			Global 3D Imaging of Yersinia ruckeri Bacterin Uptake in Rainbow Trout Fry	PLOS ONE			English	Article							ONCORHYNCHUS-MYKISS WALBAUM; SALMO-GAIRDNERI RICHARDSON; BOVINE SERUM-ALBUMIN; CARP CYPRINUS-CARPIO; VIBRIO-ANGUILLARUM; DIRECT IMMERSION; ANTIGEN UPTAKE; VACCINE DILUTION; BROWN TROUT; GILL CELLS	Yersinia ruckeri is the causative agent of enteric redmouth disease (ERM) in rainbow trout, and the first commercially available fish vaccine was an immersion vaccine against ERM consisting of Y. ruckeri bacterin. The ERM immersion vaccine has been successfully used in aquaculture farming of salmonids for more than 35 years. The gills and the gastrointestinal (GI) tract are believed to be the portals of antigen uptake during waterborne vaccination against ERM; however, the actual sites of bacterin uptake are only partly understood. In order to obtain insight into bacterin uptake during waterborne vaccination, optical projection tomography (OPT) together with immunohistochemistry (IHC) was applied to visualize bacterin uptake and processing in whole rainbow trout fry. Visualization by OPT revealed that the bacterin was initially taken up via gill lamellae from within 30 seconds post vaccination. Later, bacterin uptake was detected on other mucosal surfaces such as skin and olfactory bulb from 5 to 30 minutes post vaccination. The GI tract was found to be filled with a complex of bacterin and mucus at 3 hours post vaccination and the bacterin remained in the GI tract for at least 24 hours. Large amounts of bacterin were present in the blood, and an accumulation of bacterin was found in filtering lymphoid organs such as spleen and trunk kidney where the bacterin accumulates 24 hours post vaccination as demonstrated by OPT and IHC. These results suggest that bacterin is taken up via the gill epithelium in the earliest phases of the bath exposure and from the GI tract in the later phase. The bacterin then enters the blood circulatory system, after which it is filtered by spleen and trunk kidney, before finally accumulating in lymphoid organs where adaptive immunity against ERM is likely to develop.	[Ohtani, Maki; Villumsen, Kasper Romer; Raida, Martin Kristian] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Res Grp Fish Dis & Immunol, Frederiksberg, Denmark; [Koppang, Erling Olaf] Norwegian Univ Life Sci, Norwegian Sch Vet Med, Dept Basic Sci & Aquat Med, Oslo, Norway	University of Copenhagen; Norwegian University of Life Sciences	Ohtani, M (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Res Grp Fish Dis & Immunol, Frederiksberg, Denmark.	maki@sund.ku.dk	Villumsen, Kasper Rømer/L-2471-2019	Villumsen, Kasper Rømer/0000-0002-0616-4095	Danish research council [11-105095]	Danish research council(Det Frie Forskningsrad (DFF))	This research was supported by the Danish research council (http://ufm.dk/forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad/radet/dff-teknologi-og-produktion) Grant no. 11-105095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3000430; AMEND DF, 1976, SCIENCE, V192, P793, DOI 10.1126/science.1265480; AMEND DF, 1983, J FISH DIS, V6, P337, DOI 10.1111/j.1365-2761.1983.tb00085.x; ANDERSON DP, 1979, J FISH RES BOARD CAN, V36, P636, DOI 10.1139/f79-092; ANDERSON DP, 1979, AM ZOOL, V19, P931; ANDERSON DP, 1979, J FISH BIOL, V15, P317, DOI 10.1111/j.1095-8649.1979.tb03611.x; ANDERSON DP, 1974, J FISH RES BOARD CAN, V31, P214, DOI 10.1139/f74-035; Bassity E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033196; BOWERS A, 1981, J FISH BIOL, V18, P9, DOI 10.1111/j.1095-8649.1981.tb03754.x; Buchmann K, 2003, J FISH DIS, V26, P183, DOI 10.1046/j.1365-2761.2003.00442.x; Chettri JK, 2012, DEV COMP IMMUNOL, V36, P463, DOI 10.1016/j.dci.2011.08.014; CIPRIANO RC, 1987, J WILDLIFE DIS, V23, P545, DOI 10.7589/0090-3558-23.4.545; COSSARINIDUNIER M, 1986, J FISH DIS, V9, P27, DOI 10.1111/j.1365-2761.1986.tb00976.x; Deshmukh S, 2012, VET IMMUNOL IMMUNOP, V145, P379, DOI 10.1016/j.vetimm.2011.12.014; Evenhuis JP, 2014, DEV COMP IMMUNOL, V44, P145, DOI 10.1016/j.dci.2013.12.004; FERGUSON HW, 1976, J COMP PATHOL, V86, P377, DOI 10.1016/0021-9975(76)90005-0; Fouz B, 2006, J FISH DIS, V29, P339, DOI 10.1111/j.1365-2761.2006.00723.x; Fuglem B, 2010, DEV COMP IMMUNOL, V34, P768, DOI 10.1016/j.dci.2010.02.007; JOHNSON KA, 1982, J FISH DIS, V5, P197, DOI 10.1111/j.1365-2761.1982.tb00474.x; JOHNSON KA, 1983, J FISH DIS, V6, P331, DOI 10.1111/j.1365-2761.1983.tb00084.x; JOHNSON KA, 1982, J FISH DIS, V5, P207, DOI 10.1111/j.1365-2761.1982.tb00475.x; Joosten PHM, 1997, FISH SHELLFISH IMMUN, V7, P471, DOI 10.1006/fsim.1997.0100; Khimmakthong U, 2013, MICROB PATHOGENESIS, V59-60, P33, DOI 10.1016/j.micpath.2013.03.001; Kryvi H, 1997, FISKEANATOMI; LAURENT P, 1980, AM J PHYSIOL, V238, pR147, DOI 10.1152/ajpregu.1980.238.3.R147; Maas M. G., 1982, Developmental and Comparative Immunology, P47; MACARTHUR JI, 1983, J RETICULOENDOTH SOC, V34, P13; McIntosh D, 2000, J FISH BIOL, V56, P1053, DOI 10.1111/j.1095-8649.2000.tb02122.x; MCLEAN E, 1986, COMP BIOCHEM PHYS A, V84, P687, DOI 10.1016/0300-9629(86)90388-9; Mendez J, 2013, ENV MICROBIOL REP, V5, P179, DOI 10.1111/1758-2229.12030; Moore JD, 1998, FISH SHELLFISH IMMUN, V8, P393, DOI 10.1006/fsim.1998.0143; NELSON J S, 1985, Fish Pathology, V19, P263; Ohtani M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089672; OLESEN NJ, 1991, J APPL ICHTHYOL, V7, P36, DOI 10.1111/j.1439-0426.1991.tb00592.x; Ototake M, 1996, FISH SHELLFISH IMMUN, V6, P321, DOI 10.1006/fsim.1996.0033; Press CM, 1999, FISH SHELLFISH IMMUN, V9, P309, DOI 10.1006/fsim.1998.0181; Raida MK, 2008, VACCINE, V26, P1050, DOI 10.1016/j.vaccine.2007.12.029; Raida MK, 2007, DIS AQUAT ORGAN, V77, P41, DOI 10.3354/dao01808; Raida MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018832; ROMBOUT JWHM, 1986, DEV COMP IMMUNOL, V10, P341, DOI 10.1016/0145-305X(86)90024-8; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Smith P. D., 1982, Developmental and Comparative Immunology, P181; Stevenson RMW, 1997, DEV BIOLOGICALS, V90, P117; TATNER MF, 1987, AQUACULTURE, V62, P173, DOI 10.1016/0044-8486(87)90164-5; TATNER MF, 1985, AQUACULTURE, V46, P11, DOI 10.1016/0044-8486(85)90170-X; Tebbit G. L., 1981, Developments in Biological Standardization, V49, P395; Tobback E, 2010, J FISH DIS, V33, P197, DOI 10.1111/j.1365-2761.2009.01106.x; TORROBA M, 1993, HISTOL HISTOPATHOL, V8, P363; Vandenberg Grant W., 2004, Animal Health Research Reviews, V5, P301, DOI 10.1079/AHR200488; Welch TJ, 2011, APPL ENVIRON MICROB, V77, P3493, DOI 10.1128/AEM.02997-10; ZAPATA AG, 1987, J FISH BIOL, V31, P209, DOI 10.1111/j.1095-8649.1987.tb05315.x; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913	52	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117263	10.1371/journal.pone.0117263	http://dx.doi.org/10.1371/journal.pone.0117263			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658600	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900127
J	Overmyer, KA; Thonusin, C; Qi, NR; Burant, CF; Evans, CR				Overmyer, Katherine A.; Thonusin, Chanisa; Qi, Nathan R.; Burant, Charles F.; Evans, Charles R.			Impact of Anesthesia and Euthanasia on Metabolomics of Mammalian Tissues: Studies in a C57BL/6J Mouse Model	PLOS ONE			English	Article							RAT-LIVER; BLOOD; CANCER; PERFORMANCE; METABOLITES; SUCCINATE; SELECTION; FUMARATE; HYPOXIA; STRESS	A critical application of metabolomics is the evaluation of tissues, which are often the primary sites of metabolic dysregulation in disease. Laboratory rodents have been widely used for metabolomics studies involving tissues due to their facile handing, genetic manipulability and similarity to most aspects of human metabolism. However, the necessary step of administration of anesthesia in preparation for tissue sampling is not often given careful consideration, in spite of its potential for causing alterations in the metabolome. We examined, for the first time using untargeted and targeted metabolomics, the effect of several commonly used methods of anesthesia and euthanasia for collection of skeletal muscle, liver, heart, adipose and serum of C57BL/6J mice. The data revealed dramatic, tissue-specific impacts of tissue collection strategy. Among many differences observed, post-euthanasia samples showed elevated levels of glucose 6-phosphate and other glycolytic intermediates in skeletal muscle. In heart and liver, multiple nucleotide and purine degradation metabolites accumulated in tissues of euthanized compared to anesthetized animals. Adipose tissue was comparatively less affected by collection strategy, although accumulation of lactate and succinate in euthanized animals was observed in all tissues. Among methods of tissue collection performed pre-euthanasia, ketamine showed more variability compared to isoflurane and pentobarbital. Isoflurane induced elevated liver aspartate but allowed more rapid initiation of tissue collection. Based on these findings, we present a more optimal collection strategy mammalian tissues and recommend that rodent tissues intended for metabolomics studies be collected under anesthesia rather than post-euthanasia.	[Overmyer, Katherine A.; Thonusin, Chanisa] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Qi, Nathan R.; Burant, Charles F.; Evans, Charles R.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Evans, CR (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	chevans@umich.edu	Burant, Charles/GPC-5690-2022	Burant, Charles/0000-0001-9189-5003; Evans, Charles/0000-0001-6698-5330	National Institute of Diabetes and Digestive and Kidney Diseases [K25 DK092558, R01 DK077200]; Michigan Nutrition Obesity Research Center [P30 DK089503]; Michigan Diabetes Research and Training Center [DK020572]; Michigan Regional Comprehensive Metabolomics Research Core (NIH Common Fund) [U24 DK097153]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, P30DK020572, U24DK097153, P30DK089503, K25DK092558, R01DK077200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Michigan Nutrition Obesity Research Center; Michigan Diabetes Research and Training Center; Michigan Regional Comprehensive Metabolomics Research Core (NIH Common Fund); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (K25 DK092558 to C.R.E and R01 DK077200 to C.F.B.) and utilized core services provided by the Michigan Nutrition Obesity Research Center (P30 DK089503), the Michigan Diabetes Research and Training Center (DK020572) and the Michigan Regional Comprehensive Metabolomics Research Core (NIH Common Fund U24 DK097153) (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Sanchez B, 2010, TRAC-TREND ANAL CHEM, V29, P111, DOI 10.1016/j.trac.2009.12.003; Arnold M, 2010, PHYSIOL BEHAV, V99, P592, DOI 10.1016/j.physbeh.2010.01.021; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIEBUYCK JF, 1973, BRIT J ANAESTH, V45, P263, DOI 10.1093/bja/45.3.263; Brooks SPJ, 1999, CONTEMP TOP LAB ANIM, V38, P19; Brown MV, 2012, GENOME MED, V4, DOI 10.1186/gm332; Bruce SJ, 2009, ANAL CHEM, V81, P3285, DOI 10.1021/ac8024569; BRUNNER EA, 1975, ANNU REV MED, V26, P391, DOI 10.1146/annurev.me.26.020175.002135; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; CASCARANO J, 1976, J EXP ZOOL, V198, P149, DOI 10.1002/jez.1401980204; Cheema AK, 2014, J PROTEOME RES, V13, P3065, DOI 10.1021/pr500278t; Christians U, 2011, CURR PHARM BIOTECHNO, V12, P1053, DOI 10.2174/138920111795909078; Crouser ED, 2004, MITOCHONDRION, V4, P729, DOI 10.1016/j.mito.2004.07.023; El Rammouz R, 2010, ANAL BIOCHEM, V398, P169, DOI 10.1016/j.ab.2009.12.006; Fan TWM, 2011, METABOLOMICS, V7, P257, DOI 10.1007/s11306-010-0249-0; FAUPEL RP, 1972, ARCH BIOCHEM BIOPHYS, V148, P509, DOI 10.1016/0003-9861(72)90170-1; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Gao J, 2010, BIOINFORMATICS, V26, P971, DOI 10.1093/bioinformatics/btq048; HOBERMAN HD, 1967, BIOCHIM BIOPHYS ACTA, V148, P392, DOI 10.1016/0304-4165(67)90135-3; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Kami K, 2013, METABOLOMICS, V9, P444, DOI 10.1007/s11306-012-0452-2; Kelly AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025357; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; KRAL JG, 1974, HORM METAB RES, V6, P483, DOI 10.1055/s-0028-1093808; La Monaca E, 2012, CURR DRUG SAF, V7, P126, DOI 10.2174/157488612802715681; Lutz NW, 2013, METHODOLOGIES METABO, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; Ly-Verdu S, 2013, BIOMEDICAL CHROMATOG; Ly-Verdu S, 2014, BIOMED CHROMATOGR, V28, P231, DOI 10.1002/bmc.3010; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MUSCH TI, 1989, J APPL PHYSIOL, V66, P2895, DOI 10.1152/jappl.1989.66.6.2895; Pekkinen J, 2013, MOL NUTR FOOD RES, V57, P1959, DOI 10.1002/mnfr.201300142; PENICAUD L, 1987, AM J PHYSIOL, V252, pE365, DOI 10.1152/ajpendo.1987.252.3.E365; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Pomplun D, 2004, HORM METAB RES, V36, P67, DOI 10.1055/s-2004-814104; Romisch-Margl W, 2011, METABOLOMICS, V8, P133, DOI [DOI 10.1007/s11306-011-0293-4, DOI 10.1007/S11306-011-0293-4]; Rubingh CM, 2006, METABOLOMICS, V2, P53, DOI 10.1007/s11306-006-0022-6; Sheedy JR, 2013, METHODS MOL BIOL, V1055, P81, DOI 10.1007/978-1-62703-577-4_7; Song H, 2011, ONCOL REP, V26, P431, DOI 10.3892/or.2011.1302; Stewart S, 2014, CHEM SOC REV, V43, P70, DOI 10.1039/c3cs60183h; Takahashi K, 1998, BRIT J ANAESTH, V80, P782, DOI 10.1093/bja/80.6.782; Teahan O, 2006, ANAL CHEM, V78, P4307, DOI 10.1021/ac051972y; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Want EJ, 2013, NAT PROTOC, V8, P17, DOI 10.1038/nprot.2012.135; Wishart DS, 2007, BRIEF BIOINFORM, V8, P279, DOI 10.1093/bib/bbm030; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	51	70	71	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117232	10.1371/journal.pone.0117232	http://dx.doi.org/10.1371/journal.pone.0117232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658945	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900121
J	Reichel, CA; Hessenauer, MET; Pflieger, K; Rehberg, M; Kanse, SM; Zahler, S; Krombach, F; Berghaus, A; Strieth, S				Reichel, Christoph A.; Hessenauer, Maximilian E. T.; Pflieger, Kerstin; Rehberg, Markus; Kanse, Sandip M.; Zahler, Stefan; Krombach, Fritz; Berghaus, Alexander; Strieth, Sebastian			Components of the Plasminogen Activation System Promote Engraftment of Porous Polyethylene Biomaterial via Common and Distinct Effects	PLOS ONE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; ISCHEMIA-REPERFUSION INJURY; INFLAMMATORY RESPONSES; INHIBITOR-1 PROMOTES; UROKINASE RECEPTOR; TURKISH DELIGHT; HOST TISSUE; IMPLANTS; ANGIOGENESIS; RECONSTRUCTION	Rapid fibrovascularization is a prerequisite for successful biomaterial engraftment. In addition to their well-known roles in fibrinolysis, urokinase-type plasminogen activator (uPA) and tissue plasminogen activator (tPA) or their inhibitor plasminogen activator inhibitor-1 (PAI-1) have recently been implicated as individual mediators in non-fibrinolytic processes, including cell adhesion, migration, and proliferation. Since these events are critical for fibrovascularization of biomaterial, we hypothesized that the components of the plasminogen activation system contribute to biomaterial engraftment. Employing in vivo and ex vivo microscopy techniques, vessel and collagen network formation within porous polyethylene (PPE) implants engrafted into dorsal skinfold chambers were found to be significantly impaired in uPA-, tPA-, or PAI-1-deficient mice. Consequently, the force required for mechanical disintegration of the implants out of the host tissue was significantly lower in the mutant mice than in wild-type controls. Conversely, surface coating with recombinant uPA, tPA, non-catalytic uPA, or PAI-1, but not with non-catalytic tPA, accelerated implant vascularization in wild-type mice. Thus, uPA, tPA, and PAI-1 contribute to the fibrovascularization of PPE implants through common and distinct effects. As clinical perspective, surface coating with recombinant uPA, tPA, or PAI-1 might provide a novel strategy for accelerating the vascularization of this biomaterial.	[Reichel, Christoph A.; Hessenauer, Maximilian E. T.; Berghaus, Alexander] Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany; [Reichel, Christoph A.; Hessenauer, Maximilian E. T.; Rehberg, Markus; Krombach, Fritz] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Pflieger, Kerstin; Zahler, Stefan] Univ Munich, Dept Pharm, Munich, Germany; [Kanse, Sandip M.] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Strieth, Sebastian] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, D-55122 Mainz, Germany	University of Munich; University of Munich; University of Munich; University of Oslo; Johannes Gutenberg University of Mainz	Reichel, CA (corresponding author), Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany.	christoph.reichel@med.uni-muenchen.de		Zahler, Stefan/0000-0002-5140-7287; Rehberg, Markus/0000-0001-7314-6332; Kanse, Sandip/0000-0003-0782-9957	Forderprogramm Forschung und Lehre (FoFoLe) der Medizinischen Fakultat der Ludwig-Maximilians-Universitat Manchen	Forderprogramm Forschung und Lehre (FoFoLe) der Medizinischen Fakultat der Ludwig-Maximilians-Universitat Manchen	This study was supported by Forderprogramm Forschung und Lehre (FoFoLe) der Medizinischen Fakultat der Ludwig-Maximilians-Universitat Manchen (to CAR and AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, J IMMUNOL, V170, P5644, DOI 10.4049/jimmunol.170.11.5644; BERGHAUS A, 1985, ARCH OTOLARYNGOL, V111, P154; Berghaus A, 2010, ADV OTO-RHINO-LARYNG, V68, P53, DOI 10.1159/000314562; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Breuss JM, 2012, CELL ADHES MIGR, V6, P535, DOI 10.4161/cam.22243; Brodsky S, 2001, AM J PHYSIOL-HEART C, V281, pH1784, DOI 10.1152/ajpheart.2001.281.4.H1784; Busuttil SJ, 2004, J THROMB HAEMOST, V2, P1798, DOI 10.1111/j.1538-7836.2004.00916.x; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892; Czekay Ralf-Peter, 2011, Int J Cell Biol, V2011, P562481, DOI 10.1155/2011/562481; Das R, 2010, TRENDS CARDIOVAS MED, V20, P120, DOI 10.1016/j.tcm.2010.10.002; Deindl E, 2003, FASEB J, V17, P1174, DOI 10.1096/fj.02-0800fje; Del Rosso M, 2011, CURR PHARM DESIGN, V17, P1924; DIAMOND SL, 1989, SCIENCE, V243, P1483, DOI 10.1126/science.2467379; Ehrmantraut S, 2012, TISSUE ENG PT A, V18, P1562, DOI [10.1089/ten.tea.2011.0340, 10.1089/ten.TEA.2011.0340]; Erol OO, 2000, PLAST RECONSTR SURG, V105, P2229, DOI 10.1097/00006534-200005000-00051; Gosau M, 2006, ORAL MAXILLOFAC SURG, V10, P178, DOI 10.1007/s10006-006-0688-y; Hao S, 2010, AM J PATHOL, V177, P1164, DOI 10.2353/ajpath.2010.091269; Isogai C, 2001, CANCER RES, V61, P5587; Kim Nam Ju, 2006, Korean J Ophthalmol, V20, P143; Kim SG, 2001, INT J ORAL MAX SURG, V30, P438, DOI 10.1054/ijom.2001.0104; Laschke MW, 2012, EUR CELLS MATER, V24, P266, DOI 10.22203/eCM.v024a19; Laschke MW, 2011, EUR CELLS MATER, V22, P147, DOI 10.22203/eCM.v022a12; Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093; Lau CL, 2009, J THORAC CARDIOV SUR, V137, P1241, DOI 10.1016/j.jtcvs.2008.12.029; LEHR HA, 1993, AM J PATHOL, V143, P1055; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Menderes A, 2004, J CRANIOFAC SURG, V15, P719, DOI 10.1097/00001665-200409000-00004; Monroy A, 2007, INT J PEDIATR OTORHI, V71, P547, DOI 10.1016/j.ijporl.2006.11.025; Nicaeus TE, 1996, OPHTHALMIC PLAST REC, V12, P235, DOI 10.1097/00002341-199612000-00004; Niechajev I, 2012, AESTHET PLAST SURG, V36, P917, DOI 10.1007/s00266-012-9911-4; Park Won Chan, 2005, Korean J Ophthalmol, V19, P1; PEPPER MS, 1987, J CELL BIOL, V105, P2535, DOI 10.1083/jcb.105.6.2535; PEPPER MS, 1991, BIOCHEM BIOPH RES CO, V181, P902, DOI 10.1016/0006-291X(91)91276-I; Potter JK, 2012, ORAL MAXIL SURG CLIN, V24, P609, DOI 10.1016/j.coms.2012.07.002; Prager GW, 2009, BLOOD, V113, P1383, DOI 10.1182/blood-2008-06-164210; Rehberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028237; Reichel CA, 2012, TRENDS CARDIOVAS MED, V22, P192, DOI 10.1016/j.tcm.2012.07.019; Reichel CA, 2011, CIRCULATION, V124, P1849, DOI 10.1161/CIRCULATIONAHA.110.017012; Richardson S, 2011, INT J ORAL MAX SURG, V40, P979, DOI 10.1016/j.ijom.2011.03.013; Roelofs JJTH, 2006, J AM SOC NEPHROL, V17, P131, DOI 10.1681/ASN.2005010089; Schumann P, 2013, J BIOMED MAT RES A; Sheehan JJ, 2005, GLIA, V50, P340, DOI 10.1002/glia.20150; Shetty S, 1996, AM J RESP CELL MOL, V15, P78, DOI 10.1165/ajrcmb.15.1.8679225; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Soparkar CNS, 2000, OPHTHALMIC PLAST REC, V16, P337, DOI 10.1097/00002341-200009000-00006; Stefansson Steingrimur, 2003, Sci STKE, V2003, ppe24, DOI 10.1126/stke.2003.189.pe24; Stelter K, 2007, RHINOLOGY, V45, P325; Strieth S, 2010, J BIOMED MATER RES A, V93A, P1566, DOI 10.1002/jbm.a.32670; Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056; Thakker MM, 2004, OPHTHAL PLAST RECONS, V20, P368, DOI 10.1097/01.IOP.0000134247.29702.90; Uhl B, 2014, ARTERIOSCL THROM VAS, V34, P1495, DOI 10.1161/ATVBAHA.114.303721; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Welling TH, 1996, J SURG RES, V66, P36, DOI 10.1006/jsre.1996.0369; Yaremchuk MJ, 2003, PLAST RECONSTR SURG, V111, P1818, DOI 10.1097/01.PRS.0000056866.80665.7A; Yip HK, 2013, INT J CARDIOL, V168, P226, DOI 10.1016/j.ijcard.2012.09.090; Zhang YP, 2013, THROMB RES, V131, P64, DOI 10.1016/j.thromres.2012.09.003	57	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116883	10.1371/journal.pone.0116883	http://dx.doi.org/10.1371/journal.pone.0116883			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658820	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900075
J	Seven, E; Husemoen, LLN; Ibsen, H; Friedrich, N; Nauck, M; Wachtell, K; Linneberg, A; Jeppesen, JL				Seven, Ekim; Husemoen, Lise L. N.; Ibsen, Hans; Friedrich, Nele; Nauck, Matthias; Wachtell, Kristian; Linneberg, Allan; Jeppesen, Jorgen L.			Higher Serum Concentrations of N-Terminal Pro-B-Type Natriuretic Peptide Associate with Prevalent Hypertension whereas Lower Associate with Incident Hypertension	PLOS ONE			English	Article							BLOOD-PRESSURE TRACKING; ANGIOTENSIN-II; RISK-FACTORS; BRAIN; ENDOCRINE; IMPACT; BIOMARKERS; OBESITY; SYSTEM; AGE	Background The role of the natriuretic peptides (NPs) in hypertension is complex. Thus, a higher blood NP concentration is a robust marker of pressure-induced cardiac damage in patients with hypertension, whereas genetically elevated NP concentrations are associated with a reduced risk of hypertension and overweight individuals presumably at high risk of hypertension have lower NP concentrations. Objective To investigate the associations between serum N-terminal pro-B-type natriuretic peptide (NT-proBNP), used as a surrogate marker for active BNP, and prevalent as well as 5-year incident hypertension in a Danish general population sample. Methods Cross-sectional and prospective population-based study. Results At baseline, among 5,307 participants (51.3% women, mean age 46.0 +/- 7.9 years) with a complete set of data, we recorded 1,979 cases with prevalent hypertension (PHT). Among 2,389 normotensive participants at baseline with a complete set of data, we recorded 324 cases with incident hypertension (IHT) on follow-up 5 years later. In models adjusted for age, sex, lifestyle, social, dietary, anthropometric, pulmonic, lipid, metabolic and renal risk factors, as well as heart rate and baseline blood pressure (only incident model), one standard deviation increase in baseline log-transformed NT-proBNP concentrations was on one side associated with a 21% higher risk of PHT (odds ratio [OR]: 1.21 [95% confidence interval (CI): 1.13-1.30], P<0.001), and on the other side with a 14% lower risk of IHT (OR: 0.86 [95% CI: 0.76-0.98], P = 0.020). Conclusions Higher serum concentrations of NT-proBNP associate with PHT whereas lower concentrations associate with IHT. This suggests that a lower amount of circulating BNP, resulting in diminished vasodilation and natriuresis, could be involved in the pathogenesis of hypertension in its early stages.	[Seven, Ekim; Wachtell, Kristian; Jeppesen, Jorgen L.] Univ Copenhagen, Glostrup Hosp, Dept Internal Med, Glostrup, Denmark; [Seven, Ekim; Husemoen, Lise L. N.; Linneberg, Allan] Res Ctr Prevent & Hlth, Glostrup, Denmark; [Ibsen, Hans] Univ Copenhagen, Holbaek Hosp, Dept Internal Med, Holbaek, Denmark; [Ibsen, Hans; Wachtell, Kristian; Linneberg, Allan; Jeppesen, Jorgen L.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Friedrich, Nele; Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Linneberg, Allan] Glostrup Cty Hosp, Dept Clin Expt Res, Glostrup, Denmark	University of Copenhagen; Holbaek Hospital; University of Copenhagen; University of Copenhagen; Greifswald Medical School; University of Copenhagen	Seven, E (corresponding author), Univ Copenhagen, Glostrup Hosp, Dept Internal Med, Glostrup, Denmark.	ekim.seven@regionh.dk		Linneberg, Allan/0000-0002-0994-0184	Danish Medical Research Council; Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk Foundation; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen foundation; Interreg IVa program; European Union Region Development fund	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen foundation; Interreg IVa program; European Union Region Development fund	The Inter99 study was supported by The Danish Medical Research Council, The Danish Centre for Evaluation and Health Technology Assessment, The Novo Nordisk Foundation, The Danish Heart Foundation, The Danish Pharmaceutical Association, The Augustinus Foundation and The Ib Henriksen foundation. ES and KW have been supported by Interreg IVa program, The European Union Region Development fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2007, EUR J CARDIOV PREV R, V14, P422, DOI 10.1097/HJR.0b013e3280128d00; Asferg C, 2010, AM J HYPERTENS, V23, P327, DOI 10.1038/ajh.2009.244; Asferg CL, 2013, HYPERTENSION, V62, P147, DOI 10.1161/HYPERTENSIONAHA.111.00791; Bionda C, 2006, ANN CLIN LAB SCI, V36, P299; Bombelli M, 2011, HYPERTENSION, V58, P1029, DOI 10.1161/HYPERTENSIONAHA.111.175125; Brunner-La Rocca HP, 2001, J AM COLL CARDIOL, V37, P1221, DOI 10.1016/S0735-1097(01)01172-X; BUCKLEY MG, 1994, J HYPERTENS, V12, P809; CARGILL RI, 1994, BRIT J CLIN PHARMACO, V38, P139, DOI 10.1111/j.1365-2125.1994.tb04337.x; Clerico A, 2006, AM J PHYSIOL-HEART C, V290, pH17, DOI 10.1152/ajpheart.00684.2005; Cui JS, 2002, HYPERTENSION, V40, P7, DOI 10.1161/01.HYP.0000022693.11752.E9; Fox ER, 2013, HYPERTENSION, V61, P48, DOI 10.1161/HYPERTENSIONAHA.112.197657; Fox ER, 2011, CIRCULATION, V124, P1021, DOI 10.1161/CIRCULATIONAHA.110.991943; Freitag MH, 2003, HYPERTENSION, V41, P978, DOI 10.1161/01.HYP.0000061116.20490.8D; GANAU A, 1989, J AM COLL CARDIOL, V14, P715, DOI 10.1016/0735-1097(89)90116-2; Hall JE, 2012, COMPR PHYSIOL, V2, P2393, DOI 10.1002/cphy.c110058; Hildebrandt P, 2010, EUR HEART J, V31, P1881, DOI 10.1093/eurheartj/ehq163; HOLMES SJ, 1993, J CLIN ENDOCR METAB, V76, P91, DOI 10.1210/jc.76.1.91; Jeppesen JL, 2012, AM J HYPERTENS, V25, P1095, DOI 10.1038/ajh.2012.96; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kannel W B, 1995, Hypertens Res, V18, P181, DOI 10.1291/hypres.18.181; LANG CC, 1993, J HYPERTENS, V11, P737, DOI 10.1097/00004872-199307000-00009; LAVILLA G, 1994, J CLIN ENDOCR METAB, V78, P1166, DOI 10.1210/jc.78.5.1166; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luchner A, 2010, CLIN CHEM LAB MED, V48, P121, DOI 10.1515/CCLM.2010.011; Macheret F, 2012, J AM COLL CARDIOL, V60, P1558, DOI 10.1016/j.jacc.2012.05.049; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nadir MA, 2012, J AM COLL CARDIOL, V60, P960, DOI 10.1016/j.jacc.2012.04.049; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Olsen MH, 2005, HYPERTENSION, V46, P660, DOI 10.1161/01.HYP.0000179575.13739.72; Parikh NI, 2008, ANN INTERN MED, V148, P102, DOI 10.7326/0003-4819-148-2-200801150-00005; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; RICHARDS AM, 1993, J HYPERTENS, V11, P163, DOI 10.1097/00004872-199302000-00008; Sanchez OA, 2014, METABOLISM, V63, P475, DOI 10.1016/j.metabol.2013.11.017; Seven E, 2014, J HYPERTENS, V32, P1488, DOI 10.1097/HJH.0000000000000207; Skaaby T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090654; Takase H, 2008, HYPERTENS RES, V31, P1737, DOI 10.1291/hypres.31.1737; Toft U, 2008, EUR J CLIN NUTR, V62, P1038, DOI 10.1038/sj.ejcn.1602815; Toft UN, 2007, EUR J PUBLIC HEALTH, V17, P455, DOI 10.1093/eurpub/ckl262; van Gestel YRBM, 2009, J AM COLL CARDIOL, V53, P458, DOI 10.1016/j.jacc.2008.09.047; Wang TJ, 2007, CIRCULATION, V115, P1345, DOI 10.1161/CIRCULATIONAHA.106.655142; Wang TJ, 2007, HYPERTENSION, V49, P432, DOI 10.1161/01.HYP.0000256956.61872.aa; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Wang TJ, 2002, AM J CARDIOL, V90, P254, DOI 10.1016/S0002-9149(02)02464-5	45	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117864	10.1371/journal.pone.0117864	http://dx.doi.org/10.1371/journal.pone.0117864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658326	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900233
J	Xia, W; Shi, PJ; Xu, XX; Qian, LC; Cui, Y; Xia, MJ; Yao, B				Xia, Wei; Shi, Pengjun; Xu, Xinxin; Qian, Lichun; Cui, Ying; Xia, Mengjuan; Yao, Bin			High Level Expression of a Novel Family 3 Neutral beta-Xylosidase from Humicola insolens Y1 with High Tolerance to D-Xylose	PLOS ONE			English	Article							ALPHA-L-ARABINOFURANOSIDASE; PAECILOMYCES-THERMOPHILA; XYLANOLYTIC ENZYMES; SEQUENCE-ANALYSIS; PURIFICATION; XYLAN; GENE; DEGRADATION	A novel beta-xylosidase gene of glycosyl hydrolase (GH) family 3, xyl3A, was identified from the thermophilic fungus Humicola insolens Y1, which is an innocuous and non-toxic fungus that produces a wide variety of GHs. The cDNA of xyl3A, 2334 bp in length, encodes a 777-residue polypeptide containing a putative signal peptide of 19 residues. The gene fragment without the signal peptide-coding sequence was cloned and overexpressed in Pichia pastoris GS115 at a high level of 100 mg/L in 1-L Erlenmeyer flasks without fermentation optimization. Recombinant Xyl3A showed both beta-xylosidase and alpha-arabinfuranosidase activities, but had no hydrolysis capacity towards polysaccharides. It was optimally active at pH 6.0 and 60 degrees C with a specific activity of 11.6 U/mg. It exhibited good stability over pH 4.0-9.0 (incubated at 37 degrees C for 1 h) and at temperatures of 60 degrees C and below, retaining over 80% maximum activity. The enzyme had stronger tolerance to xylose than most fungal GH3 beta-xylosidases with a high K-I value of 29 mM, which makes Xyl3A more efficient to produce xylose in fermentation process. Sequential combination of Xyl3A following endoxylanase Xyn11A of the samemicrobial source showed significant synergistic effects on the degradation of various xylans and deconstructed xylo-oligosaccharides to xylose with high efficiency. Moreover, using pNPX as both the donor and acceptor, Xyl3A exhibited a transxylosylation activity to synthesize pNPX(2). All these favorable properties suggest that Xyl3A has good potential applications in the bioconversion of hemicelluloses to biofuels.	[Xia, Wei; Qian, Lichun] Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Xia, Wei; Shi, Pengjun; Cui, Ying; Xia, Mengjuan; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing 100081, Peoples R China; [Xu, Xinxin] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100081, Peoples R China	Zhejiang University; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Qian, LC (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China.	lcqian@zju.edu.cn; binyao@caas.cn			National High-Tech Research and Development Program of China (863 Program) [2012AA022105]; National Science Foundation for Distinguished Young Scholars of China [31225026]; 948 program of the Ministry of Agriculture [2014-S1]; China Modern Agriculture Research System [CARS-42]	National High-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 948 program of the Ministry of Agriculture; China Modern Agriculture Research System	This work was supported by the National High-Tech Research and Development Program of China (863 Program, 2012AA022105) and the National Science Foundation for Distinguished Young Scholars of China (31225026) and the 948 program of the Ministry of Agriculture (2014-S1) and the China Modern Agriculture Research System (CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XY, 2012, J IND MICROBIOL BIOT, V39, P869, DOI 10.1007/s10295-012-1087-z; DEALMEIDA EM, 1995, FEMS MICROBIOL LETT, V130, P171, DOI 10.1111/j.1574-6968.1995.tb07715.x; Dilokpimol A, 2011, CARBOHYD RES, V346, P421, DOI 10.1016/j.carres.2010.12.010; Dodd D, 2009, GCB BIOENERGY, V1, P2, DOI 10.1111/j.1757-1707.2009.01004.x; Du YL, 2013, BIORESOURCE TECHNOL, V130, P161, DOI 10.1016/j.biortech.2012.12.067; Eneyskaya EV, 2003, CARBOHYD RES, V338, P313, DOI 10.1016/S0008-6215(02)00467-6; Guerfali M, 2008, APPL BIOCHEM BIOTECH, V150, P267, DOI 10.1007/s12010-008-8260-x; HEBRAUD M, 1990, FEMS MICROBIOL LETT, V72, P11, DOI 10.1111/j.1574-6968.1990.tb03853.x; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Ito T, 2003, J BIOSCI BIOENG, V96, P354, DOI 10.1016/S1389-1723(03)90136-8; Jordan DB, 2010, APPL MICROBIOL BIOT, V86, P1647, DOI 10.1007/s00253-010-2538-y; Kitamoto N, 1999, APPL ENVIRON MICROB, V65, P20; Knob A, 2010, WORLD J MICROB BIOT, V26, P389, DOI 10.1007/s11274-009-0190-4; Kumar S, 1996, FEMS MICROBIOL LETT, V135, P287, DOI 10.1016/0378-1097(95)00468-8; Kurakake M, 1997, BIOSCI BIOTECH BIOCH, V61, P2010, DOI 10.1271/bbb.61.2010; Li YK, 2000, BIOTECHNOL APPL BIOC, V31, P119, DOI 10.1042/BA19990072; Li Z, 2013, BIORESOURCE TECHNOL, V149, P413, DOI 10.1016/j.biortech.2013.09.101; Mozolowski GA, 2009, ENZYME MICROB TECH, V45, P436, DOI 10.1016/j.enzmictec.2009.08.011; Ohta K, 2010, J BIOSCI BIOENG, V110, P152, DOI 10.1016/j.jbiosc.2010.02.008; Puchart V, 2007, J BIOTECHNOL, V128, P576, DOI 10.1016/j.jbiotec.2006.12.011; Puls J, 1993, CHEM HEMICELLULOSES, P1; Rahman AKMS, 2003, CAN J MICROBIOL, V49, P58, DOI 10.1139/W02-114; Raweesri P, 2008, BIORESOURCE TECHNOL, V99, P8981, DOI 10.1016/j.biortech.2008.05.016; Reen FJ, 2003, BIOCHEM BIOPH RES CO, V305, P579, DOI 10.1016/S0006-291X(03)00829-5; Rizzatti ACS, 2001, J IND MICROBIOL BIOT, V26, P156, DOI 10.1038/sj.jim.7000107; Saha BC, 2003, BIORESOURCE TECHNOL, V90, P33, DOI 10.1016/S0960-8524(03)00098-1; Saha BC, 2001, J IND MICROBIOL BIOT, V27, P241, DOI 10.1038/sj.jim.7000184; Shi H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-27; Sunna A, 1997, CRIT REV BIOTECHNOL, V17, P39, DOI 10.3109/07388559709146606; Teng C, 2011, BIORESOURCE TECHNOL, V102, P1822, DOI 10.1016/j.biortech.2010.09.055; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Wakiyama M, 2008, J BIOSCI BIOENG, V106, P398, DOI 10.1263/jbb.106.398; Wang LX, 2009, CURR OPIN CHEM BIOL, V13, P592, DOI 10.1016/j.cbpa.2009.08.014; Yan QJ, 2008, BIORESOURCE TECHNOL, V99, P5402, DOI 10.1016/j.biortech.2007.11.033; Yang XZ, 2014, FOOD CHEM, V148, P381, DOI 10.1016/j.foodchem.2013.10.062	35	23	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117578	10.1371/journal.pone.0117578	http://dx.doi.org/10.1371/journal.pone.0117578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658646	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900181
J	Xu, JH; Prosperi, JR; Choudhury, N; Olopade, OI; Goss, KH				Xu, Jinhua; Prosperi, Jenifer R.; Choudhury, Noura; Olopade, Olufunmilayo I.; Goss, Kathleen H.			beta-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells	PLOS ONE			English	Article							STEM-CELLS; COLON-CANCER; PATHWAY; MARKER; IDENTIFICATION; ACTIVATION; DISEASE; TARGET; ROLES	Our previous data illustrated that activation of the canonical Wnt signaling pathway was enriched in triple-negative breast cancer and associated with reduced overall survival in all patients. To determine whether Wnt signaling may be a promising therapeutic target for triple-negative breast cancer, we investigated whether beta-catenin was necessary for tumorigenic behaviors in vivo and in vitro. beta-catenin expression level was significantly reduced in two human triple-negative breast cancer cell lines, MDA-MB-231 and HCC38, using lentiviral delivery of beta-catenin-specific small hairpin RNAs (shRNAs). Upon implantation of the cells in the mammary fat pad of immunocompromised mice, we found that beta-catenin shRNA HCC38 cells formed markedly smaller tumors than control cells and grew much more slowly. In in vitro assays, beta-catenin silencing significantly reduced the percentage of Aldefluor-positive cells, a read-out of the stem-like cell population, as well as the expression of stem cell-related target genes including Bmi-1 and c-Myc. beta-catenin-knockdown cells were also significantly impaired in their ability to migrate in wound-filling assays and formanchorage-independent colonies in soft agar. beta-catenin-knockdown cells were more sensitive to chemotherapeutic agents doxorubicin and cisplatin. Collectively, these data suggest that beta-catenin is required for triple-negative breast cancer development by controlling numerous tumor-associated properties, such as migration, stemness, anchorage-independent growth and chemosensitivity.	[Xu, Jinhua; Prosperi, Jenifer R.; Choudhury, Noura; Goss, Kathleen H.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Xu, Jinhua; Prosperi, Jenifer R.; Choudhury, Noura; Goss, Kathleen H.] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Xu, Jinhua; Olopade, Olufunmilayo I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Xu, Jinhua] Jianghan Univ, Sch Med, Wuhan 430056, Hubei, Peoples R China; [Prosperi, Jenifer R.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46530 USA	University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; University of Chicago; Jianghan University; Indiana University System; Indiana University South Bend	Xu, JH (corresponding author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	xu5520@gmail.com		Goss, Kathleen/0000-0002-7379-5639; Prosperi, Jenifer/0000-0001-8439-4411	National Cancer Institute Cancer Center Breast Cancer SPORE at University of Chicago [P50 CA125183-05]; American Cancer Society Illinois Division; Breast Cancer Research Foundation [634366]; Jianghan Univesity [101006850001]; NATIONAL CANCER INSTITUTE [P50CA125183] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center Breast Cancer SPORE at University of Chicago; American Cancer Society Illinois Division(American Cancer Society); Breast Cancer Research Foundation; Jianghan Univesity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Cancer Institute Cancer Center Breast Cancer SPORE at University of Chicago (OO, P50 CA125183-05), a grant from the American Cancer Society Illinois Division (KG), and The Breast Cancer Research Foundation (OO, 634366). Start up funding was received from Jianghan Univesity (JX, 101006850001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bakker ERM, 2013, ONCOGENE, V32, P4579, DOI 10.1038/onc.2012.449; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Elsawaf Z, 2011, BREAST CARE, V6, P273, DOI 10.1159/000331643; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Guarneri V, 2013, DRUGS, V73, P1257, DOI 10.1007/s40265-013-0091-6; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Joensuu H, 2012, ANN ONCOL, V23, P40, DOI 10.1093/annonc/mds194; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; King TD, 2012, J CELL BIOCHEM, V113, P13, DOI 10.1002/jcb.23350; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Li BH, 2010, CANCER CELL, V17, P469, DOI 10.1016/j.ccr.2010.03.019; Liedtke C, 2013, BREAST CARE, V8, P408, DOI 10.1159/000357534; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Odenwald MA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-12; Prosperi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029339; Prosperi JR, 2010, CURR DRUG TARGETS, V11, P1074; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; von Minckwitz G, 2012, ANN ONCOL, V23, P35, DOI 10.1093/annonc/mds193; Wend P, 2013, EMBO MOL MED, V5, P264, DOI 10.1002/emmm.201201320; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P11312, DOI 10.1073/pnas.1203015109; Xu JH, 2010, BREAST CANCER RES TR, V120, P593, DOI 10.1007/s10549-009-0422-1; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508	36	116	120	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117097	10.1371/journal.pone.0117097	http://dx.doi.org/10.1371/journal.pone.0117097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658419	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900099
J	Xu, L; Qu, YH; Chu, XD; Wang, RW; Nelson, HH; Gao, YT; Yuan, JM				Xu, Ling; Qu, Yong-Hua; Chu, Xin-Di; Wang, Renwei; Nelson, Heather H.; Gao, Yu-Tang; Yuan, Jian-Min			Urinary Levels of N-Nitroso Compounds in Relation to Risk of Gastric Cancer: Findings from the Shanghai Cohort Study	PLOS ONE			English	Article							ENDOGENOUS FORMATION; FOLLOW-UP; NITRITE; NITRATE; ACID; ESOPHAGEAL; EXPOSURE; NITROSAMINES; MODULATION; MECHANISMS	Background N-Nitroso compounds are thought to play a significant role in the development of gastric cancer. Epidemiological data, however, are sparse in examining the associations between biomarkers of exposure to N-nitroso compounds and the risk of gastric cancer. Methods A nested case-control study within a prospective cohort of 18,244 middle-aged and older men in Shanghai, China, was conducted to examine the association between urinary level of N-nitroso compounds and risk of gastric cancer. Information on demographics, usual dietary intake, and use of alcohol and tobacco was collected through in-person interviews at enrollment. Urinary levels of nitrate, nitrite, N-nitroso-2-methylthiazolidine-4-carboxylic acid (NMTCA), N-nitrosoproline (NPRO), N-nitrososarcosine (NSAR), N-nitrosothiazolidine-4-carboxylic acid (NTCA), as well as serum H. pylori antibodies were quantified in 191 gastric cancer cases and 569 individually matched controls. Logistic regression method was used to assess the association between urinary levels of N-nitroso compounds and risk of gastric cancer. Results Compared with controls, gastric cancer patients had overall comparable levels of urinary nitrate, nitrite, and N-nitroso compounds. Among individuals seronegative for antibodies to H. pylori, elevated levels of urinary nitrate were associated with increased risk of gastric cancer. The multivariate-adjusted odds ratios for the second and third tertiles of nitrate were 3.27 (95% confidence interval = 0.76-14.04) and 4.82 (95% confidence interval = 1.05-22.17), respectively, compared with the lowest tertile (P for trend = 0.042). There was no statistically significant association between urinary levels of nitrite or N-nitroso compounds and risk of gastric cancer. Urinary NMTCA level was significantly associated with consumption of alcohol and preserved meat and fish food items. Conclusion The present study demonstrates that exposure to nitrate, a precursor of N-nitroso compounds, may increase the risk of gastric cancer among individuals without a history of H. pylori infection.	[Xu, Ling; Nelson, Heather H.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Xu, Ling; Nelson, Heather H.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Xu, Ling] Florida Int Univ, Dept Nutr & Dietet, Robert R Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA; [Qu, Yong-Hua; Chu, Xin-Di; Gao, Yu-Tang] Shanghai Jiao Tong Univ, Shanghai Canc Inst, Shanghai 200030, Peoples R China; [Qu, Yong-Hua; Chu, Xin-Di; Gao, Yu-Tang] Shanghai Jiao Tong Univ, Inst Canc, Shanghai 200030, Peoples R China; [Wang, Renwei; Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Div Canc Control & Populat Sci, Pittsburgh, PA 15260 USA; [Wang, Renwei; Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; Florida International University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yuan, JM (corresponding author), Univ Pittsburgh, Inst Canc, Div Canc Control & Populat Sci, Pittsburgh, PA 15260 USA.	yuanj@upmc.edu	Gao, Yu/HGE-1937-2022; Gao, Y./GWZ-3665-2022; gao, yi/HCI-8298-2022	Yuan, Jian-Min/0000-0002-4620-3108; Nelson, Heather/0000-0003-1901-9513	National Cancer Institute of the National Institutes of Health [R01CA043092, R01CA129534, R01CA144034]; NATIONAL CANCER INSTITUTE [R01CA129534, UM1CA182876, R01CA144034, R01CA043092] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers R01CA043092, R01CA129534 and R01CA144034. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breslow N E, 1980, IARC Sci Publ, P5; CALMELS S, 1987, CARCINOGENESIS, V8, P1085, DOI 10.1093/carcin/8.8.1085; CARBONI M, 1988, LANGENBECK ARCH CHIR, V373, P82, DOI 10.1007/BF01262769; Cross AJ, 2003, CANCER RES, V63, P2358; De Stefani E, 1998, NUTR CANCER, V30, P158, DOI 10.1080/01635589809514656; DEBERNARDINIS G, 1983, TUMORI, V69, P231, DOI 10.1177/030089168306900311; GONZALEZ CA, 1994, AM J EPIDEMIOL, V139, P466, DOI 10.1093/oxfordjournals.aje.a117029; Griesenbeck JS, 2009, NUTR METAB, V6, DOI 10.1186/1475-2891-8-16; Grosse Y, 2006, LANCET ONCOL, V7, P628, DOI 10.1016/S1470-2045(06)70789-6; He SL, 2005, CHINESE FOOD TECHNOL, V1, P94; Herod-Leszczynska T, 1992, Rocz Panstw Zakl Hig, V43, P253; HOTCHKISS JH, 1989, CANCER SURV, V8, P295; International Agenecy for Research on Cancer, 2010, IARC MONOGRAPHS EVAL, V94, P43; Jakszyn P, 2006, CARCINOGENESIS, V27, P1497, DOI 10.1093/carcin/bgl019; Jakszyn P, 2006, WORLD J GASTROENTERO, V12, P4296, DOI 10.3748/wjg.v12.i27.4296; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji FD, 2009, J FOOD PROCESS PRES, V33, P175, DOI 10.1111/j.1745-4549.2008.00291.x; Knekt P, 1999, INT J CANCER, V80, P852, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;852::AID-IJC9&gt;3.0.CO;2-S; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; LaVecchia C, 1997, NUTR CANCER, V27, P65, DOI 10.1080/01635589709514503; Lijinsky W, 1990, CHEM CARCINOGENESIS, P179; Lunn JC, 2007, CARCINOGENESIS, V28, P685, DOI 10.1093/carcin/bgl192; McCracken M, 2007, CA-CANCER J CLIN, V57, P190, DOI 10.3322/canjclin.57.4.190; MIRVISH SS, 1995, CANCER LETT, V93, P17, DOI 10.1016/0304-3835(95)03786-V; Moy KA, 2010, CANCER EPIDEM BIOMAR, V19, P2287, DOI 10.1158/1055-9965.EPI-10-0362; OHSHIMA H, 1982, CARCINOGENESIS, V3, P115, DOI 10.1093/carcin/3.1.115; OHSHIMA H, 1981, CANCER RES, V41, P3658; OHSHIMA H, 1984, J CANCER RES CLIN, V108, P121, DOI 10.1007/BF00390983; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; POBEL D, 1995, EUR J EPIDEMIOL, V11, P67, DOI 10.1007/BF01719947; ROSS RK, 1992, LANCET, V339, P943, DOI 10.1016/0140-6736(92)91528-G; Schistosomes liver flukes and Helicobacter pylori, 1994, IARC MONOGR EVAL CAR, V61, P1; SCHOENTAL R, 1962, BRIT J CANCER, V16, P92, DOI 10.1038/bjc.1962.9; Scott DR, 2002, GASTROENTEROLOGY, V123, P187, DOI 10.1053/gast.2002.34218; SEN NP, 1978, J ASSOC OFF ANA CHEM, V61, P1389; Stewart BW, 2014, WORLD CANC REPORT 20, P16, DOI DOI 10.1136/oemed-2019-106012; Stuff JE, 2009, J FOOD COMPOS ANAL, V22, pS42, DOI 10.1016/j.jfca.2009.01.008; Sun CL, 2002, CARCINOGENESIS, V23, P1497, DOI 10.1093/carcin/23.9.1497; Suzuki H, 2003, GUT, V52, P1095, DOI 10.1136/gut.52.8.1095; Tricker AR, 1997, EUR J CANCER PREV, V6, P226, DOI 10.1097/00008469-199706000-00003; TRICKER AR, 1991, MUTAT RES, V259, P277, DOI 10.1016/0165-1218(91)90123-4; vanMaanen JM, 1996, CANCER DETECT PREV, V20, P590; WAGNER DA, 1984, IARC SCI PUBL, P223; Yuan JM, 1999, CANCER EPIDEM BIOMAR, V8, P621; Yuan JM, 2004, CANCER EPIDEM BIOMAR, V13, P1772; Yuan JM, 1996, JAMA-J AM MED ASSOC, V275, P1646, DOI 10.1001/jama.275.21.1646	46	23	26	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117326	10.1371/journal.pone.0117326	http://dx.doi.org/10.1371/journal.pone.0117326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658333	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000349444900134
J	Howlader, MSA; Nair, A; Gopalan, SV; Merila, J				Howlader, Mohammad Sajid Ali; Nair, Abhilash; Gopalan, Sujith V.; Merilae, Juha			A New Species of Euphlyctis (Anura: Dicroglossidae) from Barisal, Bangladesh	PLOS ONE			English	Article							GENETIC-DIVERGENCE; AMPHIBIA; INDIA; RANIDAE	A new species of the genus Euphlyctis is described from the Barisal district of Bangladesh and compared with its morphologically similar and geographically proximate congeners. The new species is highly divergent in comparison to other congeneric species on basis of sequence divergence in mitochondrial DNA gene sequences (ranging from 5.5% to 17.8% divergence). Euphlyctis kalasgramensis sp. nov. can be readily diagnosed by having the following combination of characters: snout-vent length (SVL) 30.44 - 37.88 mm, absence of mid-dorsal line, nostril-snout length 3% of SVL, nostril much closer to snout tip than eye, nostril-snout length 48% of distance from front of eyes to nostril, relative length of fingers (shortest to longest: 1 = 2 < 4 < 3), tibia length 59% of SVL, foot length 55% of SVL.	[Howlader, Mohammad Sajid Ali; Nair, Abhilash; Merilae, Juha] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland; [Gopalan, Sujith V.] Rajiv Gandhi Ctr Biotechnol, Mol Ecol Lab, Thiruvananthapuram, Kerala, India	University of Helsinki; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Howlader, MSA (corresponding author), Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland.	sajidpabc@gmail.com	Gopalan, Sujith V/J-6807-2014; Nair, Abhilash/AAE-4011-2019; Merila, Juha/A-4061-2008	Gopalan, Sujith V/0000-0002-4744-9935; Nair, Abhilash/0000-0003-3487-1114; Merila, Juha/0000-0001-9614-0072; Howlader, Mohammad Sajid Ali/0000-0002-4941-6125	Center for International Mobility (CIMO; Finland); Finnish Cultural Foundation	Center for International Mobility (CIMO; Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was funded by the Center for International Mobility (CIMO; Finland) and the Finnish Cultural Foundation (https://www.skr.fi/en/finnishcultural-foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alam MS, 2008, MOL PHYLOGENET EVOL, V48, P515, DOI 10.1016/j.ympev.2008.04.020; Asmat G.M.S., 2003, U J ZOOL RAJSHAHI U, V22, P141; Bauer Aaron M., 1998, Hamadryad, V23, P133; Boulenger G. A., 1890; Boulenger G.A., 1882, CATALOGUE BATRACHIA, VSecond; Cantor T., 1847, J ASIATIC SOC BENGAL, V16, P1026; Chanda S.K., 1990, Hamadryad, V15, P16; Chanda SK, 2002, HDB INDIAN AMPHIBIAN; De Silva P.H.D.H., 1958, SPOLIA ZEYLANICA COL, V28; Djong TH, 2007, ZOOL SCI, V24, P1197, DOI 10.2108/zsj.24.1197; Drummond AJ, 2010, GENEIOUS V5 0 4; DUBOIS A, 1981, MONIT ZOOL ITAL, V15, P225, DOI 10.1080/03749444.1981.10736637; Dumeril A. M. C., 1841, ERPETOLOGIE GEN HIST; Dutta SK, 1996, AMPHIBIAN FAUNA SRI; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frost D.R., 2021, AMPHIBIAN SPECIES WO; Glaw F, 2007, FIELD GUIDE AMPHIBIA, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Gray J.E., 1830, ILLUSTRATIONS INDIAN; Gunther, 1860, P ZOOL SOC LOND, V1860, P148; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hasan Mahmudul, 2012, Zootaxa, V3312, P45; Hasan M, 2012, ZOOL SCI, V29, P162, DOI 10.2108/zsj.29.162; Howlader MSA, 2011, ZOOTAXA, P41, DOI 10.11646/zootaxa.2761.1.3; Howlader Mohammad Sajid Ali, 2010, Russian Journal of Herpetology, V17, P255; Islam MM, 2008, ZOOL SCI, V25, P1084, DOI 10.2108/zsj.25.1084; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Joshy S. Hareesh, 2009, Alytes (Paris), V26, P97; Khan MS, 2009, IUCN 2012 IUCN RED L; Khan Muhammad Sharif, 1997, Pakistan Journal of Zoology, V29, P107; Kurabayashi A, 2005, ZOOL SCI, V22, P525, DOI 10.2108/zsj.22.525; Kuramoto Mitsuru, 2007, Current Herpetology, V26, P81, DOI 10.3105/1881-1019(2007)26[81:TGFARI]2.0.CO;2; Kuramoto Mitsuru, 2006, Current Herpetology, V25, P15, DOI 10.3105/1345-5834(2006)25[15:MAACOM]2.0.CO;2; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schneider J.G., 1799, FASCICULUS PRIMUS CO; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Veith Michael, 2001, Alytes (Paris), V19, P5	39	17	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0116666	10.1371/journal.pone.0116666	http://dx.doi.org/10.1371/journal.pone.0116666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25651541	Green Published, gold, Green Submitted			2022-12-27	WOS:000349250700004
J	Al-Hajoj, S; Shoukri, M; Memish, Z; AlHakeem, R; AlRabiah, F; Varghese, B				Al-Hajoj, Sahal; Shoukri, Mohammed; Memish, Ziad; AlHakeem, Raafat; AlRabiah, Fahad; Varghese, Bright			Exploring the Sociodemographic and Clinical Features of Extrapulmonary Tuberculosis in Saudi Arabia	PLOS ONE			English	Article							PRIMARY IMMUNODEFICIENCY DISEASES; RISK-FACTORS; EPIDEMIOLOGY; CHILDREN; CONSANGUINITY; INFECTIONS; DISORDERS; PULMONARY	Background Saudi Arabia annually reports a relatively higher proportion (28-32%) of extrapulmonary tuberculosis (EPTB) cases in comparison to other global regions. However, there were few studies conducted so far to determine the sociodemographic factors and clinical manifestations associated with EPTB at a nationwide level. Methodology A retrospective analysis on culture positive EPTB isolates collected from all the provinces of the country were conducted for a period of 12 months to determine the spectrum of diversity in EPTB infection sites and the confounding factors. A detailed clinical and demographical data analysis was carried out along with first line drug susceptibility testing. Principal Findings Intra-thoracic and extra-thoracic lymph nodes (44.6%) were the most common sites of infection followed by gastrointestinal (17.3%) and central nervous systems (11.8%). Male patients were mostly infected (58.8%), in contrary to the global trend. Any drug resistance was observed in 23.1% isolates with a 2.1% of multi-drug resistance. HIV reactivity was found only in 2.2% cases. A higher proportion of Saudi nationals (58.8%) were infected compared to the immigrants, descending mostly from South Asia (34.4%) and South East Asia (31.2%). The Saudi population predominated with all forms of EPTB while immigrants showed no significant variations. Conclusions Saudi Arabia faces a serious threat from EPTB, particularly to the central nervous system and gastrointestinal systems. More effective diagnostic strategies and control measures must be implemented to reduce the high rate of EPTB in the country. In addition, these findings warrant further detailed research to explore all related comorbid conditions of EPTB development, particularly the host-related factors.	[Al-Hajoj, Sahal; Varghese, Bright] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia; [Shoukri, Mohammed] King Faisal Specialist Hosp & Res Ctr, Natl Biotechnol Ctr, Riyadh 11211, Saudi Arabia; [Memish, Ziad; AlHakeem, Raafat] Minist Hlth, Prevent Med Directorate, Riyadh, Saudi Arabia; [AlRabiah, Fahad] King Faisal Specialist Hosp & Res Ctr, Dept Med, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Ministry of Health - Saudi Arabia; King Faisal Specialist Hospital & Research Center	Al-Hajoj, S (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia.	hajoj@kfshrc.edu.sa	Memish, Ziad Ahmed/AEJ-9424-2022	Memish, Ziad Ahmed/0000-0002-5099-0714	King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia [AT-116/28]	King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia	The study was financially supported by King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia (www.kacst.edu.sa; Grant code AT-116/28). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daghri NM, 2012, J IMMUNOL, V188, P1325, DOI 10.4049/jimmunol.1101954; Al-Hajoj S, 2013, ANTIMICROB AGENTS CH, V57, P2161, DOI 10.1128/AAC.02403-12; Al-Herbish AS, 2008, SAUDI MED J, V29, P1285; Al-Muhsen S, 2012, ANN NY ACAD SCI, V1250, P56, DOI 10.1111/j.1749-6632.2011.06379.x; Al-Muhsen Saleh Z, 2010, Saudi J Gastroenterol, V16, P66, DOI 10.4103/1319-3767.61230; Al-Otaibi F, 2010, INDIAN J PATHOL MICR, V53, P227, DOI 10.4103/0377-4929.64327; Alrabiaah AA, 2012, ANN SAUDI MED, V32, P4, DOI 10.5144/0256-4947.2012.4; Asghar RJ, 2008, ARCH INTERN MED, V168, P936, DOI 10.1001/archinte.168.9.936; Beek LAMT, 2006, EMERG INFECT DIS, V12, P1375, DOI 10.3201/eid1209.050553; Bukhary ZA, 2004, SAUDI MED J, V25, P881; Cailhol J, 2005, J CLIN EPIDEMIOL, V58, P1066, DOI 10.1016/j.jclinepi.2005.02.023; CDC, 2013, REP TUB US 2012; Chandir S, 2010, J PAK MED ASSOC, V60, P105; Chen CY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-324; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; El Mouzan MI, 2008, ANN SAUDI MED, V28, P169, DOI 10.5144/0256-4947.2008.169; ELHAZMI MAF, 1995, J MED GENET, V32, P623, DOI 10.1136/jmg.32.8.623; Forssbohm M, 2008, EUR RESPIR J, V31, P99, DOI 10.1183/09031936.00020607; Garcia-Rodriguez JF, 2011, ENFERM INFEC MICR CL, V29, P502, DOI 10.1016/j.eimc.2011.03.005; Galkina E, 2007, ADV EXP MED BIOL, V601, P75; Gomes T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-9; Kipp AM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-107; Kruijshaar ME, 2009, THORAX, V64, P1090, DOI 10.1136/thx.2009.118133; Lee PPW, 2013, ASIAN PAC J ALLERGY, V31, P217; Lee WI, 2011, J FORMOS MED ASSOC, V110, P750, DOI 10.1016/j.jfma.2011.11.004; Mazroa Mohammed A A I, 2012, PLoS One, V7, pe45919, DOI 10.1371/journal.pone.0045919; Memish ZA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095654; Ministry of Health Saudi Arabia, 2007, STAT BOOK YEAR 1427, V1427; Ministry of Health Saudi Arabia, 2012, STAT BOOK YEAR 1432, V1432; Rowinska-Zakrzewska Ewa, 2013, Pneumonol Alergol Pol, V81, P121; Solovic I, 2013, EUROSURVEILLANCE, V18, P12; Sreeramareddy CT, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-8; Suliaman F, 2006, ALLERGY IMMUNOL, V19, P14; Suliaman Fawzi, 2009, Pediatric Asthma Allergy & Immunology, V22, P21, DOI 10.1089/pai.2008.0513; Varghese B, 2013, TUBERCULOSIS, V93, P246, DOI 10.1016/j.tube.2012.12.001; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644	37	22	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0101667	10.1371/journal.pone.0101667	http://dx.doi.org/10.1371/journal.pone.0101667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647300	Green Submitted, Green Published, gold			2022-12-27	WOS:000348822600001
J	An, Y; Toyoda, A; Zhao, C; Fujiyama, A; Agata, K				An, Yang; Toyoda, Atsushi; Zhao, Chen; Fujiyama, Asao; Agata, Kiyokazu			A Colony Multiplex Quantitative PCR-Based 3S3DBC Method and Variations of It for Screening DNA Libraries	PLOS ONE			English	Article							ARTIFICIAL CHROMOSOME CLONES; POLYMERASE-CHAIN-REACTION; RAPID IDENTIFICATION; GENOMIC LIBRARY; BAC LIBRARY; HYBRIDIZATION; CONSTRUCTION; SEQUENCES; STRATEGY; PLAQUES	A DNA library is a collection of DNA fragments cloned into vectors and stored individually in host cells, and is a valuable resource for molecular cloning, gene physical mapping, and genome sequencing projects. To take the best advantage of a DNA library, a good screening method is needed. After describing pooling strategies and issues that should be considered in DNA library screening, here we report an efficient colony multiplex quantitative PCR-based 3-step, 3-dimension, and binary-code (3S3DBC) method we used to screen genes from a planarian genomic DNA fosmid library. This method requires only 3 rounds of PCR reactions and only around 6 hours to distinguish one or more desired clones from a large DNA library. According to the particular situations in different research labs, this method can be further modified and simplified to suit their requirements.	[An, Yang; Agata, Kiyokazu] Kyoto Univ, Dept Biophys, Kyoto, Japan; [Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Comparat Genom Lab, Mishima, Shizuoka 411, Japan; [Zhao, Chen] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China	Kyoto University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Fudan University	An, Y (corresponding author), Kyoto Univ, Dept Biophys, Kyoto, Japan.	yangan@mdb.biophys.kyoto-u.ac.jp; agata@mdb.biophys.kyoto-u.ac.jp		Agata, Kiyokazu/0000-0002-5195-2576	Scientific Research on Innovative Areas [22124001]; Creative Scientific Research [17GS0318]; Global COE Program A06 of Kyoto University; National Institute of Genetics Collaborative Research Program; Japan Society for the Promotion of Science (JSPS) Research Fellowship [13J01078]	Scientific Research on Innovative Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Creative Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global COE Program A06 of Kyoto University; National Institute of Genetics Collaborative Research Program; Japan Society for the Promotion of Science (JSPS) Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas to K.A. (22124001), a Grant-in-Aid for Creative Scientific Research to K.A. (17GS0318), Global COE Program A06 of Kyoto University, National Institute of Genetics Collaborative Research Program, and a Japan Society for the Promotion of Science (JSPS) Research Fellowship to Y.A. (13J01078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa S, 1998, GENOMICS, V49, P209, DOI 10.1006/geno.1998.5242; BARILLOT E, 1991, NUCLEIC ACIDS RES, V19, P6241, DOI 10.1093/nar/19.22.6241; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BLOEM LJ, 1990, NUCLEIC ACIDS RES, V18, P2830, DOI 10.1093/nar/18.9.2830; Bouzidi MF, 2006, THEOR APPL GENET, V113, P81, DOI 10.1007/s00122-006-0274-6; Campbell TN, 2002, J MOL MICROB BIOTECH, V4, P551; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; Crooijmans RPMA, 2000, MAMM GENOME, V11, P360, DOI 10.1007/s003350010068; EDWARDS MC, 1994, PCR METH APPL, V3, pS65; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Farrar K, 2007, NAT PROTOC, V2, P1661, DOI 10.1038/nprot.2007.204; Febrer M, 2009, GENOME, V52, P993, DOI 10.1139/G09-073; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; GUSSOW D, 1989, NUCLEIC ACIDS RES, V17, P4000; Han CS, 2000, GENOME RES, V10, P714, DOI 10.1101/gr.10.5.714; HANAHAN D, 1983, METHOD ENZYMOL, V100, P333; Henegariu O, 1997, BIOTECHNIQUES, V23, P504, DOI 10.2144/97233rr01; ISRAEL DI, 1993, NUCLEIC ACIDS RES, V21, P2627, DOI 10.1093/nar/21.11.2627; Jin FL, 2006, NAT METHODS, V3, P183, DOI 10.1038/nmeth859; Kim CG, 2003, GENOMICS, V82, P571, DOI 10.1016/S0888-7543(03)00174-5; Klein PE, 2000, GENOME RES, V10, P789, DOI 10.1101/gr.10.6.789; KWIATKOWSKI TJ, 1990, NUCLEIC ACIDS RES, V18, P7191, DOI 10.1093/nar/18.23.7191; LIBERT F, 1993, GENOMICS, V18, P270, DOI 10.1006/geno.1993.1465; LIU J, 1995, GENOMICS, V26, P178, DOI 10.1016/0888-7543(95)80199-V; Liu W, 2003, ANIM BIOTECHNOL, V14, P145, DOI 10.1081/ABIO-120026484; Pollier J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024978; SANZEY B, 1976, P NATL ACAD SCI USA, V73, P3394, DOI 10.1073/pnas.73.10.3394; Seidman J, 1994, CURRENT PROTOCOLS MO; SUGGS SV, 1981, P NATL ACAD SCI-BIOL, V78, P6613, DOI 10.1073/pnas.78.11.6613; TRAVER CN, 1989, P NATL ACAD SCI USA, V86, P5898, DOI 10.1073/pnas.86.15.5898; Vu GTH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-301; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	34	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116997	10.1371/journal.pone.0116997	http://dx.doi.org/10.1371/journal.pone.0116997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646755	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600046
J	Arnold, DT; Bhatnagar, R; Fairbanks, LD; Zahan-Evans, N; Clive, AO; Morley, AJ; Medford, ARL; Maskell, NA				Arnold, David T.; Bhatnagar, Rahul; Fairbanks, Lynette D.; Zahan-Evans, Natalie; Clive, Amelia O.; Morley, Anna J.; Medford, Andrew R. L.; Maskell, Nicholas A.			Pleural Fluid Adenosine Deaminase (Pfada) in the Diagnosis of Tuberculous Effusions in a Low Incidence Population	PLOS ONE			English	Article							STORAGE TIME	Introduction Previous studies have assessed the diagnostic ability of pleural fluid adenosine deaminase (pfADA) in detecting tuberculous pleural effusions, with good specificity and sensitivity reported. However, in North Western Europe pfADA is not routinely used in the investigation of a patient with an undiagnosed pleural effusion, mainly due to a lack of evidence as to its utility in populations with low mycobacterium tuberculosis (mTB) incidence. Methods Patients presenting with an undiagnosed pleural effusion to a tertiary pleural centre in South-West England over a 3 year period, were prospectively recruited to a pleural biomarker study. Pleural fluid from consecutive patients with robust 12-month follow up data and confirmed diagnosis were sent for pfADA analysis. Results Of 338 patients enrolled, 7 had confirmed tuberculous pleural effusion (2%). All mTB effusions were lymphocyte predominant with a median pfADA of 72.0 IU/L (range-26.7 to 91.5) compared to a population median of 12.0 IU/L (range-0.3 to 568.4). The optimal pfADA cut off was 35 IU/L, which had a negative predictive value (NPV) of 99.7%(95% CI; 98.2-99.9%) for the exclusion of mTB, and sensitivity of 85.7% (95% CI; 42.2-97.6%) with an area under the curve of 0.88 (95% CI; 0.732-1.000). Discussion This is the first study examining the diagnostic utility of pfADA in a low mTB incidence area. The chance of an effusion with a pfADA under 35 IU/L being of tuberculous aetiology was negligible. A pfADA of over 35 IU/L in lymphocyte-predominant pleural fluid gives a strong suspicion of mTB.	[Arnold, David T.; Bhatnagar, Rahul; Clive, Amelia O.; Maskell, Nicholas A.] Univ Bristol, Acad Resp Unit, Sch Clin Sci, Bristol, Avon, England; [Bhatnagar, Rahul; Zahan-Evans, Natalie; Clive, Amelia O.; Morley, Anna J.; Medford, Andrew R. L.; Maskell, Nicholas A.] Southmead Hosp, North Bristol Lung Ctr, Bristol, Avon, England; [Fairbanks, Lynette D.] St Thomas Hosp, Purine Res Lab, London, England	University of Bristol; Southmead Hospital; Guy's & St Thomas' NHS Foundation Trust	Arnold, DT (corresponding author), Univ Bristol, Acad Resp Unit, Sch Clin Sci, Bristol, Avon, England.	arnold.dta@gmail.com		Arnold, David/0000-0003-3158-7740; Bhatnagar, Rahul/0000-0003-3906-1997; Medford, Andrew/0000-0001-5445-5949; maskell, nick/0000-0002-1276-6500	National Institute for Health Research [CL-2014-25-502] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Antonangelo L, 2006, RESPIROLOGY, V11, P488, DOI 10.1111/j.1440-1843.2006.00866.x; Antonangelo L, 2012, J BRAS PNEUMOL, V38, P181, DOI 10.1590/S1806-37132012000200006; Bhatnagar R, 2013, THORAX, V68, pA170, DOI 10.1136/thoraxjnl-2013-204457.361; Bielsa S, 2014, CLIN LAB, V60, P501, DOI 10.7754/Clin.Lab.2013.130311; Chakrabarti B, 2006, CHEST, V129, P1549, DOI 10.1378/chest.129.6.1549; Chung JH, 2004, YONSEI MED J, V45, P661, DOI 10.3349/ymj.2004.45.4.661; Diacon AH, 2003, EUR RESPIR J, V22, P589, DOI 10.1183/09031936.03.00017103a; Garcia-Zamalloa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038729; Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063; Hooper C, 2010, THORAX, V65, P4, DOI 10.1136/thx.2010.136978; Kapisyzi P, 2011, CHEST, V140, p703A, DOI [10.1378/chest.1108296, DOI 10.1378/CHEST.1108296]; Lee SJ, 2014, AM J MED SCI, DOI [10.1097/MAJ.0b013e31828ffcd6, DOI 10.1097/MAJ.0B013E31828FFCD6]; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; Maskell NA, 2003, THORAX, V58, pII8, DOI 10.1136/thorax.58.suppl_2.ii8; McGrath EE, 2010, EUR J CLIN MICROBIOL, V29, P1187, DOI 10.1007/s10096-010-0986-z; Porcel JM, 2010, EUR J INTERN MED, V21, P419, DOI 10.1016/j.ejim.2010.03.011; Public Health England, TUBERCULOSIS UK 2013; SEIBERT AF, 1991, CHEST, V99, P883, DOI 10.1378/chest.99.4.883; Tay TR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-546; Valdes L, 1996, EUR RESPIR J, V9, P747, DOI 10.1183/09031936.96.09040747; Valdes L, 1998, ARCH INTERN MED, V158, P2017, DOI 10.1001/archinte.158.18.2017; Villegas MV, 2000, CHEST, V118, P1355, DOI 10.1378/chest.118.5.1355; Yao CW, 2014, QJM; Zemlin AE, 2009, INT J TUBERC LUNG D, V13, P214	24	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0113047	10.1371/journal.pone.0113047	http://dx.doi.org/10.1371/journal.pone.0113047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647479	Green Submitted, Green Published, gold			2022-12-27	WOS:000348822600003
J	Harrington, KA; Hrabik, TR; Mensinger, AF				Harrington, Kelly A.; Hrabik, Thomas R.; Mensinger, Allen F.			Visual Sensitivity of Deepwater Fishes in Lake Superior	PLOS ONE			English	Article							INHABITING CHESAPEAKE BAY; DIEL VERTICAL MIGRATION; SEA FISHES; PHOTOSENSITIVE PIGMENTS; PHOTIC ENVIRONMENT; COTTOID FISH; LIGHT; ABUNDANCE; VISION; IRRADIANCE	The predator-prey interactions in the offshore food web of Lake Superior have been well documented, but the sensory systems mediating these interactions remain unknown. The deepwater sculpin, (Myoxocephalus thompsoni), siscowet (Salvelinus namaycush siscowet), and kiyi (Coregonus kiyi) inhabit low light level environments. To investigate the potential role of vision in predator-prey interactions, electroretinography was used to determine visual sensitivity for each species. Spectral sensitivity curves revealed peak sensitivity at 525 nm for each species which closely corresponds to the prevalent downwelling light spectrum at depth. To determine if sufficient light was available to mediate predator-prey interactions, visual sensitivity was correlated with the intensity of downwelling light in Lake Superior to construct visual depth profiles for each species. Sufficient daytime irradiance exists for visual interactions to approximately 325 m for siscowet and kiyi and 355 m for the deepwater sculpin during summer months. Under full moon conditions, sufficient irradiance exists to elicit ERG response to light available at approximately 30 m for the siscowet and kiyi and 45 m for the deepwater sculpin. Visual interactions are therefore possible at the depths and times when these organisms overlap in the water column indicating that vision may play a far greater role at depth in deep freshwater lakes than had been previously documented.	[Harrington, Kelly A.; Hrabik, Thomas R.; Mensinger, Allen F.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA	University of Minnesota System; University of Minnesota Duluth	Harrington, KA (corresponding author), Univ Minnesota, Dept Biol, 1035 Kirby Dr, Duluth, MN 55812 USA.	harr1582@umn.edu	Hrabik, Thomas/GYA-2566-2022		Minnesota Sea Grant (Sea Grant Research Project) [R/F 35]; United States Geological Survey; Lake Superior Biological Station; University of Minnesota Duluth Biology Department	Minnesota Sea Grant (Sea Grant Research Project); United States Geological Survey(United States Geological Survey); Lake Superior Biological Station; University of Minnesota Duluth Biology Department	Funding for this project was provided by Minnesota Sea Grant (http://www.seagrant.umn.edu/) to TH (Sea Grant Research Project R/F 35), the United States Geological Survey (usgs.gov), Lake Superior Biological Station (http://www.glsc.usgs.gov/content/lake-superior-biological-station) and the University of Minnesota Duluth Biology Department (d.umn.edu/biology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrenstorff TD, 2012, ENVIRON BIOL FISH, V94, P465, DOI 10.1007/s10641-011-9961-5; Ahrenstorff TD, 2011, T AM FISH SOC, V140, P1504, DOI 10.1080/00028487.2011.637004; Auer MT, 2013, J GREAT LAKES RES, V39, P33, DOI 10.1016/j.jglr.2012.12.020; Auer NA, 2004, J GREAT LAKES RES, V30, P340, DOI 10.1016/S0380-1330(04)70396-2; BEETON AM, 1982, HYDROBIOLOGIA, V93, P53, DOI 10.1007/BF00008098; BOWMAKER JK, 1994, VISION RES, V34, P591, DOI 10.1016/0042-6989(94)90015-9; BOWMAKER JK, 1988, J COMP PHYSIOL A, V163, P685, DOI 10.1007/BF00603853; Bridges CDB, 1972, HDB SENSORY PHYSIOLO, P417, DOI DOI 10.1007/978-3-642-65066-6_11; Clarke GL, 1936, ECOLOGY, V17, P452, DOI 10.2307/1931845; Cramer CE, 2013, J RES NATL INST STAN, V118, P396, DOI 10.6028/jres.118.020; CRESCITELLI F, 1985, J COMP PHYSIOL A, V157, P323, DOI 10.1007/BF00618122; Dartnall H. J. A., 1965, Vision Research, V5, P81, DOI 10.1016/0042-6989(65)90057-X; Dartnall H.J.A., 1975, P543; DENTON EJ, 1957, J MAR BIOL ASSOC UK, V36, P651, DOI 10.1017/S0025315400025911; Douglas RH, 1997, J FISH BIOL, V50, P68; Effler SW, 2010, J GREAT LAKES RES, V36, P656, DOI 10.1016/j.jglr.2010.08.001; FAHNENSTIEL GL, 1984, J GREAT LAKES RES, V10, P399, DOI 10.1016/S0380-1330(84)71856-9; Frank TM, 2012, J EXP BIOL, V215, P3344, DOI 10.1242/jeb.072033; Gamble AE, 2011, J GREAT LAKES RES, V37, P550, DOI 10.1016/j.jglr.2011.06.008; GEFFEN AJ, 1992, J FISH BIOL, V41, P101, DOI 10.1111/j.1095-8649.1992.tb03872.x; Gensler WG, 1984, P NATO ADV STUD I DO; Gorman OT, 2012, STATUS TRENDS FISH C; Guthrie DM, 1993, BEHAV TELEOST FISHES, P89; Habermann R, 2012, MINNESOTA SEA GRAN S; Horodysky AZ, 2008, J EXP BIOL, V211, P3601, DOI 10.1242/jeb.023358; Horodysky AZ, 2010, J EXP BIOL, V213, P1751, DOI 10.1242/jeb.038117; Hrabik TR, 2006, CAN J FISH AQUAT SCI, V63, P2286, DOI 10.1139/F06-124; Hunt DM, 1996, VISION RES, V36, P1217, DOI 10.1016/0042-6989(95)00228-6; Isaac EJ, 2012, J GREAT LAKES RES, V38, P326, DOI 10.1016/j.jglr.2012.02.017; Jerlov N.G., 1968, OPTICAL OCEANOGRAPHY; JEROME JH, 1983, J GREAT LAKES RES, V9, P60, DOI 10.1016/S0380-1330(83)71872-1; Johnsen S. N., 2012, OPTICS LIFE BIOL GUI; Jokela-Maatta M, 2007, VISUAL NEUROSCI, V24, P389, DOI 10.1017/S0952523807070459; Lepparanta M, 2003, NORD HYDROL, V34, P245; LOEW ER, 1976, PROC R SOC SER B-BIO, V193, P31, DOI 10.1098/rspb.1976.0029; LYTHGOE JN, 1989, J EXP BIOL, V146, P1; MANSFIELD PJ, 1983, T AM FISH SOC, V112, P162, DOI 10.1577/1548-8659(1983)112<162:DAAOLB>2.0.CO;2; Marshall NJ, 2003, COPEIA, P467, DOI 10.1643/01-056; McFarl WN., 1959, PUBL I MAR SCI, V6, P22; MCFARLAND WN, 1975, VISION RES, V15, P1063, DOI 10.1016/0042-6989(75)90002-4; MUNZ FW, 1973, VISION RES, V13, P1829, DOI 10.1016/0042-6989(73)90060-6; MUNZ FW, 1958, J PHYSIOL-LONDON, V140, P220, DOI 10.1113/jphysiol.1958.sp005929; Nicol J. A. C., 1978, BIOLUMINESCENE ACTIO, P367; Palmer LM, 2005, J EXP BIOL, V208, P3441, DOI 10.1242/jeb.01766; PARTRIDGE JC, 1988, J COMP PHYSIOL A, V162, P543, DOI 10.1007/BF00612519; Pitcher T. J, 1993, BEHAV TELEOST FISHES; RONG W, 1990, P NATL ACAD SCI USA, V87, P2117, DOI 10.1073/pnas.87.6.2117; SELGEBY JH, 1988, J GREAT LAKES RES, V14, P44, DOI 10.1016/S0380-1330(88)71531-2; Sitar SP, 2008, J GREAT LAKES RES, V34, P276, DOI 10.3394/0380-1330(2008)34[276:SOSLTA]2.0.CO;2; Stockwell JD, 2010, CAN J FISH AQUAT SCI, V67, P473, DOI 10.1139/F09-198; Utne-Palm AC, 2006, J EXP BIOL, V209, P2034, DOI 10.1242/jeb.02171; Warrant E, 2004, J COMP PHYSIOL A, V190, P765, DOI 10.1007/s00359-004-0546-z; WELLS L, 1968, US FISH WLD S FISH B, V67, P1	54	27	27	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116173	10.1371/journal.pone.0116173	http://dx.doi.org/10.1371/journal.pone.0116173			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646781	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600022
J	Nemirovsky, SI; Cordoba, M; Zaiat, JJ; Completa, SP; Vega, PA; Gonzalez-Moron, D; Medina, NM; Fabbro, M; Romero, S; Brun, B; Revale, S; Ogara, MF; Pecci, A; Marti, M; Vazquez, M; Turjanski, A; Kauffman, MA				Nemirovsky, Sergio I.; Cordoba, Marta; Zaiat, Jonathan J.; Completa, Sabrina P.; Vega, Patricia A.; Gonzalez-Moron, Dolores; Medina, Nancy M.; Fabbro, Monica; Romero, Soledad; Brun, Bianca; Revale, Santiago; Florencia Ogara, Maria; Pecci, Adali; Marti, Marcelo; Vazquez, Martin; Turjanski, Adrian; Kauffman, Marcelo A.			Whole Genome Sequencing Reveals a De Novo SHANK3 Mutation in Familial Autism Spectrum Disorder	PLOS ONE			English	Article							FRAMEWORK; DATABASE; DISCOVERY; RESOURCE; DBNSFP; SNPS	Introduction Clinical genomics promise to be especially suitable for the study of etiologically heterogeneous conditions such as Autism Spectrum Disorder (ASD). Here we present three siblings with ASD where we evaluated the usefulness of Whole Genome Sequencing (WGS) for the diagnostic approach to ASD. Methods We identified a family segregating ASD in three siblings with an unidentified cause. We performed WGS in the three probands and used a state-of-the-art comprehensive bioinformatic analysis pipeline and prioritized the identified variants located in genes likely to be related to ASD. We validated the finding by Sanger sequencing in the probands and their parents. Results Three male siblings presented a syndrome characterized by severe intellectual disability, absence of language, autism spectrum symptoms and epilepsy with negative family history for mental retardation, language disorders, ASD or other psychiatric disorders. We found germline mosaicism for a heterozygous deletion of a cytosine in the exon 21 of the SHANK3 gene, resulting in a missense sequence of 5 codons followed by a premature stop codon (NM_033517: c. 3259_3259delC, p. Ser1088Profs*6). Conclusions We reported an infrequent form of familial ASD where WGS proved useful in the clinic. We identified a mutation in SHANK3 that underscores its relevance in Autism Spectrum Disorder.	[Nemirovsky, Sergio I.; Zaiat, Jonathan J.; Completa, Sabrina P.; Marti, Marcelo; Turjanski, Adrian] UBA, Fac Ciencias Exactas & Nat, Inst Calculo, Buenos Aires, DF, Argentina; [Fabbro, Monica; Romero, Soledad; Brun, Bianca; Revale, Santiago; Vazquez, Martin] Consejo Nacl Invest Cient & Tecn, Predio CCT, Inst Agrobiotecnol Rosario INDEAR, Rosario, Argentina; [Marti, Marcelo; Turjanski, Adrian] Consejo Nacl Invest Cient & Tecn, INQUIMAE, UBA, Fac Ciencias Exactas & Nat,Dept Quim Biol, RA-1033 Buenos Aires, DF, Argentina; [Cordoba, Marta; Vega, Patricia A.; Gonzalez-Moron, Dolores; Medina, Nancy M.; Kauffman, Marcelo A.] Consejo Nacl Invest Cient & Tecn, Hosp JM Ramos Mejia, IBCN Eduardo, Robert UBA,Consultorio & Lab Neurogenet, RA-1033 Buenos Aires, DF, Argentina; Univ Buenos Aires, CONICET, Fac Ciencias Exactas & Nat, IFIBYNE,Dept Quim Biol, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Hospital Ramos Mejia; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Kauffman, MA (corresponding author), Consejo Nacl Invest Cient & Tecn, Hosp JM Ramos Mejia, IBCN Eduardo, Robert UBA,Consultorio & Lab Neurogenet, RA-1033 Buenos Aires, DF, Argentina.	marcelokauffman@gmail.com		Kauffman, Marcelo/0000-0003-1680-5092; Nemirovsky, Sergio I./0000-0003-4501-7052; Fabbro, Monica/0000-0003-0192-4777; Revale, Santiago/0000-0001-5219-9582; Marti, Marcelo/0000-0002-7911-9340; Cordoba, Marta/0000-0002-2814-1636; Turjanski, Adrian/0000-0003-2190-137X	Ministry of Science and Technology of the government of Argentina	Ministry of Science and Technology of the government of Argentina	This work was supported by an unrestricted grant from the Ministry of Science and Technology of the government of Argentina. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Betancur C, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-17; Boccuto L, 2013, EUR J HUM GENET, V21, P310, DOI 10.1038/ejhg.2012.175; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Jeste SS, 2014, NAT REV NEUROL, V10, P74, DOI 10.1038/nrneurol.2013.278; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Leblond CS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004580; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Wang XM, 2014, DEV NEUROBIOL, V74, P123, DOI 10.1002/dneu.22084; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229	27	40	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							116358	10.1371/journal.pone.0116358	http://dx.doi.org/10.1371/journal.pone.0116358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646853	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600025
J	Sun, Q; Zhang, JQ; Zhou, N; Liu, XR; Shen, Y				Sun, Qiang; Zhang, Jianqian; Zhou, Nan; Liu, Xiaorong; Shen, Ying			DNA Methylation in Cosmc Promoter Region and Aberrantly Glycosylated IgA1 Associated with Pediatric IgA Nephropathy	PLOS ONE			English	Article							OXFORD CLASSIFICATION; O-GLYCOSYLATION; MONONUCLEAR-CELLS; CHAPERONE COSMC; EXPRESSION; TN; GENES	IgA nephropathy (IgAN) is one of the most common glomerular diseases leading to endstage renal failure. Elevation of aberrantly glycosylated IgA1 is a key feature of it. The expression of the specific molecular chaperone of core1 beta 1, 3galactosyl transferase (Cosmc) is known to be reduced in IgAN. We aimed to investigate whether the methylation of CpG islands of Cosmc gene promoter region could act as a possible mechanism responsible for down-regulation of Cosmc and related higher secretion of aberrantly glycosylated IgA1in lymphocytes from children with IgA nephropathy. Three groups were included: IgAN children (n = 26), other renal diseases (n = 11) and healthy children (n = 13). B-lymphocytes were isolated and cultured, treated or not with IL-4 or 5-Aza-2'-deoxycytidine (AZA). The levels of DNA methylation of Cosmc promotor region were not significantly different between the lymphocytes of the three children populations (P = 0.113), but there were significant differences between IgAN lymphocytes and lymphocytes of the other two children populations after IL-4 (P<0.0001) or AZA (P<0.0001). Cosmc mRNA expression was low in IgAN lymphocytes compared to the other two groups (P<0.0001). The level of aberrantly glycosylated IgA1 was markedly higher in IgAN group compared to the other groups (P<0.0001). After treatment with IL-4, the levels of Cosmc DNA methylation and aberrantly glycosylated IgA1 in IgAN lymphocytes were remarkably higher than the other two groups (P<0.0001) with more markedly decreased Cosmc mRNA content (P<0.0001). After treatment with AZA, the levels in IgAN lymphocytes were decreased, but was still remarkably higher than the other two groups (P<0.0001), while Cosmc mRNA content in IgAN lymphocytes were more markedly increased than the other two groups (P<0.0001). The alteration of DNA methylation by IL-4 or AZA specifically correlates in IgAN lymphocytes with alterations in Cosmc mRNA expression and with the level of aberrantly glycosylated IgA1 (r = -0.948, r = 0.707). Our results suggested that hypermethylation of Cosmc promoter region could be a key mechanism for the reduction of Cosmc mRNA expression in IgAN lymphocytes with associated increase in aberrantly glycosylated IgA1.	[Sun, Qiang; Zhou, Nan; Liu, Xiaorong; Shen, Ying] Capital Med Univ, Beijing Childrens Hosp, Dept Nephrol, Beijing, Peoples R China; [Zhang, Jianqian] Capital Med Univ, Beijing Ditan Hosp, Inst Infect Dis, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Shen, Y (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Dept Nephrol, Beijing, Peoples R China.	ying_116sh@sohu.com	shen, ying/HHS-5635-2022		National Natural Science Foundation of China [81070565]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No.81070565). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryal RP, 2012, J BIOL CHEM, V287, P15317, DOI 10.1074/jbc.M111.312587; Bellur SS, 2011, NEPHROL DIAL TRANSPL, V26, P2533, DOI 10.1093/ndt/gfq812; Berger EG, 1999, BBA-MOL BASIS DIS, V1455, P255, DOI 10.1016/S0925-4439(99)00069-1; Buck KS, 2008, KIDNEY INT, V73, P1128, DOI 10.1038/sj.ki.5002748; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Coppo R, 2009, KIDNEY INT, V75, P536, DOI 10.1038/ki.2008.579; DAMICO G, 2010, AM J KIDNEY DIS, V362, P227; Hartono C, 2014, DISCOV MED, V17, P131; He LY, 2013, AM J NEPHROL, V38, P321, DOI 10.1159/000355393; ICHIEI N, 2008, CLIN EXP NEPHROL, V12, P332, DOI DOI 10.1007/S10157-008-0054-5; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Malycha F, 2009, NEPHROL DIAL TRANSPL, V24, P321, DOI 10.1093/ndt/gfn538; Mestecky J, 2008, KIDNEY BLOOD PRESS R, V31, P29, DOI 10.1159/000112922; Mi RJ, 2012, J BIOL CHEM, V287, P41523, DOI 10.1074/jbc.M112.371989; Moriyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091756; MOTOTSUGU T, 2011, CLIN DEV IMMUNOL, V2011, DOI DOI 10.1155/2011/470803; NAN Z, 2013, CHIN J PEDIAT, V51, P549; Qin W, 2008, NEPHROL DIAL TRANSPL, V23, P1608, DOI 10.1093/ndt/gfm781; Qin Wei, 2011, Sichuan Da Xue Xue Bao Yi Xue Ban, V42, P762; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Serino G, 2012, J AM SOC NEPHROL, V23, P814, DOI 10.1681/ASN.2011060567; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Suzuki H, 2014, J BIOL CHEM, V289, P5330, DOI 10.1074/jbc.M113.512277; Westman G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096779; Xie LS, 2013, INT UROL NEPHROL, V45, P571, DOI 10.1007/s11255-012-0313-y; Yamada K, 2010, NEPHROL DIAL TRANSPL, V25, P3890, DOI 10.1093/ndt/gfq325; YANG G, 2014, BIOL TRACE ELEM RES; Zhang YW, 2014, EPIGENETICS-US, V9, P896, DOI 10.4161/epi.28601	29	19	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0112305	10.1371/journal.pone.0112305	http://dx.doi.org/10.1371/journal.pone.0112305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647400	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600002
J	Zhao, WL; Wang, C; Li, ZZ; Chen, L; Li, JB; Cui, WD; Ding, SS; Xi, Q; Wang, F; Jia, F; Xiao, SH; Guo, Y; Zhao, Y				Zhao, Wenli; Wang, Chao; Li, Zhongzheng; Chen, Lei; Li, Jianbo; Cui, Weidong; Ding, Shasha; Xi, Qiang; Wang, Fan; Jia, Fei; Xiao, Shuhua; Guo, Yi; Zhao, Ye			Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation to Treat Muscle Spasticity following Brain Injury: A Double-Blinded, Multicenter, Randomized Controlled Trial	PLOS ONE			English	Article							NERVE-STIMULATION; MULTIPLE-SCLEROSIS; ACUPUNCTURE POINTS; BOTULINUM TOXIN; DYNORPHIN-A; SPINAL-CORD; POSTSTROKE; STROKE; ELECTROACUPUNCTURE; FREQUENCY	Objective This study was aimed at evaluating the clinical efficacy and safety of transcutaneous electrical acupoint stimulation (TEAS) to treat muscle spasticity after brain injury (Chinese Clinical Trial Registry: ChiCTR-TRC-11001310). Methods A total of 60 patients with muscle spasticity after brain injury were randomized to the following 3 groups: 100, 2, and 0 Hz (sham) TEAS. The acupoints Hegu (LI4)-Yuji (LU10) and Zusanli (ST36)-Chengshan (BL57) on the injured side were stimulated at 0, 2, or 100 Hz, 5 times per week for 4 weeks. The patients were followed up for 1 and 2 months after the treatments. The effects of the treatments on muscle spasticity at the wrist, thumb, the other 4 fingers, elbow, shoulder, knee, and ankle were evaluated by the Modified Ashworth Scale, and the effects on disability were assessed by the Disability Assessment Scale. The walking capability was evaluated by the Holden functional ambulation classification score. The overall performance was assessed by the Global Assessment Scale score and the improved Barthel Index. The safety of the treatments administered was also monitored. Results The wrist spasticity was significantly reduced from baseline at weeks 2, 3, and 4 of treatment and at the 1- and 2-month follow-up visits in the 100 Hz group (P < 0.01). Compared with 2 Hz or sham TEAS, 100 Hz TEAS decreased wrist spasticity at weeks 2, 3, and 4 of treatment and 1 month after treatment (P < 0.001). The other endpoints were not affected by the treatments. No treatment-emergent adverse events were reported during treatments and follow-up visits. Conclusions TEAS appears to be a safe and effective therapy to relieve muscle spasticity after brain injury, although large-scale studies are required to further verify the findings.	[Zhao, Wenli] Tianjin Nankai Hosp, Dept Neurol, Tianjin 300100, Peoples R China; [Wang, Chao; Li, Zhongzheng; Ding, Shasha; Xi, Qiang; Wang, Fan; Jia, Fei; Xiao, Shuhua; Guo, Yi] Tianjin Univ Tradit Chinese Med, Dept Acupuncture & Moxibust, Tianjin 300193, Peoples R China; [Chen, Lei; Li, Jianbo; Cui, Weidong] Tianjin Ninghe Hosp, Dept Acupuncture & Moxibust, Tianjin 301500, Peoples R China; [Zhao, Ye] Tianjin Nankai Hosp, Dept Clin Res, Tianjin 300100, Peoples R China; [Zhao, Ye] Tianjin Acad Integrat Med, Tianjin 300100, Peoples R China	Tianjin University of Traditional Chinese Medicine	Zhao, Y (corresponding author), Tianjin Nankai Hosp, Dept Clin Res, Tianjin 300100, Peoples R China.	zakzy@163.com			Science Foundation on Traditional Chinese Medicine (TCM)/Integrative Medicine of the Tianjin Administration of TCM [11031]	Science Foundation on Traditional Chinese Medicine (TCM)/Integrative Medicine of the Tianjin Administration of TCM	Author: Chao Wang. This work was supported by the Science Foundation on Traditional Chinese Medicine (TCM)/Integrative Medicine of the Tianjin Administration of TCM (grant no. 11031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo R, 2013, INT J NEUROSCI, V123, P850, DOI 10.3109/00207454.2013.812084; Aydin G, 2005, AM J PHYS MED REHAB, V84, P584, DOI 10.1097/01.phm.0000171173.86312.69; Bhakta BB, 2000, BRIT MED BULL, V56, P476, DOI 10.1258/0007142001903111; Bohannon R. W., 1987, PHYS THER, V67, P206; BROWN P, 1994, J NEUROL NEUROSUR PS, V57, P773, DOI 10.1136/jnnp.57.7.773; Chao AS, 2007, PAIN, V127, P214, DOI 10.1016/j.pain.2006.08.016; Chen CY, 2013, AM J CHINESE MED, V41, P301, DOI 10.1142/S0192415X13500225; De Wolf AC, 2012, J REHABIL MED, V44, P747, DOI 10.2340/16501977-1016; Dong HW, 2005, BRAIN RES BULL, V67, P189, DOI 10.1016/j.brainresbull.2005.06.026; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; FEI H, 1987, KEXUE TONGBAO, V32, P1496; Francis RP, 2011, ACUPUNCTURE ELECTRO, V36, P231, DOI 10.3727/036012911803634139; Francis RP, 2011, CLIN PHYSIOL FUNCT I, V31, P363, DOI 10.1111/j.1475-097X.2011.01025.x; Francisco GE, 2012, STROKE, V43, P3132, DOI 10.1161/STROKEAHA.111.639831; HAN JS, 1991, PAIN, V47, P295, DOI 10.1016/0304-3959(91)90218-M; HAN JS, 1994, CHINESE MED J-PEKING, V107, P6; Kamen L, 2008, CURR MED RES OPIN, V24, P425, DOI [10.1185/030079908X261113, 10.1185/030079908X261113 ]; Kavoussi B, 2007, INTEGR CANCER THER, V6, P251, DOI 10.1177/1534735407305892; Lance J. W., 1980, SPASTICITY DISORDERE; Lv JQ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-153; Ng SSM, 2010, J NEUROL PHYS THER, V34, P208, DOI 10.1097/NPT.0b013e3181fe0ab0; Omura Y, 2010, ACUPUNCTURE ELECTRO, V35, P147, DOI 10.3727/036012910803860922; Ozcakir S, 2007, CLIN MED RES, V5, P132, DOI 10.3121/cmr.2007.716; SHAH S, 1989, STROKE, V20, P766, DOI 10.1161/01.STR.20.6.766; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; van Kuijk AA, 2007, J REHABIL MED, V39, P33, DOI 10.2340/16501977-0009; Verplancke D, 2005, CLIN REHABIL, V19, P117, DOI 10.1191/0269215505cr827oa; Viosca E, 2005, ARCH PHYS MED REHAB, V86, P1234, DOI 10.1016/j.apmr.2004.11.016; WANG JZ, 1997, CHIN J REHAB THEORY, V3, P111; Ward AB, 2012, EUR J NEUROL, V19, P21, DOI 10.1111/j.1468-1331.2011.03448.x; White P, 2004, ANN INTERN MED, V141, P911, DOI 10.7326/0003-4819-141-12-200412210-00007; Xiang XH, 2014, J NEUROSCI RES, V92, P555, DOI 10.1002/jnr.23351; Yan TB, 2009, J REHABIL MED, V41, P312, DOI 10.2340/16501977-0325; Yu Y, 1993, Zhonghua Yi Xue Za Zhi, V73, P593; Zhang RX, 2014, ANESTHESIOLOGY, V120, P482, DOI 10.1097/ALN.0000000000000101	35	16	23	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116976	10.1371/journal.pone.0116976	http://dx.doi.org/10.1371/journal.pone.0116976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643051	Green Published, gold, Green Submitted			2022-12-27	WOS:000348821200029
J	Illien-Junger, S; Lu, Y; Qureshi, SA; Hecht, AC; Cai, WJ; Vlassara, H; Striker, GE; Iatridis, JC				Illien-Juenger, Svenja; Lu, Young; Qureshi, Sheeraz A.; Hecht, Andrew C.; Cai, Weijing; Vlassara, Helen; Striker, Gary E.; Iatridis, James C.			Chronic Ingestion of Advanced Glycation End Products Induces Degenerative Spinal Changes and Hypertrophy in Aging Pre-Diabetic Mice	PLOS ONE			English	Article							INTERVERTEBRAL DISC DEGENERATION; BODY-MASS INDEX; DIABETES-MELLITUS; NONENZYMATIC GLYCATION; DIETARY GLYCOTOXINS; INSULIN-RESISTANCE; OXIDANT STRESS; RISK-FACTOR; BONE; CALCIFICATION	Intervertebral disc (IVD) degeneration and pathological spinal changes are major causes of back pain, which is the top cause of global disability. Obese and diabetic individuals are at increased risk for back pain and musculoskeletal complications. Modern diets contain high levels of advanced glycation end products (AGEs), cyto-toxic components which are known contributors to obesity, diabetes and accelerated aging pathologies. There is little information about potential effects of AGE rich diet on spinal pathology, which may be a contributing cause for back pain which is common in obese and diabetic individuals. This study investigated the role of specific AGE precursors (e.g. methylglyoxal-derivatives (MG)) on IVD and vertebral pathologies in aging C57BL6 mice that were fed isocaloric diets with standard (dMG+) or reduced amounts of MG derivatives (dMG-; containing 60-70% less dMG). dMG + mice exhibited a pre-diabetic phenotype, as they were insulin resistant but not hyperglycemic. Vertebrae of dMG+ mice displayed increased cortical-thickness and cortical-area, greater MG-AGE accumulation and ectopic calcification in vertebral endplates. IVD morphology of dMG+ mice exhibited ectopic calcification, hypertrophic differentiation and glycosaminoglycan loss relative to dMG-mice. Overall, chronic exposure to dietary AGEs promoted age-accelerated IVD degeneration and vertebral alterations involving ectopic calcification which occurred in parallel with insulin resistance, and which were prevented with dMG-diet. This study described a new mouse model for diet-induced spinal degeneration, and results were in support of the hypothesis that chronic AGE ingestion could be a factor contributing to a pre-diabetic state, ectopic calcifications in spinal tissues, and musculoskeletal complications that are more generally known to occur with chronic diabetic conditions.	[Illien-Juenger, Svenja; Lu, Young; Qureshi, Sheeraz A.; Hecht, Andrew C.; Iatridis, James C.] Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, New York, NY 10029 USA; [Cai, Weijing; Vlassara, Helen; Striker, Gary E.] Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Care, Div Expt Diabet & Aging, New York, NY 10029 USA; [Striker, Gary E.] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Iatridis, JC (corresponding author), Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, New York, NY 10029 USA.	james.iatridis@mssm.edu	Illien-Junger, Svenja/B-9105-2018; Illien-Junger, Svenja/AAV-1853-2020	Illien-Junger, Svenja/0000-0001-9895-0693; Illien-Junger, Svenja/0000-0001-9895-0693	National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) [R01AR051146]; National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK) [RO1 AG023188]; Juvenile Diabetes Research Foundation (JDRF) [17-2008-1041]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051146, R01AR064157, R01AR057397] Funding Source: NIH RePORTER	National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS); National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding provided by JCI: National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS; R01AR051146) http://www.niams.nih.gov/.HV: National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK; RO1 AG023188) http://www.niddk.nih.gov/.GES: Juvenile Diabetes Research Foundation (JDRF; 17-2008-1041) https://jdrf.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Anekstein Y, 2010, ISR MED ASSOC J, V12, P16; BILLS CE, 1971, JOHNS HOPKINS MED J, V128, P194; Boos N, 1997, J ORTHOP RES, V15, P141, DOI 10.1002/jor.1100150121; Brodeur MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085922; Burner TW, 2009, CURR OPIN RHEUMATOL, V21, P50, DOI 10.1097/BOR.0b013e32831bc0c4; Cai WJ, 2008, AM J PATHOL, V173, P327, DOI 10.2353/ajpath.2008.080152; Cai WJ, 2007, AM J PATHOL, V170, P1893, DOI 10.2353/ajpath.2007.061281; Cai WJ, 2012, P NATL ACAD SCI USA, V109, P15888, DOI 10.1073/pnas.1205847109; Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Dahia CL, 2009, SPINE, V34, P447, DOI 10.1097/BRS.0b013e3181990c64; Dhaliwal R, 2014, OSTEOPOROSIS INT, V25, P1969, DOI 10.1007/s00198-014-2704-7; Farr JN, 2014, J BONE MINER RES, V29, P787, DOI 10.1002/jbmr.2106; Griffin TM, 2012, ARTHRITIS RHEUM-US, V64, P443, DOI 10.1002/art.33332; Gruber HE, 2007, SPINE J, V7, P444, DOI 10.1016/j.spinee.2006.08.015; Hamann C, 2014, ENDOCRINOLOGY; Hamann C, 2012, NAT REV ENDOCRINOL, V8, P297, DOI 10.1038/nrendo.2011.233; He CJ, 1999, DIABETES, V48, P1308, DOI 10.2337/diabetes.48.6.1308; Horner HA, 2001, SPINE, V26, P2543, DOI 10.1097/00007632-200112010-00006; Hristova GI, 2011, J ORTHOP RES, V29, P1888, DOI 10.1002/jor.21456; Hughes SPF, 2012, J BONE JOINT SURG BR, V94B, P1298, DOI 10.1302/0301-620X.94B10.28986; Illien-Junger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064302; Jazini E, 2012, SPINE, V37, pE209, DOI 10.1097/BRS.0b013e31822ce81f; Jeffcoate WJ, 2005, LANCET, V366, P2058, DOI 10.1016/S0140-6736(05)67029-8; Tolosa MJ, 2013, DIABETES RES CLIN PR, V101, P177, DOI 10.1016/j.diabres.2013.05.016; Karim L, 2013, OSTEOPOROSIS INT, V24, P2441, DOI 10.1007/s00198-013-2319-4; Kilpadi KL, 2014, J IMMIGR MINOR HEALT, V16, P440, DOI 10.1007/s10903-013-9833-5; Kim J, 2010, BIOCHEM BIOPH RES CO, V391, P346, DOI 10.1016/j.bbrc.2009.11.061; Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474; Leung VYL, 2009, J HISTOCHEM CYTOCHEM, V57, P249, DOI 10.1369/jhc.2008.952184; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Melrose J, 2009, EUR SPINE J, V18, P479, DOI 10.1007/s00586-008-0871-y; Monnier VM, 2014, CLIN CHEM LAB MED, V52, P21, DOI 10.1515/cclm-2013-0174; Moore RJ, 2006, EUR SPINE J, V15, pS333, DOI 10.1007/s00586-006-0170-4; Mullender MG, 2005, CALCIFIED TISSUE INT, V77, P291, DOI 10.1007/s00223-005-0043-6; Nemet I, 2005, CLIN BIOCHEM, V38, P379, DOI 10.1016/j.clinbiochem.2004.12.008; Noble Brendon, 2003, European Cells & Materials, V6, P46; Oliveria SA, 1999, EPIDEMIOLOGY, V10, P161, DOI 10.1097/00001648-199903000-00013; Pattijn V, 2001, ANN BIOMED ENG, V29, P1064, DOI 10.1114/1.1424922; Peppa M, 2003, DIABETES, V52, P2805, DOI 10.2337/diabetes.52.11.2805; Prasad C, 2014, AGING DIS, V5, P212, DOI 10.14336/AD.2014.0500212; Robinson D, 1998, SPINE, V23, P849, DOI 10.1097/00007632-199804150-00001; Rutges JPHJ, 2010, OSTEOARTHR CARTILAGE, V18, P1487, DOI 10.1016/j.joca.2010.08.006; Sakellaridis N, 2006, SURG NEUROL, V66, P152, DOI 10.1016/j.surneu.2006.01.019; Samartzis D, 2012, ARTHRITIS RHEUM-US, V64, P1488, DOI 10.1002/art.33462; Sellam J, 2013, JOINT BONE SPINE, V80, P568, DOI 10.1016/j.jbspin.2013.09.007; SILBERBERG R, 1986, EXP CELL BIOL, V54, P121; Sivan SS, 2006, BIOCHEM J, V399, P29, DOI 10.1042/BJ20060579; Srikanthan P, 2014, J BONE MINER RES, V29, P796, DOI 10.1002/jbmr.2083; Stokes IAF, 2004, SPINE, V29, P2724, DOI 10.1097/01.brs.0000146049.52152.da; Tang SY, 2007, BONE, V40, P1144, DOI 10.1016/j.bone.2006.12.056; Tang SY, 2008, CLIN BIOMECH, V23, P122, DOI 10.1016/j.clinbiomech.2007.08.010; Tanikawa T, 2009, J VASC RES, V46, P572, DOI 10.1159/000226225; Teti A, 2009, BONE, V44, P11, DOI 10.1016/j.bone.2008.09.017; Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52; URBAN JPG, 1977, CLIN ORTHOP RELAT R, P101; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Vashishth D, 2000, BONE, V26, P375, DOI 10.1016/S8756-3282(00)00236-2; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; Vos PAJM, 2012, OSTEOARTHR CARTILAGE, V20, P233, DOI 10.1016/j.joca.2011.12.007; Vulesevic B, 2014, BIOCHEM SOC T, V42, P523, DOI 10.1042/BST20130254; Wagner DR, 2006, J BIOMECH, V39, P1021, DOI 10.1016/j.jbiomech.2005.02.013; Wang Y, 2012, SPINE, V37, P1432, DOI 10.1097/BRS.0b013e31824dd20a; Wang ZQ, 2012, ATHEROSCLEROSIS, V221, P387, DOI 10.1016/j.atherosclerosis.2012.01.019; Wei Q, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-13; Williams FMK, 2011, ANN RHEUM DIS, V70, P1203, DOI 10.1136/ard.2010.146001; Wu J, 2011, LAB INVEST, V91, P1459, DOI 10.1038/labinvest.2011.93; Yamaguchi T, 2011, ENDOCR J, V58, P613, DOI 10.1507/endocrj.EJ11-0063; Yan WB, 2013, FRONT MED-PRC, V7, P81, DOI 10.1007/s11684-013-0243-9; Yoshida T, 2009, SPINE, V34, P1544, DOI 10.1097/BRS.0b013e3181a98390; Zhang LP, 2009, ACTA DIABETOL, V46, P119, DOI 10.1007/s00592-008-0068-1; ZIV I, 1992, J ORTHOPAED RES, V10, P205, DOI 10.1002/jor.1100100207	73	43	45	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0116625	10.1371/journal.pone.0116625	http://dx.doi.org/10.1371/journal.pone.0116625			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668621	gold, Green Submitted, Green Published			2022-12-27	WOS:000349493000008
J	Chowdhury, BP; Bandyopadhyay, S; Das, S; Majumder, S; Jha, MK; Majumdar, SB; Saha, B; Majumdar, S				Chowdhury, Bidisha Paul; Bandyopadhyay, Syamdas; Das, Shibali; Majumder, Saikat; Jha, Mukesh Kumar; Majumdar, Suchandra Bhattacharyya; Saha, Bhaskar; Majumdar, Subrata			The Host-Protective Effect of Arabinosylated Lipoarabinomannan against Leishmania donovani Infection Is Associated with Restoration of IFN-gamma Responsiveness	PLOS ONE			English	Article							SEQUENCE-BINDING-PROTEIN; REGULATORY FACTOR FAMILY; NF-KAPPA-B; VISCERAL LEISHMANIASIS; IMMUNE-RESPONSES; TRANSCRIPTION FACTOR; DENDRITIC CELLS; MESSENGER-RNA; T-CELLS; ACTIVATION	Visceral leishmaniasis (VL), which is endemic as a major infectious disease in the tropical and subtropical countries, is caused by a protozoan parasite Leishmania donovani. At present, restricted treatment options and lack of vaccines intensify the problem of controlling VL. Therefore, finding a novel immunoprophylactic or therapeutic principle is a pressing need. Here, we report that arabinosylated lipoarabinomannan (Ara-LAM), a TLR2-ligand isolated from Mycobacterium smegmatis, exhibits a strong immunomodulatory property that conferred protection against L. donovani infection. Although, Ara-LAM modulates TLR2 and MAPK signaling, it is not known whether Ara-LAM involves IFN-gamma signaling for effective parasite clearance. Because, it is reported that IFN-gamma signaling, a principle mediator of NO generation and macrophage and Tcell activation, is hampered during leishmanial pathogenesis. Ara-LAM increases IFN-gamma receptor expression and potentiates IFN-gamma receptor signaling through JAK-STAT pathway. Moreover, Ara-LAM reciprocally modulates IRF4 and IRF8 expression and reinstates anti-leishmanial Th1 response that eventuates in significantly reduced parasite load in spleen and liver of L. donovani-infected BALB/c mice. IFN-gamma Ra silencing resulted in the suppression of these host-protective mechanisms affected by Ara-LAM. Thus, Ara-LAM-mediated restoration of IFN-gamma responsiveness is a novel immunomodulatory principle for protection against L. donovani susceptible host.	[Chowdhury, Bidisha Paul; Bandyopadhyay, Syamdas; Das, Shibali; Majumder, Saikat; Majumdar, Suchandra Bhattacharyya; Majumdar, Subrata] Bose Inst, Div Mol Med, Kolkata, India; [Jha, Mukesh Kumar; Saha, Bhaskar] NCCS, Lab 5, Pune, Maharashtra, India	Department of Science & Technology (India); Bose Institute; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Majumdar, S (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	subrata@jcbose.ac.in	Das, Shibali/AAA-2683-2021; Majumder, Saikat/ABC-2194-2020	Das, Shibali/0000-0003-1263-8178; Majumder, Saikat/0000-0002-6591-9515	Department of Biotechnology, Govt. of India [BT/PR14435/MED/29/201/2010]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	This work was financially supported by Department of Biotechnology, Govt. of India [Grant number BT/PR14435/MED/29/201/2010]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Fakher FH, 2009, J IMMUNOL, V182, P1386, DOI 10.4049/jimmunol.182.3.1386; Ahyi ANN, 2009, J IMMUNOL, V183, P1598, DOI 10.4049/jimmunol.0803302; Akbari M, 2014, J IMMUNOL, V192, P2271, DOI 10.4049/jimmunol.1301914; Alexander J, 2005, IMMUNOL LETT, V99, P17, DOI 10.1016/j.imlet.2005.01.009; Alter-Koltunoff M, 2008, J BIOL CHEM, V283, P2724, DOI 10.1074/jbc.M707704200; Bhardwaj N, 2005, INT J PARASITOL, V35, P75, DOI 10.1016/j.ijpara.2004.10.018; Bhattacharjee S, 2007, INDIAN J BIOCHEM BIO, V44, P366; Bhattacharya P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024141; Bhattacharya P, 2010, J INFECT DIS, V202, P145, DOI 10.1086/653210; Blanchette J, 1999, EUR J IMMUNOL, V29, P3737, DOI 10.1002/(SICI)1521-4141(199911)29:11&lt;3737::AID-IMMU3737&gt;3.0.CO;2-S; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Bohsali A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-237; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Constantinescu CS, 1998, EUR J IMMUNOL, V28, P2227, DOI 10.1002/(SICI)1521-4141(199807)28:07<2227::AID-IMMU2227>3.0.CO;2-N; Contursi C, 2000, P NATL ACAD SCI USA, V97, P91, DOI 10.1073/pnas.97.1.91; Croft SL, 2006, INDIAN J MED RES, V123, P399; Delvig AA, 2002, J LEUKOCYTE BIOL, V72, P163; den Boer ML, 2009, EXPERT OPIN EMERG DR, V14, P395, DOI 10.1517/14728210903153862; Esch KJ, 2013, J IMMUNOL, V191, P5542, DOI 10.4049/jimmunol.1301810; Faria Marilia S., 2012, Journal of Parasitology Research, P930257, DOI 10.1155/2012/930257; Forget G, 2005, J BIOL CHEM, V280, P30542, DOI 10.1074/jbc.M414126200; Ghosh S, 2002, INFECT IMMUN, V70, P6828, DOI 10.1128/IAI.70.12.6828-6838.2002; Giese NA, 1997, J EXP MED, V186, P1535, DOI 10.1084/jem.186.9.1535; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Jayakumar A, 2008, INFECT IMMUN, V76, P2138, DOI 10.1128/IAI.01252-07; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Majumder N, 2008, MICROBES INFECT, V10, P349, DOI 10.1016/j.micinf.2007.12.013; Majumder N, 2006, GLYCOCONJUGATE J, V23, P675, DOI 10.1007/s10719-006-9017-9; Marinho FAV, 2013, EUR J IMMUNOL, V43, P2373, DOI 10.1002/eji.201243208; Marquis JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002097; Matte C, 2010, INFECT IMMUN, V78, P3736, DOI 10.1128/IAI.00046-10; Nylen S, 2007, J EXP MED, V204, P805, DOI 10.1084/jem.20061141; Okwor I, 2013, IMMUNOL RES, V56, P163, DOI 10.1007/s12026-013-8389-8; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Ray M, 2000, J INFECT DIS, V181, P1121, DOI 10.1086/315330; REINER NE, 1988, P NATL ACAD SCI USA, V85, P4330, DOI 10.1073/pnas.85.12.4330; Reyes JL, 2011, INT J BIOL SCI, V7, P1323, DOI 10.7150/ijbs.7.1323; Rosas LE, 2006, J IMMUNOL, V177, P22, DOI 10.4049/jimmunol.177.1.22; Sen S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002229; Srivastava S, 2013, CLIN EXP IMMUNOL, V172, P403, DOI 10.1111/cei.12074; Sundar S, 2013, EXPERT OPIN PHARMACO, V14, P53, DOI 10.1517/14656566.2013.755515; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tominaga N, 2003, INT IMMUNOL, V15, P1, DOI 10.1093/intimm/dxg001; Vanaerschot M, 2014, EXPERT REV ANTI-INFE, V12, P937, DOI 10.1586/14787210.2014.916614; Vila-del Sol V, 2008, J IMMUNOL, V181, P4461, DOI 10.4049/jimmunol.181.7.4461; Wadhone P, 2009, J IMMUNOL, V182, P7146, DOI 10.4049/jimmunol.0803859; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117247	10.1371/journal.pone.0117247	http://dx.doi.org/10.1371/journal.pone.0117247			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658110	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900124
J	Dametto, P; Lakkaraju, AKK; Bridel, C; Villiger, L; O'Connor, T; Herrmann, US; Pelczar, P; Rulicke, T; McHugh, D; Adili, A; Aguzzi, A				Dametto, Paolo; Lakkaraju, Asvin K. K.; Bridel, Claire; Villiger, Lukas; O'Connor, Tracy; Herrmann, Uli S.; Pelczar, Pawel; Ruelicke, Thomas; McHugh, Donal; Adili, Arlind; Aguzzi, Adriano			Neurodegeneration and Unfolded-Protein Response in Mice Expressing a Membrane-Tethered Flexible Tail of PrP	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PRION PROTEIN; ER STRESS; IN-VIVO; TOXICITY; DISEASE; IMPAIRMENT; AGGREGATION; ANTIBODIES; APOPTOSIS	The cellular prion protein (PrPC) consists of a flexible N-terminal tail (FT, aa 23-128) hinged to a membrane-anchored globular domain (GD, aa 129-231). Ligation of the GD with antibodies induces rapid neurodegeneration, which is prevented by deletion or functional inactivation of the FT. Therefore, the FT is an allosteric effector of neurotoxicity. To explore its mechanism of action, we generated transgenic mice expressing the FT fused to a GPI anchor, but lacking the GD (PrP Delta 141-225, or "FTgpi"). Here we report that FTgpi mice develop a progressive, inexorably lethal neurodegeneration morphologically and biochemically similar to that triggered by anti-GD antibodies. FTgpi was mostly retained in the endoplasmic reticulum, where it triggered a conspicuous unfolded protein response specifically activating the PERK pathway leading to phosphorylation of eIF2a and upregulation of CHOP ultimately leading to neurodegeration similar to what was observed in prion infection.	[Dametto, Paolo; Lakkaraju, Asvin K. K.; Bridel, Claire; Villiger, Lukas; O'Connor, Tracy; Herrmann, Uli S.; McHugh, Donal; Adili, Arlind; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Pelczar, Pawel] Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland; [Ruelicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Vienna, Austria	University of Zurich; University Zurich Hospital; University of Zurich; University of Veterinary Medicine Vienna	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	bridel, claire/GOH-1227-2022	Lakkaraju, Asvin/0000-0001-8752-148X; Herrmann, Uli Simon/0000-0002-1327-5199; Aguzzi, Adriano/0000-0002-0344-6708	European Research Council; European Union (PRIORITY, NEURINOX); Swiss National Foundation; University of Zurich; Novartis Research Foundation	European Research Council(European Research Council (ERC)European Commission); European Union (PRIORITY, NEURINOX); Swiss National Foundation(Swiss National Science Foundation (SNSF)); University of Zurich; Novartis Research Foundation	AA is the recipient of an Advanced Grant of the European Research Council and is supported by grants from the European Union (PRIORITY, NEURINOX), the Swiss National Foundation, the Clinical Research Priority Programs (KFSP) "Small RNAs" and "Human Hemato-Lymphatic Diseases" of the University of Zurich, SystemsX.ch as part of medical research and development project, and the Novartis Research Foundation. PD is supported by the Swiss National Foundation and a Career Development Award of the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; BAINTON DF, 1981, J CELL BIOL, V91, pS66, DOI 10.1083/jcb.91.3.66s; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Behrens A, 2002, TRENDS NEUROSCI, V25, P150, DOI 10.1016/S0166-2236(00)02089-0; Beland M, 2012, J NEUROCHEM, V120, P853, DOI 10.1111/j.1471-4159.2011.07613.x; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Cao SS, 2012, CURR BIOL, V22, pR622, DOI 10.1016/j.cub.2012.07.004; Carnemolla A, 2009, J BIOL CHEM, V284, P18167, DOI 10.1074/jbc.M109.018325; Colla E, 2012, J NEUROSCI, V32, P3306, DOI 10.1523/JNEUROSCI.5367-11.2012; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hoozemans JJM, 2012, INT J BIOCHEM CELL B, V44, P1295, DOI 10.1016/j.biocel.2012.04.023; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Lajoie P, 2011, J CELL SCI, V124, P3332, DOI 10.1242/jcs.087510; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; McHugh D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037881; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Rulicke T, 2004, METH MOL B, V254, P165; Sakudo A, 2007, MICROBIOL IMMUNOL, V51, P1, DOI 10.1111/j.1574-695X.2007.00284.x; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; Sun LW, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-52; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014207; Torres M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015658; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038221	47	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117412	10.1371/journal.pone.0117412	http://dx.doi.org/10.1371/journal.pone.0117412			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658480	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900144
J	Fei, L; Tian, SS; Moysey, R; Misca, M; Barker, JJ; Smith, MA; McEwan, PA; Pilka, ES; Crawley, L; Evans, T; Sun, DP				Fei, Li; Tian, SiSi; Moysey, Ruth; Misca, Mihaela; Barker, John J.; Smith, Myron A.; McEwan, Paul A.; Pilka, Ewa S.; Crawley, Lauren; Evans, Tom; Sun, Dapeng			Structural and Biochemical Studies of a Moderately Thermophilic Exonuclease I from Methylocaldum szegediense	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; ESCHERICHIA-COLI; SP-NOV.; GENOME SEQUENCE; MECHANISM; BACTERIUM; PROCESSIVITY; SPECIFICITY; STABILITY; KINETICS	A novel exonuclease, designated as MszExo I, was cloned from Methylocaldum szegediense, a moderately thermophilic methanotroph. It specifically digests single-stranded DNA in the 3' to 5' direction. The protein is composed of 479 amino acids, and it shares 47% sequence identity with E. coli Exo I. The crystal structure of MszExo I was determined to a resolution of 2.2 angstrom and it aligns well with that of E. coli Exo I. Comparative studies revealed that MszExo I and E. coli Exo I have similar metal ion binding affinity and similar activity at mesophilic temperatures (25-47 degrees C). However, the optimum working temperature of MszExo I is 10 degrees C higher, and the melting temperature is more than 4 degrees C higher as evaluated by both thermal inactivation assays and DSC measurements. More importantly, two thermal transitions during unfolding of MszExo I were monitored by DSC while only one transition was found in E. coli Exo I. Further analyses showed that magnesium ions not only confer structural stability, but also affect the unfolding of MszExo I. MszExo I is the first reported enzyme in the DNA repair systems of moderately thermophilic bacteria, which are predicted to have more efficient DNA repair systems than mesophilic ones.	[Fei, Li; Tian, SiSi; Sun, Dapeng] Shanghai R&D Ctr, New England Biolabs, Shanghai, Peoples R China; [Moysey, Ruth; Misca, Mihaela] Oxford Nanopore Technol Ltd, Oxford OX4, England; [Barker, John J.; Smith, Myron A.; McEwan, Paul A.; Pilka, Ewa S.; Crawley, Lauren] Evotec UK Ltd, Abingdon OX14 4RZ, Oxon, England; [Evans, Tom] New England Biolabs Inc, Ipswich, MA 01938 USA	Oxford Nanopore Technologies; Evotec; New England Biolabs	Sun, DP (corresponding author), Shanghai R&D Ctr, New England Biolabs, Bldg 5,917 Halei Rd, Shanghai, Peoples R China.	Sund@neb.com		mcewan, paul/0000-0001-6097-1528	New England Biolabs Shanghai RD Center; Oxford Nanopore Technologies Ltd.; New England Biolabs; Evotec (UK) Ltd	New England Biolabs Shanghai RD Center; Oxford Nanopore Technologies Ltd.; New England Biolabs; Evotec (UK) Ltd	The authors received no specific funding for this work. Li Fei, SiSi Tian, and Dapeng Sun are employees of New England Biolabs, Shanghai R&D Center. Tom Evans is an employee of New England Biolabs Inc. Ruth Moysey and Mihaela Misca are employees of Oxford Nanopore Technologies Ltd. John J. Barker, Myron A Smith, Paul A McEwan, Ewa S Pilka, and Lauren Crawley are employees of Evotec (UK) Ltd. New England Biolabs Shanghai R&D Center, Oxford Nanopore Technologies Ltd., Evotec (UK) Ltd and New England Biolabs provided support in the form of salaries, supplies, equipment, and infrastructure support for authors LF, ST, DS, TE, RM, MM, JJB, MAS, PAM, ESP and LC, provided editorial suggestions on content and data presentation for the manuscript and approved submission of the manuscript for publication, but did not have any additional role in control of the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson I, 2012, STAND GENOMIC SCI, V6, P293, DOI 10.4056/sigs.2736042; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; Bodrossy L, 1997, ARCH MICROBIOL, V168, P493, DOI 10.1007/s002030050527; Breyer WA, 2000, NAT STRUCT BIOL, V7, P1125; BRODY RS, 1986, J BIOL CHEM, V261, P7136; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; Busam RD, 2008, ACTA CRYSTALLOGR D, V64, P206, DOI 10.1107/S090744490706012X; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Didenko VV, 2001, BIOTECHNIQUES, V31, P1106, DOI 10.2144/01315rv02; Feschenko VV, 2003, P NATL ACAD SCI USA, V100, P1134, DOI 10.1073/pnas.0233122100; Frols S, 2009, BIOCHEM SOC T, V37, P36, DOI 10.1042/BST0370036; GHOSH SS, 1994, NUCLEIC ACIDS RES, V22, P3155, DOI 10.1093/nar/22.15.3155; Goker M, 2012, STAND GENOMIC SCI, V6, P230, DOI 10.4056/sigs.2726028; Kataoka M, 2013, APPL MICROBIOL BIOTE; Korada SKC, 2013, NUCLEIC ACIDS RES, V41, P5887, DOI 10.1093/nar/gkt278; LEHMAN IR, 1964, J BIOL CHEM, V239, P2628; Lenhart JS, 2012, MICROBIOL MOL BIOL R, V76, P530, DOI 10.1128/MMBR.05020-11; Li Z, 2013, BIOCHEM SOC T, V41, P332, DOI 10.1042/BST20120303; Lino T, 2008, INT J SYST EVOL MICR, V58, P1675, DOI 10.1099/ijs.0.65714-0; Liu WF, 2007, FEBS LETT, V581, P1047, DOI 10.1016/j.febslet.2007.02.008; Slobodkina GB, 2008, INT J SYST EVOL MICR, V58, P852, DOI 10.1099/ijs.0.65485-0; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Takacs E, 2004, FEBS LETT, V566, P48, DOI 10.1016/j.febslet.2004.04.039; Tori K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058497; Ueda J, 2013, INT J SYST EVOL MICR, V63, P3330, DOI 10.1099/ijs.0.048090-0; van Wolferen M, 2013, EXTREMOPHILES, V17, P545, DOI 10.1007/s00792-013-0552-6; Wigley DB, 2013, NAT REV MICROBIOL, V11, P9, DOI 10.1038/nrmicro2917; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; You ZQ, 2013, INT J SYST EVOL MICR, V63, P4243, DOI 10.1099/ijs.0.051714-0	30	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117470	10.1371/journal.pone.0117470	http://dx.doi.org/10.1371/journal.pone.0117470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658953	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900157
J	Fesquet, D; De Bettignies, G; Bellis, M; Espeut, J; Devault, A				Fesquet, Didier; De Bettignies, Geoffroy; Bellis, Michel; Espeut, Julien; Devault, Alain			Binding of Kif23-iso1/CHO1 to 14-3-3 Is Regulated by Sequential Phosphorylations at Two LATS Kinase Consensus Sites	PLOS ONE			English	Article							SIGNALING PATHWAY; CLEAVAGE FURROW; MIDBODY RING; F-ACTIN; CYTOKINESIS; PROTEIN; DEGRADATION; AUTOPHAGY; YAP; DIFFERENTIATION	Kif23 kinesin is an essential actor of cytokinesis in animals. It exists as two major isoforms, known as MKLP1 and CHO1, the longest of which, CHO1, contains two HXRXXS/T NDR/LATS kinase consensus sites. We demonstrate that these two sites are readily phosphorylated by NDR and LATS kinases in vitro, and this requires the presence of an upstream -5 histidine residue. We further show that these sites are phosphorylated in vivo and provide evidence revealing that LATS1,2 participate in the phosphorylation of the most C-terminal S814 site, present on both isoforms. This S814 phosphosite was previously reported to constitute a 14-3-3 binding site, which plays a role in Kif23 clustering during cytokinesis. Surprisingly, we found that phosphorylation of the upstream S716 NDR/LATS consensus site, present only in the longest Kif23 isoform, is required for efficient phosphorylation at S814, thus revealing sequential phosphorylation at these two sites, and differential regulation of Kif23-14-3-3 interaction for the two Kif23 isoforms. Finally, we provide evidence that Kif23 is largely unphosphorylated on S814 in post-abscission midbodies, making this Kif23 post-translational modification a potential marker to probe these structures.	[Fesquet, Didier] CNRS, CRBM UMR 5237, Montpellier, France; Univ Montpellier, F-34059 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier	Fesquet, D (corresponding author), CNRS, CRBM UMR 5237, Montpellier, France.	dfesquet@crbm.cnrs.fr; alain.devault@crbm.cnrs.fr	Fesquet, didier/M-9750-2019	Fesquet, didier/0000-0001-5657-9689	Fondation ARC [5479]	Fondation ARC	Funding by Fondation ARC 5479 (http://www.fondation-arc.org) (DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2006, FEBS LETT, V580, P782, DOI 10.1016/j.febslet.2005.12.096; Bidlingmaier S, 2001, MOL CELL BIOL, V21, P2449, DOI 10.1128/MCB.21.7.2449-2462.2001; Bohnert KA, 2013, GENE DEV, V27, P2164, DOI 10.1101/gad.224154.113; Boman AL, 1999, CELL MOTIL CYTOSKEL, V44, P119, DOI 10.1002/(SICI)1097-0169(199910)44:2<119::AID-CM4>3.3.CO;2-3; Chalamalasetty RB, 2006, J CELL SCI, V119, P3008, DOI 10.1242/jcs.03032; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Chen CT, 2013, TRENDS CELL BIOL, V23, P118, DOI 10.1016/j.tcb.2012.10.012; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Cornils H, 2011, MOL CELL BIOL, V31, P1382, DOI 10.1128/MCB.01216-10; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Crowell EF, 2013, BIOESSAYS, V35, P472, DOI 10.1002/bies.201200132; Dai XM, 2013, J BIOL CHEM, V288, P34041, DOI 10.1074/jbc.M113.518019; Douglas ME, 2010, CURR BIOL, V20, P927, DOI 10.1016/j.cub.2010.03.055; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ettinger AW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1511; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Goss JW, 2008, J CELL BIOL, V181, P1047, DOI 10.1083/jcb.200712137; Gumbiner BM, 2014, J CELL SCI, V127, P709, DOI 10.1242/jcs.140103; Gupta S, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-19; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Hergovich A, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-32; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hotz M, TRENDS CELL BIOL; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Hutterer A, 2009, CURR BIOL, V19, P2043, DOI 10.1016/j.cub.2009.10.050; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; Isakson P, 2013, AUTOPHAGY, V9, P1955, DOI 10.4161/auto.26085; Johnson AE, 2012, CYTOSKELETON, V69, P686, DOI 10.1002/cm.21044; Kuo TC, 2011, NAT CELL BIOL, V13, P1214, DOI 10.1038/ncb2332; Kuriyama R, 2002, J CELL BIOL, V156, P783, DOI 10.1083/jcb.200109090; Lee KY, 2012, J CELL SCI, V125, P3495, DOI 10.1242/jcs.094672; Lin S, 2012, J NEUROSCI, V32, P14033, DOI 10.1523/JNEUROSCI.3070-12.2012; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Matuliene J, 2004, MOL BIOL CELL, V15, P3083, DOI 10.1091/mbc.E03-12-0888; Mazanka E, 2008, PLOS BIOL, V6, P1778, DOI 10.1371/journal.pbio.0060203; Meitinger F, 2011, GENE DEV, V25, P875, DOI 10.1101/gad.622411; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Mohl DA, 2009, J CELL BIOL, V184, P527, DOI 10.1083/jcb.200812022; Oh Y, 2012, MOL BIOL CELL, V23, P2445, DOI 10.1091/mbc.E12-01-0033; Okada N, 2011, J CELL SCI, V124, P57, DOI 10.1242/jcs.072918; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pinheiro D, 2014, DEV CELL, V28, P219, DOI 10.1016/j.devcel.2014.01.026; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; Salzmann V, 2014, MOL BIOL CELL, V25, P267, DOI 10.1091/mbc.E13-09-0541; Schink KO, 2011, CURR BIOL, V21, pR958, DOI 10.1016/j.cub.2011.10.035; Scott MT, 2002, EMBO J, V21, P6771, DOI 10.1093/emboj/cdf684; Sharp DJ, 1997, J CELL BIOL, V138, P833, DOI 10.1083/jcb.138.4.833; Singh D, 2014, DEV CELL, V28, P253, DOI 10.1016/j.devcel.2014.01.002; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Suzuki H, 2013, J CELL SCI, V126, P4358, DOI 10.1242/jcs.125815; Tinti M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120103; Uchida S, 2004, J CELL SCI, V117, P3011, DOI 10.1242/jcs.01086; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	56	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117857	10.1371/journal.pone.0117857	http://dx.doi.org/10.1371/journal.pone.0117857			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658096	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900232
J	Giron, MD; Vilchez, JD; Shreeram, S; Salto, R; Manzano, M; Cabrera, E; Campos, N; Edens, NK; Rueda, R; Lopez-Pedrosa, JM				Giron, Maria D.; Vilchez, Jose D.; Shreeram, Sathyavageeswaran; Salto, Rafael; Manzano, Manuel; Cabrera, Elena; Campos, Nefertiti; Edens, Neile K.; Rueda, Ricardo; Lopez-Pedrosa, Jose M.			beta-Hydroxy-beta-Methylbutyrate (HMB) Normalizes Dexamethasone-Induced Autophagy-Lysosomal Pathway in Skeletal Muscle	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; PROTEIN-DEGRADATION; GENE-EXPRESSION; AGED RATS; ATROPHY; UBIQUITIN; CELLS; PROLIFERATION; MECHANISM; RECOVERY	Dexamethasone-induced muscle atrophy is due to an increase in protein breakdown and a decrease in protein synthesis, associated with an over-stimulation of the autophagy-lysosomal pathway. These effects are mediated by alterations in IGF-1 and PI3K/Akt signaling. In this study, we have investigated the effects of beta-Hydroxy-beta-methylbutyrate (HMB) on the regulation of autophagy and proteosomal systems. Rats were treated during 21 days with dexamethasone as a model of muscle atrophy. Co-administration of HMB attenuated the effects promoted by dexamethasone. HMB ameliorated the loss in body weight, lean mass and the reduction of the muscle fiber cross-sectional area (shrinkage) in gastrocnemius muscle. Consequently, HMB produced an improvement in muscle strength in the dexamethasone-treated rats. To elucidate the molecular mechanisms responsible for these effects, rat L6 myotubes were used. In these cells, HMB significantly attenuated lysosomal proteolysis induced by dexamethasone by normalizing the changes observed in autophagosome formation, LC3 II, p62 and Bnip3 expression after dexamethasone treatment. HMB effects were mediated by an increase in FoxO3a phosphorylation and concomitant decrease in FoxO transcriptional activity. The HMB effect was due to the restoration of Akt signaling diminished by dexamethasone treatment. Moreover, HMB was also involved in the regulation of the activity of ubiquitin and expression of MurF1 and Atrogin-1, components of the proteasome system that are activated or up-regulated by dexamethasone. In conclusion, in vivo and in vitro studies suggest that HMB exerts protective effects against dexamethasone- induced muscle atrophy by normalizing the Akt/FoxO axis that controls autophagy and ubiquitin proteolysis.	[Giron, Maria D.; Vilchez, Jose D.; Salto, Rafael; Cabrera, Elena] Univ Granada, Dept Biochem & Mol Biol 2, Granada, Spain; [Shreeram, Sathyavageeswaran] Abbott Nutr R&D, Singapore, Singapore; [Manzano, Manuel; Campos, Nefertiti; Rueda, Ricardo; Lopez-Pedrosa, Jose M.] Abbott Nutr R&D, Granada, Spain; [Edens, Neile K.] Abbott Nutr R&D, Columbus, OH USA	University of Granada	Giron, MD (corresponding author), Univ Granada, Dept Biochem & Mol Biol 2, Granada, Spain.	mgiron@ugr.es	Vílchez, Dámaso/E-9823-2016; Giron, Maria D/K-2487-2014; Salto, Rafael/A-6486-2011	Vílchez, Dámaso/0000-0003-3256-8525; Giron, Maria D/0000-0001-9638-988X; Salto, Rafael/0000-0002-7044-3611; Sathyavageeswaran, Shreeram/0000-0002-6111-1818	Abbott Nutrition RD	Abbott Nutrition RD	This project has been funded by Abbott Nutrition R&D. The funder provided support in the form of salaries for authors SS, MM, NC, NKE, RR and JMLP but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alway SE, 2013, EXP GERONTOL, V48, P973, DOI 10.1016/j.exger.2013.06.005; Aversa Z, 2012, BIOCHEM BIOPH RES CO, V423, P739, DOI 10.1016/j.bbrc.2012.06.029; Baptista IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076752; Giron MD, 2009, CLIN NUTR, V28, P565, DOI 10.1016/j.clnu.2009.04.018; Fanzani A, 2012, J CACHEXIA SARCOPENI, V3, P163, DOI 10.1007/s13539-012-0074-6; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Giron MD, 2008, DIABETOLOGIA, V51, P1285, DOI 10.1007/s00125-008-1003-2; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; GULVE EA, 1989, BIOCHEM J, V260, P377, DOI 10.1042/bj2600377; Hao YL, 2011, AM J PHYSIOL-REG I, V301, pR701, DOI 10.1152/ajpregu.00840.2010; HONG DH, 1995, MOL CELL ENDOCRINOL, V108, P199, DOI 10.1016/0303-7207(95)03476-N; Kaasik P, 2007, J STEROID BIOCHEM, V105, P85, DOI 10.1016/j.jsbmb.2006.11.024; Kimura K, 2014, NUTR RES, V34, P368, DOI 10.1016/j.nutres.2014.02.003; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kornasio R, 2009, BBA-MOL CELL RES, V1793, P755, DOI 10.1016/j.bbamcr.2008.12.017; Kovarik M, 2010, J PHYSIOL BIOCHEM, V66, P311, DOI 10.1007/s13105-010-0037-3; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marinovic AC, 2000, BIOCHEM BIOPH RES CO, V274, P537, DOI 10.1006/bbrc.2000.3171; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Neel BA, 2013, TRENDS ENDOCRIN MET, V24, P635, DOI 10.1016/j.tem.2013.09.004; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Russell ST, 2009, MOL CELL BIOCHEM, V330, P171, DOI 10.1007/s11010-009-0130-5; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Schakman O, 2013, INT J BIOCHEM CELL B, V45, P2163, DOI 10.1016/j.biocel.2013.05.036; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Shin JH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01561; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Thompson AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085495; Troncoso R, 2014, CELL CYCLE, V13, P2281, DOI 10.4161/cc.29272; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Webb AE, 2014, TRENDS BIOCHEM SCI, V39, P159, DOI 10.1016/j.tibs.2014.02.003; Wilson JM, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-18; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zheng B, 2010, FASEB J, V24, P2660, DOI 10.1096/fj.09-151480	37	40	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117520	10.1371/journal.pone.0117520	http://dx.doi.org/10.1371/journal.pone.0117520			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658432	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900171
J	Hu, YY; Wu, JF; Lu, TL; Wu, H; Sun, W; Wang, XR; Bi, HS; Jonas, JB				Hu, Yuan Yuan; Wu, Jian Feng; Lu, Tai Liang; Wu, Hui; Sun, Wei; Wang, Xing Rong; Bi, Hong Sheng; Jonas, Jost B.			Effect of Cycloplegia on the Refractive Status of Children: The Shandong Children Eye Study	PLOS ONE			English	Article							VISUAL IMPAIRMENT; SCHOOL-CHILDREN; SOUTHERN CHINA; ERROR; AUTOREFRACTION	Purpose To determine the effect of 1% cyclopentolate on the refractive status of children aged 4 to 18 years. Methods Using a random cluster sampling in a cross-sectional school-based study design, children with an age of 4-18 years were selected from kindergardens, primary schools, junior and senior high schools in a rural county and a city. Auto-refractometry was performed before and after inducing cycloplegia which was achieved by 1% cyclopentolate eye drops. Results Out of 6364 eligible children, data of 5999 (94.3%) children were included in the statistical analysis. Mean age was 10.0 +/- 3.3 years (range: 4-18 years). Mean difference between cycloplegic and non-cycloplegic refractive error (DIFF) was 0.78 +/- 0.79D (median: 0.50D; range: -1.00D to +10.75D). In univariate analysis, DIFF decreased significantly with older age (P<0.001; correlation coefficient r:-0.24), more hyperopic non-cycloplegic refractive error (P<0.001; r = 0.13) and more hyperopic cycloplegic refractive error (P<0.001; r = 0.49). In multivariate analysis, higher DIFF was associated with higher cycloplegic refractive error (P<0.001; standardized regression coefficient beta: 0.50; regression coefficient B: 0.19; 95% confidence interval (CI): 0.18, 0.20), followed by lower intraocular pressure (P<0.001; beta: -0.06; B: -0.02; 95% CI: -0.03, -0.01), rural region of habitation (P = 0.001; beta: -0.04; B: -0.07; 95% CI: -0.11, -0.03), and, to a minor degree, with age (P = 0.006; beta: 0.04; B: 0.009; 95% CI: 0.003, 0.016). 66.4% of all eyes with non-cycloplegic myopia (<=-0.50D) remained myopic after cycloplegia while the remaining 33.6% of eyes became emmetropic (18.0%) or hyperopic (15.7%) under cycloplegia. Prevalence of emmetropia decreased from 37.5% before cycloplegia to 19.8% after cycloplegia while the remaining eyes became hyperopic under cycloplegia. Conclusions The error committed by using non-cycloplegic versus cycloplegic refractometry in children with mid to dark-brown iris color decreased with older age, and in parallel manner, with more myopic cycloplegic refractive error. Non-cycloplegic refractometric measures lead to a misclassification of refractive error in a significant proportion of children.	[Hu, Yuan Yuan; Wu, Jian Feng] Shandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan, Shandong, Peoples R China; [Hu, Yuan Yuan; Lu, Tai Liang; Sun, Wei; Wang, Xing Rong; Bi, Hong Sheng] Shandong Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Ophthalmol, Jinan, Shandong, Peoples R China; [Wu, Hui; Wang, Xing Rong; Bi, Hong Sheng] Shandong Univ Tradit Chinese Med, Inst Eye, Jinan, Shandong, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Seegartenklin Heidelberg, Med Fac Mannheim, Dept Ophthalmol, D-69115 Heidelberg, Germany	Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; Ruprecht Karls University Heidelberg	Bi, HS (corresponding author), Shandong Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Ophthalmol, Jinan, Shandong, Peoples R China.	hongshengbi@126.com			Shandong Science & Technology Department [2011GGB14097, 2011GGH21835, 2012YD18081]; Shandong Health Department [2011HD014]; Jinan Science & Technology Bureau [201102061]	Shandong Science & Technology Department; Shandong Health Department; Jinan Science & Technology Bureau	This study was supported by the Shandong Science & Technology Department (2011GGB14097, 2011GGH21835, 2012YD18081), Shandong Health Department (2011HD014), Jinan Science & Technology Bureau (201102061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choong YF, 2006, AM J OPHTHALMOL, V142, P68, DOI 10.1016/j.ajo.2006.01.084; EGASHIRA SM, 1993, OPTOMETRY VISION SCI, V70, P1019, DOI 10.1097/00006324-199312000-00005; Fotedar R, 2007, AM J OPHTHALMOL, V144, P307, DOI 10.1016/j.ajo.2007.03.041; French AN, 2013, OPHTHALMOLOGY, V120, P1482, DOI 10.1016/j.ophtha.2012.12.018; GROSVENOR T, 1994, OPTOMETRY VISION SCI, V71, P573, DOI 10.1097/00006324-199409000-00005; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075260; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; He MG, 2011, OPHTHALMOLOGY, V118, P1162, DOI 10.1016/j.ophtha.2010.10.003; Hopkins S, 2012, OPTOMETRY VISION SCI, V89, P1734, DOI 10.1097/OPX.0b013e318277182c; Jiang WJ, 2014, INVEST OPHTH VIS SCI, V55, P4128, DOI 10.1167/iovs.14-14244; Lan WZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078003; Prabakaran S, 2009, OPHTHAL PHYSL OPT, V29, P422, DOI 10.1111/j.1475-1313.2008.00616.x; Rotsos T, 2009, CLIN OPHTHALMOL, V3, P429; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Zhao JL, 2004, OPTOMETRY VISION SCI, V81, P49, DOI 10.1097/00006324-200401000-00010	16	43	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117482	10.1371/journal.pone.0117482	http://dx.doi.org/10.1371/journal.pone.0117482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658329	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900161
J	Kong, LW; Wu, JF; Lin, YH; Wang, GF; Wang, J; Liu, JQ; Chen, MX; Du, X; Sun, J; Lin, JP; Dong, JC				Kong, Lingwen; Wu, Jingfeng; Lin, Yanhua; Wang, Genfa; Wang, Jia; Liu, Jiaqi; Chen, Meixia; Du, Xin; Sun, Jing; Lin, Jinpei; Dong, Jingcheng			BuShenYiQi Granule Inhibits Atopic Dermatitis via Improving Central and Skin Hypothalamic -Pituitary -Adrenal Axis Function	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; MAST-CELLS; HPA AXIS; ASTHMATIC-CHILDREN; IMMUNE-SYSTEM; MOUSE MODEL; STRESS; INFLAMMATION; RESPONSES; CRH	Background Dysfunction of central and skin Hypothalamic-Pituitary-Adrenal (HPA) axis play important roles in pathogenesis of atopic dermatitis (AD). Our previous studies showed that several Chinese herbs could improve HPA axis function. In this study, we evaluated the antiinflammatory effects of BuShenYiQi granule (BSYQ), a Chinese herbs formula, in AD mice and explored the effective mechanism from regulation of HPA axis. Methods The ovalbumin (OVA) induced AD mice model were established and treated with BSYQ. We evaluated dermatitis score and histology analysis of dorsal skin lesions, meanwhile, serum corticosterone (CORT), adrenocorticotropic hormone (ACTH), corticotropin-releasing hormone (CRH) and inflammatory cytokines were determined by ELISA. The changes of CRH/proopiomelanocortin(POMC) axis elements, corresponding functional receptors and crucial genes of glucocorticosteroidogenesis in the skin were measured by quantitative real-time PCR and western blot, respectively. Results The symptoms and pathological changes in skin of AD mice were significantly improved and several markers of inflammation and allergy descended obviously after BSYQ treatment. We found that AD mice had insufficient central HPA tone, but these conditions were markedly improved after BSYQ treatment. The AD mice also showed a disturbed expression of skin HPA. In lesion skin of AD mice, the mRNA and protein expressions of CRH decreased significantly, on the contrary, POMC and cytochrome P450 side-chain cleavage enzyme (CYP11A1) increased markedly, meanwhile, NR3C1 (mouse GR), CRHR2 and 11-hydroxylase type 1(CYP11B1) were reduced locally. Most of these tested indexes were improved after BSYQ treatment. Conclusions AD mice displayed the differential expression pattern of central and skin HPA axis and BSYQ treatment significantly alleviated the symptoms of AD mice and presented antiinflammatory and anti-allergic effects via regulating the expression of central and skin HPA axis.	[Kong, Lingwen; Lin, Yanhua; Wang, Genfa; Wang, Jia; Liu, Jiaqi; Chen, Meixia; Du, Xin; Sun, Jing; Lin, Jinpei; Dong, Jingcheng] Fudan Univ, Huashan Hosp, Dept Integrated Tradit Chinese & Western Med, Shanghai 200433, Peoples R China; [Kong, Lingwen; Lin, Yanhua; Wang, Genfa; Wang, Jia; Liu, Jiaqi; Chen, Meixia; Du, Xin; Sun, Jing; Lin, Jinpei; Dong, Jingcheng] Fudan Univ, Inst Integrated Tradit Chinese & Western Med, Shanghai 200433, Peoples R China; [Wu, Jingfeng] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Dong, JC (corresponding author), Fudan Univ, Huashan Hosp, Dept Integrated Tradit Chinese & Western Med, Shanghai 200433, Peoples R China.	jcdong2004@126.com		Dong, Jingcheng/0000-0002-5194-367X; Du, Xin/0000-0002-9682-1211	National Basic Science Program of China [2009CB523000]; National Natural Science Foundation of China [81173390/H2902]	National Basic Science Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Science Program of China (no. 2009CB523000) and the National Natural Science Foundation of China (no. 81173390/H2902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buske-Kirschbaum A, 2006, PSYCHONEUROENDOCRINO, V31, P439, DOI 10.1016/j.psyneuen.2005.10.006; Buske-Kirschbaum A, 2003, ANN NY ACAD SCI, V992, P231, DOI 10.1111/j.1749-6632.2003.tb03153.x; Buske-Kirschbaum A, 2010, BRAIN BEHAV IMMUN, V24, P1347, DOI 10.1016/j.bbi.2010.06.013; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; ELIAS PM, 1992, SEMIN DERMATOL, V11, P176; Gantz I, 2003, AM J PHYSIOL-ENDOC M, V284, pE468, DOI 10.1152/ajpendo.00434.2002; Gibb J, 2011, BRAIN BEHAV IMMUN, V25, P468, DOI 10.1016/j.bbi.2010.11.008; Gong Zhao-Hua, 2008, Zhongguo Zhong Xi Yi Jie He Za Zhi, V28, P348; Hannen RF, 2011, BIOCHEM BIOPH RES CO, V404, P62, DOI 10.1016/j.bbrc.2010.11.059; Harbuz MS, 2006, ANN NY ACAD SCI, V1069, P51, DOI 10.1196/annals.1351.005; Hendrix S, 2008, J INVEST DERMATOL, V128, P260, DOI 10.1038/sj.jid.5701171; Huang JH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/938425; Ibarguen-Vargas Y, 2008, PSYCHONEUROENDOCRINO, V33, P1357, DOI 10.1016/j.psyneuen.2008.07.010; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Jin HL, 2013, INT IMMUNOPHARMACOL, V15, P42, DOI 10.1016/j.intimp.2012.11.009; Karalis K, 1997, J NEUROIMMUNOL, V72, P131, DOI 10.1016/S0165-5728(96)00178-6; Kempuraj D, 2004, ENDOCRINOLOGY, V145, P43, DOI 10.1210/en.2003-0805; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuoka H, 2003, ALLERGY, V58, P139, DOI 10.1034/j.1398-9995.2003.23790.x; MIGLIORATI G, 1994, PHARMACOL RES, V30, P43, DOI 10.1016/1043-6618(94)80086-3; Priftis KN, 2008, TRENDS ENDOCRIN MET, V19, P32, DOI 10.1016/j.tem.2007.10.005; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Skobowiat C, 2013, GENE, V530, P1, DOI 10.1016/j.gene.2013.08.035; Slominski A, 2009, BRIT J DERMATOL, V160, P229, DOI 10.1111/j.1365-2133.2008.08958.x; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski A, 2001, FASEB J, V15, P1678, DOI 10.1096/fj.00-0850rev; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Slominski A, 2006, FRONT BIOSCI-LANDMRK, V11, P2230, DOI 10.2741/1966; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Sprecher E, 2013, J ALLERGY CLIN IMMUN, V132, P1130, DOI 10.1016/j.jaci.2013.09.026; Theoharides TC, 2004, TRENDS PHARMACOL SCI, V25, P563, DOI 10.1016/j.tips.2004.09.007; Theoharides TC, 1998, ENDOCRINOLOGY, V139, P403, DOI 10.1210/en.139.1.403; Theoharides TC, 2006, ANN NY ACAD SCI, V1088, P78, DOI 10.1196/annals.1366.025; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Vasiadi M, 2012, J ALLERGY CLIN IMMUN, V129, P1410, DOI 10.1016/j.jaci.2012.01.041; Wang GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103168; Wang J, 2014, J ETHNOPHARMACOL, V154, P131, DOI 10.1016/j.jep.2014.03.041; Wen MC, 2005, J ALLERGY CLIN IMMUN, V116, P517, DOI 10.1016/j.jaci.2005.05.029; Wu JF, 2011, IMMUNOPHARM IMMUNOT, V33, P49, DOI 10.3109/08923971003725144; Wu JF, 2011, PHARMACOL BIOCHEM BE, V98, P273, DOI 10.1016/j.pbb.2011.01.008; Xu CQ, 2010, EUR J PHARMACOL, V642, P146, DOI 10.1016/j.ejphar.2010.05.012; Zbytek B, 2007, J INVEST DERMATOL, V127, P730, DOI 10.1038/sj.jid.5700607; Zollner EW, 2007, PEDIATR ALLERGY IMMU, V18, P469, DOI 10.1111/j.1399-3038.2007.00539.x	45	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116427	10.1371/journal.pone.0116427	http://dx.doi.org/10.1371/journal.pone.0116427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658752	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900038
J	Maesawa, S; Bagarinao, E; Fujii, M; Futamura, M; Motomura, K; Watanabe, H; Mori, D; Sobue, G; Wakabayashi, T				Maesawa, Satoshi; Bagarinao, Epifanio; Fujii, Masazumi; Futamura, Miyako; Motomura, Kazuya; Watanabe, Hirohisa; Mori, Daisuke; Sobue, Gen; Wakabayashi, Toshihiko			Evaluation of Resting State Networks in Patients with Gliomas: Connectivity Changes in the Unaffected Side and Its Relation to Cognitive Function	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; BRAIN; PATTERNS; OPTIMIZATION; EFFICIENCY; ROBUST; FMRI	In this study, we investigated changes in resting state networks (RSNs) in patients with gliomas located in the left hemisphere and its relation to cognitive function. We hypothesized that long distance connection, especially between hemispheres, would be affected by the presence of the tumor. We further hypothesized that these changes would correlate with, or reflect cognitive changes observed in patients with gliomas. Resting state functional MRI datasets from 12 patients and 12 healthy controls were used in the analysis. The tumor's effect on three well-known RSNs including the default mode network (DMN), executive control network (ECN), and salience network (SN) identified using independent component analysis were investigated using dual regression analysis. Scores of neuropsychometric testing (WAIS-III and WMS-R) were also compared. Compared to the healthy control group, the patient group showed significant decrease in functional connectivity in the right angular gyrus/inferior parietal lobe of the ventral DMN and in the dorsolateral prefrontal cortex of the left ECN, whereas a significant increase in connectivity in the right ECN was observed in the right parietal lobe. Changes in connectivity in the right ECN correlated with spatial memory, while that on the left ECN correlated with attention. Connectivity changes in the ventral DMN correlated with attention, working memory, full IQ, and verbal IQ measures. Although the tumors were localized in the left side of the brain, changes in connectivity were observed in the contralateral side. Moreover, these changes correlated with some aspects of cognitive function indicating that patients with gliomas may undergo cognitive changes even in the absence of or before the onset of major symptoms. Evaluation of resting state networks could be helpful in advancing our hodological understanding of brain function in glioma cases.	[Maesawa, Satoshi; Bagarinao, Epifanio; Watanabe, Hirohisa; Mori, Daisuke; Sobue, Gen; Wakabayashi, Toshihiko] Nagoya Univ, Brain & Mind Res Ctr, Nagoya, Aichi 4648601, Japan; [Maesawa, Satoshi; Fujii, Masazumi; Motomura, Kazuya; Wakabayashi, Toshihiko] Nagoya Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 466, Japan; [Futamura, Miyako] Nagoya Hosp Org, Nagoya Med Ctr, Dept Rehabil, Nagoya, Aichi, Japan; [Watanabe, Hirohisa; Sobue, Gen] Nagoya Univ, Sch Med, Dept Neurol, Nagoya, Aichi 466, Japan	Nagoya University; Nagoya University; Nagoya Medical Center; Nagoya University	Maesawa, S (corresponding author), Nagoya Univ, Brain & Mind Res Ctr, Nagoya, Aichi 4648601, Japan.	smaesawa@med.nagoya-u.ac.jp	Wakabayashi, Toshihiko/I-3526-2012; Bagarinao, Epifanio/A-5002-2012; MAESAWA, Satoshi/I-7416-2014; Mori, Daisuke/M-4952-2014; Motomura, Kazuya/AAF-8776-2021	Wakabayashi, Toshihiko/0000-0001-5254-2088; Bagarinao, Epifanio/0000-0001-5000-6943; Mori, Daisuke/0000-0002-9072-2546; Motomura, Kazuya/0000-0002-4376-1104; Watanabe, Hirohisa/0000-0001-8553-8536	KAKENHI [26462202]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI grant number 26462202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettus G, 2010, J NEUROL NEUROSUR PS, V81, P1147, DOI 10.1136/jnnp.2009.191460; Chen S, 2008, BRAIN RES, V1239, P141, DOI 10.1016/j.brainres.2008.08.028; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; ELWOOD R W, 1991, Neuropsychology Review, V2, P179, DOI 10.1007/BF01109053; Esposito R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040231; Filippi M, 2013, CORTEX, V49, P2389, DOI 10.1016/j.cortex.2012.09.017; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Harris RJ, 2014, J NEURO-ONCOL, V116, P373, DOI 10.1007/s11060-013-1304-2; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Kokkonen SM, 2009, MAGN RESON IMAGING, V27, P733, DOI 10.1016/j.mri.2008.11.002; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; MAHALEY MS, 1989, J NEUROSURG, V71, P826, DOI 10.3171/jns.1989.71.6.0826; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ryan JJ, 2003, ASSESSMENT, V10, P151, DOI 10.1177/1073191103010002006; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Uddin LQ, 2009, NEUROSCI BIOBEHAV R, V33, P1198, DOI 10.1016/j.neubiorev.2009.06.002; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Waltz JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057257; Xu HZ, 2013, NEUROSCI LETT, V543, P27, DOI 10.1016/j.neulet.2013.02.062; Zhu DC, 2013, J ALZHEIMERS DIS, V34, P969, DOI 10.3233/JAD-121879	33	55	56	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118072	10.1371/journal.pone.0118072	http://dx.doi.org/10.1371/journal.pone.0118072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659130	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900258
J	Martin, KJS; Muessel, MJ; Pullar, CE; Willars, GB; Wardlaw, AJ				Martin, Kayleigh J. S.; Muessel, Michelle J.; Pullar, Christine E.; Willars, Gary B.; Wardlaw, Andrew J.			The Role of Phosphoinositide 3-Kinases in Neutrophil Migration in 3D Collagen Gels	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; BETA-GAMMA-SUBUNIT; PHOSPHATIDYLINOSITOL 3-KINASE; INFLAMMATION; CHEMOTAXIS; LUNG; ACTIVATION; PI3K-GAMMA; ASTHMA; TRAFFICKING	The entry of neutrophils into tissue has been well characterised; however the fate of these cells once inside the tissue microenvironment is not fully understood. A variety of signal transduction pathways including those involving class I PI3 Kinases have been suggested to be involved in neutrophil migration. This study aims to determine the involvement of PI3 Kinases in chemokinetic and chemotactic neutrophil migration in response to CXCL8 and GM-CSF in a three-dimensional collagen gel, as a model of tissue. Using a three-dimensional collagen assay chemokinetic and chemotactic migration induced by CXCL8 was inhibited with the pan PI3 Kinase inhibitor wortmannin. Analysis of the specific Class I PI3 Kinase catalytic isoforms alpha, delta and gamma using the inhibitors PIK-75, PIK-294 and AS-605240 respectively indicated differential roles in CXCL8-induced neutrophil migration. PIK-294 inhibited both chemokinetic and chemotactic CXCL8-induced migration. AS-605240 markedly reduced CXCL8 induced chemokinetic migration but had no effect on CXCL8 induced chemotactic migration. In contrast PIK-75 inhibited chemotactic migration but not chemokinetic migration. At optimal concentrations of GM-CSF the inhibitors had no effect on the percentage of neutrophil migration in comparison to the control however at suboptimal concentrations wortmannin, AS-605240 and PIK-294 inhibited chemokinesis. This study suggests that PI3 Kinase is necessary for CXCL8 induced migration in a 3D tissue environment but that chemokinetic and chemotactic migration may be controlled by different isoforms with gamma shown to be important in chemokinesis and alpha important in chemotaxis. Neutrophil migration in response to suboptimal concentrations of GM-CSF is dependent on PI3 Kinase, particularly the gamma and delta catalytic isoforms.	[Martin, Kayleigh J. S.; Muessel, Michelle J.; Wardlaw, Andrew J.] Univ Leicester, Dept Infect Immun & Inflammat, Inst Lung Hlth, Leicester, Leics, England; [Pullar, Christine E.; Willars, Gary B.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leicester	Wardlaw, AJ (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Inst Lung Hlth, Leicester, Leics, England.	aw24@le.ac.uk		Wardlaw, Andrew/0000-0001-6583-0791	National Institute for Health Research [NF-SI-0512-10030] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bergeron C, 2006, CHEST, V129, P1068, DOI 10.1378/chest.129.4.1068; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Brkovic A, 2007, J LEUKOCYTE BIOL, V81, P1093, DOI 10.1189/jlb.0906580; Chen J, 2010, BLOOD, V115, P4237, DOI 10.1182/blood-2009-11-255323; Chmiel JF, 2002, CLIN REV ALLERG IMMU, V23, P5, DOI 10.1385/CRIAI:23:1:005; Day CE, 2010, IMMUNOLOGY, V130, P564, DOI 10.1111/j.1365-2567.2010.03257.x; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Ferrandi C, 2007, J PHARMACOL EXP THER, V322, P923, DOI 10.1124/jpet.107.123026; Haldar P, 2007, J ALLERGY CLIN IMMUN, V119, P1043, DOI 10.1016/j.jaci.2007.02.042; Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; KAZLAUSKAS A, 1990, EMBO J, V9, P3279, DOI 10.1002/j.1460-2075.1990.tb07527.x; Knall C, 1996, J BIOL CHEM, V271, P2832, DOI 10.1074/jbc.271.5.2832; Knall C, 1997, P NATL ACAD SCI USA, V94, P3052, DOI 10.1073/pnas.94.7.3052; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lane HC, 2006, INT IMMUNOL, V18, P1315, DOI 10.1093/intimm/dxl064; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu LX, 2007, BLOOD, V110, P1191, DOI 10.1182/blood-2006-11-060103; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Muessel MJ, 2008, J IMMUNOL, V180, P8354, DOI 10.4049/jimmunol.180.12.8354; Nakamae-Akahori M, 2006, IMMUNOLOGY, V119, P393, DOI 10.1111/j.1365-2567.2006.02448.x; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Niggli V, 1997, EUR J PHARMACOL, V335, P43, DOI 10.1016/S0014-2999(97)01169-2; Procko E, 2005, BIOESSAYS, V27, P153, DOI 10.1002/bies.20157; Puri KD, 2005, BLOOD, V106, P150, DOI 10.1182/blood-2005-01-0023; Rahman I, 1996, AM J RESP CRIT CARE, V154, P1055, DOI 10.1164/ajrccm.154.4.8887607; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Reutershan J, 2010, EUR RESPIR J, V35, P1137, DOI 10.1183/09031936.00085509; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Woodfin A, 2010, CURR OPIN HEMATOL, V17, P9, DOI 10.1097/MOH.0b013e3283333930	38	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116250	10.1371/journal.pone.0116250	http://dx.doi.org/10.1371/journal.pone.0116250			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659107	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900032
J	Salek, ME; Zarybnicka, M				Salek, Miroslav E.; Zarybnicka, Marketa			Different Temperature and Cooling Patterns at the Blunt and Sharp Egg Poles Reflect the Arrangement of Eggs in an Avian Clutch	PLOS ONE			English	Article							INCUBATION BEHAVIOR; THERMAL-PROPERTIES; SIZE; NESTS	Incubation is an energetically demanding process during which birds apply heat to their eggs to ensure embryonic development. Parent behaviours such as egg turning and exchanging the outer and central eggs in the nest cup affect the amount of heat lost to the environment from individual eggs. Little is known, however, about whether and how egg surface temperature and cooling rates vary among the different areas of an egg and how the arrangement of eggs within the clutch influences heat loss. We performed laboratory (using Japanese quail eggs) and field (with northern lapwing eggs) experiments using infrared imaging to assess the temperature and cooling patterns of heated eggs and clutches. We found that (i) the sharp poles of individual quail eggs warmed to a higher egg surface temperature than did the blunt poles, resulting in faster cooling at the sharp poles compared to the blunt poles; (ii) both quail and lapwing clutches with the sharp poles oriented towards the clutch centre (arranged clutches) maintained higher temperatures over the central part of the clutch than occurred in those clutches where most of the sharp egg poles were oriented towards the exterior (scattered clutches); and (iii) the arranged clutches of both quail and lapwing showed slower cooling rates at both the inner and outer clutch positions than did the respective parts of scattered clutches. Our results demonstrate that egg surface temperature and cooling rates differ between the sharp and blunt poles of the egg and that the orientation of individual eggs within the nest cup can significantly affect cooling of the clutch as a whole. We suggest that birds can arrange their eggs within the nest cup to optimise thermoregulation of the clutch.	[Salek, Miroslav E.; Zarybnicka, Marketa] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic	Czech University of Life Sciences Prague	Zarybnicka, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic.	zarybnicka.marketa@seznam.cz	Šálek, Miroslav/K-1934-2016; ZÃrybnickÃ, MarkÃ©ta/AAM-3181-2020	Salek, Miroslav/0000-0002-8238-3644; Zarybnicka, Marketa/0000-0001-5883-0988	Faculty of Environmental Sciences, Czech University of Life Sciences Prague [IGA 20144273]; Czech University of Life Sciences Prague [CIGA 20144203]	Faculty of Environmental Sciences, Czech University of Life Sciences Prague; Czech University of Life Sciences Prague	This study was supported by grants from Faculty of Environmental Sciences, Czech University of Life Sciences Prague (IGA 20144273) and Czech University of Life Sciences Prague (CIGA 20144203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2007, ENVIRON INT, V33, P773, DOI 10.1016/j.envint.2007.02.012; Ar A, 2002, OX ORN SER, V13, P143; Barta Z, 1997, FUNCT ECOL, V11, P656, DOI 10.1046/j.1365-2435.1997.00136.x; Boulton RL, 2012, J AVIAN BIOL, V43, P289, DOI 10.1111/j.1600-048X.2012.05657.x; Bustnes JO, 2008, ENVIRON INT, V34, P193, DOI 10.1016/j.envint.2007.07.016; Deeming DC, 2002, OX ORN SER, V13, P161; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; Drent R., 1975, AVIAN BIOL, P333; DuRant SE, 2013, BIOL REV, V88, P499, DOI 10.1111/brv.12015; GALBRAITH H, 1988, J ZOOL, V214, P383, DOI 10.1111/j.1469-7998.1988.tb03747.x; Jimenez-Munoz JC, 2012, J THEOR BIOL, V304, P304, DOI 10.1016/j.jtbi.2012.03.029; Lamprecht I, 2004, THERMOCHIM ACTA, V415, P141, DOI 10.1016/j.tca.2003.08.029; McCafferty DJ, 2013, IBIS, V155, P4, DOI 10.1111/ibi.12010; Pinowski J, 2006, J THERM BIOL, V31, P573, DOI 10.1016/j.jtherbio.2006.05.007; R Development Core Team, 2011, R LANG ENV STAT COMP, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Reid JM, 2002, FUNCT ECOL, V16, P305, DOI 10.1046/j.1365-2435.2002.00632.x; Rockweit JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041498; Shinder D, 2009, POULTRY SCI, V88, P636, DOI 10.3382/ps.2008-00213; SILVER R, 1989, CONDOR, V91, P966, DOI 10.2307/1368081; Smart I.H.M., 1991, P101, DOI 10.1017/CBO9780511585739.009; Sockman KW, 2000, HORM BEHAV, V38, P168, DOI 10.1006/hbeh.2000.1616; Thomas L., 1980, FUNDAMENTALS HEAT TR; Tulp I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038041; Turner JS, 2002, OX ORN SER, V13, P119; Verboven N, 2009, ANIM BEHAV, V77, P411, DOI 10.1016/j.anbehav.2008.10.022; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; Windsor RL, 2013, J AVIAN BIOL, V44, P305, DOI 10.1111/j.1600-048X.2013.05768.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	28	7	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117728	10.1371/journal.pone.0117728	http://dx.doi.org/10.1371/journal.pone.0117728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658846	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900210
J	Sun, ZH; Zhang, WY; Guo, CY; Yang, XW; Liu, WJ; Wu, Y; Song, YQ; Kwok, LY; Cui, YJ; Menghe, B; Yang, RF; Hu, LP; Zhang, HP				Sun, Zhihong; Zhang, Wenyi; Guo, Chenyi; Yang, Xianwei; Liu, Wenjun; Wu, Yarong; Song, Yuqin; Kwok, Lai Yu; Cui, Yujun; Menghe, Bilige; Yang, Ruifu; Hu, Liangping; Zhang, Heping			Comparative Genomic Analysis of 45 Type Strains of the Genus Bifidobacterium: A Snapshot of Its Genetic Diversity and Evolution	PLOS ONE			English	Article							CONTROLLED-TRIAL; DOUBLE-BLIND; SEQUENCES; MILK; ANIMALIS; LONGUM; HYBRIDIZATION; ADAPTATION; BACTERIAL; PRODUCTS	Bifidobacteria are well known for their human health-promoting effects and are therefore widely applied in the food industry. Members of the Bifidobacterium genus were first identified from the human gastrointestinal tract and were then found to be widely distributed across various ecological niches. Although the genetic diversity of Bifidobacterium has been determined based on several marker genes or a few genomes, the global diversity and evolution scenario for the entire genus remain unresolved. The present study comparatively analyzed the genomes of 45 type strains. We built a robust genealogy for Bifidobacterium based on 402 core genes and defined its root according to the phylogeny of the tree of bacteria. Our results support that all human isolates are of younger lineages, and although species isolated from bees dominate the more ancient lineages, the bee was not necessarily the original host for bifidobacteria. Moreover, the species isolated from different hosts are enriched with specific gene sets, suggesting host-specific adaptation. Notably, bee-specific genes are strongly associated with respiratory metabolism and are potential in helping those bacteria adapt to the oxygen-rich gut environment in bees. This study provides a snapshot of the genetic diversity and evolution of Bifidobacterium, paving the way for future studies on the taxonomy and functional genomics of the genus.	[Sun, Zhihong; Zhang, Wenyi; Liu, Wenjun; Song, Yuqin; Kwok, Lai Yu; Menghe, Bilige; Zhang, Heping] Inner Mongolia Agr Univ, Key Lab Dairy Biotechnol & Engn, Educ Minist China, Hohhot, Inner Mongolia, Peoples R China; [Guo, Chenyi; Yang, Xianwei; Wu, Yarong; Cui, Yujun; Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Sun, Zhihong; Liu, Wenjun; Zhang, Heping] Northeast Agr Univ, Synerget Innovat Ctr Food Safety & Nutr, Harbin 150030, Peoples R China; [Hu, Liangping] Consulting Ctr Biomed Stat, Beijing 100850, Peoples R China	Inner Mongolia Agricultural University; Beijing Institute of Microbiology & Epidemiology; Northeast Agricultural University - China	Zhang, HP (corresponding author), Inner Mongolia Agr Univ, Key Lab Dairy Biotechnol & Engn, Educ Minist China, Hohhot, Inner Mongolia, Peoples R China.	hepingdd@vip.sina.com	Yang, Ruifu/A-2273-2011; Sun, Zhihong/AEN-1028-2022; Zhang, He/GXN-0028-2022	Yang, Ruifu/0000-0003-3219-7269; Sun, Zhihong/0000-0002-7605-2048; Yang, Xianwei/0000-0003-4388-9674	National Natural Science Foundation of China [31025019]; Hi-Tech Research and Development Program of China (863 Planning) [2011AA100902]; International S&T Cooperation Program of China [2014DFR311500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China (863 Planning)(National High Technology Research and Development Program of China); International S&T Cooperation Program of China	This research was supported by the National Natural Science Foundation of China (Grant No. 31025019), Hi-Tech Research and Development Program of China (863 Planning, Grant No. 2011AA100902) and International S&T Cooperation Program of China (Grant No. 2014DFR311500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson KE, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-42; Avershina E, 2013, APPL ENVIRON MICROB, V79, P497, DOI 10.1128/AEM.02359-12; Biavati B, 2000, ANN MICROBIOL, V50, P117; Bottacini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044229; Bottacini F, 2010, MICROBIOL-SGM, V156, P3243, DOI 10.1099/mic.0.039545-0; Deletoile A, 2010, RES MICROBIOL, V161, P82, DOI 10.1016/j.resmic.2009.12.006; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Felis Giovanna E, 2007, Curr Issues Intest Microbiol, V8, P44; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guyonnet D, 2007, ALIMENT PHARM THER, V26, P475, DOI 10.1111/j.1365-2036.2007.03362.x; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hyatt D, 2012, BIOINFORMATICS, V28, P2223, DOI 10.1093/bioinformatics/bts429; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jian WY, 2001, INT J SYST EVOL MICR, V51, P1633, DOI 10.1099/00207713-51-5-1633; Jiang TA, 1996, J DAIRY SCI, V79, P750, DOI 10.3168/jds.S0022-0302(96)76422-6; Kiessling G, 2002, EUR J CLIN NUTR, V56, P843, DOI 10.1038/sj.ejcn.1601399; Killer J, 2013, INT J SYST EVOL MICR, V63, P4350, DOI 10.1099/ijs.0.054957-0; Kim BJ, 2010, INT J SYST EVOL MICR, V60, P2697, DOI 10.1099/ijs.0.020339-0; Kim N, 2007, CLIN IMMUNOL, V123, P30, DOI 10.1016/j.clim.2006.11.005; Klijn A, 2005, FEMS MICROBIOL REV, V29, P491, DOI 10.1016/j.femsre.2005.04.010; Leahy SC, 2005, J APPL MICROBIOL, V98, P1303, DOI 10.1111/j.1365-2672.2005.02600.x; LoCascio RG, 2010, APPL ENVIRON MICROB, V76, P7373, DOI 10.1128/AEM.00675-10; Lukjancenko O, 2012, MICROB ECOL, V63, P651, DOI 10.1007/s00248-011-9948-y; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; McCarthy J, 2003, GUT, V52, P975, DOI 10.1136/gut.52.7.975; Milani C, 2013, APPL ENVIRON MICROB, V79, P4304, DOI 10.1128/AEM.00984-13; POUPARD JA, 1973, BACTERIOL REV, V37, P136, DOI 10.1128/MMBR.37.2.136-165.1973; Prasanna PHP, 2014, FOOD RES INT, V55, P247, DOI 10.1016/j.foodres.2013.11.013; Qiao HP, 2002, PEDIATR RES, V51, P750, DOI 10.1203/01.PDR.0000017481.64723.1F; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Turroni F, 2008, ANTON LEEUW INT J G, V94, P35, DOI 10.1007/s10482-008-9232-4; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; Turroni F, 2011, INT J FOOD MICROBIOL, V149, P37, DOI 10.1016/j.ijfoodmicro.2010.12.010; Turroni F, 2009, ISME J, V3, P745, DOI 10.1038/ismej.2009.19; Ventura M, 2003, APPL ENVIRON MICROB, V69, P7517, DOI 10.1128/AEM.69.12.7517-7522.2003; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Ventura M, 2007, ANTON LEEUW INT J G, V91, P351, DOI 10.1007/s10482-006-9122-6; Ventura M, 2006, INT J SYST EVOL MICR, V56, P2783, DOI 10.1099/ijs.0.64233-0; Ventura M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000785; Wu M, 2012, BIOINFORMATICS, V28, P1033, DOI 10.1093/bioinformatics/bts079	42	62	69	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117912	10.1371/journal.pone.0117912	http://dx.doi.org/10.1371/journal.pone.0117912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658111	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900241
J	Ndumbi, P; Gilbert, L; Tsoukas, CM				Ndumbi, Patricia; Gilbert, Louise; Tsoukas, Christos M.			Comprehensive Evaluation of the Immune Risk Phenotype in Successfully Treated HIV-Infected Individuals	PLOS ONE			English	Article							T-LYMPHOCYTE SUBPOPULATIONS; NECROSIS-FACTOR-ALPHA; SWEDISH NONA IMMUNE; ANTIRETROVIRAL THERAPY; CYTOMEGALOVIRUS-INFECTION; TELOMERE LENGTH; LATE-LIFE; RECEPTOR G1; AGE; CELLS	Background Despite successful treatment and CD4+ T-cell recovery, HIV-infected individuals often experience a profound immune dysregulation characterized by a persistently low CD4:CD8 T-cell ratio. This residual immune dysregulation is reminiscent of the Immune Risk Phenotype (IRP) previously associated with morbidity and mortality in the uninfected elderly (> 85 years). The IRP consists of laboratory markers that include: a low CD4:CD8 T-cell ratio, an expansion of CD8+CD28- T-cells and cytomegalovirus (CMV) seropositivity. Despite the significant overlap in immunological phenotypes between normal aging and HIV infection, the IRP has never been evaluated in HIV-infected individuals. In this pilot study we characterized immune changes associated with the IRP in a sample of successfully treated HIV-infected subjects. Methods 18 virologically suppressed HIV-infected subjects were categorized into 2 groups based on their IRP status; HIV+IRP+, (n = 8) and HIV+IRP-, (n = 10) and compared to 15 age-matched HIV uninfected IRP negative controls. All individuals were assessed for functional and phenotypic immune characteristics including: pro-inflammatory cytokine production, antigen-specific proliferation capacity, replicative senescence, T-cell differentiation and lymphocyte telomere length. Results Compared to HIV-infected subjects without an IRP, HIV+IRP+ subjects exhibited a higher frequency of TNF-alpha-producing CD8+ T-cells (p = 0.05) and a reduced proportion of CD8+ naive T-cells (p = 0.007). The IRP status was also associated with a marked upregulation of the replicative senescence markers CD57 and KLGR1, on the surface of CD8+ T-cells (p = 0.004). Finally, HIV+IRP+ individuals had a significantly shorter mean lymphocyte telomere length than their non-IRP counterparts (p = 0.03). Conclusions Our findings suggest that, despite similar levels of treatment-mediated viral suppression, the phenotypic and functional immune characteristics of HIV+IRP+individuals are distinct from those observed in non-IRP individuals. The IRP appears to identify a subset of treated HIV-infected individuals with a higher degree of immune senescence.	[Ndumbi, Patricia; Gilbert, Louise; Tsoukas, Christos M.] McGill Univ, Ctr Hlth, Immune Deficiency Treatment Ctr, Montreal, PQ, Canada	McGill University	Ndumbi, P (corresponding author), McGill Univ, Ctr Hlth, Immune Deficiency Treatment Ctr, Montreal, PQ, Canada.	patricia.ndumbi@mail.mcgill.ca; chris.tsoukas@muhc.mcgill.ca			Canadian Institutes of Health Research (CIHR) [HOP-75353]; Anna Maria Solinas Laroche Foundation; McGill University Health Center (MUHC) graduate fellowship award; Grete Roggenburg Research Award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Anna Maria Solinas Laroche Foundation; McGill University Health Center (MUHC) graduate fellowship award; Grete Roggenburg Research Award	This work was supported by research funding from the Canadian Institutes of Health Research (CIHR) grant HOP-75353 and by the Anna Maria Solinas Laroche Foundation. Patricia Ndumbi was also supported by the McGill University Health Center (MUHC) graduate fellowship award and the Grete Roggenburg Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almanzar G, 2005, J VIROL, V79, P3675, DOI 10.1128/JVI.79.6.3675-3683.2005; Blazevic V, 2000, AIDS RES HUM RETROV, V16, P1887, DOI 10.1089/08892220050195847; Boren E, 2004, AUTOIMMUN REV, V3, P401, DOI 10.1016/j.autrev.2004.03.004; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Breton G, 2013, J IMMUNOL, V191, P2194, DOI 10.4049/jimmunol.1200646; Bruunsgaard H, 1999, J GERONTOL A-BIOL, V54, pM357, DOI 10.1093/gerona/54.7.M357; Bruunsgaard H, 2003, AM J MED, V115, P278, DOI 10.1016/S0002-9343(03)00329-2; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chong LK, 2008, EUR J IMMUNOL, V38, P995, DOI 10.1002/eji.200737687; Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002; Derhovanessian E, 2009, CURR OPIN IMMUNOL, V21, P440, DOI 10.1016/j.coi.2009.05.012; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245; Fagnoni FF, 1996, IMMUNOLOGY, V88, P501, DOI 10.1046/j.1365-2567.1996.d01-689.x; FERGUSON FG, 1995, J GERONTOL A-BIOL, V50, pB378, DOI 10.1093/gerona/50A.6.B378; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Focosi D, 2010, J LEUKOCYTE BIOL, V87, P107, DOI 10.1189/jlb.0809566; Goronzy JJ, 2007, EXP GERONTOL, V42, P400, DOI 10.1016/j.exger.2006.11.016; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Ibegbu CC, 2005, J IMMUNOL, V174, P6088, DOI 10.4049/jimmunol.174.10.6088; Leung V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077665; McComsey GA, 2014, JAIDS-J ACQ IMM DEF, V65, P167, DOI 10.1097/01.qai.0000437171.00504.41; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Ndumbi P, 2014, HIV MED, V15, P153, DOI 10.1111/hiv.12096; Ndumbi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094018; O'Callaghan NJ, 2008, BIOTECHNIQUES, V44, P807, DOI 10.2144/000112761; Olivieri F, 2009, ATHEROSCLEROSIS, V206, P588, DOI 10.1016/j.atherosclerosis.2009.03.034; Olsson J, 2000, MECH AGEING DEV, V121, P187; Paolisso G, 1998, AM J PHYSIOL-ENDOC M, V275, pE294, DOI 10.1152/ajpendo.1998.275.2.E294; Pawelec G, 2001, MECH AGEING DEV, V122, P132, DOI 10.1016/S0047-6374(00)00240-2; Plonquet A, 2011, IMMUN AGEING, V8, DOI 10.1186/1742-4933-8-8; RIANCHO JA, 1994, GERONTOLOGY, V40, P8; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Stowe RP, 2012, J MED VIROL, V84, P1797, DOI 10.1002/jmv.23397; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; van de Berg PJEJ, 2010, J IMMUNOL, V184, P3417, DOI 10.4049/jimmunol.0903442; Voehringer D, 2002, BLOOD, V100, P3698, DOI 10.1182/blood-2002-02-0657; Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Wikby A, 2002, EXP GERONTOL, V37, P445, DOI 10.1016/S0531-5565(01)00212-1; Wikby A, 2008, BIOGERONTOLOGY, V9, P299, DOI 10.1007/s10522-008-9138-6; Wikby A, 2006, MECH AGEING DEV, V127, P695, DOI 10.1016/j.mad.2006.04.003; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Zanni F, 2003, EXP GERONTOL, V38, P981, DOI 10.1016/S0531-5565(03)00160-8	45	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117039	10.1371/journal.pone.0117039	http://dx.doi.org/10.1371/journal.pone.0117039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647167	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600051
J	Paredes, D; Cayuela, L; Gurr, GM; Campos, M				Paredes, Daniel; Cayuela, Luis; Gurr, Geoff M.; Campos, Mercedes			Is Ground Cover Vegetation an Effective Biological Control Enhancement Strategy against Olive Pests?	PLOS ONE			English	Article							NATURAL ENEMIES; HABITAT MANAGEMENT; AGRICULTURAL LANDSCAPES; BENEFICIAL ARTHROPODS; INTRAGUILD PREDATION; TETRANYCHUS-URTICAE; PEACH ORCHARDS; CONTROL AGENTS; INSECT PESTS; DIVERSITY	Ground cover vegetation is often added or allowed to generate to promote conservation biological control, especially in perennial crops. Nevertheless, there is inconsistent evidence of its effectiveness, with studies reporting positive, nil or negative effects on pest control. This might arise from differences between studies at the local scale (e.g. orchard management and land use history), the landscape context (e.g. presence of patches of natural or semi-natural vegetation near the focal orchard), or regional factors, particularly climate in the year of the study. Here we present the findings from a long-term regional monitoring program conducted on four pest species (Bactrocera oleae, Prays oleae, Euphyllura olivina, Saissetia oleae) in 2,528 olive groves in Andalusia (Spain) from 2006 to 2012. Generalized linear mixed effect models were used to analyze the effect of ground cover on different response variables related to pest abundance, while accounting for variability at the local, landscape and regional scales. There were small and inconsistent effects of ground cover on the abundance of pests whilst local, landscape and regional variability explained a large proportion of the variability in pest response variables. This highlights the importance of local and landscape-related variables in biological control and the potential effects that might emerge from their interaction with practices, such as groundcover vegetation, implemented to promote natural enemy activity. The study points to perennial vegetation close to the focal crop as a promising alternative strategy for conservation biological control that should receive more attention.	[Paredes, Daniel; Campos, Mercedes] CSIC, Estac Expt Zaidin, Dept Protecc Ambiental, Granada, Andalucia, Spain; [Cayuela, Luis] Univ Rey Juan Carlos I, Dept Biol & Geol, Madrid, Spain; [Gurr, Geoff M.] New South Wales Dept Primary Ind, Graham Ctr Agr Innovat, Orange, NSW, Australia; [Gurr, Geoff M.] Charles Sturt Univ, Orange, NSW, Australia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Universidad Rey Juan Carlos; NSW Department of Primary Industries; Charles Sturt University	Paredes, D (corresponding author), CSIC, Estac Expt Zaidin, Dept Protecc Ambiental, Granada, Andalucia, Spain.	daniel.paredes@eez.csic.es	Cayuela, Luis/K-7255-2015; GURR, GEOFFREY M/F-3519-2011; Paredes, Daniel/A-2183-2009; Campos, Mercedes/L-6323-2014	Cayuela, Luis/0000-0003-3562-2662; Paredes, Daniel/0000-0002-2681-2256; Campos, Mercedes/0000-0003-4313-7069; Gurr, Geoff/0000-0001-5008-7966	Junta de Andalucia [PO7-AGR-2747]; project REMEDINAL-2 (Comunidad de Madrid) [S2009/AMB-1783]; Ministry of Education of Spain (FPU grant) [AP-2007-03970]	Junta de Andalucia(Junta de Andalucia); project REMEDINAL-2 (Comunidad de Madrid)(Comunidad de Madrid); Ministry of Education of Spain (FPU grant)	The authors thank Mr. Ricardo Alarcon Roldan, Head of the Crop Protection Service of the Junta de Andalusia (Spain), for providing the data to develop this work. This study was grant-aided by Junta de Andalucia (PO7-AGR-2747), project REMEDINAL-2 (Comunidad de Madrid, S2009/AMB-1783), and the Ministry of Education of Spain (D. P. FPU grant AP-2007-03970). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Fenollosa E, 2011, CROP PROT, V30, P1328, DOI 10.1016/j.cropro.2011.05.011; Arambourg Y, 1986, TRAITE ENTOMOLOGIE O; ARGOV Y, 1993, ENTOMOPHAGA, V38, P89, DOI 10.1007/BF02373143; Baggen LR, 1998, BIOL CONTROL, V11, P9, DOI 10.1006/bcon.1997.0566; Bates D, 2013, IME4 LINEAR MIXED S4; Begum M, 2006, J APPL ECOL, V43, P547, DOI 10.1111/j.1365-2664.2006.01168.x; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Blitzer EJ, 2012, AGR ECOSYST ENVIRON, V146, P34, DOI 10.1016/j.agee.2011.09.005; Boccaccio L, 2009, BIOCONTROL, V54, P607, DOI 10.1007/s10526-009-9214-0; Boller E. F., 2004, ECOLOGICAL INFRASTRU; Bowie MH, 1999, INT J PEST MANAGE, V45, P69, DOI 10.1080/096708799228076; Castrignano A, 2012, PRECIS AGRIC, V13, P421, DOI 10.1007/s11119-012-9259-4; Colloff MJ, 2013, BIOL CONTROL, V67, P170, DOI 10.1016/j.biocontrol.2013.07.017; CROFT BA, 1975, ANNU REV ENTOMOL, V20, P285, DOI 10.1146/annurev.en.20.010175.001441; Cullen R, 2008, BIOL CONTROL, V45, P272, DOI 10.1016/j.biocontrol.2008.01.016; De Andres F., 2001, ENFERMEDADES PLAGAS; Ditner N, 2013, BIODIVERS CONSERV, V22, P1049, DOI 10.1007/s10531-013-0469-5; Dong Jie, 2005, Great Lakes Entomologist, V38, P186; Duarte J., 2009, SOSTENIBILIDAD PRODU; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Gurr GM, 2010, BIOL CONTROL, V52, P198, DOI 10.1016/j.biocontrol.2009.02.013; Hardman JM, 2011, EXP APPL ACAROL, V53, P215, DOI 10.1007/s10493-010-9397-1; Hartwig NL, 2002, WEED SCI, V50, P688, DOI 10.1614/0043-1745(2002)050[0688:AIACCA]2.0.CO;2; Hodge MA, 1999, J ARACHNOL, V27, P351; Jarraya A., 2004, PRINCIPAUX NUISIBLES; Junta de Andalucia, 2012, PROT CAMP PAR SEG CU; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Logan JD, 2006, ECOL MODEL, V196, P471, DOI 10.1016/j.ecolmodel.2006.02.034; Malumphy C., 2011, British Journal of Entomology and Natural History, V24, P17; Martin EA, 2013, P NATL ACAD SCI USA, V110, P5534, DOI 10.1073/pnas.1215725110; Martinat P.J., 1987, P241; MCCLURE MS, 1982, J ECON ENTOMOL, V75, P64, DOI 10.1093/jee/75.1.64; MEAGHER RL, 1990, EXP APPL ACAROL, V9, P149, DOI 10.1007/BF01193424; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P283; Ortega M, 2013, SPATIO TEMPORAL ANAL, DOI [10.1111/afe.12030, DOI 10.1111/AFE.12030]; Paredes D., 2013, Ecosistemas, V22, P56; Paredes D, 2013, PEERJ, V1, DOI 10.7717/peerj.116; Paredes D, 2013, AGR ECOSYST ENVIRON, V173, P72, DOI 10.1016/j.agee.2013.04.016; Perovic DJ, 2010, BIOL CONTROL, V52, P263, DOI 10.1016/j.biocontrol.2009.09.014; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramos P, 1998, CROP PROT, V17, P645, DOI 10.1016/S0261-2194(98)00065-9; ROSENHEIM JA, 1995, BIOL CONTROL, V5, P303, DOI 10.1006/bcon.1995.1038; Rusch A, 2013, J APPL ECOL, V50, P345, DOI 10.1111/1365-2664.12055; Silva EB, 2010, B ENTOMOL RES, V100, P489, DOI 10.1017/S0007485309990526; Simon S, 2010, AGRON SUSTAIN DEV, V30, P139, DOI 10.1051/agro/2009013; Skaug H., 2013, GEN LINEAR MIXED MOD; Smith MW, 1996, BIOL CONTROL, V6, P164, DOI 10.1006/bcon.1996.0021; Song BZ, 2010, BIOCONTROL, V55, P741, DOI 10.1007/s10526-010-9301-2; Song BZ, 2011, PEST MANAG SCI, V67, P1107, DOI 10.1002/ps.2156; Stephens MJ, 1998, BIOCONTROL SCI TECHN, V8, P547, DOI 10.1080/09583159830063; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; Tscheulin T, 2011, B ENTOMOL RES, V101, P557, DOI 10.1017/S0007485311000149; Tsitsilas A, 2011, AUST J ENTOMOL, V50, P37, DOI 10.1111/j.1440-6055.2010.00779.x; Valentine BJ, 1996, AUST J EXP AGR, V36, P501, DOI 10.1071/EA9960501; Wan Nian-feng, 2011, Shengtaixue Zazhi, V30, P30; Woltz JM, 2012, AGR ECOSYST ENVIRON, V152, P40, DOI 10.1016/j.agee.2012.02.008	57	45	46	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117265	10.1371/journal.pone.0117265	http://dx.doi.org/10.1371/journal.pone.0117265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646778	Green Submitted, gold, Green Published			2022-12-27	WOS:000348822600061
J	Samardakiewicz, S; Krzeszowiec-Jelen, W; Bednarski, W; Jankowski, A; Suski, S; Gabrys, H; Wozny, A				Samardakiewicz, Slawomir; Krzeszowiec-Jelen, Weronika; Bednarski, Waldemar; Jankowski, Artur; Suski, Szymon; Gabrys, Halina; Wozny, Adam			Pb-Induced Avoidance-Like Chloroplast Movements in Fronds of Lemna trisulca L.	PLOS ONE			English	Article							PHOTOTROPIN FAMILY PROTEINS; VAR. MACOUNII XANTHOPHYTA; BLUE-LIGHT; ARABIDOPSIS-THALIANA; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; ACTIN-FILAMENTS; PHOTOSYNTHETIC APPARATUS; MECHANICAL STIMULATION; MESOPHYLL CHLOROPLASTS	Lead ions are particularly dangerous to the photosynthetic apparatus, but little is known about the effects of trace metals, including Pb, on regulation of chloroplast redistribution. In this study a new effect of lead on chloroplast distribution patterns and movements was demonstrated in mesophyll cells of a small-sized aquatic angiosperm Lemna trisulca L. (star duckweed). An analysis of confocal microscopy images of L. trisulca fronds treated with lead (15 mu MPb2+, 24 h) in darkness or in weak white light revealed an enhanced accumulation of chloroplasts in the profile position along the anticlinal cell walls, in comparison to untreated plants. The rearrangement of chloroplasts in their response to lead ions in darkness was similar to the avoidance response of chloroplasts in plants treated with strong white light. Transmission electron microscopy X-ray microanalysis showed that intracellular chloroplast arrangement was independent of the location of Pb deposits, suggesting that lead causes redistribution of chloroplasts, which looks like a light-induced avoidance response, but is not a real avoidance response to the metal. Furthermore, a similar redistribution of chloroplasts in L. trisulca cells in darkness was observed also under the influence of exogenously applied hydrogen peroxide (H2O2). In addition, we detected an enhanced accumulation of endogenous H2O2 after treatment of plants with lead. Interestingly, H2O2-specific scavenger catalase partly abolished the Pb-induced chloroplast response. These results suggest that H2O2 can be involved in the avoidance-like movement of chloroplasts induced by lead. Analysis of photometric measurements revealed also strong inhibition (but not complete) of blue-light-induced chloroplast movements by lead. This inhibition may result from disturbances in the actin cytoskeleton, as we observed fragmentation and disappearance of actin filaments around chloroplasts. Results of this study show that the mechanisms of the toxic effect of lead on chloroplasts can include disturbances in their movement and distribution pattern.	[Samardakiewicz, Slawomir] Adam Mickiewicz Univ, Fac Biol, Lab Elect & Confocal Microscopy, Poznan, Poland; [Krzeszowiec-Jelen, Weronika; Gabrys, Halina] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Plant Biotechnol, Krakow, Poland; [Bednarski, Waldemar] Polish Acad Sci, Inst Mol Phys, Poznan, Poland; [Jankowski, Artur; Wozny, Adam] Adam Mickiewicz Univ, Fac Biol, Inst Expt Biol, Lab Gen Bot, Poznan, Poland; [Suski, Szymon] Polish Acad Sci, Nencki Inst Expt Biol, Lab Elect Microscopy, Warsaw, Poland	Adam Mickiewicz University; Jagiellonian University; Polish Academy of Sciences; Institute of Molecular Physics of the Polish Academy of Sciences; Adam Mickiewicz University; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Samardakiewicz, S (corresponding author), Adam Mickiewicz Univ, Fac Biol, Lab Elect & Confocal Microscopy, Poznan, Poland.	sas@amu.edu.pl	Krzeszowiec-Jeleń, Weronika/C-9431-2017; Krzeszowiec-Jeleń, Weronika/AAB-7814-2022; Samardakiewicz, Sławomir/A-6741-2008; Bednarski, Waldemar/U-8837-2018	Krzeszowiec-Jeleń, Weronika/0000-0003-4564-2499; Bednarski, Waldemar/0000-0003-1956-7501; Suski, Szymon/0000-0002-3805-3760; Samardakiewicz, Slawomir/0000-0003-4924-253X	Polish National Science Centre Project (NCN) [8066/B/P01/2011/40]	Polish National Science Centre Project (NCN)	Slawomir Samardakiewicz was supported by the Polish National Science Centre Project (NCN) grant no. 8066/B/P01/2011/40. The X-ray microanalysis were performed in the Laboratory of Electron Microscopy, Nencki Institute of Experimental Biology (Warsaw, Poland) by using electron microscope JEM 1400 (JEOL Co., Japan, 2008), equipped with energy-dispersive full range X-ray microanalysis system (EDS INCA Energy TEM, Oxford Instruments, Great Britain) and high resolution digital camera CCD MORADA, SiS-Olympus,	Aggarwal C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055393; Alessa L, 2001, ENVIRON EXP BOT, V45, P205, DOI 10.1016/S0098-8472(00)00087-3; Alessa L, 2001, ENVIRON EXP BOT, V45, P223, DOI 10.1016/S0098-8472(00)00088-5; Anielska-Mazur A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-64; Augustynowicz J, 1999, PLANT CELL ENVIRON, V22, P1239, DOI 10.1046/j.1365-3040.1999.00487.x; Banas AK, 2012, J EXP BOT, V63, P1559, DOI 10.1093/jxb/err429; Banas AK, 2010, ACTA PHYSIOL PLANT, V32, P773, DOI 10.1007/s11738-010-0462-5; Banas AK, 2007, PLANT SIGNAL BEHAV, V2, P221, DOI 10.4161/psb.2.4.4392; BASILE A, 1995, ANN BOT-LONDON, V76, P597, DOI 10.1006/anbo.1995.1137; BECANA M, 1986, PLANT PHYSIOL, V82, P1169, DOI 10.1104/pp.82.4.1169; Berg R, 2006, PHOTOSYNTH RES, V87, P303, DOI 10.1007/s11120-005-9012-1; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Davis PA, 2012, PHOTOSYNTH RES, V112, P153, DOI 10.1007/s11120-012-9755-4; DeBlasio SL, 2003, PLANT PHYSIOL, V133, P1471, DOI 10.1104/pp.103.029116; Delmail D, 2014, PHYSL MECH ADAPTATIO, P31, DOI DOI 10.1007/9781461486008_2; Devi R, 2013, PHYSIOL MOL BIOL PLA, V19, P81, DOI 10.1007/s12298-012-0143-5; Dong XJ, 1996, PROTOPLASMA, V195, P18, DOI 10.1007/BF01279183; Dong XJ, 1998, PLANT CELL PHYSIOL, V39, P1299, DOI 10.1093/oxfordjournals.pcp.a029334; Eckstein A, 2012, J PLANT GROWTH REGUL, V31, P90, DOI 10.1007/s00344-011-9222-z; Fahr M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00175; Frolec J, 2010, PLANT CELL REP, V29, P705, DOI 10.1007/s00299-010-0856-2; GABRYS H, 1980, Acta Physiologiae Plantarum, V2, P291; Gabrys H, 1997, J PHOTOCH PHOTOBIO B, V38, P35, DOI 10.1016/S1011-1344(96)07396-4; GABRYS H, 2014, BIOL DIVERSITY CELL, P9, DOI DOI 10.1016/J.JEP.2014.12.058; GABRYS H, 1980, ACTA PHYSIOL PLANT, V4, P281; Gabrys H, 2012, PROG BOT, V73, P189, DOI 10.1007/978-3-642-22746-2_7; GARLAND CJ, 1981, NEW PHYTOL, V87, P581, DOI 10.1111/j.1469-8137.1981.tb03229.x; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Goh CH, 2009, PLANT MOL BIOL, V69, P605, DOI 10.1007/s11103-008-9442-1; Grabalska M, 2004, PHOTOCHEM PHOTOBIOL, V79, P343, DOI 10.1562/LE-03-16.1; Guralnick LJ, 2002, FUNCT PLANT BIOL, V29, P763, DOI 10.1071/PP01176; Han IS, 2013, PLANT CELL PHYSIOL, V54, P48, DOI 10.1093/pcp/pcs098; Harada A, 2003, P NATL ACAD SCI USA, V100, P8583, DOI 10.1073/pnas.1336802100; Harada A, 2007, PHOTOCHEM PHOTOBIOL, V83, P102, DOI 10.1562/2006-03-08-IR-837; HAUPT W, 1990, PLANT CELL ENVIRON, V13, P595, DOI 10.1111/j.1365-3040.1990.tb01078.x; Heald R, 2014, CURR OPIN CELL BIOL, V26, P79, DOI 10.1016/j.ceb.2013.10.006; Huang HG, 2012, ENVIRON SCI POLLUT R, V19, P1640, DOI 10.1007/s11356-011-0675-1; Huang JW, 1996, NEW PHYTOL, V134, P75, DOI 10.1111/j.1469-8137.1996.tb01147.x; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; JELESNIANSKA J, 1981, Acta Physiologiae Plantarum, V3, P3; Kabata-Pendias Alina, 2010, P1; KADOTA A, 1992, PROTOPLASMA, V167, P97, DOI 10.1007/BF01353585; Kadota A, 2009, P NATL ACAD SCI USA, V106, P13106, DOI 10.1073/pnas.0906250106; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kagawa T, 2004, PLANT CELL PHYSIOL, V45, P416, DOI 10.1093/pcp/pch045; Kandasamy MK, 1999, CELL MOTIL CYTOSKEL, V44, P110, DOI 10.1002/(SICI)1097-0169(199910)44:2<110::AID-CM3>3.0.CO;2-O; Kasahara M, 2002, NATURE, V420, P829, DOI 10.1038/nature01213; Kaur G, 2013, PROTOPLASMA, V250, P53, DOI 10.1007/s00709-011-0372-4; Kim YY, 2002, PHYSIOL PLANTARUM, V116, P368, DOI 10.1034/j.1399-3054.2002.1160312.x; Kobayashi H, 2009, PLANT CELL PHYSIOL, V50, P129, DOI 10.1093/pcp/pcn177; Kodama Y, 2008, J PLANT RES, V121, P441, DOI 10.1007/s10265-008-0165-9; Kodama Y, 2010, P NATL ACAD SCI USA, V107, P19591, DOI 10.1073/pnas.1007836107; Koniger M, 2014, ADV PHOTOSYNTH RESP, V37, P131, DOI 10.1007/978-94-007-6988-5_8; Kondo A, 2004, PLANTA, V219, P500, DOI 10.1007/s00425-004-1252-3; Kong SG, 2014, BBA-BIOENERGETICS, V1837, P522, DOI 10.1016/j.bbabio.2013.12.004; Kong SG, 2013, PLANT CELL, V25, P572, DOI 10.1105/tpc.113.109694; Kong SG, 2011, MOL PLANT, V4, P771, DOI 10.1093/mp/ssr061; KRUPA Z, 1995, ACTA PHYSIOL PLANT, V17, P177; Krzeslowska M, 2002, BIOL PLANTARUM, V45, P99, DOI 10.1023/A:1015104726046; Krzeslowska M, 2010, ENVIRON POLLUT, V158, P325, DOI 10.1016/j.envpol.2009.06.035; Krzeszowiec W, 2007, BIOL CELL, V99, P251, DOI 10.1042/BC20060077; Krzeszowiec W, 2011, SIGNAL COMMUN PLANTS, P91, DOI 10.1007/978-3-642-19091-9_4; Kumar A, 2012, CHEMOSPHERE, V89, P1056, DOI 10.1016/j.chemosphere.2012.05.070; Kupper H, 2017, METAL IONS LIFE SCI, V17, P491, DOI [10.1590/S1677-04202005000100004, 10.1515/9783110434330-015]; Landolt E, 1986, BIOSYSTEMATIC INVEST, V2, P566; LECHOWSKI Z, 1973, Acta Societatis Botanicorum Poloniae, V42, P461; Liu DH, 2009, ECOTOXICOLOGY, V18, P134, DOI 10.1007/s10646-008-0266-1; Luesse DR, 2010, J EXP BOT, V61, P4387, DOI 10.1093/jxb/erq242; Maai E, 2011, J EXP BOT, V62, P3213, DOI 10.1093/jxb/err008; Maberly SC, 1998, FUNCT ECOL, V12, P99, DOI 10.1046/j.1365-2435.1998.00172.x; MAKSYMIEC W, 2008, ABIOTIC STRESS PLANT, P139; Maksymiec W, 2007, ACTA PHYSIOL PLANT, V29, P177, DOI 10.1007/s11738-007-0036-3; Malec P, 1996, PLANT SCI, V120, P127, DOI 10.1016/S0168-9452(96)04506-2; Malecka A, 2009, ACTA PHYSIOL PLANT, V31, P1053, DOI 10.1007/s11738-009-0326-z; Morita MT, 2012, CURR OPIN PLANT BIOL, V15, P722, DOI 10.1016/j.pbi.2012.08.003; MYSLIWAKURDZIEL B, 2004, HEAVY METAL STRESS P, P462; Naus J, 2010, PHOTOSYNTH RES, V105, P265, DOI 10.1007/s11120-010-9587-z; Oelze ML, 2012, J EXP BOT, V63, P1297, DOI 10.1093/jxb/err356; Ogasawara Y, 2013, PLANT CELL ENVIRON, V36, P1520, DOI 10.1111/pce.12085; Oikawa K, 2008, PLANT PHYSIOL, V148, P829, DOI 10.1104/pp.108.123075; Olyslaegers G, 1998, J MICROSC-OXFORD, V192, P73, DOI 10.1046/j.1365-2818.1998.00398.x; Oliver JP, 2009, PLANTA, V230, P569, DOI 10.1007/s00425-009-0969-4; Park YI, 1996, PLANT PHYSIOL, V111, P867, DOI 10.1104/pp.111.3.867; Parys E, 1998, ACTA PHYSIOL PLANT, V20, P313, DOI 10.1007/s11738-998-0064-7; Petrov VD, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls014; Pokorna J, 2004, PLANT CELL ENVIRON, V27, P641, DOI 10.1111/j.1365-3040.2004.01186.x; Pourrut B., 2013, HEAVY METAL STRESS P, P121, DOI DOI 10.1007/978-3-642-38469-1_7; Pourrut B, 2008, J PLANT PHYSIOL, V165, P571, DOI 10.1016/j.jplph.2007.07.016; Pressel S, 2008, ANN BOT-LONDON, V102, P227, DOI 10.1093/aob/mcn080; Pribyl P, 2005, PROTOPLASMA, V226, P231, DOI 10.1007/s00709-005-0123-5; Przymusinki R, 2007, ACTA PHYSIOL PLANT, V29, P411, DOI 10.1007/s11738-007-0049-y; Quan LJ, 2008, J INTEGR PLANT BIOL, V50, P2, DOI 10.1111/j.1744-7909.2007.00599.x; Rodrigues V, 2007, CURR SCI INDIA, V92, P1610; Rosler J, 2010, PLANT CELL PHYSIOL, V51, P1248, DOI 10.1093/pcp/pcq091; Romanowska E, 2006, PLANT PHYSIOL BIOCH, V44, P387, DOI 10.1016/j.plaphy.2006.06.003; Romanowska E, 2002, PHYSIOLOGY AND BIOCHEMISTRY OF METAL TOXICITY AND TOLERANCE IN PLANTS, P257; Romanowska E, 2012, J PLANT PHYSIOL, V169, P345, DOI 10.1016/j.jplph.2011.10.006; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Samardakiewicz S, 2000, PLANT SOIL, V226, P107, DOI 10.1023/A:1026440730839; Sato Y, 1999, PLANT PHYSIOL, V121, P37, DOI 10.1104/pp.121.1.37; Sato Y, 2003, PLANTA, V216, P772, DOI 10.1007/s00425-002-0927-x; Sato Y, 2003, J PLANT RES, V116, P1, DOI 10.1007/s10265-002-0073-3; Sato Y, 2001, PLANT PHYSIOL, V127, P497, DOI 10.1104/pp.010405; Sato Y, 2001, J CELL SCI, V114, P269; Sato Yoshikatsu, 2006, V23, P527; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Sharon Y., 2011, J MAR BIOL, V2011, DOI [10.1155/2011/483428, DOI 10.1155/2011/483428]; Sharon Y, 2008, AQUAT BOT, V88, P273, DOI 10.1016/j.aquabot.2007.11.006; Shiihira-Ishikawa I, 2007, PHOTOCHEM PHOTOBIOL, V83, P1101, DOI 10.1111/j.1751-1097.2007.00167.x; Singh HP, 2011, BIOL TRACE ELEM RES, V144, P1295, DOI 10.1007/s12011-011-9129-3; Singh R, 2010, BIORESOURCE TECHNOL, V101, P3025, DOI 10.1016/j.biortech.2009.12.031; Snowman BN, 2002, PLANT CELL, V14, P2613, DOI 10.1105/tpc.002998; Stobrawa K, 2007, SCI TOTAL ENVIRON, V373, P157, DOI 10.1016/j.scitotenv.2006.11.019; STRASBURGER E, 1954, KLEINE BOT PRAKTIKUM, P28669; Suetsugu N, 2005, PLANT PHYSIOL, V139, P151, DOI 10.1104/pp.105.067371; Suetsugu N, 2007, BIOL CHEM, V388, P927, DOI 10.1515/BC.2007.118; Suetsugu N, 2007, PHOTOCHEM PHOTOBIOL, V83, P87, DOI 10.1562/2006-02-27-IR-817; Suetsugu N, 2012, ADVANCES IN PHOTOSYNTHESIS - FUNDAMENTAL ASPECTS, P215; Sytar O, 2013, ACTA PHYSIOL PLANT, V35, P985, DOI 10.1007/s11738-012-1169-6; Sztatelman O, 2010, J PLANT PHYSIOL, V167, P709, DOI 10.1016/j.jplph.2009.12.015; Takagi S, 2003, J EXP BIOL, V206, P1963, DOI 10.1242/jeb.00215; Tanaka A, 2007, TREE PHYSIOL, V27, P641, DOI 10.1093/treephys/27.5.641; TERASHIMA I, 1995, PLANT CELL ENVIRON, V18, P1111, DOI 10.1111/j.1365-3040.1995.tb00623.x; Terashima I, 2014, PLANT CELL PHYSIOL, V55, P237, DOI 10.1093/pcp/pcu022; Terashima I, 2011, PLANT PHYSIOL, V155, P108, DOI 10.1104/pp.110.165472; Tholen D, 2008, PLANT CELL ENVIRON, V31, P1688, DOI 10.1111/j.1365-3040.2008.01875.x; Tlalka M, 1999, PLANT J, V20, P461, DOI 10.1046/j.1365-313x.1999.00621.x; TLALKA M, 1993, PLANTA, V189, P491, DOI 10.1007/BF00198211; Trojan A, 1996, PLANT PHYSIOL, V111, P419, DOI 10.1104/pp.111.2.419; Tsuboi H, 2007, PLANT CELL PHYSIOL, V48, P892, DOI 10.1093/pcp/pcm057; Tsuboi H, 2012, J PLANT RES, V125, P417, DOI 10.1007/s10265-011-0444-8; Tsuboi H, 2012, J PLANT RES, V125, P301, DOI 10.1007/s10265-011-0433-y; Mai VC, 2013, PHYTOCHEMISTRY, V93, P49, DOI 10.1016/j.phytochem.2013.02.011; Verma S, 2003, PLANT SCI, V164, P645, DOI 10.1016/S0168-9452(03)00022-0; Voesenek LACJ, 2006, NEW PHYTOL, V170, P213, DOI 10.1111/j.1469-8137.2006.01692.x; Vorob'yev V. N., 1995, Biophysics (English Translation of Biofizika), V40, P537; Wada M, 2004, CURR OPIN PLANT BIOL, V7, P626, DOI 10.1016/j.pbi.2004.09.005; Wada M, 2013, PLANT SCI, V210, P177, DOI 10.1016/j.plantsci.2013.05.016; WALCZAK T, 1980, PHOTOSYNTHETICA, V14, P65; Wang PF, 2012, ECOTOX ENVIRON SAFE, V78, P28, DOI 10.1016/j.ecoenv.2011.11.008; WANG WC, 1990, ENVIRON RES, V52, P7, DOI 10.1016/S0013-9351(05)80147-1; Wang YQ, 2013, J INTEGR PLANT BIOL, V55, P202, DOI 10.1111/jipb.12032; Wen F, 2008, J EXP BOT, V59, P2891, DOI 10.1093/jxb/ern147; Wierzbicka MH, 2007, PROTOPLASMA, V231, P99, DOI 10.1007/s00709-006-0227-6; Wituszynska W, 2013, ABIOTIC STRESS - PLANT RESPONSES AND APPLICATIONS IN AGRICULTURE, P207, DOI 10.5772/53127; Wong CSC, 2006, ENVIRON POLLUT, V142, P1, DOI 10.1016/j.envpol.2005.09.004; Yamada M, 2009, PLANT CELL PHYSIOL, V50, P1736, DOI 10.1093/pcp/pcp116; ZURZYCHI J, 1972, ACTA PROTOZOOL  S MO, V11, P189; ZURZYCKA A, 1950, ACTA SOC BOT POL, V20, P665; ZURZYCKA A, 1951, ACTA SOC BOT POL, V21, P113; Zurzycki J., 1980, The blue light syndrome [Senger, H. (Editor)]., P50; ZURZYCKI J, 1983, PLANTA, V157, P502, DOI 10.1007/BF00396880; ZURZYCKI J., 1955, ACTA SOC BOT POLON, V24, P27; ZURZYCKI JAN, 1962, ACTA SOC BOT POLON, V31, P489; ZURZYCKL J., 1960, ACTA SOC BOT POLON, V29, P385	156	18	18	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116757	10.1371/journal.pone.0116757	http://dx.doi.org/10.1371/journal.pone.0116757			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646776	gold, Green Submitted, Green Published			2022-12-27	WOS:000348822600034
J	Wang, O; Liu, J; Cheng, Q; Guo, XX; Wang, Y; Zhao, L; Zhou, F; Ji, BP				Wang, Ou; Liu, Jia; Cheng, Qian; Guo, Xiaoxuan; Wang, Yong; Zhao, Liang; Zhou, Feng; Ji, Baoping			Effects of Ferulic Acid and gamma-Oryzanol on High-Fat and High-Fructose Diet-Induced Metabolic Syndrome in Rats	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; RICE BRAN OIL; INSULIN-RESISTANCE; PLANT STEROLS; HEPATIC STEATOSIS; CARDIOVASCULAR RISK; HIGH-CARBOHYDRATE; LIPID-METABOLISM; LIVER-DISEASE; HEPG2 CELLS	Background The high morbidity of metabolic dysfunction diseases has heightened interest in seeking natural and safe compounds to maintain optimal health. gamma-Oryzanol (OZ), the ferulic acid (FA) ester with phytosterols, mainly present in rice bran has been shown to improve markers of metabolic syndrome. This study investigates the effects of FA and OZ on alleviating high-fat and high-fructose diet (HFFD)-induced metabolic syndrome parameters. Methods Male SD rats were fed with a regular rodent diet, HFFD, or HFFD supplemented with 0.05% FA or 0.16% OZ (equimolar concentrations) for 13 weeks. Food intake, organ indices, serum lipid profiles, glucose metabolism, insulin resistance (IR) index and cytokine levels were analyzed. The mechanisms were further investigated in oleic acid-stimulated HepG2 cells by analyzing triglyceride (TG) content and lipogenesis-related gene expressions. Results In the in vivo study, FA and OZ exhibited similar effects in alleviating HFFD-induced obesity, hyperlipidemia, hyperglycemia, and IR. However, only OZ treatment significantly decreased liver index and hepatic TG content, lowered serum levels of C-reactive protein and IL-6, and increased serum concentration of adiponectin. In the in vitro assay, only OZ administration significantly inhibited intracellular TG accumulation and down-regulated expression of stearoyl coenzyme-A desaturase-1, which might facilitate OZ to enhance its hepatoprotective effect. Conclusion OZ is more effective than FA in inhibiting hepatic fat accumulation and inflammation. Thus, FA and OZ could be used as dietary supplements to alleviate the deleterious effects of HFFD.	[Wang, Ou; Cheng, Qian; Guo, Xiaoxuan; Wang, Yong; Zhao, Liang; Zhou, Feng; Ji, Baoping] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing, Peoples R China; [Liu, Jia] China Natl Res Inst Food & Fermentat Ind, Beijing, Peoples R China	China Agricultural University	Ji, BP (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing, Peoples R China.	jibp330@hotmail.com		Zhao, Liang/0000-0003-2542-9279				Alwahsh SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104220; Ardiansyah, 2006, J AGR FOOD CHEM, V54, P1914, DOI 10.1021/jf052561l; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Baumgartner S, 2011, CURR PHARM DESIGN, V17, P922, DOI 10.2174/138161211795428795; Berger A, 2005, EUR J NUTR, V44, P163, DOI 10.1007/s00394-004-0508-9; Chen SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045693; Chotimarkorn C, 2008, PHYTOMEDICINE, V15, P951, DOI 10.1016/j.phymed.2008.02.014; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; DILLS WL, 1993, AM J CLIN NUTR, V58, P779, DOI 10.1093/ajcn/58.5.779S; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; FUJIWARA S, 1980, YAKUGAKU ZASSHI, V100, P1011, DOI 10.1248/yakushi1947.100.10_1011; GARCIA MJL, 2009, FOOD CHEM, V115, P389; Ghatak SB, 2011, CURR NUTR FOOD SCI, V7, P10, DOI 10.2174/157340111794941120; GRUNFELD C, 1990, ENDOCRINOLOGY, V127, P46, DOI 10.1210/endo-127-1-46; Hiratsuka T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013280; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang CCJ, 2003, THESIS LOUISIANA STA; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Kim HK, 2003, CLIN CHIM ACTA, V327, P129, DOI 10.1016/S0009-8981(02)00344-3; Kozuka C, 2012, DIABETES, V61, P3084, DOI 10.2337/db11-1767; Li XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061499; Liu J, 2014, FOOD FUNCT, V5, P1038, DOI 10.1039/c3fo60524h; Lomonaco R, 2012, HEPATOLOGY, V55, P1389, DOI 10.1002/hep.25539; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Micallef MA, 2009, ATHEROSCLEROSIS, V204, P476, DOI 10.1016/j.atherosclerosis.2008.09.020; Nashed B, 2005, J NUTR, V135, P2438, DOI 10.1093/jn/135.10.2438; *NAT RES COUNC, 1985, NIH PUBL, V85, P23; Othman RA, 2011, NUTR REV, V69, P371, DOI 10.1111/j.1753-4887.2011.00399.x; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pan ZX, 2011, MOL BIOL REP, V38, P3417, DOI 10.1007/s11033-010-0451-1; Panchal SK, 2010, J BIOMED BIOTECHNOL, V2011, P1; Panchal SK, 2011, J CARDIOVASC PHARM, V57, P611, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popa C, 2007, J LIPID RES, V48, P751, DOI 10.1194/jlr.R600021-JLR200; Postic C, 2008, DIABETES METAB, V34, P643, DOI 10.1016/S1262-3636(08)74599-3; Poudyal H, 2010, J NUTR, V140, P946, DOI 10.3945/jn.109.117812; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Silbernagel G, 2013, CURR OPIN LIPIDOL, V24, P12, DOI 10.1097/MOL.0b013e32835b6271; Simmons RK, 2010, DIABETOLOGIA, V53, P600, DOI 10.1007/s00125-009-1620-4; Sloboda DM, 2014, J OBESITY, V2014; Son MJ, 2011, J FOOD SCI, V76, pH7, DOI 10.1111/j.1750-3841.2010.01907.x; Son MJ, 2010, J CLIN BIOCHEM NUTR, V46, P150, DOI 10.3164/jcbn.09-98; Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Vidyashankar S, 2013, TOXICOL IN VITRO, V27, P945, DOI 10.1016/j.tiv.2013.01.014; Wijesekara N, 2010, J BIOL CHEM, V285, P33623, DOI 10.1074/jbc.M109.085084; Wilson TA, 2007, J NUTR BIOCHEM, V18, P105, DOI 10.1016/j.jnutbio.2006.03.006; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhang HJ, 2009, HORM METAB RES, V41, P40, DOI 10.1055/s-0028-1087187; Zhao ZH, 2008, FOOD CHEM, V109, P691, DOI 10.1016/j.foodchem.2008.02.039	54	87	91	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0118135	10.1371/journal.pone.0118135	http://dx.doi.org/10.1371/journal.pone.0118135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646799	Green Submitted, gold, Green Published			2022-12-27	WOS:000348822600100
J	Kandasamy, R; Gurung, M; Thapa, A; Ndimah, S; Adhikari, N; Murdoch, DR; Kelly, DF; Waldron, DE; Gould, KA; Thorson, S; Shrestha, S; Hinds, J; Pollard, AJ				Kandasamy, Rama; Gurung, Meeru; Thapa, Anushil; Ndimah, Susan; Adhikari, Neelam; Murdoch, David R.; Kelly, Dominic F.; Waldron, Denise E.; Gould, Katherine A.; Thorson, Stephen; Shrestha, Shrijana; Hinds, Jason; Pollard, Andrew J.			Multi-Serotype Pneumococcal Nasopharyngeal Carriage Prevalence in Vaccine Naive Nepalese Children, Assessed Using Molecular Serotyping	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; RESISTANT PNEUMOCOCCI; YOUNG-CHILDREN; ACQUISITION; POPULATION; RATES; DNA	Invasive pneumococcal disease is one of the major causes of death in young children in resource poor countries. Nasopharyngeal carriage studies provide insight into the local prevalence of circulating pneumococcal serotypes. There are very few data on the concurrent carriage of multiple pneumococcal serotypes. This study aimed to identify the prevalence and serotype distribution of pneumococci carried in the nasopharynx of young healthy Nepalese children prior to the introduction of a pneumococcal conjugate vaccine using a microarray-based molecular serotyping method capable of detecting multi-serotype carriage. We conducted a cross-sectional study of healthy children aged 6 weeks to 24 months from the Kathmandu Valley, Nepal between May and October 2012. Nasopharyngeal swabs were frozen and subsequently plated on selective culture media. DNA extracts of plate sweeps of pneumococcal colonies from these cultures were analysed using a molecular serotyping microarray capable of detecting relative abundance of multiple pneumococcal serotypes. 600 children were enrolled into the study: 199 aged 6 weeks to <6 months, 202 aged 6 months to < 12 months, and 199 aged 12 month to 24 months. Typeable pneumococci were identified in 297/600 (49.5%) of samples with more than one serotype being found in 67/297 (20.2%) of these samples. The serotypes covered by the thirteen-valent pneumococcal conjugate vaccine were identified in 44.4% of samples containing typeable pneumococci. Application of a molecular serotyping approach to identification of multiple pneumococcal carriage demonstrates a substantial prevalence of co-colonisation. Continued surveillance utilising this approach following the introduction of routine use of pneumococcal conjugate vaccinates in infants will provide a more accurate understanding of vaccine efficacy against carriage and a better understanding of the dynamics of subsequent serotype and genotype replacement.	[Kandasamy, Rama; Ndimah, Susan; Kelly, Dominic F.; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Kandasamy, Rama; Ndimah, Susan; Kelly, Dominic F.; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Gurung, Meeru; Thapa, Anushil; Adhikari, Neelam; Thorson, Stephen; Shrestha, Shrijana] Patan Acad Hlth Sci, Paediat Res Unit, Kathmandu, Nepal; [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Waldron, Denise E.; Hinds, Jason] Univ London, Div Clin Sci, London, England	University of Oxford; University of Oxford; University of Otago; University of London	Kandasamy, R (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England.	rama.kandasamy@paediatrics.ox.ac.uk	Murdoch, David/A-2012-2009	Kandasamy, Rama/0000-0002-3111-5586; Hinds, Jason/0000-0002-2739-1908; Gould, Katherine/0000-0002-2528-9512; Shrestha, Shrijana/0000-0001-9484-0227; Kelly, Dominic/0000-0002-6063-8896	Oxford Vaccine Group, University of Oxford, United Kingdom	Oxford Vaccine Group, University of Oxford, United Kingdom	This study was funded by the Oxford Vaccine Group, University of Oxford, United Kingdom. The University of Oxford, the study sponsor, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2007, J CLIN MICROBIOL, V45, P3408, DOI 10.1128/JCM.01393-07; Abdullahi O, 2012, J INFECT DIS, V206, P1020, DOI 10.1093/infdis/jis447; Bakkali M, 2013, ARCH MICROBIOL, V195, P279, DOI 10.1007/s00203-013-0870-1; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Brugger SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011638; Coles CL, 2008, J NUTR, V138, P2462, DOI 10.3945/jn.108.095422; Coles CL, 2009, TROP MED INT HEALTH, V14, P1025, DOI 10.1111/j.1365-3156.2009.02331.x; Coles CL, 2002, EPIDEMIOL INFECT, V129, P491, DOI 10.1017/S0950268802007586; Dagan R, 2002, J INFECT DIS, V185, P927, DOI 10.1086/339525; Donkor ES, 2011, MBIO, V2, DOI 10.1128/mBio.00040-11; Elberse KEM, 2012, VACCINE, V30, P7644, DOI 10.1016/j.vaccine.2012.04.021; *ENGL PH, 2013, CUM WEEKL NUMB REP I, P13897; Feil EJ, 2000, GENETICS, V154, P1439; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; *GAVI, GAVI ALLIANCE COUNTR, P13897; Gaynor BD, 2005, BRIT J OPHTHALMOL, V89, P1097, DOI 10.1136/bjo.2005.068981; GRATTEN M, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P501; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hanieh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098739; Hare KM, 2008, PEDIATR INFECT DIS J, V27, P178, DOI 10.1097/INF.0b013e31815bb6c5; Huebner RE, 2000, PEDIATR INFECT DIS J, V19, P1017, DOI 10.1097/00006454-200010000-00019; Johnsborg O, 2009, FEMS MICROBIOL REV, V33, P627, DOI 10.1111/j.1574-6976.2009.00167.x; Joshi HH, 2008, J CLIN MICROBIOL, V46, P3175, DOI 10.1128/JCM.00906-08; Kelly DF, 2011, INT J INFECT DIS, V15, pE17, DOI 10.1016/j.ijid.2010.05.021; Koedel U, 2002, LANCET INFECT DIS, V2, P721, DOI 10.1016/S1473-3099(02)00450-4; Lee NY, 2001, CLIN INFECT DIS, V32, P1463, DOI 10.1086/320165; Newton R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-88; Nurhonen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056079; O'Brien KL, 2007, J INFECT DIS, V196, P1211, DOI 10.1086/521833; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; Rivera-Olivero IA, 2009, J MED MICROBIOL, V58, P584, DOI 10.1099/jmm.0.006726-0; Salter SJ, 2012, MICROBIOL-SGM, V158, P1560, DOI 10.1099/mic.0.056580-0; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Turner P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038271; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; Weinberger DM, 2011, EPIDEMIOLOGY, V22, P199, DOI 10.1097/EDE.0b013e3182087634	38	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0114286	10.1371/journal.pone.0114286	http://dx.doi.org/10.1371/journal.pone.0114286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643355	gold, Green Published, Green Accepted			2022-12-27	WOS:000348821200004
J	Wang, FF; Zou, YF; Shen, YF; Zhong, YQ; Lv, YN; Huang, DM; Chen, KC; Li, Q; Qing, L; Xia, B; Su, C; Ma, SY; Yang, XB				Wang, Fenfen; Zou, Yunfeng; Shen, Yuefei; Zhong, Yaoqiu; Lv, Yingnan; Huang, Damin; Chen, Kangcheng; Li, Qin; Qing, Li; Xia, Bing; Su, Cheng; Ma, Shuyan; Yang, Xiaobo			Synergistic Impaired Effect between Smoking and Manganese Dust Exposure on Pulmonary Ventilation Function in Guangxi Manganese-Exposed Workers Healthy Cohort (GXMEWHC)	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; CIGARETTE-SMOKING; LUNG-FUNCTION; INHALATION; EMPLOYEES	Purpose The aims of this study were to investigate the effects of manganese (Mn) dust exposure on lung functions and evaluate the potential synergistic effect between smoking and Mn dust exposure among refinery workers. Methods A retrospective study including 1658 workers in a ferromanganese refinery was conducted, with subjects who were from the Guangxi manganese-exposed workers healthy cohort (GXMEWHC). Based on the Mn manganese cumulative exposure index (Mn-CEI), all subjects were divided into the low exposure group (n = 682) and the high exposure group (n = 976). A pulmonary function test was performed using an electronic spirometer, including the values and percentages of FVC, FEV1, FEV1/FVC, MMEF, PEFR, MVV, respectively. Results No significant effect of Mn dust exposure on the pulmonary function was found in the female workers (all p> 0.05). However, there was an obvious decrease in the male workers in the high exposure group compared with those in the low exposure group (FVC -60 ml, FEV1 -120 ml, MMEF -260 ml/s, MVV -5.06 L, all p< 0.05). In the high exposure group, the reduction in FVC% predicted, MMEF and MMEF% predicted was 1.0%, 210 mL/s, and 4.9%, respectively. In particular, among the exposed subjects smokers had a statistically significant decrease in lung function compared with non-smokers and the reduction in FVC% predicted, MMEF and MMEF % predicted was 1.0%, 210 mL/s, and 4.9%, respectively (p<0.05). Partial correlation analysis showed that there was also negative correlation between Mn-CEI and decreased changes in MMEF (r = -0.159, p = 0.018) and also MMEF% predicted (r = -0.163, p = 0.015). Conclusions Mn dust can impair the pulmonary ventilation function of male workers but not females, and individual smoking habits and manganese exposure had a synergistic effect on the lung function decrease.	[Wang, Fenfen; Zhong, Yaoqiu; Lv, Yingnan; Huang, Damin; Chen, Kangcheng; Xia, Bing; Su, Cheng; Yang, Xiaobo] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi, Peoples R China; [Zou, Yunfeng; Li, Qin; Qing, Li; Ma, Shuyan] Guangxi Med Univ, Sch Publ Hlth, Dept Toxicol, Nanning, Guangxi, Peoples R China; [Shen, Yuefei] Guangxi Med Univ, Affiliated Hosp 1, Dept Neurol, Nanning, Guangxi, Peoples R China; [Yang, Xiaobo] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Yang, XB (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi, Peoples R China.	yxbo21021@163.com	Yang, Xiaobo/G-3854-2016		National Natural Science Foundation of China [81472962, 21167004, 81160339]; Guangxi Science Fund for Distinguished Young Scholars [2012jjFA40011]; Guangxi Natural Science Foundation [2011jjA40294]; Guangxi science and technology development project [1355007-1]; Program for New Century Excellent Talents in University [NCET-12-0653]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Guangxi science and technology development project; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study was funded by National Natural Science Foundation of China (81472962, 21167004, and 81160339); Guangxi Science Fund for Distinguished Young Scholars (2012jjFA40011); Guangxi Natural Science Foundation (2011jjA40294); Guangxi science and technology development project (1355007-1); and Program for New Century Excellent Talents in University (NCET-12-0653). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Antonini JM, 2003, CRIT REV TOXICOL, V33, P61, DOI 10.1080/713611032; Beaupre LA, 2004, INHAL TOXICOL, V16, P231, DOI 10.1080/08958370490277245; Beckett WS, 1996, J OCCUP ENVIRON MED, V38, P1229, DOI 10.1097/00043764-199612000-00008; Boojar MMA, 2002, J OCCUP ENVIRON MED, V44, P282; Bowler RM, 2007, OCCUP ENVIRON MED, V64, P167, DOI 10.1136/oem.2006.028761; Burton NC, 2009, ENVIRON HEALTH PERSP, V117, P325, DOI [10.1289/ehp.0800035, 10.1289/ehp.1173c25]; Clougherty JE, 2010, ENVIRON HEALTH PERSP, V118, P167, DOI 10.1289/ehp.0900994; Deng Q, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-30; Dimich-Ward H, 2012, LUNG, V190, P147, DOI 10.1007/s00408-011-9344-x; Dorman DC, 2008, TOXICOL SCI, V106, P46, DOI 10.1093/toxsci/kfn159; Dorman DC, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-121; Etemadinejad Siavash, 2009, Indian J Med Sci, V63, P543, DOI 10.4103/0019-5359.59987; Jaakkola MS, 2011, INT ARCH OCC ENV HEA, V84, P151, DOI 10.1007/s00420-010-0603-6; Jaen Angeles, 2006, Environ Health, V5, P2, DOI 10.1186/1476-069X-5-2; Johnsen HL, 2008, AM J IND MED, V51, P296, DOI 10.1002/ajim.20557; Johnsen HL, 2010, AM J RESP CRIT CARE, V181, P1234, DOI 10.1164/rccm.200809-1381OC; KESSEL R, 1989, BRIT J IND MED, V46, P128; Langhammer A, 2003, EUR RESPIR J, V21, P1017, DOI 10.1183/09031936.03.00053202; Levy BS, 2003, INT J OCCUP ENV HEAL, V9, P153, DOI 10.1179/oeh.2003.9.2.153; Loukzadeh Z, 2009, OCCUP MED-OXFORD, V59, P267, DOI 10.1093/occmed/kqp033; Lv YN, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005070; Melville AM, 2010, EUR RESPIR J, V36, P488, DOI 10.1183/09031936.00038309; Meo SA, 2013, INT J ENV RES PUB HE, V10, P390, DOI 10.3390/ijerph10010390; Myers JE, 2003, NEUROTOXICOLOGY, V24, P885, DOI 10.1016/S0161-813X(03)00081-0; Neghab M, 2012, IRAN RED CRESCENT ME, V14, P549; Nemoto T, 2011, INTERNAL MED, V50, P2547, DOI 10.2169/internalmedicine.50.5948; Nicola ML, 2014, CHEST, V145, P998, DOI 10.1378/chest.13-1355; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Sharifian Seyed Akbar, 2011, Acta Med Iran, V49, P98; Soyseth V, 2011, AM J IND MED, V54, P707, DOI 10.1002/ajim.20946; Steliga MA, 2011, SURG ONCOL CLIN N AM, V20, P605, DOI 10.1016/j.soc.2011.07.003; Wittczak T, 2008, INT J OCCUP MED ENV, V21, P81, DOI 10.2478/v10001-007-0041-1; Zou L, 2014, EUR J CANCER, V50, P193, DOI 10.1016/j.ejca.2013.08.014; Zou YF, 2014, OCCUP ENVIRON MED, V71, P189, DOI 10.1136/oemed-2013-101896	35	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0116558	10.1371/journal.pone.0116558	http://dx.doi.org/10.1371/journal.pone.0116558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664879	Green Published, Green Submitted, gold			2022-12-27	WOS:000349123100010
J	Banas, M; Zegar, A; Kwitniewski, M; Zabieglo, K; Marczynska, J; Kapinska-Mrowiecka, M; LaJevic, M; Zabel, BA; Cichy, J				Banas, Magdalena; Zegar, Aneta; Kwitniewski, Mateusz; Zabieglo, Katarzyna; Marczynska, Joanna; Kapinska-Mrowiecka, Monika; LaJevic, Melissa; Zabel, Brian A.; Cichy, Joanna			The Expression and Regulation of Chemerin in the Epidermis	PLOS ONE			English	Article							SKIN INFLAMMATION; ONCOSTATIN-M; EPITHELIAL-CELLS; HUMAN KERATINOCYTES; ENDOTHELIAL-CELLS; GENE-EXPRESSION; DENDRITIC CELLS; RECEPTOR CCRL2; DISEASED SKIN; MESSENGER-RNA	Chemerin is a protein ligand for the G protein-coupled receptor CMKLR1 and also binds to two atypical heptahelical receptors, CCRL2 and GPR1. Chemerin is a leukocyte attractant, adipokine, and antimicrobial protein. Although chemerin was initially identified as a highly expressed gene in healthy skin keratinocytes that was downregulated during psoriasis, the regulation of chemerin and its receptors in the skin by specific cytokines and microbial factors remains unexplored. Here we show that chemerin, CMKLR1, CCRL2 and GPR1 are expressed in human and mouse epidermis, suggesting that this tissue may be both a source and target for chemerin mediated effects. In human skin cultures, chemerin is significantly downregulated by IL-17 and IL-22, key cytokines implicated in psoriasis, whereas it is upregulated by acute phase cytokines oncostatin M and IL-1 beta. Moreover, we show that human keratinocytes in vitro and mouse skin in vivo respond to specific microbial signals to regulate expression levels of chemerin and its receptors. Furthermore, in a cutaneous infection model, chemerin is required for maximal bactericidal effects in vivo. Together, our findings reveal previously uncharacterized regulators of chemerin expression in skin and identify a physiologic role for chemerin in skin barrier defense against microbial pathogens.	[Banas, Magdalena; Zegar, Aneta; Kwitniewski, Mateusz; Zabieglo, Katarzyna; Marczynska, Joanna; Cichy, Joanna] Jagiellonian Univ, Dept Immunol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Kapinska-Mrowiecka, Monika] Zeromski Hosp, Dept Dermatol, Krakow, Poland; [LaJevic, Melissa] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [LaJevic, Melissa; Zabel, Brian A.] VA Palo Alto Hlth Care Syst, Palo Alto Vet Inst Res, Palo Alto, CA USA	Jagiellonian University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Cichy, J (corresponding author), Jagiellonian Univ, Dept Immunol, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	Joanna.Cichy@uj.edu.pl	Kwitniewski, Mateusz/V-4523-2019	Kwitniewski, Mateusz/0000-0002-2743-6934; Cichy, Joanna/0000-0002-0552-8344	Polish National Science Center [0724/B/P01/2011/40, UMO-2014/12/W/NZ6/00454]; Foundation for Polish Science [TEAM/2010-5/1]; European Union within European Regional Development Fund; European Union [POIG.02.01.00-12-064/08]; DoD [W81XWH-11-1-0512]; NIH [AI-079320]; National Institutes of Health Training Grants [5 T32AI07290, T32CA09151, F32CA180415]; NATIONAL CANCER INSTITUTE [T32CA009151, F32CA180415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079320, T32AI007290] Funding Source: NIH RePORTER	Polish National Science Center; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union within European Regional Development Fund; European Union(European Commission); DoD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from Polish National Science Center 0724/B/P01/2011/40, UMO-2014/12/W/NZ6/00454 and the Foundation for Polish Science TEAM/2010-5/1, co-financed by the European Union within European Regional Development Fund (to JC); The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union (grant No: POIG.02.01.00-12-064/08). This work was also supported by DoD grant W81XWH-11-1-0512 and NIH grant AI-079320 (to BAZ). ML was a recipient of fellowship support under National Institutes of Health Training Grants 5 T32AI07290, T32CA09151 and F32CA180415. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Banas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058709; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Baumann H, 2000, J BIOL CHEM, V275, P22014, DOI 10.1074/jbc.M002830200; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Chiricozzi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090284; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cichy J, 1997, J BIOL CHEM, V272, P8250, DOI 10.1074/jbc.272.13.8250; CICHY J, 1995, J CLIN INVEST, V95, P2729, DOI 10.1172/JCI117975; Davenport AP, 2013, PHARMACOL REV, V65, P967, DOI 10.1124/pr.112.007179; Ernst MC, 2010, ENDOCRINOLOGY, V151, P1998, DOI 10.1210/en.2009-1098; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Flutter B, 2013, EUR J IMMUNOL, V43, P3138, DOI 10.1002/eji.201343801; Gazel A, 2006, J INVEST DERMATOL, V126, P2647, DOI 10.1038/sj.jid.5700461; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gonzalvo-Feo S, 2014, J IMMUNOL, V192, P2366, DOI 10.4049/jimmunol.1302028; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Graham KL, 2009, J IMMUNOL, V183, P6717, DOI 10.4049/jimmunol.0803435; Issa ME, 2012, AM J PHYSIOL-CELL PH, V302, pC1621, DOI 10.1152/ajpcell.00187.2011; Kaur J, 2010, BIOCHEM BIOPH RES CO, V391, P1762, DOI 10.1016/j.bbrc.2009.12.150; Kim BE, 2011, J INVEST DERMATOL, V131, P1272, DOI 10.1038/jid.2011.24; Kulig P, 2005, CYTOKINE, V30, P269, DOI 10.1016/j.cyto.2005.01.019; Kulig P, 2007, J IMMUNOL, V178, P3713, DOI 10.4049/jimmunol.178.6.3713; Kulig P, 2011, J IMMUNOL, V187, P1403, DOI 10.4049/jimmunol.1002352; KUPPER TS, 1988, J CLIN INVEST, V82, P1787, DOI 10.1172/JCI113792; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Monnier J, 2012, J IMMUNOL, V189, P956, DOI 10.4049/jimmunol.1102871; Muruganandan S, 2011, J BIOL CHEM, V286, P23982, DOI 10.1074/jbc.M111.220491; Nagpal S, 1997, J INVEST DERMATOL, V109, P91, DOI 10.1111/1523-1747.ep12276660; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rourke JL, 2014, J ENDOCRINOL; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Sell H, 2009, DIABETES, V58, P2731, DOI 10.2337/db09-0277; Skrzeczynska-Moncznik J, 2009, BIOCHEM BIOPH RES CO, V380, P323, DOI 10.1016/j.bbrc.2009.01.071; Skrzeczynska-Moncznik J, 2009, ACTA BIOCHIM POL, V56, P355; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Takahashi M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00123; Uribe-Herranz M, 2013, J INVEST DERMATOL, V133, P1541, DOI 10.1038/jid.2012.512; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zabel BA, 2006, EXP HEMATOL, V34, P1021, DOI 10.1016/j.exphem.2006.05.003; Zabel BA, 2006, EXP HEMATOL, V34, P1106, DOI 10.1016/j.exphem.2006.03.011; Zabel BA, 2014, AM J CLIN EXP IMMUNO, V3, P1	53	46	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117830	10.1371/journal.pone.0117830	http://dx.doi.org/10.1371/journal.pone.0117830			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659101	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900230
J	Chou, ML; Burnouf, T; Chang, SP; Hung, TC; Lin, CC; Richardson, CD; Lin, LT				Chou, Ming-Li; Burnouf, Thierry; Chang, Shun-Pang; Hung, Ting-Chun; Lin, Chun-Ching; Richardson, Christopher D.; Lin, Liang-Tzung			TnBP/Triton X-45 Treatment of Plasma for Transfusion Efficiently Inactivates Hepatitis C Virus	PLOS ONE			English	Article							FRESH-FROZEN PLASMA; SOLVENT/DETERGENT TREATMENT; CELL-CULTURE; PATHOGEN INACTIVATION; TREATED PLASMA; BAG SYSTEM; BLOOD; CRYOPRECIPITATE; REPLICATION; REDUCTION	Risk of transmission of hepatitis C virus (HCV) by clinical plasma remains high in countries with a high prevalence of hepatitis C, justifying the implementation of viral inactivation treatments. In this study, we assessed the extent of inactivation of HCV during minipool solvent/detergent (SD; 1% TnBP / 1% Triton X-45) treatment of human plasma. Luciferase-tagged infectious cell culture-derived HCV (HCVcc) particles were used to spike human plasma prior to treatment by SD at 31 +/- 0.5 degrees C for 30 min. Samples were taken before and after SD treatment and filtered on a Sep-Pak Plus C18 cartridge to remove the SD agents. Risk of cytotoxicity was assessed by XTT cell viability assay. Viral infectivity was analyzed based on the luciferase signals, 50% tissue culture infectious dose viral titer, and immunofluorescence staining for HCV NS5A protein. Total protein, cholesterol, and triglyceride contents were determined before and after SD treatment and C18 cartridge filtration. Binding analysis, using patient-derived HCV clinical isolates, was also examined to validate the efficacy of the inactivation by SD. SD treatment effectively inactivated HCVcc within 30 min, as demonstrated by the baseline level of reporter signals, total loss of viral infectivity, and absence of viral protein NS5A. SD specifically targeted HCV particles to render them inactive, with essentially no effect on plasma protein content and hemostatic function. More importantly, the efficacy of the SD inactivation method was confirmed against various genotypes of patient-derived HCV clinical isolates and against HCVcc infection of primary human hepatocytes. Therefore, treatment by 1% TnBP / 1% Triton X-45 at 31 degrees C is highly efficient to inactivate HCV in plasma for transfusion, showing its capacity to enhance the safety of therapeutic plasma products. We propose that the methodology used here to study HCV infectivity can be valuable in the validation of viral inactivation and removal processes of human plasma-derived products.	[Chou, Ming-Li; Lin, Liang-Tzung] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Burnouf, Thierry] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Oral Med, Taipei, Taiwan; [Chang, Shun-Pang; Lin, Chun-Ching] Kaohsiung Med Univ, Sch Pharm, Coll Pharm, Kaohsiung, Taiwan; [Hung, Ting-Chun] Chi Mei Med Ctr, Dept Clin Pathol, Tainan, Taiwan; [Richardson, Christopher D.] Izaak Walton Killam Hlth Ctr, Dept Pediat, Halifax, NS, Canada; [Richardson, Christopher D.] Izaak Walton Killam Hlth Ctr, Canadian Ctr Vaccinol, Halifax, NS, Canada; [Lin, Liang-Tzung] Taipei Med Univ, Coll Med, Sch Med, Dept Microbiol & Immunol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Kaohsiung Medical University; Chi Mei Hospital; Dalhousie University; Dalhousie University; Taipei Medical University	Lin, LT (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan.	ltlin@tmu.edu.tw	Burnouf, Thierry/H-4784-2019	Burnouf, Thierry/0000-0002-0507-9243; Lin, Liang-Tzung/0000-0001-7374-7234	Taipei Medical University [TMU101-AE3-Y19]; Ministry of Science and Technology of Taiwan [MOST101-2320-B-038-038-MY2]	Taipei Medical University; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	LTL is supported in part by research grants from Taipei Medical University (TMU101-AE3-Y19) and the Ministry of Science and Technology of Taiwan (MOST101-2320-B-038-038-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2012, J HEPATOL, V57, P675, DOI 10.1016/j.jhep.2012.04.015; Attia MA, 1998, ANTIVIR THER, V3, P1; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Blaising J, 2013, BIOCHIMIE, V95, P96, DOI 10.1016/j.biochi.2012.07.016; Burnouf T, 2008, TRANSFUS CLIN BIOL, V15, P129, DOI 10.1016/j.tracli.2008.04.007; Burnouf T, 2013, VOX SANG, V104, P1, DOI 10.1111/j.1423-0410.2012.01621.x; Burnouf T, 2007, BIOLOGICALS, V35, P349, DOI 10.1016/j.biologicals.2007.03.002; Burnouf T, 2006, TRANSFUSION, V46, P2100, DOI 10.1111/j.1537-2995.2006.01035.x; Burnouf T, 2014, LANCET, V384, P1347, DOI 10.1016/S0140-6736(14)61693-7; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; de Alarcon P, 2005, TRANSFUSION, V45, P1362, DOI 10.1111/j.1537-2995.2005.00216.x; El-Ekiaby M, 2010, TRANSFUSION MED, V20, P48, DOI 10.1111/j.1365-3148.2009.00963.x; Feeney ER, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3308; Findlay JY, 2000, J CLIN ANESTH, V12, P319, DOI 10.1016/S0952-8180(00)00162-8; Gondeau C, 2014, GUT, V63, P1490, DOI 10.1136/gutjnl-2013-304623; Hellstern P, 2011, TRANSFUS MED HEMOTH, V38, P65, DOI 10.1159/000323552; Hornsey VS, 2009, TRANSFUSION, V49, P2167, DOI 10.1111/j.1537-2995.2009.02272.x; Horowitz B, 2004, WHO TECH REP SER, V924, P1; HOROWITZ B, 1985, TRANSFUSION, V25, P516, DOI 10.1046/j.1537-2995.1985.25686071422.x; HOROWITZ B, 1992, BLOOD, V79, P826; Horowitz B, 1998, VOX SANG, V74, P203, DOI 10.1111/j.1423-0410.1998.tb05473.x; Jellinger PS, 2012, ENDOCR PRACT, V18, P270, DOI 10.4158/EP.18.2.269; Kakkar N, 2004, TRANSFUSION MED, V14, P231, DOI 10.1111/j.0958-7578.2004.00505.x; Klein HG, 2013, NEW ENGL J MED, V368, P199, DOI 10.1056/NEJMp1213134; Klein HG, 2005, J INTERN MED, V257, P224, DOI 10.1111/j.1365-2796.2005.01451.x; Kleinman SH, 2009, TRANSFUSION, V49, P2454, DOI 10.1111/j.1537-2995.2009.02322.x; Lin LT, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-187; Lin LT, 2011, J VIROL, V85, P4386, DOI 10.1128/JVI.01492-10; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LUNDSGAARDHANSEN P, 1983, B WORLD HEALTH ORGAN, V61, P7; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; MOHR H, 1993, INFUSIONSTHERAPIE, V20, P19; PIQUET Y, 1992, VOX SANG, V63, P251, DOI 10.1111/j.1423-0410.1992.tb01230.x; Reker C, 2014, INT J INFECT DIS; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Shimakami T, 2009, CURR OPIN PHARMACOL, V9, P537, DOI 10.1016/j.coph.2009.08.008; Steinmann E, 2013, TRANSFUSION, V53, P1010, DOI 10.1111/j.1537-2995.2012.03858.x; The Merck Manuals Online, 2013, NORMAL LABORATORY VA; Thursz M, 2014, NAT REV GASTRO HEPAT, V11, P28, DOI 10.1038/nrgastro.2013.179; Verna Elizabeth C, 2006, Clin Liver Dis, V10, P919; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268	41	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117800	10.1371/journal.pone.0117800	http://dx.doi.org/10.1371/journal.pone.0117800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658612	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900226
J	Cowell, JM; Samek, A; List, J; Decety, J				Cowell, Jason M.; Samek, Anya; List, John; Decety, Jean			The Curious Relation between Theory of Mind and Sharing in Preschool Age Children	PLOS ONE			English	Article							YOUNG-CHILDREN; ALTRUISTIC BEHAVIOR; PROSOCIAL BEHAVIOR; EXECUTIVE FUNCTION; HUMAN COOPERATION; CONCEPTIONS; FAIRNESS	Young children have long been known to act selfishly and gradually appear to become more generous across middle childhood. While this apparent change has been well documented, the underlying mechanisms supporting this remain unclear. The current study examined the role of early theory of mind and executive functioning in facilitating sharing in a large sample (N = 98) of preschoolers. Results reveal a curious relation between early false-belief understanding and sharing behavior. Contrary to many commonsense notions and predominant theories, competence in this ability is actually related to less sharing. Thus, the relation between developing theory of mind and sharing may not be as straightforward as it seems in preschool age children. It is precisely the children who can engage in theory of mind that decide to share less with others.	[Cowell, Jason M.; Decety, Jean] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Samek, Anya] Univ Wisconsin, Dept Consumer Sci, Madison, WI USA; [List, John] Univ Chicago, Dept Econ, Chicago, IL 60637 USA	University of Chicago; University of Wisconsin System; University of Wisconsin Madison; University of Chicago	Decety, J (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	decety@uchicago.edu		List, John/0000-0002-1740-3848	Kenneth and Anne Griffin Foundation; John Templeton Foundation ("Science of Philanthropy Initiative"); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	Kenneth and Anne Griffin Foundation; John Templeton Foundation ("Science of Philanthropy Initiative"); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by a grant from the Kenneth and Anne Griffin Foundation and the John Templeton Foundation ("Science of Philanthropy Initiative"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Pardo D, 2013, COGN PROCESS, V14, P301, DOI 10.1007/s10339-013-0552-6; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Bloom P, 2000, COGNITION, V77, pB25, DOI 10.1016/S0010-0277(00)00096-2; DAMON W, 1975, CHILD DEV, V46, P301, DOI 10.2307/1128122; Decety J, 2012, DEV COGN NEUROS-NETH, V2, P1, DOI 10.1016/j.dcn.2011.05.003; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2008, NATURE; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Gummerum M, 2010, J ECON PSYCHOL, V31, P25, DOI 10.1016/j.joep.2009.09.002; Li YY, 2013, PSYCHOL SCI, V24, P1686, DOI 10.1177/0956797613479975; Monin B, 2007, REV GEN PSYCHOL, V11, P99, DOI 10.1037/1089-2680.11.2.99; Moore C, 1998, SOC DEV, V7, P198, DOI 10.1111/1467-9507.00062; Moore C, 2009, PSYCHOL SCI; Olson KR, 2008, COGNITION, V108, P222, DOI 10.1016/j.cognition.2007.12.003; Robbins E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00353; Schmidt MFH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023223; Shaw A, 2014, J EXP PSYCHOL GEN, V143, P363, DOI 10.1037/a0031247; Sloane S, 2012, PSYCHOL SCI, V23, P196, DOI 10.1177/0956797611422072; Smith CE, 2013, PLOS ONE, V8, DOI [10.1371/annotation/4b9340db-455b-4e0d-86e5-b6783747111f, 10.1371/journal.pone.0059510]; Svetlova M, 2010, CHILD DEV, V81, P1814, DOI 10.1111/j.1467-8624.2010.01512.x; Takagishi H, 2010, J EXP CHILD PSYCHOL, V105, P130, DOI 10.1016/j.jecp.2009.09.005; Thompson RA, 2013, INFANCY, V18, P120, DOI 10.1111/j.1532-7078.2012.00139.x; Tomasello M, 2013, ANNU REV PSYCHOL, V64, P231, DOI 10.1146/annurev-psych-113011-143812; Warneken F, 2009, TRENDS COGN SCI, V13, P397, DOI 10.1016/j.tics.2009.06.008; Willoughby MT, 2012, PSYCHOL ASSESSMENT, V24, P226, DOI 10.1037/a0025361; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Zelazo PD, 2012, CHILD DEV PERSPECT, V6, P354, DOI 10.1111/j.1750-8606.2012.00246.x	27	36	41	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117947	10.1371/journal.pone.0117947	http://dx.doi.org/10.1371/journal.pone.0117947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658696	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900245
J	Mehta, S; Williamson, CM; Ball, S; Tibbit, C; Beechey, C; Fray, M; Peters, J				Mehta, Stuti; Williamson, Christine M.; Ball, Simon; Tibbit, Charlotte; Beechey, Colin; Fray, Martin; Peters, Jo			Transcription Driven Somatic DNA Methylation within the Imprinted Gnas Cluster	PLOS ONE			English	Article							PROTEIN ALPHA-SUBUNIT; GERM-CELL DEVELOPMENT; DE-NOVO METHYLATION; CONTROL REGION; CHROMOSOME 2; GS-ALPHA; MOUSE; GENE; LOCUS; IDENTIFICATION	Differential marking of genes in female and male gametes by DNA methylation is essential to genomic imprinting. In female gametes transcription traversing differentially methylated regions (DMRs) is a common requirement for de novo methylation at DMRs. At the imprinted Gnas cluster oocyte specific transcription of a protein-coding transcript, Nesp, is needed for methylation of two DMRs intragenic to Nesp, namely the Nespas-Gnasxl DMR and the Exon1A DMR, thereby enabling expression of the Gnas transcript and repression of the Gnasxl transcript. On the paternal allele, Nesp is repressed, the germline DMRs are unmethylated, Gnas is repressed and Gnasxl is expressed. Using mutant mouse models, we show that on the paternal allele, ectopic transcription of Nesp traversing the intragenic Exon1A DMR (which regulates Gnas expression) results in de novo methylation of the Exon1A DMR and de-repression of Gnas just as on the maternal allele. However, unlike the maternal allele, methylation on the mutant paternal allele occurs post-fertilisation, i.e. in somatic cells. This, to our knowledge is the first example of transcript/transcription driven DNA methylation of an intragenic CpG island, in somatic tissues, suggesting that transcription driven de novo methylation is not restricted to the germline in the mouse. Additionally, Gnasxl is repressed on a paternal chromosome on which Nesp is ectopically expressed. Thus, a paternally inherited Gnas cluster showing ectopic expression of Nesp is "maternalised" in terms of Gnasxl and Gnas expression. We show that these mice have a phenotype similar to mutants with two expressed doses of Gnas and none of Gnasxl.	[Mehta, Stuti; Williamson, Christine M.; Ball, Simon; Tibbit, Charlotte; Beechey, Colin; Peters, Jo] MRC Harwell, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; [Fray, Martin] MRC Harwell, Mary Lyon Ctr, Didcot OX11 0RD, Oxon, England	MRC Harwell; MRC Harwell	Mehta, S (corresponding author), Massachusetts Gen Hosp, Thier 340,60 Blossom St, Boston, MA 02114 USA.	smehta6@mgh.harvard.edu	Williamson, Christine/GSE-3696-2022; Mehta, Stuti/E-9477-2017	Mehta, Stuti/0000-0002-6810-6771	UK Medical Research Council; UK India Education and Research Initiative; MRC [MC_U142636336] Funding Source: UKRI; Medical Research Council [MC_U142636336] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK India Education and Research Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council. SM's doctoral studies were supported by the UK India Education and Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz J, 2004, P NATL ACAD SCI USA, V101, P8366, DOI 10.1073/pnas.0308758101; Ball ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065639; Bastepe M, 2012, HORM METAB RES, V44, P732, DOI 10.1055/s-0032-1316331; Bhogal B, 2004, GENOMICS, V84, P961, DOI 10.1016/j.ygeno.2004.08.004; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Cattanach BM, 2000, HUM MOL GENET, V9, P2263, DOI 10.1093/oxfordjournals.hmg.a018917; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Eaton SA, 2012, MOL CELL BIOL, V32, P1017, DOI 10.1128/MCB.06174-11; Fang R, 2010, MOL CELL, V39, P222, DOI 10.1016/j.molcel.2010.07.008; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Henckel A, 2012, EMBO J, V31, P606, DOI 10.1038/emboj.2011.425; Ischia R, 1997, J BIOL CHEM, V272, P11657; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kelly ML, 2009, INT J OBESITY, V33, P507, DOI 10.1038/ijo.2009.30; Kelsey G, 1999, GENOMICS, V62, P129, DOI 10.1006/geno.1999.6022; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Koerner MV, 2010, CURR OPIN GENET DEV, V20, P164, DOI 10.1016/j.gde.2010.01.009; Latos PA, 2009, DEVELOPMENT, V136, P437, DOI 10.1242/dev.032060; Li JY, 2004, GENOMICS, V84, P952, DOI 10.1016/j.ygeno.2004.08.012; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; Liu J, 2005, P NATL ACAD SCI USA, V102, P5513, DOI 10.1073/pnas.0408262102; McEwen Kirsten R., 2009, P235, DOI 10.1007/978-1-4020-9187-2_14; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Nowak K, 2011, EPIGENETICS-US, V6, P1012, DOI 10.4161/epi.6.8.16075; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Plagge A, 2008, J ENDOCRINOL, V196, P193, DOI 10.1677/JOE-07-0544; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sato S, 2011, GENOMICS, V98, P120, DOI 10.1016/j.ygeno.2011.05.003; Singh P, 2013, CELL REP, V4, P205, DOI 10.1016/j.celrep.2013.06.004; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith EY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002422; Tomizawa SI, 2012, INT J DEV BIOL, V56, P867, DOI 10.1387/ijdb.120152gk; Williamson CM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001347; Williamson CM, 2006, NAT GENET, V38, P350, DOI 10.1038/ng1731; Williamson CM, 2004, NAT GENET, V36, P894, DOI 10.1038/ng1398; Williamson CM, 2002, MAMM GENOME, V13, P74, DOI 10.1007/s00335-001-2102-2; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; Yu SH, 2000, J CLIN INVEST, V105, P615, DOI 10.1172/JCI8437; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	50	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117378	10.1371/journal.pone.0117378	http://dx.doi.org/10.1371/journal.pone.0117378			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659103	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900140
J	Alvard, M; Carlson, D; McGaffey, E				Alvard, Michael; Carlson, David; McGaffey, Ethan			Using a Partial Sum Method and GPS Tracking Data to Identify Area Restricted Search by Artisanal Fishers at Moored Fish Aggregating Devices in the Commonwealth of Dominica	PLOS ONE			English	Article							SMALL-SCALE FISHERY; SYSTEM VMS DATA; SPATIAL-DISTRIBUTION; LONGLINE FISHERY; FLOATING OBJECTS; SOLOMON-ISLANDS; PATCH; KNOWLEDGE; TIME; TRAJECTORIES	Foragers must often travel from a central place to exploit aggregations of prey. These patches can be identified behaviorally when a forager shifts from travel to area restricted search, identified by a decrease in speed and an increase in sinuosity of movement. Faster, more directed movement is associated with travel. Differentiating foraging behavior at patches from travel to patches is important for a variety of research questions and has now been made easier by the advent of small, GPS devices that can track forager movement with high resolution. In the summer and fall of 2012, movement data were collected from GPS devices placed on foraging trips originating in the artisanal fishing village of Desa Ikan (pseudonym), on the east coast of the Caribbean island nation of the Commonwealth Dominica. Moored FADs are human-made structures anchored to the ocean floor with fish attraction material on or near the surface designed to effectively create a resource patch. The ultimate goal of the research is to understand how property rights are emerging after the introduction of fish aggregating device (FAD) technology at the site in 1999. This paper reports on research to identify area-restricted search foraging behavior at FAD patches. For 22 foraging trips simultaneous behavioral observations were made to ground-truth the GPS movement data. Using a cumulative sum method, area restricted search was identified as negative deviations from the mean travel speed and the method was able to correctly identify FAD patches in every case.	[Alvard, Michael; Carlson, David] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [McGaffey, Ethan] Univ N Texas, Dept Anthropol, Denton, TX 76203 USA	Texas A&M University System; Texas A&M University College Station; University of North Texas System; University of North Texas Denton	Alvard, M (corresponding author), Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA.	alvard@tamu.edu			Wenner-Gren Foundation for Anthropological Research; National Science Foundation [BCS-126020]; Enhance Scholarly and Creative Activities, Texas A&M, Office of the Vice President for Research; Division Of Behavioral and Cognitive Sci [1260201] Funding Source: National Science Foundation	Wenner-Gren Foundation for Anthropological Research; National Science Foundation(National Science Foundation (NSF)); Enhance Scholarly and Creative Activities, Texas A&M, Office of the Vice President for Research; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Funding to MA was provided from the Program to Enhance Scholarly and Creative Activities, Texas A&M, Office of the Vice President for Research (http://vpr.tamu.edu/researchdevelopment/funding/internal/ScholarlyCreative2013), the Wenner-Gren Foundation for Anthropological Research (http://www.wennergren.org), and the National Science Foundation under Grant No. BCS-126020 (http://www.nsf.gov). The funders had no role in study	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Alvard M, 2014, FIELD METHO IN PRESS; ALVARD MS, 1993, HUM ECOL, V21, P355, DOI 10.1007/BF00891140; [Anonymous], 2014, R LANG ENV STAT COMP; Aswani S, 1998, OCEAN COAST MANAGE, V40, P207, DOI 10.1016/S0964-5691(98)00047-7; Bartumeus F, 2009, J PHYS A, V42, P1; Ben-Yami M, 1989, MAKE SET FADS FISH A; Bene C, 2001, HUM ECOL, V29, P157, DOI 10.1023/A:1011059830170; BENHAMOU S, 1992, J THEOR BIOL, V159, P67, DOI 10.1016/S0022-5193(05)80768-4; Beverly S, 2012, RAP PUBLICATION, V2012/20; Bird DW, 2009, AM ANTIQUITY, V74, P3, DOI 10.2307/25470536; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyer D, 2010, PHILOS T R SOC A, V368, P5645, DOI 10.1098/rsta.2010.0275; Breed GA, 2012, ECOL MODEL, V235, P49, DOI 10.1016/j.ecolmodel.2012.03.021; Buchin M, 2011, J SPAT INT SCI, P33, DOI 10.5311/JOSIS.2011.3.66; Bush S, 2014, ENV SCI POL IN PRESS; Castro JJ, 2001, REV FISH BIOL FISHER, V11, P255, DOI 10.1023/A:1020302414472; Chang SK, 2014, CAN J FISH AQUAT SCI, V71, P1363, DOI 10.1139/cjfas-2013-0552; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Dagorn L, 2013, FISH FISH, V14, P391, DOI 10.1111/j.1467-2979.2012.00478.x; Daw TM, 2008, FISH RES, V90, P17, DOI 10.1016/j.fishres.2007.09.027; Defoe J, 2007, 2 M WECAFC AD HOC WO; Dempster T, 2004, REV FISH BIOL FISHER, V14, P21, DOI 10.1007/s11160-004-3151-x; Dickson J, 2000, PECHE THONIERE DISPO, DOI [10.1016/j.virol.2014.12.023, DOI 10.1016/J.VIROL.2014.12.023]; Dray S, 2010, ECOL RES, V25, P673, DOI 10.1007/s11284-010-0701-7; Eifler DA, 2012, J ETHOL, V30, P197, DOI 10.1007/s10164-011-0293-x; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fonteneau A, 2013, AQUAT LIVING RESOUR, V26, P37, DOI 10.1051/alr/2013046; Freeman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009236; Fronhofer EA, 2013, OIKOS, V122, P857, DOI 10.1111/j.1600-0706.2012.21021.x; Furusawa T, 2012, FIELD METHOD, V24, P216, DOI 10.1177/1525822X11434002; Gabriel O, 2005, FISH CATCHING METHODS OF THE WORLD, 4TH EDITION, P1, DOI 10.1002/9780470995648; Gomes C, 1998, FISH RES, V34, P47, DOI 10.1016/S0165-7836(97)00079-9; GOODING RM, 1967, PAC SCI, V21, P486; Grant S, 2007, FISH RES, V84, P162, DOI 10.1016/j.fishres.2006.10.012; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Hawkins M, 1998, CUMULATIVE SUM CHART; HILL K, 1987, ETHOL SOCIOBIOL, V8, P1, DOI 10.1016/0162-3095(87)90055-0; Hills TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060488; HJORLAND B, 1995, J AM SOC INFORM SCI, V46, P400, DOI 10.1002/(SICI)1097-4571(199507)46:6<400::AID-ASI2>3.0.CO;2-Y; Hutchinson JMC, 2008, ANIM BEHAV, V75, P1331, DOI 10.1016/j.anbehav.2007.09.006; Jensen JR, 2007, REMOTE SENSING ENV E; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Knell A, 2011, THESIS U ESSEX; Knell AS, 2012, THEOR ECOL-NETH, V5, P325, DOI 10.1007/s12080-011-0130-4; Kotzerka J, 2010, J ORNITHOL, V151, P459, DOI 10.1007/s10336-009-0479-y; Laland KN, 2001, J EVOLUTION BIOL, V14, P22, DOI 10.1046/j.1420-9101.2001.00262.x; Lambert GI, 2012, ICES J MAR SCI, V69, P682, DOI 10.1093/icesjms/fss018; Laube P, 2011, T GIS, V15, P401, DOI 10.1111/j.1467-9671.2011.01256.x; Lee J, 2010, ICES J MAR SCI, V67, P1260, DOI 10.1093/icesjms/fsq010; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; [李楠 Li Nan], 2012, [高技术通讯, Chinese High Technology Letters], V22, P490; Maina J., 2011, SPATIAL BEHAV ARTISA; Marshall HH, 2013, J ANIM ECOL, V82, P894, DOI 10.1111/1365-2656.12089; Morgan A. C, 2011, FISH AGGREGATING DEV; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Orians G, 1977, ANAL ECOLOGICAL SYST, P155; Ostrom E., 1990, GOVERNING COMMONS EV; PAGE ES, 1954, BIOMETRIKA, V41, P100, DOI 10.1093/biomet/41.1-2.100; Papastamatiou YP, 2012, MAR ECOL PROG SER, V456, P233, DOI 10.3354/meps09721; Papworth SK, 2012, METHODS ECOL EVOL, V3, P584, DOI 10.1111/j.2041-210X.2012.00189.x; Pauly D., 2006, MAR STUD MAST, V4, P7, DOI DOI 10.1126/SCIENCE.279.5352.860.PMID:9452385; Postlethwaite CM, 2013, J THEOR BIOL, V317, P175, DOI 10.1016/j.jtbi.2012.10.007; Radeloff VC, 2000, ECOGRAPHY, V23, P81, DOI 10.1034/j.1600-0587.2000.230109.x; Raichlen DA, 2014, P NATL ACAD SCI USA, V111, P728, DOI 10.1073/pnas.1318616111; Rey-Valette H, 2000, AQUAT LIVING RESOUR, V13, P241, DOI 10.1016/S0990-7440(00)01060-3; RHINE R J, 1978, Primates, V19, P353, DOI 10.1007/BF02382803; Sebastian R, 2007, NATL REPORTS TECHNIC; Shainee M, 2011, FISH RES, V109, P42, DOI 10.1016/j.fishres.2011.01.015; Smith E. A., 1991, INUJJUAMIUT FORAGING; SMITH EA, 1983, CURR ANTHROPOL, V24, P625, DOI 10.1086/203066; Solana-Sansores R, 2001, CIENC MAR, V27, P423; Sommerfeld J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063742; Sosis R, 2001, HUM NATURE-INT BIOS, V12, P221, DOI 10.1007/s12110-001-1008-8; Stephens D., 2007, FORAGING BEHAV ECOLO; Stephens D.W., 1986, pi; Stewart KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014451; Taquet M, 2013, AQUAT LIVING RESOUR, V26, P25, DOI 10.1051/alr/2013043; Tremblay Y, 2007, J EXP BIOL, V210, P935, DOI 10.1242/jeb.02710; VALONE TJ, 1989, OIKOS, V56, P357, DOI 10.2307/3565621; Wajnberg E, 2006, BEHAV ECOL SOCIOBIOL, V60, P1, DOI 10.1007/s00265-005-0131-7; Wajnberg E, 2013, BEHAV ECOL SOCIOBIOL, V67, P2053, DOI 10.1007/s00265-013-1615-5; Walker E, 2010, ECOL MODEL, V221, P2008, DOI 10.1016/j.ecolmodel.2010.05.007; Webster DG, 2009, GLOB ENVIRON ACCORD, P1; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Zavalaga CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019966	87	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0115552	10.1371/journal.pone.0115552	http://dx.doi.org/10.1371/journal.pone.0115552			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647288	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600014
J	Cai, SL; Jiang, GB; Ye, NH; Chu, ZZ; Xu, XZ; Zhang, JH; Zhu, GH				Cai, Shanlan; Jiang, Guobin; Ye, Nenghui; Chu, Zhizhan; Xu, Xuezhong; Zhang, Jianhua; Zhu, Guohui			A Key ABA Catabolic Gene, OsABA8ox3, Is Involved in Drought Stress Resistance in Rice	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; SEED DORMANCY; SIGNAL-TRANSDUCTION; ARABIDOPSIS; 8'-HYDROXYLASE; TOLERANCE; METABOLISM; EXPRESSION; ACCUMULATION; GERMINATION	Expressions of ABA biosynthesis genes and catabolism genes are generally co-regulated in plant development and responses to environmental stress. Up-regulation of OsNCED3 gene, a key gene in ABA biosynthesis, has been suggested as a way to enhance plant drought resistance but little is known for the role of ABA catabolic genes during drought stress. In this study, we found that OsABA8ox3 was the most highly expressed gene of the OsABA8ox family in rice leaves. Expression of OsABA8ox3 was promptly induced by rehydration after PEG-mimic dehydration, a tendency opposite to the changes of ABA level. We therefore constructed rice OsABA8ox3 silencing (RNA interference, RNAi) and overexpression plants. There were no obvious phenotype differences between the transgenic seedlings and wild type under normal condition. However, OsABA8ox3 RNAi lines showed significant improvement in drought stress tolerance while the overexpression seedlings were hypersensitive to drought stress when compared with wild type in terms of plant survival rates after 10 days of unwatering. Enzyme activity analysis indicated that OsABA8ox3 RNAi plants had higher superoxide dismutase (SOD) and catalase (CAT) activities and lessmalondialdehyde (MDA) content than those of wild type when the plants were exposed to dehydration treatment, indicating a better anti-oxidative stress capability and less membrane damage. DNA microarray and real-time PCR analysis under dehydration treatment revealed that expressions of a group of stress/drought-related genes, i.e. LEA genes, were enhanced with higher transcript levels in OsABA8ox3 RNAi transgenic seedlings. We therefore conclude that that OsABA8ox3 gene plays an important role in controlling ABA level and drought stress resistance in rice.	[Cai, Shanlan; Jiang, Guobin; Chu, Zhizhan; Xu, Xuezhong; Zhu, Guohui] South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Ye, Nenghui] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Zhang, Jianhua] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China; [Zhu, Guohui] South China Agr Univ, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong; South China Agricultural University	Zhu, GH (corresponding author), South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	ghzhu@scau.edu.cn	Ye, Nenghui/AAU-4370-2021; Ye, Nenghui/AGK-4828-2022	Zhang, Jianhua/0000-0002-3819-2437; Ye, Nenghui/0000-0002-3126-3562	National Natural Science Foundation of China [31171466, 30900873]; National Basic Research Program (973 Program) [2012CB114306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (31171466,30900873) and the National Basic Research Program (973 Program 2012CB114306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Cho D, 2009, J PLANT BIOL, V52, P102, DOI 10.1007/s12374-009-9019-9; DAVIES WJ, 1991, ANNU REV PLANT PHYS, V42, P55, DOI 10.1146/annurev.pp.42.060191.000415; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Hu HH, 2014, ANNU REV PLANT BIOL, V65, P715, DOI 10.1146/annurev-arplant-050213-040000; Hu XL, 2006, PLANT CELL PHYSIOL, V47, P1484, DOI 10.1093/pcp/pcl014; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Hwang SG, 2010, PLANT SCI, V178, P12, DOI 10.1016/j.plantsci.2009.09.014; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Ji XM, 2011, PLANT PHYSIOL, V156, P647, DOI 10.1104/pp.111.176164; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Krochko JE, 1998, PLANT PHYSIOL, V118, P849, DOI 10.1104/pp.118.3.849; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Kwak JM, 2006, PLANT PHYSIOL, V141, P323, DOI 10.1104/pp.106.079004; Liu YG, 2009, NEW PHYTOL, V183, P1030, DOI 10.1111/j.1469-8137.2009.02899.x; Millar AA, 2006, PLANT J, V45, P942, DOI 10.1111/j.1365-313X.2006.02659.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Nitsch LMC, 2009, PLANTA, V229, P1335, DOI 10.1007/s00425-009-0913-7; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; Ren HB, 2007, J EXP BOT, V58, P211, DOI [10.1093/jxb/erl1117, 10.1093/jxb/erl117]; Saika H, 2007, PLANT CELL PHYSIOL, V48, P287, DOI 10.1093/pcp/pcm003; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Yang SH, 2006, BIOCHEM BIOPH RES CO, V350, P685, DOI 10.1016/j.bbrc.2006.09.098; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255; Zhu GH, 2009, PLANT CELL PHYSIOL, V50, P644, DOI 10.1093/pcp/pcp022; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	45	39	42	3	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116646	10.1371/journal.pone.0116646	http://dx.doi.org/10.1371/journal.pone.0116646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647508	gold, Green Published, Green Submitted			2022-12-27	WOS:000348822600031
J	Nauroth, P; Gollwitzer, M; Bender, J; Rothmund, T				Nauroth, Peter; Gollwitzer, Mario; Bender, Jens; Rothmund, Tobias			Social Identity Threat Motivates Science-Discrediting Online Comments	PLOS ONE			English	Article							COMPUTER-MEDIATED COMMUNICATION; GROUP IDENTIFICATION; SELF; PERCEPTIONS; RELIABILITY; PERFORMANCE; MODEL; ATTITUDES; BEHAVIOR; SUCCESS	Experiencing social identity threat from scientific findings can lead people to cognitively devalue the respective findings. Three studies examined whether potentially threatening scientific findings motivate group members to take action against the respective findings by publicly discrediting them on the Web. Results show that strongly (vs. weakly) identified group members (i.e., people who identified as "gamers") were particularly likely to discredit social identity threatening findings publicly (i.e., studies that found an effect of playing violent video games on aggression). A content analytical evaluation of online comments revealed that social identification specifically predicted critiques of the methodology employed in potentially threatening, but not in non-threatening research (Study 2). Furthermore, when participants were collectively (vs. self-) affirmed, identification did no longer predict discrediting posting behavior (Study 3). These findings contribute to the understanding of the formation of online collective action and add to the burgeoning literature on the question why certain scientific findings sometimes face a broad public opposition.	[Nauroth, Peter; Gollwitzer, Mario] Univ Marburg, Marburg, Germany; [Bender, Jens; Rothmund, Tobias] Univ Koblenz Landau, Landau, Germany	Philipps University Marburg; University of Koblenz & Landau	Nauroth, P (corresponding author), Univ Marburg, Marburg, Germany.	peter.nauroth@uni-marburg.de	Gollwitzer, Mario/A-4099-2015; Gollwitzer, Mario/AAE-6042-2020; Gollwitzer, Mario/ABA-7217-2021	Gollwitzer, Mario/0000-0003-4310-4793; Gollwitzer, Mario/0000-0003-4310-4793; 	German Research Foundation (Deutsche Forschungsgemeinschaft) [GO 1674/2-2]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This research was supported by a German Research Foundation (Deutsche Forschungsgemeinschaft; no. GO 1674/2-2; http://www.dfg.de) grant to the second author (MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D., 1999, SOCIAL IDENTITY SOCI; Aiken L. S., 1991, MULTIPLE REGRESSION; Anderson AA, 2014, J COMPUT-MEDIAT COMM, V19, P373, DOI 10.1111/jcc4.12009; [Anonymous], 2014, J MARK COMMUN, DOI DOI 10.1080/13527266.2013.797778; Ashmore RD, 2004, PSYCHOL BULL, V130, P80, DOI 10.1037/0033-2909.130.1.80; Batts SA, 2008, PLOS BIOL, V6, P1837, DOI 10.1371/journal.pbio.0060240; Blascovich J, 1996, ADV EXP SOC PSYCHOL, V28, P1, DOI 10.1016/S0065-2601(08)60235-X; Branscombe N.R., 1999, SOCIAL IDENTITY CONT, P35, DOI DOI 10.4135/9781446200919.N23; Brunsting S, 2002, SMALL GR RES, V33, P525, DOI 10.1177/104649602237169; Bushman BJ, 2011, VIOLENT VIDEO GAMES; Bushman BJ, 2014, EUR PSYCHOL, V19, P47, DOI 10.1027/1016-9040/a000164; Cohen J., 2003, APPL MULTIPLE REGRES; de Hoog N, 2013, SOC PSYCHOL-GERMANY, V44, P361, DOI 10.1027/1864-9335/a000133; Derks B, 2006, PERS SOC PSYCHOL B, V32, P576, DOI 10.1177/0146167205283336; Derks B, 2009, J PERS SOC PSYCHOL, V96, P183, DOI 10.1037/a0013068; Edwards C, 2007, COMMUN EDUC, V56, P255, DOI 10.1080/03634520701236866; Elson M, 2014, EUR PSYCHOL, V19, P33, DOI 10.1027/1016-9040/a000147; Fruh W, 2007, INHALTSANALYSE THEOR; Glasford DE, 2009, PERS SOC PSYCHOL B, V35, P415, DOI 10.1177/0146167208329216; Glasman LR, 2006, PSYCHOL BULL, V132, P778, DOI 10.1037/0033-2909.132.5.778; Greitemeyer T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093440; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; Houston J.B., 2011, ELECTRON NEWS, V5, P79, DOI [10.1177/1931243111407618, DOI 10.1177/1931243111407618]; Huesmann L. R., 2003, MEDIA VIOLENCE CHILD, P107; Jackson JW, 2011, GROUP DYN-THEOR RES, V15, P343, DOI 10.1037/a0024575; Kelley K, 2007, J STAT SOFTW, V20, P1; Klein O, 2007, PERS SOC PSYCHOL REV, V11, P28, DOI 10.1177/1088868306294588; Krippendorff K, 2004, HUM COMMUN RES, V30, P411, DOI 10.1111/j.1468-2958.2004.tb00738.x; Leach CW, 2008, J PERS SOC PSYCHOL, V95, P144, DOI 10.1037/0022-3514.95.1.144; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; LORD CG, 1979, J PERS SOC PSYCHOL, V37, P2098, DOI 10.1037/0022-3514.37.11.2098; MAEL FA, 1992, EDUC PSYCHOL MEAS, V52, P813, DOI 10.1177/0013164492052004002; Metzger MJ, 2010, J COMMUN, V60, P413, DOI 10.1111/j.1460-2466.2010.01488.x; Morton TA, 2006, POLIT PSYCHOL, V27, P823, DOI 10.1111/j.1467-9221.2006.00539.x; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; Munro GD, 2010, J APPL SOC PSYCHOL, V40, P579, DOI 10.1111/j.1559-1816.2010.00588.x; Nauroth P, 2014, EUR J SOC PSYCHOL, V44, P104, DOI 10.1002/ejsp.1998; Pollard Sacks D., 2011, NORTHWEST U LAW REV, V106, P1; Postmes T, 2001, PERS SOC PSYCHOL B, V27, P1243, DOI 10.1177/01461672012710001; Postmes T., 2007, OXFORD HDB INTERNET, P165, DOI [10.1093/oxfordhb/9780199561803.013.0012, DOI 10.1093/OXFORDHB/9780199561803.013.0012]; Postmes T, 2013, BRIT J SOC PSYCHOL, V52, P597, DOI 10.1111/bjso.12006; Przybylski AK, 2014, CYBERPSYCH BEH SOC N, V17, P228, DOI 10.1089/cyber.2013.0245; Reicher S. D., 1995, EUROPEAN REV SOCIAL, V6, P161, DOI [10.1080/14792779443000049, DOI 10.1080/14792779443000049]; Ryan MK, 2007, J ORGAN CHANGE MANAG, V20, P182, DOI 10.1108/09534810710724748; Scheepers D, 2003, PERS SOC PSYCHOL B, V29, P568, DOI 10.1177/0146167203029005002; Scheufele DA, 2009, NAT NANOTECHNOL, V4, P91, DOI 10.1038/NNANO.2008.361; Schuman S, 2014, THESIS U LIBRE BRUXE; Schwarz N, 1999, AM PSYCHOL, V54, P93, DOI 10.1037/0003-066X.54.2.93; Sherman DAK, 2000, PERS SOC PSYCHOL B, V26, P1046, DOI 10.1177/01461672002611003; Sherman DK, 2007, PERS SOC PSYCHOL B, V33, P1100, DOI 10.1177/0146167207303027; Sherman DK, 2006, ADV EXP SOC PSYCHOL, V38, P183, DOI 10.1016/S0065-2601(06)38004-5; Sjostrom A, 2013, J MEDIA PSYCHOL-GER, V25, P27, DOI 10.1027/1864-1105/a000077; Spears R., 2007, OXFORD HDB INTERNET; Steele CM, 1988, ADV EXPT SOCIAL PSYC, P261, DOI DOI 10.1016/S0065-2601(08)60229-4; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Suler J, 2004, CYBERPSYCHOL BEHAV, V7, P321, DOI 10.1089/1094931041291295; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Toma CL, 2013, PERS SOC PSYCHOL B, V39, P321, DOI 10.1177/0146167212474694; Turner J.C., 1987, REDISCOVERING SOCIAL; Van Laer J, 2010, INFORM COMMUN SOC, V13, P1146, DOI 10.1080/13691181003628307; van Zomeren M, 2008, PSYCHOL BULL, V134, P504, DOI 10.1037/0033-2909.134.4.504; Walther JB, 2010, HUM COMMUN RES, V36, P469, DOI 10.1111/j.1468-2958.2010.01384.x; Walther JB, 2009, COMMUN RES, V36, P229, DOI 10.1177/0093650208330251; Wilson RE, 2012, PERSPECT PSYCHOL SCI, V7, P203, DOI 10.1177/1745691612442904; Wood W, 2000, ANNU REV PSYCHOL, V51, P539, DOI 10.1146/annurev.psych.51.1.539	67	42	42	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117476	10.1371/journal.pone.0117476	http://dx.doi.org/10.1371/journal.pone.0117476			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3QZ	25646725	gold, Green Published, Green Submitted			2022-12-27	WOS:000348822600072
J	Niroula, A; Urolagin, S; Vihinen, M				Niroula, Abhishek; Urolagin, Siddhaling; Vihinen, Mauno			PON-P2: Prediction Method for Fast and Reliable Identification of Harmful Variants	PLOS ONE			English	Article							MISSENSE MUTATIONS; DISEASE; DATABASE; PATHOGENICITY; POLYMORPHISMS; CONFORMATION; EXPRESSION; INFERENCE; SELECTON; CANCER	More reliable and faster prediction methods are needed to interpret enormous amounts of data generated by sequencing and genome projects. We have developed a new computational tool, PON-P2, for classification of amino acid substitutions in human proteins. The method is a machine learning-based classifier and groups the variants into pathogenic, neutral and unknown classes, on the basis of random forest probability score. PON-P2 is trained using pathogenic and neutral variants obtained from VariBench, a database for benchmark variation datasets. PON-P2 utilizes information about evolutionary conservation of sequences, physical and biochemical properties of amino acids, GO annotations and if available, functional annotations of variation sites. Extensive feature selection was performed to identify 8 informative features among altogether 622 features. PON-P2 consistently showed superior performance in comparison to existing state-of-the-art tools. In 10-fold cross-validation test, its accuracy and MCC are 0.90 and 0.80, respectively, and in the independent test, they are 0.86 and 0.71, respectively. The coverage of PON-P2 is 61.7% in the 10-fold cross-validation and 62.1% in the test dataset. PON-P2 is a powerful tool for screening harmful variants and for ranking and prioritizing experimental characterization. It is very fast making it capable of analyzing large variant datasets. PON-P2 is freely available at http://structure.bmc.lu.se/PON-P2/.	[Niroula, Abhishek; Urolagin, Siddhaling; Vihinen, Mauno] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Vihinen, M (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	mauno.vihinen@med.lu.se	Vihinen, Mauno/A-8452-2012; Niroula, Abhishek/AAB-3998-2022; Niroula, Abhishek/G-4865-2017	Vihinen, Mauno/0000-0002-9614-7976; Niroula, Abhishek/0000-0002-5904-0635; Niroula, Abhishek/0000-0002-5904-0635	Faculty of Medicine, Lund University; Vetenskapsradet	Faculty of Medicine, Lund University; Vetenskapsradet(Swedish Research Council)	MV received funding from Faculty of Medicine, Lund University (http://www.med.lu.se/english). MV received funding from Vetenskapsradet (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anca MH, 2004, AM J MED GENET A, V124A, P89, DOI 10.1002/ajmg.a.20328; Arbiza L, 2006, J MOL BIOL, V358, P1390, DOI 10.1016/j.jmb.2006.02.067; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baux D, 2014, HUM MUTAT, V35, P1179, DOI 10.1002/humu.22608; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2008, HUM MUTAT, V29, P198, DOI 10.1002/humu.20628; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; CHOW CK, 1970, IEEE T INFORM THEORY, V16, P41, DOI 10.1109/TIT.1970.1054406; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Fawcett T., 2004, MACH LEARN, V31, P1, DOI DOI 10.1016/J.PATREC.2005.10.010; Fernald GH, 2011, BIOINFORMATICS, V27, P1741, DOI 10.1093/bioinformatics/btr295; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gnad F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S7; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hanczar B, 2008, BIOINFORMATICS, V24, P1889, DOI 10.1093/bioinformatics/btn349; Hershfield MS, 2003, CURR OPIN IMMUNOL, V15, P571, DOI 10.1016/S0952-7915(03)00104-3; Kaminker JS, 2007, CANCER RES, V67, P465, DOI 10.1158/0008-5472.CAN-06-1736; Kawabata T, 1999, NUCLEIC ACIDS RES, V27, P355, DOI 10.1093/nar/27.1.355; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; KOSHI JM, 1995, PROTEIN ENG, V8, P641; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Nair PS, 2013, HUM MUTAT, V34, P42, DOI 10.1002/humu.22204; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Olatubosun A, 2012, HUM MUTAT, V33, P1166, DOI 10.1002/humu.22102; RACKOVSKY S, 1982, MACROMOLECULES, V15, P1340, DOI 10.1021/ma00233a025; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; TANAKA S, 1977, MACROMOLECULES, V10, P9, DOI 10.1021/ma60055a002; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Vihinen M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S4-S2; Vihinen M, 2014, GENOME RES, V24, P356, DOI 10.1101/gr.157495.113; Vihinen M, 2013, HUM MUTAT, V34, P275, DOI 10.1002/humu.22253; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wei Qiong, 2013, PLoS One, V8, pe67863, DOI 10.1371/journal.pone.0067863	47	135	137	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117380	10.1371/journal.pone.0117380	http://dx.doi.org/10.1371/journal.pone.0117380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647319	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600067
J	Muriel-Millan, LF; Moreno, S; Romero, Y; Bedoya-Perez, LP; Castaneda, M; Segura, D; Espin, G				Felipe Muriel-Millan, Luis; Moreno, Soledad; Romero, Yanet; Patricia Bedoya-Perez, Leidy; Castaneda, Miguel; Segura, Daniel; Espin, Guadalupe			The Unphosphorylated EIIA(Ntr) Protein Represses the Synthesis of Alkylresorcinols in Azotobacter vinelandii	PLOS ONE			English	Article							CYST DESICCATION RESISTANCE; ESCHERICHIA-COLI; BETA-HYDROXYBUTYRATE; BIOSYNTHETIC GENES; EXPRESSION; RPOS; ENCYSTMENT; BACTERIA; IIA(NTR); CASSETTES	Upon encystment induction, Azotobacter vinelandii produces the phenolic lipids alkylresorcinols (ARs) that are structural components of the cysts. The enzymes responsible for the ARs synthesis are encoded in the arsABCD operon, whose expression is activated by ArpR. The transcription of arpR is initiated from an RpoS dependent promoter. The nitrogen-related phosphotransferase system (PTSNtr) is a global regulatory system present in Gram negative bacteria. It comprises the EINtr, NPr and EIIA(Ntr) proteins encoded by ptsP, ptsO and ptsN genes respectively. These proteins participate in a phosphoryl-group transfer from phosphoenolpyruvate to protein EIIA(Ntr) via the phosphotransferases EINtr and NPr. In A. vinelandii, the non-phosphorylated form of EIIA(Ntr) was previously shown to repress the synthesis of poly-beta-hydroxybutyrate. In this work, we show that PTSNtr also regulates the synthesis of ARs. In a strain that carries unphosphorylated EIIA(Ntr), the expression of arpR was reduced, while synthesis of ARs and transcription of arsA were almost abrogated. The expression of arpR from an RpoS-independent promoter in this strain restored the ARs synthesis. Taken together these results indicate that unphosphorylated EIIA(Ntr) negatively affects activation of arpR transcription by RpoS.	[Felipe Muriel-Millan, Luis; Moreno, Soledad; Romero, Yanet; Patricia Bedoya-Perez, Leidy; Segura, Daniel; Espin, Guadalupe] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca, Morelos, Mexico; [Castaneda, Miguel] Benemerita Univ Autonoma Puebla, Inst Ciencias, Ctr Invest Ciencias Microbiol, Puebla, Mexico	Universidad Nacional Autonoma de Mexico; Benemerita Universidad Autonoma de Puebla	Espin, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca, Morelos, Mexico.	espin@ibt.unam.mx		ROMERO, YANET/0000-0002-8383-4128; Muriel, Luis/0000-0002-0507-2519	grant DGAPA-PAPIIT [209814]; CONACyT	grant DGAPA-PAPIIT; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by grant DGAPA-PAPIIT 209814. LFMM received financial support by CONACyT during his PhD studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXEYEV MF, 1995, GENE, V160, P63, DOI 10.1016/0378-1119(95)00108-I; BALI A, 1992, APPL ENVIRON MICROB, V58, P1711, DOI 10.1128/AEM.58.5.1711-1718.1992; BARRY T, 1992, NUCLEIC ACIDS RES, V20, P4940, DOI 10.1093/nar/20.18.4940; Chang-Ro Lee S-HC, 2007, P NATL ACAD SCI USA, V104, P4124; Choi J, 2010, P NATL ACAD SCI USA, V107, P20506, DOI 10.1073/pnas.1000759107; Cocotl-Yanez M, 2014, MICROBIOL-SGM, V160, P479, DOI 10.1099/mic.0.073353-0; Cocotl-Yanez M, 2011, MICROBIOL-SGM, V157, P1685, DOI 10.1099/mic.0.046268-0; Funa N, 2006, P NATL ACAD SCI USA, V103, P6356, DOI 10.1073/pnas.0511227103; Hernandez- Eligio A, 2012, MICROBIOLOGY, V158, P11; Hernandez-Eligio A, 2011, MICROBIOL-SGM, V157, P3014, DOI 10.1099/mic.0.051649-0; Higa F, 2001, INFECT IMMUN, V69, P4782, DOI 10.1128/IAI.69.8.4782-4789.2001; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lee CR, 2010, MOL MICROBIOL, V78, P1468, DOI 10.1111/j.1365-2958.2010.07419.x; Lee CR, 2005, MOL MICROBIOL, V58, P334, DOI 10.1111/j.1365-2958.2005.04834.x; LIN LP, 1968, J BACTERIOL, V95, P2336, DOI 10.1128/JB.95.6.2336-2343.1968; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luttmann D, 2012, MOL MICROBIOL, V86, P96, DOI 10.1111/j.1365-2958.2012.08176.x; Luttmann D, 2009, MOL MICROBIOL, V72, P978, DOI 10.1111/j.1365-2958.2009.06704.x; MartinezSalazar JM, 1996, J BACTERIOL, V178, P1800, DOI 10.1128/jb.178.7.1800-1808.1996; Michiels J, 1998, J BACTERIOL, V180, P1729, DOI 10.1128/JB.180.7.1729-1740.1998; Noguez R, 2008, J MOL MICROB BIOTECH, V15, P244, DOI 10.1159/000108658; Peralta-Gil M, 2002, J BACTERIOL, V184, P5672, DOI 10.1128/JB.184.20.5672-5677.2002; Pfluger-Grau K, 2010, TRENDS MICROBIOL, V18, P205, DOI 10.1016/j.tim.2010.02.003; REUSCH RN, 1983, J BACTERIOL, V156, P778, DOI 10.1128/JB.156.2.778-788.1983; Romero Y, 2013, J BACTERIOL, V195, P1834, DOI 10.1128/JB.01946-12; Sadoff HL, 1975, MICROBIOL MOL BIOL R, V39, P516; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Segura D, 2003, ARCH MICROBIOL, V179, P437, DOI 10.1007/s00203-003-0553-4; Segura D, 2009, J BACTERIOL, V191, P3142, DOI 10.1128/JB.01575-08; Untiet V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064682; WILSON KJ, 1995, MICROBIOL-SGM, V141, P1691, DOI 10.1099/13500872-141-7-1691	32	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117184	10.1371/journal.pone.0117184	http://dx.doi.org/10.1371/journal.pone.0117184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642700	gold, Green Submitted, Green Published			2022-12-27	WOS:000348821200034
J	Zhuang, LP; Xu, LT; Wang, P; Meng, ZQ				Zhuang, Liping; Xu, Litao; Wang, Peng; Meng, Zhiqiang			Serum miR-128-2 Serves as a Prognostic Marker for Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							MICRORNA EXPRESSION; CANCER; GENE; METASTASIS; BIOMARKERS; APOPTOSIS; DIAGNOSIS; SURVIVAL	Circulating miRNAs are promising biomarkers for predicting the aggressiveness of hepatocellular carcinoma (HCC). We aimed to identify differentially expressed miRNAs in the serum of HCC patients with different Barcelona Clinic Liver Cancer (BCLC) stage, and to investigate the potential of serum miRNAs as biomarkers for patient outcomes. In the discovery stage, TaqMan Low-Density Array was used to test the difference in levels of serum miRNAs between 20 patients with portal vein tumor thrombosis (PVTT) and 20 patients without PVTT. The detected serum miRNAs then were validated in 182 patients. Fifteen serum miRNAs showed more than two-fold higher expression in patients with PVTT, and miR-128-2 was found to be significantly up-regulated and was selected for further validation. In the validation stage, patients were divided into two groups with low or high serum miR-128-2 using the median expression level of all 182 cases as the cut-off point. Kaplan-Meier analysis revealed that patients with low level of serum miR-128-2 had favorable trends of survival (log rank = 13.031, p < 0.001). The median survivals for patients with a low and high level of serum miR-128-2 were 625 (95% CI, 527-722) days and 426 (95% CI, 362-491) days, respectively. MiR-128-2 was also an independent factor of overall survival (p = 0.001, HR 2.793, 95% CI 1.550, 5.033). Serum levels of the ubiquitously expressed miR-128-2 showed no significant correlation with parameters of liver damage or liver function. In addition, expressions of miR-128-2 in HCC tissues were up-regulated in comparison with adjacent non-tumor tissues. In conclusion, serum level of miR-128-2 serves as a noninvasive biomarker for the overall survival of patients with hepatocellular carcinoma.	[Zhuang, Liping; Xu, Litao; Wang, Peng; Meng, Zhiqiang] Fudan Univ, Shanghai Canc Ctr, Dept Integrat Med, Dept Oncol,Shanghai Med Coll, Shanghai 200032, Peoples R China	Fudan University	Meng, ZQ (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Integrat Med, Dept Oncol,Shanghai Med Coll, Shanghai 200032, Peoples R China.	mengzhq@yeah.net	Meng, Zhiqiang/ABE-7747-2021	Zhuang, Liping/0000-0003-1998-8250				Adlakha YK, 2011, CELL MOL LIFE SCI, V68, P1415, DOI 10.1007/s00018-010-0528-y; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chau GY, 2005, WORLD J SURG, V29, P1374, DOI 10.1007/s00268-005-7766-4; Cheng SQ, 2007, HEPATO-GASTROENTEROL, V54, P499; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Evangelisti C, 2009, FASEB J, V23, P4276, DOI 10.1096/fj.09-134965; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Giovannetti E, 2010, CANCER RES, V70, P4528, DOI 10.1158/0008-5472.CAN-09-4467; Huitzil-Melendez FD, 2010, J CLIN ONCOL, V28, P2889, DOI 10.1200/JCO.2009.25.9895; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Lim HY, 2013, ANN SURG ONCOL, V20, P3747, DOI 10.1245/s10434-013-3070-y; Lin DX, 2011, J CANCER RES CLIN, V137, P139, DOI 10.1007/s00432-010-0868-x; Liu SP, 2012, J HEPATOL, V56, P389, DOI 10.1016/j.jhep.2011.08.008; LOK ASF, 1989, HEPATOLOGY, V9, P110, DOI 10.1002/hep.1840090119; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Peck-Radosavljevic M, 2012, J HEPATOL, V56, P488, DOI 10.1016/j.jhep.2011.06.023; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028486; Shi J, 2010, ANN SURG ONCOL, V17, P2073, DOI 10.1245/s10434-010-0940-4; Tang ZY, 2001, WORLD J GASTROENTERO, V7, P445; Venkataraman S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010748; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Yang F, 2010, HEPATOLOGY, V51, P1614, DOI 10.1002/hep.23566; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; YUKI K, 1990, CANCER-AM CANCER SOC, V66, P2174, DOI 10.1002/1097-0142(19901115)66:10<2174::AID-CNCR2820661022>3.0.CO;2-A; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697	37	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117274	10.1371/journal.pone.0117274	http://dx.doi.org/10.1371/journal.pone.0117274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642945	Green Published, Green Submitted, gold			2022-12-27	WOS:000348821200035
J	Shen, ZW; Stanger, BZ				Shen, Zhewei; Stanger, Ben Z.			YAP Regulates S-Phase Entry in Endothelial Cells	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; ORGAN SIZE CONTROL; LARGE GENE LISTS; TUMOR-SUPPRESSOR; DNA-REPLICATION; HIPPO PATHWAY; OVARIAN-CANCER; PROLIFERATION; EXPRESSION; ONCOGENE	The Hippo pathway regulates cell proliferation and apoptosis through the Yes-associated protein (YAP) transcriptional activator. YAP has a well-described role in promoting cell proliferation and survival, but the precise mechanisms and transcriptional targets that underlie these properties are still unclear and likely context-dependent. We found, using siRNA-mediated knockdown, that YAP is required for proliferation in endothelial cells but not HeLa cells. Specifically, YAP is required for S-phase entry and its absence causes cells to accumulate in G1. Microarray analysis suggests that YAP mediates this effect by regulating the transcription of genes involved in the assembly and/or firing of replication origins and homologous recombination of DNA. These findings thus provide insight into the molecular mechanisms by which YAP regulates cell cycle progression.	[Shen, Zhewei; Stanger, Ben Z.] Univ Penn, Dept Med, Div Gastroenterol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Shen, Zhewei; Stanger, Ben Z.] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Shen, Zhewei; Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Stanger, BZ (corresponding author), Univ Penn, Dept Med, Div Gastroenterol, Perelman Sch Med, Philadelphia, PA 19104 USA.	bstanger@exchange.upenn.edu		Stanger, Ben/0000-0003-0410-4037; Shen, Zhewei/0000-0002-5811-3521	National Institutes of Health Pew Charitable Trusts [R01-DK083355]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083355] Funding Source: NIH RePORTER	National Institutes of Health Pew Charitable Trusts; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health R01-DK083355 (BZS) Pew Charitable Trusts http://www.pewtrusts.org/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avruch J, 2011, BRIT J CANCER, V104, P24, DOI 10.1038/sj.bjc.6606011; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chalasani P, 2013, ONCOLOGIST, V18, P909, DOI 10.1634/theoncologist.2013-0039; Cook JG, 2002, P NATL ACAD SCI USA, V99, P1347, DOI 10.1073/pnas.032677499; Cottini F, 2014, NAT MED, V20, P599, DOI 10.1038/nm.3562; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Flygare J, 1996, BBA-MOL CELL RES, V1312, P231, DOI 10.1016/0167-4889(96)00040-7; Francken AB, 2013, BREAST, V22, P561, DOI 10.1016/j.breast.2013.07.045; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Kim JM, 2003, MUTAT RES-FUND MOL M, V532, P29, DOI 10.1016/j.mrfmmm.2003.08.008; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Liu T, 2014, CELL MOL LIFE SCI, V71, P3779, DOI 10.1007/s00018-014-1649-5; LOGAN TJ, 1995, CANCER RES, V55, P2883; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; MacLachlan TK, 2000, FUNCTIONAL INTERACTI; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mizuno T, 2012, ONCOGENE, V31, P5117, DOI 10.1038/onc.2012.5; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; Nishitani H, 2004, FRONT BIOSCI-LANDMRK, V9, P2115; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pollok S, 2007, FEBS J, V274, P3669, DOI 10.1111/j.1742-4658.2007.05900.x; Rosell R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001129; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Shimizu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034102; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Stoeber K, 2001, J CELL SCI, V114, P2027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsuyama T, 2005, NUCLEIC ACIDS RES, V33, P765, DOI 10.1093/nar/gki226; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; Xia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091770; Xiao WF, 2013, BIOCHEM BIOPH RES CO, V439, P167, DOI 10.1016/j.bbrc.2013.08.071; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yi CL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004060; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	57	40	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117522	10.1371/journal.pone.0117522	http://dx.doi.org/10.1371/journal.pone.0117522			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635998	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700089
J	Jung, M; Shin, MK; Jung, YK; Yoo, HS				Jung, Myunghwan; Shin, Min-Kyoung; Jung, Yeon-Kwon; Yoo, Han Sang			Modulation of Macrophage Activities in Proliferation, Lysosome, and Phagosome by the Nonspecific Immunostimulator, Mica	PLOS ONE			English	Article							BIOTITE-V SUPPLEMENTATION; SILICATE IN-VITRO; DNA-REPLICATION; P53 PATHWAY; ACTIVATION; NANOPARTICLES; MECHANISM; PIGS; PHAGOCYTOSIS; RECEPTORS	It was reported that the aluminosilicate material mica activated macrophages and showed its immunostimulating effects. However, the mechanisms by which it exerts these effects are unclear. To address this, we evaluated the effects of mica fine particles (MFP, 804.1 +/- 0.02 nm) on the murine macrophage cell line, RAW 264.7. Specifically, RAW 264.7 cells were treated with 100 and 500 mu g/mL MFP and their proliferative response was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Changes in global gene expression upon MFP treatment for 12 and 48 h were also determined using microarrays. Following the MFP treatment, RAW 264.7 cells showed a low level of proliferation compared to nontreated cells (p < 0.01). There was a change in an expression level of 1,128 genes after 48 h treatment. Specifically, genes associated with the cell cycle, DNA replication, and pyrimidine and purine metabolisms, were down-regulated in cells treated with MFP, which resulted in reduction of cell proliferation. MFP treatment also up-regulated genes associated with lysosome and phagosome function, which are both required for macrophage activities. We speculate that activation of macrophages by mica is in part derived from up-regulation of these pathways.	[Jung, Myunghwan; Shin, Min-Kyoung; Yoo, Han Sang] Seoul Natl Univ, Coll Vet Med, Dept Infect Dis, Seoul, South Korea; [Jung, Yeon-Kwon] Seobong BioBesstech Co Ltd, Seoul, South Korea; [Yoo, Han Sang] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Yoo, HS (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Infect Dis, Seoul, South Korea.	yoohs@snu.ac.kr	Jung, Myunghwan/AAO-3582-2021; Jung, Myunghwan/AAL-6549-2021	Jung, Myunghwan/0000-0001-8124-8945; Jung, Myunghwan/0000-0001-8124-8945	NRF grant - MSIP [2014R1A2A2A01007291]; Research Institute for Veterinary Science, Seoul National University, Seoul, Korea; Seobong Biostech Co. Ltd.	NRF grant - MSIP; Research Institute for Veterinary Science, Seoul National University, Seoul, Korea; Seobong Biostech Co. Ltd.	This work was supported by Seobong Biostech Co. Ltd., NRF grant funded by MSIP (No. 2014R1A2A2A01007291) and Research Institute for Veterinary Science, Seoul National University, Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikoh T, 1998, INT J ONCOL, V12, P1355; Araki H, 2010, BBA-PROTEINS PROTEOM, V1804, P520, DOI 10.1016/j.bbapap.2009.10.020; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chen YJ, 2005, ASIAN AUSTRAL J ANIM, V18, P1642, DOI 10.5713/ajas.2005.1642; Chen YJ, 2005, ASIAN AUSTRAL J ANIM, V18, P1147, DOI 10.5713/ajas.2005.1147; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Geiser M, 2010, J AEROSOL MED PULM D, V23, P207, DOI 10.1089/jamp.2009.0797; Graves B, 2012, P NATL ACAD SCI USA, V109, P11788, DOI 10.1073/pnas.1203789109; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Harrison RE, 2002, BIOCHEM CELL BIOL, V80, P509, DOI 10.1139/O02-142; Holian A, 1997, ENVIRON HEALTH PERSP, V105, P1139, DOI 10.2307/3433522; Huang YCT, 2009, AM J RESP CELL MOL, V41, P544, DOI 10.1165/rcmb.2008-0064OC; Jung BG, 2013, J VET SCI, V14, P135, DOI 10.4142/jvs.2013.14.2.135; Jung BG, 2010, VET MICROBIOL, V143, P117, DOI 10.1016/j.vetmic.2009.11.009; Jung M, 2012, PAK VET J, V32, P319; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; KESHAV S, 1991, J EXP MED, V174, P1049, DOI 10.1084/jem.174.5.1049; Lim DH, 2012, BIOMATERIALS, V33, P4690, DOI 10.1016/j.biomaterials.2012.03.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locati M, 2012, ADV IMMUNOL, V120, P163; Matsusaki T, 2007, J ARTHROPLASTY, V22, P960, DOI 10.1016/j.arth.2007.03.013; Mendoza M, 2009, NAT CELL BIOL, V11, P477, DOI 10.1038/ncb1855; Micheli V, 2011, CURR TOP MED CHEM, V11, P923, DOI 10.2174/156802611795347645; MOLLICK JA, 1989, SCIENCE, V244, P817, DOI 10.1126/science.2658055; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Pavlov YI, 2006, INT REV CYTOL, V255, P41, DOI 10.1016/S0074-7696(06)55002-8; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Thomson EM, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-6; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; UEKI A, 1994, IMMUNOLOGY, V82, P332; VENEZIE RD, 1995, J NEUROSCI RES, V40, P99, DOI 10.1002/jnr.490400111; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Waters KM, 2009, TOXICOL SCI, V107, P553, DOI 10.1093/toxsci/kfn250; Watts C, 2012, BBA-PROTEINS PROTEOM, V1824, P14, DOI 10.1016/j.bbapap.2011.07.006; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014525	43	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117838	10.1371/journal.pone.0117838	http://dx.doi.org/10.1371/journal.pone.0117838			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668030	gold, Green Submitted, Green Published			2022-12-27	WOS:000349493000028
J	Btadini, W; Abou Hassan, OK; Saadeh, D; Abbas, O; Ballout, F; Kibbi, AG; Dbaibo, G; Darwiche, N; Nemer, G; Kurban, M				Btadini, Waed; Abou Hassan, Ossama K.; Saadeh, Dana; Abbas, Ossama; Ballout, Farah; Kibbi, Abdul-Ghani; Dbaibo, Ghassan; Darwiche, Nadine; Nemer, Georges; Kurban, Mazen			Identification of Several Mutations in ATP2C1 in Lebanese Families: Insight into the Pathogenesis of Hailey-Hailey Disease	PLOS ONE			English	Article							CARDIOMYOCYTE-SPECIFIC EXCISION; PEMPHIGUS; HEART; GENE; ACANTHOLYSIS; DYSFUNCTION; SERCA2; GOLGI; RISK; MICE	Background Hailey-Hailey disease (HHD) is an inherited blistering dermatosis characterized by recurrent erosions and erythematous plaques that generally manifest in intertriginous areas. Genetically, HHD is an autosomal dominant disease, resulting from heterozygous mutations in ATP2C1, which encodes a Ca2+/Mn2+ ATPase. In this study, we aimed at identifying and analyzing mutations in five patients from unrelated families diagnosed with HHD and study the underlying molecular pathogenesis. Objectives To genetically study Lebanese families with HHD, and the underlying molecular pathogenesis of the disease. Methods We performed DNA sequencing for the coding sequence and exon-intron boundaries of ATP2C1. Heat shock experiments were done on several cell types. This was followed by real-time and western blotting for ATP2C1, caspase 3, and PARP proteins to examine any possible role of apoptosis in HHD. This was followed by TUNEL staining to confirm the western blotting results. We then performed heat shock experiments on neonatal rat primary cardiomyocytes. Results Four mutations were detected, three of which were novel and one recurrent mutation in two families. In order for HHD to manifest, it requires both the genetic alteration and the environmental stress, therefore we performed heat shock experiments on fibroblasts (HH and normal) and HaCaT cells, mimicking the environmental factor seen in HHD. It was found that stress stimuli, represented here as temperature stress, leads to an increase in the mRNA and protein levels of ATP2C1 in heat-shocked cells as compared to non-heat shocked ones. However, the increase in ATP2C1 and heat shock protein hsp90 is significantly lower in HH fibroblasts in comparison to normal fibroblasts and HaCaT cells. We did not find a role for apoptosis in the pathogenesis of HHD. A similar approach (heat shock experiments) done on rat cardiomyocytes, led to a significant variation in ATP2C1 transcript and protein levels. Conclusion This is the first genetic report of HHD from Lebanon in which we identified three novel mutations in ATP2C1 and shed light on the molecular mechanisms and pathogenesis of HHD by linking stress signals like heat shock to the observed phenotypes. This link was also found in cultured cardiomyocytes suggesting thus a yet uncharacterized cardiac phenotype in HHD patients masked by its in-expressivity in normal health conditions.	[Btadini, Waed; Saadeh, Dana; Abbas, Ossama; Kibbi, Abdul-Ghani; Kurban, Mazen] Amer Univ Beirut, Dept Dermatol, Beirut, Lebanon; [Abou Hassan, Ossama K.; Ballout, Farah; Dbaibo, Ghassan; Darwiche, Nadine; Nemer, Georges; Kurban, Mazen] Amer Univ Beirut, Dept Biochem & Mol Genet, Beirut, Lebanon; [Kurban, Mazen] Columbia Univ, Dept Dermatol, New York, NY 10027 USA; [Dbaibo, Ghassan] Amer Univ Beirut, Dept Pediat, Beirut, Lebanon	American University of Beirut; American University of Beirut; Columbia University; American University of Beirut	Kurban, M (corresponding author), Amer Univ Beirut, Dept Dermatol, Beirut, Lebanon.	mk104@aub.edu.lb	Nemer, Georges/H-7801-2014; Nemer, Georges/ABB-5117-2020; Dbaibo, Ghassan S./X-2978-2019	Nemer, Georges/0000-0003-2157-5279; Darwiche, Nadine/0000-0002-1862-5426; Ballout, Farah/0000-0002-6399-9179	American University of Beirut	American University of Beirut	This work was supported by a grant awarded to Mazen Kurban from the American University of Beirut.	Andersson KB, 2009, J MOL CELL CARDIOL, V47, P180, DOI 10.1016/j.yjmcc.2009.03.013; Behne MJ, 2003, J INVEST DERMATOL, V121, P688, DOI 10.1046/j.1523-1747.2003.12528.x; Boardman NT, 2014, AM J PHYSIOL-HEART C, V306, pH1018, DOI 10.1152/ajpheart.00741.2013; Chao SC, 2002, BRIT J DERMATOL, V146, P595, DOI 10.1046/j.1365-2133.2002.04697.x; Delmar M, 2010, CIRC RES, V107, P700, DOI 10.1161/CIRCRESAHA.110.223412; Francia P, 2013, J INTERV CARD ELECTR, V38, P169, DOI 10.1007/s10840-013-9827-1; Hailey H, 1939, ARCH DERMATOL SYPH, V39, P679, DOI 10.1001/archderm.1939.01480220064005; He WF, 2012, NEUROCHEM RES, V37, P455, DOI 10.1007/s11064-011-0644-6; Janse IC, 2014, J INVEST DERMATOL, V134, P2039, DOI 10.1038/jid.2014.60; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kourtis N, 2012, NATURE, V490, P213, DOI 10.1038/nature11417; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Pelacho B, 2004, FEBS LETT, V566, P6, DOI 10.1016/j.febslet.2004.03.107; Sudbrak R, 2000, HUM MOL GENET, V9, P1131, DOI 10.1093/hmg/9.7.1131; Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073; Wang X, 2004, APOPTOSIS, V9, P131, DOI 10.1023/B:APPT.0000018795.05766.1f; Windoffer R, 2002, J CELL SCI, V115, P1717; Wootton LL, 2004, BBA-BIOMEMBRANES, V1664, P189, DOI 10.1016/j.bbamem.2004.05.009; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6	19	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115530	10.1371/journal.pone.0115530	http://dx.doi.org/10.1371/journal.pone.0115530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658765	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900020
J	Shahaduzzaman, M; Nash, K; Hudson, C; Sharif, M; Grimmig, B; Lin, XY; Bai, G; Liu, H; Ugen, KE; Cao, CH; Bickford, PC				Shahaduzzaman, Md; Nash, Kevin; Hudson, Charles; Sharif, Masroor; Grimmig, Bethany; Lin, Xiaoyang; Bai, Ge; Liu, Hui; Ugen, Kenneth E.; Cao, Chuanhai; Bickford, Paula C.			Anti-Human alpha-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-alpha-Synuclein Rat Model of Parkinson's Disease	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MEMBRANE-BINDING; IMMUNOTHERAPY; IMMUNIZATION; NEURODEGENERATION; PHOSPHORYLATION; MICROGLIA; STRATEGY	The protein alpha-synuclein (alpha-Syn) has a central role in the pathogenesis of Parkinson's disease (PD) and immunotherapeutic approaches targeting this molecule have shown promising results. In this study, novel antibodies were generated against specific peptides from full length human alpha-Syn and evaluated for effectiveness in ameliorating alpha-Syn-induced cell death and behavioral deficits in an AAV-alpha-Syn expressing rat model of PD. Fisher 344 rats were injected with rAAV vector into the right substantia nigra (SN), while control rats received an AAV vector expressing green fluorescent protein (GFP). Beginning one week after injection of the AAV-alpha-Syn vectors, rats were treated intraperitoneally with either control IgG or antibodies against the N-terminal (AB1), or central region (AB2) of alpha-Syn. An unbiased stereological estimation of TH+, NeuN+, and OX6 (MHC-II) immunostaining revealed that the alpha-Syn peptide antibodies (AB1 and AB2) significantly inhibited alpha-Syn-induced dopaminergic cell (DA) and NeuN+ cell loss (one-way ANOVA (F (3, 30) = 5.8, p = 0.002 and (F (3, 29) = 7.92, p = 0.002 respectively), as well as decreasing the number of activated microglia in the ipsilateral SN (one-way ANOVA F = 14.09; p = 0.0003). Antibody treated animals also had lower levels of alpha-Syn in the ipsilateral SN (one-way ANOVA F (7, 37) = 9.786; p = 0.0001) and demonstrated a partial intermediate improvement of the behavioral deficits. Our data suggest that, in particular, an alpha-Syn peptide antibody against the N-terminal region of the protein can protect against DA neuron loss and, to some extent behavioral deficits. As such, these results may be a potential therapeutic strategy for halting the progression of PD.	[Shahaduzzaman, Md; Sharif, Masroor; Grimmig, Bethany; Bickford, Paula C.] Univ S Florida, Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg & Brain Repair, Tampa, FL 33612 USA; [Nash, Kevin; Bickford, Paula C.] Univ S Florida, Morsani Coll Med, Tampa, FL 33612 USA; [Hudson, Charles; Bickford, Paula C.] James A Haley Vet Affairs Hosp, Res Serv, Tampa, FL 33612 USA; [Nash, Kevin; Lin, Xiaoyang; Bai, Ge; Liu, Hui; Cao, Chuanhai] Univ S Florida, USF Hlth Byrd Alzheimers Inst, Tampa, FL 33612 USA; [Ugen, Kenneth E.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Ugen, Kenneth E.] Univ S Florida, Ctr Mol Delivery, Tampa, FL 33612 USA; [Cao, Chuanhai] Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Cao, CH (corresponding author), Univ S Florida, USF Hlth Byrd Alzheimers Inst, Tampa, FL 33612 USA.	ccao@health.usf.edu; pbickfor@health.usf.edu	Bickford, Paula C/J-5970-2012; Ugen, Kenneth E/H-6544-2011	Bickford, Paula C/0000-0001-9657-7725; Cao, Chuanhai/0000-0002-5765-6401	VA Medical Research Service grant [1I01BX000231]; Veterans Affairs [I01BX000231] Funding Source: NIH RePORTER	VA Medical Research Service grant; Veterans Affairs(US Department of Veterans Affairs)	Funding provided by VA Medical Research Service grant 1I01BX000231 to PCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerte TNM, 2008, NEUROSCI LETT, V435, P24, DOI 10.1016/j.neulet.2008.02.014; Anderson NL, 2009, MOL CELL PROTEOMICS, V8, P995, DOI 10.1074/mcp.M800446-MCP200; Angela M., 2005, UTILITY OF 6 HYDROXY; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Boche D, 2008, BRAIN, V131, P3299, DOI 10.1093/brain/awn261; Boche D, 2010, ACTA NEUROPATHOL, V120, P369, DOI 10.1007/s00401-010-0719-5; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Carty N, 2010, J NEUROSCI METH, V194, P144, DOI 10.1016/j.jneumeth.2010.10.010; Decressac M, 2012, NEUROBIOL DIS, V45, P939, DOI 10.1016/j.nbd.2011.12.013; Fagerqvist T, 2013, J NEUROCHEM, V126, P131, DOI 10.1111/jnc.12175; Foulds PG, 2011, FASEB J, V25, P4127, DOI 10.1096/fj.10-179192; Gardai SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071634; Ghochikyan A, 2014, NEUROSCI LETT, V560, P86, DOI 10.1016/j.neulet.2013.12.028; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Gorbatyuk OS, 2010, MOL THER, V18, P1450, DOI 10.1038/mt.2010.115; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Harms AS, 2013, J NEUROSCI, V33, P9592, DOI 10.1523/JNEUROSCI.5610-12.2013; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hutter-Saunders JAL, 2011, EXPERT REV NEUROTHER, V11, P1703, DOI [10.1586/ERN.11.163, 10.1586/ern.11.163]; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; Kim TD, 2002, BIOCHEMISTRY-US, V41, P13782, DOI 10.1021/bi026284c; Kirik D, 2002, P NATL ACAD SCI USA, V99, P4708, DOI 10.1073/pnas.062047599; Koehler NKU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064649; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Kosloski LM, 2010, J NEUROCHEM, V114, P1261, DOI 10.1111/j.1471-4159.2010.06834.x; Kothawala A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043505; Kristen Marciniuk RT, 2013, CLINICAL AND DEVELOP; Lambracht-Washington D, 2013, DISCOV MED, V15, P319; Lannfelt L, 2014, J INTERN MED, V275, P284, DOI 10.1111/joim.12168; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lemere CA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-36; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Lindstrom V, 2014, IMMUNOTHERAPY-UK, V6, P141, DOI [10.2217/imt.13.162, 10.2217/IMT.13.162]; Liu L, 2014, DRUG TODAY, V50, P33, DOI 10.1358/dot.2014.50.1.2076506; Madeo J, 2013, AGING DIS, V4, P210; Mandler M, 2014, ACTA NEUROPATHOL; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Mosley RL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009381; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Pabon MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045256; Peterson LJ, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/401264; Rafii MS, 2013, REV RECENT CLIN TRIA; Sanchez-Guajardo V, 2013, ASN NEURO, V5, P113, DOI 10.1042/AN20120066; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schneeberger A, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS11, DOI 10.1016/S1353-8020(11)70006-2; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Tran HT, 2014, CELL REP, V7, P2054, DOI 10.1016/j.celrep.2014.05.033; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Valera E, 2013, PHARMACOL THERAPEUT, V138, P311, DOI 10.1016/j.pharmthera.2013.01.013; Vamvaca K, 2009, J MOL BIOL, V389, P413, DOI 10.1016/j.jmb.2009.03.021; Vekrellis K, 2012, EXPERT OPIN THER TAR, V16, P421, DOI 10.1517/14728222.2012.674111; Yu YJ, 2013, NEUROTHERAPEUTICS, V10, P459, DOI 10.1007/s13311-013-0187-4; Zhang Y, 2011, NEUROSCIENTIST, V17, P163, DOI 10.1177/1073858410381532	56	62	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116841	10.1371/journal.pone.0116841	http://dx.doi.org/10.1371/journal.pone.0116841			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658425	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900072
J	Thompson, BC; Halliday, GM; Damian, DL				Thompson, Benjamin C.; Halliday, Gary M.; Damian, Diona L.			Nicotinamide Enhances Repair of Arsenic and Ultraviolet Radiation-Induced DNA Damage in HaCaT Keratinocytes and Ex Vivo Human Skin	PLOS ONE			English	Article							INDUCED IMMUNOSUPPRESSION; DRINKING-WATER; NITRIC-OXIDE; WEST-BENGAL; GENERATION; APOPTOSIS; CELLS; METABOLISM; SURVIVAL; PROTEIN	Arsenic-induced skin cancer is a significant global health burden. In areas with arsenic contamination of water sources, such as China, Pakistan, Myanmar, Cambodia and especially Bangladesh and West Bengal, large populations are at risk of arsenic-induced skin cancer. Arsenic acts as a co-carcinogen with ultraviolet (UV) radiation and affects DNA damage and repair. Nicotinamide (vitamin B3) reduces premalignant keratoses in sun-damaged skin, likely by prevention of UV-induced cellular energy depletion and enhancement of DNA repair. We investigated whether nicotinamide modifies DNA repair following exposure to UV radiation and sodium arsenite. HaCaT keratinocytes and ex vivo human skin were exposed to 2 mu M sodium arsenite and low dose (2J/cm(2)) solar-simulated UV, with and without nicotinamide supplementation. DNA photolesions in the form of 8-oxo-7,8-dihydro-2'-deoxyguanosine and cyclobutane pyrimidine dimers were detected by immunofluorescence. Arsenic exposure significantly increased levels of 8-oxo-7,8-dihydro-2'-deoxyguanosine in irradiated cells. Nicotinamide reduced both types of photolesions in HaCaT keratinocytes and in ex vivo human skin, likely by enhancing DNA repair. These results demonstrate a reduction of two different photolesions over time in two different models in UV and arsenic exposed cells. Nicotinamide is a nontoxic, inexpensive agent with potential for chemoprevention of arsenic induced skin cancer.	[Thompson, Benjamin C.; Halliday, Gary M.; Damian, Diona L.] Univ Sydney, Royal Prince Alfred Hosp, Bosch Inst, Sydney Canc Ctr,Dept Dermatol, Sydney, NSW 2006, Australia; [Damian, Diona L.] Melanoma Inst Australia, Sydney, NSW, Australia	University of Sydney; Melanoma Institute Australia	Damian, DL (corresponding author), Univ Sydney, Royal Prince Alfred Hosp, Bosch Inst, Sydney Canc Ctr,Dept Dermatol, Sydney, NSW 2006, Australia.	diona.damian@sswahs.nsw.gov.au			Australasian College of Dermatologists Scientific Research Fund; Sydney Medical School Foundation; Cancer Council New South Wales; National Health and Medical Research Council of Australia	Australasian College of Dermatologists Scientific Research Fund; Sydney Medical School Foundation; Cancer Council New South Wales(Cancer Council New South Wales); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The project was funded by the Australasian College of Dermatologists Scientific Research Fund (DD) the Sydney Medical School Foundation (BT), Cancer Council New South Wales and the National Health and Medical Research Council of Australia (DD, GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berg M, 2007, SCI TOTAL ENVIRON, V372, P413, DOI 10.1016/j.scitotenv.2006.09.010; Centeno JA, 2002, ENVIRON HEALTH PERSP, V110, P883, DOI 10.1289/ehp.02110s5883; Damian DL, 2008, J INVEST DERMATOL, V128, P447, DOI 10.1038/sj.jid.5701058; Damian DL, 2002, METHODS, V28, P34, DOI 10.1016/S1046-2023(02)00208-6; Ding W, 2005, MOL CELL BIOCHEM, V279, P105, DOI 10.1007/s11010-005-8227-y; Ding W, 2008, FREE RADICAL BIO MED, V45, P1065, DOI 10.1016/j.freeradbiomed.2008.06.022; Ding W, 2009, J BIOL CHEM, V284, P6809, DOI 10.1074/jbc.M805566200; Fernandez MI, 2012, J UROLOGY, V187, P856, DOI 10.1016/j.juro.2011.10.157; Gupta R, 2007, J INVEST DERMATOL, V127, P707, DOI 10.1038/sj.jid.5700597; Halliday GM, 2011, SEMIN CUTAN MED SURG, V30, P214, DOI 10.1016/j.sder.2011.08.002; Halliday GM, 2009, INT J BIOCHEM CELL B, V41, P725, DOI 10.1016/j.biocel.2008.04.026; Haque R, 2003, EPIDEMIOLOGY, V14, P174, DOI 10.1097/00001648-200303000-00011; Ivanov VN, 2006, EXP CELL RES, V312, P4120, DOI 10.1016/j.yexcr.2006.09.019; Jacobson EL, 2001, J PHOTOCH PHOTOBIO B, V63, P141, DOI 10.1016/S1011-1344(01)00211-1; Javeri A, 2008, DNA REPAIR, V7, P1542, DOI 10.1016/j.dnarep.2008.05.011; Klein CB, 2007, TOXICOL APPL PHARM, V222, P289, DOI 10.1016/j.taap.2006.12.033; Komissarova EV, 2010, TOXICOL APPL PHARM, V243, P399, DOI 10.1016/j.taap.2009.12.014; Lee CH, 2013, J INVEST DERMATOL, V133, P1890, DOI 10.1038/jid.2013.55; Lee CH, 2011, KAOHSIUNG J MED SCI, V27, P396, DOI 10.1016/j.kjms.2011.05.007; Liao WT, 2009, CARCINOGENESIS, V30, P1064, DOI 10.1093/carcin/bgp095; Moloney F, 2010, BRIT J DERMATOL, V162, P1138, DOI 10.1111/j.1365-2133.2010.09659.x; Ohno M, 2009, METHODS MOL BIOL, V554, P199, DOI 10.1007/978-1-59745-521-3_13; Park J, 2010, PHOTOCHEM PHOTOBIOL, V86, P942, DOI 10.1111/j.1751-1097.2010.00746.x; Qin XJ, 2012, TOXICOL SCI, V127, P120, DOI 10.1093/toxsci/kfs099; Rahman MM, 2001, J TOXICOL-CLIN TOXIC, V39, P683, DOI 10.1081/CLT-100108509; Rodriguez-Lado L, 2013, SCIENCE, V341, P866, DOI 10.1126/science.1237484; Rossman TG, 2001, TOXICOL APPL PHARM, V176, P64, DOI 10.1006/taap.2001.9277; Shi HL, 2004, CHEM RES TOXICOL, V17, P871, DOI 10.1021/tx049939e; Sivapirabu G, 2009, BRIT J DERMATOL, V161, P1357, DOI 10.1111/j.1365-2133.2009.09244.x; Snopov SA, 2004, PHOTOCH PHOTOBIO SCI, V3, P85, DOI 10.1039/b305135h; Sun Y, 2011, TOXICOL APPL PHARM, V255, P242, DOI 10.1016/j.taap.2011.07.006; Surjana D, 2013, CARCINOGENESIS, V34, P1144, DOI 10.1093/carcin/bgt017; Thompson BC, 2014, EXP DERMATOL, V23, P509, DOI 10.1111/exd.12430; Wang F, 2013, FREE RADICAL BIO MED, V61, P249, DOI 10.1016/j.freeradbiomed.2013.04.019; Wu F, 2005, ENVIRON HEALTH PERSP, V113, P983, DOI 10.1289/ehp.7846; Wu MM, 2001, ENVIRON HEALTH PERSP, V109, P1011, DOI 10.2307/3454955; Yiasemides E, 2009, CARCINOGENESIS, V30, P101, DOI 10.1093/carcin/bgn248; YIH LH, 1991, CELL BIOL INT REP, V15, P253, DOI 10.1016/0309-1651(91)90157-E	40	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117491	10.1371/journal.pone.0117491	http://dx.doi.org/10.1371/journal.pone.0117491			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658450	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900162
J	Pinhasi, R; Eshed, V; von Cramon-Taubadel, N				Pinhasi, Ron; Eshed, Vered; von Cramon-Taubadel, Noreen			Incongruity between Affinity Patterns Based on Mandibular and Lower Dental Dimensions following the Transition to Agriculture in the Near East, Anatolia and Europe	PLOS ONE			English	Article							HUNTER-GATHERER SUBSISTENCE; OCCLUSAL VARIATION; TOOTH WEAR; MALOCCLUSION; CULTURE; LEVANT; SIZE	While it has been suggested that malocclusion is linked with urbanisation, it remains unclear as to whether its high prevalence began 8,000 years earlier concomitant with the transition to agriculture. Here we investigate the extent to which patterns of affinity (i.e., among-population distances), based on mandibular form and dental dimensions, respectively, match across Epipalaeolithic, Mesolithic, and Neolithic samples from the Near East/Anatolia and Europe. Analyses were conducted using morphological distance matrices reflecting dental and mandibular form for the same 292 individuals across 21 archaeological populations. Thereafter, statistical analyses were undertaken on four sample aggregates defined on the basis of their subsistence strategy, geography, and chronology to test for potential differences in dental and mandibular form across and within groups. Results show a clear separation based on mandibular morphology between European hunter-gatherers, European farmers, and Near Eastern transitional farmers and semi-sedentary hunter-gatherers. In contrast, the dental dimensions show no such pattern and no clear association between the position of samples and their temporal or geographic attributes. Although later farming groups have, on average, smaller teeth and mandibles, shape analyses show that the mandibles of farmers are not simply size-reduced versions of earlier hunter-gatherer mandibles. Instead, it appears that mandibular form underwent a complex series of shape changes commensurate with the transition to agriculture that are not reflected in affinity patterns based on dental dimensions. In the case of hunter-gatherers there is a correlation between inter-individual mandibular and dental distances, suggesting an equilibrium between these two closely associated morphological units. However, in the case of semi-sedentary hunter-gatherers and farming groups, no such correlation was found, suggesting that the incongruity between dental and mandibular form began with the shift towards sedentism and agricultural subsistence practices in the core region of the Near East and Anatolia.	[Pinhasi, Ron] Univ Coll Dublin, Earth Inst, Dublin 2, Ireland; [Pinhasi, Ron] Univ Coll Dublin, Sch Archaeol, Dublin 2, Ireland; [Eshed, Vered] Israel Antiqu Author, Jerusalem, Israel; [von Cramon-Taubadel, Noreen] SUNY Buffalo, Dept Anthropol, Buffalo, NY 14260 USA	University College Dublin; University College Dublin; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Pinhasi, R (corresponding author), Univ Coll Dublin, Earth Inst, Dublin 2, Ireland.	ron.pinhasi@ucd.ie	Pinhasi, Ron/AAT-1531-2020	Pinhasi, Ron/0000-0003-1629-8131	European Research Council Starting Grant [ERC-2010-StG 263441]	European Research Council Starting Grant(European Research Council (ERC))	This research was supported by the European Research Council Starting Grant (ERC-2010-StG 263441). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel J. L., 1944, HUMAN BIOL, V16, P283; Bar-Yosef O, 1998, EVOL ANTHROPOL, V6, P159, DOI 10.1002/(SICI)1520-6505(1998)6:5<159::AID-EVAN4>3.0.CO;2-7; BarYosef O, 1995, SCH AM RES, V354, P39; BEECHER RM, 1981, ANGLE ORTHOD, V51, P61; Bilimoria KF, 1963, J ALL INDIA DENT ASS, V36, P293; BISHARA SE, 1994, ANGLE ORTHOD, V64, P89; Blockley SPE, 2011, QUATERNARY SCI REV, V30, P98, DOI 10.1016/j.quascirev.2010.09.021; Brauer G., 1988, HDB VERGLEICHENDEN B, V1, P160; Christensen AF, 1998, J HUM EVOL, V34, P333, DOI 10.1006/jhev.1997.0194; Clinch L, 1951, T EUR ORTHOD SOC, P80; Corruccini R.S, 1999, ANTHR INFORMS ORTHOD; CORRUCCINI RS, 1989, ARCH ORAL BIOL, V34, P839, DOI 10.1016/0003-9969(89)90037-X; CORRUCCINI RS, 1990, AM J PHYS ANTHROPOL, V82, P257, DOI 10.1002/ajpa.1330820304; CORRUCCINI RS, 1982, SCIENCE, V218, P74, DOI 10.1126/science.7123221; CORRUCCINI RS, 1981, AM J ORTHOD DENTOFAC, V79, P250, DOI 10.1016/0002-9416(81)90073-7; CORRUCCINI RS, 1984, AM J ORTHOD DENTOFAC, V86, P419, DOI 10.1016/S0002-9416(84)90035-6; Davies DM, 1972, INFLUENCE TEETH DIET; DAVIES G. N., 1956, JOUR DENTAL RES, V35, P115, DOI 10.1177/00220345560350010401; Eshed V, 2006, AM J PHYS ANTHROPOL, V130, P145, DOI 10.1002/ajpa.20362; FALSETTI AB, 1993, INT J PRIMATOL, V14, P551, DOI 10.1007/BF02215447; Frayer DW, 1984, ORIGINS MODERN HUMAN, P211; Goring-Morris AN, 2011, CURR ANTHROPOL, V52, pS195, DOI 10.1086/658860; Goring-Morris N., 2010, EARLY VILLAGE SOC GL, P62; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harpending H.C., 1982, BIOCH ASPECTS EVOLUT, P213; Holmes MA, 2011, AM J PHYS ANTHROPOL, V145, P615, DOI 10.1002/ajpa.21554; HUNT EE, 1961, AM J ORTHOD DENTOFAC, V47, P406, DOI 10.1016/0002-9416(61)90220-2; INOUE N, 1984, J ANTHROPOL SOC NIP, V92, P13; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kaifu Y, 2003, YEARB PHYS ANTHROPOL, V46, P47, DOI 10.1002/ajpa.10329; Kuijt I, 1994, J MEDITERR ARCHAEOL, V7, P41; LARSEN CS, 1995, ANNU REV ANTHROPOL, V24, P185, DOI 10.1146/annurev.an.24.100195.001153; LARSEN CS, 1997, BIOARCHAEOLOGY; LAVELLE CLB, 1973, ANGLE ORTHOD, V43, P412; Lieberman DE, 2004, J HUM EVOL, V46, P655, DOI 10.1016/j.jhevol.2004.03.005; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; LOMBARDI AV, 1982, AM J ORTHOD DENTOFAC, V81, P38, DOI 10.1016/0002-9416(82)90286-X; MANTEL N, 1967, CANCER RES, V27, P209; MARTIN R, 1957, LEHRBUCH ANTHR SYSTE, V1; MOHLIN B, 1978, Ossa, V5, P57; MOLNAR S, 1972, CURR ANTHROPOL, V13, P511, DOI 10.1086/201284; MOORREES COENRAAD F. A., 1957, JOUR DENTAL RES, V36, P39, DOI 10.1177/00220345570360011501; Mossey P A, 1999, Br J Orthod, V26, P103; Newman MT, 1942, BUR AM ETHNOL BULL, P393; NISWANDER JD, 1967, AM J HUM GENET, V19, P543; Pinhasi R, 2008, AM J PHYS ANTHROPOL, V135, P136, DOI 10.1002/ajpa.20715; Pinhasi R, 2011, HUMAN BIOARCHAEOLOGY OF THE TRANSITION TO AGRICULTURE, P451; PRICE W. A., 1936, Journal of the American Dental Association, V23, P417; PRICE W. A., 1935, Dental Cosmos, V77, P1033; Proffit W R, 1998, Int J Adult Orthodon Orthognath Surg, V13, P97; RELETHFORD JH, 1990, HUM BIOL, V62, P5; Rose JC, 1998, DENTAL ANTHROPOLOGY, P349; Rose Jerome C, 2009, Compend Contin Educ Dent, V30, P292; Sarig R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080771; SHARMA K, 1986, EUR J ORTHODONT, V8, P91, DOI 10.1093/ejo/8.2.91; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; Stahl AB., 1989, FORAGING FARMING EVO, P171; Varrela J, 2006, SEMIN ORTHOD, V12, P102; von Cramon-Taubadel N, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1337; von Cramon-Taubadel N, 2011, P NATL ACAD SCI USA, V108, P19546, DOI 10.1073/pnas.1113050108; Williams C, 1943, J PERIODONTOL, V14, P34; WOLPOFF MH, 1971, METRIC TRENDS HOMINI; WOOD BF, 1971, AMER J ORTHODONTICS, V60, P344, DOI 10.1016/0002-9416(71)90147-3; WRIGHT KI, 1994, AM ANTIQUITY, V59, P238, DOI 10.2307/281929	64	61	62	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0117301	10.1371/journal.pone.0117301	http://dx.doi.org/10.1371/journal.pone.0117301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25651540	gold, Green Published			2022-12-27	WOS:000349250700012
J	Pereira, IVA; Buchmann, B; Sandmann, L; Sprinzl, K; Schlaphoff, V; Dohner, K; Vondran, F; Sarrazin, C; Manns, MP; de Oliveira, CPMS; Sodeik, B; Ciesek, S; von Hahn, T				Alves Pereira, Isabel Veloso; Buchmann, Bettina; Sandmann, Lisa; Sprinzl, Kathrin; Schlaphoff, Verena; Doehner, Katinka; Vondran, Florian; Sarrazin, Christoph; Manns, Michael P.; Marques Souza de Oliveira, Claudia Pinto; Sodeik, Beate; Ciesek, Sandra; von Hahn, Thomas			Primary Biliary Acids Inhibit Hepatitis D Virus (HDV) Entry into Human Hepatoma Cells Expressing the Sodium-Taurocholate Cotransporting Polypeptide (NTCP)	PLOS ONE			English	Article							SERUM BILE-ACIDS; CHENODEOXYCHOLIC ACID; DELTA VIRUS; INTRAHEPATIC CHOLESTASIS; URSODEOXYCHOLIC ACID; CYCLOSPORINE-A; HEPATOCYTES; INFECTION; THERAPY; CHOLESTEROL	Background The sodium-taurocholate cotransporting polypeptide (NTCP) is both a key bile acid (BA) transporter mediating uptake of BA into hepatocytes and an essential receptor for hepatitis B virus (HBV) and hepatitis D virus (HDV). In this study we aimed to characterize to what extent and through what mechanism BA affect HDV cell entry. Methods HuH-7 cells stably expressing NTCP (HuH-7/NTCP) and primary human hepatocytes (PHH) were infected with in vitro generated HDV particles. Infectivity in the absence or presence of compounds was assessed using immunofluorescence staining for HDV antigen, standard 50% tissue culture infectious dose (TCID50) assays and quantitative PCR. Results Addition of primary conjugated and unconjugated BA resulted in a dose dependent reduction in the number of infected cells while secondary, tertiary and synthetic BA had a lesser effect. This effect was observed both in HuH-7/NTCP and in PHH. Other replication cycle steps such as replication and particle assembly and release were unaffected. Moreover, inhibitory BA competed with a fragment from the large HBV envelope protein for binding to NTCP-expressing cells. Conversely, the sodium/BA-cotransporter function of NTCP seemed not to be required for HDV infection since infection was similar in the presence or absence of a sodium gradient across the plasma membrane. When chenodeoxycolic acid (15 mg per kg body weight) was administered to three chronically HDV infected individuals over a period of up to 16 days there was no change in serum HDV RNA. Conclusions Primary BA inhibit NTCP-mediated HDV entry into hepatocytes suggesting that modulation of the BA pool may affect HDV infection of hepatocytes.	[Alves Pereira, Isabel Veloso; Buchmann, Bettina; von Hahn, Thomas] Hannover Med Sch, Inst Mol Biol, Hannover, Germany; [Alves Pereira, Isabel Veloso; Marques Souza de Oliveira, Claudia Pinto] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Clin Div,Hepatol Branch,LIM 07, Sao Paulo, Brazil; [Alves Pereira, Isabel Veloso; Sandmann, Lisa; Schlaphoff, Verena; Manns, Michael P.; Ciesek, Sandra; von Hahn, Thomas] Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, Hannover, Germany; [Sprinzl, Kathrin; Sarrazin, Christoph] Univ Frankfurt Klinikum, Med Klin 1, Frankfurt, Germany; [Doehner, Katinka; Sodeik, Beate] Hannover Med Sch, Inst Virol, Hannover, Germany; [Vondran, Florian] Hannover Med Sch, Klin Allgemein Viszeral & Transplantationschirurg, Hannover, Germany	Hannover Medical School; Universidade de Sao Paulo; Hannover Medical School; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hannover Medical School; Hannover Medical School	Ciesek, S (corresponding author), Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, Hannover, Germany.	Ciesek.sandra@mh-hannover.de; vonhahn.thomas@mh-hannover.de	Ciesek, Sandra/AAO-4719-2020; Oliveira, Claudia PMS/D-1216-2014; Sandmann, Lisa/ABD-1803-2020; Veloso Alves Pereira, Isabel/N-4616-2014	Ciesek, Sandra/0000-0002-1802-7565; Veloso Alves Pereira, Isabel/0000-0002-3439-1658; Sodeik, Beate/0000-0003-4650-3036	Deutsche Forschungsgemeinschaft through collaborative research center [900]; 'Emmy Noether' grant [HA4394/2-1]; Brazilian research-funding agency CNPq; 'Ciencias sem Fronteiras' program	Deutsche Forschungsgemeinschaft through collaborative research center; 'Emmy Noether' grant(German Research Foundation (DFG)); Brazilian research-funding agency CNPq; 'Ciencias sem Fronteiras' program	This work was supported by Deutsche Forschungsgemeinschaft through collaborative research center 900 (Chronic infections) to BS, SC and TVH and an 'Emmy Noether' grant (HA4394/2-1) to TVH. IVAP was the recipient of a doctoral grant from Brazilian research-funding agency CNPq and the 'Ciencias sem Fronteiras' program to IVAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros-Rudolph CM, 2007, ARCH DERMATOL, V143, P757, DOI 10.1001/archderm.143.6.757; Boyer JL, 2013, COMPR PHYSIOL, V3, P1035, DOI 10.1002/cphy.c120027; Chen W, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003181.pub2; DANZINGER RG, 1972, NEW ENGL J MED, V286, P1, DOI 10.1056/NEJM197201062860101; Gehring G, 2014, J ANTIMICROB CHEMOTH, V69, P2123, DOI 10.1093/jac/dku091; Heidrich B, 2014, HEPATOLOGY, V60, P87, DOI 10.1002/hep.27102; Heidrich B, 2013, CURR INFECT DIS REP, V15, P31, DOI 10.1007/s11908-012-0307-z; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; Jansen P.L.M., 2012, ZAKIM BOYERS HEPATOL, P47; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Konig A, 2014, J HEPATOL, V61, P867, DOI 10.1016/j.jhep.2014.05.018; KullakUblick GA, 1997, GASTROENTEROLOGY, V113, P1295, DOI 10.1053/gast.1997.v113.pm9322525; KUO MYP, 1989, J VIROL, V63, P1945, DOI 10.1128/JVI.63.5.1945-1950.1989; Mederacke I, 2010, J CLIN MICROBIOL, V48, P2022, DOI 10.1128/JCM.00084-10; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; NEALE G, 1971, GUT, V12, P145, DOI 10.1136/gut.12.2.145; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Nkongolo S, 2014, J HEPATOL, V60, P723, DOI 10.1016/j.jhep.2013.11.022; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Schukfeh N, 2012, J PEDIATR SURG, V47, P501, DOI 10.1016/j.jpedsurg.2011.08.010; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Sulkowski MS, 2014, J INFECT DIS, V209, P658, DOI 10.1093/infdis/jit503; Sureau C, 2010, METHODS MOL BIOL, V640, P463, DOI 10.1007/978-1-60761-688-7_25; THISTLE JL, 1973, NEW ENGL J MED, V289, P655, DOI 10.1056/NEJM197309272891303; TINT GS, 1986, GASTROENTEROLOGY, V91, P1007, DOI 10.1016/0016-5085(86)90708-0; Triolo M, 2014, LIVER INT, V34, P139, DOI 10.1111/liv.12394; von Hahn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024142; Watashi K, 2014, HEPATOLOGY, V59, P1726, DOI 10.1002/hep.26982; Wedemeyer H, 2011, NEW ENGL J MED, V364, P322, DOI 10.1056/NEJMoa0912696; Yan H, 2014, J VIROL, V88, P3273, DOI 10.1128/JVI.03478-13; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049	32	20	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117152	10.1371/journal.pone.0117152	http://dx.doi.org/10.1371/journal.pone.0117152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646622	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600058
J	Coley, JS; Calderon, TM; Gaskill, PJ; Eugenin, EA; Berman, JW				Coley, Jacqueline S.; Calderon, Tina M.; Gaskill, Peter J.; Eugenin, Eliseo A.; Berman, Joan W.			Dopamine Increases CD14(+)CD16(+) Monocyte Migration and Adhesion in the Context of Substance Abuse and HIV Neuropathogenesis	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; IMMUNODEFICIENCY-VIRUS-INFECTION; CENTRAL-NERVOUS-SYSTEM; CHRONIC HEPATITIS-C; FREELY MOVING RATS; NUCLEUS-ACCUMBENS; NEUROCOGNITIVE DISORDERS; PERIVASCULAR MACROPHAGES; EXTRACELLULAR DOPAMINE; ANTIRETROVIRAL THERAPY	Drug abuse is a major comorbidity of HIV infection and cognitive disorders are often more severe in the drug abusing HIV infected population. CD14(+)CD16(+) monocytes, a mature subpopulation of peripheral blood monocytes, are key mediators of HIV neuropathogenesis. Infected CD14(+)CD16(+) monocyte transmigration across the blood brain barrier mediates HIV entry into the brain and establishes a viral reservoir within the CNS. Despite successful antiretroviral therapy, continued influx of CD14(+)CD16(+) monocytes, both infected and uninfected, contributes to chronic neuroinflammation and the development of HIV associated neurocognitive disorders (HAND). Drug abuse increases extracellular dopamine in the CNS. Once in the brain, CD14(+)CD16(+) monocytes can be exposed to extracellular dopamine due to drug abuse. The direct effects of dopamine on CD14(+)CD16(+) monocytes and their contribution to HIV neuropathogenesis are not known. In this study, we showed that CD14(+)CD16(+) monocytes express mRNA for all five dopamine receptors by qRT-PCR and D1R, D5R and D4R surface protein by flow cytometry. Dopamine and the D1-like dopamine receptor agonist, SKF38393, increased CD14(+)CD16(+) monocyte migration that was characterized as chemokinesis. To determine whether dopamine affected cell motility and adhesion, live cell imaging was used to monitor the accumulation of CD14(+)CD16(+) monocytes on the surface of a tissue culture dish. Dopamine increased the number and the rate at which CD14(+)CD16(+) monocytes in suspension settled to the dish surface. In a spreading assay, dopamine increased the area of CD14(+)CD16(+) monocytes during the early stages of cell adhesion. In addition, adhesion assays showed that the overall total number of adherent CD14(+)CD16(+) monocytes increased in the presence of dopamine. These data suggest that elevated extracellular dopamine in the CNS of HIV infected drug abusers contributes to HIV neuropathogenesis by increasing the accumulation of CD14(+)CD16(+) monocytes in dopamine rich brain regions.	[Coley, Jacqueline S.; Calderon, Tina M.; Gaskill, Peter J.; Berman, Joan W.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Berman, Joan W.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Eugenin, Eliseo A.] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07102 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Berman, JW (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	joan.berman@einstein.yu.edu	Gaskill, Peter Jesse/O-5096-2019	Gaskill, Peter Jesse/0000-0003-0095-5424	National Institutes of Drug Abuse [DA025567, DA029476]; National Institutes of Mental Health [MH090958, MH075679]; National Institutes of Health Centers for AIDS Research at the Albert Einstein College of Medicine [CFAR/AI-051519]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075679, R01MH096625, R01MH090958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA029476, R01DA025567] Funding Source: NIH RePORTER	National Institutes of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health Centers for AIDS Research at the Albert Einstein College of Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institutes of Drug Abuse (http://www.drugabuse.gov/) (DA025567 to JWB and DA029476 to PJG), the National Institutes of Mental Health (http://www.nimh.nih.gov/) (MH090958 and MH075679 to JWB) and the National Institutes of Health Centers for AIDS Research (http://www.niaid.nih.gov/labsandresources/resources/cfar/Pages/default.aspx) grant (CFAR/AI-051519) at the Albert Einstein College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ancuta P, 2006, VIROLOGY, V344, P267, DOI 10.1016/j.virol.2005.10.027; Anthony IC, 2005, J NEUROPATH EXP NEUR, V64, P529, DOI 10.1093/jnen/64.6.529; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bell JE, 2002, JAIDS-J ACQ IMM DEF, V31, pS35, DOI 10.1097/00126334-200210012-00003; Beyrer C, 2010, JAIDS-J ACQ IMM DEF, V55, pS10, DOI 10.1097/QAI.0b013e3181f9c0c9; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Buckner CM, 2011, CELL IMMUNOL, V267, P109, DOI 10.1016/j.cellimm.2010.12.004; CARBONI E, 1989, NEUROSCIENCE, V28, P653, DOI 10.1016/0306-4522(89)90012-2; Chen J, 2009, EUR J NEUROSCI, V29, P287, DOI 10.1111/j.1460-9568.2008.06590.x; Cherner M, 2005, NEUROLOGY, V64, P1343, DOI 10.1212/01.WNL.0000158328.26897.0D; Cinque P, 1998, AIDS, V12, P1327, DOI 10.1097/00002030-199811000-00014; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; Czub S, 2004, ACTA NEUROPATHOL, V107, P216, DOI 10.1007/s00401-003-0801-3; Czub S, 2001, ACTA NEUROPATHOL, V101, P85; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Duport S, 1998, P NATL ACAD SCI USA, V95, P1840, DOI 10.1073/pnas.95.4.1840; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Farber K, 2005, MOL CELL NEUROSCI, V29, P128, DOI 10.1016/j.mcn.2005.01.003; Fiorentini C, 2011, J NEUROCHEM, V117, P253, DOI 10.1111/j.1471-4159.2011.07196.x; Fischer-Smith T, 2004, AM J PATHOL, V164, P2089, DOI 10.1016/S0002-9440(10)63767-4; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; Fischer-Smith T, 2008, J NEUROVIROL, V14, P318, DOI 10.1080/13550280802132857; Fischer-Smith T, 2008, AIDS RES HUM RETROV, V24, P417, DOI 10.1089/aid.2007.0193; Forton DM, 2002, HEPATOLOGY, V35, P433, DOI 10.1053/jhep.2002.30688; GARRIS PA, 1994, J NEUROSCI, V14, P6084; Gaskill PJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-203; Gaskill PJ, 2009, AM J PATHOL, V175, P1148, DOI 10.2353/ajpath.2009.081067; GRAY F, 1992, J NEUROPATH EXP NEUR, V51, P177, DOI 10.1097/00005072-199203000-00007; Grover VPB, 2012, J VIRAL HEPATITIS, V19, pE89, DOI 10.1111/j.1365-2893.2011.01510.x; Hanami K, 2013, BONE, V56, P1, DOI 10.1016/j.bone.2013.04.019; Harezlak J, 2011, AIDS, V25, P625, DOI 10.1097/QAD.0b013e3283427da7; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Hilsabeck RC, 2003, J INT NEUROPSYCH SOC, V9, P847, DOI 10.1017/S1355617703960048; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Kamat A, 2012, JAIDS-J ACQ IMM DEF, V60, P234, DOI 10.1097/QAI.0b013e318256f3bc; Kim WK, 2006, AM J PATHOL, V168, P822, DOI 10.2353/ajpath.2006.050215; Kraft-Terry SD, 2010, NEUROBIOL DIS, V37, P542, DOI 10.1016/j.nbd.2009.12.015; Kustrimovic N, 2014, J NEUROIMMUNE PHARM, V9, P302, DOI 10.1007/s11481-014-9541-5; Langford D, 2003, JAIDS-J ACQ IMM DEF, V34, P467, DOI 10.1097/00126334-200312150-00004; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; McKenna F, 2002, J NEUROIMMUNOL, V132, P34, DOI 10.1016/S0165-5728(02)00280-1; Meade CS, 2011, J BEHAV MED, V34, P128, DOI 10.1007/s10865-010-9293-5; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; NOCKHER WA, 1994, CLIN EXP IMMUNOL, V98, P369, DOI 10.1111/j.1365-2249.1994.tb05499.x; Ortega E, 2000, MOL CELL BIOCHEM, V203, P113, DOI 10.1023/A:1007094614047; PARSONS LH, 1992, J NEUROCHEM, V58, P212, DOI 10.1111/j.1471-4159.1992.tb09298.x; PELUSO R, 1985, VIROLOGY, V147, P231, DOI 10.1016/0042-6822(85)90246-6; Peng H, 2006, GLIA, V54, P619, DOI 10.1002/glia.20409; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; Pulliam L, 1997, LANCET, V349, P692, DOI 10.1016/S0140-6736(96)10178-1; Rodriguez-Munoz Y, 2011, ALIMENT PHARM THER, V34, P960, DOI 10.1111/j.1365-2036.2011.04807.x; Shiramizu B, 2007, J NEUROPSYCH CLIN N, V19, P157, DOI 10.1176/appi.neuropsych.19.2.157; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Straub RH, 2000, J LEUKOCYTE BIOL, V67, P553, DOI 10.1002/jlb.67.4.553; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Valcour VG, 2010, J LEUKOCYTE BIOL, V87, P621, DOI 10.1189/jlb.0809571; Watanabe Y, 2006, J IMMUNOL, V176, P848, DOI 10.4049/jimmunol.176.2.848; Weber E, 2013, J NEUROVIROL, V19, P65, DOI 10.1007/s13365-012-0141-y; Weiss JM, 1998, J IMMUNOL, V161, P6896; Weissenborn K, 2004, J HEPATOL, V41, P845, DOI 10.1016/j.jhep.2004.07.022; Wilkinson J, 2010, GUT, V59, P1394, DOI 10.1136/gut.2009.199356; Williams DW, 2014, CURR HIV RES, V12, P85, DOI 10.2174/1570162X12666140526114526; Williams DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069270; Williams KC, 2001, J EXP MED, V193, P905, DOI 10.1084/jem.193.8.905; Wu DT, 2000, J NEUROVIROL, V6, pS82; Xi ZX, 2009, NEUROSCIENCE, V161, P392, DOI 10.1016/j.neuroscience.2009.03.060; Zachek MK, 2010, BIOSENS BIOELECTRON, V25, P1179, DOI 10.1016/j.bios.2009.10.008; Zhang JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017484; ZIEGLERHEITBROCK HWL, 1993, EUR J IMMUNOL, V23, P2053, DOI 10.1002/eji.1830230902	79	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117450	10.1371/journal.pone.0117450	http://dx.doi.org/10.1371/journal.pone.0117450			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647501	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600069
J	Kiderlen, M; Walsh, PM; Bastiaannet, E; Kelly, MB; Audisio, RA; Boelens, PG; Brown, C; Dekkers, OM; de Craen, AJM; van de Velde, CJH; Liefers, GJ				Kiderlen, Mandy; Walsh, Paul M.; Bastiaannet, Esther; Kelly, Maria B.; Audisio, Riccardo A.; Boelens, Petra G.; Brown, Chris; Dekkers, Olaf M.; de Craen, Anton J. M.; van de Velde, Cornelis J. H.; Liefers, Gerrit-Jan			Treatment Strategies and Survival of Older Breast Cancer Patients - An International Comparison between the Netherlands and Ireland	PLOS ONE			English	Article							GERIATRIC ONCOLOGY; RELATIVE SURVIVAL; TRIALS; RECOMMENDATIONS; MANAGEMENT; SOCIETY; EUSOMA; AGE	Objectives Forty percent of breast cancers occur among older patients. Unfortunately, there is a lack of evidence for treatment guidelines for older breast cancer patients. The aim of this study is to compare treatment strategy and relative survival for operable breast cancer in the elderly between The Netherlands and Ireland. Material and Methods From the Dutch and Irish national cancer registries, women aged >= 65 years with non-metastatic breast cancer were included (2001-2009). Proportions of patients receiving guideline-adherent locoregional treatment, endocrine therapy, and chemotherapy were calculated and compared between the countries by stage. Secondly, 5-year relative survival was calculated by stage and compared between countries. Results Overall, 41,055 patients from The Netherlands and 5,826 patients from Ireland were included. Overall, more patients received guideline-adherent locoregional treatment in The Netherlands, overall (80% vs. 68%, adjusted p<0.001), stage I (83% vs. 65%, p<0.001), stage II (80% vs. 74%, p<0.001) and stage III (74% vs. 57%, P<0.001) disease. On the other hand, more systemic treatment was provided in Ireland, where endocrine therapy was prescribed to 92% of hormone receptor-positive patients, compared to 59% in The Netherlands. In The Netherlands, only 6% received chemotherapy, as compared 24% in Ireland. But relative survival was poorer in Ireland (5 years relative survival 89% vs. 83%), especially in stage II (87% vs. 85%) and stage III (61% vs. 58%) patients. Conclusion Treatment for older breast cancer patients differed significantly on all treatment modalities between The Netherlands and Ireland. More locoregional treatment was provided in The Netherlands, and more systemic therapy was provided in Ireland. Relative survival for Irish patients was worse than for their Dutch counterparts. This finding should be a strong recommendation to study breast cancer treatment and survival internationally, with the ultimate goal to equalize the survival rates for breast cancer patients across Europe.	[Kiderlen, Mandy; Bastiaannet, Esther; Boelens, Petra G.; van de Velde, Cornelis J. H.; Liefers, Gerrit-Jan] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Kiderlen, Mandy; Bastiaannet, Esther; de Craen, Anton J. M.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Walsh, Paul M.; Kelly, Maria B.; Brown, Chris] Natl Canc Registry Ireland, Cork, Ireland; [Audisio, Riccardo A.] St Helens Teaching Hosp, Dept Surg, St Helens, England; [Audisio, Riccardo A.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Dekkers, Olaf M.] Leiden Univ, Med Ctr, Dept Epidemiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Liverpool; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Liefers, GJ (corresponding author), Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands.	g.j.liefers@lumc.nl	van de Velde, Cornelis/AAY-8360-2020; Brown, Chris/H-2797-2019	Brown, Chris/0000-0003-2506-4871; Audisio, Riccardo A./0000-0002-7538-4809; Dekkers, Olaf/0000-0002-1333-7580	Dutch Cancer Society [UL 2007-3968]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was funded by a program grant of the Dutch Cancer Society (project number UL 2007-3968). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Refaie WB, 2011, ANN SURG, V254, P438, DOI 10.1097/SLA.0b013e31822a7047; Allemani C, 2012, INT J CANCER, DOI [10.1002/ijc.27983, DOI 10.1002/IJC.27983]; Allemani C, 2010, EUR J CANCER, V46, P1528, DOI 10.1016/j.ejca.2010.02.016; Altman DG, 1999, BRIT MED J, V318, P1209; [Anonymous], 1997, AJCC CANC STAGING MA; Biganzoli L, 2012, LANCET ONCOL, V13, pE148, DOI 10.1016/S1470-2045(11)70383-7; CBO, 2005, RICHTL BEH MAMM 2005; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; Dreyer NA, 2009, JAMA-J AM MED ASSOC, V302, P790, DOI 10.1001/jama.2009.1092; Garcia-Etienne CA, 2012, EUR J CANCER, V48, P1947, DOI 10.1016/j.ejca.2012.03.008; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Hakulinen T, 2011, EUR J CANCER, V47, P2202, DOI 10.1016/j.ejca.2011.03.011; Kiderlen M, 2012, BREAST CANCER RES TR, V132, P675, DOI 10.1007/s10549-011-1892-5; Mieog JSD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-42; National Cancer Screening Service, 2012, NAT BREAST SCREEN PR; O'Higgins N., 2007, NATL QUALITY ASSURAN; Rassen JA, 2009, J CLIN EPIDEMIOL, V62, P1226, DOI 10.1016/j.jclinepi.2008.12.005; RIVM, 2012, BEV BORSTK; Sullivan P, 2011, JAMA-J AM MED ASSOC, V305, P400, DOI 10.1001/jama.2011.12; Townsley CA, 2005, J CLIN ONCOL, V23, P3112, DOI 10.1200/JCO.2005.00.141; van de Water W, 2012, BRIT J SURG, V99, P813, DOI 10.1002/bjs.8743; van de Water W, 2014, JNCI-J NATL CANCER I, V106, DOI [10.1093/jnci/dju417, DOI 10.1093/JNCI/DJU417]; van Nes JGH, 2010, BRIT J SURG, V97, P671, DOI 10.1002/bjs.6962; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2; Wildiers H, 2007, LANCET ONCOL, V8, P1101, DOI 10.1016/S1470-2045(07)70378-9; [No title captured]	26	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0118074	10.1371/journal.pone.0118074	http://dx.doi.org/10.1371/journal.pone.0118074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646756	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600098
J	Hoencamp, R; Idenburg, FJ; van Dongen, TTCF; de Kruijff, LGM; Huizinga, EP; Plat, MCJ; Hoencamp, E; Leenen, LPH; Hamming, JF; Vermetten, E				Hoencamp, Rigo; Idenburg, Floris J.; van Dongen, Thijs T. C. F.; de Kruijff, Loes G. M.; Huizinga, Eelco P.; Plat, Marie-Christine J.; Hoencamp, Erik; Leenen, Luke P. H.; Hamming, Jaap F.; Vermetten, Eric			Long-Term Impact of Battle Injuries; Five-Year Follow-Up of Injured Dutch Servicemen in Afghanistan 2006-2010	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC STRESS; CASUALTIES; HEALTH; IRAQ; WAR; VALIDATION; COHORT; SCALE; CARE	Objectives Units deployed to armed conflicts are at high risk for exposure to combat events. Many battle casualties (BCs) have been reported in the recent deployment to Afghanistan. The long-term impact of these combat injuries, at their five-year end point, is currently unknown. To date, no systematic inventory has been performed of an identified group of BCs in comparison to non-injured service members from the same operational theatre. Design Observational cross-sectional cohort study. Setting Open online survey among Dutch BCs that deployed to Afghanistan (2006-2010). Participants The Dutch BCs (n = 62) were compared to two control groups of non-injured combat groups (battle exposed [n = 53], and non-battle exposed [n = 73]). Main Outcome Measures Participants rated their impact of trauma exposure (Impact of Events [IES]), post deployment reintegration (Post Deployment Reintegration Scale [PDRS]), general symptoms of distress (Symptom Checklist 90 [SCL-90]), as well as their current perceived quality of life (EuroQol-6D [EQ-6D]). Also cost effectiveness (Short From health survey [SF-36]) and care consumption were assessed (Trimbos/iMTA questionnaire). Results Over 90% of BCs were still in active duty. The mean scores of all questionnaires (IES, EQ-6D, SF-36, and SCL-90) of the BC group were significantly higher than in the control groups (p<0.05). The PDRS showed a significantly lower (p<0.05) outcome in the negative subscales. The mean consumption of care was triple that of both control groups. A lower score on quality of life was related to higher levels of distress and impact of trauma exposure. Conclusions This study showed a clear long-term impact on a wide range of scales that contributes to a reduced quality of life in a group of BCs. Low perceived cost effectiveness matched with high consumption of care in the BC group in comparison to the control groups. These results warrant continuous monitoring of BCs.	[Hoencamp, Rigo; Hamming, Jaap F.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Idenburg, Floris J.] Med Ctr Haaglanden, Dept Surg, The Hague, Netherlands; [van Dongen, Thijs T. C. F.; Huizinga, Eelco P.; Leenen, Luke P. H.] Univ Med Ctr, Dept Surg, Utrecht, Netherlands; [de Kruijff, Loes G. M.] Rehabil Ctr Hoogstraat, Dept Physiatrist, Utrecht, Netherlands; [Plat, Marie-Christine J.] Minist Def, Expert Ctr Force Hlth Protect, Utrecht, Netherlands; [Hoencamp, Erik] Leiden Univ, Med Ctr, Leiden, Netherlands; [Vermetten, Eric] Leiden Univ, Med Ctr, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haaglanden Medical Center; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hoencamp, R (corresponding author), Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands.	r.hoencamp@LUMC.nl	Vermetten, Eric/B-1335-2008; Hoencamp, Rigo/AAL-4984-2021	Vermetten, Eric/0000-0003-0579-4404; Kubickova, Karolina/0000-0002-9556-3185				Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Arrindell W.A., 1981, NEDERLANDS TIJDSCHRI, V36, P77; Arrindell WA, 1986, SCL 90 MANUAL MULTID; Baker MS, 2014, MIL MED, V179, P348, DOI 10.7205/MILMED-D-13-00471; Beder J, 2011, SOC WORK HEALTH CARE, V50, P515, DOI 10.1080/00981389.2011.554279; Blais AR, 2009, MIL PSYCHOL, V21, P365, DOI 10.1080/08995600902914727; Bouwmans C, 2013, HANDLEIDING TRIMBOS, DOI [10.1016/j.amsu.2013.12.001, DOI 10.1016/J.AMSU.2013.12.001]; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Fikretoglu D, 2010, DEV NORMS POSTDEPLOY; Greenberg N, 2008, J R Army Med Corps, V154, P124; Hakkaart-van Roijen L, 2010, HANDLEIDING KOSTENON; Hoencamp R, INJURY IN PRESS; Hoencamp R, 2014, WORLD J SUR IN PRESS; Hoencamp R, 2014, WORLD J SURG, V38, P1713, DOI 10.1007/s00268-014-2462-x; Hoencamp R, 2014, INJURY, V45, P1028, DOI 10.1016/j.injury.2014.02.012; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Kuhn E, 2014, MIL MED, V179, P12, DOI 10.7205/MILMED-D-13-00271; Nasky KM, 2009, MIL MED, V174, P689, DOI 10.7205/MILMED-D-04-3608; Oostenbrink J, 2004, HANDLEIDING KOSTENON; Scott DJ, 2014, J VASC SURG, V59, P173, DOI 10.1016/j.jvs.2013.07.103; Smith TC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-69; Spelman JF, 2012, J GEN INTERN MED, V27, P1200, DOI 10.1007/s11606-012-2061-1; Taal EM, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.23667; Turner MA, 2005, BRIT J PSYCHIAT, V186, P476, DOI 10.1192/bjp.186.6.476; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Woodruff SI, 2014, MIL MED, V179, P265, DOI 10.7205/MILMED-D-13-00444	28	9	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0115119	10.1371/journal.pone.0115119	http://dx.doi.org/10.1371/journal.pone.0115119			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3QK	25643003	Green Published, Green Submitted, gold			2022-12-27	WOS:000348821200008
J	Sawhney, S; Hood, K; Shaw, A; Braithwaite, AW; Stubbs, R; Hung, NA; Royds, JA; Slatter, TL				Sawhney, Sonal; Hood, Kylie; Shaw, Alisha; Braithwaite, Antony W.; Stubbs, Richard; Hung, Noelyn A.; Royds, Janice A.; Slatter, Tania L.			Alpha-Enolase Is Upregulated on the Cell Surface and Responds to Plasminogen Activation in Mice Expressing a Delta 133p53a Mimic	PLOS ONE			English	Article							NUCLEAR RIBONUCLEOPROTEIN K; P53 TRANSCRIPTIONAL ACTIVATION; WILD-TYPE P53; DNA-DAMAGE; TUMOR REVERSION; HNRNP-K; PROTEIN; ISOFORM; CANCER; INFLAMMATION	The p53 protein is a master regulator of the stress response. It acts as a tumor suppressor by inducing transcriptional activation of p53 target genes, with roles in apoptosis, cell cycle arrest and metabolism. The discovery of at least 12 isoforms of p53, some of which have tumor-promoting properties, has opened new avenues of research. Our previous work studied tumor phenotypes in four mouse models with different p53 backgrounds: wild-type p53, p53 null, mutant p53 lacking the proline domain (m Delta pro), and a mimic for the human Delta 133p53a p53 isoform (Delta 122p53). To identify the major proteins affected by p53 function early in the response to DNA damage, the current study investigated the entire proteome of bone marrow, thymus, and lung in the four p53 models. Protein extracts from untreated controls and those treated with amsacrine were analyzed using two-dimensional fluorescence difference gel electrophoresis. In the bone marrow, reactive proteins were universally decreased by wild-type p53, including alpha-enolase. Further analysis of alpha-enolase in the p53 models revealed that it was instead increased in Delta 122p53 hematopoietic and tumor cell cytosol and on the cell surface. Alpha-enolase on the surface of Delta 122p53 cells acted as a plasminogen receptor, with tumor necrosis factor alpha induced upon plasminogen stimulation. Taken together, these data identified new proteins associated with p53 function. One of these proteins, alpha-enolase, is regulated differently by wild-type p53 and Delta 122p53 cells, with reduced abundance as part of a wild-type p53 response and increased abundance with Delta 122p53 function. Increased cell surface alpha-enolase on Delta 122p53 cells provides a possible explanation for the model's pro-inflammatory features and suggests that p53 isoforms may direct an inflammatory response by increasing the amount of a-enolase on the cell surface.	[Sawhney, Sonal; Hood, Kylie; Stubbs, Richard] Univ Otago, Wakefield Biomed Res Unit, Wellington, New Zealand; [Shaw, Alisha; Braithwaite, Antony W.; Hung, Noelyn A.; Royds, Janice A.; Slatter, Tania L.] Univ Otago, Dept Pathol, Dunedin Sch Med, Dunedin, New Zealand; [Braithwaite, Antony W.] Univ Sydney, Childrens Med Res Inst, Westmead, NSW 2145, Australia	University of Otago; University of Otago; Children's Medical Research Institute - Australia; University of Sydney	Slatter, TL (corresponding author), Univ Otago, Dept Pathol, Dunedin Sch Med, Dunedin, New Zealand.	tania.slatter@otago.ac.nz			Health Research Council New Zealand [10/442]; Genesis Oncology Trust; Dunedin School of Medicine	Health Research Council New Zealand(Health Research Council of New Zealand); Genesis Oncology Trust; Dunedin School of Medicine	This work was supported by Health Research Council New Zealand 10/442, Genesis Oncology Trust, and Dunedin School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoubala M, 2011, CELL DEATH DIFFER, V18, P248, DOI 10.1038/cdd.2010.91; Bae S, 2012, J IMMUNOL, V189, P365, DOI 10.4049/jimmunol.1102073; Bernard H, 2013, ONCOGENE, V32, P2150, DOI 10.1038/onc.2012.242; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Campbell HG, 2013, ONCOGENE, V32, P827, DOI 10.1038/onc.2012.102; Campbell HG, 2012, CELL CYCLE, V11, P446, DOI 10.4161/cc.11.3.19054; Capello M, 2011, FEBS J, V278, P1064, DOI 10.1111/j.1742-4658.2011.08025.x; Chang GC, 2006, CLIN CANCER RES, V12, P5746, DOI 10.1158/1078-0432.CCR-06-0324; Chang JW, 2009, INT IMMUNOL, V21, P1351, DOI 10.1093/intimm/dxp106; Chen WM, 2013, CELL CYCLE, V12, P2321, DOI 10.4161/cc.25404; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Das R, 2007, BLOOD, V110, P3763, DOI 10.1182/blood-2007-03-079392; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Dreesen O, 2013, J CELL BIOL, V200, P605, DOI 10.1083/jcb.201206121; Flaman JM, 1996, ONCOGENE, V12, P813; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Gao R, 2013, J BIOL CHEM, V288, P15046, DOI 10.1074/jbc.M113.466136; Han YH, 2010, TOXICOL IN VITRO, V24, P1237, DOI 10.1016/j.tiv.2010.02.005; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hsiao KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069354; Katayama M, 2006, SURG TODAY, V36, P1085, DOI 10.1007/s00595-006-3301-y; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; Kluza J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021924; Komarova EA, 2000, ONCOGENE, V19, P3791, DOI 10.1038/sj.onc.1203717; Levine AJ, 2011, NAT REV MOL CELL BIO, V12, P259, DOI 10.1038/nrm3086; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Love Ian M, 2013, Methods Mol Biol, V962, P63, DOI 10.1007/978-1-62703-236-0_5; Lung J, 2010, FEBS J, V277, P4308, DOI 10.1111/j.1742-4658.2010.07819.x; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Marcel V, 2010, FEBS LETT, V584, P4463, DOI 10.1016/j.febslet.2010.10.005; Markowitz J, 2005, BIOCHEMISTRY-US, V44, P7305, DOI 10.1021/bi050321t; MIDGLEY CA, 1995, J CELL SCI, V108, P1843; Mizukami Y, 2004, J BIOL CHEM, V279, P50120, DOI 10.1074/jbc.M402299200; Mondal AM, 2013, J CLIN INVEST, V123, P5247, DOI 10.1172/JCI70355; Moumen A, 2013, CELL CYCLE, V12, P698, DOI 10.4161/cc.23592; Nutthasirikul N, 2013, INT J ONCOL, V42, P1181, DOI 10.3892/ijo.2013.1818; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Pant V, 2012, BLOOD, V120, P5118, DOI 10.1182/blood-2012-05-356014; Pelisch F, 2012, J BIOL CHEM, V287, P30789, DOI 10.1074/jbc.M112.390120; Petrak J, 2008, PROTEOMICS, V8, P1744, DOI 10.1002/pmic.200700919; Quadrato G, 2012, INT REV NEUROBIOL, V105, P71, DOI 10.1016/B978-0-12-398309-1.00005-6; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; Rohaly G, 2010, J VIROL, V84, P10727, DOI 10.1128/JVI.00122-10; Sawhney S, 2009, PROTEOMICS, V9, P4087, DOI 10.1002/pmic.200800949; Sedoris KC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-157; Shi HJ, 2009, ELECTROPHORESIS, V30, P2442, DOI 10.1002/elps.200800767; Slatter TL, 2010, CELL DEATH DIFFER, V17, P540, DOI 10.1038/cdd.2009.136; Slatter TL, 2011, BLOOD, V117, P5166, DOI 10.1182/blood-2010-11-321851; Stavridi ES, 2001, CANCER RES, V61, P7030; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Surget S, 2014, ONCOTARGETS THER, V7, P57, DOI 10.2147/OTT.S53876; Terrier O, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003246; Terrier O, 2012, J VIROL, V86, P8452, DOI 10.1128/JVI.07143-11; Trinidad AG, 2013, MOL CELL, V50, P805, DOI 10.1016/j.molcel.2013.05.002; Tuynder M, 2004, P NATL ACAD SCI USA, V101, P15364, DOI 10.1073/pnas.0406776101; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Wei JX, 2012, P NATL ACAD SCI USA, V109, pE2543, DOI 10.1073/pnas.1205664109; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837; Yin X, 2003, J CELL PHYSIOL, V196, P474, DOI 10.1002/jcp.10329; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Zhang Y, 2004, J BIOL CHEM, V279, P42545, DOI 10.1074/jbc.M314213200; Zhou RY, 2010, INT J CANCER, V126, P395, DOI 10.1002/ijc.24744	66	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116270	10.1371/journal.pone.0116270	http://dx.doi.org/10.1371/journal.pone.0116270			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643152	gold, Green Published, Green Submitted			2022-12-27	WOS:000348821200016
J	Argueso, D; Evans, JP; Pitman, AJ; Di Luca, A				Argueeso, Daniel; Evans, Jason P.; Pitman, Andrew J.; Di Luca, Alejandro			Effects of City Expansion on Heat Stress under Climate Change Conditions	PLOS ONE			English	Article							URBAN CANOPY MODEL; ISLAND; TEMPERATURE; ENERGY; PARAMETERIZATION; PROJECTION; WRF	We examine the joint contribution of urban expansion and climate change on heat stress over the Sydney region. A Regional Climate Model was used to downscale present (1990-2009) and future (2040-2059) simulations from a Global Climate Model. The effects of urban surfaces on local temperature and vapor pressure were included. The role of urban expansion in modulating the climate change signal at local scales was investigated using a human heat-stress index combining temperature and vapor pressure. Urban expansion and climate change leads to increased risk of heat-stress conditions in the Sydney region, with substantially more frequent adverse conditions in urban areas. Impacts are particularly obvious in extreme values; daytime heat-stress impacts are more noticeable in the higher percentiles than in the mean values and the impact at night is more obvious in the lower percentiles than in the mean. Urban expansion enhances heat-stress increases due to climate change at night, but partly compensates its effects during the day. These differences are due to a stronger contribution from vapor pressure deficit during the day and from temperature increases during the night induced by urban surfaces. Our results highlight the inappropriateness of assessing human comfort determined using temperature changes alone and point to the likelihood that impacts of climate change assessed using models that lack urban surfaces probably underestimate future changes in terms of human comfort.	[Argueeso, Daniel; Evans, Jason P.; Pitman, Andrew J.; Di Luca, Alejandro] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW, Australia; [Argueeso, Daniel; Evans, Jason P.; Pitman, Andrew J.] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW, Australia	University of New South Wales Sydney; ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney	Argueso, D (corresponding author), Univ New S Wales, Climate Change Res Ctr, Sydney, NSW, Australia.	d.argueso@unsw.edu.au	Di Luca, Alejandro/Y-4908-2019; Evans, Jason P./F-3716-2011; Argüeso, Daniel/G-1970-2012; Pitman, Andrew J/A-7353-2011	Di Luca, Alejandro/0000-0002-1481-2961; Evans, Jason P./0000-0003-1776-3429; Argüeso, Daniel/0000-0002-4792-162X; Pitman, Andrew J/0000-0003-0604-3274	Australian Research Council (ARC) as part of the Centre of Excellence for Climate System Science [CE110001028]; NSW Environment Trust [RM08603]; NSW Office of Environment and Heritage; Australian Research Council Future Fellowship [FT110100576]	Australian Research Council (ARC) as part of the Centre of Excellence for Climate System Science(Australian Research Council); NSW Environment Trust; NSW Office of Environment and Heritage; Australian Research Council Future Fellowship(Australian Research Council)	This work was made possible by funding from the Australian Research Council (ARC) as part of the Centre of Excellence for Climate System Science (CE110001028), as well as the NSW Environment Trust (RM08603) and the NSW Office of Environment and Heritage. Jason Evans was supported by the Australian Research Council Future Fellowship FT110100576. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argueso D, 2013, HYDROL EARTH SYST SC, V17, P4379, DOI 10.5194/hess-17-4379-2013; Argueso D, 2014, CLIM DYNAM, V42, P2183, DOI 10.1007/s00382-013-1789-6; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Chen F, 2012, B AM METEOROL SOC, V93, P1725, DOI 10.1175/BAMS-D-11-00217.1; Childs PP, 2005, PURE APPL GEOPHYS, V162, P1955, DOI 10.1007/s00024-005-2700-0; Diffenbaugh NS, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030000; Edenhofer O., 2014, CONTRIBUTION WORKING; Evans JP, 2014, GEOSCI MODEL DEV, V7, P621, DOI 10.5194/gmd-7-621-2014; Evans JP, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD013816; Evans JP, 2012, J CLIMATE, V25, P7232, DOI 10.1175/JCLI-D-11-00616.1; Fischer EM, 2013, NAT CLIM CHANGE, V3, P126, DOI [10.1038/nclimate1682, 10.1038/NCLIMATE1682]; Fischer EM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050576; Ganeshan M, 2013, URBAN CLIMATE; Georgescu M, 2013, NAT CLIM CHANGE, V3, P37, DOI 10.1038/nclimate1656; Georgescu M, 2014, P NATL ACAD SCI USA, V111, P2909, DOI 10.1073/pnas.1322280111; Gordon H.B., 2010, 21 CTR AUSTR WEATH C; Grimmond CSB, 2011, INT J CLIMATOL, V31, P244, DOI 10.1002/joc.2227; Hoppe P, 1999, INT J BIOMETEOROL, V43, P71, DOI 10.1007/s004840050118; Jendritzky G, 2012, INT J BIOMETEOROL, V56, P421, DOI 10.1007/s00484-011-0513-7; Kusaka H, 2004, J METEOROL SOC JPN, V82, P67, DOI 10.2151/jmsj.82.67; Kusaka H, 2001, BOUND-LAY METEOROL, V101, P329, DOI 10.1023/A:1019207923078; Kusaka H, 2012, J METEOROL SOC JPN, V90B, P47, DOI 10.2151/jmsj.2012-B04; Liu WD, 2009, THEOR APPL CLIMATOL, V96, P201, DOI 10.1007/s00704-008-0024-6; Martilli A, 2007, INT J CLIMATOL, V27, P1909, DOI 10.1002/joc.1620; McCarthy MP, 2012, INT J CLIMATOL, V32, P1875, DOI 10.1002/joc.2402; McCarthy MP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042845; OKE TR, 1982, Q J ROY METEOR SOC, V108, P1, DOI 10.1002/qj.49710845502; OKE TR, 1988, PROG PHYS GEOG, V12, P471, DOI 10.1177/030913338801200401; Oleson KW, 2008, J APPL METEOROL CLIM, V47, P1038, DOI 10.1175/2007JAMC1597.1; Oleson KW, 2008, J APPL METEOROL CLIM, V47, P1061, DOI 10.1175/2007JAMC1598.1; Oleson KW, 2015, CLIMATIC CHANGE, V129, P525, DOI 10.1007/s10584-013-0936-8; Oleson KW, 2011, INT J CLIMATOL, V31, P1848, DOI 10.1002/joc.2201; Oleson K, 2012, J CLIMATE, V25, P1390, DOI 10.1175/JCLI-D-11-00098.1; Parker DE, 2006, J CLIMATE, V19, P2882, DOI 10.1175/JCLI3730.1; Roth M, 2007, INT J CLIMATOL, V27, P1859, DOI 10.1002/joc.1591; Salamanca F, 2012, INT J CLIMATOL, V32, P2372, DOI 10.1002/joc.3398; Sertel E, 2010, INT J CLIMATOL, V30, P1942, DOI 10.1002/joc.2036; Sherwood SC, 2010, P NATL ACAD SCI USA, V107, P9552, DOI 10.1073/pnas.0913352107; Skamarock WC, 2009, NCARTN475STR, P125; Steadman R. G., 1994, Australian Meteorological Magazine, V43, P1; Theeuwes NE, 2013, J GEOPHYS RES-ATMOS, V118, P8881, DOI 10.1002/jgrd.50704; United Nations, 2012, WORLD URB PROSP 2011; USDAAF, 2003, HEAT STRESS CONTR HE, P1; Willett KM, 2012, INT J CLIMATOL, V32, P161, DOI 10.1002/joc.2257	44	73	73	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117066	10.1371/journal.pone.0117066	http://dx.doi.org/10.1371/journal.pone.0117066			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668390	Green Published, Green Submitted, gold			2022-12-27	WOS:000349493000014
J	Clark, JG; Kim, KH; Basom, RS; Gharib, SA				Clark, Joan G.; Kim, Kyoung-Hee; Basom, Ryan S.; Gharib, Sina A.			Plasticity of Airway Epithelial Cell Transcriptome in Response to Flagellin	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA FLAGELLIN; TOLL-LIKE RECEPTOR-5; GENE-EXPRESSION DATA; RNA-SEQ; RESPIRATORY EPITHELIUM; MATRILYSIN EXPRESSION; TRANSGENIC MICE; MICROARRAY DATA; IMMUNITY; CULTURES	Airway epithelial cells (AEC) are critical components of the inflammatory and immune response during exposure to pathogens. AECs in monolayer culture and differentiated epithelial cells in air-liquid interface (ALI) represent two distinct and commonly used in vitro models, yet differences in their response to pathogens have not been investigated. In this study, we compared the transcriptional effects of flagellin on AECs in monolayer culture versus ALI culture using whole-genome microarrays and RNA sequencing. We exposed monolayer and ALI AEC cultures to flagellin in vitro and analyzed the transcriptional response by microarray and RNA-sequencing. ELISA and RT-PCR were used to validate changes in select candidates. We found that AECs cultured in monolayer and ALI have strikingly different transcriptional states at baseline. When challenged with flagellin, monolayer AEC cultures greatly increased transcription of numerous genes mapping to wounding response, immunity and inflammatory response. In contrast, AECs in ALI culture had an unexpectedly muted response to flagellin, both in number of genes expressed and relative enrichment of inflammatory and immune pathways. We conclude that in vitro culturing methods have a dramatic effect on the transcriptional profile of AECs at baseline and after stimulation with flagellin. These differences suggest that epithelial responses to pathogen challenges are distinctly different in culture models of intact and injured epithelium.	[Clark, Joan G.; Gharib, Sina A.] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Clark, Joan G.; Kim, Kyoung-Hee; Basom, Ryan S.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Gharib, Sina A.] Univ Washington, Ctr Lung Biol, Computat Med Core, Seattle, WA USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Gharib, SA (corresponding author), Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA.	sagharib@u.washington.edu		GHARIB, SINA A./0000-0002-2480-4367	National Institutes of Health, the National Heart, Lung, and Blood Institute [HL091246, HL088201]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091246, R01HL088201] Funding Source: NIH RePORTER	National Institutes of Health, the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health, the National Heart, Lung, and Blood Institute grants HL091246 (JC) and HL088201 (JC).	Adamo R, 2004, AM J RESP CELL MOL, V30, P627, DOI 10.1165/rcmb.2003-0260OC; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen P, 2013, AM J PATHOL, V183, P1405, DOI 10.1016/j.ajpath.2013.07.007; Chen P, 2009, J CELL BIOCHEM, V108, P1233, DOI 10.1002/jcb.22363; Cobb LM, 2004, J IMMUNOL, V173, P5659, DOI 10.4049/jimmunol.173.9.5659; Dunsmore SE, 1998, J CLIN INVEST, V102, P1321, DOI 10.1172/JCI1516; Dvorak A, 2011, AM J RESP CELL MOL, V44, P465, DOI 10.1165/rcmb.2009-0453OC; Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gomez MI, 2008, PEDIATR PULM, V43, P11, DOI 10.1002/ppul.20735; Hackett NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018378; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kayala MA, 2012, NUCLEIC ACIDS RES, V40, pW553, DOI 10.1093/nar/gks420; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Boado YS, 2001, J BIOL CHEM, V276, P41417, DOI 10.1074/jbc.M107121200; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Prince A, 2006, AM J RESP CELL MOL, V34, P548, DOI 10.1165/rcmb.2006-0022SF; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; Rawlins EL, 2012, AM J RESP CELL MOL, V46, P269, DOI 10.1165/rcmb.2011-0372PS; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Skerrett SJ, 2007, AM J PHYSIOL-LUNG C, V292, pL312, DOI 10.1152/ajplung.00250.2006; STRIPP BR, 1992, J BIOL CHEM, V267, P14703; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tseng J, 2006, AM J PHYSIOL-CELL PH, V290, pC678, DOI 10.1152/ajpcell.00166.2005; Vijay-Kumar M, 2009, MUCOSAL IMMUNOL, V2, P197, DOI 10.1038/mi.2009.9; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WERT SE, 1993, DEV BIOL, V156, P426, DOI 10.1006/dbio.1993.1090; Yu FS, 2010, J IMMUNOL, V185, P1142, DOI 10.4049/jimmunol.1000509; Zhang Z, 2005, INFECT IMMUN, V73, P7151, DOI 10.1128/IAI.73.11.7151-7160.2005	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0115486	10.1371/journal.pone.0115486	http://dx.doi.org/10.1371/journal.pone.0115486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668187	Green Published, Green Submitted, gold			2022-12-27	WOS:000349493000002
J	Fang, Y; Sun, M; Ramani, K				Fang, Yi; Sun, Mengtian; Ramani, Karthik			Heat-Passing Framework for Robust Interpretation of Data in Networks	PLOS ONE			English	Article							OF-THE-ART; ELECTRON-MICROSCOPY; COMPLEX NETWORKS; PROTEIN; MAPS	Researchers are regularly interested in interpreting the multipartite structure of data entities according to their functional relationships. Data is often heterogeneous with intricately hidden inner structure. With limited prior knowledge, researchers are likely to confront the problem of transforming this data into knowledge. We develop a new framework, called heatpassing, which exploits intrinsic similarity relationships within noisy and incomplete raw data, and constructs a meaningful map of the data. The proposed framework is able to rank, cluster, and visualize the data all at once. The novelty of this framework is derived from an analogy between the process of data interpretation and that of heat transfer, in which all data points contribute simultaneously and globally to reveal intrinsic similarities between regions of data, meaningful coordinates for embedding the data, and exemplar data points that lie at optimal positions for heat transfer. We demonstrate the effectiveness of the heatpassing framework for robustly partitioning the complex networks, analyzing the globin family of proteins and determining conformational states of macromolecules in the presence of high levels of noise. The results indicate that the methodology is able to reveal functionally consistent relationships in a robust fashion with no reference to prior knowledge. The heatpassing framework is very general and has the potential for applications to a broad range of research fields, for example, biological networks, social networks and semantic analysis of documents.	[Fang, Yi] New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates; [Sun, Mengtian; Ramani, Karthik] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Fang, Y (corresponding author), New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates.	yfang@nyu.edu			Institute for Pure & Applied Mathematics	Institute for Pure & Applied Mathematics	The authors would like to thank the Institute for Pure & Applied Mathematics for providing fellowship to support KR's visit. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Bai X, 2004, LECT NOTES COMPUT SC, V3138, P198; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boguna M, 2009, NAT PHYS, V5, P74, DOI 10.1038/NPHYS1130; Cashon RE, 1997, COMP BIOCHEM PHYS B, V117, P613, DOI 10.1016/S0305-0491(97)00011-4; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Frank J, 2006, 3 DIMENSIONAL ELECT; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Givoni IE, 2012, THESIS U TORONTO; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Herman GT, 2008, ULTRAMICROSCOPY, V108, P327, DOI 10.1016/j.ultramic.2007.05.005; Iyer N, 2005, COMPUT AIDED DESIGN, V37, P509, DOI 10.1016/j.cad.2004.07.002; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Lafon S, 2006, IEEE T PATTERN ANAL, V28, P1393, DOI 10.1109/TPAMI.2006.184; Lerman G, 2007, P NATL ACAD SCI USA, V104, P11334, DOI 10.1073/pnas.0702965104; Leschziner AE, 2007, ANNU REV BIOPH BIOM, V36, P43, DOI 10.1146/annurev.biophys.36.040306.132742; Lipman Y, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1805964.1805971; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Page L, 1998, TECHNICAL REPORT; Qiu HJ, 2007, IEEE T PATTERN ANAL, V29, P1873, DOI 10.1109/TPAMI.2007.1103; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; Singer A, 2008, P NATL ACAD SCI USA, V105, P9507, DOI 10.1073/pnas.0709842104; Stahlberg H, 2008, ACS CHEM BIOL, V3, P268, DOI 10.1021/cb800037d; Sun JA, 2009, COMPUT GRAPH FORUM, V28, P1383, DOI 10.1111/j.1467-8659.2009.01515.x; Wang K, 2007, ACTA AUTOMATICA SINI, V33, P242; Weinan E, 2008, P NATL ACAD SCI USA, V105, P7907, DOI 10.1073/pnas.0707563105; Weston J, 2004, P NATL ACAD SCI USA, V101, P6559, DOI 10.1073/pnas.0308067101; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhang XL, 2008, LECT NOTES ARTIF INT, V5212, P628, DOI 10.1007/978-3-540-87481-2_41	34	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0116121	10.1371/journal.pone.0116121	http://dx.doi.org/10.1371/journal.pone.0116121			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668316	Green Submitted, Green Published, gold			2022-12-27	WOS:000349493000005
J	Namatovu, A; Tjornehoj, K; Belsham, GJ; Dhikusooka, MT; Wekesa, SN; Muwanika, VB; Siegismund, HR; Ayebazibwe, C				Namatovu, Alice; Tjornehoj, Kirsten; Belsham, Graham J.; Dhikusooka, Moses T.; Wekesa, Sabenzia N.; Muwanika, Vincent B.; Siegismund, Hans R.; Ayebazibwe, Chrisostom			Characterization of Foot-And-Mouth Disease Viruses (FMDVs) from Ugandan Cattle Outbreaks during 2012-2013: Evidence for Circulation of Multiple Serotypes	PLOS ONE			English	Article							IMMUNOSORBENT-ASSAY ELISA; MOLECULAR CHARACTERIZATION; SEQUENCE-ANALYSIS; ANTIBODIES; DIVERSITY; ALIGNMENT; LINEAGES; EASTERN; SURFACE; KENYA	To investigate the foot-and-mouth disease virus (FMDV) serotypes circulating in Uganda's cattle population, both serological and virological analyses of samples from outbreaks that occurred during 2012-2013 were performed. Altogether, 79 sera and 60 oropharyngeal fluid (OP)/ tissue/oral swab samples were collected from herds with reported FMD outbreaks in seven different Ugandan districts. Overall, 61/79 (77%) of the cattle sera were positive for antibodies against FMDV by PrioCHECK FMDV NS ELISA and solid phase blocking ELISA detected titres >= 80 for serotypes O, SAT 1, SAT 2 and SAT 3 in 41, 45, 30 and 45 of these 61 seropositive samples, respectively. Virus neutralisation tests detected the highest levels of neutralising antibodies (titres >= 45) against serotype O in the herds from Kween and Rakai districts, against SAT 1 in the herd from Nwoya district and against SAT 2 in the herds from Kiruhura, Isingiro and Ntungamo districts. The isolation of a SAT 2 FMDV from Isingiro was consistent with the detection of high levels of neutralising antibodies against SAT 2; sequencing (for the VP1 coding region) indicated that this virus belonged to lineage I within this serotype, like the currently used vaccine strain. From the Wakiso district 11 tissue/swab samples were collected; serotype A FMDV, genotype Africa (G-I), was isolated from the epithelial samples. This study shows that within a period of less than one year, FMD outbreaks in Uganda were caused by four different serotypes namely O, A, SAT 1 and SAT 2. Therefore, to enhance the control of FMD in Uganda, there is need for efficient and timely determination of outbreak virus strains/serotypes and vaccine matching. The value of incorporating serotype A antigen into the imported vaccines along with the current serotype O, SAT 1 and SAT 2 strains should be considered.	[Namatovu, Alice; Dhikusooka, Moses T.; Ayebazibwe, Chrisostom] Minist Agr Anim Ind & Fisheries, Natl Anim Dis Diagnost & Epidemiol Ctr, Entebbe, Uganda; [Namatovu, Alice] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Dept Biotech & Diagnost Sci, Kampala, Uganda; [Tjornehoj, Kirsten; Belsham, Graham J.] Tech Univ Denmark, Natl Vet Inst, DK-4771 Kalvehave, Denmark; [Wekesa, Sabenzia N.; Muwanika, Vincent B.] Makerere Univ, Coll Agr & Environm Sci, Dept Environm Management, Kampala, Uganda; [Wekesa, Sabenzia N.] Minist Livestock Dev, Foot & Mouth Dis Lab, Nairobi, Kenya; [Siegismund, Hans R.] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark	Makerere University; Technical University of Denmark; Makerere University; University of Copenhagen	Belsham, GJ (corresponding author), Tech Univ Denmark, Natl Vet Inst, DK-4771 Kalvehave, Denmark.	grbe@vet.dtu.dk	Ibrahim, Essam Hassan/G-1960-2018; Belsham, Graham J./H-8589-2019; Muwanika, Vincent/AGP-2612-2022; Muwanika, Vincent/GQH-5983-2022; Siegismund, Hans R./K-4332-2014; Belsham, Graham/J-3132-2019	Ibrahim, Essam Hassan/0000-0003-0130-2257; Belsham, Graham J./0000-0003-1187-4873; Siegismund, Hans R./0000-0001-5757-3131; Belsham, Graham/0000-0003-1187-4873	Danish International Development Agency (DANIDA) under the Transboundary Animal Diseases in East Africa project, DFC [10-006KU]	Danish International Development Agency (DANIDA) under the Transboundary Animal Diseases in East Africa project, DFC	This work was funded by the Danish International Development Agency (DANIDA) under the Transboundary Animal Diseases in East Africa project, DFC no. 10-006KU (HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2005, CURR TOP MICROBIOL, V288, P9; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ayebazibwe C, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-54; Ayebazibwe C, 2010, TROP ANIM HEALTH PRO, V42, P1547, DOI 10.1007/s11250-010-9605-3; Ayelet G, 2009, EMERG INFECT DIS, V15, P1409, DOI 10.3201/eid1509.090091; Balinda SN, 2010, EPIDEMIOL INFECT, V138, P1204, DOI 10.1017/S0950268809991427; Balinda SN, 2009, TRANSBOUND EMERG DIS, V56, P362, DOI 10.1111/j.1865-1682.2009.01094.x; Balinda SN, 2010, INFECT GENET EVOL, V10, P1058, DOI 10.1016/j.meegid.2010.06.017; BAXT B, 1989, J VIROL, V63, P2143, DOI 10.1128/JVI.63.5.2143-2151.1989; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; CROWTHER JR, 1993, EPIDEMIOL INFECT, V111, P391, DOI 10.1017/S0950268800057083; Domingo E, 2002, COMP IMMUNOL MICROB, V25, P297, DOI 10.1016/S0147-9571(02)00027-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; *FAO OIE, 2011, PROGR CONTR PATHW FM; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Habiela M, 2010, TRANSBOUND EMERG DIS, V57, P305, DOI 10.1111/j.1865-1682.2010.01151.x; HAMBLIN C, 1986, J IMMUNOL METHODS, V93, P123, DOI 10.1016/0022-1759(86)90442-4; HAMBLIN C, 1986, J IMMUNOL METHODS, V93, P115, DOI 10.1016/0022-1759(86)90441-2; HEDGER R S, 1982, Revue Scientifique et Technique Office International des Epizooties, V1, P387, DOI 10.20506/rst.1.2.75; Kalema-Zikusoka G, 2005, ONDERSTEPOORT J VET, V72, P145; Kasambula L, 2012, TRANSBOUND EMERG DIS, V59, P323, DOI 10.1111/j.1865-1682.2011.01276.x; KASANGA CJ, 2014, TRANSBOUND EMERG DIS; Kitching RP, 2002, REV SCI TECH OIE, V21, P499, DOI 10.20506/rst.21.3.1343; KITSON JDA, 1990, VIROLOGY, V179, P26, DOI 10.1016/0042-6822(90)90269-W; Knowles NJ, 2009, TRANSBOUND EMERG DIS, V56, P157, DOI 10.1111/j.1865-1682.2009.01074.x; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Mohapatra JK, 2011, J GEN VIROL, V92, P873, DOI 10.1099/vir.0.028555-0; Muleme M, 2012, TROP ANIM HEALTH PRO, V45, P35, DOI 10.1007/s11250-012-0254-6; Mwiine F. N., 2010, Journal of Veterinary Medicine and Animal Health, V2, P46; Mwiine FN, 2010, TRANSBOUND EMERG DIS, V57, P365, DOI 10.1111/j.1865-1682.2010.01157.x; NAMATOVU A, 2013, TRANSBOUND EMERG DIS; Namatovu A, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-19; OIE, 2012, DIAGNOSTIC TESTS VAC, V1, P721; Perry BD, 2007, VET REC, V160, P238, DOI 10.1136/vr.160.7.238; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roeder P., 2009, GLOBAL CONTROL FMD T; RUTAGWENDA T, 2 FAO AN PROD HLTH D; Rweyemamu MM, 1999, ADV VIRUS RES, V53, P111, DOI 10.1016/S0065-3527(08)60345-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samuel AR, 2001, J GEN VIROL, V82, P609, DOI 10.1099/0022-1317-82-3-609; Samuel AR, 1999, EPIDEMIOL INFECT, V122, P529, DOI 10.1017/S0950268899002265; Sangare O, 2004, EPIDEMIOL INFECT, V132, P525, DOI 10.1017/S0950268803001833; Sangula AK, 2010, ARCH VIROL, V155, P1625, DOI 10.1007/s00705-010-0742-9; SANGULA AK, 2010, EPIDEMIOL INFECT; Stanway G, 2005, VIRUS TAXONOMY, P757; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VOSLOO W, 1992, EPIDEMIOL INFECT, V109, P547, DOI 10.1017/S0950268800050536; Vosloo W, 2002, REV SCI TECH OIE, V21, P437, DOI 10.20506/rst.21.3.1349; Wekesa SN, 2014, INFECT GENET EVOL, V21, P408, DOI 10.1016/j.meegid.2013.12.006; WEKESA SN, 2013, TRANSBOUND EMERG DIS	53	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0114811	10.1371/journal.pone.0114811	http://dx.doi.org/10.1371/journal.pone.0114811			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664876	Green Published, Green Submitted, gold			2022-12-27	WOS:000349123100002
J	Yang, LS; Zhang, ZH; Sun, L; Sun, YH; Ye, DQ				Yang, Lin-Sheng; Zhang, Zhi-Hua; Sun, Liang; Sun, Ye-Huan; Ye, Dong-Qing			Prevalence of Suicide Attempts among College Students in China: A Meta-Analysis	PLOS ONE			English	Article							LIFETIME PREVALENCE; SELF-HARM; IDEATION; PLANS; SYSTEM; RATES	Background Suicide is the leading cause of death among 15-34 year olds in China, but no national data are available on the suicide and suicide attempts rates of college students, a sub-group of youth with 23 million. Several studies have reported the prevalence of suicide attempts among college students, however, no meta-analysis pooling the prevalence of suicide attempts is found. Objective and Methods This study aims to estimate the pooled prevalence of suicide attempts among college students in China. The relevant studies up to August 2014 were systematically searched via electronic databases (PubMed-Medline, Embase, Chinese Wanfang database, Chinese National Knowledge Infrastructure and Chinese VIP database). We only selected original articles that either reported the prevalence of suicide attempts or sufficient data for calculating the prevalence. Results A total of 29 eligible studies, with 88,225 college students, were finally included. The maximum and minimum reported prevalences of suicide attempts among college students in China were 0.4% and 10.5%, respectively. The pooled prevalence of suicide attempts was 2.8% (95% CI: 2.3%-3.3%). Subgroup analyses showed that the pooled estimate of prevalence of life time suicide attempts was 2.7% (95% CI: 2.1%-3.3%), and 12-month suicide attempts was 2.9% (95% CI: 2.0%-3.8%). The prevalence for males was 2.4% (95% CI: 1.8%-3.0%), and for females was 2.7% (95% CI: 1.9%-3.7%). The prevalences among college students in grade 1 through 4 were 2.8% (95% CI: 1.7%-3.8%), 1.8% (95% CI: 1.2%-2.3%), 2.0% (95% CI: 0.8%-3.1%), and 2.9% (95% CI: 0.1%6.7%), respectively. The prevalences among college students from rural and urban areas were 5.1% (95% CI: 2.8%-7.5%) and 3.7% (95% CI: 1.4%-5.9%), respectively. Conclusions 2.8% prevalence of suicide attempts and more than 600,000 suicide attempters among college students indicate that suicide attempt among college students is an important public health problem in China. More attention should be paid to the current situation.	[Yang, Lin-Sheng; Zhang, Zhi-Hua; Sun, Ye-Huan; Ye, Dong-Qing] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Peoples R China; [Sun, Liang] Fuyang Ctr Dis Control & Prevent, Dept Publ Hlth, Fuyang, Peoples R China	Anhui Medical University	Sun, YH (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Peoples R China.	sun611007@163.com; anhuiydq@126.com	zhang, zh/GWV-4677-2022		National Natural Science Foundation of China [81202224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was funded by a grant from the National Natural Science Foundation of China (grant no. 81202224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; American College Health Association, 2009, J Am Coll Health, V57, P477, DOI 10.3200/JACH.57.5.477-488; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Arria AM, 2009, ARCH SUICIDE RES, V13, P230, DOI 10.1080/13811110903044351; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bertolote JM, 2005, PSYCHOL MED, V35, P1457, DOI 10.1017/S0033291705005404; Boeninger DK, 2010, SUICIDE LIFE-THREAT, V40, P451, DOI 10.1521/suli.2010.40.5.451; Cao HY, 2009, CHIN J SCH HLTH, V30, P38; Chen JL, 2014, INT J DEV NEUROSCI, V35, P35, DOI 10.1016/j.ijdevneu.2014.03.006; CHEN RR, 2011, FOREIGN MED SCI SECT, V32, P192; Chen YF, 2008, CHIN J DIS CONTROL P, V12, P450; Chou CH, 2013, SUICIDE LIFE-THREAT, V43, P185, DOI 10.1111/sltb.12007; [邓云龙 Deng Yunlong], 2012, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V20, P332; FAN YG, 2008, CHIN J SCH HLTH, V29, P328; Fan Yin-Guang, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P241; FENG SS, 2008, CHIN J SCH HLTH, V29, P414; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Gao Rong, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P9; Gau SSF, 2009, COMPR PSYCHIAT, V50, P276, DOI 10.1016/j.comppsych.2008.08.009; GUO SF, PSYCHOL PROBLEMS COL, P87044; KUANG L, 2008, CHIN J NERV MENT DIS, V34, P594; Kuo WH, 2005, AM J PSYCHIAT, V162, P633, DOI 10.1176/appi.ajp.162.3.633; Law BMF, 2013, J PEDIATR ADOL GYNEC, V26, pS26, DOI 10.1016/j.jpag.2013.03.012; Lee S, 2007, ACTA PSYCHIAT SCAND, V116, P429, DOI 10.1111/j.1600-0447.2007.01064.x; LI LH, 2010, J CHIN TRADIT CHIN M, V2, P227; [刘丹 Liu Dan], 2013, [中华行为医学与脑科学杂志, Chinese Journal of Behavioral Medicine and Brain Science], V22, P856; Liu Ke-rong, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P1071; Liu QQ, 2007, CHINA J HLTH PSYCHOL, V15, P57; MA AH, 2010, CHIN J SCH HLTH, V31, P603; Ma X, 2009, AUST NZ J PSYCHIAT, V43, P158, DOI 10.1080/00048670802607170; MILLER JJ, 1978, AM STAT, V32, P138, DOI 10.2307/2682942; Nath Y, 2012, INT J SOC PSYCHIATR, V58, P393, DOI 10.1177/0020764011401164; Neeleman J, 2004, J AFFECT DISORDERS, V82, P43, DOI 10.1016/j.jad.2003.09.005; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Rostom A, CELIAC DIS; Shang YX, 2009, MOD PREV MED, V36, P3092; Shang YX, 2008, CHIN J PUBLIC HLTH, V24, P934; SHI WJ, 2007, CHIN J SCH HLTH, V29, P1083; Taliaferro LA, 2015, J AM COLL HEALTH, V63, P40, DOI 10.1080/07448481.2014.953166; Tang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017977; TAO FB, 1999, CHIN J SCH HLTH, V20, P249; Toprak S, 2011, PSYCHIAT RES, V187, P140, DOI 10.1016/j.psychres.2010.09.009; Tresno F, 2012, DEATH STUD, V36, P627, DOI 10.1080/07481187.2011.604464; Wan Yu-hui, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P474; Wang CW, 2014, SOC PSYCH PSYCH EPID, V49, P929, DOI 10.1007/s00127-013-0789-5; Wang L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-551; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; Wang Zhizhong, 2013, Shanghai Arch Psychiatry, V25, P287, DOI 10.3969/j.issn.1002-0829.2013.05.004; XIN X, 2010, ANHUI MED J, V31, P521; Xu Hui-lan, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P288; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; You ZQ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004096; ZEN LN, 2006, CHIN J SCH HLTH, V27, P863; ZHANG R, 2002, CHIN J DIS CONTROL P, V6, P52; Zhao Jiubo, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1111; Zhao JB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-668; ZHU JP, 2006, CHIN J SCH DOCTOR, V20, P228	59	44	45	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0116303	10.1371/journal.pone.0116303	http://dx.doi.org/10.1371/journal.pone.0116303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UO	25664661	Green Published, Green Submitted, gold			2022-12-27	WOS:000349123100007
J	Abily-Donval, L; Pinto-Cardoso, G; Chadie, A; Guerrot, AM; Torre, S; Rondeau, S; Marret, S				Abily-Donval, Lenaig; Pinto-Cardoso, Gaelle; Chadie, Alexandra; Guerrot, Anne-Marie; Torre, Stephanie; Rondeau, Stephane; Marret, Stephane		Perinatal Network Haute-Normandie	Comparison in Outcomes at Two-Years of Age of Very Preterm Infants Born in 2000, 2005 and 2010	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; CEREBRAL-PALSY; MAGNESIUM-SULFATE; GESTATIONAL-AGE; CHILDREN BORN; GROWTH; PREVALENCE; PREDICTORS; BRAIN; CARE	Objective To investigate alteration in 2-year neurological/behavioral outcomes of very preterm infants born in a French level three neonatal intensive care unit. Methods We conducted a prospective, comparative study of very preterm infants born before 33 weeks' gestation at 5-year intervals in 2000, 2005 and 2010 at Rouen University Hospital. Neonatal mortality/morbidities, ante- and neonatal treatments, and at age 2 years motor, cognitive and behavioral data were collected by standardized questionnaires. Results We included 536 very preterm infants. Follow-up rates at two years old were 78% in 2000, 93% in 2005 and 92% in 2010 respectively. No difference in gestational age, birthweight, neonatal mortality/morbidities was observed except a decrease in low grade subependymal/intraventricular hemorrhages. Care modifications concerned use of antenatal magnesium sulfate, breast-feeding and post-natal corticosteroid therapy. Significant improvement in motor outcome and dramatic decrease in cerebral palsy rates (12% in 2000, 6% in 2005, 1% in 2010, p < 0.001) were observed, as were improvements in feeding behavior. Although a non significant difference to better psychosocial behavior was reported, there was no difference in cognitive outcome. Conclusions Improvement in neuromotor outcome and behavior was reported. This could be due to multiple modifications in care: including administration of magnesium sulfate to women at risk of preterm birth, increase in breast-feeding, decrease in low grade subependymal/intraventricular hemorrhages, and decrease in post-natal corticosteroid therapy, all of which require further investigation in other studies. Extended follow-up until school age is mandatory for better detection of cognitive, learning and behavioral disorders.	[Abily-Donval, Lenaig; Pinto-Cardoso, Gaelle; Chadie, Alexandra; Guerrot, Anne-Marie; Torre, Stephanie; Rondeau, Stephane; Marret, Stephane] Rouen Univ Hosp, Dept Neonatal Med, Rouen, Haute Normandie, France; [Abily-Donval, Lenaig; Marret, Stephane] Univ Rouen, Sch Med, Inst Biomed Res & Innovat, Equipe Reg Inst Natl Sante & Rech Med,ERI 28,Neov, Rouen, Haute Normandie, France	CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite de Rouen Normandie	Marret, S (corresponding author), Rouen Univ Hosp, Dept Neonatal Med, Rouen, Haute Normandie, France.	stephane.marret@chu-rouen.fr		Marret, Stephane/0000-0002-2858-148X; Chadie, Alexandra/0000-0002-2942-7097	FEDER (European funds of regional development)	FEDER (European funds of regional development)(European Commission)	The study was supported by the FEDER (European funds of regional development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancel PY, 2006, PEDIATRICS, V117, P828, DOI 10.1542/peds.2005-0091; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Bain Emily, 2013, Aust Nurs J, V21, P34; Beaino G, 2011, ACTA PAEDIATR, V100, P370, DOI 10.1111/j.1651-2227.2010.02064.x; Beaino G, 2010, DEV MED CHILD NEUROL, V52, pE119, DOI 10.1111/j.1469-8749.2010.03612.x; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Blondel B, 2012, J Gynecol Obstet Biol Reprod (Paris), V41, pe1, DOI 10.1016/j.jgyn.2012.04.014; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Cardoso GP, 2013, ARCH PEDIATRIE, V20, P156, DOI 10.1016/j.arcped.2012.11.011; Chollat C, 2014, J PEDIATR-US, V165, P398, DOI 10.1016/j.jpeds.2014.04.007; Clark RH, 2003, PEDIATRICS, V111, P986, DOI 10.1542/peds.111.5.986; Delobel-Ayoub M, 2006, PEDIATRICS, V117, P1996, DOI 10.1542/peds.2005-2310; Doyle LW, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004661.pub3; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; FRANKENBURG WK, 1992, PEDIATRICS, V89, P91; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gosselin J, 2001, NEUROLOGICAL DEVELOP; Gross SJ, 2001, J PEDIATR-US, V138, P169, DOI 10.1067/mpd.2001.111945; Halliday HL, 2001, J PERINAT MED, V29, P281, DOI 10.1515/JPM.2001.040; Himmelmann K, 2010, ACTA PAEDIATR, V99, P1337, DOI 10.1111/j.1651-2227.2010.01819.x; INSERM Collective Expertise Centre, 2000, INSERM COLLECTIVE EX, DOI Deficiencies and handicaps of perinatal origin: Screening and management; Johnson S, 2008, DEV MED CHILD NEUROL, V50, P58, DOI 10.1111/j.1469-8749.2007.02010.x; Larroque B, 2008, ARCH PEDIATRIE, V15, P589, DOI 10.1016/S0929-693X(08)71843-8; Marret S, 2007, BJOG-INT J OBSTET GY, V114, P310, DOI 10.1111/j.1471-0528.2006.01162.x; Marret S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062683; Moore T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7961; Orcesi S, 2012, EUR J PAEDIATR NEURO, V16, P716, DOI 10.1016/j.ejpn.2012.05.006; Oskoui M, 2013, DEV MED CHILD NEUROL, V55, P509, DOI 10.1111/dmcn.12080; Payne AH, 2013, JAMA PEDIATR, V167, P451, DOI 10.1001/jamapediatrics.2013.866; Sherlock RL, 2005, EARLY HUM DEV, V81, P909, DOI 10.1016/j.earlhumdev.2005.07.007; Shojaei T, 2009, SOC PSYCH PSYCH EPID, V44, P740, DOI 10.1007/s00127-008-0489-8; Sukhov A, 2012, J MATERN-FETAL NEO M, V25, P53, DOI 10.3109/14767058.2011.564689; Tin W, 1998, ARCH DIS CHILD-FETAL, V79, pF83, DOI 10.1136/fn.79.2.F83; van Haastert IC, 2011, J PEDIATR-US, V159, P86, DOI 10.1016/j.jpeds.2010.12.053; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wu YW, 2003, JAMA-J AM MED ASSOC, V290, P2677, DOI 10.1001/jama.290.20.2677	36	0	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0114567	10.1371/journal.pone.0114567	http://dx.doi.org/10.1371/journal.pone.0114567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658321	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900008
J	Ding, YH; Zou, XJ; Jiang, X; Wu, JY; Zhang, YR; Chen, D; Liang, B				Ding, YiHong; Zou, XiaoJu; Jiang, Xue; Wu, JieYu; Zhang, YuRu; Chen, Dan; Liang, Bin			Pu-Erh Tea Down-Regulates Sterol Regulatory Element-Binding Protein and Stearyol-CoA Desaturase to Reduce Fat Storage in Caenorhaditis elegans	PLOS ONE			English	Article							GALLIC ACID; CAENORHABDITIS-ELEGANS; OXIDATIVE DAMAGE; LIPID-METABOLISM; BODY-FAT; EXTRACT; BLACK; MICE; DIET; CHOLESTEROL	Consumption of Pu-erh has been reported to result in numerous health benefits, but the mechanisms underlying purported weight-loss and lowering of lipid are poorly understood. Here, we used the nematode Caenorhaditis elegans to explore the water extract of Pu-erh tea (PTE) functions to reduce fat storage. We found that PTE down-regulates the expression of the master fat regulator SBP-1, a homologue of sterol regulatory element binding protein (SREBP) and its target stearoyl-CoA desaturase (SCD), a key enzyme in fat biosynthesis, leading to an increased ratio of stearic acid (C18:0) to oleic acid (C18:1n-9), and subsequently decreased fat storage. We also found that both the pharyngeal pumping rate and food uptake of Caenorhaditis elegans decreased with exposure to PTE. Collectively, these results provide an experimental basis for explaining the ability of Pu-erh tea in promoting inhibition of food uptake and the biosynthesis of fat via SBP-1 and SCD, thereby reducing fat storage.	[Ding, YiHong; Jiang, Xue; Wu, JieYu; Zhang, YuRu; Liang, Bin] Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Peoples R China; [Zou, XiaoJu; Chen, Dan] Kunming Univ, Dept Life Sci & Technol, Key Lab Special Biol Resource Dev & Utilizat Univ, Kunming 650214, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Kunming University	Zou, XJ (corresponding author), Kunming Univ, Dept Life Sci & Technol, Key Lab Special Biol Resource Dev & Utilizat Univ, Kunming 650214, Peoples R China.	xiaojuzou@163.com; liangb@mail.kiz.ac.cn			National Natural Science Foundation of China (NSFC) [31160216, 31171134]; Yunnan Natural Science Foundation [2011FZ179]; Kunming University Science Project [YJL11018]; Yunnan Provincial Science and Technology Department [2014HB022]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province); Kunming University Science Project; Yunnan Provincial Science and Technology Department; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Natural Science Foundation of China (NSFC) 31160216 to XJ Zou and 31171134 to B Liang; Yunnan Natural Science Foundation 2011FZ179 and Kunming University Science Project YJL11018 to XJ Zou; and Yunnan Provincial Science and Technology Department 2014HB022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery Leon, 2012, WormBook, P1, DOI 10.1895/wormbook.1.150.1; Bak EJ, 2013, SCAND J CLIN LAB INV, V73, P607, DOI 10.3109/00365513.2013.831470; Bene H, 2001, BIOCHEM BIOPH RES CO, V284, P1194, DOI 10.1006/bbrc.2001.5102; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cao ZH, 2011, PHYTOTHER RES, V25, P234, DOI 10.1002/ptr.3247; Chen HX, 2013, J FOOD SCI, V78, pC1665, DOI 10.1111/1750-3841.12288; Chiang CT, 2006, ONCOL RES, V16, P119, DOI 10.3727/000000006783981143; Duh PD, 2004, J AGR FOOD CHEM, V52, P8169, DOI 10.1021/jf0490551; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fujita H, 2008, PHYTOTHER RES, V22, P1275, DOI 10.1002/ptr.2477; Fujita H, 2008, NUTR RES, V28, P450, DOI 10.1016/j.nutres.2008.04.005; Gong JS, 2010, J FOOD SCI, V75, pH182, DOI 10.1111/j.1750-3841.2010.01675.x; Gong JiaShun, 2009, Asian Journal of Agricultural Sciences, V1, P48; Hodson L, 2013, PROG LIPID RES, V52, P15, DOI 10.1016/j.plipres.2012.08.002; Hou Y, 2009, EXP GERONTOL, V44, P434, DOI 10.1016/j.exger.2009.03.007; Huang HC, 2011, FOOD FUNCT; Huang QF, 2013, FOOD CHEM TOXICOL, V53, P75, DOI 10.1016/j.fct.2012.11.039; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Jie GL, 2006, J AGR FOOD CHEM, V54, P8058, DOI 10.1021/jf061663o; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Kade IJ, 2013, J BASIC CLIN PHYSL P, P1; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Koch B, 2001, J MICROBIOL METH, V45, P187, DOI 10.1016/S0167-7012(01)00246-9; Ku KM, 2010, J AGR FOOD CHEM, V58, P345, DOI 10.1021/jf902818c; Kuo KL, 2005, J AGR FOOD CHEM, V53, P480, DOI 10.1021/jf049375k; Liang B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009869; Ma X, 2013, J MED FOOD, V16, P259, DOI 10.1089/jmf.2012.2520; Mullaney BC, 2009, BBA-MOL CELL BIOL L, V1791, P474, DOI 10.1016/j.bbalip.2008.12.013; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; NTAMBI JM, 1995, PROG LIPID RES, V34, P139, DOI 10.1016/0163-7827(94)00010-J; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Oi Y, 2012, PHYTOTHER RES, V26, P475, DOI 10.1002/ptr.3602; Patel SS, 2011, PHARMACOGN RES, V3, P239, DOI 10.4103/0974-8490.89743; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Prince PSM, 2011, J BIOCHEM MOL TOXIC, V25, P101, DOI 10.1002/jbt.20365; Punithavathi VR, 2011, J BIOCHEM MOL TOXIC, V25, P68, DOI 10.1002/jbt.20360; Punithavathi VR, 2011, EUR J PHARMACOL, V650, P465, DOI 10.1016/j.ejphar.2010.08.059; SANO M, 1986, CHEM PHARM BULL, V34, P221; Shi X, 2013, J LIPID RES, V54, P2504, DOI 10.1194/jlr.M039669; Shimamura Y, 2013, BIOSCI BIOTECH BIOCH, V77, P1455, DOI 10.1271/bbb.130097; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2006, DEV BIOL, V292, P381, DOI 10.1016/j.ydbio.2006.01.013; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Watts JL, 2000, BIOCHEM BIOPH RES CO, V272, P263, DOI 10.1006/bbrc.2000.2772; Way TD, 2009, J AGR FOOD CHEM, V57, P5257, DOI 10.1021/jf900730e; Yamashita Y, 2012, J AGR FOOD CHEM, V60, P11366, DOI 10.1021/jf303597c; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yang TTC, 1997, PHARMACOL RES, V35, P505, DOI 10.1006/phrs.1997.0176; Yuan H, 2009, ACTA NUTR SIN, V31, P176; Yuan HuaBing, 2009, Acta Nutrimenta Sinica, V31, P167; Zhang L, 2011, J AGR FOOD CHEM, V59, P8754, DOI 10.1021/jf2015733; Zhang P, 2012, MOL CELL PROTEOMICS, V11, P317, DOI 10.1074/mcp.M111.016345; Zhang SBO, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-96; Zhang YR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-164; Zhao LJ, 2011, INT J MOL SCI, V12, P7581, DOI 10.3390/ijms12117581; Zheng J, 2011, INT J OBES LOND	62	19	22	6	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0113815	10.1371/journal.pone.0113815	http://dx.doi.org/10.1371/journal.pone.0113815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659129	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900006
J	Doshi, H; Wiseman, N; Liu, J; Wang, WT; Welch, RD; O'Neil, BJ; Zuk, C; Wang, X; Mika, V; Szaflarski, JP; Haacke, EM; Kou, ZF				Doshi, Hardik; Wiseman, Natalie; Liu, Jun; Wang, Wentao; Welch, Robert D.; O'Neil, Brian J.; Zuk, Conor; Wang, Xiao; Mika, Valerie; Szaflarski, Jerzy P.; Haacke, E. Mark; Kou, Zhifeng			Cerebral Hemodynamic Changes of Mild Traumatic Brain Injury at the Acute Stage	PLOS ONE			English	Article							OXYGEN EXTRACTION FRACTION; DEOXYGENATED BLOOD-VOLUME; IN-VIVO MEASUREMENT; HEAD-INJURY; AXONAL INJURY; INTRACRANIAL HYPERTENSION; QUANTITATIVE MEASUREMENTS; GLUCOSE-METABOLISM; ENERGY-METABOLISM; MR SUSCEPTOMETRY	Mild traumatic brain injury (mTBI) is a significant public health care burden in the United States. However, we lack a detailed understanding of the pathophysiology following mTBI and its relation to symptoms and recovery. With advanced magnetic resonance imaging (MRI), we can investigate brain perfusion and oxygenation in regions known to be implicated in symptoms, including cortical gray matter and subcortical structures. In this study, we assessed 14 mTBI patients and 18 controls with susceptibility weighted imaging and mapping (SWIM) for blood oxygenation quantification. In addition to SWIM, 7 patients and 12 controls had cerebral perfusion measured with arterial spin labeling (ASL). We found increases in regional cerebral blood flow (CBF) in the left striatum, and in frontal and occipital lobes in patients as compared to controls (p = 0.01, 0.03, 0.03 respectively). We also found decreases in venous susceptibility, indicating increases in venous oxygenation, in the left thalamostriate vein and right basal vein of Rosenthal (p = 0.04 in both). mTBI patients had significantly lower delayed recall scores on the standardized assessment of concussion, but neither susceptibility nor CBF measures were found to correlate with symptoms as assessed by neuropsychological testing. The increased CBF combined with increased venous oxygenation suggests an increase in cerebral blood flow that exceeds the oxygen demand of the tissue, in contrast to the regional hypoxia seen in more severe TBI. This may represent a neuroprotective response following mTBI, which warrants further investigation.	[Doshi, Hardik; Liu, Jun; Wang, Xiao; Mika, Valerie; Haacke, E. Mark; Kou, Zhifeng] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA; [Wiseman, Natalie; Kou, Zhifeng] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Translat Neurosci Program, Detroit, MI USA; [Liu, Jun] Cent S Univ, Sch Publ Hlth, Xiangya Hosp 2, Dept Radiol, Changsha, Hunan, Peoples R China; [Wang, Wentao] South Cent Univ Nationalities, Coll Comp Sci, Wuhan, Peoples R China; [Welch, Robert D.; O'Neil, Brian J.; Mika, Valerie] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA; [Zuk, Conor; Wang, Xiao; Haacke, E. Mark; Kou, Zhifeng] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI USA; [Wang, Xiao] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan Province, Peoples R China; [Szaflarski, Jerzy P.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA	Wayne State University; Wayne State University; Central South University; South Central Minzu University; Wayne State University; Wayne State University; Zhengzhou University; University of Alabama System; University of Alabama Birmingham	Kou, ZF (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.	zhifeng_kou@wayne.edu	Mika, Valerie H./AAO-2816-2020	Wiseman, Natalie/0000-0003-0884-6425; Liu, Jun/0000-0002-7851-6782	International Society for Magnetic Resonance in Medicine; Department of Defense [W81XWH-11-1-0493]	International Society for Magnetic Resonance in Medicine; Department of Defense(United States Department of Defense)	Supported by a Seed Grant from the International Society for Magnetic Resonance in Medicine (PI: ZFK) and a research grant from the Department of Defense (award number W81XWH-11-1-0493; PI: EMH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate MG, 2008, NEUROCRIT CARE, V9, P319, DOI 10.1007/s12028-008-9119-2; Abdul-Khaliq H, 2000, BIOMED TECH, V45, P328, DOI 10.1515/bmte.2000.45.11.328; An HY, 2001, NMR BIOMED, V14, P441, DOI 10.1002/nbm.717; An HY, 2002, MAGNET RESON MED, V47, P958, DOI 10.1002/mrm.10148; An HY, 2000, J CEREBR BLOOD F MET, V20, P1225, DOI 10.1097/00004647-200008000-00008; Ashburner John, 1997, HUMAN BRAIN FUNCTION, P43; BARCLAY L, 1985, BIOL PSYCHIAT, V20, P146, DOI 10.1016/0006-3223(85)90074-5; Barnes SRS, 2009, MAGN RESON IMAGING C, V17, P47, DOI 10.1016/j.mric.2008.12.002; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Bouma G J, 1995, New Horiz, V3, P384; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BOUMA GJ, 1993, ACTA NEUROCHIR, P34; BRANDT RB, 1984, P SOC EXP BIOL MED, V175, P328; Chen SF, 2004, J CEREBR BLOOD F MET, V24, P1025, DOI 10.1097/01.WCB.0000129415.34520.47; CHIEN D, 1994, MAGNET RESON MED, V32, P540, DOI 10.1002/mrm.1910320419; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Fernandez-Seara MA, 2006, MAGN RESON MED, V55, P967, DOI 10.1002/mrm.20892; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Golay X, 2001, MAGN RESON MED, V46, P282, DOI 10.1002/mrm.1189; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; Haacke EM, 1997, HUM BRAIN MAPP, V5, P341, DOI 10.1002/(SICI)1097-0193(1997)5:5<341::AID-HBM2>3.0.CO;2-3; Harris NG, 2012, J NEUROTRAUM, V29, P1469, DOI 10.1089/neu.2011.2161; He X, 2008, MAGN RESON MED, V60, P882, DOI 10.1002/mrm.21719; He X, 2007, MAGN RESON MED, V57, P115, DOI 10.1002/mrm.21108; HOLMES A, 1997, HUMAN BRAIN FUNCTION, P59; HOPPEL BE, 1993, MAGN RESON MED, V30, P715, DOI 10.1002/mrm.1910300609; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Jost SC, 2005, J NEUROSURG, V103, P25, DOI 10.3171/jns.2005.103.1.0025; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [DOI 10.1097/00001199-199309000-00010, 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00009]; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Krep H, 2004, RESUSCITATION, V63, P73, DOI 10.1016/j.resuscitation.2004.03.023; Langham MC, 2010, J AM COLL CARDIOL, V55, P598, DOI 10.1016/j.jacc.2009.08.068; Langham MC, 2009, MAGN RESON MED, V62, P333, DOI 10.1002/mrm.21981; Langham MC, 2009, MAGN RESON MED, V61, P626, DOI 10.1002/mrm.21499; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Li DB, 1998, MAGNET RESON MED, V39, P685, DOI 10.1002/mrm.1910390503; Li DB, 1998, JMRI-J MAGN RESON IM, V8, P1236, DOI 10.1002/jmri.1880080609; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Liu YJ, 1999, MAGNET RESON MED, V41, P407, DOI 10.1002/(SICI)1522-2594(199902)41:2<407::AID-MRM27>3.0.CO;2-4; Lu HZ, 2008, MAGN RESON MED, V60, P357, DOI 10.1002/mrm.21627; Macmillan CSA, 2000, INTENS CARE MED, V26, P1028, DOI 10.1007/s001340051315; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; MCKENNA MC, 1994, DEV NEUROSCI-BASEL, V16, P291, DOI 10.1159/000112122; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Nonaka H, 2003, NEUROPATHOLOGY, V23, P111, DOI 10.1046/j.1440-1789.2003.00486.x; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Oja JME, 1999, J CEREBR BLOOD F MET, V19, P1289, DOI 10.1097/00004647-199912000-00001; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Pandian DSJ, 2008, J MAGN RESON IMAGING, V28, P727, DOI 10.1002/jmri.21487; Pomschar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055447; Prat R, 1997, NEUROL RES, V19, P393, DOI 10.1080/01616412.1997.11740832; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Qin Q, 2011, MAGN RESON MED, V65, P471, DOI 10.1002/mrm.22556; Sedlacik J, 2010, MAGN RESON MED, V63, P910, DOI 10.1002/mrm.22274; Sedlacilk J, 2009, Z MED PHYS, V19, P48, DOI 10.1016/j.zemedi.2008.07.005; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Tang J, 2013, MAGN RESON MED, V69, P1396, DOI 10.1002/mrm.24384; Tang J, 2012, MAGN RESON MED; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; van Zijl PCM, 1998, NAT MED, V4, P159, DOI 10.1038/nm0298-159; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; Weiskoff R, 1991, QUANTITATIVE VIVO BL, P307; WRIGHT GA, 1991, JMRI-J MAGN RESON IM, V1, P275, DOI 10.1002/jmri.1880010303; Xu F, 2009, MAGN RESON MED, V62, P141, DOI 10.1002/mrm.21994; Yablonskiy DA, 1997, MAGN RESON MED, V37, P214, DOI 10.1002/mrm.1910370213; Yablonskiy DA, 1997, MAGNET RESON MED, V37, P872, DOI 10.1002/mrm.1910370611; YABLONSKIY DA, 1994, MAGNET RESON MED, V32, P749, DOI 10.1002/mrm.1910320610; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003; Zheng WL, 2013, NEUROIMAGE, V78, P68, DOI 10.1016/j.neuroimage.2013.04.022; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670; Zwienenberg M, 2001, NEUROL RES, V23, P167, DOI 10.1179/016164101101198505; [No title captured]	86	67	68	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118061	10.1371/journal.pone.0118061	http://dx.doi.org/10.1371/journal.pone.0118061			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659079	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900257
J	Ishikawa, K; Tsunekawa, S; Ikeniwa, M; Izumoto, T; Iida, A; Ogata, H; Uenishi, E; Seino, Y; Ozaki, N; Sugimura, Y; Hamada, Y; Kuroda, A; Shinjo, K; Kondo, Y; Oiso, Y				Ishikawa, Kota; Tsunekawa, Shin; Ikeniwa, Makoto; Izumoto, Takako; Iida, Atsushi; Ogata, Hidetada; Uenishi, Eita; Seino, Yusuke; Ozaki, Nobuaki; Sugimura, Yoshihisa; Hamada, Yoji; Kuroda, Akio; Shinjo, Keiko; Kondo, Yutaka; Oiso, Yutaka			Long-Term Pancreatic Beta Cell Exposure to High Levels of Glucose but Not Palmitate Induces DNA Methylation within the Insulin Gene Promoter and Represses Transcriptional Activity	PLOS ONE			English	Article							EPIGENETIC CHANGES; TYPE-2; EXPRESSION; DEMETHYLATION; METABOLISM; PDX-1	Recent studies have implicated epigenetics in the pathophysiology of diabetes. Furthermore, DNA methylation, which irreversibly deactivates gene transcription, of the insulin promoter, particularly the cAMP response element, is increased in diabetes patients. However, the underlying mechanism remains unclear. We aimed to investigate insulin promoter DNA methylation in an over-nutrition state. INS-1 cells, the rat pancreatic beta cell line, were cultured under normal-culture-glucose (11.2mmol/l) or experimental-high-glucose (22.4mmol/l) conditions for 14 days, with or without 0.4 mmol/l palmitate. DNA methylation of the rat insulin 1 gene (Ins1) promoter was investigated using bisulfite sequencing and pyrosequencing analysis. Experimental-high-glucose conditions significantly suppressed insulin mRNA and increased DNA methylation at all five CpG sites within the Ins1 promoter, including the cAMP response element, in a time-dependent and glucose concentration-dependent manner. DNA methylation under experimental-high-glucose conditions was unique to the Ins1 promoter; however, palmitate did not affect DNA methylation. Artificial methylation of Ins1 promoter significantly suppressed promoter-driven luciferase activity, and a DNA methylation inhibitor significantly improved insulin mRNA suppression by experimental-high-glucose conditions. Experimental-high-glucose conditions significantly increased DNA methyltransferase activity and decreased ten-eleven-translocation methylcytosine dioxygenase activity. Oxidative stress and endoplasmic reticulum stress did not affect DNA methylation of the Ins1 promoter. High glucose but not palmitate increased ectopic triacylglycerol accumulation parallel to DNA methylation. Metformin upregulated insulin gene expression and suppressed DNA methylation and ectopic triacylglycerol accumulation. Finally, DNA methylation of the Ins1 promoter increased in isolated islets from Zucker diabetic fatty rats. This study helps to clarify the effect of an over-nutrition state on DNA methylation of the Ins1 promoter in pancreatic beta cells. It provides new insights into the irreversible pathophysiology of diabetes.	[Ishikawa, Kota; Tsunekawa, Shin; Ikeniwa, Makoto; Iida, Atsushi; Ogata, Hidetada; Uenishi, Eita; Seino, Yusuke; Ozaki, Nobuaki; Sugimura, Yoshihisa; Oiso, Yutaka] Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Showa Ku, Nagoya, Aichi 4668550, Japan; [Izumoto, Takako] Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4668550, Japan; [Hamada, Yoji] Nagoya Univ, Grad Sch Med, Dept Metab Med, Nagoya, Aichi 4668550, Japan; [Kuroda, Akio] Univ Tokushima, Diabet Therapeut & Res Ctr, Tokushima 770, Japan; [Shinjo, Keiko; Kondo, Yutaka] Nagoya City Univ, Grad Sch Med Sci, Dept Epigen, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University; Tokushima University; Nagoya City University	Tsunekawa, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	tsune87@med.nagoya-u.ac.jp	Hamada, Yoji/I-7344-2014; Sugimura, Yoshihisa/Q-8716-2019		Japanese Ministry of Education, Culture, Sports, Science and Technology [24790920]; Grants-in-Aid for Scientific Research [24790920] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grant-in-Aid for Young Scientists B (No. 24790920) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/ english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARCON C, 1993, J BIOL CHEM, V268, P4276; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Chen JG, 2014, AM J PHYSIOL-RENAL, V306, pF916, DOI 10.1152/ajprenal.00697.2012; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; Chiang EPI, 2009, J CLIN ENDOCR METAB, V94, P1017, DOI 10.1210/jc.2008-2038; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donkena KV, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/302051; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Guillausseau PJ, 2008, DIABETES METAB, V34, pS43, DOI 10.1016/S1262-3636(08)73394-9; Harmon JS, 2001, DIABETES, V50, P2481, DOI 10.2337/diabetes.50.11.2481; Haseeb A, 2014, J BIOL CHEM; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kawamori D, 2003, DIABETES, V52, P2896, DOI 10.2337/diabetes.52.12.2896; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kuroda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006953; Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; PHILIPPE J, 1990, J BIOL CHEM, V265, P1465; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Roche E, 1998, DIABETES, V47, P1086, DOI 10.2337/diabetes.47.7.1086; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Tonna S, 2010, NAT REV NEPHROL, V6, P332, DOI 10.1038/nrneph.2010.55; WELSH M, 1985, J BIOL CHEM, V260, P3590; Wijekoon EP, 2005, DIABETES, V54, P3245, DOI 10.2337/diabetes.54.11.3245; Williams KT, 2012, DIABETES-METAB RES, V28, P123, DOI 10.1002/dmrr.1281; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yang BT, 2011, DIABETOLOGIA, V54, P360, DOI 10.1007/s00125-010-1967-6; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004	40	39	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115350	10.1371/journal.pone.0115350	http://dx.doi.org/10.1371/journal.pone.0115350			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658116	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900016
J	James, MI; Howells, LM; Karmokar, A; Higgins, JA; Greaves, P; Cai, H; Dennison, A; Metcalfe, M; Garcea, G; Lloyd, DM; Berry, DP; Steward, WP; Brown, K				James, Mark I.; Howells, Lynne M.; Karmokar, Ankur; Higgins, Jennifer A.; Greaves, Peter; Cai, Hong; Dennison, Ashley; Metcalfe, Matthew; Garcea, Giuseppe; Lloyd, David M.; Berry, David P.; Steward, William P.; Brown, Karen			Characterization and Propagation of Tumor Initiating Cells Derived from Colorectal Liver Metastases: Trials, Tribulations and a Cautionary Note	PLOS ONE			English	Article							CANCER STEM-CELLS; ALDEHYDE DEHYDROGENASE 1; COLON-CANCER; CD133 EXPRESSION; SOLID TUMORS; MARKER; TUMORIGENESIS; MORPHOGENESIS; ASSOCIATION; POPULATIONS	Tumor initiating cells (TIC) are increasingly being put forward as a potential target for intervention within colorectal cancer. Whilst characterisation and outgrowth of these cells has been extensively undertaken in primary colorectal cancers, few data are available describing characteristics within the metastatic setting. Tissue was obtained from patients undergoing surgical resection for colorectal liver metastases, and processed into single cell suspension for assessment. Tumor initiating cells from liver metastases were characterised using combinations of EPCAM, Aldehyde dehydrogenase activity, CD133 and CD26. CD133 expression was significantly lower in patients who had received chemotherapy, but this was accounted for by a decrease observed in the male patient cohort only. ALDH(high) populations were rare (0.4 and 0.3% for EPCAM(+)/ALDH(high)/CD133-and EPCAM(+)/ALDH(high)/CD133(+) populations respectively) and below the limits of detection in 28% of samples. Spheroid outgrowth of metastatic tumor cells across all samples could not be readily achieved using standard spheroid-formation techniques, thus requiring further method validation to reliably propagate cells from the majority of tissues. Spheroid formation was not enhanced using additional growth factors or fibroblast co-culture, but once cells were passaged through NOD-SCID mice, spheroid formation was observed in 82% samples, accompanied by a significant increase in CD26. Order of spheroid forming ability was ALDH(high) >CD133> CD26. Samples sorted by these markers each had the ability to reform ALDH(high), CD133 and CD26 positive populations to a similar extent, suggestive of a high degree of plasticity for each population. Ex vivo TIC models are increasingly being utilised to assess efficacy of therapeutic interventions. It is therefore essential that such investigations use well-characterised models that are able to sustain TIC populations across a large patient cohort in order that the inherent heterogeneity observed in cancer populations is maintained.	[James, Mark I.; Howells, Lynne M.; Karmokar, Ankur; Higgins, Jennifer A.; Greaves, Peter; Cai, Hong; Steward, William P.; Brown, Karen] Univ Leicester, Leicester, Leics, England; [Dennison, Ashley; Metcalfe, Matthew; Garcea, Giuseppe; Lloyd, David M.] Univ Hosp Leicester, Leicester, Leics, England; [Berry, David P.] Univ Wales Hosp, Cardiff, Wales	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Cardiff University	Howells, LM (corresponding author), Univ Leicester, Leicester, Leics, England.	lh28@le.ac.uk		Brown, Karen/0000-0002-5217-1501	Hope Against Cancer, Leicester, UK; Cancer Research UK [C325/A13101]; UK Department of Health on an Experimental Cancer Medicine Centre [C325/A15575]; MRC [MC_G0802524] Funding Source: UKRI; Cancer Research UK [13101] Funding Source: researchfish; Medical Research Council [MC_G0802524] Funding Source: researchfish	Hope Against Cancer, Leicester, UK; Cancer Research UK(Cancer Research UK); UK Department of Health on an Experimental Cancer Medicine Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a studentship from Hope Against Cancer (http://www.hfcr.org/), Leicester, UK (KB/LMH), by Cancer Research UK (http://www.cancerresearchuk.org/) on a programme grant [C325/A13101] (KB/WPS) and by Cancer Research UK in conjunction with the UK Department of Health on an Experimental Cancer Medicine Centre grant [C325/A15575] (WPS/KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonetti LR, 2012, SCAND J GASTROENTERO, V47, P1211, DOI 10.3109/00365521.2012.694904; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Bose D, 2011, BRIT J CANCER, V105, P1759, DOI 10.1038/bjc.2011.449; Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19; Cammareri P, 2008, METHOD CELL BIOL, V86, P311, DOI 10.1016/S0091-679X(08)00014-9; Chen L, 2013, REPROD SCI, DOI [10.1177/1933719113512533, DOI 10.1177/1933719113512533]; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056380; Chirgwin JM, 2012, ANTI-CANCER AGENT ME, V12, P187; Du L, 2013, CANCER RES, DOI [10.1158/0008-5472, DOI 10.1158/0008-5472.CAN-13-2440]; Fan XL, 2011, INT J COLORECTAL DIS, V26, P1279, DOI 10.1007/s00384-011-1248-y; Gao WC, 2013, GASTROENTEROLOGY, V145, P636, DOI 10.1053/j.gastro.2013.05.049; Gerber JM, 2012, BLOOD, V119, P3571, DOI 10.1182/blood-2011-06-364182; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Hermann PC, 2008, CELL CYCLE, V7, P188, DOI 10.4161/cc.7.2.5326; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Herrmann JL, 2010, J CARDIOVASC TRANSL, V3, P103, DOI 10.1007/s12265-009-9149-y; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Hong SH, 2004, MOL CELLS, V18, P320; Horst D, 2009, J PATHOL, V219, P427, DOI 10.1002/path.2597; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Irmisch A, 2013, EXP CELL RES, DOI [10.1016/j.yexcr.2013.10.012, DOI 10.1016/J.YEXCR.2013.10.012]; Irollo E, 2013, AM J TRANSL RES, V5, P563; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kunz-Schughart L, 2004, J BIOMOL SCREEN, V9, P12; Li CY, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-56; Li GQ, 2010, CLIN EXP METASTAS, V27, P517, DOI 10.1007/s10585-010-9341-0; Malanchi I, 2012, NATURE, V481, P5, DOI [10.1038/481005a, DOI 10.1038/481005A]; Masramon L, 2006, J CELL SCI, V119, P1477, DOI 10.1242/jcs.02871; Matsuyama M, 2010, ONCOL LETT, V1, P431, DOI 10.3892/ol_00000076; Mostafa G, 2004, AM SURGEON, V70, P259; NAKAMURA S, 1984, J NATL CANCER I, V73, P41; Paduch R, 2011, EXP TOXICOL PATHOL, V63, P79, DOI 10.1016/j.etp.2009.09.011; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; Preston SL, 2003, CANCER RES, V63, P3819; Ray S, 2012, J CANC, V3, P11, DOI [10.1093/jscr/2012.3.11, DOI 10.1093/JSCR/2012.3.11]; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rousseau A, 2010, FERTIL STERIL, V93, P843, DOI 10.1016/j.fertnstert.2008.10.062; Saigusa S, 2010, ONCOL REP, V24, P345, DOI 10.3892/or_00000865; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Siegel G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-146; Tamura K, 2013, J NEUROSURG, V119, P1145, DOI 10.3171/2013.7.JNS122417; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Waldron J, 2010, STEM CELLS CLONING, V3, P119, DOI 10.2147/SCCAA.S13035; Wei B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039069; Weiswald LB, 2009, BRIT J CANCER, V101, P473, DOI 10.1038/sj.bjc.6605173; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Ye J, 2014, TUMOUR BIOL; Zhang J, 2012, ONCOGENE, DOI [10.1038/onc.2012.584, DOI 10.1038/ONC.2012.584]	54	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117776	10.1371/journal.pone.0117776	http://dx.doi.org/10.1371/journal.pone.0117776			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658706	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900218
J	Mercado, ES; Espino, FE; Perez, MLM; Bilar, JM; Bajaro, JDP; Huy, NT; Baello, BQ; Kikuchi, M; Hirayama, K				Mercado, Edelwisa Segubre; Espino, Fe Esperanza; Perez, Ma. Lucila M.; Bilar, Josie M.; Bajaro, Jemimah Dawn P.; Nguyen Tien Huy; Baello, Benilda Q.; Kikuchi, Mihoko; Hirayama, Kenji			HLA-A(*)33:01 as Protective Allele for Severe Dengue in a Population of Filipino Children	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; DISEASE SEVERITY; SHOCK SYNDROME; VIRUS-INFECTION; RISK-FACTORS; HLA-A; ASSOCIATIONS; SUSCEPTIBILITY; PHILIPPINES; CORRELATE	Dengue virus infection is a leading cause of morbidity among children in the Philippines in recent years. In order to investigate the association of HLA Class I and II alleles and dengue disease severity in a cohort of Filipino children, we performed a case control study in 2 hospitals in Metro Manila from June 2008 to December 2009. A total of 250 laboratory confirmed dengue patients and 300 healthy individuals aged 5 to 15 years old were typed for HLA-A, B and DRB1 alleles. The frequency of HLA-A*33:01 was significantly decreased in severe dengue (DHF/DSS; Pc = 0.0016)) and DSS (Pc = 0.0032) compared to the background population. These findings support a previous study that this allele may confer protection against the severe form of dengue and provide the first evidence of HLA association with dengue in the Philippines. Future studies should be directed in investigating the possible mechanisms of protection.	[Mercado, Edelwisa Segubre; Bilar, Josie M.; Bajaro, Jemimah Dawn P.] Res Inst Trop Med, Mol Biol Lab, Muntinlupa, Philippines; [Espino, Fe Esperanza] Res Inst Trop Med, Dept Med, Muntinlupa, Philippines; [Perez, Ma. Lucila M.; Baello, Benilda Q.] Philippine Childrens Med Ctr, Off Res Dev, Quezon City, Philippines; [Mercado, Edelwisa Segubre; Nguyen Tien Huy; Kikuchi, Mihoko; Hirayama, Kenji] Nagasaki Univ, Dept Immunogenet, Global Ctr Excellence GCOE Program, Grad Sch Biomed Sci,Inst Trop Med NEKKEN, Nagasaki 852, Japan	Research Institute for Tropical Medicine - Philippines; Research Institute for Tropical Medicine - Philippines; Nagasaki University	Hirayama, K (corresponding author), Nagasaki Univ, Dept Immunogenet, Global Ctr Excellence GCOE Program, Grad Sch Biomed Sci,Inst Trop Med NEKKEN, Nagasaki 852, Japan.	hiraken@nagasaki-u.ac.jp	Hirayama, Kenji/AAN-7065-2021; Huy, Nguyen Tien/B-2573-2010	Huy, Nguyen Tien/0000-0002-9543-9440; Perez, Ma Lucila/0000-0001-8476-7599; Hirayama, Kenji/0000-0001-9467-1777	Global Centers of Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Philippine Children's Medical Center Research Funds; Japan Society for the Promotion of Science (JSPS)	Global Centers of Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Philippine Children's Medical Center Research Funds; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by the Global Centers of Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan, Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) and the Philippine Children's Medical Center Research Funds. ESM is an Awardee of Japan Society for the Promotion of Science (JSPS) RONPAKU (Dissertation PhD) Program.	Falcon-Lezama JA, 2009, ACTA TROP, V112, P193, DOI 10.1016/j.actatropica.2009.07.025; Appanna R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013029; Brown MG, 2011, W INDIAN MED J, V60, P126; Butt N, 2008, JCPSP-J COLL PHYSICI, V18, P282, DOI 05.2008/JCPSP.282285; Carlos CC, 2005, AM J TROP MED HYG, V73, P435, DOI 10.4269/ajtmh.2005.73.435; Coffey LL, 2009, MICROBES INFECT, V11, P143, DOI 10.1016/j.micinf.2008.12.006; Faridi MMA, 2008, TROP DOCT, V38, P28, DOI 10.1258/td.2007.006158; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; HAYES CG, 1988, AM J TROP MED HYG, V39, P110, DOI 10.4269/ajtmh.1988.39.110; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Innis BL, 1995, EXOTIC VIRAL INFECT, P103; Khanna S., 2005, Dengue Bulletin, V29, P85; Lan Nguyen Thi Phuong, 2011, Trop Med Health, V39, P73, DOI 10.2149/tmh.2011-S08; Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Loke H, 2001, J INFECT DIS, V184, P1369, DOI 10.1086/324320; Malavige GN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020581; Matheus S, 2005, J CLIN MICROBIOL, V43, P2793, DOI 10.1128/JCM.43.6.2793-2797.2005; Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397; National Cancer Institute, 1999, COMM DEV QUOT PROGR, P13; National Epidemiology Center Department of Health, 2013, DIS SURV REP DENG CA; Panchal R, 2012, INT J HUM GENET, V12, P1; Reynes JM, 2003, J CLIN MICROBIOL, V41, P3864, DOI 10.1128/JCM.41.8.3864-3867.2003; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Stephens HAF, 2010, CURR TOP MICROBIOL, V338, P99, DOI 10.1007/978-3-642-02215-9_8; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x; Tayag E, 2012, NAT DENG SUMM; Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566; Tschudy M, 2012, HARRIET LANE HDB MAN, P323, DOI [10.1111/tme.12174, DOI 10.1111/TME.12174]; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; VENZON E. L., 1972, Journal of the Philippine Islands Medical Association, V48, P297; Wagenaar J. F. P., 2004, Dengue Bulletin, V28, P126; Weerakoon K. G. A. D., 2009, Dengue Bulletin, V33, P70; White NJ, 1999, LANCET, V354, P1401, DOI 10.1016/S0140-6736(99)00236-6; WHO, 1997, DENG HAEM FEV DIAGN; WHO, 2008, DENGUE DENGUE HEMORR; World Health Organization, 2009, DENGUE GUIDELINES DI; Zhang HB, 2010, INT J IMMUNOGENET, V37, P337, DOI 10.1111/j.1744-313X.2010.00930.x	40	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115619	10.1371/journal.pone.0115619	http://dx.doi.org/10.1371/journal.pone.0115619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659158	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900024
J	Miyatake, H; Sanjoh, A; Unzai, S; Matsuda, G; Tatsumi, Y; Miyamoto, Y; Dohmae, N; Aida, Y				Miyatake, Hideyuki; Sanjoh, Akira; Unzai, Satoru; Matsuda, Go; Tatsumi, Yuko; Miyamoto, Yoichi; Dohmae, Naoshi; Aida, Yoko			Crystal Structure of Human Importin-alpha 1 (Rch1), Revealing a Potential Autoinhibition Mode Involving Homodimerization	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; PORE COMPLEX; PROTEIN CRYSTALLOGRAPHY; ALPHA; RECOGNITION; MACROMOLECULES; SOFTWARE; SPRING-8; IMPORT; SYSTEM	In this study, we determined the crystal structure of N-terminal importin-beta-binding domain (IBB)-truncated human importin-alpha 1 (Delta IBB-h-importin-alpha 1) at 2.63 angstrom resolution. The crystal structure of Delta IBB-h-importin-alpha 1 reveals a novel closed homodimer. The homodimer exists in an autoinhibited state in which both the major and minor nuclear localization signal (NLS) binding sites are completely buried in the homodimerization interface, an arrangement that restricts NLS binding. Analytical ultracentrifugation studies revealed that Delta IBB-h-importin-alpha 1 is in equilibrium between monomers and dimers and that NLS peptides shifted the equilibrium toward the monomer side. This finding suggests that the NLS binding sites are also involved in the dimer interface in solution. These results show that when the IBB domain dissociates from the internal NLS binding sites, e.g., by binding to importin-beta, homodimerization possibly occurs as an autoinhibition state.	[Miyatake, Hideyuki; Dohmae, Naoshi] RIKEN, Global Res Cluster Collaborat Promot Unit, Wako, Saitama 3510198, Japan; [Sanjoh, Akira; Tatsumi, Yuko] Prot Wave Corp, Nara 6310006, Japan; [Unzai, Satoru] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Matsuda, Go; Aida, Yoko] RIKEN, Viral Infect Dis Unit, Wako, Saitama 3510198, Japan; [Miyamoto, Yoichi] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Miyamoto, Yoichi] Natl Inst Biomed Innovat, Lab Nucl Transport Dynam, Osaka 5670085, Japan	RIKEN; Yokohama City University; RIKEN; Monash University; National Institute of Health Sciences - Japan	Miyatake, H (corresponding author), RIKEN, Global Res Cluster Collaborat Promot Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	miyatake@riken.jp; aida@riken.jp	Dohmae, Naoshi/C-2040-2011; hideyuki, miyatake/S-4993-2019	Dohmae, Naoshi/0000-0002-5242-9410; hideyuki, miyatake/0000-0001-8872-9784	RIKEN; Ministry of Health, Labor and Welfare of Japan; program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan	RIKEN; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan(National Institute of Biomedical Innovation)	This work was partly supported by the RIKEN incentive research grant (to HM), and also by a Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS) and by the program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan (to YA).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; CUOMO CA, 1994, P NATL ACAD SCI USA, V91, P6156, DOI 10.1073/pnas.91.13.6156; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Kamata M, 2005, J VIROL, V79, P3557, DOI 10.1128/JVI.79.6.3557-3564.2005; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Nair R, 2003, NUCLEIC ACIDS RES, V31, P397, DOI 10.1093/nar/gkg001; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Okazaki N, 2008, J SYNCHROTRON RADIAT, V15, P288, DOI 10.1107/S0909049507064679; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Percipalle P, 1999, J MOL BIOL, V292, P263, DOI 10.1006/jmbi.1999.3077; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stoffler D, 1999, J MOL BIOL, V287, P741, DOI 10.1006/jmbi.1999.2637; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tran EJ, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.015; Ueno Go, 2006, Journal of Structural and Functional Genomics, V7, P15, DOI 10.1007/s10969-005-9005-5; Weis K, 1998, TRENDS BIOCHEM SCI, V23, P185, DOI 10.1016/S0968-0004(98)01204-3; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965	39	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115995	10.1371/journal.pone.0115995	http://dx.doi.org/10.1371/journal.pone.0115995			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658636	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900028
J	Sargent, KM; Lu, N; Clopton, DT; Pohlmeier, WE; Brauer, VM; Ferrara, N; Silversides, DW; Cupp, AS				Sargent, Kevin M.; Lu, Ningxia; Clopton, Debra T.; Pohlmeier, William E.; Brauer, Vanessa M.; Ferrara, Napoleone; Silversides, David W.; Cupp, Andrea S.			Loss of Vascular Endothelial Growth Factor A (VEGFA) Isoforms in Granulosa Cells Using pDmrt-1-Cre or Amhr2-Cre Reduces Fertility by Arresting Follicular Development and by Reducing Litter Size in Female Mice	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; OOCYTE-SPECIFIC EXPRESSION; DIFFERENTIATION FACTOR-9; TRANSCRIPTION FACTOR; TARGETED DISRUPTION; RHESUS-MONKEY; OVARIAN; MOUSE; ESTROGEN; GENES	Because VEGFA has been implicated in follicle development, the objective of this study was to determine the effects of granulosa-and germ cell-specific VEGFA loss on ovarian morphogenesis, function, and female fertility. pDmrt1-Cre mice were mated to floxed VEGFA mice to develop granulosa-/germ cell-specific knockouts (pDmrt1-Cre; Vegfa(-/-)). The time from mating to first parturition was increased when pDmrt1-Cre;Vegfa(-/-) females were mated to control males (P = 0.0008) and tended to be longer for heterozygous females (P < 0.07). Litter size was reduced for pDmrt1-Cre; Vegfa(-/-) females (P < 0.007). The time between the first and second parturitions was also increased for heterozygous females (P < 0.04) and tended to be increased for pDmrt1-Cre;Vegfa(-/-) females (P < 0.07). pDmrt1-Cre;Vegfa(-/-) females had smaller ovaries (P < 0.04), reduced plasma estradiol (P < 0.007), fewer developing follicles (P < 0.008) and tended to have fewer corpora lutea (P < 0.08). Expression of Igf1r was reduced (P < 0.05); expression of Foxo3a tended to be increased (P < 0.06); and both Fshr (P < 0.1) and Sirt6 tended to be reduced (P < 0.06) in pDmrt1-Cre;Vegfa(-/-) ovaries. To compare VEGFA knockouts, we generated Amhr2-Cre; Vegfa(-/-) mice that required more time from mating to first parturition (P < 0.003) with variable ovarian size. Both lines had more apoptotic granulosa cells, and vascular staining did not appear different. Taken together these data indicate that the loss of all VEGFA isoforms in granulosa/germ cells (proangiogenic and antiangiogenic) causes subfertility by arresting follicular development, resulting in reduced ovulation rate and fewer pups per litter.	[Sargent, Kevin M.; Lu, Ningxia; Clopton, Debra T.; Pohlmeier, William E.; Brauer, Vanessa M.; Cupp, Andrea S.] Univ Nebraska, Dept Anim Sci, Lincoln, NE 68588 USA; [Ferrara, Napoleone] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Silversides, David W.] Univ Montreal, Fac Vet Med, Dept Vet Biomed, St Hyacinthe, PQ J2S 7C6, Canada	University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California San Diego; Universite de Montreal	Cupp, AS (corresponding author), Univ Nebraska, Dept Anim Sci, Lincoln, NE 68588 USA.	acupp2@unl.edu		Sargent, Kevin/0000-0001-6059-0776	NIH/NICHD [HD051979]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD051979] Funding Source: NIH RePORTER	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by NIH/NICHD HD051979 and a contribution from the University of Nebraska Agricultural Research Division, Lincoln, Nebraska.	Abramovich D, 2010, FERTIL STERIL, V93, P1369, DOI 10.1016/j.fertnstert.2009.01.127; Arango NA, 2008, MOL REPROD DEV, V75, P1154, DOI 10.1002/mrd.20858; Artac RA, 2009, BIOL REPROD, V81, P978, DOI 10.1095/biolreprod.109.078097; Baker J, 1996, MOL ENDOCRINOL, V10, P903, DOI 10.1210/me.10.7.903; Berisha B, 2010, BIOL REPROD, V82, P940, DOI 10.1095/biolreprod.109.076752; Bhat GK, 2006, J ANDROL, V27, P302, DOI 10.2164/jandrol.05133; Bott RC, 2010, CELL TISSUE RES, V342, P117, DOI 10.1007/s00441-010-1038-9; Boyer A, 2002, GENESIS, V34, P236, DOI 10.1002/gene.10158; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Caires KC, 2012, ENDOCRINOLOGY, V153, P887, DOI 10.1210/en.2011-1323; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Danforth DR, 2003, BIOL REPROD, V68, P1736, DOI 10.1095/biolreprod.101.000679; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gifford JAH, 2009, BIOL REPROD, V80, P1282, DOI 10.1095/biolreprod.108.072280; Ha CS, 2010, J OBSTET GYNAECOL RE, V36, P789, DOI 10.1111/j.1447-0756.2010.01212.x; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; Iijima K, 2005, J REPROD DEVELOP, V51, P161, DOI 10.1262/jrd.51.161; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Krentz AD, 2011, DEV BIOL, V356, P63, DOI 10.1016/j.ydbio.2011.05.658; Lei N, 2007, BIOL REPROD, V77, P466, DOI 10.1095/biolreprod.106.058784; Li XL, 2011, INT J BIOL SCI, V7, P575, DOI 10.7150/ijbs.7.575; Liu L, 2007, DEVELOPMENT, V134, P199, DOI 10.1242/dev.02667; Lu NX, 2013, ENDOCRINOLOGY, V154, P4790, DOI 10.1210/en.2013-1363; Mattioli M, 2001, BIOL REPROD, V65, P1014, DOI 10.1095/biolreprod65.4.1014; McFee RM, 2013, REPROD FERT DEVELOP, V25, P333, DOI 10.1071/RD12134; Mcfee RM, 2009, BIOL REPROD, V81, P966, DOI 10.1095/biolreprod.109.078071; MCGRATH SA, 1995, MOL ENDOCRINOL, V9, P131, DOI 10.1210/me.9.1.131; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Pellatt L, 2011, FERTIL STERIL, V96, P1246, DOI 10.1016/j.fertnstert.2011.08.015; Qiu Y, 2012, REPROD EPUB; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Roberts AE, 2007, BIOL REPROD, V76, P218, DOI 10.1095/biolreprod.106.050880; Sadeu JC, 2008, REPRODUCTION, V136, P195, DOI 10.1530/REP-08-0065; Schomberg DW, 1999, ENDOCRINOLOGY, V140, P2733, DOI 10.1210/en.140.6.2733; SHWEIKI D, 1993, J CLIN INVEST, V91, P2235, DOI 10.1172/JCI116450; Tao RY, 2013, J BIOL CHEM, V288, P29252, DOI 10.1074/jbc.M113.481473; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Yang MY, 2007, MOL REPROD DEV, V74, P1095, DOI 10.1002/mrd.20633; Zhou P, 2013, MOL ENDOCRINOL, V27, P511, DOI 10.1210/me.2012-1307; Zimmermann RC, 2002, ENDOCRINOLOGY, V143, P2496, DOI 10.1210/en.143.7.2496; Zimmermann RC, 2001, J CLIN ENDOCR METAB, V86, P768, DOI 10.1210/jc.86.2.768	49	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116332	10.1371/journal.pone.0116332	http://dx.doi.org/10.1371/journal.pone.0116332			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658474	Green Published, gold			2022-12-27	WOS:000349444900036
J	Wang, NL; Wu, XB; Kehrwald, N; Li, Z; Li, QL; Jiang, X; Pu, JC				Wang, Ninglian; Wu, Xiaobo; Kehrwald, Natalie; Li, Zhen; Li, Quanlian; Jiang, Xi; Pu, Jianchen			Fukushima Nuclear Accident Recorded in Tibetan Plateau Snow Pits	PLOS ONE			English	Article							ICE CORE; FALLOUT; CHERNOBYL; ACCUMULATION; RADIATION; GLACIER	The beta radioactivity of snow-pit samples collected in the spring of 2011 on four Tibetan Plateau glaciers demonstrate a remarkable peak in each snow pit profile, with peaks about ten to tens of times higher than background levels. The timing of these peaks suggests that the high radioactivity resulted from the Fukushima nuclear accident that occurred on March 11, 2011 in eastern Japan. Fallout monitoring studies demonstrate that this radioactive material was transported by the westerlies across the middle latitudes of the Northern Hemisphere. The depth of the peak beta radioactivity in each snow pit compared with observational precipitation records, suggests that the radioactive fallout reached the Tibetan Plateau and was deposited on glacier surfaces in late March 2011, or approximately 20 days after the nuclear accident. The radioactive fallout existed in the atmosphere over the Tibetan Plateau for about one month.	[Wang, Ninglian; Wu, Xiaobo; Li, Zhen; Li, Quanlian; Pu, Jianchen] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, State Key Lab Cryospher Sci, Lanzhou, Peoples R China; [Wang, Ninglian] CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing, Peoples R China; [Kehrwald, Natalie] Univ Venice, Dept Environm Sci Informat & Stat, I-30123 Venice, Italy; [Jiang, Xi] Nanjing Univ Informat Sci & Technol, Coll Atmospher Sci, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Universita Ca Foscari Venezia; Nanjing University of Information Science & Technology	Wang, NL (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, State Key Lab Cryospher Sci, Lanzhou, Peoples R China.	nlwang@lzb.ac.cn	Kehrwald, Natalie M/A-3848-2013	Kehrwald, Natalie M/0000-0002-9160-2239	Chinese Academy of Sciences [XDB03030204]; National Natural Science Foundation of China [41190084, 41150110475]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese Academy of Sciences (Grant No. XDB03030204) and the National Natural Science Foundation of China (Grant Nos. 41190084, 41150110475). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beresford NA, 2012, J ENVIRON RADIOACTIV, V114, P48, DOI 10.1016/j.jenvrad.2011.12.008; Beresford Nicholas A., 2011, Integrated Environmental Assessment and Management, V7, P371, DOI 10.1002/ieam.238; Biegalski SR, 2012, J ENVIRON RADIOACTIV, V114, P15, DOI 10.1016/j.jenvrad.2011.11.007; Bolsunovsky A, 2011, J ENVIRON RADIOACTIV, V102, P1062, DOI 10.1016/j.jenvrad.2011.06.007; Buesseler K, 2011, ENVIRON SCI TECHNOL, V45, P9931, DOI 10.1021/es202816c; Cosma C, 2012, J ENVIRON RADIOACTIV, V114, P94, DOI 10.1016/j.jenvrad.2011.11.020; Cuffey K. M., 2010, THE PHYSICS OF GLACI; DIBB JE, 1990, NATURE, V345, P25, DOI 10.1038/345025a0; Heikkila U, 2009, ATMOS CHEM PHYS, V9, P4145, DOI 10.5194/acp-9-4145-2009; Hou SG, 2007, CHINESE SCI BULL, V52, P428, DOI 10.1007/s11434-007-0041-3; Hsu SC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049986; Karlof L, 2000, J GEOPHYS RES-ATMOS, V105, P12471, DOI 10.1029/1999JD901119; Kritidis P, 2012, J ENVIRON RADIOACTIV, V114, P100, DOI 10.1016/j.jenvrad.2011.12.006; Mousseau TA, 2014, OECOLOGIA, V175, P429, DOI 10.1007/s00442-014-2908-8; Pittauerova D, 2011, J ENVIRON RADIOACTIV, V102, P877, DOI 10.1016/j.jenvrad.2011.06.003; POURCHET M, 1988, J GLACIOL, V34, P183, DOI 10.3189/S0022143000032214; Priyadarshi A, 2011, P NATL ACAD SCI USA, V108, P14422, DOI 10.1073/pnas.1109449108; Qiao FL, 2011, CHINESE SCI BULL, V56, P1890, DOI 10.1007/s11434-011-4513-0; Tian LD, 2008, SCI CHINA SER D, V51, P1121, DOI 10.1007/s11430-008-0089-1; Tian LD, 2007, CHINESE SCI BULL, V52, P1436, DOI 10.1007/s11434-007-0188-y; Tositti L, 2012, J ENVIRON RADIOACTIV, V114, P105, DOI 10.1016/j.jenvrad.2012.01.016; Wang H, 2012, CHINESE SCI BULL, V57, P3518, DOI 10.1007/s11434-012-5171-6; Wang N, 2003, GEOPHYS RES LETT, V30, DOI [10.1029/2003GL018188, DOI 10.1029/2003GL018188]; Wang NL, 2002, ANN GLACIOL-SER, V35, P273, DOI 10.3189/172756402781816825; Yao TD, 1996, J GEOPHYS RES-ATMOS, V101, P29531, DOI 10.1029/96JD02683; Yasumura S, 2011, SCIENCE, V333, P684, DOI 10.1126/science.333.6043.684; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; Zhang DQ, 2005, SCI CHINA SER D, V48, P266, DOI 10.1360/02yd0219	28	5	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116580	10.1371/journal.pone.0116580	http://dx.doi.org/10.1371/journal.pone.0116580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658094	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900052
J	Xia, WR; Fu, WL; Cai, X; Wang, M; Chen, HH; Xing, WW; Wang, YY; Zou, MJ; Xu, T; Xu, DG				Xia, Wenrong; Fu, Wenliang; Cai, Xin; Wang, Min; Chen, Huihua; Xing, Weiwei; Wang, Yuanyuan; Zou, Minji; Xu, Tao; Xu, Donggang			Angiogenin Promotes U87MG Cell Proliferation by Activating NF-kappa B Signaling Pathway and Downregulating Its Binding Partner FHL3	PLOS ONE			English	Article							VEIN ENDOTHELIAL-CELLS; CARCINOMA-CELLS; GROWTH-FACTOR; PROTEIN; EXPRESSION; IDENTIFICATION; GLIOBLASTOMA; SURVIVAL; RECEPTOR; KINASE	Angiogenin (Ang) is known to induce cell proliferation and inhibit apoptosis by cellular signaling pathways and its direct nuclear functions, but the mechanism of action for Ang in astrocytoma is not yet clear. Astrocytoma is the most frequent one among various neurogliomas, of which a subtype known as glioblastoma multiforme (GBM) is the most malignant brain glioma and seriously influences the life quality of the patients. The expression of Ang and Bcl-xL were detected in 28 cases of various grades of astrocytoma and 6 cases of normal human tissues by quantitative real-time PCR. The results showed that the expression of Ang and Bcl-xL positively correlated with the malignant grades. Cytological experiments indicated that Ang facilitated human glioblastoma U87MG cell proliferation and knock-down of endogenous Ang promoted cell apoptosis. Furthermore, Ang activated NF-kappa B pathway and entered the U87MG cell nuclei, and blocking NF-kappa B pathway or inhibiting Ang nuclear translocation partially suppressed Ang-induced cell proliferation. The results suggested that Ang participated in the regulation of evolution process of astrocytoma by interfering NF-kappa B pathway and its nucleus function. In addition, four and a half LIM domains 3 (FHL3), a novel Ang binding partner, was required for Ang-mediated HeLa cell proliferation in our previous study. We also found that knockdown of FHL3 enhanced I kappa B alpha phosphorylation and overexpression of Ang inhibited FHL3 expression in U87MG cells. Together our findings suggested that Ang could activate NF-kappa B pathway by regulating the expression of FHL3. In conclusion, the present study established a link between Ang and FHL3 proteins and identifies a new pathway for regulating astrocytoma progression.	[Xia, Wenrong; Fu, Wenliang; Cai, Xin; Wang, Min; Chen, Huihua; Xing, Weiwei; Wang, Yuanyuan; Zou, Minji; Xu, Tao; Xu, Donggang] Beijing Inst Basic Med Sci, Lab Genome Engn, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Xu, DG (corresponding author), Beijing Inst Basic Med Sci, Lab Genome Engn, Beijing, Peoples R China.	xudg@bmi.ac.cn	Chen, Huihua/D-9162-2019; Lv, Yuanjie/AER-0767-2022	Chen, Huihua/0000-0002-5045-6845; 	National Natural Science Foundation of China [81170255]; Major State Basic Research Development Program of China (973 Program) [2011CB503803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	This research was supported by grants from National Natural Science Foundation of China (No. 81170255) and the Major State Basic Research Development Program of China (973 Program) (No. 2011CB503803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Demuth T, 2007, MOL CANCER THER, V6, P1212, DOI 10.1158/1535-7163.MCT-06-0711; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Eberle K, 2000, ANTICANCER RES, V20, P1679; Fernandez-Santiago R, 2009, J NEUROL, V256, P1337, DOI 10.1007/s00415-009-5124-4; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Fisher PG, 2005, JAMA-J AM MED ASSOC, V293, P615, DOI 10.1001/jama.293.5.615; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Han W, 2013, J CLIN INVEST, V123, P2103, DOI 10.1172/JCI61820; Hu GF, 2000, J CELL BIOCHEM, V76, P452, DOI 10.1002/(SICI)1097-4644(20000301)76:3<452::AID-JCB12>3.0.CO;2-Z; Hu GF, 1998, P NATL ACAD SCI USA, V95, P9791, DOI 10.1073/pnas.95.17.9791; HU GF, 1994, P NATL ACAD SCI USA, V91, P12096, DOI 10.1073/pnas.91.25.12096; Hu GF, 1997, P NATL ACAD SCI USA, V94, P2204, DOI 10.1073/pnas.94.6.2204; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kobori M, 2004, CELL DEATH DIFFER, V11, P123, DOI 10.1038/sj.cdd.4401325; Kwak JH, 2011, EXPERT OPIN THER PAT, V21, P1897, DOI 10.1517/13543776.2011.638285; Li S, 2011, J CELL PHYSL, V227, P1639, DOI DOI 10.1002/JCP.22881; Li SP, 2013, MOL CANCER RES, V11, P1203, DOI 10.1158/1541-7786.MCR-13-0072; Li Shuping, 2010, Int J Biochem Mol Biol, V1, P26; Li SP, 2010, FEBS J, V277, P3575, DOI 10.1111/j.1742-4658.2010.07766.x; Liu SM, 2001, BIOCHEM BIOPH RES CO, V287, P305, DOI 10.1006/bbrc.2001.5568; Liu TJ, 2007, MOL CANCER THER, V6, P1357, DOI 10.1158/1535-7163.MCT-06-0476; Lopez-Gines C, 2008, NEUROPATHOLOGY, V28, P507, DOI 10.1111/j.1440-1789.2008.00911.x; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Nakamura M, 2006, NEPHROL DIAL TRANSPL, V21, P1489, DOI 10.1093/ndt/gfl041; Nogueira L, 2011, ONCOTARGET, V2, P646, DOI 10.18632/oncotarget.322; Purcell NH, 2004, MOL CELL BIOL, V24, P1081, DOI 10.1128/MCB.24.3.1081-1095.2004; Tello-Montoliu A, 2006, J THROMB HAEMOST, V4, P1864, DOI 10.1111/j.1538-7836.2006.01995.x; Xia WR, 2012, GENE, V504, P233, DOI 10.1016/j.gene.2012.05.019; Xu ZP, 2003, BIOCHEMISTRY-US, V42, P121, DOI 10.1021/bi020465x; Xu ZP, 2001, BIOCHEM BIOPH RES CO, V285, P909, DOI 10.1006/bbrc.2001.5255	30	19	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116983	10.1371/journal.pone.0116983	http://dx.doi.org/10.1371/journal.pone.0116983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659096	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900086
J	Zhao, X; Wang, Y; Shang, QH; Li, YY; Hao, HT; Zhang, YB; Guo, ZH; Yang, G; Xie, ZK; Wang, RY				Zhao, Xia; Wang, Yun; Shang, Qianhan; Li, Yuyao; Hao, Haiting; Zhang, Yubao; Guo, Zhihong; Yang, Guo; Xie, Zhongkui; Wang, Ruoyu			Collagen-Like Proteins (ClpA, ClpB, ClpC, and ClpD) Are Required for Biofilm Formation and Adhesion to Plant Roots by Bacillus amyloliquefaciens FZB42	PLOS ONE			English	Article							STREPTOCOCCUS-PYOGENES; FUNCTIONAL-CHARACTERIZATION; LEGIONELLA-PNEUMOPHILA; SURFACE HYDROPHOBICITY; SPORE SURFACE; GENE CLUSTERS; ANTHRACIS; SUBTILIS; EXOSPORIUM; BACTERIAL	The genes of collagen-like proteins (CLPs) have been identified in a broad range of bacteria, including some human pathogens. They are important for biofilm formation and bacterial adhesion to host cells in some human pathogenic bacteria, including several Bacillus spp. strains. Interestingly, some bacterial CLP-encoding genes (clps) have also been found in non-human pathogenic strains such as B. cereus and B. amyloliquefaciens, which are types of plant-growth promoting rhizobacteria (PGPR). In this study, we investigated a putative cluster of clps in B. amyloliquefaciens strain FZB42 and a collagen-related structuralmotif containing glycine-X-threonine repeats was found in the genes RBAM_007740, RBAM_007750, RBAM_007760, and RBAM_007770. Interestingly, biofilm formation was disrupted when these genes were inactivated separately. Scanning electronmicroscopy and hydrophobicity value detection were used to assess the bacterial cell shape morphology and cell surface architecture of clps mutant cells. The results showed that the CLPs appeared to have roles in bacterial autoaggregation, as well as adherence to the surface of abiotic materials and the roots of Arabidopsis thaliana. Thus, we suggest that the CLPs located in the outer layer of the bacterial cell (including the cell wall, outer membrane, flagella, or other associated structures) play important roles in biofilm formation and bacteria-plant interactions. This is the first study to analyze the function of a collagen-like motif-containing protein in a PGPR bacterium. Knocking out each clp gene produced distinctive morphological phenotypes, which demonstrated that each product may play specific roles in biofilm formation. Our in silico analysis suggested that these four tandemly ranked genes might not belong to an operon, but further studies are required at the molecular level to test this hypothesis. These results provide insights into the functions of clps during interactions between bacteria and plants.	[Zhao, Xia; Shang, Qianhan; Hao, Haiting; Zhang, Yubao; Guo, Zhihong; Yang, Guo; Xie, Zhongkui; Wang, Ruoyu] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Gaolan Stn Agr & Ecol Expt, Lanzhou, Peoples R China; [Zhao, Xia; Shang, Qianhan; Hao, Haiting; Zhang, Yubao; Guo, Zhihong; Yang, Guo; Xie, Zhongkui; Wang, Ruoyu] Key Lab Stress Physiol & Ecol Cold & Arid Reg Gan, Lanzhou, Peoples R China; [Wang, Yun] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Desert & Desertificat, Lanzhou, Peoples R China; [Li, Yuyao] Lanzhou Univ, Sch Life Sci, Key Lab Arid & Grassland Agroecol, Lanzhou 730000, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Lanzhou University	Wang, RY (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Gaolan Stn Agr & Ecol Expt, Lanzhou, Peoples R China.	wangruoyu@lzb.ac.cn	Hao, haiting/GRX-2777-2022	Wang, Ruoyu/0000-0002-0422-6408	Natural Science Foundation of China [31370447]; Chinese Academy of Sciences [27Y127L41002]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the Natural Science Foundation of China No. 31370447 and the Chinese Academy of Sciences under the "One Hundred Talents" program No.27Y127L41002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Nour M, 2013, APPLIED AND ENVIRONM; Abdel-Nour M, 2014, APPL ENVIRON MICROB, V80, P1441, DOI 10.1128/AEM.03254-13; Ahimou F, 2001, J MICROBIOL METH, V45, P119, DOI 10.1016/S0167-7012(01)00240-8; Becherelli M, 2012, MOL MICROBIOL, V83, P1035, DOI 10.1111/j.1365-2958.2012.07987.x; Boydston JA, 2006, J BACTERIOL, V188, P7440, DOI 10.1128/JB.00639-06; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Chagnot C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059386; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Chen XH, 2006, J BACTERIOL, V188, P4024, DOI 10.1128/JB.00052-06; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; Courtney HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004166; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DICKSON JS, 1989, APPL ENVIRON MICROB, V55, P832, DOI 10.1128/AEM.55.4.832-836.1989; Dietel K, 2013, PLANT PATHOLOGY J, V29, P59, DOI 10.5423/PPJ.OA.10.2012.0155; Dinkla K, 2003, MOL MICROBIOL, V47, P861, DOI 10.1046/j.1365-2958.2003.03352.x; ERICKSON PR, 1987, J IMMUNOL, V138, P3360; Espinosa-Urgel Manuel, 2002, Microbiology (Reading), V148, P341, DOI 10.1099/00221287-148-2-341; Fan B, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-307, DOI 10.1186/1471-2180-12-307]; Fan B, 2012, J MICROBIOL, V50, P38, DOI 10.1007/s12275-012-1439-4; Fan B, 2011, J BIOTECHNOL, V151, P303, DOI 10.1016/j.jbiotec.2010.12.022; Felek S, 2008, MICROBIOL-SGM, V154, P1802, DOI 10.1099/mic.0.2007/010918-0; Ghosh N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037872; Gusils C, 2002, CAN J MICROBIOL, V48, P34, DOI [10.1139/w01-122, 10.1139/W01-122]; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001; MacKichan JK, 2008, INFECT IMMUN, V76, P788, DOI 10.1128/IAI.01174-07; Makarewicz I, 2006, J BACTERIOL, V188, P6953, DOI 10.1128/JB.00681-06; Mallegol J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046462; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; O'Toole GA, 1999, GENETIC APPROACHES T; Oliver-Kozup HA, 2011, BMC MICROBIOL, V11, DOI [10.1186/1471-2180-11-269, DOI 10.1186/1471-2180-11-269]; Pan WH, 2006, ANAEROBE, V12, P148, DOI 10.1016/j.anaerobe.2006.03.001; Parsek MR, 2004, J BACTERIOL, V186, P4427, DOI 10.1128/JB.186.14.4427-4440.2004; Piao ZY, 2006, APPL ENVIRON MICROB, V72, P1613, DOI 10.1128/AEM.72.2.1613-1622.2006; Ramey BE, 2004, CURR OPIN MICROBIOL, V7, P602, DOI 10.1016/j.mib.2004.10.014; Rasmussen M, 2000, INFECT IMMUN, V68, P6370, DOI 10.1128/IAI.68.11.6370-6377.2000; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Recorbet G, 1997, LETT APPL MICROBIOL, V25, P375, DOI 10.1046/j.1472-765X.1997.00246.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Sheng GP, 2010, BIOTECHNOL ADV, V28, P882, DOI 10.1016/j.biotechadv.2010.08.001; Steichen CT, 2005, J BACTERIOL, V187, P5868, DOI 10.1128/JB.187.17.5868-5876.2005; Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x; Tayapad JB, 2013, CURR OPIN OPHTHALMOL, V24, P288, DOI 10.1097/ICU.0b013e32836229c5; Thompson BM, 2008, MOL MICROBIOL, V70, P421, DOI 10.1111/j.1365-2958.2008.06420.x; Thompson BM, 2007, J BACTERIOL, V189, P6704, DOI 10.1128/JB.00762-07; Tomich M, 2003, FEMS MICROBIOL LETT, V228, P287, DOI 10.1016/S0378-1097(03)00785-7; VERCELLOTTI GM, 1985, AM J PATHOL, V120, P13; Walker TS, 2004, PLANT PHYSIOL, V134, P320, DOI 10.1104/pp.103.027888; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Xue QO, 2011, CELL MICROBIOL, V13, P620, DOI 10.1111/j.1462-5822.2010.01558.x; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Yu Z, 2014, JOURNAL OF STRUCTURA, DOI [10.1016/j.jsb.2015.01.001, DOI 10.1016/J.JSB.2015.01.001]	58	22	25	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117414	10.1371/journal.pone.0117414	http://dx.doi.org/10.1371/journal.pone.0117414			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658640	gold, Green Submitted, Green Published			2022-12-27	WOS:000349444900145
J	Arias-Martorell, J; Potau, JM; Bello-Hellegouarch, G; Perez-Perez, A				Arias-Martorell, Julia; Maria Potau, Josep; Bello-Hellegouarch, Gaelle; Perez-Perez, Alejandro			Like Father, Like Son: Assessment of the Morphological Affinities of AL 288-1 (A. afarensis), Sts 7 (A. africanus) and Omo 119-73-2718 (Australopithecus sp.) through a Three-Dimensional Shape Analysis of the Shoulder Joint	PLOS ONE			English	Article							KNUCKLE-WALKING; POSTCRANIAL ROBUSTICITY; FUNCTIONAL-MORPHOLOGY; SKELETAL ALLOMETRY; MIDDLE MIOCENE; LOCOMOTION; MUSCLES; PROPORTIONS; EVOLUTION; HADAR	The postcranial evidence for the Australopithecus genus indicates that australopiths were able bipeds; however, the morphology of the forelimbs and particularly that of the shoulder girdle suggests that they were partially adapted to an arboreal lifestyle. The nature of such arboreal adaptations is still unclear, as are the kind of arboreal behaviors in which australopiths might have engaged. In this study we analyzed the shape of the shoulder joint (proximal humerus and glenoid cavity of the scapula) of three australopith specimens: A. L. 288-1 (A. afarensis), Sts 7 (A. africanus) and Omo 119-73-2718 (Australopithecus sp.) with three-dimensional geometric morphometrics. The morphology of the specimens was compared with that of a wide array of living anthropoid taxa and some additional fossil hominins (the Homo erectus specimen KNM-WT 15000 and the H. neanderthalensis specimen Tabun 1). Our results indicate that A. L. 288-1 shows mosaic traits resembling H. sapiens and Pongo, whereas the Sts 7 shoulder is most similar to the arboreal apes and does not present affinities with H. sapiens. Omo 119-73-2718 exhibits morphological affinities with the more arboreal and partially suspensory New World monkey Lagothrix. The shoulder of the australopith specimens thus shows a combination of primitive and derived traits (humeral globularity, enhancement of internal and external rotation of the joint), related to use of the arm in overhead positions. The genus Homo specimens show overall affinities with H. sapiens at the shoulder, indicating full correspondence of these hominin shoulders with the modern human morphotype.	[Arias-Martorell, Julia; Bello-Hellegouarch, Gaelle; Perez-Perez, Alejandro] Univ Barcelona, Dept Biol Anim, Barcelona, Spain; [Maria Potau, Josep] Univ Barcelona, Dept Obstet Ginecol Pediat Radiol & Anat, Barcelona, Spain	University of Barcelona; University of Barcelona	Perez-Perez, A (corresponding author), Univ Barcelona, Dept Biol Anim, Barcelona, Spain.	martinez.perez-perez@ub.edu	Ginés, Josep Maria Potau/L-1037-2016; Arias-Martorell, Julia/B-6764-2019; Pérez-Pérez, Alejandro/K-6715-2014; Bello-Hellegouarch, Gaëlle/F-8666-2015	Ginés, Josep Maria Potau/0000-0003-3387-8760; Arias-Martorell, Julia/0000-0001-8110-2946; Pérez-Pérez, Alejandro/0000-0002-1442-1397; 	Spanish Ministerio de Economia y Competitividad [CGL2011-22999, CGL2010-15340]; Generalitat de Catalunya (DURSI) [SGR 884]; Ajudes Predoctorals of the Universitat de Barcelona [APIF-UB 2009/10]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya (DURSI)(Generalitat de Catalunya); Ajudes Predoctorals of the Universitat de Barcelona	This research was funded by the Spanish Ministerio de Economia y Competitividad (CGL2011-22999, CGL2010-15340, both to APP; http://www.mineco.gob.es/portal/site/mineco/), the Generalitat de Catalunya (DURSI 2009 SGR 884 to APP; www.gencat.es/dursi), and the Ajudes Predoctorals of the Universitat de Barcelona (APIF-UB 2009/10 to JAM; http://www.ub.edu/beques/3rcicle/ub/apif/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Aiello L, 1990, AN INTRODUCTION TO E; Alba DM, 2003, J HUM EVOL, V44, P225, DOI 10.1016/S0047-2484(02)00207-5; Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; Almecija S, 2014, J HUM EVOL IN PRESS; [Anonymous], 1966, BOWD COLL M STUD GRO; Arias-Martorell J, 2014, AM J PRIMATOL, DOI [10.1002/ajp.22364, DOI 10.1002/AJP.22364]; Arias-Martorell J, 2014, AM J PHYS ANTHROPOL, V154, P459, DOI 10.1002/ajpa.22520; Arias-Martorell J, 2012, J ANAT, V221, P394, DOI 10.1111/j.1469-7580.2012.01560.x; ASHTON E. H., 1963, TRANS ZOOL SOC LONDON, V29, P553; Bello-Hellegouarch G, 2013, INT J PRIMATOL, V34, P315, DOI 10.1007/s10764-013-9660-5; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein F. L, 1991, MORPHOMETRIC TOOLS F; Broom R, 1950, STERKFONTEIN APE MEN; BROWN F, 1985, NATURE, V316, P788, DOI 10.1038/316788a0; Cant JGH, 2003, J HUM EVOL, V44, P685, DOI 10.1016/S0047-2484(03)00060-5; Chan LK, 2008, AM J PHYS ANTHROPOL, V136, P265, DOI 10.1002/ajpa.20800; Chan LK, 2007, FOLIA PRIMATOL, V78, P1, DOI 10.1159/000095682; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; Dainton M, 1999, J HUM EVOL, V36, P171, DOI 10.1006/jhev.1998.0265; Dean M. C., 2009, 1 HUMANS ORIGIN EARL, P101; Di Vincenzo F, 2012, J HUM EVOL, V62, P274, DOI 10.1016/j.jhevol.2011.11.010; Doran Diane M., 1994, P93; DORAN DM, 1993, AM J PHYS ANTHROPOL, V91, P83, DOI 10.1002/ajpa.1330910106; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; Duren DL, 2001, THESIS; Duren DL, 1995, AM J PHYS ANTHR S20, VS20, P86; Green DJ, 2008, J HUM EVOL, V54, P705, DOI 10.1016/j.jhevol.2007.10.007; Green DJ, 2007, J HUM EVOL, V52, P187, DOI 10.1016/j.jhevol.2006.09.001; Green DJ, 2012, SCIENCE, V338, P514, DOI 10.1126/science.1227123; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARRISON T, 1989, J HUM EVOL, V18, P3, DOI 10.1016/0047-2484(89)90022-5; Hollihn U., 1984, P85; Howell F.C., 1978, P154; Howell F. C., 1976, EARLIEST MAN ENV LAK, P522; HUNT KD, 1991, INT J PRIMATOL, V12, P95, DOI 10.1007/BF02547576; Inman VT, 1944, J BONE JOINT SURG, V26, P1; Jellema Lyman M., 1993, P294; Johanson D., 1976, AM J PHYS ANTHROPOL, V44, P188; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P403, DOI 10.1002/ajpa.1330570403; JUNGERS WL, 1983, J HUM EVOL, V12, P673, DOI 10.1016/S0047-2484(83)80007-4; JUNGERS WL, 1982, NATURE, V297, P676, DOI 10.1038/297676a0; Kagaya M, 2007, ANTHROPOL SCI, V115, P17, DOI 10.1537/ase.041209; Kapandji IA, 2007, THE PHYSIOLOGY OF TH, VI; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Kivell TL, 2009, P NATL ACAD SCI USA, V106, P14241, DOI 10.1073/pnas.0901280106; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Lague MR, 2014, J HUM EVOL, DOI [10.1016/j.jhevol.2014.10.017, DOI 10.1016/J.JHEVOL.2014.10.017]; LARSON SG, 1986, AM J ANAT, V176, P171, DOI 10.1002/aja.1001760207; LARSON SG, 1995, AM J PHYS ANTHROPOL, V98, P13, DOI 10.1002/ajpa.1330980103; Larson SG, 1996, J HUM EVOL, V31, P239, DOI 10.1006/jhev.1996.0059; LARSON SG, 1987, J ZOOL, V212, P629, DOI 10.1111/j.1469-7998.1987.tb05961.x; Larson Susan G., 1993, P45; Larson SG, 2007, EVOL ANTHROPOL, V16, P172, DOI 10.1002/evan.20149; Larson SG, 2007, AM J PHYS ANTHROPOL, V133, P819, DOI 10.1002/ajpa.20505; Larson Susan G., 2013, P247; Larson Susan G., 2007, P437, DOI 10.1007/978-0-387-33507-0_13; LATIMER B, 1987, AM J PHYS ANTHROPOL, V74, P155, DOI 10.1002/ajpa.1330740204; Latimer B., 1991, P169; Lovejoy CO, 2009, SCIENCE, V326, P100, DOI 10.1126/science.1175833; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175827; MacLatchy L, 2000, J HUM EVOL, V39, P159, DOI 10.1006/jhev.2000.0407; McCown TD, 1939, THE STONE AGE OF MOU, V2; McHenry H.M, 1979, YEARB PHYS ANTHROPOL, V22, P105; McHenry HM, 2008, J HUM EVOL, V55, P639, DOI 10.1016/j.jhevol.2008.03.012; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Nakatsukasa Masato, 1994, African Study Monographs Supplementary Issue, V21, P1; O'Higgins P, 2000, J ANAT, V197, P103, DOI 10.1046/j.1469-7580.2000.19710103.x; Ohman JC, 1997, AM J PHYS ANTHROPOL, V104, P117, DOI 10.1002/(SICI)1096-8644(199709)104:1<117::AID-AJPA8>3.0.CO;2-O; OXNARD CE, 1968, J MORPHOL, V126, P249, DOI 10.1002/jmor.1051260302; PICKFORD M, 1983, AM J PHYS ANTHROPOL, V60, P337, DOI 10.1002/ajpa.1330600306; Potau JM, 2009, INT J PRIMATOL, V30, P697, DOI 10.1007/s10764-009-9368-8; R Core Team, 2018, R LANG ENV STAT COMP; Richmond BG, 2000, NATURE, V404, P382, DOI 10.1038/35006045; Richmond BG, 2001, AM J PHYS ANTHROPOL, V116, P70, DOI DOI 10.1002/AJPA.10019; Roberts D., 1974, P171; Robinson JT, 1972, EARLY HOMININD POSTU; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rose M.D., 1991, P37; Rose M.D., 1983, P405; ROSE MD, 1989, J HUM EVOL, V18, P131, DOI 10.1016/0047-2484(89)90067-5; ROSE MD, 1986, J HUM EVOL, V15, P333, DOI 10.1016/S0047-2484(86)80016-1; Rose Michael D., 1993, P252; RUFF CB, 1993, AM J PHYS ANTHROPOL, V91, P21, DOI 10.1002/ajpa.1330910103; Scheuer L, 2004, THE JUVENILE SKELETO; Senut B, 2006, CR PALEVOL, V5, P89, DOI 10.1016/j.crpv.2005.11.003; SENUT B, 1980, COLLEGIUM ANTROPOL, V4, P87; Shapiro Liza, 1993, P121; STERN JT, 1981, AM J PHYS ANTHROPOL, V55, P153, DOI 10.1002/ajpa.1330550203; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Stern JT, 1975, YEARB PHYS ANTHROPOL, V19, P69; SUSMAN RL, 1984, FOLIA PRIMATOL, V43, P113, DOI 10.1159/000156176; Sylvester AD, 2006, J THEOR BIOL, V242, P581, DOI 10.1016/j.jtbi.2006.04.016; Tardieu C, 1996, FOLIA PRIMATOL, V66, P68, DOI 10.1159/000157186; TRINKAUS E, 1994, AM J PHYS ANTHROPOL, V93, P1, DOI 10.1002/ajpa.1330930102; Trinkaus E, 1983, THE SHANIDAR NEANDER; TUTTLE RH, 1978, AM J PHYS ANTHROPOL, V49, P57, DOI 10.1002/ajpa.1330490110; TUTTLE RH, 1978, AM J PHYS ANTHROPOL, V49, P47, DOI 10.1002/ajpa.1330490109; Voisin JL, 2006, ANAT REC, V288A, P44; VRBA ES, 1979, AM J PHYS ANTHROPOL, V51, P117, DOI 10.1002/ajpa.1330510114; Walker A, 1993, THE NARIOKOTOME HOMO; WARD C V, 1991, American Journal of Physical Anthropology, P180; Ward Carol V., 2013, P235; Ward CV, 2012, J HUM EVOL, V63, P1, DOI 10.1016/j.jhevol.2011.11.012; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Wiley D. F., 2006, LANDMARK EDITOR; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; [No title captured]	113	5	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0117408	10.1371/journal.pone.0117408	http://dx.doi.org/10.1371/journal.pone.0117408			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25651542	Green Published, gold, Green Submitted			2022-12-27	WOS:000349250700013
J	Chen, XH; Eksioglu, EA; Carter, JD; Fortenbery, N; Donatelli, SS; Zhou, JM; Liu, JH; Yang, LL; Gilvary, D; Djeu, J; Wei, S				Chen, Xianghong; Eksioglu, Erika A.; Carter, John D.; Fortenbery, Nicole; Donatelli, Sarah S.; Zhou, Junmin; Liu, Jinhong; Yang, Lili; Gilvary, Danielle; Djeu, Julie; Wei, Sheng			Inactivation of DAP12 in PMN Inhibits TREM1-Mediated Activation in Rheumatoid Arthritis	PLOS ONE			English	Article							MYELOID CELLS-1; OSTEOCLAST DIFFERENTIATION; DAP12-ASSOCIATED RECEPTOR; TREM-1 EXPRESSION; INNATE IMMUNITY; CUTTING EDGE; INFLAMMATION; NEUTROPHILS; INTERVENTION; MACROPHAGES	Rheumatoid arthritis (RA) is an autoimmune disease characterized by dysregulated and chronic systemic inflammatory responses that affect the synovium, bone, and cartilage causing damage to extra-articular tissue. Innate immunity is the first line of defense against invading pathogens and assists in the initiation of adaptive immune responses. Polymorphonuclear cells (PMNs), which include neutrophils, are the largest population of white blood cells in peripheral blood and functionally produce their inflammatory effect through phagocytosis, cytokine production and natural killer-like cytotoxic activity. TREM1 (triggering receptor expressed by myeloid cells) is an inflammatory receptor in PMNs that signals through the use of the intracellular activating adaptor DAP12 to induce downstream signaling. After TREM crosslinking, DAP12's tyrosines in its ITAM motif get phosphorylated inducing the recruitment of Syk tyrosine kinases and eventual activation of PI3 kinases and ERK signaling pathways. While both TREM1 and DAP12 have been shown to be important activators of RA pathogenesis, their activity in PMNs or the importance of DAP12 as a possible therapeutic target have not been shown. Here we corroborate, using primary RA specimens, that isolated PMNs have an increased proportion of both TREM1 and DAP12 compared to normal healthy control isolated PMNs both at the protein and gene expression levels. This increased expression is highly functional with increased activation of ERK and MAPKs, secretion of IL-8 and RANTES and cytotoxicity of target cells. Importantly, based on our hypothesis of an imbalance of activating and inhibitory signaling in the pathogenesis of RA we demonstrate that inhibition of the DAP12 signaling pathway inactivates these important inflammatory cells.	[Chen, Xianghong; Eksioglu, Erika A.; Fortenbery, Nicole; Donatelli, Sarah S.; Zhou, Junmin; Liu, Jinhong; Gilvary, Danielle; Djeu, Julie; Wei, Sheng] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Immunol, Tampa, FL 33682 USA; [Carter, John D.] Univ S Florida, Coll Med, Dept Internal Med, Div Rheumatol, Tampa, FL 33612 USA; [Yang, Lili; Wei, Sheng] Tianjin Med Univ, Canc Hosp, Dept Immunol, Tianjin, Peoples R China; [Yang, Lili; Wei, Sheng] Res Inst, Tianjin, Peoples R China	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Tianjin Medical University	Wei, S (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Dept Immunol, Tampa, FL 33682 USA.	sheng.wei@moffitt.org	Eksioglu, Erika/E-6315-2015	Eksioglu, Erika/0000-0003-4458-7192	NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA076292] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bajpai M, 2008, EXPERT OPIN INV DRUG, V17, P641, DOI [10.1517/13543784.17.5.641, 10.1517/13543784.17.5.641 ]; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Burmester GR, 2014, NAT REV RHEUMATOL, V10, P77, DOI 10.1038/nrrheum.2013.168; Chen DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086105; Chen XH, 2013, J CLIN INVEST, V123, P4595, DOI 10.1172/JCI67580; Chen XH, 2009, BLOOD, V113, P3226, DOI 10.1182/blood-2008-07-168245; Cheung R, 2011, J CLIN INVEST, V121, P4446, DOI 10.1172/JCI57682; Collins CE, 2009, ANN RHEUM DIS, V68, P1768, DOI 10.1136/ard.2008.089557; Cope AP, 2003, RHEUMATOLOGY, V42, P716, DOI 10.1093/rheumatology/keg262; Crotti TN, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4088; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; Derive Marc, 2010, Self Nonself, V1, P225, DOI 10.4161/self.1.3.12891; Feist E, 2013, RHEUMATOLOGY, V52, P1352, DOI 10.1093/rheumatology/kes417; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gibot S, 2006, J INFECT DIS, V194, P975, DOI 10.1086/506950; Gierut A, 2010, RHEUM DIS CLIN N AM, V36, P271, DOI 10.1016/j.rdc.2010.03.004; Goldring SR, 2000, CURR OPIN RHEUMATOL, V12, P195, DOI 10.1097/00002281-200005000-00006; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Humphrey MB, 2006, J BONE MINER RES, V21, P237, DOI 10.1359/JBMR.051016; Joyce-Shaikh B, 2010, J EXP MED, V207, P579, DOI 10.1084/jem.20090516; Kasama T, 2000, CLIN EXP IMMUNOL, V121, P533, DOI 10.1046/j.1365-2249.2000.01272.x; Kasama Tsuyoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P273, DOI 10.2174/1568010054022114; Kim TH, 2012, MED HYPOTHESES, V78, P270, DOI 10.1016/j.mehy.2011.10.042; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kuai J, 2009, RHEUMATOLOGY, V48, P1352, DOI 10.1093/rheumatology/kep235; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lindstrom TM, 2010, RHEUM DIS CLIN N AM, V36, P367, DOI 10.1016/j.rdc.2010.02.005; Molad Y, 2013, INNATE IMMUN-LONDON, V19, P623, DOI 10.1177/1753425913476970; Murakami Y, 2009, ARTHRITIS RHEUM-US, V60, P1615, DOI 10.1002/art.24554; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; O'Shea JJ, 2013, NEW ENGL J MED, V368, P161, DOI 10.1056/NEJMra1202117; Ornatowska M, 2007, AM J PHYSIOL-LUNG C, V293, pL1377, DOI 10.1152/ajplung.00140.2007; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; PEPPEL K, 1991, J EXP MED, V174, P1483, DOI 10.1084/jem.174.6.1483; Rankin James A, 2004, AACN Clin Issues, V15, P3, DOI 10.1097/00044067-200401000-00002; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Salliot C, 2011, ANN RHEUM DIS, V70, P266, DOI 10.1136/ard.2010.132134; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; Simard JF, 2011, RHEUMATOLOGY, V50, P204, DOI 10.1093/rheumatology/keq326; Tessarz AAS, 2008, IMMUNOL LETT, V116, P111, DOI 10.1016/j.imlet.2007.11.021; Tsao NW, 2012, BEST PRACT RES CL RH, V26, P659, DOI 10.1016/j.berh.2012.07.012; ULICH TR, 1986, AM J PATHOL, V124, P53; Walsh NC, 2005, IMMUNOL REV, V208, P228, DOI 10.1111/j.0105-2896.2005.00338.x; Wang DY, 2004, WORLD J GASTROENTERO, V10, P2744, DOI 10.3748/wjg.v10.i18.2744; Wiersinga WJ, 2007, J INFECT DIS, V196, P1707, DOI 10.1086/522141	53	63	75	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0115116	10.1371/journal.pone.0115116	http://dx.doi.org/10.1371/journal.pone.0115116			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642940	Green Published, gold, Green Submitted			2022-12-27	WOS:000348821200007
J	Cummings, MT; Joh, RI; Motamedi, M				Cummings, Michael T.; Joh, Richard I.; Motamedi, Mo			PRIMED: PRIMEr Database for Deleting and Tagging All Fission and Budding Yeast Genes Developed Using the Open-Source Genome Retrieval Script (GRS)	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; VERSATILE; RESOURCE; SEQUENCE; MODULES	The fission (Schizosaccharomyces pombe) and budding (Saccharomyces cerevisiae) yeasts have served as excellent models for many seminal discoveries in eukaryotic biology. In these organisms, genes are deleted or tagged easily by transforming cells with PCR-generated DNA inserts, flanked by short (50-100bp) regions of gene homology. These PCR reactions use especially designed long primers, which, in addition to the priming sites, carry homology for gene targeting. Primer design follows a fixed method but is tedious and time-consuming especially when done for a large number of genes. To automate this process, we developed the Python-based Genome Retrieval Script (GRS), an easily customizable open-source script for genome analysis. Using GRS, we created PRIMED, the complete PRIMEr D atabase for deleting and C-terminal tagging genes in the main S. pombe and five of the most commonly used S. cerevisiae strains. Because of the importance of noncoding RNAs (ncRNAs) in many biological processes, we also included the deletion primer set for these features in each genome. PRIMED are accurate and comprehensive and are provided as downloadable Excel files, removing the need for future primer design, especially for large-scale functional analyses. Furthermore, the open-source GRS can be used broadly to retrieve genome information from custom or other annotated genomes, thus providing a suitable platform for building other genomic tools by the yeast or other research communities.	[Motamedi, Mo] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Med, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University	Motamedi, M (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Charlestown, MA 02129 USA.	mmotamedi@hms.harvard.edu	Joh, Richard/AAJ-6753-2021	Joh, Richard/0000-0003-0583-8032	NCI Proton Beam [C06 CA059267]; V Scholar Award; NATIONAL CANCER INSTITUTE [C06CA059267] Funding Source: NIH RePORTER	NCI Proton Beam; V Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MTC is the 2014 Alvan T. and Viola D. Fuller American Cancer Society Junior Research Fellow. This work was supported by an NCI Proton Beam Grant (C06 CA059267) and a V Scholar Award (http://www.jimmyv.org/) to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Durbin R, 2008, SACCHAROMYCES GENOME; Engel SR, 2014, G3-GENES GENOM GENET, V4, P389, DOI 10.1534/g3.113.008995; Kaur R, 1997, NUCLEIC ACIDS RES, V25, P1080, DOI 10.1093/nar/25.5.1080; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Penkett CJ, 2006, YEAST, V23, P921, DOI 10.1002/yea.1422; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281, DOI DOI 10.1016/0076-6879(91)94022-5; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Yu R, 2014, MOL CELL, V53, P262, DOI 10.1016/j.molcel.2013.11.014	13	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116657	10.1371/journal.pone.0116657	http://dx.doi.org/10.1371/journal.pone.0116657			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643023	Green Published, Green Submitted, gold			2022-12-27	WOS:000348821200022
J	Cowart, DA; Pinheiro, M; Mouchel, O; Maguer, M; Grall, J; Mine, J; Arnaud-Haond, S				Cowart, Dominique A.; Pinheiro, Miguel; Mouchel, Olivier; Maguer, Marion; Grall, Jacques; Mine, Jacques; Arnaud-Haond, Sophie			Metabarcoding Is Powerful yet Still Blind: A Comparative Analysis of Morphological and Molecular Surveys of Seagrass Communities	PLOS ONE			English	Article							DNA; BIODIVERSITY; POPULATION; DIVERSITY; TAXONOMY; SEARCH; TOOL	In the context of the sixth wave of extinction, reliable surveys of biodiversity are increasingly needed to infer the cause and consequences of species and community declines, identify early warning indicators of tipping points, and provide reliable impact assessments before engaging in activities with potential environmental hazards. DNA metabarcoding has emerged as having potential to provide speedy assessment of community structure from environmental samples. Here we tested the reliability of metabarcoding by comparing morphological and molecular inventories of invertebrate communities associated with sea-grasses through estimates of alpha and beta diversity, as well as the identification of the most abundant taxa. Sediment samples were collected from six Zostera marina seagrass meadows across Brittany, France. Metabarcoding surveys were performed using both mitochondrial (Cytochrome Oxidase I) and nuclear (small subunit 18S ribosomal RNA) markers, and compared to morphological inventories compiled by a long-term benthic monitoring network. A sampling strategy was defined to enhance performance and accuracy of results by preventing the dominance of larger animals, boosting statistical support through replicates, and using two genes to compensate for taxonomic biases. Molecular barcodes proved powerful by revealing a remarkable level of diversity that vastly exceeded the morphological survey, while both surveys identified congruent differentiation of the meadows. However, despite the addition of individual barcodes of common species into taxonomic reference databases, the retrieval of only 36% of these species suggest that the remaining were either not present in the molecular samples or not detected by the molecular screening. This finding exemplifies the necessity of comprehensive and well-curated taxonomic reference libraries and multi-gene surveys. Overall, results offer methodological guidelines and support for metabarcoding as a powerful and repeatable method of characterizing communities, while also presenting suggestions for improvement, including implementation of pilotstudies prior to performing full "blind" metabarcoding assessments to optimize sampling and amplification protocols.	[Cowart, Dominique A.; Mouchel, Olivier; Arnaud-Haond, Sophie] IFREMER, Unite Environm Profond, Dept Ressources Phys & Ecosyst Fond Mer REM, F-29280 Plouzane, France; [Pinheiro, Miguel] Univ St Andrews, St Andrews KY16 9TF, Fife, Scotland; [Maguer, Marion; Grall, Jacques] Inst Univ Europeen Mer, F-29280 Plouzane, France; [Mine, Jacques] Direct HSE, F-92078 Paris, France	Ifremer; University of St Andrews; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Arnaud-Haond, S (corresponding author), IFREMER, Unite Environm Profond, Dept Ressources Phys & Ecosyst Fond Mer REM, BP 70, F-29280 Plouzane, France.	dominique.cowart@gmail.com; sophie.arnaud@ifremer.fr	Arnaud-Haond, Sophie/B-2479-2008; Pinheiro, Miguel/K-6572-2017	Arnaud-Haond, Sophie/0000-0001-5814-8452; Pinheiro, Miguel/0000-0002-6601-7513; Mouchel, Olivier/0000-0002-5991-3360; Cowart, Dominique/0000-0002-2581-0355; Grall, Jacques/0000-0002-3107-6740	Total Exploration Production [FR00003996]	Total Exploration Production(Total SA)	This research was funded by a grant from Total Exploration & Production (FR00003996) to SAH. The funding institution had no role in the data collections, analyses and interpretations of this study. However, the funding organization did have a role in conceiving and designing the study, as well as in the contributions to the final manuscript. Additionally, the funding organization in no way restricted the data and results presented in this manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baird DJ, 2012, MOL ECOL, V21, P2039, DOI 10.1111/j.1365-294X.2012.05519.x; Barber P, 2006, P ROY SOC B-BIOL SCI, V273, P2053, DOI 10.1098/rspb.2006.3540; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Becheler R, 2014, HEREDITY, V112, P114, DOI 10.1038/hdy.2013.82; Becheler R, 2010, MOL ECOL, V19, P2394, DOI 10.1111/j.1365-294X.2010.04649.x; Berney C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-13; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ficetola GF, 2014, MOL ECOLOGY RESOURCE, DOI [10.1111/1755-0998.12366, DOI 10.1111/1755-0998.12366]; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Jain S, 2001, P NATL ACAD SCI USA, V98, P543, DOI 10.1073/pnas.021545098; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Leray M, 2012, CORAL REEFS, V31, P383, DOI 10.1007/s00338-011-0845-0; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lindeque PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081327; Markmann M, 2005, PHILOS T R SOC B, V360, P1917, DOI 10.1098/rstb.2005.1723; MCINTYRE AD, 1969, BIOL REV, V44, P245, DOI 10.1111/j.1469-185X.1969.tb00828.x; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Pawlowski DR, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017585, 10.1371/journal.pone.0018169]; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Porazinska DL, 2010, MOL ECOL, V19, P5521, DOI 10.1111/j.1365-294X.2010.04891.x; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Puillandre N, 2012, MOL ECOLOGY RESOURCE, V12, DOI [10.1111/1755-0998.12018, DOI 10.1111/1755-0998.12018]; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Tang CQ, 2012, P NATL ACAD SCI USA, V109, P16208, DOI 10.1073/pnas.1209160109; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Travis J, 2014, P NATL ACAD SCI USA, V111, P581, DOI 10.1073/pnas.1305853111; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; UHLIG G, 1973, HELGOLAND WISS MEER, V25, P173, DOI 10.1007/BF01609968; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x	60	138	140	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117562	10.1371/journal.pone.0117562	http://dx.doi.org/10.1371/journal.pone.0117562			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668035	Green Published, gold			2022-12-27	WOS:000349493000019
J	Maggi, M; Chiarelli, LR; Valentini, G; Scotti, C				Maggi, Maristella; Chiarelli, Laurent R.; Valentini, Giovanna; Scotti, Claudia			Engineering of Helicobacter pylori L-Asparaginase: Characterization of Two Functionally Distinct Groups of Mutants	PLOS ONE			English	Article							CONJUGATED L-ASPARAGINASE; COLI L-ASPARAGINASE; CRYSTAL-STRUCTURE; GLUTAMINE DEPLETION; PHASE-I; SYNTHETASE; LEUKEMIA	Bacterial L-asparaginases have been used as anti-cancer drugs for over 4 decades though presenting, along with their therapeutic efficacy, several side effects due to their bacterial origin and, seemingly, to their secondary glutaminase activity. Helicobacter pylori type II L-asparaginase possesses interesting features, among which a reduced catalytic efficiency for L-GLN, compared to the drugs presently used in therapy. In the present study, we describe some enzyme variants with catalytic and in vitro cytotoxic activities different from the wild type enzyme. Particularly, replacements on catalytic threonines (T16D and T95E) deplete the enzyme of both its catalytic activities, once more underlining the essential role of such residues. One serendipitous mutant, M121C/T169M, had a preserved efficiency vs L-asparagine but was completely unable to carry out L-glutamine hydrolysis. Interestingly, this variant did not exert any cytotoxic effect on HL-60 cells. The M121C and T169M single mutants had reduced catalytic activities (nearly 2.5- to 4-fold vs wild type enzyme, respectively). Mutant Q63E, endowed with a similar catalytic efficiency versus asparagine and halved glutaminase efficiency with respect to the wild type enzyme, was able to exert a cytotoxic effect comparable to, or higher than, the one of the wild type enzyme when similar asparaginase units were used. These findings may be relevant to determine the role of glutaminase activity of L-asparaginase in the anti-proliferative effect of the drug and to shed light on how to engineer the best asparaginase/glutaminase combination for an ever improved, patients-tailored therapy.	[Maggi, Maristella; Scotti, Claudia] Univ Pavia, Dept Mol Med, Unit Immunol & Gen Pathol, I-27100 Pavia, Italy; [Chiarelli, Laurent R.] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, Mol Microbiol Lab, I-27100 Pavia, Italy; [Maggi, Maristella; Valentini, Giovanna] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, Lab Prot Biochem, I-27100 Pavia, Italy	University of Pavia; University of Pavia; University of Pavia	Scotti, C (corresponding author), Univ Pavia, Dept Mol Med, Unit Immunol & Gen Pathol, Via Palestro 3, I-27100 Pavia, Italy.	claudia.scotti@unipv.it	Scotti, Claudia/A-7126-2012; Chiarelli, Laurent Roberto/J-8368-2016; Scotti, Claudia/AAM-3372-2021; Maggi, Maristella/O-6759-2014; Maggi, Maristella/P-2896-2019	Scotti, Claudia/0000-0002-5790-1833; Chiarelli, Laurent Roberto/0000-0003-0348-9764; Maggi, Maristella/0000-0002-9075-8143; Maggi, Maristella/0000-0002-9075-8143	Regione Lombardia Ricerca	Regione Lombardia Ricerca	MM's salary comes from an Istituto Universitario di Studi Superiori fellowship. The salaries for LRC, GV and CS come from Ministero dell' Istruzione, Universitae e Ricerca. The funds of Regione Lombardia Ricerca. tissimi prize was used to buy the reagents needed for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal NR, 2003, CANCER, V98, P94, DOI 10.1002/cncr.11480; Aung HP, 2000, BBA-PROTEIN STRUCT M, V1481, P349, DOI 10.1016/S0167-4838(00)00179-5; Avramis VI, 2014, BLOOD, V123, P3532, DOI 10.1182/blood-2014-04-565523; Balcao VM, 2001, BIOTECHNOL PROGR, V17, P537, DOI 10.1021/bp000163r; Berlier W, 2013, BLOOD, V122; Bunpo P, 2008, J NUTR, V138, P338, DOI 10.1093/jn/138.2.338; Cantor JR, 2009, BIOCHEMISTRY-US, V48, P11026, DOI 10.1021/bi901397h; Cappelletti D, 2008, BIOCHEM BIOPH RES CO, V377, P1222, DOI 10.1016/j.bbrc.2008.10.118; Chan WK, 2014, BLOOD; Derst C, 2000, PROTEIN SCI, V9, P2009, DOI 10.1110/ps.9.10.2009; Dhavala P, 2009, ACTA CRYSTALLOGR D, V65, P1253, DOI 10.1107/S0907444909038244; Ehsanipour EA, 2013, CANCER RES, V73, P2998, DOI 10.1158/0008-5472.CAN-12-4402; HILL JM, 1967, J AMER MED ASSOC, V202, P882, DOI 10.1001/jama.202.9.882; KILLANDER D, 1976, CANCER, V37, P220, DOI 10.1002/1097-0142(197601)37:1<220::AID-CNCR2820370132>3.0.CO;2-W; Krejci O, 2004, LEUKEMIA, V18, P434, DOI 10.1038/sj.leu.2403259; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsumoto Y, 2003, LEUKEMIA LYMPHOMA, V44, P879, DOI 10.1080/1042819031000067873; Michalska K, 2006, ACTA BIOCHIM POL, V53, P627, DOI 10.18388/abp.2006_3291; Miller AJ, 1996, LYMPHOLOGY, V29, P158; Offman MN, 2011, BLOOD, V117, P1614, DOI 10.1182/blood-2010-07-298422; OLLENSCHLAGER G, 1988, EUR J CLIN INVEST, V18, P512, DOI 10.1111/j.1365-2362.1988.tb01049.x; Palm GJ, 1996, FEBS LETT, V390, P211, DOI 10.1016/0014-5793(96)00660-6; Parmentier J, 2014, GLUTAMINASE ACTIVITY; Reinert RB, 2006, J BIOL CHEM, V281, P31222, DOI 10.1074/jbc.M604511200; Rempe DA, 2010, NEUROTHERAPEUTICS, V7, P335, DOI 10.1016/j.nurt.2010.08.003; Sanches M, 2007, CURR CHEM BIOL, V1, P75, DOI DOI 10.2174/2212796810701010075; Scotti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013892; Stams WAG, 2003, BLOOD, V101, P2743, DOI 10.1182/blood-2002-08-2446; STORY MD, 1993, CANCER CHEMOTH PHARM, V32, P129, DOI 10.1007/BF00685615; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SWAIN AL, 1993, P NATL ACAD SCI USA, V90, P1474, DOI 10.1073/pnas.90.4.1474; Taylor CW, 2001, CANCER CHEMOTH PHARM, V47, P83, DOI 10.1007/s002800000207; Yun MK, 2007, J MOL BIOL, V369, P794, DOI 10.1016/j.jmb.2007.03.061	33	21	21	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117025	10.1371/journal.pone.0117025	http://dx.doi.org/10.1371/journal.pone.0117025			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664771	Green Published, Green Submitted, gold			2022-12-27	WOS:000349123100016
J	Oumeraci, T; Jensen, V; Talbot, SR; Hofmann, W; Kostrzewa, M; Schlegelberger, B; von Neuhoff, N; Haussler, S				Oumeraci, Tonio; Jensen, Vanessa; Talbot, Steven R.; Hofmann, Winfried; Kostrzewa, Markus; Schlegelberger, Brigitte; von Neuhoff, Nils; Haeussler, Susanne			Comprehensive MALDI-TOF Biotyping of the Non-Redundant Harvard Pseudomonas aeruginosa PA14 Transposon Insertion Mutant Library	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; ASSISTED-LASER-DESORPTION/IONIZATION; ROUTINE IDENTIFICATION; RAPID IDENTIFICATION; PEAK DETECTION; BACTERIA; CLASSIFICATION; OPTIMIZATION; STRAINS	Background Pseudomonas aeruginosa is a gram-negative bacterium that is ubiquitously present in the aerobic biosphere. As an antibiotic-resistant facultative pathogen, it is a major cause of hospital- acquired infections. Its rapid and accurate identification is crucial in clinical and therapeutic environments. Methods In a large-scale MALDI-TOF mass spectrometry-based screen of the Harvard transposon insertion mutant library of P. aeruginosa strain PA14, intact-cell proteome profile spectra of 5547 PA14 transposon mutants exhibiting a plethora of different phenotypes were acquired and analyzed. Results Of all P. aeruginosa PA14 mutant profiles 99.7% were correctly identified as P. aeruginosa with the Biotyper software on the species level. On the strain level, 99.99% of the profiles were mapped to five different individual P. aeruginosa Biotyper database entries. A principal component analysis-based approach was used to determine the most important discriminatory mass features between these Biotyper groups. Although technical replicas were consistently categorized to specific Biotyper groups in 94.2% of the mutant profiles, biological replicas were not, indicating that the distinct proteotypes are affected by growth conditions. Conclusions The PA14 mutant profile collection presented here constitutes the largest coherent P. aeruginosa MALDI-TOF spectral dataset publicly available today. Transposon insertions in thousands of different P. aeruginosa genes did not affect species identification from MALDI-TOF mass spectra, clearly demonstrating the robustness of the approach. However, the assignment of the individual spectra to sub-groups proved to be non-consistent in biological replicas, indicating that the differentiation between biotyper groups in this nosocomial pathogen is unassured.	[Oumeraci, Tonio; Hofmann, Winfried; Schlegelberger, Brigitte; von Neuhoff, Nils] Hannover Med Sch MHH, Inst Cell & Mol Pathol, Hannover, Germany; [Jensen, Vanessa; Haeussler, Susanne] Helmholtz Ctr Infect Res, Dept Mol Bacteriol, Braunschweig, Germany; [Jensen, Vanessa; Haeussler, Susanne] Twincore, Ctr Expt & Clin Infect Res, Inst Mol Bacteriol, Hannover, Germany; [Talbot, Steven R.] MHH, Inst Mol & Cell Physiol, Hannover, Germany; [Kostrzewa, Markus] Bruker Daltonik GmbH, Bremen, Germany	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Bruker Corporation; Bruker Daltonik GmbH	Haussler, S (corresponding author), Helmholtz Ctr Infect Res, Dept Mol Bacteriol, Braunschweig, Germany.	Susanne.haeussler@helmholtz-hzi.de	Häussler, Susanne/I-2605-2014; Pohl, Sarah/B-3102-2016	Häussler, Susanne/0000-0001-6141-9102; Pohl, Sarah/0000-0003-2655-7037				Alatoom AA, 2011, J CLIN MICROBIOL, V49, P2868, DOI 10.1128/JCM.00506-11; Anderson NW, 2012, J CLIN MICROBIOL, V50, P1008, DOI 10.1128/JCM.05209-11; Berrazeg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061428; Bessede E, 2011, CLIN MICROBIOL INFEC, V17, P533, DOI 10.1111/j.1469-0691.2010.03274.x; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; Coombes KR, 2005, PROTEOMICS, V5, P4107, DOI 10.1002/pmic.200401261; Cunningham SA, 2013, J CLIN MICROBIOL, V51, P1639, DOI 10.1128/JCM.00267-13; Davies AP, 2012, J CLIN MICROBIOL, V50, P4087, DOI 10.1128/JCM.02387-12; Deak E, 2015, DIAGN MICR INFEC DIS, V81, P27, DOI 10.1016/j.diagmicrobio.2014.09.018; Dossat N, 2007, CANCER INFORM, V3, P295; Ford BA, 2013, J CLIN MICROBIOL, V51, P1412, DOI 10.1128/JCM.01803-12; He Y, 2010, J CLIN MICROBIOL, V48, P3888, DOI 10.1128/JCM.01290-10; Holland RD, 1996, RAPID COMMUN MASS SP, V10, P1227, DOI 10.1002/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO;2-6; Khot PD, 2012, J CLIN MICROBIOL, V50, P3845, DOI 10.1128/JCM.00626-12; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Liu QZ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S3; Novais A, 2014, EUR J CLIN MICROBIOL, V33, P1391, DOI 10.1007/s10096-014-2071-5; Pommerenke C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001074; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Sogawa K, 2012, ANAL BIOANAL CHEM, V403, P1811, DOI 10.1007/s00216-011-5656-1; Sogawa K, 2011, ANAL BIOANAL CHEM, V400, P1905, DOI 10.1007/s00216-011-4877-7; Szabados F, 2010, J MED MICROBIOL, V59, P787, DOI 10.1099/jmm.0.016733-0; Tani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040784; TeKippe EM, 2013, J CLIN MICROBIOL, V51, P1421, DOI 10.1128/JCM.02680-12; Teramoto K, 2007, ANAL CHEM, V79, P8712, DOI 10.1021/ac701905r; Tong Dong L, 2011, Clin Proteomics, V8, P14, DOI 10.1186/1559-0275-8-14; Wang ZP, 2002, ANAL CHEM, V74, P3174, DOI 10.1021/ac015725f; WIETEN G, 1981, J GEN MICROBIOL, V122, P109; Wolters M, 2011, INT J MED MICROBIOL, V301, P64, DOI 10.1016/j.ijmm.2010.06.002; Yang C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-4	30	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117144	10.1371/journal.pone.0117144	http://dx.doi.org/10.1371/journal.pone.0117144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25665154	Green Published, Green Submitted, gold			2022-12-27	WOS:000349123100020
J	Czysz, K; Minger, S; Thomas, N				Czysz, Katherine; Minger, Stephen; Thomas, Nick			DMSO Efficiently Down Regulates Pluripotency Genes in Human Embryonic Stem Cells during Definitive Endoderm Derivation and Increases the Proficiency of Hepatic Differentiation	PLOS ONE			English	Article							HEPATOCYTE-LIKE CELLS; DIMETHYL-SULFOXIDE; LIVER DEVELOPMENT; IN-VITRO; RAT HEPATOCYTES; DRUG; GENERATION; THERAPIES; PROTOCOL	Background Definitive endoderm (DE) is one of the three germ layers which during in vivo vertebrate development gives rise to a variety of organs including liver, lungs, thyroid and pancreas; consequently efficient in vitro initiation of stem cell differentiation to DE cells is a prerequisite for successful cellular specification to subsequent DE-derived cell types [1, 2]. In this study we present a novel approach to rapidly and efficiently down regulate pluripotency genes during initiation of differentiation to DE cells by addition of dimethyl sulfoxide (DMSO) to Activin Abased culture medium and report its effects on the downstream differentiation to hepatocyte-like cells. Materials and Methods Human embryonic stem cells (hESC) were differentiated to DE using standard methods in medium supplemented with 100ng/ml of Activin A and compared to cultures where DE specification was additionally enhanced with different concentrations of DMSO. DE cells were subsequently primed to generate hepatic-like cells to investigate whether the addition of DMSO during formation of DE improved subsequent expression of hepatic markers. A combination of flow cytometry, real-time quantitative reverse PCR and immunofluorescence was applied throughout the differentiation process to monitor expression of pluripotency (POUF5/OCT4 & NANOG), definitive endoderm (SOX17, CXCR4 & GATA4) and hepatic (AFP & ALB) genes to generate differentiation stage-specific signatures. Results Addition of DMSO to the Activin A-based medium during DE specification resulted in rapid down regulation of the pluripotency genes OCT4 and NANOG, accompanied by an increase expression of the DE genes SOX17, CXCR4 and GATA4. Importantly, the expression level of ALB in DMSO-treated cells was also higher than in cells which were differentiated to the DE stage via standard Activin A treatment.	[Czysz, Katherine; Minger, Stephen; Thomas, Nick] GE Healthcare Life Sci, Maynard Ctr, Cardiff, S Glam, Wales	General Electric	Czysz, K (corresponding author), GE Healthcare Life Sci, Maynard Ctr, Cardiff, S Glam, Wales.	katherine.czysz@yahoo.co.uk			GE Healthcare; MRC ITTP PhD studentship	GE Healthcare(General ElectricGE Healthcare); MRC ITTP PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by GE Healthcare and a MRC ITTP PhD studentship to KC. All of the authors have an affiliation to the commercial funders of this research study (GE Healthcare). GE Healthcare provided support in the form of salaries for authors Nick Thomas and Stephen Minger, as well as covered laboratory bench fees for Katherine Czysz. MRC ITTP provided support in the form of salary for Katherine Czysz, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson SP, 2013, BRIT J PHARMACOL, V169, P269, DOI 10.1111/j.1476-5381.2012.01978.x; Bukong TN, 2012, LIVER INT, V32, P732, DOI 10.1111/j.1478-3231.2011.02743.x; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chen YF, 2012, HEPATOLOGY, V55, P1193, DOI 10.1002/hep.24790; Chetty S, 2013, NAT METHODS, V10, P553, DOI [10.1038/NMETH.2442, 10.1038/nmeth.2442]; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; DELAVEGA FM, 1991, BIOCHIMIE, V73, P621, DOI 10.1016/0300-9084(91)90033-W; Fletcher J, 2008, CLONING STEM CELLS, V10, P331, DOI 10.1089/clo.2007.0094; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hollebeeck S, 2011, TOXICOL LETT, V206, P268, DOI 10.1016/j.toxlet.2011.08.010; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Kung JWC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/984248; Lemaigre FP, 2009, GASTROENTEROLOGY, V137, P62, DOI 10.1053/j.gastro.2009.03.035; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Ochiya T, 2010, DIFFERENTIATION, V79, P65, DOI 10.1016/j.diff.2009.10.002; Pal R, 2012, ARCH TOXICOL, V86, P651, DOI 10.1007/s00204-011-0782-2; Rowntree RK, 2010, REGEN MED, V5, P557, DOI [10.2217/rme.10.36, 10.2217/RME.10.36]; Singh MK, 2013, REPROD DOMEST ANIM, V48, P284, DOI 10.1111/j.1439-0531.2012.02146.x; Su T, 2004, ARCH BIOCHEM BIOPHYS, V424, P226, DOI 10.1016/j.abb.2004.02.008; Synnergren J, 2010, STEM CELLS DEV, V19, P961, DOI 10.1089/scd.2009.0220; Tanimizu N, 2007, INT REV CYTOL, V259, P1, DOI 10.1016/S0074-7969(06)59001-1; Thaler R, 2012, EPIGENETICS-US, V7, P635, DOI 10.4161/epi.20163; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Yoshizawa T, 1997, J GASTROEN HEPATOL, V12, P325, DOI 10.1111/j.1440-1746.1997.tb00429.x; Yu Y, 2012, STEM CELL RES, V9, P196, DOI 10.1016/j.scr.2012.06.004; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zorn A.M., 2008, LIVER DEV	30	45	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117689	10.1371/journal.pone.0117689	http://dx.doi.org/10.1371/journal.pone.0117689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659159	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900204
J	David, AS; Zarnetske, PL; Hacker, SD; Ruggiero, P; Biel, RG; Seabloom, EW				David, Aaron S.; Zarnetske, Phoebe L.; Hacker, Sally D.; Ruggiero, Peter; Biel, Reuben G.; Seabloom, Eric W.			Invasive Congeners Differ in Successional Impacts across Space and Time	PLOS ONE			English	Article							AMMOPHILA-ARENARIA; VEGETATION DYNAMICS; RANGE SIZE; COASTAL; PLANTS; GRASSES; NICHE; COMMUNITIES; MECHANISMS; ALIEN	Invasive species can alter the succession of ecological communities because they are often adapted to the disturbed conditions that initiate succession. The extent to which this occurs may depend on how widely they are distributed across environmental gradients and how long they persist over the course of succession. We focus on plant communities of the USA Pacific Northwest coastal dunes, where disturbance is characterized by changes in sediment supply, and the plant community is dominated by two introduced grasses - the long-established Ammophila arenaria and the currently invading A. breviligulata. Previous studies showed that A. breviligulata has replaced A. arenaria and reduced community diversity. We hypothesize that this is largely due to A. breviligulata occupying a wider distribution across spatial environmental gradients and persisting in later-successional habitat than A. arenaria. We used multi-decadal chronosequences and a resurvey study spanning 2 decades to characterize distributions of both species across space and time, and investigated how these distributions were associated with changes in the plant community. The invading A. breviligulata persisted longer and occupied a wider spatial distribution across the dune, and this corresponded with a reduction in plant species richness and native cover. Furthermore, backdunes previously dominated by A. arenaria switched to being dominated by A. breviligulata, forest, or developed land over a 23-yr period. Ammophila breviligulata likely invades by displacing A. arenaria, and reduces plant diversity by maintaining its dominance into later successional backdunes. Our results suggest distinct roles in succession, with A. arenaria playing a more classically facilitative role and A. breviligulata a more inhibitory role. Differential abilities of closely-related invasive species to persist through time and occupy heterogeneous environments allows for distinct impacts on communities during succession.	[David, Aaron S.; Seabloom, Eric W.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Zarnetske, Phoebe L.; Hacker, Sally D.; Biel, Reuben G.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Zarnetske, Phoebe L.] Michigan State Univ, Dept Forestry, E Lansing, MI 48824 USA; [Ruggiero, Peter] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	University of Minnesota System; University of Minnesota Twin Cities; Oregon State University; Michigan State University; Oregon State University	David, AS (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	david250@umn.edu	Zarnetske, Phoebe/V-3974-2019; Zarnetske, Phoebe/C-5484-2012	Zarnetske, Phoebe/0000-0001-6257-6951; Zarnetske, Phoebe/0000-0001-6257-6951; Ruggiero, Peter/0000-0001-7425-9953; Seabloom, Eric/0000-0001-6780-9259	Oregon Sea Grant Program [NA060AR4170010]; United States Environmental Protection Agency (EPA/NCER) [R833836]; National Science Foundation Integrative Graduate Education and Research Traineeship (NSF-IGERT); Introduced Species and Genotypes program [DGE-0653827]; NSF Graduate Research Fellowship program (NSF) [00039202]; NSF-IGERT Ecosystem Informatics program (NSF) [0333257]	Oregon Sea Grant Program; United States Environmental Protection Agency (EPA/NCER)(United States Environmental Protection Agency); National Science Foundation Integrative Graduate Education and Research Traineeship (NSF-IGERT)(National Science Foundation (NSF)); Introduced Species and Genotypes program; NSF Graduate Research Fellowship program (NSF); NSF-IGERT Ecosystem Informatics program (NSF)(National Science Foundation (NSF))	Funding provided by Oregon Sea Grant Program (NA060AR4170010, http://seagrant.oregonstate.edu/) and United States Environmental Protection Agency (EPA/NCER R833836, http://www.epa.gov/) to SDH, EWS, and PR, by the National Science Foundation Integrative Graduate Education and Research Traineeship (NSF-IGERT, http://www. nsf.gov/crssprgm/igert/gradopps.jsp) Introduced Species and Genotypes program (DGE-0653827) and NSF Graduate Research Fellowship program (NSF 00039202, http://www.nsfgrfp.org/) to ASD, and by the NSF-IGERT Ecosystem Informatics program to PLZ (NSF 0333257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APLET GH, 1994, J ECOL, V82, P137, DOI 10.2307/2261393; Bates D., 2013, LME4 LINEAR MIXED EF; Batten KM, 2006, BIOL INVASIONS, V8, P217, DOI 10.1007/s10530-004-3856-8; Beckstead J, 2003, ECOLOGY, V84, P2824, DOI 10.1890/02-0517; Brunbjerg AK, 2014, BIOL CONSERV, V174, P101, DOI 10.1016/j.biocon.2014.04.002; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Cooper W. S., 1958, MEMOIR, V72; Cowles H.C., 1899, BOT GAZ, V27, P95, DOI [10.1086/327796, DOI 10.1086/327796]; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; de la Pena E, 2006, NEW PHYTOL, V169, P829, DOI 10.1111/j.1469-8137.2005.01602.x; Donnegan JA, 1999, ECOLOGY, V80, P1370, DOI 10.1890/0012-9658(1999)080[1370:RAMOSF]2.0.CO;2; Duran O, 2013, P NATL ACAD SCI USA, V110, P17217, DOI 10.1073/pnas.1307580110; Gilbert B, 2013, P NATL ACAD SCI USA, V110, P1744, DOI 10.1073/pnas.1212375110; Gram WK, 2004, PLANT ECOL, V172, P159, DOI 10.1023/B:VEGE.0000026332.57007.7b; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hacker SD, 2012, OIKOS, V121, P138, DOI 10.1111/j.1600-0706.2011.18887.x; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; HESP PA, 1989, P ROY SOC EDINB B, V96, P181, DOI 10.1017/S0269727000010927; Hilton M, 2005, J COASTAL RES, V21, P175, DOI 10.2112/01041.1; Keeley JE, 2005, ECOL APPL, V15, P2109, DOI 10.1890/04-1222; Kery M., 2010, INTRO WINBUGS ECOLOG, VFirst, DOI [10.1016/B978-0-12-378605-0.00054-5, DOI 10.1016/B978-0-12-378605-0.00054-5]; Lambdon PW, 2008, J BIOGEOGR, V35, P1095, DOI 10.1111/j.1365-2699.2008.01894.x; Lichter J, 1998, ECOL MONOGR, V68, P487, DOI 10.1890/0012-9615(1998)068[0487:PSAFDO]2.0.CO;2; Lortie CJ, 2007, J ECOL, V95, P468, DOI 10.1111/j.1365-2745.2007.01231.x; Lubke RA, 2004, ECOL STU AN, V171, P67; McConkey KR, 2012, BIOL CONSERV, V146, P1, DOI 10.1016/j.biocon.2011.09.018; Moles AT, 2012, J ECOL, V100, P116, DOI 10.1111/j.1365-2745.2011.01915.x; OLFF H, 1993, J ECOL, V81, P693, DOI 10.2307/2261667; Pacala SW, 1998, AM NAT, V152, P729, DOI 10.1086/286203; Pickett STA, 2009, APPL VEG SCI, V12, P9, DOI 10.1111/j.1654-109X.2009.01019.x; Prach K, 2011, TRENDS ECOL EVOL, V26, P119, DOI 10.1016/j.tree.2010.12.007; Psuty N.P., 1988, J COASTAL RES, V3, P1; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Ruesink JL, 2010, BIOL INVASIONS, V12, P1773, DOI 10.1007/s10530-009-9588-z; Ruggiero P., 2013, 20121007 US GEOL SUR, P62, DOI [10.3133/ofr20121007, DOI 10.3133/0FR20121007]; SCHWENDIMAN JL, 1977, INT J BIOMETEOROL, V21, P281, DOI 10.1007/BF01552882; Seabloom EW, 2013, GLOBAL CHANGE BIOL, V19, P824, DOI 10.1111/gcb.12078; SEABLOOM EW, 1994, J COASTAL RES, V10, P178; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140; Su Y.-S, 2011, R2JAGS PACKAGE RUNNI; TILMAN D, 1985, AM NAT, V125, P827, DOI 10.1086/284382; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; van der Putten WH, 2005, BIOL INVASIONS, V7, P733, DOI 10.1007/s10530-004-1196-3; Veeneklaas RM, 2013, APPL VEG SCI, V16, P205, DOI 10.1111/j.1654-109X.2012.01228.x; Vitousek PM, 2002, J BIOGEOGR, V29, P573, DOI 10.1046/j.1365-2699.2002.00707.x; Wiedemann AM, 2004, ECOL STU AN, V171, P53; Zarnetske PL, 2013, J ECOL, V101, P905, DOI 10.1111/1365-2745.12093; Zarnetske PL, 2012, ECOLOGY, V93, P1439, DOI 10.1890/11-1112.1; Zarnetske PL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00101.1	52	17	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117283	10.1371/journal.pone.0117283	http://dx.doi.org/10.1371/journal.pone.0117283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658824	Green Published, gold			2022-12-27	WOS:000349444900129
J	Wang, CZ; Wang, XY; Zhou, HM; Dong, GF; Guan, X; Wang, LF; Xu, XP; Wang, SM; Chen, P; Peng, RY; Hu, XJ				Wang, Changzhen; Wang, Xiaoyan; Zhou, Hongmei; Dong, Guofu; Guan, Xue; Wang, Lifeng; Xu, Xinping; Wang, Shuiming; Chen, Peng; Peng, Ruiyun; Hu, Xiangjun			Effects of Pulsed 2.856 GHz Microwave Exposure on BM-MSCs Isolated from C57BL/6 Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ELECTROMAGNETIC-FIELD; BRAIN-TUMORS; RADIATION; MOBILE; MHZ; DIFFERENTIATION; WAVES; ULTRASOUND; INDUCTION	The increasing use of microwave devices over recent years has meant the bioeffects of microwave exposure have been widely investigated and reported. However the exact biological fate of bone marrow MSCs (BM-MSCs) after microwave radiation remains unknown. In this study, the potential cytotoxicity on MSC proliferation, apoptosis, cell cycle, and in vitro differentiation were assayed following 2.856 GHz microwave exposure at a specific absorption rate (SAR) of 4 W/kg. Importantly, our findings indicated no significant changes in cell viability, cell division and apoptosis after microwave treatment. Furthermore, we detected no significant effects on the differentiation ability of these cells in vitro, with the exception of reduction in mRNA expression levels of osteopontin (OPN) and osteocalcin (OCN). These findings suggest that microwave treatment at a SAR of 4 W/kg has undefined adverse effects on BM-MSCs. However, the reduced-expression of proteins related to osteogenic differentiation suggests that microwave can the influence at the mRNA expression genetic level.	[Wang, Changzhen; Zhou, Hongmei; Dong, Guofu; Wang, Lifeng; Xu, Xinping; Wang, Shuiming; Chen, Peng; Peng, Ruiyun; Hu, Xiangjun] Beijing Inst Radiat Med, Beijing, Peoples R China; [Wang, Xiaoyan] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Guan, Xue] Peoples Liberat Army, Hosp 281, Qinhuangdao, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China	Wang, CZ (corresponding author), Beijing Inst Radiat Med, Beijing, Peoples R China.	wangcz2002@aliyun.com; fei21@sohu.com						Aksoy U, 2005, SAUDI MED J, V26, P1388; Baan R, 2011, LANCET ONCOL, V12, P624, DOI 10.1016/S1470-2045(11)70147-4; BELYAEV IY, 1993, ELECTRO MAGNETOBIOL, V12, P39, DOI 10.3109/15368379309012861; Belyaev IY, 2006, BIOELECTROMAGNETICS, V27, P295, DOI 10.1002/bem.20216; Cao Y, 2011, INT J RADIAT BIOL, V87, P720, DOI 10.3109/09553002.2010.550981; Cao Y, 2010, J TOXICOL ENV HEAL A, V73, P507, DOI 10.1080/15287390903523451; Cao Y, 2009, J TOXICOL ENV HEAL A, V72, P727, DOI 10.1080/15287390902841466; Carlberg M, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-60; Ceccarelli G, 2013, BIORESEARCH OPEN ACC, V2, P283, DOI 10.1089/biores.2013.0016; Celuch M, 2007, J MICROWAVE POWER EE, V41, P62; Cleary SF, 1996, FASEB J, V10, P913; Coureau G, 2014, OCCUP ENVIRON MED, V71, P514, DOI 10.1136/oemed-2013-101754; Cucurachi S, 2013, ENVIRON INT, V51, P116, DOI 10.1016/j.envint.2012.10.009; Das Madhurima, 2013, J Stem Cells, V8, P1; de Vocht F, 2013, OCCUP ENVIRON MED, V70, P349, DOI 10.1136/oemed-2012-100954; Diem E, 2005, MUTAT RES-GEN TOX EN, V583, P178, DOI 10.1016/j.mrgentox.2005.03.006; Esmekaya MA, 2010, INT J RADIAT BIOL, V86, P1106, DOI 10.3109/09553002.2010.502960; Esposito M, 2013, IN VIVO, V27, P495; Ghanbari M, 2013, INT J FERTIL STERIL, V7, P21; Hardell L, 2013, INT J ONCOL, V43, P1833, DOI 10.3892/ijo.2013.2111; Hardell L, 2013, INT J ONCOL, V43, P1036, DOI 10.3892/ijo.2013.2025; Hardell Lennart, 2013, Pathophysiology, V20, P85, DOI 10.1016/j.pathophys.2012.11.001; Hardell L, 2013, NEUROEPIDEMIOLOGY, V40, P101, DOI 10.1159/000341905; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2013, IARC Monogr Eval Carcinog Risks Hum, V102, P1; Kesari KK, 2013, INDIAN J EXP BIOL, V51, P187; Kesari KK, 2013, CELL BIOCHEM BIOPHYS, V65, P85, DOI 10.1007/s12013-012-9414-6; Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420; Kubinyi G, 1996, BIOELECTROMAGNETICS, V17, P497, DOI 10.1002/(SICI)1521-186X(1996)17:6<497::AID-BEM10>3.0.CO;2-I; Lin JC, 2003, IEEE MICROW MAG, V4, P22, DOI 10.1109/MMW.2003.1266063; Markova E, 2010, ENVIRON HEALTH PERSP, V118, P394, DOI 10.1289/ehp.0900781; Massari L, 2009, CLIN CASES MINER BON, V6, P149; McNamee JP, 2003, RADIAT RES, V159, P693, DOI 10.1667/0033-7587(2003)159[0693:NEFGEF]2.0.CO;2; Midura RJ, 2005, J ORTHOP RES, V23, P1035, DOI 10.1016/j.orthres.2005.03.015; Pakhomov AG, 1998, BIOELECTROMAGNETICS, V19, P393, DOI 10.1002/(SICI)1521-186X(1998)19:7<393::AID-BEM1>3.0.CO;2-X; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Szmigielski S, 2013, SCI TOTAL ENVIRON, V454, P393, DOI 10.1016/j.scitotenv.2013.03.034; Teven CM, 2012, J CRANIOFAC SURG, V23, P586, DOI 10.1097/SCS.0b013e31824cd6de; Tice RR, 2002, BIOELECTROMAGNETICS, V23, P113, DOI 10.1002/bem.104; Velizarov S, 1999, BIOELECTROCH BIOENER, V48, P177, DOI 10.1016/S0302-4598(98)00238-4; Vijayalaxmi, 2000, RADIAT RES, V153, P479, DOI 10.1667/0033-7587(2000)153[0479:PDDIHB]2.0.CO;2; Walker NA, 2007, J ATHL TRAINING, V42, P530; Wang C, 2013, FREE RADICAL RES, V47, P276, DOI 10.3109/10715762.2013.768342; Wang H, 2013, INT J RADIAT BIOL, V89, P1100, DOI 10.3109/09553002.2013.817701; Wang XY, 2008, BLOOD, V111, P2436, DOI 10.1182/blood-2007-07-099333; Wu GW, 2009, INT J MOL MED, V23, P461, DOI 10.3892/ijmm_00000152; Yang Yan-Mei, 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V21, P1563, DOI 10.7534/j.issn.1009-2137.2013.06.037	46	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117550	10.1371/journal.pone.0117550	http://dx.doi.org/10.1371/journal.pone.0117550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658708	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900173
J	Bann, D; Hire, D; Manini, T; Cooper, R; Botoseneanu, A; McDermott, MM; Pahor, M; Glynn, NW; Fielding, R; King, AC; Church, T; Ambrosius, WT; Gill, T				Bann, David; Hire, Don; Manini, Todd; Cooper, Rachel; Botoseneanu, Anda; McDermott, Mary M.; Pahor, Marco; Glynn, Nancy W.; Fielding, Roger; King, Abby C.; Church, Timothy; Ambrosius, Walter T.; Gill, Thomas		Life Study Grp	Light Intensity Physical Activity and Sedentary Behavior in Relation to Body Mass Index and Grip Strength in Older Adults: Cross-Sectional Findings from the Lifestyle Interventions and Independence for Elders (LIFE) Study	PLOS ONE			English	Article							MUSCLE STRENGTH; AEROBIC EXERCISE; WEIGHT-LOSS; OBESITY; HEALTH; AGE; ASSOCIATIONS; PERFORMANCE; DISABILITY; RESISTANCE	Background Identifying modifiable determinants of fat mass and muscle strength in older adults is important given their impact on physical functioning and health. Light intensity physical activity and sedentary behavior are potential determinants, but their relations to these outcomes are poorly understood. We evaluated associations of light intensity physical activity and sedentary time-assessed both objectively and by self-report-with body mass index (BMI) and grip strength in a large sample of older adults. Methods We used cross-sectional baseline data from 1130 participants of the Lifestyle Interventions and Independence for Elders (LIFE) study, a community-dwelling sample of relatively sedentary older adults (70-89 years) at heightened risk of mobility disability. Time spent sedentary and in light intensity activity were assessed using an accelerometer worn for 3-7 days (Actigraph GT3X) and by self-report. Associations between these exposures and measured BMI and grip strength were evaluated using linear regression. Results Greater time spent in light intensity activity and lower sedentary times were both associated with lower BMI. This was evident using objective measures of lower-light intensity, and both objective and self-reported measures of higher-light intensity activity. Time spent watching television was positively associated with BMI, while reading and computer use were not. Greater time spent in higher but not lower intensities of light activity (assessed objectively) was associated with greater grip strength in men but not women, while neither objectively assessed nor self-reported sedentary time was associated with grip strength. Conclusions In this cross-sectional study, greater time spent in light intensity activity and lower sedentary times were associated with lower BMI. These results are consistent with the hypothesis that replacing sedentary activities with light intensity activities could lead to lower BMI levels and obesity prevalence among the population of older adults. However, longitudinal and experimental studies are needed to strengthen causal inferences.	[Bann, David; Cooper, Rachel] UCL, MRC, Unit Lifelong Hlth & Ageing, London, England; [Hire, Don; Ambrosius, Walter T.] Wake Forest Sch Med, Div Publ Hlth Sci, Dept Biostat Sci, Winston Salem, NC USA; [Manini, Todd; Pahor, Marco] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA; [Botoseneanu, Anda] Univ Michigan, Dept Hlth Policy Studies, Ann Arbor, MI 48109 USA; [Botoseneanu, Anda] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Glynn, Nancy W.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Fielding, Roger] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Nutr Exercise Physiol & Sarcopenia Lab, Boston, MA 02111 USA; [King, Abby C.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Church, Timothy] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Gill, Thomas] Yale Univ, Sch Med, New Haven, CT USA	University of London; University College London; Wake Forest University; State University System of Florida; University of Florida; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tufts University; United States Department of Agriculture (USDA); Stanford University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Yale University	Bann, D (corresponding author), UCL, MRC, Unit Lifelong Hlth & Ageing, London, England.	david.bann@ucl.ac.uk	King, Abby/AAD-5257-2021; Gill, Thomas M./H-7043-2019; Cooper, Rachel/ABE-3768-2021; Buford, Thomas W/B-1111-2011	Gill, Thomas M./0000-0002-6450-0368; Cooper, Rachel/0000-0003-3370-5720; Buford, Thomas W/0000-0002-9541-4358; Bann, David/0000-0002-6454-626X; Botoseneanu, Anda/0000-0003-0628-5820; King, Abby/0000-0002-7949-8811; Handberg, Eileen/0000-0002-7805-9577; Glynn, Nancy/0000-0003-2265-0162; Kaplan, Robert/0000-0003-4837-5330; Marsiske, Michael/0000-0001-5973-2116	Medical Research Council (UK) [MC_UU_12019/1, MC_UU_12019/4]; MRC Centenary Early Career Award; National Institutes of Health/National Institute on Aging Cooperative Agreement [U01AG22376]; National Heart, Lung and Blood Institute [3U01AG022376-05A2S]; Intramural Research Program, National Institute on Aging, NIH; Claude D. Pepper Older Americans Independence Centers at the University of Florida [1 P30 AG028740]; Wake Forest University [1 P30 AG21332]; Tufts University [1P30AG031679]; University of Pittsburgh [P30 AG024827]; Yale University [P30AG021342]; NIH/NCRR CTSA at Stanford University [UL1 RR025744]; Boston Rehabilitation Outcomes Center [1R24HD065688-01A1]; Academic Leadership Award [K07AG3587]; U.S. Department of Agriculture [58-1950-0-014]; Economic and Social Research Council [ES/M001660/1] Funding Source: researchfish; Medical Research Council [MC_UU_12019/1, MC_UU_12019/4] Funding Source: researchfish; ESRC [ES/M001660/1] Funding Source: UKRI; MRC [MC_UU_12019/4, MC_UU_12019/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD065688] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142, UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG031679, P30AG028740, P30AG024827, P30AG021332, P30AG021342, U01AG022376] Funding Source: NIH RePORTER	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Centenary Early Career Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health/National Institute on Aging Cooperative Agreement; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program, National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Claude D. Pepper Older Americans Independence Centers at the University of Florida; Wake Forest University; Tufts University; University of Pittsburgh(University of Pittsburgh); Yale University; NIH/NCRR CTSA at Stanford University; Boston Rehabilitation Outcomes Center; Academic Leadership Award; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	DB and RC are supported by the Medical Research Council (UK) (grant codes MC_UU_12019/1and MC_UU_ 12019/4). DB received an MRC Centenary Early Career Award to facilitate this work. The Lifestyle Interventions and Independence for Elders Study is funded by a National Institutes of Health/National Institute on Aging Cooperative Agreement #U01AG22376 and a supplement from the National Heart, Lung and Blood Institute 3U01AG022376-05A2S, and sponsored in part by the Intramural Research Program, National Institute on Aging, NIH. The research is partially supported by the Claude D. Pepper Older Americans Independence Centers at the University of Florida (1P30 AG028740), Wake Forest University (1 P30 AG21332), Tufts University (1P30AG031679), University of Pittsburgh (P30 AG024827), and Yale University (P30AG021342) and the NIH/NCRR CTSA at Stanford University (UL1 RR025744), Tufts University is also supported by the Boston Rehabilitation Outcomes Center (1R24HD065688-01A1). LIFE investigators are also partially supported by the following: Dr. Thomas Gill (Yale University) is the recipient of an Academic Leadership Award (K07AG3587) from the National Institute on Aging. Dr. Roger Fielding (Tufts University) is partially supported by the U.S. Department of Agriculture, under agreement No. 58-1950-0-014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Bann D, 2014, AM J EPIDEMIOL, V179, P1197, DOI 10.1093/aje/kwu033; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bouchard DR, 2010, J GERONTOL A-BIOL, V65, P71, DOI 10.1093/gerona/glp159; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Cooper R, 2011, AM J PREV MED, V41, P376, DOI 10.1016/j.amepre.2011.06.035; Copeland JL, 2009, J AGING PHYS ACTIV, V17, P17, DOI 10.1123/japa.17.1.17; Crane JD, 2013, J GERONTOL A-BIOL, V68, P631, DOI 10.1093/gerona/gls237; den Ouden MEM, 2011, MATURITAS, V69, P208, DOI 10.1016/j.maturitas.2011.04.008; Dodds R, 2013, AGE AGEING, V42, P794, DOI 10.1093/ageing/aft124; Donnelly JE, 2013, OBESITY, V21, pE219, DOI 10.1002/oby.20145; Ekelund U, 2011, AM J CLIN NUTR, V93, P826, DOI 10.3945/ajcn.110.006593; Espana-Romero V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087085; Fielding RA, 2011, J GERONTOL A-BIOL, V66, P1226, DOI 10.1093/gerona/glr123; Finucane FM, 2010, DIABETOLOGIA, V53, P624, DOI 10.1007/s00125-009-1641-z; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Ford ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078; Goldman SE, 2008, SLEEP, V31, P733, DOI 10.1093/sleep/31.5.733; Hagobian TA, 2013, CURR OBES REP, V2, P86, DOI 10.1007/s13679-012-0035-6; Hamer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066222; Hardy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056483; Harris JL, 2009, ANNU REV PUBL HEALTH, V30, P211, DOI 10.1146/annurev.publhealth.031308.100304; Hekler EB, 2012, J PHYS ACT HEALTH, V9, P225, DOI 10.1123/jpah.9.2.225; HOYENGA KB, 1982, PHYSIOL BEHAV, V28, P545, DOI 10.1016/0031-9384(82)90153-6; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; Kim CJ, 2014, INT J NURS PRACT, V20, P212, DOI 10.1111/ijn.12139; KONOPKA AR, 2014, EXERCISE SPORT SCI R, V42, DOI DOI 10.1249/JES.0000000000000028; Kowalski K, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-148; Manini TM, 2009, AM J CLIN NUTR, V90, P1336, DOI 10.3945/ajcn.2009.27659; Marsh AP, 2013, J GERONTOL A-BIOL, V68, P1549, DOI 10.1093/gerona/glt064; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Miller DK, 2010, J AGING HEALTH, V22, P183, DOI 10.1177/0898264309355816; Newton RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063171; Park H, 2010, EUR J APPL PHYSIOL, V109, P953, DOI 10.1007/s00421-010-1424-8; Peterson MD, 2010, AGEING RES REV, V9, P226, DOI 10.1016/j.arr.2010.03.004; Pulsford RM, 2013, AM J PREV MED, V44, P132, DOI 10.1016/j.amepre.2012.10.009; Schaap LA, 2013, EPIDEMIOL REV, V35, P51, DOI 10.1093/epirev/mxs006; Scott D, 2011, SCAND J MED SCI SPOR, V21, pE168, DOI 10.1111/j.1600-0838.2010.01229.x; *SED BEH OB EXP WO, 2011, SED BEH OB REV CURR; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Stenholm S, 2012, J AM GERIATR SOC, V60, P77, DOI 10.1111/j.1532-5415.2011.03779.x; Stewart AL, 2001, MED SCI SPORT EXER, V33, P1126, DOI 10.1097/00005768-200107000-00010; Strath SJ, 2012, MED SCI SPORT EXER, V44, pS77, DOI 10.1249/MSS.0b013e3182399eb1; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tikkanen P, 2012, J GERONTOL A-BIOL, V67, P905, DOI 10.1093/gerona/gls005; van der Bij AK, 2002, AM J PREV MED, V22, P120, DOI 10.1016/S0749-3797(01)00413-5; Vincent HK, 2010, OBES REV, V11, P568, DOI 10.1111/j.1467-789X.2009.00703.x; Wells JCK, 2012, SOC SCI MED, V75, P482, DOI 10.1016/j.socscimed.2012.03.029; Yang M, 2014, J AM MED DIR ASSOC, V15, DOI 10.1016/j.jamda.2013.10.009; Yassine HN, 2009, J GERONTOL A-BIOL, V64, P90, DOI 10.1093/gerona/gln032	53	70	71	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116058	10.1371/journal.pone.0116058	http://dx.doi.org/10.1371/journal.pone.0116058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3QZ	25647685	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000348822600018
J	Nagata, Y; Yoshihisa, Y; Matsunaga, K; Rehman, MU; Kitaichi, N; Shimizu, T				Nagata, Yuka; Yoshihisa, Yoko; Matsunaga, Kenji; Rehman, Mati Ur; Kitaichi, Nobuyuki; Shimizu, Tadamichi			Role of Macrophage Migration Inhibitory Factor (MIF) in Pollen-Induced Allergic Conjunctivitis and Pollen Dermatitis in Mice	PLOS ONE			English	Article							JAPANESE CEDAR POLLEN; II INVARIANT CHAIN; ATOPIC-DERMATITIS; EPITHELIAL-CELLS; CYTOKINE; CD74; EXPRESSION; ASTHMA; ENDOTOXEMIA; ACTIVATION	Pollen is a clinically important airborne allergen and one of the major causes of allergic conjunctivitis. A subpopulation of patients with atopic dermatitis (AD) are also known to have exacerbated skin eruptions on the face, especially around the eyelids, after contact with pollen. This pollen-induced skin reaction is now known as pollen dermatitis. Macrophage migration inhibitory factor (MIF) is a pluripotent cytokine that plays an essential role in allergic inflammation. Recent findings suggest that MIF is involved in several allergic disorders, including AD. In this study, MIF knockout (KO), MIF transgenic (Tg) and WT littermate mice were immunized with ragweed (RW) pollen or Japanese cedar (JC) pollen and challenged via eye drops. We observed that the numbers of conjunctiva-and eyelid-infiltrating eosinophils were significantly increased in RW and JC pollen-sensitized MIF Tg compared with WT mice or MIF KO mice. The mRNA expression levels of eotaxin, interleukin (IL)-5 and IL-13 were increased in pollen-sensitized eyelid skin sites of MIF Tg mice. An in vitro analysis revealed that high eotaxin expression was induced in dermal fibroblasts by MIF combined with stimulation of IL-4 or IL-13. This eotaxin expression was inhibited by the treatment with CD74 siRNA in fibroblasts. These findings indicate that MIF can induce eosinophil accumulation in the conjunctiva and eyelid dermis exposed to pollen. Therefore, targeted inhibition of MIF might result as a new option to control pollen-induced allergic conjunctivitis and pollen dermatitis.	[Nagata, Yuka; Yoshihisa, Yoko; Matsunaga, Kenji; Rehman, Mati Ur; Shimizu, Tadamichi] Toyama Univ, Dept Dermatol, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Kitaichi, Nobuyuki] Hlth Sci Univ Hokkaido, Dept Ophthalmol, Sapporo, Hokkaido, Japan	University of Toyama; Health Sciences University of Hokkaido	Shimizu, T (corresponding author), Toyama Univ, Dept Dermatol, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan.	shimizut@med.u-toyama.ac.jp	Rehman, Mati Ur/AAE-6885-2019	Shimizu, Tadamichi/0000-0002-3231-0279				ADINOFF AD, 1988, J ALLERGY CLIN IMMUN, V81, P736, DOI 10.1016/0091-6749(88)91047-0; Akagi Y, 1997, KIDNEY INT, V51, P1265, DOI 10.1038/ki.1997.172; Barrera CA, 2005, J HISTOCHEM CYTOCHEM, V53, P1481, DOI 10.1369/jhc.4A6552.2005; Benedek G, 2013, EUR J IMMUNOL, V43, P1309, DOI 10.1002/eji.201243162; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bernhagen J, 1998, J MOL MED-JMM, V76, P151, DOI 10.1007/s001090050204; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bucala R, 1996, FASEB J, V7, P19; Calheiros AS, 2011, AM J RESP CELL MOL B, V44, P509, DOI [10.1165/rcmb.2010-0004OC, DOI 10.1165/RCMB.2010-00040C]; Das R, 2011, J CLIN IMMUNOL, V31, P666, DOI 10.1007/s10875-011-9541-7; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Grize L, 2006, ALLERGY, V61, P556, DOI 10.1111/j.1398-9995.2006.01030.x; Honma N, 2000, IMMUNOLOGY, V100, P84, DOI 10.1046/j.1365-2567.2000.00011.x; Kitaichi N, 2006, GRAEF ARCH CLIN EXP, V244, P825, DOI 10.1007/s00417-005-0168-3; Kondo H, 1998, EUR J IMMUNOL, V28, P769, DOI 10.1002/(SICI)1521-4141(199803)28:03<769::AID-IMMU769>3.0.CO;2-H; Kusunoki Takashi, 2002, Arerugi, V51, P15; Leung DYM, 2004, ANN ALLERG ASTHMA IM, V93, pS1, DOI 10.1016/S1081-1206(10)61385-3; Lue HQ, 2011, CELL SIGNAL, V23, P135, DOI 10.1016/j.cellsig.2010.08.013; Magalhaes ES, 2009, FASEB J, V23, P1262, DOI 10.1096/fj.08-124248; Murakami Yukako, 2011, Allergology International, V60, P397, DOI 10.2332/allergolint.10-CR-0268; Oiwa M, 2008, CLIN EXP ALLERGY, V38, P1357, DOI 10.1111/j.1365-2222.2008.03007.x; Ong GL, 1999, IMMUNOLOGY, V98, P296; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Sasaki S, 2004, KIDNEY INT, V65, P469, DOI 10.1111/j.1523-1755.2004.00394.x; Schopf L, 2005, INVEST OPHTH VIS SCI, V46, P2772, DOI 10.1167/iovs.04-0899; Schwartz V, 2012, EUR J CELL BIOL, V91, P435, DOI 10.1016/j.ejcb.2011.08.006; Shimizu T, 2005, J DERMATOL SCI, V37, P65, DOI 10.1016/j.jdermsci.2004.08.007; Shimizu T, 1999, J ALLERGY CLIN IMMUN, V104, P659, DOI 10.1016/S0091-6749(99)70339-8; Shimizu T, 2004, CLIN EXP ALLERGY, V34, P103, DOI 10.1111/j.1365-2222.2004.01836.x; Shimizu T, 1997, BIOCHEM BIOPH RES CO, V240, P173, DOI 10.1006/bbrc.1997.7633; Tanihara S, 1999, J Epidemiol, V9, P20; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; WEISER WY, 1989, P NATL ACAD SCI USA, V86, P7522, DOI 10.1073/pnas.86.19.7522; WRAIGHT CJ, 1990, J BIOL CHEM, V265, P5787; Xie LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016428; Yokozeki H, 2006, ACTA DERM-VENEREOL, V86, P148, DOI 10.2340/00015555-0020; Yokozeki H, 2007, CONTACT DERMATITIS, V56, P224, DOI 10.1111/j.1600-0536.2004.00491.x; Yoshihisa Y, 2011, J INVEST DERMATOL, V131, P925, DOI 10.1038/jid.2010.418	38	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0115593	10.1371/journal.pone.0115593	http://dx.doi.org/10.1371/journal.pone.0115593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647395	gold, Green Published, Green Submitted			2022-12-27	WOS:000348822600015
J	Shi, JL; Fu, L; Li, YH; Yu, L; Wang, WD				Shi Jinlong; Fu Lin; Li Yonghui; Yu Li; Wang Weidong			Identification of let-7a-2-3p or/and miR-188-5p as Prognostic Biomarkers in Cytogenetically Normal Acute Myeloid Leukemia	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; TUMOR-SUPPRESSOR; CEBPA MUTATIONS; OLDER PATIENTS; CELL-CYCLE; CANCER; GENE; PROLIFERATION; TRANSCRIPTION; PATHWAY	Cytogenetically normal acute myeloid leukemia (CN-AML) is the largest and most heterogeneous AML subgroup. It lacks sensitive and specific biomarkers. Emerging evidences have suggested that microRNAs are involved in the pathogenesis of various leukemias. This paper evaluated the association between microRNA expression and prognostic outcome for CN-AML, based on the RNA/microRNA sequencing data of CN-AML patients. High let-7a-2-3p expression and low miR-188-5p expression were identified to be significantly associated with longer overall survival (OS) and event free survival (EFS) for CN-AML, independently or in a combined way. Their prognostic values were further confirmed in European Leukemia Net (ELN) genetic categories. Also, in multivariable analysis with other known risk factors, high let-7a-2-3p and low miR-188-5p expression remained to be associated with longer OS and EFS. In addition, the prognostic value of these two microRNAs was confirmed in patients who received hematopoietic stem cell transplantation (HSCT). To gain more biological insights of the underlying mechanisms, we derived the genome-wide differential gene/microRNA signatures associated with the expression of let-7a-2-3p and miR-188-5p. Several common microRNA signatures indicating favorable outcome in previous studies were up-regulated in both high let-7a-2-3p expressers and low miR-188-5p expressers, including miR-135a, miR-335 and miR-125b and all members of miR-181 family. Additionally, common up-regulated genes included FOSB, IGJ, SNORD50A and ZNF502, and FOSB was a known favorable signature in AML. These common signatures further confirmed the underlying common mechanisms for these two microRNAs value as favorable prognostic biomarkers. We concluded that high let-7a-2-3p and low miR-188-5p expression could be potentially used as favorably prognostic biomarkers independently or in a combined way in CN-AML patients, whether they received HSCT or not.	[Shi Jinlong] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Med Engn Div, Sanya, Hainan, Peoples R China; [Shi Jinlong; Wang Weidong] Chinese Peoples Liberat Army Gen Hosp, Med Engn Support Ctr, Beijing 100853, Peoples R China; [Fu Lin] Peking Univ, Hosp 3, Dept Hematol, Beijing, Peoples R China; [Fu Lin] Peking Univ, Hosp 3, Lymphoma Res Ctr, Beijing, Peoples R China; [Li Yonghui; Yu Li] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Peking University; Peking University; Chinese People's Liberation Army General Hospital	Yu, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing 100853, Peoples R China.	chunhuiliyu@yahoo.com; wangwd301@126.com		Yu, Li/0000-0001-6872-2665	National Natural Science Foundation of China [61372047]; National High-tech R&D Program of China [2013BAI03B04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China(National High Technology Research and Development Program of China)	The work was supported by grants from the National Natural Science Foundation of China (61372047) and the National High-tech R&D Program of China (2013BAI03B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemdehy MF, 2012, CURR OPIN HEMATOL, V19, P261, DOI 10.1097/MOH.0b013e328353d4e9; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker H, 2010, BLOOD, V116, P788, DOI 10.1182/blood-2010-01-262543; Burnett  AK, 2002, BRIT J HAEMATOL, V118, P357, DOI 10.1046/j.1365-2141.2002.03698.x; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Emmrich S, 2014, LEUKEMIA, V28, P1022, DOI 10.1038/leu.2013.357; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Frohling S, 2004, J CLIN ONCOL, V22, P624, DOI 10.1200/JCO.2004.06.060; GAO L, 2014, TUMOUR BIOL, P28669; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Khanim FL, 2009, BRIT J HAEMATOL, V144, P332, DOI 10.1111/j.1365-2141.2008.07449.x; Kiyoi H, 1999, BLOOD, V93, P3074; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Lee HJ, 2013, CLIN CANCER RES, V19, P327, DOI 10.1158/1078-0432.CCR-12-2087; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; McLaughlin SK, 2013, CANCER CELL, V24, P365, DOI 10.1016/j.ccr.2013.08.004; Metzeler KH, 2012, BLOOD, V120, P2118, DOI 10.1182/blood-2012-02-411827; Mian YA, 2010, CURR DRUG TARGETS, V11, P801; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Navarro A, 2009, BLOOD, V114, P2945, DOI 10.1182/blood-2009-02-204842; Preudhomme C, 2002, BLOOD, V100, P2717, DOI 10.1182/blood-2002-03-0990; Qiu TZ, 2014, FEBS LETT, V588, P1168, DOI 10.1016/j.febslet.2014.02.054; Schotte D, 2012, LEUKEMIA, V26, P1, DOI 10.1038/leu.2011.151; Schwind S, 2010, BLOOD, V116, P5660, DOI 10.1182/blood-2010-06-290536; Schwind S, 2010, J CLIN ONCOL, V28, P5257, DOI 10.1200/JCO.2010.29.2953; Sirotkin AV, 2010, J CELL PHYSIOL, V223, P49, DOI 10.1002/jcp.21999; Song SJ, 2013, CELL STEM CELL, V13, P87, DOI 10.1016/j.stem.2013.06.003; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tang WW, 2014, CELL SIGNAL, V26, P1420, DOI 10.1016/j.cellsig.2014.03.002; Ufkin ML, 2014, LEUKEMIA RES, V38, P402, DOI 10.1016/j.leukres.2013.12.021; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van der Weyden L, 2013, ONCOGENE, V32, P397, DOI 10.1038/onc.2012.56; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zheng YS, 2012, ONCOGENE, V31, P80, DOI 10.1038/onc.2011.208	42	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0118099	10.1371/journal.pone.0118099	http://dx.doi.org/10.1371/journal.pone.0118099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646775	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600099
J	Silva-Angulo, AB; Zanini, SF; Rosenthal, A; Rodrigo, D; Klein, G; Martinez, A				Silva-Angulo, Angela B.; Zanini, Surama F.; Rosenthal, Amauri; Rodrigo, Dolores; Klein, Guenter; Martinez, Antonio			Comparative Study of the Effects of Citral on the Growth and Injury of Listeria innocua and Listeria monocytogenes Cells	PLOS ONE			English	Article							ESCHERICHIA-COLI; LAG PHASE; ANTIMICROBIAL ACTIVITY; ESSENTIAL OILS; INOCULUM SIZE; FOOD; TIME; INACTIVATION; INHIBITION; COMPONENTS	This study investigates the effect of citral on growth and on the occurrence of sublethal damage in Listeria innocua Serovar 6a (CECT 910) and Listeria monocytogenes Serovar 4b (CECT 4032) cells that were exposed to citral as a natural antimicrobial agent. Two initial inoculum concentrations were considered in this investigation: 10(2) and 10(6) cfu/mL. Citral exhibited antilisterial activity against L. innocua and L. monocytogenes, and the observed effects were dependent on the concentration of citral present in the culture medium (0, 0.150 and 0.250 mu L/mL) (p <= 0.05). L. innocua had a shorter lag phase than L. monocytogenes, and the two species had nearly identical maximum specific growth rates. These results indicate that L. innocua could be used as surrogate for L. monocytogenes when testing the effects of this antimicrobial. Significant differences in the lag phase and growth rate were observed between the small and large inoculum concentration (p <= 0.05). Citral-treated L. innocua and L. monocytogenes that were recovered on selective medium (i.e., TSA-YE-SC) had a shorter lag phase and a higher maximum specific growth rate than cells that were recovered on non-selective medium (i.e., TSA-YE) (p <= 0.05). This result suggests that damage occurs at sublethal concentrations of citral.	[Silva-Angulo, Angela B.] Biopolis SL, Dept Biotecnol Agrolimentaria, Paterna 46980, Spain; [Zanini, Surama F.] Univ Fed Espirito Santo, Dept Vet Med, Alegre, Brazil; [Rosenthal, Amauri] Embrapa Food Technol, BR-23020470 Rio De Janeiro, RJ, Brazil; [Rodrigo, Dolores; Martinez, Antonio] CSIC, IATA, Dept Preservat & Food Qual, Valencia, Spain; [Klein, Guenter] Univ Vet Med, Inst Food Qual & Food Safety, Hannover, Germany	Universidade Federal do Espirito Santo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Veterinary Medicine Hannover, Foundation	Klein, G (corresponding author), Univ Vet Med, Inst Food Qual & Food Safety, Hannover, Germany.	guenter.klein@tiho-hannover.de	Rodrigo, Dolores/H-6083-2012; Klein, Günter/G-5321-2013; Martinez, Antonio/H-4094-2012	Rodrigo, Dolores/0000-0001-9854-111X; Klein, Günter/0000-0003-1931-2701; Martinez, Antonio/0000-0002-2323-8463	CNPq Postdoctoral Fellowship Programme, Embrapa Labex Europa [AGL 2010-22206-Co2-01]; FEDER programme; CNPq Postdoctoral Fellowship Programme, Embrapa Labex Europa	CNPq Postdoctoral Fellowship Programme, Embrapa Labex Europa; FEDER programme(European Commission); CNPq Postdoctoral Fellowship Programme, Embrapa Labex Europa	This work was supported by the CNPq Postdoctoral Fellowship Programme, Embrapa Labex Europa, which provided SZ with a grant to perform this investigation, Project AGL 2010-22206-Co2-01 and the FEDER programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. S. Zanini was supported by a grant from the CNPq Postdoctoral Fellowship Programme, Embrapa Labex Europa. However SZ was independent in her role as co-author to contribute to the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo C, 2010, LETT APPL MICROBIOL, V51, P525, DOI 10.1111/j.1472-765X.2010.02931.x; Augustin JC, 2000, INT J FOOD MICROBIOL, V56, P29, DOI 10.1016/S0168-1605(00)00223-3; Augustin JC, 2000, APPL ENVIRON MICROB, V66, P1706, DOI 10.1128/AEM.66.4.1706-1710.2000; Baranyi J, 1998, J THEOR BIOL, V192, P403, DOI 10.1006/jtbi.1998.0673; Belda-Galbis C. M., 2011, P 6 C NAC CIENC TECN; Belda-Galbis C. M., 2011, 1 CIGR INT WORKSH FO; Benvenuti F, 2001, J SUPERCRIT FLUID, V20, P29, DOI 10.1016/S0896-8446(01)00058-4; Berends BR, 1997, INT J FOOD MICROBIOL, V36, P199, DOI 10.1016/S0168-1605(97)01267-1; Bloomfield S.F., 1991, TECHNICAL SERIES SOC; Buncic S, 1996, LETT APPL MICROBIOL, V23, P18, DOI 10.1111/j.1472-765X.1996.tb00020.x; BUSCH SV, 1992, APPL ENVIRON MICROB, V58, P14, DOI 10.1128/AEM.58.1.14-20.1992; Coleman ME, 2003, INT J FOOD MICROBIOL, V83, P147, DOI 10.1016/S0168-1605(02)00367-7; Dykes GA, 1999, LETT APPL MICROBIOL, V28, P45, DOI 10.1046/j.1365-2672.1999.00472.x; Encinas JP, 1999, INT J FOOD MICROBIOL, V46, P167, DOI 10.1016/S0168-1605(98)00184-6; FAIRCHILD TM, 1993, APPL ENVIRON MICROB, V59, P1247, DOI 10.1128/AEM.59.4.1247-1250.1993; FAO/OMS, 2004, SER EV RIESG MICR, V4; FDA/FSIS (U.S. Food and Drug Administration/Food Safety and Inspection Service), 2003, QUANT ASS REL RISK P; Ferrer C, 2009, FOODBORNE PATHOG DIS, V6, P33, DOI 10.1089/fpd.2008.0133; Fisher K, 2006, J APPL MICROBIOL, V101, P1232, DOI 10.1111/j.1365-2672.2006.03035.x; Fisher K, 2009, J APPL MICROBIOL, V106, P1343, DOI 10.1111/j.1365-2672.2008.04102.x; Fisher K, 2008, TRENDS FOOD SCI TECH, V19, P156, DOI 10.1016/j.tifs.2007.11.006; GIBSON AM, 1988, INT J FOOD MICROBIOL, V6, P155, DOI [10.1016/0168-1605(88)90051-7, 10.1016/S0168-1605(00)00395-0]; Gill AO, 2006, INT J FOOD MICROBIOL, V111, P170, DOI 10.1016/j.ijfoodmicro.2006.04.046; Gill AO, 2006, INT J FOOD MICROBIOL, V108, P1, DOI 10.1016/j.ijfoodmicro.2005.10.009; Guillier L, 2005, APPL ENVIRON MICROB, V71, P2940, DOI 10.1128/AEM.71.6.2940-2948.2005; Hyldgaard M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00012; Barba FJ, 2014, FOOD CHEM, V148, P261, DOI 10.1016/j.foodchem.2013.10.048; Klein G, 2013, CURR MICROBIOL, V67, P200, DOI 10.1007/s00284-013-0354-1; Lado BH, 2002, MICROBES INFECT, V4, P433, DOI 10.1016/S1286-4579(02)01557-5; Mackey B. M., 2000, MICROBIOLOGICAL SAFE, VI, P315; MACKEY BM, 1982, J APPL BACTERIOL, V53, P243, DOI 10.1111/j.1365-2672.1982.tb04683.x; MACKEY BM, 1984, J APPL BACTERIOL, V57, P299, DOI 10.1111/j.1365-2672.1984.tb01394.x; McLauchlin J, 1996, FOOD CONTROL, V7, P187, DOI 10.1016/S0956-7135(96)00038-2; McMeekin TA, 1993, PREDICTIVE MICROBIOL; Pina-Perez MC, 2009, INT J FOOD MICROBIOL, V130, P196, DOI 10.1016/j.ijfoodmicro.2009.01.021; Robinson TP, 2001, INT J FOOD MICROBIOL, V70, P163, DOI 10.1016/S0168-1605(01)00541-4; Ryser E. T., 1999, LISTERIA LISTERIOSIS; Saucedo-Reyes D, 2009, INNOV FOOD SCI EMERG, V10, P135, DOI 10.1016/j.ifset.2008.11.004; Si W, 2006, J APPL MICROBIOL, V100, P296, DOI 10.1111/j.1365-2672.2005.02789.x; Silva-Angulo A, 2012, LISTERIA INFECT EPID, P99; Somolinos M, 2010, J APPL MICROBIOL, V108, P1928, DOI 10.1111/j.1365-2672.2009.04597.x; Stephens PJ, 1997, J APPL MICROBIOL, V83, P445, DOI 10.1046/j.1365-2672.1997.00255.x; Walsh SE, 2003, J HOSP INFECT, V55, P98, DOI 10.1016/S0195-6701(03)00240-8; Yousef AE, 2003, MICROBIAL STRESS ADAPTATION AND FOOD SAFETY, P1	44	38	44	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0114026	10.1371/journal.pone.0114026	http://dx.doi.org/10.1371/journal.pone.0114026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643164	gold, Green Submitted, Green Published			2022-12-27	WOS:000348821200002
J	Saha, C; Hegde, P; Friboulet, A; Bayry, J; Kaveri, SV				Saha, Chaitrali; Hegde, Pushpa; Friboulet, Alain; Bayry, Jagadeesh; Kaveri, Srinivas V.			Viscum album-Mediated COX-2 Inhibition Implicates Destabilization of COX-2 mRNA	PLOS ONE			English	Article							QUALITY-OF-LIFE; CYCLOOXYGENASE-2 EXPRESSION; POSTTRANSCRIPTIONAL REGULATION; MISTLETOE EXTRACTS; CANCER-PATIENTS; IMMUNE-SYSTEM; L. EXTRACTS; MOUSE SKIN; IN-VIVO; CELLS	Extensive use of Viscum album (VA) preparations in the complementary therapy of cancer and in several other human pathologies has led to an increasing number of cellular and molecular approaches to explore the mechanisms of action of VA. We have recently demonstrated that, VA preparations exert a potent anti-inflammatory effect by selectively downregulating the COX-2-mediated cytokine-induced secretion of prostaglandin E2 (PGE2), one of the important molecular signatures of inflammatory reactions. In this study, we observed a significant down-regulation of COX-2 protein expression in VA-treated A549 cells however COX-2 mRNA levels were unaltered. Therefore, we hypothesized that VA induces destabilisation of COX-2 mRNA, thereby depleting the available functional COX-2 mRNA for the protein synthesis and for the subsequent secretion of PGE2. To address this question, we analyzed the molecular degradation of COX-2 protein and its corresponding mRNA in A549 cell line. Using cyclohexamide pulse chase experiment, we demonstrate that, COX-2 protein degradation is not affected by the treatment with VA whereas experiments on transcriptional blockade with actinomycin D, revealed a marked reduction in the half life of COX-2 mRNA due to its rapid degradation in the cells treated with VA compared to that in IL-1 beta-stimulated cells. These results thus demonstrate that VA-mediated inhibition of PGE2 implicates destabilization of COX-2 mRNA.	[Saha, Chaitrali; Hegde, Pushpa; Bayry, Jagadeesh; Kaveri, Srinivas V.] INSERM, Unite 1138, Paris, France; [Saha, Chaitrali; Hegde, Pushpa; Friboulet, Alain] Univ Technol Compiegne, UMR CNRS 6022, Compiegne, France; [Saha, Chaitrali; Hegde, Pushpa; Bayry, Jagadeesh; Kaveri, Srinivas V.] Ctr Rech Cordeliers Equipe Immunopathol & therape, Paris, France; [Bayry, Jagadeesh; Kaveri, Srinivas V.] Univ Paris 06, Sorbonne Univ, UMR S 1138, Paris, France; [Bayry, Jagadeesh; Kaveri, Srinivas V.] Univ Paris 05, Sorbonne Paris Cite, UMR S 1138, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Picardie Universites; Universite de Technologie de Compiegne; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Kaveri, SV (corresponding author), INSERM, Unite 1138, Paris, France.	srini.kaveri@crc.jussieu.fr	Bayry, Jagadeesh/A-6589-2011	Bayry, Jagadeesh/0000-0003-0498-9808; Kaveri, Srini/0000-0002-0837-4053; Hegde, Pushpa/0000-0002-2376-8659	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Universite Pierre et Marie Curie; French Ministry of Foreign and European Affairs and Institut Hiscia, Arlesheim, Switzerland	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie; French Ministry of Foreign and European Affairs and Institut Hiscia, Arlesheim, Switzerland	This work is supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universite Pierre et Marie Curie and Universite Paris Descartes, Regional Program Bio-Asie 2010 by the French Ministry of Foreign and European Affairs and Institut Hiscia, Arlesheim, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock PR, 2004, ARZNEIMITTELFORSCH, V54, P456; Bussing A, 1999, ANTICANCER RES, V19, P23; Bussing A, 2005, ANTICANCER RES, V25, P4753; Cai Y, 2008, INT J CANCER, V123, P195, DOI 10.1002/ijc.23481; Cerella C, 2010, BIOCHEM PHARMACOL, V80, P1801, DOI 10.1016/j.bcp.2010.06.050; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; Christen-Clottu O, 2010, J VET INTERN MED, V24, P1483, DOI 10.1111/j.1939-1676.2010.0597.x; Chrubasik S, 2001, RHEUMATOLOGY, V40, P1388, DOI 10.1093/rheumatology/40.12.1388; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Cravotto G, 2010, J CLIN PHARM THER, V35, P11, DOI 10.1111/j.1365-2710.2009.01096.x; Crofford LJ, 1997, J RHEUMATOL, V24, P15; DAVENPORT HW, 1967, NEW ENGL J MED, V276, P1307, DOI 10.1056/NEJM196706082762308; Elluru SR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-161; Elluru SR, 2009, ANTICANCER RES, V29, P2945; Elluru S, 2006, ARZNEIMITTEL-FORSCH, V56, P461; Giulietti A, 2007, DIABETES RES CLIN PR, V77, P47, DOI 10.1016/j.diabres.2006.10.007; Hegde P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026312; Hostanska K, 1995, NAT IMMUN, V14, P295; Kam PCA, 2000, ANAESTHESIA, V55, P442, DOI 10.1046/j.1365-2044.2000.01271.x; Kienle GS, 2010, INTEGR CANCER THER, V9, P142, DOI 10.1177/1534735410369673; Kis B, 2003, J CEREBR BLOOD F MET, V23, P1287, DOI 10.1097/01.WCB.0000090681.07515.81; Klopp R, 2005, ANTICANCER RES, V25, P601; Kundu JK, 2003, J NUTR, V133, p3805S, DOI 10.1093/jn/133.11.3805S; Lavastre V, 2004, CLIN EXP IMMUNOL, V137, P272, DOI 10.1111/j.1365-2249.2004.02545.x; Marnett LJ, 2009, ANNU REV PHARMACOL, V49, P265, DOI 10.1146/annurev.pharmtox.011008.145638; Martel-Pelletier J, 2003, SEMIN ARTHRITIS RHEU, V33, P155, DOI 10.1016/S0049-0172(03)00134-3; RISTIMAKI A, 1994, J BIOL CHEM, V269, P11769; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Shrotriya S, 2010, CANCER RES, V70, P1932, DOI 10.1158/0008-5472.CAN-09-3501; Surh YJ, 2005, ARCH PHARM RES, V28, P1, DOI 10.1007/BF02975128; Tamura M, 2002, J CLIN ENDOCR METAB, V87, P3263, DOI 10.1210/jc.87.7.3263; Tetsuka T, 1996, J BIOL CHEM, V271, P11689, DOI 10.1074/jbc.271.20.11689; Tong X, 2007, MOL CELL BIOL, V27, P283, DOI 10.1128/MCB.01282-06; Tusenius KJ, 2005, ARZNEIMITTELFORSCH, V55, P749; Van Huyen JPD, 2006, CANCER LETT, V243, P32, DOI 10.1016/j.canlet.2005.11.016; Van Huyen JPD, 2003, CHEMOTHERAPY, V49, P298, DOI 10.1159/000074530; Van Huyen JPD, 2002, MOL MED, V8, P600, DOI 10.1007/BF03402170; Van Huyen JPD, 2001, CHEMOTHERAPY, V47, P366, DOI 10.1159/000048545; Zhang L, 2007, ARTHRITIS RHEUM-US, V56, P4132, DOI 10.1002/art.23054; Zhao XS, 2008, CANCER RES, V68, P467, DOI 10.1158/0008-5472.CAN-07-0782	40	15	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0114965	10.1371/journal.pone.0114965	http://dx.doi.org/10.1371/journal.pone.0114965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664986	Green Published, gold, Green Submitted			2022-12-27	WOS:000349123100003
J	Cattane, N; Minelli, A; Milanesi, E; Maj, C; Bignotti, S; Bortolomasi, M; Chiavetto, LB; Gennarelli, M				Cattane, Nadia; Minelli, Alessandra; Milanesi, Elena; Maj, Carlo; Bignotti, Stefano; Bortolomasi, Marco; Chiavetto, Luisella Bocchio; Gennarelli, Massimo			Altered Gene Expression in Schizophrenia: Findings from Transcriptional Signatures in Fibroblasts and Blood	PLOS ONE			English	Article							FUNCTIONAL DOPAMINERGIC-NEURONS; BIPOLAR DISORDER; DIFFERENTIAL EXPRESSION; COMMON VARIANTS; CONFERRING RISK; STEM-CELLS; TCF4; COMPARABILITY; CALCINEURIN; EPIGENETICS	Background Whole-genome expression studies in the peripheral tissues of patients affected by schizophrenia (SCZ) can provide new insight into the molecular basis of the disorder and innovative biomarkers that may be of great utility in clinical practice. Recent evidence suggests that skin fibroblasts could represent a non-neural peripheral model useful for investigating molecular alterations in psychiatric disorders. Methods A microarray expression study was conducted comparing skin fibroblast transcriptomic profiles from 20 SCZ patients and 20 controls. All genes strongly differentially expressed were validated by real-time quantitative PCR (RT-qPCR) in fibroblasts and analyzed in a sample of peripheral blood cell (PBC) RNA from patients (n = 25) and controls (n = 22). To evaluate the specificity for SCZ, alterations in gene expression were tested in additional samples of fibroblasts and PBCs RNA from Major Depressive Disorder (MDD) (n = 16; n = 21, respectively) and Bipolar Disorder (BD) patients (n = 15; n = 20, respectively). Results Six genes (JUN, HIST2H2BE, FOSB, FOS, EGR1, TCF4) were significantly upregulated in SCZ compared to control fibroblasts. In blood, an increase in expression levels was confirmed only for EGR1, whereas JUN was downregulated; no significant differences were observed for the other genes. EGR1 upregulation was specific for SCZ compared to MDD and BD. Conclusions Our study reports the upregulation of JUN, HIST2H2BE, FOSB, FOS, EGR1 and TCF4 in the fibroblasts of SCZ patients. A significant alteration in EGR1 expression is also present in SCZ PBCs compared to controls and to MDD and BD patients, suggesting that this gene could be a specific biomarker helpful in the differential diagnosis of major psychoses.	[Cattane, Nadia; Minelli, Alessandra; Gennarelli, Massimo] Univ Brescia, Dept Mol & Translat Med, Biol & Genet Div, Brescia, Italy; [Milanesi, Elena; Maj, Carlo; Chiavetto, Luisella Bocchio; Gennarelli, Massimo] IRCCS Ist Ctr San Giovanni di Dio Fatebenefratell, Genet Unit, Brescia, Italy; [Bignotti, Stefano] IRCCS Ist Ctr San Giovanni di Dio Fatebenefratell, Psychiat Unit, Brescia, Italy; [Bortolomasi, Marco] Psychiat Hosp Villa Santa Chiara, Verona, Italy; [Chiavetto, Luisella Bocchio] eCampus Univ, Fac Psychol, Novedrate, Como, Italy	University of Brescia; Universita Ecampus	Gennarelli, M (corresponding author), Univ Brescia, Dept Mol & Translat Med, Biol & Genet Div, Brescia, Italy.	massimo.gennarelli@unibs.it	BIGNOTTI, STEFANO/AAB-6036-2022; Cattane, Nadia/K-5906-2016; Maj, Carlo/I-4245-2015; Chiavetto, Luisella Bocchio/D-3884-2012; Milanesi, Elena/J-9489-2014; Minelli, Alessandra/ABI-2890-2020; Gennarelli, Massimo/AAL-3542-2020; Cattane, Nadia/AAE-4316-2022	BIGNOTTI, STEFANO/0000-0002-7840-9637; Cattane, Nadia/0000-0002-6532-583X; Maj, Carlo/0000-0002-9559-1725; Chiavetto, Luisella Bocchio/0000-0002-9801-603X; Minelli, Alessandra/0000-0002-9463-7808; Cattane, Nadia/0000-0002-6532-583X; Milanesi, Elena/0000-0003-2753-3395; GENNARELLI, Massimo/0000-0003-4192-945X	Italian Ministry of Health (RC); Italian Ministry of Health (RF2007 Conv.42); Regione Lombardia [17387 SAL-13]	Italian Ministry of Health (RC)(Ministry of Health, Italy); Italian Ministry of Health (RF2007 Conv.42); Regione Lombardia(Regione Lombardia)	This research was supported by grants from the Italian Ministry of Health (RC and RF2007 Conv.42) and Regione Lombardia (ID: 17387 SAL-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarian S, 2010, CURR TOP BEHAV NEURO, V4, P611, DOI 10.1007/7854_2010_38; Akin D, 2004, NEUROPSYCHOPHARMACOL, V29, P2081, DOI 10.1038/sj.npp.1300505; Asp L, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-25; Auburger G, 2012, MOL NEUROBIOL, V46, P20, DOI 10.1007/s12035-012-8245-1; Ayalew M, 2012, MOL PSYCHIATR, V17, P887, DOI 10.1038/mp.2012.37; Baumgartel K, 2008, NAT NEUROSCI, V11, P572, DOI 10.1038/nn.2113; Bongiovanni R, 2013, SCHIZOPHR RES, V150, P386, DOI 10.1016/j.schres.2013.08.041; Brennand KJ, 2012, MOL PSYCHIATR, V17, P1239, DOI 10.1038/mp.2012.20; Brzozka MM, 2010, BIOL PSYCHIAT, V68, P33, DOI 10.1016/j.biopsych.2010.03.015; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Duff BJ, 2013, SCHIZOPHR RES, V147, P1, DOI 10.1016/j.schres.2013.03.015; Forrest MP, 2014, TRENDS MOL MED, V20, P322, DOI 10.1016/j.molmed.2014.01.010; Garbett KA, 2015, BIOL PSYCHIAT, V77, P256, DOI 10.1016/j.biopsych.2014.05.015; Gasso P, 2013, J PSYCHIATR RES; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Girard SL, 2012, CURR NEUROL NEUROSCI, V12, P261, DOI 10.1007/s11910-012-0266-7; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Guella I, 2013, J PSYCHIATR RES, V47, P1215, DOI 10.1016/j.jpsychires.2013.05.021; Hall J, 2015, BIOL PSYCHIAT, V77, P52, DOI 10.1016/j.biopsych.2014.07.011; Hansson AC, 2008, BRAIN RES, V1215, P1, DOI 10.1016/j.brainres.2008.03.080; Hayashi-Takagi A, 2014, BIOL PSYCHIAT, V75, P920, DOI 10.1016/j.biopsych.2013.09.035; Hendrickx A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099467; Johansson AS, 2013, J PSYCHIATR RES, V47, P1815, DOI 10.1016/j.jpsychires.2013.08.008; Kalman S, 2014, EXP CELL RES, V320, P343, DOI 10.1016/j.yexcr.2013.10.019; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Koldamova R, 2014, NEUROBIOL DIS, V63, P107, DOI 10.1016/j.nbd.2013.11.005; Kumarasinghe N, 2012, AUST NZ J PSYCHIAT, V46, P598, DOI 10.1177/0004867412442405; Kurian SM, 2011, MOL PSYCHIATR, V16, P37, DOI 10.1038/mp.2009.117; Kyosseva SV, 2004, PROG NEURO-PSYCHOPH, V28, P997, DOI 10.1016/j.pnpbp.2004.05.017; Le-Niculescu H, 2007, AM J MED GENET B, V144B, P129, DOI 10.1002/ajmg.b.30481; Lennertz L, 2011, EUR ARCH PSY CLIN N, V261, P161, DOI 10.1007/s00406-011-0256-9; Mahgoub M, 2013, NEUROTHERAPEUTICS, V10, P734, DOI 10.1007/s13311-013-0213-6; Matigian NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002412; Mattheisen M, 2012, SCHIZOPHR RES, V141, P262, DOI 10.1016/j.schres.2012.08.027; Matthews PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038211; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Middleton FA, 2005, AM J MED GENET B, V136B, P12, DOI 10.1002/ajmg.b.30171; Mistry M, 2013, MOL PSYCHIATR, V18, P215, DOI 10.1038/mp.2011.172; Monin A, 2014, MOL PSYCHIAT; Mowry BJ, 2013, MOL PSYCHIATR, V18, P38, DOI 10.1038/mp.2012.34; Navarrete K, 2013, AM J MED GENET B, V162B, P1, DOI 10.1002/ajmg.b.32109; Pae CU, 2009, NEUROPSYCHOBIOLOGY, V59, P135, DOI 10.1159/000218075; Perez-Santiago J, 2012, J PSYCHIATR RES, V46, P1464, DOI 10.1016/j.jpsychires.2012.08.005; Phipson B, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1585; Pitman KA, 2014, EUR J NEUROSCI; Quednow BB, 2014, CELL MOL LIFE SCI, V71, P2815, DOI 10.1007/s00018-013-1553-4; Reul JMHM, 2014, FRONT PSYCHIATRY, V5, DOI [10.3389/fpsyt.2014.00005, 10.3389/fpsyt.2004.0005]; Rieske P, 2005, DIFFERENTIATION, V73, P474, DOI 10.1111/j.1432-0436.2005.00050.x; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Rollins B, 2010, AM J MED GENET B, V153B, P919, DOI 10.1002/ajmg.b.31062; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Slot LAB, 2009, EUR J PHARMACOL, V620, P27, DOI 10.1016/j.ejphar.2009.08.019; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2011, HUM MOL GENET, V20, P4076, DOI 10.1093/hmg/ddr325; Steullet P, 2014, SCHIZOPHR RES; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Theka I, 2013, STEM CELL TRANSL MED, V2, P473, DOI 10.5966/sctm.2012-0133; Todorova VK, 2003, NEUROPSYCHOPHARMACOL, V28, P1506, DOI 10.1038/sj.npp.1300211; Tomasik J, 2014, SCHIZOPHR RES; Tylee DS, 2013, AM J MED GENET B, V162, P595, DOI 10.1002/ajmg.b.32150; Wang L, 2010, J PROTEOME RES, V9, P521, DOI 10.1021/pr900867x; Wirgenes KV, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.39; Wolf J, 2012, EXP GERONTOL, V47, P749, DOI 10.1016/j.exger.2012.07.001; Yamada K, 2007, P NATL ACAD SCI USA, V104, P2815, DOI 10.1073/pnas.0610765104; Zhang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056108	67	44	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116686	10.1371/journal.pone.0116686	http://dx.doi.org/10.1371/journal.pone.0116686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658856	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900057
J	Deng, Y; Xie, M; Xie, L; Wang, J; Li, TJ; He, Y; Li, RL; Li, S; Qin, X				Deng, Yan; Xie, Ming; Xie, Li; Wang, Jian; Li, Taijie; He, Yu; Li, Ruolin; Li, Shan; Qin, Xue			Association between Polymorphism of the Interleukin-13 Gene and Susceptibility to Hepatocellular Carcinoma in the Chinese Population	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; IL-13; RISK; CANCER; PATHOGENESIS; VACCINATION; VARIANTS; RHINITIS; IMMUNITY; DISEASES	Objective Interleukin-13 (IL-13) is a potent pleiotropic cytokine that is produced by activated CD4 T cells. This study was undertaken to determine the relationship between two IL-13 gene single nucleotide polymorphisms (SNP rs1800925 and SNP rs20541) and the incidence of hepatitis B virus-related (HBV) hepatocellular carcinoma (HCC). Method Three hundred and ninety-eight HBV-positive individuals (192 HCC and 206 patients with chronic hepatitis) and one hundred and ninety-two healthy participants from the First Affiliated Hospital of Guangxi Medical University were enrolled in this study. Results The results showed no significant differences between the genotype and allele frequencies of the IL-13 gene rs1800925 and rs20541 polymorphisms and chronic hepatitis B risk after adjusting for age, sex, tobacco use, and alcohol intake using binary logistic regression analyses. Regarding the rs20541 SNP, the GA genotype was significantly related to a decreased risk of HCC after adjusting for age, sex, tobacco use, and alcohol intake using binary logistic regression analyses (The odds ratio (OR) = 0.54, 95% confidence intervals (CI) 0.34-0.87). The adjusted OR for the GA and AA genotypes combined was 0.68 (95% CI 0.39-0.90). Conclusion This study indicates that the functional IL-13 rs20541 polymorphism may contribute to the risk of HCC and that the rs20541 polymorphism is a protective factor for HCC.	[Deng, Yan; Xie, Ming; Xie, Li; Wang, Jian; Li, Taijie; He, Yu; Li, Shan; Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Li, Ruolin] Guangxi Med Univ, Affiliated Hosp 1, Dept Med Res, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Li, S (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.	lis8858@126.com; qinxue919@126.com			Youth Science Foundation of Guangxi Medical University [GXMUYSF201334]	Youth Science Foundation of Guangxi Medical University	This research was supported by Youth Science Foundation of Guangxi Medical University (GXMUYSF201334). The funder had a role in the preparation of this manuscript.	Chiurillo MA, 2014, WORLD J GASTROENTERO, V20, P4503, DOI 10.3748/wjg.v20.i16.4503; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; Bottema RWB, 2010, INT ARCH ALLERGY IMM, V153, P259, DOI 10.1159/000314366; Brenner AV, 2007, CARCINOGENESIS, V28, P2543, DOI 10.1093/carcin/bgm210; Brombacher F, 2000, BIOESSAYS, V22, P646, DOI 10.1002/1521-1878(200007)22:7&lt;646::AID-BIES7&gt;3.0.CO;2-9; Cameron L, 2006, J IMMUNOL, V177, P8633, DOI 10.4049/jimmunol.177.12.8633; Chang JJ, 2007, IMMUNOL CELL BIOL, V85, P16, DOI 10.1038/sj.icb.7100009; Chen WG, 2004, J ALLERGY CLIN IMMUN, V114, P553, DOI 10.1016/j.jaci.2004.04.044; Chu HY, 2012, MOL BIOL REP, V39, P5349, DOI 10.1007/s11033-011-1334-9; Cui L, 2012, CLIN BIOCHEM, V45, P285, DOI 10.1016/j.clinbiochem.2011.12.012; Formentini A, 2012, INT J COLORECTAL DIS, V27, P1369, DOI 10.1007/s00384-012-1456-0; Gelfand EW, 2004, J ALLERGY CLIN IMMUN, V114, pS135, DOI 10.1016/j.jaci.2004.08.043; Grzegorzewska AE, 2013, MOL BIOL REP, V40, P6899, DOI 10.1007/s11033-013-2809-7; Hohler T, 2005, HEPATOLOGY, V42, P72, DOI 10.1002/hep.20740; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Lesina M, 2014, SEMIN IMMUNOL, V26, P80, DOI 10.1016/j.smim.2014.01.002; Li S, 2011, INFECT GENET EVOL, V11, P2083, DOI 10.1016/j.meegid.2011.09.025; Liu HY, 2000, CANCER IMMUNOL IMMUN, V49, P319, DOI 10.1007/s002620000110; McKillop IH, 2006, J SURG RES, V136, P125, DOI 10.1016/j.jss.2006.04.013; Moradpour D, 2005, EUR J GASTROEN HEPAT, V17, P477, DOI 10.1097/00042737-200505000-00002; Sainz J, 2012, J CLIN ENDOCR METAB, V97, pE845, DOI 10.1210/jc.2011-2565; Skinnider BF, 2001, INT ARCH ALLERGY IMM, V126, P267, DOI 10.1159/000049523; Su T, 2013, GENE, V515, P56, DOI 10.1016/j.gene.2012.11.035; Sun G, 2013, CANCER EPIDEMIOL, V37, P306, DOI 10.1016/j.canep.2013.01.003; Terabe M, 2004, CANCER IMMUNOL IMMUN, V53, P79, DOI 10.1007/s00262-003-0445-0; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Vercelli D, 2002, CURR OPIN ALLERGY CL, V2, P389, DOI 10.1097/00130832-200210000-00004; Vladich FD, 2005, J CLIN INVEST, V115, P747, DOI 10.1172/JCI200522818; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Ying XJ, 2013, GENE, V521, P222, DOI 10.1016/j.gene.2013.03.088; YU MW, 1994, CRIT REV ONCOL HEMAT, V17, P71, DOI 10.1016/1040-8428(94)90020-5; Zhu VF, 2012, CANCER LETT, V316, P139, DOI 10.1016/j.canlet.2011.11.001	32	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116682	10.1371/journal.pone.0116682	http://dx.doi.org/10.1371/journal.pone.0116682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658755	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900056
J	Ge, H; Yuan, W; Liu, JD; He, Q; Ding, S; Pu, J; He, B				Ge, Heng; Yuan, Wei; Liu, Jidong; He, Qing; Ding, Song; Pu, Jun; He, Ben			Functional Relevance of Protein Glycosylation to the Pro-Inflammatory Effects of Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) on Monocytes/Macrophages	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; ATHEROSCLEROTIC PLAQUE; IMMUNOGLOBULIN SUPERFAMILY; THERAPEUTIC PROTEINS; EXPRESSION; CD147; IMMUNE; MACROPHAGES; INHIBITOR; MONOCYTES	Background and Objective Extracellular matrix metalloproteinase inducer (EMMPRIN) is an important pro-inflammatory protein involved in the cellular functions of monocytes/macrophages. We have hypothesized that high-level heterogeneousness of protein glycosylation of EMMPRIN may have functional relevance to its biological effects and affect the inflammatory activity of monocytes/macrophages. Methods The glycosylation patterns of EMMPRIN expressed by monocytes/macrophages (THP-1 cells) in response to different extracellular stimuli were observed, and the structures of different glycosylation forms were identified. After the purification of highly-and less-glycosylated proteins respectively, the impacts of different glycosylation forms on the pro-inflammatory effects of EMMPRIN were examined in various aspects, such as cell adhesion to endothelial cells, cell migrations, cytokine expression, and activation of inflammatory signalling pathway. Results 1) It was mainly the highly-glycosylated form of EMMPRIN (HG-EMMPRIN) that increased after being exposed to inflammatory signals (PMA and H2O2).2) Glycosylation of EMMPRIN in monocytes/macrophages led to N-linked-glycans being added to the protein, with the HG form containing complex-type glycans and the less-glycosylated form (LG) the simple type. 3) Only the HG-EMMPRIN but not the LG-EMMPRIN exhibited pro-inflammatory effects and stimulated inflammatory activities of the monocytes/macrophages (i.e., activation of ERK1/2 and NF-kappa B pathway, enhancedmonocyte-endothelium adhesion, cell migration and matrix metalloproteinase - 9 expression). Conclusions Post-transcriptional glycosylation represents an important mechanism that determines the biological effects of EMMPRIN in monocytes/macrophages. Glycosylation of EMMPRIN may serve as a potential target for regulating the inflammatory activities of monocytes/macrophages.	[Ge, Heng; Yuan, Wei; He, Qing; Ding, Song; Pu, Jun; He, Ben] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Liu, Jidong] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Cardiac Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Pu, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Cardiol, Shanghai 200030, Peoples R China.	pujun310@hotmail.com; heben@medmail.com.cn			Natural Science Foundation of China [81000114, 81200163, 81330006, 81270282]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (grant numbers 81000114 (GH), 81200163 (PJ), 81330006 (HB) and 81270282(PJ) [www.nsfc.gov.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISWAS C, 1995, CANCER RES, V55, P434; Chen HC, 2005, BOYDEN CHAMBER ASSAY, P15; Chi Z, 2007, CELL ADHES MIGR, V1, P171, DOI 10.4161/cam.1.4.5321; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; ELBEIN AD, 1981, P NATL ACAD SCI-BIOL, V78, P7393, DOI 10.1073/pnas.78.12.7393; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Ge H, 2007, VASC PHARMACOL, V46, P114, DOI 10.1016/j.vph.2006.08.412; Gough DR, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.96; Halvorsen B, 2008, PROG CARDIOVASC DIS, V51, P183, DOI 10.1016/j.pcad.2008.09.001; Hansson GK, 2009, ATHEROSCLEROSIS, V202, P2, DOI 10.1016/j.atherosclerosis.2008.08.039; Huang W, 2013, BIOCHEM J, V449, P437, DOI 10.1042/BJ20120343; Huang ZQ, 2008, BIOCHEM BIOPH RES CO, V374, P517, DOI 10.1016/j.bbrc.2008.07.058; Iacono KT, 2007, EXP MOL PATHOL, V83, P283, DOI 10.1016/j.yexmp.2007.08.014; Kim Ju-Young, 2009, Immune Netw, V9, P90, DOI 10.4110/in.2009.9.3.90; Li RS, 2001, J CELL PHYSIOL, V186, P371, DOI 10.1002/1097-4652(2000)9999:999<000::AID-JCP1042>3.0.CO;2-8; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Major TC, 2002, ARTERIOSCL THROM VAS, V22, P1200, DOI 10.1161/01.ATV.0000021411.53577.1C; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; Narizhneva NV, 2005, FASEB J, V19, P1158, DOI 10.1096/fj.04-3310fje; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Pamukcu B, 2010, ANN MED, V42, P394, DOI 10.3109/07853890.2010.497767; Schmidt R, 2006, CIRCULATION, V113, P834, DOI 10.1161/CIRCULATIONAHA.105.568162; Schulz C, 2011, J THROMB HAEMOST, V9, P1007, DOI 10.1111/j.1538-7836.2011.04235.x; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Sluijter JPG, 2006, STROKE, V37, P235, DOI 10.1161/01.STR.0000196986.50059.e0; Sola RJ, 2010, BIODRUGS, V24, P9, DOI 10.2165/11530550-000000000-00000; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wei YA, 2010, ATHEROSCLEROSIS, V213, P415, DOI 10.1016/j.atherosclerosis.2010.09.033; Yoon YW, 2005, ATHEROSCLEROSIS, V180, P37, DOI 10.1016/j.atherosclerosis.2004.11.021; Yu XL, 2006, INT J BIOCHEM CELL B, V38, P1939, DOI 10.1016/j.biocel.2006.05.008; Zhang JF, 2007, INT J CARDIOL, V117, P373, DOI 10.1016/j.ijcard.2006.05.023	34	19	19	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117463	10.1371/journal.pone.0117463	http://dx.doi.org/10.1371/journal.pone.0117463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658763	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900155
J	Kimura, D; Nakatani, K; Takeda, T; Fujita, T; Sunahara, N; Inoue, K; Notoya, M				Kimura, Daisuke; Nakatani, Ken; Takeda, Tokunori; Fujita, Takashi; Sunahara, Nobuyuki; Inoue, Katsumi; Notoya, Masako			Analysis of Causal Relationships by Structural Equation Modeling to Determine the Factors Influencing Cognitive Function in Elderly People in Japan	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; LEISURE ACTIVITY; DEMENTIA; RISK; DECLINE; PREVENTION; IMPAIRMENT; EXERCISE	The purpose of this study is to identify a potentiality factor that is a preventive factor for decline in cognitive function. Additionally, this study pursues to clarify the causal relationship between the each potential factor and its influence on cognitive function. Subjects were 366 elderly community residents (mean age 73.7 +/- 6.4, male 51, female 315) who participated in the Taketoyo Project from 2007 to 2011. Factor analysis was conducted to identify groupings within mental, social, life, physical and cognitive functions. In order to detect clusters of 14 variables, the item scores were subjected to confirmatory factor analysis. We performed Structural Equation Modeling analysis to calculate the standardization coefficient and correlation coefficient for every factor. The cause and effect hypothesis model was used to gather two intervention theory hypotheses for dementia prevention (direct effect, indirect effect) in one system. Finally, we performed another Structural Equation Modeling analysis to calculate the standardization of the cause and effect hypothesis model. Social participation was found to be activated by the improvement of four factors, and in turn, activated "Social participation" acted on cognitive function.	[Kimura, Daisuke; Takeda, Tokunori; Fujita, Takashi] Seijoh Univ, Fac Care & Rehabil, Div Occupat Therapy, Tokai, Aichi, Japan; [Kimura, Daisuke] Kanazawa Univ, Grad Sch Med Sci, Div Hlth Sci, Tokai, Ibaraki, Japan; [Nakatani, Ken] Kansai Univ Welf Sci, Fac Allied Hlth Sci, Dept Rehabil Sci, Kashiwara, Osaka, Japan; [Sunahara, Nobuyuki; Inoue, Katsumi; Notoya, Masako] Kanazawa Univ, Coll Med Pharmaceut & Hlth Sci, Sch Hlth Sci, Kanazawa, Ishikawa, Japan	Kanazawa University	Kimura, D (corresponding author), Seijoh Univ, Fac Care & Rehabil, Div Occupat Therapy, Tokai, Aichi, Japan.	kimura@seijoh-u.ac.jp			KAKENHI [24653150]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (Grant-in-Aid for Challenging Exploratory Research) Grant Number 24653150 to DK and TT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2010, ACSMS GUID EX TEST P, P183, DOI [10.1111/j.1744-6163.2010.00288.x, DOI 10.1111/J.1744-6163.2010.00288.X]; [Anonymous], 2014, DEM PREV SUPP MAN, DOI [10. 1016/ j. leukres. 2014.12.002, DOI 10.1016/J.LEUKRES.2014.12.002]; Atsuko H, 2006, JPN J ED TECHNOL, V29, P463; BRINKMAN GL, 1963, AM REV RESPIR DIS, V87, P684; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Coley N, 2008, EPIDEMIOL REV, V30, P35, DOI 10.1093/epirev/mxn010; Erikson E.H., 1994, VITAL INVOLVEMENT OL; Ferreira N, 2015, INT J GERIATR PSYCH, V30, P422, DOI 10.1002/gps.4155; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Fratiglioni L, 2011, LANCET NEUROL, V10, P778, DOI 10.1016/S1474-4422(11)70145-4; Ghisletta P, 2006, J GERONTOL B-PSYCHOL, V61, pP253, DOI 10.1093/geronb/61.5.P253; Golden J, 2009, PSYCHOL HEALTH MED, V14, P280, DOI 10.1080/13548500902730135; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hyyppa MT, 2008, SOC INDIC RES, V88, P389, DOI 10.1007/s11205-007-9199-y; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Katagiri K, 2013, JAPANESE J GERONTOLO, V35, P342; Kwok TCY, 2011, CLIN INTERV AGING, V6, P261, DOI 10.2147/CIA.S19883; Langlois F, 2013, J GERONTOL B-PSYCHOL, V68, P400, DOI 10.1093/geronb/gbs069; Lytle ME, 2004, ALZ DIS ASSOC DIS, V18, P57, DOI 10.1097/01.wad.0000126614.87955.79; Pett MA, 2003, MAKING SENSE FACTOR, DOI DOI 10.4135/9781412984898; Podewils LJ, 2005, AM J EPIDEMIOL, V161, P639, DOI 10.1093/aje/kwi092; Saczynski JS, 2006, AM J EPIDEMIOL, V163, P433, DOI 10.1093/aje/kwj061; Seidler A, 2004, OCCUP ENVIRON MED, V61, P962, DOI 10.1136/oem.2003.012153; Sherod MG, 2009, J INT NEUROPSYCH SOC, V15, P258, DOI 10.1017/S1355617709090365; Sorman DE, 2014, J GERONTOL B-PSYCHOL, V69, P493, DOI 10.1093/geronb/gbt056; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Takeda T, 2009, J JAPANESE OCCUPATIO, V28, P178; Wang JYJ, 2006, NEUROLOGY, V66, P911, DOI 10.1212/01.wnl.0000192165.99963.2a; Zunzunegui MV, 2003, J GERONTOL B-PSYCHOL, V58, pS93, DOI 10.1093/geronb/58.2.S93	30	2	2	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117554	10.1371/journal.pone.0117554	http://dx.doi.org/10.1371/journal.pone.0117554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658829	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900174
J	Rahman, MA; Mitra, S; Sarkar, A; Wewers, MD				Rahman, Mohd Akhlakur; Mitra, Srabani; Sarkar, Anasuya; Wewers, Mark D.			Alpha 1-Antitrypsin Does Not Inhibit Human Monocyte Caspase-1	PLOS ONE			English	Article							ALPHA1-ANTITRYPSIN DEFICIENCY; INTERLEUKIN-1-BETA-CONVERTING ENZYME; WHOLE-BLOOD; TNF-ALPHA; IN-VITRO; ACTIVATION; LIPOPOLYSACCHARIDE; ELASTASE; RELEASE; ALPHA(1)-ANTITRYPSIN	Background Alpha 1-antitrypsin (A1AT) is a 52 kDa serine protease inhibitor produced largely by hepatocytes but also by mononuclear phagocytes. A1AT chiefly inhibits neutrophil elastase and proteinase-3 but has also been reported to have immune modulatory functions including the ability to inhibit caspases. Its clinical availability for infusion suggests that A1AT therapy might modulate caspase related inflammation. Here we tested the ability of A1AT to modulate caspase-1 function in human mononuclear phagocytes. Methods Purified plasma derived A1AT was added to active caspase-1 in a cell-free system (THP-1 lysates) as well as added exogenously to cell-culture models and human whole blood models of caspase-1 activation. Functional caspase-1 activity was quantified by the cleavage of the caspase-1 specific fluorogenic tetrapeptide substrate (WEHD-afc) and the release of processed IL-18 and IL-1 beta. Results THP-1 cell lysates generated spontaneous activation of caspase-1 both by WEHD-afc cleavage and the generation of p20 caspase-1. A1AT added to this cell free system was unable to inhibit caspase-1 activity. Release of processed IL-18 by THP-1 cells was also unaffected by the addition of exogenous A1AT prior to stimulation with LPS/ATP, a standard caspase-1 activating signal. Importantly, the A1AT exhibited potent neutrophil elastase inhibitory capacity. Furthermore, A1AT complexed to NE (and hence conformationally modified) also did not affect THP-1 cell caspase-1 activation. Finally, exogenous A1AT did not inhibit the ability of human whole blood samples to process and release IL-1 beta. Conclusions A1AT does not inhibit human monocyte caspase-1.	[Rahman, Mohd Akhlakur; Mitra, Srabani; Sarkar, Anasuya; Wewers, Mark D.] Ohio State Univ, Dept Internal Med, Dorothy M Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med,Wexner Med, Columbus, OH 43210 USA	Ohio State University	Wewers, MD (corresponding author), Ohio State Univ, Dept Internal Med, Dorothy M Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med,Wexner Med, Columbus, OH 43210 USA.	wewers.2@osu.edu	Wewers, Mark/AAB-6202-2021		National Institute of Health (NIH) [HL07627]; Alpha-1 Foundation	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpha-1 Foundation	This study was supported by the National Institute of Health (NIH HL07627) and Alpha-1 Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALLEN JN, 1992, J LAB CLIN MED, V119, P538; Bergin DA, 2010, J CLIN INVEST, V120, P4236, DOI 10.1172/JCI41196; Carroll TP, 2010, J IMMUNOL, V184, P4538, DOI 10.4049/jimmunol.0802864; Exline MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090968; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; Ghonime MG, 2012, BIOCHEM BIOPH RES CO, V425, P384, DOI 10.1016/j.bbrc.2012.07.102; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Hu CB, 2002, AM J PHYSIOL-LUNG C, V282, pL757, DOI 10.1152/ajplung.00271.2001; Janciauskiene S, 2004, BIOCHEM BIOPH RES CO, V321, P592, DOI 10.1016/j.bbrc.2004.06.123; JANOFF A, 1972, AM REV RESPIR DIS, V105, P121; Knoell DL, 1998, AM J RESP CRIT CARE, V157, P246, DOI 10.1164/ajrccm.157.1.9702033; Lockett AD, 2013, AM J RESP CELL MOL, V49, P143, DOI 10.1165/rcmb.2012-0515OC; Lockett AD, 2012, MOL MED, V18, P445, DOI 10.2119/molmed.2011.00207; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; MEYER JF, 1975, CLIN CHIM ACTA, V62, P43, DOI 10.1016/0009-8981(75)90278-8; MILLER DK, 1993, J BIOL CHEM, V268, P18062; MOLMENTI EP, 1993, J CLIN INVEST, V92, P2022, DOI 10.1172/JCI116797; MORSE JO, 1978, NEW ENGL J MED, V299, P1045, DOI 10.1056/NEJM197811092991905; MORSE JO, 1978, NEW ENGL J MED, V299, P1099, DOI 10.1056/NEJM197811162992003; OHLSSON K, 1971, SCAND J CLIN LAB INV, V28, P251, DOI 10.3109/00365517109095696; PERLMUTTER DH, 1985, P NATL ACAD SCI USA, V82, P795, DOI 10.1073/pnas.82.3.795; PERLMUTTER DH, 1990, J BIOL CHEM, V265, P16713; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Petrache L, 2006, AM J RESP CRIT CARE, V173, P1222, DOI 10.1164/rccm.200512-1842OC; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; PUTNAM CW, 1977, SURGERY, V81, P258; Ralston DR, 1997, J CLIN INVEST, V100, P1416, DOI 10.1172/JCI119662; Rooney CP, 2001, AM J RESP CELL MOL, V24, P747, DOI 10.1165/ajrcmb.24.6.4147; Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140; SIFERS RN, 1989, AM J RESP CELL MOL, V1, P341, DOI 10.1165/ajrcmb/1.5.341; SINGER II, 1995, J EXP MED, V182, P1447, DOI 10.1084/jem.182.5.1447; Swaan PW, 2001, PHARMACEUT RES, V18, P1083, DOI 10.1023/A:1010958406364; Toldo S, 2011, J MOL CELL CARDIOL, V51, P244, DOI 10.1016/j.yjmcc.2011.05.003; Walsh JG, 2011, J BIOL CHEM, V286, P32513, DOI 10.1074/jbc.M111.225862; Wang YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051078; WEWERS MD, 1988, J CLIN INVEST, V82, P1260, DOI 10.1172/JCI113724; Wewers MD, 1997, J IMMUNOL, V159, P5964; WEWERS MD, 1993, J IMMUNOL METHODS, V165, P269, DOI 10.1016/0022-1759(93)90353-9; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; Zakharova E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009900	43	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117330	10.1371/journal.pone.0117330	http://dx.doi.org/10.1371/journal.pone.0117330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658455	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900135
J	Tian, C; Jiang, Q; Wang, F; Wang, GL; Xu, ZS; Xiong, AS				Tian, Chang; Jiang, Qian; Wang, Feng; Wang, Guang-Long; Xu, Zhi-Sheng; Xiong, Ai-Sheng			Selection of Suitable Reference Genes for qPCR Normalization under Abiotic Stresses and Hormone Stimuli in Carrot Leaves	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; TRANSCRIPTION FACTOR DREB2A; TIME RT-PCR; HOUSEKEEPING GENES; SALICYLIC-ACID; QUANTITATIVE-PCR; INTERNAL CONTROL; RNA EXPRESSION; IDENTIFICATION; VALIDATION	Carrot, a biennial herb of the Apiaceae family, is among the most important vegetable crops in the world. In this study, nine candidate reference genes (GAPDH, ACTIN, eIF-4 alpha, PP2A, SAND, TIP41, UBQ, EF-1 alpha, and TUB) were cloned from carrot. Carrot plants were subjected to abiotic stresses (heat, cold, salt, and drought) and hormone stimuli (gibberellin, salicylic acid, methyl jasmonate, and abscisic acid). The expression profiles of the candidate reference genes were evaluated in three technical and biological replicates. Real-time qPCR data analyses were performed using three commonly used Excel-based applets namely, BestKeeper, geNorm, and NormFinder. ACTIN and TUB were the most stable genes identified among all sample groups, but individual analysis revealed changes in their expression profiles. GAPDH displayed the maximum stability for most of single stresses. To further validate the suitability of the reference genes identified in this study, the expression profile of DcDREB-A1 gene (homolog of AtDREB-A1 gene of Arabidophsis) was studied in carrot. The appropriate reference genes were selected that showed stable expression under the different experimental conditions.	[Tian, Chang; Jiang, Qian; Wang, Feng; Wang, Guang-Long; Xu, Zhi-Sheng; Xiong, Ai-Sheng] Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Xiong, AS (corresponding author), Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.	xiongaisheng@njau.edu.cn	Wang, Guang-Long/ABC-2687-2020	Xiong, Ai-Sheng/0000-0002-7900-5001	New Century Excellent Talents in University [NCET-11-0670]; Jiangsu Natural Science Foundation [BK20130027]; China Postdoctoral Science Foundation [2014M551609]; Priority Academic Program Development of Jiangsu Higher Education Institutions	New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Priority Academic Program Development of Jiangsu Higher Education Institutions	The research was supported by the New Century Excellent Talents in University (NCET-11-0670); Jiangsu Natural Science Foundation (BK20130027); China Postdoctoral Science Foundation (2014M551609); Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Charron CS, 2009, J AGR FOOD CHEM, V57, P1226, DOI 10.1021/jf802988s; Chung HJ, 2005, PLANTA, V220, P424, DOI 10.1007/s00425-004-1366-7; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Ding JY, 2004, J AGR FOOD CHEM, V52, P3372, DOI 10.1021/jf049915d; Eraslan F, 2007, SCI HORTIC-AMSTERDAM, V113, P120, DOI 10.1016/j.scienta.2007.03.012; Fan XT, 2000, PHYSIOL PLANTARUM, V110, P450, DOI 10.1111/j.1399-3054.2000.1100404.x; Feng YJ, 2012, J CHEM ECOL, V38, P984, DOI 10.1007/s10886-012-0155-1; Galli V, 2013, PLANT CELL REP, V32, P1869, DOI 10.1007/s00299-013-1499-x; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Haller F, 2004, ANAL BIOCHEM, V335, P1, DOI 10.1016/j.ab.2004.08.024; 何亚丽, 2002, [植物生理与分子生物学学报, Journal of Plant Physiology and Molecular Biology], V28, P89; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HIBBERD KA, 1980, PLANTA, V148, P183, DOI 10.1007/BF00386420; HILLER LK, 1979, PLANT PHYSIOL, V63, P1055, DOI 10.1104/pp.63.6.1055; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; IKUMA H, 1960, PLANT PHYSIOL, V35, P557, DOI 10.1104/pp.35.5.557; Ishitani R, 1996, J NEUROCHEM, V66, P928; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jiang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092262; Jones R., 2000, BIOCH MOL BIOL PLANT, P1158, DOI DOI 10.12691/WJAR-2-2-2; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Li MY, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.10; Li MY, 2013, PLANT MOL BIOL REP, V31, P1002, DOI 10.1007/s11105-013-0570-7; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Ling H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097469; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Luby CH, 2014, HORTICULTURE RES, V1, P1, DOI DOI 10.1038/H0RTRES.2014.15; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Monteiro F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072998; Nakashima A, 2013, FEBS LETT, V587, P2924, DOI 10.1016/j.febslet.2013.07.027; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Qin F, 2007, PLANT J, V50, P54, DOI 10.1111/j.1365-313X.2007.03034.x; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ransbotyn V, 2006, LIMNOL OCEANOGR-METH, V4, P367, DOI 10.4319/lom.2006.4.367; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Sabater-Jara AB, 2014, PLANT PHYSIOL BIOCH, V77, P133, DOI 10.1016/j.plaphy.2014.02.006; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Schramm F, 2008, PLANT J, V53, P264, DOI 10.1111/j.1365-313X.2007.03334.x; Senaratna T, 2000, PLANT GROWTH REGUL, V30, P157, DOI 10.1023/A:1006386800974; Simon P. W., 1997, Journal of Applied Genetics, V38A, P57; Simon PW, 2008, CARROT VEGETABLES, P327; Singh B, 2003, PLANT GROWTH REGUL, V39, P137, DOI 10.1023/A:1022556103536; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Small IM, 2012, CROP PROT, V41, P10, DOI 10.1016/j.cropro.2012.05.016; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Tanaka Y, 2005, PLANT PHYSIOL, V138, P2337, DOI 10.1104/pp.105.063503; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; WIXOM RL, 1961, PLANT PHYSIOL, V36, P598, DOI 10.1104/pp.36.5.598; Xu ZS, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau096; Xu ZS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0262-y; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yoo WG, 2009, PARASITOL RES, V104, P321, DOI 10.1007/s00436-008-1195-x; Yperman J, 2006, CELL REPOPULATION BI, V13, P25; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; Zhuang J, 2014, CRIT REV PLANT SCI, V33, P225, DOI 10.1080/07352689.2014.870420	79	112	121	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117569	10.1371/journal.pone.0117569	http://dx.doi.org/10.1371/journal.pone.0117569			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658122	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900178
J	Chang, JT; Yang, CS; Chen, YS; Chen, BC; Chiang, AJ; Chang, YH; Tsai, WL; Lin, YS; Chao, D; Chang, TH				Chang, Jenn-Tzong; Yang, Chih-Shiang; Chen, Yao-Shen; Chen, Bao-Chen; Chiang, An-Jen; Chang, Yu-Hsiang; Tsai, Wei-Lun; Lin, You-Sheng; Chao, David; Chang, Tsung-Hsien			Genome and Infection Characteristics of Human Parechovirus Type 1: The Interplay between Viral Infection and Type I Interferon Antiviral System	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; REAL-TIME PCR; PICORNAVIRUS GROUP; IRF-3 ACTIVATION; CLINICAL-SAMPLES; CELL-CULTURE; VIRUS; RECOMBINATION; IDENTIFICATION; ENTEROVIRUS	Human parechoviruses (HPeVs), members of the family Picornaviridae, are associated with severe human clinical conditions such as gastrointestinal disease, encephalitis, meningitis, respiratory disease and neonatal sepsis. A new contemporary strain of HPeV1, KVP6 (accession no. KC769584), was isolated from a clinical specimen. Full-genome alignment revealed that HPeV1 KVP6 shares high genome homology with the German strain of HPeV1, 7555312 (accession no. FM178558) and could be classified in the clade 1B group. An intertypic recombination was shown within the P2-P3 genome regions of HPeV1. Celltype tropism test showed that T84 cells (colon carcinoma cells), A549 cells (lung carcinoma cells) and DBTRG-5MG cells (glioblastoma cells) were susceptible to HPeV1 infection, which might be relevant clinically. A facilitated cytopathic effect and increased viral titers were reached after serial viral passages in Vero cells, with viral genome mutation found in later passages. HPeV1 is sensitive to elevated temperature because 39 degrees C incubation impaired virion production. HPeV1 induced innate immunity with phosphorylation of interferon (IFN) regulatory transcription factor 3 and production of type I IFN in A549 but not T84 cells. Furthermore, type I IFN inhibited HPeV1 production in A549 cells but not T84 cells; T84 cells may be less responsive to type I IFN stimulation. Moreover, HPeV1-infected cells showed downregulated type I IFN activation, which indicated a type I IFN evasion mechanism. The characterization of the complete genome and infection features of HPeV1 provide comprehensive information about this newly isolated HPeV1 for further diagnosis, prevention or treatment strategies.	[Chang, Jenn-Tzong; Chiang, An-Jen; Chao, David] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Chang, Jenn-Tzong; Yang, Chih-Shiang; Lin, You-Sheng; Chang, Tsung-Hsien] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Chang, Jenn-Tzong; Chang, Yu-Hsiang] Kaohsiung Vet Gen Hosp, Dept Pediat, Kaohsiung, Taiwan; [Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Dept Infect Dis, Kaohsiung, Taiwan; [Chen, Bao-Chen] Kaohsiung Vet Gen Hosp, Dept Microbiol, Kaohsiung, Taiwan; [Chiang, An-Jen] Kaohsiung Vet Gen Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Tsai, Wei-Lun] Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan; [Chang, Tsung-Hsien] Tajen Univ, Dept Pharm, Pingtung, Taiwan; [Chang, Tsung-Hsien] Tajen Univ, Grad Inst Pharmaceut Technol, Pingtung, Taiwan	National Sun Yat Sen University; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital	Chang, TH (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan.	david@mail.nsysu.edu.tw	Chang, Tsung-Hsien/AAG-9384-2019	Chang, Tsung-Hsien/0000-0003-4806-7864	National Science Council, Taiwan [NSC 101-2320-B-075B-001-MY3]; Kaohsiung Veterans General Hospital [VGHKS101-017]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Veterans General Hospital	This work was supported by grants from the National Science Council, Taiwan (NSC 101-2320-B-075B-001-MY3) (http://www.most.gov.tw/mp. aspx?mp=7) and Kaohsiung Veterans General Hospital (VGHKS101-017) (http://www.vghks.gov.tw/English/). The funders had no role in the study design, data collection and analysis, preparation of the manuscript, or decision to publish.	Abed Y, 2007, J CLIN MICROBIOL, V45, P2037, DOI 10.1128/JCM.02432-06; Abed Y, 2006, EMERG INFECT DIS, V12, P969, DOI 10.3201/eid1206.051675; Al-Sunaidi M, 2007, J VIROL, V81, P1013, DOI 10.1128/JVI.00584-06; Barral PM, 2007, J VIROL, V81, P3677, DOI 10.1128/JVI.01360-06; Benschop KSM, 2008, J GEN VIROL, V89, P1030, DOI 10.1099/vir.0.83498-0; Benschop KSM, 2010, J GEN VIROL, V91, P145, DOI 10.1099/vir.0.014670-0; Benschop K, 2008, J CLIN VIROL, V41, P69, DOI 10.1016/j.jcv.2007.10.004; Benschop KSM, 2006, CLIN INFECT DIS, V42, P204, DOI 10.1086/498905; BERKOVIC.S, 1968, B NEW YORK ACAD MED, V44, P377; Birenbaum E, 1997, AM J PERINAT, V14, P469, DOI 10.1055/s-2007-994182; Boonyakiat Y, 2001, J VIROL, V75, P10000, DOI 10.1128/JVI.75.20.10000-10004.2001; Bowie AG, 2008, BIOCHEM SOC T, V36, P449, DOI 10.1042/BST0360449; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493; COLLER BAG, 1990, J VIROL, V64, P2692, DOI 10.1128/JVI.64.6.2692-2701.1990; Dalton RM, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-58; Drahos J, 2009, J VIROL, V83, P11581, DOI 10.1128/JVI.01490-09; Drexler JF, 2009, EMERG INFECT DIS, V15, P310, DOI 10.3201/eid1502.081028; Eckerle LD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000896; Feng Q, 2014, J VIROL, V88, P3369, DOI 10.1128/JVI.02712-13; Fensterl V, 2005, J VIROL, V79, P10968, DOI 10.1128/JVI.79.17.10968-10977.2005; FIGUEROA JP, 1989, J MED VIROL, V29, P315, DOI 10.1002/jmv.1890290418; Ghanem-Zoubi N, 2013, J CLIN VIROL, V58, P205, DOI 10.1016/j.jcv.2013.06.001; Ghazi F, 1998, J GEN VIROL, V79, P2641, DOI 10.1099/0022-1317-79-11-2641; Grist N R, 1978, Prog Med Virol, V24, P114; Harvala H, 2009, J INFECT DIS, V199, P1753, DOI 10.1086/599094; Harvala H, 2009, J CLIN VIROL, V45, P1, DOI 10.1016/j.jcv.2009.03.009; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Ho LJ, 2005, J IMMUNOL, V174, P8163, DOI 10.4049/jimmunol.174.12.8163; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hu NZ, 2002, WORLD J GASTROENTERO, V8, P872, DOI 10.3748/wjg.v8.i5.872; HYYPIA T, 1992, P NATL ACAD SCI USA, V89, P8847, DOI 10.1073/pnas.89.18.8847; Ito M, 2004, J GEN VIROL, V85, P391, DOI 10.1099/vir.0.19456-0; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Khetsuriani N, 2006, PEDIATR INFECT DIS J, V25, P889, DOI 10.1097/01.inf.0000237798.07462.32; Li LL, 2009, EMERG INFECT DIS, V15, P288, DOI 10.3201/eid1502.080341; Lorenzo FR, 2008, VIRUS RES, V137, P86, DOI 10.1016/j.virusres.2008.06.005; Lu J, 2012, J VIROL, V86, P3767, DOI 10.1128/JVI.06687-11; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Nateri AS, 2000, J VIROL, V74, P6269, DOI 10.1128/JVI.74.14.6269-6277.2000; Prendergast AJ, 2012, NAT REV IMMUNOL, V12, P636, DOI 10.1038/nri3277; Samuilova O, 2004, J BIOL CHEM, V279, P37822, DOI 10.1074/jbc.M314203200; SCHULTHEISS T, 1995, J VIROL, V69, P1727, DOI 10.1128/JVI.69.3.1727-1733.1995; Seitsonen J, 2010, J VIROL, V84, P8509, DOI 10.1128/JVI.02176-09; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; STANTON GJ, 1977, INFECT IMMUN, V18, P370, DOI 10.1128/IAI.18.2.370-376.1977; Stanway G, 1999, J VIROL, V73, P5249, DOI 10.1128/JVI.73.7.5249-5254.1999; STANWAY G, 1994, J VIROL, V68, P8232, DOI 10.1128/JVI.68.12.8232-8238.1994; Tapia G, 2008, J MED VIROL, V80, P1835, DOI 10.1002/jmv.21283; Tauriainen S, 2008, J INFECT DIS, V198, P35, DOI 10.1086/588677; Verboon-Maciolek MA, 2008, ANN NEUROL, V64, P266, DOI 10.1002/ana.21445; Wang D, 2011, J VIROL, V85, P3758, DOI 10.1128/JVI.02589-10; Watanabe K, 2007, EMERG INFECT DIS, V13, P889, DOI 10.3201/eid1306.060896; Westerhuis BM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-146; Westerhuis BM, 2012, J GEN VIROL, V93, P2363, DOI 10.1099/vir.0.043323-0; WIGAND REINHARD, 1961, ARCH GES VIRUSFORSCH, V11, P224, DOI 10.1007/BF01241688; Williams CH, 2009, J GEN VIROL, V90, P1702, DOI 10.1099/vir.0.008813-0; Zoll J, 2009, J VIROL, V83, P3379, DOI 10.1128/JVI.02529-08	61	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116158	10.1371/journal.pone.0116158	http://dx.doi.org/10.1371/journal.pone.0116158			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646764	gold, Green Published, Green Submitted			2022-12-27	WOS:000348822600021
J	Yu, H; Wang, Q; Sun, Y; Shen, M; Li, H; Duan, YR				Yu, Hui; Wang, Qi; Sun, Ying; Shen, Ming; Li, He; Duan, Yourong			A New PAMPA Model Proposed on the Basis of a Synthetic Phospholipid Membrane	PLOS ONE			English	Article							IN-VITRO MODEL; MIMETIC ARTIFICIAL MEMBRANE; UNSTIRRED WATER LAYER; BLOOD-BRAIN-BARRIER; DRUG ABSORPTION; CACO-2 PERMEABILITY; INTESTINAL-ABSORPTION; PERMEATION ASSAY; BBB PERMEABILITY; FAST PREDICTION	The purpose of this work was to investigate the synthetic phospholipid dependence of permeability measured by parallel artificial membrane permeability assay (PAMPA) method. Three phospholipids with hydrophobic groups of different lengths and phosphorylcholine as the hydrophilic group were concisely synthesized. Ten model drug molecules were selected because of their distinct human fraction absorbed (% FA) values and various pK(a) characteristics. In vitro drug permeation experiments were designed to determine the effect of the incubation time (4-20 h), pH gradient (4.6-9.32) and carbon chain length (8, 10, 12) on the drug permeability through the synthetic phospholipid membrane in the PAMPA system. The results showed that intensive and significant synthetic phospholipids dependence of permeability influenced by the length of lipid's hydrophobic carbon chain. The effective permeability constant (P-e) of each drug increased rapidly with time, then decreased slightly after reaching the maximum; the pH gradient changed the drug permeability according to the pH-partition hypothesis for drugs with diverse pK(a) values; and longer hydrophobic chains in the synthetic phospholipid membrane improved the drug permeability, as observed for all test drugs at almost all incubation time points. This newly proposed PAMPA model considered the synthetic phospholipid membrane and showed good P-e-% FA correlation for the passive transport of drugs, making it a helpful supplementary method for PAMPA systems.	[Yu, Hui; Wang, Qi; Sun, Ying; Shen, Ming; Duan, Yourong] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, State Key Lab Oncogenes & Related Genes,Shanghai, Shanghai 200032, Peoples R China; [Yu, Hui] Wuyi Univ, Coll Text & Clothing, Engn Technol Res Ctr Funct Text Higher Educ Guang, Jiangmen 529020, Guangdong, Peoples R China; [Li, He] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Tradit Chinese Med Dept, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University; Wuyi University; Shanghai Jiao Tong University	Li, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Tradit Chinese Med Dept, Shanghai 200127, Peoples R China.	lihe1972@hotmail.com; yrduan@shsci.org	Wang, Qi/T-9749-2018	Wang, Qi/0000-0003-3694-5826	Natural Science Foundation of China [81272568, 81301973, 81472841]; Science Foundation for Young Teachers of Wuyi University [2013zk12]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation for Young Teachers of Wuyi University	This research was supported by the Natural Science Foundation of China (No. 81272568, No. 81301973 and No. 81472841) and the Science Foundation for Young Teachers of Wuyi University (No. 2013zk12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avdeef A, 2006, EUR J PHARM SCI, V28, P43, DOI 10.1016/j.ejps.2005.12.008; Avdeef A, 2005, EUR J PHARM SCI, V24, P333, DOI 10.1016/j.ejps.2004.11.011; Avdeef A, 2004, EUR J PHARM SCI, V22, P365, DOI 10.1016/j.ejps.2004.04.009; Avdeef A, 2001, EUR J PHARM SCI, V14, P271, DOI 10.1016/S0928-0987(01)00191-9; Avdeef Alex, 2005, Expert Opin Drug Metab Toxicol, V1, P325, DOI 10.1517/17425255.1.2.325; Balimane PV, 2005, J PHARMACEUT BIOMED, V39, P8, DOI 10.1016/j.jpba.2005.03.043; Bendels S, 2006, PHARM RES-DORDR, V23, P2525, DOI 10.1007/s11095-006-9137-8; Bermejo M, 2004, EUR J PHARM SCI, V21, P429, DOI 10.1016/j.ejps.2003.10.009; Corti G, 2006, EUR J PHARM SCI, V27, P354, DOI 10.1016/j.ejps.2005.11.005; Dagenais C, 2009, EUR J PHARM SCI, V38, P121, DOI 10.1016/j.ejps.2009.06.009; Di L, 2003, EUR J MED CHEM, V38, P223, DOI 10.1016/S0223-5234(03)00012-6; Fujikawa M, 2005, BIOORGAN MED CHEM, V13, P4721, DOI 10.1016/j.bmc.2005.04.076; GUTKNECHT J, 1973, SCIENCE, V182, P1258, DOI 10.1126/science.182.4118.1258; Hanlan L, 2003, PHARM RES, V20, P1820, DOI DOI 10.1023/B:PHAM.0000003380.44755.5a; Heseya K, 1998, ANAL CHEM, V70, P943, DOI [10.1021/ac9707038, DOI 10.1021/AC9707038]; HIDALGO IJ, 1990, BIOCHIM BIOPHYS ACTA, V1028, P25, DOI 10.1016/0005-2736(90)90261-L; Hidalgo Ismael J., 2001, Current Topics in Medicinal Chemistry, V1, P385, DOI 10.2174/1568026013395010; Hou TJ, 2007, J CHEM INF MODEL, V47, P208, DOI 10.1021/ci600343x; Kansy M, 1998, J MED CHEM, V41, P1007, DOI 10.1021/jm970530e; Karadzovska D, 2013, EUR J PHARM SCI, V50, P569, DOI 10.1016/j.ejps.2013.02.020; Kerns EH, 2004, J PHARM SCI-US, V93, P1440, DOI 10.1002/jps.20075; KIM DC, 1993, PHARMACEUT RES, V10, P1710; Konradsdottir F, 2009, J PHARM PHARMACOL, V61, P121, DOI 10.1211/jpp/61.01.0017; LUCAS ML, 1994, J THEOR BIOL, V167, P147, DOI 10.1006/jtbi.1994.1059; Mandagere AK, 2002, J MED CHEM, V45, P304, DOI 10.1021/jm010152k; Mensch J, 2010, INT J PHARMACEUT, V395, P182, DOI 10.1016/j.ijpharm.2010.05.037; Mensch J, 2010, EUR J PHARM BIOPHARM, V74, P495, DOI 10.1016/j.ejpb.2010.01.003; Nagahara N, 2004, J PHARM SCI-US, V93, P2972, DOI 10.1002/jps.20206; Neuhoff S, 2003, PHARMACEUT RES, V20, P1141, DOI 10.1023/A:1025032511040; Ottaviani G, 2006, J MED CHEM, V49, P3948, DOI 10.1021/jm060230+; PINTO M, 1983, BIOL CELL, V47, P323; Ruell JA, 2003, EUR J PHARM SCI, V20, P393, DOI 10.1016/j.ejps.2003.08.006; Sinko B, 2012, EUR J PHARM SCI, V45, P698, DOI 10.1016/j.ejps.2012.01.011; Sugano K, 2004, INT J PHARM, V275, P271, DOI 10.1016/j.ijpharm.2004.02.010; Sugano K, 2003, INT J PHARM, V257, P245, DOI 10.1016/S0378-5173(03)00161-3; Sugano K, 2001, INT J PHARM, V228, P181, DOI 10.1016/S0378-5173(01)00845-6; SUGAWARA M, 1990, J PHARM PHARMACOL, V42, P314, DOI 10.1111/j.2042-7158.1990.tb05418.x; WALTER A, 1984, J MEMBRANE BIOL, V77, P255, DOI 10.1007/BF01870573; Wessel MD, 1998, J CHEM INF COMP SCI, V38, P726, DOI 10.1021/ci980029a; Yu H, 2008, J APPL POLYM SCI, V110, P2058, DOI 10.1002/app.28694	40	34	35	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116502	10.1371/journal.pone.0116502	http://dx.doi.org/10.1371/journal.pone.0116502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647086	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600027
J	Zhao, HW; Wang, J; Lu, ZL; Wu, QJ; Lv, HJ; Liu, H; Gong, XY				Zhao, Hongwei; Wang, Jin; Lu, Zhonglie; Wu, Qingjie; Lv, Haijuan; Liu, Hu; Gong, Xiangyang			Superficial Siderosis of the Central Nervous System Induced by a Single-Episode of Traumatic Subarachnoid Hemorrhage: A Study Using MRI-Enhanced Gradient Echo T2 Star-Weighted Angiography	PLOS ONE			English	Article							DEPOSITION; DIAGNOSIS; BRAIN	The purpose of this study was to examine whether a single episode of traumatic subarachnoid hemorrhage (tSAH) could cause superficial siderosis of the central nervous system (SS-CNS). This study was approved by the local ethics committee. Thirty-two patients with a history of a single episode of tSAH were enrolled in the study. An episode of tSAH was confirmed in patients based on a CT scan or a lumbar puncture, and a follow-up examination was conducted at least six weeks after the brain trauma. A follow-up MRI examination was performed, using enhanced gradient echo T2 star-weighted angiography (ESWAN) to detect hemosiderin deposition on the cortical surface. The extent to which hemosiderin deposition was associated with several clinical factors was investigated. Various degrees of hemosiderin deposition were detected in 31 of 32 (96.9%) single-episode tSAH patients. Analysis of contingency tables revealed an association between the regions of subarachnoid bleeding based on CT images and the regions of hemosiderin deposition based on ESWAN images (X-2 = 17.73, P<0.05). SS-CNS was determined to be a common consequence after a single episode of tSAH. The extent of hemosiderin deposition is closely correlated with the initial bleeding sites and bleeding volume.	[Zhao, Hongwei; Lu, Zhonglie; Wu, Qingjie; Lv, Haijuan; Liu, Hu] Jiaxing Univ, Affiliated Hosp 2, Dept Radiol, Jiaxing, Peoples R China; [Zhao, Hongwei] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Radiol, Sch Med, Hangzhou 310027, Zhejiang, Peoples R China; [Wang, Jin] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Neurol, Sch Med, Hangzhou 310027, Zhejiang, Peoples R China; [Gong, Xiangyang] Zhejiang Prov Peoples Hosp, Dept Radiol, Hangzhou, Zhejiang, Peoples R China	Jiaxing University; Zhejiang University; Zhejiang University; Zhejiang Provincial People's Hospital	Gong, XY (corresponding author), Zhejiang Prov Peoples Hosp, Dept Radiol, Hangzhou, Zhejiang, Peoples R China.	cjr.gxy@hotmail.com			Foundation of Science Technology Department of Zhejiang Provincial [2012C33019]; Grant of Health Bureau of Zhejiang Province [2011KYA082]; Science Foundation of Jiaxing Science and Technology Bureau of China [2012AY1071-11]	Foundation of Science Technology Department of Zhejiang Provincial; Grant of Health Bureau of Zhejiang Province; Science Foundation of Jiaxing Science and Technology Bureau of China	This study was supported by the Foundation of Science Technology Department of Zhejiang Provincial (2012C33019), the Grant of Health Bureau of Zhejiang Province (2011KYA082) and the Science Foundation of Jiaxing Science and Technology Bureau of China under Grant (2012AY1071-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angstwurm K, 2002, J NEUROL, V249, P1223, DOI 10.1007/s00415-002-0815-0; FEARNLEY JM, 1995, BRAIN, V118, P1051, DOI 10.1093/brain/118.4.1051; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Haacke EM, 2007, AM J NEURORADIOL, V28, P316; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hayashida Y, 2014, ACTA RADIOL, V55, P201, DOI 10.1177/0284185113495836; Imaizumi T, 2003, STROKE, V34, P1693, DOI 10.1161/01.STR.0000075771.88719.CE; IWANOWSKI L, 1960, J NEUROPATH EXP NEUR, V19, P433, DOI 10.1097/00005072-196007000-00010; JANSS AJ, 1993, J NEUROSURG, V79, P756, DOI 10.3171/jns.1993.79.5.0756; Jiang JY, 2013, INJURY, V44, P1453, DOI 10.1016/j.injury.2012.08.045; Jurkiewicz E, 2010, POL J RADIOL, V75, P47; Kakeda S, 2010, ACAD RADIOL, V17, P871, DOI 10.1016/j.acra.2010.02.014; Khalatbari Kimia, 2009, Radiology, V250, P292, DOI 10.1148/radiol.2501051201; KOEPPEN AH, 1991, J NEUROPATH EXP NEUR, V50, P579, DOI 10.1097/00005072-199109000-00005; Koeppen AH, 2008, ACTA NEUROPATHOL, V116, P371, DOI 10.1007/s00401-008-0421-z; Kumar N, 2006, NEUROLOGY, V66, P1144, DOI 10.1212/01.wnl.0000208510.76323.5b; Kumar N, 2010, AM J NEURORADIOL, V31, P5, DOI 10.3174/ajnr.A1628; Kumar N, 2007, ARCH NEUROL-CHICAGO, V64, P491, DOI 10.1001/archneur.64.4.491; Kumar N, 2009, NEUROLOGY, V72, P671, DOI 10.1212/01.wnl.0000342457.22536.af; Leussink VI, 2003, ACTA NEUROL SCAND, V107, P54, DOI 10.1034/j.1600-0404.2003.02001.x; Levy M, 2007, NAT CLIN PRACT NEURO, V3, P54, DOI 10.1038/ncpneuro0356; Levy M, 2012, STROKE, V43, P120, DOI 10.1161/STROKEAHA.111.628032; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Rumzan R, 2013, EUR J RADIOL, V82, pE95, DOI 10.1016/j.ejrad.2012.09.006; Sehgal V, 2006, J MAGN RESON IMAGING, V24, P41, DOI 10.1002/jmri.20598; Thomas B, 2008, NEURORADIOLOGY, V50, P105, DOI 10.1007/s00234-007-0316-z; Wang J, 2011, CLIN IMAG, V35, P217, DOI 10.1016/j.clinimag.2010.06.003; Wang J, 2009, NEUROLOGY, V72, P1187, DOI 10.1212/01.wnl.0000345359.14275.f2; Yamawaki Takemori, 2013, Brain Nerve, V65, P843	29	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116632	10.1371/journal.pone.0116632	http://dx.doi.org/10.1371/journal.pone.0116632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647424	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600030
J	Lindner, MS; Renard, BY				Lindner, Martin S.; Renard, Bernhard Y.			Metagenomic Profiling of Known and Unknown Microbes with MicrobeGPS	PLOS ONE			English	Article							SINGLE-CELL; COMMUNITY; INSIGHTS	Microbial community profiling identifies and quantifies organisms in metagenomic sequencing data using either reference based or unsupervised approaches. However, current reference based profiling methods only report the presence and abundance of single reference genomes that are available in databases. Since only a small fraction of environmental genomes is represented in genomic databases, these approaches entail the risk of false identifications and often suggest a higher precision than justified by the data. Therefore, we developed MicrobeGPS, a novel metagenomic profiling approach that overcomes these limitations. MicrobeGPS is the first method that identifies microbiota in the sample and estimates their genomic distances to known reference genomes. With this strategy, MicrobeGPS identifies organisms down to the strain level and highlights possibly inaccurate identifications when the correct reference genome is missing. We demonstrate on three metagenomic datasets with different origin that our approach successfully avoids misleading interpretation of results and additionally provides more accurate results than current profiling methods. Our results indicate that MicrobeGPS can enable reference based taxonomic profiling of complex and less characterized microbial communities. MicrobeGPS is open source and available from https://sourceforge.net/projects/microbegps/ as source code and binary distribution for Windows and Linux operating systems.	[Lindner, Martin S.; Renard, Bernhard Y.] Robert Koch Inst, Res Grp Bioinformat NG4, Berlin, Germany	Robert Koch Institute	Renard, BY (corresponding author), Robert Koch Inst, Res Grp Bioinformat NG4, Berlin, Germany.	RenardB@rki.de		Renard, Bernhard/0000-0003-4589-9809	German Federal Ministry of Health [IIA5-2512-FSB-725]	German Federal Ministry of Health	This work was supported by the German Federal Ministry of Health [IIA5-2512-FSB-725 to B.Y.R.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonfert T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073071; Dodsworth JA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2884; Francis OE, 2013, GENOME RES, V23, P1721, DOI 10.1101/gr.150151.112; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lindner MS, 2013, BIOINFORMATICS, V29, P1260, DOI 10.1093/bioinformatics/btt147; Lindner MS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks803; Loman NJ, 2013, JAMA-J AM MED ASSOC, V309, P1502, DOI 10.1001/jama.2013.3231; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; Meinicke P, 2011, BIOINFORMATICS, V27, P1618, DOI 10.1093/bioinformatics/btr266; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nagarajan N, 2013, NAT REV GENET, V14, P157, DOI 10.1038/nrg3367; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Oh S, 2011, APPL ENVIRON MICROB, V77, P6000, DOI 10.1128/AEM.00107-11; Poretsky R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093827; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Sedlazeck FJ, 2013, BIOINFORMATICS, V29, P2790, DOI 10.1093/bioinformatics/btt468; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Siragusa E, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt005; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]; VANRIJSBERGEN C, 1979, INFORM RETRIEVAL; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Wu YW, 2011, J COMPUT BIOL, V18, P523, DOI 10.1089/cmb.2010.0245	30	14	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117711	10.1371/journal.pone.0117711	http://dx.doi.org/10.1371/journal.pone.0117711			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643362	Green Published, gold			2022-12-27	WOS:000348821200040
J	Zhou, MX; Yan, X; Xie, HB; Zheng, H; Xu, DR; Yang, G				Zhou, Min-Xiong; Yan, Xu; Xie, Hai-Bin; Zheng, Hui; Xu, Dongrong; Yang, Guang			Evaluation of Non-Local Means Based Denoising Filters for Diffusion Kurtosis Imaging Using a New Phantom	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; GAUSSIAN WATER DIFFUSION; RICIAN NOISE REMOVAL; MR-IMAGES; MOTION CORRECTION; TENSOR; REDUCTION; CONSTRUCTION; FRAMEWORK; COILS	Image denoising has a profound impact on the precision of estimated parameters in diffusion kurtosis imaging (DKI). This work first proposes an approach to constructing a DKI phantom that can be used to evaluate the performance of denoising algorithms in regard to their abilities of improving the reliability of DKI parameter estimation. The phantom was constructed from a real DKI dataset of a human brain, and the pipeline used to construct the phantom consists of diffusion-weighted (DW) image filtering, diffusion and kurtosis tensor regularization, and DW image reconstruction. The phantom preserves the image structure while minimizing image noise, and thus can be used as ground truth in the evaluation. Second, we used the phantom to evaluate three representative algorithms of non-local means (NLM). Results showed that one scheme of vector-based NLM, which uses DWI data with redundant information acquired at different b-values, produced the most reliable estimation of DKI parameters in terms of Mean Square Error (MSE), Bias and standard deviation (Std). The result of the comparison based on the phantom was consistent with those based on real datasets.	[Zhou, Min-Xiong; Xie, Hai-Bin; Zheng, Hui; Yang, Guang] E China Normal Univ, Dept Phys, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Zhou, Min-Xiong] Univ Shanghai Sci & Technol, Shanghai Med Instrumentat Coll, Shanghai, Peoples R China; [Yan, Xu] Siemens Healthcare, MR Collaborat NE Asia, Shanghai, Peoples R China; [Xu, Dongrong] E China Normal Univ, Inst Cognit Neurosci, Key Lab Brain Funct Genom, Shanghai 200062, Peoples R China; [Xu, Dongrong] Columbia Univ, MRI Unit, New York, NY 10032 USA; [Xu, Dongrong] Columbia Univ, Dept Psychiat, Div Epidemiol, New York, NY 10032 USA; [Xu, Dongrong] New York State Psychiat Inst & Hosp, Unit 24, New York, NY 10032 USA	East China Normal University; University of Shanghai for Science & Technology; Siemens AG; East China Normal University; Columbia University; Columbia University; New York State Psychiatry Institute	Xu, DR (corresponding author), E China Normal Univ, Inst Cognit Neurosci, Key Lab Brain Funct Genom, Shanghai 200062, Peoples R China.	dx2103@columbia.edu; gyang@phy.ecnu.edu.cn	Yang, Guang/AAU-3926-2020	Yang, Guang/0000-0001-8942-427X	Science Research Startup Foundation of Shanghai Medical Instrumentation College [E102001400132]; China National Science Foundation [81471734]; Large Scale Equipment Foundation of East China Normal University; NIBIB [1R03EB008235]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB008235] Funding Source: NIH RePORTER	Science Research Startup Foundation of Shanghai Medical Instrumentation College; China National Science Foundation(National Natural Science Foundation of China (NSFC)); Large Scale Equipment Foundation of East China Normal University; NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work is supported by Science Research Startup Foundation of Shanghai Medical Instrumentation College (Grant E102001400132), China National Science Foundation (Grant 81471734), the Large Scale Equipment Foundation of East China Normal University, and NIBIB Grant 1R03EB008235. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AELTERMAN J, 2009, SUPPRESSION CORRELAT, P13897; Aja-Fernandez S, 2008, IEEE T MED IMAGING, V27, P1389, DOI 10.1109/TMI.2008.920609; Aksoy M, 2011, MAGN RESON MED, V66, P366, DOI 10.1002/mrm.22787; Alhamud A, 2012, MAGN RESON MED, V68, P1097, DOI 10.1002/mrm.23314; Bansal R, 2009, MED IMAGE ANAL, V13, P580, DOI 10.1016/j.media.2009.05.001; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basu S, 2006, LECT NOTES COMPUT SC, V4190, P117; Blockx I, 2012, NEUROIMAGE, V59, P957, DOI 10.1016/j.neuroimage.2011.08.062; Brion V, 2011, LECT NOTES COMPUT SC, V6892, P226, DOI 10.1007/978-3-642-23629-7_28; Buades A, 2005, MULTISCALE MODEL SIM, V4, P490, DOI 10.1137/040616024; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; Coupe P, 2008, IEEE T MED IMAGING, V27, P425, DOI 10.1109/TMI.2007.906087; Coupe P, 2006, LECT NOTES COMPUT SC, V4191, P33; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Ding ZH, 2005, MAGN RESON MED, V53, P485, DOI 10.1002/mrm.20339; Falangola MF, 2008, J MAGN RESON IMAGING, V28, P1345, DOI 10.1002/jmri.21604; Goerner FL, 2011, MED PHYS, V38, P5049, DOI 10.1118/1.3618730; Haldar JP, 2013, MAGN RESON MED, V69, P277, DOI 10.1002/mrm.24229; Helpern JA, 2011, J MAGN RESON IMAGING, V33, P17, DOI 10.1002/jmri.22397; JENSEN CR, 2011, WHITE MATTER CHARACT, P13897; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Liu H, 2010, MAGN RESON IMAGING, V28, P1485, DOI 10.1016/j.mri.2010.06.023; Lu HZ, 2006, NMR BIOMED, V19, P236, DOI 10.1002/nbm.1020; Manjon JV, 2008, MED IMAGE ANAL, V12, P514, DOI 10.1016/j.media.2008.02.004; Manjon JV, 2009, INT J BIOMED IMAGING, V2009, DOI 10.1155/2009/756897; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; Naegel B, 2009, MED IMAGE ANAL, V13, P598, DOI 10.1016/j.media.2009.05.006; Parker GJM, 2000, J MAGN RESON IMAGING, V11, P702, DOI 10.1002/1522-2586(200006)11:6<702::AID-JMRI18>3.0.CO;2-A; Pennec X, 2006, INT J COMPUT VISION, V66, P41, DOI 10.1007/s11263-005-3222-z; POOT DHJ, 2009, P INT SOC MAG RESON, V17, P1394; Porter DA, 2009, MAGN RESON MED, V62, P468, DOI 10.1002/mrm.22024; Raab P, 2010, RADIOLOGY, V254, P876, DOI 10.1148/radiol.09090819; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Sijbers J, 2004, MAGNET RESON MED, V51, P586, DOI 10.1002/mrm.10728; Tabelow K, 2008, NEUROIMAGE, V39, P1763, DOI 10.1016/j.neuroimage.2007.10.024; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Tristan-Vega A, 2010, MED IMAGE ANAL, V14, P205, DOI 10.1016/j.media.2009.11.001; Tristan-Vega A, 2009, LECT NOTES COMPUT SC, V5761, P951, DOI 10.1007/978-3-642-04268-3_117; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Van Hecke W, 2009, NEUROIMAGE, V46, P692, DOI 10.1016/j.neuroimage.2009.02.032; Veraart J, 2011, MAGN RESON MED, V66, P678, DOI 10.1002/mrm.22835; Veraart J, 2011, MAGN RESON MED, V65, P138, DOI 10.1002/mrm.22603; Wang JJ, 2011, RADIOLOGY, V261, P210, DOI 10.1148/radiol.11102277; Wiest-Daessle N, 2007, LECT NOTES COMPUT SC, V4792, P344; Wiest-Daessle N, 2008, LECT NOTES COMPUT SC, V5242, P171, DOI 10.1007/978-3-540-85990-1_21; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Xu D, 2004, MAGN RESON IMAGING, V22, P751, DOI 10.1016/j.mri.2004.01.075; Yan X, 2014, COMPUT MED IMAG GRAP, V38, P469, DOI 10.1016/j.compmedimag.2014.06.010; Yan X, 2013, COMPUT MED IMAG GRAP, V37, P272, DOI 10.1016/j.compmedimag.2013.04.007; Zhang YZ, 2013, CLIN NEURORADIOL, V23, P293, DOI 10.1007/s00062-013-0212-3	50	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116986	10.1371/journal.pone.0116986	http://dx.doi.org/10.1371/journal.pone.0116986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643162	Green Published, Green Submitted, gold			2022-12-27	WOS:000348821200030
J	Bernardino, F; Rentmeister, K; Schmidt, MJ; Bruehschwein, A; Matiasek, K; Matiasek, LA; Lauda, A; Schoon, HA; Fischer, A				Bernardino, Filipa; Rentmeister, Kai; Schmidt, Martin J.; Bruehschwein, Andreas; Matiasek, Kaspar; Matiasek, Lara A.; Lauda, Alexander; Schoon, Heinz A.; Fischer, Andrea			Inferior Cerebellar Hypoplasia Resembling a Dandy-Walker-Like Malformation in Purebred Eurasier Dogs with Familial Non-Progressive Ataxia: A Retrospective and Prospective Clinical Cohort Study	PLOS ONE			English	Article							LIPOPROTEIN RECEPTOR GENE; IMAGING DIAGNOSIS; DYSEQUILIBRIUM SYNDROME; VERMIAN HYPOPLASIA; PRENATAL-DIAGNOSIS; MENTAL-RETARDATION; VARIANT; CLASSIFICATION; HYDROCEPHALUS; MUTATIONS	Cerebellar malformations can be inherited or caused by insults during cerebellar development. To date, only sporadic cases of cerebellar malformations have been reported in dogs, and the genetic background has remained obscure. Therefore, this study's objective was to describe the clinical characteristics, imaging features and pedigree data of a familial cerebellar hypoplasia in purebred Eurasier dogs. A uniform cerebellar malformation characterized by consistent absence of the caudal portions of the cerebellar vermis and, to a lesser degree, the caudal portions of the cerebellar hemispheres in association with large retrocerebellar fluid accumulations was recognized in 14 closely related Eurasier dogs. Hydrocephalus was an additional feature in some dogs. All dogs displayed non-progressive ataxia, which had already been noted when the dogs were 5 - 6 weeks old. The severity of the ataxia varied between dogs, from mild truncal sway, subtle dysmetric gait, dysequilibrium and pelvic limb ataxia to severe cerebellar ataxia in puppies and episodic falling or rolling. Follow-up examinations in adult dogs showed improvement of the cerebellar ataxia and a still absent menace response. Epileptic seizures occurred in some dogs. The association of partial vermis agenesis with an enlarged fourth ventricle and an enlarged caudal (posterior) fossa resembled a Dandy-Walker-like malformation in some dogs. Pedigree analyses were consistent with autosomal recessive inheritance.	[Bernardino, Filipa; Matiasek, Lara A.; Lauda, Alexander; Fischer, Andrea] Univ Munich, Ctr Clin Vet Med, Clin Small Anim Med, Munich, Germany; [Rentmeister, Kai] Tierarztliche Praxis Neurol, Dettelbach, Germany; [Schmidt, Martin J.] Univ Giessen, Dept Vet Clin Sci, Small Anim Clin, D-35390 Giessen, Germany; [Bruehschwein, Andreas] Univ Munich, Ctr Clin Vet Med, Clin Small Anim Surg & Reprod, Munich, Germany; [Matiasek, Kaspar] Univ Munich, Ctr Clin Vet Med, Sect Clin & Comparat Neuropathol, Munich, Germany; [Schoon, Heinz A.] Univ Leipzig, Fac Vet Med, Inst Pathol, D-04109 Leipzig, Germany	University of Munich; Justus Liebig University Giessen; University of Munich; University of Munich; Leipzig University	Fischer, A (corresponding author), Univ Munich, Ctr Clin Vet Med, Clin Small Anim Med, Munich, Germany.	andreafischer@lmu.de	Fischer, Andrea/AFV-0155-2022	Matiasek, Kaspar/0000-0001-5021-3280; Fischer, Andrea/0000-0001-7094-1947				Abdel-Salam GMH, 2006, BRAIN DEV-JPN, V28, P529, DOI 10.1016/j.braindev.2006.01.009; Aldinger KA, 2009, NAT GENET, V41, P1037, DOI 10.1038/ng.422; Alexiou GA, 2010, J CHILD NEUROL, V25, P188, DOI 10.1177/0883073809338410; Ali BR, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-80; Barkovich AJ, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00007; Barkovich AJ, 2009, BRAIN, V132, P3199, DOI 10.1093/brain/awp247; BARKOVICH AJ, 1989, AM J NEURORADIOL, V10, P977; BENDA CE, 1954, J NEUROPATH EXP NEUR, V13, P14, DOI 10.1093/jnen/13.1.14; Blank MC, 2011, DEVELOPMENT, V138, P1207, DOI 10.1242/dev.054114; Bolduc ME, 2009, DEV MED CHILD NEUROL, V51, P256, DOI 10.1111/j.1469-8749.2008.03224.x; Boycott KM, 2009, J CHILD NEUROL, V24, P1310, DOI 10.1177/0883073809332696; Carrera I, 2009, AM J VET RES, V70, P340, DOI 10.2460/ajvr.70.3.340; Choi H, 2007, VET RADIOL ULTRASOUN, V48, P129, DOI 10.1111/j.1740-8261.2007.00217.x; Dandy WE, 1914, AM J DIS CHILD, V8, P406; DeLahunta A, 2009, CEREBELLUM VET NEURO, P348, DOI [10.1002/wsbm.50, DOI 10.1002/WSBM.50]; Dow RS, 1940, J COMP NEUROL, V72, P569, DOI 10.1002/cne.900720307; Economou A, 2012, J CHILD NEUROL, V27, P930, DOI 10.1177/0883073811429500; Ferraris A, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-75; Garel C, 2011, J CHILD NEUROL, V26, P1483, DOI 10.1177/0883073811420148; Gerber M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0108917; Glass HC, 2005, DEV MED CHILD NEUROL, V47, P691, DOI 10.1017/S0012162205001404; Grinberg I, 2004, NAT GENET, V36, P1053, DOI 10.1038/ng1420; Guibaud L, 2012, PRENATAL DIAG, V32, P185, DOI 10.1002/pd.3828; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Imataka George, 2007, Congenital Anomalies, V47, P113, DOI 10.1111/j.1741-4520.2007.00158.x; Klein O, 2003, CHILD NERV SYST, V19, P484, DOI 10.1007/s00381-003-0782-5; KNECHT CD, 1979, J AM ANIM HOSP ASSOC, V15, P51; Kobatake Y, 2013, J VET MED SCI, V75, P1379, DOI 10.1292/jvms.12-0550; Kolb LE, 2010, NEUROGENETICS, V11, P319, DOI 10.1007/s10048-009-0232-y; KORNEGAY JN, 1986, VET PATHOL, V23, P374, DOI 10.1177/030098588602300405; Lim BC, 2011, J CHILD NEUROL, V26, P615, DOI 10.1177/0883073810384996; Lim JH, 2008, J VET SCI, V9, P215, DOI 10.4142/jvs.2008.9.2.215; Mademont-Soler I, 2010, AM J MED GENET A, V152A, P2308, DOI 10.1002/ajmg.a.33550; Malinger G, 2009, PRENATAL DIAG, V29, P372, DOI 10.1002/pd.2196; McCormack WM, 2002, AM J MED GENET, V112, P384, DOI 10.1002/ajmg.10659; Millen KJ, 2008, CURR OPIN NEUROBIOL, V18, P12, DOI 10.1016/j.conb.2008.05.010; Moheb LA, 2008, EUR J HUM GENET, V16, P270, DOI 10.1038/sj.ejhg.5201967; MURRAY JC, 1985, CLIN GENET, V28, P272; Niesen Charles E, 2002, Semin Pediatr Neurol, V9, P320, DOI 10.1053/spen.2002.32508; Notaridis G, 2006, NEUROPATH APPL NEURO, V32, P344, DOI 10.1111/j.1365-2990.2006.00719.x; Noureddine C, 2004, VET RADIOL ULTRASOUN, V45, P336, DOI 10.1111/j.1740-8261.2004.04064.x; Oczelik T, 2008, P NATL ACAD SCI USA, V105, P4032, DOI [10.1073/pnas.0800376105, DOI 10.1073/PNAS.0800376105]; PALMER AC, 1973, J SMALL ANIM PRACT, V14, P343, DOI 10.1111/j.1748-5827.1973.tb06468.x; Parisi MA, 2003, MOL GENET METAB, V80, P36, DOI 10.1016/j.ymgme.2003.08.010; PASS DA, 1981, VET PATHOL, V18, P405, DOI 10.1177/030098588101800315; Patel S, 2002, AM J NEURORADIOL, V23, P1074; Resibois A, 2007, VET PATHOL, V44, P831, DOI 10.1354/vp.44-6-831; Sarac O, 2012, OPHTHALMIC GENET, V33, P249, DOI 10.3109/13816810.2012.689412; Sasaki-Adams D, 2008, J NEUROSURG-PEDIATR, V2, P194, DOI 10.3171/PED/2008/2/9/194; Schatzberg SJ, 2003, J VET INTERN MED, V17, P538, DOI 10.1892/0891-6640(2003)017&lt;0538:PCRPAO&gt;2.3.CO;2; SCHMID V, 1992, J AM ANIM HOSP ASSOC, V28, P355; Schmidt MJ, 2008, VET RADIOL ULTRASOUN, V49, P264, DOI 10.1111/j.1740-8261.2008.00362.x; Shekdar K, 2011, SEMIN ULTRASOUND CT, V32, P228, DOI 10.1053/j.sult.2011.02.003; Spennato P, 2011, CHILD NERV SYST, V27, P1665, DOI 10.1007/s00381-011-1544-4; STOLL C, 1990, AM J MED GENET, V37, P124, DOI 10.1002/ajmg.1320370129; Taggart JK, 1942, ARCH NEURO PSYCHIATR, V48, P583, DOI 10.1001/archneurpsyc.1942.02290100083008; Turkmen S, 2008, EUR J HUM GENET, V16, P1070, DOI 10.1038/ejhg.2008.73; Vasudevan C, 2012, SEMIN FETAL NEONAT M, V17, P295, DOI 10.1016/j.siny.2012.07.001; Wakeling EL, 2002, CLIN DYSMORPHOL, V11, P15, DOI 10.1097/00019605-200201000-00003; Weimer J, 2006, CYTOGENET GENOME RES, V114, P235, DOI 10.1159/000094206; Zanni G, 2011, NEUROGENETICS, V12, P241, DOI 10.1007/s10048-011-0283-8	61	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117670	10.1371/journal.pone.0117670	http://dx.doi.org/10.1371/journal.pone.0117670			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668516	gold, Green Published, Green Submitted			2022-12-27	WOS:000349493000025
J	D'Aoust, LN; Cummings, AC; Laux, R; Fuzzell, D; Caywood, L; Reinhart-Mercer, L; Scott, WK; Pericak-Vance, MA; Haines, JL				D'Aoust, Laura N.; Cummings, Anna C.; Laux, Renee; Fuzzell, Denise; Caywood, Laura; Reinhart-Mercer, Lori; Scott, William K.; Pericak-Vance, Margaret A.; Haines, Jonathan L.			Examination of Candidate Exonic Variants for Association to Alzheimer Disease in the Amish	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN-E; IDENTIFIES VARIANTS; COGNITIVE DECLINE; COMMON VARIANTS; DEMENTIA; ONSET; ALLELE; GENOTYPE; AGE	Alzheimer disease (AD) is the most common cause of dementia. As with many complex diseases, the identified variants do not explain the total expected genetic risk that is based on heritability estimates for AD. Isolated founder populations, such as the Amish, are advantageous for genetic studies as they overcome heterogeneity limitations associated with complex population studies. We determined that Amish AD cases harbored a significantly higher burden of the known risk alleles compared to Amish cognitively normal controls, but a significantly lower burden when compared to cases from a dataset of unrelated individuals. Whole-exome sequencing of a selected subset of the overall study population was used as a screening tool to identify variants located in the regions of the genome that are most likely to contribute risk. By then genotyping the top candidate variants from the known AD genes and from linkage regions implicated previous studies in the full dataset, new associations could be confirmed. The most significant result (p = 0.0012) was for rs73938538, a synonymous variant in LAMA1 within the previously identified linkage peak on chromosome 18. However, this association is specific to the Amish and did not generalize when tested in a dataset of unrelated individuals. These results suggest that additional risk variation in the Amish remains to be identified and likely resides outside of the classical protein coding gene regions.	[D'Aoust, Laura N.; Cummings, Anna C.; Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Med Ctr, Nashville, TN 37232 USA; [Laux, Renee; Fuzzell, Denise; Haines, Jonathan L.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Laux, Renee; Fuzzell, Denise; Haines, Jonathan L.] Case Western Reserve Univ, Inst Computat Biol, Cleveland, OH 44106 USA; [Caywood, Laura; Reinhart-Mercer, Lori; Scott, William K.; Pericak-Vance, Margaret A.] Univ Miami, Hussman Inst Human Genom, Miller Sch Med, Miami, FL 33101 USA	Vanderbilt University; Case Western Reserve University; Case Western Reserve University; University of Miami	Cummings, AC (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, Med Ctr, Nashville, TN 37232 USA.	laura.n.daoust@vanderbilt.edu	Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728; Scott, William/0000-0001-9336-6404	National Institutes of Health [AG019085, AG019726]; National Institute of General Medical Sciences [T32 GM007347]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019085, R01AG019726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health [AG019085 to JLH and MAP-V, AG019726 to WKS]; and the National Institute of General Medical Sciences [T32 GM007347]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2003, AM J MED GENET C, V121C, P32, DOI 10.1002/ajmg.c.20004; Beachy L, 2011, UNSER LEIT THE STORY; Bomboi G, 2010, NEUROL SCI, V31, P1, DOI 10.1007/s10072-009-0151-6; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; Cummings AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062615; Cummings AC, 2012, ANN HUM GENET, V76, P342, DOI 10.1111/j.1469-1809.2012.00721.x; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Goldstein FC, 2001, NEUROLOGY, V57, P1923, DOI 10.1212/WNL.57.10.1923; Graff-Radford NR, 2002, ARCH NEUROL-CHICAGO, V59, P594, DOI 10.1001/archneur.59.4.594; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; HENDERSON AS, 1995, LANCET, V346, P1387, DOI 10.1016/S0140-6736(95)92405-1; Holder J, 1998, J NEUROPSYCH CLIN N, V10, P100, DOI 10.1176/jnp.10.1.100; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hsiung GYR, 2004, CAN MED ASSOC J, V171, P863, DOI 10.1503/cmaj.1031789; Johnson CC, 1997, INT J EPIDEMIOL, V26, P387, DOI 10.1093/ije/26.2.387; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Karlin S, 1996, J MOL BIOL, V262, P459, DOI 10.1006/jmbi.1996.0528; Lambert JC, 2013, NAT GENET, DOI [10.1038/ng.2856, DOI 10.1038/NG.2856]; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Myers RH, 1996, NEUROLOGY, V46, P673, DOI 10.1212/WNL.46.3.673; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; POLVIKOSKI T, 1995, NEW ENGL J MED, V333, P1242, DOI 10.1056/NEJM199511093331902; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Skoog I, 1998, J NEUROL NEUROSUR PS, V64, P37, DOI 10.1136/jnnp.64.1.37; Slooter AJC, 2004, NEUROLOGY, V62, P1196, DOI 10.1212/01.WNL.0000118302.66674.E1; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Thornton T, 2007, AM J HUM GENET, V81, P321, DOI 10.1086/519497; Virtanen I, 2000, EXP CELL RES, V257, P298, DOI 10.1006/excr.2000.4883; Yousif LF, 2013, CELL ADHES MIGR, V7, P101, DOI 10.4161/cam.22680	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0118043	10.1371/journal.pone.0118043	http://dx.doi.org/10.1371/journal.pone.0118043			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668194	gold, Green Published, Green Submitted			2022-12-27	WOS:000349493000039
J	Denes, J; Kasuki, L; Trivellin, G; Colli, LM; Takiya, CM; Stiles, CE; Barry, S; de Castro, M; Gadelha, MR; Korbonits, M				Denes, Judit; Kasuki, Leandro; Trivellin, Giampaolo; Colli, Leandro M.; Takiya, Christina M.; Stiles, Craig E.; Barry, Sayka; de Castro, Margaret; Gadelha, Monica R.; Korbonits, Marta			Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas	PLOS ONE			English	Article							PITUITARY-ADENOMA PREDISPOSITION; SOMATOSTATIN ANALOGS; CELL-LINE; MUTATIONS; GROWTH; GENE; PREDICTOR; MICRORNAS; MIRNAS; FAMILY	Introduction Patients with germline AIP mutations or low AIP protein expression have large, invasive somatotroph adenomas and poor response to somatostatin analogues (SSA). Methods To study the mechanism of low AIP protein expression 31 sporadic somatotropinomas with low (n = 13) or high (n = 18) AIP protein expression were analyzed for expression of AIP messenger RNA (mRNA) and 11 microRNAs (miRNAs) predicted to bind the 3'UTR of AIP. Luciferase reporter assays of wild-type and deletion constructs of AIP-3'UTR were used to study the effect of the selected miRNAs in GH3 cells. Endogenous AIP protein and mRNA levels were measured after miRNA over-and underexpression in HEK293 and GH3 cells. Results No significant difference was observed in AIP mRNA expression between tumors with low or high AIP protein expression suggesting post-transcriptional regulation. miR-34a was highly expressed in low AIP protein samples compared high AIP protein adenomas and miR-34a levels were inversely correlated with response to SSA therapy. miR-34a inhibited the luciferase-AIP-3'UTR construct, suggesting that miR-34a binds to AIP-3'UTR. Deletion mutants of the 3 different predicted binding sites in AIP-3'UTR identified the c.*6-30 site to be involved in miR-34a's activity. miR-34a overexpression in HEK293 and GH3 cells resulted in inhibition of endogenous AIP protein expression. Conclusion Low AIP protein expression is associated with high miR-34a expression. miR-34a can down-regulate AIP-protein but not RNA expression in vitro. miR-34a is a negative regulator of AIP-protein expression and could be responsible for the low AIP expression observed in somatotropinomas with an invasive phenotype and resistance to SSA.	[Denes, Judit; Trivellin, Giampaolo; Stiles, Craig E.; Barry, Sayka; Korbonits, Marta] Queen Mary Univ London, Barts & London Sch Med, Dept Endocrinol, William Harvey Res Inst, London, England; [Denes, Judit] Semmelweis Univ, Doctoral Sch Clin Med, Sch PhD Studies, H-1085 Budapest, Hungary; [Kasuki, Leandro; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Endocrinol Unit, Rio De Janeiro, Brazil; [Colli, Leandro M.; de Castro, Margaret] Univ Sao Paulo, Ribeirao Preto Med Sch, Endocrinol Lab, Dept Internal Med, Sao Paulo, Brazil; [Takiya, Christina M.] Univ Fed Rio de Janeiro, Biofis Carlos Chagas Filho Inst, Rio De Janeiro, Brazil	University of London; Queen Mary University London; Semmelweis University; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro	Korbonits, M (corresponding author), Queen Mary Univ London, Barts & London Sch Med, Dept Endocrinol, William Harvey Res Inst, London, England.	m.korbonits@qmul.ac.uk	de Castro, Margaret/A-4918-2009; Colli, Leandro/A-3445-2009; Trivellin, Giampaolo/J-6583-2016; Takiya, Christina/AAU-5959-2021; Kasuki, Leandro/R-8117-2019	de Castro, Margaret/0000-0003-4932-4623; Colli, Leandro/0000-0001-6928-1195; Trivellin, Giampaolo/0000-0003-2384-4153; Takiya, Christina/0000-0002-8019-628X; Korbonits, Marta/0000-0002-4101-9432	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [142479/2011-0, 308105 2011-7]; Wellcome Trust Clinical Training Fellowship [097970/Z/11/Z]; Pfizer [WS 733753]; National Institute for Health Research [ACF-2010-19-002] Funding Source: researchfish	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Wellcome Trust Clinical Training Fellowship(Wellcome Trust); Pfizer(Pfizer); National Institute for Health Research(National Institute for Health Research (NIHR))	LK received a grant (142479/2011-0) from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, www.cnpq.br). CES was supported by a Wellcome Trust Clinical Training Fellowship (097970/Z/11/Z, www.wellcome.ac.uk) and part of the work was supported by a research grant from Pfizer to MK (WS 733753, www.pfizer.com). MRG received a grant (308105 2011-7) from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; BANCROFT FC, 1969, J CELL BIOL, V43, P432, DOI 10.1083/jcb.43.3.432; Beckers A, 2013, ENDOCR REV, V34, P239, DOI 10.1210/er.2012-1013; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Bottoni A, 2007, J CELL PHYSIOL, V210, P370, DOI 10.1002/jcp.20832; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chahal HS, 2012, J CLIN ENDOCR METAB, V97, pE1411, DOI 10.1210/jc.2012-1111; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; D'Angelo D, 2012, J CLIN ENDOCR METAB, V97, pE1128, DOI 10.1210/jc.2011-3482; Daly AF, 2007, J CLIN ENDOCR METAB, V92, P1891, DOI 10.1210/jc.2006-2513; Daly AF, 2010, J CLIN ENDOCR METAB, V95, pE373, DOI 10.1210/jc.2009-2556; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fougner SL, 2012, CLIN ENDOCRINOL, V76, P96, DOI 10.1111/j.1365-2265.2011.04163.x; Gadelha MR, 2013, TRENDS ENDOCRIN MET, V24, P238, DOI 10.1016/j.tem.2012.11.007; Giustina A, 2010, J CLIN ENDOCR METAB, V95, P3141, DOI 10.1210/jc.2009-2670; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Igreja S, 2010, HUM MUTAT, V31, P950, DOI 10.1002/humu.21292; Jaffrain-Rea ML, 2009, ENDOCR-RELAT CANCER, V16, P1029, DOI 10.1677/ERC-09-0094; de Pinho LKJ, 2011, NEUROENDOCRINOLOGY, V94, P39, DOI 10.1159/000322787; Kastl L, 2012, BREAST CANCER RES TR, V131, P445, DOI 10.1007/s10549-011-1424-3; Kasuki L, 2013, EUR J ENDOCRINOL, V169, P217, DOI 10.1530/EJE-13-0349; Kasuki L, 2012, ENDOCR-RELAT CANCER, V19, pL25, DOI 10.1530/ERC-12-0020; KNOSP E, 1993, NEUROSURGERY, V33, P610, DOI 10.1227/00006123-199310000-00008; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mao ZG, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-79; Nanzer AM, 2004, EUR J ENDOCRINOL, V151, P233, DOI 10.1530/eje.0.1510233; Obari A, 2008, ENDOCR PATHOL, V19, P82, DOI 10.1007/s12022-008-9029-z; Pabinger S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-268; Palumbo T, 2013, ONCOGENE, V32, P1651, DOI 10.1038/onc.2012.190; Patel MI, 2005, BIOTECHNOL LETT, V27, P805, DOI 10.1007/s10529-005-5803-x; Raitila A, 2007, ENDOCR-RELAT CANCER, V14, P901, DOI 10.1677/ERC-07-0025; Rizzo M, 2012, NUCLEIC ACID THER, V22, P283, DOI 10.1089/nat.2012.0343; Sotillo E, 2011, ONCOGENE, V30, P2587, DOI 10.1038/onc.2010.634; TASHJIAN AH, 1968, ENDOCRINOLOGY, V82, P342, DOI 10.1210/endo-82-2-342; Trivellin G, 2012, AM J PHYSIOL-ENDOC M, V303, pE708, DOI 10.1152/ajpendo.00546.2011; Neto LV, 2011, ARQ BRAS ENDOCRINOL, V55, P91, DOI 10.1590/S0004-27302011000200001; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Vogt M, 2011, VIRCHOWS ARCH, V458, P313, DOI 10.1007/s00428-010-1030-5; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; Zatelli MC, 2013, PITUITARY, V16, P238, DOI 10.1007/s11102-012-0409-5	44	43	46	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117107	10.1371/journal.pone.0117107	http://dx.doi.org/10.1371/journal.pone.0117107			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658813	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900102
J	Gabruk, M; Stecka, A; Strzalka, W; Kruk, J; Strzalka, K; Mysliwa-Kurdziel, B				Gabruk, Michal; Stecka, Anna; Strzalka, Wojciech; Kruk, Jerzy; Strzalka, Kazimierz; Mysliwa-Kurdziel, Beata			Photoactive Protochlorophyllide-Enzyme Complexes Reconstituted with PORA, PORB and PORC Proteins of A. thaliana: Fluorescence and Catalytic Properties	PLOS ONE			English	Article							ETIOPLAST INNER MEMBRANES; ARABIDOPSIS-THALIANA; CHLOROPHYLL BIOSYNTHESIS; PROLAMELLAR BODIES; BARLEY ETIOPLASTS; WHEAT ETIOPLASTS; OXIDOREDUCTASE; LIGHT; NADPH; FORMS	Photoactive Pchlide-POR-NADPH complexes were reconstituted using protochlorophyllide (Pchlide) and recombinant light-dependent protochlorophyllide oxidoreductase (POR) proteins, His(6)-PORA, His(6)-PORB and His(6)-PORC, from Arabidopsis thaliana. We did not observe any differences in the kinetics of the protochlorophyllide photoreduction at room temperature among the PORA, PORB and PORC proteins. In contrast, the PORC protein showed lower yield of Chlide formation than PORA and PORB when preincubated in the dark for 30 min and then illuminated for a short time. The most significant observation was that reconstituted Pchlide-POR-NADPH complexes showed fluorescence maxima at 77 K similar to those observed for highly aggregated Pchlide-POR-NADPH complexes in prolamellar bodies (PLBs) in vivo. Homology models of PORA, PORB and PORC of Arabidopsis thaliana were developed to compare predicted structures of POR isoforms. There were only slight structural differences, mainly in the organisation of helices and loops, but not in the shape of whole molecules. This is the first comparative analysis of all POR isoforms functioning at different stages of A. thaliana development.	[Gabruk, Michal; Stecka, Anna; Kruk, Jerzy; Strzalka, Kazimierz; Mysliwa-Kurdziel, Beata] Jagiellonian Univ, Dept Plant Physiol & Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Strzalka, Wojciech] Jagiellonian Univ, Dept Plant Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland	Jagiellonian University; Jagiellonian University	Mysliwa-Kurdziel, B (corresponding author), Jagiellonian Univ, Dept Plant Physiol & Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	b.mysliwa-kurdziel@uj.edu.pl	Mysliwa-Kurdziel, Beata/AAF-1478-2020	Mysliwa-Kurdziel, Beata/0000-0002-3361-7934; Strzalka, Wojciech/0000-0002-4541-8545; Gabruk, Michal/0000-0002-5639-2475	Polish National Centre of Science (NCN) [2011/01/B/NZ1/00119]	Polish National Centre of Science (NCN)	This work was supported by grant 2011/01/B/NZ1/00119 from the Polish National Centre of Science (NCN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG GA, 1995, PLANT PHYSIOL, V108, P1505, DOI 10.1104/pp.108.4.1505; Armstrong GA, 2000, TRENDS PLANT SCI, V5, P40, DOI 10.1016/S1360-1385(99)01513-7; Belyaeva OB, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1458, DOI 10.1134/S0006297907130044; Blomqvist LA, 2008, PHOTOSYNTH RES, V96, P37, DOI 10.1007/s11120-007-9281-y; BODDI B, 1993, J PHOTOCH PHOTOBIO B, V21, P125, DOI 10.1016/1011-1344(93)80174-8; BODDI B, 1992, J PHOTOCH PHOTOBIO B, V12, P389, DOI 10.1016/1011-1344(92)85043-T; BODDI B, 1989, PHYSIOL PLANTARUM, V76, P135, DOI 10.1111/j.1399-3054.1989.tb05622.x; BODDI B, 1991, PHOTOCHEM PHOTOBIOL, V53, P667; BODDI B, 1990, PHOTOCHEM PHOTOBIOL, V52, P83, DOI 10.1111/j.1751-1097.1990.tb01759.x; Boddi B, 1994, HUM ENV SCI, V3, P39; Bollivar DW, 2006, PHOTOSYNTH RES, V90, P173, DOI 10.1007/s11120-006-9076-6; Chahdi MAO, 1998, PLANTA, V206, P673, DOI 10.1007/s004250050446; Gabruk M, 2012, PHOTOSYNTHETICA, V50, P529, DOI 10.1007/s11099-012-0057-z; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; HOLTORF H, 1995, P NATL ACAD SCI USA, V92, P3254, DOI 10.1073/pnas.92.8.3254; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kis-Petik K, 1999, PHOTOSYNTH RES, V60, P87, DOI 10.1023/A:1006238921189; Klement H, 2000, FEBS LETT, V480, P306, DOI 10.1016/S0014-5793(00)01887-1; Kosa A, 2006, BBA-BIOENERGETICS, V1757, P811, DOI 10.1016/j.bbabio.2006.05.039; KOTZABASIS K, 1990, PHOTOCHEM PHOTOBIOL, V52, P95, DOI 10.1111/j.1751-1097.1990.tb01761.x; Kruk J, 2004, CHROMATOGRAPHIA, V60, P117, DOI 10.1365/s10337-004-0320-y; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebedev N, 2001, BIOCHEMISTRY-US, V40, P12562, DOI 10.1021/bi0105025; Lebedev N, 1998, PHOTOSYNTH RES, V58, P5, DOI 10.1023/A:1006082119102; Masuda T, 2003, PLANT CELL PHYSIOL, V44, P963, DOI 10.1093/pcp/pcg128; Masuda T, 2008, PHOTOSYNTH RES, V96, P121, DOI 10.1007/s11120-008-9291-4; Mylsiwa-Kurdziel B, 2004, PHOTOCHEM PHOTOBIOL, V79, P62; Mysliwa-Kurdziel B, 2013, BIOPHYS CHEM, V175, P28, DOI 10.1016/j.bpc.2013.02.002; Oosawa N, 2000, FEBS LETT, V474, P133, DOI 10.1016/S0014-5793(00)01568-4; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Paddock TN, 2010, PLANT MOL BIOL, V72, P445, DOI 10.1007/s11103-009-9582-y; Ploscher M, 2009, FEBS J, V276, P1074, DOI 10.1111/j.1742-4658.2008.06850.x; Reinbothe C, 1999, NATURE, V397, P80, DOI 10.1038/16283; Reinbothe C, 2010, TRENDS PLANT SCI, V15, P614, DOI 10.1016/j.tplants.2010.07.002; RYBERG M, 1982, PHYSIOL PLANTARUM, V56, P133, DOI 10.1111/j.1399-3054.1982.tb00314.x; RYBERG M, 1986, PHYSIOL PLANTARUM, V66, P616, DOI 10.1111/j.1399-3054.1986.tb05589.x; Scheumann V, 1999, FEBS LETT, V445, P445, DOI 10.1016/S0014-5793(99)00169-6; Schoefs B, 2005, PHOTOSYNTHETICA, V43, P329, DOI 10.1007/s11099-005-0056-4; Schoefs B, 2003, PHOTOCHEM PHOTOBIOL, V78, P543, DOI 10.1562/0031-8655(2003)078&lt;0543:PRMAE&gt;2.0.CO;2; Schoefs B, 2000, FEBS LETT, V486, P243, DOI 10.1016/S0014-5793(00)02309-7; SELISKAR CJ, 1968, BIOCHIM BIOPHYS ACTA, V153, P685, DOI 10.1016/0005-2728(68)90195-3; Solymosi K, 2010, PHOTOSYNTH RES, V105, P143, DOI 10.1007/s11120-010-9568-2; Sperling U, 1998, PLANT CELL, V10, P283, DOI 10.1105/tpc.10.2.283; Su QX, 2001, PLANT MOL BIOL, V47, P805, DOI 10.1023/A:1013699721301; Townley HE, 2001, PROTEINS, V44, P329, DOI 10.1002/prot.1098; Yang J, 2004, PLANT BIOLOGY, V6, P537, DOI 10.1055/s-2004-821270; Yuan M, 2012, J PLANT PHYSIOL, V169, P1311, DOI 10.1016/j.jplph.2012.05.010	48	25	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116990	10.1371/journal.pone.0116990	http://dx.doi.org/10.1371/journal.pone.0116990			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659137	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900087
J	Geltz, JJ; Gershburg, E; Halford, WP				Geltz, Joshua J.; Gershburg, Edward; Halford, William P.			Herpes Simplex Virus 2 (HSV-2) Infected Cell Proteins Are among the Most Dominant Antigens of a Live-Attenuated HSV-2 Vaccine	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; GLYCOPROTEIN-D; GENITAL HERPES; RECOMBINANT GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; PROTECTS MICE; TYPE-2 GLYCOPROTEINS; IMMUNE-RESPONSE; UNITED-STATES; SUBUNIT	Virion glycoproteins such as glycoprotein D (gD) are believed to be the dominant antigens of herpes simplex virus 2 (HSV-2). We have observed that mice immunized with a live HSV-2 ICP0(-) mutant virus, HSV-2 0 Delta NLS, are 10 to 100 times better protected against genital herpes than mice immunized with a HSV-2 gD subunit vaccine (PLoS ONE 6:e17748). In light of these results, we sought to determine which viral proteins were the dominant antibody- generators (antigens) of the live HSV-2 0 Delta NLS vaccine. Western blot analyses indicated the live HSV-2 0 Delta NLS vaccine elicited an IgG antibody response against 9 or more viral proteins. Many antibodies were directed against infected-cell proteins of > 100 kDa in size, and only 10 +/- 5% of antibodies were directed against gD. Immunoprecipitation (IP) of total HSV-2 antigen with 0 Delta NLS antiserum pulled down 19 viral proteins. Mass spectrometry suggested 44% of immunoprecipitated viral peptides were derived from two HSV-2 infected cells proteins, RR-1 and ICP8, whereas only 14% of immunoprecipitated peptides were derived from HSV-2's thirteen glycoproteins. Collectively, the results suggest the immune response to the live HSV-2 0 Delta NLS vaccine includes antibodies specific for infected cell proteins, capsid proteins, tegument proteins, and glycoproteins. This increased breadth of antibody-generating proteins may contribute to the live HSV-2 vaccine's capacity to elicit superior protection against genital herpes relative to a gD subunit vaccine.	[Geltz, Joshua J.; Gershburg, Edward; Halford, William P.] So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL 62702 USA	Southern Illinois University System; Southern Illinois University	Halford, WP (corresponding author), So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL 62702 USA.	halford@siumed.edu		Gershburg, Edward/0000-0003-3584-9947	Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine; National Institutes of Health [R21 AI81072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081072] Funding Source: NIH RePORTER	Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine, as well as a grant from the National Institutes of Health to study the Development of an Effective Genital Herpes Vaccine (R21 AI81072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARSENAKIS M, 1981, INFECT IMMUN, V33, P22, DOI 10.1128/IAI.33.1.22-28.1981; ARSENAKIS M, 1982, BRIT J VENER DIS, V58, P48; ASHER LVS, 1978, AM J OBSTET GYNECOL, V131, P788; ASHLEY R, 1985, J VIROL, V56, P475, DOI 10.1128/JVI.56.2.475-481.1985; ASHLEY RL, 1987, J VIROL METHODS, V18, P159, DOI 10.1016/0166-0934(87)90121-2; AURELIAN L, 1973, SCIENCE, V181, P161, DOI 10.1126/science.181.4095.161; BACCHETTI S, 1984, J VIROL, V49, P591, DOI 10.1128/JVI.49.2.591-593.1984; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Belur Lalitha R., 2008, V434, P267, DOI 10.1007/978-1-60327-248-3_16; BERMAN PW, 1985, SCIENCE, V227, P1490, DOI 10.1126/science.2983428; BERNSTEIN DI, 1985, J MED VIROL, V15, P251, DOI 10.1002/jmv.1890150306; Brockman MA, 2006, J VIROL, V80, P7111, DOI 10.1128/JVI.01421-05; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07; COHEN GH, 1984, J VIROL, V49, P102, DOI 10.1128/JVI.49.1.102-108.1984; Cohen ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020597; Corey L, 1999, JAMA-J AM MED ASSOC, V282, P331, DOI 10.1001/jama.282.4.331; Delagrave S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046714; Dinh TH, 2008, SEX TRANSM DIS, V35, P19, DOI 10.1097/OLQ.0b013e318162c4c6; Dolan A, 1998, J VIROL, V72, P2010, DOI 10.1128/JVI.72.3.2010-2021.1998; EVANS L, 1983, J VIROL METHODS, V6, P245, DOI 10.1016/0166-0934(83)90039-3; EVANS LA, 1985, ARCH VIROL, V85, P13, DOI 10.1007/BF01317002; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; GAO M, 1988, VIROLOGY, V163, P319, DOI 10.1016/0042-6822(88)90272-3; GOULD EA, 1986, J GEN VIROL, V67, P591, DOI 10.1099/0022-1317-67-3-591; Guan YJ, 2013, P NATL ACAD SCI USA, V110, pE69, DOI 10.1073/pnas.1217609110; Halford WP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-44; Halford WP, 2014, EXPERT REV VACCINES, V13, P691, DOI 10.1586/14760584.2014.910121; Halford WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065523; Halford WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017748; Halford WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012251; Halford WP, 2001, J VIROL, V75, P6143, DOI 10.1128/JVI.75.13.6143-6153.2001; Harle P, 2002, VIROLOGY, V293, P295, DOI 10.1006/viro.2001.1280; Higgins TJ, 2000, J INFECT DIS, V182, P1311, DOI 10.1086/315879; HIGHLANDER SL, 1987, J VIROL, V61, P3356, DOI 10.1128/JVI.61.11.3356-3364.1987; Hildinger M, 1999, GENE THER, V6, P1222, DOI 10.1038/sj.gt.3300942; Hooper JW, 2000, VIROLOGY, V266, P329, DOI 10.1006/viro.1999.0096; Hoshino Y, 2005, J VIROL, V79, P410, DOI 10.1128/JVI.79.1.410-418.2005; Hosken N, 2006, J VIROL, V80, P5509, DOI 10.1128/JVI.02659-05; HUNTER JCR, 1995, VIROLOGY, V210, P345, DOI 10.1006/viro.1995.1351; Ivics Z, 2004, CURR ISSUES MOL BIOL, V6, P43; Laing KJ, 2010, J CLIN IMMUNOL, V30, P703, DOI 10.1007/s10875-010-9441-2; Lee LY, 1998, J VIROL, V72, P4250, DOI 10.1128/JVI.72.5.4250-4264.1998; LEFRANCOIS L, 1984, J VIROL, V51, P208, DOI 10.1128/JVI.51.1.208-214.1984; LIGAS MW, 1988, J VIROL, V62, P1486, DOI 10.1128/JVI.62.5.1486-1494.1988; LONG D, 1984, INFECT IMMUN, V43, P761, DOI 10.1128/IAI.43.2.761-764.1984; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Lubinski JM, 1998, J VIROL, V72, P8257, DOI 10.1128/JVI.72.10.8257-8263.1998; MAINGAY JP, 1988, MICROBIOL SCI, V5, P211; MERTZ GJ, 1990, J INFECT DIS, V161, P653, DOI 10.1093/infdis/161.4.653; MOREIN B, 1985, VACCINE, V3, P83, DOI 10.1016/0264-410X(85)90055-6; Morello CS, 2011, J VIROL, V85, P3461, DOI 10.1128/JVI.02521-10; Mossman KL, 2000, J VIROL, V74, P2052, DOI 10.1128/JVI.74.4.2052-2056.2000; Nagashunmugam T, 1998, J VIROL, V72, P5351, DOI 10.1128/JVI.72.7.5351-5359.1998; Peng T, 1998, J VIROL, V72, P65, DOI 10.1128/JVI.72.1.65-72.1998; Posavad CM, 2010, J IMMUNOL, V184, P3250, DOI 10.4049/jimmunol.0900722; Richardus JH, 2013, VACCINE, V31, P6136, DOI 10.1016/j.vaccine.2013.06.081; Samaniego LA, 1998, J VIROL, V72, P3307, DOI 10.1128/JVI.72.4.3307-3320.1998; Schmeisser F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-22; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; STANBERRY LR, 1987, J INFECT DIS, V155, P914, DOI 10.1093/infdis/155.5.914; Straus SE, 1997, J INFECT DIS, V176, P1129, DOI 10.1086/514103; STRAUS SE, 1994, LANCET, V343, P1460, DOI 10.1016/S0140-6736(94)92581-X; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; WEIS JH, 1983, NATURE, V302, P72, DOI 10.1038/302072a0; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456; Xu FJ, 2002, J INFECT DIS, V185, P1019, DOI 10.1086/340041; ZARLING JM, 1988, J VIROL, V62, P4481, DOI 10.1128/JVI.62.12.4481-4485.1988; Zhang PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101373; ZWEERINK HJ, 1982, INFECT IMMUN, V37, P413, DOI 10.1128/IAI.37.2.413-421.1982	73	12	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116091	10.1371/journal.pone.0116091	http://dx.doi.org/10.1371/journal.pone.0116091			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658852	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900030
J	Gonzalez, CC; Mon-Williams, M; Burke, MR				Gonzalez, Claudia C.; Mon-Williams, Mark; Burke, Melanie R.			Children and Older Adults Exhibit Distinct Sub-Optimal Cost-Benefit Functions when Preparing to Move Their Eyes and Hands	PLOS ONE			English	Article							SACCADE GENERATION; INHIBITORY CONTROL; PREFRONTAL CORTEX; VOLUNTARY CONTROL; WORKING-MEMORY; MOVEMENTS; AGE; TASK; PERFORMANCE; ATTENTION	Numerous activities require an individual to respond quickly to the correct stimulus. The provision of advance information allows response priming but heightened responses can cause errors (responding too early or reacting to the wrong stimulus). Thus, a balance is required between the online cognitive mechanisms (inhibitory and anticipatory) used to prepare and execute a motor response at the appropriate time. We investigated the use of advance information in 71 participants across four different age groups: (i) children, (ii) young adults, (iii) middle-aged adults, and (iv) older adults. We implemented 'cued' and 'non-cued' conditions to assess age-related changes in saccadic and touch responses to targets in three movement conditions: (a) Eyes only; (b) Hands only; (c) Eyes and Hand. Children made less saccade errors compared to young adults, but they also exhibited longer response times in cued versus non-cued conditions. In contrast, older adults showed faster responses in cued conditions but exhibited more errors. The results indicate that young adults (18-25 years) achieve an optimal balance between anticipation and execution. In contrast, children show benefits (few errors) and costs (slow responses) of good inhibition when preparing a motor response based on advance information; whilst older adults show the benefits and costs associated with a prospective response strategy (i.e., good anticipation).	[Gonzalez, Claudia C.] Brunel Univ, Uxbridge UB8 3PH, Middx, England; [Mon-Williams, Mark; Burke, Melanie R.] Univ Leeds, Fac Med & Hlth, Sch Psychol, Leeds, W Yorkshire, England	Brunel University; University of Leeds	Gonzalez, CC (corresponding author), Brunel Univ, Uxbridge UB8 3PH, Middx, England.	Claudia.Gonzalez@brunel.ac.uk		Burke, Melanie/0000-0002-2561-053X; Mon-Williams, Mark/0000-0001-7595-8545				Boisseau E, 2002, AGING NEUROPSYCHOL C, V9, P266, DOI 10.1076/anec.9.4.266.8769; Bucci MP, 2012, EXP BRAIN RES, V222, P21, DOI 10.1007/s00221-012-3192-7; Burke MR, 2008, CEREB CORTEX, V18, P126, DOI 10.1093/cercor/bhm038; Burke MR, 2006, EXP BRAIN RES, V175, P596, DOI 10.1007/s00221-006-0576-6; Butler KM, 1999, MEM COGNITION, V27, P584, DOI 10.3758/BF03211552; COHEN ME, 1978, J EXP CHILD PSYCHOL, V26, P517, DOI 10.1016/0022-0965(78)90130-3; Coxon JP, 2012, J NEUROSCI, V32, P8401, DOI 10.1523/JNEUROSCI.6360-11.2012; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; Ettinger U, 2008, CEREB CORTEX, V18, P1148, DOI 10.1093/cercor/bhm147; Fischer B, 1997, BRAIN RES, V754, P285, DOI 10.1016/S0006-8993(97)00094-2; Fukushima J, 2000, BRAIN DEV-JPN, V22, P173, DOI 10.1016/S0387-7604(00)00101-7; Goh JO, 2009, RESTOR NEUROL NEUROS, V27, P391, DOI 10.3233/RNN-2009-0493; Haaland KY, 2000, BRAIN, V123, P2306, DOI 10.1093/brain/123.11.2306; Hasher L, PSYCHOL LEARNING MOT, V22, P193; Hikosaka Okihide, 1997, No To Hattatsu, V29, P213; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; KRAMER AF, 1994, PSYCHOL AGING, V9, P491, DOI 10.1037/0882-7974.9.4.491; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; Lyons J, 1996, J AGING PHYS ACTIV, V4, P165, DOI 10.1123/japa.4.2.165; Mon-Williams M, 2005, Q J EXP PSYCHOL-A, V58, P1249, DOI 10.1080/02724980443000575; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Olincy A, 1997, NEUROBIOL AGING, V18, P483, DOI 10.1016/S0197-4580(97)00109-7; Pettit L, 2008, HUM MOVEMENT SCI, V27, P286, DOI 10.1016/j.humov.2008.02.014; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; PRATT J, 1994, PSYCHOL AGING, V9, P325, DOI 10.1037/0882-7974.9.2.325; Reuter B, 2010, J COGNITIVE NEUROSCI, V22, P728, DOI 10.1162/jocn.2009.21235; ROSENBAUM DA, 1980, J EXP PSYCHOL GEN, V109, P444, DOI 10.1037/0096-3445.109.4.444; ROSS RG, 1994, J AUTISM DEV DISORD, V24, P413, DOI 10.1007/BF02172126; Salman MS, 2006, VISION RES, V46, P1432, DOI 10.1016/j.visres.2005.06.011; SALTHOUSE TA, 1979, ERGONOMICS, V22, P811, DOI 10.1080/00140137908924659; SMIT AC, 1989, EXP BRAIN RES, V76, P64, DOI 10.1007/BF00253624; STELMACH GE, 1987, EXP AGING RES, V13, P39; Sweeney JA, 2001, NEUROBIOL AGING, V22, P39, DOI 10.1016/S0197-4580(00)00175-5; Weber H, 1998, EXP BRAIN RES, V120, P417, DOI 10.1007/s002210050415; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Wilmut K, 2006, EXP BRAIN RES, V175, P654, DOI 10.1007/s00221-006-0580-x; Wyatt HJ, 1998, VISION RES, V38, P2147, DOI 10.1016/S0042-6989(97)00410-0; Yan JH, 1998, EXP AGING RES, V24, P155	41	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117783	10.1371/journal.pone.0117783	http://dx.doi.org/10.1371/journal.pone.0117783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25659134	Green Published, gold			2022-12-27	WOS:000349444900222
J	Jiang, D; Fang, JJ; Lou, LM; Zhao, JF; Yuan, SJ; Yin, L; Sun, W; Peng, LX; Guo, BT; Li, XY				Jiang, Dan; Fang, Jingjing; Lou, Lamei; Zhao, Jinfeng; Yuan, Shoujiang; Yin, Liang; Sun, Wei; Peng, Lixiang; Guo, Baotai; Li, Xueyong			Characterization of a Null Allelic Mutant of the Rice NAL1 Gene Reveals Its Role in Regulating Cell Division	PLOS ONE			English	Article							POLAR AUXIN TRANSPORT; ADVENTITIOUS ROOT-FORMATION; VASCULAR PATTERN-FORMATION; S-PHASE PROGRESSION; FUNCTIONAL-ANALYSIS; LEAF DEVELOPMENT; INCREASES YIELD; LATERAL ORGANS; ARABIDOPSIS; PROTEIN	Leaf morphology is closely associated with cell division. In rice, mutations in Narrow leaf 1 (NAL1) show narrow leaf phenotypes. Previous studies have shown that NAL1 plays a role in regulating vein patterning and increasing grain yield in indica cultivars, but its role in leaf growth and development remains unknown. In this report, we characterized two allelic mutants of NARROW LEAF1 (NAL1), nal1-2 and nal1-3, both of which showed a 50% reduction in leaf width and length, as well as a dwarf culm. Longitudinal and transverse histological analyses of leaves and internodes revealed that cell division was suppressed in the anticlinal orientation but enhanced in the periclinal orientation in the mutants, while cell size remained unaltered. In addition to defects in cell proliferation, the mutants showed abnormal midrib in leaves. Map-based cloning revealed that nal1-2 is a null allelic mutant of NAL1 since both the whole promoter and a 404-bp fragment in the first exon of NAL1 were deleted, and that a 6-bp fragment was deleted in the mutant nal1-3. We demonstrated that NAL1 functions in the regulation of cell division as early as during leaf primordia initiation. The altered transcript level of G1-and S-phase-specific genes suggested that NAL1 affects cell cycle regulation. Heterogenous expression of NAL1 in fission yeast (Schizosaccharomyces pombe) further supported that NAL1 affects cell division. These results suggest that NAL1 controls leaf width and plant height through its effects on cell division.	[Jiang, Dan; Guo, Baotai] Qingdao Agr Univ, Coll Life Sci, Qingdao, Peoples R China; [Jiang, Dan; Fang, Jingjing; Lou, Lamei; Zhao, Jinfeng; Peng, Lixiang; Li, Xueyong] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Yuan, Shoujiang; Yin, Liang; Sun, Wei] Shandong Rice Res Inst, Jinan, Peoples R China	Qingdao Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Guo, BT (corresponding author), Qingdao Agr Univ, Coll Life Sci, Qingdao, Peoples R China.	btguo12@163.com; lixueyong@caas.cn			Ministry of Agriculture of China [2013ZX08009-003]; Agricultural Science and Technology Innovation Program of China	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Agricultural Science and Technology Innovation Program of China	This work was supported by grants from the Ministry of Agriculture of China (2013ZX08009-003) and the Agricultural Science and Technology Innovation Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autran D, 2002, EMBO J, V21, P6036, DOI 10.1093/emboj/cdf614; Bowman JL, 2000, CURR OPIN PLANT BIOL, V3, P17, DOI 10.1016/S1369-5266(99)00035-7; Bowman JL, 2002, TRENDS GENET, V18, P134, DOI 10.1016/S0168-9525(01)02601-4; Cebolla A, 1999, EMBO J, V18, P4476, DOI 10.1093/emboj/18.16.4476; Chandler PM, 1999, PLANT PHYSIOL, V120, P623, DOI 10.1104/pp.120.2.623; Chen ML, 2012, PLANT CELL REP, V31, P863, DOI 10.1007/s00299-011-1207-7; Cho SH, 2014, PLANT MOL BIOL REP, V32, P270, DOI 10.1007/s11105-013-0675-z; Cho SH, 2013, NEW PHYTOL, V198, P1071, DOI 10.1111/nph.12231; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Dai MQ, 2007, PLANT PHYSIOL, V144, P380, DOI 10.1104/pp.107.095737; De Rybel B, 2013, DEV CELL, V24, P426, DOI 10.1016/j.devcel.2012.12.013; De Veylder L, 2001, PLANT CELL, V13, P1653, DOI 10.2307/3871392; Dhondt S, 2010, PLANT PHYSIOL, V154, P1183, DOI 10.1104/pp.110.158857; Eloy NB, 2011, PLANT J, V68, P351, DOI 10.1111/j.1365-313X.2011.04691.x; Errera L., 1888, BOTTANISCHES CENTRAL, V34, P395, DOI DOI 10.1002/CPLX.20074; Fabian-Marwedel T, 2002, PLANT CELL, V14, P197, DOI 10.1105/tpc.010386; Fleming AJ, 1997, SCIENCE, V276, P1415, DOI 10.1126/science.276.5317.1415; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Fujita D, 2013, P NATL ACAD SCI USA, V110, P20431, DOI 10.1073/pnas.1310790110; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Genschik P, 1998, PLANT CELL, V10, P2063; Gonzalez N, 2012, TRENDS PLANT SCI, V17, P332, DOI 10.1016/j.tplants.2012.02.003; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Guo J, 2010, PLANTA, V231, P293, DOI 10.1007/s00425-009-1051-y; HOWELL SH, 1998, MOL GENETICS PLANT D; Kessler S, 2002, DEVELOPMENT, V129, P1859; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Kitomi Y, 2011, PLANT J, V67, P472, DOI 10.1111/j.1365-313X.2011.04610.x; Lee BH, 2009, PLANT PHYSIOL, V151, P655, DOI 10.1104/pp.109.141838; Lewis D, 2009, PLANT CELL PHYSIOL, V50, P554, DOI 10.1093/pcp/pcp015; Liu HJ, 2005, PLANT J, V43, P47, DOI 10.1111/j.1365-313X.2005.02434.x; Liu SP, 2009, CELL RES, V19, P1110, DOI 10.1038/cr.2009.70; Lyndon R F, 1986, Symp Soc Exp Biol, V40, P233; Lyndon R.F., 1998, Q REV BIOL, V144, P51; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Nagasawa N, 2003, DEVELOPMENT, V130, P705, DOI 10.1242/dev.00294; Narita NN, 2004, PLANT J, V38, P699, DOI 10.1111/j.1365-313X.2004.02078.x; Nelson T, 1997, PLANT CELL, V9, P1121, DOI 10.1105/tpc.9.7.1121; Qi J, 2008, PLANT PHYSIOL, V147, P1947, DOI 10.1104/pp.108.118778; Rasmussen CG, 2011, ANNU REV PLANT BIOL, V62, P387, DOI 10.1146/annurev-arplant-042110-103802; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Renaudin JP, 1996, PLANT MOL BIOL, V32, P1003, DOI 10.1007/BF00041384; Sauter M, 1997, PLANT J, V11, P181, DOI 10.1046/j.1365-313X.1997.11020181.x; Scanlon MJ, 2003, PLANT PHYSIOL, V133, P597, DOI 10.1104/pp.103.026880; Scarpella E, 2003, DEVELOPMENT, V130, P645, DOI 10.1242/dev.00243; Smith LG, 2001, NAT REV MOL CELL BIO, V2, P33, DOI 10.1038/35048050; Takada S, 2013, DEVELOPMENT, V140, P1919, DOI 10.1242/dev.094417; Takai T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02149; Yamaguchi T, 2004, PLANT CELL, V16, P500, DOI 10.1105/tpc.018044; Yoshikawa T, 2013, J EXP BOT, V64, P2049, DOI 10.1093/jxb/ert060; Zhang GH, 2014, MOL PLANT, V7, P1350, DOI 10.1093/mp/ssu055; Zhao SQ, 2010, CELL RES, V20, P935, DOI 10.1038/cr.2010.109; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306	53	58	71	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118169	10.1371/journal.pone.0118169	http://dx.doi.org/10.1371/journal.pone.0118169			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658704	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900272
J	Makita, N; Kawamura, A				Makita, Naoki; Kawamura, Ayumi			Temperature Sensitivity of Microbial Respiration of Fine Root Litter in a Temperate Broad-Leaved Forest	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; RHIZOSPHERE RESPIRATION; WATER-CONTENT; DECOMPOSITION; CLIMATE; QUALITY; ADAPTATION; EFFLUX; RATES; LEAF	The microbial decomposition respiration of plant litter generates a major CO2 efflux from terrestrial ecosystems that plays a critical role in the regulation of carbon cycling on regional and global scales. However, the respiration from root litter decomposition and its sensitivity to temperature changes are unclear in current models of carbon turnover in forest soils. Thus, we examined seasonal changes in the temperature sensitivity and decomposition rates of fine root litter of two diameter classes (0-0.5 and 0.5-2.0 mm) of Quercus serrata and Ilex pedunculosa in a deciduous broad-leaved forest. During the study period, fine root litter of both diameter classes and species decreased approximately exponentially over time. The Q(10) values of microbial respiration rates of root litter for the two classes were 1.59-3.31 and 1.28-6.27 for Q. serrata and 1.36-6.31 and 1.65-5.86 for I. pedunculosa. A significant difference in Q(10) was observed between the diameter classes, indicating that root diameter represents the initial substrate quality, which may determine the magnitude of Q(10) value of microbial respiration. Changes in these Q(10) values were related to seasonal soil temperature patterns; the values were higher in winter than in summer. Moreover, seasonal variations in Q(10) were larger during the 2-year decomposition period than the 1-year period. These results showed that the Q(10) values of fine root litter of 0-0.5 and 0.5-2.0 mm have been shown to increase with lower temperatures and with the higher recalcitrance pool of the decomposed substrate during 2 years of decomposition. Thus, the temperature sensitivity of microbial respiration in root litter showed distinct patterns according to the decay period and season because of the temperature acclimation and adaptation of the microbial decomposer communities in root litter.	[Makita, Naoki] Forestry & Forest Prod Res Inst, Kansai Res Ctr, Kyoto 6120855, Japan; [Kawamura, Ayumi] Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan	Forestry & Forest Products Research Institute - Japan; Kyoto University	Makita, N (corresponding author), Forestry & Forest Prod Res Inst, Kansai Res Ctr, Kyoto 6120855, Japan.	makita701@gmail.com			Japan Society for the Promotion of Science [JSPS] [13J09602]	Japan Society for the Promotion of Science [JSPS](Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding was provided by the Japan Society for the Promotion of Science [JSPS; grant number 13J09602 (http://www.jsps.go.jp/english/index.html)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Barcenas-Moreno G, 2009, GLOBAL CHANGE BIOL, V15, P2950, DOI 10.1111/j.1365-2486.2009.01882.x; Bond-Lamberty B, 2004, GLOBAL CHANGE BIOL, V10, P1756, DOI 10.1111/j.1365-2486.2004.00816.x; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Chen H, 2000, FOREST ECOL MANAG, V138, P51, DOI 10.1016/S0378-1127(00)00411-4; Conant RT, 2008, ECOLOGY, V89, P2384, DOI 10.1890/08-0137.1; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Epron D, 2001, TREE PHYSIOL, V21, P145, DOI 10.1093/treephys/21.2-3.145; Fan PP, 2010, OECOLOGIA, V163, P509, DOI 10.1007/s00442-009-1541-4; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Fierer N, 2005, ECOLOGY, V86, P320, DOI 10.1890/04-1254; Finer L, 2011, FOREST ECOL MANAG, V262, P2008, DOI 10.1016/j.foreco.2011.08.042; Frey SD, 2008, SOIL BIOL BIOCHEM, V40, P2904, DOI 10.1016/j.soilbio.2008.07.020; Friedlingstein P, 2003, TELLUS B, V55, P692, DOI 10.1034/j.1600-0889.2003.01461.x; Fujii S, 2010, SOIL BIOL BIOCHEM, V42, P2224, DOI 10.1016/j.soilbio.2010.08.022; Hamdi S, 2013, SOIL BIOL BIOCHEM, V58, P115, DOI 10.1016/j.soilbio.2012.11.012; Harmon ME, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001495; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Karhu K, 2010, ECOLOGY, V91, P370, DOI 10.1890/09-0478.1; Kawamura A, 2013, PLANT ROOT, V7, P77, DOI 10.3117/plantroot.7.77; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Lin CF, 2011, PLANT SOIL, V338, P311, DOI 10.1007/s11104-010-0547-3; Liski J, 1999, AMBIO, V28, P171; Makita N, 2011, ECOL RES, V26, P95, DOI 10.1007/s11284-010-0764-5; Malcolm GM, 2009, SOIL BIOL BIOCHEM, V41, P1075, DOI 10.1016/j.soilbio.2009.02.011; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; Ostertag R, 1999, OECOLOGIA, V121, P564, DOI 10.1007/s004420050963; Pregitzer KS, 2002, ECOL MONOGR, V72, P293, DOI 10.1890/0012-9615(2002)072[0293:FRAONN]2.0.CO;2; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Reichstein M, 2009, SOIL CARBON DYNAMICS, P207; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Silver WL, 2001, OECOLOGIA, V129, P407, DOI 10.1007/s004420100740; Sulzman EW, 2005, BIOGEOCHEMISTRY, V73, P231, DOI 10.1007/s10533-004-7314-6; Suzina NE, 2004, MICROBIOLOGY+, V73, P435, DOI 10.1023/B:MICI.0000036990.94039.af; Talbot JM, 2012, BIOGEOCHEMISTRY, V108, P279, DOI 10.1007/s10533-011-9599-6; von Lutzow M, 2009, BIOL FERT SOILS, V46, P1, DOI 10.1007/s00374-009-0413-8; Wang W, 2014, PLANT SOIL, V374, P677, DOI 10.1007/s11104-013-1902-y; Zhou T, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000850	42	7	7	6	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117694	10.1371/journal.pone.0117694	http://dx.doi.org/10.1371/journal.pone.0117694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658106	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900205
J	Zhang, J; Wong, MG; Wong, M; Gross, S; Chen, J; Pollock, C; Saad, S				Zhang, Jie; Wong, Muh Geot; Wong, May; Gross, Simon; Chen, Jason; Pollock, Carol; Saad, Sonia			A Cationic-Independent Mannose 6-Phosphate Receptor Inhibitor (PXS64) Ameliorates Kidney Fibrosis by Inhibiting Activation of Transforming Growth Factor-beta(1)	PLOS ONE			English	Article							BETA SIGNAL-TRANSDUCTION; TGF-BETA; RENAL FIBROSIS; IN-VITRO; DISEASE; LATENT; CELLS; MANNOSE-6-PHOSPHATE; INFLAMMATION; NEPHROPATHY	The activity of transforming growth factor-beta(1) (TGF-beta(1)) is regulated by its conversion from the latent to the active form. We have previously shown that the conversion is at least in part mediated by the cationic-independent mannose 6-phosphate receptor (CI-M6PR), as the CI-M6PR inhibitor, PXS-25 has anti-fibrotic properties in human kidney tubular (HK-2) cells under high glucose conditions. However, its clinical use is limited by low bioavailability. Our aim was to determine the effects of PXS64, a pro-drug of PXS25, in in vitro and in vivo models of renal fibrosis. HK-2 cells were exposed to latent TGF beta(1)+/- PXS64 for 48 hours. The mRNA and protein levels of pro-fibrotic and pro-inflammatory markers were determined. A 7 day unilateral ureteric obstruction (UUO) model was used and the following experimental groups were studied: (i) Sham operated, (ii) UUO, (iii) UUO + telmisartan (iv) UUO + PSX64. HK-2 cells exposed to PXS64 reduced TGF beta mediated effects on collagen IV, fibronectin, macrophage chemotactic protein-1 (MCP-1) and phospho-smad2 protein expression, consistent with inhibition of the conversion of latent to active TGF-beta(1). PXS 64 treated UUO mice had a lower tubulointerstitial fibrosis index, collagen IV and fibronectin protein and mRNA expression when compared to untreated UUO mice. In addition, these animals had lower MCP-1 mRNA expression, reduced inflammarory cell infiltrate, as indicated by fewer CD45, F4/80 positive cells, and reduced phospho-Smad2 protein expression when compared to untreated UUO animals. Our data demonstrates that PSX64 is an effective anti-fibrotic agent by inhibiting the activation of latent TGF-beta(1).	[Zhang, Jie; Wong, Muh Geot; Wong, May; Gross, Simon; Pollock, Carol; Saad, Sonia] Kolling Inst Med Res, Sydney, NSW, Australia; [Chen, Jason] Royal N Shore Hosp, St Leonards, NSW 2065, Australia	University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital	Saad, S (corresponding author), Kolling Inst Med Res, Sydney, NSW, Australia.	sonia.saad@sydney.edu.au	Saad, Sonia/D-2914-2015	Saad, Sonia/0000-0001-8067-8046	Australian Research Council (ARC) industry partnership linkage grant	Australian Research Council (ARC) industry partnership linkage grant(Australian Research Council)	The study is funded by the Australian Research Council (ARC) industry partnership linkage grant. None the co-authors has a financial disclosure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; Bates SJ, 2006, J BONE JOINT SURG AM, V88A, P2465, DOI 10.2106/JBJS.E.00143; Berl Tomas, 2009, J Renin Angiotensin Aldosterone Syst, V10, P1, DOI 10.1177/1470320309102747; Black David A, 2012, Biomed Sci Instrum, V48, P43; Bohle A, 1979, Contrib Nephrol, V16, P109; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Czupalla C, 2006, MOL CELL PROTEOMICS, V5, P134, DOI 10.1074/mcp.M500291-MCP200; Dennler S, 2002, J LEUKOCYTE BIOL, V71, P731; Djamali A, 2010, TRANSPLANTATION, V90, P387, DOI 10.1097/TP.0b013e3181e6ae0a; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2964, DOI 10.1681/ASN.2006070704; Gewin L, 2012, SEMIN NEPHROL, V32, P228, DOI 10.1016/j.semnephrol.2012.04.001; Godar S, 1999, EUR J IMMUNOL, V29, P1004, DOI 10.1002/(SICI)1521-4141(199903)29:03<1004::AID-IMMU1004>3.0.CO;2-Q; Harris WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070196; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hsieh PF, 2012, MOL IMMUNOL, V50, P74, DOI 10.1016/j.molimm.2011.12.004; Jones-Carson J, 2005, J INFECT DIS, V192, P1039, DOI 10.1086/432727; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Li JH, 2004, FASEB J, V18, P176, DOI 10.1096/fj.02-1117fje; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066356; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; Meng XM, 2012, KIDNEY INT, V81, P266, DOI 10.1038/ki.2011.327; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Ngeow WC, 2011, BRAIN RES, V1394, P40, DOI 10.1016/j.brainres.2011.04.021; Pan MM, 2013, FOOD CHEM TOXICOL, V58, P487, DOI 10.1016/j.fct.2013.04.037; Rogers ML, 1996, J ENDOCRINOL, V151, P77, DOI 10.1677/joe.0.1510077; Ruiz-Torres MP, 2005, J NEPHROL, V18, P334; Sakairi T, 2011, NEPHROLOGY, V16, P76, DOI 10.1111/j.1440-1797.2010.01367.x; Schnaper HW, 2009, FRONT BIOSCI-LANDMRK, V14, P2448, DOI 10.2741/3389; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Strutz F, 1999, KIDNEY BLOOD PRESS R, V22, P71, DOI 10.1159/000025911; Vaughan E Darracott Jr, 2004, J Urol, V172, P2563, DOI 10.1097/01.ju.0000144286.53562.95; White KE, 2000, J AM SOC NEPHROL, V11, P1667, DOI 10.1681/ASN.V1191667; WILLENBORG DO, 1989, FASEB J, V3, P1968, DOI 10.1096/fasebj.3.8.2721857; Wong MG, 2011, AM J PHYSIOL-RENAL, V301, pF84, DOI 10.1152/ajprenal.00287.2010; Yu Q, 2000, GENE DEV, V14, P163	37	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116888	10.1371/journal.pone.0116888	http://dx.doi.org/10.1371/journal.pone.0116888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658916	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900076
J	Zhu, ZJ; Qian, FJ; Yang, R; Chen, JJ; Luo, QJ; Chen, HM; Yan, XJ				Zhu, Zhujun; Qian, Feijian; Yang, Rui; Chen, Juanjuan; Luo, Qijun; Chen, Haimin; Yan, Xiaojun			A Lipoxygenase from Red Alga Pyropia haitanensis, a Unique Enzyme Catalyzing the Free Radical Reactions of Polyunsaturated Fatty Acids with Triple Ethylenic Bonds	PLOS ONE			English	Article							ALLENE OXIDE SYNTHASE; FUNGUS GAEUMANNOMYCES-GRAMINIS; FUSION PROTEIN; CHONDRUS-CRISPUS; INNATE IMMUNITY; HYDROPEROXIDE; OXYLIPINS; CATALYSIS; PURIFICATION; HEMOPROTEIN	Lipoxygenases (LOXs) are key enzymes to regulate the production of hormones and defensive metabolites in plants, animals and algae. In this research, a full length LOX gene has been cloned and expressed from the red alga Pyropia haitanensis (Bangiales, Rhodophyta) gametophyte (PhLOX2). Subsequent phylogenetic analysis showed that such LOX enzymes are separated at the early stage of evolution, establishing an independent branch. The LOX activity was investigated at the optimal pH of 8.0. It appears that PhLOX2 is a multifunctional enzyme featuring both lipoxygenase and hydroperoxidase activities. Additionally, PhLOX2 exhibits remarkable substrate and position flexibility, and it can catalyze an array of chemical reactions involving various polyunsaturated fatty acids, ranging from C18 to C22. As a matter of fact, mono-hydroperoxy, di-hydroperoxy and hydroxyl products have been obtained from such transformations, and eicosapentaenoic acid seem to be the most preferred substrate. It was found that at least triple ethylenic bonds are required for PhLOX2 to function as a LOX, and the resulting hydroxy products should be originated from the PhLOX2 mediated reduction of mono-hydroperoxides, in which the hydrogen abstraction occurs on the carbon atom between the second and third double bond. Most of the di-hydroperoxides observed seem to be missing their mono-position precursors. The substrate and position flexibility, as well as the function versatility of PhLOXs represent the ancient enzymatic pathway for organisms to control intracellular oxylipins.	[Zhu, Zhujun; Qian, Feijian; Yang, Rui; Chen, Juanjuan; Luo, Qijun; Chen, Haimin] Ningbo Univ, Key Lab Appl Marine Biotechnol, Ningbo 315211, Zhejiang, Peoples R China; [Yan, Xiaojun] Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University; Ningbo University	Chen, HM (corresponding author), Ningbo Univ, Key Lab Appl Marine Biotechnol, Ningbo 315211, Zhejiang, Peoples R China.	haiminch75@hotmail.com; yanxiaojun@nbu.edu.cn	LUO, QI/GQH-7209-2022	Yan, Xiaojun/0000-0003-0257-0157	National Natural Science Foundation of China [81370532]; Ningbo Marine Algae Biotechnology Innovative Team [2011B81007]; National Spark Major Project [2013GA701001]; Ningbo Programs for Science and Technology Development [201201C1011016]; Zhejiang major technology project for breeding of new variety [2012C12907-6]; K.C. Wong Magna Fund in Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ningbo Marine Algae Biotechnology Innovative Team; National Spark Major Project; Ningbo Programs for Science and Technology Development; Zhejiang major technology project for breeding of new variety; K.C. Wong Magna Fund in Ningbo University	This project was funded by National Natural Science Foundation of China (81370532), Ningbo Marine Algae Biotechnology Innovative Team (No. 2011B81007), National Spark Major Project (2013GA701001), Ningbo Programs for Science and Technology Development (201201C1011016), Zhejiang major technology project for breeding of new variety (2012C12907-6), K.C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Andreou AZ, 2009, LIPIDS, V44, P207, DOI 10.1007/s11745-008-3264-4; BILD GS, 1977, BIOCHEM BIOPH RES CO, V74, P949, DOI 10.1016/0006-291X(77)91610-2; Bouarab K, 2004, PLANT PHYSIOL, V135, P1838, DOI 10.1104/pp.103.037622; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Brodhun F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064919; Collen J, 2013, P NATL ACAD SCI USA, V110, P5247, DOI 10.1073/pnas.1221259110; d'Ippolito G, 2009, NEW PHYTOL, V183, P1064, DOI 10.1111/j.1469-8137.2009.02887.x; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; FURSTENBERGER G, 1991, J BIOL CHEM, V266, P15738; Gao BL, 2009, J BIOL CHEM, V284, P22087, DOI 10.1074/jbc.M109.013151; Gaquerel E, 2007, BBA-MOL CELL BIOL L, V1771, P565, DOI 10.1016/j.bbalip.2007.02.007; Graber MA, 1996, TETRAHEDRON LETT, V37, P4635, DOI 10.1016/0040-4039(96)00921-5; Grechkin A, 1998, PROG LIPID RES, V37, P317, DOI 10.1016/S0163-7827(98)00014-9; GREGSON RP, 1979, TETRAHEDRON LETT, P4505; HAMBERG M, 1994, ARCH BIOCHEM BIOPHYS, V309, P77, DOI 10.1006/abbi.1994.1087; Jiang ZD, 1997, LIPIDS, V32, P231, DOI 10.1007/s11745-997-0029-9; Jiang ZD, 2000, PHYTOCHEMISTRY, V53, P129, DOI 10.1016/S0031-9422(99)00445-8; Joo YC, 2012, BIOTECHNOL ADV, V30, P1524, DOI 10.1016/j.biotechadv.2012.04.004; Kantarci A, 2003, CRIT REV ORAL BIOL M, V14, P4, DOI 10.1177/154411130301400102; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; OHKI S, 1979, J BIOL CHEM, V254, P829; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; Potin P, 2002, CURR OPIN PLANT BIOL, V5, P308, DOI 10.1016/S1369-5266(02)00273-X; Qian FJ, 2014, J APPL PHYCOL; Schneider C, 2007, P NATL ACAD SCI USA, V104, P18941, DOI 10.1073/pnas.0707148104; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Senger T, 2005, J BIOL CHEM, V280, P7588, DOI 10.1074/jbc.M411738200; Su C, 1998, J BIOL CHEM, V273, P20744, DOI 10.1074/jbc.273.33.20744; Su C, 1996, J BIOL CHEM, V271, P14112, DOI 10.1074/jbc.271.24.14112; Wang XJ, 2013, J APPL PHYCOL, V25, P1895, DOI 10.1007/s10811-013-0009-4; Weinberger F, 2007, BIOL BULL-US, V213, P290, DOI 10.2307/25066646; Youn B, 2006, PROTEINS, V65, P1008, DOI 10.1002/prot.21182	35	19	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117351	10.1371/journal.pone.0117351	http://dx.doi.org/10.1371/journal.pone.0117351			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658744	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900137
J	Zuo, QS; Li, D; Zhang, L; Elsayed, AK; Lian, C; Shi, QQ; Zhang, ZT; Zhu, R; Wang, YJ; Jin, K; Zhang, YN; Li, BC				Zuo, Qisheng; Li, Dong; Zhang, Lei; Elsayed, Ahmed Kamel; Lian, Chao; Shi, Qingqing; Zhang, Zhentao; Zhu, Rui; Wang, Yinjie; Jin, Kai; Zhang, Yani; Li, Bichun			Study on the Regulatory Mechanism of the Lipid Metabolism Pathways during Chicken Male Germ Cell Differentiation Based on RNA-Seq	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS	Here, we explore the regulatory mechanism of lipid metabolic signaling pathways and related genes during differentiation of male germ cells in chickens, with the hope that better understanding of these pathways may improve in vitro induction. Fluorescence-activated cell sorting was used to obtain highly purified cultures of embryonic stem cells (ESCs), primitive germ cells (PGCs), and spermatogonial stem cells (SSCs). The total RNA was then extracted from each type of cell. High-throughput analysis methods (RNA-seq) were used to sequence the transcriptome of these cells. Gene Ontology (GO) analysis and the KEGG database were used to identify lipid metabolism pathways and related genes. Retinoic acid (RA), the end-product of the retinol metabolism pathway, induced in vitro differentiation of ESC into male germ cells. Quantitative real-time PCR (qRT-PCR) was used to detect changes in the expression of the genes involved in the retinol metabolic pathways. From the results of RNA-seq and the database analyses, we concluded that there are 328 genes in 27 lipid metabolic pathways continuously involved in lipid metabolism during the differentiation of ESC into SSC in vivo, including retinol metabolism. Alcohol dehydrogenase 5 (ADH5) and aldehyde dehydrogenase 1 family member A1 (ALDH1A1) are involved in RA synthesis in the cell. ADH5 was specifically expressed in PGC in our experiments and aldehyde dehydrogenase 1 family member A1 (ALDH1A1) persistently increased throughout development. CYP26b1, a member of the cytochrome P450 superfamily, is involved in the degradation of RA. Expression of CYP26b1, in contrast, decreased throughout development. Exogenous RA in the culture medium induced differentiation of ESC to SSC-like cells. The expression patterns of ADH5, ALDH1A1, and CYP26b1 were consistent with RNA-seq results. We conclude that the retinol metabolism pathway plays an important role in the process of chicken male germ cell differentiation.	[Zuo, Qisheng; Li, Dong; Zhang, Lei; Elsayed, Ahmed Kamel; Lian, Chao; Shi, Qingqing; Zhang, Zhentao; Zhu, Rui; Wang, Yinjie; Jin, Kai; Zhang, Yani; Li, Bichun] Yangzhou Univ, Coll Anim Sci & Technol, Key Lab Anim Breeding Reprod & Mol Design Jiangsu, Yangzhou 225009, Jiangsu, Peoples R China; [Elsayed, Ahmed Kamel] Suez Canal Univ, Coll Vet Med, Ismailia 41522, Egypt	Yangzhou University; Egyptian Knowledge Bank (EKB); Suez Canal University	Zhang, YN (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Key Lab Anim Breeding Reprod & Mol Design Jiangsu, Yangzhou 225009, Jiangsu, Peoples R China.	ynzhang@yzu.edu.cn; yubcli@yzu.edu.cn	Elsayed, Ahmed/AAC-9689-2020; JIN, KAI/AAY-8565-2020	JIN, KAI/0000-0003-2489-2173; Zhu, Rui/0000-0002-8791-677X; Kamel, Ahmed/0000-0002-2519-1531	National Natural Science Foundation of China [31272429, 31301959]; Research and Innovation Program for Graduate Cultivation of Jiangsu Proviance; Major Basic Research Program for Natural Science of Jiangsu Proviance Jiangsu Proviance; Research Fund for the Doctoral Program of Higher Education [20123250120009, 20103250110006]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research and Innovation Program for Graduate Cultivation of Jiangsu Proviance; Major Basic Research Program for Natural Science of Jiangsu Proviance Jiangsu Proviance; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was supported by the National Natural Science Foundation of China (31272429, 31301959); Research and Innovation Program for Graduate Cultivation of Jiangsu Proviance in 2010; Major Basic Research Program for Natural Science of Jiangsu Proviance Jiangsu Proviance; Research Fund for the Doctoral Program of Higher Education(20123250120009, 20103250110006); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflatoonian B, 2005, CURR OPIN BIOTECH, V16, P530, DOI 10.1016/j.copbio.2005.08.008; Andreola F, 1997, CANCER RES, V57, P2835; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; Dong YL, 2011, CHINESE J FAMILY PLA, V19, P247; Dyce PW, 2006, NAT CELL BIOL, V8, P384, DOI 10.1038/ncb1388; Fujisawa Y, 2013, EARLY HUM DEV, V89, P713, DOI 10.1016/j.earlhumdev.2013.05.002; Gan QA, 2010, CELL RES, V20, P763, DOI 10.1038/cr.2010.64; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kerkis A, 2007, CLONING STEM CELLS, V9, P535, DOI 10.1089/clo.2007.0031; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Li BiChun, 2002, Journal of Yangzhou University, Agricultural and Life Sciences Edition, V23, P18; Lu JianXiong, 2006, Veterinary Science in China, V36, P306; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Oresti GM, 2013, REPRODUCTION, V146, P471, DOI 10.1530/REP-13-0199; Pan SH, 2010, STUDY MOUSE EMBRYONI; Sun M, 2012, STUDYON MALE GERM CE; Sun SY, 2008, CHINESE J VET SCI, V28, P102; [唐新燕 Tang Xinyan], 2006, [农业生物技术学报, Journol of Agricultural Biotechnology], V14, P174; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Trofimova-Griffin ME, 2000, DEV BRAIN RES, V120, P7, DOI 10.1016/S0165-3806(99)00185-6; [王萍 WANG Ping], 2011, [中国临床药理学与治疗学, Chinese Journal of Clinical Pharmacology and Therapeutics], V16, P474; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu XS, 2008, CHINA POULTRY, V30, P30, DOI DOI 10.16372/J.ISSN.1004-6364.2008.22.007	27	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0109469	10.1371/journal.pone.0109469	http://dx.doi.org/10.1371/journal.pone.0109469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658587	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900001
J	Kim, V; Oros, M; Durra, H; Kelsen, S; Aksoy, M; Cornwell, WD; Rogers, TJ; Criner, GJ				Kim, Victor; Oros, Michelle; Durra, Heba; Kelsen, Steven; Aksoy, Mark; Cornwell, William D.; Rogers, Thomas J.; Criner, Gerard J.			Chronic Bronchitis and Current Smoking Are Associated with More Goblet Cells in Moderate to Severe COPD and Smokers without Airflow Obstruction	PLOS ONE			English	Article							LUNG-VOLUME REDUCTION; PULMONARY-DISEASE; PERIPHERAL AIRWAYS; SPUTUM PRODUCTION; INFLAMMATION; PATHOLOGY; SYMPTOMS; GLANDS	Background Goblet cell hyperplasia is a classic but variable pathologic finding in COPD. Current literature shows that smoking is a risk factor for chronic bronchitis but the relationship of these clinical features to the presence and magnitude of large airway goblet cell hyperplasia has not been well described. We hypothesized that current smokers and chronic bronchitics would have more goblet cells than nonsmokers or those without chronic bronchitis (CB), independent of airflow obstruction. Methods We recruited 15 subjects with moderate to severe COPD, 12 healthy smokers, and 11 healthy nonsmokers. Six endobronchial mucosal biopsies per subject were obtained by bronchoscopy and stained with periodic acid Schiff-Alcian Blue. Goblet cell density (GCD) was quantified as goblet cell number per millimeter of basement membrane. Mucin volume density (MVD) was quantified as volume of mucin per unit area of basement membrane. Results Healthy smokers had a greater GCD and MVD than nonsmokers and COPD subjects. COPD subjects had a greater GCD than nonsmokers. When current smokers (healthy smokers and COPD current smokers, n = 19) were compared with all nonsmokers (nonsmoking controls and COPD ex-smokers, n = 19), current smokers had a greater GCD and MVD. When those with CB (n = 12) were compared to those without CB (n = 26), the CB group had greater GCD. This finding was also seen in those with CB in the COPD group alone. In multivariate analysis, current smoking and CB were significant predictors of GCD using demographics, lung function, and smoking pack years as covariates. All other covariates were not significant predictors of GCD or MVD. Conclusions Current smoking is associated with a more goblet cell hyperplasia and number, and CB is associated with more goblet cells, independent of the presence of airflow obstruction. This provides clinical and pathologic correlation for smokers with and without COPD.	[Kim, Victor; Kelsen, Steven; Aksoy, Mark; Criner, Gerard J.] Temple Univ, Div Pulm & Crit Care Med, Sch Med, Philadelphia, PA 19122 USA; [Oros, Michelle; Durra, Heba] Temple Univ, Dept Pathol, Sch Med, Philadelphia, PA 19122 USA; [Cornwell, William D.; Rogers, Thomas J.] Temple Univ, Sch Med, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kim, V (corresponding author), Temple Univ, Div Pulm & Crit Care Med, Sch Med, Philadelphia, PA 19122 USA.	Victor.kim@tuhs.temple.edu			National Heart, Lung, and Blood Institute (National Institute of Health) [K23HL094696]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL094696] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (National Institute of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work came from the National Heart, Lung, and Blood Institute (National Institute of Health) K23HL094696. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, NHLMI WHO WORKSH REP; [Anonymous], 1979, STEREOLOGICAL METHOD; Burgel PR, 2009, CHEST, V135, P975, DOI 10.1378/chest.08-2062; Caramori G, 2009, HISTOPATHOLOGY, V55, P321, DOI 10.1111/j.1365-2559.2009.03377.x; Forey BA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-36; HARKEMA JR, 1987, J HISTOCHEM CYTOCHEM, V35, P279, DOI 10.1177/35.3.2434556; Hattotuwa K, 2002, CHEST, V122, P1909, DOI 10.1378/chest.122.6.1909; Hogg JC, 2007, AM J RESP CRIT CARE, V176, P454, DOI 10.1164/rccm.200612-1772OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Innes AL, 2006, CHEST, V130, P1102, DOI 10.1378/chest.130.4.1102; Kim V, 2005, AM J RESP CRIT CARE, V171, P40, DOI 10.1164/rccm.200405-659OC; Kim V, 2011, CHEST, V140, P626, DOI 10.1378/chest.10-2948; Kim V, 2011, COPD, V8, P114, DOI 10.3109/15412555.2011.558546; Kim V, 2008, COPD, V5, P329, DOI 10.1080/15412550802522445; Martinez CH, 2013, RESP MED, V15; MULLEN JBM, 1985, BMJ-BRIT MED J, V291, P1235, DOI 10.1136/bmj.291.6504.1235; NAGAI A, 1985, AM REV RESPIR DIS, V132, P946; Pelkonen M, 2006, CHEST, V130, P1129, DOI 10.1378/chest.130.4.1129; REID LM, 1954, LANCET, V1, P275; Saetta M, 1997, AM J RESP CRIT CARE, V156, P1633, DOI 10.1164/ajrccm.156.5.9701081; Saetta M, 2000, AM J RESP CRIT CARE, V161, P1016, DOI 10.1164/ajrccm.161.3.9907080; Sciurba F, 2006, P AM THORAC SOC, V3, pA712; THURLBECK WM, 1975, AM REV RESPIR DIS, V112, P65; Vestbo J, 1996, AM J RESP CRIT CARE, V153, P1530, DOI 10.1164/ajrccm.153.5.8630597; 2006, IMAGE J	25	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116108	10.1371/journal.pone.0116108	http://dx.doi.org/10.1371/journal.pone.0116108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646735	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600020
J	Kumar, D; Kirti, PB				Kumar, Dilip; Kirti, Pulugurtha Bharadwaja			Transcriptomic and Proteomic Analyses of Resistant Host Responses in Arachis diogoi Challenged with Late Leaf Spot Pathogen, Phaeoisariopsis personata	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; CDNA-AFLP ANALYSIS; THAUMATIN-LIKE PROTEIN; DISEASE RESISTANCE; CELL-DEATH; ANALYSIS REVEALS; ASCORBIC-ACID; CERCOSPORIDIUM-PERSONATUM; ARABIDOPSIS-THALIANA; PROCESSING ENZYME	Late leaf spot is a serious disease of peanut caused by the imperfect fungus, Phaeoisariopsis personata. Wild diploid species, Arachis diogoi. is reported to be highly resistant to this disease and asymptomatic. The objective of this study is to investigate the molecular responses of the wild peanut challenged with the late leaf spot pathogen using cDNA-AFLP and 2D proteomic study. A total of 233 reliable, differentially expressed genes were identified in Arachis diogoi. About one third of the TDFs exhibit no significant similarity with the known sequences in the data bases. Expressed sequence tag data showed that the characterized genes are involved in conferring resistance in the wild peanut to the pathogen challenge. Several genes for proteins involved in cell wall strengthening, hypersensitive cell death and resistance related proteins have been identified. Genes identified for other proteins appear to function in metabolism, signal transduction and defence. Nineteen TDFs based on the homology analysis of genes associated with defence, signal transduction and metabolism were further validated by quantitative real time PCR (qRT-PCR) analyses in resistant wild species in comparison with a susceptible peanut genotype in time course experiments. The proteins corresponding to six TDFs were differentially expressed at protein level also. Differentially expressed TDFs and proteins in wild peanut indicate its defence mechanism upon pathogen challenge and provide initial breakthrough of genes possibly involved in recognition events and early signalling responses to combat the pathogen through subsequent development of resistivity. This is the first attempt to elucidate the molecular basis of the response of the resistant genotype to the late leaf spot pathogen, and its defence mechanism.	[Kumar, Dilip; Kirti, Pulugurtha Bharadwaja] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Kumar, D (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India.	dilip.hcu@gmail.com	Kirti, P.B./R-1504-2019; KUMAR, DINESH/GRJ-5448-2022; Kumar, Dilip/GQB-0364-2022	KUMAR, DINESH/0000-0002-9641-6662; Kumar, Dilip/0000-0003-3721-4718; Kumar, Dilip/0000-0003-4566-1446	Department of Biotechnology, Government of India [BT/PR/6835/PB/16/627/2005]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was supported by funding from the Department of Biotechnology, Government of India (BT/PR/6835/PB/16/627/2005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou Y. A.-M., 1974, Peanut Science, V1, P6, DOI 10.3146/i0095-3679-1-1-3; AGRIOS GN, 1997, PLANT PATHOLOGY; Agudelo-Romero P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-92; Castillejo MA, 2012, J EXP BOT, V63, P107, DOI 10.1093/jxb/err246; Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; BABIYCHUK E, 1995, J BIOL CHEM, V270, P26224, DOI 10.1074/jbc.270.44.26224; Bachem CWB, 1996, PLANT J, V9, P745, DOI 10.1046/j.1365-313X.1996.9050745.x; Bahramnejad B, 2009, PLANT CELL REP, V28, P703, DOI 10.1007/s00299-009-0672-8; Baisakh N, 2006, PLANT SCI, V170, P1141, DOI 10.1016/j.plantsci.2006.02.001; Bangrak P, 2011, PLANT PHYSIOL BIOCH, V49, P244, DOI 10.1016/j.plaphy.2010.12.007; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; Boter M, 2007, PLANT CELL, V19, P3791, DOI 10.1105/tpc.107.050427; Brand Yael, 2010, Peanut Science, V37, P12, DOI 10.3146/PS09-014.1; Bulgarelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012599; Chan YW, 1999, J EXP BOT, V50, P1627, DOI 10.1093/jexbot/50.339.1627; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Cheng SF, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-286; Chivasa S, 2006, J EXP BOT, V57, P1553, DOI 10.1093/jxb/erj149; Conklin PL, 2001, PLANT CELL ENVIRON, V24, P383, DOI 10.1046/j.1365-3040.2001.00686.x; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dangl JL, 1996, PLANT CELL, V8, P1793, DOI 10.1105/tpc.8.10.1793; Dastoor Z, 2000, J CELL SCI, V113, P2845; Datta K, 1999, THEOR APPL GENET, V98, P1138, DOI 10.1007/s001220051178; Ding YF, 2012, ELECTRON J BIOTECHN, V15, DOI 10.2225/vol15-issue5-fulltext-1; Ditt RF, 2001, P NATL ACAD SCI USA, V98, P10954, DOI 10.1073/pnas.191383498; Eltayeb AE, 2006, PHYSIOL PLANTARUM, V127, P57, DOI 10.1111/j.1399-3054.2006.00624.x; Feller U., 2004, PLANT CELL DEATH PRO, P107; Feng SP, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/373768; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fukumura R, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng094; Gao HY, 2005, MOL PLANT MICROBE IN, V18, P1035, DOI 10.1094/MPMI-18-1035; GRICHAR WJ, 1998, GROUNDNUT SCI, V25, P35; Guo BZ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-12; Guo BZ, 2011, TOXINS, V3, P737, DOI 10.3390/toxins3070737; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Hu X, 1997, PLANT MOL BIOL, V34, P949, DOI 10.1023/A:1005893119263; Ibeas JI, 2000, PLANT J, V23, P375, DOI 10.1046/j.1365-313x.2000.00792.x; Ishitani R, 1998, MOL PHARMACOL, V53, P701, DOI 10.1124/mol.53.4.701; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones JT, 1998, FUND APPL NEMATOL, V21, P81; Katam R, 2010, J PROTEOME RES, V9, P2236, DOI 10.1021/pr901009n; Kaur P, 2011, J EXP BOT, V62, P1285, DOI 10.1093/jxb/erq365; Kawasaki T, 1999, P NATL ACAD SCI USA, V96, P10922, DOI 10.1073/pnas.96.19.10922; Kohler A, 2008, PLANT MOL BIOL, V66, P619, DOI 10.1007/s11103-008-9293-9; Kottapalli KR, 2008, PLANT SCI, V175, P321, DOI 10.1016/j.plantsci.2008.05.005; Kottapalli KR, 2009, PLANT CELL ENVIRON, V32, P380, DOI 10.1111/j.1365-3040.2009.01933.x; Kuhn E, 2001, ANN BOT-LONDON, V87, P139, DOI 10.1006/anbo.2000.1314; Kumar KRR, 2011, PLANT MOL BIOL, V75, P497, DOI 10.1007/s11103-011-9747-3; Kundu S, 2011, J PROTEOMICS, V74, P337, DOI 10.1016/j.jprot.2010.11.012; Kuroyanagi M, 2005, J BIOL CHEM, V280, P32914, DOI 10.1074/jbc.M504476200; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Lefebvre S, 2005, PLANT PHYSIOL, V138, P451, DOI 10.1104/pp.104.055046; Lherminier J, 2009, MOL PLANT MICROBE IN, V22, P868, DOI 10.1094/MPMI-22-7-0868; Liao JL, 2012, PLANT SCI, V196, P32, DOI 10.1016/j.plantsci.2012.07.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo M, 2005, PHYTOPATHOLOGY, V95, P381, DOI 10.1094/PHYTO-95-0381; Mahmood T, 2006, PROTEOMICS, V6, P6053, DOI 10.1002/pmic.200600470; Martinez DE, 2007, J EXP BOT, V58, P1099, DOI 10.1093/jxb/erl270; Mehta A, 2008, FEBS J, V275, P3731, DOI 10.1111/j.1742-4658.2008.06528.x; Munis MFH, 2010, BIOCHEM BIOPH RES CO, V393, P38, DOI 10.1016/j.bbrc.2010.01.069; Muskett PR, 2002, PLANT CELL, V14, P979, DOI 10.1105/tpc.001040; Nobile PM, 2008, PLANT SCI, V174, P78, DOI 10.1016/j.plantsci.2007.09.009; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Noel LD, 2007, PLANT CELL, V19, P4061, DOI 10.1105/tpc.107.051896; Okamoto T, 1999, PLANT MOL BIOL, V39, P63, DOI 10.1023/A:1006170518002; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Osbourn AE, 1999, FUNGAL GENET BIOL, V26, P163, DOI 10.1006/fgbi.1999.1133; Padovan L, 2010, PROTEIN PEPTIDE LETT, V17, P297, DOI 10.2174/092986610790780350; Pande S, 2001, PLANT DIS, V85, P851, DOI 10.1094/PDIS.2001.85.8.851; Payton P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-265; Peng Wen-Fang, 2011, Yichuan, V33, P389, DOI 10.3724/SP.J.1005.2011.00389; Polesani M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-142; Rao NK, 2003, GENET RESOUR CROP EV, V50, P707, DOI 10.1023/A:1025055018954; Rojo E, 2004, CURR BIOL, V14, P1897, DOI 10.1016/j.cub.2004.09.056; Romeis T, 2001, CURR OPIN PLANT BIOL, V4, P407, DOI 10.1016/S1369-5266(00)00193-X; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; Sestili S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-122; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shokes F.M., 1997, COMPENDIUM PEANUT DI, V2nd ed., P17; Archana Singh, 1997, International Chickpea and Pigeonpea Newsletter, P39; Smirnoff N, 1996, ANN BOT-LONDON, V78, P661, DOI 10.1006/anbo.1996.0175; Song YP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-286; Stevens R, 2008, PLANT CELL ENVIRON, V31, P1086, DOI 10.1111/j.1365-3040.2008.01824.x; SUTHERLAND MW, 1991, PHYSIOL MOL PLANT P, V39, P79, DOI 10.1016/0885-5765(91)90020-I; Swidzinski JA, 2002, PLANT J, V30, P431, DOI 10.1046/j.1365-313X.2002.01301.x; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Valdes-Rodriguez S, 2010, PLANT PHYSIOL BIOCH, V48, P469, DOI 10.1016/j.plaphy.2010.03.012; Van der Weerden NL, 2013, FUNGAL BIOL REV, V26, P121, DOI 10.1016/j.fbr.2012.08.004; Vinagre F, 2006, J EXP BOT, V57, P559, DOI 10.1093/jxb/erj041; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang L, 2004, PLANT MOL BIOL, V56, P929, DOI 10.1007/s11103-004-6236-y; Wang T, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-267; Wang XJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-9; Wang XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-289; Wang XC, 2007, BIOTECHNOL LETT, V29, P1599, DOI 10.1007/s10529-007-9425-3; Wang ZZ, 2012, J PROTEOME RES, V11, P2739, DOI 10.1021/pr201105d; Wolf I, 2006, CANCER RES, V66, P7818, DOI 10.1158/0008-5472.CAN-05-4368; Wu LJ, 2013, J PROTEOMICS, V89, P124, DOI 10.1016/j.jprot.2013.06.005; WYNNE JC, 1991, ANNU REV PHYTOPATHOL, V29, P279, DOI 10.1146/annurev.py.29.090191.001431; Xing T, 1997, PLANT CELL, V9, P249, DOI 10.1105/tpc.9.2.249; Yoon HS, 2004, BBA-BIOENERGETICS, V1658, P181, DOI 10.1016/j.bbabio.2004.05.013; Young ND, 1996, GENOME MAPPING PLANT, P211; Yu CL, 2008, PHYTOCHEMISTRY, V69, P1989, DOI 10.1016/j.phytochem.2008.04.006; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhu BL, 1996, PLANTA, V198, P70	108	23	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117559	10.1371/journal.pone.0117559	http://dx.doi.org/10.1371/journal.pone.0117559			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646800	gold, Green Published, Green Submitted			2022-12-27	WOS:000348822600074
J	Lee, KC; Han, K; Kim, JY; Nam, GE; Han, BD; Shin, KE; Lee, A; Ko, BJ				Lee, Kyu-Chong; Han, Kyungdo; Kim, Jin Yong; Nam, Ga Eun; Han, Byoung-Duck; Shin, Koh-Eun; Lee, Anna; Ko, Byung Joon			Socioeconomic Status and Other Related Factors of Seasonal Influenza Vaccination in the South Korean Adult Population Based on a Nationwide Cross-Sectional Study	PLOS ONE			English	Article							OLDER-ADULTS; COVERAGE; DETERMINANTS; HEALTH; MORTALITY; DISEASE; PEOPLE; IMPACT; RATES	Purpose We investigated the association between seasonal influenza vaccination in South Korea and socioeconomic status (SES) as well as other potential related factors. Methods The study was based on data obtained in the Korea National Health and Nutrition Examination Survey from 2010 to 2011. Education level and household income were used as indicators for SES. Univariate and multiple logistic regression analyses were used to evaluate SES and other demographic variables as related factors for influenza vaccination, the primary outcome. Results Higher household income was positively associated with higher vaccine uptake in the younger (19-49 years) group [adjusted odds ratio (aOR) 1.55, 95% confidence interval (CI) 1.08-2.23], whereas the low-income and low-education group had increased vaccination coverage than the middle-income and middle-education group in the older (>= 50 years) group (aOR 1.36, 95% CI 1.09-1.69). Current smokers tend to be unvaccinated in all age groups. Among individuals aged >= 50, older age, mild to moderate alcohol consumption, regular exercise, and having co-morbidities were positively associated with vaccination, while those who self-reported their health status as good were less likely to be vaccinated. Conclusions The relationship between SES and seasonal influenza vaccination coverage differed between the age groups throughout the adult South Korean population. Public health policies need to address these inequalities.	[Lee, Kyu-Chong] Korea Univ, Coll Med, Dept Radiol, Seoul 136705, South Korea; [Han, Kyungdo] Catholic Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Kim, Jin Yong] Korea Univ, Coll Med, Dept Neurosci, Seoul 136705, South Korea; [Nam, Ga Eun; Shin, Koh-Eun; Ko, Byung Joon] Korea Univ, Coll Med, Dept Family Med, Seoul 136705, South Korea; [Han, Byoung-Duck] SahmYook Med Ctr, Dept Family Med, Seoul, South Korea; [Lee, Anna] Univ Pacific, Coll Hlth Professionals, Sch Phys Assistant Studies, Hillsboro, OR USA; [Ko, Byung Joon] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA USA; [Ko, Byung Joon] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Total Healthcare Ctr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); University of the Pacific; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Sungkyunkwan University (SKKU); Samsung Medical Center	Ko, BJ (corresponding author), Korea Univ, Coll Med, Dept Family Med, Seoul 136705, South Korea.	basslove1@hanmail.net	Nam, Ga Eun/AAU-6055-2020; Nam, Ga Eun/AAA-1577-2021	Nam, Ga Eun/0000-0002-6739-9904; Kim, Jin Yong/0000-0001-8080-3206; Lee, Kyu-chong/0000-0002-4518-8567; han, byoungduck/0000-0003-2830-1174				Andrew MK, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-36; Bohmer MM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-938; Bryant WK, 2006, PREV MED, V43, P60, DOI 10.1016/j.ypmed.2006.03.018; Christenson B, 2002, EPIDEMIOL INFECT, V129, P515, DOI 10.1017/S095026880200780X; Damiani G, 2007, PREV MED, V45, P373, DOI 10.1016/j.ypmed.2007.07.007; Dip RM, 2010, CAD SAUDE PUBLICA, V26, P1035, DOI 10.1590/S0102-311X2010000500025; Endrich MM, 2009, VACCINE, V27, P4018, DOI 10.1016/j.vaccine.2009.04.029; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Galarce EM, 2011, VACCINE, V29, P5284, DOI 10.1016/j.vaccine.2011.05.014; Heo JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064230; HUTCHISON BG, 1989, CAN J PUBLIC HEALTH, V80, P271; Jones TF, 2004, CLIN INFECT DIS, V39, P1824, DOI 10.1086/427153; Kee SY, 2007, J INFECTION, V55, P273, DOI 10.1016/j.jinf.2007.04.354; *KOR CTR DIS CONTR, 2012 2013 INFLUENZA, P28669; Landi F, 2005, VACCINE, V23, P3896, DOI 10.1016/j.vaccine.2005.03.008; Lang PO, 2012, CLIN INTERV AGING, V7, P55, DOI 10.2147/CIA.S25215; Lau JTF, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4164; Lee YK, 2012, AM J INFECT CONTROL, V40, P481, DOI 10.1016/j.ajic.2011.05.015; Link MW, 2006, AM J EPIDEMIOL, V163, P571, DOI 10.1093/aje/kwj086; de Andres A, 2007, EUR J PUBLIC HEALTH, V17, P272, DOI 10.1093/eurpub/ckl242; Lu PJ, 2005, ARCH INTERN MED, V165, P1849, DOI 10.1001/archinte.165.16.1849; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; Mangtani P, 2005, PREV MED, V41, P545, DOI 10.1016/j.ypmed.2005.02.001; Maurer J, 2010, PREV MED, V51, P185, DOI 10.1016/j.ypmed.2010.05.008; Petersen RL, 1999, MED CARE, V37, P502, DOI 10.1097/00005650-199905000-00009; Phonrat B, 2013, VACCINE, V31, P1503, DOI 10.1016/j.vaccine.2012.12.082; Ryu SY, 2011, INT J ENV RES PUB HE, V8, P4197, DOI 10.3390/ijerph8114197; Sander B, 2010, VACCINE, V28, P6210, DOI 10.1016/j.vaccine.2010.07.010; Savy V, 2013, INFLUENZA OTHER RESP, V7, P1017, DOI 10.1111/irv.12036; Schwartz KL, 2006, J GEN INTERN MED, V21, P346, DOI 10.1111/j.1525-1497.2006.00401.x; SPRENGER MJW, 1993, INT J EPIDEMIOL, V22, P334, DOI 10.1093/ije/22.2.334; Talbot HK, 2011, J INFECT DIS, V203, P500, DOI 10.1093/infdis/jiq076; Vaux S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-159; Wong CM, 2013, INFLUENZA OTHER RESP, V7, P531, DOI 10.1111/j.1750-2659.2012.00411.x; Wu SS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-636	35	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117305	10.1371/journal.pone.0117305	http://dx.doi.org/10.1371/journal.pone.0117305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646847	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600063
J	Xu, CC; Xue, T; Wang, QM; Zhou, YN; Huang, JH; Yu, AY				Xu, Chen-Chen; Xue, Ting; Wang, Qin-Mei; Zhou, Yi-Ni; Huang, Jin-Hai; Yu, A-Yong			Repeatability and Reproducibility of a Double-Pass Optical Quality Analysis Device	PLOS ONE			English	Article							INTRAOCULAR-LENS IMPLANTATION; RETINAL IMAGE QUALITY; VISUAL PERFORMANCE; INSTRUMENT; SYSTEM	Purpose To evaluate the repeatability and reproducibility of a double-pass instrument (OQASII, Visiomereics SL, Spain), which objectively measures overall optical quality of the human eyes. Methods The right eye of 119 healthy subjects with best corrected visual acuity of 20/25 or better was included in this prospective, comparative, observational study. Two separate tests with OQASII were conducted sequentially on the same day by two different examiners. A week later, the first examiner conducted the third measurement. All subjects underwent three consecutive tests during each session. The repeatability and reproducibility of the modulation transfer function cut off frequency (MTF cutoff), the Strehl ratio, the OQAS values (OVs) at contrasts of 100%, 20% and 9%, and the objective scatter index (OSI) were analyzed. Results For MTF cutoff, Strehl ratio, OV100%, OV20%, OV9%, and OSI, the mean values were 39.32 +/- 9.75cpd, 0.22 +/- 0.06, 1.31 +/- 0.33, 1.33 +/- 0.39, 1.33 +/- 0.41, 0.60 +/- 0.42, respectively. Repeatability and reproducibility were good with a very low coefficient of variation and high interclass correlation coefficients (>0.88) for all parameters. Bland-Altman plots showed good correlation with 95% limits of agreement ranged from -6.04 to 6.78cpd, -0.05 to 0.05, -0.20 to 0.23, -0.29 to 0.32, -0.40 to 0.42, -0.23 to 0.21 in inter-observer, and -6.56 to 7.42cpd, -0.06 to 0.06, -0.22 to 0.24, -0.30 to 0.32, -0.35 to 0.34, -0.24 to 0.23 in inter-visit, respectively. Conclusion The OQASII system yields excellent repeatability and good reproducibility for objective measurements of overall optical quality in clinic.	[Xu, Chen-Chen; Xue, Ting; Wang, Qin-Mei; Zhou, Yi-Ni; Huang, Jin-Hai; Yu, A-Yong] Wenzhou Med Univ, Hosp Eye, Wenzhou, Peoples R China	Wenzhou Medical University	Yu, AY (corresponding author), Wenzhou Med Univ, Hosp Eye, Wenzhou, Peoples R China.	yaybetter@hotmail.com	Huang, Jinhai/ABH-4519-2020					Alio JL, 2005, J CATARACT REFR SURG, V31, P1557, DOI 10.1016/j.jcrs.2005.01.026; Artal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016823; British Standards Institution, 1994, 5725 BS ISO 2; Cheng X, 2004, INVEST OPHTH VIS SCI, V45, P351, DOI 10.1167/iovs.03-0265; Diaz-Douton F, 2006, INVEST OPHTH VIS SCI, V47, P1710, DOI 10.1167/iovs.05-1049; Fernandez-Vega L, 2009, J CATARACT REFR SURG, V35, P825, DOI 10.1016/j.jcrs.2008.12.040; Jimenez JR, 2009, CORNEA, V28, P783, DOI 10.1097/ICO.0b013e318196703a; Ortiz D, 2008, J CATARACT REFR SURG, V34, P1345, DOI 10.1016/j.jcrs.2008.04.022; Saad A, 2010, J CATARACT REFR SURG, V36, P28, DOI 10.1016/j.jcrs.2009.07.033; Tutt R, 2000, INVEST OPHTH VIS SCI, V41, P4117; Vilaseca M, 2010, OPTOMETRY VISION SCI, V87, P675, DOI 10.1097/OPX.0b013e3181ea1ad3; Vilaseca M, 2009, J REFRACT SURG, V25, P689, DOI 10.3928/1081597X-20090707-03; Vilaseca M, 2009, J CATARACT REFR SURG, V35, P1415, DOI 10.1016/j.jcrs.2009.03.022; ZADNIK K, 1992, INVEST OPHTH VIS SCI, V33, P2325	14	33	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117587	10.1371/journal.pone.0117587	http://dx.doi.org/10.1371/journal.pone.0117587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646846	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600076
J	Galvani, RG; Lemos, R; Areal, RB; Salvador, PA; Zamboni, DS; Wanderley, JLM; Bonomo, A				Galvani, Romulo G.; Lemos, Ramon; Areal, Romulo B.; Salvador, Pollyanna A.; Zamboni, Dario S.; Wanderley, Joao Luiz M.; Bonomo, Adriana			Disease Severity and Mortality Can Be Independently Regulated in a Mouse Model of Experimental Graft versus Host Disease	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; INNATE IMMUNE-SYSTEM; ALPHA TNF-ALPHA; DENDRITIC CELLS; T-CELLS; INFECTIOUS COMPLICATIONS; SECONDARY DISEASE; INTERFERON-GAMMA; MURINE MODEL	Graft versus host disease (GVHD) is the major limitation of allogeneic hematopoietic stem cell transplantation (HSCT) presenting high mortality and morbidity rates. However, the exact cause of death is not completely understood and does not correlate with specific clinical and histological parameters of disease. Here we show, by using a semi-allogeneic mouse model of GVHD, that mortality and morbidity can be experimentally separated. We injected bone marrow-derived dendritic cells (BMDC) from NOD2/CARD15-deficient donors into semi-allogeneic irradiated chimaeras and observed that recipients were protected from death. However, no protection was observed regarding clinical or pathological scores up to 20 days after transplantation. Protection from death was associated with decreased bacterial translocation, faster hematologic recovery and epithelial integrity maintenance despite mononuclear infiltration at day 20 post-GVHD induction with no skew towards different T helper phenotypes. The protected mice recovered from aGVHD and progressively reached scores compatible with healthy animals. Altogether, our data indicate that severity and mortality can be separate events providing a model to study transplant-related mortality.	[Galvani, Romulo G.; Lemos, Ramon; Areal, Romulo B.; Salvador, Pollyanna A.; Wanderley, Joao Luiz M.; Bonomo, Adriana] Inst Nacl Canc, Div Expt Med, Rio De Janeiro, Brazil; [Galvani, Romulo G.; Lemos, Ramon; Bonomo, Adriana] Univ Fed Rio de Janeiro, Dept Imunol, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil; [Zamboni, Dario S.] Univ Sao Paulo, Dept Biol Celular Mol & Bioagentes Patogen, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Wanderley, Joao Luiz M.] Univ Fed Rio de Janeiro, NUPEM, Rio De Janeiro, Brazil; [Bonomo, Adriana] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Timo, BR-21045900 Rio De Janeiro, Brazil	National Cancer Institute (Inca); Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Wanderley, JLM (corresponding author), Inst Nacl Canc, Div Expt Med, Rio De Janeiro, Brazil.	lmwjoao@macae.ufrj.br	Wanderley, Joao Luiz/J-6711-2014; Zamboni, Dario S/D-3024-2012	Zamboni, Dario S/0000-0002-7856-7512; Braga Areal, Romulo/0000-0001-9531-0092	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alousi AM, 2009, BLOOD, V114, P511, DOI 10.1182/blood-2009-03-212290; BEELEN DW, 1992, BLOOD, V80, P2668; Beelen DW, 1999, BLOOD, V93, P3267, DOI 10.1182/blood.V93.10.3267.410k22_3267_3275; Beyrau M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120134; Bjorklund A, 2007, BONE MARROW TRANSPL, V40, P1055, DOI 10.1038/sj.bmt.1705856; Body-Malapel M, 2008, LAB INVEST, V88, P318, DOI 10.1038/labinvest.3700716; Bogunovic M, 2006, J EXP MED, V203, P2627, DOI 10.1084/jem.20060667; BROK HPM, 1993, J IMMUNOL, V151, P6451; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Choi SW, 2012, BIOL BLOOD MARROW TR, V18, P1525, DOI 10.1016/j.bbmt.2012.03.013; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Couriel D, 2004, BLOOD, V104, P649, DOI 10.1182/blood-2003-12-4241; Dilek N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00208; Duffner UA, 2004, J IMMUNOL, V172, P7393, DOI 10.4049/jimmunol.172.12.7393; Durakovic N, 2006, J IMMUNOL, V177, P4414, DOI 10.4049/jimmunol.177.7.4414; Elmaagacli AH, 2006, TRANSPLANTATION, V81, P247, DOI 10.1097/01.tp.0000188671.94646.16; Eriguchi Y, 2012, BLOOD, V120, P223, DOI 10.1182/blood-2011-12-401166; FERRARA J, 1986, J INVEST DERMATOL, V86, P371, DOI 10.1111/1523-1747.ep12285612; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gerbitz A, 2004, BLOOD, V103, P4365, DOI 10.1182/blood-2003-11-3769; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Goiriz R, 2009, J EUR ACAD DERMATOL, V23, P1398, DOI 10.1111/j.1468-3083.2009.03326.x; Granell M, 2006, HAEMATOLOGICA, V91, P1372; Highfill SL, 2010, BLOOD, V116, P5738, DOI 10.1182/blood-2010-06-287839; Hill GR, 1998, J CLIN INVEST, V102, P115, DOI 10.1172/JCI3132; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Holler E, 2008, INT J IMMUNOGENET, V35, P381, DOI 10.1111/j.1744-313X.2008.00795.x; Holler E, 2006, BLOOD, V107, P4189, DOI 10.1182/blood-2005-09-3741; HOLLER E, 1995, BLOOD, V86, P890, DOI 10.1182/blood.V86.3.890.890; Horwitz BH, 2007, INFLAMM BOWEL DIS, V13, P490, DOI 10.1002/ibd.20098; JONES JM, 1971, RADIAT RES, V45, P577, DOI 10.2307/3573066; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; KORNGOLD R, 1978, J EXP MED, V148, P1687; Koyama M, 2009, BLOOD, V113, P2088, DOI 10.1182/blood-2008-07-168609; Langier S, 2012, BRAZ J MED BIOL RES, V45, P942, DOI 10.1590/S0100-879X2012007500089; Lorenz E, 2001, BIOL BLOOD MARROW TR, V7, P384, DOI 10.1053/bbmt.2001.v7.pm11529488; Mahnke K, 2005, CURR TOP MICROBIOL, V293, P133, DOI 10.1007/3-540-27702-1_7; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Matte CC, 2004, NAT MED, V10, P987, DOI 10.1038/nm1089; Mayor NP, 2007, J CLIN ONCOL, V25, P4262, DOI 10.1200/JCO.2007.12.1897; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Penack O, 2009, J EXP MED, V206, P2101, DOI 10.1084/jem.20090623; Pidala J, 2011, HAEMATOL-HEMATOL J, V96, P1678, DOI 10.3324/haematol.2011.049841; PIGUET PF, 1987, J EXP MED, V166, P1280, DOI 10.1084/jem.166.5.1280; Rigato O, 1996, INFECTION, V24, P314, DOI 10.1007/BF01743367; Rosenzweig HL, 2009, J LEUKOCYTE BIOL, V85, P711, DOI 10.1189/jlb.0808478; Sairafi D, 2008, BONE MARROW TRANSPL, V41, P961, DOI 10.1038/bmt.2008.9; Shaw MH, 2009, NAT IMMUNOL, V10, P1267, DOI 10.1038/ni.1816; Shimabukuro-Vornhagen A, 2009, BLOOD, V114, P4919, DOI 10.1182/blood-2008-10-161638; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Silva GK, 2010, J IMMUNOL, V184, P1148, DOI 10.4049/jimmunol.0902254; SKINHOJ P, 1987, SCAND J INFECT DIS, V19, P91, DOI 10.3109/00365548709032383; STORB R, 1983, NEW ENGL J MED, V308, P302, DOI 10.1056/NEJM198302103080602; SYMINGTON FW, 1990, TRANSPLANTATION, V50, P518, DOI 10.1097/00007890-199009000-00033; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575; Travassos LH, 2005, J BIOL CHEM, V280, P36714, DOI 10.1074/jbc.M501649200; van den Brink MRM, 2002, NAT REV IMMUNOL, V2, P273, DOI 10.1038/nri775; van den Brink MRM, 2000, J IMMUNOL, V164, P469, DOI 10.4049/jimmunol.164.1.469; van der Velden WJFM, 2009, BONE MARROW TRANSPL, V44, P243, DOI 10.1038/bmt.2009.21; VANBEKKU.DW, 1974, J NATL CANCER I, V52, P401, DOI 10.1093/jnci/52.2.401; Vasconcelos ZFM, 2006, BLOOD, V107, P2192, DOI 10.1182/blood-2005-08-3239; VOSSEN JM, 1990, EUR J CLIN MICROBIOL, V9, P14, DOI 10.1007/BF01969527; Wanderley JLM, 2013, PARASITE IMMUNOL, V35, P109, DOI 10.1111/pim.12019; Welniak LA, 2000, BIOL BLOOD MARROW TR, V6, P604, DOI 10.1016/S1083-8791(00)70025-5; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Wilson J, 2009, J EXP MED, V206, P387, DOI 10.1084/jem.20070723; WOJNO KJ, 1994, TRANSPLANTATION, V57, P88, DOI 10.1097/00007890-199401000-00016	71	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0118079	10.1371/journal.pone.0118079	http://dx.doi.org/10.1371/journal.pone.0118079			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643148	Green Published, Green Submitted, gold			2022-12-27	WOS:000348821200044
J	Garibaldi, S; Frisoli, K; Ke, L; Lim, M				Garibaldi, Skip; Frisoli, Kayla; Ke, Li; Lim, Melody			Lottery Spending: A Non-Parametric Analysis	PLOS ONE			English	Article							PERMUTATION TESTS; RISK-FACTORS; PARTICIPATION; DISTRIBUTIONS; KURTOSIS; PURCHASE; TAX	We analyze the spending of individuals in the United States on lottery tickets in an average month, as reported in surveys. We view these surveys as sampling from an unknown distribution, and we use non-parametric methods to compare properties of this distribution for various demographic groups, as well as claims that some properties of this distribution are constant across surveys. We find that the observed higher spending by Hispanic lottery players can be attributed to differences in education levels, and we dispute previous claims that the top 10% of lottery players consistently account for 50% of lottery sales.	[Garibaldi, Skip; Frisoli, Kayla; Ke, Li; Lim, Melody] Univ Calif Los Angeles, Inst Pure & Appl Math, Los Angeles, CA 90095 USA; [Garibaldi, Skip] Emory Univ, Dept Math & Comp Sci, Atlanta, GA 30322 USA	University of California System; University of California Los Angeles; Emory University	Garibaldi, S (corresponding author), Univ Calif Los Angeles, Inst Pure & Appl Math, 460 Portola Plaza,Box 957121, Los Angeles, CA 90095 USA.	skip@garibaldibros.com		Garibaldi, Skip/0000-0001-8924-5933; Lim, Melody/0000-0002-2347-057X	Division Of Mathematical Sciences [0931852] Funding Source: National Science Foundation	Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		[Anonymous], 1989, COURIER J; [Anonymous], 1989, NEW YORK TIMES CBS N; [Anonymous], 1993, STAR TRIBUNE; [Anonymous], 1989, SELLING HOPE STATE L; Ariyabuddhiphongs V, 2011, J GAMBL STUD, V27, P15, DOI 10.1007/s10899-010-9194-0; Arratia R, 2014, SOME PEOPLE HAVE ALL; Baker R, 2014, PAPERS REGIONAL SCI, V93; BALANDA KP, 1988, AM STAT, V42, P111, DOI 10.2307/2684482; Berger VW, 2000, STAT MED, V19, P1319, DOI 10.1002/(SICI)1097-0258(20000530)19:10<1319::AID-SIM490>3.0.CO;2-0; Blest DC, 2003, AUST NZ J STAT, V45, P175, DOI 10.1111/1467-842X.00273; Borg M. O., 1991, EC CONSEQUENCES STAT; Campos M, 2013, HISPANIC GAMBLERS CP; Center for Public Policy U, 2007, TEX LOTT SURV 2007 2; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Clotfelter C, 1999, STATE LOTTERIES TURN; Delucchi KL, 2004, AM J PSYCHIAT, V161, P1159, DOI 10.1176/appi.ajp.161.7.1159; Good P. I, 2004, PERMUTATION PARAMETR; HERRING M, 1994, POLICY STUD J, V22, P245, DOI 10.1111/j.1541-0072.1994.tb01466.x; HOGG RV, 1974, J AM STAT ASSOC, V69, P909, DOI 10.2307/2286160; JAFFE ED, 1983, PUBLIC OPIN QUART, V47, P419, DOI 10.1086/268799; Johansson A, 2009, J GAMBL STUD, V25, P67, DOI 10.1007/s10899-008-9088-6; Kaizeler MJ, 2014, J GAMBL STUD, V30, P729, DOI 10.1007/s10899-013-9387-4; Light MK., 2014, MARKET SIZE DEMAND M; Ludbrook J, 1998, AM STAT, V52, P127, DOI 10.2307/2685470; McCrary J, 2002, PUBLIC POLICY RES SE; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Mower L, 2014, GAMING THE LOTTERY; Organization G, 2011, GALL NEWS SERV POLL; Pearson K, 1929, BIOMETRIKA, V21, P370; Perez L, 2013, J ECON SURV, V27, P915, DOI 10.1111/j.1467-6419.2012.00732.x; Pesarin F., 2010, PERMUTATION TESTS CO; Resnick SI, 2007, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-45024-7; Rosco JF, 2015, COMMUN STAT-THEOR M, V44, P3628, DOI 10.1080/03610926.2013.771747; Rubenstein R, 2002, NATL TAX J, V55, P223, DOI 10.17310/ntj.2002.2.02; SCOTT F, 1994, J PUBLIC ECON, V54, P121, DOI 10.1016/0047-2727(94)90073-6; Stark PB, 2012, STAT 240 NONPARAMETR; Stranahan H, 1998, NATL TAX J, V51, P71; Stranahan HA, 1998, PUBLIC FINANC REV, V26, P99, DOI 10.1177/109114219802600201; Welte John W, 2002, J Gambl Stud, V18, P313, DOI 10.1023/A:1021019915591; Welte JW, 2004, ADDICT BEHAV, V29, P323, DOI 10.1016/j.addbeh.2003.08.007	41	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0115730	10.1371/journal.pone.0115730	http://dx.doi.org/10.1371/journal.pone.0115730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3QK	25642699	Green Submitted, gold, Green Published			2022-12-27	WOS:000348821200013
J	Figueroa, JP; Cooper, CJ; Edwards, JK; Byfield, L; Eastman, S; Hobbs, MM; Weir, SS				Figueroa, J. Peter; Cooper, Carol Jones; Edwards, Jessie K.; Byfield, Lovette; Eastman, Shashauna; Hobbs, Marcia M.; Weir, Sharon S.			Understanding the High Prevalence of HIV and Other Sexually Transmitted Infections among Socio-Economically Vulnerable Men Who Have Sex with Men in Jamaica	PLOS ONE			English	Article							EPIDEMIC; CHALLENGES; PREVENTION; HIV/AIDS	Objectives This study estimates HIV prevalence among men who have sex with men (MSM) in Jamaica and explores social determinants of HIV infection among MSM. Design An island-wide cross-sectional survey of MSM recruited by peer referral and outreach was conducted in 2011. A structured questionnaire was administered and HIV/STI tests done. We compared three groups: MSM who accepted cash for sex within the past 3 months (MSM SW), MSM who did not accept cash for sex (MSM non-SW), and MSM with adverse life events (ever raped, jailed, homeless, victim of violence or low literacy). Results HIV prevalence among 449 MSM was 31.4%, MSM SW 41.1%, MSM with adverse life events 38.5%, 17 transgender MSM (52.9%), and MSM non-SW without adverse events 21.0%. HIV prevalence increased with age and number of adverse life events (test for trend P < 0.001), as did STI prevalence (P = 0.03). HIV incidence was 6.7 cases/100 personyears (95% CI: 3.74, 12.19). HIV prevalence was highest among MSM reporting high-risk sex; MSM SW who had been raped (65.0%), had a STI (61.2%) and who self identified as female (55.6%). Significant risk factors for HIV infection common to all 3 subgroups were participation in both receptive and insertive anal intercourse, high-risk sex, and history of a STI. Perception of no or little risk, always using a condom, and being bisexual were protective. Conclusion HIV prevalence was high among MSM SW and MSM with adverse life events. Given the characteristics of the sample, HIV prevalence among MSM in Jamaica is probably in the range of 20%. The study illustrates the importance of social vulnerability in driving the HIV epidemic. Programs to empower young MSM, reduce social vulnerability and other structural barriers including stigma and discrimination against MSM are critical to reduce HIV transmission.	[Figueroa, J. Peter; Byfield, Lovette] Univ W Indies, Dept Community Hlth & Psychiat, Kingston 7, Jamaica; [Cooper, Carol Jones] Epidemiol & Res Training Unit, Kingston, Jamaica; [Edwards, Jessie K.; Weir, Sharon S.] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Edwards, Jessie K.; Weir, Sharon S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Eastman, Shashauna] Comprehens Hlth Ctr, Kingston, Jamaica; [Hobbs, Marcia M.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Hobbs, Marcia M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University West Indies Mona Jamaica; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Figueroa, JP (corresponding author), Univ W Indies, Dept Community Hlth & Psychiat, Kingston 7, Jamaica.	peter.figueroa10@gmail.com		Edwards, Jessie/0000-0002-1741-335X	United States Agency for International Development (USAID) [GHA-A-00-08-00003-00]; MEASURE Evaluation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); MEASURE Evaluation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by the United States Agency for International Development (USAID) through a cooperative agreement (GHA-A-00-08-00003-00) with MEASURE Evaluation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Aho J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099591; Anderson AM, 2015, AIDS CARE, V27, P63, DOI 10.1080/09540121.2014.951597; [Anonymous], 2012, LANCET, P1; Beyrer C, 2012, LANCET; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Boerma JT, 2005, J INFECT DIS, V191, pS61, DOI 10.1086/425282; Eaton LA, 2015, AM J PUBLIC HEALTH, V105, pE75, DOI 10.2105/AJPH.2014.302322; Figueroa JP, 2008, W INDIAN MED J, V57, P195; Figueroa JP, 2013, W INDIAN MED J, V62, P286, DOI 10.7727/WIMJ.2011.207; Figueroa JP, 2008, W INDIAN MED J, V57, P562; Figueroa JP, 2014, CURR HIV-AIDS REP, V11, P158, DOI 10.1007/s11904-014-0199-7; Howe CJ, 2011, EPIDEMIOLOGY, V22, P874, DOI 10.1097/EDE.0b013e31823029dd; Millett GA, 2012, LANCET, P11; Millett GA, 2012, LANCET, P63; Mwangome M, 2010, 5 IAS C HIV PATH TRE; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; Sullinvan PS, 2012, LANCET, P40; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; United Nations & AIDS (UNAIDS), 2012, WORLD AIDS DAY REP; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001	21	32	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117686	10.1371/journal.pone.0117686	http://dx.doi.org/10.1371/journal.pone.0117686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25659122	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900203
J	Jin, J; Wu, RJ; Zhu, J; Yang, SY; Lei, Z; Wang, N; Singh, VK; Zheng, JM; Jia, ZC				Jin, Jin; Wu, Ruijuan; Zhu, Jia; Yang, Shaoyuan; Lei, Zhen; Wang, Nan; Singh, Vinay K.; Zheng, Jimin; Jia, Zongchao			Insights into the Cellular Function of YhdE, a Nucleotide Pyrophosphatase from Escherichia coli	PLOS ONE			English	Article							BACILLUS-SUBTILIS; RNASE-E; IDENTIFICATION; PROTEINS; FTSZ; MAF; INHIBITION; FILAMENTS; GROWTH; DOMAIN	YhdE, a Maf-like protein in Escherichia coli, exhibits nucleotide pyrophosphatase (PPase) activity, yet its cellular function remains unknown. Here, we characterized the PPase activity of YhdE on dTTP, UTP and TTP and determined two crystal structures of YhdE, revealing 'closed' and 'open' conformations of an adaptive active site. Our functional studies demonstrated that YhdE retards cell growth by prolonging the lag and log phases, particularly under stress conditions. Morphology studies showed that yhdE-knockout cells transformed the normal rod shape of wild-type cells to a more spherical form, and the cell wall appeared to become more flexible. In contrast, YhdE overexpression resulted in filamentous cells. This study reveals the previously unknown involvement of YhdE in cell growth inhibition under stress conditions, cell-division arrest and cell-shape maintenance, highlighting YhdE's important role in Escherichia coli cell-cycle checkpoints.	[Jin, Jin; Wu, Ruijuan; Zhu, Jia; Yang, Shaoyuan; Lei, Zhen; Wang, Nan; Zheng, Jimin; Jia, Zongchao] Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China; [Singh, Vinay K.; Jia, Zongchao] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Beijing Normal University; Queens University - Canada	Zheng, JM (corresponding author), Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China.	jimin_z@bnu.edu.cn; jia@queensu.ca		Wang, Nan/0000-0001-7129-6089	National Natural Science Foundation of China [21133003, 21273023]; Canadian Institutes of Health Research	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the National Natural Science Foundation of China (No. 21133003 and No. 21273023) and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Tran AT, 2013, ORG BIOMOL CHEM, V11, P8113, DOI 10.1039/c3ob41896k; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BEALL B, 1991, GENE DEV, V5, P447, DOI 10.1101/gad.5.3.447; BI E, 1991, RES MICROBIOL, V142, P249, DOI 10.1016/0923-2508(91)90037-B; Briley K, 2011, MOL MICROBIOL, V81, P23, DOI 10.1111/j.1365-2958.2011.07695.x; BUTLER YX, 1993, J BACTERIOL, V175, P3139, DOI 10.1128/JB.175.10.3139-3145.1993; Hwang KY, 1999, NAT STRUCT BIOL, V6, P691; JANCARIK J, 1991, J MOL BIOL, V221, P31, DOI 10.1016/0022-2836(91)80198-4; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kawai Y, 2003, MOL MICROBIOL, V47, P1113, DOI 10.1046/j.1365-2958.2003.03360.x; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Leaver M, 2005, MOL MICROBIOL, V57, P1196, DOI 10.1111/j.1365-2958.2005.04736.x; Li ZW, 1999, EMBO J, V18, P2878, DOI 10.1093/emboj/18.10.2878; McDowall KJ, 1996, J MOL BIOL, V255, P349, DOI 10.1006/jmbi.1996.0027; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Minasov G, 2000, P NATL ACAD SCI USA, V97, P6328, DOI 10.1073/pnas.97.12.6328; OKADA Y, 1994, J BACTERIOL, V176, P917, DOI 10.1128/jb.176.3.917-922.1994; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tamura M, 2006, J BACTERIOL, V188, P5145, DOI 10.1128/JB.00367-06; Tchigvintsev A, 2013, CHEM BIOL, V20, P1386, DOI 10.1016/j.chembiol.2013.09.011; Trusca D, 1998, J BACTERIOL, V180, P3946, DOI 10.1128/JB.180.15.3946-3953.1998; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wachi M, 1999, BIOCHEM BIOPH RES CO, V259, P483, DOI 10.1006/bbrc.1999.0806; Zhang ZL, 2005, J BIOL CHEM, V280, P9698, DOI 10.1074/jbc.M411211200; Zheng JM, 2005, STRUCTURE, V13, P1511, DOI 10.1016/j.str.2005.07.007; Zhou HJ, 2005, J BACTERIOL, V187, P2846, DOI 10.1128/JB.187.8.2846-2857.2005	28	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117823	10.1371/journal.pone.0117823	http://dx.doi.org/10.1371/journal.pone.0117823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658941	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900229
J	Koide, N; Kubo, T; Nishida, S; Shibata, T; Ikeda, K				Koide, Naoko; Kubo, Takatomi; Nishida, Satoshi; Shibata, Tomohiro; Ikeda, Kazushi			Art Expertise Reduces Influence of Visual Salience on Fixation in Viewing Abstract-Paintings	PLOS ONE			English	Article							EYE; ATTENTION; ARTISTS; SHIFTS; PERCEPTION; APPRAISAL; OVERT	When viewing a painting, artists perceive more information from the painting on the basis of their experience and knowledge than art novices do. This difference can be reflected in eye scan paths during viewing of paintings. Distributions of scan paths of artists are different from those of novices even when the paintings contain no figurative object (i.e. abstract paintings). There are two possible explanations for this difference of scan paths. One is that artists have high sensitivity to high-level features such as textures and composition of colors and therefore their fixations are more driven by such features compared with novices. The other is that fixations of artists are more attracted by salient features than those of novices and the fixations are driven by low-level features. To test these, we measured eye fixations of artists and novices during the free viewing of various abstract paintings and compared the distribution of their fixations for each painting with a topological attentional map that quantifies the conspicuity of low-level features in the painting (i.e. saliency map). We found that the fixation distribution of artists was more distinguishable from the saliency map than that of novices. This difference indicates that fixations of artists are less driven by low-level features than those of novices. Our result suggests that artists may extract visual information from paintings based on high-level features. This ability of artists may be associated with artists' deep aesthetic appreciation of paintings.	[Koide, Naoko; Kubo, Takatomi; Shibata, Tomohiro; Ikeda, Kazushi] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300101, Japan; [Nishida, Satoshi] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Osaka, Japan; [Shibata, Tomohiro] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Fukuoka, Japan	Nara Institute of Science & Technology; National Institute of Information & Communications Technology (NICT) - Japan; Kyushu Institute of Technology	Ikeda, K (corresponding author), Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300101, Japan.	kazushi@is.naist.jp		Nishida, Satoshi/0000-0003-0555-518X; Shibata, Tomohiro/0000-0002-8766-4250; Koide-Majima, Naoko/0000-0002-3805-5758	JSPS KAKENHI [23240028]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant number: JSPS KAKENHI Grant Number 23240028. URL: https://kaken.nii.ac.jp/d/p/23240028.en.html. Author: TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTES JR, 1991, PERCEPT MOTOR SKILL, V73, P893, DOI 10.2466/PMS.73.7.893-894; BACON WF, 1994, PERCEPT PSYCHOPHYS, V55, P485, DOI 10.3758/BF03205306; Borji A, 2013, IEEE T PATTERN ANAL, V35, P185, DOI 10.1109/TPAMI.2012.89; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brunye TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103447; Cela-Conde CJ, 2011, PROG NEUROBIOL, V94, P39, DOI 10.1016/j.pneurobio.2011.03.003; Cohen DJ., 2008, PSYCHOL ASTHETICS CR, V2, P8, DOI [10.1037/1931-3896.2.1.8, DOI 10.1037/1931-3896.2.1.8]; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Cupchik G, 1992, VIS ARTS RES, V14, P37; Einhauser W, 2008, J VISION, V8, DOI 10.1167/8.2.2; Fuchs I, 2011, COGN COMPUT, V3, P25, DOI 10.1007/s12559-010-9062-3; GREENSPAN H, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P222, DOI 10.1109/CVPR.1994.323833; Hekkert P, 1996, AM J PSYCHOL, V109, P389, DOI 10.2307/1423013; Henderson JM, 1999, J EXP PSYCHOL HUMAN, V25, P210, DOI 10.1037/0096-1523.25.1.210; Hou XD, 2012, IEEE T PATTERN ANAL, V34, P194, DOI 10.1109/TPAMI.2011.146; Hoyer PO, 2004, J MACH LEARN RES, V5, P1457; Humphrey K, 2009, BRIT J PSYCHOL, V100, P377, DOI 10.1348/000712608X344780; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Itti L, 1999, P SOC PHOTO-OPT INS, V3644, P473, DOI 10.1117/12.348467; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Kozbelt A, 2001, VIS COGN, V8, P705, DOI 10.1080/13506280042000090; Lansdale M, 2010, APPL COGNITIVE PSYCH, V24, P213, DOI 10.1002/acp.1552; Long ZY, 2011, NEUROSCI LETT, V487, P191, DOI 10.1016/j.neulet.2010.10.020; NODINE CF, 1993, LEONARDO, V26, P219, DOI 10.2307/1575815; Nothdurft HC, 2002, VISION RES, V42, P1287, DOI 10.1016/S0042-6989(02)00016-0; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Putko A, 1989, POLISH PSYCHOL B, V20, P33; Tatler BW, 2005, VISION RES, V45, P643, DOI 10.1016/j.visres.2004.09.017; van Zoest W, 2004, J EXP PSYCHOL HUMAN, V30, P746, DOI 10.1037/0096-1523.30.4.749; Vogt S, 2007, PERCEPTION, V36, P91, DOI 10.1068/p5262; Yamamura H, 2009, NEUROREPORT, V20, P1630, DOI 10.1097/WNR.0b013e3283331322; ZANGEMEISTER WH, 1995, NEUROPSYCHOLOGIA, V33, P1009, DOI 10.1016/0028-3932(95)00014-T; Zhao Q, 2011, J VISION, V11, DOI 10.1167/11.3.9	34	36	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117696	10.1371/journal.pone.0117696	http://dx.doi.org/10.1371/journal.pone.0117696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658327	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900206
J	LeCain, D; Smith, D; Morgan, J; Kimball, BA; Pendall, E; Miglietta, F				LeCain, Daniel; Smith, David; Morgan, Jack; Kimball, Bruce A.; Pendall, Elise; Miglietta, Franco			Microclimatic Performance of a Free-Air Warming and CO2 Enrichment Experiment in Windy Wyoming, USA	PLOS ONE			English	Article							INFRARED HEATER ARRAYS; WATER RELATIONS; PHOTOSYNTHETIC RESPONSES; C-4 GRASSES; ECOSYSTEM; SOIL; PRACTICALITY; GRASSLAND; ARONSON; WHEAT	In order to plan for global changing climate experiments are being conducted in many countries, but few have monitored the effects of the climate change treatments (warming, elevated CO2) on the experimental plot microclimate. During three years of an eight year study with year-round feedback-controlled infra-red heater warming (1.5/3.0 degrees C day/night) and growing season free-air CO2 enrichment (600 ppm) in the mixed-grass prairie of Wyoming, USA, we monitored soil, leaf, canopy-air, above-canopy-air temperatures and relative humidity of control and treated experimental plots and evaluated ecologically important temperature differentials. Leaves were warmed somewhat less than the target settings (1.1 & 1.5 degrees C day/night) but soil was warmed more creating an average that matched the target settings extremely well both during the day and night plus the summer and winter. The site typically has about 50% bare or litter covered soil, therefore soil heat transfer is more critical than in dense canopy ecosystems. The Wyoming site commonly has strong winds (5 ms(-1) average) and significant daily and seasonal temperature fluctuations (as much as 30 degrees C daily) but the warming system was nearly always able to maintain the set temperatures regardless of abiotic variation. The within canopy-air was only slightly warmed and above canopy-air was not warmed by the system, therefore convective warming was minor. Elevated CO2 had no direct effect nor interaction with the warming treatment on microclimate. Relative humidity within the plant canopy was only slightly reduced by warming. Soil water content was reduced by warming but increased by elevated CO2. This study demonstrates the importance of monitoring the microclimate in manipulative field global change experiments so that critical physiological and ecological conclusions can be determined. Highly variable energy demand fluctuations showed that passive IR heater warming systems will not maintain desired warming for much of the time.	[LeCain, Daniel; Smith, David; Morgan, Jack] ARS, USDA, Rangelands Resources Res Unit, Northern Plains Area, Ft Collins, CO 80521 USA; [Kimball, Bruce A.] USDA ARS, US Arid Land Agr Res Ctr, Maricopa, AZ USA; [Pendall, Elise] Univ Western Sydney, Hawkesbury Inst Environm, Sydney, NSW, Australia; [Miglietta, Franco] Ist Biometeorol, Florence, Italy	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Western Sydney University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR)	LeCain, D (corresponding author), ARS, USDA, Rangelands Resources Res Unit, Northern Plains Area, Ft Collins, CO 80521 USA.	dan.lecain@ars.usda.gov	Pendall, Elise/AAF-5667-2020; Miglietta, Franco/B-6137-2008	Miglietta, Franco/0000-0003-1474-8143; Pendall, Elise/0000-0002-1651-8969	US Department of Agriculture Agricultural Research Service Climate Change, Soils & Emissions Program; USDA-CSREES Soil Processes Program [2008-35107-18655]; US Department of Energy Office of Science (BER), through Terrestrial Ecosystem Science program [DE-SC0006973]; Western Regional Center of the National Institute for Climatic Change Research; National Science Foundation (DEB) [1021559]	US Department of Agriculture Agricultural Research Service Climate Change, Soils & Emissions Program; USDA-CSREES Soil Processes Program; US Department of Energy Office of Science (BER), through Terrestrial Ecosystem Science program(United States Department of Energy (DOE)); Western Regional Center of the National Institute for Climatic Change Research; National Science Foundation (DEB)(National Science Foundation (NSF))	This material is based upon work supported by the US Department of Agriculture Agricultural Research Service Climate Change, Soils & Emissions Program, USDA-CSREES Soil Processes Program (#2008-35107-18655), US Department of Energy Office of Science (BER), through the Terrestrial Ecosystem Science program (#DE-SC0006973) and the Western Regional Center of the National Institute for Climatic Change Research, and by the National Science Foundation (DEB#1021559). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amthor JS, 2010, AGR FOREST METEOROL, V150, P497, DOI 10.1016/j.agrformet.2009.11.020; Aronson EL, 2010, AGR FOREST METEOROL, V150, P499, DOI 10.1016/j.agrformet.2009.11.021; Aronson EL, 2009, AGR FOREST METEOROL, V149, P1791, DOI 10.1016/j.agrformet.2009.06.007; Brigham SD, 1999, ECOL APPL, V9, P134; Campbell G.S., 1977, INTRO ENV PHYS; de Boeck HJ, 2011, J ECOL, V99, P724, DOI 10.1111/j.1365-2745.2011.01799.x; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Frelich LE, 2010, FRONT ECOL ENVIRON, V8, P371, DOI 10.1890/080191; HARTE J, 1995, ECOL APPL, V5, P132, DOI 10.2307/1942058; Hovenden MJ, 2006, AUST J BOT, V54, P1, DOI 10.1071/BT04194; IPCC, 2007, CONTRIBUTION WORKING; Gaihre YK, 2014, AGR ECOSYST ENVIRON, V184, P88, DOI 10.1016/j.agee.2013.11.024; Kimball BA, 1999, WATER RESOUR RES, V35, P1179, DOI 10.1029/1998WR900115; Kimball BA, 2005, GLOBAL CHANGE BIOL, V11, P2041, DOI 10.1111/j.1365-2486.2005.01028.x; Kimball BA, 2011, HDB CLIMATE CHANGE A, P87; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Kimball BA, 2012, THEOR APPL CLIMATOL, V108, P247, DOI 10.1007/s00704-011-0518-5; Kimball BA, 2011, AGR FOREST METEOROL, V151, P420, DOI 10.1016/j.agrformet.2010.11.013; Lecain DR, 2003, ANN BOT-LONDON, V92, P41, DOI 10.1093/aob/mcg109; Loik ME, 2000, FUNCT ECOL, V14, P166, DOI 10.1046/j.1365-2435.2000.00411.x; Luo CY, 2010, GLOBAL CHANGE BIOL, V16, P1606, DOI 10.1111/j.1365-2486.2009.02026.x; MCNAUGHTON KG, 1991, AGR FOREST METEOROL, V54, P279, DOI 10.1016/0168-1923(91)90010-N; Miglietta F, 2001, NEW PHYTOL, V150, P465, DOI 10.1046/j.1469-8137.2001.00115.x; Morgan JA, 2004, OECOLOGIA, V140, P11, DOI 10.1007/s00442-004-1550-2; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Pinter PJ, 2000, AGR FOREST METEOROL, V103, P319, DOI 10.1016/S0168-1923(00)00150-7; Rehmani MIA, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-41; Ruiz-Vera UM, 2013, PLANT PHYSIOL, V162, P410, DOI 10.1104/pp.112.211938; Seager R, 2010, P NATL ACAD SCI USA, V107, P21277, DOI 10.1073/pnas.0910856107; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Wall GW, 2011, GLOBAL CHANGE BIOL, V17, P2113, DOI 10.1111/j.1365-2486.2011.02399.x; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Xia J, 2009, BIOGEOSCIENCES, V6, P1361, DOI 10.5194/bg-6-1361-2009	34	24	24	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116834	10.1371/journal.pone.0116834	http://dx.doi.org/10.1371/journal.pone.0116834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658313	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900071
J	McCulloh, RJ; Koster, MP; Yin, DE; Milner, TL; Ralston, SL; Hill, VL; Alverson, BK; Biondi, EA				McCulloh, Russell J.; Koster, Michael P.; Yin, Dwight E.; Milner, Tiffany L.; Ralston, Shawn L.; Hill, Vanessa L.; Alverson, Brian K.; Biondi, Eric A.			Evaluating the Use of Blood Cultures in the Management of Children Hospitalized for Community-Acquired Pneumonia	PLOS ONE			English	Article							CARE; OUTCOMES	Background Blood cultures are often recommended for the evaluation of community-acquired pneumonia (CAP). However, institutions vary in their use of blood cultures, and blood cultures have unclear utility in CAP management in hospitalized children. Objective To identify clinical factors associated with obtaining blood cultures in children hospitalized with CAP, and to estimate the association between blood culture obtainment and hospital length of stay (LOS). Methods We performed a multicenter retrospective cohort study of children admitted with a diagnosis of CAP to any of four pediatric hospitals in the United States from January 1, 2011-December 31, 2012. Demographics, medical history, diagnostic testing, and clinical outcomes were abstracted via manual chart review. Multivariable logistic regression evaluated patient and clinical factors for associations with obtaining blood cultures. Propensity score-matched Kaplan-Meier analysis compared patients with and without blood cultures for hospital LOS. Results Six hundred fourteen charts met inclusion criteria; 390 children had blood cultures obtained. Of children with blood cultures, six (1.5%) were positive for a pathogen and nine (2.3%) grew a contaminant. Factors associated with blood culture obtainment included presenting with symptoms of systemic inflammatory response syndrome (OR 1.78, 95% CI 1.10-2.89), receiving intravenous hydration (OR 3.94, 95% CI 3.22-4.83), receiving antibiotics before admission (OR 1.49, 95% CI 1.17-1.89), hospital admission fromthe ED (OR 1.65, 95% CI 1.05-2.60), and having health insurance (OR 0.42, 95% CI 0.30-0.60). In propensity score-matched analysis, patients with blood cultures hadmedian 0.8 days longer LOS (2.0 vs 1.2 days, P < .0001) without increased odds of readmission (OR 0.94, 95% CI 0.45-1.97) or death (P = .25). Conclusions Obtaining blood cultures in children hospitalized with CAP rarely identifies a causative pathogen and is associated with increased LOS. Our results highlight the need to refine the role of obtaining blood cultures in children hospitalized with CAP.	[McCulloh, Russell J.; Yin, Dwight E.] Univ Missouri, Childrens Mercy Hosp, Dept Pediat, Kansas City, MO 64108 USA; [Koster, Michael P.; Alverson, Brian K.] Brown Univ, Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA; [Milner, Tiffany L.; Ralston, Shawn L.] Dartmouth Hitchcock Med Ctr, Dept Pediat, Lebanon, NH 03766 USA; [Hill, Vanessa L.] Childrens Hosp San Antonio, Dept Pediat, San Antonio, TX USA; [Biondi, Eric A.] Rochester Med Ctr, Dept Pediat, New Rochelle, NY USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Dartmouth College	McCulloh, RJ (corresponding author), Univ Missouri, Childrens Mercy Hosp, Dept Pediat, Kansas City, MO 64108 USA.	rmcculloh@cmh.edu	McCulloh, Russell/GVU-6139-2022; McCulloh, Russell/W-6128-2019	McCulloh, Russell/0000-0002-0403-6639	Rhode Island Foundation Clinical Research Grant - Rhode Island Foundation	Rhode Island Foundation Clinical Research Grant - Rhode Island Foundation	This work was supported by Rhode Island Foundation Clinical Research Grant: Sponsored by The Rhode Island Foundation (http://www.rifoundation.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATES DW, 1991, JAMA-J AM MED ASSOC, V265, P365, DOI 10.1001/jama.265.3.365; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Brogan TV, 2012, PEDIATR INFECT DIS J, V31, P1036, DOI 10.1097/INF.0b013e31825f2b10; Feudtner C, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e99; Florin TA, 2013, PEDIATRICS, V132, P237, DOI 10.1542/peds.2013-0179; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Heine Daniel, 2013, Hosp Pediatr, V3, P92; Leyenaar JK, 2014, J PEDIAT; Mannix R, 2012, J PEDIATR-US, V161, P536, DOI 10.1016/j.jpeds.2012.03.013; Myers AL, 2013, PEDIATR INFECT DIS J, V32, P736, DOI 10.1097/INF.0b013e318290bf63; Neuman MI, 2013, ACAD EMERG MED, V20, P240, DOI 10.1111/acem.12088; Neuman MI, 2012, PEDIATRICS, V130, P823, DOI 10.1542/peds.2012-1285; Newman RE, 2012, PEDIATRICS, V129, pE597, DOI 10.1542/peds.2011-1533; Ramsook C, 2000, INFECT CONT HOSP EP, V21, P649, DOI 10.1086/501708; Schroeder Alan R, 2014, Hosp Pediatr, V4, P85, DOI 10.1542/hpeds.2013-0122; Shah SS, 2011, PEDIATR INFECT DIS J, V30, P475, DOI 10.1097/INF.0b013e31820a5adb; Shoham Y, 2005, PEDIATRICS, V115, P1213, DOI 10.1542/peds.2004-1285; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Weddle G, 2014, J PEDIATR HEALTH CAR, V28, P148, DOI 10.1016/j.pedhc.2013.01.001; Weddle G, 2011, PEDIATR EMERG CARE, V27, P179, DOI 10.1097/PEC.0b013e31820d652b; Westreich D, 2010, AM J EPIDEMIOL, V171, P674, DOI 10.1093/aje/kwp436	24	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117462	10.1371/journal.pone.0117462	http://dx.doi.org/10.1371/journal.pone.0117462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658645	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900154
J	Singh, DN; Gupta, A; Singh, VS; Mishra, R; Kateriya, S; Tripathi, AK				Singh, Durgesh Narain; Gupta, Ankush; Singh, Vijay Shankar; Mishra, Rajeev; Kateriya, Suneel; Tripathi, Anil Kumar			Identification and Characterization of a Novel Phosphodiesterase from the Metagenome of an Indian Coalbed	PLOS ONE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; METAL-ION BINDING; ALKALINE-PHOSPHATASE; GENE; SUPERFAMILY; GMP; BED	Phosphoesterases are involved in the degradation of organophosphorus compounds. Although phosphomonoesterases and phosphotriesterases have been studied in detail, studies on phosphodiesterases are rather limited. In our search to find novel phosphodiesterases using metagenomic approach, we cloned a gene encoding a putative phosphodiesterase (PdeM) from the metagenome of the formation water collected from an Indian coal bed. Bioinformatic analysis showed that PdeM sequence possessed the characteristic signature motifs of the class III phosphodiesterases and phylogenetic study of PdeM enabled us to identify three distinct subclasses (A, B, and C) within class III phosphodiesterases, PdeM clustering in new subclass IIIB. Bioinformatic, biochemical and biophysical characterization of PdeM further revealed some of the characteristic features of the phosphodiesterases belonging to newly described subclass IIIB. PdeM is a monomer of 29.3 kDa, which exhibits optimum activity at 25 degrees C and pH 8.5, but low affinity for bis(pNPP) as well as pNPPP. The recombinant PdeM possessed phosphodiesterase, phosphonate-ester hydrolase and nuclease activity. It lacked phosphomonoesterase, phosphotriesterase, and RNAse activities. Overexpression of PdeM in E. coli neither affected catabolite respression nor did the recombinant protein hydrolyzed cAMP in vitro, indicating its inability to hydrolyze cAMP. Although Mn2+ was required for the activity of PdeM, but addition of metals (Mn2+ or Fe3+) did not induce oligomerization. Further increase in concentration of Mn2+ upto 3 mM, increased alpha-helical content as well as the phosphodiesterase activity. Structural comparison of PdeM with its homologs showed that it lacked critical residues required for dimerization, cAMP hydrolysis, and for the high affinity binding of bis(pNPP). PdeM, thus, is a novel representative of new subclass of class III phosphodiesterases.	[Singh, Durgesh Narain; Gupta, Ankush; Singh, Vijay Shankar; Tripathi, Anil Kumar] Banaras Hindu Univ, Fac Sci, Sch Biotechnol, Varanasi 221005, Uttar Pradesh, India; [Mishra, Rajeev] Banaras Hindu Univ, Mahila Maha Vidyalaya, Bioinformat Programme, Varanasi 221005, Uttar Pradesh, India; [Kateriya, Suneel] Univ Delhi South Campus, Dept Biochem, New Delhi 110021, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU); University of Delhi	Tripathi, AK (corresponding author), Banaras Hindu Univ, Fac Sci, Sch Biotechnol, Varanasi 221005, Uttar Pradesh, India.	tripathianil@rediffmail.com	Tripathi, Anil Kumar/AAP-8558-2020	Kateriya, Suneel/0000-0001-5428-4297; Mishra, Rajeev/0000-0001-8559-5258; Gupta, Ankush/0000-0001-7575-3187; Tripathi, Anil Kumar/0000-0001-5662-3344	Department of Biotechnology, Government of India; University Grants Commission, New Delhi, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grants Commission, New Delhi, India(University Grants Commission, India)	This work was supported by a grant from the Department of Biotechnology, Government of India to AKT. DNS and AG were supported by fellowships from University Grants Commission, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmada E, 2012, J BIOMOL STRUC DYNAM, V1, P1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bharati BK, 2012, MICROBIOL-SGM, V158, P1415, DOI 10.1099/mic.0.053892-0; Bougie I, 2003, J BIOL CHEM, V278, P3868, DOI 10.1074/jbc.M209785200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAUDHRY GR, 1988, APPL ENVIRON MICROB, V54, P288, DOI 10.1128/AEM.54.2.288-293.1988; de Seny D, 2001, J BIOL CHEM, V276, P45065, DOI 10.1074/jbc.M106447200; Dermol U, 2011, J MOL BIOL, V412, P481, DOI 10.1016/j.jmb.2011.07.060; EIVAZI F, 1977, SOIL BIOL BIOCHEM, V9, P167, DOI 10.1016/0038-0717(77)90070-0; FAISON BD, 1991, CRIT REV BIOTECHNOL, V11, P347, DOI 10.3109/07388559109040624; Igunnu A, 2001, BIOCHEM J, V5, P67; Imamura R, 1996, J BIOL CHEM, V271, P25423, DOI 10.1074/jbc.271.41.25423; Kim YG, 2011, PROTEINS, V79, P1205, DOI 10.1002/prot.22954; KOONIN EV, 1994, PROTEIN SCI, V3, P356; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lorenzetti R, 2007, J CHROMATOGR B, V859, P37, DOI 10.1016/j.jchromb.2007.09.008; Manavathi B, 2005, PESTIC BIOCHEM PHYS, V83, P37, DOI 10.1016/j.pestbp.2005.03.007; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McLaughlin K, 2004, LIMNOL OCEANOGR-METH, V2, P202, DOI 10.4319/lom.2004.2.202; Miller DJ, 2007, PROTEIN SCI, V16, P1338, DOI 10.1110/ps.072764907; Miller JH, 1992, SHORT COURSE BACTERI; O'Brien PJ, 2001, BIOCHEMISTRY-US, V40, P5691, DOI 10.1021/bi0028892; Pasek MA, 2013, P NATL ACAD SCI USA, V110, P10089, DOI 10.1073/pnas.1303904110; Penner TJ, 2010, INT J COAL GEOL, V82, P81, DOI 10.1016/j.coal.2010.02.002; Richter W, 2002, PROTEINS, V46, P278, DOI 10.1002/prot.10049; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; Shim H, 1998, J BIOL CHEM, V273, P17445, DOI 10.1074/jbc.273.28.17445; Singh BK, 2009, NAT REV MICROBIOL, V7, P156, DOI 10.1038/nrmicro2050; Singh DN, 2012, APPL MICROBIOL BIOT, V93, P1337, DOI 10.1007/s00253-011-3778-1; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Strapoc D, 2008, APPL ENVIRON MICROB, V74, P2424, DOI 10.1128/AEM.02341-07; Tehara SK, 2003, APPL ENVIRON MICROB, V69, P504, DOI 10.1128/AEM.69.1.504-508.2003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Unneberg P, 2001, PROTEINS, V42, P460, DOI 10.1002/1097-0134(20010301)42:4<460::AID-PROT50>3.0.CO;2-U; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wilcox DE, 1996, CHEM REV, V96, P2435, DOI 10.1021/cr950043b; Zalatan JG, 2008, J MOL BIOL, V384, P1174, DOI 10.1016/j.jmb.2008.09.059; Zambonelli C, 2003, J BIOL CHEM, V278, P13706, DOI 10.1074/jbc.M210363200	40	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118075	10.1371/journal.pone.0118075	http://dx.doi.org/10.1371/journal.pone.0118075			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658120	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900259
J	Song, DL; Altice, FL; Copenhaver, MM; Long, EF				Song, Dahye L.; Altice, Frederick L.; Copenhaver, Michael M.; Long, Elisa F.			Cost-Effectiveness Analysis of Brief and Expanded Evidence-Based Risk Reduction Interventions for HIV-Infected People Who Inject Drugs in the United States	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; RANDOMIZED CLINICAL-TRIAL; HETEROSEXUAL TRANSMISSION; HEROIN USERS; PREVENTION; CARE; BEHAVIORS; ADHERENCE; COMMUNITY; METHADONE	Aims Two behavioral HIV prevention interventions for people who inject drugs (PWID) infected with HIV include the Holistic Health Recovery Program for HIV+ (HHRP+), a comprehensive evidence-based CDC-supported program, and an abbreviated Holistic Health for HIV (3H+) Program, an adapted HHRP+ version in treatment settings. We compared the projected health benefits and cost-effectiveness of both programs, in addition to opioid substitution therapy (OST), to the status quo in the U.S. Methods A dynamic HIV transmission model calibrated to epidemic data of current US populations was created. Projected outcomes include future HIV incidence, HIV prevalence, and quality-adjusted life years (QALYs) gained under alternative strategies. Total medical costs were estimated to compare the cost-effectiveness of each strategy. Results Over 10 years, expanding HHRP+ access to 80% of PWID could avert up to 29,000 HIV infections, or 6% of the projected total, at a cost of $7,777/QALY gained. Alternatively, 3H+ could avert 19,000 infections, but is slightly more cost-effective ($7,707/QALY), and remains so under widely varying effectiveness and cost assumptions. Nearly two-thirds of infections averted with either program are among non-PWIDs, due to reduced sexual transmission from PWID to their partners. Expanding these programs with broader OST coverage could avert up to 74,000 HIV infections over 10 years and reduce HIV prevalence from 16.5% to 14.1%, but is substantially more expensive than HHRP+ or 3H+ alone. Conclusions Both behavioral interventions were effective and cost-effective at reducing HIV incidence among both PWID and the general adult population; however, 3H+, the economical HHRP+ version, was slightly more cost-effective than HHRP+.	[Song, Dahye L.] Harvard Univ, PhD Program Hlth Policy, Cambridge, MA 02138 USA; [Altice, Frederick L.] Yale Univ, Sch Med, Infect Dis Sect, AIDS Program, New Haven, CT USA; [Copenhaver, Michael M.] Yale Univ, Sch Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT USA; [Copenhaver, Michael M.] Univ Connecticut, Dept Allied Hlth Sci, Storrs, CT USA; [Long, Elisa F.] UCLA Anderson Sch Management, Los Angeles, CA USA	Harvard University; Yale University; Yale University; University of Connecticut; University of California System; University of California Los Angeles	Song, DL (corresponding author), Harvard Univ, PhD Program Hlth Policy, Cambridge, MA 02138 USA.	dsong@fas.harvard.edu	Long, Elisa/AFQ-5915-2022	Altice, Frederick/0000-0002-7860-693X	National Institute on Drug Abuse [R01 DA032290]; career development awards [K24 DA017072, K02 DA033139]; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072, R01DA032290, K02DA033139] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); career development awards; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was funded by the National Institute on Drug Abuse (http://www.drugabuse.gov/) for research (R01 DA032290 for FLA and MMC) and career development awards (K24 DA017072 for FLA and K02 DA033139 for MMC.) The funding sources played no role in study design, data collection, analysis, or interpretation, writing of the manuscript, or the decision to submit the paper for publication.	Alistar SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000423; Anglemyer A, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009153, 10.1002/14651858.CD009153.pub2]; [Anonymous], 2013, WHO GLOBAL HLTH OBSE; [Anonymous], 2017, 2013 UNAIDS REP GLOB; Arias E, 2012, NATL VITAL STAT REP, V61, P1; Armstrong GL, 2007, ARCH INTERN MED, V167, P166, DOI 10.1001/archinte.167.2.166; Avants SK, 2004, J SUBST ABUSE TREAT, V26, P67, DOI 10.1016/S0740-5472(03)00159-4; Baggaley RF, 2006, AIDS, V20, P805, DOI 10.1097/01.aids.0000218543.46963.6d; Barnett PG, 2001, ADDICTION, V96, P1267, DOI 10.1046/j.1360-0443.2001.96912676.x; Binford MC, 2012, CURR HIV-AIDS REP, V9, P287, DOI 10.1007/s11904-012-0134-8; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; BOOTH RE, 1993, AM J PUBLIC HEALTH, V83, P1144, DOI 10.2105/AJPH.83.8.1144; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Centers for Disease Control and Prevention, 2012, HIV US STAG CAR; Centers for Disease Control and Prevention (CDC), 2013, HIV SURV REP 2011; Centers for Disease Control and Prevention (CDC), 2012, ESTIMATED HIV INCIDE; Centers for Disease Control and Prevention (CDC), 2009, EFF ANT THER RISK SE; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; Copenhaver MM, 2011, SUBST ABUS, V32, P16, DOI 10.1080/08897077.2011.540466; Coyle S L, 1998, Public Health Rep, V113 Suppl 1, P19; Degenhardt L, 2006, SEX TRANSM INFECT, V82, pIII56, DOI 10.1136/sti.2005.019273; Dolan KA, 2003, DRUG ALCOHOL DEPEN, V72, P59, DOI 10.1016/S0376-8716(03)00187-X; Effective Interventions, 2012, HIGH IMP HIV AIDS PR; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Evans JL, 2003, J URBAN HEALTH, V80, P137, DOI 10.1093/jurban/jtg137; Fisher JD, 2006, JAIDS-J ACQ IMM DEF, V41, P44, DOI 10.1097/01.qai.0000192000.15777.5c; FISHER JD, 1992, PSYCHOL BULL, V111, P455, DOI 10.1037/0033-2909.111.3.455; Friedman SR, 2004, J URBAN HEALTH, V81, P377, DOI 10.1093/jurban/jth125; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gebo KA, 2010, AIDS, V24, P2705, DOI 10.1097/QAD.0b013e32833f3c14; Gowing L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub4; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grigoryan A., 2009, Morbidity and Mortality Weekly Report, V58, P1291; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Harris ZK, 2006, HEALTH ECON, V15, P147, DOI 10.1002/hec.1021; Holtgrave DR, 1997, J ACQ IMMUN DEF SYND, V16, P54, DOI 10.1097/00042560-199709010-00009; Howden LM, 2011, AGE SEX COMPOSITION, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Kral AH, 2005, J URBAN HEALTH, V82, pI43, DOI 10.1093/jurban/jti023; Krentz HB, 2008, HIV MED, V9, P721, DOI 10.1111/j.1468-1293.2008.00613.x; Lankenau SE, 2012, INT J DRUG POLICY, V23, P37, DOI 10.1016/j.drugpo.2011.05.014; Latkin CA, 2003, HEALTH PSYCHOL, V22, P332, DOI 10.1037/0278-6133.22.4.332; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; Margolin A, 2003, HEALTH PSYCHOL, V22, P223, DOI 10.1037/0278-6133.22.2.223; Martin Joyce A, 2012, Natl Vital Stat Rep, V61, P1; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2013, B WORLD HEALTH ORGAN, V91, P102, DOI 10.2471/BLT.12.108282; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Meader N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007192.pub2; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; Neaigus A, 2001, ADDICTION, V96, P847, DOI 10.1046/j.1360-0443.2001.9668476.x; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013, GUIDELINES USE ANTIR; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rachlis B, 2007, DRUG ALCOHOL DEPEN, V90, P107, DOI 10.1016/j.drugalcdep.2007.03.014; SAMHSA, 2012, RES 2011 NAT SURV DR; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Spittal PM, 2002, CAN MED ASSOC J, V166, P894; Strathdee SA, 2012, CURR OPIN HIV AIDS, V7, P320, DOI 10.1097/COH.0b013e32835369ad; Strathdee Steffanie A, 2010, Curr HIV/AIDS Rep, V7, P99, DOI 10.1007/s11904-010-0043-7; Substance Abuse and Mental Health Services Administration (SAMHSA), 2011, RES 2010 NAT SURV DR, VH-41; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Tyndall MW, 2002, SEX TRANSM INFECT, V78, pI170, DOI 10.1136/sti.78.suppl_1.i170; U.S. Bureau of Labor Statistics, 2014, CONS PRIC IND ALL UR; Valdez A, 2011, DRUG ALCOHOL DEPEN, V114, P233, DOI 10.1016/j.drugalcdep.2010.09.014; Vlahov D, 2005, AM J EPIDEMIOL, V161, P999, DOI 10.1093/aje/kwi133; Vlahov D, 2010, CLIN INFECT DIS, V50, pS114, DOI 10.1086/651482; Walensky RP, 2013, ANN INTERN MED, V158, P84, DOI 10.7326/0003-4819-158-2-201301150-00002; WHO, 2003, MAKING CHOICES HLTH; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008; Wood E, 2012, CURR OPIN HIV AIDS, V7, P151, DOI 10.1097/COH.0b013e32834f9927; World Bank, 2013, GDP PER CAP CURR US; World Health Organization, 2014, TABL THRESH VAL INT, DOI [10.3928/01913913-20140923-03, DOI 10.3928/01913913-20140923-03]; Zaric GS, 2000, AM J PUBLIC HEALTH, V90, P1100, DOI 10.2105/AJPH.90.7.1100	79	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116694	10.1371/journal.pone.0116694	http://dx.doi.org/10.1371/journal.pone.0116694			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658949	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900058
J	Vaillancourt, K; LeBel, G; Frenette, M; Gottschalk, M; Grenier, D				Vaillancourt, Katy; LeBel, Genevieve; Frenette, Michel; Gottschalk, Marcelo; Grenier, Daniel			Suicin 3908, a New Lantibiotic Produced by a Strain of Streptococcus suis Serotype 2 Isolated from a Healthy Carrier Pig	PLOS ONE			English	Article							NISIN; BACTERIOCINS; VIRULENT	While Streptococcus suis serotype 2 is known to cause severe infections in pigs, it can also be isolated from the tonsils of healthy animals that do not develop infections. We hypothesized that S. suis strains in healthy carrier pigs may have the ability to produce bacteriocins, which may contribute to preventing infections by pathogenic S. suis strains. Two of ten S. suis serotype 2 strains isolated from healthy carrier pigs exhibited antibacterial activity against pathogenic S. suis isolates. The bacteriocin produced by S. suis 3908 was purified to homogeneity using a three-step procedure: ammonium sulfate precipitation, cationic exchange HPLC, and reversed-phase HPLC. The bacteriocin, called suicin 3908, had a low molecular mass; was resistant to heat, pH, and protease treatments; and possessed membrane permeabilization activity. Additive effects were obtained when suicin 3908 was used in combination with penicillin G or amoxicillin. The amino acid sequence of suicin 3908 suggested that it is lantibiotic-related and made it possible to identify a bacteriocin locus in the genome of S. suis D12. The putative gene cluster involved in suicin production by S. suis 3908 was amplified by PCR, and the sequence analysis revealed the presence of nine open reading frames (ORFs), including the structural gene and those required for the modification of amino acids, export, regulation, and immunity. Suicin 3908, which is encoded by the suiA gene, exhibited approximately 50% identity with bovicin HJ50 (Streptococcus bovis), thermophilin 1277 (Streptococcus thermophilus), and macedovicin (Streptococcus macedonicus). Given that S. suis 3908 cannot cause infections in animal models, that it is susceptible to conventional antibiotics, and that it produces a bacteriocin with antibacterial activity against all pathogenic S. suis strains tested, it could potentially be used to prevent infections and to reduce antibiotic use by the swine industry.	[Vaillancourt, Katy; LeBel, Genevieve; Frenette, Michel; Grenier, Daniel] Univ Laval, Fac Med Dent, GREB, Quebec City, PQ, Canada; [Frenette, Michel; Gottschalk, Marcelo; Grenier, Daniel] FRQNT, CRIPA, Quebec City, PQ, Canada; [Gottschalk, Marcelo] Univ Montreal, Fac Med Vet, Grp Rech Malad Infect Porc GREMIP, St Hyacinthe, PQ J2S 7C6, Canada	Laval University; Universite de Montreal	Grenier, D (corresponding author), Univ Laval, Fac Med Dent, GREB, Quebec City, PQ, Canada.	Daniel.Grenier@greb.ulaval.ca	Grenier, Daniel/E-5557-2015; Gottschalk, Marcelo/I-8116-2012	Grenier, Daniel/0000-0003-0878-4674; 	Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec (MAPAQ)	Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec (MAPAQ)	This study was supported by a grant from the Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec (MAPAQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib Z, 2012, J BIOTECHNOL, V159, P145, DOI 10.1016/j.jbiotec.2012.01.032; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; BRETON J, 1986, CAN J VET RES, V50, P338; Callens BF, 2013, MICROB DRUG RESIST, V19, P146, DOI 10.1089/mdr.2012.0131; Cao LT, 2007, J DAIRY SCI, V90, P3980, DOI 10.3168/jds.2007-0153; Cromwell GL, 2002, ANIM BIOTECHNOL, V13, P7, DOI 10.1081/ABIO-120005767; de Arauz LJ, 2009, TRENDS FOOD SCI TECH, V20, P146, DOI 10.1016/j.tifs.2009.01.056; ELIOPOULOS GM, 1996, ANTIBIOTICS LAB MED, P330; Fittipaldi N, 2011, EMERG INFECT DIS, V17, P2239, DOI 10.3201/eid1712.110609; Gottschalk M., 2012, DIS SWINE, P841; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Hagiwara A, 2010, FOOD CHEM TOXICOL, V48, P2421, DOI 10.1016/j.fct.2010.06.002; Hammami R, 2013, CELL MOL LIFE SCI, V70, P2947, DOI 10.1007/s00018-012-1202-3; Jabes D, 2011, ANTIMICROB AGENTS CH, V55, P1671, DOI 10.1128/AAC.01288-10; JOOSTEN HMLJ, 1995, LETT APPL MICROBIOL, V21, P389, DOI 10.1111/j.1472-765X.1995.tb01089.x; LeBel G, 2014, APPL ENVIRON MICROB, V80, P5484, DOI 10.1128/AEM.01055-14; Lebel G, 2013, PEPTIDES, V50, P19, DOI 10.1016/j.peptides.2013.09.014; Luque I, 2010, VET J, V186, P396, DOI 10.1016/j.tvjl.2009.09.005; MEYER HE, 1994, ANAL BIOCHEM, V223, P185, DOI 10.1006/abio.1994.1571; Norton PM, 1999, FEMS IMMUNOL MED MIC, V26, P25, DOI 10.1111/j.1574-695X.1999.tb01369.x; QUESSY S, 1995, INFECT IMMUN, V63, P1975, DOI 10.1128/IAI.63.5.1975-1979.1995; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Snyder AB, 2014, J SCI FOOD AGR, V94, P28, DOI 10.1002/jsfa.6293; Svetoch EA, 2008, J AGR FOOD CHEM, V56, P1942, DOI 10.1021/jf073284g; Varela NP, 2013, ANIM HEALTH RES REV, V20, P1; Wang J, 2014, APPL ENVIRON MICROB, V80, P1062, DOI 10.1128/AEM.03213-13; Zhang CP, 2009, AGR SCI CHINA, V8, P638, DOI 10.1016/S1671-2927(08)60257-6	27	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117245	10.1371/journal.pone.0117245	http://dx.doi.org/10.1371/journal.pone.0117245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659110	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900122
J	Wang, M; Wu, CP; Pan, JY; Zheng, WW; Cao, XJ; Fan, GK				Wang, Mei; Wu, Chun-Ping; Pan, Jun-Yan; Zheng, Wen-Wei; Cao, Xiao-Juan; Fan, Guo-Kang			Cancer-Associated Fibroblasts in a Human HEp-2 Established Laryngeal Xenografted Tumor Are Not Derived from Cancer Cells through Epithelial-Mesenchymal Transition, Phenotypically Activated but Karyotypically Normal	PLOS ONE			English	Article							CARCINOMA-ASSOCIATED FIBROBLASTS; HUMAN BREAST; STROMAL FIBROBLASTS; MICROENVIRONMENT; GROWTH; LINE; PROGRESSION; METASTASIS; TISSUES; PROTEIN	Cancer-associated fibroblasts (CAFs) play a crucial role in cancer progression and even initiation. However, the origins of CAFs in various cancer types remain controversial, and one of the important hypothesized origins is through epithelial-mesenchymal transition (EMT) from cancer cells. In this study, we investigated whether the HEp-2 laryngeal cancer cells are able to generate CAFs via EMT during tumor formation, which is now still unknown. The laryngeal xenografted tumor model was established by inoculating the HEp-2 laryngeal cancer cell line in nude mice. Primary cultured CAFs from the tumor nodules and matched normal fibroblasts (NFs) from the adjacent connective tissues were subcultured, purified, and verified by immunofluorescence. Migration, invasion, and proliferation potentials were compared between the CAFs and NFs. A co-culture of CAFs with HEp-2 cells and a co-injection of CAFs with HEp-2 cells in nude mice were performed to examine the cancer-promoting potential of CAFs to further verify their identity. Karyotypic analyses of the CAFs, NFs, and HEp-2 cells were conducted. A co-culture of NFs with HEp-2 cells was also performed to examine the expression of activated markers of CAFs. A pathological examination confirmed that the laryngeal xenografted tumor model was successfully established, containing abundant CAFs. Immunocytochemical staining verified the purities and identities of the CAFs and NFs. Although the CAFs manifested higher migration, invasion, proliferation, and cancer-promoting capacities compared with the NFs, an analysis of chromosomes revealed that both the CAFs and NFs showed typical normal mouse karyotypes. In addition, the NFs co-cultured with HEp-2 cells did not show induced expressions of activated markers of CAFs. Our findings reveal that the CAFs in the HEp-2 established laryngeal xenografted tumor are not of laryngeal cancer origin but of mouse origin, indicating that the HEp-2 laryngeal cancer cells cannot generate their own CAFs via EMT in this model.	[Wang, Mei; Pan, Jun-Yan; Zheng, Wen-Wei; Cao, Xiao-Juan] Shanghai Municipal Hosp Tradit Chinese Med, Dept Otolaryngol, Shanghai, Peoples R China; [Wang, Mei] Jiaxing Univ, Affiliated Hosp 2, Dept Otolaryngol, Jiaxing, Zhejiang, Peoples R China; [Wu, Chun-Ping] Fudan Univ, Eye Ear Nose & Throat Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200433, Peoples R China; [Fan, Guo-Kang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Otolaryngol, Hangzhou 310003, Zhejiang, Peoples R China	Jiaxing University; Fudan University; Zhejiang University	Fan, GK (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Otolaryngol, Hangzhou 310003, Zhejiang, Peoples R China.	fgkxfz@hzcnc.com		Wu, Chunping/0000-0002-0712-8715				CORNIL I, 1991, P NATL ACAD SCI USA, V88, P6028, DOI 10.1073/pnas.88.14.6028; Delort L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066284; Du HD, 2013, ACTA OTO-LARYNGOL, V133, P755, DOI 10.3109/00016489.2013.766925; Erez N, 2013, BIOCHEM BIOPH RES CO, V437, P397, DOI 10.1016/j.bbrc.2013.06.089; FJELDE A, 1962, LIFE SCI, P683, DOI 10.1016/0024-3205(62)90135-2; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; Haviv I, 2009, CELL CYCLE, V8, P589, DOI 10.4161/cc.8.4.7669; Jacob M, 2012, CURR MOL MED, V12, P1220, DOI 10.2174/156652412803833607; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kucerova L, 2013, NEOPLASMA, V60, P1, DOI 10.4149/neo_2013_001; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Li G, 2003, ONCOGENE, V22, P3162, DOI 10.1038/sj.onc.1206455; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Liu R, 2012, CANCER BIOL THER, V13, P123, DOI 10.4161/cbt.13.3.18696; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; McDonald LT, 2012, INT J CLIN EXP PATHO, V5, P863; NORRYD C, 1963, CANCER RES, V23, P197; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Petersen OW, 2003, AM J PATHOL, V162, P391, DOI 10.1016/S0002-9440(10)63834-5; Petersen OW, 2001, BREAST CANCER RES, V3, P213; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Weber CE, 2012, SURG ONCOL, V21, P172, DOI 10.1016/j.suronc.2011.09.001; Xing F, 2010, FRONT BIOSCI-LANDMRK, V15, P166, DOI 10.2741/3613; Zeisberg M, 2000, J NEPHROL, V13, pS111	29	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117405	10.1371/journal.pone.0117405	http://dx.doi.org/10.1371/journal.pone.0117405			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658113	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900142
J	Webb, RC; Pielak, RM; Bastien, P; Ayers, J; Niittynen, J; Kurniawan, J; Manco, M; Lin, A; Cho, NH; Malyrchuk, V; Balooch, G; Rogers, JA				Webb, R. Chad; Pielak, Rafal M.; Bastien, Philippe; Ayers, Joshua; Niittynen, Juha; Kurniawan, Jonas; Manco, Megan; Lin, Athena; Cho, Nam Heon; Malyrchuk, Viktor; Balooch, Guive; Rogers, John A.			Thermal Transport Characteristics of Human Skin Measured In Vivo Using Ultrathin Conformal Arrays of Thermal Sensors and Actuators	PLOS ONE			English	Article							STRATUM-CORNEUM THICKNESS; CONDUCTIVITY; DIFFUSIVITY; PRESSURE; DESIGN	Measurements of the thermal transport properties of the skin can reveal changes in physical and chemical states of relevance to dermatological health, skin structure and activity, thermoregulation and other aspects of human physiology. Existing methods for in vivo evaluations demand complex systems for laser heating and infrared thermography, or they require rigid, invasive probes; neither can apply to arbitrary regions of the body, offers modes for rapid spatial mapping, or enables continuous monitoring outside of laboratory settings. Here we describe human clinical studies using mechanically soft arrays of thermal actuators and sensors that laminate onto the skin to provide rapid, quantitative in vivo determination of both the thermal conductivity and thermal diffusivity, in a completely non-invasive manner. Comprehensive analysis of measurements on six different body locations of each of twenty-five human subjects reveal systematic variations and directional anisotropies in the characteristics, with correlations to the thicknesses of the epidermis (EP) and stratum corneum (SC) determined by optical coherence tomography, and to the water content assessed by electrical impedance based measurements. Multivariate statistical analysis establishes four distinct locations across the body that exhibit different physical properties: heel, cheek, palm, and wrist/volar forearm/dorsal forearm. The data also demonstrate that thermal transport correlates negatively with SC and EP thickness and positively with water content, with a strength of correlation that varies from region to region, e. g., stronger in the palmar than in the follicular regions.	[Webb, R. Chad; Ayers, Joshua; Kurniawan, Jonas; Lin, Athena; Cho, Nam Heon; Malyrchuk, Viktor; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Frederick Seitz Mat Res Lab, Urbana, IL USA; [Pielak, Rafal M.; Balooch, Guive] LOreal Calif Res Ctr, San Francisco, CA 94109 USA; [Bastien, Philippe] LOreal Res & Innovat, Aulnay Sous Bois, France; [Niittynen, Juha] Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland; [Manco, Megan] LOreal Early Clin, Clark, NJ USA; [Balooch, Guive] LOreal Digital Incubator, Clark, NJ USA	University of Illinois System; University of Illinois Urbana-Champaign; L'Oreal Group; L'Oreal Group; Tampere University	Balooch, G (corresponding author), LOreal Calif Res Ctr, San Francisco, CA 94109 USA.	gbalooch@rd.us.loreal.com; jrogers@illinois.edu	huang, yonggang/O-6236-2019; Rogers, John/L-2798-2016; Cho, Nam Heon/ABF-9534-2020	Bastien, Philippe/0000-0002-5602-5827; Kurniawan, Jonas/0000-0002-1840-632X	National Science Foundation [DGE-1144245]; Tekes [40150/12]; L'Oreal Research Innovation	National Science Foundation(National Science Foundation (NSF)); Tekes(Finnish Funding Agency for Technology & Innovation (TEKES)); L'Oreal Research Innovation(L'Oreal Group)	RCW acknowledges support from the National Science Foundation under grant no. DGE-1144245 (http://www.nsf.gov/). JN acknowledges support from Tekes grant no: 40150/12 (http://www.tekes.fi/). The above funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Materials, instrumentation and human study costs were supported by L'Oreal Research & Innovation. RMP PB MM and GB are employed by L'Oreal and contributed to study design, data analysis and writing of the paper.	ARNAUD F, 1994, SENSOR ACTUAT A-PHYS, V41, P240, DOI 10.1016/0924-4247(94)80117-7; Bohling A, 2014, SKIN RES TECHNOL, V20, P50, DOI 10.1111/srt.12082; Carslaw H.S., 1986, CONDUCTION HEAT SOLI; DUCHARME MB, 1991, J APPL PHYSIOL, V70, P2682, DOI 10.1152/jappl.1991.70.6.2682; Egawa M, 2007, ACTA DERM-VENEREOL, V87, P4, DOI 10.2340/00015555-0183; El-Brawany M. A., 2009, Journal of Medical Engineering & Technology, V33, P249, DOI 10.1080/03091900802451265; Graffe KVD, 2001, HUMAN ANATOMY; GUSTAFSSON SE, 1991, REV SCI INSTRUM, V62, P797, DOI 10.1063/1.1142087; Huang X, 2013, IEEE T BIO-MED ENG, V60, P2848, DOI 10.1109/TBME.2013.2264879; Jin C, 2012, INFRARED PHYS TECHN, V55, P462, DOI 10.1016/j.infrared.2012.07.007; Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Lacour SP, 2004, IEEE ELECTR DEVICE L, V25, P179, DOI 10.1109/LED.2004.825190; Li T, 2004, APPL PHYS LETT, V85, P3435, DOI 10.1063/1.1806275; Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/NMAT2834, 10.1038/nmat2834]; Raamat R, 2002, MICROVASC RES, V64, P214, DOI 10.1006/mvre.2002.2433; Robertson K, 2010, ACTA DERM-VENEREOL, V90, P368, DOI 10.2340/00015555-0875; Someya T, 2005, P NATL ACAD SCI USA, V102, P12321, DOI 10.1073/pnas.0502392102; Sun JY, 2009, J MATER RES, V24, P3338, DOI 10.1557/JMR.2009.0417; TOGAWA T, 1994, PHYSIOL MEAS, V15, P291, DOI 10.1088/0967-3334/15/3/007; Wang SD, 2012, J APPL MECH-T ASME, V79, DOI 10.1115/1.4005963; Webb RC, 2013, NAT MATER, V12, P938, DOI [10.1038/NMAT3755, 10.1038/nmat3755]; WERNER U, 1992, PHYS MED BIOL, V37, P21, DOI 10.1088/0031-9155/37/1/002	23	52	58	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118131	10.1371/journal.pone.0118131	http://dx.doi.org/10.1371/journal.pone.0118131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658947	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900265
J	Zhang, J; Wang, B; Dong, SL; Cao, DP; Dong, JF; Walker, WB; Liu, Y; Wang, GR				Zhang, Jin; Wang, Bing; Dong, Shuanglin; Cao, Depan; Dong, Junfeng; Walker, William B.; Liu, Yang; Wang, Guirong			Antennal Transcriptome Analysis and Comparison of Chemosensory Gene Families in Two Closely Related Noctuidae Moths, Helicoverpa armigera and H-assulta	PLOS ONE			English	Article							PHEROMONE-BINDING PROTEIN; NEURON MEMBRANE-PROTEINS; HELIOTHIS-VIRESCENS; BOMBYX-MORI; EXPRESSION PATTERN; DIFFERENTIAL EXPRESSION; CHEMICAL COMMUNICATION; SPODOPTERA-LITTORALIS; ANTHERAEA-POLYPHEMUS; SIGNAL-TRANSDUCTION	To better understand the olfactory mechanisms in the two lepidopteran pest model species, the Helicoverpa armigera and H. assulta, we conducted transcriptome analysis of the adult antennae using Illumina sequencing technology and compared the chemosensory genes between these two related species. Combined with the chemosensory genes we had identified previously in H. armigera by 454 sequencing, we identified 133 putative chemosensory unigenes in H. armigera including 60 odorant receptors (ORs), 19 ionotropic receptors (IRs), 34 odorant binding proteins (OBPs), 18 chemosensory proteins (CSPs), and 2 sensory neuron membrane proteins (SNMPs). Consistent with these results, 131 putative chemosensory genes including 64 ORs, 19 IRs, 29 OBPs, 17 CSPs, and 2 SNMPs were identified through male and female antennal transcriptome analysis in H. assulta. Reverse Transcription-PCR (RT-PCR) was conducted in H. assulta to examine the accuracy of the assembly and annotation of the transcriptome and the expression profile of these unigenes in different tissues. Most of the ORs, IRs and OBPs were enriched in adult antennae, while almost all the CSPs were expressed in antennae as well as legs. We compared the differences of the chemosensory genes between these two species in detail. Our work will surely provide valuable information for further functional studies of pheromones and host volatile recognition genes in these two related species.	[Zhang, Jin; Wang, Bing; Cao, Depan; Liu, Yang; Wang, Guirong] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Zhang, Jin; Dong, Shuanglin] Nanjing Agr Univ, Coll Plant Protect, Key Lab Integrated Management Crop Dis & Pests, Educ Minist, Nanjing 210095, Jiangsu, Peoples R China; [Dong, Junfeng] Henan Univ Sci & Technol, Coll Forestry, Luoyang 471003, Peoples R China; [Walker, William B.] Swedish Univ Agr Sci, Dept Plant Protect Biol, Chem Ecol Res Grp, Alnarp, Sweden	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Nanjing Agricultural University; Henan University of Science & Technology; Swedish University of Agricultural Sciences	Liu, Y (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yangliu@ippcaas.cn; grwang@ippcaas.cn	dong, junfeng/GZL-6072-2022	dong, junfeng/0000-0002-5908-9981; Liu, Yang/0000-0002-3424-7111; Zhang, Jin/0000-0002-0077-0748	National Natural Science Foundation of China [31230062, 31201578]; China National "973" Basic Research Program [2012CB114104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National "973" Basic Research Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (31230062 to G. W. and 31201578 to Y.L.) and the China National "973" Basic Research Program (2012CB114104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Berg BG, 2002, J COMP NEUROL, V446, P123, DOI 10.1002/cne.10180; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; Cao DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101187; Carlsson MA, 2002, CHEM SENSES, V27, P231, DOI 10.1093/chemse/27.3.231; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Forstner M, 2008, CHEM SENSES, V33, P291, DOI 10.1093/chemse/bjm087; Gomez-Diaz C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001546; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103420; Gu SH, 2013, J INSECT PHYSIOL, V59, P430, DOI 10.1016/j.jinsphys.2013.02.003; Hua JF, 2013, J INSECT PHYSIOL, V59, P690, DOI 10.1016/j.jinsphys.2013.04.013; Ishida Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051779; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jacquin-Joly E, 2012, INT J BIOL SCI, V8, P1036, DOI 10.7150/ijbs.4469; Jiang XJ, 2014, INSECT BIOCHEM MOLEC, V48, P63, DOI 10.1016/j.ibmb.2014.02.010; Kaissling K-E, 1987, RH WRIGHT LECT INSEC; Kaissling KE, 2009, J COMP PHYSIOL A, V195, P895, DOI 10.1007/s00359-009-0461-4; KANAUJIA S, 1985, J INSECT PHYSIOL, V31, P71, DOI 10.1016/0022-1910(85)90044-7; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Lautenschlager C, 2007, STRUCTURE, V15, P1148, DOI 10.1016/j.str.2007.07.013; Leal WS, 2007, COMP BIOCHEM PHYS A, V148, pS81, DOI 10.1016/j.cbpa.2007.06.210; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Li PY, 2011, APPL ENTOMOL ZOOL, V46, P497, DOI 10.1007/s13355-011-0067-5; Li ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083180; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Liu CC, 2014, ARCH INSECT BIOCHEM, V85, P114, DOI 10.1002/arch.21150; Liu NY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-597; Liu S, 2013, ARCH INSECT BIOCHEM, V82, P29, DOI 10.1002/arch.21069; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062094; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Liu YL, 2014, J EXP BIOL, V217, P1821, DOI 10.1242/jeb.102020; Liu ZD, 2004, ENVIRON ENTOMOL, V33, P1570, DOI 10.1603/0046-225X-33.6.1570; Nichols Z, 2008, INSECT BIOCHEM MOLEC, V38, P398, DOI 10.1016/j.ibmb.2007.11.003; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Picimbon JF, 2001, INSECT BIOCHEM MOLEC, V31, P1173, DOI 10.1016/S0965-1748(01)00063-7; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Pophof B, 2004, CHEM SENSES, V29, P117, DOI 10.1093/chemse/bjh012; Prestwich GD, 1996, BIOORGAN MED CHEM, V4, P505, DOI 10.1016/0968-0896(96)00033-8; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; Rutzler M, 2005, J COMP PHYSIOL A, V191, P777, DOI 10.1007/s00359-005-0044-y; Sato K, 2009, RESULTS PROBL CELL D, V47, P121, DOI 10.1007/400_2008_10; Sengul MS, 2008, INSECT MOL BIOL, V17, P631, DOI 10.1111/j.1365-2583.2008.00837.x; Sun MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062098; Sun MJ, 2013, J INSECT PHYSIOL, V59, P46, DOI 10.1016/j.jinsphys.2012.10.020; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Wang HL, 2005, INSECT BIOCHEM MOLEC, V35, P575, DOI 10.1016/j.ibmb.2005.01.018; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zhang J, 2014, INSECT SCI; Zhang YN, 2014, J CHEM ECOL, V40, P439, DOI 10.1007/s10886-014-0433-1; Zhang YN, 2014, GENE, V536, P279, DOI 10.1016/j.gene.2013.12.011; Zhang YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069715; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2006, CHEM SENSES, V31, P453, DOI 10.1093/chemse/bjj050; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9	83	80	98	6	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117054	10.1371/journal.pone.0117054	http://dx.doi.org/10.1371/journal.pone.0117054			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659090	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900095
J	Zhang, L; Song, HY; Ge, YL; Ji, G; Yao, ZM				Zhang, Li; Song, Haiyan; Ge, Yingli; Ji, Guang; Yao, Zemin			Temporal Relationship between Diet-Induced Steatosis and Onset of Insulin/Leptin Resistance in Male Wistar Rats	PLOS ONE			English	Article							FATTY LIVER-DISEASE; SOLUBLE LEPTIN RECEPTOR; HEPATIC STEATOSIS; INDUCED OBESITY; CARBOHYDRATE-METABOLISM; GLUCONEOGENIC GENES; SIGNAL TRANSDUCER; TRANSCRIPTION 3; SERUM LEPTIN; MICE	Rats fed with high-fat-high-sucrose (HFHS) diet are known to manifest metabolic syndrome including hyperinsulinemia, hyperleptinemia, hyperglycemia, diabetic dyslipidemia, and hepatic steatosis. The aim of the current study is to determine the temporal relationships between the development of hepatic steatosis and the onset of insulin and leptin resistance in hypothalamus and liver in male Wistar rats (six weeks of age) fed chow or HFHS diet for up to 8 weeks. Fasting plasma glucose, lipids/lipoproteins, insulin and leptin levels were quantified, histopathologic score of hepatic steatosis and inflammation were assessed, and the responses of common checkpoints of insulin and leptin signalling responsible for lipogenesis and gluconeogenesis were analyzed. In addition, acute insulin or leptin administration was performed at different stages of HFHS dieting to determine the responsiveness of the respective signalling pathways. Hyperinsulinemia, hyperglycemia, dyslipidemia, and increased homeostasis model assessment of basal insulin resistance occurred 1-week after HFHS dieting, coinciding with upregulation of suppressor of cytokine signalling 3 in both hypothalamus and liver. However, hepatosteatosis, accompanied with increased expression of sterol regulatory element binding protein 1c and phosphoenolpyruvate carboxykinase, did not manifest until 4- to 8-week after HFHS dieting. Lowered insulin sensitivity (shown by decreased insulin receptor substrate 1 and protein kinase B phosphorylation) occurred approximately 2 weeks prior to leptin resistance (shown by impaired signal transducer and activator of transcription 3 activation) in both the liver and hypothalamus. Acute insulin/leptin administration also demonstrated the impaired insulin or leptin signalling transduction. These data suggest that lowered insulin sensitivity and leptin resistance occurred at least 2-3 weeks earlier than the manifestation of hepatosteatosis in rats fed HFHS diet.	[Zhang, Li; Song, Haiyan; Ge, Yingli; Ji, Guang] Shanghai Univ Tradit Chinese Med, Inst Digest Dis, Longhua Hosp, Shanghai 200032, Peoples R China; [Ji, Guang] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Educ Commiss, E Inst, Shanghai 200032, Peoples R China; [Yao, Zemin] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, Ottawa, ON, Canada	Shanghai University of Traditional Chinese Medicine; Shanghai Municipal Education Commission (SHMEC); Shanghai University of Traditional Chinese Medicine; University of Ottawa	Ji, G (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Digest Dis, Longhua Hosp, Shanghai 200032, Peoples R China.	jiliver@vip.sina.com; zyao@uottawa.ca			National Nature Science Foundation of China [81273727, 81302927]; Innovation Program of Shanghai Municipal Education Commission [14YZ053]; Shanghai Discipline Project [ZYSNXD-CC-ZDYJ042]; Longhua Medicial Project [D-09]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai Discipline Project; Longhua Medicial Project	This work was supported by the National Nature Science Foundation of China (No. 81273727, 81302927), Innovation Program of Shanghai Municipal Education Commission, No. 14YZ053, Shanghai Discipline Project (No. ZYSNXD-CC-ZDYJ042), and Longhua Medicial Project (No. D-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bhandari U, 2011, HUM EXP TOXICOL, V30, P1313, DOI 10.1177/0960327110389499; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bugianesi E, 2010, CURR PHARM DESIGN, V16, P1941, DOI 10.2174/138161210791208875; Chiarelli F, 2008, EUR J ENDOCRINOL, V159, pS67, DOI 10.1530/EJE-08-0245; Cline GW, 2002, DIABETES, V51, P2903, DOI 10.2337/diabetes.51.10.2903; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fishman S, 2007, FASEB J, V21, P53, DOI 10.1096/fj.06-6557com; Fraulob JC, 2012, CLIN SCI, V123, P259, DOI 10.1042/CS20110373; Guo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005370; Hajiaghamohammadi AA, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.6099; Higuchi T, 2008, J NUTR BIOCHEM, V19, P577, DOI 10.1016/j.jnutbio.2007.08.001; Horiguchi N, 2008, GASTROENTEROLOGY, V134, P1148, DOI 10.1053/j.gastro.2008.01.016; Huang W, 2006, ENDOCRINOLOGY, V147, P1480, DOI 10.1210/en.2005-0731; Huang XD, 2008, WORLD J GASTROENTERO, V14, P2888, DOI 10.3748/wjg.14.2888; Hubschle T, 2001, J NEUROSCI, V21, P2413, DOI 10.1523/JNEUROSCI.21-07-02413.2001; Huynh FK, 2013, HEPATOLOGY, V57, P543, DOI 10.1002/hep.26043; Huynh FK, 2010, DIABETES, V59, P3032, DOI 10.2337/db10-0074; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Kanu A, 2003, METABOLISM, V52, P60, DOI 10.1053/meta.2003.50005; Kim IK, 2008, ANN NUTR METAB, V53, P109, DOI 10.1159/000165360; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lacombe Veronique A, 2014, ISRN Vet Sci, V2014, P409547, DOI 10.1155/2014/409547; Li JM, 2010, HEPATOLOGY, V51, P1555, DOI 10.1002/hep.23524; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Medici V, 2010, OBESITY, V18, P2268, DOI 10.1038/oby.2010.95; Metlakunta AS, 2008, ENDOCRINOLOGY, V149, P1121, DOI 10.1210/en.2007-1307; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Nobili V, 2006, EUR J ENDOCRINOL, V155, P735, DOI 10.1530/eje.1.02288; Ramadoss P, 2009, MOL ENDOCRINOL, V23, P827, DOI 10.1210/me.2008-0264; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tom RZ, 2011, ENDOCRINOLOGY, V152, P2237, DOI 10.1210/en.2010-0040; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Wang H, 2011, INT J BIOL SCI, V7, P536, DOI 10.7150/ijbs.7.536; Xing LJ, 2011, EUR J PHARMACOL, V668, P467, DOI 10.1016/j.ejphar.2011.07.036; Yang G, 2009, J BIOL CHEM, V284, P3719, DOI 10.1074/jbc.M804965200; Yang ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047493; Yue JTY, 2012, CELL METAB, V15, P646, DOI 10.1016/j.cmet.2012.01.013	49	23	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117008	10.1371/journal.pone.0117008	http://dx.doi.org/10.1371/journal.pone.0117008			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658428	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900090
J	Astegiano, J; Massol, F; Vidal, MM; Cheptou, PO; Guimaraes, PR				Astegiano, Julia; Massol, Francois; Vidal, Mariana Morais; Cheptou, Pierre-Olivier; Guimaraes, Paulo R., Jr.			The Robustness of Plant-Pollinator Assemblages: Linking Plant Interaction Patterns and Sensitivity to Pollinator Loss	PLOS ONE			English	Article							MUTUALISTIC NETWORKS; REPRODUCTIVE SUSCEPTIBILITY; COEVOLUTIONARY NETWORKS; HABITAT FRAGMENTATION; POLLEN LIMITATION; SEED-DISPERSAL; MATING SYSTEM; BAKERS LAW; SPECIALIZATION; NESTEDNESS	Most flowering plants depend on pollinators to reproduce. Thus, evaluating the robustness of plant-pollinator assemblages to species loss is a major concern. How species interaction patterns are related to species sensitivity to partner loss may influence the robustness of plant-pollinator assemblages. In plants, both reproductive dependence on pollinators (breeding system) and dispersal ability may modulate plant sensitivity to pollinator loss. For instance, species with strong dependence (e.g. dioecious species) and low dispersal (e.g. seeds dispersed by gravity) may be the most sensitive to pollinator loss. We compared the interaction patterns of plants differing in dependence on pollinators and dispersal ability in a meta-dataset comprising 192 plant species from 13 plant-pollinator networks. In addition, network robustness was compared under different scenarios representing sequences of plant extinctions associated with plant sensitivity to pollinator loss. Species with different dependence on pollinators and dispersal ability showed similar levels of generalization. Although plants with low dispersal ability interacted with more generalized pollinators, low-dispersal plants with strong dependence on pollinators (i.e. the most sensitive to pollinator loss) interacted with more particular sets of pollinators (i.e. shared a low proportion of pollinators with other plants). Only two assemblages showed lower robustness under the scenario considering plant generalization, dependence on pollinators and dispersal ability than under the scenario where extinction sequences only depended on plant generalization (i.e. where higher generalization level was associated with lower probability of extinction). Overall, our results support the idea that species generalization and network topology may be good predictors of assemblage robustness to species loss, independently of plant dispersal ability and breeding system. In contrast, since ecological specialization among partners may increase the probability of disruption of interactions, the fact that the plants most sensitive to pollinator loss interacted with more particular pollinator assemblages suggest that the persistence of these plants and their pollinators might be highly compromised.	[Astegiano, Julia; Massol, Francois; Cheptou, Pierre-Olivier] Univ Montpellier 3, Univ Montpellier, CNRS, CEFE UMR 5175, F-34032 Montpellier, France; [Astegiano, Julia; Vidal, Mariana Morais; Guimaraes, Paulo R., Jr.] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil; [Massol, Francois] Univ Lille 1, CNRS UMR 8198, Lab GEPV, F-59655 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Montpellier; Universite Paul-Valery; Universidade de Sao Paulo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Lille - ISITE; Universite de Lille	Astegiano, J (corresponding author), Univ Montpellier 3, Univ Montpellier, CNRS, CEFE UMR 5175, EPHE Campus CNRS, F-34032 Montpellier, France.	juastegiano@gmail.com	Guimaraes, Paulo R./E-1915-2016; Guimarães-Junior, Paulo R/M-1298-2016; Vidal, Mariana Morais/B-1216-2013; Massol, Francois/D-9872-2013	Guimaraes, Paulo R./0000-0001-9161-8305; Vidal, Mariana Morais/0000-0003-0863-7818; Massol, Francois/0000-0002-4098-955X; Astegiano, Julia/0000-0003-0583-7291	Sao Paulo Research Foundation-FAPESP [2011/09951-2, 2012/04941-1, 2010/11633-6, 2009/54422-8]; CNPq	Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	JA was supported by grant 2011/09951-2 and grant 2012/04941-1 (Sao Paulo Research Foundation-FAPESP, http://www.fapesp.br); MMV was supported by grant 2010/11633-6 (Sao Paulo Research Foundation-FAPESP, http://www.fapesp.br); FM and POC are researchers from the CNRS; and PRG Jr. was supported by grant 2009/54422-8 (Sao Paulo Research Foundation-FAPESP, http://www.fapesp.br) and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JD, 2012, OIKOS, V121, P1821, DOI 10.1111/j.1600-0706.2011.20193.x; Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Aizen M.A., 2006, ECOLOGY EVOLUTION FL, P159; Aizen MA, 2002, J VEG SCI, V13, P885, DOI 10.1111/j.1654-1103.2002.tb02118.x; Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson SH, 2011, SCIENCE, V331, P1068, DOI 10.1126/science.1199092; [Anonymous], MATLAB STAT TOOLB RE; [Anonymous], 2013, R PROJECT STAT COMPU; Ashworth L, 2004, J ECOL, V92, P717, DOI 10.1111/j.0022-0477.2004.00910.x; Ashworth L, 2009, BIOL CONSERV, V142, P1050, DOI 10.1016/j.biocon.2009.01.016; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; BAKER HG, 1967, EVOLUTION, V21, P853, DOI 10.1111/j.1558-5646.1967.tb03440.x; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; BAWA KS, 1994, AM J BOT, V81, P456, DOI 10.2307/2445495; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Cheptou PO, 2012, ANN BOT-LONDON, V109, P633, DOI 10.1093/aob/mcr127; Cheptou PO, 2009, AM NAT, V174, P46, DOI 10.1086/599303; Cresswell JE, 2000, ECOL ENTOMOL, V25, P19, DOI 10.1046/j.1365-2311.2000.00230.x; Diaz S, 2013, ECOL EVOL, V3, P2958, DOI 10.1002/ece3.601; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Evans DM, 2013, ECOL LETT, V16, P844, DOI 10.1111/ele.12117; Fenster CB, 2007, INT J PLANT SCI, V168, P215, DOI 10.1086/509647; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gomez JM, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P145; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Heilbuth JC, 2001, EVOLUTION, V55, P880, DOI 10.1554/0014-3820(2001)055[0880:TCODFS]2.0.CO;2; HERRERA CM, 1988, BIOL J LINN SOC, V35, P95, DOI 10.1111/j.1095-8312.1988.tb00461.x; HUGHES L, 1994, J ECOL, V82, P933, DOI 10.2307/2261456; James A, 2012, NATURE, V487, P227, DOI 10.1038/nature11214; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Lever JJ, 2014, ECOL LETT, V17, P350, DOI 10.1111/ele.12236; Marten-Rodriguez S, 2010, ECOLOGY, V91, P155, DOI 10.1890/08-2115.1; Massol F, 2011, EVOLUTION, V65, P591, DOI 10.1111/j.1558-5646.2010.01134.x; McConkey KR, 2012, BIOL CONSERV, V146, P1, DOI 10.1016/j.biocon.2011.09.018; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.1890/0012-9658(2002)083[2416:GPIPPM]2.0.CO;2; Ollerton J, 2007, TAXON, V56, P717, DOI 10.2307/25065856; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Perez F, 2009, AM J BOT, V96, P1168, DOI 10.3732/ajb.0800306; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; ROUBIK DW, 1987, OECOLOGIA, V73, P321, DOI 10.1007/BF00385247; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; Sahli HF, 2006, OECOLOGIA, V148, P365, DOI 10.1007/s00442-006-0396-1; Schuett EM, 2010, EVOL BIOL, V37, P19, DOI 10.1007/s11692-010-9082-7; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Vidal MM, 2013, BIOL CONSERV, V163, P42, DOI 10.1016/j.biocon.2013.03.025; Vieira MC, 2014, ECOL LETT IN PRESS; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6	64	26	26	6	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117243	10.1371/journal.pone.0117243	http://dx.doi.org/10.1371/journal.pone.0117243			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646762	gold, Green Published, Green Submitted			2022-12-27	WOS:000348822600060
J	Gabor, KA; Kim, D; Kim, CH; Hess, ST				Gabor, Kristin A.; Kim, Dahan; Kim, Carol H.; Hess, Samuel T.			Nanoscale Imaging of Caveolin-1 Membrane Domains In Vivo	PLOS ONE			English	Article							FLUORESCENT PROTEINS; SINGLE-MOLECULE; ZEBRAFISH; MICROSCOPY; MODEL; DISEASE; CELLS; ORGANIZATION; INFECTION; EMISSION	Light microscopy enables noninvasive imaging of fluorescent species in biological specimens, but resolution is generally limited by diffraction to similar to 200-250 nm. Many biological processes occur on smaller length scales, highlighting the importance of techniques that can image below the diffraction limit and provide valuable single-molecule information. In recent years, imaging techniques have been developed which can achieve resolution below the diffraction limit. Utilizing one such technique, fluorescence photoactivation localization microscopy (FPALM), we demonstrated its ability to construct super-resolution images from single molecules in a living zebrafish embryo, expanding the realm of previous super-resolution imaging to a living vertebrate organism. We imaged caveolin-1 in vivo, in living zebrafish embryos. Our results demonstrate the successful image acquisition of super-resolution images in a living vertebrate organism, opening several opportunities to answer more dynamic biological questions in vivo at the previously inaccessible nanoscale.	[Gabor, Kristin A.; Kim, Dahan; Hess, Samuel T.] Univ Maine, Dept Phys & Astron, Orono, ME 04469 USA; [Gabor, Kristin A.; Kim, Carol H.] Univ Maine, Grad Sch Biomed Sci, Orono, ME 04469 USA; [Gabor, Kristin A.; Kim, Carol H.; Hess, Samuel T.] Univ Maine, Dept Mol & Biomed Sci, Orono, ME USA	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Kim, CH (corresponding author), Univ Maine, Grad Sch Biomed Sci, Orono, ME 04469 USA.	carolkim@maine.edu; sam.hess@umit.maine.edu		Kim, Carol/0000-0002-0465-4496	National Institutes of Health [R15-GM094713, K25-AI65459, RO1 GM087308, R15A1065509]; National Science Foundation (NSF) [IGERT-0221625, MRI CHE-0722759]; Maine Technology Institute MTAF [1106, 2061]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [451, 452, P20RR024475-01A2]; Maine Agricultural and Forest Experiment Station Publication [3400]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI065459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103534, R01GM087308, R15GM094713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Maine Technology Institute MTAF; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; Maine Agricultural and Forest Experiment Station Publication; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health (R15-GM094713, K25-AI65459, RO1 GM087308 and R15A1065509), National Science Foundation (NSF IGERT-0221625 and NSF MRI CHE-0722759) and Maine Technology Institute MTAF (1106 and 2061). Research reported in this publication was also supported by an Institutional Development Award (IDeA) 451 from the National Institute of General Medical Sciences of the National Institutes of Health under grant 452 number 20RR024475-01A2, and Maine Agricultural and Forest Experiment Station Publication #3400. The funders had no role in study design, data collection	Bassett DI, 2003, DEVELOPMENT, V130, P5851, DOI 10.1242/dev.00799; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Biteen JS, 2008, NAT METHODS, V5, P947, DOI 10.1038/nmeth.1258; Biteen JS, 2011, METHODS MOL BIOL, V783, P139, DOI 10.1007/978-1-61779-282-3_8; Biteen JS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000448; Chudakov DM, 2007, NAT PROTOC, V2, P2024, DOI 10.1038/nprot.2007.291; Chudakov DM, 2007, BIOTECHNIQUES, V42, P553, DOI 10.2144/000112470; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Gabor KG, 2011, MICROSCOPY TODAY, V19, P12; Gabor KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068759; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Goody MF, 2010, DEV BIOL, V344, P809, DOI 10.1016/j.ydbio.2010.05.513; Gould TJ, 2008, METHOD CELL BIOL, V89, P329, DOI 10.1016/S0091-679X(08)00612-2; Gould TJ, 2009, NAT PROTOC, V4, P291, DOI 10.1038/nprot.2008.246; Gould TJ, 2008, NAT METHODS, V5, P1027, DOI 10.1038/nmeth.1271; Gudheti MV, 2013, BIOPHYS J, V104, P2182, DOI 10.1016/j.bpj.2013.03.054; Gunewardene MS, 2011, BIOPHYS J, V101, P1522, DOI 10.1016/j.bpj.2011.07.049; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hess ST, 2009, METHODS MOL BIOL, V544, P483, DOI 10.1007/978-1-59745-483-4_32; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Kanther M, 2010, CURR OPIN IMMUNOL, V22, P10, DOI 10.1016/j.coi.2010.01.006; Lee SH, 2012, OPT EXPRESS, V20, P12177, DOI 10.1364/OE.20.012177; Lee SH, 2012, P NATL ACAD SCI USA, V109, P17436, DOI 10.1073/pnas.1215175109; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Meeker ND, 2008, DEV COMP IMMUNOL, V32, P745, DOI 10.1016/j.dci.2007.11.011; Mione M, 2009, ZEBRAFISH, V6, P445, DOI 10.1089/zeb.2009.0638; Mlodzianoski MJ, 2011, OPT EXPRESS, V19, P15009, DOI 10.1364/OE.19.015009; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Phelan PE, 2005, J VIROL, V79, P1842, DOI 10.1128/JVI.79.3.1842-1852.2005; Phennicie RT, 2010, INFECT IMMUN, V78, P4542, DOI 10.1128/IAI.00302-10; Prouty MG, 2003, FEMS MICROBIOL LETT, V225, P177, DOI 10.1016/S0378-1097(03)00446-4; Rankin BR, 2011, BIOPHYS J, V100, pL63, DOI 10.1016/j.bpj.2011.05.020; Reck-Peterson S. L., 2010, COLD SPRING HARB PRO, DOI 10/1101/pdb.top73; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schaaf MJM, 2009, BIOPHYS J, V97, P1206, DOI 10.1016/j.bpj.2009.05.044; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; Sullivan C, 2008, FISH SHELLFISH IMMUN, V25, P341, DOI 10.1016/j.fsi.2008.05.005; van der Sar AM, 2004, TRENDS MICROBIOL, V12, P451, DOI 10.1016/j.tim.2004.08.001; van der Sar AM, 2003, CELL MICROBIOL, V5, P601, DOI 10.1046/j.1462-5822.2003.00303.x; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002	46	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117225	10.1371/journal.pone.0117225	http://dx.doi.org/10.1371/journal.pone.0117225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646724	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600059
J	Gao, Y; Zong, CJ; Liu, F; Fang, L; Cai, RL; Shi, Y; Chen, X; Qi, Y				Gao, Yuan; Zong, Chuanjie; Liu, Fen; Fang, Lei; Cai, Runlan; Shi, Yue; Chen, Xi; Qi, Yun			Evaluation of the Intestinal Transport of a Phenylethanoid Glycoside-Rich Extract from Cistanche deserticola across the Caco-2 Cell Monolayer Model	PLOS ONE			English	Article							PERMEABILITY; ABSORPTION; PREDICTION; SYSTEM	Phenylethanoid glycosides (PhGs), a class of polyphenolic compounds, are considered one of major bioactive constituents of Cistanche deserticola Y.C. Ma (CD), whose extract is orally used in traditional Chinese medicine. Although previous pharmacological studies have reported that PhGs exert many activities, their intestinal transport profiles have not been clarified. In this study, we investigated the intestinal permeability of a PhG-rich extract (PRE) from CD as an integrated system in the Caco-2 cell monolayer model using a bioassay system. The results showed that PRE is primarily transported via poorly absorbed passive diffusion down a concentration gradient without efflux, which provides the pharma-cokinetic basis for the clinical application of PhGs in CD. We also determined the intestinal permeability of three major PhGs [acteoside (AC), isoacteoside (IS) and echinacoside (EC)] by HLPC. Furthermore, we developed a novel HPLC-fluorescence detection method to accurately determine the flux amount of AC and IS. As expected, the transport characteristics of the three PhGs are consistent with those of PRE, indicating that the present bioassay system is appropriate and reliable for the evaluation of the transport characteristics of active ingredient groups (AIG) in PRE. Moreover, this system may also be suitable for other plant extracts given appropriate bioactivity.	[Gao, Yuan; Liu, Fen; Fang, Lei; Cai, Runlan; Shi, Yue; Chen, Xi; Qi, Yun] Chinese Acad Med Sci, Inst Med Plant Dev, Dept Res Ctr Pharmacol & Toxicol, Beijing 100730, Peoples R China; [Gao, Yuan; Liu, Fen; Fang, Lei; Cai, Runlan; Shi, Yue; Chen, Xi; Qi, Yun] Peking Union Med Coll, Beijing 100730, Peoples R China; [Zong, Chuanjie] Heilongjiang Univ Chinese Med, Harbin, Heilongjiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Heilongjiang University of Chinese Medicine	Chen, X (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Dept Res Ctr Pharmacol & Toxicol, Beijing 100730, Peoples R China.	chenxi@implad.ac.cn; yqi@implad.ac.cn	Fang, Lei/HHN-8887-2022	Fang, Lei/0000-0001-9980-8285	National Natural Science Foundation of China [81173645, 81274163]; Ministry of Science and Technology of the People's Republic of China [2012ZX09301-002-001, 2014ZX09201022-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation of China (Nos. 81173645 and 81274163) and National S&T Major Project and Scientific Researchers Aiding Enterprise Item (Nos. 2012ZX09301-002-001 and 2014ZX09201022-006) from the Ministry of Science and Technology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; Cai RL, 2010, PHYTOTHER RES, V24, P313, DOI 10.1002/ptr.2927; [蔡润兰 CAI Run-lan], 2008, [中国药学杂志, Chinese Pharmaceutical Journal], V43, P1871; Center for Drug Evaluation and Research, 2004, GUID IND BOT DRUG PR, P5; Center for Drug Evaluation and Research, 2012, GUID IND DRUG INT ST, P64, DOI [10.1177/0091270007312153, DOI 10.1177/0091270007312153]; Dong Q, 2007, CARBOHYD RES, V342, P1343, DOI 10.1016/j.carres.2007.03.017; Eguchi A, 2005, FREE RADICAL RES, V39, P1367, DOI 10.1080/10715760500045624; Fu G, 2008, CURR MED CHEM, V15, P2592, DOI 10.2174/092986708785908996; Jiang Y, 2009, J CHROMATOGR A, V1216, P1970, DOI 10.1016/j.chroma.2008.07.031; Jung SJ, 2006, J PHARMACEUT BIOMED, V41, P469, DOI 10.1016/j.jpba.2005.12.020; Li N, 2012, PLANTA MED, V78, P692, DOI 10.1055/s-0031-1298368; MURAI M, 1995, PLANTA MED, V61, P479, DOI 10.1055/s-2006-958143; RANALDI G, 1992, ANTIMICROB AGENTS CH, V36, P1374, DOI 10.1128/AAC.36.7.1374; Sandri G, 2007, EUR J PHARM BIOPHARM, V65, P68, DOI 10.1016/j.ejpb.2006.07.016; The State Commission of Chinese Pharmacopoeia, 2010, PHARM PEOPL 2 REP 1, P126, DOI [10.1016/j.ijpddr.2014.09.001, DOI 10.1016/J.IJPDDR.2014.09.001]; Wang LN, 2008, XI BEI YAO XUE ZA ZH, V23, P67; Wang M, 2008, AM J CHINESE MED, V36, P1199, DOI 10.1142/S0192415X08006521; Wang T, 2012, AM J CHINESE MED, V40, P1123, DOI 10.1142/S0192415X12500838; Xiong Q, 2000, EUR J PHARMACOL, V400, P137, DOI 10.1016/S0014-2999(00)00354-X; Xiong QB, 1996, BIOL PHARM BULL, V19, P1580, DOI 10.1248/bpb.19.1580; Xiong QB, 1998, PLANTA MED, V64, P120, DOI 10.1055/s-2006-957387; Yamashita S, 2000, EUR J PHARM SCI, V10, P195, DOI 10.1016/S0928-0987(00)00076-2; Yang DZ, 2013, J CHROMATOGR SCI, V51, P716, DOI 10.1093/chromsci/bmt057; Yang XW, 2010, PLANTA MED, V76, P1587, DOI 10.1055/s-0030-1249810; Yee SY, 1997, PHARMACEUT RES, V14, P763, DOI 10.1023/A:1012102522787; Zhao B, 2011, PLANTA MED, V77, P1531, DOI 10.1055/s-0030-1270741	27	17	19	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116490	10.1371/journal.pone.0116490	http://dx.doi.org/10.1371/journal.pone.0116490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646971	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600026
J	Jiang, XX; Dang, HY; Jiao, NZ				Jiang, Xuexia; Dang, Hongyue; Jiao, Nianzhi			Ubiquity and Diversity of Heterotrophic Bacterial nasA Genes in Diverse Marine Environments	PLOS ONE			English	Article							NITRATE ASSIMILATION GENES; HARMFUL ALGAL BLOOMS; DISSOLVED ORGANIC-MATTER; ALTEROMONAS-MACLEODII; COMPARATIVE GENOMICS; INTERACTIVE TREE; NITROGEN UPTAKE; BARENTS SEA; PHYTOPLANKTON; BACTERIOPLANKTON	Nitrate uptake by heterotrophic bacteria plays an important role in marine N cycling. However, few studies have investigated the diversity of environmental nitrate assimilating bacteria (NAB). In this study, the diversity and biogeographical distribution of NAB in several global oceans and particularly in the western Pacific marginal seas were investigated using both cultivation and culture-independent molecular approaches. Phylogenetic analyses based on 16S rRNA and nasA (encoding the large subunit of the assimilatory nitrate reductase) gene sequences indicated that the cultivable NAB in South China Sea belonged to the alpha-Proteobacteria, gamma-Proteobacteria and CFB (Cytophaga-Flavobacteria-Bacteroides) bacterial groups. In all the environmental samples of the present study, alpha-Proteobacteria, gamma-Proteobacteria and Bacteroidetes were found to be the dominant nasA-harboring bacteria. Almost all of the alpha-Proteobacteria OTUs were classified into three Roseobacter-like groups (I to III). Clone library analysis revealed previously underestimated nasA diversity; e.g. the nasA gene sequences affiliated with beta-Proteobacteria, epsilon-Proteobacteria and Lentisphaerae were observed in the field investigation for the first time, to the best of our knowledge. The geographical and vertical distributions of seawater nasA-harboring bacteria indicated that NAB were highly diverse and ubiquitously distributed in the studied marginal seas and world oceans. Niche adaptation and separation and/or limited dispersal might mediate the NAB composition and community structure in different water bodies. In the shallow-water Kueishantao hydrothermal vent environment, chemolithoautotrophic sulfur-oxidizing bacteria were the primary NAB, indicating a unique nitrate-assimilating community in this extreme environment. In the coastal water of the East China Sea, the relative abundance of Alteromonas and Roseobacter-like nasA gene sequences responded closely to algal blooms, indicating that NAB may be active participants contributing to the bloom dynamics. Our statistical results suggested that salinity, temperature and nitrate may be some of the key environmental factors controlling the composition and dynamics of the marine NAB communities.	[Jiang, Xuexia; Dang, Hongyue; Jiao, Nianzhi] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361102, Peoples R China; [Jiang, Xuexia; Dang, Hongyue; Jiao, Nianzhi] Xiamen Univ, Inst Marine Microbes & Ecospheres, Xiamen 361102, Peoples R China	Xiamen University; Xiamen University	Dang, HY (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361102, Peoples R China.	DangHY@xmu.edu.cn	Dang, Hongyue/H-6577-2019		China MOST 973 grant [2013CB955700]; NSFC [91028001, 91328209, 91428308]; SOA grant [201105021]	China MOST 973 grant; NSFC(National Natural Science Foundation of China (NSFC)); SOA grant	This work was supported by China MOST 973 grant 2013CB955700 (http://www.973.gov.cn/English/Index.aspx), NSFC grants 91028001, 91328209, and 91428308 (http://www.nsfc.gov.cn/publish/portal1), and SOA grant 201105021 (http://www.soa.gov.cn/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhitya A, 2007, MICROB ECOL, V54, P587, DOI 10.1007/s00248-006-9175-0; Allen AE, 2005, AQUAT MICROB ECOL, V39, P247, DOI 10.3354/ame039247; Allen AE, 2002, J MARINE SYST, V38, P93, DOI 10.1016/S0924-7963(02)00171-9; Allen AE, 2001, APPL ENVIRON MICROB, V67, P5343, DOI 10.1128/AEM.67.11.5343-5348.2001; Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; Bano N, 2002, APPL ENVIRON MICROB, V68, P505, DOI 10.1128/AEM.68.2.505-518.2002; Bernhard AE, 2005, FEMS MICROBIOL ECOL, V52, P115, DOI 10.1016/j.femsec.2004.10.016; Bouvier TC, 2002, LIMNOL OCEANOGR, V47, P453, DOI 10.4319/lo.2002.47.2.0453; Brinkhoff T, 1999, APPL ENVIRON MICROB, V65, P3843; Burger M, 2003, SOIL BIOL BIOCHEM, V35, P29, DOI 10.1016/S0038-0717(02)00233-X; Burland T G, 2000, Methods Mol Biol, V132, P71; Cai HY, 2008, MICROB ECOL, V56, P751, DOI 10.1007/s00248-008-9394-7; Chen CTA, 2005, CHEM GEOL, V224, P69, DOI 10.1016/j.chemgeo.2005.07.022; Chen YC, 2011, BREAKING FEM WAVES, P1, DOI 10.1057/9780230119185; Church MJ, 2000, APPL ENVIRON MICROB, V66, P455, DOI 10.1128/AEM.66.2.455-466.2000; DANDONNEAU Y, 1992, J GEOPHYS RES-OCEANS, V97, P3581, DOI 10.1029/91JC02848; Dang HY, 2008, MICROBIOL-SGM, V154, P2084, DOI 10.1099/mic.0.2007/013581-0; Davidson K, 2007, LIMNOL OCEANOGR, V52, P2147, DOI 10.4319/lo.2007.52.5.2147; Fernandez-Gomez B, 2013, ISME J, V7, P1026, DOI 10.1038/ismej.2012.169; Fouilland E, 2007, J PLANKTON RES, V29, P369, DOI 10.1093/plankt/fbm022; Gorfer M, 2011, ISME J, V5, P1771, DOI 10.1038/ismej.2011.53; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; HJ Qu, 2011, REG ENV CHANG J, V6, P1; HOWARTH RW, 1988, ANNU REV ECOL SYST, V19, P89, DOI 10.1146/annurev.es.19.110188.000513; Hu AY, 2010, FRESHWATER BIOL, V55, P2375, DOI 10.1111/j.1365-2427.2010.02454.x; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; Jacquet S, 2002, MAR ECOL PROG SER, V228, P3, DOI 10.3354/meps228003; Jiao NZ, 2011, NAT REV MICROBIOL, V9, DOI 10.1038/nrmicro2386-c2; Joint I, 2002, AQUAT MICROB ECOL, V29, P145, DOI 10.3354/ame029145; Kirchman DL, 2013, ENV MICROBIOL REP, V5, P188, DOI 10.1111/j.1758-2229.2012.00367.x; KIRCHMAN DL, 2000, UPTAKE REGENERATION; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Kudela RM, 2010, PROG OCEANOGR, V85, P122, DOI 10.1016/j.pocean.2010.02.008; Lee K, 2007, INT J SYST EVOL MICR, V57, P1653, DOI 10.1099/ijs.0.64960-0; Leps J, 2003, MULTIVARIATE ANAL EC; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liu KK, 2002, DEEP-SEA RES PT I, V49, P1387, DOI 10.1016/S0967-0637(02)00035-3; Lopez-Lopez A, 2005, ENVIRON MICROBIOL, V7, P649, DOI 10.1111/j.1462-2920.2005.00733.x; Luque-Almagro VM, 2011, BIOCHEM SOC T, V39, P1838, DOI 10.1042/BST20110688; Mann AJ, 2013, APPL ENVIRON MICROB, V79, P6813, DOI 10.1128/AEM.01937-13; McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09; Middelburg JJ, 2000, MAR ECOL PROG SER, V203, P13, DOI 10.3354/meps203013; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Moran MA, 2007, NAT REV MICROBIOL, V5, P792, DOI 10.1038/nrmicro1746; Pedler BE, 2014, P NATL ACAD SCI USA, V111, P7202, DOI 10.1073/pnas.1401887111; Rodrigues RMNV, 2002, LIMNOL OCEANOGR, V47, P1608, DOI 10.4319/lo.2002.47.6.1608; Romera-Castillo C, 2011, APPL ENVIRON MICROB, V77, P7490, DOI 10.1128/AEM.00200-11; Rowe JM, 2012, FEMS MICROBIOL ECOL, V79, P359, DOI 10.1111/j.1574-6941.2011.01223.x; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Scott KM, 2006, PLOS BIOL, V4, P2196, DOI 10.1371/journal.pbio.0040383; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041204; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thrash JC, 2010, J BACTERIOL, V192, P5552, DOI 10.1128/JB.00873-10; TIBBLES BJ, 1994, MICROBIAL ECOL, V27, P65, DOI 10.1007/BF00170115; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Wawrik B, 2012, FEMS MICROBIOL ECOL, V79, P400, DOI 10.1111/j.1574-6941.2011.01226.x; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002; Yan WJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003575; Yang TF, 2005, GEOCHEM J, V39, P469, DOI 10.2343/geochemj.39.469; Zehr JP, 2011, ANNU REV MAR SCI, V3, P197, DOI 10.1146/annurev-marine-120709-142819	65	16	18	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117473	10.1371/journal.pone.0117473	http://dx.doi.org/10.1371/journal.pone.0117473			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647610	gold, Green Published, Green Submitted			2022-12-27	WOS:000348822600070
J	Zhang, YS; Li, YQ; Deng, JH; Ji, ZG; Yu, HY; Li, HZ				Zhang, Yushi; Li, Yongqiang; Deng, Jianhua; Ji, Zhigang; Yu, Hongyan; Li, Hanzhong			Sorafenib Neoadjuvant Therapy in the Treatment of High Risk Renal Cell Carcinoma	PLOS ONE			English	Article							GUIDELINES; EFFICACY; ADJUVANT	Objective To evaluate the clinical efficacy of sorafenib as preoperative neoadjuvant therapy in patients with high risk renal cell carcinoma (RCC). Materials and Methods Clinical data of 18 patients with high risk RCC who received surgery done successfully after preoperative neoadjuvant therapy with sorafenib in Peking Union Medical College Hospital (PUMCH) from April 2007 to October 2013 have been reviewed and analyzed in this study. Results Among the 18 patients there were 13 male and 5 female, with a median age of 54.6 years. The objective response rate (ORR) of the operation on the selected patients is very high (94.4%), including 4 cases (22.2%) of partial response (PR) and 13 cases (72.2%) of stable disease (SD). After preoperative sorafenib treatment, the average tumor size of the 18 patients decreased from 7.8 cm (ranging from 3.6 to 19.2 cm) to 6.2 cm (ranging from 2.4 to 16.8 cm), and the median value of average tumor CT value decreased from 61HU to 52 HU. Among the 5 patients who had IVC tumor thrombi, the grades of tumor thrombi in 2 patients who were grade II before sorafenib treatment became grade I and grade 0 respectively, 2 patients of grade III both became grade II. Conclusion Preoperative neoadjuvant therapy with sorafenib for high risk RCC patients can significantly decrease primary tumor volume as well as tumor thrombus, which could help the nephron-sparing surgery (NSS) or radical nephrectomy to be done successfully.	[Zhang, Yushi; Li, Yongqiang; Deng, Jianhua; Ji, Zhigang; Yu, Hongyan; Li, Hanzhong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Urol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Li, HZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Urol, Beijing 100730, Peoples R China.	lihanzhongpro@126.com	Yu, Houyong/R-1592-2016	Yu, Houyong/0000-0002-6543-5924				Baccala A, 2007, INT J UROL, V14, P1095, DOI 10.1111/j.1442-2042.2007.01902.x; Choueiri M, 2011, CURR CLIN PHARMACOL, V6, P144, DOI 10.2174/157488411797189415; Chow WH, 2013, CANCER-AM CANCER SOC, V119, P388, DOI 10.1002/cncr.27690; Di Silverio F, 2008, UROL INT, V80, P451, DOI 10.1159/000132708; Dutcher JP, 2013, THER ADV UROL, V5, P338, DOI 10.1177/1756287213505672; Escudier B, 2012, ANN ONCOL, V23, P65, DOI 10.1093/annonc/mds227; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; King SC, 2014, J UROLOGY, V191, P1665, DOI 10.1016/j.juro.2013.12.046; LAW TM, 1995, CANCER-AM CANCER SOC, V76, P824, DOI 10.1002/1097-0142(19950901)76:5<824::AID-CNCR2820760517>3.0.CO;2-N; Miles KA, 2012, EUR RADIOL, V22, P1430, DOI 10.1007/s00330-012-2379-4; Porta C, 2009, ANTI-CANCER DRUG, V20, P409, DOI 10.1097/CAD.0b013e32831fb500; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Schrader AJ, 2012, INT J UROL, V19, P903, DOI 10.1111/j.1442-2042.2012.03065.x; Strumberg D, 2012, EXPERT OPIN PHARMACO, V13, P407, DOI 10.1517/14656566.2012.654776; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tobert CM, 2013, UROL ONCOL-SEMIN ORI, V31, P1316, DOI 10.1016/j.urolonc.2011.12.014; Weikert S, 2010, WORLD J UROL, V28, P247, DOI 10.1007/s00345-010-0555-1; Yang L, 2012, ONCOL LETT, V3, P935, DOI 10.3892/ol.2012.585; Ye DW, 2014, ONCOTARGETS THER, V7, P925, DOI 10.2147/OTT.S41828; Zhang HL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-249	20	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0115896	10.1371/journal.pone.0115896	http://dx.doi.org/10.1371/journal.pone.0115896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647522	gold, Green Published, Green Submitted			2022-12-27	WOS:000348822600016
J	Trend, S; Strunk, T; Hibbert, J; Kok, CH; Zhang, GC; Doherty, DA; Richmond, P; Burgner, D; Simmer, K; Davidson, DJ; Currie, AJ				Trend, Stephanie; Strunk, Tobias; Hibbert, Julie; Kok, Chooi Heen; Zhang, Guicheng; Doherty, Dorota A.; Richmond, Peter; Burgner, David; Simmer, Karen; Davidson, Donald J.; Currie, Andrew J.			Antimicrobial Protein and Peptide Concentrations and Activity in Human Breast Milk Consumed by Preterm Infants at Risk of Late-Onset Neonatal Sepsis	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; GASTROINTESTINAL-TRACT; BACTERICIDAL ACTIVITY; HUMAN LACTOFERRIN; LYSOZYME; TERM; GUT; IDENTIFICATION; TRANSLOCATION; DEFENSINS	Objective We investigated the levels and antimicrobial activity of antimicrobial proteins and peptides (AMPs) in breast milk consumed by preterm infants, and whether deficiencies of these factors were associated with late-onset neonatal sepsis (LOS), a bacterial infection that frequently occurs in preterm infants in the neonatal period. Study design Breast milk from mothers of preterm infants (<= 32 weeks gestation) was collected on days 7 (n = 88) and 21 (n = 77) postpartum. Concentrations of lactoferrin, LL-37, beta-defensins 1 and 2, and alpha-defensin 5 were measured by enzyme-linked immunosorbent assay. The antimicrobial activity of breast milk samples against Staphylococcus epidermidis, Staphylococcus aureus, Escherichia coli, and Streptococcus agalactiae was compared to the activity of infant formula, alone or supplemented with physiological levels of AMPs. Samples of breast milk fed to infants with and without subsequent LOS were compared for levels of AMPs and inhibition of bacterial growth. Results Levels of most AMPs and antibacterial activity in preterm breast milk were higher at day 7 than at day 21. Lactoferrin was the only AMP that limited pathogen growth >50% when added to formula at a concentration equivalent to that present in breast milk. Levels of AMPs were similar in the breast milk fed to infants with and without LOS, however, infants who developed LOS consumed significantly less breast milk and lower doses of milk AMPs than those who were free from LOS. Conclusions The concentrations of lactoferrin and defensins in preterm breast milk have antimicrobial activity against common neonatal pathogens.	[Trend, Stephanie; Strunk, Tobias; Kok, Chooi Heen; Simmer, Karen; Currie, Andrew J.] Univ Western Australia, Ctr Neonatal Res & Educ, Perth, WA 6009, Australia; [Trend, Stephanie; Strunk, Tobias; Hibbert, Julie; Richmond, Peter; Simmer, Karen; Currie, Andrew J.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Strunk, Tobias; Kok, Chooi Heen; Simmer, Karen] King Edward Mem Hosp Women, Neonatal Clin Care Unit, Perth, WA, Australia; [Zhang, Guicheng] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia; [Doherty, Dorota A.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Burgner, David] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Burgner, David] Univ Melbourne, Melbourne, Vic, Australia; [Davidson, Donald J.] Univ Edinburgh, MRC Ctr Inflammat Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Currie, Andrew J.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia	University of Western Australia; University of Western Australia; King Edward Memorial Hospital; University of Western Australia; Curtin University; University of Western Australia; Murdoch Children's Research Institute; University of Melbourne; University of Edinburgh; Murdoch University	Currie, AJ (corresponding author), Univ Western Australia, Ctr Neonatal Res & Educ, Perth, WA 6009, Australia.	a.currie@murdoch.edu.au	Strunk, Tobias/AIE-3407-2022; Zhang, Brad/AAF-8719-2021; Richmond, Peter C/G-3379-2012; Currie, Andrew/C-2778-2015	Strunk, Tobias/0000-0001-7079-2339; Richmond, Peter C/0000-0001-7562-7228; Simmer, Karen/0000-0003-4777-9069; Trend, Stephanie/0000-0003-0210-3452; Burgner, David/0000-0002-8304-4302; Currie, Andrew/0000-0002-5193-3404; Zhang, Guicheng/0000-0001-9888-5385; Hibbert, Julie/0000-0002-8839-3966	National Health and Medical Research Council [572548, APP1064629]; Princess Margaret Hospital Foundation; Telethon New Childrens Hospital Research Fund; Clive and Vera Ramaciotti Foundation; Medical Research Council [G1002046]; Murdoch University; Honorary National Heart Foundation Australia Future Leader Fellowship [100026]; Victorian Government's Operational Infrastructure Support Program; Brightspark Foundation Fellowship; Women and Infants Research Foundation; MRC [G1002046] Funding Source: UKRI	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Princess Margaret Hospital Foundation; Telethon New Childrens Hospital Research Fund; Clive and Vera Ramaciotti Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Murdoch University; Honorary National Heart Foundation Australia Future Leader Fellowship; Victorian Government's Operational Infrastructure Support Program; Brightspark Foundation Fellowship; Women and Infants Research Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this study was awarded to AC, TS, KS, PR, DAD and DB by the National Health and Medical Research Council (572548; www.nhmrc.gov.au), to AC, TS, KS and DB from the Princess Margaret Hospital Foundation (www.pmhfoundation.com), to AC, DJD, TS, and DB from the Telethon New Childrens Hospital Research Fund (http://www.health.wa.gov.au), and to TS from the Clive and Vera Ramaciotti Foundation (www.perpetual.com.au/ramaciotti). DJD is supported by a Medical Research Council Senior Non-clinical Fellowship (G1002046; http://www.mrc.ac.uk) and a Distinguished Collaborator Award from Murdoch University (www.murdoch.edu.au). DB is supported by a National Health and Medical Research Council Senior Research Fellowship (APP1064629; www.nhmrc.gov.au) and an Honorary National Heart Foundation Australia Future Leader Fellowship (100026; www.heartfoundation.org.au). Research at the Murdoch Childrens Research Institute is supported by the Victorian Government's Operational Infrastructure Support Program (www.vic.gov.au). GZ is supported by a Brightspark Foundation Fellowship (www.brightsparkfoundation.com.au). ST is supported by an Australian postgraduate award (www.education.gov.au), and postgraduate scholarships from the Women and Infants Research Foundation (www.wirf.com.au) and the Princess Margaret Hospital Foundation (www.pmhfoundation.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila A, 2001, FEMS IMMUNOL MED MIC, V31, P145, DOI 10.1111/j.1574-695X.2001.tb00511.x; AKIN IM, 2014, AM J PERINATOL, P13897; Armogida SA, 2004, ALLERGY ASTHMA PROC, V25, P297; ARNOLD RR, 1980, INFECT IMMUN, V28, P893; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Beaumont PE, 2013, ANTIMICROBIAL PEPTID, P97; Bera A, 2006, INFECT IMMUN, V74, P4598, DOI 10.1128/IAI.00301-06; Berg Rodney D., 1995, Trends in Microbiology, V3, P149, DOI 10.1016/S0966-842X(00)88906-4; Bowdish DME, 2005, CURR PROTEIN PEPT SC, V6, P35, DOI 10.2174/1389203053027494; Camacho-Gonzalez A, 2013, PEDIATR CLIN N AM, V60, P367, DOI 10.1016/j.pcl.2012.12.003; Campos LF, 2013, J PEDIAT-BRAZIL, V89, P394, DOI 10.1016/j.jped.2012.12.003; Carl MA, 2014, CLIN INFECT DIS, V58, P1211, DOI 10.1093/cid/ciu084; Castellote C, 2011, J NUTR, V141, P1181, DOI 10.3945/jn.110.133652; Chan Gary M, 2003, J Perinatol, V23, P620, DOI 10.1038/sj.jp.7211003; Chantry CJ, 2011, BREASTFEED MED, V6, P111, DOI 10.1089/bfm.2010.0078; Chen XJ, 2005, J DERMATOL SCI, V40, P123, DOI 10.1016/j.jdermsci.2005.03.014; DAWARKADAS AM, 1991, J TROP PEDIATRICS, V37, P214, DOI 10.1093/tropej/37.5.214; de Ferrer PAR, 2000, J AM COLL NUTR, V19, P370; Edde L, 2001, AM J PHYSIOL-GASTR L, V281, pG1140, DOI 10.1152/ajpgi.2001.281.5.G1140; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Findlay EG, 2013, BIODRUGS, V27, P479, DOI 10.1007/s40259-013-0039-0; Guerrero A, 2014, MOL CELL PROTEOMICS, V13, P3343, DOI 10.1074/mcp.M113.036194; HUTCHENS TW, 1991, PEDIATR RES, V29, P243, DOI 10.1203/00006450-199103000-00005; Isaacs D, 2003, ARCH DIS CHILD-FETAL, V88, pF89, DOI 10.1136/fn.88.2.F89; Jenssen H, 2009, BIOCHIMIE, V91, P19, DOI 10.1016/j.biochi.2008.05.015; KOO WWK, 1982, ARCH DIS CHILD, V57, P500, DOI 10.1136/adc.57.7.500; Lavoie PM, 2009, J PERINATOL, V29, P448, DOI 10.1038/jp.2009.8; Legrand D, 2012, BIOCHEM CELL BIOL, V90, P252, DOI [10.1139/O11-056, 10.1139/o11-056]; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Leitch EC, 1999, J MED MICROBIOL, V48, P867, DOI 10.1099/00222615-48-9-867; Leitch EC, 1999, CURR EYE RES, V19, P12, DOI 10.1076/ceyr.19.1.12.5342; Manzoni P, 2009, JAMA-J AM MED ASSOC, V302, P1421, DOI 10.1001/jama.2009.1403; Mehta R, 2011, BREASTFEED MED, V6, P21, DOI 10.1089/bfm.2010.0024; Mitoulas LR, 2002, BRIT J NUTR, V88, P29, DOI [10.1079/BJN2002579, 10.1079/BJNBJN2002579]; Montagne P, 2001, ADV EXP MED BIOL, V501, P241; NGUYEN DN, 2013, BR J NUTR, P1; Pammi M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007137.pub3; Patel AL, 2013, J PERINATOL, V33, P514, DOI 10.1038/jp.2013.2; Porter EM, 1997, INFECT IMMUN, V65, P2396, DOI 10.1128/IAI.65.6.2396-2401.1997; Redline Raymond W, 2004, Semin Neonatol, V9, P265, DOI 10.1016/j.siny.2003.09.005; Ronnestad A, 2005, PEDIATRICS, V115, pE269, DOI 10.1542/peds.2004-1833; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Silvestre D, 2006, BRIT J BIOMED SCI, V63, P59, DOI 10.1080/09674845.2006.11732721; Sinha Mau, 2013, Int J Pept, V2013, P390230, DOI 10.1155/2013/390230; Soeorg H, 2013, PEDIATR INFECT DIS J, V32, P389, DOI 10.1097/INF.0b013e3182791abd; Steinwender G, 1996, PEDIATR RES, V39, P415, DOI 10.1203/00006450-199603000-00007; Van Gysel M, 2012, EUR J PEDIATR, V171, P1231, DOI 10.1007/s00431-012-1750-4; Velona T, 1999, PEDIATR RES, V45, P658, DOI 10.1203/00006450-199905010-00008; Venkatesh MP, 2008, J MED MICROBIOL, V57, P1113, DOI 10.1099/jmm.0.2008/001263-0; Wagner CL, 2008, CLIN REV ALLERG IMMU, V34, P191, DOI 10.1007/s12016-007-8032-3; Wang XF, 2014, BRIT J NUTR, V111, P867, DOI 10.1017/S0007114513003292; Yen CC, 2009, J INFECT DIS, V199, P590, DOI 10.1086/596212	53	48	50	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117038	10.1371/journal.pone.0117038	http://dx.doi.org/10.1371/journal.pone.0117038			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643281	Green Published, gold			2022-12-27	WOS:000348821200031
J	Wang, LJ; Feng, LS; Yao, Y; Wang, YZ; Chen, Y; Feng, JC; Xing, YQ				Wang, Lijuan; Feng, Liangshu; Yao, Yan; Wang, Yuzhi; Chen, Ying; Feng, Jiachun; Xing, Yingqi			Optimal Optic Nerve Sheath Diameter Threshold for the Identification of Elevated Opening Pressure on Lumbar Puncture in a Chinese Population	PLOS ONE			English	Article							RAISED INTRACRANIAL-PRESSURE; CEREBRAL PERFUSION-PRESSURE; ULTRASOUND; ULTRASONOGRAPHY; SONOGRAPHY	Ultrasonography of the optic nerve sheath diameter (ONSD) is a non-invasive and rapid method that might be helpful in the identification of increased intracranial pressure (ICP). The use of an ONSD greater than 5 mm on ultrasound as an indicator of increased ICP in a Caucasian population has been studied. However, the cut-off point of this predictor in Chinese patients has not been established. Thus, we conducted this study to identify the ONSD criterion for the detection of elevated opening pressure on lumbar puncture (LP) in a Chinese population and to investigate the influencing factors. This study was a blind cross-sectional study. Patients who presented with suspected increased ICP were included. The opening pressure on LP of each participant was confirmed. We analyzed the clinical differences between the groups of patients with abnormal and normal opening pressures on LP. A receiver operating characteristic curve was constructed to determine the ONSD cut-off point for the identification of abnormal opening pressure on LP. In total, 279 patients were recruited, and 101 patients presented with elevated opening pressure on LP. ONSD was a significant independent predictor of elevated opening pressure on LP (p<0.001). However, no statistical significance was observed regarding the factors that might have affected this relationship including gender, age, body mass index, waistline, head circumference, hypertension and pathological subtype. The ONSD cut-off point for the identification of elevated opening pressure on LP was 4.1 mm; this cut-off yielded a sensitivity of 95% and a specificity of 92%. ONSD is a strong and accurate predictor of elevated opening pressure on LP. The cut-off point of this predictor in a Chinese population was remarkably lower than that found in a Caucasian population. Thus, ethnic differences should be noted when using the ONSD as an indicator of increased ICP.	[Wang, Lijuan; Feng, Liangshu; Chen, Ying; Feng, Jiachun; Xing, Yingqi] Jilin Univ, Hosp 1, Neurosci Ctr, Dept Neurol, Changchun 130023, Peoples R China; [Yao, Yan] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Changchun 130023, Peoples R China	Jilin University; Jilin University	Feng, JC (corresponding author), Jilin Univ, Hosp 1, Neurosci Ctr, Dept Neurol, Changchun 130023, Peoples R China.	fengjcfrank@163.com; xingyq@sina.com		Wang, Li-juan/0000-0002-5439-8988; Xing, Yingqi/0000-0002-7403-5789				Adams RD, 2001, PRINCIPLES NEUROLOGY; Amini A, 2013, AM J EMERG MED, V31, P236, DOI 10.1016/j.ajem.2012.06.025; Bauerle J, 2012, J NEUROIMAGING, V22, P42, DOI 10.1111/j.1552-6569.2010.00546.x; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1111/j.1553-2712.2003.tb01352.x; Dubourg J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-62; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc7006; Hamilton DR, 2011, J ULTRAS MED, V30, P651, DOI 10.7863/jum.2011.30.5.651; Hansen HC, 2011, ACTA OPHTHALMOL, V89, pE528, DOI 10.1111/j.1755-3768.2011.02159.x; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; HAYREH SS, 1968, DOC OPHTHALMOL, V24, P289, DOI 10.1007/BF02550944; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; Lagreze WA, 2007, INVEST OPHTH VIS SCI, V48, P1913, DOI 10.1167/iovs.06-1075; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; LIU D, 1993, AM J OPHTHALMOL, V116, P548, DOI 10.1016/S0002-9394(14)73195-2; Lundberg N, 1959, ACTA PSYCHIAT SCAND, V36, P1; Maude RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081013; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; Moretti R, 2009, NEUROCRIT CARE, V11, P406, DOI 10.1007/s12028-009-9250-8; Newman WD, 2002, BRIT J OPHTHALMOL, V86, P1109, DOI 10.1136/bjo.86.10.1109; Potgieter DW, 2011, ANAESTH INTENS CARE, V39, P95, DOI 10.1177/0310057X1103900116; Raboel P, 2012, CRITICAL CARE RES PR, V2012, DOI [10.1155/2012/964547, DOI 10.1155/2012/964547]; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Romagnuolo L, 2005, AM J EMERG MED, V23, P686, DOI 10.1016/j.ajem.2004.11.004; Soldatos T, 2009, EMERG MED J, V26, P630, DOI 10.1136/emj.2008.058453; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Tsung JW, 2005, PEDIATR EMERG CARE, V21, P94, DOI 10.1097/01.pec.0000159052.64930.64; Vaiman M, 2014, HEAD FACE MED, V10, DOI 10.1186/1746-160X-10-32	34	55	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117939	10.1371/journal.pone.0117939	http://dx.doi.org/10.1371/journal.pone.0117939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664663	Green Submitted, Green Published, gold			2022-12-27	WOS:000349123100023
J	Hauer, A; De Cruz, K; Cochard, T; Godreuil, S; Karoui, C; Henault, S; Bulach, T; Banuls, AL; Biet, F; Boschiroli, ML				Hauer, Amandine; De Cruz, Krystel; Cochard, Thierry; Godreuil, Sylvain; Karoui, Claudine; Henault, Sylvie; Bulach, Tabatha; Banuls, Anne-Laure; Biet, Franck; Boschiroli, Maria Laura			Genetic Evolution of Mycobacterium bovis Causing Tuberculosis in Livestock and Wildlife in France since 1978	PLOS ONE			English	Article							TANDEM REPEATS; VARIABLE NUMBERS; CLONAL COMPLEX; SURVEILLANCE; DIVERSITY; STRAINS; EPIDEMIOLOGY; SPOLIGOTYPE; ANIMALS; HUMANS	To study the dynamics of bovine tuberculosis (bTB) in France, 4,654 M. bovis strains isolated mainly from livestock and wildlife since 1978 were characterized by spoligotyping and MLVA based on MIRU-VNTR. In our study spoligotyping allowed the discrimination of 176 types although 3 spoligotypes are predominant and account for more than half of the total strain population: SB0120 (26%), SB0134 (11%) and SB0121 (6%). In addition, 11% of the isolates, principally from Southern France, showing close spoligotypes and MIRU-VNTR types have been gathered in a family designated as the "F4-family". MLVA typing allowed extensive discrimination, particularly for strains with predominant spoligotypes, with a total of 498 genotypes, several of which were highly regionalized. The similarity of the strains' genetic relationships based on spoligotyping and MIRU-VNTR markers supports the coexistence of different clonal populations within the French M. bovis population. A genetic evolution of the strains was observed both geographically and in time. Indeed, as a result of the reduction of bTB due to the national control campaigns, a large reduction of the strains' genetic variability took place in the last ten years. However, in the regions were bTB is highly prevalent at present, cases in both livestock and in wildlife are due to the spread of unique local genotype profiles. Our results show that the highly discriminating genotyping tools used in this study for molecular studies of bTB are useful for addressing pending questions, which would lead to a better insight into the epidemiology of the disease, and for finding proper solutions for its sustainable control in France.	[Hauer, Amandine; De Cruz, Krystel; Karoui, Claudine; Henault, Sylvie; Bulach, Tabatha; Boschiroli, Maria Laura] Univ Paris Est, Lab Natl Reference Tuberculose, Unite Zoonoses Bacteriennes, Lab Sante Anim,ANSES, Maisons Alfort, France; [Hauer, Amandine; Cochard, Thierry; Biet, Franck] INRA, UMR1282, F-37380 Nouzilly, France; [Godreuil, Sylvain] INSERM, Infect VIH & Agents Tropisme Cutaneomuqueux Patho, Montpellier, France; [Godreuil, Sylvain] Hop Arnaud de Villeneuve, Ctr Hosp Reg Univ Montpellier, Dept Bacteriol Virol, Montpellier, France; [Banuls, Anne-Laure] Univ Montpellier I, MIVEGEC, UMR IRD CNRS 5290 224, Ctr IRD, Montpellier, France; [Banuls, Anne-Laure] Univ Montpellier 2, MIVEGEC, UMR IRD CNRS 5290 224, Ctr IRD, Montpellier, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Boschiroli, ML (corresponding author), Univ Paris Est, Lab Natl Reference Tuberculose, Unite Zoonoses Bacteriennes, Lab Sante Anim,ANSES, Maisons Alfort, France.	maria-laura.boschiroli@anses.fr	Boschiroli, Maria Laura/AAR-3319-2021; Biet, Franck/ABA-4151-2021	Biet, Franck/0000-0001-8425-6158; Banuls, Anne-Laure/0000-0002-2106-8667; godreuil, sylvain/0000-0003-3436-0082	CNRSMIE project	CNRSMIE project	This work was partly funded by a CNRSMIE project (MLB, ALB and SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The rest of the funding was internal to the authors' organization.	Allix C, 2006, J CLIN MICROBIOL, V44, P1951, DOI 10.1128/JCM.01775-05; Amanfu W, 2006, TUBERCULOSIS, V86, P330, DOI 10.1016/j.tube.2006.01.007; [Anonymous], 2000, EUR COMMUN J L, V176, P51; Aranaz A, 1996, J CLIN MICROBIOL, V34, P2734, DOI 10.1128/JCM.34.11.2734-2740.1996; Bekara ME, 2014, TRANSBOUND EMERG DIS, DOI [10.1111/tbed.12310, DOI 10.1111/TBED.12310]; Berg S, 2014, TRENDS MICROBIOL, V22, P552, DOI 10.1016/j.tim.2014.08.007; Berg S, 2011, J BACTERIOL, V193, P670, DOI 10.1128/JB.00750-10; Biek R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003008; Boniotti MB, 2009, J CLIN MICROBIOL, V47, P636, DOI 10.1128/JCM.01192-08; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Dommergues L, 2012, TRANSBOUND EMERG DIS, V59, P292, DOI 10.1111/j.1865-1682.2011.01269.x; Fitzgerald SD, 2013, VET PATHOL, V50, P488, DOI 10.1177/0300985812467472; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Gonzalo-Asensio J, 2014, P NATL ACAD SCI USA, V111, P11491, DOI 10.1073/pnas.1406693111; Gordejo FJR, 2006, VET MICROBIOL, V112, P101, DOI 10.1016/j.vetmic.2005.11.034; Haddad N, 2001, J CLIN MICROBIOL, V39, P3623, DOI 10.1128/JCM.39.10.3623-3632.2001; Henault S, 2006, DEV BIOLOGICALS, V126, P123; Humblet MF, 2009, VET RES, V40, DOI 10.1051/vetres/2009033; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Joshi D, 2012, J CLIN MICROBIOL, V50, P3853, DOI 10.1128/JCM.01499-12; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kohl TA, 2014, J CLIN MICROBIOL, V52, P2479, DOI 10.1128/JCM.00567-14; le Roex N, 2013, PHYSIOL GENOMICS, V45, P631, DOI 10.1152/physiolgenomics.00061.2013; Michel AL, 2010, VET MICROBIOL, V140, P371, DOI 10.1016/j.vetmic.2009.08.029; Muller B, 2013, EMERG INFECT DIS, V19, P899, DOI 10.3201/eid1906.120543; Muller B, 2009, J BACTERIOL, V191, P1951, DOI 10.1128/JB.01590-08; [OIE OIE], 2012, MAN DIAGN TESTS VACC, P674; Palmer Mitchell V., 2012, Veterinary Medicine International, P236205, DOI 10.1155/2012/236205; Payne A, 2013, EUR J WILDLIFE RES, V59, P331, DOI 10.1007/s10344-012-0678-3; Richomme C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077842; Richomme C, 2010, J WILDLIFE DIS, V46, P627, DOI 10.7589/0090-3558-46.2.627; Rodriguez S, 2010, VET MICROBIOL, V141, P89, DOI 10.1016/j.vetmic.2009.08.007; Rodriguez-Campos S, 2014, RES VET SCI, DOI [10.1016/j.rvsc.2014.12.013, DOI 10.1016/J.RVSC.2014.12.013]; Rodriguez-Campos S, 2013, J CLIN MICROBIOL, V51, P3658, DOI 10.1128/JCM.01271-13; Rodriguez-Campos S, 2012, INFECT GENET EVOL, V12, P866, DOI 10.1016/j.meegid.2011.09.004; Roring S, 2002, J CLIN MICROBIOL, V40, P2126, DOI 10.1128/JCM.40.6.2126-2133.2002; Schiller I, 2011, VET MICROBIOL, V151, P153, DOI 10.1016/j.vetmic.2011.02.039; Skuce RA, 2005, VET REC, V157, P501, DOI 10.1136/vr.157.17.501; Smith NH, 2006, NAT REV MICROBIOL, V4, P670, DOI 10.1038/nrmicro1472; Smith NH, 2012, INFECT GENET EVOL, V12, P857, DOI 10.1016/j.meegid.2011.09.007; Smith NH, 2011, INFECT GENET EVOL, V11, P1340, DOI 10.1016/j.meegid.2011.04.027; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Thoen C, 2006, VET MICROBIOL, V112, P339, DOI 10.1016/j.vetmic.2005.11.047; Torgerson PR, 2010, TRENDS MICROBIOL, V18, P67, DOI 10.1016/j.tim.2009.11.002; Wright DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074503; Zanella G, 2008, J WILDLIFE DIS, V44, P99, DOI 10.7589/0090-3558-44.1.99; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0	47	55	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117103	10.1371/journal.pone.0117103	http://dx.doi.org/10.1371/journal.pone.0117103			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658691	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900101
J	Hundt, J; Li, ZB; Liu, Q				Hundt, Jana; Li, Zhubing; Liu, Qiang			The Inhibitory Effects of Anacardic Acid on Hepatitis C Virus Life Cycle	PLOS ONE			English	Article							HISTONE ACETYLTRANSFERASE; CORE PROTEIN; SUMOYLATION; SUMO; APOPTOSIS; PRODUCTS; NUCLEAR; PATHWAY; ALPHA; ASSAY	Hepatitis C virus (HCV) is a small positive-sense single-stranded RNA virus that causes severe liver diseases. Current anti-HCV therapies involving direct-acting antivirals have significantly enhanced efficacy in comparison to traditional interferon and ribavirin combination. However, further improvement is needed to eradicate HCV. Anacardic acid (AnA) is a phytochemical compound that can inhibit the activity of various cellular enzymes including histone acetyltransferases (HATs). In this study, we investigated the effects of AnA on different phases of HCV life cycle. Our data showed that AnA can inhibit HCV entry, replication, translation, and virion secretion in a dose-dependent manner with no measurable effects on cell viability. In addition, we showed that two HAT inhibitors and knocking down HAT (PCAF) by RNAi can reduce HCV replication, suggesting a mechanism of AnA's inhibitory effects on HCV. Elucidation of the AnA-mediated inhibitory mechanism should facilitate the development of new drug candidates for HCV infection.	[Hundt, Jana] Univ Saskatchewan, VIDO InterVac, Saskatoon, SK, Canada; [Li, Zhubing; Liu, Qiang] Univ Saskatchewan, Vaccinol & Immunotherapeut Program, VIDO InterVac, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Liu, Q (corresponding author), Univ Saskatchewan, Vaccinol & Immunotherapeut Program, VIDO InterVac, Saskatoon, SK, Canada.	qiang.liu@usask.ca			Science and Technology Department of Jiangsu Province [BL2014025]; Jiangsu Province Department of Health [F201305]; Wuxi Municipal Hospital Management Center in China [YGZZ1107, YGZXL1317]	Science and Technology Department of Jiangsu Province; Jiangsu Province Department of Health; Wuxi Municipal Hospital Management Center in China	The present study was supported by grants: BL2014025 from Science and Technology Department of Jiangsu Province, F201305 from Jiangsu Province Department of Health, YGZZ1107 and YGZXL1317 from Wuxi Municipal Hospital Management Center in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argentini C, 2009, FUTURE MICROBIOL, V4, P359, DOI [10.2217/fmb.09.8, 10.2217/FMB.09.8]; Ashfaq UA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-161; Assis DN, 2012, CLIN PHARMACOL THER, V92, P294, DOI 10.1038/clpt.2012.103; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Baugh JM, 2013, ANTIVIR RES, V100, P555, DOI 10.1016/j.antiviral.2013.09.020; Bose SK, 2014, J VIROL, V88, P4195, DOI 10.1128/JVI.03327-13; Bradrick SS, 2006, NUCLEIC ACIDS RES, V34, P1293, DOI 10.1093/nar/gkl019; Costi R, 2007, J MED CHEM, V50, P1973, DOI 10.1021/jm060943s; Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009; Ge XJ, 2009, MOL BIOL CELL, V20, P419, DOI 10.1091/mbc.E08-08-0792; Gomez-Gonzalo M, 2004, VIROLOGY, V328, P120, DOI 10.1016/j.virol.2004.06.044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hemshekhar M, 2012, BASIC CLIN PHARMACOL, V110, P122, DOI 10.1111/j.1742-7843.2011.00833.x; Hussar DA, 2014, J AM PHARM ASSOC, V54, P202, DOI 10.1331/JAPhA.2014.14513; ITOKAWA H, 1987, CHEM PHARM BULL, V35, P3016; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jothimani D, 2013, INDIAN J GASTROENTER, V32, P71, DOI 10.1007/s12664-012-0254-5; KUBO I, 1994, J NAT PROD, V57, P545, DOI 10.1021/np50106a021; Kusio-Kobialka M, 2013, ANTI-CANCER AGENT ME, V13, P762; Lee HS, 2014, J VIRAL HEPATITIS, V21, pE108, DOI 10.1111/jvh.12241; Li QS, 2013, NAT MED, V19, P722, DOI 10.1038/nm.3190; Lindenbach BD, 2013, CURR TOP MICROBIOL, V369, P199, DOI 10.1007/978-3-642-27340-7_8; Maasoumy B, 2012, BEST PRACT RES CL GA, V26, P401, DOI 10.1016/j.bpg.2012.09.009; Mamidyala SK, 2013, BIOORG MED CHEM LETT, V23, P1667, DOI 10.1016/j.bmcl.2013.01.074; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Muroi H, 1996, J APPL BACTERIOL, V80, P387, DOI 10.1111/j.1365-2672.1996.tb03233.x; Olmstead AD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002468; Ortega AGO, 1999, J ETHNOPHARMACOL, V68, P109, DOI 10.1016/S0378-8741(99)00047-1; Park WJ, 2012, MOLECULES, V17, P13116, DOI 10.3390/molecules171113116; Pawlotsky JM, 2013, CURR TOP MICROBIOL, V369, P321, DOI 10.1007/978-3-642-27340-7_13; Phan T, 2009, J VIROL, V83, P8379, DOI 10.1128/JVI.00891-09; Qiao L, 2013, BIOCHEM BIOPH RES CO, V432, P643, DOI 10.1016/j.bbrc.2013.02.030; Rea AI, 2003, FITOTERAPIA, V74, P732, DOI 10.1016/j.fitote.2003.08.007; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shukla P, 2010, J MED VIROL, V82, P783, DOI 10.1002/jmv.21660; Sung B, 2008, BLOOD, V111, P4880, DOI 10.1182/blood-2007-10-117994; Trevisan MTS, 2006, FOOD CHEM TOXICOL, V44, P188, DOI 10.1016/j.fct.2005.06.012; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Wimmer P, 2012, J VIROL, V86, P642, DOI 10.1128/JVI.06227-11; Winder T, 2010, GASTROENTEROLOGY, V138, P2163, DOI 10.1053/j.gastro.2010.02.005; Wisastra R, 2012, BIOORGAN MED CHEM, V20, P5027, DOI 10.1016/j.bmc.2012.06.019; Wu YY, 2011, J PHARMACOL EXP THER, V339, P403, DOI 10.1124/jpet.111.181891	45	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117514	10.1371/journal.pone.0117514	http://dx.doi.org/10.1371/journal.pone.0117514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658101	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900169
J	Kaiser, ML; Romisch, K				Kaiser, Marie-Luise; Roemisch, Karin			Proteasome 19S RP Binding to the Sec61 Channel Plays a Key Role in ERAD	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; MISFOLDED SECRETORY PROTEIN; TRANSLOCATION; DEGRADATION; YEAST; SUBSTRATE; UBIQUITIN; RETROTRANSLOCATION; IDENTIFICATION; PREDICTION	Import of secretory proteins into the Endoplasmic Reticulum (ER) is an established function of the Sec61 channel. The contribution of the Sec61 channel to export of misfolded proteins from the ER for degradation by proteasomes is still controversial, but the proteasome 19S regulatory particle (RP) is necessary and sufficient for extraction of specific misfolded proteins from the ER, and binds directly to the Sec61 channel. In this work we have identified an import-competent sec61 mutant, S353C, carrying a point mutation in ER-lumenal loop 7 which reduces affinity of the cytoplasmic face of the Sec61 channel for the 19S RP. This indicates that the interaction between the 19S RP and the Sec61 channel is dependent on conformational changes in Sec61p hinging on loop 7. The sec61-S353C mutant had no measurable ER import defects and did not cause ER stress in intact cells, but reduced ER-export of a 19S RP-dependent misfolded protein when proteasomes were limiting in a cell-free assay. Our data suggest that the interaction between the 19S RP and the Sec61 channel is essential for the export of specific substrates from the ER to the cytosol for proteasomal degradation.	[Kaiser, Marie-Luise; Roemisch, Karin] Univ Saarland, Dept Microbiol, Fac Nat Sci & Technol 8, D-66123 Saarbrucken, Germany	Saarland University	Romisch, K (corresponding author), Univ Saarland, Dept Microbiol, Fac Nat Sci & Technol 8, D-66123 Saarbrucken, Germany.	k.roemisch@mx.uni-saarland.de	Römisch, Karin/AAO-1210-2021	Römisch, Karin/0000-0003-0415-6558	Saarland University	Saarland University	This work was supported by core research funding of the Saarland University to KR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Dudek J, 2014, J MOL BIOL, DOI [10.1016/j.jmb.2014.12.016, DOI 10.1016/J.JMB.2014.12.016]; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Isakov E, 2011, J BIOL CHEM, V286, P30274, DOI 10.1074/jbc.M111.240309; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kalies KU, 2005, EMBO J, V24, P2284, DOI 10.1038/sj.emboj.7600731; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Levy R, 2001, J BIOL CHEM, V276, P2340, DOI 10.1074/jbc.M004867200; Lloyd DJ, 2010, DIABETES, V59, P460, DOI 10.2337/db08-1362; MAYINGER P, 1993, EMBO J, V12, P659, DOI 10.1002/j.1460-2075.1993.tb05699.x; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Morris LL, 2014, J BIOL CHEM, V289, P19053, DOI 10.1074/jbc.M114.576652; Neuhof A, 1998, MOL BIOL CELL, V9, P103, DOI 10.1091/mbc.9.1.103; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Ng WY, 2007, J CELL SCI, V120, P682, DOI 10.1242/jcs.03351; Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720; Pilon M, 1998, MOL BIOL CELL, V9, P3455, DOI 10.1091/mbc.9.12.3455; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Prajapati RS, 2007, PROTEINS, V66, P480, DOI 10.1002/prot.21215; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Romisch K, 2003, J CELL SCI, V116, P2875, DOI 10.1242/jcs.00597; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Servas C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082058; Sharon M, 2006, PLOS BIOL, V4, P1314, DOI 10.1371/journal.pbio.0040267; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Tretter T, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-56; Trueman SF, 2011, MOL BIOL CELL, V22, P2983, DOI 10.1091/mbc.E11-01-0070; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Wahlman J, 2007, CELL, V129, P943, DOI 10.1016/j.cell.2007.03.046; Wheeler MC, 2012, BIOCHEM BIOPH RES CO, V427, P768, DOI 10.1016/j.bbrc.2012.09.136; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a	59	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117260	10.1371/journal.pone.0117260	http://dx.doi.org/10.1371/journal.pone.0117260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658429	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900126
J	Liu, WH; Wang, T; Yan, HT; Chen, T; Xu, C; Ye, P; Zhang, N; Liu, ZC; Tang, LJ				Liu, Wei-hui; Wang, Tao; Yan, Hong-tao; Chen, Tao; Xu, Chuan; Ye, Ping; Zhang, Ning; Liu, Zheng-cai; Tang, Li-jun			Predictors of Percutaneous Catheter Drainage (PCD) after Abdominal Paracentesis Drainage (APD) in Patients with Moderately Severe or Severe Acute Pancreatitis along with Fluid Collections	PLOS ONE			English	Article							INFECTED NECROTIZING PANCREATITIS; STEP-UP APPROACH; ATLANTA CLASSIFICATION; NECROSECTOMY; MORTALITY; MANAGEMENT; NECROSIS; DISEASE	Aims Although we previously demonstrated abdominal paracentesis drainage (APD) preceding percutaneous catheter drainage (PCD) as the central step for treating patients with moderately severe (MSAP) or severe acute pancreatitis (SAP), the predictors leading to PCD after APD have not been studied. Methods Consecutive patients with MSAP or SAP were recruited between June 2011 and June 2013. As a step-up approach, all patients initially received medical management, later underwent ultrasound-guided APD before PCD, if necessary, followed by endoscopic necrosectomy through the path formed by PCD. APD primarily targeted fluid in the abdominal or pelvic cavities, whereas PCD aimed at (peri)pancreatic fluid. Results Of the 92 enrolled patients, 40 were managed with APD alone and 52 received PCD after APD (14 required necrosectomy after initial PCD). The overall mortality was 6.5%. Univariate analysis showed that among the 20 selected parameters, 13 factors significantly affected PCD intervention after APD. Multivariate analysis revealed that infected (peri)pancreatic collections (P = -0.001), maximum extent of necrosis of more than 30% of the pancreas (P = -0.024), size of the largest necrotic peri(pancreatic) collection (P = -0.007), and reduction of (peri) pancreatic fluid collections by <50% after APD (P = -0.008) were all independent predictors of PCD. Conclusions Infected (peri)pancreatic collections, a largest necrotic peri(pancreatic) collection of more than 100 ml, and reduction of (peri) pancreatic fluid collections by <50% after APD could effectively predict the need for PCD in the early course of the disease.	[Liu, Wei-hui; Wang, Tao; Yan, Hong-tao; Chen, Tao; Xu, Chuan; Ye, Ping; Liu, Zheng-cai; Tang, Li-jun] Chengdu Mil Gen Hosp, Gen Surg Ctr, Chengdu 610083, Sichuan Provinc, Peoples R China; [Zhang, Ning] Xijing Hosp, Gen Surg Ctr, Xian 710032, Shanxi Province, Peoples R China	Air Force Military Medical University	Liu, WH (corresponding author), Chengdu Mil Gen Hosp, Gen Surg Ctr, Chengdu 610083, Sichuan Provinc, Peoples R China.	audiliu12@163.com; whjtlj1251@163.com		XU, CHUAN/0000-0002-5320-2277	National Natural Science Foundation of China [81302168]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81302168). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Thank Dr. Li-na Ren for statistical assistance.	Ai XB, 2010, J GASTROENTEROL, V45, P77, DOI 10.1007/s00535-009-0129-4; Babu RY, 2013, ANN SURG, V257, P737, DOI 10.1097/SLA.0b013e318269d25d; Bakker OJ, 2012, JAMA-J AM MED ASSOC, V307, P1053, DOI 10.1001/jama.2012.276; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Baudin G, 2012, AM J ROENTGENOL, V199, P192, DOI 10.2214/AJR.11.6984; Bausch D, 2012, SURGERY, V152, pS128, DOI 10.1016/j.surg.2012.05.021; Berzin TM, 2008, J VASC INTERV RADIOL, V19, P1002, DOI 10.1016/j.jvir.2008.03.002; Besselink Marc G H, 2006, BMC Surg, V6, P6, DOI 10.1186/1471-2482-6-6; Brun A, 2011, J CLIN GASTROENTEROL, V45, P614, DOI 10.1097/MCG.0b013e318213ef3e; Carter CR, 2000, ANN SURG, V232, P175, DOI 10.1097/00000658-200008000-00004; Cho JH, 2009, GASTROINTEST ENDOSC, V69, P1244, DOI 10.1016/j.gie.2008.10.017; Cui ML, 2013, DIG DIS SCI; de-Madaria Enrique, 2012, Gastroenterol Hepatol, V35 Suppl 1, P98, DOI 10.1016/S0210-5705(12)70041-9; de-Madaria Enrique, 2011, Gastroenterol Hepatol, V34 Suppl 2, P89, DOI 10.1016/S0210-5705(11)70027-9; Escourrou J, 2008, ANN SURG, V248, P1074, DOI 10.1097/SLA.0b013e31818b728b; Freeny PC, 1998, AM J ROENTGENOL, V170, P969, DOI 10.2214/ajr.170.4.9530046; Hartwig Werner, 2002, J Hepatobiliary Pancreat Surg, V9, P429, DOI 10.1007/s005340200053; Horvath K, 2010, ARCH SURG-CHICAGO, V145, P817, DOI 10.1001/archsurg.2010.178; Jurgensen C, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-48; Lerch MM, 2013, GUT, V62, P2, DOI 10.1136/gutjnl-2012-303724; Liu WH, 2014, CRIT CARE MED; Lu CW, 2013, J GASTROENTEROL, V48, P374, DOI 10.1007/s00535-012-0636-6; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Negm AA, 2013, GASTROINTEST ENDOSC, V78, P303, DOI 10.1016/j.gie.2013.03.001; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Petrov MS, 2010, GASTROENTEROLOGY, V139, P813, DOI 10.1053/j.gastro.2010.06.010; Tang Chun, 2011, Front Med, V5, P302, DOI 10.1007/s11684-011-0145-7; Thandassery RB, 2013, DIG DIS SCI; Uhl W, 2003, PANCREATOLOGY, V3, DOI 10.1159/000067684; van Baal MC, 2011, BRIT J SURG, V98, P18, DOI 10.1002/bjs.7304; van Brunschot S, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-161; van Santvoort HC, 2011, GASTROENTEROLOGY, V141, P1254, DOI 10.1053/j.gastro.2011.06.073; van Santvoort HC, 2010, NEW ENGL J MED, V362, P1491, DOI 10.1056/NEJMoa0908821; Warshaw AL, 2010, NEW ENGL J MED, V362, P1535, DOI 10.1056/NEJMe1001835; Will U, 2012, PANCREAS, V41, P652, DOI 10.1097/MPA.0b013e31823d7b1e; Wronski M, 2013, SURG ENDOSC, V27, P2841, DOI 10.1007/s00464-013-2831-9; Zaheer A, 2013, ABDOM IMAGING, V38, P125, DOI 10.1007/s00261-012-9908-0; Zerem E, 2011, DIGEST LIVER DIS, V43, P478, DOI 10.1016/j.dld.2011.02.020; Zerem E, 2009, SURG ENDOSC, V23, P2770, DOI 10.1007/s00464-009-0487-2	39	13	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115348	10.1371/journal.pone.0115348	http://dx.doi.org/10.1371/journal.pone.0115348			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659143	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900015
J	Liu, YF; Li, DW; Yan, L; Huang, HW				Liu, Yifei; Li, Dawei; Yan, Ling; Huang, Hongwen			The Microgeographical Patterns of Morphological and Molecular Variation of a Mixed Ploidy Population in the Species Complex Actinidia chinensis	PLOS ONE			English	Article							KIWIFRUIT ACTINIDIA; INTROGRESSION; HYBRIDIZATION; COEXISTENCE; ADAPTATION; DIVERGENCE; DIVERSITY; CYTOTYPES; SELECTION; INVASION	Polyploidy and hybridization are thought to have significant impacts on both the evolution and diversification of the genus Actinidia, but the structure and patterns of morphology and molecular diversity relating to ploidy variation of wild Actinidia plants remain much less understood. Here, we examine the distribution of morphological variation and ploidy levels along geographic and environmental variables of a large mixed-ploidy population of the A. chinensis species complex. We then characterize the extent of both genetic and epigenetic diversity and differentiation exhibited between individuals of different ploidy levels. Our results showed that while there are three ploidy levels in this population, hexaploids were constituted the majority (70.3%). Individuals with different ploidy levels were microgeographically structured in relation to elevation and extent of niche disturbance. The morphological characters examined revealed clear difference between diploids and hexaploids, however tetraploids exhibited intermediate forms. Both genetic and epigenetic diversity were high but the differentiation among cytotypes was weak, suggesting extensive gene flow and/or shared ancestral variation occurred in this population even across ploidy levels. Epigenetic variation was clearly correlated with changes in altitudes, a trend of continuous genetic variation and gradual increase of epigenomic heterogeneities of individuals was also observed. Our results show that complex interactions between the locally microgeographical environment, ploidy and gene flow impact A. chinensis genetic and epigenetic variation. We posit that an increase in ploidy does not broaden the species habitat range, but rather permits A. chinensis adaptation to specific niches.	[Liu, Yifei; Huang, Hongwen] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Li, Dawei; Yan, Ling] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specially A, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Huang, HW (corresponding author), Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	huanghw@mail.scbg.ac.cn		LI, Dawei/0000-0002-5138-4492	National Natural Science Foundation of China [30900119]; Youth Innovation Promotion Association of the Chinese Academy of Sciences; National Actinidia Germplasm Repository in Wuhan Botanical Garden	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association of the Chinese Academy of Sciences; National Actinidia Germplasm Repository in Wuhan Botanical Garden	This work was supported by the National Natural Science Foundation of China grant no. 30900119 and also supported by the Youth Innovation Promotion Association of the Chinese Academy of Sciences, and the National Actinidia Germplasm Repository in Wuhan Botanical Garden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birchler JA, 2010, PLANT CELL, V22, P2105, DOI 10.1105/tpc.110.076133; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Chapman MA, 2010, NEW PHYTOL, V186, P63, DOI 10.1111/j.1469-8137.2009.03091.x; Chat J, 2004, AM J BOT, V91, P736, DOI 10.3732/ajb.91.5.736; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Cui Z.X., 2002, ACTINIDIA CHINA; Doyle J. J., 1987, PHYTOCHEM B, P11; Duchoslav M, 2010, ANN BOT-LONDON, V105, P719, DOI 10.1093/aob/mcq035; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Ferguson A. R., 2007, Horticultural Reviews, V33, P1, DOI 10.1002/9780470168011.ch1; Garnier S, 2004, MOL ECOL, V13, P1883, DOI 10.1111/j.1365-294X.2004.02212.x; Grativol C, 2012, BBA-GENE REGUL MECH, V1819, P176, DOI 10.1016/j.bbagrm.2011.08.010; He ZC, 2005, BOT J LINN SOC, V147, P369, DOI 10.1111/j.1095-8339.2005.00372.x; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; Huang SX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3640; Jackson S, 2010, CURR OPIN PLANT BIOL, V13, P153, DOI 10.1016/j.pbi.2009.11.004; Kliber A, 2005, EVOLUTION, V59, P1900; Kolar F, 2009, ANN BOT-LONDON, V103, P963, DOI 10.1093/aob/mcp016; Levin D. A., 1975, Taxon, V24, P35, DOI 10.2307/1218997; Li DW, 2010, BOT J LINN SOC, V164, P72, DOI 10.1111/j.1095-8339.2010.01073.x; Li DW, 2010, NEW ZEAL J CROP HORT, V38, P137, DOI 10.1080/01140671.2010.482966; Li JQ, 2002, SYST BOT, V27, P408; Li JQ, 2007, FLORA CHINA, V12, P334, DOI DOI 10.3233/BME-141227; Liu YF, 2010, TREE GENET GENOMES, V6, P801, DOI 10.1007/s11295-010-0293-y; Madlung A, 2013, HEREDITY, V110, P99, DOI 10.1038/hdy.2012.79; MANTEL N, 1967, CANCER RES, V27, P209; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Petit C, 1999, EVOL ECOL, V13, P45, DOI 10.1023/A:1006534130327; Pinheiro F, 2010, MOL ECOL, V19, P3981, DOI 10.1111/j.1365-294X.2010.04780.x; R DCT, 2011, R LANG ENV STAT COMP, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Ramsey J, 2008, EVOLUTION, V62, P639, DOI 10.1111/j.1558-5646.2007.00264.x; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Richards CL, 2012, ECOL LETT, V15, P1016, DOI 10.1111/j.1461-0248.2012.01824.x; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Rieseberg LH, 2004, NEW PHYTOL, V161, P3; Roulin A, 2013, PLANT J, V73, P143, DOI 10.1111/tpj.12026; Soltis DE, 2007, TAXON, V56, P13, DOI 10.2307/25065732; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Sonnleitner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078959; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; Travnicek P, 2011, ANN BOT-LONDON, V107, P77, DOI 10.1093/aob/mcq217; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Weigel D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-249; Weiss H, 2002, NEW PHYTOL, V156, P85, DOI 10.1046/j.1469-8137.2002.00500.x; Zhang Tian, 2007, Shengwu Duoyangxing, V15, P1, DOI 10.1360/biodiv.060277	47	11	11	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117596	10.1371/journal.pone.0117596	http://dx.doi.org/10.1371/journal.pone.0117596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658107	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900187
J	Loo, LWM; Fong, AYW; Cheng, I; Le Marchand, L				Loo, Lenora W. M.; Fong, Aaron Y. W.; Cheng, Iona; Le Marchand, Loic			In Silico Functional Pathway Annotation of 86 Established Prostate Cancer Risk Variants	PLOS ONE			English	Article							LONG-RANGE INTERACTION; NONCODING RNA; ANDROGEN; TRANSCRIPTION; EXPRESSION; RESOURCE; BINDING; GENE; MYC	Heritability is one of the strongest risk factors of prostate cancer, emphasizing the importance of the genetic contribution towards prostate cancer risk. To date, 86 established prostate cancer risk variants have been identified by genome-wide association studies (GWAS). To determine if these risk variants are located near genes that interact together in biological networks or pathways contributing to prostate cancer initiation or progression, we generated gene sets based on proximity to the 86 prostate cancer risk variants. We took two approaches to generate gene lists. The first strategy included all immediate flanking genes, up-and downstream of the risk variant, regardless of distance from the index variant, and the second strategy included genes closest to the index GWAS marker and to variants in high LD (r(2) >= 0.8 in Europeans) with the index variant, within a 100 kb window up-and downstream. Pathway mapping of the two gene sets supported the importance of the androgen receptor-mediated signaling in prostate cancer biology. In addition, the hedgehog andWnt/beta-catenin signaling pathways were identified in pathway mapping for the flanking gene set. We also used the HaploReg resource to examine the 86 risk loci and variants high LD (r(2) >= 0.8) for functional elements. We found that there was a 12.8 fold (p = 2.9 x 10(-4)) enrichment for enhancer motifs in a stem cell line and a 4.4 fold (p = 1.1 x 10(-3)) enrichment of DNase hypersensitivity in a prostate adenocarcinoma cell line, indicating that the risk and correlated variants are enriched for transcriptional regulatory motifs. Our pathway-based functional annotation of the prostate cancer risk variants highlights the potential regulatory function that GWAS risk markers, and their highly correlated variants, exert on genes. Our study also shows that these genes may function cooperatively in key signaling pathways in prostate cancer biology.	[Loo, Lenora W. M.; Fong, Aaron Y. W.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Cheng, Iona] Canc Prevent Inst Calif, Epidemiol Res Dept, Fremont, CA USA	Cancer Research Center of Hawaii; University of Hawaii System; Cancer Prevention Institute of California	Loo, LWM (corresponding author), Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA.	lloo@cc.hawaii.edu						Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Culig Z, 2006, J CELL BIOCHEM, V99, P373, DOI 10.1002/jcb.20898; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Feau C, 2009, ACS CHEM BIOL, V4, P834, DOI 10.1021/cb900143a; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Goh CL, 2012, J INTERN MED, V271, P353, DOI 10.1111/j.1365-2796.2012.02511.x; Gowda PS, 2013, MOL CANCER RES, V11, P1448, DOI 10.1158/1541-7786.MCR-13-0278; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hazelett DJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004102; Hindorff L., 2013, CATALOG PUBLISHED GE; Kicinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027130; Kim T, 2014, P NATL ACAD SCI USA, V111, P4173, DOI 10.1073/pnas.1400350111; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Manser C, 2012, ONCOGENE, V31, P2773, DOI 10.1038/onc.2011.437; Martens-Uzunova ES, 2014, EUR UROL, V65, P1140, DOI 10.1016/j.eururo.2013.12.003; Martin JJ, 2001, PROSTATE, V46, P11; Mita P, 2011, MOL CELL BIOL, V31, P3639, DOI 10.1128/MCB.05429-11; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Puri C, 2010, ONCOGENE, V29, P188, DOI 10.1038/onc.2009.328; Rattray M, 2012, J NEUROCHEM, V121, P327, DOI 10.1111/j.1471-4159.2012.07654.x; Richards TJ, 2012, AM J PHYSIOL-LUNG C, V302, pL746, DOI 10.1152/ajplung.00319.2011; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072; Schmidt LJ, 2013, CURR DRUG TARGETS, V14, P401; Shin S, 2013, ONCOL REP, V29, P306, DOI 10.3892/or.2012.2079; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Xu LL, 2000, GENOMICS, V66, P257, DOI 10.1006/geno.2000.6214	37	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117873	10.1371/journal.pone.0117873	http://dx.doi.org/10.1371/journal.pone.0117873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658610	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900235
J	Nissen, KB; Haugaard-Kedstrom, LM; Wilbek, TS; Nielsen, LS; Aberg, E; Kristensen, AS; Bach, A; Jemth, P; Stromgaard, K				Nissen, Klaus B.; Haugaard-Kedstrom, Linda M.; Wilbek, Theis S.; Nielsen, Line S.; Aberg, Emma; Kristensen, Anders S.; Bach, Anders; Jemth, Per; Stromgaard, Kristian			Targeting Protein-Protein Interactions with Trimeric Ligands: High Affinity Inhibitors of the MAGUK Protein Family	PLOS ONE			English	Article							GUANYLATE KINASE PROTEINS; ISCHEMIC BRAIN-DAMAGE; POSTSYNAPTIC DENSITY; PDZ DOMAIN; FLUORESCENCE POLARIZATION; SUPERTERTIARY STRUCTURE; RECEPTOR INTERACTION; GLUTAMATE RECEPTORS; BINDING SELECTIVITY; DIMERIC INHIBITOR	PDZ domains in general, and those of PSD-95 in particular, are emerging as promising drug targets for diseases such as ischemic stroke. We have previously shown that dimeric ligands that simultaneously target PDZ1 and PDZ2 of PSD-95 are highly potent inhibitors of PSD-95. However, PSD-95 and the related MAGUK proteins contain three consecutive PDZ domains, hence we envisioned that targeting all three PDZ domains simultaneously would lead to more potent and potentially more specific interactions with the MAGUK proteins. Here we describe the design, synthesis and characterization of a series of trimeric ligands targeting all three PDZ domains of PSD-95 and the related MAGUK proteins, PSD93, SAP-97 and SAP-102. Using our dimeric ligands targeting the PDZ1-2 tandem as starting point, we designed novel trimeric ligands by introducing a PDZ3-binding peptide moiety via a cysteine-derivatized NPEG linker. The trimeric ligands generally displayed increased affinities compared to the dimeric ligands in fluorescence polarization binding experiments and optimized trimeric ligands showed low nanomolar inhibition towards the four MAGUK proteins, thus being the most potent inhibitors described. Kinetic experiments using stopped-flow spectrometry showed that the increase in affinity is caused by a decrease in the dissociation rate of the trimeric ligand as compared to the dimeric ligands, likely reflecting the lower probability of simultaneous dissociation of all three PDZ ligands. Thus, we have provided novel inhibitors of the MAGUK proteins with exceptionally high affinity, which can be used to further elucidate the therapeutic potential of these proteins.	[Nissen, Klaus B.; Haugaard-Kedstrom, Linda M.; Wilbek, Theis S.; Nielsen, Line S.; Kristensen, Anders S.; Bach, Anders; Stromgaard, Kristian] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Aberg, Emma; Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, Uppsala, Sweden	University of Copenhagen; Uppsala University	Stromgaard, K (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Univ Pk 2, Copenhagen, Denmark.	kristian.stromgaard@sund.ku.dk	Haugaard-Kedstrom, Linda/O-7121-2014; Kristensen, Anders Skov/B-4414-2009	Haugaard-Kedstrom, Linda/0000-0003-0113-6535; Kristensen, Anders Skov/0000-0001-8955-6790; Stromgaard, Kristian/0000-0003-2206-4737; Bach, Anders/0000-0003-4305-9910	University of Copenhagen	University of Copenhagen	Support was provided by the University of Copenhagen. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Aarts MM, 2003, BIOCHEM PHARMACOL, V66, P877, DOI 10.1016/S0006-2952(03)00297-1; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bach A, 2008, J MED CHEM, V51, P6450, DOI 10.1021/jm800836w; Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Bach A, 2009, ANGEW CHEM INT EDIT, V48, P9685, DOI 10.1002/anie.200904741; BOLLHAGEN R, 1994, J CHEM SOC CHEM COMM, P2559, DOI 10.1039/c39940002559; Chi CN, 2011, J BIOL CHEM, V286, P3597, DOI 10.1074/jbc.M110.190264; Chi CN, 2010, J BIOL CHEM, V285, P28252, DOI 10.1074/jbc.M110.124040; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Cook DJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003824; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Cousins SL, 2008, J NEUROCHEM, V104, P903, DOI 10.1111/j.1471-4159.2007.05067.x; Cousins SL, 2012, J BIOL CHEM, V287, P13465, DOI 10.1074/jbc.M111.292862; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; D'Mello R, 2011, MOL THER, V19, P1780, DOI 10.1038/mt.2011.42; Doucet MV, 2012, PHARMACOL THERAPEUT, V133, P218, DOI 10.1016/j.pharmthera.2011.11.005; Eildal JNN, 2015, CHEMBIOCHEM, V16, P64, DOI 10.1002/cbic.201402547; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Gardoni F, 2009, NEUROSCIENCE, V158, P324, DOI 10.1016/j.neuroscience.2008.07.068; Gardoni F, 2008, EUR J PHARMACOL, V585, P147, DOI 10.1016/j.ejphar.2008.01.048; Gianni S, 2011, J BIOL CHEM, V286, P27167, DOI 10.1074/jbc.M111.239541; Hill MD, 2012, LANCET NEUROL, V11, P942, DOI 10.1016/S1474-4422(12)70225-9; Howard MA, 2010, P NATL ACAD SCI USA, V107, P3805, DOI 10.1073/pnas.0914422107; Huang XY, 2003, J BIOMOL SCREEN, V8, P34, DOI 10.1177/1087057102239666; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim E, 2009, CURR BIOL, V19, pR723, DOI 10.1016/j.cub.2009.07.047; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; McCann JJ, 2012, P NATL ACAD SCI USA, V109, P15775, DOI 10.1073/pnas.1200254109; McCann JJ, 2011, STRUCTURE, V19, P810, DOI 10.1016/j.str.2011.02.017; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Niethammer M, 1996, J NEUROSCI, V16, P2157; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Saro D, 2007, BIOCHEMISTRY-US, V46, P6340, DOI 10.1021/bi062088k; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Sun HS, 2008, STROKE, V39, P2544, DOI 10.1161/STROKEAHA.107.506048; Tymianski M, 2011, NAT NEUROSCI, V14, P1369, DOI 10.1038/nn.2951; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Zhang J, 2013, STRUCTURE, V21, P402, DOI 10.1016/j.str.2012.12.014	47	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117668	10.1371/journal.pone.0117668	http://dx.doi.org/10.1371/journal.pone.0117668			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658767	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900200
J	Seo, H; Yoon, SJ; Yoon, J; Kim, D; Gong, Y; Kim, AR; Oh, IH; Kim, EJ; Lee, YH				Seo, Hyeyoung; Yoon, Seok-Jun; Yoon, Jihyun; Kim, Dongwoo; Gong, Younghoon; Kim, A. Rim; Oh, In-Hwan; Kim, Eun-Jung; Lee, Yo-Han			Recent Trends in Economic Burden of Acute Myocardial Infarction in South Korea	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASES; GLOBAL BURDEN; RISK-FACTORS; COST; MORTALITY; REGISTRY; STROKE; RATES; UK	In 2010, ischemic heart disease was the leading cause of disability-adjusted life-years (DALYs) worldwide. More specially, the prevalence of acute myocardial infarctions (AMI) is increasing in the aged population as mortality decreases; South Korea is no exception. This study aims to examine the economic burden of AMI in the Korean population between 2007 and 2012. AMI-related costs were assessed from a societal perspective. A prevalence-based cost-of-illness framework was used for this analysis. The subjects included all South Koreans with AMI-related ICD-10 codes (I21, I22, I23, I25.0, and I25.1). Data on direct (medical and non-medical) costs and indirect (productivity loss due to AMI-associated morbidity and mortality) costs were collected from the Korean National Health Insurance Service's claims data. The human capital approach was used to calculate indirect costs. The total estimated cost of AMI in 2012 was $1,177,649,323 USD. The majority (52%) of this amount was made up of medical costs, followed by productivity losses due to mortality and morbidity (42% of annual cost). Although the total cost declined by approximately 18% compared to 2007 ($1,427,643,854 USD), the cost of AMI in the over 60 age group amounted to 47% of the total cost of AMI in 2012. AMI led to a high economic burden in 2012. This study, which identified not only the size, but also the trends of AMI-related costs, will provide information to evaluate effects of governmental health projects and the effective allocation of public research funds.	[Seo, Hyeyoung; Yoon, Jihyun; Kim, A. Rim; Lee, Yo-Han] Korea Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea; [Yoon, Seok-Jun; Kim, Dongwoo; Gong, Younghoon] Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea; [Oh, In-Hwan] Kyung Hee Univ, Sch Med, Dept Prevent Med, Seoul, South Korea; [Kim, Eun-Jung] Korea Univ, Econ Res Inst, Seoul, South Korea	Korea University; Korea University; Korea University Medicine (KU Medicine); Kyung Hee University; Korea University	Yoon, SJ (corresponding author), Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea.	yoonsj02@korea.ac.kr	Lee, Yo Han/J-1911-2019; Oh, In Hwan/AAI-9070-2020	Lee, Yo Han/0000-0002-9631-9969; Oh, In Hwan/0000-0002-5450-9887; Yoon, Seok-Jun/0000-0003-3297-0071	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Korea Health Industry Development Institute [H113C0729]	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI))	This work was supported by the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea and by grant H113C0729 from the Korea Health Industry Development Institute. URL: https://www.khidi.or.kr/eps. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cartwright WS, 1999, J MENT HEALTH POLICY, V2, P43, DOI DOI 10.1002/(SICI)1099-176X(199903)2:1<43::AID-MHP36>3.0.CO;2-7; Chang Hoo-Sun, 2012, J Prev Med Public Health, V45, P291, DOI 10.3961/jpmph.2012.45.5.291; Cheng YW, 2005, INT J CARDIOL, V100, P47, DOI 10.1016/j.ijcard.2004.05.021; Cook C, 2014, INT J CARDIOL, V171, P368, DOI 10.1016/j.ijcard.2013.12.028; Dewey HM, 2001, STROKE, V32, P2409, DOI 10.1161/hs1001.097222; Hong Jae Seok, 2009, Korean Circ J, V39, P467, DOI 10.4070/kcj.2009.39.11.467; Kauf TL, 2006, AM HEART J, V151, P206, DOI 10.1016/j.ahj.2005.02.028; Kim HJ, 2012, J KOREAN MED ASSOC, V55, P1226, DOI 10.5124/jkma.2012.55.12.1226; Kim J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-55; Kim Y, 2013, COSTING METHODS HEAL, P2; Kolansky Daniel M, 2009, Am J Manag Care, V15, pS36; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733; Leeder S, 2004, RACE TIME CHALLENGE; Liu JLY, 2002, HEART, V88, P597, DOI 10.1136/heart.88.6.597; Luengo-Fernandez R, 2006, HEART, V92, P1384, DOI 10.1136/hrt.2005.072173; Mantovani LG, 2011, INT J CARDIOL, V150, P111, DOI 10.1016/j.ijcard.2011.04.030; Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Oh IH, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-157; Pearson-Stuttard J, 2012, HEART, V98, P1573, DOI 10.1136/heartjnl-2012-302435; Seo HY, 2013, RHEUMATOL INT, V33, P1505, DOI 10.1007/s00296-012-2554-6; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; Takii T, 2010, CIRC J, V74, P93, DOI 10.1253/circj.CJ-09-0619; Turpie AGG, 2006, AM J MANAG CARE, V12, pS430	25	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117446	10.1371/journal.pone.0117446	http://dx.doi.org/10.1371/journal.pone.0117446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658119	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900151
J	Shin, HJ; Kim, HG; Kim, MJ; Koh, H; Kim, HY; Roh, YH; Lee, MJ				Shin, Hyun Joo; Kim, Hyun Gi; Kim, Myung-Joon; Koh, Hong; Kim, Ha Yan; Roh, Yun Ho; Lee, Mi-Jung			Normal Range of Hepatic Fat Fraction on Dual- and Triple-Echo Fat Quantification MR in Children	PLOS ONE			English	Article							LIVER-DISEASE; IRON DEPOSITION; STEATOSIS; SPECTROSCOPY; VALIDATION; ULTRASOUND; SEVERITY; FIBROSIS	Objectives To evaluate hepatic fat fraction on dual-and triple-echo gradient-recalled echo MRI sequences in healthy children. Materials and Methods We retrospectively reviewed the records of children in a medical check-up clinic from May 2012 to November 2013. We excluded children with abnormal laboratory findings or those who were overweight. Hepatic fat fraction was measured on dual-and triple-echo sequences using 3T MRI. We compared fat fractions using the Wilcoxon signed rank test and the Bland-Altman 95% limits of agreement. The correlation between fat fractions and clinical and laboratory findings was evaluated using Spearman's correlation test, and the cut-off values of fat fractions for diagnosing fatty liver were obtained from reference intervals. Results In 54 children (M:F = 26: 28; 5-15 years; mean 9 years), the dual fat fraction (0.1-8.0%; median 1.6%) was not different from the triple fat fraction (0.4-6.5%; median 2.7%) (p = 0.010). The dual-and triple-echo fat fractions showed good agreement using a Bland-Altman plot (-0.6 +/- 2.8%). Eight children (14.8%) on dual-echo sequences and six (11.1%) on tripleecho sequences had greater than 5% fat fraction. From these children, six out of eight children on dual-echo sequences and four out of six children on triple-echo sequences had a 5-6% hepatic fat fraction. When using a cut-off value of a 6% fat fraction derived from a reference interval, only 3.7% of children were diagnosed with fatty liver. There was no significant correlation between clinical and laboratory findings with dual and triple-echo fat fractions. Conclusions Dual fat fraction was not different from triple fat fraction. We suggest a cut-off value of a 6% fat fraction is more appropriate for diagnosing fatty liver on both dual-and triple-echo sequences in children.	[Shin, Hyun Joo; Kim, Hyun Gi; Kim, Myung-Joon; Lee, Mi-Jung] Yonsei Univ, Coll Med, Severance Childrens Hosp, Dept Radiol, Seoul, South Korea; [Shin, Hyun Joo; Kim, Hyun Gi; Kim, Myung-Joon; Lee, Mi-Jung] Yonsei Univ, Coll Med, Severance Childrens Hosp, Res Inst Radiol Sci, Seoul, South Korea; [Koh, Hong] Yonsei Univ, Coll Med, Severance Childrens Hosp, Dept Pediat, Seoul, South Korea; [Kim, Ha Yan; Roh, Yun Ho] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, MJ (corresponding author), Yonsei Univ, Coll Med, Severance Childrens Hosp, Dept Radiol, Seoul, South Korea.	mjl1213@yuhs.ac	Shin, Hyun Joo/AAG-2016-2019	Lee, Mi-Jung/0000-0003-3244-9171; Koh, Hong/0000-0002-3660-7483; Shin, Hyun Joo/0000-0002-7462-2609; Kim, Myung-Joon/0000-0002-4608-0275	new faculty research seed money grant of Yonsei University College of Medicine [8-2013-0028]	new faculty research seed money grant of Yonsei University College of Medicine	This study was supported by a new faculty research seed money grant of Yonsei University College of Medicine for 2013 (8-2013-0028). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awai HI, 2013, CLIN GASTROENTEROL H; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Cali AMG, 2009, HEPATOLOGY, V49, P1896, DOI 10.1002/hep.22858; Cassidy FH, 2009, RADIOGRAPHICS, V29, P231, DOI 10.1148/rg.291075123; d'Assignies G, 2009, EUR RADIOL, V19, P2033, DOI 10.1007/s00330-009-1351-4; Fishbein M, 2005, J CLIN GASTROENTEROL, V39, P619, DOI 10.1097/00004836-200508000-00012; Fishbein MH, 1997, MAGN RESON IMAGING, V15, P287, DOI 10.1016/S0730-725X(96)00224-X; Fishbein MH, 2003, J PEDIATR GASTR NUTR, V36, P54, DOI 10.1097/00005176-200301000-00012; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; Guiu B, 2009, EUR RADIOL, V19, P1786, DOI 10.1007/s00330-009-1330-9; Hamer OW, 2006, RADIOGRAPHICS, V26, P1637, DOI 10.1148/rg.266065004; Lee MJ, 2013, PATHOL RES PRACT, V209, P371, DOI 10.1016/j.prp.2013.04.001; Lee SS, 2011, J MAGN RESON IMAGING, V33, P1390, DOI 10.1002/jmri.22583; Leitao HS, 2013, ACAD RADIOL, V20, P957, DOI 10.1016/j.acra.2013.05.004; Ma XZ, 2009, RADIOGRAPHICS, V29, P1253, DOI 10.1148/rg.295085186; Marchesini G, 2006, Minerva Cardioangiol, V54, P229; McPherson S, 2009, J HEPATOL, V51, P389, DOI 10.1016/j.jhep.2009.04.012; Middleton JP, 2014, CLIN PEDIAT PHILA; Pacifico L, 2011, WORLD J GASTROENTERO, V17, P3012, DOI 10.3748/wjg.v17.i25.3012; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Rinella ME, 2003, LIVER TRANSPLANT, V9, P851, DOI 10.1053/jlts.2003.50153; Schwimmer JB, 2008, CIRCULATION, V118, P277, DOI 10.1161/CIRCULATIONAHA.107.739920; Shannon A, 2011, J PEDIATR GASTR NUTR, V53, P190, DOI 10.1097/MPG.0b013e31821b4b61; Towbin AJ, 2013, MAGN RESON IMAGING C, V21, P669, DOI 10.1016/j.mric.2013.05.001; Westheim BH, 2013, J PEDIATR GASTR NUTR, V57, P638, DOI 10.1097/MPG.0b013e3182a0c7a5; Westphalen ACA, 2007, RADIOLOGY, V242, P450, DOI 10.1148/radiol.2422052024; Wu CH, 2014, J GASTROEN HEPATOL, V29, P807, DOI 10.1111/jgh.12451	28	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117480	10.1371/journal.pone.0117480	http://dx.doi.org/10.1371/journal.pone.0117480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659155	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900159
J	Stellmann, JP; Sturner, KH; Young, KL; Siemonsen, S; Friede, T; Heesen, C				Stellmann, Jan-Patrick; Stuerner, Klarissa Hanja; Young, Kim Lea; Siemonsen, Susanne; Friede, Tim; Heesen, Christoph			Regression to the Mean and Predictors of MRI Disease Activity in RRMS Placebo Cohorts - Is There a Place for Baseline-to-Treatment Studies in MS?	PLOS ONE			English	Article							REMITTING MULTIPLE-SCLEROSIS; SUBCUTANEOUS INTERFERON BETA-1A; DOUBLE-BLIND; CONTROLLED-TRIAL; CONTROLLED PHASE-3; CLINICAL-TRIALS; ORAL BG-12; MULTICENTER; FINGOLIMOD; LAQUINIMOD	Background Gadolinium-enhancing (GD+) lesions and T2 lesions are MRI outcomes for phase-2 treatment trials in relapsing-remitting Multiple Sclerosis (RRMS). Little is known about predictors of lesion development and regression-to-the-mean, which is an important aspect in early baseline-to-treatment trials. Objectives To quantify regression-to-the-mean and identify predictors of MRI lesion development in placebo cohorts. Methods 21 Phase-2 and Phase-3 trials were identified by a systematic literature research. Random-effects meta-analyses were performed to estimate development of T2 and GD+ after 6 months (phase-2) or 2 years (phase-3). Predictors of lesion development were evaluated with mixed-effect meta-regression. Results The mean number of GD+-lesions per scan was similar after 6 months (1.19, 95% CI: 0.87-1.51) and 2 years (1.19, 95% CI: 1.00-1.39). 39% of the patients were without new T2-lesion after 6 month and 19% after 2 years (95% CI: 12-25%). Mean number of baseline GD+-lesions was the best predictor for new lesions after 6 months. Conclusion Baseline GD-enhancing lesions predict evolution of Gd-and T2 lesions after 6 months and might be used to control for regression to the mean effects. Overall, proof-of-concept studies with a baseline to treatment design have to face a regression to 1.2 GD+ lesions per scan within 6 months.	[Stellmann, Jan-Patrick; Stuerner, Klarissa Hanja; Young, Kim Lea; Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & MS Inims, Hamburg, Germany; [Stellmann, Jan-Patrick; Stuerner, Klarissa Hanja; Young, Kim Lea; Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Siemonsen, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Friede, Tim] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen	Stellmann, JP (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & MS Inims, Hamburg, Germany.	j.stellmann@uke.de	Friede, Tim/ABF-1132-2021; Stellmann, Jan-Patrick/ABA-7132-2020	Friede, Tim/0000-0001-5347-7441; Stellmann, Jan-Patrick/0000-0003-2565-2833; Sturner, Klarissa Hanja/0000-0003-2199-3315; Gellissen, Susanne/0000-0002-7444-7265	NEU2 consortium; Federal Ministry of Education and Research (BMBF) [Fo0315610-0315620]	NEU2 consortium; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was funded by the NEU2 consortium, which is supported by the Federal Ministry of Education and Research (BMBF) (Fo0315610-0315620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MULT SCLER; Bech E, 2002, NEUROLOGY, V58, P31, DOI 10.1212/WNL.58.1.31; Chataway J, 2011, MULT SCLER J, V17, P81, DOI 10.1177/1352458510382129; Comi G, 2008, LANCET, V371, P2085, DOI 10.1016/S0140-6736(08)60918-6; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64; Comi G, 2012, NEW ENGL J MED, V366, P1000, DOI 10.1056/NEJMoa1104318; De Stefano N, 2012, J NEUROL SCI, V312, P97, DOI 10.1016/j.jns.2011.08.013; De Stefano N, 2010, MULT SCLER J, V16, P888, DOI 10.1177/1352458510362442; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; European Medicines Agency, 2012, GUIDELINE ON CLINICA; Fox RJ, 2012, MULT SCLER; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Friede T, 2010, METHOD INFORM MED, V49, P618, DOI 10.3414/ME09-02-0060; Friede T, 2011, STAT MED; Garren H, 2008, ANN NEUROL, V63, P611, DOI 10.1002/ana.21370; Gelman A, 2009, DATA ANALYSIS USING; Giovannoni G, 2011, LANCET NEUROL, V10, P329, DOI 10.1016/S1474-4422(11)70023-0; Gold R, 2013, LANCET, V381, P2167, DOI 10.1016/S0140-6736(12)62190-4; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Harrell Jr FE, 2010, R PACKAGE VERSION; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Kappos L, 1999, LANCET, V353, P964, DOI 10.1016/S0140-6736(98)03053-0; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; Kappos L, 2011, LANCET, V378, P1779, DOI 10.1016/S0140-6736(11)61649-8; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Martinez-Yelamos S, 2006, MULT SCLER J, V12, P826, DOI 10.1177/1352458506070820; Merrifield Alistair, 2012, N S W Public Health Bull, V23, P142, DOI 10.1071/NB11017; Miller D, 1996, MULT SCLER; Miller DH, 2012, LANCET NEUROL, V11, P131, DOI 10.1016/S1474-4422(11)70299-X; Miller DH, 1996, ANN NEUROL, V39, P6, DOI 10.1002/ana.410390104; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nicholas R, 2011, MULT SCLER; O'Connor P, 2011, NEW ENGL J MED, V365, P1293, DOI 10.1056/NEJMoa1014656; Polman Chris H, 2006, N Engl J Med, V354, P899; R Core Team, 2021, R LANGUAGE ENV STAT; Radue EW, 2012, ARCH NEUROL-CHICAGO, V69, P1259, DOI 10.1001/archneurol.2012.1051; Saida T, 2012, MULT SCLER J, V18, P1269, DOI 10.1177/1352458511435984; Schimrigk S, 2006, EUR J NEUROL, V13, P604, DOI 10.1111/j.1468-1331.2006.01292.x; Sormani MP, 2008, ANN NEUROL, V64, P428, DOI 10.1002/ana.21464; Sormani MP, 2009, ANN NEUROL, V65, P268, DOI 10.1002/ana.21606; Sormani MP, 2001, MULT SCLER, V7, P298, DOI 10.1177/135245850100700505; Stellmann JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050347; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Viechtbauer W, 2010, RES SYNTH METHODS, V1, P112, DOI 10.1002/jrsm.11; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Weinshenker BG, 1996, NEUROLOGY, V46, P1613, DOI 10.1212/WNL.46.6.1613; Zhao YS, 2008, NEUROLOGY, V70, P1092, DOI 10.1212/01.wnl.0000285426.73143.f7	47	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116559	10.1371/journal.pone.0116559	http://dx.doi.org/10.1371/journal.pone.0116559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659100	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900050
J	Bajic, D; Soiza-Reilly, M; Spalding, AL; Berde, CB; Commons, KG				Bajic, Dusica; Soiza-Reilly, Mariano; Spalding, Allegra L.; Berde, Charles B.; Commons, Kathryn G.			Endogenous Cholinergic Neurotransmission Contributes to Behavioral Sensitization to Morphine	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; NICOTINIC ACETYLCHOLINE-RECEPTORS; PERIAQUEDUCTAL GRAY; ANTINOCICEPTIVE TOLERANCE; NUCLEUS-ACCUMBENS; DOPAMINE EFFLUX; LATERODORSAL TEGMENTUM; SYNAPTIC MECHANISMS; EXCITOTOXIC LESIONS; PHYSICAL-DEPENDENCE	Neuroplasticity in the mesolimbic dopaminergic system is critical for behavioral adaptations associated with opioid reward and addiction. These processes may be influenced by cholinergic transmission arising from the laterodorsal tegmental nucleus (LDTg), a main source of acetylcholine to mesolimbic dopaminergic neurons. To examine this possibility we asked if chronic systemic morphine administration affects expression of genes in ventral and ventrolateral periaqueductal gray at the level of the LDTg using rtPCR. Specifically, we examined gene expression changes in the area of interest using Neurotransmitters and Receptors PCR array between chronic morphine and saline control groups. Analysis suggested that chronic morphine administration led to changes in expression of genes associated, in part, with cholinergic neurotransmission. Furthermore, using a quantitative immunofluorescent technique, we found that chronic morphine treatment produced a significant increase in immunolabeling of the cholinergic marker (vesicular acetylcholine transporter) in neurons of the LDTg. Finally, systemic administration of the nonselective and noncompetitive neuronal nicotinic antagonist mecamylamine (0.5 or 2 mg/kg) dose-dependently blocked the expression, and to a lesser extent the development, of locomotor sensitization. The same treatment had no effect on acute morphine antinociception, antinociceptive tolerance or dependence to chronic morphine. Taken together, the results suggest that endogenous nicotinic cholinergic neurotransmission selectively contributes to behavioral sensitization to morphine and this process may, in part, involve cholinergic neurons within the LDTg.	[Bajic, Dusica; Soiza-Reilly, Mariano; Spalding, Allegra L.; Berde, Charles B.; Commons, Kathryn G.] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Bajic, Dusica; Soiza-Reilly, Mariano; Berde, Charles B.; Commons, Kathryn G.] Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Bajic, D (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, 300 Longwood Ave, Boston, MA 02115 USA.	dusica.bajic@childrens.harvard.edu	Bajic, Dusica/GPF-9150-2022; Soiza-Reilly, Mariano/AAV-4369-2021; Soiza-Reilly, Mariano/AAO-3973-2020	Soiza-Reilly, Mariano/0000-0002-5800-865X; Bajic, Dusica/0000-0002-3943-2105; Commons, Kathryn/0000-0002-9217-5857	Foundation for Anesthesia Education and Research; Endo Pharmaceuticals; NIH [R03 DA030874, R01 DA021801]; Mayo Family Research Endowment Fund; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021801, R03DA030874] Funding Source: NIH RePORTER	Foundation for Anesthesia Education and Research; Endo Pharmaceuticals; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Family Research Endowment Fund; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Presented work was supported by Foundation for Anesthesia Education and Research, Endo Pharmaceuticals, and NIH R03 DA030874 (DB), Mayo Family Research Endowment Fund (CBB), and NIH R01 DA021801 (KGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaro A, 2007, BRAIN RES REV, V56, P283, DOI 10.1016/j.brainresrev.2007.07.014; Azam L, 2003, NEUROSCIENCE, V119, P965, DOI 10.1016/S0306-4522(03)00220-3; Bagley EE, 2011, NAT NEUROSCI, V14, P1548, DOI 10.1038/nn.2940; Bajic D, 2012, NEUROSCIENCE, V226, P165, DOI 10.1016/j.neuroscience.2012.09.028; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; BHARGAVA HN, 1976, EUR J PHARMACOL, V36, P79, DOI 10.1016/0014-2999(76)90259-4; Bhargava V. K., 2001, Indian Journal of Pharmacology, V33, P212; Blaha CD, 1996, J NEUROSCI, V16, P714; Buccafusco JJ, 2000, BRAIN RES, V852, P76, DOI 10.1016/S0006-8993(99)02197-6; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cicero TJ, 2005, J PAIN, V6, P662, DOI 10.1016/j.jpain.2005.05.004; CORNWALL J, 1990, BRAIN RES BULL, V25, P271, DOI 10.1016/0361-9230(90)90072-8; CROSSLAND J, 1984, NEUROCHEM RES, V9, P351, DOI 10.1007/BF00963983; ESPEJO EF, 1995, PSYCHOPHARMACOLOGY, V122, P122, DOI 10.1007/BF02246086; Forster GL, 2000, EUR J NEUROSCI, V12, P3596, DOI 10.1046/j.1460-9568.2000.00250.x; Forster GL, 2002, NEUROSCIENCE, V114, P817, DOI 10.1016/S0306-4522(02)00365-2; FREDERICKSON RCA, 1975, J PHARMACOL EXP THER, V193, P44; GELLERT VF, 1978, J PHARMACOL EXP THER, V205, P536; Gilmor ML, 1996, J NEUROSCI, V16, P2179; GODFREY DA, 1977, J HISTOCHEM CYTOCHEM, V25, P397, DOI 10.1177/25.6.69653; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; HARRIS LS, 1964, J PHARMACOL EXP THER, V143, P141; HARTVIG P, 1989, TRENDS PHARMACOL SCI, P75; HAYES RL, 1978, SCIENCE, V200, P343, DOI 10.1126/science.635595; HEDREEN JC, 1985, J HISTOCHEM CYTOCHEM, V33, P134, DOI 10.1177/33.2.2578498; Hikida T, 2003, P NATL ACAD SCI USA, V100, P6169, DOI 10.1073/pnas.0631749100; Hikida T, 2001, P NATL ACAD SCI USA, V98, P13351, DOI 10.1073/pnas.231488998; Holmstrand EC, 2011, BRAIN STRUCT FUNCT, V216, P331, DOI 10.1007/s00429-011-0320-2; JACQUET YF, 1976, BRAIN RES, V103, P501, DOI 10.1016/0006-8993(76)90448-0; JENSEN TS, 1986, BRAIN RES, V363, P99, DOI 10.1016/0006-8993(86)90662-1; JOHANNESSON T, 1973, ACTA PHARMACOL TOX, V33, P429; Jones SL, 1992, INITIAL PROCESSING P, P203; JOYCE EM, 1979, NEUROSCI LETT, V14, P207, DOI 10.1016/0304-3940(79)96149-4; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; KIMES AS, 1990, NEUROSCIENCE, V34, P633, DOI 10.1016/0306-4522(90)90170-9; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; KOELLE GB, 1963, SCIENCE, V141, P63, DOI 10.1126/science.141.3575.63; Lane DA, 2005, NEUROSCIENCE, V135, P227, DOI 10.1016/j.neuroscience.2005.06.014; Lane DA, 2005, BRAIN RES, V1047, P65, DOI 10.1016/j.brainres.2005.04.001; Lane DA, 2004, NEUROSCIENCE, V125, P63, DOI 10.1016/j.neuroscience.2004.01.023; Lester DB, 2010, CNS NEUROSCI THER, V16, P137, DOI 10.1111/j.1755-5949.2010.00142.x; LICHTENSTEIGER W, 1982, NEUROPHARMACOLOGY, V21, P963, DOI 10.1016/0028-3908(82)90107-1; Lodge DJ, 2006, P NATL ACAD SCI USA, V103, P5167, DOI 10.1073/pnas.0510715103; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Mandl P, 2003, NEUROCHEM RES, V28, P407, DOI 10.1023/A:1022884231313; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; Mansvelder HD, 2002, J NEUROBIOL, V53, P606, DOI 10.1002/neu.10148; Mark GP, 2011, PHYSIOL BEHAV, V104, P76, DOI 10.1016/j.physbeh.2011.04.052; MASTERS DB, 1993, ANESTHESIOLOGY, V79, P340, DOI 10.1097/00000542-199308000-00020; MCHAFFIE JG, 1991, J COMP NEUROL, V313, P113, DOI 10.1002/cne.903130109; Mena-Segovia J, 2008, BRAIN RES REV, V58, P265, DOI 10.1016/j.brainresrev.2008.02.003; Miller AD, 2002, NEUROSCIENCE, V111, P351, DOI 10.1016/S0306-4522(01)00595-4; Morgan MM, 2006, PHARMACOL BIOCHEM BE, V85, P214, DOI 10.1016/j.pbb.2006.08.003; Morgan MM, 1998, BRAIN RES, V804, P159, DOI 10.1016/S0006-8993(98)00669-6; Neugebauer NM, 2013, PHARMACOL BIOCHEM BE, V109, P77, DOI 10.1016/j.pbb.2013.04.015; Norwood AP, 2014, PSYCHOPHARMACOLOGY B; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; OAKMAN SA, 1995, J NEUROSCI, V15, P5859; Omelchenko N, 2006, J COMP NEUROL, V494, P863, DOI 10.1002/cne.20852; Omelchenko N, 2005, J COMP NEUROL, V483, P217, DOI 10.1002/cne.20417; Papke RL, 2001, J PHARMACOL EXP THER, V297, P646; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; Plone MA, 1996, PAIN, V66, P265, DOI 10.1016/0304-3959(96)03048-5; Rezayof A, 2007, EUR J PHARMACOL, V562, P92, DOI 10.1016/j.ejphar.2007.01.081; Rho B, 1998, NEUROREPORT, V9, P1283, DOI 10.1097/00001756-199805110-00004; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; RONKEN E, 1993, J NEUROCHEM, V61, P1634, DOI 10.1111/j.1471-4159.1993.tb09797.x; Rothman RB, 2008, EXP CLIN PSYCHOPHARM, V16, P458, DOI 10.1037/a0014103; Schmidt BL, 2001, NEUROSCIENCE, V106, P129, DOI 10.1016/S0306-4522(01)00264-0; Schmidt HD, 2005, EUR J PHARMACOL, V526, P65, DOI 10.1016/j.ejphar.2005.09.068; SCHOFFELMEER ANM, 1993, J PHARMACOL EXP THER, V267, P205; Shytle RD, 2002, J HUM HYPERTENS, V16, P453, DOI 10.1038/sj.jhh.1001416; Silver A, 1967, Int Rev Neurobiol, V10, P57, DOI 10.1016/S0074-7742(08)60151-8; SIUCIAK JA, 1987, BRAIN RES, V424, P311, DOI 10.1016/0006-8993(87)91476-4; SPANAGEL R, 1993, NEUROSCI LETT, V153, P232, DOI 10.1016/0304-3940(93)90329-J; Stein C, 2013, EUR J PHARMACOL, DOI [10.1016/j.ejphar.2013.10.023, DOI 10.1016/J.EJPHAR.2013.10.023]; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; STOOF JC, 1992, NEUROSCIENCE, V47, P755, DOI 10.1016/0306-4522(92)90027-Y; Tapocik JD, 2009, J NEUROSCI, V29, P5295, DOI 10.1523/JNEUROSCI.4020-08.2009; Taraschenko OD, 2005, EUR J PHARMACOL, V513, P207, DOI 10.1016/j.ejphar.2005.03.005; TAYLOR JR, 1988, PSYCHOPHARMACOLOGY, V96, P121, DOI 10.1007/BF02431544; TJON GHK, 1995, EUR J PHARMACOL, V283, P169, DOI 10.1016/0014-2999(95)00319-G; Tortorici V, 1999, BEHAV NEUROSCI, V113, P833, DOI 10.1037/0735-7044.113.4.833; Tortorici V, 2001, PAIN, V89, P237, DOI 10.1016/S0304-3959(00)00367-5; Umberg EN, 2011, PHYSIOL BEHAV, V104, P69, DOI 10.1016/j.physbeh.2011.04.045; Van den Heuvel DMA, 2008, PROG NEUROBIOL, V85, P75, DOI 10.1016/j.pneurobio.2008.01.003; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; VEZINA P, 1984, PHARMACOL BIOCHEM BE, V20, P925, DOI 10.1016/0091-3057(84)90018-2; VEZINA P, 1989, PHARMACOL BIOCHEM BE, V32, P581, DOI 10.1016/0091-3057(89)90201-3; Vezina P, 2009, NEUROPHARMACOLOGY, V56, P160, DOI 10.1016/j.neuropharm.2008.06.070; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zhou XP, 2002, J PHARMACOL EXP THER, V302, P889, DOI 10.1124/jpet.102.033548; Zhu HB, 2003, PAIN, V104, P437, DOI 10.1016/S0304-3959(03)00051-4; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	98	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117601	10.1371/journal.pone.0117601	http://dx.doi.org/10.1371/journal.pone.0117601			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647082	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600078
J	Fields, AT; Abercrombie, DL; Eng, R; Feldheim, K; Chapman, DD				Fields, Andrew T.; Abercrombie, Debra L.; Eng, Rowena; Feldheim, Kevin; Chapman, Demian D.			A Novel Mini-DNA Barcoding Assay to Identify Processed Fins from Internationally Protected Shark Species	PLOS ONE			English	Article							GENETIC IDENTIFICATION; TRADE; CONSERVATION; RECORDS; RATES	There is a growing need to identify shark products in trade, in part due to the recent listing of five commercially important species on the Appendices of the Convention on International Trade in Endangered Species (CITES; porbeagle, Lamna nasus, oceanic whitetip, Carcharhinus longimanus scalloped hammerhead, Sphyrna lewini, smooth hammerhead, S. zygaena and great hammerhead S. mokarran) in addition to three species listed in the early part of this century (whale, Rhincodon typus, basking, Cetorhinus maximus, and white, Carcharodon carcharias). Shark fins are traded internationally to supply the Asian dried seafood market, in which they are used to make the luxury dish shark fin soup. Shark fins usually enter international trade with their skin still intact and can be identified using morphological characters or standard DNA-barcoding approaches. Once they reach Asia and are traded in this region the skin is removed and they are treated with chemicals that eliminate many key diagnostic characters and degrade their DNA ("processed fins"). Here, we present a validated mini-barcode assay based on partial sequences of the cytochrome oxidase I gene that can reliably identify the processed fins of seven of the eight CITES listed shark species. We also demonstrate that the assay can even frequently identify the species or genus of origin of shark fin soup (31 out of 50 samples).	[Fields, Andrew T.; Eng, Rowena; Chapman, Demian D.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Abercrombie, Debra L.] Abercrombie & Fish, Miller Pl, NY 11764 USA; [Feldheim, Kevin] Field Museum Nat Hist, Pritzker Lab Mol Systemat & Evolut, Chicago, IL 60605 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Field Museum of Natural History (Chicago)	Chapman, DD (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	demian.chapman@stonybrook.edu		Abercrombie, Debra/0000-0002-2572-1862	Pew Charitable Trusts; Pew Fellowship Program; Roe Foundation; Pritzker Foundation	Pew Charitable Trusts; Pew Fellowship Program; Roe Foundation; Pritzker Foundation	This research was funded by The Pew Charitable Trusts (Global Shark Campaign and Ocean Science Division), the Pew Fellowship Program and the Roe Foundation (to DDC). Genetic data were collected in the Field Museum's Pritzker Laboratory for Molecular Systematics and Evolution operated with support from the Pritzker Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie D.L., 2013, VISUAL IDENTIFICATIO; Abercrombie DL, 2005, CONSERV GENET, V6, P775, DOI 10.1007/s10592-005-9036-2; Chapman DD, 2003, CONSERV GENET, V4, P415, DOI 10.1023/A:1024771215616; Clarke SC, 2006, CONSERV BIOL, V20, P201, DOI 10.1111/j.1523-1739.2005.00247.x; Dawnay N, 2007, FORENSIC SCI INT, V173, P1, DOI 10.1016/j.forsciint.2006.09.013; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Naylor GJP, 2012, B AM MUS NAT HIST, P1; Naylor GJP, 2012, CRC MAR BIOL SER, P31; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Shivji M, 2002, CONSERV BIOL, V16, P1036, DOI 10.1046/j.1523-1739.2002.01188.x; Vannuccini S., 1999, SHARK UTILIZATION MA; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wesche PL, 2004, DNA SEQUENCE, V15, P362, DOI 10.1080/10425170400008972; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	19	58	63	4	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0114844	10.1371/journal.pone.0114844	http://dx.doi.org/10.1371/journal.pone.0114844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646789	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600008
J	Michelutti, N; Wolfe, AP; Cooke, CA; Hobbs, WO; Vuille, M; Smol, JP				Michelutti, Neal; Wolfe, Alexander P.; Cooke, Colin A.; Hobbs, William O.; Vuille, Mathias; Smol, John P.			Climate Change Forces New Ecological States in Tropical Andean Lakes	PLOS ONE			English	Article							ARCTIC LAKES; HISTORY; RECORD; COMMUNITIES; CORDILLERA; VEGETATION; AMERICAN; GLACIERS; TRENDS; SHIFTS	Air temperatures in the tropical Andes have risen at an accelerated rate relative to the global average over recent decades. However, the effects of climate change on Andean lakes, which are vital to sustaining regional biodiversity and serve as an important water resource to local populations, remain largely unknown. Here, we show that recent climate changes have forced alpine lakes of the equatorial Andes towards new ecological and physical states, in close synchrony to the rapid shrinkage of glaciers regionally. Using dated sediment cores from three lakes in the southern Sierra of Ecuador, we record abrupt increases in the planktonic thalassiosiroid diatom Discostella stelligera from trace abundances to dominance within the phytoplankton. This unprecedented shift occurs against the backdrop of rising temperatures, changing atmospheric pressure fields, and declining wind speeds. Ecological restructuring in these lakes is linked to warming and/or enhanced water column stratification. In contrast to seasonally ice-covered Arctic and temperate alpine counterparts, aquatic production has not increased universally with warming, and has even declined in some lakes, possibly because enhanced thermal stability impedes the recirculation of hypolimnetic nutrients to surface waters. Our results demonstrate that these lakes have already passed important ecological thresholds, with potentially far-reaching consequences for Andean water resources.	[Michelutti, Neal; Smol, John P.] Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada; [Wolfe, Alexander P.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Cooke, Colin A.] Govt Alberta, Dept Environm & Sustainable Resource Dev, Edmonton, AB T5K 2M4, Canada; [Hobbs, William O.] Washington State Dept Ecol, Olympia, WA 98504 USA; [Vuille, Mathias] SUNY Albany, Dept Atmospher & Environm Sci, Albany, NY 12222 USA	Queens University - Canada; University of Alberta; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Smol, JP (corresponding author), Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada.	smolj@queensu.ca	Vuille, Mathias/S-3906-2019; Vuille, Mathias/O-8128-2019; Hobbs, William/P-1110-2016	Vuille, Mathias/0000-0002-9736-4518; Hobbs, William/0000-0001-7321-0779; Cooke, Colin/0000-0002-7417-5263; Smol, John/0000-0002-2499-6696	Natural Sciences and Engineering Research Council of Canada, (NSERC) Discovery awards; National Geographic Society award	Natural Sciences and Engineering Research Council of Canada, (NSERC) Discovery awards(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Geographic Society award(National Geographic Society)	This work was supported by Natural Sciences and Engineering Research Council of Canada, (NSERC) Discovery awards to JPS and APW, and National Geographic Society award to CAC.	Abbott MB, 2003, PALAEOGEOGR PALAEOCL, V194, P123, DOI 10.1016/S0031-0182(03)00274-8; Baraer M, 2012, J GLACIOL, V58, P134, DOI 10.3189/2012JoG11J186; Battarbee R.W., 2001, TRACKING ENV CHANGE; Bird BW, 2011, P NATL ACAD SCI USA, V108, P8583, DOI 10.1073/pnas.1003719108; Bradley RS, 2006, SCIENCE, V312, P1755, DOI 10.1126/science.1128087; Bush MB, 2005, J QUATERNARY SCI, V20, P703, DOI 10.1002/jqs.983; Cremer H, 2004, CAN J BOT, V82, P1744, DOI [10.1139/b04-127, 10.1139/B04-127]; Cremer H, 2001, J PALEOLIMNOL, V26, P67, DOI 10.1023/A:1011179321529; *ENV CAN, 1994, MAN AN METH MAJ IONS, V1; *ENV CAN, 1994, TRAC MET, V2; Glew J.R., 1988, J PALEOLIMNOL, V1, P235, DOI DOI 10.1007/BF00177769; Gunkel G, 2002, LIMNOLOGICA, V32, P33, DOI 10.1016/S0075-9511(02)80015-9; Hansen BCS, 2003, PALAEOGEOGR PALAEOCL, V194, P79, DOI 10.1016/S0031-0182(03)00272-4; Herzog S.K., 2011, CLIMATE CHANGE BIODI; Jacobsen D, 2012, NAT CLIM CHANGE, V2, P361, DOI [10.1038/nclimate1435, 10.1038/NCLIMATE1435]; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kelly M. G, 2005, COMMON FRESHWATER DI; LEAVITT PR, 2001, TRACKING ENV CHANGE, V3; Maldonado M., 2011, CLIMATE CHANGE BIODI; Michelutti N, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023693; Michelutti N, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000396; Michelutti N, 2010, J PALEOLIMNOL, V43, P205, DOI 10.1007/s10933-009-9325-8; Niemann H, 2008, J QUATERNARY SCI, V23, P203, DOI 10.1002/jqs.1134; O'Reilly CM, 2003, NATURE, V424, P766, DOI 10.1038/nature01833; Polissar PJ, 2013, P NATL ACAD SCI USA, V110, P14551, DOI 10.1073/pnas.1219681110; Rabatel A, 2013, CRYOSPHERE, V7, P81, DOI 10.5194/tc-7-81-2013; Rodbell DT, 1999, SCIENCE, V283, P516, DOI 10.1126/science.283.5401.516; Ruhland KM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1887; Ruhland K, 2008, GLOBAL CHANGE BIOL, V14, P2740, DOI 10.1111/j.1365-2486.2008.01670.x; Schelske C.L., 1994, J PALEOLIMNOL, V10, P115, DOI [10.1007/BF00682508, DOI 10.1007/BF00682508]; Smol J.P., 2010, DIATOMS APPL ENV EAR; Smol JP, 2007, FRONT ECOL ENVIRON, V5, P466, DOI 10.1890/060162; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; Tierney JE, 2010, NAT GEOSCI, V3, P422, DOI [10.1038/ngeo865, 10.1038/NGEO865]; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; Vuille M, 2000, GEOPHYS RES LETT, V27, P3885, DOI 10.1029/2000GL011871; Vuille M, 2003, CLIMATIC CHANGE, V59, P75, DOI 10.1023/A:1024406427519; Vuille M, 2008, EARTH-SCI REV, V89, P79, DOI 10.1016/j.earscirev.2008.04.002; Wolfe AP, 2013, EARTH-SCI REV, V116, P17, DOI 10.1016/j.earscirev.2012.11.001	39	68	69	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0115338	10.1371/journal.pone.0115338	http://dx.doi.org/10.1371/journal.pone.0115338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647018	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600012
J	Sinclair, L; Osman, OA; Bertilsson, S; Eiler, A				Sinclair, Lucas; Osman, Omneya Ahmed; Bertilsson, Stefan; Eiler, Alexander			Microbial Community Composition and Diversity via 16S rRNA Gene Amplicons: Evaluating the Illumina Platform	PLOS ONE			English	Article							RARE BIOSPHERE; GENERATION; SEQUENCES; ECOLOGY	As new sequencing technologies become cheaper and older ones disappear, laboratories switch vendors and platforms. Validating the new setups is a crucial part of conducting rigorous scientific research. Here we report on the reliability and biases of performing bacterial 16S rRNA gene amplicon paired-end sequencing on the MiSeq Illumina platform. We designed a protocol using 50 barcode pairs to run samples in parallel and coded a pipeline to process the data. Sequencing the same sediment sample in 248 replicates as well as 70 samples from alkaline soda lakes, we evaluated the performance of the method with regards to estimates of alpha and beta diversity. Using different purification and DNA quantification procedures we always found up to 5-fold differences in the yield of sequences between individually barcodes samples. Using either a one-step or a two-step PCR preparation resulted in significantly different estimates in both alpha and beta diversity. Comparing with a previous method based on 454 pyrosequencing, we found that our Illumina protocol performed in a similar manner - with the exception for evenness estimates where correspondence between the methods was low. We further quantified the data loss at every processing step eventually accumulating to 50% of the raw reads. When evaluating different OTU clustering methods, we observed a stark contrast between the results of QIIME with default settings and the more recent UPARSE algorithm when it comes to the number of OTUs generated. Still, overall trends in alpha and beta diversity corresponded highly using both clustering methods. Our procedure performed well considering the precisions of alpha and beta diversity estimates, with insignificant effects of individual barcodes. Comparative analyses suggest that 454 and Illumina sequence data can be combined if the same PCR protocol and bioinformatic workflows are used for describing patterns in richness, beta-diversity and taxonomic composition.	[Sinclair, Lucas; Osman, Omneya Ahmed; Bertilsson, Stefan; Eiler, Alexander] Uppsala Univ, Dept Ecol & Genet Limnol & Sci, Life Lab, Uppsala, Sweden	Uppsala University	Eiler, A (corresponding author), Uppsala Univ, Dept Ecol & Genet Limnol & Sci, Life Lab, Uppsala, Sweden.	alexander.eiler@ebc.uu.se	Eiler, Alexander/V-9220-2017	Eiler, Alexander/0000-0001-9916-9567; Sinclair, Lucas/0000-0003-4134-3571	Swedish Foundation for Strategic Research [ICA10-0015]; Carl Tryggers Foundation; Swedish Research Council	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Carl Tryggers Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The Swedish Foundation for Strategic Research Grant Number "ICA10-0015" (to AE). Carl Tryggers Foundation (to OO). Swedish Research Council (to SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Andrews S., 2010, FASTQC QUALITY CONTR; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson Marcus J, 2010, Nucleic Acids Res, V38, pe200, DOI 10.1093/nar/gkq873; Curtis TP, 2006, PHILOS T R SOC B, V361, P2023, DOI 10.1098/rstb.2006.1921; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eiler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053516; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hugerth LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095567; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Illumina I, 2013, TRUSEQ DNA SAMPLE PR; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lanzen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049334; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mahe F, 2014, PEERJ PREPRINTS; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mercier C, 2013, SUMATRA SUMACLUSTFAS; Mizrahi-Man O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053608; Oksanen J., 2020, VEGAN COMMUNITY ECOL; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; Osman OA, 2014, FEMS MICROBIOL ECOL, V88, P468, DOI 10.1111/1574-6941.12312; Peura S, 2012, ISME J, P1; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160; Zhou JZ, 2008, P NATL ACAD SCI USA, V105, P7768, DOI 10.1073/pnas.0709016105	48	216	233	1	211	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116955	10.1371/journal.pone.0116955	http://dx.doi.org/10.1371/journal.pone.0116955			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647581	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600044
J	Zhang, XT; Wang, XM				Zhang, Xiaotao; Wang, Ximing			Adsorption and Desorption of Nickel(II) Ions from Aqueous Solution by a Lignocellulose/Montmorillonite Nanocomposite	PLOS ONE			English	Article							WASTE-WATER; METAL-IONS; II IONS; NI II; REMOVAL; BIOSORPTION; NI(II); EQUILIBRIUM; BIOSORBENT; ADSORBENT	A new and inexpensive lignocellulose/montmorillonite (LNC/MMT) nanocomposite was prepared by a chemical intercalation of LNC into MMT and was subsequently investigated as an adsorbent in batch systems for the adsorption-desorption of Ni(II) ions in an aqueous solution. The optimum conditions for the Ni(II) ion adsorption capacity of the LNC/MMT nanocomposite were studied in detail by varying parameters such as the initial Ni(II) concentration, the solution pH value, the adsorption temperature and time. The results indicated that the maximum adsorption capacity of Ni(II) reached 94.86 mg/g at an initial Ni(II) concentration of 0.0032 mol/L, a solution pH of 6.8, an adsorption temperature of 70 degrees C, and adsorption time of 40 min. The represented adsorption kinetics model exhibited good agreement between the experimental data and the pseudo-second-order kinetic model. The Langmuir isotherm equation best fit the experimental data. The structure of the LNC/MMT nanocomposite was characterized by X-ray diffraction (XRD) and transmission electron microscopy (TEM), whereas the adsorption mechanism was discussed in combination with the results obtained from scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDX), and Fourier-transform infrared spectroscopy analyses (FTIR). The desorption capacity of the LNC/MMT nanocomposite depended on parameters such as HNO3 concentration, desorption temperature, and desorption time. The satisfactory desorption capacity of 81.34 mg/g was obtained at a HNO3 concentration, desorption temperature, and desorption time of 0.2 mol/L, 60 degrees C, and 30 min, respectively. The regeneration studies showed that the adsorption capacity of the LNC/MMT nanocomposite was consistent for five cycles without any appreciable loss in the batch process and confirmed that the LNC/MMT nanocomposite was reusable. The overall study revealed that the LNC/MMT nanocomposite functioned as an effective adsorbent in the detoxification of Ni(II)-contaminated wastewater.	[Zhang, Xiaotao] Inner Mongolia Agr Univ, Coll Sci, Hohhot, Peoples R China; [Wang, Ximing] Inner Mongolia Agr Univ, Coll Mat Sci & Art Design, Hohhot, Peoples R China	Inner Mongolia Agricultural University; Inner Mongolia Agricultural University	Wang, XM (corresponding author), Inner Mongolia Agr Univ, Coll Mat Sci & Art Design, Hohhot, Peoples R China.	w_ximing@263.net	xiaotao, zhang/HGC-2346-2022	xiaotao, zhang/0000-0001-9492-1123	Special Funds for Forestry Research and Public Service Industry of China [201104004]; Science Foundation for College of the Inner Mongolia Autonomous Region [JC2012004]	Special Funds for Forestry Research and Public Service Industry of China; Science Foundation for College of the Inner Mongolia Autonomous Region	This work was supported by Special Funds for Forestry Research and Public Service Industry of China (No. 201104004) and Science Foundation for College of the Inner Mongolia Autonomous Region (No. JC2012004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah MA, 2010, J BASIC APPL SCI RES, V4, P3591; Akbal F, 2011, DESALINATION, V269, P214, DOI 10.1016/j.desal.2010.11.001; Barati A, 2013, ENVIRON SCI POLLUT R, V20, P6242, DOI 10.1007/s11356-013-1672-3; Basso MC, 2002, IND ENG CHEM RES, V41, P3580, DOI 10.1021/ie020023h; Betancur M, 2009, BIORESOURCE TECHNOL, V100, P1130, DOI 10.1016/j.biortech.2008.08.023; Bhatnagar A, 2010, COLLOID SURFACE B, V76, P544, DOI 10.1016/j.colsurfb.2009.12.016; Cukierman AL, 2007, ADSORPT SCI TECHNOL, V25, P227, DOI 10.1260/026361707782398182; Elshazly AH, 2003, DESALINATION, V158, P189, DOI 10.1016/S0011-9164(03)00450-8; Ewecharoen A, 2008, CHEM ENG J, V137, P181, DOI 10.1016/j.cej.2007.04.007; Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042; Gill R, 2013, J MATER CYCLES WASTE, V15, P115, DOI 10.1007/s10163-012-0079-4; Flores-Garnica JG, 2013, BIORESOURCE TECHNOL, V136, P635, DOI 10.1016/j.biortech.2013.02.059; Gupta Vinod K, 2010, J Colloid Interface Sci, V342, P533, DOI 10.1016/j.jcis.2009.10.074; Hanif MA, 2007, J HAZARD MATER, V139, P345, DOI 10.1016/j.jhazmat.2006.06.040; Ho YS, 2000, ADSORPT SCI TECHNOL, V18, P639, DOI 10.1260/0263617001493693; Ijagbemi CO, 2010, J HAZARD MATER, V174, P746, DOI 10.1016/j.jhazmat.2009.09.115; Katal R, 2012, J CHEM ENG DATA, V57, P374, DOI 10.1021/je200953h; Khan MA, 2012, BIORESOURCE TECHNOL, V103, P35, DOI 10.1016/j.biortech.2011.09.065; Lalhruaitluanga H, 2010, J HAZARD MATER, V175, P311, DOI 10.1016/j.jhazmat.2009.10.005; Li JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090440; Malkoc E, 2006, J HAZARD MATER, V137, P899, DOI 10.1016/j.jhazmat.2006.03.004; Pahlavanzadeh H, 2010, J HAZARD MATER, V175, P304, DOI 10.1016/j.jhazmat.2009.10.004; Pandey Piyush Kant, 2007, Int J Environ Res Public Health, V4, P332, DOI 10.3390/ijerph200704040009; Parab H, 2010, WATER RES, V44, P854, DOI 10.1016/j.watres.2009.09.038; Plazinski W, 2009, ADV COLLOID INTERFAC, V152, P2, DOI 10.1016/j.cis.2009.07.009; Ramana DKV, 2012, CAN J CHEM ENG, V90, P111, DOI 10.1002/cjce.20565; Sharma YC, 2009, CAN J CHEM ENG, V87, P921, DOI 10.1002/cjce.20230; Shinde NR, 2012, J ENVIRON MANAGE, V102, P115, DOI 10.1016/j.jenvman.2012.02.026; Shroff KA, 2011, ENG LIFE SCI, V11, P588, DOI 10.1002/elsc.201000205; Subbaiah MV, 2009, COLLOID SURFACE B, V74, P260, DOI 10.1016/j.colsurfb.2009.07.028; Sud D, 2008, BIORESOURCE TECHNOL, V99, P6017, DOI 10.1016/j.biortech.2007.11.064; Turp SM, 2011, FRESEN ENVIRON BULL, V20, P3158; Weng CH, 2002, J ENVIRON ENG-ASCE, V128, P716, DOI 10.1061/(ASCE)0733-9372(2002)128:8(716); Yadav S, 2013, ENVIRON SCI POLLUT R, V20, P558, DOI 10.1007/s11356-012-0892-2; Zhang H, 2010, J RADIOANAL NUCL CH, V286, P249, DOI 10.1007/s10967-010-0656-8; Zhang JP, 2010, J CHEM ENG DATA, V55, P2379, DOI 10.1021/je900813z; Zhou YF, 2011, WATER AIR SOIL POLL, V218, P457, DOI 10.1007/s11270-010-0659-7	37	65	70	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117077	10.1371/journal.pone.0117077	http://dx.doi.org/10.1371/journal.pone.0117077			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647398	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600053
J	Cruse, MJ; Kucharik, CJ; Norman, JM				Cruse, Michael J.; Kucharik, Christopher J.; Norman, John M.			Using a Simple Apparatus to Measure Direct and Diffuse Photosynthetically Active Radiation at Remote Locations	PLOS ONE			English	Article							SOLAR-RADIATION; CANOPY PHOTOSYNTHESIS; MODEL; FRACTION; COMPONENTS; ERRORS	Plant canopy interception of photosynthetically active radiation (PAR) drives carbon dioxide (CO2), water and energy cycling in the soil-plant-atmosphere system. Quantifying intercepted PAR requires accurate measurements of total incident PAR above canopies and direct beam and diffuse PAR components. While some regional data sets include these data, e. g. from Atmospheric Radiation Measurement (ARM) Program sites, they are not often applicable to local research sites because of the variable nature (spatial and temporal) of environmental variables that influence incoming PAR. Currently available instrumentation that measures diffuse and direct beam radiation separately can be cost prohibitive and require frequent adjustments. Alternatively, generalized empirical relationships that relate atmospheric variables and radiation components can be used but require assumptions that increase the potential for error. Our goal here was to construct and test a cheaper, highly portable instrument alternative that could be used at remote field sites to measure total, diffuse and direct beam PAR for extended time periods without supervision. The apparatus tested here uses a fabricated, solar powered rotating shadowband and other commercially available parts to collect continuous hourly PAR data. Measurements of total incident PAR had nearly a one-to-one relationship with total incident radiation measurements taken at the same research site by an unobstructed point quantum sensor. Additionally, measurements of diffuse PAR compared favorably with modeled estimates from previously published data, but displayed significant differences that were attributed to the important influence of rapidly changing local environmental conditions. The cost of the system is about 50% less than comparable commercially available systems that require periodic, but not continual adjustments. Overall, the data produced using this apparatus indicates that this instrumentation has the potential to support ecological research via a relatively inexpensive method to collect continuous measurements of total, direct beam and diffuse PAR in remote locations.	[Cruse, Michael J.; Kucharik, Christopher J.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Cruse, Michael J.; Kucharik, Christopher J.] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA; [Norman, John M.] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Cruse, MJ (corresponding author), Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA.	mcruse@wisc.edu		Kucharik, Christopher/0000-0002-0400-758X	USDA Hatch grant [WIS01419]; Water Sustainability and Climate Program of the National Science Foundation [DEB-1038759]	USDA Hatch grant; Water Sustainability and Climate Program of the National Science Foundation	This study was supported by USDA Hatch grant (#WIS01419) CJK; Water Sustainability and Climate Program of the National Science Foundation (DEB-1038759) CJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alton PB, 2007, GLOBAL CHANGE BIOL, V13, P776, DOI 10.1111/j.1365-2486.2007.01316.x; Boland J, 2001, ENVIRONMETRICS, V12, P103, DOI 10.1002/1099-095X(200103)12:2<103::AID-ENV447>3.0.CO;2-2; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; BRISTOW KL, 1984, AGR FOREST METEOROL, V31, P159, DOI 10.1016/0168-1923(84)90017-0; BROCK TD, 1981, ECOL MODEL, V14, P1, DOI 10.1016/0304-3800(81)90011-9; Campbell G.S., 1998, INTRO ENV BIOPHYSICS, Vsecond, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; Chen JM, 1999, ECOL MODEL, V124, P99, DOI 10.1016/S0304-3800(99)00156-8; ClimateZone, 2013, MONTHL CLIM MAD WI 1; Dai YJ, 2004, J CLIMATE, V17, P2281, DOI 10.1175/1520-0442(2004)017&lt;2281:ATMFCT&gt;2.0.CO;2; de Jong J. B. R. M., 1980, KARAKTERISERING ZONN; De Miguel A, 2001, SOL ENERGY, V70, P143, DOI 10.1016/S0038-092X(00)00135-3; Deal A.M., 2009, SAS MACRO DEMING REG, V17, P1; dePury DGG, 1997, PLANT CELL ENVIRON, V20, P537, DOI 10.1111/j.1365-3040.1997.00094.x; ERBS DG, 1982, SOL ENERGY, V28, P293, DOI 10.1016/0038-092X(82)90302-4; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63, DOI 10.1071/PP9880063; Grant RH, 1997, AGR FOREST METEOROL, V87, P213, DOI 10.1016/S0168-1923(97)00022-1; Jacovides CP, 2010, RENEW ENERG, V35, P1820, DOI 10.1016/j.renene.2009.11.015; Knohl A, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000663; Kucharik CJ, 2003, EARTH INTERACT, V7; Kucharik CJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P795, DOI 10.1029/1999GB001138; LiCor, 2014, LI190 QUANT SENS SPE; LiCor, 2014, LI 200SA PYR SENS, V3576; LIU BYH, 1960, SOL ENERGY, V4, P1, DOI 10.1016/0038-092X(60)90062-1; Michalsky JJ, 2009, SOL ENERGY, V83, P2144, DOI 10.1016/j.solener.2009.08.007; MICHALSKY JJ, 1988, SOL ENERGY, V41, P577, DOI 10.1016/0038-092X(88)90060-6; Norman J.M., 1993, SCALING PHYSL PROCES, P41; REINDL DT, 1990, SOL ENERGY, V45, P1, DOI 10.1016/0038-092X(91)90123-E; Ross J, 2000, AGR FOREST METEOROL, V100, P103, DOI 10.1016/S0168-1923(99)00144-6; SPITTERS CJT, 1986, AGR FOREST METEOROL, V38, P217, DOI 10.1016/0168-1923(86)90060-2; TWOMEY S, 1991, ATMOS ENVIRON A-GEN, V25, P2435, DOI 10.1016/0960-1686(91)90159-5; WeatherSpark, 2013, AV WEATH MAD; WESELY ML, 1982, J APPL METEOROL, V21, P373, DOI 10.1175/1520-0450(1982)021<0373:STTSCO>2.0.CO;2; Xing HY, 2012, OPT ENG, V51, DOI 10.1117/1.OE.51.4.046001	33	14	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0115633	10.1371/journal.pone.0115633	http://dx.doi.org/10.1371/journal.pone.0115633			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668208	gold, Green Published, Green Submitted			2022-12-27	WOS:000349493000004
J	Lee, MY; Huang, CH; Kuo, CJ; Lin, CLS; Lai, WT; Chiou, SH				Lee, Min-Yi; Huang, Chun-Hao; Kuo, Chao-Jen; Lin, Chen-Lung Steve; Lai, Wen-Ter; Chiou, Shyh-Horng			Clinical Proteomics Identifies Urinary CD14 as a Potential Biomarker for Diagnosis of Stable Coronary Artery Disease	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; SOLUBLE CD14; HELICOBACTER-PYLORI; RECEPTOR 4; ACTIVATION; INFLAMMATION; COMPLEXES; MONOCYTES; ENDOTOXIN; MARKER	Inflammation plays a key role in coronary artery disease (CAD) and other manifestations of atherosclerosis. Recently, urinary proteins were found to be useful markers for reflecting inflammation status of different organs. To identify potential biomarker for diagnosis of CAD, we performed one-dimensional SDS-gel electrophoresis followed by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Among the proteins differentially expressed in urine samples, monocyte antigen CD14 was found to be consistently expressed in higher amounts in the CAD patients as compared to normal controls. Using enzyme-linked immunosorbent assays to analyze the concentrations of CD14 in urine and serum, we confirmed that urinary CD14 levels were significantly higher in patients (n = 73) with multi-vessel and single vessel CAD than in normal control (n = 35) (P < 0.001). Logistic regression analysis further showed that urinary CD14 concentration level is associated with severity or number of diseased vessels and SYNTAX score after adjustment for potential confounders. Concomitantly, the proportion of CD14+ monocytes was significantly increased in CAD patients (59.7 +/- 3.6%) as compared with healthy controls (14.9 +/- 2.1%) (P < 0.001), implicating that a high level of urinary CD14 may be potentially involved in mechanism(s) leading to CAD pathogenesis. By performing shotgun proteomics, we further revealed that CD14-associated inflammatory response networks may play an essential role in CAD. In conclusion, the current study has demonstrated that release of CD14 in urine coupled with more CD14+ monocytes in CAD patients is significantly correlated with severity of CAD, pointing to the potential application of urinary CD14 as a novel noninvasive biomarker for large-scale diagnostic screening of susceptible CAD patients.	[Lee, Min-Yi; Huang, Chun-Hao; Kuo, Chao-Jen; Lin, Chen-Lung Steve; Chiou, Shyh-Horng] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Lee, Min-Yi] Kaohsiung Municipal Ming Sheng Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Kuo, Chao-Jen; Chiou, Shyh-Horng] Kaohsiung Med Univ, Ctr Res Resources & Dev, Quantitat Proteom Ctr, Kaohsiung, Taiwan; [Lin, Chen-Lung Steve] Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan; [Lai, Wen-Ter] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Chiou, Shyh-Horng] Acad Sinica, Inst Biol Chem, Taipei, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Academia Sinica - Taiwan	Lai, WT (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.	wtlai@kmu.edu.tw; shchiou@kmu.edu.tw			National Science Council (NSC), Taipei, Taiwan [96-2311-B-037-005-MY3, 100-2320-B-037-019, 101-2113-M-037-004, 02-2320-B-037-025]; Quantitative Proteomics Center (NSC) at the Center for Research Resources and Development (CRRD) [99-2745-B-037-005]; Kaohsiung Medical University under National Science Council, Taipei, Taiwan; Kaohsiung Medical University (KMU); Academia Sinica	National Science Council (NSC), Taipei, Taiwan(Ministry of Science and Technology, Taiwan); Quantitative Proteomics Center (NSC) at the Center for Research Resources and Development (CRRD); Kaohsiung Medical University under National Science Council, Taipei, Taiwan; Kaohsiung Medical University (KMU); Academia Sinica(Academia Sinica - Taiwan)	work was supported in part by Kaohsiung Medical University (KMU), Academia Sinica and the National Science Council (NSC Grants 96-2311-B-037-005-MY3, 100-2320-B-037-019, 101-2113- M-037-004 and 102-2320-B-037-025 to S.-H. Chiou), Taipei, Taiwan. The authors also thank the core facility grant from the Quantitative Proteomics Center (NSC Grant 99-2745-B-037-005 to S.-H. Chiou) at the Center for Research Resources and Development (CRRD), Kaohsiung Medical University under the auspices of National Science Council, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2010, MOL CELL PROTEOMICS, V9, P2195, DOI 10.1074/mcp.M110.000992; BAZIL V, 1991, J IMMUNOL, V147, P1567; Bhagat K, 1996, CARDIOVASC RES, V32, P822; Chiou SH, 2011, KAOHSIUNG J MED SCI, V27, P1, DOI 10.1016/j.kjms.2010.12.001; Mello APD, 2010, LIPIDS, V45, P619, DOI 10.1007/s11745-010-3439-7; Estruch M, 2013, ATHEROSCLEROSIS, V229, P356, DOI 10.1016/j.atherosclerosis.2013.05.011; Fitzsimmons PJ, 2007, ATHEROSCLEROSIS, V194, P196, DOI 10.1016/j.atherosclerosis.2006.07.027; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Greco TP, 2010, AM J CLIN PATHOL, V133, P737, DOI 10.1309/AJCP88WVRDRDFBAS; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harsimran K, 2009, DIABETES VASC DIS RE, V6, P288, DOI 10.1177/1479164109346364; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; HORNEFF G, 1993, CLIN EXP IMMUNOL, V91, P207; Huang CH, 2014, WORLD J GASTROENTERO, V20, P1529, DOI 10.3748/wjg.v20.i6.1529; Huang CH, 2011, KAOHSIUNG J MED SCI, V27, P544, DOI 10.1016/j.kjms.2011.06.019; Huang CH, 2011, BIOCHIMIE, V93, P1115, DOI 10.1016/j.biochi.2011.03.008; Huang CH, 2011, MOL VIS, V17, P186; Huang CH, 2010, J BIOCHEM, V147, P535, DOI 10.1093/jb/mvp200; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Inoue T, 2008, ATHEROSCLEROSIS, V201, P385, DOI 10.1016/j.atherosclerosis.2008.03.010; Koenig W, 2002, J AM COLL CARDIOL, V40, P34, DOI 10.1016/S0735-1097(02)01937-X; Kolch W, 2005, MASS SPECTROM REV, V24, P959, DOI 10.1002/mas.20051; Laufer EM, 2010, ARTERIOSCL THROM VAS, V30, P1269, DOI 10.1161/ATVBAHA.109.200394; Liao W, 1996, J LAB CLIN MED, V128, P452, DOI 10.1016/S0022-2143(96)90042-6; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nair A, 2012, ARTHRITIS RHEUM-US, V64, P2268, DOI 10.1002/art.34495; Niccoli G, 2010, ATHEROSCLEROSIS, V211, P606, DOI 10.1016/j.atherosclerosis.2010.02.038; NOCKHER WA, 1994, CLIN EXP IMMUNOL, V96, P15; Pugin J, 1998, INFECT IMMUN, V66, P1174, DOI 10.1128/IAI.66.3.1174-1180.1998; Roy S, 2014, J BIOL CHEM, V289, P1174, DOI 10.1074/jbc.M113.523167; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Schroder NWJ, 2000, J IMMUNOL, V165, P2683, DOI 10.4049/jimmunol.165.5.2683; Schroecksnadel K, 2010, THROMB HAEMOSTASIS, V103, P926, DOI 10.1160/TH09-07-0422; SCHUMANN RR, 1994, MED MICROBIOL IMMUN, V183, P279; Sianos Georgios, 2005, EuroIntervention, V1, P219; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; Sonmez K, 2006, ANGIOLOGY, V57, P15, DOI 10.1177/000331970605700103; Stelter F, 1996, EUR J BIOCHEM, V236, P457, DOI 10.1111/j.1432-1033.1996.00457.x; Su GL, 1999, J HEPATOL, V31, P435, DOI 10.1016/S0168-8278(99)80034-8; Takeshita S, 2000, CLIN EXP IMMUNOL, V119, P376; van der Laan AM, 2012, AM HEART J, V163, P57, DOI 10.1016/j.ahj.2011.09.002; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; WUTHRICH B, 1992, ARCH DERMATOL RES, V284, P339, DOI 10.1007/BF00372036; Yu S, 1998, RHEUMATOL INT, V17, P237, DOI 10.1007/s002960050041; Zakynthinos E, 2009, J CARDIOL, V53, P317, DOI 10.1016/j.jjcc.2008.12.007	47	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117169	10.1371/journal.pone.0117169	http://dx.doi.org/10.1371/journal.pone.0117169			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668619	Green Submitted, Green Published, gold			2022-12-27	WOS:000349493000016
J	Lin, XB; Racette, SB; Ma, LN; Wallendorf, M; Spearie, CA; Ostlund, RE				Lin, Xiaobo; Racette, Susan B.; Ma, Lina; Wallendorf, Michael; Spearie, Catherine Anderson; Ostlund, Richard E., Jr.			Plasma Biomarker of Dietary Phytosterol Intake	PLOS ONE			English	Article							SERUM PLANT STEROLS; CHOLESTEROL-METABOLISM; CEREBROTENDINOUS XANTHOMATOSIS; FUNCTIONAL FOODS; LDL-CHOLESTEROL; CHOLESTANOL; ABSORPTION; NPC1L1; TRANSPORTERS; DISEASE	Background Dietary phytosterols, plant sterols structurally similar to cholesterol, reduce intestinal cholesterol absorption and have many other potentially beneficial biological effects in humans. Due to limited information on phytosterol levels in foods, however, it is difficult to quantify habitual dietary phytosterol intake (DPI). Therefore, we sought to identify a plasma biomarker of DPI. Methods and Findings Data were analyzed from two feeding studies with a total of 38 subjects during 94 dietary periods. DPI was carefully controlled at low, intermediate, and high levels. Plasma levels of phytosterols and cholesterol metabolites were assessed at the end of each diet period. Based on simple ordinary least squares regression analysis, the best biomarker for DPI was the ratio of plasma campesterol to the endogenous cholesterol metabolite 5-alpha-cholestanol (R-2 = 0.785, P < 0.0001). Plasma campesterol and 5-alpha-cholestanol levels varied greatly among subjects at the same DPI level, but were positively correlated at each DPI level in both studies (r > 0.600; P < 0.01). Conclusion The ratio of plasma campesterol to the coordinately regulated endogenous cholesterol metabolite 5-a-cholestanol is a biomarker of dietary phytosterol intake. Conversely, plasma phytosterol levels alone are not ideal biomarkers of DPI because they are confounded by large inter-individual variation in absorption and turnover of non-cholesterol sterols. Further work is needed to assess the relation between non-cholesterol sterol metabolism and associated cholesterol transport in the genesis of coronary heart disease.	[Lin, Xiaobo; Racette, Susan B.; Ma, Lina; Ostlund, Richard E., Jr.] Washington Univ, Sch Med, Inst Clin & Translat Sci, Div Endocrinol Metab & Lipid Res,Dept Med, St Louis, MO 63110 USA; [Ma, Lina] Washington Univ, Sch Med, Inst Clin & Translat Sci, Program Phys Therapy, St Louis, MO 63110 USA; [Wallendorf, Michael] Washington Univ, Sch Med, Inst Clin & Translat Sci, Div Biostat, St Louis, MO 63110 USA; [Spearie, Catherine Anderson] Washington Univ, Sch Med, Inst Clin & Translat Sci, Lifestyle Intervent Res Core, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Ostlund, RE (corresponding author), Washington Univ, Sch Med, Inst Clin & Translat Sci, Div Endocrinol Metab & Lipid Res,Dept Med, 660 South Euclid Ave, St Louis, MO 63110 USA.	ROstlund@dom.wustl.edu	Racette, Susan B/GLS-6669-2022; Racette, Susan/GXV-8800-2022	Racette, Susan B/0000-0002-6932-1887; 	National Institutes of Health [R01-108160, R01-50420]; National Institutes of Health Clinical and Translational Science Award [UL1 RR-024992, RR-00954, P60-DK20579, P30 DK056341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954, UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108160, R01HL050420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, P30DK056341, P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health grants R01-108160 and R01-50420 to REO: http://www.nih.gov; National Institutes of Health Clinical and Translational Science Award UL1 RR-024992, RR-00954, P60-DK20579, and P30 DK056341, all to Washington University: http://www.nih.gov.	Adamson AJ, 2009, EUR J CLIN NUTR, V63, pS6, DOI 10.1038/ejcn.2008.60; Betters JL, 2010, FEBS LETT, V584, P2740, DOI 10.1016/j.febslet.2010.03.030; Bhattacharyya AK, 2007, J LIPID RES, V48, P185, DOI 10.1194/jlr.M600113-JLR200; Brown J. Mark, 2009, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V9, P18; Demonty I, 2009, J NUTR, V139, P271, DOI 10.3945/jn.108.095125; Hallikainen M, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-72; Igel M, 2003, J LIPID RES, V44, P533, DOI 10.1194/jlr.M200393-JLR200; Jew S, 2009, J MED FOOD, V12, P925, DOI 10.1089/jmf.2008.0268; Jones PJH, 2009, CURR OPIN CLIN NUTR, V12, P147, DOI 10.1097/MCO.0b013e328326770f; Kidambi S, 2008, XENOBIOTICA, V38, P1119, DOI [10.1080/00498250802007930, 10.1080/00498250802007930 ]; Lin X, 2010, EUR J CLIN NUTR, V64, P1481, DOI 10.1038/ejcn.2010.180; Marinangeli CPF, 2009, J FOOD SCI, V74, pS385, DOI 10.1111/j.1750-3841.2009.01347.x; MIETTINEN TA, 1989, METABOLISM, V38, P136, DOI 10.1016/0026-0495(89)90252-7; MIETTINEN TA, 1990, AM J EPIDEMIOL, V131, P20, DOI 10.1093/oxfordjournals.aje.a115479; Ntanios FY, 2003, ATHEROSCLEROSIS, V169, P41, DOI 10.1016/S0021-9150(03)00132-1; Ostlund Richard E Jr, 2006, Curr Atheroscler Rep, V8, P487, DOI 10.1007/s11883-006-0024-x; Othman RA, 2011, NUTR REV, V69, P371, DOI 10.1111/j.1753-4887.2011.00399.x; Racette SB, 2010, AM J CLIN NUTR, V91, P32, DOI 10.3945/ajcn.2009.28070; SALEN G, 1984, GASTROENTEROLOGY, V87, P276; Schaefer EJ, 1997, AM J CLIN NUTR, V65, P823, DOI 10.1093/ajcn/65.3.823; Seyama Yousuke, 2003, Journal of Medicinal Food, V6, P217, DOI 10.1089/10966200360716634; TILVIS RS, 1986, AM J CLIN NUTR, V43, P92, DOI 10.1093/ajcn/43.1.92	22	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0116912	10.1371/journal.pone.0116912	http://dx.doi.org/10.1371/journal.pone.0116912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668184	Green Submitted, Green Published, gold			2022-12-27	WOS:000349493000011
J	Pratesi, C; Zanussi, S; Tedeschi, R; Bortolin, MT; Talamini, R; Rupolo, M; Scaini, C; Basaglia, G; Di Maso, M; Mazzucato, M; Zanet, E; Tirelli, U; Michieli, M; Carbone, A; De Paoli, P				Pratesi, Chiara; Zanussi, Stefania; Tedeschi, Rosamaria; Bortolin, Maria Teresa; Talamini, Renato; Rupolo, Maurizio; Scaini, Chiara; Basaglia, Giancarlo; Di Maso, Matteo; Mazzucato, Mario; Zanet, Ernesto; Tirelli, Umberto; Michieli, Mariagrazia; Carbone, Antonino; De Paoli, Paolo			Upsilon-Herpesvirus Load as Surrogate Marker of Early Death in HIV-1 Lymphoma Patients Submitted to High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation	PLOS ONE			English	Article							BARR-VIRUS-DNA; T-CELL; VIRAL LOAD; LYMPHOPROLIFERATIVE DISORDER; NON-HODGKIN; COOPERATIVE GROUP; INFECTED PATIENTS; AIDS; HUMAN-HERPESVIRUS-8; THERAPY	Autologous stem cell transplantation (ASCT) is a feasible procedure for human immunodeficiency virus-1 (HIV-1) lymphoma patients, whose underlying disease and intrinsic HIV-1- and ASCT-associated immunodeficiency might increase the risk for gamma-herpesvirus load persistence and/or reactivation. We evaluated this hypothesis by investigating the levels of Epstein-Barr virus (EBV)- and Kaposi sarcoma-associated herpesvirus (KSHV)-DNA levels in the peripheral blood of 22 HIV-1-associated lymphoma patients during ASCT, highlighting their relationship with.-herpesvirus lymphoma status, immunological parameters, and clinical events. EBV-DNA was detected in the pre-treatment plasma and peripheral blood mononuclear cells (PBMCs) of 12 (median 12135 copies/mL) and 18 patients (median 417 copies/10(6) PBMCs), respectively; the values in the two compartments were correlated (r = 0.77, p = 0.0001). Only EBV-positive lymphomas showed detectable levels of plasma EBV-DNA. After debulking chemotherapy, plasma EBV-DNA was associated with lymphoma chemosensitivity (p = 0.03) and a significant higher mortality risk by multivariate Cox analysis adjusted for EBV-lymphoma status (HR, 10.46, 95% CI, 1.11-98.32, p = 0.04). After infusion, EBV-DNA was detectable in five EBV-positive lymphoma patients who died within six months. KSHV-DNA load was positive in only one patient, who died from primary effusion lymphoma. Fluctuations in levels of KSHV-DNA reflected the patient's therapy and evolution of his underlying lymphoma. Other gamma-herpesvirus-associated malignancies, such as multicentric Castleman disease and Kaposi sarcoma, or end-organ complications after salvage treatment were not found. Overall, these findings suggest a prognostic and predictive value of EBV-DNA and KSHV-DNA, the monitoring of which could be a simple, complementary tool for the management of gamma-herpesvirus-positive lymphomas in HIV-1 patients submitted to ASCT.	[Pratesi, Chiara; Zanussi, Stefania; Tedeschi, Rosamaria; Bortolin, Maria Teresa; Scaini, Chiara; Basaglia, Giancarlo] CRO Natl Canc Inst, IRCCS, Microbiol Immunol & Virol Unit, Aviano, Pordenone, Italy; [Talamini, Renato; Di Maso, Matteo] CRO Natl Canc Inst, IRCCS, Epidemiol & Biostat Unit, Aviano, Pordenone, Italy; [Rupolo, Maurizio; Zanet, Ernesto; Michieli, Mariagrazia] CRO Natl Canc Inst, IRCCS, Cellular Therapy & High Dose Chemotherapy Unit, Aviano, Pordenone, Italy; [Mazzucato, Mario] CRO Natl Canc Inst, IRCCS, Stem Cell Collect & Proc Unit, Aviano, Pordenone, Italy; [Tirelli, Umberto] CRO Natl Canc Inst, IRCCS, Div Med Oncol A, Aviano, Pordenone, Italy; [Carbone, Antonino] CRO Natl Canc Inst, IRCCS, Dept Pathol, Aviano, Pordenone, Italy; [De Paoli, Paolo] CRO Natl Canc Inst, IRCCS, Sci Directorate, Aviano, Pordenone, Italy	IRCCS Aviano (CRO); IRCCS Aviano (CRO); IRCCS Aviano (CRO); IRCCS Aviano (CRO); IRCCS Aviano (CRO); IRCCS Aviano (CRO); IRCCS Aviano (CRO)	Zanussi, S (corresponding author), CRO Natl Canc Inst, IRCCS, Microbiol Immunol & Virol Unit, Aviano, Pordenone, Italy.	szanussi@cro.it	Mazzucato, Mario/ABF-5472-2020; Rupolo, Maurizio/ABE-7008-2020; Zanet, Ernesto/ABD-8879-2020; Di Maso, Matteo/AAC-4816-2022; Zanussi, Stefania/I-2558-2018; Michieli, Mariagrazia/AAC-3302-2020; Carbone, Antonino/AAA-2217-2019; De Paoli, Paolo/AAG-2586-2021	Mazzucato, Mario/0000-0001-8319-053X; Rupolo, Maurizio/0000-0001-7932-2827; Zanet, Ernesto/0000-0002-3451-075X; Di Maso, Matteo/0000-0002-6481-990X; Zanussi, Stefania/0000-0003-0608-9766; Michieli, Mariagrazia/0000-0001-6302-0488; Carbone, Antonino/0000-0003-2211-639X; Bortolin, Maria Teresa/0000-0003-0589-1669; De Paoli, Paolo/0000-0002-9502-1781	Ministero del lavoro, della salute e delle politiche sociali [40H73]	Ministero del lavoro, della salute e delle politiche sociali	This work was supported by Grant N. 40H73 from "Ministero del lavoro, della salute e delle politiche sociali." The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awaya N, 2006, LEUKEMIA RES, V30, P1059, DOI 10.1016/j.leukres.2005.10.022; Balsalobre P, 2009, J CLIN ONCOL, V27, P2192, DOI 10.1200/JCO.2008.18.2683; Benicchi T, 2005, TRANSPLANTATION, V80, P673, DOI 10.1097/01.tp.0000168490.29862.b8; Bonnet F, 2006, J CLIN VIROL, V36, P258, DOI 10.1016/j.jcv.2006.04.005; Bortolin MT, 2010, AIDS RES HUM RETROV, V26, P245, DOI 10.1089/aid.2009.0081; Bortolin MT, 2006, CANCER LETT, V233, P247, DOI 10.1016/j.canlet.2005.03.015; Capobianchi A, 2011, J CLIN VIROL, V52, P247, DOI 10.1016/j.jcv.2011.07.003; Carbone A, 2009, BLOOD, V113, P1213, DOI 10.1182/blood-2008-09-180315; Cesarman E, 2011, CANCER LETT, V305, P163, DOI 10.1016/j.canlet.2011.03.003; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Chijioke O, 2013, J LEUKOCYTE BIOL, V94, P1185, DOI 10.1189/jlb.0313173; COX DR, 1972, J R STAT SOC B, V34, P187; Cuzzola M, 2003, CLIN INFECT DIS, V37, pE102, DOI 10.1086/377268; Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4; Diez-Martin JL, 2009, BLOOD, V113, P6011, DOI 10.1182/blood-2008-12-195388; Fan HX, 2005, J MED VIROL, V75, P59, DOI 10.1002/jmv.20238; Gabarre J, 2004, HAEMATOLOGICA, V89, P1100; Gabriel I, 2008, AIDS, V22, P539, DOI 10.1097/QAD.0b013e3282f0e3e5; Gallagher A, 1999, INT J CANCER, V84, P442, DOI 10.1002/(SICI)1097-0215(19990820)84:4<442::AID-IJC20>3.3.CO;2-A; Gloghini A, 2013, SEMIN CANCER BIOL, V23, P457, DOI 10.1016/j.semcancer.2013.08.004; Gulley ML, 2010, CLIN MICROBIOL REV, V23, P350, DOI 10.1128/CMR.00006-09; Heslop Helen E, 2005, Hematology Am Soc Hematol Educ Program, P260; Hong GK, 2005, J VIROL, V79, P13993, DOI 10.1128/JVI.79.22.13993-14003.2005; Jansen CA, 2006, ANTIVIR THER, V11, P105; Juvonen E, 2007, HAEMATOLOGICA, V92, P819, DOI 10.3324/haematol.10751; Kanakry JA, 2013, BLOOD, V121, P3547, DOI 10.1182/blood-2012-09-454694; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Koh YW, 2012, ANN HEMATOL, V91, P1403, DOI 10.1007/s00277-012-1464-8; Krishnan A, 2010, CURR OPIN ONCOL, V22, P456, DOI 10.1097/CCO.0b013e32833d2cf0; Leruez-Ville M, 2012, HIV MED, V13, P479, DOI 10.1111/j.1468-1293.2012.00998.x; Lin L, 2009, J CLIN ONCOL, V27, P2496, DOI 10.1200/JCO.2008.20.1707; Luppi M, 2000, BLOOD, V96, P2355; Luppi M, 2000, NEW ENGL J MED, V343, P1378, DOI 10.1056/NEJM200011093431905; Ma SD, 2011, J VIROL, V85, P165, DOI 10.1128/JVI.01512-10; Marcelin AG, 2007, J INFECT DIS, V196, P1163, DOI 10.1086/521625; Navarro JT, 2010, MED CLIN-BARCELONA, V135, P485, DOI 10.1016/j.medcli.2010.02.041; Park S, 2007, BLOOD, V110, P972, DOI 10.1182/blood-2007-01-067769; Paydas S, 2008, LEUKEMIA RES, V32, P1424, DOI 10.1016/j.leukres.2008.01.008; Piriou E, 2005, J IMMUNOL, V175, P2010, DOI 10.4049/jimmunol.175.3.2010; Pratesi C, 2008, CLIN EXP IMMUNOL, V151, P101, DOI 10.1111/j.1365-2249.2007.03516.x; Raphael M, 2008, WHO CLASSIFICATION T, P340; Re A, 2009, BLOOD, V114, P1306, DOI 10.1182/blood-2009-02-202762; Shamay M, 2012, J INFECT DIS, V205, P1095, DOI 10.1093/infdis/jis032; Simonelli C, 2010, CLIN INFECT DIS, V50, P1672, DOI 10.1086/652866; Smets F, 2002, TRANSPLANTATION, V73, P1603, DOI 10.1097/00007890-200205270-00014; Spacek M, 2011, APMIS, V119, P10, DOI 10.1111/j.1600-0463.2010.02685.x; Stevens SJC, 2007, AIDS, V21, P2141, DOI 10.1097/QAD.0b013e3282eeeba0; Styczynski J, 2009, BONE MARROW TRANSPL, V43, P757, DOI 10.1038/bmt.2008.386; Suwiwat S, 2007, J CLIN VIROL, V40, P277, DOI 10.1016/j.jcv.2007.08.013; Suzuki R, 2011, BLOOD, V118, P6018, DOI 10.1182/blood-2011-05-354142; Takahashi S, 2007, EUR J DERMATOL, V17, P242; Tedeschi R, 2001, J CLIN MICROBIOL, V39, P4269, DOI 10.1128/JCM.39.12.4269-4273.2001; Tedeschi R, 2012, J CLIN VIROL, V53, P297, DOI 10.1016/j.jcv.2011.12.021; van Esser JWJ, 2001, BLOOD, V98, P972, DOI 10.1182/blood.V98.4.972; Yin CC, 2006, EXPERT REV MOL DIAGN, V6, P831, DOI 10.1586/14737159.6.6.831; Yufu Y, 2000, BONE MARROW TRANSPL, V26, P1339, DOI 10.1038/sj.bmt.1702721	56	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0116887	10.1371/journal.pone.0116887	http://dx.doi.org/10.1371/journal.pone.0116887			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668032	Green Published, Green Submitted, gold			2022-12-27	WOS:000349493000010
J	Cote, R; Katani, R; Moreau, MR; Kudva, IT; Arthur, TM; DebRoy, C; Mwangi, MM; Albert, I; Garay, JAR; Li, LL; Brandl, MT; Carter, MQ; Kapur, V				Cote, Rebecca; Katani, Robab; Moreau, Matthew R.; Kudva, Indira T.; Arthur, Terrance M.; DebRoy, Chitrita; Mwangi, Michael M.; Albert, Istvan; Garay, Juan Antonio Raygoza; Li, Lingling; Brandl, Maria T.; Carter, Michelle Q.; Kapur, Vivek			Comparative Analysis of Super-Shedder Strains of Escherichia coli O157:H7 Reveals Distinctive Genomic Features and a Strongly Aggregative Adherent Phenotype on Bovine Rectoanal Junction Squamous Epithelial Cells	PLOS ONE			English	Article							EFFACEMENT-ENCODED PROTEINS; TERMINAL RECTAL MUCOSA; PHYLOGENETIC GROUP; HUMAN INFECTION; FEEDLOT CATTLE; UNITED-STATES; O157-H7; COLONIZATION; VIRULENCE; GENE	Shiga toxin-producing Escherichia coli O157:H7 (O157) are significant foodborne pathogens and pose a serious threat to public health worldwide. The major reservoirs of O157 are asymptomatic cattle which harbor the organism in the terminal recto-anal junction (RAJ). Some colonized animals, referred to as "super-shedders" (SS), are known to shed O157 in exceptionally large numbers (> 104 CFU/g of feces). Recent studies suggest that SS cattle play a major role in the prevalence and transmission of O157, but little is known about the molecular mechanisms associated with super-shedding. Whole genome sequence analysis of an SS O157 strain (SS17) revealed a genome of 5,523,849 bp chromosome with 5,430 open reading frames and two plasmids, pO157 and pSS17, of 94,645 bp and 37,446 bp, respectively. Comparative analyses showed that SS17 is clustered with spinach-associated O157 outbreak strains, and belongs to the lineage I/II, clade 8, D group, and genotype 1, a subgroup of O157 with predicted hyper-virulence. A large number of non-synonymous SNPs and other polymorphisms were identified in SS17 as compared with other O157 strains (EC4115, EDL933, Sakai, TW14359), including in key adherence-and virulence-related loci. Phenotypic analyses revealed a distinctive and strongly adherent aggregative phenotype of SS17 on bovine RAJ stratified squamous epithelial (RSE) cells that was conserved amongst other SS isolates. Molecular genetic and functional analyses of defined mutants of SS17 suggested that the strongly adherent aggregative phenotype amongst SS isolates is LEE-independent, and likely results from a novel mechanism. Taken together, our study provides a rational framework for investigating the molecular mechanisms associated with SS, and strong evidence that SS O157 isolates have distinctive features and use a LEE-independent mechanism for hyper-adherence to bovine rectal epithelial cells.	[Cote, Rebecca; Katani, Robab; Moreau, Matthew R.; DebRoy, Chitrita; Garay, Juan Antonio Raygoza; Li, Lingling; Kapur, Vivek] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Cote, Rebecca; Albert, Istvan; Garay, Juan Antonio Raygoza; Kapur, Vivek] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Kudva, Indira T.] ARS, Food Safety & Enter Pathogens Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA; [Arthur, Terrance M.] ARS, Roman L Hruska US Meat Anim Res Ctr, USDA, Clay Ctr, NE USA; [DebRoy, Chitrita] Penn State Univ, E Coli Reference Ctr, University Pk, PA 16802 USA; [Mwangi, Michael M.; Albert, Istvan] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Brandl, Maria T.; Carter, Michelle Q.] ARS, Res Unit, USDA, Albany, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Agriculture (USDA)	Kapur, V (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	vkapur@psu.edu	Katani, Robab/AAS-1292-2020; Garay, Juan Antonio Raygoza/AAM-9568-2021; Albert, Istvan/J-3734-2015	Albert, Istvan/0000-0001-8366-984X; Arthur, Terrance/0000-0001-9035-0474; Raygoza Garay, Juan Antonio/0000-0003-4296-4118; Carter, Michelle Qiu/0000-0002-0710-7420				Abu-Ali GS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010167; Andrews SC, 1997, MICROBIOL-SGM, V143, P3633, DOI 10.1099/00221287-143-11-3633; Arthur TM, 2013, APPL ENVIRON MICROB, V79, P4294, DOI 10.1128/AEM.00846-13; Arthur TM, 2011, APPL ENVIRON MICROB, V77, P3002, DOI 10.1128/AEM.02238-10; Arthur TM, 2010, MEAT SCI, V86, P32, DOI 10.1016/j.meatsci.2010.04.019; Arthur TM, 2010, J FOOD PROTECT, V73, P366, DOI 10.4315/0362-028X-73.2.366; Arthur TM, 2009, APPL ENVIRON MICROB, V75, P6515, DOI 10.1128/AEM.00081-09; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Besser TE, 2007, APPL ENVIRON MICROB, V73, P671, DOI 10.1128/AEM.01035-06; Bono JL, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-98; Boyd EF, 1998, J BACTERIOL, V180, P1159, DOI 10.1128/JB.180.5.1159-1165.1998; Brichta-Harhay DM, 2007, J APPL MICROBIOL, V103, P1657, DOI 10.1111/j.1365-2672.2007.03405.x; Bugarel M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-142; CALLAWAY TR, 2004, J ANIM SCI, V82, P93; Carlos C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-161; Carlson BA, 2009, APPL ENVIRON MICROB, V75, P5927, DOI 10.1128/AEM.00972-09; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Chase-Topping ME, 2007, J CLIN MICROBIOL, V45, P1594, DOI 10.1128/JCM.01690-06; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Cobbold RN, 2007, APPL ENVIRON MICROB, P1742; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Dobrindt U, 2010, MED MICROBIOL IMMUN, V199, P145, DOI 10.1007/s00430-010-0161-2; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Franz E, 2012, J CLIN MICROBIOL, V50, P772, DOI 10.1128/JCM.05964-11; Fuentes LG, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-42; Gansheroff LJ, 2000, P NATL ACAD SCI USA, V97, P2959, DOI 10.1073/pnas.97.7.2959; Geanacopoulos M, 1997, J BACTERIOL, V179, P228, DOI 10.1128/jb.179.1.228-234.1997; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Hartzell A, 2011, FOODBORNE PATHOG DIS, V8, P763, DOI 10.1089/fpd.2010.0762; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hu Y, 1999, J APPL MICROBIOL, V87, P867, DOI 10.1046/j.1365-2672.1999.00938.x; Kalchayanand N, 2012, J FOOD PROTECT, V75, P1207, DOI 10.4315/0362-028X.JFP-11-531; Kansal R, 2013, INFECT IMMUN, V81, P259, DOI 10.1128/IAI.00919-12; Ko HJ, 2012, APPL ENVIRON MICROB, V78, P3051, DOI 10.1128/AEM.07004-11; Korea CG, 2010, ENVIRON MICROBIOL, V12, P1957, DOI 10.1111/j.1462-2920.2010.02202.x; Kudva IT, 2011, J APPL MICROBIOL, V111, P1283, DOI 10.1111/j.1365-2672.2011.05139.x; Kudva IT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-103; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Laing CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-287; Latreille P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-321; Lelong C, 2007, MOL CELL PROTEOMICS, V6, P660, DOI 10.1074/mcp.M600192-MCP200; Leveille S, 2006, INFECT IMMUN, V74, P3427, DOI 10.1128/IAI.00107-06; Lim JY, 2007, APPL ENVIRON MICROB, V73, P1380, DOI 10.1128/AEM.02242-06; Low JC, 2005, APPL ENVIRON MICROB, V71, P93, DOI 10.1128/AEM.71.1.93-97.2005; Lu J, 2012, APPL MICROBIOL BIOT, V93, P2455, DOI 10.1007/s00253-011-3752-y; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Meng J, 1998, ESCHERICHIA COLI O15, P85; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Naylor SW, 2005, MICROBIOL-SGM, V151, P2773, DOI 10.1099/mic.0.28060-0; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Omisakin F, 2003, APPL ENVIRON MICROB, V69, P2444, DOI 10.1128/AEM.69.5.2444-2447.2003; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Roux A, 2005, J BACTERIOL, V187, P1001, DOI 10.1128/JB.187.3.1001-1013.2005; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; SCHMIDT H, 1995, INFECT IMMUN, V63, P1055, DOI 10.1128/IAI.63.3.1055-1061.1995; Sheng HQ, 2008, APPL ENVIRON MICROB, V74, P5015, DOI 10.1128/AEM.00743-08; Sheng HQ, 2006, INFECT IMMUN, V74, P4685, DOI 10.1128/IAI.00406-06; Stanton E, 2014, MICROBIOL-SGM, V160, P502, DOI 10.1099/mic.0.073437-0; Stevens MP, 2004, INFECT IMMUN, V72, P5402, DOI 10.1128/IAI.72.9.5402-5411.2004; TARR PI, 1989, J INFECT DIS, V159, P344, DOI 10.1093/infdis/159.2.344; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Torres AG, 2005, APPL ENVIRON MICROB, V71, P8008, DOI 10.1128/AEM.71.12.8008-8015.2005; Torres AG, 2002, INFECT IMMUN, V70, P5416, DOI 10.1128/IAI.70.10.5416-5427.2002; Torres AG, 2002, MOL MICROBIOL, V45, P951, DOI 10.1046/j.1365-2958.2002.03094.x; Wells TJ, 2010, MICROBIOL-SGM, V156, P2459, DOI 10.1099/mic.0.039024-0; Yang Z, 2004, APPL ENVIRON MICROB, V70, P6846, DOI 10.1128/AEM.70.11.6846-6854.2004; Yu DG, 2003, P NATL ACAD SCI USA, V100, P7207, DOI 10.1073/pnas.1232375100; YU J, 1992, MOL MICROBIOL, V6, P411, DOI 10.1111/j.1365-2958.1992.tb01484.x; Zhang YX, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-121	85	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0116743	10.1371/journal.pone.0116743	http://dx.doi.org/10.1371/journal.pone.0116743			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664460	Green Published, gold			2022-12-27	WOS:000349123100013
J	Capraro, J; Sessa, F; Magni, C; Scarafoni, A; Maffioli, E; Tedeschi, G; Croy, RRD; Duranti, M				Capraro, Jessica; Sessa, Fabio; Magni, Chiara; Scarafoni, Alessio; Maffioli, Elisa; Tedeschi, Gabriella; Croy, Ron R. D.; Duranti, Marcello			Proteolytic Cleavage at Twin Arginine Residues Affects Structural and Functional Transitions of Lupin Seed 11S Storage Globulin	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; PROTEINS; IDENTIFICATION; BIOSYNTHESIS; PRECURSOR; SUBUNITS; PLANTS; ALBUS; SITE	The 11S storage globulin of white lupin seeds binds to a metal affinity chromatography matrix. Two unusual stretches of contiguous histidine residues, reminiscent of the multiple histidines forming metal binding motifs, at the C-terminal end of 11S globulin acidic chains were hypothesized as candidate elements responsible for the binding capacity. To prove this, the protein was incubated with a lupin seed endopeptidase previously shown to cleave at twin arginine motifs, recurrent in the sequence region of interest. Upon incubation with this enzyme, the loss of metal binding capacity paralleled that of the anti-his-tag reactive polypeptides. The recovered small proteolytic fragment was analyzed by mass spectrometry and N-terminal sequencing and found to correspond to the 24-mer region cleaved off at twin arginine residues and containing the natural his-tag-like region. Similarly, when lupin seeds were germinated for a few days, the his-tag containing 11S globulin chain was converted to a form devoid of such region, suggesting that this mechanism is a part of the natural degradatory process of the protein. The hypothesis that the ordered and controlled dismantling of storage proteins may generate peptide fragments with potential functional roles in plant ontogenesis is presented and discussed.	[Capraro, Jessica; Sessa, Fabio; Magni, Chiara; Scarafoni, Alessio; Duranti, Marcello] Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy; [Maffioli, Elisa; Tedeschi, Gabriella] Univ Milan, Dept Vet Sci & Publ Hlth, Milan, Italy; [Croy, Ron R. D.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	University of Milan; University of Milan; Durham University	Scarafoni, A (corresponding author), Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy.	alessio.scarafoni@unimi.it	Maffioli, Elisa/U-5511-2017; Tedeschi, Gabriella/I-6247-2017; Scarafoni, Alessio/Q-1093-2015	Maffioli, Elisa/0000-0002-5539-1825; Tedeschi, Gabriella/0000-0003-2082-6443; Scarafoni, Alessio/0000-0003-1970-0122; CAPRARO, JESSICA/0000-0002-9114-3212; MAGNI, CHIARA/0000-0002-9641-2223	"Dote Ricerca" of Regione Lombardia; European Social Fund	"Dote Ricerca" of Regione Lombardia; European Social Fund(European Social Fund (ESF))	JC was supported by a grant "Dote Ricerca" of Regione Lombardia and European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD RR, 1982, INFECT IMMUN, V35, P792, DOI 10.1128/IAI.35.3.792-799.1982; Avitabile C, 2013, J PEPT SCI, V19, P240, DOI 10.1002/psc.2479; Becker K. L., 2001, PRINCIPLES PRACTICE, V3rd; Boulter D, 1997, ADV BOT RES, V27, P1; Candido ED, 2011, FASEB J, V25, P3290, DOI 10.1096/fj.11-184291; CHESNEAU V, 1994, J BIOL CHEM, V269, P2056; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; CROY RRD, 1982, NATURE, V295, P76, DOI 10.1038/295076a0; DIEFENBACHJAGGER H, 1995, EUR J BIOCHEM, V229, P91, DOI 10.1111/j.1432-1033.1995.tb20442.x; dosRamos PCR, 1997, PLANTA, V203, P26, DOI 10.1007/s004250050161; Duranti M, 2004, J NUTR, V134, P1334, DOI 10.1093/jn/134.6.1334; DURANTI M, 1984, J AGR FOOD CHEM, V32, P490, DOI 10.1021/jf00123a018; DURANTI M, 1992, EUR J BIOCHEM, V206, P941, DOI 10.1111/j.1432-1033.1992.tb17004.x; Eggert K, 2013, METALLOMICS, V5, P1316, DOI 10.1039/c3mt00109a; Elliott AG, 2014, PLANT CELL, V26, P981, DOI 10.1105/tpc.114.123620; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Magni C, 2005, J AGR FOOD CHEM, V53, P4567, DOI 10.1021/jf0500785; Magni C, 2007, PHYTOCHEMISTRY, V68, P997, DOI 10.1016/j.phytochem.2007.01.003; Magni C, 2012, MOL PLANT, V5, P1011, DOI 10.1093/mp/ssr116; Matos JL, 2008, FEBS LETT, V582, P3343, DOI 10.1016/j.febslet.2008.08.025; Monteiro S, 2010, PLOS ONE, V5, P1; Muntz K, 2002, TRENDS PLANT SCI, V7, P340, DOI 10.1016/S1360-1385(02)02298-7; Rehman S, 2011, PAK J BOT, V43, P2971; Schaller A, 2012, PHYSIOL PLANTARUM, V145, P52, DOI 10.1111/j.1399-3054.2011.01529.x; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; SHUTOV AD, 1987, PHYTOCHEMISTRY, V26, P1557, DOI 10.1016/S0031-9422(00)82245-1; Silva FD, 2009, J BIOL CHEM, V284, P34735, DOI 10.1074/jbc.M109.016410; Tandang-Silvas MRG, 2011, ANNU REV FOOD SCI T, V2, P59, DOI 10.1146/annurev-food-022510-133718; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wright DJ, 1988, DEV FOOD PROTEINS, V6, P119; Xiaoping Fu, 2010, Biochemical Journal, V427, P313; Yamada K, 1999, J BIOL CHEM, V274, P2563, DOI 10.1074/jbc.274.4.2563	32	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117406	10.1371/journal.pone.0117406	http://dx.doi.org/10.1371/journal.pone.0117406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658355	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000349444900143
J	Chen, J; Wu, MP; Liu, RB; Li, SY; Gao, RH; Song, B				Chen, Jie; Wu, Mingpeng; Liu, Rongbo; Li, Siyi; Gao, Ronghui; Song, Bin			Preoperative Evaluation of the Histological Grade of Hepatocellular Carcinoma with Diffusion-Weighted Imaging: A Meta-Analysis	PLOS ONE			English	Article							FOCAL LIVER-LESIONS; ACID-ENHANCED MRI; MICROVASCULAR INVASION; B-VALUE; TRANSPLANTATION; DIFFERENTIATION; COEFFICIENT; RESECTION; EFFICACY; PHASE	Objective To evaluate the diagnostic performance of diffusion-weighted imaging (DWI) in the preoperative prediction of the histological grade of hepatocellular carcinoma (HCC). Materials and Methods A comprehensive literature search was performed in several authoritative databases to identify relevant articles. QUADAS-2 was used to assess the quality of included studies. Data were extracted to calculate the pooled sensitivity, specificity, positive likelihood ratio (PLR) and negative likelihood ratio (NLR). Summary receiver operating characteristic (SROC) curves were derived and areas under the SROC curve (AUC) were computed to indicate the diagnostic accuracy. Heterogeneity test, meta-regression analysis and sensitivity analysis were performed to identify factors and studies contributed to the heterogeneity. Results A total of 11 studies with 912 HCCs were included in this meta-analysis. The pooled sensitivity, specificity, PLR and NLR with corresponding 95% confidence intervals (CI) were 0.54 (0.47-0.61), 0.90(0.87-0.93), 4.88(2.99-7.97) and 0.46(0.27-0.77) for the prediction of well-differentiated HCC (w-HCC), 0.84(0.78-0.89), 0.48(0.43-0.52), 2.29(1.43-3.69) and 0.30(0.22-0.41) for the prediction of poorly-differentiated HCC (p-HCC). The AUC were 0.9311 and 0.8513 in predicting w-HCC and p-HCC, respectively. Results were further evaluated according to the method of image interpretation. Significant heterogeneity was observed. Conclusion DWI had excellent and moderately high diagnostic accuracy for the detection of w-HCC and p-HCC, respectively. Nonetheless, further studies in larger populations and an optimized image acquisition and interpretation are required before DWI-derived parameters can be used as a useful image biomarker for the prediction of the histological grade of HCC.	[Chen, Jie; Wu, Mingpeng; Liu, Rongbo; Li, Siyi; Gao, Ronghui; Song, Bin] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Song, B (corresponding author), Sichuan Univ, West China Hosp, Dept Radiol, Chengdu 610064, Sichuan, Peoples R China.	songb_radiology@163.com	Song, Bin/AAD-3670-2020	Wu, Mingpeng/0000-0002-9083-1638; Song, Bin/0000-0002-7269-2101				An C, 2012, EUR RADIOL, V22, P1701, DOI 10.1007/s00330-012-2421-6; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Arends LR, 2008, MED DECIS MAKING, V28, P621, DOI 10.1177/0272989X08319957; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chang WC, 2014, ABDOM IMAGING, V29, P29; Choi JW, 2013, RADIOLOGY, V267, P776, DOI 10.1148/radiol.13120775; Choi JY, 2011, AM J ROENTGENOL, V197, P399, DOI 10.2214/AJR.10.5439; Choi YS, 2013, J MAGN RESON IMAGING, V37, P1384, DOI 10.1002/jmri.23940; Chou CT, 2010, J MAGN RESON IMAGING, V32, P895, DOI 10.1002/jmri.22316; Cillo U, 2004, ANN SURG, V239, P150, DOI 10.1097/01.sla.0000109146.72827.76; de Lope CR, 2012, J HEPATOL, V56, P60009; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Enomoto S, 2011, HEPATOL INT, V5, P730, DOI 10.1007/s12072-010-9245-8; Erturk SM, 2008, J COMPUT ASSIST TOMO, V32, P865, DOI 10.1097/RCT.0b013e3181591cf2; Girometti R, 2013, RADIOL MED, V118, P343, DOI 10.1007/s11547-012-0873-z; Goshima S, 2008, J MAGN RESON IMAGING, V28, P691, DOI 10.1002/jmri.21467; Heo SH, 2010, KOREAN J RADIOL, V11, P295, DOI 10.3348/kjr.2010.11.3.295; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Honest H, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-4; Jonas S, 2001, HEPATOLOGY, V33, P1080, DOI 10.1053/jhep.2001.23561; Kakite S, 2015, J MAGN RESON IMAGING, V41, P149, DOI 10.1002/jmri.24538; Kim AY, 2012, ACTA RADIOL, V53, P830, DOI 10.1258/ar.2012.120099; Kim BK, 2008, J SURG ONCOL, V97, P246, DOI 10.1002/jso.20953; Kim HY, 2012, LIVER TRANSPLANT, V18, P850, DOI 10.1002/lt.23426; Kim I, 2012, KOREAN J RADIOL, V13, P586, DOI 10.3348/kjr.2012.13.5.586; Kogita S, 2010, EUR RADIOL, V20, P2405, DOI 10.1007/s00330-010-1812-9; Le Moigne F, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130763; Lee MH, 2011, AM J ROENTGENOL, V197, DOI [10.2214/AJR.10.6198, DOI 10.2214/AJR.10.6198]; Lim KS, 2014, CLIN RADIOL, V69, P1, DOI 10.1016/j.crad.2013.07.022; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Muhi A, 2009, J MAGN RESON IMAGING, V30, P1005, DOI 10.1002/jmri.21931; Murakami Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-99; Nakanishi M, 2012, ANN SURG ONCOL, V19, P1302, DOI 10.1245/s10434-011-2066-8; Nasu Katsuhiro, 2006, Radiat Med, V24, P438, DOI 10.1007/s11604-006-0053-y; Nasu K, 2009, AM J ROENTGENOL, V193, P438, DOI 10.2214/AJR.08.1424; Nishie A, 2011, EUR J RADIOL, V80, P8; Oishi K, 2007, J SURG ONCOL, V95, P311, DOI 10.1002/jso.20661; Panic N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082806, DOI 10.1371/JOURNAL.PONE.0082806]; Pawlik TM, 2007, ANN SURG, V245, P435, DOI 10.1097/01.sla.0000250420.73854.ad; Perez-Saborido B, 2007, TRANSPL P, V39, P2304, DOI 10.1016/j.transproceed.2007.06.059; Piana G, 2011, J HEPATOL, V55, P126, DOI 10.1016/j.jhep.2010.10.023; Pirisi M, 2010, ARCH PATHOL LAB MED, V134, P1818, DOI 10.1043/2009-0551-OAR1.1; Rampone B, 2010, CURR ONCOL REP, V12, P186, DOI 10.1007/s11912-010-0094-3; Saito K, 2012, J MED IMAG RADIAT ON, V56, P261, DOI 10.1111/j.1754-9485.2012.02374.x; Saito K, 2011, WORLD J GASTROENTERO, V17, P3503, DOI 10.3748/wjg.v17.i30.3503; Sandrasegaran K, 2013, CLIN RADIOL, V68, P708, DOI 10.1016/j.crad.2012.10.023; Schmid-Tannwald C, 2013, ACAD RADIOL, V20, P440, DOI 10.1016/j.acra.2012.10.012; Song FJ, 2002, INT J EPIDEMIOL, V31, P88, DOI 10.1093/ije/31.1.88; Suh KS, 2007, DIGEST DIS, V25, P329, DOI 10.1159/000106913; Tahir B, 2011, CLIN RADIOL, V66, P845, DOI 10.1016/j.crad.2011.03.021; Tamura S, 2001, ARCH SURG-CHICAGO, V136, P25, DOI 10.1001/archsurg.136.1.25; Taouli B, 2010, RADIOLOGY, V254, P47, DOI 10.1148/radiol.09090021; Vamvakas EC, 1998, ARCH PATHOL LAB MED, V122, P675; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Witjes CDM, 2012, J MAGN RESON IMAGING, V36, P641, DOI 10.1002/jmri.23681; Woo S, 2014, RADIOLOGY, V270, P758, DOI 10.1148/radiol.13130444; Yamada I, 1999, RADIOLOGY, V210, P617, DOI 10.1148/radiology.210.3.r99fe17617; Yu GR, 2007, EXP MOL MED, V39, P641, DOI 10.1038/emm.2007.70; Yu MH, 2014, RADIOLOGY, V271, P748, DOI 10.1148/radiol.14131996; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zhou L, 2014, PATHOL ONCOL RES, V8, P8, DOI DOI 10.1371/J0URNAL.P0NE.0104875	61	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117661	10.1371/journal.pone.0117661	http://dx.doi.org/10.1371/journal.pone.0117661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658359	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900197
J	Finch, ML; Passman, AM; Strauss, RP; Yeoh, GC; Callus, BA				Finch, Megan L.; Passman, Adam M.; Strauss, Robyn P.; Yeoh, George C.; Callus, Bernard A.			Sub-Cellular Localisation Studies May Spuriously Detect the Yes-Associated Protein, YAP, in Nucleoli Leading to Potentially Invalid Conclusions of Its Function	PLOS ONE			English	Article							HIPPO PATHWAY; PROGENITOR CELLS; SIZE-CONTROL; ORGAN SIZE; OVAL CELLS; DOMAIN; GROWTH; MST2; INACTIVATION; ONCOPROTEIN	The Yes-associated protein (YAP) is a potent transcriptional co-activator that functions as a nuclear effector of the Hippo signaling pathway. YAP is oncogenic and its activity is linked to its cellular abundance and nuclear localisation. Activation of the Hippo pathway restricts YAP nuclear entry via its phosphorylation by Lats kinases and consequent cytoplasmic retention bound to 14-3-3 proteins. We examined YAP expression in liver progenitor cells (LPCs) and surprisingly found that transformed LPCs did not show an increase in YAP abundance compared to the non-transformed LPCs from which they were derived. We then sought to ascertain whether nuclear YAP was more abundant in transformed LPCs. We used an antibody that we confirmed was specific for YAP by immunoblotting to determine YAP's sub-cellular localisation by immunofluorescence. This antibody showed diffuse staining for YAP within the cytosol and nuclei, but, noticeably, it showed intense staining of the nucleoli of LPCs. This staining was non-specific, as shRNA treatment of cells abolished YAP expression to undetectable levels by Western blot yet the nucleolar staining remained. Similar spurious YAP nucleolar staining was also seen in mouse embryonic fibroblasts and mouse liver tissue, indicating that this antibody is unsuitable for immunological applications to determine YAP sub-cellular localisation in mouse cells or tissues. Interestingly nucleolar staining was not evident in D645 cells suggesting the antibody may be suitable for use in human cells. Given the large body of published work on YAP in recent years, many of which utilise this antibody, this study raises concerns regarding its use for determining sub-cellular localisation. From a broader perspective, it serves as a timely reminder of the need to perform appropriate controls to ensure the validity of published data.	[Finch, Megan L.; Passman, Adam M.; Strauss, Robyn P.; Yeoh, George C.; Callus, Bernard A.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA 6009, Australia; [Yeoh, George C.] QEII Med Ctr, Harry Perkins Inst Med Res, Nedlands, WA, Australia; [Yeoh, George C.] Univ Western Australia, Med Res Ctr, Crawley, WA 6009, Australia	University of Western Australia; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia	Callus, BA (corresponding author), Univ Western Australia, Sch Chem & Biochem, Crawley, WA 6009, Australia.	Bernard.Callus@uwa.edu.au	Yeoh, George/B-5339-2011; Finch-Edmondson, Megan/S-7340-2017	Yeoh, George/0000-0002-4740-4702; Strauss, Robyn/0000-0002-5571-5797; Finch-Edmondson, Megan/0000-0002-9628-5842; Passman, Adam/0000-0003-3212-6938	Association of International Cancer Research [09-0084]; Cancer Council of Western Australia (CCWA) [APP1010749, APP1067515]; CCWA [1030183]; NHMRC of Australia [APP1023187, APP1022498, APP1042368]; Australian Postgraduate Award from University of Western Australia (UWA); National Stem Cell Foundation of Australia; University Postgraduate Award and top-up scholarship from UWA; top-up scholarship from the CCWA; Prescott Postgraduate Scholarship from UWA; top-up scholarships from the University of Western Australia (UWA); STFC [ST/H000429/1] Funding Source: UKRI	Association of International Cancer Research; Cancer Council of Western Australia (CCWA)(Cancer Council Western Australia); CCWA(Cancer Council Western Australia); NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award from University of Western Australia (UWA); National Stem Cell Foundation of Australia; University Postgraduate Award and top-up scholarship from UWA; top-up scholarship from the CCWA; Prescott Postgraduate Scholarship from UWA; top-up scholarships from the University of Western Australia (UWA); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by funding from the Association of International Cancer Research (#09-0084; http://www.aicr.org.uk) and the Cancer Council of Western Australia (CCWA; http://www.cancerwa.asn.au) (APP1010749 and APP1067515) to BAC and from the CCWA (1030183) and the NHMRC (http://www.nhmrc.gov.au) of Australia (APP1023187, APP1022498 and APP1042368) to GCY. MLF is a recipient of an Australian Postgraduate Award and top-up scholarships from the University of Western Australia (UWA) and the National Stem Cell Foundation of Australia. AMP is a recipient of a University Postgraduate Award and top-up scholarship from UWA and a top-up scholarship from the CCWA. RPS is a recipient of a Prescott Postgraduate Scholarship from UWA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The financial support from the funders does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ALEXANDER WS, 1989, ONCOGENE, V4, P575; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; BENAVENTE R, 1988, CHROMOSOMA, V97, P115, DOI 10.1007/BF00327368; Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Callus BA, 2008, J MOL BIOL, V384, P313, DOI 10.1016/j.jmb.2008.09.041; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Dong G, 1997, J CELL BIOCHEM, P90; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dumble ML, 2002, CARCINOGENESIS, V23, P435, DOI 10.1093/carcin/23.3.435; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hirate Y, 2012, P NATL ACAD SCI USA, V109, pE3389, DOI 10.1073/pnas.1211810109; Jellicoe MM, 2008, CARCINOGENESIS, V29, P1124, DOI 10.1093/carcin/bgn093; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Oka T, 2010, BIOCHEM J, V432, P461, DOI 10.1042/BJ20100870; Oka T, 2009, GENES CELLS, V14, P607, DOI 10.1111/j.1365-2443.2009.01292.x; Oudhoff MJ, 2013, DEV CELL, V26, P188, DOI 10.1016/j.devcel.2013.05.025; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Strick-Marchand H, 2002, HEPATOLOGY, V36, P794, DOI 10.1053/jhep.2002.36123; Tirnitz-Parker JEE, 2007, INT J BIOCHEM CELL B, V39, P2226, DOI 10.1016/j.biocel.2007.06.008; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao B, 2009, CANCER CELL, V16, P363, DOI 10.1016/j.ccr.2009.10.008; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0114813	10.1371/journal.pone.0114813	http://dx.doi.org/10.1371/journal.pone.0114813			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658431	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900009
J	Heidegger, I; Skradski, V; Steiner, E; Klocker, H; Pichler, R; Pircher, A; Horninger, W; Bektic, J				Heidegger, Isabel; Skradski, Viktor; Steiner, Eberhard; Klocker, Helmut; Pichler, Renate; Pircher, Andreas; Horninger, Wolfgang; Bektic, Jasmin			High Risk of Under-Grading and -Staging in Prostate Cancer Patients Eligible for Active Surveillance	PLOS ONE			English	Article							CONSERVATIVE MANAGEMENT; PSA LEVELS; MEN; PREDICTORS; BIOPSY; ANTIGEN	Background Active surveillance (AS) is increasingly offered to patients with low risk prostate cancer. The present study was conducted to evaluate the risk of tumor under-grading and -staging for AS eligibility. Moreover, we analyzed possible biomarkers for predicting more unfavorable final tumor histology. Methods 197 patients who underwent radical prostatectomy (RPE) but would have met the EAU (European Association of Urology) criteria for AS (PSA<10 ng/ml, biopsy GS <= 6, <= 2 cancer- positive biopsy cores with <= 50% of tumor in any core and clinical stage <= T2a) were included in the study. These AS inclusion parameters were correlated to the final histology of the RPE specimens. The impact of preoperative PSA level (low PSA <= 4 ng/ml vs. intermediate PSA of >4-10 ng/ml), PSA density (< 15 vs. >= 15 ng/ml) and the number of positive biopsy cores (1 vs. 2 positive cores) on predicting upgrading and final adverse histology of the RPE specimens was analyzed in uni- and multivariate analyses. Moreover, clinical courses of undergraded patients were assessed. Results In our patient cohort 41.1% were found under-graded in the biopsy (final histology 40.1% GS7, 1% GS8). Preoperative PSA levels, PSA density or the number of positive cores were not predictive for worse final pathological findings including GS > 6, extraprostatic extension and positive resection margin (R1) or correlated significantly with up-grading and/or extraprostatic extension in a multivariate model. Only R1 resections were predictable by combining intermediate PSA levels with two positive biopsy cores (p = 0.004). Sub-analyses showed that the number of biopsy cores (10 vs. 15 biopsy cores) had no influence on above mentioned results on predicting biopsy undergrading. Clinical courses of patients showed that 19.9% of patients had a biochemical relapse after RPE, among all of them were undergraded in the initial biopsy. Conclusion In summary, this study shows that a multitude of patients fulfilling the criteria for AS are under-diagnosed. The use of preoperative PSA levels, PSA density and the number of positive cores were not predictable for undergrading in the present patient collective.	[Heidegger, Isabel; Skradski, Viktor; Steiner, Eberhard; Klocker, Helmut; Pichler, Renate; Horninger, Wolfgang; Bektic, Jasmin] Med Univ Innsbruck, Dept Urol, A-6020 Innsbruck, Austria; [Pircher, Andreas] Med Univ Innsbruck, Dept Haematol & Oncol, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Bektic, J (corresponding author), Med Univ Innsbruck, Dept Urol, A-6020 Innsbruck, Austria.	Jasmin.bektic@uki.at	Bektic, Jasmin/AAB-3952-2021; Pircher, Andreas/L-2150-2019; Klocker, Helmut/AAI-7130-2020	Pircher, Andreas/0000-0002-7747-3012; 				Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Berg KD, 2011, APMIS, V119, P239, DOI 10.1111/j.1600-0463.2011.02723.x; Bill-Axelson A, 2013, EUR UROL; Bul M, 2013, EUR UROL, V63, P597, DOI 10.1016/j.eururo.2012.11.005; Bul M, 2012, EUR UROL, V61, P370, DOI 10.1016/j.eururo.2011.06.027; Catalona WJ, 1999, UROLOGY, V54, P220, DOI 10.1016/S0090-4295(99)00185-5; CHODAK GW, 1994, NEW ENGL J MED, V330, P242, DOI 10.1056/NEJM199401273300403; Ehdaie B, 2013, J UROL; Fleshner NE, 1998, UROLOGY, V52, P659, DOI 10.1016/S0090-4295(98)00226-X; Graefen M, 2013, EUR UROL, V63, P604, DOI 10.1016/j.eururo.2012.12.003; Han JS, 2012, UROLOGY, V80, P883, DOI 10.1016/j.urology.2012.05.045; Heidegger I, 2012, ANTICANCER RES, V32, P5481; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Klotz Laurence, 2012, F1000 Med Rep, V4, P16, DOI 10.3410/M4-16; Krakowsky Y, 2010, J UROLOGY, V184, P131, DOI 10.1016/j.juro.2010.03.041; Oh JJ, 2012, BJU INT, V110, pE494, DOI 10.1111/j.1464-410X.2012.11182.x; Oliveira IS, 2010, INT BRAZ J UROL, V36, P292, DOI 10.1590/S1677-55382010000300005; Punnen S, 2013, BJU INT, V112, pE67, DOI 10.1111/bju.12209; Reissigl A, 1997, CANCER-AM CANCER SOC, V80, P1818, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1818::AID-CNCR21>3.0.CO;2-7; Thomsen FB, 2013, DAN MED J, V60; Vellekoop A, 2014, J UROLOGY, V191, P350, DOI 10.1016/j.juro.2013.09.034	21	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115537	10.1371/journal.pone.0115537	http://dx.doi.org/10.1371/journal.pone.0115537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658878	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900021
J	Hirosawa, T; Kikuchi, M; Okumura, E; Yoshimura, Y; Hiraishi, H; Munesue, T; Takesaki, N; Furutani, N; Ono, Y; Higashida, H; Minabe, Y				Hirosawa, Tetsu; Kikuchi, Mitsuru; Okumura, Eiichi; Yoshimura, Yuko; Hiraishi, Hirotoshi; Munesue, Toshio; Takesaki, Natsumi; Furutani, Naoki; Ono, Yasuki; Higashida, Haruhiro; Minabe, Yoshio			Attentional Control and Interpretation of Facial Expression after Oxytocin Administration to Typically Developed Male Adults	PLOS ONE			English	Article							ACUTE TRYPTOPHAN DEPLETION; ANTERIOR CINGULATE; EXECUTIVE FUNCTION; RESPONSE-INHIBITION; PREFRONTAL CORTEX; SOCIAL-BEHAVIOR; NEURAL BASIS; TASK; MIND; DISORDER	Deficits in attentional-inhibitory control have been reported to correlate to anger, hostility, and aggressive behavior; therefore, inhibitory control appears to play an important role in prosocial behavior. Moreover, recent studies have demonstrated that oxytocin (OT) exerts a prosocial effect (e.g., decreasing negative behaviors, such as aggression) on humans. However, it is unknown whether the positively valenced effect of OT on sociality is associated with enhanced attentional-inhibitory control. In the present study, we hypothesized that OT enhances attentional-inhibitory control and that the positively valenced effect of OT on social cognition is associated with enhanced attentional-inhibitory control. In a single-blind, placebo-controlled crossover trial, we tested this hypothesis using 20 healthy male volunteers. We considered a decrease in the hostility detection ratio, which reflects the positively valenced interpretation of other individuals' facial expressions, to be an index of the positively valenced effects of OT (we reused the results of our previously published study). As a measure of attentional-inhibitory control, we employed a modified version of the flanker task (i.e., a shorter conflict duration indicated higher inhibitory control). These results failed to demonstrate any significant behavioral effects of OT (i.e., neither a positively valenced effect on facial cognition nor an effect on attentional-inhibitory control). However, the enhancement of attentional-inhibitory control after OT administration significantly correlated to the positively valenced effects on the interpretation of uncertain facial cognition (i.e., neutral and ambiguous facial expressions).	[Hirosawa, Tetsu; Kikuchi, Mitsuru; Munesue, Toshio; Takesaki, Natsumi; Furutani, Naoki; Ono, Yasuki; Minabe, Yoshio] Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan; [Kikuchi, Mitsuru; Yoshimura, Yuko; Hiraishi, Hirotoshi; Munesue, Toshio; Higashida, Haruhiro; Minabe, Yoshio] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan; [Okumura, Eiichi] Tohoku Univ, Sch Med, Dept Epileptol, Sendai, Miyagi 980, Japan	Kanazawa University; Kanazawa University; Tohoku University	Kikuchi, M (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan.	mitsuru@zc4.so-net.ne.jp	higashida, haruhiro/L-3773-2015	higashida, haruhiro/0000-0002-1779-0606; Furutani, Naoki/0000-0001-5953-2114	Strategic Research Program for Brain Sciences; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [24000012]; Japan Science and Technology Agency, JST, Japan; Grants-in-Aid for Scientific Research [26670537] Funding Source: KAKEN	Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency, JST, Japan(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	H. Higashida was supported by the Strategic Research Program for Brain Sciences, M. Kikuchi was supported by Grant-in-Aid for Specially Promoted Research (Number 24000012) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and Y. Minabe was supported by the Center of Innovation Program from Japan Science and Technology Agency, JST, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Bari A, 2011, J NEUROSCI, V31, P9254, DOI 10.1523/JNEUROSCI.1543-11.2011; Barraza JA, 2009, ANN NY ACAD SCI, V1167, P182, DOI 10.1111/j.1749-6632.2009.04504.x; Bartz J, 2010, SOC COGN AFFECT NEUR; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Bartz JA, 2010, P NATL ACAD SCI USA, V107, P21371, DOI 10.1073/pnas.1012669107; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Beacher FDCC, 2011, PSYCHOPHARMACOLOGY, V213, P603, DOI 10.1007/s00213-010-1897-5; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Brophy M, 2002, INFANT CHILD DEV, V11, P125, DOI 10.1002/icd.301; Carlin JD, 2013, CURR OPIN NEUROBIOL, V23, P450, DOI 10.1016/j.conb.2012.11.014; Carlson SM, 2001, CHILD DEV, V72, P1032, DOI 10.1111/1467-8624.00333; De Dreu CKW, 2011, P NATL ACAD SCI USA, V108, P1262, DOI 10.1073/pnas.1015316108; Dolan M, 2002, PSYCHOL MED, V32, P417, DOI 10.1017/S0033291702005378; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Eggum ND, 2011, J POSIT PSYCHOL, V6, P4, DOI 10.1080/17439760.2010.536776; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Hala S, 2003, J COGN DEV, V4, P275, DOI 10.1207/S15327647JCD0403_03; Higashida H, 2010, J NEUROENDOCRINOL, V22, P373, DOI 10.1111/j.1365-2826.2010.01976.x; Hirosawa T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00384; Hughes C, 1998, J CHILD PSYCHOL PSYC, V39, P981, DOI 10.1017/S0021963098003059; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kerns JG, 2006, NEUROIMAGE, V33, P399, DOI 10.1016/j.neuroimage.2006.06.012; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; Korn CW, 2012, J NEUROSCI, V32, P16832, DOI 10.1523/JNEUROSCI.3016-12.2012; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Macoveanu J, 2013, NEUROPSYCHOPHARMACOL, V38, P996, DOI 10.1038/npp.2012.264; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Munesue T, 2010, NEUROSCI RES, V67, P181, DOI 10.1016/j.neures.2010.03.004; Naber FBA, 2013, J AUTISM DEV DISORD, V43, P224, DOI 10.1007/s10803-012-1536-6; Oosterlaan J, 1998, BEHAV BRAIN RES, V94, P33, DOI 10.1016/S0166-4328(97)00167-8; Passamonti L, 2012, BIOL PSYCHIAT, V71, P36, DOI 10.1016/j.biopsych.2011.07.033; Perner J, 2002, CHILD DEV, V73, P752, DOI 10.1111/1467-8624.00436; Petrovic P, 2008, J NEUROSCI, V28, P6607, DOI 10.1523/JNEUROSCI.4572-07.2008; Pizzagalli DA, 2006, HUM BRAIN MAPP, V27, P185, DOI 10.1002/hbm.20172; Sellbom M, 2007, J RES PERS, V41, P276, DOI 10.1016/j.jrp.2006.04.001; Shamay-Tsoory SG, 2009, BIOL PSYCHIAT, V66, P864, DOI 10.1016/j.biopsych.2009.06.009; Somerville LH, 2013, PSYCHOL SCI, V24, P1554, DOI 10.1177/0956797613475633; Sprague J, 2011, EMOTION, V11, P61, DOI 10.1037/a0021788; Sripada CS, 2013, INT J NEUROPSYCHOPH, V16, P255, DOI 10.1017/S1461145712000533; Theodoridou A, 2009, HORM BEHAV, V56, P128, DOI 10.1016/j.yhbeh.2009.03.019; Watanabe T, 2014, JAMA PSYCHIAT, V71, P166, DOI 10.1001/jamapsychiatry.2013.3181; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009; Zak PJ, 2004, ANN NY ACAD SCI, V1032, P224, DOI 10.1196/annals.1314.025	45	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116918	10.1371/journal.pone.0116918	http://dx.doi.org/10.1371/journal.pone.0116918			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25659131	Green Published, gold			2022-12-27	WOS:000349444900078
J	Jin, QJ; Xue, ZY; Dong, CL; Wang, YJ; Chu, LL; Xu, YC				Jin, Qijiang; Xue, Zeyun; Dong, Chunlan; Wang, Yanjie; Chu, Lingling; Xu, Yingchun			Identification and Characterization of MicroRNAs from Tree Peony (Paeonia ostii) and Their Response to Copper Stress	PLOS ONE			English	Article							HEAVY-METAL DETOXIFICATION; SMALL RNAS; DOWN-REGULATION; ARABIDOPSIS; GENES; ROLES; MECHANISMS; PHYTOCHELATINS; EXPRESSION; TOLERANCE	MicroRNAs (miRNAs) are a class of non-coding, small RNAs recognized as important regulators of gene expression. Although plant miRNAs have been extensively studied in model systems, less is known in other plants with limited genome sequence data, including Paeonia ostii. In this work, we used high-throughput sequencing to identify conserved and nonconserved miRNAs and other short RNAs in Paeonia ostii under control and copper stressed condition. 102 previously known plant miRNAs were identified and classified into 89 families according to their gene sequence identity. Some miRNAs were highly conserved in the plant kingdom suggesting that these miRNA play important and conserved roles. Combined our transcriptome sequencing data of Paeonia ostii under same conditions, 34 novel potential miRNAs were identified. The potential targets of the identified known and novel miRNAs were also predicted based on sequence homology search. Comparing the two libraries, it was observed that 12 conserved miRNAs and 18 novel miRNAs showed significantly changes in response to copper stress. Some of the new identified potential miRNAs might be involved in Paeonia ostii-specific regulating mechanisms under copper stress. These results provide a framework for further analysis of miRNAs and their role in regulating Paeonia ostii response to copper stress.	[Jin, Qijiang; Xue, Zeyun; Dong, Chunlan; Wang, Yanjie; Chu, Lingling; Xu, Yingchun] Nanjing Agr Univ, Coll Hort, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Xu, YC (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing 210095, Jiangsu, Peoples R China.	wbshenh@njau.edu.cn; xyc@njau.edu.cn			National Natural Science Foundation of China [31101560]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (grant no. 31101560). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Clemens S, 2001, PLANTA, V212, P475, DOI 10.1007/s004250000458; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; Delhaize E, 2003, PLANT CELL, V15, P1131, DOI 10.1105/tpc.009134; Ding YF, 2009, BIOCHEM BIOPH RES CO, V386, P6, DOI 10.1016/j.bbrc.2009.05.137; Dolgosheina EV, 2008, RNA, V14, P1508, DOI 10.1261/rna.1052008; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gai SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055297; Gielen H, 2012, INT J MOL SCI, V13, P15826, DOI 10.3390/ijms131215826; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Hong DY, 2007, ACTA PHYTOTAXON SIN, V45, P285, DOI 10.1360/aps07043; Hong DY, 2005, ACTA PHYTOTAXON SIN, V43, P169, DOI 10.1360/aps040065; Huang SQ, 2009, J INORG BIOCHEM, V103, P282, DOI 10.1016/j.jinorgbio.2008.10.019; Jin QJ, 2013, PLANT SOIL, V366, P605, DOI 10.1007/s11104-012-1451-9; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Leitao AL, 2014, METHODS MOL BIOL, V1182, P265, DOI 10.1007/978-1-4939-1062-5_23; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Pelaez P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-83; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Sancenon V, 2003, PLANT MOL BIOL, V51, P577, DOI 10.1023/A:1022345507112; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Wang C, 2011, PHYSIOL PLANTARUM, V143, P64, DOI 10.1111/j.1399-3054.2011.01481.x; Yadav SK, 2010, S AFR J BOT, V76, P167, DOI 10.1016/j.sajb.2009.10.007; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072840; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	27	32	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117584	10.1371/journal.pone.0117584	http://dx.doi.org/10.1371/journal.pone.0117584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658957	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900184
J	Marinova, IN; Engelbrecht, J; Ewald, A; Langholm, LL; Holmberg, C; Kragelund, BB; Gordon, C; Nielsen, O; Hartmann-Petersen, R				Marinova, Irina N.; Engelbrecht, Jacob; Ewald, Adrian; Langholm, Lasse L.; Holmberg, Christian; Kragelund, Birthe B.; Gordon, Colin; Nielsen, Olaf; Hartmann-Petersen, Rasmus			Single Site Suppressors of a Fission Yeast Temperature-Sensitive Mutant in cdc48 Identified by Whole Genome Sequencing	PLOS ONE			English	Article							AAA-ATPASE; TRANSCRIPTION FACTOR; UBIQUITIN; P97; SEGREGASE; ER; CDC48(UFD1/NPL4); STABILITY; PROTEINS; ADAPTER	The protein called p97 in mammals and Cdc48 in budding and fission yeast is a homo-hexameric, ring-shaped, ubiquitin-dependent ATPase complex involved in a range of cellular functions, including protein degradation, vesicle fusion, DNA repair, and cell division. The cdc48(+) gene is essential for viability in fission yeast, and point mutations in the human orthologue have been linked to disease. To analyze the function of p97/Cdc48 further, we performed a screen for cold-sensitive suppressors of the temperature-sensitive cdc48-353 fission yeast strain. In total, 29 independent pseudo revertants that had lost the temperature- sensitive growth defect of the cdc48-353 strain were isolated. Of these, 28 had instead acquired a cold-sensitive phenotype. Since the suppressors were all spontaneous mutants, and not the result of mutagenesis induced by chemicals or UV irradiation, we reasoned that the genome sequences of the 29 independent cdc48-353 suppressors were most likely identical with the exception of the acquired suppressor mutations. This prompted us to test if a whole genome sequencing approach would allow us to map the mutations. Indeed genome sequencing unambiguously revealed that the cold-sensitive suppressors were all second site intragenic cdc48 mutants. Projecting these onto the Cdc48 structure revealed that while the original temperature-sensitive G338D mutation is positioned near the central pore in the hexameric ring, the suppressor mutations locate to subunit-subunit and inter-domain boundaries. This suggests that Cdc48-353 is structurally compromized at the restrictive temperature, but re-established in the suppressor mutants. The last suppressor was an extragenic frame shift mutation in the ufd1 gene, which encodes a known Cdc48 co-factor. In conclusion, we show, using a novel whole genome sequencing approach, that Cdc48-353 is structurally compromized at the restrictive temperature, but stabilized in the suppressors.	[Marinova, Irina N.; Engelbrecht, Jacob; Ewald, Adrian; Langholm, Lasse L.; Holmberg, Christian; Kragelund, Birthe B.; Nielsen, Olaf; Hartmann-Petersen, Rasmus] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Gordon, Colin] Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Copenhagen; University of Edinburgh	Hartmann-Petersen, R (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	rhpetersen@bio.ku.dk	Nielsen, Olaf/G-4980-2012; Hartmann-Petersen, Rasmus/K-4434-2014; Holmberg, Christian/L-8011-2014; Kragelund, Birthe/M-3927-2014	Nielsen, Olaf/0000-0001-7440-5201; Hartmann-Petersen, Rasmus/0000-0002-4155-7791; Holmberg, Christian/0000-0001-9224-0543; Kragelund, Birthe/0000-0002-7454-1761; Langholm, Lasse Locke/0000-0003-0549-5797; Marinova, Irina/0000-0002-3626-7095; Ewald, David Adrian/0000-0001-6620-2738	Medical Research Council; Danish Council for Independent Research (Natural Sciences); Novo Nordisk Foundation; Lundbeck Foundation	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Council for Independent Research (Natural Sciences)(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Medical Research Council funding to C. G. as well as by grants from the Danish Council for Independent Research (Natural Sciences), The Novo Nordisk Foundation and the Lundbeck Foundation to R. H. P. and J.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bebeacua C, 2012, P NATL ACAD SCI USA, V109, P1098, DOI 10.1073/pnas.1114341109; Bergink S, 2013, NAT CELL BIOL, V15, P526, DOI 10.1038/ncb2729; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; Dobrynin G, 2011, J CELL SCI, V124, P1571, DOI 10.1242/jcs.069500; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Hayles J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130053; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Ikai N, 2006, J STRUCT BIOL, V156, P50, DOI 10.1016/j.jsb.2006.04.003; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Ju JS, 2010, HUM MOL GENET, V19, pR38, DOI 10.1093/hmg/ddq157; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kohler JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080442; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kriegenburg F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004140; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Madsen L, 2009, INT J BIOCHEM CELL B, V41, P2380, DOI 10.1016/j.biocel.2009.05.017; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MOIR D, 1982, GENETICS, V100, P547; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Naula N, 2003, CURR GENET, V43, P400, DOI 10.1007/s00294-003-0413-4; Nie MH, 2012, J BIOL CHEM, V287, P29610, DOI 10.1074/jbc.M112.379768; Park S, 2005, STRUCTURE, V13, P995, DOI 10.1016/j.str.2005.04.013; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Sommer T, 2001, REV PHYSIOL BIOCH P, V142, P97, DOI 10.1007/BFb0117492; Stewart EV, 2012, J BIOL CHEM, V287, P672, DOI 10.1074/jbc.M111.317370; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tang WK, 2013, J BIOL CHEM, V288, P36624, DOI 10.1074/jbc.M113.488924; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yuasa T, 2004, GENES CELLS, V9, P1069, DOI 10.1111/j.1365-2443.2004.00790.x	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117779	10.1371/journal.pone.0117779	http://dx.doi.org/10.1371/journal.pone.0117779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658828	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900219
J	Mlynarek, JJ; Iserbyt, A; Nagel, L; Forbes, MR				Mlynarek, Julia J.; Iserbyt, Arne; Nagel, Laura; Forbes, Mark R.			Differential Water Mite Parasitism, Phenoloxidase Activity, and Resistance to Mites Are Unrelated across Pairs of Related Damselfly Species	PLOS ONE			English	Article							IMMUNE-RESPONSE; GENETIC DIVERSITY; HOST DAMSELFLIES; EXPRESSION; MELANIZATION; DRAGONFLIES; MAINTENANCE; INFECTION; ECOLOGY; ODONATA	Related host species often demonstrate differences in prevalence and/or intensity of infection by particular parasite species, as well as different levels of resistance to those parasites. The mechanisms underlying this interspecific variation in parasitism and resistance expression are not well understood. Surprisingly, few researchers have assessed relations between actual levels of parasitism and resistance to parasites seen in nature across multiple host species. The main goal of this study was to determine whether interspecific variation in resistance against ectoparasitic larval water mites either was predictive of interspecific variation in parasitism for ten closely related species of damselflies (grouped into five "species pairs"), or was predicted by interspecific variation in a commonly used measure of innate immunity (total Phenoloxidase or potential PO activity). Two of five species pairs had interspecific differences in proportions of individuals resisting larval Arrenurus water mites, only one of five species pairs had species differences in prevalence of larval Arrenurus water mites, and another two of five species pairs showed species differences in mean PO activity. Within the two species pairs where species differed in proportion of individuals resisting mites the species with the higher proportion did not have correspondingly higher PO activity levels. Furthermore, the proportion of individuals resisting mites mirrored prevalence of parasitism in only one species pair. There was no interspecific variation in median intensity of mite infestation within any species pair. We conclude that a species' relative ability to resist particular parasites does not explain interspecific variation in parasitism within species pairs and that neither resistance nor parasitism is reflected by interspecific variation in total PO or potential PO activity.	[Mlynarek, Julia J.; Forbes, Mark R.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Iserbyt, Arne] Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Iserbyt, Arne] Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; [Nagel, Laura] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Carleton University; University of Antwerp; University of Antwerp; Queens University - Canada	Mlynarek, JJ (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	Julia.mlynarek@carleton.ca		Mlynarek, Julia J./0000-0002-1569-9403; Forbes, Mark/0000-0002-2288-3209; Iserbyt, Arne/0000-0002-6414-6688	Natural Sciences and Engineering Research Council (NSERC) Canada; agency for Innovation by Science and Technology (IWT Flanders); Fund for Scientific Research (FWO Flanders); Natural Sciences and Engineering Research Council (NSERC)	Natural Sciences and Engineering Research Council (NSERC) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); agency for Innovation by Science and Technology (IWT Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific Research (FWO Flanders)(FWO); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Research Council (NSERC) Canada Graduate Scholarship awarded to JJM and a Natural Sciences and Engineering Research Council (NSERC) discovery grant awarded to MRF. AI was funded by the agency for Innovation by Science and Technology (IWT Flanders) and the Fund for Scientific Research (FWO Flanders).	Armitage SAO, 2005, HEREDITY, V94, P650, DOI 10.1038/sj.hdy.6800675; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Bidla G, 2009, J INNATE IMMUN, V1, P301, DOI 10.1159/000168009; Binggeli O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004067; Contreras-Garduno J, 2007, J INSECT PHYSIOL, V53, P612, DOI 10.1016/j.jinsphys.2007.03.003; Corby-Harris V, 2008, J ANIM ECOL, V77, P768, DOI 10.1111/j.1365-2656.2008.01399.x; Fedorka KM, 2013, EVOL ECOL, V27, P521, DOI 10.1007/s10682-012-9620-0; Forbes MR, 2014, IDEAS ECOL EVOL, V7, P17, DOI 10.4033/iee.2014.7.5.n; Forbes MR, 1999, INT J PARASITOL, V29, P991, DOI 10.1016/S0020-7519(99)00061-2; Gonzalez-Santoyo I, 2010, BEHAVIOUR, V147, P1285, DOI 10.1163/000579510X516777; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; HAM PJ, 1995, PARASITOL TODAY, V11, P63, DOI 10.1016/0169-4758(95)80118-9; Iserbyt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032648; Jearaphunt M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004059; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Kaunisto KM, 2013, J EVOLUTION BIOL, V26, P1784, DOI 10.1111/jeb.12177; Marden JH, 2000, ANNU REV PHYSIOL, V62, P157, DOI 10.1146/annurev.physiol.62.1.157; Marmaras VJ, 1996, ARCH INSECT BIOCHEM, V31, P119, DOI 10.1002/(SICI)1520-6327(1996)31:2&lt;119::AID-ARCH1&gt;3.0.CO;2-V; May ML, 2002, SYST ENTOMOL, V27, P387, DOI 10.1046/j.1365-3113.2002.00188.x; Mlynarek JJ, 2014, EVOL BIOL, V41, P115, DOI 10.1007/s11692-013-9251-6; Mlynarek JJ, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-50; Mlynarek JJ, 2012, ECOL ENTOMOL, V37, P419, DOI 10.1111/j.1365-2311.2012.01381.x; Morand S, 2010, BIOGEOGRAPHY HOST PA, P159; Morand S, 2010, BIOGEOGRAPHY HOST PA, DOI [10.1111/j.1758-8111.2010.00001.x, DOI 10.1111/J.1758-8111.2010.00001.X]; Moreno-Garcia M, 2013, B ENTOMOL RES, V103, P127, DOI 10.1017/S000748531200048X; Nagel Laura, 2010, BMC Ecology, V10, P5, DOI 10.1186/1472-6785-10-5; Nagel L, 2011, ECOL ENTOMOL, V36, P736, DOI 10.1111/j.1365-2311.2011.01323.x; Pauwels K, 2011, BIOL LETTERS, V7, P156, DOI 10.1098/rsbl.2010.0634; Poulin R., 2007, EVOL ECOL, V2; Rolff J, 2001, CAN J ZOOL, V79, P2176, DOI 10.1139/cjz-79-12-2176; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Sanchez-Guillen RA, 2013, OECOLOGIA, V171, P105, DOI 10.1007/s00442-012-2388-7; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Smilanich AM, 2009, ECOLOGY, V90, P1434, DOI 10.1890/08-1906.1; Stoks R, 2006, ECOLOGY, V87, P809, DOI 10.1890/0012-9658(2006)87[809:TCMPPI]2.0.CO;2; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Sugumaran M, 2000, ARCH BIOCHEM BIOPHYS, V379, P252, DOI 10.1006/abbi.2000.1884; Vogelweith F, 2014, J INSECT PHYSIOL, V64, P54, DOI 10.1016/j.jinsphys.2014.03.009; Whitehorn PR, 2011, P ROY SOC B-BIOL SCI, V278, P1195, DOI 10.1098/rspb.2010.1550; Wilson K, 2013, ADV STUD BEHAV, V45, P81, DOI 10.1016/B978-0-12-407186-5.00003-3; Yourth CP, 2002, ECOL ENTOMOL, V27, P123, DOI 10.1046/j.1365-2311.2002.0376a.x; Yourth CP, 2001, CAN J ZOOL, V79, P815, DOI 10.1139/cjz-79-5-815; Zar JH, 1999, BIOSTATISTICAL ANAL	43	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115539	10.1371/journal.pone.0115539	http://dx.doi.org/10.1371/journal.pone.0115539			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658982	gold, Green Published			2022-12-27	WOS:000349444900022
J	Moyle, GJ; Orkin, C; Fisher, M; Dhar, J; Anderson, J; Wilkins, E; Ewan, J; Ebrahimi, R; Wang, H				Moyle, Graeme J.; Orkin, Chloe; Fisher, Martin; Dhar, Jyoti; Anderson, Jane; Wilkins, Edmund; Ewan, Jacqueline; Ebrahimi, Ramin; Wang, Hui		Rocket 1	A Randomized Comparative Trial of Continued Abacavir/Lamivudine plus Efavirenz or Replacement with Efavirenz/Emtricitabine/Tenofovir DF in Hypercholesterolemic HIV-1 Infected Individuals	PLOS ONE			English	Article							QUALITY-OF-LIFE; MYOCARDIAL-INFARCTION; TENOFOVIR DF/EMTRICITABINE; ANTIRETROVIRAL THERAPY; UPDATED GUIDELINES; ABACAVIR USE; HIV; ADHERENCE; TENOFOVIR/EMTRICITABINE; ZIDOVUDINE/LAMIVUDINE	Background Drug choice and metabolic changes with antiretroviral therapy contribute to cardiovascular risk in persons with HIV-1 infection. Methods A randomized, 12 week, open-label, comparative study of the impact on lipids of continuation of abacavir/lamivudine (ABC/3TC) plus efavirenz (EFV) or replacement with the single tablet regimen of EFV/emtricitabine/tenofovir DF (EFV/FTC/TDF) in hypercholesterolaemic subjects on successful antiretroviral therapy, with a 12-week extension with all subjects on EFV/FTC/TDF. Results 157 subjects received study drug, 79 switched to EFV/FTC/TDF and 78 subjects continued ABC/3TC+EFV. At Week 12, 73 subjects on ABC/3TC+EFV switched to EFV/FTC/TDF. The switch was well tolerated and no subject experienced viral rebound. Median baseline fasting total cholesterol was 6.32mmol/L. 12 weeks following switch, the difference in the means (LSM) between treatment groups (EFV/FTC/TDF minus ABC/3TC+EFV) in total cholesterol change from baseline was -0.74mmol/l (95% CI -1.00, -0.47, p < 0.001). The median change from baseline in total cholesterol following switch in the EFV/FTC/TDF arm was -0.86mmol/l (p < 0.001) compared with +0.01mmol/l (p = 0.45) in the continuation arm at Week 12. Significant (p < 0.001) differences between treatment groups following switch were seen for all lipid fractions from baseline to Week 12: LDL cholesterol (-0.47 mmol/L [-0.70, -0.25]), HDL cholesterol (-0.15 mmol/L [-0.21, -0.08]), triglycerides (-0.43 mmol/L [-0.75, -0.11]), and non HDL cholesterol (-0.56 mmol/L [-0.80, -0.31]). In the extension phase, similar declines in total cholesterol were observed with a median change from Week 12 to Week 24 of -0.73mmol/L (p < 0.001). Conclusions Switching from ABC/3TC+EFV to EFV/FTC/TDF in persons with hypercholesterolemia maintains virological control and significantly improves key lipid parameters.	[Moyle, Graeme J.] Chelsea & Westminster Hosp, London SW10 9NH, England; [Orkin, Chloe] St Bartholomews Hosp, London, England; [Orkin, Chloe] Royal London Hosp, London E1 1BB, England; [Fisher, Martin] Brighton Univ Hosp, Brighton BN2 5BE, E Sussex, England; [Fisher, Martin] Sussex Univ Hosp, Brighton BN2 5BE, E Sussex, England; [Dhar, Jyoti] Leicester Royal Infirm, Leicester, Leics, England; [Anderson, Jane] Homerton Univ Hosp, London, England; [Wilkins, Edmund] North Manchester Gen, Manchester, Lancs, England; [Ewan, Jacqueline] Gilead Sci Ltd, Cambridge, England; [Ebrahimi, Ramin; Wang, Hui] Gilead Sci Inc, Foster City, CA 94404 USA	Imperial College London; University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital; University of Brighton; University of Sussex; University of Leicester; University of London; Queen Mary University London; Gilead Sciences; Gilead Sciences	Moyle, GJ (corresponding author), Chelsea & Westminster Hosp, London SW10 9NH, England.	gm@moyleg.demon.co.uk	Anderson, Jane/A-1632-2012	Anderson, Jane/0000-0001-5294-8707; Leen, Clifford/0000-0001-8439-7719; Ong, Edmund/0000-0002-6594-0509	Gilead Sciences	Gilead Sciences(Gilead Sciences)	Gilead Sciences are the Sponsor and funders of this study. Gilead designed the study with input from the lead investigators. Gilead collected and analysed the data, made the decision to publish and reviewed and commented on the manuscript. The authors on this manuscript were Principal Investigators on this clinical trial and as such their institutions were paid a per patient fee for the work they performed and they were each paid travel expenses to attend study meetings. Dr Moyle, Dr Fisher and Dr Orkin presented the study on Gilead's behalf at International conferences and as such were supported to attend the conferences.	Airoldi M, 2010, PATIENT PREFER ADHER, V4, P115; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Cooper V, 2011, AIDS CARE, V23, P705, DOI 10.1080/09540121.2010.534433; Cruciani M, 2011, AIDS, V25, P1993, DOI 10.1097/QAD.0b013e328349c6ee; Ding X, 2012, JAIDS-J ACQ IMM DEF, V61, P441, DOI 10.1097/QAI.0b013e31826f993c; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Fisher M, 2009, JAIDS-J ACQ IMM DEF, V51, P562, DOI 10.1097/QAI.0b013e3181ae2eb9; Hall AM, 2011, AM J KIDNEY DIS, V57, P773, DOI 10.1053/j.ajkd.2011.01.022; Lima V, 2009, JAIDS-J ACQ IMM DEF, V51, P3, DOI 10.1097/QAI.0b013e31819e721b; Lundgren JD, 2008, AIDS, V22, pF17, DOI 10.1097/QAD.0b013e32830fe35e; Maitland D, 2008, HIV MED, V9, P667, DOI 10.1111/j.1468-1293.2008.00618.x; May Margaret, 2011, BMJ, V343, pd6016, DOI 10.1136/bmj.d6016; Mihos CG, 2010, CARDIOL REV, V18, P298, DOI 10.1097/CRD.0b013e3181f52a7f; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Moyle GJ, 2001, AIDS, V15, P1503, DOI 10.1097/00002030-200108170-00007; Moyle GJ, 2006, AIDS, V20, P2043, DOI 10.1097/01.aids.0000247574.33998.03; Portsmouth SD, 2005, HIV MED, V6, P185, DOI 10.1111/j.1468-1293.2005.00287.x; Post FA, 2010, JAIDS-J ACQ IMM DEF, V55, P49, DOI 10.1097/QAI.0b013e3181dd911e; Randell PA, 2010, ANTIVIR THER, V15, P227, DOI 10.3851/IMP1518; Sax PE, 2011, J INFECT DIS, V204, P1191, DOI 10.1093/infdis/jir505; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Smith KY, 2009, AIDS, V23, P1547, DOI 10.1097/QAD.0b013e32832cbcc2; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Vo TTN, 2008, J INFECT DIS, V197, P1685, DOI 10.1086/588141; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897	25	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116297	10.1371/journal.pone.0116297	http://dx.doi.org/10.1371/journal.pone.0116297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658097	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900034
J	Picazo, C; Orozco, H; Matallana, E; Aranda, A				Picazo, Cecilia; Orozco, Helena; Matallana, Emilia; Aranda, Agustn			Interplay among Gcn5, Sch9 and Mitochondria during Chronological Aging of Wine Yeast Is Dependent on Growth Conditions	PLOS ONE			English	Article							LIFE-SPAN; RETROGRADE RESPONSE; SACCHAROMYCES-CEREVISIAE; GENOME STABILITY; LONGEVITY; AUTOPHAGY; STRESS; METABOLISM; CHROMATIN; STRAINS	Saccharomyces cerevisiae chronological life span (CLS) is determined by a wide variety of environmental and genetic factors. Nutrient limitation without malnutrition, i.e. dietary restriction, expands CLS through the control of nutrient signaling pathways, of which TOR/Sch9 has proven to be the most relevant, particularly under nitrogen deprivation. The use of prototrophic wine yeast allows a better understanding of the role of nitrogen in longevity in natural and more demanding environments, such as grape juice fermentation. We previously showed that acetyltransferase Gcn5, a member of the SAGA complex, has opposite effects on CLS under laboratory and winemaking conditions, and is detrimental under the latter. Here we demonstrate that integrity of the SAGA complex is necessary for prolonged longevity, as its dismantling by SPT20 deletion causes a drop in CLS under both laboratory and winemaking conditions. The sch9 Delta mutant is long-lived in synthetic SC medium, as expected, and the combined deletion of GCN5 partially suppresses this phenotype. However it is short-lived in grape juice, likely due to its low nitrogen/carbon ratio. Therefore, unbalance of nutrients can be more relevant for life span than total amounts of them. Deletion of RTG2, which codes for a protein associated with Gcn5 and is a component of the mitochondrial retrograde signal, and which communicates mitochondrial dysfunction to the nucleus, is detrimental under laboratory, but not under winemaking conditions, where respiration seems not so relevant for longevity. Transcription factor Rgm1 was found to be a novel CLS regulator Sch9-dependently.	[Picazo, Cecilia; Orozco, Helena; Matallana, Emilia; Aranda, Agustn] IATA CSIC, Inst Agrochem & Food Technol, Dept Biotechnol, Paterna, Spain; [Picazo, Cecilia; Orozco, Helena; Matallana, Emilia] Univ Valencia, Dept Biochem & Mol Biol, E-46100 Burjassot, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Valencia	Aranda, A (corresponding author), IATA CSIC, Inst Agrochem & Food Technol, Dept Biotechnol, Paterna, Spain.	arandaa@iata.csic.es	Picazo, Cecilia/AAT-7426-2021; Aranda, Agustin/K-6483-2017; Matallana, Emilia/L-4619-2014	Picazo, Cecilia/0000-0002-2882-9537; Aranda, Agustin/0000-0003-3320-7326; Matallana, Emilia/0000-0002-3889-0454	Spanish Ministry of Science [AGL2011-24353]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been funded by a grant from the Spanish Ministry of Science (AGL2011-24353). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1998, METHODS YEAST GENETI, Vxiv; Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Bisson LF, 2007, ADV FOOD NUTR RES, V53, P65, DOI 10.1016/S1043-4526(07)53003-2; Cai L, 2013, CELL REP, V4, P1063, DOI 10.1016/j.celrep.2013.08.016; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; CURRAN BPG, 1986, CURR GENET, V10, P943, DOI 10.1007/BF00398292; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Delneri D, 2000, GENE, V252, P127, DOI 10.1016/S0378-1119(00)00217-1; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fleet GH, 1993, WINE MICROBIOLOGY BI; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Huang XH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002493; Jazwinski SM, 2013, BBA-MOL CELL RES, V1833, P400, DOI 10.1016/j.bbamcr.2012.02.010; Jazwinski SM, 2005, GENE, V354, P22, DOI 10.1016/j.gene.2005.03.040; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Kim SY, 2004, BIOGERONTOLOGY, V5, P305, DOI 10.1007/s10522-004-2568-x; Kirchman PA, 1999, GENETICS, V152, P179; Lavoie H, 2008, EUKARYOT CELL, V7, P1127, DOI 10.1128/EC.00330-07; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Lu JY, 2011, CELL, V146, P968, DOI 10.1016/j.cell.2011.07.044; Mak HC, 2009, GENOME RES, V19, P1014, DOI 10.1101/gr.084178.108; McCormick MA, 2014, CELL REP, V8, P476, DOI 10.1016/j.celrep.2014.06.037; Mirzaei H, 2014, TRENDS ENDOCRIN MET, DOI [10.1016/j.tem.2014.11.005, DOI 10.1016/J.TEM.2014.11.005]; Murakami CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024530; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Orozco H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-1; Orozco H, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-104; Orozco H, 2012, MECH AGEING DEV, V133, P348, DOI 10.1016/j.mad.2012.03.013; Orozco H, 2012, APPL ENVIRON MICROB, V78, P2748, DOI 10.1128/AEM.07261-11; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; Rachidi N, 2000, CURR GENET, V37, P1, DOI 10.1007/s002940050001; Ribereau-Gayon P., 2006, HDB ENOLOGY MICROBIO, VVolume 1, P327, DOI [10.1002/0470010398, DOI 10.1002/0470010398]; ROBYT JF, 1972, ANAL BIOCHEM, V45, P510, DOI 10.1016/0003-2697(72)90213-8; Rodriguez-Navarro S, 2009, EMBO REP, V10, P843, DOI 10.1038/embor.2009.168; Sampaio-Marques B, 2011, BIOCHEM SOC T, V39, P1466, DOI 10.1042/BST0391466; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Tesniere C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061645; Walker ME, 2003, FEMS YEAST RES, V4, P339, DOI 10.1016/S1567-1356(03)00161-2; Wu ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079319; Zuzuarregui A, 2004, FEMS YEAST RES, V4, P699, DOI 10.1016/j.femsyr.2004.01.008	47	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117267	10.1371/journal.pone.0117267	http://dx.doi.org/10.1371/journal.pone.0117267			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658705	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900128
J	Rabilotta, A; Desrosiers, M; Labbe, JC				Rabilotta, Alexia; Desrosiers, Marianne; Labbe, Jean-Claude			CDK-1 and Two B-Type Cyclins Promote PAR-6 Stabilization during Polarization of the Early C. elegans Embryo	PLOS ONE			English	Article							POLO-LIKE KINASE; CAENORHABDITIS-ELEGANS; CELL-CYCLE; OOCYTE MATURATION; POLARITY; PROTEINS; ASYMMETRY; DIVISION; CUL-2; ESTABLISHMENT	In the C. elegans embryo, formation of an antero-posterior axis of polarity relies on signaling by the conserved PAR proteins, which localize asymmetrically in two mutually exclusive groups at the embryonic cortex. Depletion of any PAR protein causes a loss of polarity and embryonic lethality. A genome-wide RNAi screen previously identified two B-type cyclins, cyb-2.1 and cyb-2.2, as suppressors of par-2(it5ts) lethality. We found that the loss of cyb-2.1 or cyb-2.2 suppressed the lethality and polarity defects of par-2(it5ts) mutants and that these cyclins act in cell polarity with their cyclin-dependent kinase partner, CDK-1. Interestingly, cyb-2.1; cyb-2.2 double mutants did not show defects in cell cycle progression or timing of polarity establishment, suggesting that they regulate polarity independently of their typical role in cell cycle progression. Loss of both cyclin genes or of cdk-1 resulted in a decrease in PAR-6 levels in the embryo. Furthermore, the activity of the cullin CUL-2 was required to achieve suppression of par-2 lethality when both cyclins were absent. Our results support a model in which CYB-2.1/2/CDK-1 antagonize CUL-2 activity to promote stabilization of PAR-6 levels during polarization of the early C. elegans embryo. They also suggest that CYB-2.1 and CYB-2.2 contribute to the coupling of cell cycle progression and asymmetric segregation of cell fate determinants.	[Rabilotta, Alexia; Desrosiers, Marianne; Labbe, Jean-Claude] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Labbe, Jean-Claude] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Labbe, JC (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada.	jc.labbe@umontreal.ca		Labbe, Jean-Claude/0000-0003-0520-4566	Canadian Institutes of Health Research (CIHR); Cole Foundation; Cancer Research Society of Canada; Canada Foundation for Innovation; Fonds de Recherche du Quebec-Sante	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cole Foundation; Cancer Research Society of Canada; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	AR held studentships from the Canadian Institutes of Health Research (CIHR; http://www.cihr.ca) and the Cole Foundation (http://colefoundation.ca). This work was funded by a grant from the Cancer Research Society of Canada (http://www.crssrc.ca) to JCL, who holds the Canada Research Chair in Cell Division and Differentiation. The Institute of Research in Immunology and Cancer is supported in part by the Canada Foundation for Innovation (http://www.innovation.ca) and the Fonds de Recherche du Quebec-Sante (http://www.frsq.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatty A, 2013, DEVELOPMENT, V140, P2005, DOI 10.1242/dev.088310; Benkemoun L, 2014, J CELL BIOL, V205, P447, DOI 10.1083/jcb.201312029; Boxem M, 1999, DEVELOPMENT, V126, P2227; Boyd L, 1996, DEVELOPMENT, V122, P3075; BRENNER S, 1974, GENETICS, V77, P71; Budirahardja Y, 2008, DEVELOPMENT, V135, P1303, DOI 10.1242/dev.019075; Burger J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003375; Burrows AE, 2006, DEVELOPMENT, V133, P697, DOI 10.1242/dev.02241; Chartier NT, 2011, CURR BIOL, V21, P259, DOI 10.1016/j.cub.2011.01.010; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Goehring NW, 2011, J CELL BIOL, V193, P583, DOI 10.1083/jcb.201011094; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hao YS, 2006, DEV CELL, V10, P199, DOI 10.1016/j.devcel.2005.12.015; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hung TJ, 1999, DEVELOPMENT, V126, P127; Hyenne V, 2008, DEV BIOL, V321, P368, DOI 10.1016/j.ydbio.2008.06.037; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kemphues KJ, 1997, C ELEGANS; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Labbe JC, 2006, GENETICS, V174, P285, DOI 10.1534/genetics.106.060517; LEVITAN DJ, 1994, P NATL ACAD SCI USA, V91, P6108, DOI 10.1073/pnas.91.13.6108; Lin RL, 2003, DEV BIOL, V258, P226, DOI 10.1016/S0012-1606(03)00119-2; Liu J, 2004, DEVELOPMENT, V131, P3513, DOI 10.1242/dev.01245; Moore R, 2004, GENESIS, V38, P1, DOI 10.1002/gene.10243; Motegi F, 2011, NAT CELL BIOL, V13, P1361, DOI 10.1038/ncb2354; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Narayan N, 2009, J CELL SCI, V122, P65, DOI 10.1242/jcs.024554; Noatynska A, 2010, DEVELOPMENT, V137, P3315, DOI 10.1242/dev.055293; Pacquelet A, 2008, DEV BIOL, V319, P267, DOI 10.1016/j.ydbio.2008.04.016; Rivers DM, 2008, J CELL BIOL, V180, P877, DOI 10.1083/jcb.200710018; Shakes DC, 2003, DEVELOPMENT, V130, P1605, DOI 10.1242/dev.00385; Shirayama M, 2006, CURR BIOL, V16, P47, DOI 10.1016/j.cub.2005.11.070; Sonneville R, 2004, DEVELOPMENT, V131, P3527, DOI 10.1242/dev.01244; Starostina NG, 2007, DEV CELL, V13, P127, DOI 10.1016/j.devcel.2007.05.008; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Tio M, 2001, NATURE, V409, P1063, DOI 10.1038/35059124; van der Voet M, 2009, CELL CYCLE, V8, P4091, DOI 10.4161/cc.8.24.10171; Watts JL, 1996, DEVELOPMENT, V122, P3133	41	10	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117656	10.1371/journal.pone.0117656	http://dx.doi.org/10.1371/journal.pone.0117656			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658117	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900196
J	Zhang, XD; Tong, F; Li, CX; Yan, YM; Kempf, D; Nair, G; Wang, SL; Muly, EC; Zola, S; Howell, L				Zhang, Xiaodong; Tong, Frank; Li, Chun-Xia; Yan, Yumei; Kempf, Doty; Nair, Govind; Wang, Silun; Muly, E. Chris; Zola, Stuart; Howell, Leonard			Temporal Evolution of Ischemic Lesions in Nonhuman Primates: A Diffusion and Perfusion MRI Study	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; STROKE MODEL; SERIAL DIFFUSION; INFARCT VOLUME; TISSUE SODIUM; INJURY; BRAIN; TIME; MISMATCH; RECOVERY	Background and Purpose Diffusion-weighted imaging (DWI) and perfusion MRI were used to examine the spatiotemporal evolution of stroke lesions in adult macaques with ischemic occlusion. Methods Permanent MCA occlusion was induced with silk sutures through an interventional approach via the femoral artery in adult rhesus monkeys (n = 8, 10-21 years old). The stroke lesions were examined with high-resolution DWI and perfusion MRI, and T2-weighted imaging (T2W) on a clinical 3T scanner at 1-6, 48, and 96 hours post occlusion and validated with H&E staining. Results The stroke infarct evolved via a natural logarithmic pattern with the mean infarct growth rate = 1.38 +/- 1.32 ml per logarithmic time scale (hours) (n = 7) in the hyperacute phase (1-6 hours). The mean infarct volume after 6 hours post occlusion was 3.6 +/- 2.8 ml (n = 7, by DWI) and increased to 3.9 +/- 2.9 ml (n = 5, by T2W) after 48 hours, and to 4.7 +/- 2.2ml (n = 3, by T2W) after 96 hours post occlusion. The infarct volumes predicted by the natural logarithmic function were correlated significantly with the T2W-derived lesion volumes (n = 5, r = 0.92, p = 0.01) at 48 hours post occlusion. The final infarct volumes derived from T2W were correlated significantly with those from H&E staining (r = 0.999, p < 0.0001, n = 4). In addition, the diffusion-perfusion mismatch was visible generally at 6 hours but nearly diminished at 48 hours post occlusion. Conclusion The infarct evolution follows a natural logarithmic pattern in the hyperacute phase of stroke. The logarithmic pattern of evolution could last up to 48 hours after stroke onset and may be used to predict the infarct volume growth during the acute phase of ischemic stroke. The nonhuman primate model, MRI protocols, and post data processing strategy may provide an excellent platform for characterizing the evolution of acute stroke lesion in mechanistic studies and therapeutic interventions of stroke disease.	[Zhang, Xiaodong; Li, Chun-Xia; Yan, Yumei; Kempf, Doty; Nair, Govind; Wang, Silun; Muly, E. Chris; Zola, Stuart; Howell, Leonard] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Tong, Frank] Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA; [Nair, Govind] Emory Univ, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Nair, Govind] Georgia Inst Technol, Atlanta, GA 30322 USA; [Muly, E. Chris; Zola, Stuart; Howell, Leonard] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Zola, Stuart] Atlanta Vet Affairs Med Ctr, Decatur, GA 30033 USA	Emory University; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Zhang, XD (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.	xzhang8@emory.edu		Nair, Govind/0000-0003-3725-615X	NCRR; Office of Research Infrastructure Programs [P51RR000165, OD P51OD011132, DA 031246]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA031246] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported in part by NCRR and currently by the Office of Research Infrastructure Programs (P51RR000165 and OD P51OD011132), DA 031246 (LH), and by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454 (XZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardutzky J, 2005, BRAIN RES, V1043, P155, DOI 10.1016/j.brainres.2005.02.073; Bardutzky J, 2005, STROKE, V36, P2000, DOI 10.1161/01.STR.0000177486.85508.4d; Bihel E, 2010, J CEREBR BLOOD F MET, V30, P273, DOI 10.1038/jcbfm.2009.209; BOLAS NM, 1988, STROKE, V19, P608, DOI 10.1161/01.STR.19.5.608; Cheng BT, 2013, J CEREBR BLOOD F MET, V33, P76, DOI 10.1038/jcbfm.2012.129; Chin Y, 2010, NEUROSCI RES, V66, P406, DOI 10.1016/j.neures.2010.01.001; Cook DJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003824; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Coon AL, 2006, AM J NEURORADIOL, V27, P1053; Crowell RM, 1970, STROKE, V1, P439, DOI 10.1161/01.STR.1.6.439; D'Arceuil HE, 2006, J MED PRIMATOL, V35, P78, DOI 10.1111/j.1600-0684.2006.00147.x; de Crespigny Alex J, 2005, J Stroke Cerebrovasc Dis, V14, P80, DOI 10.1016/j.jstrokecerebrovasdis.2004.12.005; Freret T, 2008, J CEREBR BLOOD F MET, V28, P786, DOI 10.1038/sj.jcbfm.9600575; Gonzalez RG, 1999, RADIOLOGY, V210, P155, DOI 10.1148/radiology.210.1.r99ja02155; Hudgins WR, 1970, STROKE, V1, P107, DOI 10.1161/01.STR.1.2.107; Karonen JO, 1999, STROKE, V30, P1583, DOI 10.1161/01.STR.30.8.1583; Li CX, 2013, NEUROSCI LETT, V541, P58, DOI 10.1016/j.neulet.2013.02.007; Liu YR, 2007, STROKE, V38, P138, DOI 10.1161/01.STR.0000252127.07428.9c; MACDONALD RL, 1995, STROKE, V26, P1247, DOI 10.1161/01.STR.26.7.1247; Marshall JWB, 2003, BRAIN RES BULL, V61, P577, DOI 10.1016/S0361-9230(03)00214-4; Meng XJ, 2004, ANN NEUROL, V55, P207, DOI 10.1002/ana.10803; Murphy SJ, 2008, COMPARATIVE MED, V58, P588; Olivot JM, 2009, STROKE, V40, P3245, DOI 10.1161/STROKEAHA.109.558635; Reid E, 2012, J CEREBR BLOOD F MET, V32, P1765, DOI 10.1038/jcbfm.2012.69; Rivers CS, 2006, STROKE, V37, P98, DOI 10.1161/01.STR.0000195197.66606.bb; Rodriguez-Mercado R, 2012, COMPARATIVE MED, V62, P427; Roitberg B, 2003, NEUROL RES, V25, P68, DOI 10.1179/016164103101200950; Roof RL, 2001, STROKE, V32, P2648, DOI 10.1161/hs1101.097397; Rordorf G, 1998, STROKE, V29, P939, DOI 10.1161/01.STR.29.5.939; Sato Y, 2009, NEUROSCI RES, V65, P71, DOI 10.1016/j.neures.2009.05.010; Schaefer PW, 2002, AM J NEURORADIOL, V23, P1785; Schellinger PD, 2000, STROKE, V31, P1318, DOI 10.1161/01.STR.31.6.1318; Schwamm LH, 1998, STROKE, V29, P2268, DOI 10.1161/01.STR.29.11.2268; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Tatlisumak Turgut, 2004, Current Vascular Pharmacology, V2, P343, DOI 10.2174/1570161043385493; Thulborn KR, 1999, RADIOLOGY, V213, P156, DOI 10.1148/radiology.213.1.r99se15156; Wang Y, 2000, STROKE, V31, P1386, DOI 10.1161/01.STR.31.6.1386; West GA, 2009, J CEREBR BLOOD F MET, V29, P1175, DOI 10.1038/jcbfm.2009.43; Wheeler HM, 2013, STROKE, V44, P681, DOI 10.1161/STROKEAHA.111.000135; Wu O, 2001, STROKE, V32, P933, DOI 10.1161/01.STR.32.4.933; Zhang XD, 2014, QUANT IMAGING MED SU, V4, P112, DOI [10.3978/j.issn.2223-4292.2014.03.01, 10.3978/j.issn.2223-4292.2014.04.06]; [Zhang Xiaodong 张晓东], 2010, [波谱学杂志, Chinese Journal of Magnetic Resonance], V27, P548; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	43	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117290	10.1371/journal.pone.0117290	http://dx.doi.org/10.1371/journal.pone.0117290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659092	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900131
J	Kobayashi, Y; Tamiya, N; Moriyama, Y; Nishi, A				Kobayashi, Yoko; Tamiya, Nanako; Moriyama, Yoko; Nishi, Akihiro			Triple Difficulties in Japanese Women with Hearing Loss: Marriage, Smoking, and Mental Health Issues	PLOS ONE			English	Article							HARD-OF-HEARING; ADULTS; DEAF; AGE; RELIABILITY; POPULATION; PREVALENCE; DISTRESS; VALIDITY; INCOME	Objective To examine the consequences of early-onset hearing loss on several social and health measures and any related gender differences in Japanese populations. Methods Data from a 2007 nationally representative cross-sectional household survey of 136,849 men and women aged 20 to 39 years were obtained (prevalence of self-reported hearing loss: 0.74%). We focused particularly on four social and health measures: employment status (employed/unemployed), marital status (married/unmarried), smoking behavior (yes/no), and psychological distress (K6 instrument: >= 5 or not). We examined the association of hearing loss for each measure using generalized estimating equations to account for correlated individuals within households. Findings There was no significant association with employment status (p = 0.447). Men with hearing loss were more likely to be married, whereas women with hearing loss were less likely to be married (p < 0.001 for interaction). Although hearing loss was not associated with a current smoking status in men, women with hearing loss were more likely to be current smokers (p < 0.001 for interaction). Moreover, hearing loss was associated with psychological distress in men and women (both p < 0.001). Conclusion These findings suggest that hearing loss is related to social and health issues in daily life, including a lower likelihood of marriage, more frequent smoking, and poorer mental health, especially in women. These issues may reflect a gap between the actual needs of women with hearing loss and the formal support received as a result of existing public health policies in Japan.	[Kobayashi, Yoko; Tamiya, Nanako; Moriyama, Yoko] Univ Tsukuba, Dept Hlth Serv Res, Fac Med, Tsukuba, Ibaraki, Japan; [Kobayashi, Yoko] Tsukuba Univ Technol, Tsukuba, Ibaraki, Japan; [Nishi, Akihiro] Yale Univ, Yale Inst Network Sci, New Haven, CT 06520 USA; [Nishi, Akihiro] Yale Univ, Dept Sociol, New Haven, CT 06520 USA	University of Tsukuba; Tsukuba University of Technology; Yale University; Yale University	Tamiya, N (corresponding author), Univ Tsukuba, Dept Hlth Serv Res, Fac Med, Tsukuba, Ibaraki, Japan.	ntamiya@md.tsukuba.ac.jp		Nishi, Akihiro/0000-0003-1629-5985	JSPS KAKENHI [24249031, 26245086, 26893030]; Japanese Ministry of Health, Labour and Welfare [H22 Seisaku Shitei 033]; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [26245086] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the JSPS KAKENHI No. 24249031 (Grant-in-Aid for Scientific Research A); the Japanese Ministry of Health, Labour and Welfare (H22 Seisaku Shitei 033); the JSPS KAKENHI No. 26245086 (Grant-in-Aid for Scientific Research A), and JSPS KAKENHI No. 26893030 (Grant-in-Aid for Research Activity start-up). AN is awarded by the Japan Society for the Promotion of Science (JSPS) for his research at Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A, 2012, LANCET, V379, P979, DOI 10.1016/S0140-6736(11)61670-X; Arlinger S, 2003, INT J AUDIOL, V42, pS17; Barnett S, 1999, AM ANN DEAF, V144, P44, DOI 10.1353/aad.2012.0120; Barnett S, 2011, PREV CHRONIC DIS, V8; BELL AG, 1883, NAT ACAD SCI MEM, V2, P177; BERGMAN I, 1985, J PEDIATR-US, V106, P95, DOI 10.1016/S0022-3476(85)80476-5; Berman BA, 2007, AM ANN DEAF, V152, P344, DOI 10.1353/aad.2007.0024; BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x; Cabral L, 2013, COMMUNITY MENT HLT J, V49, P649, DOI 10.1007/s10597-012-9569-z; Center for Japanese Sign Language Interpreters Problems, 2007, REP SING LANG INT EM; Daniel E, 2007, J SCHOOL HEALTH, V77, P225, DOI 10.1111/j.1746-1561.2007.00197.x; de Graaf R, 2002, PSYCHOSOM MED, V64, P61, DOI 10.1097/00006842-200201000-00009; Deepthi R, 2012, ARCH GERONTOL GERIAT, V55, P762, DOI 10.1016/j.archger.2012.07.006; Donahue A, 2010, EAR HEARING, V31, P2, DOI 10.1097/AUD.0b013e3181cbc783; Elliott D. B., 2011, ACS13 US CENS BUR; Fellinger J, 2005, SOC PSYCH PSYCH EPID, V40, P737, DOI 10.1007/s00127-005-0936-8; Fukuda Y, 2005, ANN EPIDEMIOL, V15, P365, DOI 10.1016/j.annepidem.2004.09.003; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; Gussenhoven AHM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-151; HATZIANDREU EJ, 1989, AM J PUBLIC HEALTH, V79, P1020, DOI 10.2105/AJPH.79.8.1020; Hayashi R, 2001, DISABIL SOC, V16, P855, DOI 10.1080/09687590120083994; He Y, 1999, THESIS U TORONTO OTT; HOLM JE, 1992, BEHAV ASSESS, V14, P465; Hong OS, 2011, NURS RES, V60, P326, DOI 10.1097/NNR.0b013e3182281ca0; Ikeda N, 2009, AM J EPIDEMIOL, V170, P80, DOI 10.1093/aje/kwp097; Iwayama M, 2013, SCI RES REGIONAL POL, V10, P1; Japan Ministry of Health Labour and Welfare, 2008, SURV DIS PEOP 2006; Japan Ministry of Health Labour and Welfare, 2013, EMPL TREND FIELD SOC; Japanese Federation of the Deaf, 2005, STUD PROJ REC UND CU; Jung D, 2012, ANN OTO RHINOL LARYN, V121, P771, DOI 10.1177/000348941212101201; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Kiely KM, 2012, J AGING HEALTH, V24, P439, DOI 10.1177/0898264311425088; Kochkin S., 2007, IMPACT UNTREATED HEA; Kvam MH, 2007, J DEAF STUD DEAF EDU, V12, P1, DOI 10.1093/deafed/enl015; Lane H, 2005, J DEAF STUD DEAF EDU, V10, P291, DOI 10.1093/deafed/eni030; Lee DJ, 1996, EPIDEMIOLOGY, V7, P443, DOI 10.1097/00001648-199607000-00019; Lin FR, 2012, MEDICINE, V91, P229, DOI 10.1097/MD.0b013e31826b145a; Margolis S, 1999, J HOPKINS SYMPTOMS R; Mathers C, 2000, GLOB BURD HEAR LOSS; Ministry of Foreign Affairs of Japan, 2014, PERS DIS VOIC COM EF, DOI [10.1038/mp.2014.179, DOI 10.1038/MP.2014.179]; Ministry of International Affairs and Communications, 2012, LAW WELF PEOPL PHYS; Mitchell RE, 2006, J DEAF STUD DEAF EDU, V11, P112, DOI 10.1093/deafed/enj004; Monzani D, 2008, ACTA OTORHINOLARYNGO, V28, P61; Nishi A, 2011, ENV HLTH PREV MED, V17, P252; Nishi A, 2012, B WORLD HEALTH ORGAN, V90, P426, DOI 10.2471/BLT.11.095380; Oikawa R, 1998, NATL U CORPORATION T, V5, P53; Organization for Economic Cooperation and Development, 2014, LIST OECD MEMB COUNT; Organization WH, 2014, DEAFN HEAR LOSS; Osamu N, 2012, RIGHTS PERSONS DISAB, DOI [10.3233/WOR-131592, DOI 10.3233/WOR-131592]; Osamu N, 2013, J POLICY PRACT INTEL, V10, P93, DOI 10.1111/jppi.12030; Oshio T, 2013, PUBLIC HEALTH, V127, P754, DOI 10.1016/j.puhe.2013.05.005; Preston Paul, 1995, MOTHER FATHER DEAF L; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Schley S, 2011, J DEAF STUD DEAF EDU, V16, P524, DOI 10.1093/deafed/enq060; Seyama N, 2009, ASIA JAPAN WOMENS RE, V23, P28; Steinberg AG, 2006, J GEN INTERN MED, V21, P260, DOI 10.1111/j.1525-1497.2006.00340.x; Takamiya A, 2005, SPECIAL ED STUDY J, V43, P279; The Census Bureau, 2014, CENS BUR INF QUAL GU; Timmer B, 2014, HEARING REV, V21, P30; United Nations, 2008, CONV PROT PROM RIGHT; United Nations, 2014, CONV OPT PROT SIGN R; WHO, 2011, WORLD REPORT ON DISABILITY, P1; *WHO CIBA, 1996, PREV HEAR IMP CHRON; Yatougo T, 2005, B FACULTY ED BUNKYO, V39, P79	64	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0116648	10.1371/journal.pone.0116648	http://dx.doi.org/10.1371/journal.pone.0116648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA9NG	25651532	Green Published, Green Submitted, gold			2022-12-27	WOS:000349250700003
J	Baklouti, H; Aloui, A; Chtourou, H; Briki, W; Chaouachi, A; Souissi, N				Baklouti, Hana; Aloui, Asma; Chtourou, Hamdi; Briki, Walid; Chaouachi, Anis; Souissi, Nizar			Does Increasing Active Warm-Up Duration Affect Afternoon Short-Term Maximal Performance during Ramadan?	PLOS ONE			English	Article							TIME-OF-DAY; PHYSICAL PERFORMANCE; MUSCULAR PERFORMANCE; DIURNAL-VARIATION; POWER; TEMPERATURE; STRENGTH; DEHYDRATION; HYDRATION; FLUID	Aim The purpose of this study was to examine the effect of active warm-up duration on short-term maximal performance assessed during Ramadan in the afternoon. Methods Twelve healthy active men took part in the study. The experimental design consisted of four test sessions conducted at 5 p. m., before and during Ramadan, either with a 5-minute or a 15-minute warm-up. The warm-up consisted in pedaling at 50% of the power output obtained at the last stage of a submaximal multistage cycling test. During each session, the subjects performed two vertical jump tests (squat jump and counter movement jump) for measurement of vertical jump height followed by a 30-second Wingate test for measurement of peak and mean power. Oral temperature was recorded at rest and after warming-up. Moreover, ratings of perceived exertion were obtained immediately after the Wingate test. Results Oral temperature was higher before Ramadan than during Ramadan at rest, and was higher after the 15-minute warm-up than the 5-minute warm-up both before and during Ramadan. In addition, vertical jump heights were not significantly different between the two warm-up conditions before and during Ramadan, and were lower during Ramadan than before Ramadan after both warm-up conditions. Peak and mean power were not significantly different between the two warm-up durations before Ramadan, but were significantly higher after the 5-minute warm-up than the 15-minute warm-up during Ramadan. Moreover, peak and mean power were lower during Ramadan than before Ramadan after both warm-up conditions. Furthermore, ratings of perceived exertion were higher after the 15-minute warm-up than the 5-minute warm-up only during Ramadan. Conclusion The prolonged active warm-up has no effect on vertical jump height but impairs anaerobic power assessed during Ramadan in the afternoon.	[Baklouti, Hana; Aloui, Asma; Chtourou, Hamdi; Chaouachi, Anis; Souissi, Nizar] Natl Ctr Med & Sci Sport, Res Lab Sport Performance Optimizat, Tunis, Tunisia; [Aloui, Asma] Univ Gafsa, High Inst Sport & Phys Educ Gafsa, Gafsa, Tunisia; [Chtourou, Hamdi] Univ Sfax, High Inst Sport & Phys Educ Sfax, Sfax, Tunisia; Univ French West Indies & Guyana, ACTES Lab, Pointe A Pitre, Guadeloupe, France	Centre National de la Medecine Sciences des Sports; Universite de Gafsa; Universite de Sfax	Chtourou, H (corresponding author), Natl Ctr Med & Sci Sport, Res Lab Sport Performance Optimizat, Tunis, Tunisia.	h_chtourou@yahoo.fr	Aloui, Asma/J-1300-2019; Nizar, Souissi/AAF-4490-2019; Chtourou, Hamdi/GVU-1967-2022	Aloui, Asma/0000-0001-5054-1540; Nizar, Souissi/0000-0003-1227-8221; Chtourou, Hamdi/0000-0002-5482-9151; Briki, Walid/0000-0002-6298-811X	Ministry of Higher Education and Scientific Research of Tunisia; Ministry of Higher Education and Scientific Research of Tunisia	Ministry of Higher Education and Scientific Research of Tunisia; Ministry of Higher Education and Scientific Research of Tunisia	The study was financially supported by the Ministry of Higher Education and Scientific Research of Tunisia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloui A, 2013, INT J SPORT PHYSIOL, V8, P254, DOI 10.1123/ijspp.8.3.254; BAROR O, 1987, SPORTS MED, V4, P381, DOI 10.2165/00007256-198704060-00001; Barr SI, 1999, CAN J APPL PHYSIOL, V24, P164, DOI 10.1139/h99-014; Bishop D, 2003, SPORTS MED, V33, P483, DOI 10.2165/00007256-200333070-00002; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bosco J S, 1968, J Sports Med Phys Fitness, V8, P81; Bouhlel H, 2013, CLIN J SPORT MED, V23, P222, DOI 10.1097/JSM.0b013e318275d213; Chaouachi A, 2012, J SPORT SCI, V30, pS53, DOI 10.1080/02640414.2012.698297; Chaouachi A, 2009, J STRENGTH COND RES, V23, P2702, DOI 10.1519/JSC.0b013e3181bc17fc; Chennaoui M, 2009, APPL PHYSIOL NUTR ME, V34, P587, DOI 10.1139/H09-014; Chourou H., 2014, SPORT SCI HLTH, V10, P143, DOI [10.1007/s11332-014-0185-x, DOI 10.1007/S11332-014-0185-X]; Chtourou H, 2012, INT J SPORTS MED, V33, P142, DOI 10.1055/s-0031-1286251; Chtourou H., 2012, SCI SPORT, V27, pe85, DOI [10.1016/j.scispo.2012.02.006, DOI 10.1016/J.SCISPO.2012.02.006, 10.1016/j.meatsci.2014.12.009, DOI 10.1016/J.SCISP0.2012.02.006]; Chtourou Hamdi, 2011, Asian J Sports Med, V2, P177; Drust B, 2005, ACTA PHYSIOL SCAND, V183, P181, DOI 10.1111/j.1365-201X.2004.01390.x; Edwards AM, 2007, BRIT J SPORT MED, V41, P385, DOI 10.1136/bjsm.2006.033860; FELLAH, 2010, ASIAN J SPORTS MED, V1, P130; Girard O, 2012, SCI SPORT, V27, P237, DOI 10.1016/j.scispo.2011.09.006; Hamouda O, 2012, BIOL RHYTHM RES, V43, P177, DOI 10.1080/09291016.2011.560050; Judelson DA, 2007, SPORTS MED, V37, P907, DOI 10.2165/00007256-200737100-00006; Judelson DA, 2007, MED SCI SPORT EXER, V39, P1817, DOI 10.1249/mss.0b013e3180de5f22; Kirkendall DT, 2008, J SPORT SCI, V26, P15, DOI 10.1080/02640410802422199; Maughan RJ, 2010, BRIT J SPORT MED, V44, P473, DOI 10.1136/bjsm.2010.072157; Maughan RJ, 2004, INT J SPORT NUTR EXE, V14, P333, DOI 10.1123/ijsnem.14.3.333; Meckel Y, 2008, EUR J APPL PHYSIOL, V102, P651, DOI 10.1007/s00421-007-0633-2; Racinais S, 2005, MED SCI SPORT EXER, V37, P2134, DOI 10.1249/01.mss.0000179099.81706.11; Racinais S, 2005, MED SCI SPORT EXER, V37, P256, DOI 10.1249/01.MSS.0000149885.82163.9F; Racinais S, 2004, CHRONOBIOL INT, V21, P485, DOI 10.1081/CBI-120038632; Rebai H, 2014, INT J SPORTS MED, V35, P432, DOI 10.1055/s-0033-1353216; Roky R, 2000, ANN NUTR METAB, V44, P101, DOI 10.1159/000012830; Roky R, 2004, ANN NUTR METAB, V48, P296, DOI 10.1159/000081076; Rothenberg JA, 2008, CURR REV MUSCULOSKE, V1, P131, DOI 10.1007/s12178-008-9020-9; Souissi N, 2007, CHRONOBIOL INT, V24, P991, DOI 10.1080/07420520701661914; Souissi N, 2010, CHRONOBIOL INT, V27, P640, DOI 10.3109/07420528.2010.483157; Taylor K, 2011, INT J SPORTS MED, V32, P185, DOI 10.1055/s-0030-1268437; Tian Ho-Heng, 2011, Asian J Sports Med, V2, P145; WALSH RM, 1994, INT J SPORTS MED, V15, P392, DOI 10.1055/s-2007-1021076; Waterhouse J, 2010, BRIT J SPORT MED, V44, P509, DOI 10.1136/bjsm.2007.071712; WIEGNER AW, 1987, J APPL PHYSIOL, V62, P1615, DOI 10.1152/jappl.1987.62.4.1615; Zerguini Y, 2007, BRIT J SPORT MED, V41, P398, DOI 10.1136/bjsm.2006.032037	41	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116809	10.1371/journal.pone.0116809	http://dx.doi.org/10.1371/journal.pone.0116809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646955	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600038
J	Kabir, AUI; Bin Samad, M; Ahmed, A; Jahan, MR; Akhter, F; Tasnim, J; Hasan, SMN; Sayfe, SS; Hannan, JMA				Kabir, Ashraf U. I.; Bin Samad, Mehdi; Ahmed, Arif; Jahan, Mohammad Rajib; Akhter, Farjana; Tasnim, Jinat; Hasan, S. M. Nageeb; Sayfe, Sania Sarker; Hannan, J. M. A.			Aqueous Fraction of Beta vulgaris Ameliorates Hyperglycemia in Diabetic Mice due to Enhanced Glucose Stimulated Insulin Secretion, Mediated by Acetylcholine and GLP-1, and Elevated Glucose Uptake via Increased Membrane Bound GLUT4 Transporters	PLOS ONE			English	Article							MEDICAL NUTRITION THERAPY; VAR. CICLA EXTRACT; SKELETAL-MUSCLE; GLYCEMIC CONTROL; IN-VIVO; B-CELLS; GLUCAGON; RESISTANCE; RELEASE; PATHOGENESIS	Background The study was designed to investigate the probable mechanisms of anti-hyperglycemic activity of B. Vulgaris. Methodology/Principal Findings Aqueous fraction of B. Vulgaris extract was the only active fraction (50mg/kg). Plasma insulin level was found to be the highest at 30 mins after B. Vulgaris administration at a dose of 200mg/kg.B. Vulgaris treated mice were also assayed for plasma Acetylcholine, Glucagon Like Peptide-1 (GLP-1), Gastric Inhibitory Peptide (GIP), Vasoactive Intestinal Peptide, Pituitary Adenylate Cyclase-Activating Peptide (PACAP), Insulin Like Growth Factor-1 (IGF-1), Pancreatic Polypeptides (PP), and Somatostatin, along with the corresponding insulin levels. Plasma Acetylcholine and GLP-1 significantly increased in B. Vulgaris treated animals and were further studied. Pharmacological enhancers, inhibitors, and antagonists of Acetylcholine and GLP-1 were also administered to the test animals, and corresponding insulin levels were measured. These studies confirmed the role of acetylcholine and GLP-1 in enhanced insulin secretion (p<0.05). Principal signaling molecules were quantified in isolated mice islets for the respective pathways to elucidate their activities. Elevated concentrations of Acetylcholine and GLP-1 in B. Vulgaris treated mice were found to be sufficient to activate the respective pathways for insulin secretion (p<0.05). The amount of membrane bound GLUT1 and GLUT4 transporters were quantified and the subsequent glucose uptake and glycogen synthesis were assayed. We showed that levels of membrane bound GLUT4 transporters, glucose-6-phosphate in skeletal myocytes, activity of glycogen synthase, and level of glycogen deposited in the skeletal muscles all increased (p<0.05). Conclusion Findings of the present study clearly prove the role of Acetylcholine and GLP-1 in the Insulin secreting activity of B. Vulgaris. Increased glucose uptake in the skeletal muscles and subsequent glycogen synthesis may also play a part in the anti-hyperglycemic activity of B. Vulgaris.	[Kabir, Ashraf U. I.; Bin Samad, Mehdi; Ahmed, Arif; Jahan, Mohammad Rajib; Akhter, Farjana; Tasnim, Jinat; Hasan, S. M. Nageeb; Hannan, J. M. A.] North South Univ, Dept Pharmaceut Sci, Dhaka, Bangladesh; [Sayfe, Sania Sarker] Khulna Univ, Sch Life Sci, Pharm Discipline, Khulna, Bangladesh	North South University (NSU); Khulna University	Kabir, AUI (corresponding author), North South Univ, Dept Pharmaceut Sci, Dhaka, Bangladesh.	ashraful_kabir@ymail.com	KABIR, ASHRAF UL/AAR-9200-2020	KABIR, ASHRAF UL/0000-0002-9449-8238; Jahan, Mohammad Rajib/0000-0002-1289-2435; Samad, Mehdi Bin/0000-0002-1774-7069; Akhter, Farjana/0000-0003-3258-6854				Amer Diabet Associat, 2008, DIABETES CARE, V31, pS61, DOI 10.2337/dc08-S061; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; [Anonymous], 1996, PHYSIOLOGIST; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Baron AD, 1995, J CLIN INVEST, V96, P2792, DOI 10.1172/JCI118349; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Bolkent S, 2000, J ETHNOPHARMACOL, V73, P251, DOI 10.1016/S0378-8741(00)00328-7; Boulton AJM, 1998, MED CLIN N AM, V82, P909, DOI 10.1016/S0025-7125(05)70029-8; DANFORTH WH, 1965, J BIOL CHEM, V240, P588; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Escribano J, 1998, PHYTOCHEM ANALYSIS, V9, P124, DOI 10.1002/(SICI)1099-1565(199805/06)9:3&lt;124::AID-PCA401&gt;3.0.CO;2-0; EVANS DJ, 1984, J CLIN INVEST, V74, P1515, DOI 10.1172/JCI111565; FEHMANN HC, 1989, SIGNAL TRANSMISSION, P28669; FRANZ MJ, 1995, J AM DIET ASSOC, V95, P1009, DOI 10.1016/S0002-8223(95)00276-6; Gerich JE, 2003, ARCH INTERN MED, V163, P1306, DOI 10.1001/archinte.163.11.1306; Hannan JMA, 2012, BRIT J NUTR, V107, P1316, DOI 10.1017/S0007114511004284; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; HONEY RN, 1980, ENDOCRINOLOGY, V107, P1065, DOI 10.1210/endo-107-4-1065; Ilkova H, 1997, DIABETES CARE, V20, P1353, DOI 10.2337/diacare.20.9.1353; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; KLEIN R, 1994, ARCH INTERN MED, V154, P2169, DOI 10.1001/archinte.154.19.2169; KLIP A, 1987, FEBS LETT, V224, P224, DOI 10.1016/0014-5793(87)80452-0; KORANYI LI, 1991, DIABETOLOGIA, V34, P763, DOI 10.1007/BF00401526; KRAEGEN EW, 1993, BIOCHEM J, V295, P287, DOI 10.1042/bj2950287; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; LOUBATIE.MM, 1973, DIABETOLOGIA, V9, P439, DOI 10.1007/BF00461685; MALAISSE WJ, 1979, METABOLISM, V28, P373, DOI 10.1016/0026-0495(79)90111-2; MOJSOV S, 1987, J CLIN INVEST, V79, P616, DOI 10.1172/JCI112855; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; MORGAN HE, 1961, J BIOL CHEM, V236, P253; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Parks M, 2010, NEW ENGL J MED, V362, P774, DOI 10.1056/NEJMp1001578; Pastors JG, 2002, DIABETES CARE, V25, P608, DOI 10.2337/diacare.25.3.608; PORTE D, 1967, J CLIN INVEST, V46, P86, DOI 10.1172/JCI105514; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; RASMUSSEN H, 1990, DIABETES CARE, V13, P655, DOI 10.2337/diacare.13.6.655; Ravid M, 1998, ARCH INTERN MED, V158, P998, DOI 10.1001/archinte.158.9.998; RUBIN RJ, 1994, J CLIN ENDOCR METAB, V78, pA809, DOI 10.1210/jcem.78.4.8157701; Sener G., 2002, Journal of Medicinal Food, V5, P37, DOI 10.1089/109662002753723205; SOWERS JR, 1993, AM J HYPERTENS, V6, pS260, DOI 10.1093/ajh/6.7.260S; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Trinder P., 1969, ANN CLIN BIOCHEM, V6, p24?27, DOI DOI 10.1177/000456326900600108; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; Vilsboll T, 2007, DIABETES CARE, V30, P1608, DOI 10.2337/dc06-2593; Wang Q, 2004, DIABETOLOGIA, V47, P478, DOI 10.1007/s00125-004-1327-5; YANARDA GR, 1998, PHARM PHARM COMMUNIC, V4, P309; Yanardag R, 2002, PHYTOTHER RES, V16, P758, DOI 10.1002/ptr.1041; Yarat Aysen, 1998, Pharmacy and Pharmacology Communications, V4, P271; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	54	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116546	10.1371/journal.pone.0116546	http://dx.doi.org/10.1371/journal.pone.0116546			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647228	Green Submitted, Green Published, gold			2022-12-27	WOS:000348822600028
J	Tan, CM; Li, MY; Yang, PY; Chang, SH; Ho, YP; Lin, H; Deng, WL; Yang, JY				Tan, Choon Meng; Li, Meng-Ying; Yang, Pei-Yun; Chang, Shu Heng; Ho, Yi-Ping; Lin, Hong; Deng, Wen-Ling; Yang, Jun-Yi			Arabidopsis HFR1 Is a Potential Nuclear Substrate Regulated by the Xanthomonas Type III Effector XopD(Xcc8004)	PLOS ONE			English	Article							SUMO MODIFICATION; SALICYLIC ACID; TRANSCRIPTIONAL REPRESSION; XOPD TARGETS; PROTEINS; PATHOGEN; DEFENSE; LIGHT; DEGRADATION; SUMOYLATION	XopD(Xcc8004), a type III effector of Xanthomonas campestris pv. campestris (Xcc) 8004, is considered a shorter version of the XopD, which lacks the N-terminal domain. To understand the functions of XopD(Xcc8004), in planta, a transgenic approach combined with inducible promoter to analyze the effects of XopD(Xcc8004) in Arabidopsis was done. Here, the expression of XopD(Xcc8004), in Arabidopsis elicited the accumulation of host defense-response genes. These molecular changes were dependent on salicylic acid and correlated with lesion-mimic phenotypes observed in XVE::XopD(Xcc8004) transgenic plants. Moreover, XopD(Xcc8004) was able to desumoylate HFR1, a basic helix-loop-helix transcription factor involved in photomorphogenesis, through SUMO protease activity. Interestingly, the hfr1-201 mutant increased the expression of host defense-response genes and displayed a resistance phenotype to Xcc8004. These data suggest that HFR1 is involved in plant innate immunity and is potentially regulated by XopD(Xcc8004).	[Tan, Choon Meng; Li, Meng-Ying; Yang, Pei-Yun; Chang, Shu Heng; Ho, Yi-Ping; Lin, Hong; Yang, Jun-Yi] Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan; [Tan, Choon Meng; Yang, Jun-Yi] Natl Chung Hsing Univ, Program Microbial Genom, Taipei, Taiwan; [Tan, Choon Meng; Yang, Jun-Yi] Acad Sinica, Taipei 115, Taiwan; [Deng, Wen-Ling] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan; [Yang, Jun-Yi] Natl Chung Hsing Univ, Inst Biotechnol, Taichung 40227, Taiwan; [Yang, Jun-Yi] Natl Chung Hsing Univ, NCHU UCD Plant & Food Biotechnol Ctr, Taichung 40227, Taiwan; [Yang, Jun-Yi] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Yang, JY (corresponding author), Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan.	jyang@nchu.edu.tw	Yang, Jun-Yi/ABA-2044-2021	Yang, Jun-Yi/0000-0002-6332-6265; Chang, Shu-Heng/0000-0002-0584-4152	Ministry of Science and Technology [NSC 100-2321-B-005-007-MY3, NSC 103-2911-I-005-301, MOST 103-2321-B-005-020]; Ministry of Education (ATU plan), Taiwan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education (ATU plan), Taiwan	This work was supported by the Ministry of Science and Technology (NSC 100-2321-B-005-007-MY3, NSC 103-2911-I-005-301, MOST 103-2321-B-005-020) and Ministry of Education (ATU plan), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ballare CL, 2012, PLANT PHYSIOL, V160, P145, DOI 10.1104/pp.112.200733; Canonne J, 2011, PLANT CELL, V23, P3498, DOI 10.1105/tpc.111.088815; Canonne J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015773; Cheong MS, 2009, PLANT PHYSIOL, V151, P1930, DOI 10.1104/pp.109.143719; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colby T, 2006, PLANT PHYSIOL, V142, P318, DOI 10.1104/pp.106.085415; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Desveaux D, 2006, CURR OPIN PLANT BIOL, V9, P376, DOI 10.1016/j.pbi.2006.05.005; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Duek PD, 2004, CURR BIOL, V14, P2296, DOI 10.1016/j.cub.2004.12.026; Faigon-Soverna A, 2006, PLANT CELL, V18, P2919, DOI 10.1105/tpc.105.038810; Genoud T, 2002, PLANT J, V31, P87, DOI 10.1046/j.1365-313X.2002.01338.x; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Ho YP, 2013, MOL PLANT MICROBE IN, V26, P419, DOI 10.1094/MPMI-06-12-0164-R; Hotson A, 2004, CURR OPIN PLANT BIOL, V7, P384, DOI 10.1016/j.pbi.2004.05.003; Hotson A, 2003, MOL MICROBIOL, V50, P377, DOI 10.1046/j.1365-2958.2003.03730.x; Jang IC, 2005, GENE DEV, V19, P593, DOI 10.1101/gad.1247205; Jang IC, 2012, PLANT J, V72, P345, DOI 10.1111/j.1365-313X.2012.05060.x; Kangasjarvi S, 2012, J EXP BOT, V63, P1619, DOI 10.1093/jxb/err402; Kim JG, 2013, CELL HOST MICROBE, V13, P143, DOI 10.1016/j.chom.2013.01.006; Kim JG, 2011, MOL PLANT PATHOL, V12, P715, DOI 10.1111/J.1364-3703.2011.00706.X; Kim M, 2013, MOL CELLS, V35, P70, DOI 10.1007/s10059-013-2281-1; Kim YM, 2002, PLANT J, V30, P711, DOI 10.1046/j.1365-313X.2002.01326.x; Lee AHY, 2013, MICROB BIOTECHNOL, V6, P230, DOI 10.1111/1751-7915.12042; Lee J, 2007, PLANT J, V49, P79, DOI 10.1111/j.1365-313X.2006.02947.x; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lu H, 2009, PLANT SIGNAL BEHAV, V4, P713, DOI 10.4161/psb.4.8.9173; Moreno JE, 2009, P NATL ACAD SCI USA, V106, P4935, DOI 10.1073/pnas.0900701106; NISHINO H, 1994, BIOCHEM MOL BIOL INT, V34, P409; Okada S, 2009, PLANT CELL PHYSIOL, V50, P1049, DOI 10.1093/pcp/pcp056; Park BS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1408; Park HC, 2011, MOL CELLS, V32, P143, DOI 10.1007/s10059-011-2297-3; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Ribet D, 2010, FEBS LETT, V584, P2748, DOI 10.1016/j.febslet.2010.05.012; Rohira AD, 2013, J BIOL CHEM, V288, P19288, DOI 10.1074/jbc.M113.473744; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Stulemeijer IJE, 2008, MOL PLANT PATHOL, V9, P545, DOI 10.1111/J.1364-3703.2008.00468.X; Tan LT, 2014, NEW PHYTOL, V204, P595, DOI 10.1111/nph.12918; Vaghchhipawala Z, 2011, METHODS MOL BIOL, V678, P65, DOI 10.1007/978-1-60761-682-5_6; van den Burg HA, 2010, PLANT SIGNAL BEHAV, V5, P1597, DOI 10.4161/psb.5.12.13913; van den Burg HA, 2010, PLANT CELL, V22, P1998, DOI 10.1105/tpc.109.070961; Wang YX, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003039; Wise AA, 2006, METH MOL B, V343, P43; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321; Yang JP, 2005, PLANT CELL, V17, P804, DOI 10.1105/tpc.104.030205; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	49	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117067	10.1371/journal.pone.0117067	http://dx.doi.org/10.1371/journal.pone.0117067			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647296	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600052
J	Hung, PY; Ho, BC; Lee, SY; Chang, SY; Kao, CL; Lee, SS; Lee, CN				Hung, Pei-Yun; Ho, Bing-Ching; Lee, Szu-Yuan; Chang, Sui-Yuan; Kao, Chuan-Liang; Lee, Shoei-Sheng; Lee, Chun-Nan			Houttuynia cordata Targets the Beginning Stage of Herpes Simplex Virus Infection	PLOS ONE			English	Article							NF-KAPPA-B; ANTI-HSV ACTIVITY; INFLUENZA-VIRUS; GLYCOPROTEIN-D; TYPE-1; CELLS; PROTEIN; ENTRY; TRANSCRIPTION; RESISTANCE	Herpes simplex virus (HSV), a common latent virus in humans, causes certain severe diseases. Extensive use of acyclovir (ACV) results in the development of drug-resistant HSV strains, hence, there is an urgent need to develop new drugs to treat HSV infection. Houttuynia cordata (H. cordata), a natural herbal medicine, has been reported to exhibit anti-HSV effects which is partly NF-kappa B-dependent. However, the molecular mechanisms by which H. cordata inhibits HSV infection are not elucidated thoroughly. Here, we report that H. cordata water extracts (HCWEs) inhibit the infection of HSV-1, HSV-2, and acyclovir-resistant HSV-1 mainly via blocking viral binding and penetration in the beginning of infection. HCWEs also suppress HSV replication. Furthermore, HCWEs attenuate the first-wave of NF-kappa B activation, which is essential for viral gene expressions. Further analysis of six compounds in HCWEs revealed that quercetin and isoquercitrin inhibit NF-kappa B activation and additionally, quercetin also has an inhibitory effect on viral entry. These results indicate that HCWEs can inhibit HSV infection through multiple mechanisms and could be a potential lead for development of new drugs for treating HSV.	[Hung, Pei-Yun; Ho, Bing-Ching; Lee, Szu-Yuan; Chang, Sui-Yuan; Kao, Chuan-Liang; Lee, Chun-Nan] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 100, Taiwan; [Ho, Bing-Ching] Natl Taiwan Univ, Coll Med, Ctr Genom Med, Taipei 100, Taiwan; [Chang, Sui-Yuan; Kao, Chuan-Liang; Lee, Chun-Nan] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan; [Lee, Shoei-Sheng] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lee, CN (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 100, Taiwan.	cnalee@ntu.edu.tw		KAO, CHUAN-LIANG/0000-0002-1020-2605; HO, BING-CHING/0000-0003-4356-3279; LEE, SHOEI-SHENG/0000-0002-6628-2448; CHANG, SUI-YUAN/0000-0002-6009-6724	National Research Program for Genomic Medicine of Taiwan [CCMP97-RD-208]	National Research Program for Genomic Medicine of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Research Program for Genomic Medicine of Taiwan (CCMP97-RD-208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUKARAM M, 1992, J NAT PROD, V55, P1525, DOI 10.1021/np50088a022; Amici C, 2006, J BIOL CHEM, V281, P7110, DOI 10.1074/jbc.M512366200; BALFOUR HH, 1983, ANN INTERN MED, V98, P404, DOI 10.7326/0003-4819-98-3-404; BARINGER JR, 1974, NEW ENGL J MED, V291, P828, DOI 10.1056/NEJM197410172911606; BEVILACQUA F, 1991, J ACQ IMMUN DEF SYND, V4, P967; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Chen SH, 2008, J CLIN INVEST, V118, P3470, DOI 10.1172/JCI35114; Chen XQ, 2011, ANTIVIR RES, V92, P341, DOI 10.1016/j.antiviral.2011.09.005; Chen YY, 2003, J NUTR SCI VITAMINOL, V49, P327, DOI 10.3177/jnsv.49.327; Chiang LC, 2003, AM J CHINESE MED, V31, P355, DOI 10.1142/S0192415X03001090; Choi HJ, 2009, EUR J PHARM SCI, V37, P329, DOI 10.1016/j.ejps.2009.03.002; EPSTEIN JB, 1991, ORAL SURG ORAL MED O, V72, P47, DOI 10.1016/0030-4220(91)90188-I; ERLICH KS, 1989, NEW ENGL J MED, V320, P293, DOI 10.1056/NEJM198902023200506; EVERETT RD, 1984, EMBO J, V3, P3135, DOI 10.1002/j.1460-2075.1984.tb02270.x; Faith SA, 2006, ANTIVIR RES, V72, P242, DOI 10.1016/j.antiviral.2006.06.011; Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554; Farooq AV, 2012, SURV OPHTHALMOL, V57, P448, DOI 10.1016/j.survophthal.2012.01.005; FULLER AO, 1992, J VIROL, V66, P5002, DOI 10.1128/JVI.66.8.5002-5012.1992; GELMAN IH, 1985, P NATL ACAD SCI USA, V82, P5265, DOI 10.1073/pnas.82.16.5265; HAYASHI K, 1995, PLANTA MED, V61, P237, DOI 10.1055/s-2006-958063; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Jo HY, 2008, J VET SCI, V9, P267, DOI 10.4142/jvs.2008.9.3.267; JOHNSON DC, 1988, J VIROL, V62, P4605, DOI 10.1128/JVI.62.12.4605-4612.1988; JOHNSON DC, 1990, J VIROL, V64, P2569, DOI 10.1128/JVI.64.6.2569-2576.1990; JONES KA, 1985, NATURE, V317, P179, DOI 10.1038/317179a0; Kavouras JH, 2007, J NEUROVIROL, V13, P416, DOI 10.1080/13550280701460573; Kim JC, 2008, MOL BIOL+, V42, P413, DOI 10.1134/S0026893308030096; Knopf CW, 2000, ACTA VIROL, V44, P289; Kupila L, 2006, NEUROLOGY, V66, P75, DOI 10.1212/01.wnl.0000191407.81333.00; Lau KM, 2008, J ETHNOPHARMACOL, V118, P79, DOI 10.1016/j.jep.2008.03.018; LEE WC, 1993, J VIROL, V67, P5088, DOI 10.1128/JVI.67.9.5088-5097.1993; Liu Zhao-Mei, 2006, Zhongguo Zhong Yao Za Zhi, V31, P1753; Lu HM, 2006, J ETHNOPHARMACOL, V104, P245, DOI 10.1016/j.jep.2005.09.012; Lyu SY, 2005, ARCH PHARM RES, V28, P1293, DOI 10.1007/BF02978215; Marcelletti JF, 2002, ANTIVIR RES, V56, P153, DOI 10.1016/S0166-3542(02)00105-5; MCLAREN C, 1985, ANTIMICROB AGENTS CH, V28, P740, DOI 10.1128/AAC.28.6.740; Melancon JM, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-120; Meng J, 2005, CHEM PHARM BULL, V53, P1604, DOI 10.1248/cpb.53.1604; Meng Jiang, 2006, Zhongguo Zhong Yao Za Zhi, V31, P1335; Moerdyk-Schauwecker M, 2009, ANTIVIR RES, V84, P131, DOI 10.1016/j.antiviral.2009.07.020; Mommeja-Marin H, 2003, CLIN INFECT DIS, V37, P1527, DOI 10.1086/379520; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Ng LT, 2007, AM J CHINESE MED, V35, P465, DOI 10.1142/S0192415X07004989; Ottosen S, 2006, VIROLOGY, V345, P468, DOI 10.1016/j.virol.2005.10.011; Piret J, 2011, ANTIMICROB AGENTS CH, V55, P459, DOI 10.1128/AAC.00615-10; SACKS WR, 1987, J VIROL, V61, P829, DOI 10.1128/JVI.61.3.829-839.1987; Sato M, 1997, J RHEUMATOL, V24, P1680; Savov VM, 2006, EXP TOXICOL PATHOL, V58, P59, DOI 10.1016/j.etp.2006.05.002; Shih CM, 2004, EUR J PHARMACOL, V496, P41, DOI 10.1016/j.ejphar.2004.06.016; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Su CT, 2008, ANTIVIR RES, V79, P62, DOI 10.1016/j.antiviral.2008.01.156; Taddeo B, 2003, P NATL ACAD SCI USA, V100, P12408, DOI 10.1073/pnas.2034952100; Tao J, 2007, ANTIVIR RES, V75, P227, DOI 10.1016/j.antiviral.2007.03.008; Tatti S, 2010, BRIT J DERMATOL, V162, P176, DOI 10.1111/j.1365-2133.2009.09375.x; Thi THN, 2012, BIOTECHNOL LETT, V34, P831, DOI 10.1007/s10529-011-0845-8; TUTUPALLI LV, 1975, LLOYDIA, V38, P92; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; Wutzler P, 1997, INTERVIROLOGY, V40, P343, DOI 10.1159/000150567; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Xu GH, 2009, ARCH PHARM RES, V32, P275, DOI 10.1007/s12272-009-1233-y; Yasin B, 2004, J VIROL, V78, P5147, DOI 10.1128/JVI.78.10.5147-5156.2004	63	46	52	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0115475	10.1371/journal.pone.0115475	http://dx.doi.org/10.1371/journal.pone.0115475			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643242	Green Published, gold, Green Submitted			2022-12-27	WOS:000348821200010
J	Chen, Y; Feng, J; Gilbert, C; Yin, H; Liang, JH; Li, XX				Chen, Yi; Feng, Jing; Gilbert, Clare; Yin, Hong; Liang, Jianhong; Li, Xiaoxin			Time at Treatment of Severe Retinopathy of Prematurity in China: Recommendations for Guidelines in More Mature Infants	PLOS ONE			English	Article							THRESHOLD RETINOPATHY; OUTCOMES	Purpose To investigate the postmenstrual (PMA) age at treatment of severe retinopathy of prematurity (i.e. Type 1 prethreshold or threshold) in infants in a tertiary referral center in China. Principal Findings 76.6% (359/469) of infants were treated for threshold disease. 67.5% (317/469) of infants had a birth weight (BW) of 1250g or above and almost 30% (126) had a gestational age (GA) of 32 weeks or above. There was little difference in the characteristics of infants treated for Type 1 prethreshold or threshold ROP. After controlling for GA, PMA age at treatment was highest in infants with BW >= 2000g (mean PMA 40.3 +/- 4.4 weeks, p<0.001); after controlling for BW, higher GA was associated with higher PMA at treatment (mean PMA 41.5 weeks for gestational age >34 weeks, p<0.001). For every three weeks increase in GA there was a two-week increase in PMA at treatment (R2 = 0.20, p<0.001). The time at treatment of Type 1 prethreshold disease was similar to that for threshold disease i.e. chronological age 5.6-7.4 weeks, or PMA 34.1-40.2 weeks but the lower end of the 95% confidence interval for chronological age for Type 1 prethreshold disease among infants with BW >= 2000g was 3.7 weeks (i.e. before the recommended interval of 4-6 weeks after birth). Significance The Chinese guidelines regarding timing of the first examination are appropriate for infants with BW <2000g, but more mature infants should be examined a little earlier, at 3 weeks after birth, in order to detect Type 1 prethreshold disease which has a better prognosis than threshold.	[Chen, Yi; Feng, Jing; Yin, Hong; Liang, Jianhong; Li, Xiaoxin] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China; [Chen, Yi; Feng, Jing; Yin, Hong; Liang, Jianhong; Li, Xiaoxin] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Gilbert, Clare] London Sch Hyg & Trop Med, Dept Clin Res, Int Ctr Eye Hlth, London WC1, England	Peking University; University of London; London School of Hygiene & Tropical Medicine	Li, XX (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China.	drli_xiao_xin@163.com		Feng, Jing/0000-0002-7658-9865				Asano Matthew K, 2014, Int Ophthalmol Clin, V54, P225, DOI 10.1097/IIO.0000000000000012; Blencowe H, 2013, PEDIATR RES, V74, P35, DOI 10.1038/pr.2013.205; Carden SM, 2008, CLIN EXP OPHTHALMOL, V36, P159, DOI 10.1111/j.1442-9071.2008.01682.x; Chen Y, 2006, BRIT J OPHTHALMOL, V90, P268, DOI 10.1136/bjo.2005.078063; Chinese Medical Association, 2005, ZHONGHUA YAN KE ZA Z, V41, P375; Coats DK, 2000, J AAPOS, V4, P183, DOI 10.1016/S1091-8531(00)70011-5; Coordination Group for the Survey of Present Status of Oxygen Use in Premature Infants in NICUs and Prevention and Treatment of ROP, 2012, Zhonghua Er Ke Za Zhi, V50, P167; Fierson WM, 2013, PEDIATRICS, V131, P189, DOI 10.1542/peds.2012-2996; Gilbert C, 2005, PEDIATRICS, V115, pE518, DOI 10.1542/peds.2004-1180; Gilbert C, 1997, LANCET, V350, P12, DOI 10.1016/S0140-6736(97)01107-0; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good WV, 2010, ARCH OPHTHALMOL-CHIC, V128, P663, DOI 10.1001/archophthalmol.2010.72; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Good WV, 2005, PEDIATRICS, V116, P15, DOI 10.1542/peds.2004-1413; Houston SK, 2013, LASER MED SCI, V28, P683, DOI 10.1007/s10103-011-1021-z; Hutchinson AK, 1998, ARCH OPHTHALMOL-CHIC, V116, P608, DOI 10.1001/archopht.116.5.608; Limburg H, 2012, OPHTHALMOLOGY, V119, P355, DOI 10.1016/j.ophtha.2011.07.037; Nguyen TH, 2000, OBSTET GYNECOL, V95, P867, DOI 10.1016/S0029-7844(99)00639-0; Nicoara SD, 2014, J PEDIAT OPHTH STRAB, V51, P39, DOI 10.3928/01913913-20131112-02; Palmer EA, 2005, ARCH OPHTHALMOL-CHIC, V123, P311; Palmer EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P595; Palmer EA, 2006, J AAPOS, V10, P500, DOI 10.1016/j.jaapos.2006.09.005; Repka MX, 2011, ARCH OPHTHALMOL-CHIC, V129, P1175, DOI 10.1001/archophthalmol.2011.229; Sinha Renu, 2014, J Anaesthesiol Clin Pharmacol, V30, P258, DOI 10.4103/0970-9185.130050; Wei KL., 2005, CHIN J NAT MED, V7, P25; Weller A, 1998, J PSYCHOSOM OBST GYN, V19, P111, DOI 10.3109/01674829809048504; Wilkinson AR, 2009, EYE, V23, P2137, DOI 10.1038/eye.2008.128; Yang CY, 2011, PEDIATR NEONATOL, V52, P321, DOI 10.1016/j.pedneo.2011.08.004; 黎晓新, 2004, [中华眼底病杂志, Chinese Journal of Ocular Fundus Diseases], V20, P384	29	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0116669	10.1371/journal.pone.0116669	http://dx.doi.org/10.1371/journal.pone.0116669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664992	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000349123100011
J	Deng, Y; Gao, L; Wang, BB; Guo, XL				Deng, Yue; Gao, Lin; Wang, Bingbo; Guo, Xingli			HPOSim: An R Package for Phenotypic Similarity Measure and Enrichment Analysis Based on the Human Phenotype Ontology	PLOS ONE			English	Article							SEMANTIC SIMILARITY; GENE ONTOLOGY; TOOL; GO; INTERACTOME; NETWORK	Background Phenotypic features associated with genes and diseases play an important role in diseaserelated studies and most of the available methods focus solely on the Online Mendelian Inheritance in Man (OMIM) database without considering the controlled vocabulary. The Human Phenotype Ontology (HPO) provides a standardized and controlled vocabulary covering phenotypic abnormalities in human diseases, and becomes a comprehensive resource for computational analysis of human disease phenotypes. Most of the existing HPObased software tools cannot be used offline and provide only few similarity measures. Therefore, there is a critical need for developing a comprehensive and offline software for phenotypic features similarity based on HPO. Results HPOSim is an R package for analyzing phenotypic similarity for genes and diseases based on HPO data. Seven commonly used semantic similarity measures are implemented in HPOSim. Enrichment analysis of gene sets and disease sets are also implemented, including hypergeometric enrichment analysis and network ontology analysis (NOA). Conclusions HPOSim can be used to predict disease genes and explore disease-related function of gene modules. HPOSim is open source and freely available at SourceForge (https://sourceforge.net/p/hposim/).	[Deng, Yue; Gao, Lin; Wang, Bingbo; Guo, Xingli] Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China; [Deng, Yue] Xidian Univ, Inst Software Engn, Xian, Peoples R China	Xidian University; Xidian University	Gao, L (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China.	lgao@mail.xidian.edu.cn			National Natural Science Foundation of China [61402349, 91130006, 61303122, 61303118]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (Grant Numbers: 61402349 to YD, 91130006 to LG, 61303122 to BW and 61303118 to XG), and the website is http://www.nsfc.gov.cn/publish/portal1/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2010, TOPGO TOPGO ENRICHME; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Freudenberg J, 2002, BIOINFORMATICS, V18, pS110, DOI 10.1093/bioinformatics/18.suppl_2.S110; Frohlich H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-166; Fulop T, 2006, MECH AGEING DEV, V127, P526, DOI 10.1016/j.mad.2006.01.025; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hoehndorf R, 2012, BIOINFORMATICS, V28, P2169, DOI 10.1093/bioinformatics/bts350; Hoehndorf R, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr538; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang J, 1997, INTERNATIONAL CONFERENCE ON CONSUMER ELECTRONICS, 1997 DIGEST OF TECHNICAL PAPERS, P94; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; KOHLER S, 2013, NUCL ACIDS RES, P87044; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Li B., 2010, ARXIV10010958; Li J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-266; Lin D, 1998, P INT C MACH LEARN; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Pesquita C, 2007, P 10 ANN BIOONT M; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; SANO T, 1993, MAYO CLIN PROC, V68, P971, DOI 10.1016/S0025-6196(12)62269-1; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; SILVERBERG SJ, 1989, NEW ENGL J MED, V320, P277, DOI 10.1056/NEJM198902023200503; Smedley D, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat025; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vulto-van Silfhout AT, 2013, EUR J MED GENET, V56, P471, DOI 10.1016/j.ejmg.2013.06.010; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wang JG, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr251; Wang JG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000521; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247; Wittkop T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-53; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064	41	32	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0115692	10.1371/journal.pone.0115692	http://dx.doi.org/10.1371/journal.pone.0115692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664462	Green Published, gold, Green Submitted			2022-12-27	WOS:000349123100005
J	Zhang, JP; Yang, ZJ; Xiao, JZ; Xing, XY; Lu, JM; Weng, JP; Jia, WP; Ji, LN; Shan, ZY; Liu, J; Tian, HM; Ji, QH; Zhu, DL; Ge, JP; Chen, L; Guo, XH; Zhao, ZG; Li, Q; Zhou, ZG; Lin, LX; Wang, N; Yang, WY				Zhang, Jinping; Yang, Zhaojun; Xiao, Jianzhong; Xing, Xiaoyan; Lu, Juming; Weng, Jianping; Jia, Weiping; Ji, Linong; Shan, Zhongyan; Liu, Jie; Tian, Haoming; Ji, Qiuhe; Zhu, Dalong; Ge, Jiapu; Chen, Li; Guo, Xiaohui; Zhao, Zhigang; Li, Qiang; Zhou, Zhiguang; Lin, Lixiang; Wang, Na; Yang, Wenying		China Natl Diabet Metab Disorders	Association between Family History Risk Categories and Prevalence of Diabetes in Chinese Population	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; INSULIN SENSITIVITY; FASTING GLUCOSE; SECRETION; OBESITY; HYPERINSULINEMIA; TRANSMISSION; INDIVIDUALS; RELATIVES; INDEXES	Aim To investigate the association between different family history risk categories and prevalence of diabetes in the Chinese population. Methods The family history of diabetes was obtained from each subject, and an oral glucose tolerance test was performed for measuring the fasting and postload glucose and insulin levels based on a national representative cross-sectional survey of 46,239 individuals (age >= 20 years) in the 2007-2008 China National Diabetes and Metabolism Disorders Study. The family history risk categories of diabetes were high, moderate, and average (FH2 and FH1: at least two generations and one generation of first-degree relatives with diabetes, respectively; FH0: no first-degree relatives with diabetes). Results The age-and gender-adjusted prevalence rates of diabetes were 32.7% (95% confidence interval (CI): 26.4-39.7%) in FH2, 20.1% (95% CI: 18.2-22.1%) in FH1, and 8.4% (95% CI: 7.9-8.9%) in FH0 (P < 0.0001). The calculated homeostatic model assessment-estimated insulin resistance (HOMA-IR), Matsuda insulin sensitivity index (ISI), and insulinogenic index (Delta I30/Delta G30) values showed significant trending changes among the three risk categories, with the most negative effects in FH2. Multivariate logistic regression analysis showed that the odds ratios of having diabetes were 6.16 (95% CI: 4.46-8.50) and 2.86 (95% CI: 2.41-3.39) times higher in FH2 and FH1, respectively, than in FH0 after adjustment for classical risk factors for diabetes. Conclusions Family history risk categories of diabetes have a significant, independent, and graded association with the prevalence of this disease in the Chinese population.	[Zhang, Jinping; Yang, Zhaojun; Xiao, Jianzhong; Xing, Xiaoyan; Wang, Na; Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China; [Lu, Juming] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Hosp 3, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol, Shanghai 200030, Peoples R China; [Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol, Beijing 100871, Peoples R China; [Shan, Zhongyan] Chinese Med Univ, Affiliated Hosp 1, Dept Endocrinol, Liaoling, Peoples R China; [Liu, Jie] Shanxi Prov Peoples Hosp, Dept Endocrinol, Taiyuan, Shanxi, Peoples R China; [Tian, Haoming] Sichuan Univ, West China Hosp, Dept Endocrinol, Chengdu 610064, Sichuan, Peoples R China; [Ji, Qiuhe] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol, Xian 710032, Shanxi, Peoples R China; [Zhu, Dalong] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Endocrinol, Nanjing 210008, Jiangsu, Peoples R China; [Ge, Jiapu] Xinjiang Uygur Autonomous Reg Hosp, Dept Endocrinol, Urumqi, Xinjiang, Peoples R China; [Chen, Li] Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan 250100, Shandong, Peoples R China; [Guo, Xiaohui] Peking Univ, Hosp 1, Dept Endocrinol, Beijing 100871, Peoples R China; [Zhao, Zhigang] Henan Prov Peoples Hosp, Dept Endocrinol, Zhengzhou, Henan, Peoples R China; [Li, Qiang] Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol, Harbin, Heilongjiang, Peoples R China; [Zhou, Zhiguang] Xiangya Second Hosp, Dept Endocrinol, Changsha, Hunan, Peoples R China; [Lin, Lixiang] Fujian Prov Hosp, Dept Endocrinol, Fuzhou, Fujiang, Peoples R China	China-Japan Friendship Hospital; Chinese People's Liberation Army General Hospital; Sun Yat Sen University; Shanghai Jiao Tong University; Peking University; China Medical University; Shanxi People's Hospital; Sichuan University; Air Force Military Medical University; Nanjing University; Shandong University; Peking University; Zhengzhou University; Harbin Medical University; Central South University; Fujian Provincial Hospital	Yang, ZJ (corresponding author), China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China.	yzj69@aliyun.com; ywying_1010@163.com	Jia, Weiping/B-7483-2012; zhang, jin/GXV-9154-2022; Linong, Ji/AAB-6543-2020	Yang, Wenying/0000-0002-7997-9404; Weng, Jianping/0000-0002-7889-1697	Chinese Medical Association Foundation; Chinese Diabetes Society [07020470055]	Chinese Medical Association Foundation; Chinese Diabetes Society	This study was supported by grants from the Chinese Medical Association Foundation and the Chinese Diabetes Society (grant numbers: 07020470055). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ZHONGHUA XIN XUE GUA, V35, P390, DOI DOI 10.3760/J.ISSN:0253-3758.2007.05.003; Bao YQ, 2008, ATHEROSCLEROSIS, V201, P378, DOI 10.1016/j.atherosclerosis.2008.03.001; Davies MJ, 2000, DIABETIC MED, V17, P433, DOI 10.1046/j.1464-5491.2000.00246.x; Department of Noncommunicable Disease Surveillance, 1999, DEF DIAGN CLASS DI 1; Franks PW, 2010, DIABETES, V59, P2732, DOI 10.2337/db10-0768; Goran MI, 2003, J CLIN ENDOCR METAB, V88, P192, DOI 10.1210/jc.2002-020917; Grill V, 1999, DIABETOLOGIA, V42, P15, DOI 10.1007/s001250051106; GULLI G, 1992, DIABETES, V41, P1575, DOI 10.2337/diabetes.41.12.1575; Haffner SM, 1996, DIABETOLOGIA, V39, P1201, DOI 10.1007/BF02658507; Hanefeld M, 2003, DIABETES CARE, V26, P868, DOI 10.2337/diacare.26.3.868; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Hariri S, 2006, GENET MED, V8, P102, DOI 10.1097/01.gim.0000200949.52795.df; International Diabetes Federation, 2013, IDF DIABETES ATLAS, DOI [10.3390/jpm3040288, DOI 10.3390/JPM3040288]; Ishikawa M, 1998, DIABETES, V47, P788, DOI 10.2337/diabetes.47.5.788; Isomaa B, 2010, DIABETOLOGIA, V53, P1709, DOI 10.1007/s00125-010-1776-y; Kim DJ, 2004, DIABETES RES CLIN PR, V65, P117, DOI 10.1016/j.diabres.2003.11.020; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Moonesinghe R, 2012, EUR J HUM GENET, V20, P831, DOI 10.1038/ejhg.2012.15; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Temelkova-Kurktschiev T, 2012, EXP CLIN ENDOCR DIAB, V120, P1, DOI 10.1055/s-0031-1285832; Utzschneider KM, 2006, DIABETES CARE, V29, P356, DOI 10.2337/diacare.29.02.06.dc05-1963; Valdez R, 2007, DIABETES CARE, V30, P2517, DOI 10.2337/dc07-0720; van Haeften TW, 1998, DIABETES CARE, V21, P278, DOI 10.2337/diacare.21.2.278; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Weyer C, 1999, DIABETES, V48, P2197, DOI 10.2337/diabetes.48.11.2197; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	30	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117044	10.1371/journal.pone.0117044	http://dx.doi.org/10.1371/journal.pone.0117044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664814	Green Published, Green Submitted, gold			2022-12-27	WOS:000349123100017
J	Caldwell, JZK; Armstrong, JM; Hanson, JL; Sutterer, MJ; Stodola, DE; Koenigs, M; Kalin, NH; Essex, MJ; Davidson, RJ				Caldwell, Jessica Z. K.; Armstrong, Jeffrey M.; Hanson, Jamie L.; Sutterer, Matthew J.; Stodola, Diane E.; Koenigs, Michael; Kalin, Ned H.; Essex, Marilyn J.; Davidson, Richard J.			Preschool Externalizing Behavior Predicts Gender-Specific Variation in Adolescent Neural Structure	PLOS ONE			English	Article							CONDUCT DISORDER; AMYGDALA VOLUME; BRAIN STRUCTURE; DEVELOPMENTAL PATHWAYS; ACADEMIC DIFFICULTIES; PSYCHOPATHIC TRAITS; PREFRONTAL CORTEX; MIDDLE CHILDHOOD; MENTAL-HEALTH; NEUROBIOLOGY	Dysfunction in the prefrontal cortex, amygdala, and hippocampus is believed to underlie the development of much psychopathology. However, to date only limited longitudinal data relate early behavior with neural structure later in life. Our objective was to examine the relationship of early life externalizing behavior with adolescent brain structure. We report here the first longitudinal study linking externalizing behavior during preschool to brain structure during adolescence. We examined the relationship of preschool externalizing behavior with amygdala, hippocampus, and prefrontal cortex volumes at age 15 years in a community sample of 76 adolescents followed longitudinally since their mothers' pregnancy. A significant gender by externalizing behavior interaction revealed that males-but not females-with greater early childhood externalizing behavior had smaller amygdala volumes at adolescence (t = 2.33, p =.023). No significant results were found for the hippocampus or the prefrontal cortex. Greater early externalizing behavior also related to smaller volume of a cluster including the angular gyrus and tempoparietal junction across genders. Results were not attributable to the impact of preschool anxiety, preschool maternal stress, school-age internalizing or externalizing behaviors, or adolescent substance use. These findings demonstrate a novel, gender-specific relationship between early-childhood externalizing behavior and adolescent amygdala volume, as well as a cross-gender result for the angular gyrus and tempoparietal junction.	[Caldwell, Jessica Z. K.; Hanson, Jamie L.; Sutterer, Matthew J.; Stodola, Diane E.; Davidson, Richard J.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Armstrong, Jeffrey M.; Koenigs, Michael; Kalin, Ned H.; Essex, Marilyn J.; Davidson, Richard J.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Davidson, Richard J.] Univ Wisconsin, Ctr Investigating Hlth Minds, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Caldwell, JZK (corresponding author), Michigan State Univ, Marquette Gen Hosp, Marquette, MI 49855 USA.	Jessica.kirklandcaldwell@mghs.org	Hanson, Jamie/B-9420-2014	Hanson, Jamie/0000-0002-0469-8886; Davidson, Richard/0000-0002-8506-4964; Kalin, Ned/0000-0003-1184-0868; Sutterer, Matthew/0000-0001-5223-857X; Koenigs, Michael/0000-0002-5799-4881	National Institutes of Health [P30-HD003352, R01-MH044340, P50-MH052354, P50-MH069315, P50-MH084051, P50-MH100031]; Ruth L. Kirschstein National Research Service Award [F31-DA028087]; John D. and Catherine T. MacArthur Foundation Research Network on Psychopathology and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH084051, P50MH052354, R01MH044340, T32MH018931, P50MH069315, R01MH043454, P50MH100031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John D. and Catherine T. MacArthur Foundation Research Network on Psychopathology and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (www.nih.gov) grants: P30-HD003352 (Marsha Seltzer, Waisman Center Core), R01-MH044340 (MJE), P50-MH052354 (RJD), P50-MH069315 (RJD), P50-MH084051 (RJD), and P50-MH100031 (RJD); Ruth L. Kirschstein National Research Service Award F31-DA028087 (JLH); and the John D. and Catherine T. MacArthur Foundation Research Network on Psychopathology and Development (MJE) (www.macfound.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablow JC, 1999, J AM ACAD CHILD PSY, V38, P1580, DOI 10.1097/00004583-199912000-00020; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Anderson NE, 2012, TRENDS COGN SCI, V16, P52, DOI 10.1016/j.tics.2011.11.008; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1111/1469-7610.00424; Avants B, 2004, NEUROIMAGE, V23, pS139, DOI 10.1016/j.neuroimage.2004.07.010; Avants B, 2008, ACAD RADIOL, V15, P1360, DOI 10.1016/j.acra.2008.07.007; BEHAR L, 1974, DEV PSYCHOL, V10, P601, DOI 10.1037/h0037058; Blair RJR, 2010, CURR PSYCHIAT REP, V12, P76, DOI 10.1007/s11920-009-0086-x; Blair RJR, 2013, NAT REV NEUROSCI, V14, P786, DOI 10.1038/nrn3577; Boccardi M, 2011, PSYCHIAT RES-NEUROIM, V193, P85, DOI 10.1016/j.pscychresns.2010.12.013; Bornstein MH, 2013, DEV PSYCHOPATHOL, V25, P857, DOI 10.1017/S0954579413000217; Boyce WT, 2002, J AM ACAD CHILD PSY, V41, P580, DOI 10.1097/00004583-200205000-00016; Bubier JL, 2009, CLIN PSYCHOL REV, V29, P658, DOI 10.1016/j.cpr.2009.08.005; Buhler M, 2011, ALCOHOL CLIN EXP RES, V35, P1771, DOI 10.1111/j.1530-0277.2011.01540.x; Burghy CA, 2012, NAT NEUROSCI, V15, P1736, DOI 10.1038/nn.3257; Burk LR, 2011, PSYCHOL ADDICT BEHAV, V25, P1, DOI 10.1037/a0022349; Burk LR, 2011, J ABNORM CHILD PSYCH, V39, P225, DOI 10.1007/s10802-010-9454-6; Cheetham A, 2014, PSYCHOPHARMACOLOGY, V231, P1731, DOI 10.1007/s00213-014-3483-8; Convit A, 1999, PSYCHIAT RES-NEUROIM, V90, P113, DOI 10.1016/S0925-4927(99)00007-4; Costello EJ, 2011, J CHILD PSYCHOL PSYC, V52, P1015, DOI 10.1111/j.1469-7610.2011.02446.x; Crowe SL, 2008, DEV PSYCHOPATHOL, V20, P1145, DOI 10.1017/S0954579408000540; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; Debiec J, 2010, NAT NEUROSCI, V13, P536, DOI 10.1038/nn.2520; Dennison M, 2013, DEVELOPMENTAL SCI, V16, P772, DOI 10.1111/desc.12057; Duvernoy HM, 1999, THE HUMAN BRAIN SURF; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P85, DOI 10.1017/S0954579410000660; Ermer E, 2011, J ABNORM PSYCHOL; Essex MJ, 2002, J AM ACAD CHILD PSY, V41, P588, DOI 10.1097/00004583-200205000-00017; Essex MJ, 2002, BIOL PSYCHIAT, V52, P776, DOI 10.1016/S0006-3223(02)01553-6; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fairchild G, 2013, J CHILD PSYCHOL PSYC, V54, P86, DOI 10.1111/j.1469-7610.2012.02617.x; Fox J., 1991, SAGE U PAPER SERIES; Gao Y, 2009, CAN J PSYCHIAT, V54, P813, DOI 10.1177/070674370905401204; Giedd JN, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-19; Giedd JN, 2010, NEUROPSYCHOL REV, V20, P349, DOI 10.1007/s11065-010-9151-9; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Hanson JL, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00166; Hanson JL, 2010, J NEUROSCI, V30, P7466, DOI 10.1523/JNEUROSCI.0859-10.2010; Hicks BM, 2007, J ABNORM PSYCHOL, V116, P433, DOI 10.1037/0021-843X.116.3.433; Hill SY, 2010, PSYCHIAT RES-NEUROIM, V182, P14, DOI 10.1016/j.pscychresns.2009.11.006; Hill SY, 2001, BIOL PSYCHIAT, V49, P894, DOI 10.1016/S0006-3223(01)01088-5; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; HYDE JS, 1995, PSYCHOL WOMEN QUART, V19, P257, DOI 10.1111/j.1471-6402.1995.tb00291.x; Kendler KS, 2014, PSYCHOL MED, V44, P647, DOI 10.1017/S0033291713000585; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kochanska G, 2012, DEV PSYCHOPATHOL, V24, P783, DOI 10.1017/S0954579412000375; Koenigs M, 2012, REV NEUROSCIENCE, V23, P253, DOI 10.1515/revneuro-2012-0036; Kraemer HC, 2003, AM J PSYCHIAT, V160, P1566, DOI 10.1176/appi.ajp.160.9.1566; Kruesi MJP, 2004, PSYCHIAT RES-NEUROIM, V132, P1, DOI 10.1016/j.pscychresns.2004.07.002; Laakso MP, 2001, BEHAV BRAIN RES, V118, P187, DOI 10.1016/S0166-4328(00)00324-7; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lemery-Chalfant K, 2007, J AM ACAD CHILD PSY, V46, P1315, DOI 10.1097/chi.0b013e3180f616c6; Lenroot RK, 2010, BRAIN COGNITION, V72, P46, DOI 10.1016/j.bandc.2009.10.008; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mackey S, 2013, NEUROSCI BIOBEHAV R, V37, P300, DOI 10.1016/j.neubiorev.2012.12.003; Mai JK, 1997, ATLAS OF THE HUMAN B; Malykhin NV, 2007, PSYCHIAT RES-NEUROIM, V155, P155, DOI 10.1016/j.pscychresns.2006.11.011; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Martin-Santos R, 2010, PSYCHOL MED, V40, P383, DOI 10.1017/S0033291709990729; Meintjes EM, NEUROIMAGE CLIN; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Morishima Y, 2012, NEURON, V75, P73, DOI 10.1016/j.neuron.2012.05.021; MORRIS NM, 1980, J YOUTH ADOLESCENCE, V9, P271, DOI 10.1007/BF02088471; Nacewicz BM, 2006, ARCH GEN PSYCHIAT, V63, P1417, DOI 10.1001/archpsyc.63.12.1417; Pardini DA, 2014, BIOL PSYCHIAT, V75, P73, DOI 10.1016/j.biopsych.2013.04.003; Paus T, 2010, PROG BRAIN RES, V186, P13, DOI 10.1016/B978-0-444-53630-3.00002-6; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; Raine A, 2004, BIOL PSYCHIAT, V55, P185, DOI 10.1016/S0006-3223(03)00727-3; Rusch BD, 2001, BIOL PSYCHIAT, V50, P960, DOI 10.1016/S0006-3223(01)01248-3; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Schiffer B, 2011, ARCH GEN PSYCHIAT, V68, P1039, DOI 10.1001/archgenpsychiatry.2011.61; Schwartz CE, 2012, MOL PSYCHIATR, V17, P1042, DOI 10.1038/mp.2011.96; Schwartz CE, 2010, ARCH GEN PSYCHIAT, V67, P78, DOI 10.1001/archgenpsychiatry.2009.171; Schwartz CE, 2003, SCIENCE, V300, P1952, DOI 10.1126/science.1083703; Shirtcliff EA, 2009, CHILD DEV, V80, P327, DOI 10.1111/j.1467-8624.2009.01263.x; Somerville LH, 2010, CURR OPIN NEUROBIOL, V20, P236, DOI 10.1016/j.conb.2010.01.006; Sterzer P, 2007, NEUROIMAGE, V37, P335, DOI 10.1016/j.neuroimage.2007.04.043; Tanner JM, 1962, GROWTH AT ADOLESCENC, V2nd; Visser TAW, 2014, SOC COGN AFFECT NEUR, V9, P553, DOI 10.1093/scan/nst013; Wallace GL, 2014, J AM ACAD CHILD PSY, V53, P456, DOI 10.1016/j.jaac.2013.12.008; Whittle S, 2013, J AM ACAD CHILD PSY, V52, P940, DOI 10.1016/j.jaac.2013.06.007; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Worsley KJ, 2004, NEUROIMAGE, V23, pS189, DOI 10.1016/j.neuroimage.2004.07.026; Yang YL, 2011, J NEUROPSYCH CLIN N, V23, P107, DOI 10.1176/appi.neuropsych.23.1.107; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Yang YL, 2009, ARCH GEN PSYCHIAT, V66, P986, DOI 10.1001/archgenpsychiatry.2009.110; Yoon U, 2011, NEUROSCI LETT, V493, P8, DOI 10.1016/j.neulet.2011.01.070; Zahn-Waxler C, 2008, ANNU REV CLIN PSYCHO, V4, P275, DOI 10.1146/annurev.clinpsy.3.022806.091358; Zaki J, 2012, NAT NEUROSCI, V15, P675, DOI 10.1038/nn.3085; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	95	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117453	10.1371/journal.pone.0117453	http://dx.doi.org/10.1371/journal.pone.0117453			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658357	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900152
J	da Silva, LG; Ribeiro, MC; Hasui, E; da Costa, CA; da Cunha, RGT				da Silva, Lucas Goulart; Ribeiro, Milton Cezar; Hasui, Erica; da Costa, Carla Aparecida; Teixeira da Cunha, Rogerio Grassetto			Patch Size, Functional Isolation, Visibility and Matrix Permeability Influences Neotropical Primate Occurrence within Highly Fragmented Landscapes	PLOS ONE			English	Article							ATLANTIC FOREST; TRICHROMATIC VISION; FEEDING ADAPTATIONS; SPECIES RICHNESS; SEED DISPERSAL; HOME-RANGE; SAO-PAULO; BODY SIZE; CONSERVATION; HABITAT	Forest fragmentation and habitat loss are among the major current extinction causes. Remaining fragments are mostly small, isolated and showing poor quality. Being primarily arboreal, Neotropical primates are generally sensitive to fragmentation effects. Furthermore, primates are involved in complex ecological process. Thus, landscape changes that negatively interfere with primate population dynamic affect the structure, composition, and ultimately the viability of the whole community. We evaluated if fragment size, isolation and visibility and matrix permeability are important for explaining the occurrence of three Neotropical primate species. Employing playback, we verified the presence of Callicebus nigrifrons, Callithrix aurita and Sapajus nigritus at 45 forest fragments around the municipality of Alfenas, Brazil. We classified the landscape and evaluated the metrics through predictive models of occurrence. We selected the best models through Akaike Selection Criterion. Aiming at validating our results, we applied the plausible models to another region (20 fragments at the neighboring municipality of Poco Fundo, Brazil). Twelve models were plausible, and three were validated, two for Sapajus nigritus (Area and Area+Visibility) and one for Callicebus nigrifrons (Area+Matrix). Our results reinforce the contribution of fragment size to maintain biodiversity within highly degraded habitats. At the same time, they stress the importance of including novel, biologically relevant metrics in landscape studies, such as visibility and matrix permeability, which can provide invaluable help for similar studies in the future and on conservation practices in the long run.	[da Silva, Lucas Goulart; Hasui, Erica; da Costa, Carla Aparecida; Teixeira da Cunha, Rogerio Grassetto] Fed Univ Alfenas UNIFAL MG, Inst Nat Sci, Alfenas, Brazil; [Ribeiro, Milton Cezar] Sao Paulo State Univ, UNESP, Dept Ecol, Spatial Ecol & Conservat Lab LEEC, Rio Claro, Brazil	Universidade Federal de Alfenas; Universidade Estadual Paulista	da Cunha, RGT (corresponding author), Fed Univ Alfenas UNIFAL MG, Inst Nat Sci, Alfenas, Brazil.	rogcunha@hotmail.com	Hasui, Erica/AAF-5580-2019; Rotta, Polyana P/L-4722-2016; Rotta, Polyana/AAT-8719-2020; da Cunha, Rogério Grassetto Teixeira/AAS-6530-2020; Costa e Silva, Luiz Fernando/T-6073-2019; Silva, Flávia/AAQ-6163-2021; da Cunha, Rogério Grassetto Teixeira/J-1738-2012; Marcondes, Marcos/AAH-7553-2020	Hasui, Erica/0000-0002-9938-9284; Rotta, Polyana/0000-0002-1185-8120; da Cunha, Rogério Grassetto Teixeira/0000-0002-2368-3540; Silva, Flávia/0000-0001-5819-5638; da Cunha, Rogério Grassetto Teixeira/0000-0002-2368-3540; Marcondes, Marcos/0000-0003-4843-2809	Foundation for Research Support of the State of Minas Gerais (FAPEMIG); Vale S.A. [CRA-RDP-00104-10]; National Council for Scientific and Technological Development (CNPq) [472250/2010-8, process 312045/2013-1]; Sao Paulo Research Foundation (FAPESP) [process 2013/50421-2]	Foundation for Research Support of the State of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Vale S.A.; National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	LGS, EH, CAC and RGTC thank the Foundation for Research Support of the State of Minas Gerais (FAPEMIG, http://www.fapemig.br/) and Vale S.A. (joint process CRA-RDP-00104-10) and the National Council for Scientific and Technological Development (CNPq, Process N 472250/2010-8, http://www.cnpq.br) for financial support. MCR thanks the National Council for Scientific and Technological Development (CNPq, process 312045/2013-1, http://www.cnpq.br) and Sao Paulo Research Foundation (FAPESP, process 2013/50421-2, http://www.fapesp.br) for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert A, 2013, INT J PRIMATOL, V34, P170, DOI 10.1007/s10764-012-9649-5; Anderson J, 2007, BIOL CONSERV, V135, P212, DOI 10.1016/j.biocon.2006.10.022; [Anonymous], 2000, GENETICS DEMOGRAPHY, DOI [DOI 10.1017/CBO9780511623448, 10.1017/CBO9780511623448.008]; Anzures-Dadda A, 2007, ANIM CONSERV, V10, P69, DOI 10.1111/j.1469-1795.2006.00074.x; Arroyo-Rodriguez V, 2006, INT J PRIMATOL, V27, P1079, DOI 10.1007/s10764-006-9061-0; Arroyo-Rodriguez V, 2009, INT J PRIMATOL, V30, P497, DOI 10.1007/s10764-009-9355-0; Bezerra BM, 2008, INT J PRIMATOL, V29, P671, DOI 10.1007/s10764-008-9250-0; Bicca-Marques JC, 2006, MAMIFEROS BRASIL; Bonilla-Sanchez YM, 2010, ORYX, V44, P293, DOI 10.1017/S0030605310000025; Boscolo D, 2006, AN ACAD BRAS CIENC, V78, P629, DOI 10.1590/S0001-37652006000400003; Bueno RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056252; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Chapman CA, 2001, EVOL ANTHROPOL, V10, P16, DOI 10.1002/1520-6505(2001)10:1<16::AID-EVAN1010>3.0.CO;2-O; Chapman CA, 1998, AM J PRIMATOL, V45, P127; Chapman Colin A., 1995, Evolutionary Anthropology, V4, P74, DOI 10.1002/evan.1360040303; Chapman CA, 2006, AM J PHYS ANTHROPOL, V131, P525, DOI 10.1002/ajpa.20477; Chiarello AG, 1999, BIOL CONSERV, V89, P71, DOI 10.1016/S0006-3207(98)00130-X; Chiarello AG, 2001, INT J PRIMATOL, V22, P379, DOI 10.1023/A:1010751527749; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cowlishaw G., 2000, PRIMATE CONSERVATION; Dew JL, 1998, BIOTROPICA, V30, P425, DOI 10.1111/j.1744-7429.1998.tb00076.x; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Emmons LH, 1997, SOUNDS NEOTROPICAL R; Estrada A, 1996, INT J PRIMATOL, V17, P759, DOI 10.1007/BF02735263; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Falls J.B., 1981, Studies in Avian Biology, P86; Fonseca CR, 2009, BIOL CONSERV, V142, P1209, DOI 10.1016/j.biocon.2009.02.017; FORD SM, 1992, AM J PHYS ANTHROPOL, V88, P415, DOI 10.1002/ajpa.1330880403; Fragaszy D. M., 2004, COMPLETE CAPUCHIN BI; Garber PA, 2012, AM J PRIMATOL, V74, P344, DOI 10.1002/ajp.20957; GARBER PA, 1992, AM J PHYS ANTHROPOL, V88, P469, DOI 10.1002/ajpa.1330880404; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gonzalez-Solis J, 2001, BIODIVERS CONSERV, V10, P1267, DOI 10.1023/A:1016678126099; Greenberg DB, 2008, COPEIA, P801, DOI 10.1643/CE-07-119; Heiduck S, 2002, ORYX, V36, P133, DOI 10.1017/S0030605302000200; Hershkovitz P., 1990, FIELDIANA ZOOL, V55, P1, DOI DOI 10.5962/BHL.TITLE.2843; Hill JL, 2003, J BIOGEOGR, V30, P1391, DOI 10.1046/j.1365-2699.2003.00930.x; Hobbs RJ, 2003, AUST J BOT, V51, P471, DOI 10.1071/BT03037; IUCN, 2013, IUCN RED LIST THREAT; Izar P, 1999, THESIS U SAO PAULO S; Jerusalinsky L, 2013, THESIS; Jorgensen SE, 2001, FUNDAMENTALS ECOLOGI; LAURANCE WF, 1991, BIOL CONSERV, V55, P77, DOI 10.1016/0006-3207(91)90006-U; Lima EF, 2012, ESTRUTURA COMUNIDADE; Lovejoy T.E., 1986, P257; MAC ARTHUR ROBERT H., 1967; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Martensen AC, 2012, CONSERV BIOL, V26, P1100, DOI 10.1111/j.1523-1739.2012.01940.x; Martins MM, 2005, BIODIVERS CONSERV, V14, P2321, DOI 10.1007/s10531-004-1666-z; Matthies D, 2004, OIKOS, V105, P481, DOI 10.1111/j.0030-1299.2004.12800.x; Mesquita RCG, 1999, BIOL CONSERV, V91, P129, DOI 10.1016/S0006-3207(99)00086-5; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Mittermeier R.A., 1982, International Zoo Yearbook, V22, P2, DOI 10.1111/j.1748-1090.1982.tb02004.x; MUSKIN A, 1984, AM J PRIMATOL, V7, P377, DOI 10.1002/ajp.1350070406; Norconk MA, 2007, PRIMATES PERSPECTIVE, P123, DOI DOI 10.1017/CBO9781139034210.023.; Nowak RM, 1999, WALKERS PRIMATES WOR; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Pearson RG, 2010, AM MUSEUM NATURAL HI, V3, P56; Pereira ACR, 2010, REV CIENTIFICA DEP C, V1, P49; Pontes ARM, 2005, J ZOOL, V266, P55, DOI 10.1017/S095283690500662X; Pozo-Montuy G, 2011, PRIMATES, V52, P139, DOI 10.1007/s10329-010-0231-5; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; R Core Team, 2021, R LANGUAGE ENV STAT; Riketts TH, 2001, AM NAT, V158, P87, DOI [10.1086/320863, DOI 10.1086/320863]; ROBINSON J G, 1981, Primates, V22, P161, DOI 10.1007/BF02382607; Rocha VJ, 1995, THESIS U FEDERAL PAR; Rocha VJ, 2007, INT J PRIMATOL, V28, P231, DOI 10.1007/s10764-006-9108-2; Rosner B, 2010, FUNDAMENTALS BIOSTAT; Rowe N, 1996, PICTORIAL GUIDE LIVI; Rylands Anthony B., 1993, P262; SOS Mata Atlantica, 2008, ATL REM MAT ATL; Stone KD, 1997, AM MIDL NAT, V137, P106, DOI 10.2307/2426759; Surridge AK, 2003, TRENDS ECOL EVOL, V18, P198, DOI 10.1016/S0169-5347(03)00012-0; Tabarelli M, 2005, CONSERV BIOL, V19, P695, DOI 10.1111/j.1523-1739.2005.00694.x; Trevelin LC, 2007, REV BRAS ZOOL, V24, P1071, DOI 10.1590/S0101-81752007000400026; Umetsu F, 2008, ECOGRAPHY, V31, P359, DOI 10.1111/j.0906-7590.2008.05302.x; Vieira MV, 2009, BIOL CONSERV, V142, P1191, DOI 10.1016/j.biocon.2009.02.006; Wheeler BC, 2008, ANIM BEHAV, V76, P1465, DOI 10.1016/j.anbehav.2008.06.023; Wieczkowski J, 2004, AM J PRIMATOL, V63, P125, DOI 10.1002/ajp.20046; Youngentob KN, 2013, J BIOGEOGR, V40, P2082, DOI 10.1111/jbi.12158; Zuur Alain F., 2009, P1	84	47	49	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0114025	10.1371/journal.pone.0114025	http://dx.doi.org/10.1371/journal.pone.0114025			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658108	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900007
J	Fan, FL; Gao, JB; Liang, SH				Fan, Fangli; Gao, Jianbo; Liang, Shuhong			Crisis-Like Behavior in China's Stock Market and Its Interpretation	PLOS ONE			English	Article							FINANCIAL-CRISIS; CURRENCY CRISES; INDICATORS	In order for China to play a bigger, more positive role in the world, it is important for China to have a healthy capital market. This perception motivates us to examine the health of China's capital market, especially the severity of the overall loss of the listed companies in China and the effects of accounting irregularities on the losses. We show the overall loss of the listed companies was very severe, in particular, crisis-like behavior emerged in the fourth quarter of 2002, 2004, 2005, and 2008. We further observe that loss in the fourth quarter was much greater than the average loss of the first three quarters in the same year. The most straightforward interpretation of this loss pattern is that companies underreported losses in the first three quarters, to boost their stock values in most time of the year. However, in the fourth quarter, accounting balance of the whole year dictated that the reported loss in the fourth quarter had to be much greater than the actual loss. Fortunately, such irregularity has been greatly reduced, thanks to the accounting reforms in China in 2007.	[Fan, Fangli; Gao, Jianbo] Guangxi Univ, Inst Complex Sci & Big Data Technol, Nanning 530004, Guangxi, Peoples R China; [Fan, Fangli; Liang, Shuhong] Guangxi Univ, Sch Business, Nanning 530004, Guangxi, Peoples R China; [Gao, Jianbo] PMB Intelligence LLC, Sunnyvale, CA USA	Guangxi University; Guangxi University	Gao, JB (corresponding author), Guangxi Univ, Inst Complex Sci & Big Data Technol, Nanning 530004, Guangxi, Peoples R China.	jbgao.pmb@gmail.com	Fan, Fang/GRO-2696-2022; fan, fang/GQY-9173-2022					Berg A, 1999, INT MONET FUND S PAP, V46, P107; Berg A, 1999, J INT MONEY FINANC, V18, P561, DOI 10.1016/S0261-5606(99)00024-8; Bussiere M, 2006, J INT MONEY FINANC, V25, P953, DOI 10.1016/j.jimonfin.2006.07.007; Cover T. M., 1991, ELEMENTS INFORM THEO; Feynman R.P., 1964, FEYNMAN LECT PHYS; Gao JB, 2014, INT REV FINANC ANAL, V33, P79, DOI 10.1016/j.irfa.2013.07.013; Johnson S, 2000, AM ECON REV, V90, P22, DOI 10.1257/aer.90.2.22; Kaminsky G, 1998, INT MONET FUND S PAP, V45, P1; Li Y, 2005, IEEE COMMUN LETT, V9, P1, DOI 10.1109/LCOMM.200501010; Li YX, 2007, FORECASTING, V3, P56; Ma J, 2006, RES FINANCIAL EC ISS, V8, P71; Maddala GS, 1986, ECONOMETRIC SOC MONO; Niemira MP, 2004, INT J FORECASTING, V20, P573, DOI 10.1016/j.ijforecast.2003.09.013; Ozkan-Gunay EN, 2007, J RISK FINANC, V8, P465, DOI 10.1108/15265940710834753; Pattillo C, 2004, ASSESSING EARLY WARN, P1, DOI DOI 10.5089/9781451847284.0; Peng HD, 2012, FISCAL FINANCIAL, V1, P70; Reinhart CM, 2008, AM ECON REV, V98, P339, DOI 10.1257/aer.98.2.339; Rose AK, 2012, JPN WORLD ECON, V24, P1, DOI 10.1016/j.japwor.2011.11.001; Xu WJ, 2009, J CENTRAL U FINANCE, V3, P31, DOI [10.1136/bmjopen-2014-005657, DOI 10.1136/BMJOPEN-2014-005657]; Yan CL, 2004, MANAGEMENT WORLD, V4, P111; Yang GM, 2007, FRIENDS ACCOUNTING, V6, P25; Zhang X, 2008, CHINA ACCOUNTING REV, V6, P309; Zhang X, 2010, FINANCE EC, V6, P33; Zhang XJ, 2007, NANKAI EC STUDIES, V6, P76; Zheng BW, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019510, 10.1371/journal.pone.0019976]	26	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117209	10.1371/journal.pone.0117209	http://dx.doi.org/10.1371/journal.pone.0117209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658454	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900117
J	Kodigepalli, KM; Nanjundan, M				Kodigepalli, Karthik M.; Nanjundan, Meera			Induction of PLSCR1 in a STING/IRF3-Dependent Manner upon Vector Transfection in Ovarian Epithelial Cells	PLOS ONE			English	Article							PHOSPHOLIPID SCRAMBLASE 1; PROTEIN FAMILY-MEMBERS; GROWTH-FACTOR RECEPTOR; TOLL-LIKE RECEPTORS; PLASMA-MEMBRANE; GENE-EXPRESSION; SNON/SKIL EXPRESSION; COLORECTAL-CANCER; VIRUS-REPLICATION; INTERFERON-ALPHA	Toll-like receptors (TLRs) are the primary sensors of the innate immune system that recognize pathogenic nucleic acids including double-stranded plasmid DNA (dsDNA). TLR signaling activates multiple pathways including IRF3 which is involved in transcriptional induction of inflammatory cytokines (i.e. interferons (IFNs)). Phospholipid scramblase 1, PLSCR1, is a highly inducible IFN-regulated gene mediating anti-viral properties of IFNs. Herein, we report a novel finding that dsDNA transfection in T80 immortalized normal ovarian surface epithelial cell line leads to a marked increase in PLSCR1 mRNA and protein. We also noted a comparable response in primary mammary epithelial cells (HMECs). Similar to IFN-2 alpha treated cells, de novo synthesized PLSCR1 was localized predominantly to the plasma membrane. dsDNA transfection, in T80 and HMEC cells, led to activation of MAPK and IRF3. Although inhibition of MAPK (using U0126) did not modulate PLSCR1 mRNA and protein, IRF3 knockdown (using siRNA) significantly ablated the PLSCR1 induction. In prior studies, the activation of IRF3 was shown to be mediated by cGAS-STING pathway. To investigate the contribution of STING to PLSCR1 induction, we utilized siRNA to reduce STING expression and observed that PLSCR1 protein was markedly reduced. In contrast to normal T80/HMECs, the phosphorylation of IRF3 as well as induction of STING and PLSCR1 were absent in ovarian cancer cells (serous, clear cell, and endometrioid) suggesting that the STING/IRF3 pathway may be dysregulated in these cancer cells. However, we also noted induction of different TLR and IFN mRNAs between the T80 and HEY (serous epithelial ovarian carcinoma) cell lines upon dsDNA transfection. Collectively, these results indicate that the STING/IRF3 pathway, activated following dsDNA transfection, contributes to upregulation of PLSCR1 in ovarian epithelial cells.	[Kodigepalli, Karthik M.; Nanjundan, Meera] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Nanjundan, M (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	mnanjund@usf.edu			University of South Florida CMMB Departmental Start-up Funds	University of South Florida CMMB Departmental Start-up Funds	Funding from the University of South Florida CMMB Departmental Start-up Funds to MN were used to support this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir-Moazami O, 2008, J BIOL CHEM, V283, P25514, DOI 10.1074/jbc.M705320200; An HZ, 2002, IMMUNOLOGY, V106, P38, DOI 10.1046/j.1365-2567.2002.01401.x; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Basith S, 2012, ARCH PHARM RES, V35, P1297, DOI 10.1007/s12272-012-0802-7; Basse F, 1996, J BIOL CHEM, V271, P17205, DOI 10.1074/jbc.271.29.17205; Bauckman KA, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.87; Bhat N, 2014, EUR J IMMUNOL, V44, P634, DOI 10.1002/eji.201344127; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Chen CW, 2011, J LEUKOCYTE BIOL, V90, P221, DOI 10.1189/jlb.0111006; Chen N, 2014, ONCOL REP, V31, P376, DOI 10.3892/or.2013.2847; Civas A, 2002, BIOCHIMIE, V84, P643, DOI 10.1016/S0300-9084(02)01431-1; Cui W, 2012, HEPATOB PANCREAT DIS, V11, P393, DOI 10.1016/S1499-3872(12)60197-0; Dong BH, 2004, J VIROL, V78, P8983, DOI 10.1128/JVI.78.17.8983-8993.2004; Fan CW, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-254; Francis VG, 2014, BIOCHEM BIOPH RES CO, V450, P172, DOI 10.1016/j.bbrc.2014.05.094; He XB, 2013, ACTA BIOCH BIOPH SIN, V45, P241, DOI 10.1093/abbs/gms122; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Huang Y, 2006, ONCOGENE, V25, P6618, DOI 10.1038/sj.onc.1209677; Jacobsen LB, 2009, BIOTECHNIQUES, V47, P617, DOI 10.2144/000113132; Kametaka S, 2003, J BIOL CHEM, V278, P15239, DOI 10.1074/jbc.M208611200; Kodigepalli KM, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-32; Kodigepalli KM, 2013, FEBS LETT, V587, P5, DOI 10.1016/j.febslet.2012.11.003; Kundu SD, 2008, PROSTATE, V68, P223, DOI 10.1002/pros.20710; Kuo YB, 2011, MOL MED, V17, P41, DOI 10.2119/molmed.2010.00115; Kusano S, 2013, BIOCHEM BIOPH RES CO, V433, P438, DOI 10.1016/j.bbrc.2013.02.098; Kusano S, 2012, VIROLOGY, V432, P343, DOI 10.1016/j.virol.2012.06.019; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Lizak M, 2012, CELL HOST MICROBE, V11, P70, DOI 10.1016/j.chom.2011.12.004; Metz P, 2012, HEPATOLOGY, V56, P2082, DOI 10.1002/hep.25908; Midoux P, 2008, CURR GENE THER, V8, P335, DOI 10.2174/156652308786071014; Nanjundan M, 2003, J BIOL CHEM, V278, P37413, DOI 10.1074/jbc.M306182200; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Nanjundan M, 2008, MOL ONCOL, V2, P164, DOI 10.1016/j.molonc.2008.05.001; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; Silverman RH, 2002, CANCER RES, V62, P397; Sims PJ, 2001, THROMB HAEMOSTASIS, V86, P266; Smith DM, 2010, CELL DEATH DIFFER, V17, P1867, DOI 10.1038/cdd.2010.53; Sun J, 2002, BIOCHEMISTRY-US, V41, P6338, DOI 10.1021/bi025610l; Sun J, 2001, J BIOL CHEM, V276, P28984, DOI 10.1074/jbc.M102505200; Suzuki J, 2014, J BIOL CHEM, V289, P30257, DOI 10.1074/jbc.M114.583419; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Talukder AH, 2012, CELL RES, V22, P1129, DOI 10.1038/cr.2012.45; Tamassia N, 2012, J IMMUNOL, V189, P1500, DOI 10.4049/jimmunol.1102985; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; Wyles JP, 2007, NUCLEIC ACIDS RES, V35, P4076, DOI 10.1093/nar/gkm434; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang J, 2012, ANTIVIR RES, V94, P9, DOI 10.1016/j.antiviral.2012.01.010; Yoshida H, 2009, J GENE MED, V11, P708, DOI 10.1002/jgm.1348; Zhao KW, 2005, J BIOL CHEM, V280, P42707, DOI 10.1074/jbc.M506178200; Zhou QS, 2000, BLOOD, V95, P2593, DOI 10.1182/blood.V95.8.2593.008k32_2593_2599; Zhou QS, 2005, J BIOL CHEM, V280, P35062, DOI 10.1074/jbc.M504821200	57	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117464	10.1371/journal.pone.0117464	http://dx.doi.org/10.1371/journal.pone.0117464			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658875	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900156
J	Musameh, MD; Wang, WYS; Nelson, CP; Lluis-Ganella, C; Debiec, R; Subirana, I; Elosua, R; Balmforth, AJ; Ball, SG; Hall, AS; Kathiresan, S; Thompson, JR; Lucas, G; Samani, NJ; Tomaszewski, M				Musameh, Muntaser D.; Wang, William Y. S.; Nelson, Christopher P.; Lluis-Ganella, Carla; Debiec, Radoslaw; Subirana, Isaac; Elosua, Roberto; Balmforth, Anthony J.; Ball, Stephen G.; Hall, Alistair S.; Kathiresan, Sekar; Thompson, John R.; Lucas, Gavin; Samani, Nilesh J.; Tomaszewski, Maciej			Analysis of Gene-Gene Interactions among Common Variants in Candidate Cardiovascular Genes in Coronary Artery Disease	PLOS ONE			English	Article							ASSOCIATION ANALYSIS; LOCI; SUSCEPTIBILITY; EPISTASIS; ARCHITECTURE	Objective Only a small fraction of coronary artery disease (CAD) heritability has been explained by common variants identified to date. Interactions between genes of importance to cardiovascular regulation may account for some of the missing heritability of CAD. This study aimed to investigate the role of gene-gene interactions in common variants in candidate cardiovascular genes in CAD. Approach and Results 2,101 patients with CAD from the British Heart Foundation Family Heart Study and 2,426 CAD-free controls were included in the discovery cohort. All subjects were genotyped with the Illumina HumanCVD BeadChip enriched for genes and pathways relevant to the cardiovascular system and disease. The primary analysis in the discovery cohort examined pairwise interactions among 913 common (minor allele frequency >0.1) independent single nucleotide polymorphisms (SNPs) with at least nominal association with CAD in single locus analysis. A secondary exploratory interaction analysis was performed among all 11,332 independent common SNPs surviving quality control criteria. Replication analyses were conducted in 2,967 patients and 3,075 controls from the Myocardial Infarction Genetics Consortium. None of the interactions amongst 913 SNPs analysed in the primary analysis was statistically significant after correction for multiple testing (required P<1.2x10(-7)). Similarly, none of the pairwise gene-gene interactions in the secondary analysis reached statistical significance after correction formultiple testing (required P = 7.8x10(-10)). None of 36 suggestive interactions from the primary analysis or 31 interactions from the secondary analysis was significant in the replication cohort. Our study had 80% power to detect odds ratios >1.7 for common variants in the primary analysis. Conclusions Moderately large additive interactions between common SNPs in genes relevant to cardiovascular disease do not appear to play a major role in genetic predisposition to CAD. The role of genetic interactions amongst less common SNPs and with medium and small magnitude effects remain to be investigated.	[Musameh, Muntaser D.; Nelson, Christopher P.; Debiec, Radoslaw; Thompson, John R.; Samani, Nilesh J.; Tomaszewski, Maciej] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Musameh, Muntaser D.; Nelson, Christopher P.; Debiec, Radoslaw; Samani, Nilesh J.; Tomaszewski, Maciej] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Wang, William Y. S.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Lluis-Ganella, Carla; Subirana, Isaac; Elosua, Roberto; Lucas, Gavin] IMIM, Barcelona, Spain; [Subirana, Isaac] Epidemiol & Publ Hlth Network CIBERESP, Barcelona, Spain; [Ball, Stephen G.] Univ Leeds, MCRC, Leeds Inst Genet Hlth & Therapeut, Leeds, W Yorkshire, England; [Balmforth, Anthony J.; Hall, Alistair S.] Univ Leeds, Sch Med, LIGHT, Div Epidemiol, Leeds LS2 9JT, W Yorkshire, England; [Kathiresan, Sekar] Broad Inst MIT & Harvard, Cambridge, MA USA	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Queensland; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Leeds; University of Leeds; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Musameh, MD (corresponding author), Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England.	mdmm2@le.ac.uk	Hall, Alistair/K-1953-2019; Wang, William/E-7862-2013	Wang, William/0000-0002-5369-5446; Debiec, Radoslaw/0000-0003-2292-467X; Hall, Alistair/0000-0003-0306-7887; Nelson, Christopher/0000-0001-8025-2897; Tomaszewski, Maciej/0000-0001-8215-6567; ELOSUA, ROBERTO/0000-0001-8235-0095; Lucas, Gavin/0000-0003-4166-9416	Wellcome Trust [085475]; National Institutes of Health, USA [R01 HL087676]; Fondo de Investigacion Sanitaria-Instituto Carlos III/European Development Research Funds (Red de Investigacion Cardiovascular) [RD12/0042/0013, RD12/0042/0061]; Fundacio Marato TV3 [1081810]; Juan de la Cierva Program, Ministerio de Educacion [JCI-2009-04684]; National Institute for Health Research (NIHR); Royal Australasian College of Physicians Barry Young Fellowship; Leicester Biomedical Research Unit in Cardiovascular Disease; British Heart Foundation Chair of Cardiology; Medical Research Council [MR/L01629X/1] Funding Source: researchfish; National Institute for Health Research [CL-2010-11-001, NF-SI-0611-10170, ACF-2012-11-001] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087676] Funding Source: NIH RePORTER; MRC [MR/L01629X/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo de Investigacion Sanitaria-Instituto Carlos III/European Development Research Funds (Red de Investigacion Cardiovascular); Fundacio Marato TV3; Juan de la Cierva Program, Ministerio de Educacion; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Royal Australasian College of Physicians Barry Young Fellowship; Leicester Biomedical Research Unit in Cardiovascular Disease; British Heart Foundation Chair of Cardiology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Wellcome Trust Case-Control Consortium 2 was funded by the Wellcome Trust under award 085475. The Myocardial Infarction Genetics Consortium (MIGen) was funded by grant R01 HL087676 from the National Institutes of Health, USA. The replication analysis was funded by grants from the Fondo de Investigacion Sanitaria-Instituto Carlos III/European Development Research Funds (Red de Investigacion Cardiovascular RD12/0042/0013, RD12/0042/0061), Fundacio Marato TV3 (1081810). GL was funded by the Juan de la Cierva Program, Ministerio de Educacion (JCI-2009-04684). MDM is supported by the National Institute for Health Research (NIHR). WYSW was supported by the Royal Australasian College of Physicians Barry Young Fellowship. NJS holds a British Heart Foundation Chair of Cardiology and is a NIHR Senior Investigator. This study is a part of the portfolio of research supported by the Leicester Biomedical Research Unit in Cardiovascular Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MA, 2005, INT J CARDIOL, V103, P27, DOI 10.1016/j.ijcard.2004.07.009; Baurley JW, 2010, STAT MED, V29, P1998, DOI 10.1002/sim.3962; Becker T, 2011, ANN HUM GENET, V75, P29, DOI 10.1111/j.1469-1809.2010.00610.x; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Emily M, 2009, EUR J HUM GENET, V17, P1231, DOI 10.1038/ejhg.2009.15; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Herold C, 2009, BIOINFORMATICS, V25, P3275, DOI 10.1093/bioinformatics/btp596; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Lippert C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01099; Liu Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001338; Lucas G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041730; Ma L, 2012, J LIPID RES, V53, P2425, DOI 10.1194/jlr.M028829; Ma L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002714; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Millstein J, 2006, AM J HUM GENET, V78, P15, DOI 10.1086/498850; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Samani NJ, 2005, AM J HUM GENET, V77, P1011; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Sun YV, 2010, HUM MOL GENET, V19, P4345, DOI 10.1093/hmg/ddq356; The IBC 50K CAD Consortium, 2011, PLOS GENET, V7, DOI [10.1371/journal.pgen. 1002260, DOI 10.1371/JOURNAL.PGEN.1002260]; Tomaszewski M, 2010, HYPERTENSION, V56, P1069, DOI 10.1161/HYPERTENSIONAHA.110.155721; Tsai CT, 2007, ATHEROSCLEROSIS, V195, P172, DOI 10.1016/j.atherosclerosis.2006.09.014; Wan XA, 2010, AM J HUM GENET, V87, P325, DOI 10.1016/j.ajhg.2010.07.021; Wei WH, 2012, EUR J HUM GENET, V20, P857, DOI 10.1038/ejhg.2012.17	32	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117684	10.1371/journal.pone.0117684	http://dx.doi.org/10.1371/journal.pone.0117684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658981	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900202
J	Qu, YLW; Chi, W; Hua, X; Deng, RZ; Li, J; Liu, ZG; Pflugfelder, SC; Li, DQ				Qu, Yangluowa; Chi, Wei; Hua, Xia; Deng, Ruzhi; Li, Jin; Liu, Zuguo; Pflugfelder, Stephen C.; Li, De-Quan			Unique Expression Pattern and Functional Role of Periostin in Human Limbal Stem Cells	PLOS ONE			English	Article							ADULT STEM; EPITHELIAL-CELLS; PROTEIN; POPULATION; MARKERS; BONE; SKIN; IDENTIFICATION; REGENERATION; PHENOTYPE	Periostin is a non-structural matricellular protein. Little is known about periostin in human limbal stem cells (LSCs). This study was to explore the unique expression pattern and functional role of periostin in maintaining the properties of human LSCs. Fresh donor corneal tissues were used to make cryosections for evaluation of periostin expression on ex vivo tissues. Primary human limbal epithelial cells (HLECs) were generated from limbal explant culture. In vitro culture models for proliferation and epithelial regeneration were performed to explore functional role of periostin in LSCs. The mRNA expression was determined by reverse transcription and quantitative real-time PCR (RT-qPCR), and the protein production and localization were detected by immunofluorescent staining and Western blot analysis. Periostin protein was found to be exclusively immunolocalized in the basal layer of human limbal epithelium. Periostin localization was well matched with nuclear factor p63, but not with corneal epithelial differentiation marker Keratin 3. Periostin transcripts was also highly expressed in limbal than corneal epithelium. In primary HLECs, periostin expression at mRNA and protein levels was significantly higher in 50% and 70% confluent cultures at exponential growth stage than in 100% confluent cultures at slow growth or quiescent condition. This expression pattern was similar to other stem/progenitor cell markers (p63, integrin beta 1 and TCF4). Periostin expression at transcripts, protein and immunoreactivity levels increased significantly during epithelial regeneration in wound healing process, especially in 16-24 hours at wound edge, which was accompanied by similar upregulation and activation of p63, integrin beta 1 and TCF4. Our findings demonstrated that periostin is exclusively produced by limbal basal epithelium and co-localized with p63, where limbal stem cells reside. Periostin promotes HLEC proliferation and regeneration with accompanied activation of stem/progenitor cell markers p63, integrin beta 1 and TCF4, suggesting its novel role in maintaining the phenotype and functional properties of LSC.	[Qu, Yangluowa; Liu, Zuguo] Xiamen Univ, Inst Eye, Xiamen, Peoples R China; [Qu, Yangluowa; Chi, Wei; Hua, Xia; Deng, Ruzhi; Li, Jin; Pflugfelder, Stephen C.; Li, De-Quan] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Ocular Surface Ctr, Houston, TX 77030 USA; [Chi, Wei] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Hua, Xia] Tianjin Med Univ, Clin Coll Ophthalmol, Tianjin Key Lab Ophthalmol & Visual Sci, Tianjin Eye Hosp, Tianjin, Peoples R China	Xiamen University; Baylor College of Medicine; Sun Yat Sen University; Tianjin Medical University	Liu, ZG (corresponding author), Xiamen Univ, Inst Eye, Xiamen, Peoples R China.	zuguoliu@xmu.edu.cn; dequanl@bcm.tmc.edu			NIH NEI Grant [R01EY023598]; Research to Prevent Blindness; Oshman Foundation; William Stamps Farish Fund; Lions Foundation for Sight; NATIONAL EYE INSTITUTE [R01EY023598] Funding Source: NIH RePORTER	NIH NEI Grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Oshman Foundation; William Stamps Farish Fund; Lions Foundation for Sight; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NIH NEI Grant R01EY023598 (DQL), Lions Foundation for Sight, Research to Prevent Blindness, Oshman Foundation, and William Stamps Farish Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian F, 2010, STEM CELLS, V28, P2172, DOI 10.1002/stem.539; Bian F, 2010, INT J BIOCHEM CELL B, V42, P1142, DOI 10.1016/j.biocel.2010.03.022; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Bonnet N, 2012, P NATL ACAD SCI USA, V109, P15048, DOI 10.1073/pnas.1203085109; Borge OJ, 2004, ACTA VET SCAND, V45, P39; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Chen Z, 2006, STEM CELLS, V24, P1265, DOI 10.1634/stemcells.2005-0363; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Cotsarelis G, 1999, EXP DERMATOL, V8, P80, DOI 10.1111/j.1600-0625.1999.tb00351.x; De Paiva CS, 2006, STEM CELLS, V24, P368, DOI 10.1634/stemcells.2005-0148; De Paiva CS, 2005, STEM CELLS, V23, P63, DOI 10.1634/stemcells.2004-0093; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Diaz-Flores L, 2006, HISTOL HISTOPATHOL, V21, P995, DOI 10.14670/HH-21.995; Donisi PM, 2003, CORNEA, V22, P533, DOI 10.1097/00003226-200308000-00009; Dua HS, 2000, SURV OPHTHALMOL, V44, P415, DOI 10.1016/S0039-6257(00)00109-0; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Germain L, 2000, PROG RETIN EYE RES, V19, P497, DOI 10.1016/S1350-9462(00)00005-7; Gillan L, 2002, CANCER RES, V62, P5358; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kim BY, 2009, J BIOL CHEM, V284, P19580, DOI 10.1074/jbc.M109.013607; Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015; Kim SY, 2009, J CUTAN PATHOL, V36, P825, DOI 10.1111/j.1600-0560.2008.01167.x; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Kudo Y, 2007, HISTOL HISTOPATHOL, V22, P1167, DOI 10.14670/HH-22.1167; Lavker RM, 2000, P NATL ACAD SCI USA, V97, P13473, DOI 10.1073/pnas.250380097; Li DQ, 2005, EXP EYE RES, V80, P581, DOI 10.1016/j.exer.2004.11.011; Liu AY, 2014, MATRIX BIOL; Lu R, 2012, STEM CELLS, V30, P753, DOI 10.1002/stem.1032; Lu R, 2011, INT J BIOCHEM CELL B, V43, P751, DOI 10.1016/j.biocel.2011.01.018; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; Norris RA, 2009, J CELL COMMUN SIGNAL, V3, P275, DOI 10.1007/s12079-009-0063-5; Pajoohesh-Ganji A, 2005, BIOL CELL, V97, P265, DOI 10.1042/BC20040114; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Siriwardena BSMS, 2006, BRIT J CANCER, V95, P1396, DOI 10.1038/sj.bjc.6603431; Stepp MA, 2005, OCUL SURF, V3, P15, DOI 10.1016/S1542-0124(12)70119-2; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22; Tsunoda T, 2009, PROSTATE, V69, P1398, DOI 10.1002/pros.20988; van Rossum MM, 2002, J IMMUNOL METHODS, V267, P109, DOI 10.1016/S0022-1759(02)00151-5; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yoon KC, 2007, INVEST OPHTH VIS SCI, V48, P2561, DOI 10.1167/iovs.07-0002	49	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117139	10.1371/journal.pone.0117139	http://dx.doi.org/10.1371/journal.pone.0117139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658308	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900107
J	Samad, M; Chung, AJ; Shams, L				Samad, Majed; Chung, Albert Jin; Shams, Ladan			Perception of Body Ownership Is Driven by Bayesian Sensory Inference	PLOS ONE			English	Article							BODILY SELF-CONSCIOUSNESS; MULTISENSORY INTEGRATION; PERIPERSONAL SPACE; SKIN-CONDUCTANCE; RUBBER HAND; ILLUSION; LIMB; PROPRIOCEPTION; RECALIBRATION; ATTRIBUTION	Recent studies have shown that human perception of body ownership is highly malleable. A well-known example is the rubber hand illusion (RHI) wherein ownership over a dummy hand is experienced, and is generally believed to require synchronized stroking of real and dummy hands. Our goal was to elucidate the computational principles governing this phenomenon. We adopted the Bayesian causal inference model of multisensory perception and applied it to visual, proprioceptive, and tactile stimuli. The model reproduced the RHI, predicted that it can occur without tactile stimulation, and that synchronous stroking would enhance it. Various measures of ownership across two experiments confirmed the predictions: a large percentage of individuals experienced the illusion in the absence of any tactile stimulation, and synchronous stroking strengthened the illusion. Altogether, these findings suggest that perception of body ownership is governed by Bayesian causal inference-i.e., the same rule that appears to govern the perception of outside world.	[Samad, Majed; Chung, Albert Jin; Shams, Ladan] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Shams, Ladan] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Samad, M (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	majedsamad@ucla.edu			Direct For Social, Behav & Economic Scie [1057969] Funding Source: National Science Foundation	Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Beierholm UR, 2009, J VISION, V9, DOI 10.1167/9.5.23; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Christie M, 1980, TECHNIQUES PSYCHOPHY, P2; Desmurget M, 2000, EXP BRAIN RES, V134, P363, DOI 10.1007/s002210000473; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; EPSTEIN S, 1970, J PERS SOC PSYCHOL, V16, P20, DOI 10.1037/h0029786; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Gentile G, 2013, J NEUROSCI, V33, P13350, DOI 10.1523/JNEUROSCI.1363-13.2013; Guterstam A, 2013, J COGNITIVE NEUROSCI, V25, P1078, DOI 10.1162/jocn_a_00393; HAY JC, 1966, J EXP PSYCHOL, V71, P150, DOI 10.1037/h0022611; Hein A, 1958, PERCEPT MOTOR SKILL, V8, P87, DOI [DOI 10.2466/PMS.1958.8.3.87, 10.2466/pms.1958.8.3.87]; HIRSH IJ, 1961, J EXP PSYCHOL, V62, P423, DOI 10.1037/h0045283; Holle H, 2011, COGN NEUROSCI-UK, V2, P171, DOI 10.1080/17588928.2011.603828; Jones SAH, 2010, EXP BRAIN RES, V204, P373, DOI 10.1007/s00221-009-2079-8; Kalckert A, 2012, MOVING RUBBER HAND F; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Magnotti JF, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00798; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Paillard J, 1968, NEUROPSYCHOLOGY SPAT, P37; Parise CV, 2012, CURR BIOL, V22, P46, DOI 10.1016/j.cub.2011.11.039; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Rincon-Gonzalez L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025214; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Rohe T, PLOS BIOL IN PRESS; Shams L, 2005, NEUROREPORT, V16, P1923, DOI 10.1097/01.wnr.0000187634.68504.bb; Shams L, 2010, TRENDS COGN SCI, V14, P425, DOI 10.1016/j.tics.2010.07.001; STAUB E, 1971, J PERS SOC PSYCHOL, V18, P157, DOI 10.1037/h0030851; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; Walsh LD, 2011, J PHYSIOL-LONDON, V589, P3009, DOI 10.1113/jphysiol.2011.204941; WANN JP, 1992, EXP BRAIN RES, V91, P162; Wozny DR, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00075; Wozny DR, 2011, J NEUROSCI, V31, P4607, DOI 10.1523/JNEUROSCI.6079-10.2011; Wozny DR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000871; Wozny DR, 2008, J VISION, V8, DOI 10.1167/8.3.24	46	175	176	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117178	10.1371/journal.pone.0117178	http://dx.doi.org/10.1371/journal.pone.0117178			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658822	Green Published, gold			2022-12-27	WOS:000349444900111
J	Srinivasan, R; Karaoz, U; Volegova, M; MacKichan, J; Kato-Maeda, M; Miller, S; Nadarajan, R; Brodie, EL; Lynch, SV				Srinivasan, Ramya; Karaoz, Ulas; Volegova, Marina; MacKichan, Joanna; Kato-Maeda, Midori; Miller, Steve; Nadarajan, Rohan; Brodie, Eoin L.; Lynch, Susan V.			Use of 16S rRNA Gene for Identification of a Broad Range of Clinically Relevant Bacterial Pathogens	PLOS ONE			English	Article							REAL-TIME PCR; STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; SEQUENCE-ANALYSIS; RAPID DETECTION; SYSTEM; IMPACT; DIFFERENTIATION; DATABASE; ASSAY	According to World Health Organization statistics of 2011, infectious diseases remain in the top five causes of mortality worldwide. However, despite sophisticated research tools for microbial detection, rapid and accurate molecular diagnostics for identification of infection in humans have not been extensively adopted. Time-consuming culture-based methods remain to the forefront of clinical microbial detection. The 16S rRNA gene, a molecular marker for identification of bacterial species, is ubiquitous to members of this domain and, thanks to ever-expanding databases of sequence information, a useful tool for bacterial identification. In this study, we assembled an extensive repository of clinical isolates (n = 617), representing 30 medically important pathogenic species and originally identified using traditional culture-based or non-16S molecular methods. This strain repository was used to systematically evaluate the ability of 16S rRNA for species level identification. To enable the most accurate species level classification based on the paucity of sequence data accumulated in public databases, we built a Naive Bayes classifier representing a diverse set of high-quality sequences from medically important bacterial organisms. We show that for species identification, a model-based approach is superior to an alignment based method. Overall, between 16S gene based and clinical identities, our study shows a genus-level concordance rate of 96% and a species-level concordance rate of 87.5%. We point to multiple cases of probable clinical misidentification with traditional culture based identification across a wide range of gram-negative rods and gram-positive cocci as well as common gram-negative cocci.	[Srinivasan, Ramya; Lynch, Susan V.] Univ Calif San Francisco, Div Gastroenterol, Dept Med, San Francisco, CA 94143 USA; [Karaoz, Ulas; Brodie, Eoin L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Miller, Steve; Nadarajan, Rohan] Univ Calif San Francisco, Clin Microbiol Lab, San Francisco, CA 94107 USA; [Volegova, Marina] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Kato-Maeda, Midori] San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA; [MacKichan, Joanna] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California Berkeley; San Francisco General Hospital Medical Center; Victoria University Wellington	Lynch, SV (corresponding author), Univ Calif San Francisco, Div Gastroenterol, Dept Med, 513 Parnassus Ave, San Francisco, CA 94143 USA.	susan.lynch@ucsf.edu	Brodie, Eoin L/A-7853-2008; Karaoz, Ulas/J-7093-2014; Nadarajan, R/AAB-8676-2019	Brodie, Eoin L/0000-0002-8453-8435; Karaoz, Ulas/0000-0002-8238-6757; MacKichan, Joanna/0000-0001-9309-3282	NIH [U01 AI075410]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075410] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by NIH U01 AI075410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2009, TRENDS MICROBIOL, V17, P37, DOI 10.1016/j.tim.2008.09.008; Barbut F, 2011, EUR J CLIN MICROBIOL, V30, P1279, DOI 10.1007/s10096-011-1224-z; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bergey DH., 2001, BERGEYS MANUAL SYSTE; Bernards AT, 1996, EUR J CLIN MICROBIOL, V15, P303, DOI 10.1007/BF01695662; Bosshard PP, 2003, J CLIN MICROBIOL, V41, P4134, DOI 10.1128/JCM.41.9.4134-4140.2003; Brouqui P, 2001, CLIN MICROBIOL REV, V14, P177, DOI 10.1128/CMR.14.1.177-207.2001; Brown J, 2010, PHARMACOECONOMICS, V28, P567, DOI 10.2165/11533020-000000000-00000; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Carvalho MGS, 2003, J CLIN MICROBIOL, V41, P4415, DOI 10.1128/JCM.41.9.4415-4417.2003; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Coenye T, 2002, J CLIN MICROBIOL, V40, P3300, DOI 10.1128/JCM.40.9.3300-3307.2002; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Conlan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047075; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Day AM, 2001, LETT APPL MICROBIOL, V33, P392, DOI 10.1046/j.1472-765X.2001.01017.x; de Filippis I, 2007, LETT APPL MICROBIOL, V45, P426, DOI 10.1111/j.1472-765X.2007.02205.x; Deasy BM, 2000, SYST APPL MICROBIOL, V23, P510, DOI 10.1016/S0723-2020(00)80025-9; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; Enright MC, 2000, EUR J CLIN MICROBIOL, V19, P627, DOI 10.1007/s100960000321; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Fettweis JM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S17; Fontana C, 2005, J CLIN MICROBIOL, V43, P615, DOI 10.1128/JCM.43.2.615-619.2005; Fournier PE, 2011, ANNU REV MICROBIOL, V65, P169, DOI 10.1146/annurev-micro-090110-102922; Hall L, 2003, J CLIN MICROBIOL, V41, P1447, DOI 10.1128/JCM.41.4.1447-1453.2003; Hallin M, 2003, J CLIN MICROBIOL, V41, P3942, DOI 10.1128/JCM.41.8.3942-3944.2003; Hanage WP, 2005, J BACTERIOL, V187, P6223, DOI 10.1128/JB.187.17.6223-6230.2005; Harmsen D, 2002, NUCLEIC ACIDS RES, V30, P416, DOI 10.1093/nar/30.1.416; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; Hawkey PM, 2008, J ANTIMICROB CHEMOTH, V62, pI1, DOI 10.1093/jac/dkn241; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Hulbert RR, 2009, CURR PROTOC MICROBIO; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Joyanes P, 2001, J CLIN MICROBIOL, V39, P3247, DOI 10.1128/JCM.39.9.3247-3253.2001; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Koneman E., 2006, KONEMANS COLOR ATLAS, V6; LaClaire LL, 2000, J CLIN MICROBIOL, V38, P2037; Larson E, 2007, ANNU REV PUBL HEALTH, V28, P435, DOI 10.1146/annurev.publhealth.28.021406.144020; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; LiPuma JJ, 2005, CURR OPIN PULM MED, V11, P528, DOI 10.1097/01.mcp.0000181475.85187.ed; Liu D, 2011, MOL DETECTION HUMAN, Vxxvii; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Mignard S, 2006, J MICROBIOL METH, V67, P574, DOI 10.1016/j.mimet.2006.05.009; Newton ILG, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-221; Park JS, 2011, J MED MICROBIOL, V60, P492, DOI 10.1099/jmm.0.020768-0; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Plowman R, 2001, J HOSP INFECT, V47, P198, DOI 10.1053/jhin.2000.0881; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R Development Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.fsigen.2014.12.009, DOI 10.1016/J.FSIGEN.2014.12.009]; ROGALL T, 1990, INT J SYST BACTERIOL, V40, P323, DOI 10.1099/00207713-40-4-323; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shorr AF, 2011, CRIT CARE MED, V39, P46, DOI 10.1097/CCM.0b013e3181fa41a7; Simmon KE, 2006, J CLIN MICROBIOL, V44, P4400, DOI 10.1128/JCM.01364-06; Slack AT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-95; Spilker T, 2004, J CLIN MICROBIOL, V42, P2074, DOI 10.1128/JCM.42.5.2074-2079.2004; Teng JLL, 2014, DIAGN MICR INFEC DIS, V78, P105, DOI 10.1016/j.diagmicrobio.2013.10.019; Versalovic J., 2011, MANUAL CLIN MICROBIO, V10, DOI DOI 10.1111/J.1758-8111.2010.00005.X; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000; Woo PCY, 2011, J CLIN MICROBIOL, V49, P1799, DOI 10.1128/JCM.02350-10; Woo PCY, 2003, J CLIN PATHOL, V56, P690, DOI 10.1136/jcp.56.9.690; Woo PCY, 2003, J CLIN MICROBIOL, V41, P1996, DOI 10.1128/JCM.41.5.1996-2001.2003	70	166	177	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117617	10.1371/journal.pone.0117617	http://dx.doi.org/10.1371/journal.pone.0117617			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658760	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900191
J	Yu, X; Liu, X; Zhao, Z; Liu, JL; Zhang, SX				Yu, Xuan; Liu, Xu; Zhao, Zhong; Liu, Jinliang; Zhang, Shunxiang			Effect of Monospecific and Mixed SeaBuckthorn (Hippophae rhamnoides) Plantations on the Structure and Activity of Soil Microbial Communities	PLOS ONE			English	Article							ORGANIC-CARBON POOLS; LOESS PLATEAU; NORWAY SPRUCE; LEAF-LITTER; SCOTS PINE; BIOMASS; DIVERSITY; PATTERNS; FORESTS; DECOMPOSITION	This study aims to evaluate the effect of different afforestation models on soil microbial composition in the Loess Plateau in China. In particular, we determined soil physicochemical properties, enzyme activities, and microbial community structures in the top 0 cm to 10 cm soil underneath a pure Hippophae rhamnoides (SS) stand and three mixed stands, namely, H. rhamnoides and Robinia pseucdoacacia (SC), H. rhamnoides and Pinus tabulaeformis (SY), and H. rhamnoides and Platycladus orientalis (SB). Results showed that total organic carbon (TOC), total nitrogen, and ammonium (NH4+) contents were higher in SY and SB than in SS. The total microbial biomass, bacterial biomass, and Gram(+) biomass of the three mixed stands were significantly higher than those of the pure stand. However, no significant difference was found in fungal biomass. Correlation analysis suggested that soil microbial communities are significantly and positively correlated with some chemical parameters of soil, such as TOC, total phosphorus, total potassium, available phosphorus, NH4+ content, nitrate content (NH3-), and the enzyme activities of urease, peroxidase, and phosphatase. Principal component analysis showed that the microbial community structures of SB and SS could clearly be discriminated from each other and from the others, whereas SY and SC were similar. In conclusion, tree species indirectly but significantly affect soil microbial communities and enzyme activities through soil physicochemical properties. In addition, mixing P. tabulaeformis or P. orientalis in H. rhamnoides plantations is a suitable afforestation model in the Loess Plateau, because of significant positive effects on soil nutrient conditions, microbial community, and enzyme activities over pure plantations.	[Yu, Xuan; Zhao, Zhong; Liu, Jinliang; Zhang, Shunxiang] Northwest A&F Univ, Coll Forestry, Dept Forestry, Yangling, Peoples R China; [Yu, Xuan; Zhao, Zhong] Minist Educ, Key Lab Environm & Ecol Western China, Yangling, Peoples R China; [Liu, Xu] Northwest A&F Univ, Coll Enol, Yangling, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Zhao, Z (corresponding author), Northwest A&F Univ, Coll Forestry, Dept Forestry, Yangling, Peoples R China.	zhaozh@nwsuaf.edu.cn			National Natural Science Foundation of China [305021210]; Northwest Agriculture & Forestry University [QN2011160]; Ph.D. Programs Foundation of Ministry of Education of China [20120204120043]; Natural Science Foundation of Shannxi Province, China [2013JQ3004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwest Agriculture & Forestry University; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Shannxi Province, China(Natural Science Foundation of Shanxi Province)	Project supported by the National Natural Science Foundation of China (305021210, http://www.nsfc.gov.cn) and Northwest Agriculture & Forestry University (QN2011160, http://www.nwsuaf.edu.cn). Ph.D. Programs Foundation of Ministry of Education of China (20120204120043, http://www.moe.gov.cn/), project supported by the Natural Science Foundation of Shannxi Province, China (2013JQ3004, http://www.sninfo.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk B, 2014, PEDOBIOLOGIA, V57, P97, DOI 10.1016/j.pedobi.2013.12.003; Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; Aon MA, 2001, APPL SOIL ECOL, V18, P239, DOI 10.1016/S0929-1393(01)00153-6; Binkley D, 1998, BIOGEOCHEMISTRY, V42, P89, DOI 10.1023/A:1005948126251; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Caldwell BA, 1999, SOIL BIOL BIOCHEM, V31, P1603, DOI 10.1016/S0038-0717(99)00067-X; [陈金泉 CHEN Jinquan], 2011, [土壤通报, Journal of Soil Science], V42, P616; Chen MM, 2007, EUR J SOIL BIOL, V43, P31, DOI 10.1016/j.ejsobi.2006.05.001; Drenovsky RE, 2004, MICROB ECOL, V48, P424, DOI 10.1007/s00248-003-1063-2; Fang SZ, 2013, PLOS ONE, V8, P1, DOI DOI 10.1371/J0URNAL.P0NE.0085642; Fanin N, 2014, PLANT SOIL, V379, P79, DOI 10.1007/s11104-014-2051-7; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1991, J MICROBIOL METH, V14, P151, DOI 10.1016/0167-7012(91)90018-L; Galka B, 2014, GEODERMA, V213, P287, DOI 10.1016/j.geoderma.2013.08.029; Grayston SJ, 2005, SOIL BIOL BIOCHEM, V37, P1157, DOI 10.1016/j.soilbio.2004.11.014; Guan S.Y., 1986, SOIL ENZYME ITS STUD, P270; Hahn AS, 2013, PLANT SOIL, V363, P331, DOI 10.1007/s11104-012-1306-4; Hansson K, 2011, FOREST ECOL MANAG, V262, P522, DOI 10.1016/j.foreco.2011.04.021; Hao A, 2005, J FAC AGR KYUSHU U, V50, P223; Hassett JE, 2005, SOIL SCI SOC AM J, V69, P227, DOI 10.2136/sssaj2005.0227; Hobbie SE, 2010, OECOLOGIA, V162, P505, DOI 10.1007/s00442-009-1479-6; Huang XM, 2014, SOIL BIOL BIOCHEM, V73, P42, DOI 10.1016/j.soilbio.2014.01.021; Huang ZQ, 2013, SOIL BIOL BIOCHEM, V62, P68, DOI 10.1016/j.soilbio.2013.03.008; Jandl R, 2007, GEODERMA, V137, P253, DOI 10.1016/j.geoderma.2006.09.003; Jiang YM, 2012, J SOIL SEDIMENT, V12, P228, DOI 10.1007/s11368-011-0442-4; Kiikkila O, 2014, PLANT SOIL, V377, P169, DOI 10.1007/s11104-013-1988-2; Koller R, 2013, NEW PHYTOL, V199, P203, DOI 10.1111/nph.12249; Koranda M, 2013, SOIL BIOL BIOCHEM, V60, P95, DOI 10.1016/j.soilbio.2013.01.025; [张金屯 Li Bin], 2003, [生态学报, Acta Ecologica Sinica], V23, P82; Li YF, 2013, FOREST ECOL MANAG, V303, P121, DOI 10.1016/j.foreco.2013.04.021; Li YY, 2006, J ARID ENVIRON, V64, P77, DOI 10.1016/j.jaridenv.2005.04.005; Lin L, 2012, MICROBES ENVIRON, V27, P391, DOI 10.1264/jsme2.ME11275; Liu G., 1996, SOIL PHYS CHEM ANAL; Liu L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052287, 10.1371/journal.pone.0061188, 10.1371/journal.pone.0083052]; Liu L, 2010, PLANT SOIL, V327, P413, DOI 10.1007/s11104-009-0067-1; Lucas-Borja ME, 2012, PLANT SOIL, V354, P359, DOI 10.1007/s11104-011-1072-8; Lucas-Borja ME, 2011, LAND DEGRAD DEV, V22, P383, DOI 10.1002/ldr.1014; Mancinelli R, 2010, APPL SOIL ECOL, V46, P64, DOI 10.1016/j.apsoil.2010.06.013; Mao R, 2010, EUR J SOIL BIOL, V46, P325, DOI 10.1016/j.ejsobi.2010.05.005; MONTAGNINI F, 2005, TROP FOR, P1; Moore-Kucera J, 2008, SOIL BIOL BIOCHEM, V40, P2485, DOI 10.1016/j.soilbio.2008.06.002; Myers RT, 2001, SOIL SCI SOC AM J, V65, P359, DOI 10.2136/sssaj2001.652359x; Nichols JD, 2006, FOREST ECOL MANAG, V233, P344, DOI 10.1016/j.foreco.2006.05.031; Phillips LA, 2014, ISME J, V8, P699, DOI 10.1038/ismej.2013.195; Porazinska DL, 2003, ECOL MONOGR, V73, P377, DOI 10.1890/0012-9615(2003)073[0377:RATAIP]2.0.CO;2; Prescott CE, 2013, FOREST ECOL MANAG, V309, P19, DOI 10.1016/j.foreco.2013.02.034; Rinklebe J, 2006, SOIL BIOL BIOCHEM, V38, P2144, DOI 10.1016/j.soilbio.2006.01.018; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Sowerby A, 2005, SOIL BIOL BIOCHEM, V37, P1805, DOI 10.1016/j.soilbio.2005.02.023; Sundh I, 1997, APPL ENVIRON MICROB, V63, P1476, DOI 10.1128/AEM.63.4.1476-1482.1997; Swallow M, 2013, APPL SOIL ECOL, V63, P120, DOI 10.1016/j.apsoil.2012.09.006; Thoms C, 2013, SOIL BIOL BIOCHEM, V66, P239, DOI 10.1016/j.soilbio.2013.05.018; Thoms C, 2010, SOIL BIOL BIOCHEM, V42, P1558, DOI 10.1016/j.soilbio.2010.05.030; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Trasar-Cepeda C, 1998, BIOL FERT SOILS, V26, P100, DOI 10.1007/s003740050350; Ushio M, 2008, SOIL BIOL BIOCHEM, V40, P2699, DOI 10.1016/j.soilbio.2008.06.023; Ushio M, 2010, PEDOBIOLOGIA, V53, P227, DOI 10.1016/j.pedobi.2009.12.003; Vitousek P, 2006, J ECOL, V94, P510, DOI 10.1111/j.1365-2745.2006.01119.x; Wang QK, 2014, SOIL BIOL BIOCHEM, V71, P13, DOI 10.1016/j.soilbio.2014.01.004; Weand MP, 2010, SOIL BIOL BIOCHEM, V42, P2161, DOI 10.1016/j.soilbio.2010.08.012; WHITE DC, 1979, OECOLOGIA, V40, P51, DOI 10.1007/BF00388810; Xue D, 2010, J ENVIRON SCI, V22, P1253, DOI 10.1016/S1001-0742(09)60246-1; Yang YQ, 2005, PHYSIOL PLANTARUM, V124, P431, DOI 10.1111/j.1399-3054.2005.00517.x; ZELLES L, 1994, SOIL BIOL BIOCHEM, V26, P439, DOI 10.1016/0038-0717(94)90175-9; Zhang C, 2013, EUR J SOIL BIOL, V54, P16, DOI 10.1016/j.ejsobi.2012.10.007; Zhang JT, 2007, ECOL ENG, V31, P115, DOI 10.1016/j.ecoleng.2007.06.003; Zhao TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090807	67	10	11	8	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117505	10.1371/journal.pone.0117505	http://dx.doi.org/10.1371/journal.pone.0117505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658843	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900165
J	Ido, Y; Duranton, A; Lan, F; Weikel, KA; Breton, L; Ruderman, NB				Ido, Yasuo; Duranton, Albert; Lan, Fan; Weikel, Karen A.; Breton, Lionel; Ruderman, Neil B.			Resveratrol Prevents Oxidative Stress-Induced Senescence and Proliferative Dysfunction by Activating the AMPK-FOXO3 Cascade in Cultured Primary Human Keratinocytes	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PROTEIN-KINASE; LIFE-SPAN; HUMAN LONGEVITY; HUMAN SKIN; OSTEOBLASTIC DIFFERENTIATION; CELLULAR SENESCENCE; INSULIN-RESISTANCE; FOXO3A GENE; IN-VIVO	The aging process is perceived as resulting from a combination of intrinsic factors such as changes in intracellular signaling and extrinsic factors, most notably environmental stressors. In skin, the relationship between intrinsic changes and keratinocyte function is not clearly understood. Previously, we found that increasing the activity of AMP-activated protein kinase (AMPK) suppressed senescence in hydrogen peroxide (H2O2)-treated human primary keratinocytes, a model of oxidative stress-induced cellular aging. Using this model in the present study, we observed that resveratrol, an agent that increases the activities of both AMPK and sirtuins, ameliorated two age-associated phenotypes: cellular senescence and proliferative dysfunction. In addition, we found that treatment of keratinocytes with Ex527, a specific inhibitor of sirtuin 1 (SIRT1), attenuated the ability of resveratrol to suppress senescence. In keeping with the latter observation, we noted that compared to non-senescent keratinocytes, senescent cells lacked SIRT1. In addition to these effects on H2O2-induced senescence, resveratrol also prevented the H2O2-induced decrease in proliferation (as indicated by H-3-thymidine incorporation) in the presence of insulin. This effect was abrogated by inhibition of AMPK but not SIRT1. Compared to endothelium, we found that human keratinocytes expressed relatively high levels of Forkhead box O-3 (FOXO3), a downstream target of both AMPK and SIRT1. Treatment of keratinocytes with resveratrol transactivated FOXO3 and increased the expression of its target genes including catalase. Resveratrol's effects on both senescence and proliferation disappeared when FOXO3 was knocked down. Finally, we performed an exploratory study which showed that skin from humans over 50 years old had lower AMPK activity than skin from individuals under age 20. Collectively, these findings suggest that the effects of resveratrol on keratinocyte senescence and proliferation are regulated by the AMPK-FOXO3 pathway and in some situations, but not all, by SIRT1.	[Ido, Yasuo; Weikel, Karen A.; Ruderman, Neil B.] Boston Univ, Med Ctr, Sch Med, Diabet & Metab Unit, Boston, MA 02118 USA; [Duranton, Albert; Breton, Lionel] LOREAL Res & Innovat, Aulnay Sous Bois, France; [Lan, Fan] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China	Boston University; L'Oreal Group; Chongqing Medical University	Ido, Y (corresponding author), Boston Univ, Med Ctr, Sch Med, Diabet & Metab Unit, Boston, MA 02118 USA.	yido@bu.edu		Weikel, Karen/0000-0003-0317-7891; Duranton, Albert/0000-0002-4057-7176	L'Oreal [C140305]; NIH [PO1-HL 08758-01]	L'Oreal(L'Oreal Group); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	N.R. received funding from L'Oreal (L'Oreal reference C140305). The funder provided support in the form of salaries for authors (A.D. and L.B) and had roles in the decision to publish and preparation of the manuscript. The specific roles of A.D. and L.B. are articulated in the "author contributions" section. N.R. received funding from the NIH (PO1-HL 08758-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Boric M, 2013, J CHEM NEUROANAT, V53, P33, DOI 10.1016/j.jchemneu.2013.10.001; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Bulow MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04048; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Castino R, 2011, J AGR FOOD CHEM, V59, P4264, DOI 10.1021/jf104917q; Chiacchiera F, 2010, CELL CYCLE, V9, P1091, DOI 10.4161/cc.9.6.11035; Christensen K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5262; Coffer PJ, 1997, ONCOGENE, V15, P2529, DOI 10.1038/sj.onc.1201429; Corbi G, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00324; Cordisco S, 2010, J INVEST DERMATOL, V130, P1048, DOI 10.1038/jid.2009.355; Dai Z, 2007, PHYTOMEDICINE, V14, P806, DOI 10.1016/j.phymed.2007.04.003; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Franco SS, 2014, HAEMATOLOGICA, V99, P267, DOI 10.3324/haematol.2013.090076; Frojdo S, 2011, MOL CELL ENDOCRINOL, V335, P166, DOI 10.1016/j.mce.2011.01.008; Garg D, 2014, AGEING RES REV; Giacomoni PU, 2004, MICRON, V35, P179, DOI 10.1016/j.micron.2003.11.004; Gilhar A, 2004, J GERONTOL A-BIOL, V59, P411; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Gunschmann C, 2013, DEV CELL, V26, P176, DOI 10.1016/j.devcel.2013.05.017; Gunn DA, 2013, J GERONTOL A-BIOL, V68, P145, DOI 10.1093/gerona/gls154; Gunn DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008021; Hibino T, 1999, J INVEST DERMATOL, V112, P85, DOI 10.1046/j.1523-1747.1999.00466.x; Hori YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073875; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Ido Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035092; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001; Jiang H, 2010, NEUROCHEM RES, V35, P152, DOI 10.1007/s11064-009-0040-7; Kadic AJ, 2014, J TISSUE VIABILITY, V23, P7, DOI 10.1016/j.jtv.2013.11.002; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kola B, 2008, J CLIN ENDOCR METAB, V93, P4969, DOI 10.1210/jc.2008-1297; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Mandinova A, 2008, EMBO J, V27, P1243, DOI 10.1038/emboj.2008.45; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Nelson LE, 2012, AM J PHYSIOL-CELL PH, V303, pC4, DOI 10.1152/ajpcell.00296.2011; Paris M, 2012, CELL DEATH DIFFER, V19, P186, DOI 10.1038/cdd.2011.181; Peltz L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037162; Peserico A, 2013, CELL MOL LIFE SCI, V70, P2015, DOI 10.1007/s00018-012-1244-6; Pirinen E, 2012, BEST PRACT RES CL EN, V26, P759, DOI 10.1016/j.beem.2012.05.001; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Reznikova TV, 2010, MOL CARCINOGEN, V49, P398, DOI 10.1002/mc.20612; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Saha AK, 2011, CELL CYCLE, V10, P3447, DOI 10.4161/cc.10.20.17886; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Senoo M, 2013, ADV WOUND CARE, V2, P273, DOI 10.1089/wound.2012.0372; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shen S, 2001, DIABETES, V50, P255, DOI 10.2337/diabetes.50.2.255; Soerensen M, 2010, AGING CELL, V9, P1010, DOI 10.1111/j.1474-9726.2010.00627.x; Song LH, 2006, TOXICOL IN VITRO, V20, P915, DOI 10.1016/j.tiv.2006.01.016; Stachelscheid H, 2008, EMBO J, V27, P2091, DOI 10.1038/emboj.2008.141; Suchankova G, 2009, BIOCHEM BIOPH RES CO, V378, P836, DOI 10.1016/j.bbrc.2008.11.130; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tullet JMA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004109; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Velarde MC, 2012, AGING-US, V4, P3, DOI 10.18632/aging.100423; Vierkotter A, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.19858; Waaijer MEC, 2012, AGING CELL, V11, P722, DOI 10.1111/j.1474-9726.2012.00837.x; Wallace DC, 2010, DEV DISABIL RES REV, V16, P114, DOI 10.1002/ddrr.113; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; WARREN R, 1991, J AM ACAD DERMATOL, V25, P751, DOI 10.1016/S0190-9622(08)80964-4; Webb AE, 2013, NAT CELL BIOL, V15, P444, DOI 10.1038/ncb2749; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Winter MC, 2009, J INVEST DERMATOL, V129, P2541, DOI 10.1038/jid.2009.236; Xu XJ, 2012, J LIPID RES, V53, P792, DOI 10.1194/jlr.P022905; YU CCW, 1992, HISTOCHEM J, V24, P121, DOI 10.1007/BF01047461; Zobiri O, 2012, STEM CELLS CLONING, V5, P1, DOI 10.2147/SCCAA.S28355	77	88	91	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0115341	10.1371/journal.pone.0115341	http://dx.doi.org/10.1371/journal.pone.0115341			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647160	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600013
J	Liu, T; Green, AR; Rodriguez, LF; Ramirez, BC; Shike, DW				Liu, Tong; Green, Angela R.; Rodriguez, Luis F.; Ramirez, Brett C.; Shike, Daniel W.			Effects of Number of Animals Monitored on Representations of Cattle Group Movement Characteristics and Spatial Occupancy	PLOS ONE			English	Article							GPS MEASUREMENT ERROR; COLLAR DATA; BEHAVIOR; HERD; MODEL; LIVESTOCK; TRACKING; DISTANCE; PIGEONS; PATTERN	The number of animals required to represent the collective characteristics of a group remains a concern in animal movement monitoring with GPS. Monitoring a subset of animals from a group instead of all animals can reduce costs and labor; however, incomplete data may cause information losses and inaccuracy in subsequent data analyses. In cattle studies, little work has been conducted to determine the number of cattle within a group needed to be instrumented considering subsequent analyses. Two different groups of cattle (a mixed group of 24 beef cows and heifers, and another group of 8 beef cows) were monitored with GPS collars at 4 min intervals on intensively managed pastures and corn residue fields in 2011. The effects of subset group size on cattle movement characterization and spatial occupancy analysis were evaluated by comparing the results between subset groups and the entire group for a variety of summarization parameters. As expected, more animals yield better results for all parameters. Results show the average group travel speed and daily travel distances are overestimated as subset group size decreases, while the average group radius is underestimated. Accuracy of group centroid locations and group radii are improved linearly as subset group size increases. A kernel density estimation was performed to quantify the spatial occupancy by cattle via GPS location data. Results show animals among the group had high similarity of spatial occupancy. Decisions regarding choosing an appropriate subset group size for monitoring depend on the specific use of data for subsequent analysis: a small subset group may be adequate for identifying areas visited by cattle; larger subset group size (e.g. subset group containing more than 75% of animals) is recommended to achieve better accuracy of group movement characteristics and spatial occupancy for the use of correlating cattle locations with other environmental factors.	[Liu, Tong; Green, Angela R.; Rodriguez, Luis F.; Ramirez, Brett C.] Univ Illinois, Dept Agr & Biol Engn, Urbana, IL 61820 USA; [Shike, Daniel W.] Univ Illinois, Dept Anim Sci, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Liu, T (corresponding author), Univ Illinois, Dept Agr & Biol Engn, Urbana, IL 61820 USA.	tongliu3@illinois.edu	Ramirez, Brett/A-8646-2018	Ramirez, Brett/0000-0002-3205-9723; Green-Miller, Angela/0000-0003-3404-4995				Agouridis CT, 2004, T ASAE, V47, P1321, DOI 10.13031/2013.16566; Akasbi Z, 2012, RANGELAND J, V34, P415, DOI 10.1071/RJ12036; Anderson D. M., 2013, POSITIONING, V4, P115, DOI [10.4236/pos.2013.41012, DOI 10.4236/POS.2013.41012]; Anderson DM, 2012, RANGELAND J, V34, P149, DOI 10.1071/RJ11062; Brooks C, 2008, J WILDLIFE MANAGE, V72, P527, DOI 10.2193/2007-061; Davis JD, 2011, APPL ENG AGRIC, V27, P143; Dell'Ariccia G, 2008, ANIM BEHAV, V76, P1165, DOI 10.1016/j.anbehav.2008.05.022; Della-Rossa L, 2013, BEHAVIOUR, V150, P153, DOI 10.1163/1568539X-00003043; Fritz H, 2003, P ROY SOC B-BIOL SCI, V270, P1143, DOI 10.1098/rspb.2003.2350; Ganskopp DC, 2007, RANGELAND ECOL MANAG, V60, P350, DOI 10.2111/1551-5028(2007)60[350:GEISAA]2.0.CO;2; Gudbjornsson S, 2004, SEA TECHNOL, V45, P23; Guo Y, 2009, ECOL MODEL, V220, P2068, DOI 10.1016/j.ecolmodel.2009.04.047; Hurford A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005632; ION, 1997, 101 ION STD; Jerde CL, 2005, ECOL APPL, V15, P806, DOI 10.1890/04-0895; Johnson DD, 2008, RANGELAND ECOL MANAG, V61, P226, DOI 10.2111/07-044.1; LIU T, 2012, AM SOC AGR BIOL ENG, V7004, P3514; Mech LD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025328; Morales JM, 2005, LANDSCAPE ECOL, V20, P301, DOI 10.1007/s10980-005-0061-9; Moritz M, 2012, HUM ECOL, V40, P623, DOI 10.1007/s10745-012-9483-6; Pandey V., 2013, Biological Engineering Transactions, V6, P59; Pepin D, 2004, J MAMMAL, V85, P774, DOI 10.1644/BER-022; Perotto-Baldivieso HL, 2012, APPL ANIM BEHAV SCI, V136, P117, DOI 10.1016/j.applanim.2011.11.009; Rands SA, 2014, PEERJ, V2, DOI 10.7717/peerj.344; Rodgers AR, 1996, WILDLIFE SOC B, V24, P559; Sarova R, 2007, APPL ANIM BEHAV SCI, V108, P327, DOI 10.1016/j.applanim.2007.01.009; Sarova R, 2010, ANIM BEHAV, V79, P1037, DOI 10.1016/j.anbehav.2010.01.019; Shiyomi M, 1999, ECOL MODEL, V119, P231, DOI 10.1016/S0304-3800(99)00059-9; Silverman B.W., 1986, DENSITY ESTIMATION S, DOI [10.1007/978-1-4899-3324-9, DOI 10.1007/978-1-4899-3324-9]; Swain DL, 2011, ANIM PROD SCI, V51, P167, DOI 10.1071/AN10255; Tremblay Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004711; Turner LW, 2000, CAN J ANIM SCI, V80, P405, DOI 10.4141/A99-093; Ungar ED, 2005, RANGELAND ECOL MANAG, V58, P256, DOI 10.2111/1551-5028(2005)58[256:IOAAFG]2.0.CO;2; Vyssotski AL, 2006, J NEUROPHYSIOL, V95, P1263, DOI 10.1152/jn.00879.2005; Yasuda T, 2005, ZOOL SCI, V22, P547, DOI 10.2108/zsj.22.547	35	9	11	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0113117	10.1371/journal.pone.0113117	http://dx.doi.org/10.1371/journal.pone.0113117			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647571	gold, Green Published, Green Submitted			2022-12-27	WOS:000348822600004
J	Peng, Y; Gao, XL; Yang, J; Shekhar, S; Wang, SH; Fan, YJ; Yang, X				Peng, Ying; Gao, Xiaoling; Yang, Jie; Shekhar, Sudhanshu; Wang, Shuhe; Fan, Yijun; Yang, Xi			Chlamydial Lung Infection Induces Transient IL-9 Production Which Is Redundant for Host Defense against Primary Infection	PLOS ONE			English	Article							DENDRITIC CELLS; IFN-GAMMA; T-CELLS; T(H)17; IMMUNITY; ROLES; MICE; INTERFERON; PATHWAYS; ALPHA	IL-9/Th9 responses are recently found to be important for innate and adaptive immunity particularly in parasitic infections. To date, the study on the role of IL-9 in bacterial infections is limited and the reported data are contradictory. One reported function of IL-9/Th9 is to modulate Th1/Th17 responses. Since our and others' previous work has shown a critical role of Th1 and Th17 cells in host defense against chlamydial lung infection, we here examined the role of IL-9 responses in Chlamydia muridarum (Cm) lung infection, particularly its effect on Th1 and Th17 responses and outcome infection. Our data showed quick but transient IL-9 production in the lung following infection, peaking at day 3 and back to baseline around day 7. CD4+ T cell was the major source of IL-9 production in the lung infection. Blockade of endogenous IL-9 using neutralizing antibody failed to change Interferon-Upsilon (IFN-Upsilon) and IL-17 production by cultured spleen mononuclear cells isolated from Cm infected mice. Similarly, in vivo neutralization of IL-9 failed to show significant effect on T cell (Th1 and Th17) and antibody responses (IgA, IgG1 and IgG2a). Consistently, the neutralization of IL-9 had no significant effect on disease process, including body weight change, bacterial burden and histopathological score. The data suggest that IL-9 production following chlamydial lung infection is redundant for host defense against the intracellular bacteria.	[Yang, Xi] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Yang, X (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	yangxi@cc.umanitoba.ca	Gao, xiao ling/GQI-2790-2022	Yang, Xi/0000-0002-8831-7488	Canadian Institutes of Health Research (CIHR); Manitoba Health Research Council (MHRC); Manitoba Institutes of Child Health (MICH)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council (MHRC); Manitoba Institutes of Child Health (MICH)	This work was supported by grants to XY from Canadian Institutes of Health Research (CIHR), Manitoba Health Research Council (MHRC) and Manitoba Institutes of Child Health (MICH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AS, 2009, CURR OPIN IMMUNOL, V21, P161, DOI 10.1016/j.coi.2009.03.013; Bai H, 2009, J IMMUNOL, V183, P5886, DOI 10.4049/jimmunol.0901584; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bilenki L, 2006, J IMMUNOL, V177, P7067, DOI 10.4049/jimmunol.177.10.7067; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Demoulin J B, 1998, Int Rev Immunol, V16, P345, DOI 10.3109/08830189809043001; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Finiasz MR, 2007, CLIN EXP IMMUNOL, V147, P139, DOI 10.1111/j.1365-2249.2006.03241.x; Gao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052657; Geng YM, 2000, INFECT IMMUN, V68, P2245, DOI 10.1128/IAI.68.4.2245-2253.2000; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Grohmann U, 2000, J IMMUNOL, V164, P4197, DOI 10.4049/jimmunol.164.8.4197; Han XB, 2006, J IMMUNOL, V176, P5232, DOI 10.4049/jimmunol.176.9.5232; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Jabeen R, 2012, CURR OPIN IMMUNOL, V24, P303, DOI 10.1016/j.coi.2012.02.001; Joyee AG, 2008, AM J RESP CRIT CARE, V178, P745, DOI 10.1164/rccm.200804-517OC; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; Nowak EC, 2010, IMMUNOLOGY, V131, P169, DOI 10.1111/j.1365-2567.2010.03332.x; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Qiu HY, 2008, J IMMUNOL, V181, P2092, DOI 10.4049/jimmunol.181.3.2092; SCHACHTER J, 1978, NEW ENGL J MED, V298, P428, DOI 10.1056/NEJM197802232980805; Schmitt E, 2014, TRENDS IMMUNOL, V35, P61, DOI 10.1016/j.it.2013.10.004; Tan CY, 2010, J IMMUNOL, V185, P6795, DOI 10.4049/jimmunol.1001676; Wang SH, 1999, EUR J IMMUNOL, V29, P3782, DOI 10.1002/(SICI)1521-4141(199911)29:11<3782::AID-IMMU3782>3.0.CO;2-B; Wu B, 2008, CLIN IMMUNOL, V126, P202, DOI 10.1016/j.clim.2007.09.009; Yang X, 1998, IMMUNOLOGY, V94, P469; Yang X, 1996, J IMMUNOL, V156, P4338; YIN TG, 1994, J BIOL CHEM, V269, P26614; Zhao L, 2011, IMMUNOLOGY, V134, P172, DOI 10.1111/j.1365-2567.2011.03477.x; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0115195	10.1371/journal.pone.0115195	http://dx.doi.org/10.1371/journal.pone.0115195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646821	Green Submitted, Green Published, gold			2022-12-27	WOS:000348822600010
J	Tarasenko, TN; Rosas, OR; Singh, LN; Kristaponis, K; Vernon, H; McGuire, PJ				Tarasenko, Tatyana N.; Rosas, Odrick R.; Singh, Larry N.; Kristaponis, Kara; Vernon, Hilary; McGuire, Peter J.			A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation	PLOS ONE			English	Article							UREA CYCLE DISORDERS; AMMONIA METABOLISM; HYPERAMMONEMIA; MANAGEMENT; MUTANT; EXPRESSION; ADULT	Ornithine transcarbamylase deficiency (OTCD, OMIM# 311250) is an inherited X-linked urea cycle disorder that is characterized by hyperammonemia and orotic aciduria. In this report, we describe a new animal model of OTCD caused by a spontaneous mutation in the mouse Otc gene (c.240T>A, p.K80N). This transversion in exon 3 of ornithine transcarbamylase leads to normal levels of mRNA with low levels of mature protein and is homologous to a mutation that has also been described in a single patient affected with late-onset OTCD. With higher residual enzyme activity, spf-J were found to have normal plasma ammonia and orotate. Baseline plasma amino acid profiles were consistent with mild OTCD: elevated glutamine, and lower citrulline and arginine. In contrast to WT, spf-J displayed baseline elevations in cerebral amino acids with depletion following immune challenge with polyinosinic: polycytidylic acid. Our results indicate that the mild spf-J mutation constitutes a new mouse model that is suitable for mechanistic studies of mild OTCD and the exploration of cerebral pathophysiology during acute decompensation that characterizes proximal urea cycle dysfunction in humans.	[Tarasenko, Tatyana N.; Singh, Larry N.; McGuire, Peter J.] NHGRI, NIH, Bethesda, MD 20892 USA; Univ Cent Caribe, Bayamon, PR USA; [Kristaponis, Kara] Johns Hopkins Univ, Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD USA; [Vernon, Hilary] Johns Hopkins Univ, Kennedy Krieger Inst, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University; Kennedy Krieger Institute	McGuire, PJ (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	peter.mcguire@nih.gov	Singh, Larry N./AAG-6880-2021	Singh, Larry N./0000-0002-2478-5864; Vernon, Hilary/0000-0001-9940-9866	intramural research program of the National Institutes of Health; Kennedy Kreiger Institute at Johns Hopkins University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200381] Funding Source: NIH RePORTER	intramural research program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kennedy Kreiger Institute at Johns Hopkins University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Work performed by T.N.T., L.N.S., O.R.R., and P.J.M. was supported by the intramural research program of the National Institutes of Health. Work performed by H.V. and K.K. was supported by institutional funding from the Kennedy Kreiger Institute at Johns Hopkins University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann C, 2003, EUR J PEDIATR, V162, pS29, DOI 10.1007/s00431-003-1347-z; BATSHAW ML, 1980, NEW ENGL J MED, V302, P482, DOI 10.1056/NEJM198002283020902; Ben-Ari Z, 2010, J HEPATOL, V52, P292, DOI 10.1016/j.jhep.2009.11.014; Brosnan JT, 2003, J NUTR, V133, p2068S, DOI 10.1093/jn/133.6.2068S; D'Apolito O, 2010, J SEP SCI, V33, P966, DOI 10.1002/jssc.200900758; Dong ZJ, 2004, J HEPATOL, V41, P966, DOI 10.1016/j.jhep.2004.08.021; Fernandes J, 2006, INBORN METABOLIC DIS, P263; Galloway PJ, 2000, ANN CLIN BIOCHEM, V37, P727, DOI 10.1258/0004563001899807; Gropman A, 2010, MOL GENET METAB, V100, pS20, DOI 10.1016/j.ymgme.2010.01.017; Gropman AL, 2013, METAB BRAIN DIS, V28, P269, DOI 10.1007/s11011-012-9348-0; Holecek M, 2013, NUTRITION, V29, P1186, DOI 10.1016/j.nut.2013.01.022; KREBS HA, 1978, BIOCHEM J, V176, P733, DOI 10.1042/bj1760733; Krivitzky L, 2009, PEDIAT RES; MAESTRI NE, 1992, J PEDIATR-US, V121, P259, DOI 10.1016/S0022-3476(05)81200-4; Marcaggi P, 2004, GLIA, V47, P217, DOI 10.1002/glia.20027; Matsuda I, 1996, J MED GENET, V33, P645, DOI 10.1136/jmg.33.8.645; McCullough BA, 2000, AM J MED GENET, V93, P313, DOI 10.1002/1096-8628(20000814)93:4<313::AID-AJMG11>3.0.CO;2-M; McGuire PJ, 2013, J PEDIATR-US, V163, P1705, DOI 10.1016/j.jpeds.2013.08.029; Meijer AJ, 2004, BIOCHEM BIOPH RES CO, V313, P397, DOI 10.1016/j.bbrc.2003.07.012; Morizono H, 1997, HUM MOL GENET, V6, P963, DOI 10.1093/hmg/6.6.963; Morizono H, 1997, BIOCHEM J, V322, P625, DOI 10.1042/bj3220625; Moscioni D, 2006, MOL THER, V14, P25, DOI 10.1016/j.ymthe.2006.03.009; MSALL M, 1984, NEW ENGL J MED, V310, P1500, DOI 10.1056/NEJM198406073102304; Pacheco-Colon I, 2014, ADV UREA CYCLE NEURO; PASTRALANDIS SC, 1981, ANAL BIOCHEM, V118, P358, DOI 10.1016/0003-2697(81)90594-7; Singh LN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002345; Singh RH, 2007, J INHERIT METAB DIS, V30, P880, DOI 10.1007/s10545-007-0718-4; Snodgrass PJ, 2004, ANIMAL MODELS OTC DE, P94; Sprouse C, 2014, MOL GENET METAB, V113, P136, DOI 10.1016/j.ymgme.2014.05.007; Summar M, 2001, J PEDIATR-US, V138, pS6, DOI 10.1067/mpd.2001.111831; USA Jackson Laboratory, 1995, Mouse Genome, V93, P1030	31	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116594	10.1371/journal.pone.0116594	http://dx.doi.org/10.1371/journal.pone.0116594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647322	gold, Green Submitted, Green Published			2022-12-27	WOS:000348822600029
J	Peretz, Y; Wu, H; Patel, S; Bellacosa, A; Katz, RA				Peretz, Yuval; Wu, Hong; Patel, Shayan; Bellacosa, Alfonso; Katz, Richard A.			Inhibitor of DNA Binding 4 (ID4) Is Highly Expressed in Human Melanoma Tissues and May Function to Restrict Normal Differentiation of Melanoma Cells	PLOS ONE			English	Article							CANCER STEM-CELLS; HUMAN-MALIGNANT-MELANOMA; NEURAL CREST; SELF-RENEWAL; GROWTH; HETEROGENEITY; GLIOBLASTOMA; PROTEINS; PHENOTYPE; THERAPY	Melanoma tissues and cell lines are heterogeneous, and include cells with invasive, proliferative, stem cell-like, and differentiated properties. Such heterogeneity likely contributes to the aggressiveness of the disease and resistance to therapy. One model suggests that heterogeneity arises from rare cancer stem cells (CSCs) that produce distinct cancer cell lineages. Another model suggests that heterogeneity arises through reversible cellular plasticity, or phenotype-switching. Recent work indicates that phenotype-switching may include the ability of cancer cells to dedifferentiate to a stem cell-like state. We set out to investigate the phenotype-switching capabilities of melanoma cells, and used unbiased methods to identify genes that may control such switching. We developed a system to reversibly synchronize melanoma cells between 2D-monolayer and 3D-stem cell-like growth states. Melanoma cells maintained in the stem cell-like state showed a striking upregulation of a gene set related to development and neural stem cell biology, which included SRY-box 2 (SOX2) and Inhibitor of DNA Binding 4 (ID4). A gene set related to cancer cell motility and invasiveness was concomitantly downregulated. Intense and pervasive ID4 protein expression was detected in human melanoma tissue samples, suggesting disease relevance for this protein. SiRNA knockdown of ID4 inhibited switching from monolayer to 3D-stem cell-like growth, and instead promoted switching to a highly differentiated, neuronal-like morphology. We suggest that ID4 is upregulated in melanoma as part of a stem cell-like program that facilitates further adaptive plasticity. ID4 may contribute to disease by preventing stem cell-like melanoma cells from progressing to a normal differentiated state. This interpretation is guided by the known role of ID4 as a differentiation inhibitor during normal development. The melanoma stem cell-like state may be protected by factors such as ID4, thereby potentially identifying a new therapeutic vulnerability to drive differentiation to the normal cell phenotype.	[Peretz, Yuval; Wu, Hong; Patel, Shayan; Bellacosa, Alfonso; Katz, Richard A.] Temple Univ Hlth Syst, Fox Chase Canc Ctr, Philadelphia, PA 19140 USA	Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Katz, RA (corresponding author), Temple Univ Hlth Syst, Fox Chase Canc Ctr, Philadelphia, PA 19140 USA.	Richard.Katz@fccc.edu			National Institutes of Health [DK082498, CA071515, CA006927]; NATIONAL CANCER INSTITUTE [R01CA071515, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institutes of Health Grants DK082498 (RAK), CA071515, and CA006927. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2013, J INVEST DERMATOL, V133, P1384, DOI 10.1038/jid.2012.508; Bailey CM, 2012, PIGM CELL MELANOMA R, V25, P573, DOI 10.1111/j.1755-148X.2012.01025.x; Bedford L, 2005, DEV BIOL, V280, P386, DOI 10.1016/j.ydbio.2005.02.001; Bellido M, 2003, HAEMATOLOGICA, V88, P994; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Carey JPW, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-173; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Cartier L, 2006, J NEUROBIOL, V66, P421, DOI 10.1002/neu.20225; Chen SS, 2011, BLOOD, V117, P862, DOI 10.1182/blood-2010-05-284638; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Coradini D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/254085; Dell'Orso S, 2010, ONCOTARGET, V1, P48, DOI 10.18632/oncotarget.108; DiVito KA, 2014, CARCINOGENESIS, V35, P951, DOI 10.1093/carcin/bgt479; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Feder-Mengus C, 2007, BRIT J CANCER, V96, P1072, DOI 10.1038/sj.bjc.6603664; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Flammiger A, 2009, J INVEST DERMATOL, V129, P945, DOI 10.1038/jid.2008.316; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Ghislin S, 2012, MELANOMA RES, V22, P184, DOI 10.1097/CMR.0b013e328351e7c4; Ghosh S, 2005, J CELL PHYSIOL, V204, P522, DOI 10.1002/jcp.20320; Gilbertson RJ, 2012, NATURE, V488, P462, DOI 10.1038/nature11480; Girouard SD, 2011, LAB INVEST, V91, P647, DOI 10.1038/labinvest.2011.50; Grichnik JM, 2006, J INVEST DERMATOL, V126, P142, DOI 10.1038/sj.jid.5700017; Guo SJ, 2011, MOL BIOL REP, V38, P4637, DOI 10.1007/s11033-010-0597-x; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hamid O, 2013, N ENGL J MED; HERLYN D, 1990, CANCER RES, V50, P2296; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Hong S, 2008, J NEUROCHEM, V104, P316, DOI 10.1111/j.1471-4159.2007.04952.x; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; Iyengar B, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-87; Jeon HM, 2008, GENE DEV, V22, P2028, DOI 10.1101/gad.1668708; Jeon HM, 2011, CANCER RES, V71, P3410, DOI 10.1158/0008-5472.CAN-10-3340; JUHASZ I, 1993, AM J PATHOL, V143, P528; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Koledova Z, 2010, STEM CELLS DEV, V19, P1663, DOI 10.1089/scd.2010.0136; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Kulesa PM, 2013, CELLS TISSUES ORGANS, V198, P12, DOI 10.1159/000348418; Kulesa PM, 2006, P NATL ACAD SCI USA, V103, P3752, DOI 10.1073/pnas.0506977103; Kurooka H, 2005, J BIOL CHEM, V280, P4313, DOI 10.1074/jbc.M412614200; Kuzontkoski PM, 2010, ONCOGENE, V29, P3793, DOI 10.1038/onc.2010.147; La Porta CAM, 2013, CANCER LETT, V338, P69, DOI 10.1016/j.canlet.2012.03.017; Laga AC, 2011, EXP DERMATOL, V20, P339, DOI 10.1111/j.1600-0625.2011.01247.x; Laga AC, 2010, ARCH PATHOL LAB MED, V134, P1750, DOI 10.1043/2009-0394-RAR.1; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Lee N, 2014, LAB INVEST, V94, P13, DOI 10.1038/labinvest.2013.116; Li YQ, 2012, CANCER RES, V72, P576, DOI 10.1158/0008-5472.CAN-11-3070; Liang Y, 2005, BMC CLIN PATHOL, V5, DOI 10.1186/1472-6890-5-6; Lottaz C, 2010, CANCER RES, V70, P2030, DOI 10.1158/0008-5472.CAN-09-1707; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Martini M, 2013, CANCER-AM CANCER SOC, V119, P1004, DOI 10.1002/cncr.27821; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Mothe AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027079; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Ohsie SJ, 2008, J CUTAN PATHOL, V35, P433, DOI 10.1111/j.1600-0560.2007.00891.x; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Ramgolam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018784; Ren Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003778; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Schatton T, 2010, J INVEST DERMATOL, V130, P1769, DOI 10.1038/jid.2010.135; Seftor EA, 2014, SEMIN ONCOL, V41, P259, DOI 10.1053/j.seminoncol.2014.02.001; Shakhova O, 2013, CANCER LETT, V338, P74, DOI 10.1016/j.canlet.2012.10.009; Shan L, 2003, AM J PATHOL, V163, P2495, DOI 10.1016/S0002-9440(10)63604-8; Sikder HA, 2003, CANCER CELL, V3, P525, DOI 10.1016/S1535-6108(03)00141-7; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Sullivan RJ, 2013, EUR J CANCER, V49, P1297, DOI 10.1016/j.ejca.2012.11.019; Sztiller-Sikorska M, 2012, MELANOMA RES, V22, P215, DOI 10.1097/CMR.0b013e3283531317; Thurber AE, 2011, ONCOGENE, V30, P3036, DOI 10.1038/onc.2011.33; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; Wen YH, 2012, BREAST CANCER RES TR, V135, P93, DOI 10.1007/s10549-012-2070-0; Woolard K, 2009, CELL STEM CELL, V4, P466, DOI 10.1016/j.stem.2009.05.013; Yuen HF, 2006, MODERN PATHOL, V19, P931, DOI 10.1038/modpathol.3800602; Yun K, 2004, DEVELOPMENT, V131, P5441, DOI 10.1242/dev.01430; Zeng WF, 2010, J CANCER, V1, P1	82	7	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116839	10.1371/journal.pone.0116839	http://dx.doi.org/10.1371/journal.pone.0116839			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642713	Green Submitted, Green Published, gold			2022-12-27	WOS:000348821200027
J	Jansen, SEM; Tiest, WMB; Kappers, AML				Jansen, Sander E. M.; Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.			Haptic Exploratory Behavior During Object Discrimination: A Novel Automatic Annotation Method	PLOS ONE			English	Article							HAND; RECOGNITION; SYSTEM	In order to acquire information concerning the geometry and material of handheld objects, people tend to execute stereotypical hand movement patterns called haptic Exploratory Procedures (EPs). Manual annotation of haptic exploration trials with these EPs is a laborious task that is affected by subjectivity, attentional lapses, and viewing angle limitations. In this paper we propose an automatic EP annotation method based on position and orientation data from motion tracking sensors placed on both hands and inside a stimulus. A set of kinematic variables is computed from these data and compared to sets of predefined criteria for each of four EPs. Whenever all criteria for a specific EP are met, it is assumed that that particular hand movement pattern was performed. This method is applied to data from an experiment where blindfolded participants haptically discriminated between objects differing in hardness, roughness, volume, and weight. In order to validate the method, its output is compared to manual annotation based on video recordings of the same trials. Although mean pairwise agreement is less between human-automatic pairs than between human-human pairs (55.7% vs 74.5%), the proposed method performs much better than random annotation (2.4%). Furthermore, each EP is linked to a specific object property for which it is optimal (e. g., Lateral Motion for roughness). We found that the percentage of trials where the expected EP was found does not differ between manual and automatic annotation. For now, this method cannot yet completely replace a manual annotation procedure. However, it could be used as a starting point that can be supplemented by manual annotation.	[Jansen, Sander E. M.; Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.] Vrije Univ Amsterdam, MOVE Res Inst, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Jansen, SEM (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst, Amsterdam, Netherlands.	s.e.m.jansen@vu.nl		Kappers, Astrid/0000-0003-4101-7717	European Commission within program "Cognitive Systems and Robotics." [FP7-ICT-2009-4-2-1]; Collaborative Project "THE Hand Embodied," [248587]	European Commission within program "Cognitive Systems and Robotics."; Collaborative Project "THE Hand Embodied,"	This work has been supported by the European Commission with the Collaborative Project no. 248587, "THE Hand Embodied," within the FP7-ICT-2009-4-2-1 program " Cognitive Systems and Robotics." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal JK, 2011, ACM COMPUT SURV, V43, DOI 10.1145/1922649.1922653; COREN S, 1993, PERCEPT MOTOR SKILL, V76, P1035, DOI 10.2466/pms.1993.76.3.1035; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; Holden EJ, 1996, INT J EXPERT SYST, V9, P465; Jansen SEM, 2013, IEEE T HAPTICS, V6, P464, DOI [10.1109/ToH.2013.22, 10.1109/TOH.2013.22]; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; Klatzky RL, 2009, SCHOLARPEDIA, V4, P7941, DOI [10.4249/scholarpedia.7941, DOI 10.4249/SCHOLARPEDIA.7941]; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Oz C, 2011, ENG APPL ARTIF INTEL, V24, P1204, DOI 10.1016/j.engappai.2011.06.015; van Dam EA, 2013, J NEUROSCI METH, V218, P214, DOI 10.1016/j.jneumeth.2013.05.012; van Polanen V, 2012, ATTEN PERCEPT PSYCHO, V74, P204, DOI 10.3758/s13414-011-0216-5; Wang XY, 2012, MYCOPATHOLOGIA, V173, P295, DOI 10.1007/s11046-011-9484-9; Withagen A, 2013, ATTEN PERCEPT PSYCHO, V75, P1451, DOI 10.3758/s13414-013-0479-0	13	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117017	10.1371/journal.pone.0117017	http://dx.doi.org/10.1371/journal.pone.0117017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658703	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900092
J	Kim, Y; Welk, GJ; Braun, SI; Kang, M				Kim, Youngdeok; Welk, Gregory J.; Braun, Saori I.; Kang, Minsoo			Extracting Objective Estimates of Sedentary Behavior from Accelerometer Data: Measurement Considerations for Surveillance and Research Applications	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CANCER SURVIVORS; UNITED-STATES; TIME; ASSOCIATIONS; ENERGY; HEALTH; TOO; VALIDITY; MONITORS	Background Accelerometer-based activity monitors are widely used in research and surveillance applications for quantifying sedentary behavior (SB) and physical activity (PA). Considerable research has been done to refine methods for assessing PA, but relatively little attention has been given to operationalizing SB parameters (i.e., sedentary time and breaks) from accelerometer data - particularly in relation to health outcomes. This study investigated: (a) the accrued patterns of sedentary time and breaks; and (b) the associations of sedentary time and breaks in different bout durations with cardiovascular risk factors. Methods Accelerometer data on 5,917 adults from the National Health Examination and Nutrition Survey (NHANES) 2003-2006 were used. Sedentary time and breaks at different bout durations (i.e., 1, 2-4, 5-9, 10-14, 15-19, 20-24, 25-29, and >= 30-min) were obtained using a threshold of <100 counts per minute. Sedentary time and breaks were regressed on cardiovascular risk factors (waist circumference, triglyceride, and high-density lipoprotein cholesterol) and body mass index across bout durations. Results The results revealed that the majority of sedentary time occurred within relatively short bout durations (approximate to 70% and approximate to 85% for < 5-min and < 10-min, respectively). The associations of sedentary time and breaks with health outcomes varied depending on how bout time was defined. Estimates of SB parameters based on bout durations of 5 min or shorter were associated with reduced cardiovascular risk factors while durations longer than 10-min were generally associated with increased risk factors. Conclusions The present study demonstrates that the duration of sedentary bouts should be further considered when operationalizing the SB parameters from accelerometer data. The threshold of 5 minutes to define a bout is defensible, but a 10 minute threshold would provide a more conservative estimate to clearly capture the prolonged nature of sedentary behavior. Additional research is needed to determine the relative sensitivity and specificity of these thresholds.	[Kim, Youngdeok] Texas Tech Univ, Dept Hlth Exercise & Sport Sci, Lubbock, TX 79409 USA; [Welk, Gregory J.] Iowa State Univ, Dept Kinesiol, Ames, IA USA; [Braun, Saori I.] Univ Wisconsin, Dept Kinesiol, Eau Claire, WI 54701 USA; [Kang, Minsoo] Middle Tennessee State Univ, Dept Hlth & Human Performance, Murfreesboro, TN 37130 USA	Texas Tech University System; Texas Tech University; Iowa State University; University of Wisconsin System; Middle Tennessee State University	Kim, Y (corresponding author), Texas Tech Univ, Dept Hlth Exercise & Sport Sci, Lubbock, TX 79409 USA.	youngdeok.kim@ttu.edu			Texas Tech University	Texas Tech University	Funding to pay the Open Access publication charges was provided by the Texas Tech University institutional startup funds to Y.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, OXFORD DICT ONLINE, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Carr LJ, 2012, J OBES, V2012, DOI 10.1155/2012/460271; Carson Valerie, 2011, BMC Public Health, V11, P274, DOI 10.1186/1471-2458-11-274; Clark BK, 2011, MED SCI SPORT EXER, V43, P822, DOI 10.1249/MSS.0b013e3182019510; Colley RC, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-200, 10.1186/1471-2458-13-554]; Cordain L, 1998, INT J SPORTS MED, V19, P328, DOI 10.1055/s-2007-971926; Crouter SE, 2013, J PHYS ACT HEALTH, V10, P504, DOI 10.1123/jpah.10.4.504; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Dunstan DW, 2010, EUR ENDOCRINOL, V6, P19, DOI DOI 10.17925/EE.2010.06.00.19; Granat MH, 2012, PHYSIOL MEAS, V33, P1785, DOI 10.1088/0967-3334/33/11/1785; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Harrington DM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-120; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Henson J, 2013, DIABETOLOGIA, P1; Kim Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090630; Kozey SL, 2010, MED SCI SPORT EXER, V42, P1776, DOI 10.1249/MSS.0b013e3181d479f2; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Lyden K, 2012, MED SCI SPORT EXER, V44, P2243, DOI 10.1249/MSS.0b013e318260c477; Lynch BM, 2011, EUR J CANCER CARE, V20, P514, DOI 10.1111/j.1365-2354.2010.01205.x; Lynch BM, 2010, CANCER CAUSE CONTROL, V21, P283, DOI 10.1007/s10552-009-9460-6; Maher CA, 2013, OBESITY, V21, pE730, DOI 10.1002/oby.20430; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Owen N, 2009, BRIT J SPORT MED, V43, P81, DOI 10.1136/bjsm.2008.055269; Owen N, 2000, Exerc Sport Sci Rev, V28, P153; Owen N, 2012, PHYSIOL MEAS, V33, P1801, DOI 10.1088/0967-3334/33/11/1801; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO, V2008, pA1; Satia-Abouta J, 2003, AM J EPIDEMIOL, V158, P951, DOI 10.1093/aje/kwg248; Saunders TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079143; Sedentary Behaviour Research Network, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/h2012-024, DOI 10.1139/H2012-024]; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110332; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P848, DOI 10.1093/oxfordjournals.aje.a117333; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Winkler EAH, 2012, BRIT J SPORT MED, V46, P436, DOI 10.1136/bjsm.2010.079699	42	45	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118078	10.1371/journal.pone.0118078	http://dx.doi.org/10.1371/journal.pone.0118078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658473	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900261
J	Kitamura, S; Morisseau, C; Inceoglu, B; Kamita, SG; De Nicola, GR; Nyegue, M; Hammock, BD				Kitamura, Seiya; Morisseau, Christophe; Inceoglu, Bora; Kamita, Shizuo G.; De Nicola, Gina R.; Nyegue, Maximilienne; Hammock, Bruce D.			Potent Natural Soluble Epoxide Hydrolase Inhibitors from Pentadiplandra brazzeana Baillon: Synthesis, Quantification, and Measurement of Biological Activities In Vitro and In Vivo	PLOS ONE			English	Article							EPOXYEICOSATRIENOIC ACIDS; DOCOSAHEXAENOIC ACID; INFLAMMATORY PAIN; UREA DERIVATIVES; MORINGA-OLEIFERA; RAT MODEL; ETHNOBOTANY; DISCOVERY; PRODUCTS; PROFILE	We describe here three urea-based soluble epoxide hydrolase (sEH) inhibitors from the root of the plant Pentadiplandra brazzeana. The concentration of these ureas in the root was quantified by LC-MS/MS, showing that 1, 3-bis (4-methoxybenzyl) urea (MMU) is the most abundant (42.3 mu g/g dry root weight). All of the ureas were chemically synthesized, and their inhibitory activity toward recombinant human and recombinant rat sEH was measured. The most potent compound, MMU, showed an IC50 of 92 nM via fluorescent assay and a Ki of 54 nM via radioactivity-based assay on human sEH. MMU effectively reduced inflammatory pain in a rat nociceptive pain assay. These compounds are among the most potent sEH inhibitors derived from natural sources. Moreover, inhibition of sEH by these compounds may mechanistically explain some of the therapeutic effects of P. brazzeana.	[Kitamura, Seiya; Morisseau, Christophe; Inceoglu, Bora; Kamita, Shizuo G.; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Kitamura, Seiya; Morisseau, Christophe; Inceoglu, Bora; Kamita, Shizuo G.; Hammock, Bruce D.] Univ Calif Davis, Ctr Comprehens Canc, Davis, CA 95616 USA; [De Nicola, Gina R.] Ctr Ric Colture Ind CRA CIN, Consiglio Ric & Sperimentaz Agr, Bologna, Italy; [Nyegue, Maximilienne] Univ Yaounde I, Dept Biochem, Yaounde, Cameroon; [Nyegue, Maximilienne] Univ Yaounde I, Dept Microbiol, Yaounde, Cameroon	University of California System; University of California Davis; University of California System; University of California Davis; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Yaounde I; University of Yaounde I	Hammock, BD (corresponding author), Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.	bdhammock@ucdavis.edu	De Nicola, Gina Rosalinda/AAC-9218-2021; Inceoglu, Bora/G-2892-2015	De Nicola, Gina Rosalinda/0000-0002-2916-8662; Inceoglu, Bora/0000-0002-8473-6036	National Institute of Environmental Health Sciences (NIEHS) grant [R01ES002710]; NIEHS Superfund Research Program grant [P42 ES04699]; National Institute Of Arthritis And Musculoskeletal And Skin Diseases of the National Institutes of Health (NIH) [R21AR062866]; NIH Counter Act Program [U54 NS079202-01]; Japan Student Services Organization; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR062866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS079202] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS) grant; NIEHS Superfund Research Program grant; National Institute Of Arthritis And Musculoskeletal And Skin Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH Counter Act Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Student Services Organization(Japan Student Services Organization); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially funded by National Institute of Environmental Health Sciences (NIEHS) grant R01ES002710, NIEHS Superfund Research Program grant P42 ES04699, National Institute Of Arthritis And Musculoskeletal And Skin Diseases of the National Institutes of Health (NIH) under Award Number R21AR062866, and NIH Counter Act Program U54 NS079202-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. SK is financially supported by Japan Student Services Organization. BDH is a George and Judy Marcus Senior Fellow of the American Asthma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahroun A, 1985, J SOC CHIMIQUE TUNIS, V2, P15; BEETHAM JK, 1993, ARCH BIOCHEM BIOPHYS, V305, P197, DOI 10.1006/abbi.1993.1411; Bennett RN, 2003, J AGR FOOD CHEM, V51, P3546, DOI 10.1021/jf0211480; Betti J.L., 2004, AFRICAN STUDY MONOGR, V25, P1, DOI DOI 10.14989/68229; BORHAN B, 1995, ANAL BIOCHEM, V231, P188, DOI 10.1006/abio.1995.1520; De Nicola GR, 2012, PHYTOCHEMISTRY, V73, P51, DOI 10.1016/j.phytochem.2011.09.006; DIXON M, 1972, BIOCHEM J, V129, P197, DOI 10.1042/bj1290197; Dounias E, 2008, PROTA; GIL V, 1980, PHYTOCHEMISTRY, V19, P1369, DOI 10.1016/0031-9422(80)80176-2; Guedes AGP, 2013, VET ANAESTH ANALG, V40, P440, DOI 10.1111/vaa.12030; Inceoglu B, 2007, PROSTAG OTH LIPID M, V82, P42, DOI 10.1016/j.prostaglandins.2006.05.004; Inceoglu B, 2006, LIFE SCI, V79, P2311, DOI 10.1016/j.lfs.2006.07.031; Inceoglu B, 2012, P NATL ACAD SCI USA, V109, P11390, DOI 10.1073/pnas.1208708109; Inceoglu B, 2008, P NATL ACAD SCI USA, V105, P18901, DOI 10.1073/pnas.0809765105; Jiofack T, 2009, AFR J PHARM PHARMACO, V3, P144; Jones PD, 2005, ANAL BIOCHEM, V343, P66, DOI 10.1016/j.ab.2005.03.041; la Buscato E, 2013, CHEMMEDCHEM, V8, P919, DOI 10.1002/cmdc.201300057; Lee GH, 2014, FOOD CHEM TOXICOL, V64, P225, DOI 10.1016/j.fct.2013.11.042; Lee KSS, 2013, ANAL BIOCHEM, V434, P259, DOI 10.1016/j.ab.2012.11.015; LIN WK, 1990, BIOCHEM BIOPH RES CO, V167, P977, DOI 10.1016/0006-291X(90)90619-X; Liu JY, 2009, MOL CANCER THER, V8, P2193, DOI 10.1158/1535-7163.MCT-09-0119; Makumbelo E., 2008, Tropicultura, V26, P129; Morisseau C, 1999, P NATL ACAD SCI USA, V96, P8849, DOI 10.1073/pnas.96.16.8849; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Morisseau C, 2010, J LIPID RES, V51, P3481, DOI 10.1194/jlr.M006007; Nakagawa Y, 2000, BIOORGAN MED CHEM, V8, P2663, DOI 10.1016/S0968-0896(00)00198-X; Nyegue M, 2009, ADV PHYTOTHERAPY RES, P91; RAY AB, 1975, CHEM IND-LONDON, P517; Reema KT, 2013, BIOORG MED CHEM LETT, V23, P3584, DOI 10.1016/j.bmcl.2013.04.019; Rodman JE, 1998, AM J BOT, V85, P997, DOI 10.2307/2446366; Rose TE, 2010, J MED CHEM, V53, P7067, DOI 10.1021/jm100691c; Sashidhara KV, 2009, EUR J MED CHEM, V44, P432, DOI 10.1016/j.ejmech.2007.12.018; Shen HC, 2012, J MED CHEM, V55, P1789, DOI 10.1021/jm201468j; Sofrata A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023045; Titanji VPK, 2008, AFR J TRADIT COMPLEM, V5, P302; Tsopmo A, 1999, J NAT PROD, V62, P1435, DOI 10.1021/np990111f; Wagner K, 2011, J AGR FOOD CHEM, V59, P2816, DOI 10.1021/jf102559q; WIXTROM RN, 1988, ANAL BIOCHEM, V169, P71, DOI 10.1016/0003-2697(88)90256-4; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Zhang GD, 2013, P NATL ACAD SCI USA, V110, P6530, DOI 10.1073/pnas.1304321110	40	15	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117438	10.1371/journal.pone.0117438	http://dx.doi.org/10.1371/journal.pone.0117438			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659109	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900149
J	Richter, M; Dayaram, T; Gilmartin, AG; Ganji, G; Pemmasani, SK; Van der Key, H; Shohet, JM; Donehower, LA; Kumar, R				Richter, Mark; Dayaram, Tajhal; Gilmartin, Aidan G.; Ganji, Gopinath; Pemmasani, Sandhya Kiran; Van der Key, Harjeet; Shohet, Jason M.; Donehower, Lawrence A.; Kumar, Rakesh			WIP1 Phosphatase as a Potential Therapeutic Target in Neuroblastoma	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; MDM2 ANTAGONIST NUTLIN-3; CELL-CYCLE CONTROL; TUMOR-SUPPRESSOR; PROTEIN PHOSPHATASE; PPM1D MUTATIONS; DOWN-REGULATION; STEM-CELLS; P53; TUMORIGENESIS	The wild-type p53-induced phosphatase 1 (WIP1) is a serine/threonine phosphatase that negatively regulates multiple proteins involved in DNA damage response including p53, CHK2, Histone H2AX, and ATM, and it has been shown to be overexpressed or amplified in human cancers including breast and ovarian cancers. We examined WIP1 mRNA levels across multiple tumor types and found the highest levels in breast cancer, leukemia, medulloblastoma and neuroblastoma. Neuroblastoma is an exclusively TP53 wild type tumor at diagnosis and inhibition of p53 is required for tumorigenesis. Neuroblastomas in particular have previously been shown to have 17q amplification, harboring the WIP1 (PPM1D) gene and associated with poor clinical outcome. We therefore sought to determine whether inhibiting WIP1 with a selective antagonist, GSK2830371, can attenuate neuroblastoma cell growth through reactivation of p53 mediated tumor suppression. Neuroblastoma cell lines with wild-type TP53 alleles were highly sensitive to GSK2830371 treatment, while cell lines with mutant TP53 were resistant to GSK2830371. The majority of tested neuroblastoma cell lines with copy number gains of the PPM1D locus were also TP53 wild-type and sensitive to GSK2830371A; in contrast cell lines with no copy gain of PPM1D were mixed in their sensitivity to WIP1 inhibition, with the primary determinant being TP53 mutational status. Since WIP1 is involved in the cellular response to DNA damage and drugs used in neuroblastoma treatment induce apoptosis through DNA damage, we sought to determine whether GSK2830371 could act synergistically with standard of care chemotherapeutics. Treatment of wild-type TP53 neuroblastoma cell lines with both GSK2830371 and either doxorubicin or carboplatin resulted in enhanced cell death, mediated through caspase 3/7 induction, as compared to either agent alone. Our data suggests that WIP1 inhibition represents a novel therapeutic approach to neuroblastoma that could be integrated with current chemotherapeutic approaches.	[Richter, Mark; Gilmartin, Aidan G.; Ganji, Gopinath; Kumar, Rakesh] GlaxoSmithKline, Oncol R&D, Collegeville, PA USA; [Dayaram, Tajhal; Donehower, Lawrence A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Dayaram, Tajhal; Donehower, Lawrence A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Pemmasani, Sandhya Kiran] Ocimum Biosolut Ltd, HUDA Techno Enclave, Hyderabad, Andhra Pradesh, India; [Van der Key, Harjeet] GlaxoSmithKline, Platform Technol & Sci, Collegeville, PA USA; [Shohet, Jason M.] Baylor Coll Med, Dept Pediat, Texas Childrens Canc Ctr, Houston, TX 77030 USA	GlaxoSmithKline; Baylor College of Medicine; Baylor College of Medicine; GlaxoSmithKline; Baylor College of Medicine; Texas Children's Cancer Center	Donehower, LA (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	larryd@bcm.edu; rakesh.2.kumar@gsk.com	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803	GlaxoSmithKline; Cancer Research and Prevention Institute of Texas [RP110040]	GlaxoSmithKline(GlaxoSmithKline); Cancer Research and Prevention Institute of Texas	Support for this research has been provided by GlaxoSmithKline (employer of MR, GG, HVDK, AGG and RK); and Cancer Research and Prevention Institute of Texas (Grant Number RP110040) (LAD).	Barone G, 2014, CURR DRUG TARGETS, V15, P114, DOI 10.2174/13894501113149990194; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Belova GI, 2005, CANCER BIOL THER, V4, P1154, DOI 10.4161/cbt.4.10.2204; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Carr-Wilkinson J, 2010, CLIN CANCER RES, V16, P1108, DOI 10.1158/1078-0432.CCR-09-1865; Castellino RC, 2008, J NEURO-ONCOL, V86, P245, DOI 10.1007/s11060-007-9470-8; CASTRESANA JS, 1994, GENE CHROMOSOME CANC, V10, P136, DOI 10.1002/gcc.2870100209; Chen ZW, 2009, NEOPLASIA, V11, P753, DOI 10.1593/neo.09466; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Demidov ON, 2007, CELL STEM CELL, V1, P180, DOI 10.1016/j.stem.2007.05.020; Ehrbrecht A, 2006, J PATHOL, V208, P554, DOI 10.1002/path.1925; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fuku T, 2007, PATHOL INT, V57, P566, DOI 10.1111/j.1440-1827.2007.02140.x; Gilmartin AG, 2014, NAT CHEM BIOL, V10, P181, DOI [10.1038/NCHEMBIO.1427, 10.1038/nchembio.1427]; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; IMAMURA J, 1993, CANCER RES, V53, P4053; Kim E, 2009, JNCI-J NATL CANCER I, V101, P1527, DOI 10.1093/jnci/djp376; Kleiblova P, 2013, J CELL BIOL, V201, P511, DOI 10.1083/jcb.201210031; Le Guezennec X, 2010, TRENDS BIOCHEM SCI, V35, P109, DOI 10.1016/j.tibs.2009.09.005; Lee JS, 2009, STEM CELLS, V27, P1963, DOI 10.1002/stem.121; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; Loukopoulos P, 2007, CANCER SCI, V98, P392, DOI 10.1111/j.1349-7006.2007.00395.x; Lu XB, 2005, CELL CYCLE, V4, P1060; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Lu XB, 2008, CELL CYCLE, V7, P164, DOI 10.4161/cc.7.2.5299; Medrano S, 2009, NEUROBIOL AGING, V30, P483, DOI 10.1016/j.neurobiolaging.2007.07.016; Mendrzyk F, 2005, J CLIN ONCOL, V23, P8853, DOI 10.1200/JCO.2005.02.8589; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Moon SH, 2010, CELL CYCLE, V9, P2092, DOI 10.4161/cc.9.11.11810; Moon SH, 2010, J BIOL CHEM, V285, P12935, DOI 10.1074/jbc.M109.071696; Nannenga B, 2006, MOL CARCINOGEN, V45, P594, DOI 10.1002/mc.20195; Rauta J, 2006, BREAST CANCER RES TR, V95, P257, DOI 10.1007/s10549-005-9017-7; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Saito-Ohara F, 2003, CANCER RES, V63, P1876; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shohet JM, 2011, CANCER RES, V71, P3841, DOI 10.1158/0008-5472.CAN-10-4391; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan DSP, 2009, CLIN CANCER RES, V15, P2269, DOI 10.1158/1078-0432.CCR-08-2403; Van Maerken T, 2009, CELL DEATH DIFFER, V16, P1563, DOI 10.1038/cdd.2009.138; Van Maerken T, 2011, MOL CANCER THER, V10, P983, DOI 10.1158/1535-7163.MCT-10-1090; Van Maerken T, 2009, JNCI-J NATL CANCER I, V101, P1562, DOI 10.1093/jnci/djp355; VOGAN K, 1993, CANCER RES, V53, P5269; Yamaguchi H, 2005, BIOCHEMISTRY-US, V44, P5285, DOI 10.1021/bi0476634; Zhang LW, 2014, NAT GENET, V46, P726, DOI 10.1038/ng.2995; Zhu YH, 2009, STEM CELLS, V27, P1433, DOI 10.1002/stem.65; Zhu YH, 2014, J CLIN INVEST, V124, P3263, DOI 10.1172/JCI73015	50	52	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115635	10.1371/journal.pone.0115635	http://dx.doi.org/10.1371/journal.pone.0115635			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658463	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900027
J	Xu, YH; Li, ZR; Yin, Y; Lan, H; Wang, J; Zhao, J; Feng, J; Li, Y; Zhang, WZ				Xu, Yanhui; Li, Ziru; Yin, Yue; Lan, He; Wang, Jun; Zhao, Jing; Feng, Juan; Li, Yin; Zhang, Weizhen			Ghrelin Inhibits the Differentiation of T Helper 17 Cells through mTOR/STAT3 Signaling Pathway	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PROINFLAMMATORY CYTOKINE EXPRESSION; ROR-GAMMA; TH17 CELLS; MTOR; ACTIVATION; RECEPTOR; MICE; HOMEOSTASIS; PROMOTES	Enhanced activity of interleukin 17 (IL-17) producing T helper 17 (Th17) cells plays an important role in autoimmune and inflammatory diseases. Significant loss of body weight and appetite is associated with chronic inflammation and immune activation, suggesting the cross talk between immune and neuroendocrine systems. Ghrelin has been shown to regulate the organism immune function. However, the effects of ghrelin on the differentiation of Th17 cells remain elusive. In the present study, we observed the enhanced differentiation of Th17 cells in spleens of growth hormone secretagogue receptor 1a (GHSR1a)(-/-) mice. Treatment of ghrelin repressed Th17 cell differentiation in a time- and concentration-dependent manner. Phosphorylation of mammalian target of rapamycin (mTOR) and signal transducer and activator of transcription 3 (STAT3) was increased in the spleens of GHSR1a(-/-) mice. Activation of mTOR signaling by injection of Cre-expressiong adenovirus into tuberous sclerosis complex 1 (TSC1) (loxp/loxp) mice increased the differentiation of Th17 cells in spleen, which was associated with an increment in the phosphorylation of STAT3. Activation of mTOR signaling by leucine or overexpression of p70 ribosome protein subunit 6 kinase 1 (S6K1) activated mTOR signaling in isolated T cells, while reversed the ghrelin-induced inhibition of iTh17 cell differentiation. In conclusion, mTOR mediates the inhibitory effect of ghrelin on the differentiation of Th17 cells by interacting with STAT3.	[Xu, Yanhui; Li, Ziru; Yin, Yue; Lan, He; Wang, Jun; Zhao, Jing; Feng, Juan; Li, Yin; Zhang, Weizhen] Peking Univ, Dept Physiol & Pathophysiol, Key Lab Mol Cardiovasc Sci, Hlth Sci Ctr,Minist Educ, Beijing 100191, Peoples R China; [Zhang, Weizhen] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	Peking University; University of Michigan System; University of Michigan	Li, Y (corresponding author), Peking Univ, Dept Physiol & Pathophysiol, Key Lab Mol Cardiovasc Sci, Hlth Sci Ctr,Minist Educ, Beijing 100191, Peoples R China.	yinli@bjmu.edu.cn	zhang, weizhen/K-1484-2018; Li, Yin/P-9296-2016	zhang, weizhen/0000-0001-8791-2798; Li, Yin/0000-0002-4019-3391; Li, Ziru/0000-0002-2755-9299	National Natural Science Foundation of China [81170795, 81370962, 81390354, 81330010, 81030012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81170795, 81370962, 81390354, 81330010, and 81030012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Dart ML, 2010, CIRC RES, V107, P1106, DOI 10.1161/CIRCRESAHA.110.221069; Delgoffe GM, 2009, IMMUNOLOGY, V127, P459, DOI 10.1111/j.1365-2567.2009.03125.x; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Dixit VD, 2009, BLOOD, V113, P5202, DOI 10.1182/blood-2008-09-181255; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Gao Q, 2010, J IMMUNOL, V185, P5820, DOI 10.4049/jimmunol.1000116; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Gonzalez-Rey E, 2006, GASTROENTEROLOGY, V130, P1707, DOI 10.1053/j.gastro.2006.01.041; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hattori N, 2009, GROWTH HORM IGF RES, V19, P187, DOI 10.1016/j.ghir.2008.12.001; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kopf H, 2007, INT IMMUNOPHARMACOL, V7, P1819, DOI 10.1016/j.intimp.2007.08.027; Li ZR, 2013, PROG MOL BIOL TRANSL, V114, P45, DOI 10.1016/B978-0-12-386933-3.00002-9; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Pernis AB, 2009, J INTERN MED, V265, P644, DOI 10.1111/j.1365-2796.2009.02099.x; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Smith RG, 2005, TRENDS ENDOCRIN MET, V16, P436, DOI 10.1016/j.tem.2005.09.004; Souza-Moreira L, 2013, BRAIN BEHAV IMMUN, V30, P54, DOI 10.1016/j.bbi.2013.01.080; Theil MM, 2009, J IMMUNOL, V183, P2859, DOI 10.4049/jimmunol.0803362; Xia Q, 2004, REGUL PEPTIDES, V122, P173, DOI 10.1016/j.regpep.2004.06.016; Xu XJ, 2012, SEMIN IMMUNOL, V24, P429, DOI 10.1016/j.smim.2012.12.005; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang HW, 2013, INT J MOL MED, V32, P851, DOI 10.3892/ijmm.2013.1452; Zhang WZ, 2013, EXP PHYSIOL, V98, P1696, DOI 10.1113/expphysiol.2013.074930; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou Z, 2012, PPAR RES, V2012, DOI [10.1155/2012/145654, DOI 10.1155/2012/145654]; Zhu JH, 2014, PEPTIDES, V52, P23, DOI 10.1016/j.peptides.2013.11.015	30	31	35	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117081	10.1371/journal.pone.0117081	http://dx.doi.org/10.1371/journal.pone.0117081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658305	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900098
J	Zheng, XQ; Gao, Y; Zhang, Q; Liu, YQ; Peng, Y; Fu, M; Ji, YH				Zheng, Xiaoqun; Gao, Yan; Zhang, Qi; Liu, Yanqing; Peng, Ying; Fu, Miao; Ji, Yanhong			Identification of Transcription Factor AML-1 Binding Site Upstream of Human Cytomegalovirus UL111A Gene	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; LATENT HUMAN CYTOMEGALOVIRUS; IMMEDIATE-EARLY PROMOTER; HISTONE MODIFICATIONS; HUMAN INTERLEUKIN-10; DENDRITIC CELLS; EXPRESSION; INFECTION; HOMOLOG; DIFFERENTIATION	Human cytomegalovirus (HCMV) interleukin-10 (hcmvIL-10), encoded by HCMV UL111A gene, is a homolog of human IL-10. It exerts immunomodulatory effects that allow HCMV to evade host defense mechanisms. However, the exact mechanism underlying the regulation of hcmvIL-10 expression is not well understood. The transcription factor acute myeloid leukemia 1 (AML-1) plays an important role in the regulation of various genes involved in the differentiation of hematopoietic lineages. A putative AML-1 binding site is present within the upstream regulatory region (URR) of UL111A gene. To provide evidence that AML-1 is involved in regulating UL111A gene expression, we examined the interaction of AML-1 with the URR of UL111A in HCMV-infected human monocytic THP-1 cells using a chromatin immunoprecipitation assay. HcmvIL-10 transcription was detected in differentiated THP-1 cells, but not in undifferentiated ones. Furthermore, the URR of UL111A showed a higher intensity of AML-1 binding, a higher level of histone H3 acetyl-K9, but a lower level of histone H3 dimethyl-K9 in differentiated THP-1 cells than undifferentiated cells. Down-regulation of AML1 by RNA interference decreased the expression of the UL111A gene. Our results suggest that AML-1 may contribute to the epigenetic regulation of UL111A gene via histone modification in HCMV-infected differentiated THP-1 cells. This finding could be useful for the development of new anti-viral therapies.	[Zheng, Xiaoqun; Ji, Yanhong] Xi An Jiao Tong Univ, Sch Med, Dept Immunol & Pathogen Biol, Xian 710049, Shaanxi, Peoples R China; [Zheng, Xiaoqun; Zhang, Qi; Liu, Yanqing] Wenzhou Med Univ, Affiliated Hosp 2, Dept Lab Med, Wenzhou, Zhejiang, Peoples R China; [Zheng, Xiaoqun; Zhang, Qi; Liu, Yanqing] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China; [Zheng, Xiaoqun; Zhang, Qi; Liu, Yanqing; Peng, Ying] Wenzhou Med Univ, Sch Lab Med, Wenzhou, Zhejiang, Peoples R China; [Zheng, Xiaoqun; Zhang, Qi; Liu, Yanqing; Peng, Ying] Educ Minist China, Key Lab Lab Med, Wenzhou, Zhejiang, Peoples R China; [Gao, Yan] First Peoples Hosp Changde, Changde, Hunan, Peoples R China; [Fu, Miao] Jinhua Municipal Cent Hosp, Jinhua, Zhejiang, Peoples R China	Xi'an Jiaotong University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Ji, YH (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Immunol & Pathogen Biol, Xian 710049, Shaanxi, Peoples R China.	jiyanhong@mail.xjtu.edu.cn	peng, ye/GXZ-9245-2022	Liu, Yanqing/0000-0003-4033-4016	Chinese National Science Foundation Grant (NSFC) [81071365]; Zhejiang Provincial Natural Science Foundation Grant (ZJSFC) [LY13H190006]	Chinese National Science Foundation Grant (NSFC); Zhejiang Provincial Natural Science Foundation Grant (ZJSFC)	This study was supported by Chinese National Science Foundation Grant (NSFC) 81071365 (URL:http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list), and Zhejiang Provincial Natural Science Foundation Grant (ZJSFC) LY13H190006 (URL:http://www.zjnsf.gov.cn/1/xm/lx.aspx). Xiao-Qun Zheng received those two grants, and designed the project. In addition, both NSFC and ZJSFC also contributed to design this project.	Alazard N, 2003, J VIROL, V77, P8166, DOI 10.1128/JVI.77.14.8166-8172.2003; Avdic S, 2013, J VIROL, V87, P10273, DOI 10.1128/JVI.00912-13; Bain M, 2003, J GEN VIROL, V84, P41, DOI 10.1099/vir.0.18633-0; Boomker JM, 2006, VIRUS RES, V118, P196, DOI 10.1016/j.virusres.2005.12.011; Chang LK, 2000, NUCLEIC ACIDS RES, V28, P3918, DOI 10.1093/nar/28.20.3918; Chang WLW, 2004, J VIROL, V78, P8720, DOI 10.1128/JVI.78.16.8720-8731.2004; Chao SH, 2004, J BIOL CHEM, V279, P16111, DOI 10.1074/jbc.M312304200; Cheung AKL, 2009, BLOOD, V114, P4128, DOI 10.1182/blood-2008-12-197111; de la Hoz RE, 2002, J CLIN VIROL, V25, pS1, DOI 10.1016/S1386-6532(02)00091-4; Duan YL, 2014, J VIROL, V88, P3861, DOI 10.1128/JVI.01166-13; Friedman AD, 2007, BLOOD CELL MOL DIS, V39, P340, DOI 10.1016/j.bcmd.2007.06.010; Goodrum FD, 2002, P NATL ACAD SCI USA, V99, P16255, DOI 10.1073/pnas.252630899; Ioudinkova E, 2006, GENE, V384, P120, DOI 10.1016/j.gene.2006.07.021; Jenkins C, 2008, J VIROL, V82, P3736, DOI 10.1128/JVI.02173-07; Jenkins C, 2004, J VIROL, V78, P1440, DOI 10.1128/JVI.78.3.1440-1447.2004; Jenkins C, 2008, VIROLOGY, V370, P285, DOI 10.1016/j.virol.2007.09.002; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Kubat NJ, 2004, J VIROL, V78, P1139, DOI 10.1128/JVI.78.3.1139-1149.2004; Kumano K, 2010, J CELL PHYSIOL, V222, P282, DOI 10.1002/jcp.21953; Lockridge KM, 2000, VIROLOGY, V268, P272, DOI 10.1006/viro.2000.0195; Mao ZQ, 2007, ARCH VIROL, V152, P115, DOI 10.1007/s00705-006-0826-8; Meier JL, 2001, J VIROL, V75, P1581, DOI 10.1128/JVI.75.4.1581-1593.2001; Miller G, 1997, J VIROL, V71, P314, DOI 10.1128/JVI.71.1.314-324.1997; Murphy E, 2003, P NATL ACAD SCI USA, V100, P13585, DOI 10.1073/pnas.1735466100; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Paradowska E, 2012, EUR J CLIN MICROBIOL, V31, P1335, DOI 10.1007/s10096-011-1447-z; Penkert RR, 2013, MBIO, V4, DOI 10.1128/mBio.00298-13; Pleskoff O, 2005, FEBS J, V272, P4163, DOI 10.1111/j.1742-4658.2005.04829.x; Raftery MJ, 2004, J IMMUNOL, V173, P3383, DOI 10.4049/jimmunol.173.5.3383; Rawlinson William, 2003, Aust Fam Physician, V32, P789; Reeves MB, 2010, J GEN VIROL, V91, P599, DOI 10.1099/vir.0.015602-0; Retiere C, 2000, J VIROL, V74, P3948, DOI 10.1128/JVI.74.9.3948-3952.2000; Sanchez V, 2012, VIROLOGY, V433, P64, DOI 10.1016/j.virol.2012.07.015; Sarid R, 1998, J VIROL, V72, P1005, DOI 10.1128/JVI.72.2.1005-1012.1998; Sinclair J, 2008, J CLIN VIROL, V41, P180, DOI 10.1016/j.jcv.2007.11.014; Smith MS, 2004, J VIROL, V78, P4444, DOI 10.1128/JVI.78.9.4444-4453.2004; Soderberg-Naucler C, 2001, J VIROL, V75, P7543, DOI 10.1128/JVI.75.16.7543-7554.2001; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Tabi Z, 2001, J IMMUNOL, V166, P5695, DOI 10.4049/jimmunol.166.9.5695; Valledor AF, 1998, J LEUKOCYTE BIOL, V63, P405, DOI 10.1002/jlb.63.4.405; Vancikova Z., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P179; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Yurochko AD, 1999, J IMMUNOL, V162, P4806	45	102	104	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117773	10.1371/journal.pone.0117773	http://dx.doi.org/10.1371/journal.pone.0117773			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658598	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900217
J	Grabowski, K; Riemenschneider, M; Schulte, L; Witten, A; Schulz, A; Stoll, M; Kreutz, R				Grabowski, Katja; Riemenschneider, Mona; Schulte, Leonard; Witten, Anika; Schulz, Angela; Stoll, Monika; Kreutz, Reinhold			Fetal-Adult Cardiac Transcriptome Analysis in Rats with Contrasting Left Ventricular Mass Reveals New Candidates for Cardiac Hypertrophy	PLOS ONE			English	Article							SOLUBLE EPOXIDE HYDROLASE; HYPERTENSIVE HEART-DISEASE; GENE-EXPRESSION PROFILES; FAILURE; MECHANISMS; MICROARRAY; PROGRAM; PROGRESSION; FIBROBLASTS; INHIBITORS	Reactivation of fetal gene expression patterns has been implicated in common cardiac diseases in adult life including left ventricular (LV) hypertrophy (LVH) in arterial hypertension. Thus, increased wall stress and neurohumoral activation are discussed to induce the return to expression of fetal genes after birth in LVH. We therefore aimed to identify novel potential candidates for LVH by analyzing fetal-adult cardiac gene expression in a genetic rat model of hypertension, i.e. the stroke-prone spontaneously hypertensive rat (SHRSP). To this end we performed genome-wide transcriptome analysis in SHRSP to identify differences in expression patterns between day 20 of fetal development (E20) and adult animals in week 14 in comparison to a normotensive rat strain with contrasting low LV mass, i. e. Fischer (F344). 15232 probes were detected as expressed in LV tissue obtained from rats at E20 and week 14 (p < 0.05) and subsequently screened for differential expression. We identified 24 genes with SHRSP specific up-regulation and 21 genes with down-regulation as compared to F344. Further bioinformatic analysis presented Efcab6 as a new candidate for LVH that showed only in the hypertensive SHRSP rat differential expression during development (logFC = 2.41, p < 0.001) and was significantly higher expressed in adult SHRSP rats compared with adult F344 (+ 76%) and adult normotensive Wistar-Kyoto rats (+ 82%). Thus, it represents an interesting new target for further functional analyses and the elucidation of mechanisms leading to LVH. Here we report a new approach to identify candidate genes for cardiac hypertrophy by combining the analysis of gene expression differences between strains with a contrasting cardiac phenotype with a comparison of fetal-adult cardiac expression patterns.	[Grabowski, Katja; Schulte, Leonard; Schulz, Angela; Kreutz, Reinhold] Charite, Charite Ctr Therapieforsch, Dept Clin Pharmacol & Toxicol, D-13353 Berlin, Germany; [Riemenschneider, Mona; Witten, Anika; Stoll, Monika] Univ Munster, D-48149 Munster, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster	Grabowski, K (corresponding author), Charite, Charite Ctr Therapieforsch, Dept Clin Pharmacol & Toxicol, D-13353 Berlin, Germany.	katja.grabowski@charite.de	Witten, Anika/C-5297-2019; Kreutz, Reinhold/AEV-0507-2022	Kreutz, Reinhold/0000-0002-4818-211X; Schulz, Angela/0000-0002-4576-8035	Deutsche Forschungsgemeinschaft [KR1152/3-1]; Bundesministerium fur Bildung und Forschung; Nationales Genomforschungsnetzwerk (NGFN); Herzkreislaufnetz in NGFNplus in Germany [01GS0839]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Nationales Genomforschungsnetzwerk (NGFN); Herzkreislaufnetz in NGFNplus in Germany	This study was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/) grant KR1152/3-1 and Bundesministerium fur Bildung und Forschung (http://www.bmbf.de/), Nationales Genomforschungsnetzwerk (NGFN), Herzkreislaufnetz in NGFNplus (http://www.ngfn.de/de/ngfn_plus.html) Grant 01GS0839 in Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai D, 2009, P NATL ACAD SCI USA, V106, P564, DOI 10.1073/pnas.0811022106; Andersson KB, 2006, ACTA PHYSIOL, V186, P17, DOI 10.1111/j.1748-1716.2005.01503.x; Arnett DK, 2004, CURR HYPERTENS REP, V6, P36, DOI 10.1007/s11906-004-0009-5; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asp J, 2012, PHYSIOL GENOMICS, V44, P89, DOI 10.1152/physiolgenomics.00137.2011; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Bella JN, 2012, AM J CARDIOVASC DIS, V2, P267; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Boerma M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-6; Burchfield JS, 2013, CIRCULATION, V128, P388, DOI 10.1161/CIRCULATIONAHA.113.001878; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Fujiu K, 2014, J MOL CELL CARDIOL, V70, P64, DOI 10.1016/j.yjmcc.2014.01.013; Grabowski K, 2013, PHYSIOL GENOMICS, V45, P827, DOI 10.1152/physiolgenomics.00067.2013; Hacker TA, 2006, AM J PHYSIOL-HEART C, V290, pH304, DOI 10.1152/ajpheart.00290.2005; Heineke J, 2010, NAT MED, V16, P872, DOI 10.1038/nm.2181; Houweling AC, 2005, CARDIOVASC RES, V67, P583, DOI 10.1016/j.cardiores.2005.06.013; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kuwahara K, 2012, J PHARMACOL SCI, V119, P198, DOI 10.1254/jphs.12R04CP; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; Marques FZ, 2010, HYPERTENSION, V56, P319, DOI 10.1161/HYPERTENSIONAHA.110.155366; Monti J, 2008, NAT GENET, V40, P529, DOI 10.1038/ng.129; Niki T, 2003, MOL CANCER RES, V1, P247; Pu Q, 2001, AM J HYPERTENS, V14, P1067, DOI 10.1016/S0895-7061(01)02157-4; Qiu H, 2011, CARDIOVASC THER, V29, P99, DOI 10.1111/j.1755-5922.2010.00150.x; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Rebelo RMD, 2012, J PHYSIOL-LONDON, V590, P5389, DOI 10.1113/jphysiol.2012.241141; Rothermund L, 2000, BRIT J PHARMACOL, V130, P205, DOI 10.1038/sj.bjp.0703320; Rothermund L, 2001, HYPERTENSION, V37, P275, DOI 10.1161/01.HYP.37.2.275; Ruilope LM, 2008, AM J HYPERTENS, V21, P500, DOI 10.1038/ajh.2008.16; Rysa J, 2005, HYPERTENSION, V45, P927, DOI 10.1161/01.HYP.0000161873.27088.4c; Schulz A, 2002, J AM SOC NEPHROL, V13, P2706, DOI 10.1097/01.ASN.0000031803.55613.86; Sebkhi A, 1999, HYPERTENSION, V33, P949, DOI 10.1161/01.HYP.33.4.949; Siegel AK, 2003, ARTERIOSCL THROM VAS, V23, P1211, DOI 10.1161/01.ATV.0000079509.20542.C9; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Susic D, 2000, Curr Hypertens Rep, V2, P565, DOI 10.1007/s11906-996-0042-7; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Tan SC, 2012, MOL BIOL REP, V39, P4857, DOI 10.1007/s11033-011-1281-5; TANASE H, 1982, HYPERTENSION, V4, P864, DOI 10.1161/01.HYP.4.6.864; van den Hoff MJB, 2006, J HYPERTENS, V24, P273, DOI 10.1097/01.hjh.0000200520.93190.7d; Wadley GD, 2013, PHYSIOL GENOMICS, V45, P99, DOI 10.1152/physiolgenomics.00095.2012; Wang W, 2013, NAT MED, V19, P305, DOI 10.1038/nm.3079; Zhang P, 2012, AM J PHYSIOL-HEART C, V303, pH1385, DOI 10.1152/ajpheart.01167.2011; Zhao TT, 2012, INT J CARDIOL, V155, P181, DOI 10.1016/j.ijcard.2011.05.067; Zhao XS, 2002, PHYSIOL GENOMICS, V12, P53, DOI 10.1152/physiolgenomics.00086.2002	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116807	10.1371/journal.pone.0116807	http://dx.doi.org/10.1371/journal.pone.0116807			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646840	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600037
J	Liu, BL; Zhu, YC; Zhang, TZ				Liu, Bingliang; Zhu, Yichao; Zhang, Tianzhen			The R3-MYB Gene GhCPC Negatively Regulates Cotton Fiber Elongation	PLOS ONE			English	Article							EPIDERMAL-CELL DIFFERENTIATION; MYB TRANSCRIPTION FACTORS; TRICHOME DEVELOPMENT; ARABIDOPSIS; CAPRICE; INITIATION; PROTEINS; TRIPTYCHON; ENCODES; BINDING	Cotton (Gossypium spp.) fibers are single-cell trichomes that arise from the outer epidermal layer of seed coat. Here, we isolated a R3-MYB gene GhCPC, identified by cDNA microarray analysis. The only conserved R3 motif and different expression between TM-1 and fuzzless-lintless mutants suggested that it might be a negative regulator in fiber development. Transgenic evidence showed that GhCPC overexpression not only delayed fiber initiation but also led to significant decreases in fiber length. Interestingly, Yeast two-hybrid analysis revealed an interaction complex, in which GhCPC and GhTTG1/4 separately interacted with GhMYC1. In transgenic plants, Q-PCR analysis showed that GhHOX3 (GL2) and GhRDL1 were significantly down regulated in -1-5 DPA ovules and fibers. In addition, Yeast one-hybrid analysis demonstrated that GhMYC1 could bind to the E-box cis-elements and the promoter of GhHOX3. These results suggested that GhHOX3 (GL2) might be downstream gene of the regulatory complex. Also, overexpression of GhCPC in tobacco led to differential loss of pigmentation. Taken together, the results suggested that GhCPC might negatively regulate cotton fiber initiation and early elongation by a potential CPC-MYC1-TTG1/4 complex. Although the fibers were shorter in transgenic cotton lines than in the wild type, no significant difference was detected in stem or leaf trichomes, even in cotton mutants (five naked seed or fuzzless), suggesting that fiber and trichome development might be regulated by two sets of genes sharing a similar model.	[Liu, Bingliang; Zhu, Yichao; Zhang, Tianzhen] Nanjing Agr Univ, Cotton Hybrid R&D Engn Ctr, Natl Key Lab Crop Genet & Germplasm Enhancement, Minist Educ, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhang, TZ (corresponding author), Nanjing Agr Univ, Cotton Hybrid R&D Engn Ctr, Natl Key Lab Crop Genet & Germplasm Enhancement, Minist Educ, Nanjing, Jiangsu, Peoples R China.	cotton@njau.edu.cn			National Science Foundation of China [31330058]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was financially supported in part by grants from the National Science Foundation of China (31330058) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt C, 2003, DEVELOPMENT, V130, P6431, DOI 10.1242/dev.00880; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Chaudhary J, 1999, MOL ENDOCRINOL, V13, P774, DOI 10.1210/me.13.5.774; Deng FL, 2012, PLANT PHYSIOL, V158, P890, DOI 10.1104/pp.111.186742; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Esch JJ, 2003, DEVELOPMENT, V130, P5885, DOI 10.1242/dev.00812; Hong GJ, 2012, PLANT CELL, V24, P2635, DOI 10.1105/tpc.112.098749; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; Ishida T, 2007, PLANT CELL, V19, P2531, DOI 10.1105/tpc.107.052274; [蒋建雄 Jiang Jianxiong], 2003, [棉花学报, Cotton Science], V15, P166; Jiang YJ, 2012, PLANT BIOTECHNOL J, V10, P301, DOI 10.1111/j.1467-7652.2011.00662.x; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kirik V, 2004, PLANT MOL BIOL, V55, P389, DOI 10.1007/s11103-004-0893-8; Kirik V, 2004, DEV BIOL, V268, P506, DOI 10.1016/j.ydbio.2003.12.037; Koshino-Kimura Y, 2005, PLANT CELL PHYSIOL, V46, P817, DOI 10.1093/pcp/pci096; Li FF, 2009, PLANT CELL TISS ORG, V97, P225, DOI 10.1007/s11240-009-9521-2; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Machado A, 2009, PLANT J, V59, P52, DOI 10.1111/j.1365-313X.2009.03847.x; Morohashi K, 2007, PLANT PHYSIOL, V145, P736, DOI 10.1104/pp.107.104521; OGATA K, 1992, P NATL ACAD SCI USA, V89, P6428, DOI 10.1073/pnas.89.14.6428; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Payne CT, 2000, GENETICS, V156, P1349; RERIE WG, 1994, GENE DEV, V8, P1388, DOI 10.1101/gad.8.12.1388; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; Schnittger A, 1999, PLANT CELL, V11, P1105, DOI 10.1105/tpc.11.6.1105; Serna L, 2006, TRENDS PLANT SCI, V11, P274, DOI 10.1016/j.tplants.2006.04.008; Shan CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6519; Szymanski DB, 2000, TRENDS PLANT SCI, V5, P214, DOI 10.1016/S1360-1385(00)01597-1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tominaga R, 2007, PLANT CELL, V19, P2264, DOI 10.1105/tpc.106.045732; Uhrig JF, 2006, PLANTA, V224, P771, DOI 10.1007/s00425-006-0260-x; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Wada T, 2002, DEVELOPMENT, V129, P5409, DOI 10.1242/dev.00111; Walford SA, 2012, PLANT J, V71, P464, DOI 10.1111/j.1365-313X.2012.05003.x; Walford SA, 2011, PLANT J, V65, P785, DOI 10.1111/j.1365-313X.2010.04464.x; Walker AR, 1999, PLANT CELL, V11, P1337, DOI 10.1105/tpc.11.7.1337; Wang S, 2004, PLANT CELL, V16, P2323, DOI 10.1105/tpc.104.024844; Wang SC, 2007, DEVELOPMENT, V134, P3873, DOI 10.1242/dev.009597; Wu YR, 2006, PLANT CELL PHYSIOL, V47, P107, DOI 10.1093/pcp/pci228; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhang F, 2010, J EXP BOT, V61, P3599, DOI 10.1093/jxb/erq173; Zhang W, 2009, BIOCHEM BIOPH RES CO, V388, P742, DOI 10.1016/j.bbrc.2009.08.092; Zhao M, 2008, DEVELOPMENT, V135, P1991, DOI 10.1242/dev.016873; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	46	30	31	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116272	10.1371/journal.pone.0116272	http://dx.doi.org/10.1371/journal.pone.0116272			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646816	gold, Green Submitted, Green Published			2022-12-27	WOS:000348822600024
J	Aguiar, RWS; dos Santos, SF; Morgado, FD; Ascencio, SD; Lopes, MD; Viana, KF; Didonet, J; Ribeiro, BM				Souza Aguiar, Raimundo Wagner; dos Santos, Suetonio Fernandes; Morgado, Fabricio da Silva; Ascencio, Sergio Donizeti; Lopes, Magnolia de Mendonca; Viana, Kelvinson Fernandes; Didonet, Julcemar; Ribeiro, Bergmann Morais			Insecticidal and Repellent Activity of Siparuna guianensis Aubl. (Negramina) against Aedes aegypti and Culex quinquefasciatus	PLOS ONE			English	Article							PLANT ESSENTIAL OILS; LARVICIDAL ACTIVITY; L. DIPTERA; TOXICITY; EXTRACT; LEAVES; ADULTS	This study investigated the toxic effects of essential oils isolated from Siparuna guianensis against Aedes aegypti, Culex quinquefasciatus (eggs, larvae, pupae, and adult) and Aedes albopictus (C6/36) cells. The oviposition-deterring activity, egg viability, and repellence activity in the presence of different essential oils concentrations were determined. The essential oils showed high toxicity to all developmental stages of A. aegypti and C. quinquefasciatus. Furthermore, the oils also showed high repellent activity towards the adult stage of mosquitoes (0.025 to 0.550 mu g/cm2 skin conferred 100% repellence up to 120 min) and in contact with cultured insect cells (C6/36) induced death possibly by necrosis. The results presented in this work show the potential of S. guianensis essential oils for the development of an alternative and effective method for the natural control of mosquitoes in homes and urban areas.	[Souza Aguiar, Raimundo Wagner; dos Santos, Suetonio Fernandes; Lopes, Magnolia de Mendonca; Viana, Kelvinson Fernandes; Didonet, Julcemar] Univ Fed Tocantins, Dept Biotecnol, Gurupi, Tocantins, Brazil; [Ascencio, Sergio Donizeti] Univ Fed Tocantins, Gurupi, Tocantins, Brazil; [Morgado, Fabricio da Silva; Ribeiro, Bergmann Morais] Univ Brasilia, Dept Biol Celular, Brasilia, DF, Brazil	Universidade Federal do Tocantins (UFT); Universidade Federal do Tocantins (UFT); Universidade de Brasilia	Aguiar, RWS (corresponding author), Univ Fed Tocantins, Dept Biotecnol, Campus Univ Gurupi, Gurupi, Tocantins, Brazil.	rwsa@uft.edu.br	Viana, Kelvinson/Y-4325-2019; Ribeiro, Bergmann Morais/C-7114-2015; Aguiar, Raimundo Wagner/ABC-9785-2021	Ribeiro, Bergmann Morais/0000-0002-1061-196X; da Silva Morgado, Fabricio/0000-0002-4612-5613	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); SECT (Secretaria de Ciencia Tecnologia do estado do Tocantins); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); SECT (Secretaria de Ciencia Tecnologia do estado do Tocantins); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), www.cnpq.br, SECT (Secretaria de Ciencia Tecnologia do estado do Tocantins), http://www.sedecti.to.gov.br/sedecti/, and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), www.capes.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Aguiar RWD, 2014, SCI WORLD J, DOI 10.1155/2014/492138; Amorim LB, 2013, PEST MANAG SCI, V69, P1307, DOI 10.1002/ps.3502; Andrade MA, 2013, ANTIOXIDANTS-BASEL, V2, P384, DOI 10.3390/antiox2040384; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P377; Autran ES, 2009, BIORESOURCE TECHNOL, V100, P2284, DOI 10.1016/j.biortech.2008.10.055; Bianco EM, 2013, IND CROP PROD, V43, P270, DOI 10.1016/j.indcrop.2012.07.032; Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410; Cheng SS, 2003, BIORESOURCE TECHNOL, V89, P99, DOI 10.1016/S0960-8524(03)00008-7; Conti B, 2012, PARASITOL RES, V110, P2013, DOI 10.1007/s00436-011-2730-8; Coria C, 2008, BIORESOURCE TECHNOL, V99, P3066, DOI 10.1016/j.biortech.2007.06.012; Macoris MDD, 2007, MEM I OSWALDO CRUZ, V102, P895, DOI 10.1590/S0074-02762007000800001; Diniz JA, 2014, THESIS U FEDERAL VIC; Ferrari James A., 1996, P512; Ferreira DF, 2001, SISTEMA ANALISES VAR; Finney D.L., 1971, PROBIT ANAL; Fischer DCH, 2005, J ESSENT OIL RES, V17, P101, DOI 10.1080/10412905.2005.9698844; Govindarajan M, 2011, PARASITOL RES, V109, P93, DOI 10.1007/s00436-010-2224-0; Grenand P., 2004, PHARMACOPEES TRADITI, P816; Kabir KE, 2013, ECOTOX ENVIRON SAFE, V90, P52, DOI 10.1016/j.ecoenv.2012.12.028; Kennedy GG, 2003, ANNU REV ENTOMOL, V48, P51, DOI 10.1146/annurev.ento.48.091801.112733; Kiran SR, 2006, BIORESOURCE TECHNOL, V97, P2481, DOI 10.1016/j.biortech.2005.10.003; Leyva Maureen, 2009, Rev Cubana Med Trop, V61, P239; Lucia A, 2009, BIORESOURCE TECHNOL, V100, P6083, DOI 10.1016/j.biortech.2009.02.075; MULLA MS, 1974, J ECON ENTOMOL, V67, P165, DOI 10.1093/jee/67.2.165; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007; Rajkumar S., 2008, Canadian Journal of Pure & Applied Sciences, V2, P129; Renner SS, 2005, MONOGRAPH SIPARUNACE, V95, P256, DOI [10.1016/j.talanta.2005.07.013, DOI 10.1016/J.TALANTA.2005.07.013]; Roe RM, 2004, METHOD REPELLING INS, Patent No. 20040242703; Senthilkumar A, 2013, PARASITOL RES, V112, P1337, DOI 10.1007/s00436-012-3188-z; Senthilkumar A., 2012, Asian Pacific Journal of Tropical Disease, V2, P324; Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048; Valentini C.M.A, 2010, Rev. bras. plantas med., V12, P96, DOI 10.1590/S1516-05722010000100014; Venkatachalam MR, 2001, BIORESOURCE TECHNOL, V76, P287, DOI 10.1016/S0960-8524(00)00096-1; World Health Organization, 2009, REP WHO INF CONS EV, P69, DOI [DOI 10.1016/J.JACL.2009.12.003, 10.1016/j.jacl.2009.12.003]; Yeom HJ, 2013, PESTIC BIOCHEM PHYS, V107, P200, DOI 10.1016/j.pestbp.2013.07.003; Zoghbi M. das G. B., 1998, Journal of Essential Oil Research, V10, P543	38	46	51	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116765	10.1371/journal.pone.0116765	http://dx.doi.org/10.1371/journal.pone.0116765			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646797	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600035
J	Kim, NKD; Higashi, T; Lee, KY; Kim, AR; Kitajiri, S; Kim, MY; Chang, MY; Kim, V; Oh, SH; Kim, D; Furuse, M; Park, WY; Choi, BY				Kim, Nayoung K. D.; Higashi, Tomohito; Lee, Kyoung Yeul; Kim, Ah Reum; Kitajiri, Shin-ichiro; Kim, Min Young; Chang, Mun Young; Kim, Veronica; Oh, Seung-Ha; Kim, Dongsup; Furuse, Mikio; Park, Woong-Yang; Choi, Byung Yoon			Downsloping High-Frequency Hearing Loss Due to Inner Ear Tricellular Tight Junction Disruption by a Novel ILDR1 Mutation in the Ig-Like Domain	PLOS ONE			English	Article							AUTOSOMAL RECESSIVE DEAFNESS; PROTEIN; IMPAIRMENT; BARRIER; PERMEABILITY; OCCLUDIN; CELLS; SMPX	The immunoglobulin (Ig)-like domain containing receptor 1 (ILDR1) gene encodes angulin-2/ILDR1, a recently discovered tight junction protein, which forms tricellular tight junction (tTJ) structures with tricellulin and lipolysis-stimulated lipoprotein receptor (LSR) at tricellular contacts (TCs) in the inner ear. Previously reported recessive mutations within ILDR1 have been shown to cause severe to profound nonsyndromic sensorineural hearing loss (SNHL), DFNB42. Whole-exome sequencing of a Korean multiplex family segregating partial deafness identified a novel homozygous ILDR1 variant (p.P69H) within the Ig-like domain. To address the pathogenicity of p. P69H, the angulin-2/ILDR1 p.P69H variant protein, along with the previously reported pathogenic ILDR1 mutations, was expressed in angulin-1/LSR knockdown epithelial cells. Interestingly, partial mislocalization of the p.P69H variant protein and tricellulin at TCs was observed, in contrast to a severe mislocalization and complete failure of tricellulin recruitment of the other reported ILDR1 mutations. Additionally, three-dimensional protein modeling revealed that angulin-2/ILDR1 contributed to tTJ by forming a homo-trimer structure through its Ig-like domain, and the p.P69H variant was predicted to disturb homo-trimer formation. In this study, we propose a possible role of angulin-2/ILDR1 in tTJ formation in the inner ear and a wider audiologic phenotypic spectrum of DFNB42 caused by mutations within ILDR1.	[Kim, Nayoung K. D.; Park, Woong-Yang] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea; [Higashi, Tomohito; Furuse, Mikio] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Kobe, Hyogo 657, Japan; [Lee, Kyoung Yeul; Kim, Dongsup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kim, Ah Reum; Oh, Seung-Ha] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Seoul, South Korea; [Kitajiri, Shin-ichiro] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan; [Kim, Min Young; Choi, Byung Yoon] Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol, Songnam, South Korea; [Kim, Dongsup] Univ Toronto St George, Dept Cell & Syst Biol, Toronto, ON, Canada; [Park, Woong-Yang] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea	Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Kobe University; Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University Hospital; Kyoto University; Seoul National University (SNU); University of Toronto; Sungkyunkwan University (SKKU)	Park, WY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea.	woongyang.park@samsung.com; choiby@snubh.org	Higashi, Tomohito/AHE-7942-2022; Kim, Dongsup/C-1612-2011	Higashi, Tomohito/0000-0001-5616-1477; Park, Woong-Yang/0000-0003-4234-0380; Furuse, Mikio/0000-0003-2847-8156	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [HI11C13310000, A111377]; Seoul National University Bundang Hospital Research Fund [14-2014-033]; Korean Health Technology R&D Project, Ministry of health and Welfare, Republic of Korea [HI12C0014]; Funding Program for Next Generation World Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science [LS084]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea; Seoul National University Bundang Hospital Research Fund; Korean Health Technology R&D Project, Ministry of health and Welfare, Republic of Korea; Funding Program for Next Generation World Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science	This work was supported by the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea, Grant HI11C13310000 (previously A111377 to B. Y. Choi), the Seoul National University Bundang Hospital Research Fund 14-2014-033 (to B. Y. Choi), the Korean Health Technology R&D Project, Ministry of health and Welfare, Republic of Korea (HI12C0014) and the Funding Program for Next Generation World Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science initiated by the Council for Science and Technology Policy [Grand number LS084] (to M. Furuse). T. Higashi is a research fellow of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BonneTamir B, 1996, AM J HUM GENET, V58, P1254; Borck G, 2011, AM J HUM GENET, V88, P127, DOI 10.1016/j.ajhg.2010.12.011; Brozkova DS, 2012, CLIN GENET, V82, P579, DOI 10.1111/j.1399-0004.2011.01817.x; Chandra R, 2013, J CLIN INVEST, V123, P3343, DOI 10.1172/JCI68587; Chishti MS, 2008, J HUM GENET, V53, P101, DOI 10.1007/s10038-007-0209-3; Chung J, 2014, J MOL MED BERL; Diaz-Horta O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050628; FRIEND DS, 1972, J CELL BIOL, V53, P758, DOI 10.1083/jcb.53.3.758; Higashi T, 2013, J CELL SCI, V126, P966, DOI 10.1242/jcs.116442; Huebner AK, 2011, AM J HUM GENET, V88, P621, DOI 10.1016/j.ajhg.2011.04.007; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Ikenouchi J, 2008, MOL BIOL CELL, V19, P4687, DOI 10.1091/mbc.E08-05-0530; Krug SM, 2009, MOL BIOL CELL, V20, P3713, DOI 10.1091/mbc.E09-01-0080; Lee YJ, 2003, J MED GENET, V40, P629, DOI 10.1136/jmg.40.8.629; Mariano C, 2011, EUR J CELL BIOL, V90, P787, DOI 10.1016/j.ejcb.2011.06.005; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; MARTINEZPALOMO A, 1975, P NATL ACAD SCI USA, V72, P4487, DOI 10.1073/pnas.72.11.4487; Masuda S, 2011, J CELL SCI, V124, P548, DOI 10.1242/jcs.072058; Morozko EL, 2014, HUM MOL GENET; Nayak G, 2013, J CLIN INVEST, V123, P4036, DOI 10.1172/JCI69031; Raleigh DR, 2010, MOL BIOL CELL, V21, P1200, DOI 10.1091/mbc.E09-08-0734; Ramzan K, 2014, EUR J MED GENET; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022; Santos-Cortez RLP, 2013, AM J HUM GENET, V93, P132, DOI 10.1016/j.ajhg.2013.05.018; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Schraders M, 2011, AM J HUM GENET, V88, P628, DOI 10.1016/j.ajhg.2011.04.012; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Sirmaci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032000; STAEHELIN LA, 1973, J CELL SCI, V13, P763; Tekin M, 2013, J CLIN INVEST, V123, P2094, DOI 10.1172/JCI65853; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Yariz KO, 2012, AM J HUM GENET, V91, P872, DOI 10.1016/j.ajhg.2012.09.011	33	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0116931	10.1371/journal.pone.0116931	http://dx.doi.org/10.1371/journal.pone.0116931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668204	Green Published, Green Submitted, gold			2022-12-27	WOS:000349493000012
J	Nijmeijer, KJ; Fabbricotti, IN; Huijsman, R				Nijmeijer, Karlijn Jojanneke; Fabbricotti, Isabelle Natalina; Huijsman, Robbert			Creating Advantages with Franchising in Healthcare: An Explorative Mixed Methods Study on the Role of the Relationship between the Franchisor and Units	PLOS ONE			English	Article							SATISFACTION	Background Franchising is a promising and increasingly used organizational form to improve strategic, organizational, professional and client-related results in healthcare. However, evidence is scarce regarding how franchises should be operated to actualize such results. This paper aimed to explore the association between the results achieved by healthcare franchises and the working relationships among actors in these franchises. Methods A sequential mixed methods approach was used to obtain both in-depth and broader quantifiable insights into a little-investigated phenomenon. We first employed a qualitative multiple embedded case study. Data were collected through observations, document analyses, and 96 in-depth semi-structured interviews in three Dutch healthcare franchises. Withincase and cross-case comparative analyses were conducted. Subsequently, a crosssectional survey was developed based on the qualitative study and disseminated among 19 healthcare franchises. 40 franchisors and 346 unit actors filled in the questionnaire. Findings It seems important to have open, committed, cooperative franchise relationships in which professional franchisees and unit managers feel and trust that they have the opportunity to introduce ideas and articulate their needs to the franchisor. Such relationships help ensure satisfaction, survival, and quality of care, because they serve to foster synergy realization and local fit and prevent reinventing the wheel and professional resistance.	[Nijmeijer, Karlijn Jojanneke; Fabbricotti, Isabelle Natalina; Huijsman, Robbert] Erasmus Univ, Inst Hlth Policy & Management, NL-3000 DR Rotterdam, Netherlands; [Nijmeijer, Karlijn Jojanneke] Rotterdam Eye Hosp, NL-3000 LM Rotterdam, Netherlands	Erasmus University Rotterdam; Rotterdam Eye Hospital	Nijmeijer, KJ (corresponding author), Erasmus Univ, Inst Hlth Policy & Management, POB 1738, NL-3000 DR Rotterdam, Netherlands.	nijmeijer@bmg.eur.nl		Huijsman, Robbert/0000-0002-9776-129X				Agha S, 2007, HEALTH POLICY PLANN, V22, P320, DOI 10.1093/heapol/czm025; Baucus DA, 1996, J BUS VENTURING, V11, P359, DOI 10.1016/0883-9026(96)00055-9; Bordonaba-Juste V, 2008, J MARK CHANNELS, V15, P71, DOI 10.1080/10466690802081392; Bordonova-Juste M. V., 2004, INT REV RETAIL DISTR, V14, P101, DOI DOI 10.1080/0959396032000154329; Boselie P., 2005, Human Resource Management Journal, V15, P67, DOI 10.1111/j.1748-8583.2005.tb00154.x; CHRISTENSEN DB, 1977, J AM PHARM ASSOC, V17, P696, DOI 10.1016/S0003-0465(16)33231-1; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Creswell JW, 2011, BEST PRACTICES MIXED, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Doyle L, 2009, J RES NURS, V14, P175, DOI 10.1177/1744987108093962; Dubost Nathalie, 2008, International Journal of Entrepreneurship and Small Business, V6, P155, DOI 10.1504/IJESB.2008.017396; Elango B, 1997, J SMALL BUS MANAGE, V35, P68; Falbe CM, 1998, J BUS VENTURING, V13, P151, DOI 10.1016/S0883-9026(97)00068-2; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Rodriguez NG, 2005, J MARK CHANNELS, V13, P3, DOI 10.1300/J049v13n02_02; Geyskens I, 1999, J MARKETING RES, V36, P223, DOI 10.2307/3152095; HART S, 1994, STRATEGIC MANAGE J, V15, P251, DOI 10.1002/smj.4250150402; Hogan P, 2006, HOME HLTH CARE MAN P, V18, P138, DOI 10.1177/1084822305280986; Inma C., 2006, SINGAPORE MANAGEMENT, V28, P1; Kidwell RE, 2007, J BUS VENTURING, V22, P522, DOI 10.1016/j.jbusvent.2006.06.002; Knott AM, 2008, J SUBST ABUSE TREAT, V35, P99, DOI 10.1016/j.jsat.2007.09.005; Komoto K, 2005, JPN EC, V33, P119; Montagu D, 2002, HEALTH POLICY PLANN, V17, P121, DOI 10.1093/heapol/17.2.121; Nijmeijer KJ, 2014, HEALTH POLICY PLANN, V29, P164, DOI 10.1093/heapol/czt001; Nijmeijer KJ, 2014, INT J MANAG REV, V16, P62, DOI 10.1111/ijmr.12009; Prajogo D. I., 2003, International Journal of Quality Reliability Management, V20, P901, DOI 10.1108/02656710310493625; Schlein K, 2012, CLIN SOCIAL FRANCHIS, DOI [10.1016/j.asjsur.2012.06.010, DOI 10.1016/J.ASJSUR.2012.06.010]; Schul PL, 1987, J ACAD MARKET SCI, V15, P42; Sekaran U., 2002, RES METHODS BUSINESS; Watson A, 2010, J MARK CHANNELS, V17, P51, DOI 10.1080/10466690903436305; Yin R. K., 2011, APPL CASE STUDY RES	30	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0115829	10.1371/journal.pone.0115829	http://dx.doi.org/10.1371/journal.pone.0115829			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UO	25664581	gold, Green Published, Green Submitted			2022-12-27	WOS:000349123100006
J	Banlaki, Z; Elek, Z; Nanasi, T; Szekely, A; Nemoda, Z; Sasvari-Szekely, M; Ronai, Z				Banlaki, Zsofia; Elek, Zsuzsanna; Nanasi, Tibor; Szekely, Anna; Nemoda, Zsofia; Sasvari-Szekely, Maria; Ronai, Zsolt			Polymorphism in the Serotonin Receptor 2a (HTR2A) Gene as Possible Predisposal Factor for Aggressive Traits	PLOS ONE			English	Article							INTERMITTENT EXPLOSIVE DISORDER; ACUTE TRYPTOPHAN DEPLETION; DEFENSIVE RAGE BEHAVIOR; HUMAN ESTERASE D; PERSONALITY-TRAITS; PROACTIVE AGGRESSION; HAPLOTYPE RECONSTRUCTION; ENVIRONMENTAL-INFLUENCES; ANTIAGGRESSIVE RESPONSE; MEDIAL HYPOTHALAMUS	Aggressive manifestations and their consequences are a major issue of mankind, highlighting the need for understanding the contributory factors. Still, aggression-related genetic analyses have so far mainly been conducted on small population subsets such as individuals suffering from a certain psychiatric disorder or a narrow-range age cohort, but no data on the general population is yet available. In the present study, our aim was to identify polymorphisms in genes affecting neurobiological processes that might explain some of the inter-individual variation between aggression levels in the non-clinical Caucasian adult population. 55 single nucleotide polymorphisms (SNP) were simultaneously determined in 887 subjects who also filled out the self-report Buss-Perry Aggression Questionnaire (BPAQ). Single marker association analyses between genotypes and aggression scores indicated a significant role of rs7322347 located in the HTR2A gene encoding serotonin receptor 2a following Bonferroni correction for multiple testing (p = 0.0007) both for males and females. Taking the four BPAQ subscales individually, scores for Hostility, Anger and Physical Aggression showed significant association with rs7322347 T allele in themselves, while no association was found with Verbal Aggression. Of the subscales, relationship with rs7322347 was strongest in the case of Hostility, where statistical significance virtually equaled that observed with the whole BPAQ. In conclusion, this is the first study to our knowledge analyzing SNPs in a wide variety of genes in terms of aggression in a large sample-size non-clinical adult population, also describing a novel candidate polymorphism as predisposal to aggressive traits.	[Banlaki, Zsofia; Elek, Zsuzsanna; Nanasi, Tibor; Nemoda, Zsofia; Sasvari-Szekely, Maria; Ronai, Zsolt] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary; [Szekely, Anna] Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary	Semmelweis University; Eotvos Lorand University	Ronai, Z (corresponding author), Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary.	ronai.zsolt@med.semmelweis-univ.hu	Ronai, Zsolt/A-2473-2008	Ronai, Zsolt/0000-0002-0909-7932	NIH Fogarty International Research grant [R03 TW007656]; Hungarian Scientific Research Funds [OTKA K100845, K83766]; FOGARTY INTERNATIONAL CENTER [R03TW007656] Funding Source: NIH RePORTER	NIH Fogarty International Research grant; Hungarian Scientific Research Funds(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the NIH R03 TW007656 Fogarty International Research grant to Maria Sasvari-Szekely and the following Hungarian Scientific Research Funds: OTKA K100845 and K83766. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh MD, 2010, J AM ACAD CHILD PSY, V49, P841, DOI 10.1016/j.jaac.2010.05.015; Alia-Klein N, 2008, J NEUROSCI, V28, P5099, DOI 10.1523/JNEUROSCI.0925-08.2008; Aluja A, 2011, PSYCHIAT GENET, V21, P229, DOI 10.1097/YPG.0b013e328345465e; Angoa-Perez M, 2014, GENES BRAIN BEHAV, V13, P579, DOI 10.1111/gbb.12159; Aslund C, 2013, AGGRESSIVE BEHAV, V39, P52, DOI 10.1002/ab.21451; Azmitia EC, 2007, INT REV NEUROBIOL, V77, P31, DOI 10.1016/S0074-7742(06)77002-7; Baker LA, 2008, J ABNORM CHILD PSYCH, V36, P1265, DOI 10.1007/s10802-008-9249-1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ben-Efraim Y, 2013, MOL PSYCHIATR, V18, P758, DOI 10.1038/mp.2012.86; Berman ME, 2009, PSYCHOL SCI, V20, P714, DOI 10.1111/j.1467-9280.2009.02355.x; Bezdjian S, 2011, CHILD DEV, V82, P1267, DOI 10.1111/j.1467-8624.2011.01598.x; Blasi G, 2013, JAMA PSYCHIAT, V70, P921, DOI 10.1001/jamapsychiatry.2013.1378; Boor K, 2002, CURR MED CHEM, V9, P793, DOI 10.2174/0929867024606821; Bray NJ, 2004, MOL PSYCHIATR, V9, P109, DOI 10.1038/sj.mp.4001366; Brendgen M, 2006, DEV PSYCHOL, V42, P1299, DOI 10.1037/0012-1649.42.6.1299; BROWN GL, 1990, J CLIN PSYCHIAT, V51, P31; BROWN GL, 1979, PSYCHIAT RES, V1, P131, DOI 10.1016/0165-1781(79)90053-2; Bryant CD, 2012, NEUROPSYCHOPHARMACOL, V37, P1026, DOI 10.1038/npp.2011.287; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Cairns RB, 1996, CIBA F SYMP, V194, P45; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Chiao JY, 2010, P ROY SOC B-BIOL SCI, V277, P529, DOI 10.1098/rspb.2009.1650; Coccaro EF, 1997, BIOL PSYCHIAT, V42, P546, DOI 10.1016/S0006-3223(97)00309-0; Coccaro EF, 1997, ARCH GEN PSYCHIAT, V54, P1081; Coccaro EF, 2010, J PSYCHIATR RES, V44, P137, DOI 10.1016/j.jpsychires.2009.07.004; Coccaro EF, 2010, J NEURAL TRANSM, V117, P241, DOI 10.1007/s00702-009-0359-x; Coccaro EF, 2010, NEUROPSYCHOPHARMACOL, V35, P435, DOI 10.1038/npp.2009.148; Coccaro EF, 2009, J CLIN PSYCHIAT, V70, P653, DOI 10.4088/JCP.08m04150; Constantino JN, 1997, J CHILD ADOL PSYCHOP, V7, P31, DOI 10.1089/cap.1997.7.31; Craig IW, 2009, HUM GENET, V126, P101, DOI 10.1007/s00439-009-0695-9; Crockett MJ, 2008, SCIENCE, V320, P1739, DOI 10.1126/science.1155577; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Dijkstra JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054821; Erdmann J, 1996, HUM GENET, V97, P614, DOI 10.1007/s004390050104; Fairbanks LA, 2001, NEUROPSYCHOPHARMACOL, V24, P370, DOI 10.1016/S0893-133X(00)00211-6; Fanning JR, 2014, J PERS DISORD, V28, P449, DOI 10.1521/pedi_2012_26_065; Ferris CF, 1997, J NEUROSCI, V17, P4331; Fink KB, 2007, PHARMACOL REV, V59, P360, DOI 10.1124/pr.107.07103; Georgiev AV, 2013, EVOL PSYCHOL-US, V11, P678, DOI 10.1177/147470491301100313; Gerevich J, 2007, INT J METH PSYCH RES, V16, P124, DOI 10.1002/mpr.221; Godar SC, 2014, J PSYCHIATR RES, V56, P1, DOI 10.1016/j.jpsychires.2014.04.014; Goveas JS, 2004, PSYCHIAT RES, V126, P23, DOI 10.1016/j.psychres.2004.01.006; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Grigorenko EL, 2010, AGGRESSIVE BEHAV, V36, P158, DOI 10.1002/ab.20339; Harms N, 1996, J BACTERIOL, V178, P6296, DOI 10.1128/jb.178.21.6296-6299.1996; Hassanain M, 2005, BRAIN RES, V1048, P1, DOI 10.1016/j.brainres.2005.04.086; Hassanain M, 2003, BRAIN RES, V981, P201, DOI 10.1016/S0006-8993(03)03036-1; Hazelwood LA, 2004, MOL PHARMACOL, V66, P1293, DOI 10.1124/mol.66.5.1293; Herculano AM, 2014, PROG NEURO-PSYCHOPH, V55, P50, DOI 10.1016/j.pnpbp.2014.03.008; Ho HP, 2001, NEUROPSYCHOPHARMACOL, V24, P502, DOI 10.1016/S0893-133X(00)00219-0; Jakubczyk A, 2012, J PSYCHIATR RES, V46, P44, DOI 10.1016/j.jpsychires.2011.09.001; Kachadourian LK, 2012, PSYCHOL ADDICT BEHAV, V26, P414, DOI 10.1037/a0025842; Kiryanova V, 2014, DEV NEUROSCI-BASEL, V36, P396, DOI 10.1159/000363102; Kotyuk E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080613; Kovacs-Nagy R, 2013, AM J MED GENET B, V162B, P404, DOI 10.1002/ajmg.b.32157; KRUESI MJP, 1990, ARCH GEN PSYCHIAT, V47, P419; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; KRUK MR, 1983, BRAIN RES, V260, P61, DOI 10.1016/0006-8993(83)90764-3; Kuepper Y, 2013, BEHAV BRAIN RES, V247, P73, DOI 10.1016/j.bbr.2013.03.002; Kusumi I, 2002, J AFFECT DISORDERS, V68, P235, DOI 10.1016/S0165-0327(00)00324-4; Latalova K, 2014, INT J CLIN PRACT, V68, P330, DOI 10.1111/ijcp.12327; LINNOILA M, 1983, LIFE SCI, V33, P2609, DOI 10.1016/0024-3205(83)90344-2; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Manuck SB, 1998, NEUROPSYCHOPHARMACOL, V19, P287, DOI 10.1038/sj.npp.1395199; Marseille R, 2012, PROG NEURO-PSYCHOPH, V36, P277, DOI 10.1016/j.pnpbp.2011.10.004; McCloskey M, 2009, PSYCHOPHARMACOLOGY, V203, P53, DOI 10.1007/s00213-008-1374-6; Meng YJ, 2013, RICE, V6, DOI 10.1186/1939-8433-6-8; Miller GA, 2010, PERSPECT PSYCHOL SCI, V5, P716, DOI 10.1177/1745691610388774; Mosienko V, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.44; Ni XQ, 2006, NEUROSCI LETT, V408, P214, DOI 10.1016/j.neulet.2006.09.002; Niv S, 2013, J CRIM JUST, V41, P285, DOI 10.1016/j.jcrimjus.2013.06.014; Oades RD, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-48; Ozaki N, 1997, J NEUROCHEM, V68, P2186; Passamonti L, 2012, BIOL PSYCHIAT, V71, P36, DOI 10.1016/j.biopsych.2011.07.033; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Pavlov KA, 2012, J APPL GENET, V53, P61, DOI 10.1007/s13353-011-0069-6; Phan KL, 2011, INT CLIN PSYCHOPHARM, V26, P278, DOI 10.1097/YIC.0b013e32834978ac; Rhee SH, 2002, PSYCHOL BULL, V128, P490, DOI 10.1037//0033-2909.128.3.490; Ribases M, 2009, MOL PSYCHIATR, V14, P71, DOI 10.1038/sj.mp.4002100; Ricci LA, 2012, BEHAV NEUROSCI, V126, P640, DOI 10.1037/a0029761; Robinson OJ, 2012, PSYCHOPHARMACOLOGY, V219, P599, DOI 10.1007/s00213-011-2410-5; Rubin DH, 2013, J CHILD PSYCHOL PSYC, V54, P1337, DOI 10.1111/jcpp.12108; Saiz PA, 2011, PROG NEURO-PSYCHOPH, V35, P1518, DOI 10.1016/j.pnpbp.2011.04.011; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siddiq A, 2009, J NEUROSCI, V29, P8828, DOI 10.1523/JNEUROSCI.1779-09.2009; Siegel A, 1999, NEUROSCI BIOBEHAV R, V23, P359, DOI 10.1016/S0149-7634(98)00040-2; Siegel A, 2007, CURR NEUROPHARMACOL, V5, P135, DOI 10.2174/157015907780866929; SMITH JM, 1988, PHILOS T ROY SOC B, V319, P557, DOI 10.1098/rstb.1988.0065; Spurlock G, 1998, MOL PSYCHIATR, V3, P42, DOI 10.1038/sj.mp.4000342; Stanley B, 2000, AM J PSYCHIAT, V157, P609, DOI 10.1176/appi.ajp.157.4.609; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stoltenberg SF, 2012, PROG NEURO-PSYCHOPH, V39, P182, DOI 10.1016/j.pnpbp.2012.06.012; Swann AC, 2003, J CLIN PSYCHIAT, V64, P26; Ten Eyck GR, 2014, PHARMACOL BIOCHEM BE, V124, P86, DOI 10.1016/j.pbb.2014.05.018; Terranova C, 2012, J FORENSIC SCI, V57, P1343, DOI 10.1111/j.1556-4029.2012.02243.x; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tops M, 2009, BRAIN COGNITION, V71, P427, DOI 10.1016/j.bandc.2009.03.009; Turecki G, 1999, AM J PSYCHIAT, V156, P1456; Tuvblad C, 2009, AGGRESSIVE BEHAV, V35, P437, DOI 10.1002/ab.20319; VARTIAINEN H, 1995, ACTA PSYCHIAT SCAND, V91, P348, DOI 10.1111/j.1600-0447.1995.tb09793.x; Volavka J, 2013, PSYCHIAT DANUB, V25, P24; Weber ET, 2010, FRONT NEUROSCI, V4, DOI [10.3389/fnins.2010.00300, DOI 10.3389/FNINS.2010.00300]; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wexler E, 2013, NEUROL CLIN, V31, P1121, DOI 10.1016/j.ncl.2013.04.016; Wilkie MJV, 2009, PHARMACOGENOMICS J, V9, P61, DOI 10.1038/sj.tpj.6500491; Winstanley CA, 2011, NEUROPSYCHOPHARMACOL, V36, P359, DOI 10.1038/npp.2010.136; Wu D, 2009, FASEB J, V23, P1441, DOI 10.1096/fj.08-125286; Xu H, 2013, FASEB J, V27, P4157, DOI 10.1096/fj.12-226555; Yildirim BO, 2013, NEUROSCI BIOBEHAV R, V37, P1254, DOI 10.1016/j.neubiorev.2013.04.009; Zahodne LB, 2015, AM J GERIAT PSYCHIAT, V23, P130, DOI 10.1016/j.jagp.2013.03.014	114	28	32	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117792	10.1371/journal.pone.0117792	http://dx.doi.org/10.1371/journal.pone.0117792			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658328	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900224
J	Deng, T; Nie, ZL; Drew, BT; Volis, S; Kim, C; Xiang, CL; Zhang, JW; Wang, YH; Sun, H				Deng, Tao; Nie, Ze-Long; Drew, Bryan T.; Volis, Sergei; Kim, Changkyun; Xiang, Chun-Lei; Zhang, Jian-Wen; Wang, Yue-Hua; Sun, Hang			Does the Arcto-Tertiary Biogeographic Hypothesis Explain the Disjunct Distribution of Northern Hemisphere Herbaceous Plants? The Case of Meehania (Lamiaceae)	PLOS ONE			English	Article							DISPERSAL-VICARIANCE ANALYSIS; SCRUB MINTS LAMIACEAE; MOLECULAR PHYLOGENY; NONCODING REGIONS; EVOLUTION; NUCLEAR; GENUS; DNA; HYBRIDIZATION; PATTERNS	Despite considerable progress, many details regarding the evolution of the Arcto-Tertiary flora, including the timing, direction, and relative importance of migration routes in the evolution of woody and herbaceous taxa of the Northern Hemisphere, remain poorly understood. Meehania (Lamiaceae) comprises seven species and five subspecies of annual or perennial herbs, and is one of the few Lamiaceae genera known to have an exclusively disjunct distribution between eastern Asia and eastern North America. We analyzed the phylogeny and biogeographical history of Meehania to explore how the Arcto-Tertiary biogeographic hypothesis and two possible migration routes explain the disjunct distribution of Northern Hemisphere herbaceous plants. Parsimony and Bayesian inference were used for phylogenetic analyses based on five plastid sequences (rbcL, rps16, rpl32-trnH, psbA-trnH, and trnL-F) and two nuclear (ITS and ETS) gene regions. Divergence times and biogeographic inferences were performed using Bayesian methods as implemented in BEAST and S-DIVA, respectively. Analyses including 11 of the 12 known Meehania taxa revealed incongruence between the chloroplast and nuclear trees, particularly in the positions of Glechoma and Meehania cordata, possibly indicating allopolyploidy with chloroplast capture in the late Miocene. Based on nrDNA, Meehania is monophyletic, and the North American species M. cordata is sister to a clade containing the eastern Asian species. The divergence time between the North American M. cordata and the eastern Asian species occurred about 9.81 Mya according to the Bayesian relaxed clock methods applied to the combined nuclear data. Biogeographic analyses suggest a primary role of the Arcto-Tertiary flora in the study taxa distribution, with a northeast Asian origin of Meehania. Our results suggest an Arcto-Tertiary origin of Meehania, with its present distribution most probably being a result of vicariance and southward migrations of populations during climatic oscillations in the middle Miocene with subsequent migration into eastern North America via the Bering land bridge in the late Miocene.	[Deng, Tao; Wang, Yue-Hua] Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China; [Deng, Tao; Volis, Sergei; Kim, Changkyun; Xiang, Chun-Lei; Zhang, Jian-Wen; Sun, Hang] Chinese Acad Sci, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Deng, Tao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Nie, Ze-Long] Jishou Univ, Coll Biol & Environm Sci, Key Lab Plant Resources Conservat & Utilizat, Jishou, Hunan, Peoples R China; [Drew, Bryan T.] Univ Nebraska Kearney, Dept Biol, Kearney, NE USA	Yunnan University; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jishou University; University of Nebraska System	Wang, YH (corresponding author), Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China.	wangyh58212@126.com; sunhang@mail.kib.ac.cn	Nie, Ze-Long/N-8471-2015; , wenzi/ABB-4126-2021; Volis, Sergei/GLU-5848-2022; Xiang, Chun-Lei/AAC-8433-2021; Xiang, Chunlei/Z-1799-2019; ZHANG, Jianwen/AAG-7743-2020	Nie, Ze-Long/0000-0001-8065-3981; Xiang, Chunlei/0000-0001-8775-6967; ZHANG, Jianwen/0000-0002-4735-168X	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB03030106]; NSFC-Yunnan Natural Science Foundation United Project [U1136601]; CAS/SAFEA International Partnership Program for Creative Research Teams, Hundred Talents Program of the Chinese Academy of Sciences [2011312D11022]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC-Yunnan Natural Science Foundation United Project; CAS/SAFEA International Partnership Program for Creative Research Teams, Hundred Talents Program of the Chinese Academy of Sciences	This study was supported by grants-in-aid from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB03030106), NSFC-Yunnan Natural Science Foundation United Project (Grant no. U1136601) and The CAS/SAFEA International Partnership Program for Creative Research Teams, Hundred Talents Program of the Chinese Academy of Sciences (2011312D11022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini G, 2012, MOL PHYLOGENET EVOL, V65, P739, DOI 10.1016/j.ympev.2012.07.030; Albaladejo RG, 2005, TAXON, V54, P987, DOI 10.2307/25065483; [安芷生 An Zhisheng], 2006, [第四纪研究, Quaternary Sciences], V26, P678; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; [Anonymous], 2014, TRACER V1 6; [Anonymous], 1967, BERING LAND BRIDGE; Baird KE, 2010, J SYST EVOL, V48, P161, DOI 10.1111/j.1759-6831.2010.00077.x; Barber JC, 2007, TAXON, V56, P74, DOI 10.2307/25065737; BUDANTSEV LY, 1992, BOT REV, V58, P1, DOI 10.1007/BF02858542; CHANEY RW, 1947, ECOL MONOGR, V17, P139, DOI 10.2307/1943260; CHEN C, 1979, Acta Botanica Yunnanica, V1, P81; Chen CH, 2009, BOT STUD, V50, P425; Conn BJ, 2009, AUST SYST BOT, V22, P243, DOI 10.1071/SB09011; Donoghue MJ, 2004, PHILOS T R SOC B, V359, P1633, DOI 10.1098/rstb.2004.1538; Douglas R.G., 1981, OCEANIC LITHOSPHERE, P1233; Drew BT, 2013, BOT J LINN SOC, V171, P171, DOI 10.1111/j.1095-8339.2012.01325.x; Drew BT, 2012, AM J BOT, V99, P933, DOI 10.3732/ajb.1100549; Drew BT, 2011, SYST BOT, V36, P1038, DOI 10.1600/036364411X605047; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards CE, 2006, SYST BOT, V31, P193, DOI 10.1600/036364406775971688; Edwards CE, 2008, INT J PLANT SCI, V169, P579, DOI 10.1086/528758; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fehrer J, 2007, MOL PHYLOGENET EVOL, V42, P347, DOI 10.1016/j.ympev.2006.07.004; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Funamoto Tsuneo, 2000, Chromosome Science, V4, P107; Gobert V, 2006, PLANT BIOLOGY, V8, P470, DOI 10.1055/s-2006-924043; Gould Katherine R., 2000, Harvard Papers in Botany, V5, P157; Guggisberg A, 2009, SYSTEMATIC BIOL SYP0; Guo YP, 2004, TAXON, V53, P657, DOI 10.2307/4135441; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Harley RM, 2004, FA GE VAS P, V7, P167; Huang WP, 2013, BOT J LINN SOC, V171, P395, DOI 10.1111/j.1095-8339.2012.01321.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Janssens SB, 2009, MOL PHYLOGENET EVOL, V52, P806, DOI 10.1016/j.ympev.2009.04.013; Kar RK, 1996, PALAEOBOTANIST, V43; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Li XW, 1994, FLORA CHINA, P122; MAI DH, 1991, REV PALAEOBOT PALYNO, V68, P29, DOI 10.1016/0034-6667(91)90055-8; Manchester SR, 2001, INT J PLANT SCI, V162, pS19, DOI 10.1086/323657; Martinez-Millan M, 2010, BOT REV, V76, P83, DOI 10.1007/s12229-010-9040-1; MCKENNA MC, 1983, ANN MO BOT GARD, V70, P459, DOI 10.2307/2992083; Meng Y, 2008, MOL PHYLOGENET EVOL, V49, P424, DOI 10.1016/j.ympev.2008.07.017; Milne RI, 2002, ADV BOT RES, V38, P281, DOI 10.1016/S0065-2296(02)38033-9; Moon HK, 2010, TAXON, V59, P1065, DOI 10.1002/tax.594007; Murata G., 1993, FLORA JAPAN, P289; Nie ZL, 2010, AM J BOT, V97, P1342, DOI 10.3732/ajb.1000085; Nie ZL, 2005, AM J BOT, V92, P642, DOI 10.3732/ajb.92.4.642; NYLANDER J.A.A., 2004, MRMODELTEST V2 3; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Oliveira LO, 2007, AM J BOT, V94, P1017, DOI 10.3732/ajb.94.6.1017; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Reid E.M., 1926, CATALOGUE CAINZOIC P, VI; RIESEBERG LH, 1991, EVOL TREND PLANT, V5, P65; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryding O, 2007, PLANT SYST EVOL, V268, P45, DOI 10.1007/s00606-007-0537-y; SAKAI A, 1971, NEW PHYTOL, V70, P1199, DOI 10.1111/j.1469-8137.1971.tb04598.x; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Savage J.M., 1973, EVOLUTIONARY BIOL AN, P351; Scheen AC, 2010, ANN MO BOT GARD, V97, P191, DOI 10.3417/2007174; Schonhofer AL, 2013, MOL PHYLOGENET EVOL, V66, P303, DOI 10.1016/j.ympev.2012.10.001; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; SOLTIS DE, 1995, EVOLUTION, V49, P727, DOI 10.1111/j.1558-5646.1995.tb02309.x; Soltis DE, 1996, SYST BOT, V21, P169, DOI 10.2307/2419746; Sun Hang, 2002, Acta Botanica Yunnanica, V24, P671; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Sytsma KJ, 2014, BIOL J LINN IN PRESS; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Takhtajan A, 1969, FLOWERING PLANTS ORI; THORNE RF, 1972, Q REV BIOL, V47, P365, DOI 10.1086/407399; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Tiffney BH, 2001, INT J PLANT SCI, V162, pS3, DOI 10.1086/323880; Tiffney BH, 2008, ANN MO BOT GARD, V95, P135, DOI 10.3417/2006199; Trusty JL, 2004, SYST BOT, V29, P702, DOI 10.1600/0363644041744347; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Wen J., 2010, DARWINS HERITAGE TOD, P252; Wen J, 2009, J SYST EVOL, V47, P327, DOI 10.1111/j.1759-6831.2009.00052.x; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI 10.1007/978-1-4615-5419-6_10; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WOLFE JA, 1975, ANN MO BOT GARD, V62, P264, DOI 10.2307/2395198; Wu CY, 1959, ACTA PHYTOTAXONOMICA, V8, P3; Wu CY, 1977, FLORA REIPUBLICAE PO, P334; [夏国华 Xia Guohua], 2011, [广西植物, Guihaia], V31, P581; Xiang CL, 2013, TAXON, V62, P375, DOI 10.12705/622.11; Xiang QY, 2000, MOL PHYLOGENET EVOL, V15, P462, DOI 10.1006/mpev.2000.0766; Xie L, 2009, MOL PHYLOGENET EVOL, V53, P995, DOI 10.1016/j.ympev.2009.09.009; Xu XW, 2010, MOL PHYLOGENET EVOL, V55, P1008, DOI 10.1016/j.ympev.2009.11.018; Yu Y, 2013, RASP RECONSTRUCT ANC, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Yuan YW, 2008, MOL PHYLOGENET EVOL, V48, P23, DOI 10.1016/j.ympev.2008.04.004; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhu WD, 2013, BOT J LINN SOC, V171, P377, DOI 10.1111/j.1095-8339.2012.01318.x; ZURAWSKI G, 1981, NUCLEIC ACIDS RES, V9, P3251, DOI 10.1093/nar/9.14.3251	96	37	41	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117171	10.1371/journal.pone.0117171	http://dx.doi.org/10.1371/journal.pone.0117171			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658699	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900110
J	Matsuda, Y; Ishiwata, T; Izumiyama-Shimomura, N; Hamayasu, H; Fujiwara, M; Tomita, KI; Hiraishi, N; Nakamura, K; Ishikawa, N; Aida, J; Takubo, K; Arai, T				Matsuda, Yoko; Ishiwata, Toshiyuki; Izumiyama-Shimomura, Naotaka; Hamayasu, Hideki; Fujiwara, Mutsunori; Tomita, Ken-ichiro; Hiraishi, Naoki; Nakamura, Ken-ichi; Ishikawa, Naoshi; Aida, Junko; Takubo, Kaiyo; Arai, Tomio			Gradual Telomere Shortening and Increasing Chromosomal Instability among PanIN Grades and Normal Ductal Epithelia with and without Cancer in the Pancreas	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; TISSUE; LENGTH; CELLS; FISH; ASSOCIATION; SECTIONS; FIGURES; BIOLOGY	A large body of evidence supports a key role for telomere dysfunction in carcinogenesis due to the induction of chromosomal instability. To study telomere shortening in precancerous pancreatic lesions, we measured telomere lengths using quantitative fluorescence in situ hybridization in the normal pancreatic duct epithelium, pancreatic intraepithelial neoplasias (PanINs), and cancers. The materials employed included surgically resected pancreatic specimens without cancer (n = 33) and with invasive ductal carcinoma (n = 36), as well as control autopsy cases (n = 150). In comparison with normal ducts, telomere length was decreased in PanIN-1, -2 and -3 and cancer. Furthermore, telomeres were shorter in cancer than in PanIN-1 and -2. Telomere length in cancer was not associated with histological type, lesion location, or cancer stage. PanINs with or without cancer showed similar telomere lengths. The incidences of atypical mitosis and anaphase bridges, which are morphological characteristics of chromosomal instability, were negatively correlated with telomere length. The telomeres in normal duct epithelium became shorter with aging, and those in PanINs or cancers were shorter than in age-matched controls, suggesting that telomere shortening occurs even when histological changes are absent. Our data strongly suggest that telomere shortening occurs in the early stages of pancreatic carcinogenesis and progresses with precancerous development. Telomere shortening and chromosomal instability in the duct epithelium might be associated with carcinogenesis of the pancreas. Determination of telomere length in pancreatic ductal lesions may be valuable for accurate detection and risk assessment of pancreatic cancer.	[Matsuda, Yoko; Hamayasu, Hideki; Arai, Tomio] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Itabashi Ku, Tokyo 1730015, Japan; [Ishiwata, Toshiyuki] Nippon Med Sch, Grad Sch Med, Dept Integrated Diagnost Pathol, Bunkyo Ku, Tokyo, Japan; [Izumiyama-Shimomura, Naotaka; Nakamura, Ken-ichi; Ishikawa, Naoshi; Aida, Junko; Takubo, Kaiyo] Tokyo Metropolitan Geriatr Hosp, Res Team Geriatr Pathol, Itabashi Ku, Tokyo 1730015, Japan; [Matsuda, Yoko; Nakamura, Ken-ichi; Ishikawa, Naoshi; Aida, Junko; Takubo, Kaiyo] Inst Gerontol, Itabashi Ku, Tokyo 1730015, Japan; [Fujiwara, Mutsunori; Tomita, Ken-ichiro] Japanese Red Cross Med Ctr, Dept Pathol, Shibuya Ku, Tokyo 1508935, Japan; [Hiraishi, Naoki] Hadano Red Cross Hosp, Dept Lab Med, Hadano, Kanagawa 2570017, Japan	Nippon Medical School; Japanese Red Cross Medical Center	Matsuda, Y (corresponding author), Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	yoko_matsuda@tmghig.jp; takubo@tmig.or.jp	Aida, Junko/Q-5697-2019	Aida, Junko/0000-0003-4923-5540	Japan Society for the Promotion of Science [25462127]; Cancer Research Institute of Kanazawa University; Alumni Association of Kagawa University Faculty of Medicine Sanjukai	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cancer Research Institute of Kanazawa University; Alumni Association of Kagawa University Faculty of Medicine Sanjukai	This work was supported in part by a grant-in-aid from the Japan Society for the Promotion of Science (C, No. 25462127) and grants from the Cancer Research Institute of Kanazawa University and the Alumni Association of Kagawa University Faculty of Medicine Sanjukai to Y. Matsuda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida J, 2008, EXP GERONTOL, V43, P833, DOI 10.1016/j.exger.2008.06.001; Aida J, 2007, HUM PATHOL, V38, P1192, DOI 10.1016/j.humpath.2006.11.023; Aida J, 2010, EUR J CANCER, V46, P430, DOI 10.1016/j.ejca.2009.10.018; Amosenko FA, 2009, MOL BIOL+, V43, P381, DOI 10.1134/S0026893309030054; Arai T, 2007, PATHOL INT, V57, P303, DOI 10.1111/j.1440-1827.2007.02101.x; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Baumgart M, 2010, PANCREAS, V39, P1093, DOI 10.1097/MPA.0b013e3181dc62f6; Bidoli E, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-443; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Boardman LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080015; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Friis-Ottessen M, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-8; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hong SM, 2011, MODERN PATHOL, V24, P256, DOI 10.1038/modpathol.2010.181; Hou LF, 2012, CANCER LETT, V319, P130, DOI 10.1016/j.canlet.2012.01.028; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Hruban RH, 2000, AM J PATHOL, V156, P1821, DOI 10.1016/S0002-9440(10)65054-7; Hruban RH, 2010, WHO CLASSIFICATION T; Ikeda H, 2014, HUM PATHOL, V45, P473, DOI 10.1016/j.humpath.2013.10.009; Ishii A, 2006, EXP GERONTOL, V41, P882, DOI 10.1016/j.exger.2006.06.036; Joergensen MT, 2010, PANCREAS, V39, P243, DOI 10.1097/MPA.0b013e3181bae8ab; Kawano Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093749; Koorstra JBM, 2009, MODERN PATHOL, V22, P1439, DOI 10.1038/modpathol.2009.114; Korc M, 2010, CANCER BIOL THER, V10, P588, DOI 10.4161/cbt.10.6.13128; Kurabayashi R, 2008, HUM PATHOL, V39, P1647, DOI 10.1016/j.humpath.2008.04.005; Kure S, 2010, MOYAMOYA DISEASE UPDATE, P41, DOI 10.1007/978-4-431-99703-0_6; Li AG, 2013, CLIN CANCER RES, V19, P3600, DOI 10.1158/1078-0432.CCR-12-3092; Lillemoe KD, 2000, CA-CANCER J CLIN, V50, P241, DOI 10.3322/canjclin.50.4.241; Londono-Vallejo JA, 2008, BIOCHIMIE, V90, P73, DOI 10.1016/j.biochi.2007.07.009; Luttges J, 2001, AM J PATHOL, V158, P1677, DOI 10.1016/S0002-9440(10)64123-5; Montgomery E, 2003, CANCER BIOL THER, V2, P248, DOI 10.4161/cbt.2.3.362; Nakamura K, 2000, CANCER LETT, V158, P179, DOI 10.1016/S0304-3835(00)00521-8; Nakamura KI, 2007, EXP GERONTOL, V42, P944, DOI 10.1016/j.exger.2007.05.003; O'Sullivan JN, 2004, CYTOM PART A, V58A, P120, DOI 10.1002/cyto.a.20006; OHASHI M, 1980, EXP GERONTOL, V15, P121, DOI 10.1016/0531-5565(80)90083-2; Pandol S, 2012, J GASTROEN HEPATOL, V27, P127, DOI 10.1111/j.1440-1746.2011.07013.x; Sanada Y, 2012, WORLD J SURG, V36, P908, DOI 10.1007/s00268-012-1453-z; Shiraishi H, 2009, SCAND J GASTROENTERO, V44, P538, DOI 10.1080/00365520902718705; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sipos B, 2009, PANCREATOLOGY, V9, P45, DOI 10.1159/000178874; Takubo K, 1999, AGE, V22, P95, DOI 10.1007/s11357-999-0011-6; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Takubo K, 2010, J PATHOL, V221, P201, DOI 10.1002/path.2704; Tamura Y, 2014, J CLIN ENDOCR METAB; Terai M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02401; van Heek NT, 2002, AM J PATHOL, V161, P1541, DOI 10.1016/S0002-9440(10)64432-X; VANLEEUWEN AM, 1995, VIRCHOWS ARCH, V427, P139, DOI 10.1007/BF00196518	50	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117575	10.1371/journal.pone.0117575	http://dx.doi.org/10.1371/journal.pone.0117575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658358	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900179
J	Nascimento, FRF; Gomes, EA; Russo, M; Lepique, AP				Nascimento, Flavia R. F.; Gomes, Eliane A.; Russo, Momtchilo; Lepique, Ana P.			Interferon Regulatory Factor (IRF)-1 Is a Master Regulator of the Cross Talk between Macrophages and L929 Fibrosarcoma Cells for Nitric Oxide Dependent Tumoricidal Activity	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MURINE MACROPHAGES; TRANSCRIPTIONAL ACTIVATION; CHRONIC INFLAMMATION; SYNTHASE GENE; UP-REGULATION; IRF FAMILY; TNF-ALPHA; FACTOR-I; EXPRESSION	Macrophage tumoricidal activity relies, mainly, on the release of Tumor Necrosis Factor alpha (TNF alpha) and/or on reactive oxygen or nitrogen intermediates. In the present work, we investigated the cytotoxic activity of resident peritoneal macrophages against L929 fibrosarcoma cell line in vitro and in vivo. Resident macrophages lysed L929 cells in a mechanism independent of TNF alpha and cell-to-cell contact. The cytotoxic activity was largely dependent on nitric oxide (NO) release since treatment with L-NAME (NOS inhibitor) inhibited L929 cells killing. Macrophages from mice with targeted deletion of inducible NO synthase (iNOS) together with L929 cells produced less NO and displayed lower, but still significant, tumoricidal activity. Notably, NO production and tumor lysis were abolished in co-cultures with macrophages deficient in Interferon Regulatory Factor, IRF-1. Importantly, the in vitro findings were reproduced in vivo as IRF-1 deficient animals inoculated i.p with L929 cells were extremely susceptible to tumor growth and their macrophages did not produce NO, while WT mice killed L929 tumor cells and their macrophages produced high levels of NO. Our results indicate that IRF-1 is a master regulator of bi-directional interaction between macrophages and tumor cells. Overall, IRF-1 was essential for NO production by co-cultures and macrophage tumoricidal activity in vitro as well as for the control of tumor growth in vivo.	[Nascimento, Flavia R. F.] Univ Fed Maranhao, Ctr Biol Sci & Hlth, Dept Pathol, Sao Luis, Brazil; [Gomes, Eliane A.; Russo, Momtchilo; Lepique, Ana P.] Univ Sao Paulo, Inst Biomed Sci, Dept Imunol, Sao Paulo, Brazil	Universidade Federal do Maranhao; Universidade de Sao Paulo	Russo, M (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Imunol, Sao Paulo, Brazil.	momrusso@icb.usp.br	Nascimento, F/F-8173-2016; Lepique, Ana Paula/T-2427-2019; Lepique, Ana Paula/D-5878-2013	Nascimento, F/0000-0001-9328-1806; Lepique, Ana Paula/0000-0002-4707-2912	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/20010-2, 2013/24694-1]; FAPESP doctorate scholarship; Universidade Federal do Maranhao (UFMA)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP doctorate scholarship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Universidade Federal do Maranhao (UFMA)	The main funder was from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grants 2010/20010-2 to APL and 2013/24694-1 to MR. FRFN had a FAPESP doctorate scholarship and support from Universidade Federal do Maranhao (UFMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; BOLTZNITULESCU G, 1987, J LEUKOCYTE BIOL, V41, P83, DOI 10.1002/jlb.41.1.83; CUI SJ, 1994, CANCER RES, V54, P2462; Darnell JE, 1998, J INTERF CYTOK RES, V18, P549, DOI 10.1089/jir.1998.18.549; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DARZYNKIEWICZ Z, 1984, CANCER RES, V44, P83; FAST DJ, 1992, J LEUKOCYTE BIOL, V52, P255, DOI 10.1002/jlb.52.3.255; FLICK DA, 1984, J IMMUNOL METHODS, V68, P167, DOI 10.1016/0022-1759(84)90147-9; Goossens V, 1999, BIOFACTORS, V10, P145, DOI 10.1002/biof.5520100210; Harhaji L, 2006, FREE RADICAL BIO MED, V40, P226, DOI 10.1016/j.freeradbiomed.2005.08.027; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; HOSSHOMFELD A, 1989, VIROLOGY, V173, P539, DOI 10.1016/0042-6822(89)90566-7; Humphreys DT, 1999, CYTOKINE, V11, P773, DOI 10.1006/cyto.1998.0492; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; ISOBE K, 1993, BIOCHEM BIOPH RES CO, V192, P499, DOI 10.1006/bbrc.1993.1443; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; KLOSTERGAARD J, 1991, J IMMUNOL, V147, P2802; Kobayashi A, 2008, MUCOSAL IMMUNOL, V1, P412, DOI 10.1038/mi.2008.33; KOIDE M, 1993, FEBS LETT, V318, P213, DOI 10.1016/0014-5793(93)80514-U; Kojima H, 1998, NEUROREPORT, V9, P3345, DOI 10.1097/00001756-199810260-00001; Kroger A, 2002, J INTERF CYTOK RES, V22, P5, DOI 10.1089/107999002753452610; Lehtonen A, 1997, J IMMUNOL, V159, P794; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; MARTIN E, 1994, J EXP MED, V180, P977, DOI 10.1084/jem.180.3.977; Massi D, 2007, HUM PATHOL, V38, P1516, DOI 10.1016/j.humpath.2007.02.018; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MONCADA S, 1991, PHARMACOL REV, V43, P109; Nascimento FRF, 1998, BRAZ J MED BIOL RES, V31, P1593; Nascimento FRF, 2003, BRAZ J MED BIOL RES, V36, P1221, DOI 10.1590/S0100-879X2003000900012; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; NOZAKI Y, 1993, INT J ONCOL, V2, P1053; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Park YH, 2013, BIOCHEM BIOPH RES CO, V435, P244, DOI 10.1016/j.bbrc.2013.04.071; Raber PL, 2014, INT J CANCER, V134, P2853, DOI 10.1002/ijc.28622; REIS LFL, 1994, EMBO J, V13, P4798, DOI 10.1002/j.1460-2075.1994.tb06805.x; Schwartsburd PM, 2003, CANCER METAST REV, V22, P95, DOI 10.1023/A:1022220219975; SHOJI Y, 1995, IMMUNOLOGY, V84, P543; Sodhi A, 2007, MOL IMMUNOL, V44, P2265, DOI 10.1016/j.molimm.2006.11.008; Solinas G, 2010, CANCER METAST REV, V29, P243, DOI 10.1007/s10555-010-9227-2; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tazawa H, 2013, EXP CELL RES, V319, P2835, DOI 10.1016/j.yexcr.2013.08.006; Tonetti M, 1997, BIOCHEM BIOPH RES CO, V230, P636, DOI 10.1006/bbrc.1996.6022; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Tsai SY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003848; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; VASILIEV VY, 1990, TSITOLOGIYA+, V32, P275; Vercammen E, 2008, ONCOGENE, V27, P3780, DOI 10.1038/onc.2008.4; WRIGHT SC, 1992, J CELL BIOCHEM, V48, P344, DOI 10.1002/jcb.240480403; ZEMBALA M, 1994, EUR J IMMUNOL, V24, P435, DOI 10.1002/eji.1830240225	52	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117782	10.1371/journal.pone.0117782	http://dx.doi.org/10.1371/journal.pone.0117782			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659093	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900221
J	Ring, M; Eskofier, BM				Ring, Matthias; Eskofier, Bjoern M.			Data Mining in the US National Toxicology Program (NTP) Database Reveals a Potential Bias Regarding Liver Tumors in Rodents Irrespective of the Test Agent	PLOS ONE			English	Article							NONGENOTOXIC CARCINOGENESIS; GENDER-DIFFERENCES; B6C3F(1) MICE; BODY-WEIGHT; PREDICTION; TOXICITY; VALIDATION; MUTAGENS; BIOASSAY; DESIGNS	Long-term studies in rodents are the benchmark method to assess carcinogenicity of single substances, mixtures, and multi-compounds. In such a study, mice and rats are exposed to a test agent at different dose levels for a period of two years and the incidence of neoplastic lesions is observed. However, this two-year study is also expensive, time-consuming, and burdensome to the experimental animals. Consequently, various alternatives have been proposed in the literature to assess carcinogenicity on basis of short-term studies. In this paper, we investigated if effects on the rodents' liver weight in short-term studies can be exploited to predict the incidence of liver tumors in long-term studies. A set of 138 paired short-and long-term studies was compiled from the database of the U.S. National Toxicology Program (NTP), more precisely, from (long-term) two-year carcinogenicity studies and their preceding (short-term) dose finding studies. In this set, data mining methods revealed patterns that can predict the incidence of liver tumors with accuracies of over 80%. However, the results simultaneously indicated a potential bias regarding liver tumors in two-year NTP studies. The incidence of liver tumors does not only depend on the test agent but also on other confounding factors in the study design, e.g., species, sex, type of substance. We recommend considering this bias if the hazard or risk of a test agent is assessed on basis of a NTP carcinogenicity study.	[Ring, Matthias; Eskofier, Bjoern M.] Univ Erlangen Nurnberg, Pattern Recognit Lab, Digital Sports Grp, D-91054 Erlangen, Fau, Germany	University of Erlangen Nuremberg	Ring, M (corresponding author), Univ Erlangen Nurnberg, Pattern Recognit Lab, Digital Sports Grp, D-91054 Erlangen, Fau, Germany.	matthias.ring@cs.fau.de	Ring, Matthias/I-3822-2016; Eskofier, Bjoern/ABF-1284-2021	Ring, Matthias/0000-0003-3601-3228; Eskofier, Bjoern/0000-0002-0417-0336	Deutsche Telekom Stiftung	Deutsche Telekom Stiftung	MR is supported by a research fellowship from the Deutsche Telekom Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden CL, 1996, TOXICOL PATHOL, V24, P722, DOI 10.1177/019262339602400610; Allen DG, 2004, TOXICOL PATHOL, V32, P393, DOI 10.1080/01926230490440934; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Anisimov VN, 2005, NAT REV CANCER, V5, P807, DOI 10.1038/nrc1715; Argiriadi MA, 1999, P NATL ACAD SCI USA, V96, P10637, DOI 10.1073/pnas.96.19.10637; Benfenati E, 2009, J ENVIRON SCI HEAL C, V27, P57, DOI 10.1080/10590500902885593; Benigni R, 1996, ENVIRON HEALTH PERSP, V104, P1041, DOI 10.2307/3433028; Benigni R, 2008, TOXICOL MECH METHOD, V18, P137, DOI 10.1080/15376510701857056; Boobis AR, 2009, TOXICOL PATHOL, V37, P714, DOI 10.1177/0192623309343779; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bristol DW, 1996, ENVIRON HEALTH PERSP, V104, P1001, DOI 10.1289/ehp.96104s51001; Bucher JR, 2002, ANN NY ACAD SCI, V982, P198; CHHABRA RS, 1990, ENVIRON HEALTH PERSP, V86, P313, DOI 10.2307/3430970; Duda RO, 2001, PATTERN CLASSIFICATI, P2; Dunnick JK, 2013, TOXICOL PATHOL, V41, P374, DOI 10.1177/0192623312466451; Ekor M, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00177; Elcombe CR, 2002, ENVIRON HEALTH PERSP, V110, P363, DOI 10.1289/ehp.02110363; Faustman E.M., 2008, CASARETT DOULLS TOXI; Frank E., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P144; Freund Y., 1996, P 13 INT C MACH LEAR, V96, P148, DOI DOI 10.5555/3091696.3091715; GRASSO P, 1991, MUTAT RES, V248, P271, DOI 10.1016/0027-5107(91)90062-S; Greaves P, 2012, HISTOPATHOLOGY OF PRECLINICAL TOXICITY STUDIES: INTERPRETATION AND RELEVANCE IN DRUG SAFETY EVALUATION, 4TH EDITION, P1; Gutlein M, 2013, MOL INFORM, V32, P516, DOI 10.1002/minf.201200134; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Haseman JK, 1997, TOXICOL PATHOL, V25, P256, DOI 10.1177/019262339702500302; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hayes AW, 2011, REGUL TOXICOL PHARM, V60, pS1, DOI 10.1016/j.yrtph.2010.10.002; Helma C, 2000, STAT METHODS MED RES, V9, P329, DOI 10.1191/096228000701555190; Helma C, 2003, BIOINFORMATICS, V19, P1179, DOI 10.1093/bioinformatics/btg084; HIRTZ J, 1985, BRIT J CLIN PHARMACO, V19, pS77, DOI 10.1111/j.1365-2125.1985.tb02746.x; Kadekar S, 2012, TOXICOL PATHOL, V40, P1160, DOI 10.1177/0192623312446527; Maronpot RR, 2010, TOXICOL PATHOL, V38, P776, DOI 10.1177/0192623310373778; Moore NP, 2013, EXP TOXICOL PATHOL, V65, P1109, DOI 10.1016/j.etp.2013.05.001; Moriguchi I, 1996, ENVIRON HEALTH PERSP, V104, P1051, DOI 10.2307/3433030; NTP, 2014, CHEM ASS SIT SPEC NE; NTP, 2011, SPEC COND STUD EV TO; NTP, 2013, NTP TECHN REP; NTP, 2013, CARTOX DAT; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; R Core Team, 2021, R LANGUAGE ENV STAT; Reddy MV, 2010, VET PATHOL, V47, P614, DOI 10.1177/0300985810373242; SEILKOP SK, 1995, FUND APPL TOXICOL, V24, P247, DOI 10.1006/faat.1995.1028; Spielmann H, 2003, TOXICOL PATHOL, V31, P54, DOI 10.1080/01926230390173897; Toivonen H, 2003, BIOINFORMATICS, V19, P1183, DOI 10.1093/bioinformatics/btg130; Travlos GS, 2011, TOXICOL PATHOL, V39, P381, DOI 10.1177/0192623310388432; Ward JM, 2007, J TOXICOL PATHOL, V20, P13, DOI DOI 10.1293/TOX.20.13; Williams GM, 2002, TOXICOL PATHOL, V30, P41, DOI 10.1080/01926230252824699; Witten IH, 2011, MOR KAUF D, P1	48	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116488	10.1371/journal.pone.0116488	http://dx.doi.org/10.1371/journal.pone.0116488			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658102	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900043
J	Sanders, YY; Cui, ZB; Le Saux, CJ; Horowitz, JC; Rangarajan, S; Kurundkar, A; Antony, VB; Thannickal, VJ				Sanders, Yan Y.; Cui, Zongbin; Le Saux, Claude Jourdan; Horowitz, Jeffrey C.; Rangarajan, Sunad; Kurundkar, Ashish; Antony, Veena B.; Thannickal, Victor J.			SMAD-Independent Down-Regulation of Caveolin-1 by TGF-beta: Effects on Proliferation and Survival of Myofibroblasts	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; IDIOPATHIC PULMONARY-FIBROSIS; HUMAN LUNG FIBROBLASTS; GENE-EXPRESSION; MAP KINASE; CELL-PROLIFERATION; P38 MAPK; GROWTH-FACTOR-BETA-1; ACTIVATION; INDUCTION	Transforming growth factor-beta (TGF-beta) mediates growth-inhibitory effects on most target cells via activation of the canonical SMAD signaling pathway. This growth-inhibitory activity may be coupled with cellular differentiation. Our studies demonstrate that TGF-beta 1 inhibits proliferation of primary, non-transformed human lung fibroblasts in association with the induction of myofibroblast differentiation. Differentiated myofibroblasts maintain the capacity to proliferate in response to exogenous mitogenic stimuli and are resistant to serum deprivation-induced apoptosis. These proliferative and anti-apoptotic properties of myofibroblasts are related, in part, to the down-regulation of caveolin-1 (Cav-1) by TGF-beta 1. Cav-1 down-regulation is mediated by early activation of p38 MAPK and does not require SMAD signaling. In contrast, myofibroblast differentiation is dependent on activation of the SMAD pathway, but not on p38 MAPK. Thus, combinatorial signaling by TGF-beta 1 of myofibroblast differentiation and down-regulation of Cav-1 by SMAD and p38 MAPK pathways, respectively, confer proliferative and apoptosis-resistant properties to myofibroblasts. Selective targeting of this SMAD-independent, p38-MAPK/Cav-1-dependent pathway is likely to be effective in the treatment of pathological conditions characterized by TGF-beta signaling and myofibroblast activation.	[Sanders, Yan Y.; Rangarajan, Sunad; Kurundkar, Ashish; Antony, Veena B.; Thannickal, Victor J.] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care, Birmingham, AL 35294 USA; [Cui, Zongbin; Horowitz, Jeffrey C.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Sch Med, Ann Arbor, MI 48109 USA; [Le Saux, Claude Jourdan] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Cardiol, San Antonio, TX 78229 USA	University of Alabama System; University of Alabama Birmingham; University of Michigan System; University of Michigan; University of Texas System; University of Texas Health San Antonio	Thannickal, VJ (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care, Birmingham, AL 35294 USA.	vjthan@uab.edu	Rangarajan, Sunad/AAQ-5285-2021; Le Saux, Claude/AGF-7659-2022; Horowitz, Jeffrey/AAY-7238-2021; Sanders, Yan/AAJ-3413-2020	Rangarajan, Sunad/0000-0001-5313-4828; Le Saux, Claude/0000-0002-6041-2870; Horowitz, Jeffrey/0000-0002-1505-2837	National Institutes of Health [P01 HL114470, R01 AG046210]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105489, P01HL114470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by a National Institutes of Health grant P01 HL114470 and R01 AG046210 (VJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Boopathi E, 2011, AM J PATHOL, V178, P2236, DOI 10.1016/j.ajpath.2011.01.038; Capozza F, 2003, AM J PATHOL, V162, P2029, DOI 10.1016/S0002-9440(10)64335-0; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Chen ST, 2004, INT J MOL MED, V14, P577; Dai CS, 2003, J BIOL CHEM, V278, P12537, DOI 10.1074/jbc.M300777200; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; Engelman JA, 1999, J BIOL CHEM, V274, P32333, DOI 10.1074/jbc.274.45.32333; Finlay GA, 2000, J BIOL CHEM, V275, P27650; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Fujimoto T, 2000, J CELL SCI, V113, P3509; Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Ho CC, 2002, AM J PATHOL, V161, P1647, DOI 10.1016/S0002-9440(10)64442-2; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Jin Y, 2011, AM J PHYSIOL-LUNG C, V300, pL151, DOI 10.1152/ajplung.00170.2010; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KEHRL JH, 1986, J IMMUNOL, V137, P3855; Khalil N, 2005, J BIOL CHEM, V280, P43000, DOI 10.1074/jbc.M510441200; LEOF EB, 1986, P NATL ACAD SCI USA, V83, P2453, DOI 10.1073/pnas.83.8.2453; Liu J, 2001, AM J PHYSIOL-CELL PH, V280, pC823, DOI 10.1152/ajpcell.2001.280.4.C823; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; MULLER G, 1987, P NATL ACAD SCI USA, V84, P5600, DOI 10.1073/pnas.84.16.5600; Muraoka-Cook RS, 2005, CLIN CANCER RES, V11, p937S; NABEL EG, 1993, P NATL ACAD SCI USA, V90, P10759, DOI 10.1073/pnas.90.22.10759; Nho RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061017; Oeztuerk-Winder F, 2012, EMBO J, V31, P3431, DOI 10.1038/emboj.2012.192; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Qiu P, 2003, J MOL CELL CARDIOL, V35, P1407, DOI 10.1016/j.yjmcc.2003.09.002; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; ROSENBAUM J, 1995, GASTROENTEROLOGY, V109, P1986, DOI 10.1016/0016-5085(95)90767-X; Sanders YY, 2014, EUR RESPIR J, V43, P1448, DOI 10.1183/09031936.00095113; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; TAKEHARA K, 1987, CELL, V49, P415, DOI 10.1016/0092-8674(87)90294-7; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; Thannickal VJ, 1998, BIOCHEM BIOPH RES CO, V251, P437, DOI 10.1006/bbrc.1998.9443; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; TUCKER RF, 1984, SCIENCE, V226, P705, DOI 10.1126/science.6093254; Walker GA, 2001, CURR TOP DEV BIOL, V51, P91, DOI 10.1016/S0070-2153(01)51003-0; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Williams TM, 2004, J BIOL CHEM, V279, P24745, DOI 10.1074/jbc.M402064200; Xia H, 2010, AM J PATHOL, V176, P2626, DOI 10.2353/ajpath.2010.091117; Yang G, 1998, CLIN CANCER RES, V4, P1873; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366	57	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116995	10.1371/journal.pone.0116995	http://dx.doi.org/10.1371/journal.pone.0116995			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658089	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900088
J	Zhou, ZH; Wu, SC; Wang, CY; Ma, HY; Lin, CC; Tsui, PH				Zhou, Zhuhuang; Wu, Shuicai; Wang, Chiao-Yin; Ma, Hsiang-Yang; Lin, Chung-Chih; Tsui, Po-Hsiang			Monitoring Radiofrequency Ablation Using Real-Time Ultrasound Nakagami Imaging Combined with Frequency and Temporal Compounding Techniques	PLOS ONE			English	Article							INTENSITY FOCUSED ULTRASOUND; INDUCED THERMAL LESIONS; IN-VIVO; STATISTICAL-MODEL; EX-VIVO; ELASTOGRAPHY; FEASIBILITY; RECONSTRUCTION; DIVERSITY; TISSUES	Gas bubbles induced during the radiofrequency ablation (RFA) of tissues can affect the detection of ablation zones (necrosis zone or thermal lesion) during ultrasound elastography. To resolve this problem, our previous study proposed ultrasound Nakagami imaging for detecting thermal-induced bubble formation to evaluate ablation zones. To prepare for future applications, this study (i) created a novel algorithmic scheme based on the frequency and temporal compounding of Nakagami imaging for enhanced ablation zone visualization, (ii) integrated the proposed algorithm into a clinical scanner to develop a real-time Nakagami imaging system for monitoring RFA, and (iii) investigated the applicability of Nakagami imaging to various types of tissues. The performance of the real-time Nakagami imaging system in visualizing RFA-induced ablation zones was validated by measuring porcine liver (n = 18) and muscle tissues (n = 6). The experimental results showed that the proposed algorithm can operate on a standard clinical ultrasound scanner to monitor RFA in real time. The Nakagami imaging system effectively monitors RFA-induced ablation zones in liver tissues. However, because tissue properties differ, the system cannot visualize ablation zones in muscle fibers. In the future, real-time Nakagami imaging should be focused on the RFA of the liver and is suggested as an alternative monitoring tool when advanced elastography is unavailable or substantial bubbles exist in the ablation zone.	[Zhou, Zhuhuang; Wu, Shuicai] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China; [Wang, Chiao-Yin; Ma, Hsiang-Yang; Tsui, Po-Hsiang] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Wang, Chiao-Yin; Ma, Hsiang-Yang] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Lin, Chung-Chih] Chang Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan; [Tsui, Po-Hsiang] Chang Gung Univ, Inst Radiol Res, Med Imaging Res Ctr, Taoyuan, Taiwan; [Tsui, Po-Hsiang] Chang Gung Mem Hosp Linkou, Taoyuan, Taiwan	Beijing University of Technology; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Wu, SC (corresponding author), Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China.	wushuicai@bjut.edu.cn; tsuiph@mail.cgu.edu.tw	Tsui, Po-Hsiang/AHE-7426-2022; Zhou, Zhuhuang/M-3301-2019	Zhou, Zhuhuang/0000-0003-0570-8473; Tsui, Po-Hsiang/0000-0002-5604-1800	Ministry of Science and Technology (Taiwan) [MOST 103-2221-E-182-001-MY3]; Chang Gung Memorial Hospital (Linkou, Taiwan) [CMRPD1C0711]; Doctoral Fund of Innovation of Beijing University of Technology; National Natural Science Foundation of China [81127006]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital (Linkou, Taiwan)(Chang Gung Memorial Hospital); Doctoral Fund of Innovation of Beijing University of Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology (Taiwan) (Grant No. MOST 103-2221-E-182-001-MY3) and the Chang Gung Memorial Hospital (Linkou, Taiwan) (Grant No. CMRPD1C0711). This work was also supported by the Doctoral Fund of Innovation of Beijing University of Technology and in part by the National Natural Science Foundation of China (Grant No. 81127006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chiou SY, 2007, J ULTRAS MED, V26, P487, DOI 10.7863/jum.2007.26.4.487; Curley SA, 1999, ANN SURG, V230, P1, DOI 10.1097/00000658-199907000-00001; DeWall RJ, 2012, IEEE T BIO-MED ENG, V59, P728, DOI 10.1109/TBME.2011.2178848; DeWall RJ, 2012, IEEE T ULTRASON FERR, V59, P168, DOI 10.1109/TUFFC.2012.2169; Dumane VA, 2002, IEEE T ULTRASON FERR, V49, P664, DOI 10.1109/TUFFC.2002.1002466; Dumane VA, 2001, IEEE T ULTRASON FERR, V48, P1139, DOI 10.1109/58.935733; Fahey BJ, 2004, ULTRASOUND MED BIOL, V30, P321, DOI 10.1016/j.ultrasmedbio.2003.11.012; Fahey BJ, 2008, ULTRASOUND MED BIOL, V34, P1590, DOI 10.1016/j.ultrasmedbio.2008.03.006; Foroughi P, 2012, P SOC PHOTO-OPT INS, V8320; Gazelle GS, 2000, RADIOLOGY, V217, P633, DOI 10.1148/radiology.217.3.r00dc26633; Ingle A, 2014, IEEE T MED IMAGING, V33, P1677, DOI 10.1109/TMI.2014.2321285; Jiang JF, 2009, IEEE T MED IMAGING, V28, P1325, DOI 10.1109/TMI.2009.2015355; Kolokythas O, 2008, J ULTRAS MED, V27, P935, DOI 10.7863/jum.2008.27.6.935; Kwon HJ, 2011, WORLD J GASTROENTERO, V17, P1874, DOI 10.3748/wjg.v17.i14.1874; Machi J, 2001, J GASTROINTEST SURG, V5, P477, DOI 10.1016/S1091-255X(01)80085-8; Malkin RA, 2007, ANNU REV BIOMED ENG, V9, P567, DOI 10.1146/annurev.bioeng.9.060906.151913; Mariani A, 2014, J SURG RES, V188, P37, DOI 10.1016/j.jss.2013.12.024; Pareek G, 2006, J ENDOUROL, V20, P959, DOI 10.1089/end.2006.20.959; Rangraz P, 2014, P I MECH ENG H, V228, P19, DOI 10.1177/0954411913511777; Rivaz H, 2008, LECT NOTES COMPUT SC, V5242, P458, DOI 10.1007/978-3-540-85990-1_55; Shankar PM, 2000, IEEE T ULTRASON FERR, V47, P727, DOI 10.1109/58.842062; Tanter M, 2014, IEEE T ULTRASON FERR, V61, P102, DOI [10.1109/TUFFC.2014.2882, 10.1109/TUFFC.2014.6689779]; Tsui PH, 2004, ULTRASOUND MED BIOL, V30, P1345, DOI 10.1016/j.ultrasmedbio.2004.08.009; Tsui PH, 2007, ULTRASOUND MED BIOL, V33, P608, DOI 10.1016/j.ultrasmedbio.2006.10.005; van Vledder MG, 2010, HPB, V12, P717, DOI 10.1111/j.1477-2574.2010.00247.x; Varghese T, 2004, ULTRASONIC IMAGING, V26, P18, DOI 10.1177/016173460402600102; Varghese T, 2004, J ULTRAS MED, V23, P535, DOI 10.7863/jum.2004.23.4.535; Varghese T, 2003, AM J ROENTGENOL, V181, P701, DOI 10.2214/ajr.181.3.1810701; Varghese T, 2002, ULTRASOUND MED BIOL, V28, P1467, DOI 10.1016/S0301-5629(02)00656-7; Wang CY, 2013, MED PHYS, V40, DOI 10.1118/1.4808115; Zhang M, 2008, MED PHYS, V35, P4132, DOI 10.1118/1.2968939; Zhang SY, 2014, J ULTRAS MED, V33, P959, DOI 10.7863/ultra.33.6.959; Zhang SY, 2012, J ACOUST SOC AM, V131, P4836, DOI 10.1121/1.4711005; Zhou ZH, 2014, P I MECH ENG H, V228, P1069, DOI 10.1177/0954411914554438; Zhou ZH, 2014, ULTRASONIC IMAGING, V36, P256, DOI 10.1177/0161734614524735; Zhou ZH, 2013, ULTRASONICS, V53, P1325, DOI 10.1016/j.ultras.2013.03.018	37	41	44	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118030	10.1371/journal.pone.0118030	http://dx.doi.org/10.1371/journal.pone.0118030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658424	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900252
J	Hanke, K; Liu, JH; Sibley, CG; Paez, D; Gaines, SO; Moloney, G; Leong, CH; Wagner, WG; Licata, L; Klein, O; Garber, I; Bohm, G; Hilton, DJ; Valchev, V; Khan, SS; Cabecinhas, R				Hanke, Katja; Liu, James H.; Sibley, Chris G.; Paez, Dario; Gaines, Stanley O., Jr.; Moloney, Gail; Leong, Chan-Hoong; Wagner, Wolfgang; Licata, Laurent; Klein, Olivier; Garber, Ilya; Boehm, Gisela; Hilton, Denis J.; Valchev, Velichko; Khan, Sammyh S.; Cabecinhas, Rosa			"Heroes" and "Villains" of World History across Cultures	PLOS ONE			English	Article							SOCIAL REPRESENTATIONS; COLLECTIVE MEMORY; IDENTITY; EVENTS; DYNAMICS; BELIEFS; PEOPLE	Emergent properties of global political culture were examined using data from the World History Survey (WHS) involving 6,902 university students in 37 countries evaluating 40 figures from world history. Multidimensional scaling and factor analysis techniques found only limited forms of universality in evaluations across Western, Catholic/Orthodox, Muslim, and Asian country clusters. The highest consensus across cultures involved scientific innovators, with Einstein having the most positive evaluation overall. Peaceful humanitarians like Mother Theresa and Gandhi followed. There was much less cross-cultural consistency in the evaluation of negative figures, led by Hitler, Osama bin Laden, and Saddam Hussein. After more traditional empirical methods (e.g., factor analysis) failed to identify meaningful cross-cultural patterns, Latent Profile Analysis (LPA) was used to identify four global representational profiles: Secular and Religious Idealists were overwhelmingly prevalent in Christian countries, and Political Realists were common in Muslim and Asian countries. We discuss possible consequences and interpretations of these different representational profiles.	[Hanke, Katja] Jacobs Univ Bremen, Bremen Int Grad Sch Social Sci, D-28759 Bremen, Germany; [Liu, James H.] Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand; [Sibley, Chris G.] Univ Auckland, Sch Psychol, Auckland 1, New Zealand; [Paez, Dario] Univ Basque Country, Sch Psychol, San Sebastian, Spain; [Gaines, Stanley O., Jr.] Brunel Univ, Sch Social Sci, London, England; [Moloney, Gail] So Cross Univ, Dept Psychol, Lismore, NSW 2480, Australia; [Leong, Chan-Hoong] Natl Univ Singapore, Inst Policy Studies, Singapore 117548, Singapore; [Wagner, Wolfgang] Johannes Kepler Univ Linz, Dept Social & Econ Psychol, A-4040 Linz, Austria; [Licata, Laurent; Klein, Olivier] Univ Libre Bruxelles, Ctr Social & Cultural Psychol, Brussels, Belgium; [Garber, Ilya] Saratov NG Chernyshevskii State Univ, Dept Pedag & Psychol Profess Educ, Saratov, Russia; [Boehm, Gisela] Univ Bergen, Fac Psychol, Bergen, Norway; [Hilton, Denis J.] Univ Toulouse 2, Toulouse, France; [Valchev, Velichko] Tilburg Univ, Dept Cross Cultural Psychol, NL-5000 LE Tilburg, Netherlands; [Khan, Sammyh S.] Univ Exeter, Sch Med, Exeter, Devon, England; [Cabecinhas, Rosa] Univ Minho, Inst Social Sci, Braga, Portugal	Jacobs University; Victoria University Wellington; University of Auckland; University of Basque Country; Brunel University; University of Greenwich; Southern Cross University; National University of Singapore; Johannes Kepler University Linz; Universite Libre de Bruxelles; Saratov State University; University of Bergen; Universite de Toulouse; Universite de Toulouse - Jean Jaures; Tilburg University; University of Exeter; Universidade do Minho	Liu, JH (corresponding author), Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand.	james.liu@vuw.ac.nz	Sibley, Chris G/D-2974-2009; Garber, Ilya/AET-1120-2022; Wagner, Wolfgang/A-3199-2009; Garber, Ilya E./O-1959-2015; Fetvadjiev, Velichko H./M-7570-2016; Paez, Dario/D-5207-2009; Khan, Sammyh/AAS-7704-2020; Leong, Chan-Hoong/AAL-2896-2020; Cabecinhas, Rosa/W-4198-2017; Moloney, Gail/P-4631-2015; Klein, Olivier/F-1954-2011	Sibley, Chris G/0000-0002-4064-8800; Garber, Ilya/0000-0001-9429-8976; Wagner, Wolfgang/0000-0001-8272-0551; Garber, Ilya E./0000-0001-9429-8976; Fetvadjiev, Velichko H./0000-0002-5475-5121; Paez, Dario/0000-0002-8459-6037; Khan, Sammyh/0000-0001-7048-9786; Leong, Chan-Hoong/0000-0002-6337-2157; Cabecinhas, Rosa/0000-0002-1491-3420; Moloney, Gail/0000-0002-3022-9637; Meiring, Deon/0000-0003-3458-2064; Klein, Olivier/0000-0003-2737-8049; Licata, Laurent/0000-0002-7379-7335; Liu, James/0000-0001-9520-5727	Chiang Ching-Kuo Foundation for International Scholarly Exchange [RG016-P-10]	Chiang Ching-Kuo Foundation for International Scholarly Exchange	This research was supported by grant RG016-P-10 from the Chiang Ching-Kuo Foundation for International Scholarly Exchange (http://www.cckf.org.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, MPLUS USERS GUIDE; Appadurai A., 1998, MODERNITY LARGE CULT, V4; ASCH SE, 1946, J ABNORM SOC PSYCH, V41, P258, DOI 10.1037/h0055756; Bliese P.D., 2000, MULTILEVEL THEORY RE, P349; Bobowik M, 2010, REV PSICOL-LIMA, V28, P111; Burke Edmund, 2009, REFLECTIONS REVOLUTI; Calhoun C, 2002, S ATL Q, V101, P869, DOI 10.1215/00382876-101-4-869; Douglas M., 1970, NATURAL SYMBOLS EXPL; Fowler C, 2004, ARCHAEOLOGY PERSONHO; Freud S, 1922, GROUP PSYCHOL ANAL E; Fuchs D., 2007, OXFORD HDB POLITICAL, P161, DOI 10.1093/OXFORDHB/9780199270125.003.0009; Fukuyama F., 1992, END HIST LAST MAN; Garcia-- Moreno Laura, 1996, TEXT NATION CROSSDIS, P191; GREENSTEIN FI, 1960, AM POLIT SCI REV, V54, P934, DOI 10.2307/1952644; Greenstein Fred, 1975, HDB POLITICAL SCI; GUPTA A, 1992, CULT ANTHROPOL, V7, P6, DOI 10.1525/can.1992.7.1.02a00020; Hagenaars J., 2002, APPL LATENT CLASS AN, DOI DOI 10.1017/CBO9780511499531; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hilton DJ, 2008, HANDBOOK OF MOTIVATION AND COGNITION ACROSS CULTURES, P343, DOI 10.1016/B978-0-12-373694-9.00015-5; Hobsbawm Eric, 1983, INVENTED TRADITION; Hofstede G, 2001, CULTURES CONSEQUENCE, DOI [10.1007/s10508-008-9420-3, DOI 10.1007/S10508-008-9420-3]; Hogg MA, 2001, PERS SOC PSYCHOL REV, V5, P184, DOI 10.1207/S15327957PSPR0503_1; Inda Jonathan Xavier, 2002, ANTHR GLOBALIZATION, P1; Inglehart R, 2000, AM SOCIOL REV, V65, P19, DOI 10.2307/2657288; Kaplan R. D., 2012, REVENGE GEOGRAPHY; Leichtman MA, 2012, CITY SOC, V24, P1, DOI 10.1111/j.1548-744X.2012.01064.x; Liu J.H., 2010, OXFORD HDB CHINESE P, P579, DOI DOI 10.1093/OXFORDHB/9780199541850.001.0001; Liu JH, 2012, J CROSS CULT PSYCHOL, V43, P251, DOI 10.1177/0022022110390926; Liu JH, 2009, J CROSS CULT PSYCHOL, V40, P667, DOI 10.1177/0022022109335557; Liu JH, 2005, BRIT J SOC PSYCHOL, V44, P537, DOI 10.1348/014466605X27162; Liu JH, 2005, J CROSS CULT PSYCHOL, V36, P171, DOI 10.1177/0022022104272900; Macrae CN., 2010, HDB SOCIAL PSYCHOL, P428, DOI [10.1002/9780470561119.socpsy001012, DOI 10.1002/9780470561119.SOCPSY001012]; Moscovici S., 1961, PSYCHANALYSE; Nussbaum Martha, 1994, BOSTON REV, V19, P3; Olick JK, 1998, ANNU REV SOCIOL, V24, P105, DOI 10.1146/annurev.soc.24.1.105; Reicher S, 2005, LEADERSHIP QUART, V16, P547, DOI 10.1016/j.leaqua.2005.06.007; Reicher Stephen D., 2001, SELF NATION CATEGORI; RINDSKOPF D, 1986, STAT MED, V5, P21, DOI 10.1002/sim.4780050105; Ritzer G., 2011, GLOBALIZATION ESSENT; Sahlins M, 2004, APOLOGIES THUCYDIDES; SCHNEIDER DJ, 1973, PSYCHOL BULL, V79, P294, DOI 10.1037/h0034496; Schwartz B, 1997, SOCIOL QUART, V38, P469, DOI 10.1111/j.1533-8525.1997.tb00488.x; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; Sears D.O., 2013, OXFORD HDB POLITICAL, V2nd, P59; Sibley CG, 2013, EUR J SOC PSYCHOL, V43, P160, DOI 10.1002/ejsp.1931; Sibley CG, 2012, EUR J SOC PSYCHOL, V42, P589, DOI 10.1002/ejsp.1870; van de Vijver FJR, 2002, J CROSS CULT PSYCHOL, V33, P141, DOI 10.1177/0022022102033002002; van Hooft Stan, 2009, COSMOPOLITANISM PHIL; van Ypersele L, 2006, QUESTIONS HIST CONT, P149, DOI [10.1111/pan.12575, DOI 10.1111/PAN.12575]; Wagner W., 2005, EVERYDAY DISCOURSE C; Wertsch J.V., 2002, VOICES COLLECTIVE RE; Wilson MS, 2014, RELIG BRAIN BEHAV, V4, P104, DOI 10.1080/2153599X.2013.779934	52	29	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0115641	10.1371/journal.pone.0115641	http://dx.doi.org/10.1371/journal.pone.0115641			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CA9NG	25651504	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000349250700002
J	Nakatochi, M; Ushida, Y; Yasuda, Y; Yoshida, Y; Kawai, S; Kato, R; Nakashima, T; Iwata, M; Kuwatsuka, Y; Ando, M; Hamajima, N; Kondo, T; Oda, H; Hayashi, M; Kato, S; Yamaguchi, M; Maruyama, S; Matsuo, S; Honda, H				Nakatochi, Masahiro; Ushida, Yasunori; Yasuda, Yoshinari; Yoshida, Yasuko; Kawai, Shun; Kato, Ryuji; Nakashima, Toru; Iwata, Masamitsu; Kuwatsuka, Yachiyo; Ando, Masahiko; Hamajima, Nobuyuki; Kondo, Takaaki; Oda, Hiroaki; Hayashi, Mutsuharu; Kato, Sawako; Yamaguchi, Makoto; Maruyama, Shoichi; Matsuo, Seiichi; Honda, Hiroyuki			Identification of an Interaction between VWF rs7965413 and Platelet Count as a Novel Risk Marker for Metabolic Syndrome: An Extensive Search of Candidate Polymorphisms in a Case-Control Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VON-WILLEBRAND-FACTOR; CORONARY-HEART-DISEASE; INSULIN-RESISTANCE; GENETIC-VARIANTS; DIABETIC-NEPHROPATHY; SUSCEPTIBILITY; OBESITY; LOCI; METAANALYSIS	Although many single nucleotide polymorphisms (SNPs) have been identified to be associated with metabolic syndrome (MetS), there was only a slight improvement in the ability to predict future MetS by the simply addition of SNPs to clinical risk markers. To improve the ability to predict future MetS, combinational effects, such as SNP-SNP interaction, SNP-environment interaction, and SNP-clinical parameter (SNP x CP) interaction should be also considered. We performed a case-control study to explore novel SNP x CP interactions as risk markers for MetS based on health check-up data of Japanese male employees. We selected 99 SNPs that were previously reported to be associated with MetS and components of MetS; subsequently, we genotyped these SNPs from 360 cases and 1983 control subjects. First, we performed logistic regression analyses to assess the association of each SNP with MetS. Of these SNPs, five SNPs were significantly associated with MetS (P < 0.05): LRP2 rs2544390, rs1800592 between UCP1 and TBC1D9, APOA5 rs662799, VWF rs7965413, and rs1411766 between MYO16 and IRS2. Furthermore, we performed multiple logistic regression analyses, including an SNP term, a CP term, and an SNP x CP interaction term for each CP and SNP that was significantly associated with MetS. We identified a novel SNP x CP interaction between rs7965413 and platelet count that was significantly associated with MetS [SNP term: odds ratio ( OR) = 0.78, P = 0.004; SNP x CP interaction term: OR = 1.33, P = 0.001]. This association of the SNP x CP interaction with MetS remained nominally significant in multiple logistic regression analysis after adjustment for either the number of MetS components or MetS components excluding obesity. Our results reveal new insight into platelet count as a risk marker for MetS.	[Nakatochi, Masahiro; Kuwatsuka, Yachiyo; Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Ushida, Yasunori; Honda, Hiroyuki] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Nagoya, Aichi 4648601, Japan; [Yasuda, Yoshinari; Kato, Sawako; Yamaguchi, Makoto; Maruyama, Shoichi; Matsuo, Seiichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan; [Yasuda, Yoshinari] Nagoya Univ, Grad Sch Med, Dept CKD Initiat, Nagoya, Aichi 4648601, Japan; [Yoshida, Yasuko; Honda, Hiroyuki] Nagoya Univ, Innovat Res Ctr Prevent Med Engn, Nagoya, Aichi 4648601, Japan; [Kawai, Shun; Kato, Ryuji] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Nagoya, Aichi 4648601, Japan; [Nakashima, Toru; Iwata, Masamitsu] Toyota Motor Co Ltd, Safety & Hlth Promot Div, Toyota, Japan; [Hamajima, Nobuyuki] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi 4648601, Japan; [Kondo, Takaaki] Nagoya Univ, Grad Sch Med, Program Radiol & Med Lab Sci, Nagoya, Aichi 4648601, Japan; [Oda, Hiroaki] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan; [Hayashi, Mutsuharu] Fujita Hlth Univ, Hosp 2, Dept Cardiol, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; Nagoya University; Nagoya University; Toyota Motor Corporation; Nagoya University; Nagoya University; Nagoya University; Fujita Health University	Honda, H (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Nagoya, Aichi 4648601, Japan.	honda@nubio.nagoya-u.ac.jp	Nakatochi, Masahiro/Q-1247-2015; Hamajima, Nobuyuki/I-7237-2014; Kato, Sawako/T-2422-2019; ANDO, Masahiko/F-7035-2015; Kato, Ryuji/I-6952-2014	Nakatochi, Masahiro/0000-0002-1838-4837; Kato, Sawako/0000-0001-7210-1888; 	Toyota Motor Co., Ltd; Grants-in-Aid for Scientific Research [15H04792] Funding Source: KAKEN	Toyota Motor Co., Ltd; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support for this work was provided by Toyota Motor Co., Ltd which employs two authors (TN MI). Toyota Motor contributed to study design and decision to publish.	Aiken L. S., 1991, MULTIPLE REGRESSION, V11; Dalgaard LT, 2001, DIABETOLOGIA, V44, P946, DOI 10.1007/s001250100596; Defago MD, 2013, AM J HYPERTENS, V26, P643, DOI 10.1093/ajh/hps099; Di Bitondo R, 2001, BRIT J HAEMATOL, V115, P701, DOI 10.1046/j.1365-2141.2001.03176.x; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Grallert H, 2007, J LIPID RES, V48, P2614, DOI 10.1194/jlr.M700011-JLR200; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jia JJ, 2010, MOL BIOL REP, V37, P1513, DOI 10.1007/s11033-009-9550-2; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Keightley AM, 1999, BLOOD, V93, P4277, DOI 10.1182/blood.V93.12.4277.412k03_4277_4283; Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Maeda S, 2010, DIABETES, V59, P2075, DOI 10.2337/db10-0067; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Maric C, 2011, CONTRIB NEPHROL, V170, P28, DOI 10.1159/000324941; McCurry J, 2004, LANCET, V363, P1126, DOI 10.1016/S0140-6736(04)15942-4; Meigs JB, 2000, JAMA-J AM MED ASSOC, V283, P221, DOI 10.1001/jama.283.2.221; Metabolic Syndrome Diagnostic Criteria Review Committee, 2005, J JPN SOC INT MED, V94, P188; *MIN HLTH LAB WELF, 2007, THE WHITE PAPER OF T, P97; *MIN HLTH LAB WELF, 2007, OUTLINE FOR THE RESU, P28669, DOI DOI 10.1093/JXB/ERM028; Nakatochi M, 2011, DIABETES RES CLIN PR, V92, pE61, DOI 10.1016/j.diabres.2011.02.029; Nebeck K, 2012, DIABETES METAB SYND, V6, P22, DOI 10.1016/j.dsx.2012.05.009; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Paulik MA, 1998, PHARM RES-DORDR, V15, P944, DOI 10.1023/A:1011993019385; Pezzolesi MG, 2009, DIABETES, V58, P1403, DOI 10.2337/db08-1514; Povel CM, 2011, OBES REV, V12, P952, DOI 10.1111/j.1467-789X.2011.00907.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ragab Amany, 2008, Lab Hematol, V14, P1, DOI 10.1532/LH96.07017; RUGGERI ZM, 1993, FASEB J, V7, P308, DOI 10.1096/fasebj.7.2.8440408; Taniguchi A, 2003, METABOLISM, V52, P1246, DOI 10.1016/S0026-0495(03)00099-4; TAO LX, 2013, ENDOCRINE, P28669, DOI DOI 10.1007/S12020-013-0144-3; Ushida Y, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-80; van der Meer IM, 2004, BRIT J HAEMATOL, V124, P343, DOI 10.1046/j.1365-2141.2003.04776.x; Vischer UM, 2006, J THROMB HAEMOST, V4, P1186, DOI 10.1111/j.1538-7836.2006.01949.x; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Whincup RH, 2002, EUR HEART J, V23, P1764, DOI 10.1053/euhj.2001.3237; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-989; Xu CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056216; Yamada Y, 2007, ATHEROSCLEROSIS, V191, P298, DOI 10.1016/j.atherosclerosis.2006.05.035; Yin RX, 2008, AM J MED, V121, P811, DOI 10.1016/j.amjmed.2008.04.026; Zabaneh D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011961	44	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117591	10.1371/journal.pone.0117591	http://dx.doi.org/10.1371/journal.pone.0117591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646961	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600077
J	White, MJ; Eren, F; Agirbasli, D; Williams, SM; Agirbasli, M				White, Marquitta J.; Eren, Fatih; Agirbasli, Deniz; Williams, Scott M.; Agirbasli, Mehmet			SHBG Gene Polymorphism (rs1799941) Associates with Metabolic Syndrome in Children and Adolescents	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; BODY-MASS INDEX; CHOLESTEROL LEVELS; SEX-HORMONES; DISEASE RISK; LIPID-LEVELS; INSULIN; TURKISH; OBESITY; POPULATION	Background Metabolic syndrome (MetS) is a complex disorder characterized by coexistence of several cardiometabolic (CM) factors, i.e. hyperlipidemia, obesity, high blood pressure and insulin resistance. The presence of MetS is strongly associated with increased risk of cardiovascular disease (CVD). The syndrome was originally defined as an adult disorder, but MetS has become increasingly recognized in children and adolescents. Methods Genetic variants influence biological components common to the CM factors that comprise MetS. We investigated single locus associations between six single nucleotide polymorphisms (SNPs), previously shown to modulate lipid or sex hormone binding globulin (SHBG) levels, with MetS in a Turkish pediatric cohort (37 cases, 323 controls). Results Logistic regression analysis revealed a significant association between rs1799941, located in SHBG, and MetS (OR = 3.09, p-value = 0.006). The association with MetS remained after sequential adjustment for each CM factor included in the syndrome definition, indicating that the identified association is not being driven by any single trait. A relationship between rs1799941 and SHBG levels, was also discovered, but it was dependent on MetS status. In control subjects, the A allele of rs1799941 associated with a significant increase in SHBG levels (p = 0.012), while in cases there was no association between rs1799941 and SHBG levels (p = 0.963). Conclusions The significant association between rs1799941 and MetS in children is not contingent on any single CM trait. Additionally, the presence of MetS may abrogate effect of rs1799941 polymorphism on SHBG levels in children.	[White, Marquitta J.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [White, Marquitta J.; Williams, Scott M.] Dartmouth Coll, Inst Quantitat Biomed Sci, Dept Genet, Hanover, NH 03755 USA; [Eren, Fatih] Marmara Univ, Sch Med, Dept Med Biol, Istanbul, Turkey; [Agirbasli, Deniz] Acibadem Univ, Sch Med, Dept Med Biol, Istanbul, Turkey; [Agirbasli, Mehmet] Marmara Univ, Sch Med, Dept Cardiol, Istanbul, Turkey	Vanderbilt University; Dartmouth College; Marmara University; Acibadem University; Marmara University	Agirbasli, M (corresponding author), Marmara Univ, Sch Med, Dept Cardiol, Istanbul, Turkey.	magirbasli@gmail.com	Williams, Scott/Q-4812-2019; Ağırbaşlı, Deniz/ABG-4903-2021; Agirbasli, Deniz/D-2525-2015; eren, fatih/AAS-6286-2020; Ağırbaşlı, Deniz/AAY-6306-2020	Williams, Scott/0000-0002-4835-9544; Ağırbaşlı, Deniz/0000-0003-2584-451X; eren, fatih/0000-0001-8126-2413; 	Scientific Research Council of Turkey (TUBITAK) [109S282]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER	Scientific Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was funded by the Scientific Research Council of Turkey (TUBITAK) Project Number: 109S282. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahaman A, 2005, METABOLISM, V54, P91, DOI 10.1016/j.metabol.2004.07.018; Agirbasli M, 2005, PREV MED, V41, P843, DOI 10.1016/j.ypmed.2005.08.001; Agirbasli M, 2013, OMICS, V17, P636, DOI 10.1089/omi.2013.0066; Agirbasli M, 2010, HORM RES PAEDIAT, V73, P166, DOI 10.1159/000284357; Agirbasli M, 2009, METABOLISM, V58, P1256, DOI 10.1016/j.metabol.2009.03.024; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Asselbergs FW, 2013, CURR OPIN LIPIDOL, V24, P123, DOI 10.1097/MOL.0b013e32835df2d6; Balkau B, 1999, DIABETIC MED, V16, P442; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Oya I, 2010, PEDIATR DIABETES, V11, P188, DOI 10.1111/j.1399-5448.2009.00559.x; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Dunning AM, 2004, JNCI-J NATL CANCER I, V96, P936, DOI 10.1093/jnci/djh167; Genuth S, 2003, DIABETES CARE, V26, P3160; Gungor N, 2004, J PEDIATR-US, V144, P47, DOI 10.1016/j.jpeds.2003.09.045; Haiman CA, 2005, J CLIN ENDOCR METAB, V90, P2198, DOI 10.1210/jc.2004-1417; Hammond GL, 2012, CURR OPIN ENDOCRINOL, V19, P183, DOI 10.1097/MED.0b013e328353732f; Hatipoglu N, 2008, EUR J PEDIATR, V167, P383, DOI 10.1007/s00431-007-0502-3; Hergenc G, 1999, ATHEROSCLEROSIS, V145, P147, DOI 10.1016/S0021-9150(99)00027-1; Hodoglugil U, 1999, J LIPID RES, V40, P432; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Jago R, 2006, PEDIATRICS, V117, P2065, DOI 10.1542/peds.2005-1716; Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F; Keskin M, 2005, PEDIATRICS, V115, pE500, DOI 10.1542/peds.2004-1921; Koyama S, 2014, PEDIATRICS, V133, pE114, DOI 10.1542/peds.2013-0966; Krishnasamy SS, 2012, ENDOCR PRACT, V18, P668, DOI 10.4158/EP12026.OR; LAAKSO M, 1993, AM J EPIDEMIOL, V137, P959, DOI 10.1093/oxfordjournals.aje.a116768; Messiah SE, 2013, OBESITY, V21, P424, DOI 10.1002/oby.20343; Neyzi O., 1993, PEDIATRI, P69, DOI [10.1007/BF00235292, DOI 10.1007/BF00235292]; NGHS Coordinating Center, 1998 NHLBI GROWTH HL; Onat A, 2008, METABOLISM, V57, P207, DOI 10.1016/j.metabol.2007.09.002; Ordovas JM, 2000, ARTERIOSCL THROM VAS, V20, P1323, DOI 10.1161/01.ATV.20.5.1323; Ozanne SE, 2002, TRENDS ENDOCRIN MET, V13, P368, DOI 10.1016/S1043-2760(02)00666-5; Pirruccello J, 2010, CURR OPIN CARDIOL, V25, P238, DOI 10.1097/HCO.0b013e328338574d; Prodam F, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-44; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Riancho JA, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-112; ROSNER B, 1993, J PEDIATR-US, V123, P871, DOI 10.1016/S0022-3476(05)80382-8; Skilton MR, 2013, PEDIATRICS, V131, pE1821, DOI 10.1542/peds.2012-2789; StataCorp, 2021, STATA STAT SOFTWARE; Sunbul M, 2013, CARDIOL J, V20, P287, DOI 10.5603/CJ.2013.0074; Svartberg J, 2014, ANDROLOGY-US, V2, P212, DOI 10.1111/j.2047-2927.2013.00174.x; Team R Core, 2013, R LANG ENV STAT COMP; Warnes GR, 2013, GPLOTS VARIOUS R PRO; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Weissglas-Volkov D, 2010, J LIPID RES, V51, P2032, DOI 10.1194/jlr.R004739; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	47	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116915	10.1371/journal.pone.0116915	http://dx.doi.org/10.1371/journal.pone.0116915			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647406	gold, Green Submitted, Green Published			2022-12-27	WOS:000348822600042
J	Matthijsse, SM; van Rosmalen, J; Hontelez, JAC; Bakker, R; de Kok, IMCM; van Ballegooijen, M; de Vlas, SJ				Matthijsse, Suzette M.; van Rosmalen, Joost; Hontelez, Jan A. C.; Bakker, Roel; de Kok, Inge M. C. M.; van Ballegooijen, Marjolein; de Vlas, Sake J.			The Role of Acquired Immunity in the Spread of Human Papillomavirus (HPV): Explorations with a Microsimulation Model	PLOS ONE			English	Article							AGE-DEPENDENT PREVALENCE; NATURAL-HISTORY; CERVICAL-CANCER; CONTROLLED-TRIAL; SEXUAL-BEHAVIOR; NORMAL CYTOLOGY; INFECTION; WOMEN; RISK; EPIDEMIOLOGY	Background: Knowledge of the natural history of human papillomavirus (HPV), in particular the role of immunity, is crucial in estimating the (cost-) effectiveness of HPV vaccination and cervical cancer screening strategies, because naturally acquired immunity after clearing an infection may already protect part of the risk population against new HPV infections. Methods: We used STDSIM, an established stochastic microsimulation model, quantified to the Netherlands. We explored different assumptions regarding the natural history of HPV-16 and HPV-18, and estimated the transmission probabilities and durations of acquired immunity necessary to reproduce age-specific prevalence. Results: A model without acquired immunity cannot reproduce the age-specific patterns of HPV. Also, it is necessary to assume a high degree of individual variation in the duration of infection and acquired immunity. According to the model estimates, on average 20% of women are immune for HPV-16 and 15% for HPV-18. After an HPV-16 infection, 50% are immune for less than 1 year, whereas 20% exceed 30 years. For HPV-18, up to 12% of the individuals are immune for less than 1 year, and about 50% over 30 years. Almost half of all women will never acquire HPV-16 or HPV-18. Conclusions: Acquired immunity likely plays a major role in HPV epidemiology, but its duration shows substantial variation. Combined with the lifetime risk, this explains to a large extent why many women will never develop cervical cancer.	[Matthijsse, Suzette M.; Hontelez, Jan A. C.; Bakker, Roel; de Kok, Inge M. C. M.; van Ballegooijen, Marjolein; de Vlas, Sake J.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [van Rosmalen, Joost] Erasmus MC, Univ Med Ctr Rotterdam, Dept Biostat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Matthijsse, SM (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands.	s.matthijsse@erasmusmc.nl		de Vlas, Sake J./0000-0002-1830-5668; van Rosmalen, Joost/0000-0002-9187-244X				Alexander MG, 2003, J SEX RES, V40, P27, DOI 10.1080/00224490309552164; Antonsson A, 2010, VIROLOGY, V407, P26, DOI 10.1016/j.virol.2010.07.046; BAKKER F, 2009, SEXUAL HEALTH IN THE; BAKKER F, 2006, SEXUAL HEALTH IN THE; Barnabas RV, 2006, PLOS MED, V3, P624, DOI 10.1371/journal.pmed.0030138; Baussano I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081171; Baussano I, 2010, EPIDEMICS-NETH, V2, P21, DOI 10.1016/j.epidem.2010.02.002; Berkhof J, 2010, INT J CANCER, V127, P2147, DOI 10.1002/ijc.25211; Bogaards JA, 2011, EPIDEMIOLOGY, V22, P505, DOI 10.1097/EDE.0b013e31821d107b; Bogaards JA, 2010, AM J EPIDEMIOL, V171, P817, DOI 10.1093/aje/kwp466; Bulkmans NWJ, 2004, INT J CANCER, V110, P94, DOI 10.1002/ijc.20076; Burchell AN, 2006, AM J EPIDEMIOL, V163, P534, DOI 10.1093/aje/kwj077; Burchell AN, 2006, VACCINE, V24, P52, DOI 10.1016/j.vaccine.2006.05.031; Carter JJ, 2000, J INFECT DIS, V181, P1911, DOI 10.1086/315498; Coupe VMH, 2008, BRIT J CANCER, V98, P646, DOI 10.1038/sj.bjc.6604162; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; DEGRAAF H, 2006, RUTGERS NISSO GROUP, V7; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Fischer E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014061; Franceschi S, 2014, J INFECT DIS, V210, P507, DOI 10.1093/infdis/jiu143; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Goodman MT, 2008, CANCER RES, V68, P8813, DOI 10.1158/0008-5472.CAN-08-1380; Hontelez JAC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001534; Johnson HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049614; Kim JJ, 2007, AM J EPIDEMIOL, V166, P137, DOI 10.1093/aje/kwm086; Korenromp EL, 2000, MATH POPUL STUD, V8, P135, DOI DOI 10.1080/08898480009525479; LAW A, 2000, SIMULATION MODELING, P622; Lenselink CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003743; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Manhart LE, 2002, SEX TRANSM DIS, V29, P725, DOI 10.1097/00007435-200211000-00018; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; McCallum EB, 2012, J SEX RES, V49, P212, DOI 10.1080/00224499.2012.658923; Mikolajczyk RT, 2012, J NATL CANCER I, V104, P163, DOI 10.1093/jnci/djr517; Molano M, 2003, AM J EPIDEMIOL, V158, P486, DOI 10.1093/aje/kwg171; Moscicki AB, 2012, VACCINE, V30, pF24, DOI 10.1016/j.vaccine.2012.05.089; Orroth KK, 2007, SEX TRANSM INFECT, V83, pI5, DOI 10.1136/sti.2006.023531; *SIG INF CTR HLTH, 1985, HOSPITAL DIAGNOSIS S; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Trottier H, 2008, J INFECT DIS, V197, P1436, DOI 10.1086/587698; *US DEP EC SOC AFF, 2011, WORLD POPULATION PRO; Van de Velde N, 2010, VACCINE, V28, P5473, DOI 10.1016/j.vaccine.2010.05.056; van den Broek IVF, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4316; Van der Ploeg CPB, 1998, INTERFACES, V28, P84, DOI 10.1287/inte.28.3.84; VOLKSGEZONDHEID NA, 2013, VACCINE COVERAGE LOW; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wheeler CM, 2013, OBSTET GYN CLIN N AM, V40, P165, DOI 10.1016/j.ogc.2013.02.004; *WHO ICO HPV INF C, 2010, SUMMARY REPORT UPDAT; Wilson L, 2014, J INFECT DIS, V210, P448, DOI 10.1093/infdis/jiu104	49	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116618	10.1371/journal.pone.0116618	http://dx.doi.org/10.1371/journal.pone.0116618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642941	gold, Green Published, Green Submitted			2022-12-27	WOS:000348821200021
J	Okada, K; Abe, H; Ike, F; Ogura, Y; Hayashi, T; Fukui-Miyazaki, A; Nakamura, K; Shinzawa, N; Horiguchi, Y				Okada, Keisuke; Abe, Hiroyuki; Ike, Fumio; Ogura, Yoshitoshi; Hayashi, Tetsuya; Fukui-Miyazaki, Aya; Nakamura, Keiji; Shinzawa, Naoaki; Horiguchi, Yasuhiko			Polymorphisms Influencing Expression of Dermonecrotic Toxin in Bordetella bronchiseptica	PLOS ONE			English	Article							III SECRETION SYSTEM; ACTIN STRESS FIBERS; GENE-EXPRESSION; BINDING; PERTUSSIS; BVGA; PROMOTER; IDENTIFICATION; PATHOGENESIS; ACTIVATION	Bordetella bronchiseptica is a pathogenic bacterium causing respiratory infections in a broad range of mammals. Recently, we determined the whole genome sequence of B. bronchiseptica S798 strain isolated from a pig infected with atrophic rhinitis and found four single-nucleotide polymorphisms (SNPs) at positions -129, -72, + 22, and + 38 in the region upstream of dnt encoding dermonecrotic toxin (DNT), when compared with a rabbit isolate, RB50. DNT is known to be involved in turbinate atrophy observed in atrophic rhinitis. Immunoblotting, quantitative real-time PCR, and beta-galactosidase reporter assay revealed that these SNPs resulted in the increased promoter activity of dnt and conferred the increased ability to produce DNT on the bacteria. Similar or identical SNPs were also found in other pig isolates kept in our laboratory, all of which produce a larger amount of DNT than RB50. Our analysis revealed that substitution of at least two of the four bases, at positions -72 and +22, influenced the promoter activity for dnt. These results imply that these SNPs are involved in the pathogenicity of bordetellae specific to pig diseases.	[Okada, Keisuke; Abe, Hiroyuki; Fukui-Miyazaki, Aya; Nakamura, Keiji; Shinzawa, Naoaki; Horiguchi, Yasuhiko] Osaka Univ, Microbial Dis Res Inst, Dept Mol Bacteriol, Osaka, Japan; [Ike, Fumio] RIKEN BioResource Ctr, Expt Anim Div, Ibaraki, Japan; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Miyazaki Univ, Frontier Sci Res Ctr, Dept Genom & Bioenvironm Sci, Div Microbial Genom, Miyazaki, Japan; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Miyazaki Univ, Fac Med, Dept Infect Dis, Div Microbiol, Miyazaki, Japan	Osaka University; RIKEN; University of Miyazaki; University of Miyazaki	Abe, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Bacteriol, Osaka, Japan.	hirop@biken.osaka-u.ac.jp	Hayashi, Tetsuya/ABA-1074-2020	jia si, zhong cun/0000-0002-8500-9359	Japan Society for the Promotion of Science [26293096, 26460525];  [25670212]; Grants-in-Aid for Scientific Research [25670212] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grants-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (26293096) (http://www.jsps.go.jp/j-grantsinaid/index.html), Grants-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (26460525) (http://www.jsps.go.jp/j-grantsinaid/index.html), Grants-in-Aid for Scientific Research for Challenging Exploratory Research (25670212) (http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUCHER PE, 1995, J BACTERIOL, V177, P6486, DOI 10.1128/jb.177.22.6486-6491.1995; Boucher PE, 2001, MOL MICROBIOL, V40, P991, DOI 10.1046/j.1365-2958.2001.02442.x; Brockmeier SL, 2002, INFECT IMMUN, V70, P481, DOI 10.1128/IAI.70.2.481-490.2002; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; COWELL JL, 1979, INFECT IMMUN, V25, P896, DOI 10.1128/IAI.25.3.896-901.1979; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; HORIGUCHI Y, 1991, INFECT IMMUN, V59, P1112, DOI 10.1128/IAI.59.3.1112-1116.1991; HORIGUCHI Y, 1990, FEMS MICROBIOL LETT, V66, P39, DOI 10.1111/j.1574-6968.1990.tb03969.x; Horiguchi Y, 1997, P NATL ACAD SCI USA, V94, P11623, DOI 10.1073/pnas.94.21.11623; HORIGUCHI Y, 1993, INFECT IMMUN, V61, P3611, DOI 10.1128/IAI.61.9.3611-3615.1993; HORIGUCHI Y, 1995, J CELL SCI, V108, P3243; HORIGUCHI Y, 1995, FEMS IMMUNOL MED MIC, V12, P29, DOI 10.1111/j.1574-695X.1995.tb00170.x; Horiguchi Y, 2012, CURR TOP MICROBIOL, V361, P113, DOI 10.1007/82_2012_206; Karimova G, 1996, MOL MICROBIOL, V20, P489, DOI 10.1046/j.1365-2958.1996.5231057.x; Kurushima J, 2012, MICROBIOL IMMUNOL, V56, P356, DOI 10.1111/j.1348-0421.2012.00442.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masuda M, 2000, EMBO J, V19, P521, DOI 10.1093/emboj/19.4.521; Matsuzawa T, 2002, INFECT IMMUN, V70, P3427, DOI 10.1128/IAI.70.7.3427-3432.2002; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Merkel TJ, 2003, J BACTERIOL, V185, P6902, DOI 10.1128/JB.185.23.6902-6912.2003; Miller JH., 1972, EXPT MOL GENETICS; Nagamatsu K, 2009, J EXP MED, V206, P3073, DOI 10.1084/jem.20090494; NAKAI T, 1985, AM J VET RES, V46, P870; Okada K, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00436-14; Park J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-545; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pullinger GD, 1996, INFECT IMMUN, V64, P4163, DOI 10.1128/IAI.64.10.4163-4171.1996; ROY CR, 1991, J BACTERIOL, V173, P2385, DOI 10.1128/JB.173.7.2385-2392.1991; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Zu T, 1996, MOL MICROBIOL, V21, P557, DOI 10.1111/j.1365-2958.1996.tb02564.x	34	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116604	10.1371/journal.pone.0116604	http://dx.doi.org/10.1371/journal.pone.0116604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642712	Green Published, Green Submitted, gold			2022-12-27	WOS:000348821200020
J	Yamane, C; Yamazaki, T; Nakamura, S; Matsuo, J; Ishida, K; Yamazaki, S; Oguri, S; Shouji, N; Hayashi, Y; Yoshida, M; Yimin; Yamaguchi, H				Yamane, Chikayo; Yamazaki, Tomohiro; Nakamura, Shinji; Matsuo, Junji; Ishida, Kasumi; Yamazaki, Sumire; Oguri, Satoshi; Shouji, Natsumi; Hayashi, Yasuhiro; Yoshida, Mitsutaka; Yimin; Yamaguchi, Hiroyuki			Amoebal Endosymbiont Parachlamydia acanthamoebae Bn-9 Can Grow in Immortal Human Epithelial HEp-2 Cells at Low Temperature; An In Vitro Model System to Study Chlamydial Evolution	PLOS ONE			English	Article							CHLAMYDOPHILA-PNEUMONIAE; III SECRETION; FACTOR CPAF; HOST-RANGE; INFECTION; EPIDEMIOLOGY; PROTEINS; PATHOGEN; HISTORY; GENOME	Ancient chlamydiae diverged into pathogenic and environmental chlamydiae 0.7-1.4 billion years ago. However, how pathogenic chlamydiae adapted to mammalian cells that provide a stable niche at approximately 37 degrees C, remains unknown, although environmental chlamydiae have evolved as endosymbionts of lower eukaryotes in harsh niches of relatively low temperatures. Hence, we assessed whether an environmental chlamydia, Parachlamydia Bn-9, could grow in human HEp-2 cells at a low culture temperature of 30 degrees C. The assessment of inclusion formation by quantitative RT-PCR revealed that the numbers of bacterial inclusion bodies and the transcription level of 16SrRNA significantly increased after culture at 30 degrees C compared to at 37 degrees C. Confocal microscopy showed that the bacteria were located close to HEp-2 nuclei and were actively replicative. Transmission electron microscopy also revealed replicating bacteria consisting of reticular bodies, but with a few elementary bodies. Cytochalasin D and rifampicin inhibited inclusion formation. Lactacystin slightly inhibited bacterial inclusion formation. KEGG analysis using a draft genome sequence of the bacteria revealed that it possesses metabolic pathways almost identical to those of pathogenic chlamydia. Interestingly, comparative genomic analysis with pathogenic chlamydia revealed that the Parachlamydia similarly possess the genes encoding Type III secretion system, but lacking genes encoding inclusion membrane proteins (IncA to G) required for inclusion maturation. Taken together, we conclude that ancient chlamydiae had the potential to grow in human cells, but overcoming the thermal gap was a critical event for chlamydial adaptation to human cells.	[Yamane, Chikayo; Yamazaki, Tomohiro; Matsuo, Junji; Ishida, Kasumi; Yamazaki, Sumire; Oguri, Satoshi; Shouji, Natsumi; Hayashi, Yasuhiro; Yamaguchi, Hiroyuki] Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Yamazaki, Tomohiro] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Nakamura, Shinji] Juntendo Univ, Grad Sch Med, Div Biomed Imaging Res, Bunkyo Ku, Tokyo, Japan; [Oguri, Satoshi; Hayashi, Yasuhiro] Hokkaido Univ Hosp, Kita Ku, Sapporo, Hokkaido 060, Japan; [Yoshida, Mitsutaka] Juntendo Univ, Grad Sch Med, Div Ultrastruct Res, Bunkyo Ku, Tokyo, Japan; [Yimin] Hokkaido Univ, Grad Sch Med, Dept Adv Med, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; Japan Society for the Promotion of Science; Juntendo University; Hokkaido University; Juntendo University; Hokkaido University	Yamaguchi, H (corresponding author), Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Kita Ku, North 12,West 5, Sapporo, Hokkaido, Japan.	hiroyuki@med.hokudai.ac.jp			KAKENHI, "Innovation Areas (Matryoshka-type evolution)" [21590474, 24659194, 24117501];  [13J04219]	KAKENHI, "Innovation Areas (Matryoshka-type evolution)"; 	This study was supported by grants-in-aid for Japan Society for the Promotion Science (JSPS) fellows (13J04219) and scientific research from KAKENHI, grant numbers 21590474, 24659194, and 24117501, "Innovation Areas (Matryoshka-type evolution)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Amann R, 1997, APPL ENVIRON MICROB, V63, P115, DOI 10.1128/AEM.63.1.115-121.1997; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bednar MM, 2011, BIOCHEMISTRY-US, V50, P7441, DOI 10.1021/bi201098r; Bertelli C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010890; Blasi F, 2009, CLIN MICROBIOL INFEC, V15, P29, DOI 10.1111/j.1469-0691.2008.02130.x; Boleti H, 1999, J CELL SCI, V112, P1487; Burillo A, 2010, INFECT DIS CLIN N AM, V24, P61, DOI 10.1016/j.idc.2009.10.002; Collingro A, 2005, MICROBIOL-SGM, V151, P301, DOI 10.1099/mic.0.27406-0; Collingro A, 2011, MOL BIOL EVOL, V28, P3253, DOI 10.1093/molbev/msr161; Cooksey CMJL, 2010, OBSTET GYNECOL SURV, V65, P729, DOI 10.1097/OGX.0b013e3182110204; Corsaro D, 2002, RES MICROBIOL, V153, P563, DOI 10.1016/S0923-2508(02)01369-4; Coulon C, 2012, FEMS IMMUNOL MED MIC, V64, P364, DOI 10.1111/j.1574-695X.2011.00919.x; Da Ros CT, 2008, ASIAN J ANDROL, V10, P110, DOI 10.1111/j.1745-7262.2008.00367.x; Fischer H, 1995, J PHYSIOL-LONDON, V489, P745, DOI 10.1113/jphysiol.1995.sp021088; Gimenez G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-542; Greub G, 2003, INFECT IMMUN, V71, P5979, DOI 10.1128/IAI.71.10.5979-5985.2003; Greub G, 2003, APPL ENVIRON MICROB, V69, P5530, DOI 10.1128/AEM.69.9.5530-5535.2003; Hayashi Y, 2010, MICROBIOL IMMUNOL, V54, P707, DOI 10.1111/j.1348-0421.2010.00265.x; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Hu VH, 2010, TROP MED INT HEALTH, V15, P673, DOI 10.1111/j.1365-3156.2010.02521.x; Ishida K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095166; Jorgensen I, 2011, CELL HOST MICROBE, V10, P21, DOI 10.1016/j.chom.2011.06.008; Kobayashi M, 2011, MICROB PATHOGENESIS, V51, P209, DOI 10.1016/j.micpath.2011.03.010; Madej T, 2012, NUCLEIC ACIDS RES, V40, pD461, DOI 10.1093/nar/gkr1162; Matsuo J, 2008, APPL ENVIRON MICROB, V74, P6397, DOI 10.1128/AEM.00841-08; Matsuo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056005; Matsuo J, 2010, RES MICROBIOL, V161, P711, DOI [10.1016/J.resmic.2010.07.004, 10.1016/j.resmic.2010.07.004]; Matsuo J, 2010, MICROBIOL IMMUNOL, V54, P63, DOI 10.1111/j.1348-0421.2009.00182.x; Mueller KE, 2014, INFECT IMMUN, V82, P2, DOI 10.1128/IAI.00917-13; Mylonas I, 2012, ARCH GYNECOL OBSTET, V285, P1271, DOI 10.1007/s00404-012-2240-7; Paschen SA, 2008, J CELL BIOL, V182, P117, DOI 10.1083/jcb.200804023; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Pirbhai M, 2006, J BIOL CHEM, V281, P31495, DOI 10.1074/jbc.M602796200; Sampo A, 2014, ENVIRON MICROBIOL, V16, P486, DOI 10.1111/1462-2920.12266; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Watson C, 2008, CLIN SCI, V114, P509, DOI 10.1042/CS20070298	38	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116486	10.1371/journal.pone.0116486	http://dx.doi.org/10.1371/journal.pone.0116486			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643359	gold, Green Published, Green Submitted			2022-12-27	WOS:000348821200019
J	Cao, Z; Xu, JW; Huang, H; Shen, P; You, L; Zhou, L; Zheng, LF; Zhang, TP; Zhao, YP				Cao, Zhe; Xu, Jianwei; Huang, Hua; Shen, Peng; You, Lei; Zhou, Li; Zheng, Lianfang; Zhang, Taiping; Zhao, Yupei			MiR-1178 Promotes the Proliferation, G1/S Transition, Migration and Invasion of Pancreatic Cancer Cells by Targeting CHIP	PLOS ONE			English	Article							HSC70-INTERACTING PROTEIN; INDUCED DEGRADATION; TUMOR-SUPPRESSOR; C-TERMINUS; MUTANT P53; CARCINOMA; CHAPERONE; GROWTH; ADENOCARCINOMA; INACTIVATION	CHIP, a co-chaperone protein that interacts with Hsc/Hsp70, has been shown to be underexpressed in pancreatic cancer cells and has demonstrated a potential tumor suppressor property. Nevertheless, the underlying mechanisms of CHIP regulation in pancreatic cancer cells remain unknown. In this study, we found that miR-1178 decreased the translation of the CHIP protein by targeting the 30-UTR region. We observed that over-expression of miR-1178 facilitated the proliferation, G1/S transition, migration and invasion of pancreatic cancer cells. Conversely, the inhibition of miR-1178 expression significantly suppressed these phenotypes. Furthermore, CHIP over-expression abrogated miR-1178-induced cell proliferation and invasion. Our data suggest that miR-1178 acts as an oncomiR in pancreatic cancer cells by inhibiting CHIP expression.	[Cao, Zhe; Xu, Jianwei; Huang, Hua; Shen, Peng; You, Lei; Zhou, Li; Zhang, Taiping; Zhao, Yupei] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China; [Cao, Zhe; Xu, Jianwei; Huang, Hua; Shen, Peng; You, Lei; Zhou, Li; Zheng, Lianfang; Zhang, Taiping; Zhao, Yupei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zheng, Lianfang] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nucl Med, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Zhang, TP (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China.	tpingzhang@yahoo.com; zhao8028@263.net			National Natural Science Foundation of China [81272484]; Beijing Natural Science Foundation [7132179]; Major State Basic Research Development Program of China (973 Program) [2014CB542300]; Research Special Fund for Public Welfare Industry of Health [201202007]; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2014BAI09B11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Research Special Fund for Public Welfare Industry of Health; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period	This study was supported by grants from the National Natural Science Foundation of China (No. 81272484), Beijing Natural Science Foundation (No. 7132179), Major State Basic Research Development Program of China (973 Program, No. 2014CB542300), the Research Special Fund for Public Welfare Industry of Health (No. 201202007), and National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (No. 2014BAI09B11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Choi YN, 2014, BIOCHEM BIOPH RES CO, V446, P1060, DOI 10.1016/j.bbrc.2014.03.061; Chuong MD, 2014, J GASTROINTEST ONCOL, V5, P166, DOI 10.3978/j.issn.2078-6891.2014.025; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; DRUCKER BJ, 1988, IN VITRO CELL DEV B, V24, P1179, DOI 10.1007/BF02624187; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Funamizu N, 2014, INT J ONCOL, V44, P725, DOI 10.3892/ijo.2014.2243; Guo JW, 2012, J BONE MINER RES, V27, P1607, DOI 10.1002/jbmr.1597; Jang KW, 2011, J CELL BIOCHEM, V112, P3612, DOI 10.1002/jcb.23292; Jang KW, 2011, J THORAC ONCOL, V6, P679, DOI 10.1097/JTO.0b013e31820d9c7e; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Lee JH, 2010, J BIOL CHEM, V285, P42033, DOI 10.1074/jbc.M110.149831; Lennon AM, 2014, CANCER RES, V74, P3381, DOI 10.1158/0008-5472.CAN-14-0734; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li D, 2011, MOL CANCER RES, V9, P577, DOI 10.1158/1541-7786.MCR-10-0534; Li Y., 2010, CANCER RES, V70, P5703, DOI [10.1158/1538-7445.AM10-5703, DOI 10.1158/1538-7445.AM10-5703]; Li YY, 2013, CANCER LETT, V339, P260, DOI 10.1016/j.canlet.2013.06.018; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Liu C, 2013, CURR MOL MED, V13, P467; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Maftouh M, 2014, NUCLEOS NUCLEOT NUCL, V33, P384, DOI 10.1080/15257770.2014.891741; Nagathihalli NS, 2012, FRONT BIOSCI-LANDMRK, V17, P2059, DOI 10.2741/4037; Naito AT, 2010, CIRC RES, V106, P1692, DOI 10.1161/CIRCRESAHA.109.214346; Ruckova E, 2012, CELL MOL BIOL LETT, V17, P446, DOI 10.2478/s11658-012-0021-8; Shimamoto S, 2013, J BIOL CHEM, V288, P7158, DOI 10.1074/jbc.M112.436758; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sisoula C, 2011, FREE RADICAL BIO MED, V50, P157, DOI 10.1016/j.freeradbiomed.2010.10.701; Trevino JG, 2006, AM J PATHOL, V168, P962, DOI 10.2353/ajpath.2006.050570; Villanueva M Teresa, 2013, Nat Rev Clin Oncol, V10, P665, DOI 10.1038/nrclinonc.2013.209; Wang J, 2011, J CELL BIOCHEM, V112, P509, DOI 10.1002/jcb.22941; Wang TX, 2014, ONCOTARGET, V5, P1969, DOI 10.18632/oncotarget.1890; Wang YM, 2014, CARCINOGENESIS, V35, P983, DOI 10.1093/carcin/bgt393; Wolin EM, 2013, CANCER LETT, V335, P1, DOI 10.1016/j.canlet.2013.02.016; Yao Z, 2002, PANCREAS, V24, P42, DOI 10.1097/00006676-200201000-00006; Zhang J, 2014, ONCOL REP, V31, P1157, DOI 10.3892/or.2013.2960; Zhao G, 2013, MOL CANCER THER, V12, P2569, DOI 10.1158/1535-7163.MCT-13-0296	39	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116934	10.1371/journal.pone.0116934	http://dx.doi.org/10.1371/journal.pone.0116934			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635996	Green Submitted, Green Published, gold			2022-12-27	WOS:000350680700065
J	Jongen, S; Perrier, J; Vuurman, EF; Ramaekers, JG; Vermeeren, A				Jongen, Stefan; Perrier, Joy; Vuurman, Eric F.; Ramaekers, Johannes G.; Vermeeren, Annemiek			Sensitivity and Validity of Psychometric Tests for Assessing Driving Impairment: Effects of Sleep Deprivation	PLOS ONE			English	Article							FIELD-OF-VIEW; PSYCHOMOTOR PERFORMANCE; ALCOHOL; RISK; DURATION; ZOLPIDEM; PLACEBO; MDMA; METAANALYSIS; WAKEFULNESS	Objective To assess drug induced driving impairment, initial screening is needed. However, no consensus has been reached about which initial screening tools have to be used. The present study aims to determine the ability of a battery of psychometric tests to detect performance impairing effects of clinically relevant levels of drowsiness as induced by one night of sleep deprivation. Methods Twenty four healthy volunteers participated in a 2-period crossover study in which the highway driving test was conducted twice: once after normal sleep and once after one night of sleep deprivation. The psychometric tests were conducted on 4 occasions: once after normal sleep (at 11 am) and three times during a single night of sleep deprivation (at 1 am, 5 am, and 11 am). Results On-the-road driving performance was significantly impaired after sleep deprivation, as measured by an increase in Standard Deviation of Lateral Position (SDLP) of 3.1 cm compared to performance after a normal night of sleep. At 5 am, performance in most psychometric tests showed significant impairment. As expected, largest effect sizes were found on performance in the Psychomotor Vigilance Test (PVT). Large effects sizes were also found in the Divided Attention Test (DAT), the Attention Network Test (ANT), and the test for Useful Field of View (UFOV) at 5 and 11 am during sleep deprivation. Effects of sleep deprivation on SDLP correlated significantly with performance changes in the PVT and the DAT, but not with performance changes in the UFOV. Conclusion From the psychometric tests used in this study, the PVT and DAT seem most promising for initial evaluation of drug impairment based on sensitivity and correlations with driving impairment. Further studies are needed to assess the sensitivity and validity of these psychometric tests after benchmark sedative drug use.	[Jongen, Stefan; Perrier, Joy; Vuurman, Eric F.; Ramaekers, Johannes G.; Vermeeren, Annemiek] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, NL-6200 MD Maastricht, Netherlands; [Perrier, Joy] INSERM, COMETE U1075, Caen, France	Maastricht University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie	Jongen, S (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, NL-6200 MD Maastricht, Netherlands.	stefan.jongen@maastrichtuniversity.nl		Perrier, Joy/0000-0002-8639-9985; Jongen, Stefan/0000-0002-9798-651X	GlaxoSmithKline; Transcept; Merck companies; NWO; ZonMW; EU; Dutch Ministry of Infrastructure and Environment; Lundbeck; Transcept Pharmaceuticals Inc; Purdue Pharma LP; Merck Sharp and Dohme	GlaxoSmithKline(GlaxoSmithKline); Transcept; Merck companies; NWO(Netherlands Organization for Scientific Research (NWO)); ZonMW(Netherlands Organization for Health Research and Development); EU(European Commission); Dutch Ministry of Infrastructure and Environment; Lundbeck(Lundbeck Corporation); Transcept Pharmaceuticals Inc; Purdue Pharma LP; Merck Sharp and Dohme(Merck & Company)	Dr. E.F. Vuurman is a full time employee of Maastricht University and has received grants/research support grants from GlaxoSmithKline, Transcept, and Merck companies. Prof. Dr. J.G. Ramaekers is a full time employee of Maastricht University and has received grants/research support from NWO, ZonMW, EU, Dutch Ministry of Infrastructure and Environment and Lundbeck. Dr. A. Vermeeren is a full time employee of Maastricht University. As employee of Maastricht University, she participated-as investigator-in studies sponsored by for-profit businesses (Transcept Pharmaceuticals Inc, Purdue Pharma LP, Merck Sharp and Dohme) and non-profit organizations (Dutch Ministry of Infrastructure and Environment) She acted as a consultant for IntecPharma. The other authors have nothing to disclose. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Akerstedt T, 2001, SLEEP, V24, P401, DOI 10.1093/sleep/24.4.401; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Baulk SD, 2008, ACCIDENT ANAL PREV, V40, P396, DOI 10.1016/j.aap.2007.07.008; Borbely A.A, 1982, HUM NEUROBIOL; Borkenstein F, 1964, ROLE DRINKING DRIVER; Bosker WM, 2012, PSYCHOPHARMACOLOGY, V222, P367, DOI 10.1007/s00213-011-2497-8; Bosker WM, 2010, PSYCHOPHARMACOLOGY, V209, P69, DOI 10.1007/s00213-009-1767-1; Boyle J, 2009, BRIT J CLIN PHARMACO, V67, P180, DOI 10.1111/j.1365-2125.2008.03331.x; Brookhuis K, 1985, EFFECTS INCREASING D; Brookhuis KA, 2003, ERGONOMICS, V46, P433, DOI 10.1080/001401302/1000039556; Brunnauer A, 2008, J CLIN PSYCHIAT, V69, P1880, DOI 10.4088/JCP.v69n1205; Clark PG, 2011, CONTEMP CLIN TRIALS, V32, P129, DOI 10.1016/j.cct.2010.10.002; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Dorrian J, 2005, THESIS U PENSYLVANIA; Dry MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050977; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Edwards JD, 2005, J CLIN EXP NEUROPSYC, V27, P529, DOI 10.1080/13803390490515432; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Forsman P, 2014, ACCIDENT ANAL PREV, V62, P186, DOI 10.1016/j.aap.2013.09.015; Gillberg M, 1998, PHYSIOL BEHAV, V64, P599, DOI 10.1016/S0031-9384(98)00063-8; Greenblatt DJ, 2006, J CLIN PHARMACOL, V46, P1469, DOI 10.1177/0091270006293303; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; Howard ME, 2007, SLEEP, V30, P1334, DOI 10.1093/sleep/30.10.1334; International Council on Alcohol Drugs and Traffic Safety (ICADTS), 1999, GUID EXP STUD UND DE, P1; Jackson ML, 2013, ACCIDENT ANAL PREV, V50, P438, DOI 10.1016/j.aap.2012.05.020; Jewett ME, 1999, SLEEP, V22, P171, DOI 10.1093/sleep/22.2.171; Jex HR., 1966; Jongen S, 2014, PSYCHOPHARMACOLOGY, V231, P2435, DOI 10.1007/s00213-013-3408-y; Jugovac D, 2012, EXP PSYCHOL, V59, P115, DOI 10.1027/1618-3169/a000133; Kay G., 2011, DRUGGED DRIVING EXPE; Kleykamp BA, 2010, EXP CLIN PSYCHOPHARM, V18, P1, DOI 10.1037/a0018407; Kuypers KPC, 2007, PSYCHOPHARMACOLOGY, V192, P111, DOI 10.1007/s00213-006-0679-6; Lamond N, 1999, J SLEEP RES, V8, P255, DOI 10.1046/j.1365-2869.1999.00167.x; Leufkens TRM, 2014, CLIN THER, V36, P141, DOI 10.1016/j.clinthera.2013.11.005; Leufkens TRM, 2009, J SLEEP RES, V18, P387, DOI 10.1111/j.1365-2869.2009.00746.x; Leufkens TRM, 2014, PSYCHOPHARMACOLOGY, P1, DOI [10.1007/s00213-014-3807-8, DOI 10.1007/S00213-014-3807-8]; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Louwerens JW., 1987, ALCOHOL DRUGS TRAFFI, P183, DOI DOI 10.1080/15389588.2014.935356; Martella D, 2011, EXP BRAIN RES, V210, P81, DOI 10.1007/s00221-011-2605-3; Martiniuk ALC, 2013, JAMA PEDIATR, V167, P647, DOI 10.1001/jamapediatrics.2013.1429; MCLEOD DR, 1982, BEHAV RES METH INSTR, V14, P463, DOI 10.3758/BF03203313; Mets MAJ, 2011, SLEEP, V34, P1327, DOI 10.5665/SLEEP.1272; Mets MAJ, 2010, SLEEP MED REV, V14, P259, DOI 10.1016/j.smrv.2009.10.008; MOSKOWITZ H, 1973, J SAFETY RES, V5, P185; Mulder-Hajonides van der Meulen WREH, 1984, 14 CINP C FLOR; Myers RS, 2000, PERCEPT MOTOR SKILL, V91, P279, DOI 10.2466/PMS.91.5.279-290; O'Hanlon J, 1986, DRUGS AND DRIVING; OHANLON JF, 1984, BRIT J CLIN PHARMACO, V18, pS121, DOI 10.1111/j.1365-2125.1984.tb02590.x; OHANLON JF, 1995, ALLERGY, V50, P234, DOI 10.1111/j.1398-9995.1995.tb01140.x; OHANLON JF, 1982, SCIENCE, V217, P79, DOI 10.1126/science.7089544; Owens Katherine, 2009, P43, DOI 10.1007/978-3-7643-9923-8_3; Ramaekers JG, 2003, J CLIN PSYCHIAT, V64, P20, DOI 10.4088/JCP.v64n0106; Riedel WJ, 2006, CURR PHARM DESIGN, V12, P2525, DOI 10.2174/138161206777698882; ROBBE HWJ, 1995, EUR NEUROPSYCHOPHARM, V5, P35, DOI 10.1016/0924-977X(94)00130-4; Roge J, 2003, VISION RES, V43, P1465, DOI 10.1016/S0042-6989(03)00143-3; Roth T, 2014, TRAFFIC INJ PREV, V15, P439, DOI 10.1080/15389588.2013.830211; Roth T, 2008, HUM PSYCHOPHARM CLIN, V23, P13, DOI 10.1002/hup.884; Schnabel E, 2010, METAANALYSIS EMPIRIC; Schuhfried G., 2005, MANUAL EXPERT SYSTEM; SEPPALA T, 1979, DRUGS, V17, P389, DOI 10.2165/00003495-197917050-00008; Silva MT, 2009, REV ASSOC MED BRAS, V55, P484, DOI 10.1590/S0104-42302009000400027; Tiplady B, 2003, J PSYCHOPHARMACOL, V17, P41, DOI 10.1177/0269881103017001691; Valent F, 2010, SLEEP, V33, P349, DOI 10.1093/sleep/33.3.349; Van der Elst W, 2006, PSYCHOL ASSESSMENT, V18, P424, DOI 10.1037/1040-3590.18.4.424; van Steveninck AL, 1999, J PSYCHOPHARMACOL, V13, P10, DOI 10.1177/026988119901300102; Vermeeren A, 2002, SLEEP, V25, P224; Vermeeren A, 1994, J TRAFFIC MED, V22, P173; Vermeeren A, 2014, SLEEP, V37, P489, DOI 10.5665/sleep.3482; Verster JC, 2012, PSYCHOPHARMACOLOGY, V220, P293, DOI 10.1007/s00213-011-2484-0; Verster JC, 2011, INT J GEN MED, V4, P359, DOI 10.2147/IJGM.S19639; Verstraete A., 2011, SE LIMITS METHODS DE; Vingilis E, 2002, TRAFFIC INJ PREV, V3, P1, DOI DOI 10.1080/15389580210522; Vuurman EFPM, 2004, EUR J CLIN PHARMACOL, V60, P307, DOI 10.1007/s00228-004-0757-9; Walsh JM, 2008, ADDICTION, V103, P1258, DOI 10.1111/j.1360-0443.2008.02277.x; Walsh J Michael, 2004, Traffic Inj Prev, V5, P241; Weaver B, 2009, ACCIDENT ANAL PREV, V41, P76, DOI 10.1016/j.aap.2008.09.006; Williamson AM, 2000, OCCUP ENVIRON MED, V57, P649, DOI 10.1136/oem.57.10.649	82	40	41	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117045	10.1371/journal.pone.0117045	http://dx.doi.org/10.1371/journal.pone.0117045			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2XY	25668292	Green Published, gold			2022-12-27	WOS:000349493000013
J	Foran, CM; Baker, KM; Grosso, NR; Linkov, I				Foran, Christy M.; Baker, Kelsie M.; Grosso, Nancy R.; Linkov, Igor			An Enhanced Adaptive Management Approach for Remediation of Legacy Mercury in the South River	PLOS ONE			English	Article								Uncertainties about future conditions and the effects of chosen actions, as well as increasing resource scarcity, have been driving forces in the utilization of adaptive management strategies. However, many applications of adaptive management have been criticized for a number of shortcomings, including a limited ability to learn from actions and a lack of consideration of stakeholder objectives. To address these criticisms, we supplement existing adaptive management approaches with a decision-analytical approach that first informs the initial selection of management alternatives and then allows for periodic re-evaluation or phased implementation of management alternatives based on monitoring information and incorporation of stakeholder values. We describe the application of this enhanced adaptive management (EAM) framework to compare remedial alternatives for mercury in the South River, based on an understanding of the loading and behavior of mercury in the South River near Waynesboro, VA. The outcomes show that the ranking of remedial alternatives is influenced by uncertainty in the mercury loading model, by the relative importance placed on different criteria, and by cost estimates. The process itself demonstrates that a decision model can link project performance criteria, decision-maker preferences, environmental models, and short- and long-term monitoring information with management choices to help shape a remediation approach that provides useful information for adaptive, incremental implementation.	[Foran, Christy M.; Linkov, Igor] US Army Corps Engineers New England Dist, US States Army Engineer Res & Dev Ctr, Duty Stn, Concord, MA 01742 USA; [Baker, Kelsie M.] US States Army Engineer Res & Dev Ctr, Concord, MA 01742 USA; [Grosso, Nancy R.] DuPont Corp, Remediat Grp, Wilmington, DE 19805 USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); ERDC - Risk Modeling; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); ERDC - Risk Modeling; DuPont	Linkov, I (corresponding author), US Army Corps Engineers New England Dist, US States Army Engineer Res & Dev Ctr, Duty Stn, Concord, MA 01742 USA.	Igor.Linkov@usace.army.mil	Linkov, Igor/AAH-5981-2019	Linkov, Igor/0000-0002-0823-8107	USACE through Cooperative Research and Development Agreement (CRADA); DuPont	USACE through Cooperative Research and Development Agreement (CRADA); DuPont	This study was funded by DuPont and USACE through Cooperative Research and Development Agreement (CRADA). One author, Nancy Grosso, has an affiliation to the commercial funders of this research study (DuPont). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolgiano RW, 1981, BASIC DATA B, V48; Brent RN, 2011, ARCH ENVIRON CON TOX, V61, P614, DOI 10.1007/s00244-011-9664-0; Convertino M, 2013, SCI REPORTS; Gregory R, 2006, ECOL APPL, V16, P2411, DOI 10.1890/1051-0761(2006)016[2411:DAMCFA]2.0.CO;2; Gregory R., 2012, STRUCTURED DECISION, DOI [DOI 10.1002/9781444398557, 10.1002/9781444398557]; Holling C.S., 1978, ADAPTIVE ENV ASSESSM; Johnson BL, 1999, CONSERV ECOL, V3; Keeney L.R., 1976, DECISIONS MULTIPLE O; Lee K.N., 1999, CONSERV ECOL, V3, P3, DOI DOI 10.5751/ES-00131-030203; Light S., 2013, Journal of Sustainable Development, V6, P31; Linkov I, 2006, ENVIRON INT, V32, P1072, DOI 10.1016/j.envint.2006.06.013; Linkov I, 2012, MULTICRITERIA DECISI; Linkov I, 2006, INTEGR ENVIRON ASSES, V2, P92, DOI 10.1002/ieam.5630020116; McLain RJ, 1996, ENVIRON MANAGE, V20, P437, DOI 10.1007/BF01474647; National Research Council, 2006, PROGR REST EV 1 BIEN; National Research Council, 2004, AD MAN WAT RES PROJ; Pi J.H, 2014, EVALUATION IMPACT DA; RECOVER (Restoration Coordination and Verification), 2010, CERP AD MAN INT GUID; URS, 2012, FIN REP EC STUD S RI; Walters C., 1986, ADAPTIVE MANAGEMENT; Walters Carl, 1997, Conservation Ecology, V1, pUnpaginated; Yu RQ, 2012, ENVIRON SCI TECHNOL, V46, P2684, DOI 10.1021/es2033718	22	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117140	10.1371/journal.pone.0117140	http://dx.doi.org/10.1371/journal.pone.0117140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25665032	Green Published, gold, Green Submitted			2022-12-27	WOS:000349123100019
J	Ratto-Kim, S; de Souza, MS; Currier, JR; Karasavvas, N; Sidney, J; Rolland, M; Valencia-Micolta, A; Madnote, S; Sette, A; Nitayaphan, S; Pitisuttuthum, P; Kaewkungwal, J; Rerks-Ngarm, S; O'Connell, R; Michael, N; Robb, ML; Marovich, M; Kim, JH				Ratto-Kim, Silvia; de Souza, Mark S.; Currier, Jeffrey R.; Karasavvas, Nicos; Sidney, John; Rolland, Morgane; Valencia-Micolta, Anais; Madnote, Sirinan; Sette, Alessandro; Nitayaphan, Sorachai; Pitisuttuthum, Punnee; Kaewkungwal, Jaranit; Rerks-Ngarm, Supachai; O'Connell, Robert; Michael, Nelson; Robb, Merlin L.; Marovich, Mary; Kim, Jerome H.			Identification of Immunodominant CD4-Restricted Epitopes Co-Located with Antibody Binding Sites in Individuals Vaccinated with ALVAC-HIV and AIDSVAX B/E	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; THAI ADULTS; SUBTYPE-B; TRIAL; V2; IMMUNOGENICITY; EFFICACY; ENVELOPE; SAFETY; LOOP	We performed fine epitope mapping of the CD4+ responses in the ALVAC-HIV-AIDSVAX B/E prime-boost regimen in the Thai Phase III trial (RV144). Non-transformed Env-specific T cell lines established from RV144 vaccinees were used to determine the fine epitope mapping of the V2 and C1 responses and the HLA class II restriction. Data showed that there are two CD4+ epitopes contained within the V2 loop: one encompassing the alpha 4 beta 7 integrin binding site (AA179-181) and the other nested between two previously described genetic sieve signatures (AA169, AA181). There was no correlation between the frequencies of CD4+ fine epitope responses and binding antibody.	[Ratto-Kim, Silvia; Currier, Jeffrey R.; Rolland, Morgane; Valencia-Micolta, Anais; Michael, Nelson; Robb, Merlin L.; Kim, Jerome H.] Walter Reed Army Inst Res, United States Mil HIV Res Program, Silver Spring, MD 20910 USA; [de Souza, Mark S.; Karasavvas, Nicos; Madnote, Sirinan; O'Connell, Robert] US Army Med Component, Armed Forces Res Inst Med Sci, United States Mil HIV Res Program, Bangkok, Thailand; [Sidney, John; Sette, Alessandro] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Nitayaphan, Sorachai] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [Pitisuttuthum, Punnee] Mahidol Univ, Fac Trop Med, Vaccine Trials Ctr, Bangkok 10400, Thailand; [Kaewkungwal, Jaranit] Mahidol Univ, Fac Trop Med, Ctr Excellence Biomed & Publ Hlth Informat, Bangkok 11000, Thailand; [Rerks-Ngarm, Supachai] Minist Publ Hlth, Dept Dis Control, Nonthaburi 11000, Thailand; [Marovich, Mary] NIH, Off AIDS Res, Bethesda, MD 20892 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); La Jolla Institute for Immunology; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Mahidol University; Mahidol University; Ministry of Public Health - Thailand; National Institutes of Health (NIH) - USA	Ratto-Kim, S (corresponding author), Walter Reed Army Inst Res, United States Mil HIV Res Program, Silver Spring, MD 20910 USA.	sratto-kim@hivresearch.org	Sette, Alessandro/AFO-8916-2022	Kaewkungwal, Jaranit/0000-0001-7916-8460; Ratto-Kim, Silvia/0000-0003-2025-6399	Henry M. Jackson Foundation [W81XWH-07-2-0067]; U.S. Department of Defense	Henry M. Jackson Foundation; U.S. Department of Defense(United States Department of Defense)	This work was funded by the cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the U.S. Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed herein are those of the authors and should not be construed to represent the positions of the U.S. Army or Department of Defense.	Chandanayingyong D, 1997, HUM IMMUNOL, V53, P174, DOI 10.1016/S0198-8859(96)00284-4; de Souza MS, 2012, J IMMUNOL, V188, P5166, DOI 10.4049/jimmunol.1102756; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Foley B, 2013, HIV SEQUENCE COMPEND, P448, DOI [10.1002/jmri.24359, DOI 10.1002/JMRI.24359]; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Nitayaphan S, 2000, VACCINE, V18, P1448, DOI 10.1016/S0264-410X(99)00421-1; Nitayaphan S, 2004, J INFECT DIS, V190, P702, DOI 10.1086/422258; Pitisuttithum P, 2003, J INFECT DIS, V188, P219, DOI 10.1086/376506; Ratto S, 1996, J ACQ IMMUN DEF SYND, V11, P128, DOI 10.1097/00042560-199602010-00003; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Steede NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065748; Steers NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042579; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568	16	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0115582	10.1371/journal.pone.0115582	http://dx.doi.org/10.1371/journal.pone.0115582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25665096	gold, Green Submitted, Green Published			2022-12-27	WOS:000349123100004
J	Bang, MA; Seo, JH; Seo, JW; Jo, GH; Jung, SK; Yu, R; Park, DH; Park, SJ				Bang, Mi-Ae; Seo, Ji-Hye; Seo, Joung-Wook; Jo, Gyung Hyun; Jung, Seoung Ki; Yu, Ri; Park, Dae-Hun; Park, Sang-Joon			Bacillus subtilis KCTC 11782BP-Produced Alginate Oligosaccharide Effectively Suppresses Asthma via T-Helper Cell Type 2-Related Cytokines	PLOS ONE			English	Article							SODIUM ALGINATE; TRANSCRIPTION FACTOR; IMMUNOLOGY; PATHWAYS; PREVENTS; DISEASES; BET	According to the World Health Organization in 2013, 235 million people are afflicted with asthma. Asthma is a severe pulmonary disease that can be caused by the imbalance of T-helper (Th) type 1 (Th1) and type 2 (Th2) cells, and it is potentially fatal. In this study, we evaluated the anti-asthmatic effect of alginate oligosaccharide (AO), which was prepared from seaweed and converted by Bacillus subtilis KCTC 11782BP, in the mouse model of ovalbumin (OVA)-induced asthma. BALB/c mice were divided into the vehicle control (sensitized but not challenged), asthma induction, positive control (1 mg/kg dexamethasone), 50 mg/kg/day AO-treated, 200 mg/kg/day AO-treated, and 400 mg/kg/day AO-treated groups. The numbers or levels of inflammatory cells, eosinophils, and immunoglobulin (Ig) E were measured in bronchoalveolar lavage fluid (BALF), and asthma-related morphological and cytokine changes were analyzed in lung tissues. Our results show that AO dramatically reduced inflammatory cell numbers, eosinophil count, and IgE levels in BALF, and it dose-dependently inhibited asthmatic histopathological changes in the lung. In addition, AO dose-dependently suppressed the expression of CD3+ T-cell co-receptors, CD4+ Th cells, CD8+ cytotoxic T-cell-related factors, macrophages, and MHCII class. AO dose-dependently decreased the expression levels of Th1/2 cells-regulatory transcription factors such as GATA-3 which modulates Th2 cell proliferation and T-bet which does Th1 cell proliferation. The mRNA levels of all Th1/2-related cytokines, except IL-12 alpha, were dose-dependently suppressed by AO treatment. In particular, the mRNA levels of IL-5, IL-6, and IL-13 were significantly inhibited by AO treatment. Our findings suggest that AO has the potential to be an anti-asthmatic drug candidate, due to its modulation of Th1/Th2 cytokines, which contribute to the pathogenesis of asthma.	[Bang, Mi-Ae] Jeonnam Biofood Technol Ctr, Food Ind Dev Team, Naju, South Korea; [Seo, Ji-Hye; Park, Dae-Hun] Dongshin Univ, Dept Oriental Med Mat, Naju, South Korea; [Seo, Joung-Wook] Korea Inst Toxicol, Taejon, South Korea; [Jo, Gyung Hyun; Jung, Seoung Ki] Bioresource Inc, Res Inst Biosci & Biotechnol, Naju, South Korea; [Yu, Ri; Park, Sang-Joon] Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea	Dongshin University; Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT); Kyungpook National University	Park, DH (corresponding author), Dongshin Univ, Dept Oriental Med Mat, Naju, South Korea.	dhj1221@paran.com; psj26@knu.ac.kr			Fishery Commercialization Technology Development Program, Korea [112098-03-2-SB010]; Research Institute of Bioscience and Biotechnology, Bioresource Inc.	Fishery Commercialization Technology Development Program, Korea; Research Institute of Bioscience and Biotechnology, Bioresource Inc.	The Fishery Commercialization Technology Development Program, Korea (112098-03-2-SB010). The Research Institute of Bioscience and Biotechnology, Bioresource Inc., provided support in the form of salaries for authors GHJ & SKJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Akinbami O.J., 2012, TRENDS ASTHMA PREVAL; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnes PJ, 1998, J ALLERGY CLIN IMMUN, V101, pS427, DOI 10.1016/S0091-6749(98)70154-X; Bosnjak B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-114; Brightling CE, 2002, J ALLERGY CLIN IMMUN, V110, P899, DOI 10.1067/mai.2002.129698; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Foster KA, 2013, J PHARM SCI-US, V102, P2440, DOI 10.1002/jps.23630; Hamid Q, 2005, CYTOKINES CHEMOKINES, P453; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Jung S- K, 2012, Korea Patent, DOI 10.3346/jkms.2014.29.11.1544, Patent No. [10- 2012- 0097841, 1020120097841]; KAM JC, 1993, J IMMUNOL, V151, P3460; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Khan S, 2012, ANTIMICROB AGENTS CH, V56, P5134, DOI 10.1128/AAC.00525-12; Liu K, 2013, J AGR FOOD CHEM, V61, P6562, DOI 10.1021/jf4010065; Mamessier E, 2006, EUR J DERMATOL, V16, P103; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Mattes J, 2002, J EXP MED, V195, P1433, DOI 10.1084/jem.20020009; McGrath MG, 2014, EUR J PHARM BIOPHARM, V86, P200, DOI 10.1016/j.ejpb.2013.04.023; Moriya C, 2013, CLIN EXP HYPERTENS, V35, P607, DOI 10.3109/10641963.2013.776568; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; Razavi A, 2008, IRAN J ALLERGY ASTHM, V7, P13, DOI 07.01/ijaai.1318; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; Sarithakumari CH, 2013, INFLAMMOPHARMACOLOGY, V21, P261, DOI 10.1007/s10787-012-0159-z; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Slejko JF, 2014, J ALLERGY CLIN IMMUN, V133, P1579, DOI 10.1016/j.jaci.2013.10.028; Stirling RG, 2000, EUR RESPIR J, V16, P1158, DOI 10.1034/j.1399-3003.2000.16f24.x; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yoshida T, 2004, INT ARCH ALLERGY IMM, V133, P239, DOI 10.1159/000076830; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007	35	20	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117524	10.1371/journal.pone.0117524	http://dx.doi.org/10.1371/journal.pone.0117524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658604	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900172
J	Blonde, GD; Bales, MB; Spector, AC				Blonde, Ginger D.; Bales, Michelle B.; Spector, Alan C.			Extensive Lesions in Rat Insular Cortex Significantly Disrupt Taste Sensitivity to NaCl and KCl and Slow Salt Discrimination Learning	PLOS ONE			English	Article							CONCENTRATION-DEPENDENT LICKING; GUSTATORY CORTEX; PARABRACHIAL NUCLEI; ALBINO RAT; AVERSION; AMYGDALA; NEOCORTEX; AVOIDANCE; RESPONSES; SUCROSE	While studies of the gustatory cortex (GC) mostly focus on its role in taste aversion learning and memory, the necessity of GC for other fundamental taste-guided behaviors remains largely untested. Here, rats with either excitotoxic lesions targeting GC (n = 26) or sham lesions (n = 14) were assessed for postsurgical retention of a presurgically LiCl-induced conditioned taste aversion (CTA) to 0.1M sucrose using a brief-access taste generalization test in a gustometer. The same animals were then trained in a two-response operant taste detection task and psychophysically tested for their salt (NaCl or KCl) sensitivity. Next, the rats were trained and tested in a NaCl vs. KCl taste discrimination task with concentrations varied. Rats meeting our histological inclusion criterion had large lesions (resulting in a group averaging 80% damage to GC and involving surrounding regions) and showed impaired postsurgical expression of the presurgical CTA (LiCl-injected, n = 9), demonstrated rightward shifts in the NaCl (0.54 log(10) shift) and KCl (0.35 log(10) shift) psychometric functions, and displayed retarded salt discrimination acquisition (n = 18), but eventually learned and performed the discrimination comparable to sham-operated animals. Interestingly, the degree of deficit between tasks correlated only modestly, if at all, suggesting that idiosyncratic differences in insular cortex lesion topography were the root of the individual differences in the behavioral effects demonstrated here. This latter finding hints at some degree of interanimal variation in the functional topography of insular cortex. Overall, GC appears to be necessary to maintain normal taste sensitivity to NaCl and KCl and for salt discrimination learning. However, higher salt concentrations can be detected and discriminated by rats with extensive damage to GC suggesting that the other resources of the gustatory system are sufficient to maintain partial competence in these tasks, supporting the view that such basic sensory-discriminative taste functions involve distributed processes among central gustatory structures.	[Spector, Alan C.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Spector, AC (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	spector@psy.fsu.edu	Spector, Alan/W-2925-2019		National Institute on Deafness and Other Communication Disorders [R01-DC-DC009821, T32-DC-000044]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000044, R01DC009821, K08DC000044] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by the National Institute on Deafness and Other Communication Disorders: R01-DC-DC009821 (ACS); T32-DC-000044 (MBB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accolla R, 2007, J NEUROSCI, V27, P1396, DOI 10.1523/JNEUROSCI.5188-06.2007; Adolphs R, 2005, NAT NEUROSCI, V8, P860, DOI 10.1038/nn1489; ALLEN GV, 1991, J COMP NEUROL, V311, P1, DOI 10.1002/cne.903110102; BENJAMIN RM, 1959, J COMP NEUROL, V111, P231, DOI 10.1002/cne.901110203; BENJAMIN RM, 1955, J COMP PHYSIOL PSYCH, V48, P119, DOI 10.1037/h0041257; BENJAMIN RM, 1955, J NEUROPHYSIOL, V18, P56, DOI 10.1152/jn.1955.18.1.56; Bermudez-Rattoni F, 2004, NAT REV NEUROSCI, V5, P209, DOI 10.1038/nrn1344; BERMUDEZRATTONI F, 1991, BRAIN RES, V549, P165, DOI 10.1016/0006-8993(91)90616-4; Blonde G, 2010, AM J PHYSIOL-REG I, V299, pR1027, DOI 10.1152/ajpregu.00843.2009; Blonde GD, 2006, BEHAV NEUROSCI, V120, P580, DOI 10.1037/0735-7044.120.3.580; BRAUN JJ, 1981, EXP NEUROL, V72, P711, DOI 10.1016/0014-4886(81)90020-0; BRAUN JJ, 1972, PHYSIOL BEHAV, V9, P637; BRAUN JJ, 1982, PHYSIOL PSYCHOL, V10, P13; CECHETTO DF, 1987, J COMP NEUROL, V262, P27, DOI 10.1002/cne.902620104; Cereda C, 2002, NEUROLOGY, V59, P1950, DOI 10.1212/01.WNL.0000038905.75660.BD; Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Cubero I, 1999, BRAIN RES, V839, P323, DOI 10.1016/S0006-8993(99)01745-X; DUNN LT, 1988, BEHAV NEUROSCI, V102, P3, DOI 10.1037/0735-7044.102.1.3; Fontanini A, 2006, J NEUROPHYSIOL, V96, P3183, DOI 10.1152/jn.00804.2006; Fresquet N, 2004, BEHAV BRAIN RES, V153, P357, DOI 10.1016/j.bbr.2003.12.011; Gal-Ben-Ari S, 2012, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00087; Geddes RI, 2008, BEHAV NEUROSCI, V122, P1038, DOI 10.1037/a0012748; Grossman SE, 2008, J NEUROSCI, V28, P2864, DOI 10.1523/JNEUROSCI.4063-07.2008; Hanamori T, 1998, J NEUROPHYSIOL, V79, P2535, DOI 10.1152/jn.1998.79.5.2535; Hashimoto K, 2014, CHEM SENSES, V39, P57, DOI 10.1093/chemse/bjt054; John SJS, 1997, BEHAV NEUROSCI, V111, P450; Kany Y, 2009, BRAIN RES, V1248, P76, DOI 10.1016/j.brainres.2008.10.075; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; KIEFER SW, 1984, BEHAV NEUROSCI, V98, P590; KIEFER SW, 1992, BEHAV NEUROSCI, V106, P140, DOI 10.1037/0735-7044.106.1.140; KOSAR E, 1986, BRAIN RES, V379, P342, DOI 10.1016/0006-8993(86)90788-2; KOSAR E, 1986, BRAIN RES, V379, P329, DOI 10.1016/0006-8993(86)90787-0; LORDEN JF, 1976, J COMP PHYSIOL PSYCH, V90, P665, DOI 10.1037/h0077237; Lundy RF, 2004, J NEUROPHYSIOL, V91, P1143, DOI 10.1152/jn.00840.2003; MacDonald CJ, 2012, J PHYSIOL-LONDON, V590, P3169, DOI 10.1113/jphysiol.2012.233486; Maier JX, 2013, J NEUROPHYSIOL, V109, P2108, DOI 10.1152/jn.00917.2012; Moo L, 1999, J Stroke Cerebrovasc Dis, V8, P353, DOI 10.1016/S1052-3057(99)80011-1; Naor C, 1996, BEHAV BRAIN RES, V79, P61, DOI 10.1016/0166-4328(95)00262-6; Nerad L, 1996, NEUROBIOL LEARN MEM, V66, P44, DOI 10.1006/nlme.1996.0042; Paxinos G, 2007, RAT BRAIN STEREOTAXI, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; PFAFFMANN C, 1977, ANN NY ACAD SCI, V290, P18, DOI 10.1111/j.1749-6632.1977.tb39713.x; Pritchard T. C., 2004, HUMAN NERVOUS SYSTEM, P1171, DOI DOI 10.1016/B978-012547626-3/50032-6; Pritchard TC, 1999, BEHAV NEUROSCI, V113, P663, DOI 10.1037/0735-7044.113.4.663; Roman C, 2007, EUR J NEUROSCI, V26, P2627, DOI 10.1111/j.1460-9568.2007.05872.x; Roman C, 2006, BEHAV NEUROSCI, V120, P1257, DOI 10.1037/0735-7044.120.6.1257; Rosenblum K, 1997, J NEUROSCI, V17, P5129; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Samuelsen CL, 2012, NEURON, V74, P410, DOI 10.1016/j.neuron.2012.02.031; Schafe GE, 1998, BRAIN RES, V800, P40, DOI 10.1016/S0006-8993(98)00492-2; Schier LA, 2014, P NATL ACAD SCI USA, V111, P1162, DOI 10.1073/pnas.1315624111; Shi CJ, 1998, J COMP NEUROL, V399, P440, DOI 10.1002/(SICI)1096-9861(19981005)399:4<440::AID-CNE2>3.0.CO;2-1; Small DM, 2005, NEUROLOGY, V64, P311, DOI 10.1212/01.WNL.0000149515.77718.35; Spector A. C., 2003, Handbook of olfaction and gustation, P861; SPECTOR AC, 1995, REV NEUROSCIENCE, V6, P143, DOI 10.1515/REVNEURO.1995.6.2.143; SPECTOR AC, 1995, BEHAV NEUROSCI, V109, P939, DOI 10.1037/0735-7044.109.5.939; Spector AC, 1996, J NEUROSCI, V16, P8115; SPECTOR AC, 1993, PHYSIOL BEHAV, V53, P277, DOI 10.1016/0031-9384(93)90205-T; Spector AC, 2010, BRAIN RES, V1310, P46, DOI 10.1016/j.brainres.2009.11.021; Stapleton JR, 2006, J NEUROSCI, V26, P4126, DOI 10.1523/JNEUROSCI.0092-06.2006; Stehberg J, 2011, NEUROBIOL LEARN MEM, V95, P14, DOI 10.1016/j.nlm.2010.10.002; Stone ME, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00003; Treesukosol Y, 2012, AM J PHYSIOL-REG I, V303, pR218, DOI 10.1152/ajpregu.00089.2012; VANDERKOOY D, 1984, J COMP NEUROL, V224, P1, DOI 10.1002/cne.902240102; YAMAMOTO T, 1980, J NEUROPHYSIOL, V44, P440, DOI 10.1152/jn.1980.44.3.440	64	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117515	10.1371/journal.pone.0117515	http://dx.doi.org/10.1371/journal.pone.0117515			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658323	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900170
J	Chrystal, JG; Glover, DL; Young, AS; Whelan, F; Austin, EL; Johnson, NK; Pollio, DE; Holt, CL; Stringfellow, E; Gordon, AJ; Kim, TA; Daigle, SG; Steward, JL; Kertesz, SG				Chrystal, Joya G.; Glover, Dawn L.; Young, Alexander S.; Whelan, Fiona; Austin, Erika L.; Johnson, Nancy K.; Pollio, David E.; Holt, Cheryl L.; Stringfellow, Erin; Gordon, Adam J.; Kim, Theresa A.; Daigle, Shanette G.; Steward, Jocelyn L.; Kertesz, Stefan G.			Experience of Primary Care among Homeless Individuals with Mental Health Conditions	PLOS ONE			English	Article							MEDICAL-CARE; PROSPECTIVE COHORT; LOS-ANGELES; ADULTS; QUALITY; ILLNESS; VETERANS; SERVICES; ACCESS; DETOXIFICATION	The delivery of primary care to homeless individuals with mental health conditions presents unique challenges. To inform healthcare improvement, we studied predictors of favorable primary care experience among homeless persons with mental health conditions treated at sites that varied in degree of homeless-specific service tailoring. This was a multi-site, survey-based comparison of primary care experiences at three mainstream primary care clinics of the Veterans Administration (VA), one homeless-tailored VA clinic, and one tailored non-VA healthcare program. Persons who accessed primary care service two or more times from July 2008 through June 2010 (N = 366) were randomly sampled. Predictor variables included patient and organization characteristics suggested by the patient perception model developed by Sofaer and Firminger (2005), with an emphasis on mental health. The primary care experience was assessed with the Primary Care Quality-Homeless (PCQ-H) questionnaire, a validated survey instrument. Multiple regression identified predictors of positive experiences (i.e. higher PCQ-H total score). Significant predictors of a positive experience included a site offering tailored service design, perceived choice among providers, and currently domiciled status. There was an interaction effect between site and severe psychiatric symptoms. For persons with severe psychiatric symptoms, a homeless-tailored service design was significantly associated with a more favorable primary care experience. For persons without severe psychiatric symptoms, this difference was not significant. This study supports the importance of tailored healthcare delivery designed for homeless persons' needs, with such services potentially holding special relevance for persons with mental health conditions. To improve patient experience among the homeless, organizations may want to deliver services that are tailored to homelessness and offer a choice of providers.	[Chrystal, Joya G.; Glover, Dawn L.; Young, Alexander S.] Vet Affairs Greater Los Angeles Healthcare Syst, MIRECC, Los Angeles, CA 90073 USA; [Young, Alexander S.; Whelan, Fiona] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Austin, Erika L.; Johnson, Nancy K.; Daigle, Shanette G.; Steward, Jocelyn L.; Kertesz, Stefan G.] Birmingham Vet Affairs Med Ctr, Ctr Surg Med Acute Care Res & Transit C SMART, Birmingham, AL USA; [Pollio, David E.] Univ Alabama, Sch Social Work, Tuscaloosa, AL USA; [Holt, Cheryl L.] Univ Maryland, Dept Behav & Community Hlth, College Pk, MD 20742 USA; [Stringfellow, Erin] Boston Hlth Care Homeless Program, Boston, MA USA; [Gordon, Adam J.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Gordon, Adam J.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Kim, Theresa A.] Boston Med Ctr, Boston, MA USA; [Kim, Theresa A.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Kertesz, Stefan G.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Tuscaloosa; University System of Maryland; University of Maryland College Park; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Boston Medical Center; Boston University; University of Alabama System; University of Alabama Birmingham	Chrystal, JG (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, MIRECC, Los Angeles, CA 90073 USA.	Joya.Chrystal@va.gov	Gordon, Adam Joseph/AAX-9001-2020; Stringfellow, Erin/AAW-6804-2020; Stringfellow, Erin/AAZ-5843-2020; Young, Alexander/A-1523-2009	Gordon, Adam Joseph/0000-0002-2453-8871; Kertesz, Stefan/0000-0001-6101-8421; Kim, Theresa/0000-0001-6043-0721; Stringfellow, Erin/0000-0002-2286-1448; Knott, Cheryl L./0000-0002-2261-7875; Young, Alexander/0000-0002-9367-9213	Department of Veterans Affairs, Health Services Research Development [SDR-11-233, IAA-07-06902]; Desert Pacific Mental Illness Research, Education and Clinical Center (MIRECC); United States Department of Veterans Affairs Research and Development (RD) branch; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA015035] Funding Source: NIH RePORTER	Department of Veterans Affairs, Health Services Research Development(US Department of Veterans Affairs); Desert Pacific Mental Illness Research, Education and Clinical Center (MIRECC); United States Department of Veterans Affairs Research and Development (RD) branch; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Support was provided by the Department of Veterans Affairs, Health Services Research & Development Grants SDR-11-233 and IAA-07-06902, and the Desert Pacific Mental Illness Research, Education and Clinical Center (MIRECC). The United States Department of Veterans Affairs Research and Development (R&D) branch funded this project as part of its competitive merit review program. The Department''s R&D branch functions in a manner similar to the National Institutes of Health (USA), assembling peer review and acting as "funder" and it has no role in design, data collection, analysis or preparation of manuscripts. By regulation the principal investigator must be an employee of the United States Department of Veterans Affairs (typically within a VA Medical Center). Applicable US federal regulations require a formal disclaimer by the author of any VAfunded research, that underscores the separation of the researcher from VA official views: "The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government." Applicants for R&D funds include VA employees (noted with asterisks below) who are eligible to serve as investigator. However, the funder is VA Research and Development. J.G. Chrystal* conceptualized this study, collected data, analyzed and interpreted results, wrote the primary draft of results, and wrote revisions of the article. D.L. Glover* analyzed and interpreted results, and contributed to revisions of the article. A.S. Young* analyzed and interpreted results, and contributed to revisions of the article. F. Whelan* analyzed and interpreted results, and contributed to the primary draft of the article. E.L. Austin* and N.K. Johnson* designed data collection procedures, collected data, analyzed and interpreted results, and contributed to the primary draft of the article. D.E. Pollio designed data collection procedures, analyzed and interpreted results, and contributed to the primary draft of the article. C.L. Holt conceptualized and designed data collection procedures, analyzed and interpreted results, and contributed to the primary draft of the article. E. Stringfellow designed data collection procedures, collected data, analyzed and interpreted results, and contributed to the primary draft of the article. A. J. Gordon* and T.A. Kim conceptualized and designed the primary study, analyzed and interpreted results, and contributed to the primary draft of the article. S.G. Daigle* designed data collection procedures, collected data, analyzed and interpreted results, and contributed to the primary draft of the article. J.L. Steward designed data collection procedures, collected data, and analyzed and interpreted results. S.G. Kertesz* conceptualized and designed the primary study where, designed the data collection procedures, analyzed and interpreted results, and wrote revisions of the article. All authors gave final approval of the article.	Ali R, 2002, ADDICTION, V97, P1183; Baggett TP, 2010, AM J PUBLIC HEALTH, V100, P1326, DOI 10.2105/AJPH.2009.180109; Bamberger J, VAS HPACT PROGRAM CO; Bhandari A, 2006, MED CARE RES REV, V63, P217, DOI 10.1177/1077558705285298; Blue-Howells J, 2008, SOC WORK HEALTH CARE, V47, P219, DOI 10.1080/00981380801985341; Boothroyd RA, 2008, ADM POLICY MENT HLTH, V35, P370, DOI 10.1007/s10488-008-0179-6; Conrad K J, 2001, Ment Health Serv Res, V3, P141, DOI 10.1023/A:1011571531303; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Desai MM, 2005, GEN HOSP PSYCHIAT, V27, P418, DOI 10.1016/j.genhosppsych.2005.06.003; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; Edlund MJ, 2003, HEALTH SERV RES, V38, P631, DOI 10.1111/1475-6773.00137; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Gallagher TC, 1997, MED CARE, V35, P814, DOI 10.1097/00005650-199708000-00007; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; Gelberg L, 1997, AM J PUBLIC HEALTH, V87, P217, DOI 10.2105/AJPH.87.2.217; Goldberg RW, 2002, PSYCHIATR SERV, V53, P879, DOI 10.1176/appi.ps.53.7.879; Gordon AJ, 2006, MED CARE, V44, pS37, DOI 10.1097/01.mlr.0000223705.00175.3d; Health Services and Resources Administration, 2013, BUILD MED HOM MULT D; Hwang SW, 2010, AM J PUBLIC HEALTH, V100, P1454, DOI 10.2105/AJPH.2009.182022; Hwang SW, 2001, J HEALTH CARE POOR U, V12, P50; IDLER EL, 1995, J GERONTOL B-PSYCHOL, V50, pS344, DOI 10.1093/geronb/50B.6.S344; Kertesz SG, 2003, J SUBST ABUSE TREAT, V24, P197, DOI 10.1016/S0740-5472(03)00026-6; Kertesz SG, 2014, MED CARE, V52, P734, DOI 10.1097/MLR.0000000000000160; Kertesz SG, 2014, J URBAN HEALTH, V91, P33, DOI 10.1007/s11524-013-9801-3; Khandor Erika, 2011, Open Med, V5, pe94; Kilbourne AM, 2006, INT J PSYCHIAT MED, V36, P383, DOI 10.2190/04XR-3107-4004-4670; Kim TW, 2007, HEALTH SERV RES, V42, P755, DOI 10.1111/j.1475-6773.2006.00630.x; Kushel MB, 2001, JAMA-J AM MED ASSOC, V285, P200, DOI 10.1001/jama.285.2.200; Lam JA, 2000, PSYCHIATR SERV, V51, P116, DOI 10.1176/ps.51.1.116; Levitt AJ, 2009, PSYCHIAT SERV, V60, P978, DOI 10.1176/appi.ps.60.7.978; Lin N., 1986, SOCIAL SUPPORT LIFE; Lu N, 2004, J HEALTH CARE POOR U, V15, P618, DOI 10.1353/hpu.2004.0053; McCabe S, 2001, ARCH PSYCHIAT NURS, V15, P78, DOI 10.1053/apnu.2001.22407; McGuire J, 2009, ADM POLICY MENT HLTH, V36, P255, DOI 10.1007/s10488-009-0210-6; Morrison DS, 2009, INT J EPIDEMIOL, V38, P877, DOI 10.1093/ije/dyp160; O'Connell JJ, 2010, AM J PUBLIC HEALTH, V100, P1400, DOI 10.2105/AJPH.2009.173609; O'Toole TP, 2013, AM J PUBLIC HEALTH, V103, pS374, DOI 10.2105/AJPH.2013.301632; O'Toole TP, 2011, J GEN INTERN MED, V26, pS683, DOI 10.1007/s11606-011-1818-2; Resnick SG, 2009, PSYCHIATR REHABIL J, V33, P262, DOI 10.2975/33.4.2010.262.268; Roumie CL, 2011, J BEHAV MED, V34, P244, DOI 10.1007/s10865-010-9304-6; Safran DG, 2001, J FAM PRACTICE, V50, P130; Saitz R, 2004, HEALTH SERV RES, V39, P587, DOI 10.1111/j.1475-6773.2004.00246.x; Salit SA, 1998, NEW ENGL J MED, V338, P1734, DOI 10.1056/NEJM199806113382406; SHERN DL, 1994, MILBANK Q, V72, P123, DOI 10.2307/3350341; Sofaer S, 2005, ANNU REV PUBL HEALTH, V26, P513, DOI 10.1146/annurev.publhealth.25.050503.153958; Stange KC, 2010, J GEN INTERN MED, V25, P601, DOI 10.1007/s11606-010-1291-3; Toole TPO, 2010, AM J PUBLIC HEALTH, V100, P2493, DOI 10.2105/AJPH.2009.179416; U.S. Interagency Council on the Homeless (ICH), 2003, FED REGISTER, V68, P4018; US Department of Housing and Urban Development, 2010, 2010 ANN HOM ASS REP; Wen CK, 2007, J GEN INTERN MED, V22, P1011, DOI 10.1007/s11606-007-0183-7; Young A S, 1999, Ment Health Serv Res, V1, P201, DOI 10.1023/A:1022369323451	51	16	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117395	10.1371/journal.pone.0117395	http://dx.doi.org/10.1371/journal.pone.0117395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25659142	Green Accepted, gold, Green Published			2022-12-27	WOS:000349444900141
J	Kim, JY; Sohn, JH; Lee, JH; Park, JW				Kim, Joo Young; Sohn, Jung-Ho; Lee, Jae-Hyun; Park, Jung-Won			Obesity Increases Airway Hyperresponsiveness via the TNF-alpha Pathway and Treating Obesity Induces Recovery	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ADIPOSE-TISSUE; WEIGHT-LOSS; ASTHMA; INFLAMMATION; DISEASE; DIET	Obesity is a known risk factor for allergic asthma. It has been recognized as a key player in the pathogenesis of several inflammatory disorders via activation of macrophages, which is also vital to the development of allergic asthma. We investigated the mechanism of obesity-related asthma and whether treating obesity through exercise or diet ameliorates the severity of asthma in the obesity-related asthma model. We generated diet-induced obesity (DIO) in C57BL/6 mice by high-fat-feeding and ovalbumin-induced asthma (lean-OVA or DIOOVA). The DIO-OVA mice were then treated with tumor necrosis factor (TNF)-alpha neutralizing antibody as a TNF-alpha blockade or a Cl2MDP-containing liposome to induce an alveolar macrophage deficiency. To treat obesity, the DIO-OVA mice were under dietary restrictions or exercised. The pathophysiological and immunological responses were analyzed. Airway hyperresponsiveness (AHR), serum IgE and TNF-alpha levels in the lung tissue increased in the DIO-OVA mice compared to the lean-OVA mice. Both the TNF-alpha blockade and depletion of alveolar macrophages in the DIO-OVA mice decreased AHR compared to the DIOOVA mice. Treating obesity by exercise or through dietary means also reduced pulmonary TNF-alpha levels and AHR in the DIO-OVA mice. These results suggest that restoring normal body weight is an appropriate strategy for reducing TNF-alpha levels, and controlling inflammation may help improve asthma severity and control in obesity-related asthma.	[Kim, Joo Young] Ewha Womans Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea; [Sohn, Jung-Ho; Lee, Jae-Hyun; Park, Jung-Won] Yonsei Univ, Coll Med, Inst Allergy, Dept Internal Med, Seoul, South Korea	Ewha Womans University; Yonsei University; Yonsei University Health System	Park, JW (corresponding author), Yonsei Univ, Coll Med, Inst Allergy, Dept Internal Med, Seoul, South Korea.	parkjw@yuhs.ac	Kim, Jooyoung/R-5839-2018; Lee, Jae-Hyun/ABE-3803-2020; Lee, Jae-Hyun/H-2260-2016	Kim, Jooyoung/0000-0003-4846-6259; Lee, Jae-Hyun/0000-0002-0760-0071; Lee, Jae-Hyun/0000-0002-0760-0071; Park, Jung-Won/0000-0003-0249-8749	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0010]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0010). JWP received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeniyi FB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009339.pub2; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Bradley RL, 2008, AM J PHYSIOL-ENDOC M, V295, pE586, DOI 10.1152/ajpendo.00309.2007; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Calixto MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076786; Celedon JC, 2014, NAT MED, V20, P20, DOI 10.1038/nm.3433; Centers for Disease Control and Prevention, 2012, BRFSS 2010 SURVEY DA; Chiu S, 2004, OBES RES, V12, P1243, DOI 10.1038/oby.2004.158; Dixon AE, 2011, J ALLERGY CLIN IMMUN, V128, P508, DOI 10.1016/j.jaci.2011.06.009; Eneli IU, 2008, THORAX, V63, P671, DOI 10.1136/thx.2007.086470; Feola DJ, 2010, ANTIMICROB AGENTS CH, V54, P2437, DOI 10.1128/AAC.01424-09; Gibson Peter G, 2013, Ann Am Thorac Soc, V10 Suppl, pS138, DOI 10.1513/AnnalsATS.201302-038AW; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Irani BG, 2005, BIOCHEM BIOPH RES CO, V326, P638, DOI 10.1016/j.bbrc.2004.11.084; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Kim JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047971; Lee BK, 2004, CLIN EXP ALLERGY, V34, P1642, DOI 10.1111/j.1365-2222.2004.02077.x; Lessard A, 2008, CHEST, V134, P317, DOI 10.1378/chest.07-2959; Mizutani N, 2014, J IMMUNOL, V192, P1372, DOI 10.4049/jimmunol.1301538; Ronmark E, 2005, EUR RESPIR J, V25, P282, DOI 10.1183/09031936.05.00054304; Scott HA, 2013, CLIN EXP ALLERGY, V43, P36, DOI 10.1111/cea.12004; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Sideleva O, 2012, AM J RESP CRIT CARE, V186, P598, DOI 10.1164/rccm.201203-0573OC; Sutherland TJT, 2008, AM J RESP CRIT CARE, V178, P469, DOI 10.1164/rccm.200802-301OC; THEPEN T, 1989, J EXP MED, V170, P499, DOI 10.1084/jem.170.2.499; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wenzel SE, 2009, AM J RESP CRIT CARE, V179, P549, DOI 10.1164/rccm.200809-1512OC; World Health Organization Office of Health Communications and Public Relations, 2006, OB OV, P3; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yang M, 2010, CLIN EXP ALLERGY, V40, P163, DOI 10.1111/j.1365-2222.2009.03393.x; Ziccardi P, 2002, CIRCULATION, V105, P804, DOI 10.1161/hc0702.104279	34	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116540	10.1371/journal.pone.0116540	http://dx.doi.org/10.1371/journal.pone.0116540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658739	Green Submitted, Green Published, gold			2022-12-27	WOS:000349444900047
J	Mouden, C; de Tayrac, M; Dubourg, C; Rose, S; Carre, W; Hamdi-Roze, H; Babron, MC; Akloul, L; Heron-Longe, B; Odent, S; Dupe, V; Giet, R; David, V				Mouden, Charlotte; de Tayrac, Marie; Dubourg, Christele; Rose, Sophie; Carre, Wilfrid; Hamdi-Roze, Houda; Babron, Marie-Claude; Akloul, Linda; Heron-Longe, Benedicte; Odent, Sylvie; Dupe, Valerie; Giet, Regis; David, Veronique			Homozygous STIL Mutation Causes Holoprosencephaly and Microcephaly in Two Siblings	PLOS ONE			English	Article							MEIER-GORLIN SYNDROME; CHICK-EMBRYOS; HUMAN-CELLS; GENE; CENTRIOLE; PROTEIN; SIL; SHH; AMPLIFICATION; PHENOTYPE	Holoprosencephaly (HPE) is a frequent congenital malformation of the brain characterized by impaired forebrain cleavage and midline facial anomalies. Heterozygous mutations in 14 genes have been identified in HPE patients that account for only 30% of HPE cases, suggesting the existence of other HPE genes. Data from homozygosity mapping and whole-exome sequencing in a consanguineous Turkish family were combined to identify a homozygous missense mutation (c.2150G>A; p.Gly717Glu) in STIL, common to the two affected children. STIL has a role in centriole formation and has previously been described in rare cases of microcephaly. Rescue experiments in U2OS cells showed that the STIL p.Gly717Glu mutation was not able to fully restore the centriole duplication failure following depletion of endogenous STIL protein indicating the deleterious role of the mutation. In situ hybridization experiments using chick embryos demonstrated that expression of Stil was in accordance with a function during early patterning of the forebrain. It is only the second time that a STIL homozygous mutation causing a recessive form of HPE was reported. This result also supports the genetic heterogeneity of HPE and increases the panel of genes to be tested for HPE diagnosis.	[Mouden, Charlotte; de Tayrac, Marie; Dubourg, Christele; Rose, Sophie; Hamdi-Roze, Houda; Odent, Sylvie; Dupe, Valerie; David, Veronique] Univ Rennes 1, Fac Med, Inst Genet & Dev Rennes, Equipe Genet Pathol Liees Dev, F-35043 Rennes, France; [Giet, Regis] Univ Rennes 1, Fac Med, Inst Genet & Dev Rennes, Equipe Cytosquelette & Proliferat Cellulaire, F-35043 Rennes, France; [Dubourg, Christele; Carre, Wilfrid; Hamdi-Roze, Houda; David, Veronique] CHU Pontchaillou, Lab Genet Mol & Genom, F-35033 Rennes, France; [Babron, Marie-Claude] Univ Paris Diderot, INSERM, Variabil Genet & Malad Humaines U946, F-75010 Paris, France; [Akloul, Linda; Odent, Sylvie] Hop Sud, Serv Genet Clin, F-35200 Rennes, France; [Heron-Longe, Benedicte] Hop Jean Verdier, APHP, Serv Pediat, F-93140 Bondy, France; [de Tayrac, Marie] Univ Rennes 1, F-35033 Rennes, France	Universite de Rennes; Universite de Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Jean-Verdier - APHP; Universite de Rennes	David, V (corresponding author), Univ Rennes 1, Fac Med, Inst Genet & Dev Rennes, Equipe Genet Pathol Liees Dev, F-35043 Rennes, France.	veronique.david@univ-rennes1.fr	de Tayrac, Marie/AAG-7800-2020; Dupe, Valerie/CJQ-0939-2022; Dupe, Valerie/P-2140-2018	Dupe, Valerie/0000-0003-4859-0612; Dupe, Valerie/0000-0003-4859-0612; Babron, Marie-Claude/0000-0002-4100-0299; Hamdi-Roze, Houda/0000-0003-2175-9190	Agence de la Biomedecine; Agence Nationale de la Recherche [ANR-12-BSV1-0007-01]	Agence de la Biomedecine; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Agence de la Biomedecine (to V. David) and the Agence Nationale de la Recherche (grant no. ANR-12-BSV1-0007-01 (to V. Dupe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglyamova GV, 2007, DEV DYNAM, V236, P1363, DOI 10.1002/dvdy.21146; Arquint C, 2014, CURR BIOL, V24, P351, DOI 10.1016/j.cub.2013.12.016; Bae GU, 2011, AM J HUM GENET, V89, P231, DOI 10.1016/j.ajhg.2011.07.001; Bendavid C, 2010, AM J MED GENET C, V154C, P86, DOI 10.1002/ajmg.c.30250; Bennett H, 2014, PEDIATR NEUROL, DOI [10.1016/j.pediatrneurol.2014.11.008, DOI 10.1016/J.PEDIATRNEUR0L.2014.11.008]; Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776; Chapman SC, 2002, DEV BIOL, V245, P187, DOI 10.1006/dbio.2002.0641; Darvish H, 2010, J MED GENET, V47, P823, DOI 10.1136/jmg.2009.076398; de Munnik SA, 2012, AM J MED GENET A, V158A, P2733, DOI 10.1002/ajmg.a.35681; Dubourg C, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-8; Dupe V, 2011, HUM MOL GENET, V20, P1122, DOI 10.1093/hmg/ddq556; Franck N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014600; Gazal S, 2014, BIOINFORMATICS, V30, P1940, DOI 10.1093/bioinformatics/btu149; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; Izraeli S, 2001, GENESIS, V31, P72, DOI 10.1002/gene.10004; Izraeli S, 1999, NATURE, V399, P691, DOI 10.1038/21429; Kakar N, 2014, HUM GENET, DOI [10.1007/s00439-014-1519-0, DOI 10.1007/S00439-014-1519-0]; Karkera JD, 2002, CYTOGENET GENOME RES, V97, P62, DOI 10.1159/000064057; Kasai K, 2008, CANCER RES, V68, P7723, DOI 10.1158/0008-5472.CAN-07-6661; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Lacruz RS, 2011, J DENT RES, V90, P1228, DOI 10.1177/0022034511418231; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746; Mercier S, 2013, DIS MODEL MECH, V6, P537, DOI 10.1242/dmm.010132; Mercier S, 2011, J MED GENET, V48, P752, DOI 10.1136/jmedgenet-2011-100339; Papari E, 2013, CLIN GENET, V83, P488, DOI 10.1111/j.1399-0004.2012.01949.x; Pineda-Alvarez DE, 2012, HUM GENET, V131, P301, DOI 10.1007/s00439-011-1078-6; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Solomon BD, 1993, GENEREVIEWS R; Sun L, 2014, BIOCHEM BIOPH RES CO, V449, P444, DOI 10.1016/j.bbrc.2014.05.048; Tang CJC, 2011, EMBO J, V30, P4790, DOI 10.1038/emboj.2011.378; Vulprecht J, 2012, J CELL SCI, V125, P1353, DOI 10.1242/jcs.104109; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	35	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117418	10.1371/journal.pone.0117418	http://dx.doi.org/10.1371/journal.pone.0117418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658757	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900146
J	Okamoto, A; Sehouli, J; Yanaihara, N; Hirata, Y; Braicu, I; Kim, BG; Takakura, S; Saito, M; Yanagida, S; Takenaka, M; Yamaguchi, N; Morikawa, A; Tanabe, H; Yamada, K; Yoshihara, K; Enomoto, T; Itamochi, H; Kigawa, J; Matsumura, N; Konishi, I; Aida, S; Aoki, Y; Ishii, N; Ochiai, K; Akiyama, T; Urashima, M				Okamoto, Aikou; Sehouli, Jalid; Yanaihara, Nozomu; Hirata, Yukihiro; Braicu, Ioana; Kim, Byoung-Gie; Takakura, Satoshi; Saito, Misato; Yanagida, Satoshi; Takenaka, Masataka; Yamaguchi, Noriko; Morikawa, Asuka; Tanabe, Hiroshi; Yamada, Kyosuke; Yoshihara, Kosuke; Enomoto, Takayuki; Itamochi, Hiroaki; Kigawa, Junzo; Matsumura, Noriomi; Konishi, Ikuo; Aida, Satoshi; Aoki, Yuko; Ishii, Nobuya; Ochiai, Kazunori; Akiyama, Tetsu; Urashima, Mitsuyoshi			Somatic Copy Number Alterations Associated with Japanese or Endometriosis in Ovarian Clear Cell Adenocarcinoma	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; POOR-PROGNOSIS; VENOUS THROMBOEMBOLISM; FOLLOW-UP; CANCER; AMPLIFICATION; CARCINOMA; EGFR; EXPRESSION; MUTATIONS	When compared with other epithelial ovarian cancers, the clinical characteristics of ovarian clear cell adenocarcinoma (CCC) include 1) a higher incidence among Japanese, 2) an association with endometriosis, 3) poor prognosis in advanced stages, and 4) a higher incidence of thrombosis as a complication. We used high resolution comparative genomic hybridization (CGH) to identify somatic copy number alterations (SCNAs) associated with each of these clinical characteristics of CCC. The Human Genome CGH 244A Oligo Microarray was used to examine 144 samples obtained from 120 Japanese, 15 Korean, and nine German patients with CCC. The entire 8q chromosome (minimum corrected p-value: q = 0.0001) and chromosome 20q13.2 including the ZNF217 locus (q = 0.0078) were amplified significantly more in Japanese than in Korean or German samples. This copy number amplification of the ZNF217 gene was confirmed by quantitative real-time polymerase chain reaction (Q-PCR). ZNF217 RNA levels were also higher in Japanese tumor samples than in non-Japanese samples (P = 0.027). Moreover, endometriosis was associated with amplification of EGFR gene (q = 0.047), which was again confirmed by Q-PCR and correlated with EGFR RNA expression. However, no SCNAs were significantly associated with prognosis or thrombosis. These results indicated that there may be an association between CCC and ZNF217 amplification among Japanese patients as well as between endometriosis and EGFR gene amplifications.	[Okamoto, Aikou; Yanaihara, Nozomu; Hirata, Yukihiro; Takakura, Satoshi; Saito, Misato; Yanagida, Satoshi; Takenaka, Masataka; Yamaguchi, Noriko; Morikawa, Asuka; Tanabe, Hiroshi; Yamada, Kyosuke; Ochiai, Kazunori] Jikei Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan; [Sehouli, Jalid; Braicu, Ioana] Charite, Dept Obstet & Gynecol, Berlin, Germany; [Kim, Byoung-Gie] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Yoshihara, Kosuke; Enomoto, Takayuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Obstet & Gynecol, Niigata, Japan; [Itamochi, Hiroaki; Kigawa, Junzo] Tottori Univ, Sch Med, Dept Obstet & Gynecol, Yonago, Tottori 683, Japan; [Matsumura, Noriomi; Konishi, Ikuo] Kyoto Univ, Dept Obstet & Gynecol, Grad Sch Med, Kyoto, Japan; [Aoki, Yuko; Ishii, Nobuya] Chugai Pharmaceut Co Ltd, Pharmaceut Res Dept 2, Div Res, Kamakura, Kanagawa, Japan; [Aida, Satoshi; Akiyama, Tetsu] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Tokyo, Japan; [Urashima, Mitsuyoshi] Jikei Univ, Sch Med, Div Mol Epidemiol, Tokyo, Japan	Jikei University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Sungkyunkwan University (SKKU); Samsung Medical Center; Niigata University; Tottori University; Kyoto University; Chugai Pharmaceutical Co., Ltd.; Roche Holding; University of Tokyo; Jikei University	Urashima, M (corresponding author), Jikei Univ, Sch Med, Div Mol Epidemiol, Tokyo, Japan.	urashima@jikei.ac.jp	Yoshihara, Kosuke/AAU-9874-2020	Yoshihara, Kosuke/0000-0002-2254-3378; Matsumura, Noriomi/0000-0002-4512-7975; Enomoto, Takayuki/0000-0003-4538-5541; Braicu, Ioana/0000-0001-5357-6001	Ministry of Education, Culture, Sports, Science and Technology in the Japan; Jikei University School of Medicine; Chugai Pharmaceutical Co., Ltd.	Ministry of Education, Culture, Sports, Science and Technology in the Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Jikei University School of Medicine(Jikei University); Chugai Pharmaceutical Co., Ltd.	The Ministry of Education, Culture, Sports, Science and Technology in the Japan-Supported Program for the Strategic Research Foundation at Private Universities and by the Jikei University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Chugai Pharmaceutical Co., Ltd. provided support in the form of salaries for authors YA and NI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	American Cancer Society, 2012, CANCER FACTS FIGURES; Arnold N, 1996, GENE CHROMOSOME CANC, V16, P46, DOI 10.1002/(SICI)1098-2264(199605)16:1<46::AID-GCC7>3.0.CO;2-3; Arteaga CL, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.35642; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; CLARKEPEARSON DL, 1983, AM J OBSTET GYNECOL, V145, P606, DOI 10.1016/0002-9378(83)91205-X; Collins C, 2010, CLIN CANCER RES, V16, P1997, DOI [10.1158/1078-0432.CCR-09-2105, DOI 10.1158/1078-0432.CCR-09-2105]; Duska LR, 2010, GYNECOL ONCOL, V116, P374, DOI 10.1016/j.ygyno.2009.10.069; Ettl T, 2012, BRIT J CANCER, V106, P719, DOI 10.1038/bjc.2011.605; Freeman SS, 2008, CANCER-AM CANCER SOC, V113, P1453, DOI 10.1002/cncr.23782; Gilks CB, 2008, HUM PATHOL, V39, P1239, DOI 10.1016/j.humpath.2008.01.003; Hama T, 2009, ONCOLOGIST, V14, P900, DOI 10.1634/theoncologist.2009-0058; Hanawa M, 2006, INT J CANCER, V118, P1173, DOI 10.1002/ijc.21454; Hirsch FR, 2005, J CLIN ONCOL, V23, P6838, DOI 10.1200/JCO.2005.01.2823; Hobbs J, 2012, AM J SURG PATHOL, V36, P1186, DOI 10.1097/PAS.0b013e3182518e12; Huang GQ, 2005, HUM MOL GENET, V14, P3219, DOI 10.1093/hmg/ddi352; Huang HN, 2014, MODERN PATHOL, V27, P983, DOI 10.1038/modpathol.2013.216; Inagaki M, 2007, GYNECOL ENDOCRINOL, V23, P474, DOI 10.1080/09513590701521057; Itamochi H, 2008, CANCER SCI, V99, P653, DOI 10.1111/j.1349-7006.2008.00747.x; Jacoby VL, 2010, AM J OBSTET GYNECOL, V202, P514, DOI 10.1016/j.ajog.2010.02.039; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kitao K, 2007, REPROD SCI, V14, P349, DOI 10.1177/1933719107303383; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Kuo KT, 2010, CLIN CANCER RES, V16, P1997, DOI 10.1158/1078-0432.CCR-09-2105; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Mackay HJ, 2010, INT J GYNECOL CANCER, V20, P945, DOI 10.1111/IGC.0b013e3181dd0110; Matsuda T, 2012, JPN J CLIN ONCOL, V42, P139, DOI 10.1093/jjco/hyr184; MELEGA C, 1991, ANN NY ACAD SCI, V622, P256; Mizuno M, 2006, J SURG ONCOL, V94, P138, DOI 10.1002/jso.20251; Okamoto A, 2005, CLIN CANCER RES, V11, P6030, DOI 10.1158/1078-0432.CCR-04-2671; Pearce CL, 2012, LANCET ONCOL, V13, P385, DOI 10.1016/S1470-2045(11)70404-1; Piccart MJ, 2000, JNCI-J NATL CANCER I, V92, P699, DOI 10.1093/jnci/92.9.699; Rahman MT, 2012, CANCER-AM CANCER SOC, V118, P2846, DOI 10.1002/cncr.26598; Rustin GJS, 1996, ANN ONCOL, V7, P361; Satoh T, 2007, BRIT J CANCER, V97, P1053, DOI 10.1038/sj.bjc.6603989; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Takano M, 2006, BRIT J CANCER, V94, P1369, DOI 10.1038/sj.bjc.6603116; Tan DSP, 2011, CLIN CANCER RES, V17, P1521, DOI 10.1158/1078-0432.CCR-10-1688; Uno S, 2010, NAT GENET, V42, P707, DOI 10.1038/ng.612; Vasey PA, 2004, JNCI-J NATL CANCER I, V96, P1682, DOI 10.1093/jnci/djh323; Vergote I, 2000, J NATL CANCER I, V92, P1534, DOI 10.1093/jnci/92.18.1534; von Tempelhoff GF, 1998, CANCER-AM CANCER SOC, V82, P1104, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1104::AID-CNCR14>3.0.CO;2-A; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Xie T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042001, 10.1371/journal.pone.0047577]; Yahata T, 2012, J OBSTET GYNAECOL RE, V38, P645, DOI 10.1111/j.1447-0756.2011.01755.x	45	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116977	10.1371/journal.pone.0116977	http://dx.doi.org/10.1371/journal.pone.0116977			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658832	gold, Green Published, Green Submitted			2022-12-27	WOS:000349444900084
J	Philp, LK; Heilbronn, LK; Janovska, A; Wittert, GA				Philp, Lisa K.; Heilbronn, Leonie K.; Janovska, Alena; Wittert, Gary A.			Dietary Enrichment with Fish Oil Prevents High Fat-Induced Metabolic Dysfunction in Skeletal Muscle in Mice	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE KINASE; FIBER-TYPE; UP-REGULATION; UNCOUPLING PROTEIN-3; GLUCOSE-INTOLERANCE; INSULIN-RESISTANCE; ACID OXIDATION; SOLEUS MUSCLE; VISCERAL FAT; BODY-WEIGHT	High saturated fat (HF-S) diets increase intramyocellular lipid, an effect ameliorated by omega-3 fatty acids in vitro and in vivo, though little is known about sex-and muscle fiber type-specific effects. We compared effects of standard chow, HF-S, and 7.5% HF-S replaced with fish oil (HF-FO) diets on the metabolic profile and lipid metabolism gene and protein content in red (soleus) and white (extensor digitorum longus) muscles of male and female C57BL/6 mice (n = 9-12/group). Weight gain was similar in HF-S- and HF-FO-fed groups. HF-S feeding increased mesenteric fat mass and lipid marker, Oil Red O, in red and mixed muscle; HF-FO increased interscapular brown fat mass. Compared to chow, HF-S and HF-FO increased expression of genes regulating triacylglycerol synthesis and fatty acid transport, HF-S suppressed genes and proteins regulating fatty acid oxidation, whereas HF-FO increased oxidative genes, proteins and enzymes and lipolytic gene content, whilst suppressing lipogenic genes. In comparison to HF-S, HF-FO further increased fat transporters, markers of fatty acid oxidation and mitochondrial content, and reduced lipogenic genes. No diet-by-sex interactions were observed. Neither diet influenced fiber type composition. However, some interactions between muscle type and diet were observed. HF-S induced changes in triacylglycerol synthesis and lipogenic genes in red, but not white, muscle, and mitochondrial biogenesis and oxidative genes were suppressed by HF-S and increased by HF-FO in red muscle only. In conclusion, HF-S feeding promotes lipid storage in red muscle, an effect abrogated by the fish oil, which increases mediators of lipolysis, oxidation and thermogenesis while inhibiting lipogenic genes. Greater storage and synthesis, and lower oxidative genes in red, but not white, muscle likely contribute to lipid accretion encountered in red muscle. Despite several gender-dimorphic genes, both sexes exhibited a similar HF-S-induced metabolic and gene expression profile; likewise fish oil was similarly protective in both sexes.	[Philp, Lisa K.; Heilbronn, Leonie K.; Janovska, Alena; Wittert, Gary A.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia	University of Adelaide	Philp, LK (corresponding author), Univ Adelaide, Discipline Med, Adelaide, SA, Australia.	lisa.philp@qut.edu.au	wittert, gary/AAE-2398-2019; Heilbronn, Leonie/H-1874-2013	Philp, Lisa/0000-0001-8365-295X; Wittert, Gary/0000-0001-6818-6065; Heilbronn, Leonie/0000-0003-2106-7303	Australian Post-graduate Award	Australian Post-graduate Award(Australian Government)	This work was funded by an Australian Post-graduate Award (http://education.gov.au/australian-postgraduate-awards) - LKP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas V, 2006, J LIPID RES, V47, P366, DOI 10.1194/jlr.M500300-JLR200; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; BELZUNG F, 1993, AM J PHYSIOL, V264, pR1111, DOI 10.1152/ajpregu.1993.264.6.R1111; Bertrand C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078874; Bezaire V, 2006, AM J PHYSIOL-ENDOC M, V290, pE509, DOI 10.1152/ajpendo.00312.2005; Bezaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev; Biscione F, 2007, CURR VASC PHARMACOL, V5, P163, DOI 10.2174/157016107780368334; Blaak EE, 2006, J CLIN ENDOCR METAB, V91, P1462, DOI 10.1210/jc.2005-1598; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Cameron-Smith D, 2003, AM J CLIN NUTR, V77, P313, DOI 10.1093/ajcn/77.2.313; Catala-Niell A, 2008, CELL PHYSIOL BIOCHEM, V22, P327, DOI 10.1159/000149811; Coen PM, 2010, DIABETES, V59, P80, DOI 10.2337/db09-0988; Doh KO, 2005, LIFE SCI, V77, P435, DOI 10.1016/j.lfs.2004.11.032; DREON DM, 1988, AM J CLIN NUTR, V47, P995, DOI 10.1093/ajcn/47.6.995; Feillet-Coudray C, 2013, BRIT J NUTR, V110, P1789, DOI 10.1017/S0007114513001311; Fiamoncini J, 2013, OBESITY, V21, P1200, DOI 10.1002/oby.20132; FRYER LGD, 1995, EUR J BIOCHEM, V229, P741, DOI 10.1111/j.1432-1033.1995.tb20522.x; Guillerm-Regost C, 2006, OBESITY, V14, P1700, DOI 10.1038/oby.2006.195; GUTH L, 1970, EXP NEUROL, V28, P365, DOI 10.1016/0014-4886(70)90244-X; Han XX, 2007, AM J PHYSIOL-ENDOC M, V293, pE566, DOI 10.1152/ajpendo.00106.2007; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; HICKEY MS, 1995, AM J PHYSIOL-ENDOC M, V268, pE453, DOI 10.1152/ajpendo.1995.268.3.E453; Hihi AK, 2002, CELL MOL LIFE SCI, V59, P790, DOI 10.1007/s00018-002-8467-x; HINTZ CS, 1980, AM J PHYSIOL, V239, pC58, DOI 10.1152/ajpcell.1980.239.3.C58; Hoeks J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027274; Holness MJ, 2000, DIABETES, V49, P775, DOI 10.2337/diabetes.49.5.775; Horakova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043764; Janczyk W, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-85; Janovska A, 2008, MOL CELL ENDOCRINOL, V284, P1, DOI 10.1016/j.mce.2007.12.013; Jeoung NH, 2008, AM J PHYSIOL-ENDOC M, V295, pE46, DOI 10.1152/ajpendo.00536.2007; Kaneko S, 2011, ANAT REC, V294, P1904, DOI 10.1002/ar.21472; Kim CH, 2003, METABOLISM, V52, P1586, DOI 10.1016/S0026-0495(03)00328-7; Kim JY, 2000, AM J PHYSIOL-REG I, V279, pR2057, DOI 10.1152/ajpregu.2000.279.6.R2057; Kuda O, 2009, DIABETOLOGIA, V52, P941, DOI 10.1007/s00125-009-1305-z; Lam YY, 2011, BBA-MOL CELL BIOL L, V1811, P468, DOI 10.1016/j.bbalip.2011.04.011; Lanza IR, 2013, AM J PHYSIOL-ENDOC M, V304, pE1391, DOI 10.1152/ajpendo.00584.2012; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Lombardo YB, 2006, J NUTR BIOCHEM, V17, P1, DOI 10.1016/j.jnutbio.2005.08.002; Marotta M, 2004, METABOLISM, V53, P1032, DOI 10.1016/j.metabol.2004.03.011; Mathai AS, 2008, J APPL PHYSIOL, V105, P1098, DOI 10.1152/japplphysiol.00847.2007; Mizunoya W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080152; Mullen KL, 2007, AM J PHYSIOL-ENDOC M, V293, pE83, DOI 10.1152/ajpendo.00545.2006; PARRISH CC, 1990, METABOLISM, V39, P217, DOI 10.1016/0026-0495(90)90038-E; Perez-Echarri N, 2009, J NUTR BIOCHEM, V20, P705, DOI 10.1016/j.jnutbio.2008.06.013; Piers LS, 2003, BRIT J NUTR, V90, P717, DOI 10.1079/BJN2003948; Priego T, 2008, OBESITY, V16, P819, DOI 10.1038/oby.2007.117; Rokling-Andersen MH, 2009, BRIT J NUTR, V102, P995, DOI 10.1017/S0007114509353210; Rossmeisl M, 2009, OBESITY, V17, P1023, DOI 10.1038/oby.2008.602; Samec S, 2002, PFLUG ARCH EUR J PHY, V445, P80, DOI 10.1007/s00424-002-0879-9; Schrauwen P, 2006, PROG LIPID RES, V45, P17, DOI 10.1016/j.plipres.2005.11.001; Schrauwen P, 1997, AM J CLIN NUTR, V66, P276, DOI 10.1093/ajcn/66.2.276; Smith AC, 2007, AM J PHYSIOL-ENDOC M, V293, pE172, DOI 10.1152/ajpendo.00677.2006; THOMAS CD, 1992, AM J CLIN NUTR, V55, P934, DOI 10.1093/ajcn/55.5.934; Thyfault JP, 2004, AM J PHYSIOL-ENDOC M, V287, pE1076, DOI 10.1152/ajpendo.00177.2004; Turvey EA, 2005, J APPL PHYSIOL, V98, P350, DOI [10.1152/japplphysiol.00604.2004, 10.1152/japplphysiol.00604.2005]; Watt MJ, 2004, J MOL ENDOCRINOL, V33, P533, DOI 10.1677/jme.1.01499; Westerbacka J, 2005, J CLIN ENDOCR METAB, V90, P2804, DOI 10.1210/jc.2004-1983; WOLFE RR, 1990, AM J PHYSIOL, V258, pE382, DOI 10.1152/ajpendo.1990.258.2.E382; Yu YH, 2011, J NUTR BIOCHEM, V22, P179, DOI 10.1016/j.jnutbio.2010.01.006; Zderic TW, 2004, AM J PHYSIOL-ENDOC M, V286, pE217, DOI 10.1152/ajpendo.00159.2003	63	38	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117494	10.1371/journal.pone.0117494	http://dx.doi.org/10.1371/journal.pone.0117494			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658742	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900164
J	Shave, S; Blackburn, EA; Adie, J; Houston, DR; Auer, M; Webster, SP; Taylor, P; Walkinshaw, MD				Shave, Steven; Blackburn, Elizabeth A.; Adie, Jillian; Houston, Douglas R.; Auer, Manfred; Webster, Scott P.; Taylor, Paul; Walkinshaw, Malcolm D.			UFSRAT: Ultra-Fast Shape Recognition with Atom Types -The Discovery of Novel Bioactive Small Molecular Scaffolds for FKBP12 and 11 beta HSD1	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; DRUG-LIKE COMPOUNDS; LIGAND DISCOVERY; PROGRAM LIDAEUS; INHIBITORS; IDENTIFICATION; PROTEIN; DESCRIPTORS; DATABASES; BINDING	Motivation Using molecular similarity to discover bioactive small molecules with novel chemical scaffolds can be computationally demanding. We describe Ultra-fast Shape Recognition with Atom Types (UFSRAT), an efficient algorithm that considers both the 3D distribution (shape) and electrostatics of atoms to score and retrieve molecules capable of making similar interactions to those of the supplied query. Results Computational optimization and pre-calculation of molecular descriptors enables a query molecule to be run against a database containing 3.8 million molecules and results returned in under 10 seconds on modest hardware. UFSRAT has been used in pipelines to identify bioactive molecules for two clinically relevant drug targets; FK506-Binding Protein 12 and 11 beta-hydroxysteroid dehydrogenase type 1. In the case of FK506-Binding Protein 12, UFSRAT was used as the first step in a structure-based virtual screening pipeline, yielding many actives, of which the most active shows a K-D, (app) of 281 mu M and contains a substructure present in the query compound. Success was also achieved running solely the UFSRAT technique to identify new actives for 11 beta-hydroxysteroid dehydrogenase type 1, for which the most active displays an IC50 of 67 nM in a cell based assay and contains a substructure radically different to the query. This demonstrates the valuable ability of the UFSRAT algorithm to perform scaffold hops. Availability and Implementation A web-based implementation of the algorithm is freely available at http://opus.bch.ed.ac.uk/ufsrat/.	[Shave, Steven; Blackburn, Elizabeth A.; Adie, Jillian; Houston, Douglas R.; Auer, Manfred; Taylor, Paul; Walkinshaw, Malcolm D.] Univ Edinburgh, Ctr Translat & Chem Biol, Edinburgh, Midlothian, Scotland; [Webster, Scott P.] Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Walkinshaw, MD (corresponding author), Univ Edinburgh, Ctr Translat & Chem Biol, Edinburgh, Midlothian, Scotland.	m.walkinshaw@ed.ac.uk	walkinshaw, malcolm/AAB-7497-2019	Shave, Steven/0000-0001-6996-3663; Houston, Douglas/0000-0002-3469-1546; Auer, Manfred/0000-0001-8920-3522; Webster, Scott/0000-0003-4656-4744; Adie, Jillian/0000-0002-5048-9583; Blackburn, Elizabeth A/0000-0003-1325-9575; walkinshaw, malcolm/0000-0001-5955-9325; Taylor, Paul/0000-0002-8213-0380	Wellcome Trust [101527/Z/13/Z]; studentships from Biotechnology and Biological Sciences Research Council; Medical Research Council [MC_G0802522] Funding Source: researchfish; MRC [MC_G0802522] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); studentships from Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Experiments were carried out in the Centre for Translational and Chemical Biology (CTCB) and the Edinburgh Protein Production Facility (EPPF). The CTCB and the EPPF were funded by the Wellcome Trust http://www.wellcome.ac.uk/ (Grant number 101527/Z/13/Z). JA, EAB and SS were funded by studentships from the Biotechnology and Biological Sciences Research Council (http:w//www.bbsrc.ac.uk/home/home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie J, 2010, THESIS U EDINBURGH; Arampatzis S, 2005, J NEUROIMMUNOL, V157, P126; Ballester PJ, 2007, J COMPUT CHEM, V28, P1711, DOI [10.1002/jcc.20681, 10.1002/JCC.20681]; Ballester PJ, 2007, P R SOC A, V463, P1307, DOI 10.1098/rspa.2007.1823; Ballester PJ, 2012, J R SOC INTERFACE, V9, P3196, DOI 10.1098/rsif.2012.0569; Ballester PJ, 2010, J R SOC INTERFACE, V7, P335, DOI 10.1098/rsif.2009.0170; Bender A, 2004, ORG BIOMOL CHEM, V2, P3204, DOI 10.1039/b409813g; BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231; BRANDTS JF, 1990, BIOCHEMISTRY-US, V29, P6927, DOI 10.1021/bi00481a024; Brown RD, 1997, J CHEM INF COMP SCI, V37, P1, DOI 10.1021/ci960373c; Brown RD, 1996, J CHEM INF COMP SCI, V36, P572, DOI 10.1021/ci9501047; Bujalska IJ, 1997, LANCET, V349, P1210, DOI 10.1016/S0140-6736(96)11222-8; Dagum L, 1998, IEEE COMPUT SCI ENG, V5, P46, DOI 10.1109/99.660313; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P297, DOI 10.1067/mcp.2001.115446; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Fulton KF, 2003, BIOCHEMISTRY-US, V42, P2364, DOI 10.1021/bi020564a; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Hsin KY, 2011, NUCLEIC ACIDS RES, V39, pD1042, DOI 10.1093/nar/gkq878; Landrum g, 2006, RDKIT OPEN SOURCE CH; Li HL, 2009, J MED CHEM, V52, P4936, DOI 10.1021/jm801622x; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Martin YC, 2002, J MED CHEM, V45, P4350, DOI 10.1021/jm020155c; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Mundt S, 2005, ASSAY DRUG DEV TECHN, V3, P367, DOI 10.1089/adt.2005.3.367; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Patil SP, 2014, J COMPUT AID MOL DES, V28, P89, DOI 10.1007/s10822-014-9732-4; Patterson DE, 1996, J MED CHEM, V39, P3049, DOI 10.1021/jm960290n; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Schreyer AM, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-27; Shave SR, 2008, IBM J RES DEV, V52, P57, DOI 10.1147/rd.521.0057; Shaw G, 2008, STRUCTURE, V16, P1417, DOI 10.1016/j.str.2008.06.012; Sheridan RP, 2002, J CHEM INF COMP SCI, V42, P103, DOI 10.1021/ci0100806; Sheridan RP, 2003, J CHEM INF COMP SCI, V43, P1037, DOI [10.1021/ci030004y, 10.1021/ci03(9)04y]; Stebbins JL, 2007, J MED CHEM, V50, P6607, DOI 10.1021/jm0707424; Steinbeck C, 2006, CURR PHARM DESIGN, V12, P2111, DOI 10.2174/138161206777585274; STEINER JP, 1992, NATURE, V358, P584, DOI 10.1038/358584a0; Taylor P, 2008, BRIT J PHARMACOL, V153, pS55, DOI 10.1038/sj.bjp.0707532; Tjernberg A, 2004, ANAL CHEM, V76, P4325, DOI 10.1021/ac0497914; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Valentine H, 2007, EUR UROL, V51, P1724, DOI 10.1016/j.eururo.2006.11.026; van de Waterbeemd H, 2003, NAT REV DRUG DISCOV, V2, P192, DOI 10.1038/nrd1032; Wear MA, 2007, PROTEIN EXPRES PURIF, V51, P80, DOI 10.1016/j.pep.2006.06.019; Webster SP, 2007, EXPERT OPIN THER PAT, V17, P1407, DOI 10.1517/13543776.17.12.1407; Wu SY, 2003, STRUCTURE, V11, P399, DOI 10.1016/S0969-2126(03)00060-1; Xing L, 2004, J COMPUT AID MOL DES, V18, P333, DOI 10.1023/B:JCAM.0000047812.39758.ab	46	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116570	10.1371/journal.pone.0116570	http://dx.doi.org/10.1371/journal.pone.0116570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659145	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900051
J	Stefanou, DT; Bamias, A; Episkopou, H; Kyrtopoulos, SA; Likka, M; Kalampokas, T; Photiou, S; Gavalas, N; Sfikakis, PP; Dimopoulos, MA; Souliotis, VL				Stefanou, Dimitra T.; Bamias, Aristotelis; Episkopou, Hara; Kyrtopoulos, Soterios A.; Likka, Maria; Kalampokas, Theodore; Photiou, Stylianos; Gavalas, Nikos; Sfikakis, Petros P.; Dimopoulos, Meletios A.; Souliotis, Vassilis L.			Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer	PLOS ONE			English	Article							INTERSTRAND CROSS-LINKS; CIRCULATING TUMOR-CELLS; STRAND BREAK REPAIR; COMET ASSAY; CHROMATIN-STRUCTURE; LUNG-CANCER; IN-VITRO; BLOOD; GENE; RISK	Ovarian carcinoma (OC) is the most lethal gynecological malignancy. Despite the advances in the treatment of OC with combinatorial regimens, including surgery and platinum-based chemotherapy, patients generally exhibit poor prognosis due to high chemotherapy resistance. Herein, we tested the hypothesis that DNA damage response (DDR) pathways are involved in resistance of OC patients to platinum chemotherapy. Selected DDR signals were evaluated in two human ovarian carcinoma cell lines, one sensitive (A2780) and one resistant (A2780/C30) to platinum treatment as well as in peripheral blood mononuclear cells (PBMCs) from OC patients, sensitive (n = 7) or resistant (n = 4) to subsequent chemotherapy. PBMCs from healthy volunteers (n = 9) were studied in parallel. DNA damage was evaluated by immunofluorescence gamma H2AX staining and comet assay. Higher levels of intrinsic DNA damage were found in A2780 than in A2780/C30 cells. Moreover, the intrinsic DNA damage levels were significantly higher in OC patients relative to healthy volunteers, as well as in platinum-sensitive patients relative to platinum-resistant ones (all P < 0.05). Following carboplatin treatment, A2780 cells showed lower DNA repair efficiency than A2780/C30 cells. Also, following carboplatin treatment of PBMCs ex vivo, the DNA repair efficiency was significantly higher in healthy volunteers than in platinum-resistant patients and lowest in platinum-sensitive ones (t(1/2) for loss of gamma H2AX foci: 2.7 +/- 0.5h, 8.8 +/- 1.9h and 15.4 +/- 3.2h, respectively; using comet assay, t(1/2) of platinum-induced damage repair: 4.8 +/- 1.4h, 12.9 +/- 1.9h and 21.4 +/- 2.6h, respectively; all P < 0.03). Additionally, the carboplatin-induced apoptosis rate was higher in A2780 than in A2780/C30 cells. In PBMCs, apoptosis rates were inversely correlated with DNA repair efficiencies of these cells, being significantly higher in platinum-sensitive than in platinum-resistant patients and lowest in healthy volunteers (all P < 0.05). We conclude that perturbations of DNA repair pathways as measured in PBMCs from OC patients correlate with the drug sensitivity of these cells and reflect the individualized response to platinum-based chemotherapy.	[Stefanou, Dimitra T.; Episkopou, Hara; Kyrtopoulos, Soterios A.; Souliotis, Vassilis L.] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Athens 11635, Greece; [Stefanou, Dimitra T.; Bamias, Aristotelis; Likka, Maria; Gavalas, Nikos; Dimopoulos, Meletios A.] Univ Athens, Sch Med, Dept Clin Therapeut, Athens 11528, Greece; [Episkopou, Hara] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Kalampokas, Theodore; Photiou, Stylianos] Univ Athens, Sch Med, Dept Obstet & Gynaecol 2, Athens 11528, Greece; [Sfikakis, Petros P.] Univ Athens, Sch Med, Dept Propedeut Med 1, GR-11527 Athens, Greece	National Hellenic Research Foundation; Athens Medical School; National & Kapodistrian University of Athens; Universite Catholique Louvain; Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens	Souliotis, VL (corresponding author), Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Athens 11635, Greece.	vls@eie.gr	Bamias, Aristotelis/AAD-5332-2019; Dimopoulos, Meletios Athanasios/AAD-4130-2019; Kyrtopoulos, Soterios/AAI-6426-2020; Sfikakis, Petros/AAD-7289-2019	Bamias, Aristotelis/0000-0002-5996-7262; Dimopoulos, Meletios/0000-0001-8990-3254; Kyrtopoulos, Soterios/0000-0002-6821-6532	Athens University Medical School [ELKE 097]; ECNIS (Environmental Cancer, Nutrition and Individual Susceptibility) Network of Excellence of the European Union [513943]	Athens University Medical School; ECNIS (Environmental Cancer, Nutrition and Individual Susceptibility) Network of Excellence of the European Union	This work was supported in part by the Athens University Medical School grant ELKE 097, and by the ECNIS (Environmental Cancer, Nutrition and Individual Susceptibility) Network of Excellence of the European Union (contract no. 513943). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Minawi AZ, 2009, NUCLEIC ACIDS RES, V37, P6400, DOI 10.1093/nar/gkp705; Alberg AJ, 2013, CARCINOGENESIS, V34, P86, DOI 10.1093/carcin/bgs304; Anderson D, 2014, FASEB J, V28, P4563, DOI 10.1096/fj.14-254748; Bowden NA, 2014, CANCER LETT, V346, P163, DOI 10.1016/j.canlet.2014.01.005; Clingen PH, 2008, BIOCHEM PHARMACOL, V76, P19, DOI 10.1016/j.bcp.2008.03.025; Colombo N, 2013, ANN ONCOL SUPPL 7, V23, pvii20; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Dimopoulos MA, 2005, J CLIN ONCOL, V23, P4381, DOI 10.1200/JCO.2005.07.385; Dimopoulos MA, 2007, HAEMATOLOGICA, V92, P1505, DOI 10.3324/haematol.11435; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; FICHTINGERSCHEPMAN AMJ, 1985, BIOCHEMISTRY-US, V24, P707, DOI 10.1021/bi00324a025; Forchhammer L, 2012, MUTAGENESIS, V27, P665, DOI 10.1093/mutage/ges032; Frgala T, 2007, MOL CANCER THER, V6, P886, DOI 10.1158/1535-7163.MCT-04-0331; Gkotzamanidou M, 2014, BRIT J CANCER, V111, P1293, DOI 10.1038/bjc.2014.410; Gospodinov A, 2013, DNA REPAIR, V12, P800, DOI 10.1016/j.dnarep.2013.07.006; HAMAGUCHI K, 1993, CANCER RES, V53, P5225; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Hoebers FJP, 2006, INT J CANCER, V119, P750, DOI 10.1002/ijc.21919; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Huang RY, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-47; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; Kemp Z, 2013, INT J WOMENS HEALTH, V5, P45, DOI 10.2147/IJWH.S30231; Kim A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-14; Kim JH, 2013, INT J NANOMED, V8, P2247, DOI 10.2147/IJN.S45059; Kuo LJ, 2008, IN VIVO, V22, P305; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu JF, 2013, GYNECOL ONCOL, V131, P352, DOI 10.1016/j.ygyno.2013.08.006; Marshall KW, 2010, INT J CANCER, V126, P1177, DOI 10.1002/ijc.24910; Marsit CJ, 2011, J CLIN ONCOL, V29, P1133, DOI 10.1200/JCO.2010.31.3577; Mogi S, 2006, DNA REPAIR, V5, P731, DOI 10.1016/j.dnarep.2006.03.009; Moller P, 2006, BASIC CLIN PHARMACOL, V98, P336, DOI 10.1111/j.1742-7843.2006.pto_167.x; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Ozols RF, 2000, SEMIN ONCOL, V27, P47; Povirk LR, 2006, DNA REPAIR, V5, P1199, DOI 10.1016/j.dnarep.2006.05.016; REED E, 1987, P NATL ACAD SCI USA, V84, P5024, DOI 10.1073/pnas.84.14.5024; Reed E, 2006, NEW ENGL J MED, V355, P1054, DOI 10.1056/NEJMe068162; Rotunno M, 2011, CANCER PREV RES, V4, P1599, DOI 10.1158/1940-6207.CAPR-10-0170; Scarpato R, 2013, MUTAGENESIS, V28, P465, DOI 10.1093/mutage/get024; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Solier S, 2009, MOL CELL BIOL, V29, P68, DOI 10.1128/MCB.00581-08; Souliotis VL, 2003, CLIN CANCER RES, V9, P4465; Stefanou DT, 2012, BRIT J CLIN PHARMACO, V74, P842, DOI 10.1111/j.1365-2125.2012.04274.x; Stellas D, 2007, CLIN CANCER RES, V13, P1831, DOI 10.1158/1078-0432.CCR-06-1585; Teschendorff AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008274; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Tompkins JD, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-10; Udumudi A, 1998, MUTAT RES-GEN TOX EN, V412, P195, DOI 10.1016/S1383-5718(97)00164-2; Unger FT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-359; Wang LE, 2011, J CLIN ONCOL, V29, P4121, DOI 10.1200/JCO.2010.34.3616; Weberpals J, 2009, INT J CANCER, V124, P806, DOI 10.1002/ijc.23987; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Widschwendter M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002656; Zander T, 2011, CLIN CANCER RES, V17, P3360, DOI 10.1158/1078-0432.CCR-10-0533	61	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117654	10.1371/journal.pone.0117654	http://dx.doi.org/10.1371/journal.pone.0117654			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659114	Green Published, Green Submitted, gold			2022-12-27	WOS:000349444900194
J	Gizzo, S; Andrisani, A; Noventa, M; Di Gangi, S; Quaranta, M; Cosmi, E; D'Antona, D; Nardelli, GB; Ambrosini, G				Gizzo, Salvatore; Andrisani, Alessandra; Noventa, Marco; Di Gangi, Stefania; Quaranta, Michela; Cosmi, Erich; D'Antona, Donato; Nardelli, Giovanni Battista; Ambrosini, Guido			Caesarean Section: Could Different Transverse Abdominal Incision Techniques Influence Postpartum Pain and Subsequent Quality of Life? A Systematic Review	PLOS ONE			English	Article							MISGAV-LADACH METHOD; JOEL-COHEN INCISION; LONG-TERM OUTCOMES; PFANNENSTIEL INCISION; NON-CLOSURE; DELIVERY; WOMEN; ANATOMY; NERVES; RISK	The choice of the type of abdominal incision performed in caesarean delivery is made chiefly on the basis of the individual surgeon's experience and preference. A general consensus on the most appropriate surgical technique has not yet been reached. The aim of this systematic review of the literature is to compare the two most commonly used transverse abdominal incisions for caesarean delivery, the Pfannenstiel incision and the modified Joel-Cohen incision, in terms of acute and chronic post-surgical pain and their subsequent influence in terms of quality of life. Electronic database searches formed the basis of the literature search and the following databases were searched in the time frame between January 1997 and December 2013: MEDLINE, EMBASE Sciencedirect and the Cochrane Library. Key search terms included: "acute pain", "chronic pain", "Pfannenstiel incision", "MisgavLadach", "Joel Cohen incision", in combination with "Caesarean Section", "abdominal incision", "numbness", "neuropathic pain"and "nerve entrapment". Data on 4771 patients who underwent caesarean section (CS) was collected with regards to the relation between surgical techniques and postoperative outcomes defined as acute or chronic pain and future pregnancy desire. The Misgav-Ladach incision was associated with a significant advantage in terms of reduction of post-surgical acute and chronic pain. It was indicated as the optimal technique in view of its characteristic of reducing lower pelvic discomfort and pain, thus improving quality of life and future fertility desire. Further studies which are not subject to important bias like pre-existing chronic pain, non-standardized analgesia administration, variable length of skin incision and previous abdominal surgery are required.	[Gizzo, Salvatore; Andrisani, Alessandra; Noventa, Marco; Di Gangi, Stefania; Cosmi, Erich; D'Antona, Donato; Nardelli, Giovanni Battista; Ambrosini, Guido] Univ Padua, Dept Womens & Childrens Health, Padua, Italy; [Quaranta, Michela] Univ Verona, Dept Obstet & Gynecol, I-37100 Verona, Italy	University of Padua; University of Verona	Noventa, M (corresponding author), Univ Padua, Dept Womens & Childrens Health, Padua, Italy.	marco.noventa@gmail.com	Noventa, Marco/ABB-4669-2020	Noventa, Marco/0000-0002-7809-6001				*AG HEALTHC RES QU, 2010, AHRQ PUBLICATION, pE3; Almeida ECS, 2002, INT J GYNECOL OBSTET, V79, P101, DOI 10.1016/S0020-7292(02)00227-8; Altinbas SK, 2013, J MATERN-FETAL NEO M, V26, P1128, DOI 10.3109/14767058.2013.770458; Ansaloni L, 2001, WORLD J SURG, V25, P1164, DOI 10.1007/BF03215866; Berretta R, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/686027; Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103; Darj E, 1999, ACTA OBSTET GYN SCAN, V78, P37, DOI 10.1034/j.1600-0412.1999.780109.x; Eisenach JC, 2008, PAIN, V140, P87, DOI 10.1016/j.pain.2008.07.011; Eisenach JC, 2013, ANESTHESIOLOGY, V118, P143, DOI 10.1097/ALN.0b013e318278ccfd; Fatusic Z, 2011, J MATERN-FETAL NEO M, V24, P1138, DOI 10.3109/14767058.2010.545919; Ferrari AG, 2001, INT J GYNECOL OBSTET, V72, P135, DOI 10.1016/S0020-7292(00)00315-5; Franchi M, 2002, ACTA OBSTET GYN SCAN, V81, P1040, DOI 10.1034/j.1600-0412.2002.811108.x; Gedikbasi A, 2011, ARCH GYNECOL OBSTET, V283, P711, DOI 10.1007/s00404-010-1428-y; Ghahiry A, 2012, J OBSTET GYNAECOL RE, V38, P1235, DOI 10.1111/j.1447-0756.2011.01777.x; Gizzo S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/638093; Gizzo S, 2014, ARCH GYNECOL OBSTET, V290, P21, DOI 10.1007/s00404-014-3212-x; Gizzo S, 2014, J PERINAT MED, V42, P339, DOI 10.1515/jpm-2013-0160; Gizzo S, 2013, SCI WORLD J, DOI 10.1155/2013/254901; Gizzo S, 2013, FERTIL STERIL, V99, P496, DOI 10.1016/j.fertnstert.2012.10.019; Gizzo S, 2012, BREASTFEED MED, V7, P262, DOI 10.1089/bfm.2011.0099; Hofmeyr GJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004662.pub2; Hofmeyr JG, 2009, AM J OBSTET GYNECOL, V201, P431, DOI 10.1016/j.ajog.2009.03.018; Hojberg KE, 1998, ACTA OBSTET GYN SCAN, V77, P741, DOI 10.1034/j.1600-0412.1998.770708.x; Holmgren G, 1996, TROP DOCT, V26, P150, DOI 10.1177/004947559602600404; *IT NAT I STAT, BRIEF STAT, P28669; Jansen AJG, 2007, J PSYCHOSOM RES, V63, P275, DOI 10.1016/j.jpsychores.2007.06.003; Jansen AJG, 2007, ACTA OBSTET GYN SCAN, V86, P579, DOI 10.1080/00016340701275424; Kainu JP, 2010, INT J OBSTET ANESTH, V19, P4, DOI 10.1016/j.ijoa.2009.03.013; Klaassen Z, 2011, CLIN ANAT, V24, P454, DOI 10.1002/ca.21098; Loos MJ, 2008, OBSTET GYNECOL, V111, P839, DOI 10.1097/AOG.0b013e31816a4efa; Loos MJA, 2008, ANN SURG, V248, P880, DOI 10.1097/SLA.0b013e318185da2e; Luijendijk RW, 1997, ANN SURG, V225, P365, DOI 10.1097/00000658-199704000-00004; Lurie S, 2003, AM J OBSTET GYNECOL, V189, P1803, DOI 10.1016/S0002-9378(03)00856-1; Malvasi A, 2007, J MATERN-FETAL NEO M, V20, P757, DOI 10.1080/14767050701580531; Mathai M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004453.pub3; Nabhan AF, 2008, INT J GYNECOL OBSTET, V100, P69, DOI 10.1016/j.ijgo.2007.07.011; Naki MM, 2011, J MATERN-FETAL NEO M, V24, P239, DOI 10.3109/14767058.2010.482612; Nikolajsen L, 2004, ACTA ANAESTH SCAND, V48, P111, DOI 10.1111/j.1399-6576.2004.00271.x; Shahin AY, 2009, INT J GYNECOL OBSTET, V104, P135, DOI 10.1016/j.ijgo.2008.09.012; SIPPO WC, 1987, AM J OBSTET GYNECOL, V157, P420, DOI 10.1016/S0002-9378(87)80184-9; Torkan B, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-4; Tosun K, 2006, UROLOGY, V67, DOI 10.1016/j.urology.2005.09.053; Walsh CA, 2010, CURR OPIN OBSTET GYN, V22, P110, DOI 10.1097/GCO.0b013e3283372327; Whiteside JL, 2003, AM J OBSTET GYNECOL, V189, P1574, DOI 10.1016/S0002-9378(03)00934-7; Xavier P, 2005, ACTA OBSTET GYN SCAN, V84, P878, DOI 10.1111/j.0001-6349.2005.00631.x	45	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0114190	10.1371/journal.pone.0114190	http://dx.doi.org/10.1371/journal.pone.0114190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646621	gold, Green Submitted, Green Published			2022-12-27	WOS:000348822600006
J	Jansen, C; Reiberger, T; Huang, J; Eischeid, H; Schierwagen, R; Mandorfer, M; Anadol, E; Schwabl, P; Schwarze-Zander, C; Warnecke-Eberz, U; Strassburg, CP; Rockstroh, JK; Peck-Radosavljevic, M; Odenthal, M; Trebicka, J				Jansen, Christian; Reiberger, Thomas; Huang, Jia; Eischeid, Hannah; Schierwagen, Robert; Mandorfer, Mattias; Anadol, Evrim; Schwabl, Philipp; Schwarze-Zander, Carolynne; Warnecke-Eberz, Ute; Strassburg, Christian P.; Rockstroh, Juergen K.; Peck-Radosavljevic, Markus; Odenthal, Margarete; Trebicka, Jonel			Circulating MiRNA-122 Levels Are Associated with Hepatic Necroinflammation and Portal Hypertension in HIV/HCV Coinfection	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; CO-INFECTED PATIENTS; HEPATOCELLULAR-CARCINOMA; LIVER-DISEASE; VIRUS; HIV; CIRRHOSIS; FIBROSIS; THERAPY; DECOMPENSATION	Background Introduction of combined antiretroviral therapy (cART) has improved survival of HIV infected individuals, while the relative contribution of liver-related mortality increased. Especially in HIV/HCV-coinfected patients hepatic fibrosis and portal hypertension represent the main causes of liver-related morbidity and mortality. Circulating miRNA-122 levels are elevated in HIV patients and have been shown to correlate with severity of liver injury. However, the association of miRNA-122 levels and hepatic fibrosis and portal hypertension remains to be explored in HIV/HCV coinfection. Methods From a total of 74 (31% female) patients with HIV/HCV coinfection were included. Serum levels of miRNA-122 were analyzed by quantitative polymerase chain reaction (PCR) and normalized to SV-40 spike-in RNA. Hepatic venous pressure gradient (HVPG) was measured in 52 (70%) patients and the fibrosis stage was determined in 63 (85%) patients using transient elastography. Results The levels of circulating miRNA-122 were increased in HIV/HCV coinfected patients and significantly correlated with the alanine aminotransferase (ALT) (r(s) = 0.438; p<0.001) and aspartate transaminase AST values (r(s) = 0.336; p = 0.003), but not with fibrosis stage (p = n.s.). Interestingly, miRNA-122 levels showed an inverse correlation with hepatic venous pressure gradient (HVPG) (r(s) = -0.302; p = 0.03). Conclusion Elevated miRNA-122 levels are associated with liver injury, and with low HVPG. Though, miRNA-122 levels are not suitable to predict the degree of fibrosis, they might function as indicators for portal hypertension in HIV/HCV coinfected patients.	[Jansen, Christian; Schierwagen, Robert; Anadol, Evrim; Schwarze-Zander, Carolynne; Strassburg, Christian P.; Rockstroh, Juergen K.; Trebicka, Jonel] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Reiberger, Thomas; Schwabl, Philipp; Peck-Radosavljevic, Markus] Med Univ Vienna, Vienna Hepat Hemodynam Lab, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria; [Huang, Jia; Eischeid, Hannah; Odenthal, Margarete] Univ Cologne, Dept Pathol, D-50931 Cologne, Germany; [Warnecke-Eberz, Ute] Univ Cologne, Dept Gen Visceral & Canc Surg, D-50931 Cologne, Germany; [Rockstroh, Juergen K.] Partner Site Bonn Cologne, German Ctr Infect Res DZIF, Bonn, Germany	University of Bonn; Medical University of Vienna; University of Cologne; University of Cologne; German Center for Infection Research	Trebicka, J (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.	jonel.trebicka@ukb.uni-bonn.de	Reiberger, Thomas/H-7613-2019; Schierwagen, Robert/AAE-6305-2019; Mandorfer, Mattias/H-7603-2019	Reiberger, Thomas/0000-0002-4590-3583; Schierwagen, Robert/0000-0002-2195-3666; Mandorfer, Mattias/0000-0003-2330-0017; Trebicka, Jonel/0000-0002-7028-3881; Schwabl, Philipp/0000-0002-7183-8076; Warnecke-Eberz, Ute/0000-0002-2833-5633	Deutsche Forschungsgemeinschaft [SFB TRR57 P18]; J. & W. Hector-Foundation [M60.2]; Roche Austria; MSD Austria; DZIF TTU HIV Project [05.803]; German Center for Infection Research (DZIF); Research and Education program of the Medical Faculty of the University of Cologne; German Competence Network for Viral Hepatitis (Hepnet); German Ministry of Education and Research (BMBF) [01KI0601]; German Liver Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); J. & W. Hector-Foundation; Roche Austria(Roche Holding); MSD Austria; DZIF TTU HIV Project; German Center for Infection Research (DZIF); Research and Education program of the Medical Faculty of the University of Cologne; German Competence Network for Viral Hepatitis (Hepnet); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Liver Foundation	This work was supported by the Deutsche Forschungsgemeinschaft (SFB TRR57 P18 to J.T.), J. & W. Hector-Foundation (M60.2 to J.T.), unrestricted research grants from Roche Austria (to M.P.R.), MSD Austria (to M.P.R.), DZIF TTU HIV Project 05.803, and the German Center for Infection Research (DZIF), Research and Education program of the Medical Faculty of the University of Cologne, German Competence Network for Viral Hepatitis (Hepnet), German Ministry of Education and Research (BMBF), Grant No 01KI0601 (to M.O.), and German Liver Foundation (to M.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anadol E, 2014, HEPATOLOGY; Aranzabal L, 2005, CLIN INFECT DIS, V40, P588, DOI 10.1086/427216; Bosch J, 2009, NAT REV GASTRO HEPAT, V6, P573, DOI 10.1038/nrgastro.2009.149; Brau N, 2005, SEMIN LIVER DIS, V25, P33, DOI 10.1055/s-2005-864780; Castiella A, 2010, WORLD J HEPATOL, V2, P251, DOI 10.4254/wjh.v2.i7.251; Casu S, 2014, LIVER INT; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Dimitroulis D, 2013, WORLD J HEPATOL, V5, P323, DOI 10.4254/wjh.v5.i6.323; Ferlitsch M, 2012, HEPATOLOGY, V56, P1439, DOI 10.1002/hep.25806; Fernandes FF, 2014, J CLIN GASTROENTEROL; Frulio N, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-405; Gelley F, 2014, J GASTROEN HEPATOL, V29, P121, DOI 10.1111/jgh.12362; Jansen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108544; Jansen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103779; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Klein MB, 2014, AIDS, V28, P1957, DOI 10.1097/QAD.0000000000000377; Koberle V, 2013, EUR J CANCER, V49, P3442, DOI 10.1016/j.ejca.2013.06.002; Lee CH, 2014, J MICROBIOL, V52, P445, DOI 10.1007/s12275-014-4267-x; Lee LM, 2001, JAMA-J AM MED ASSOC, V285, P1308, DOI 10.1001/jama.285.10.1308; Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829; Mandorfer M, 2014, AIDS PATIENT CARE ST, V28, P221, DOI 10.1089/apc.2013.0359; Marcellin F, 2014, SEX TRANSM INFECT; Merchante N, 2014, AIDS, V28, P41, DOI 10.1097/QAD.0000000000000005; Mocroft A, 2005, AIDS, V19, P2117, DOI 10.1097/01.aids.0000194799.43799.ea; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Nunnari G, 2012, EUR REV MED PHARMACO, V16, P1257; Pineda JA, 2005, HEPATOLOGY, V41, P779, DOI 10.1002/hep.20626; Reiberger T, 2010, J VIRAL HEPATITIS, V17, P400, DOI 10.1111/j.1365-2893.2009.01197.x; Reiberger T, 2013, GUT, V62, P1634, DOI 10.1136/gutjnl-2012-304038; Reiberger T, 2011, ANTIVIR THER, V16, P815, DOI 10.3851/IMP1831; Reiberger T, 2011, CLIN GASTROENTEROL H, V9, P602, DOI 10.1016/j.cgh.2011.03.002; Roderburg C, 2014, LIVER INT; Rosenthal E, 2007, J VIRAL HEPATITIS, V14, P183, DOI 10.1111/j.1365-2893.2006.00791.x; Rotman Y, 2009, J VIROL, V83, P7366, DOI 10.1128/JVI.00191-09; Takaki Y, 2014, CANC SCI; Trebicka J, 2013, J HEPATOL, V58, P234, DOI 10.1016/j.jhep.2012.10.015; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; Uchino K, 2013, J CLIN VIROL, V57, P173, DOI 10.1016/j.jcv.2013.01.012; UNAIDS, 2013, GLOB REP 2013; van Beek JHDA, 2013, BEHAV GENET, V43, P329, DOI 10.1007/s10519-013-9593-y; Yoshioka K, 2014, HEPATOL RES	41	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116768	10.1371/journal.pone.0116768	http://dx.doi.org/10.1371/journal.pone.0116768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646812	Green Published, Green Submitted, gold			2022-12-27	WOS:000348822600036
J	Li, W; O'Brien, JE; Snyder, SM; Howard, MO				Li, Wen; O'Brien, Jennifer E.; Snyder, Susan M.; Howard, Matthew O.			Characteristics of Internet Addiction/Pathological Internet Use in US University Students: A Qualitative-Method Investigation	PLOS ONE			English	Article							PROPOSED DIAGNOSTIC-CRITERIA; TURKISH COLLEGE-STUDENTS; FACEBOOK ADDICTION; SCHOOL-STUDENTS; USE DISORDERS; ALCOHOL-USE; ASSOCIATION; EXPERIENCES; SYMPTOMS; CHINA	Studies have identified high rates and severe consequences of Internet Addiction/Pathological Internet Use (IA/PIU) in university students. However, most research concerning IA/PIU in U.S. university students has been conducted within a quantitative research paradigm, and frequently fails to contextualize the problem of IA/PIU. To address this gap, we conducted an exploratory qualitative study using the focus group approach and examined 27 U.S. university students who self-identified as intensive Internet users, spent more than 25 hours/week on the Internet for non-school or non-work-related activities and who reported Internet-associated health and/or psychosocial problems. Students completed two IA/PIU measures (Young's Diagnostic Questionnaire and the Compulsive Internet Use Scale) and participated in focus groups exploring the natural history of their Internet use; preferred online activities; emotional, interpersonal, and situational triggers for intensive Internet use; and health and/or psychosocial consequences of their Internet overuse. Students' self-reports of Internet overuse problems were consistent with results of standardized measures. Students first accessed the Internet at an average age of 9 (SD = 2.7), and first had a problem with Internet overuse at an average age of 16 (SD = 4.3). Sadness and depression, boredom, and stress were common triggers of intensive Internet use. Social media use was nearly universal and pervasive in participants' lives. Sleep deprivation, academic under-achievement, failure to exercise and to engage in face-to-face social activities, negative affective states, and decreased ability to concentrate were frequently reported consequences of intensive Internet use/Internet overuse. IA/PIU may be an underappreciated problem among U.S. university students and warrants additional research.	[Li, Wen; O'Brien, Jennifer E.; Snyder, Susan M.; Howard, Matthew O.] Univ N Carolina, Sch Social Work, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	Howard, MO (corresponding author), Univ N Carolina, Sch Social Work, Chapel Hill, NC 27514 USA.	mohoward@email.unc.edu	Snyder, Susan M/AAN-2386-2021	Snyder, Susan M/0000-0002-6909-336X; , Wen/0000-0003-1631-0161				American Psychiatric Association, 2013, DIAGN STAT MAN MENT, DOI [10.1016/j.jsps.2013.12.015, DOI 10.1016/J.JSPS.2013.12.015]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderson KJ, 2001, J AM COLL HEALTH, V50, P21, DOI 10.1080/07448480109595707; Andreassen CS, 2012, PSYCHOL REP, V110, P501, DOI 10.2466/02.09.18.PR0.110.2.501-517; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Belcher AM, 2014, TRENDS COGN SCI, V18, P211, DOI 10.1016/j.tics.2014.01.010; Byun S, 2009, CYBERPSYCHOL BEHAV, V12, P203, DOI 10.1089/cpb.2008.0102; Canan F, 2014, CYBERPSYCH BEH SOC N, V17, P40, DOI 10.1089/cyber.2012.0733; Canan F, 2012, COMPR PSYCHIAT, V53, P422, DOI 10.1016/j.comppsych.2011.08.006; Caplan SE, 2010, COMPUT HUM BEHAV, V26, P1089, DOI 10.1016/j.chb.2010.03.012; Caplan SE, 2002, COMPUT HUM BEHAV, V18, P553, DOI 10.1016/S0747-5632(02)00004-3; Carr N., 2011, SHALLOWS WHAT INTERN; Cheng SH, 2012, PSYCHIAT RES, V197, P270, DOI 10.1016/j.psychres.2011.08.011; Christakis DA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-77; Davis RA, 2002, CYBERPSYCHOL BEHAV, V5, P331, DOI 10.1089/109493102760275581; Davis RA, 2001, COMPUT HUM BEHAV, V17, P187, DOI 10.1016/S0747-5632(00)00041-8; DeCuir-Gunby JT, 2011, FIELD METHOD, V23, P136, DOI 10.1177/1525822X10388468; Derbyshire KL, 2013, COMPR PSYCHIAT, V54, P415, DOI 10.1016/j.comppsych.2012.11.003; Dong GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014703; Dowling NA, 2009, CYBERPSYCHOL BEHAV, V12, P21, DOI 10.1089/cpb.2008.0162; Fortson BL, 2007, J AM COLL HEALTH, V56, P137, DOI 10.3200/JACH.56.2.137-146; Frangos C. C., 2010, INT J EC SCI APPL RE, V3, P49; Gonzalez E, 2014, COMPUT HUM BEHAV, V31, P151, DOI 10.1016/j.chb.2013.10.038; Hsu SH, 2009, COMPUT EDUC, V53, P990, DOI 10.1016/j.compedu.2009.05.016; Jackson LA, 2011, COMPUT HUM BEHAV, V27, P228, DOI 10.1016/j.chb.2010.08.001; Jelenchick LA, 2012, PSYCHIAT RES, V196, P296, DOI 10.1016/j.psychres.2011.09.007; Kerkhof P, 2011, HUM COMMUN RES, V37, P147, DOI 10.1111/j.1468-2958.2010.01397.x; Kim SH, 2011, NEUROREPORT, V22, P407, DOI 10.1097/WNR.0b013e328346e16e; Ko CH, 2012, EUR PSYCHIAT, V27, P1, DOI 10.1016/j.eurpsy.2010.04.011; Ko CH, 2008, CNS SPECTRUMS, V13, P147, DOI 10.1017/S1092852900016308; Koc M, 2013, CYBERPSYCH BEH SOC N, V16, P279, DOI 10.1089/cyber.2012.0249; Krueger R.A., 2015, FOCUS GROUPS PRACTIC; Kuhn S, 2015, ADDICT BIOL, V20, P415, DOI 10.1111/adb.12128; Lam LT, 2009, INJURY PREV, V15, P403, DOI 10.1136/ip.2009.021949; Lam LT, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0444-1; LaRose R, 2004, J BROADCAST ELECTRON, V48, P358, DOI 10.1207/s15506878jobem4803_2; Lee HW, 2012, CYBERPSYCH BEH SOC N, V15, P373, DOI 10.1089/cyber.2012.0063; Li ML, 2014, OBESITY, V22, P482, DOI 10.1002/oby.20595; Li W, 2014, COMPUT HUM BEHAV, V31, P393, DOI 10.1016/j.chb.2013.11.004; Liu T, 2007, CNS SPECTRUMS, V12, P453, DOI 10.1017/S1092852900015339; Lortie CL, 2013, ADDICTION, V108, P1207, DOI 10.1111/add.12202; Meerkerk GJ, 2009, CYBERPSYCHOL BEHAV, V12, P1, DOI 10.1089/cpb.2008.0181; Miniwatts Marketing Group, 2014, INT WORKS STATS US P; Morahan-Martin J, 2003, COMPUT HUM BEHAV, V19, P659, DOI 10.1016/S0747-5632(03)00040-2; Moreno MA, 2011, ARCH PEDIAT ADOL MED, V165, P797, DOI 10.1001/archpediatrics.2011.58; Ni XL, 2009, CYBERPSYCHOL BEHAV, V12, P327, DOI 10.1089/cpb.2008.0321; Niemz K, 2005, CYBERPSYCHOL BEHAV, V8, P562, DOI 10.1089/cpb.2005.8.562; Padgett D.K., 2017, QUALITATIVE METHODS; PADGETT DK, 1998, QUALITATIVE METHODS; Park S, 2013, AUST NZ J PSYCHIAT, V47, P153, DOI 10.1177/0004867412463613; Pempek TA, 2009, J APPL DEV PSYCHOL, V30, P227, DOI 10.1016/j.appdev.2008.12.010; Rohde P, 2001, J AM ACAD CHILD PSY, V40, P83, DOI 10.1097/00004583-200101000-00020; Scherer K, 1997, J COLL STUDENT DEV, V38, P655; Shapira NA, 2000, J AFFECT DISORDERS, V57, P267, DOI 10.1016/S0165-0327(99)00107-X; Spada MM, 2014, ADDICT BEHAV, V39, P3, DOI 10.1016/j.addbeh.2013.09.007; Sun P, 2012, INT J ENV RES PUB HE, V9, P660, DOI 10.3390/ijerph9030660; Tao R, 2010, ADDICTION, V105, P556, DOI 10.1111/j.1360-0443.2009.02828.x; U.S. Pew Research Center Pew Internet & American Life Project, 2012, COLL STUD TECHN; Vandelanotte C, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1084; Wegner L, 2009, J CHILD ADOLESC MENT, V21, P1, DOI 10.2989/JCAMH.2009.21.1.4.806; Weinstein A, 2010, AM J DRUG ALCOHOL AB, V36, P277, DOI 10.3109/00952990.2010.491880; Yen JY, 2009, PSYCHIAT CLIN NEUROS, V63, P218, DOI 10.1111/j.1440-1819.2009.01943.x; Yen JY, 2009, CYBERPSYCHOL BEHAV, V12, P187, DOI 10.1089/cpb.2008.0113; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Young KS, 2004, AM BEHAV SCI, V48, P402, DOI 10.1177/0002764204270278; Zhang LX, 2008, CYBERPSYCHOL BEHAV, V11, P727, DOI 10.1089/cpb.2008.0026	66	80	84	2	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117372	10.1371/journal.pone.0117372	http://dx.doi.org/10.1371/journal.pone.0117372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3QZ	25647224	Green Submitted, Green Published, gold			2022-12-27	WOS:000348822600066
J	Li, YJ; Jiang, YR; Li, SH; Shen, XM; Liu, JF; Jiang, F				Li, Youjin; Jiang, Yanrui; Li, Shenghui; Shen, Xiaoming; Liu, Jinfen; Jiang, Fan			Pre- and Postnatal Risk Factors in Relation to Allergic Rhinitis in School-Aged Children in China	PLOS ONE			English	Article							CESAREAN-SECTION; PREVALENCE; ASTHMA; DELIVERY; CHILDHOOD; SCHOOLCHILDREN; DISEASES; IMPACT; ECZEMA; MICROFLORA	Objective The objective of this study was to investigate the relationship between prenatal and postnatal risk factors and the prevalence of allergic rhinitis (AR) in Chinese children of specific ages. Study Design This study was a cross-sectional survey. Students from 8 metropolitan cities in China were studied in November and December, 2005. There were 20,803 elementary-school Chinese children (49.6% boys, mean age, 9.19 years) enrolled. Questions from the standard questionnaire of the International Study of Asthma and Allergies in Children were completed to enable us to examine the pattern of current AR. The potential confounders and pre-and postnatal risk factors were analyzed using logistic regression. Results The overall prevalence of AR was found in this study to be 9.8%. After adjusting for several likely confounders, there was a higher likelihood of AR in school-aged children who were not exclusively breastfed in the first 4 months of their lives (odds ratio [OR]: 1.28; 95% confidence interval [CI]: 1.16-1.41), children who were born post-term (OR: 1.34; 95% CI: 1.12-1.60), children delivered by cesarean section (OR: 1.07; 95% CI: 1.00-1.19), or children born to mothers who experienced depressive symptoms during the pre-and postnatal periods (OR: 1.28; 95% CI: 1.15-1.42). Conclusions AR in school-aged children was found to be associated with pre- and postnatal events. These findings indicate that strategies to reduce exposure to risk factors during pre- and postnatal periods for childhood allergies might be warranted.	[Li, Youjin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China; [Li, Youjin; Jiang, Yanrui; Li, Shenghui; Shen, Xiaoming; Jiang, Fan] MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai, Peoples R China; [Jiang, Yanrui; Jiang, Fan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Dev & Behav Pediat, Shanghai 200030, Peoples R China; [Liu, Jinfen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Pediat, Shanghai 200030, Peoples R China; [Liu, Jinfen] Shanghai Jiao Tong Univ, Inst Pediat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, JF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Pediat, Shanghai 200030, Peoples R China.	liujinfen2002@126.com; fanjiang@shsmu.edu.cn	Jiang, Fan/AHA-6297-2022; Jiang, Fan/AGX-9052-2022	Jiang, Fan/0000-0003-0634-101X	Chinese National Natural Science Foundation [81172685]; Ministry of Science and Technology [2010CB535000]; Ministry of Health [201002006]; Shanghai Science and Technology Commission [12411950405, 13QH1401800]; Shanghai Municipal Committee of Education [11SG19, HJTY-2010-A09]; Shanghai Key Discipline of Public Health, AFINS research project [AFINS-HOPE-2011025]; Shengyuan Research Project	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Committee of Education; Shanghai Key Discipline of Public Health, AFINS research project; Shengyuan Research Project	The study was supported by Chinese National Natural Science Foundation (81172685); Ministry of Science and Technology (2010CB535000); Ministry of Health (201002006), Shanghai Science and Technology Commission (12411950405, 13QH1401800); and Shanghai Municipal Committee of Education (11SG19, HJTY-2010-A09), Shanghai Key Discipline of Public Health, AFINS research project (AFINS-HOPE-2011025), Shengyuan Research Project.	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Bloch AM, 2002, ACTA PAEDIATR, V91, P275, DOI 10.1080/08035250252833914; Bolte G, 2004, CLIN EXP ALLERGY, V34, P381, DOI 10.1111/j.1365-2222.2004.01890.x; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Braback L, 1998, CLIN EXP ALLERGY, V28, P936; Chen Yuzhi, 1998, CHIN J PEDIAT, V36, P352; Chiang LC, 2007, ASIAN PAC J ALLERGY, V25, P1; Department of urban social and economic survey, 2006, NAT BUR STAT CHIN CH; Eggesbo M, 2003, J ALLERGY CLIN IMMUN, V112, P420, DOI 10.1067/mai.2003.1610; Elliott L, 2008, J ALLERGY CLIN IMMUN, V122, P49, DOI 10.1016/j.jaci.2008.04.001; Futamura Masaki, 2011, Allergology International, V60, P509, DOI 10.2332/allergolint.10-OA-0293; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Hanson LA, 2007, P NUTR SOC, V66, P384, DOI 10.1017/S0029665107005654; Katz KA, 2003, CLIN EXP ALLERGY, V33, P737, DOI 10.1046/j.1365-2222.2003.01670.x; Kneepkens CMF, 2010, EUR J PEDIATR, V169, P911, DOI 10.1007/s00431-010-1141-7; Kolokotroni O, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-179; Kozyrskyj AL, 2008, AM J RESP CRIT CARE, V177, P142, DOI 10.1164/rccm.200703-381OC; Li F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-437; Li SH, 2008, SLEEP MED, V9, P555, DOI 10.1016/j.sleep.2007.07.008; Li SH, 2007, SLEEP, V30, P361, DOI 10.1093/sleep/30.3.361; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Ma Y, 2009, PEDIATR PULM, V44, P793, DOI 10.1002/ppul.21061; Madar J, 1999, ACTA PAEDIATR, V88, P1244, DOI 10.1080/080352599750030365; Mallen CD, 2008, J ASTHMA, V45, P309, DOI 10.1080/02770900801911194; MURPHY BEP, 1983, ENDOCR REV, V4, P150; Pekkanen J, 2001, CLIN EXP ALLERGY, V31, P95, DOI 10.1046/j.1365-2222.2001.00930.x; Penaranda A, 2012, RHINOLOGY, V50, P122, DOI [10.4193/Rhin11.175, 10.4193/Rhino11.175]; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Renz-Polster H, 2005, CLIN EXP ALLERGY, V35, P1466, DOI 10.1111/j.1365-2222.2005.02356.x; Spiekermann GM, 2001, J PEDIATR GASTR NUTR, V32, P237, DOI 10.1097/00005176-200103000-00003; Tamay Z, 2007, INT J PEDIATR OTORHI, V71, P463, DOI 10.1016/j.ijporl.2006.11.013; Tulic MK, 2011, J ALLERGY CLIN IMMUN, V127, P470, DOI 10.1016/j.jaci.2010.09.020; von Hertzen LC, 2002, J ALLERGY CLIN IMMUN, V109, P923, DOI 10.1067/mai.2002.124776; Wang L, 1999, J PERINAT MED, V27, P195; Xu B, 1999, ALLERGY, V54, P829, DOI 10.1034/j.1398-9995.1999.00117.x; Zhang YM, 2013, LARYNGOSCOPE, V123, P28, DOI 10.1002/lary.23573; Zhao J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-551	39	14	18	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0114022	10.1371/journal.pone.0114022	http://dx.doi.org/10.1371/journal.pone.0114022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647669	Green Published, gold, Green Submitted			2022-12-27	WOS:000348822600005
J	Ai, M; Cui, Y; Sy, MS; Lee, DM; Zhang, LX; Larson, KM; Kurek, KC; Jay, GD; Warman, ML				Ai, Minrong; Cui, Yajun; Sy, Man-Sun; Lee, David M.; Zhang, Ling Xiu; Larson, Katherine M.; Kurek, Kyle C.; Jay, Gregory D.; Warman, Matthew L.			Anti-Lubricin Monoclonal Antibodies Created Using Lubricin-Knockout Mice Immunodetect Lubricin in Several Species and in Patients with Healthy and Diseased Joints	PLOS ONE			English	Article							SUPERFICIAL ZONE PROTEIN; CRUCIATE LIGAMENT TRANSECTION; HUMAN SYNOVIAL FIBROBLASTS; ARTICULAR-CARTILAGE; BOUNDARY LUBRICATION; PROTEOGLYCAN-4 PRG4; GENE-EXPRESSION; PREVENTION; FRICTION; FLUID	Lubricin, encoded by the gene PRG4, is the principal lubricant in articulating joints. We immunized mice genetically deficient for lubricin (Prg4-/-) with purified human lubricin, and generated several mAbs. We determined each mAb's binding epitope, sensitivity, and specificity using biologic samples and recombinant lubricin sub-domains, and we also developed a competition ELISA assay to measure lubricin in synovial fluid and blood. We found the mAbs all recognized epitopes containing O-linked oligosaccharides conjugated to the peptide motif KEPAPTTT. By western blot, the mAbs detected lubricin in 1 mu l of synovial fluid from several animal species, including human. The mAbs were specific for lubricin since they did not cross-react with other synovial fluid constituents from patients with camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP), who genetically lack this protein. The competition ELISA detected lubricin in blood samples from healthy individuals but not from patients with CACP, indicating blood can be used in a diagnostic test for patients suspected of having CACP. Lubricin epitopes in blood do not represent degradation fragments from synovial fluid. Therefore, although blood lubricin levels did not differentiate patients with inflammatory joint disease from healthy controls, epitope-specific anti-lubricin mAbs could be useful for monitoring disease activity in synovial fluid.	[Ai, Minrong; Cui, Yajun; Warman, Matthew L.] Case Western Reserve Univ, Sch Med, Howard Hughes Med Inst, Cleveland, OH 44106 USA; [Ai, Minrong; Cui, Yajun; Warman, Matthew L.] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Sy, Man-Sun] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Lee, David M.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Zhang, Ling Xiu; Larson, Katherine M.; Jay, Gregory D.] Rhode Isl Hosp, Dept Emergency Med, Providence, RI USA; [Larson, Katherine M.; Jay, Gregory D.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Kurek, Kyle C.] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Warman, Matthew L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Warman, Matthew L.] Harvard Univ, Sch Med, Boston Childrens Hosp, Orthopaed Res Labs, Boston, MA USA; [Warman, Matthew L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Warman, Matthew L.] Harvard Univ, Dept Orthopaed Surg, Sch Med, Boston, MA USA	Case Western Reserve University; Howard Hughes Medical Institute; Case Western Reserve University; Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Warman, ML (corresponding author), Boston Childrens Hosp, Boston, MA 02115 USA.	matthew.warman@childrens.harvard.edu		Jay, Gregory/0000-0003-1517-8488	NIH [AR050180]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant AR050180 to GDJ and MLW. MLW is an employee of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazami AM, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9399; Coles JM, 2010, ARTHRITIS RHEUM-US, V62, P1666, DOI 10.1002/art.27436; Drewniak EI, 2012, ARTHRITIS RHEUM-US, V64, P465, DOI 10.1002/art.33337; Elsaid KA, 2008, ARTHRITIS RHEUM-US, V58, P1707, DOI 10.1002/art.23495; Elsaid KA, 2012, OSTEOARTHR CARTILAGE, V20, P940, DOI 10.1016/j.joca.2012.04.021; Elsaid KA, 2005, ARTHRITIS RHEUM-US, V52, P1746, DOI 10.1002/art.21038; Elsaid KA, 2007, ARTHRITIS RHEUM, V56, P108, DOI 10.1002/art.22321; Estrella RP, 2010, BIOCHEM J, V429, P359, DOI 10.1042/BJ20100360; Flannery CR, 1999, BIOCHEM BIOPH RES CO, V254, P535, DOI 10.1006/bbrc.1998.0104; Gleghorn JP, 2009, J ORTHOP RES, V27, P771, DOI 10.1002/jor.20798; Jay GD, 2001, GLYCOCONJUGATE J, V18, P807, DOI 10.1023/A:1021159619373; Jay GD, 2001, J ORTHOPAED RES, V19, P677, DOI 10.1016/S0736-0266(00)00040-1; Jay GD, 2000, J RHEUMATOL, V27, P594; Jay GD, 2007, ARTHRITIS RHEUM-US, V56, P3662, DOI 10.1002/art.22974; Jay GD, 2012, ARTHRITIS RHEUM-US, V64, P1162, DOI 10.1002/art.33461; Jay GD, 2010, ARTHRITIS RHEUM-US, V62, P2382, DOI 10.1002/art.27550; Jones ARC, 2007, J ORTHOP RES, V25, P283, DOI 10.1002/jor.20325; Liu YJ, 2004, BLOOD, V103, P4449, DOI 10.1182/blood-2003-06-1825; Marcelino J, 1999, NAT GENET, V23, P319, DOI 10.1038/15496; Nugent GE, 2006, BIORHEOLOGY, V43, P191; Piccard H, 2007, J LEUKOCYTE BIOL, V81, P870, DOI 10.1189/jlb.1006629; Rees SG, 2002, MATRIX BIOL, V21, P593, DOI 10.1016/S0945-053X(02)00056-2; Rhee DK, 2005, J BIOL CHEM, V280, P31325, DOI 10.1074/jbc.M505401200; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Schmidt TA, 2007, OSTEOARTHR CARTILAGE, V15, P35, DOI 10.1016/j.joca.2006.06.005; Schmidt TA, 2009, BBA-GEN SUBJECTS, V1790, P375, DOI 10.1016/j.bbagen.2009.03.016; Schumacher BL, 2005, J ORTHOP RES, V23, P562, DOI 10.1016/j.orthres.2004.11.011; Schumacher BL, 1999, J ORTHOP RES, V17, P110, DOI 10.1002/jor.1100170117; Steele BL, 2013, OSTEOARTHR CARTILAGE, V21, P498, DOI 10.1016/j.joca.2012.12.002; Su JL, 2001, HYBRIDOMA, V20, P149, DOI 10.1089/027245701750293475; Sun YL, 2013, J BONE JOINT SURG AM, V95A, P273, DOI 10.2106/JBJS.K.01522; Sun YL, 2006, J ORTHOP RES, V24, P1861, DOI 10.1002/jor.20239; SWANN DA, 1985, BIOCHEM J, V225, P195, DOI 10.1042/bj2250195; Waller KA, 2013, P NATL ACAD SCI USA, V110, P5852, DOI 10.1073/pnas.1219289110; Young AA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1898	35	28	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116237	10.1371/journal.pone.0116237	http://dx.doi.org/10.1371/journal.pone.0116237			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642942	Green Submitted, Green Published, gold			2022-12-27	WOS:000348821200014
J	Lin, JX; Huang, CM; Zheng, CH; Li, P; Xie, JW; Wang, JB; Lu, J; Chen, QY; Cao, LL; Lin, M				Lin, Jian-Xian; Huang, Chang-Ming; Zheng, Chao-Hui; Li, Ping; Xie, Jian-Wei; Wang, Jia-Bin; Lu, Jun; Chen, Qi-Yue; Cao, Long-Long; Lin, Mi			Surgical Outcomes of 2041 Consecutive Laparoscopic Gastrectomy Procedures for Gastric Cancer: A Large-Scale Case Control Study	PLOS ONE			English	Article							ASSISTED DISTAL GASTRECTOMY; LYMPH-NODE DISSECTION; MULTICENTER; EXPERIENCE	Background Laparoscopic gastrectomy (LG) for gastric cancer has increased in popularity due to advances in surgical techniques. The aim of this study is to validate the efficacy and safety of laparoscopic gastrectomy for gastric cancer compared with open gastrectomy (OG). Methods The study comprised 3,580 patients who were treated with curative intent either by laparoscopic gastrectomy (2,041 patients) or open gastrectomy (1,539 patents) between January 2005 and October 2013. The surgical outcomes were compared between the two groups. Results Laparoscopic gastrectomy was associated with significantly less blood loss, transfused patient number, time to ground activities, and post-operative hospital stay, but with similar operation time, time to first flatus, and time to resumption of diet, compared with the open gastrectomy. No significant difference in the number of lymph nodes dissected was observed between these two groups. The morbidity and mortality rates of the LG group were comparable to those of the OG group (13.6% vs. 14.4%, P = 0.526, and 0.3% vs. 0.2%, P = 0.740). The 3-year disease-free and overall survival rates between the two groups were statistically significant (P < 0.05). According to the UICC TNM classification of gastric cancer, the 3-year disease-free and overall survival rates were not statistically different at each stage. Conclusions Our single-center study of a large patient series revealed that LG for gastric cancer yields comparable surgical outcomes. This result was also true of local advanced gastric cancer (AGC). A well-designed randomized controlled trial comparing surgical outcomes between LG and OG in a larger number of patients for AGC can be carried out.	[Lin, Jian-Xian; Huang, Chang-Ming; Zheng, Chao-Hui; Li, Ping; Xie, Jian-Wei; Wang, Jia-Bin; Lu, Jun; Chen, Qi-Yue; Cao, Long-Long; Lin, Mi] Fujian Med Univ, Union Hosp, Dept Gastr Surg, Fuzhou 350001, Fujian, Peoples R China	Fujian Medical University	Huang, CM (corresponding author), Fujian Med Univ, Union Hosp, Dept Gastr Surg, 29 Xinquan Rd, Fuzhou 350001, Fujian, Peoples R China.	hcmlr2002@163.com	Li, Ping/GYV-4914-2022; Zheng, Chao-hui/HGE-3348-2022	Zheng, Chao-hui/0000-0001-8680-3127	National Key Clinical Specialty Discipline Construction Program of China [[2012]649]; Key Project of Science and Technology Plan of Fujian Province, China [2014Y0025]	National Key Clinical Specialty Discipline Construction Program of China; Key Project of Science and Technology Plan of Fujian Province, China	Our funding was provided by National Key Clinical Specialty Discipline Construction Program of China (No. [2012] 649) and The Key Project of Science and Technology Plan of Fujian Province, China (Grant No. 2014Y0025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bo T, 2013, J GASTROINTEST SURG, V17, P1202, DOI 10.1007/s11605-013-2218-1; Han HS, 2003, SURG LAPARO ENDO PER, V13, P361, DOI 10.1097/00129689-200312000-00002; Hu Yan-feng, 2010, Zhonghua Wei Chang Wai Ke Za Zhi, V13, P510; Huang Chang-ming, 2012, Zhonghua Wei Chang Wai Ke Za Zhi, V15, P1265; Hur H, 2008, J SURG ONCOL, V98, P515, DOI 10.1002/jso.21155; Hwang SI, 2009, SURG ENDOSC, V23, P1252, DOI 10.1007/s00464-008-0140-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong O, 2012, SURG ENDOSC, V26, P3418, DOI 10.1007/s00464-012-2356-7; Kawamura H, 2008, WORLD J SURG, V32, P2366, DOI 10.1007/s00268-008-9697-3; Kim HH, 2010, ANN SURG, V251, P417, DOI 10.1097/SLA.0b013e3181cc8f6b; Kim JP, 2002, J SURG ONCOL, V79, P79, DOI 10.1002/jso.10050.abs; Kim KH, 2012, J GASTRIC CANCER, V12, P18, DOI 10.5230/jgc.2012.12.1.18; KITANO S, 1994, SURG LAPAROSC ENDOSC, V4, P146; Kitano S, 2007, ANN SURG, V245, P68, DOI 10.1097/01.sla.0000225364.03133.f8; Kunisaki C, 2008, SURG LAPARO ENDO PER, V18, P236, DOI 10.1097/SLE.0b013e31816aa13f; Lee JH, 2005, SURG ENDOSC, V19, P168, DOI 10.1007/s00464-004-8808-y; Lee JH, 2009, SURG ENDOSC, V23, P1759, DOI 10.1007/s00464-008-0198-0; Lee SI, 2006, J AM COLL SURGEONS, V202, P874, DOI 10.1016/j.jamcollsurg.2006.02.028; Lin JX, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-4; Miura S, 2004, J AM COLL SURGEONS, V198, P933, DOI 10.1016/j.jamcollsurg.2004.01.021; Nam BH, 2013, J GASTRIC CANCER, V13, P164, DOI 10.5230/jgc.2013.13.3.164; Pak KH, 2012, SURG ENDOSC, V26, P130, DOI 10.1007/s00464-011-1838-3; PARKDO J, 2012, SURG ENDOSC, V26, P1548, DOI DOI 10.1007/S00464-011-2065-7; Shuang JB, 2011, J GASTROINTEST SURG, V15, P57, DOI 10.1007/s11605-010-1361-1; SOBIN LH, 2010, TNM CLASSIFICATION O; Song KY, 2008, SURG ENDOSC, V22, P655, DOI 10.1007/s00464-007-9431-5; Sugimoto M, 2013, SURG ENDOSC, V27, P4291, DOI 10.1007/s00464-013-3045-x; Tanimura S, 2008, SURG ENDOSC, V22, P1161, DOI 10.1007/s00464-008-9786-2; Wang Jia-bin, 2010, Zhonghua Wai Ke Za Zhi, V48, P502	31	45	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0114948	10.1371/journal.pone.0114948	http://dx.doi.org/10.1371/journal.pone.0114948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642698	Green Submitted, Green Published			2022-12-27	WOS:000348821200006
J	Morgan, WH; Abdul-Rahman, A; Yu, DY; Hazelton, ML; Betz-Stablein, B; Lind, CRP				Morgan, William H.; Abdul-Rahman, Anmar; Yu, Dao-Yi; Hazelton, Martin L.; Betz-Stablein, Brigid; Lind, Christopher R. P.			Objective Detection of Retinal Vessel Pulsation	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; VENOUS PULSATION; VEIN; FREQUENCY; GLAUCOMA	Purpose Retinal venous pulsation detection is a subjective sign, which varies in elevated intracranial pressure, venous obstruction and glaucoma. To date no method can objectively measure and identify pulsating regions. Method Using high resolution video-recordings of the optic disk and retina we measured fluctuating light absorption by haemoglobin during pulsation. Pulsation amplitude was calculated from all regions of the retinal image video-frames in a raster pattern. Segmented retinal images were formed by objectively selecting regions with amplitudes above a range of threshold values. These were compared to two observers manually drawing an outline of the pulsating areas while viewing video-clips in order to generate receiver operator characteristics. Results 216,515 image segments were analysed from 26 eyes in 18 research participants. Using data from each eye, the median area under the receiver operator curve (AU-ROC) was 0.95. With all data analysed together the AU-ROC was 0.89. We defined the ideal threshold amplitude for detection of any pulsating segment being that with maximal sensitivity and specificity. This was 5 units (95% confidence interval 4.3 to 6.0) compared to 12 units before any regions were missed. A multivariate model demonstrated that ideal threshold amplitude increased with increased variation in video-sequence illumination (p = 0.0119), but between the two observers (p = 0.0919) or other variables. Conclusion This technique demonstrates accurate identification of retinal vessel pulsating regions with no areas identified manually being missed with the objective technique. The amplitude values are derived objectively and may be a significant advance upon subjective ophthalmodynamometric threshold techniques.	[Morgan, William H.; Yu, Dao-Yi] Univ Western Australia, Lions Eye Inst, Nedlands, WA 6009, Australia; [Hazelton, Martin L.; Betz-Stablein, Brigid] Massey Univ, Inst Fundamental Sci, Stat & Bioinformat Grp, Palmerston North, New Zealand; [Lind, Christopher R. P.] Univ Western Australia, Sch Surg, Nedlands, WA 6009, Australia; [Abdul-Rahman, Anmar] Manukau Hlth, Dept Ophthalmol, Auckland, New Zealand	Lions Eye Institute; University of Western Australia; Massey University; University of Western Australia	Morgan, WH (corresponding author), Univ Western Australia, Lions Eye Inst, Nedlands, WA 6009, Australia.	BillMorgan@lei.org.au	Hazelton, Martin/AAB-9373-2019; Abdul-Rahman, Anmar/ABA-5090-2021; Betz-Stablein, Brigid/S-6925-2018; Lind, Christopher/K-3629-2012	Hazelton, Martin/0000-0001-7831-725X; Abdul-Rahman, Anmar/0000-0002-0812-8944; Betz-Stablein, Brigid/0000-0003-3876-501X; Lind, Christopher/0000-0001-9991-1725; Yu, Dao-Yi/0000-0002-9490-534X	National Health and Medical Research Council NHMRC [APP1020367, 102367, 107310]	National Health and Medical Research Council NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council NHMRC (https://www.nhmrc.gov.au), NHMRC Grant Reference Number APP1020367 WHM, NHMRC Project Grant 102367 WHM, and NHMRC Development Grant 107310 WHM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaratnasingam C, 2007, BRIT J OPHTHALMOL, V91, P441, DOI 10.1136/bjo.2006.105338; BEAUMONT PE, 1994, AUST NZ J OPHTHALMOL, V22, P271, DOI 10.1111/j.1442-9071.1994.tb00796.x; Coccius E.A., 1853, UEBER ANWENDUNG AUGE; Firsching R, 1998, LANCET, V351, P523, DOI 10.1016/S0140-6736(05)78717-1; Foo JYA, 2005, PHYSIOL MEAS, V26, P531, DOI 10.1088/0967-3334/26/4/017; Gibbs FA, 1936, ARCH NEURO PSYCHIATR, V35, P292, DOI 10.1001/archneurpsyc.1936.02260020086006; Golzan SM, 2011, CURR EYE RES, V36, P53, DOI 10.3109/02713683.2010.530731; Jonas JB, 2007, AM J OPHTHALMOL, V143, P112, DOI 10.1016/j.ajo.2006.09.019; Kain S, 2010, BRIT J OPHTHALMOL, V94, P854, DOI 10.1136/bjo.2009.169813; Kim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097943; Legler U, 2009, J GLAUCOMA, V18, P210, DOI 10.1097/IJG.0b013e318182edd2; Morgan WH, 2004, OPHTHALMOLOGY, V111, P1489, DOI 10.1016/j.ophtha.2003.12.053; Morgan WH, 2014, INVEST OPHTHALMOL VI; Morgan WH, 2014, INVEST OPHTH VIS SCI, V55, P5998, DOI 10.1167/iovs.14-15104; Morgan WH, 2010, GRAEF ARCH CLIN EXP, V248, P401, DOI 10.1007/s00417-009-1288-y; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Popovic Djordje, 2009, Recent Patents on Biomedical Engineering, V2, P165, DOI 10.2174/1874764710902030165; R Core Development Team, 2013, R LANG ENV STAT COMP; Seo JH, 2012, OPHTHALMOLOGY, V119, P2254, DOI 10.1016/j.ophtha.2012.06.007; Stodtmeister R, 2008, KLIN MONATSBL AUGENH, V225, P632, DOI 10.1055/s-2008-1027233; WALSH TJ, 1969, AM J OPHTHALMOL, V67, P954, DOI 10.1016/0002-9394(69)90094-4; ZIJLSTRA WG, 1991, CLIN CHEM, V37, P1633; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929; Zou KH, 2004, STAT MED, V23, P1259, DOI 10.1002/sim.1723	24	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116475	10.1371/journal.pone.0116475	http://dx.doi.org/10.1371/journal.pone.0116475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643350	Green Submitted, gold, Green Published			2022-12-27	WOS:000348821200018
J	O'Brien, KM; Lindsay, EL; Starai, VJ				O'Brien, Kevin M.; Lindsay, Elizabeth L.; Starai, Vincent J.			The Legionella pneumophila Effector Protein, LegC7, Alters Yeast Endosomal Trafficking	PLOS ONE			English	Article							LEGIONNAIRES-DISEASE; PLASMA-MEMBRANE; ENDOCYTOSIS; IDENTIFICATION; BACTERIUM; COMPLEX; DOMAIN; HRS; UBIQUITINATION; PHAGOSOME	The intracellular pathogen, Legionella pneumophila, relies on numerous secreted effector proteins to manipulate host endomembrane trafficking events during pathogenesis, thereby preventing fusion of the bacteria-laden phagosome with host endolysosomal compartments, and thus escaping degradation. Upon expression in the surrogate eukaryotic model Saccharomyces cerevisiae, we find that the L. pneumophila LegC7/YlfA effector protein disrupts the delivery of both biosynthetic and endocytic cargo to the yeast vacuole. We demonstrate that the effects of LegC7 are specific to the endosome: vacuole delivery pathways; LegC7 expression does not disrupt other known vacuole-directed pathways. Deletions of the ESCRT-0 complex member, VPS27, provide resistance to the LegC7 toxicity, providing a possible target for LegC7 function in vivo. Furthermore, a single amino acid substitution in LegC7 abrogates both its toxicity and ability to alter endosomal traffic in vivo, thereby identifying a critical functional domain. LegC7 likely inhibits endosomal trafficking during L. pneumophila pathogenesis to prevent entry of the phagosome into the endosomal maturation pathway and eventual fusion with the lysosome.	[O'Brien, Kevin M.; Lindsay, Elizabeth L.; Starai, Vincent J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Starai, Vincent J.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Starai, VJ (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	vjstarai@uga.edu		Tinder, Elizabeth/0000-0002-0262-5253	National Institute of Allergy and Infectious Diseases award [R01-AI100913]; National Science Foundation's Research Experience for Undergraduates Site Award to The University of Georgia [DBI-1062589]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100913] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1062589] Funding Source: National Science Foundation	National Institute of Allergy and Infectious Diseases award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation's Research Experience for Undergraduates Site Award to The University of Georgia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	VJS is supported by National Institute of Allergy and Infectious Diseases award R01-AI100913. ELL was supported by the National Science Foundation's Research Experience for Undergraduates Site Award to The University of Georgia (DBI-1062589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bennett TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056798; Brachmann CB, 1998, YEAST, V14, P115; BURNSTEIN D, 2009, PLOS PATHOG, V5, DOI DOI 10.1371/JOURNAL.PPAT.1000508; Campodonico EM, 2005, MOL MICROBIOL, V56, P918, DOI 10.1111/j.1365-2958.2005.04595.x; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Cowles CR, 1997, EMBO J, V16, P2769, DOI 10.1093/emboj/16.10.2769; Darsow T, 1998, J CELL BIOL, V142, P913, DOI 10.1083/jcb.142.4.913; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; FIELDS BS, 1986, INFECT IMMUN, V53, P553, DOI 10.1128/IAI.53.3.553-559.1986; FLIERMANS CB, 1981, APPL ENVIRON MICROB, V41, P9, DOI 10.1128/AEM.41.1.9-16.1981; Gaspar AH, 2014, P NATL ACAD SCI USA, V111, P4560, DOI 10.1073/pnas.1316376111; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; KAUFMANN AF, 1981, AM J EPIDEMIOL, V114, P337, DOI 10.1093/oxfordjournals.aje.a113200; KLIONSKY DJ, 1992, JOURNAL OF CELL BIOL, V119, DOI DOI 10.1083/JCB.119.2.287; KOLLING R, 1994, EMBO J, V13, P3261, DOI 10.1002/j.1460-2075.1994.tb06627.x; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Ku B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003082; Leber R, 2001, J BIOL CHEM, V276, P29210, DOI 10.1074/jbc.M101438200; Lifshitz Z, 2013, P NATL ACAD SCI USA, V110, pE707, DOI 10.1073/pnas.1215278110; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; MacDonald C, 2012, TRAFFIC, V13, P586, DOI 10.1111/j.1600-0854.2011.01326.x; Maldonado-Baez L, 2008, MOL BIOL CELL, V19, P2936, DOI 10.1091/mbc.E07-10-1019; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; McNatt MW, 2007, MOL BIOL CELL, V18, P697, DOI 10.1091/mbc.E06-08-0663; Neunuebel MR, 2012, J BACTERIOL, V194, P1389, DOI 10.1128/JB.06306-11; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Paumet F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007375; Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013; Progida C, 2007, J CELL SCI, V120, P3729, DOI 10.1242/jcs.017301; Prosser DC, 2010, TRAFFIC, V11, P1141, DOI 10.1111/j.1600-0854.2010.01088.x; Raiborg C, 2001, J CELL SCI, V114, P2255; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; RIEZMAN H, 1985, CELL, V40, P1001, DOI 10.1016/0092-8674(85)90360-5; ROBINSON JS, 1988, MOLECULAR AND CELLUL, V8, P13; Roth AF, 1998, J CELL BIOL, V142, P949, DOI 10.1083/jcb.142.4.949; ROTHMAN JH, 1989, EMBO J, V8, P2057, DOI 10.1002/j.1460-2075.1989.tb03614.x; SCHUH AL, 2014, CRITICAL REVIEWS IN, P1549; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; SOLINGER JA, 2012, THE FEBS JOURNAL, V280, P2743, DOI DOI 10.1111/FEBS.12151; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Tilney LG, 2001, J CELL SCI, V114, P4637; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; von der Haar T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001078; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Yao DQ, 2014, ACTA CRYSTALLOGR D, V70, P436, DOI 10.1107/S139900471302991X	60	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116824	10.1371/journal.pone.0116824	http://dx.doi.org/10.1371/journal.pone.0116824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643265	Green Published, Green Submitted, gold			2022-12-27	WOS:000348821200024
J	de Oliveira, ML; Santos, LMP; da Silva, EN				de Oliveira, Michele Lessa; Pacheco Santos, Leonor Maria; da Silva, Everton Nunes			Direct Healthcare Cost of Obesity in Brazil: An Application of the Cost-of-Illness Method from the Perspective of the Public Health System in 2011	PLOS ONE			English	Article							BODY-MASS INDEX; ECONOMIC BURDEN; OVERWEIGHT; CANCER; MORTALITY; CONSEQUENCES; METAANALYSIS; WEIGHT; IMPACT; RISK	Background Obesity is a global public health problem and a risk factor for several diseases that financially impact healthcare systems. Objective To estimate the direct costs attributable to obesity (body mass index {BMI} >= 30 kg/m(2)) and morbid obesity (BMI >= 40 kg/m(2)) in adults aged >= 20 incurred by the Brazilian public health system in 2011. Settings Public hospitals and outpatient care. Methods A cost-of-illness method was adopted using a top-down approach based on prevalence. The proportion of the cost of each obesity-associated comorbidity was calculated and obesity prevalence was used to calculate attributable risk. Direct healthcare cost data (inpatient care, bariatric surgery, outpatient care, medications and diagnostic procedures) were extracted from the Ministry of Health information systems, available on the web. Results Direct costs attributable to obesity totaled US$ 269.6 million (1.86% of all expenditures on medium-and high-complexity health care). The cost of morbid obesity accounted for 23.8% (US$ 64.2 million) of all obesity-related costs despite being 18 times less prevalent than obesity. Bariatric surgery costs in Brazil totaled US$ 17.4 million in 2011. The cost of morbid obesity in women was five times higher than it was in men. Conclusion The cost of morbid obesity was found to be proportionally higher than the cost of obesity. If the current epidemic were not reversed, the prevalence of obesity in Brazil will increase gradually in the coming years, as well as its costs, having serious implications for the financial sustainability of the Brazilian public health system.	[de Oliveira, Michele Lessa; Pacheco Santos, Leonor Maria; da Silva, Everton Nunes] Univ Brasilia, Brasilia, DF, Brazil	Universidade de Brasilia	da Silva, EN (corresponding author), Univ Brasilia, Brasilia, DF, Brazil.	evertonsilva@unb.br	Porto, Jorge/T-4694-2019; Oliveira, Claudio/D-7713-2012; Porto, Jorge/K-1441-2014; da Silva Batista, Jacqueline/AAD-4349-2020; Zuanon, Jansen A. S./E-5791-2013	Oliveira, Claudio/0000-0002-7010-8880; Porto, Jorge/0000-0003-1393-6492; da Silva Batista, Jacqueline/0000-0002-6649-6200; Zuanon, Jansen A. S./0000-0001-8354-2750; santos, leonor maria pacheco/0000-0002-6739-6260; Silva, Everton/0000-0001-8747-4185				Access Economics, 2006, EC COSTS OB REP ACC; Andreyeva T, 2004, OBES RES, V12, P1936, DOI 10.1038/oby.2004.243; [Anonymous], 2000, WHO TECH REP SER, P894; Arterburn DE, 2005, INT J OBESITY, V29, P334, DOI 10.1038/sj.ijo.0802896; Bachman KH, 2007, DIS MANAGE, V10, P129, DOI 10.1089/dis.2007.103643; Bahia L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-440; Barrett A, 2008, ISPOR 13 ANN INT M; Branca F, 2007, CHALLENGE OBESITY WH, P11; Brasil, PROD AMB PROC MENT H; Brasil. Instituto Brasileiro de Geografia e Estatistica, 2010, PESQ ORC FAM 2008 20, P130; Brasil. Ministerio da Saude, 2008, AR EC SAUD DES AV EC, P104, DOI [10.1016/j.rpsm.2014.10.004, DOI 10.1016/J.RPSM.2014.10.004]; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cordeiro Ricardo, 2005, Rev. bras. epidemiol., V8, P111; Cremieux PY, 2008, AM J MANAG CARE, V14, P589; Dai Z, 2007, WORLD J GASTROENTERO, V13, P4199, DOI 10.3748/wjg.v13.i31.4199; Engeland A, 2005, CANCER CAUSE CONTROL, V16, P987, DOI 10.1007/s10552-005-3638-3; Ezzati M, 2004, COMP QUANTIFICATION, V1, P497; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Finkelstein EA, 2003, HEALTH AFFAIR, V22, pW219; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hensrud DD, 2006, MAYO CLIN PROC, V81, pS5; International Association for the Study of Obesity International Obesity Taskforce, EST REL RISKS BMI CA; Lehnert T, 2013, BEST PRACT RES CL EN, V27, P105, DOI 10.1016/j.beem.2013.01.002; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Martinez J, 2004, PANCREATOLOGY, V4, P42, DOI 10.1159/000077025; McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Oliveira IV, 2007, THESIS U BRASILIA BR; Santos LMP, 2010, OBES SURG, V20, P943, DOI 10.1007/s11695-008-9570-3; Pereira J, 1999, CUSTOS OBESIDADE POR; Pereira MG, 2001, EPIDEMIOLOGIA TEORIA, P412; Quesenberry CP, 1998, ARCH INTERN MED, V158, P466, DOI 10.1001/archinte.158.5.466; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sarno F, 2007, REV SAUDE PUBL, V41, P788, DOI 10.1590/S0034-89102007000500013; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Sichieri R, 2007, CAD SAUDE PUBLICA, V23, P1721, DOI 10.1590/S0102-311X2007000700025; Sussenbach SP, 2012, OBES SURG, V22, P266, DOI 10.1007/s11695-011-0558-z; Sussenbach SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099976; Thompson D, 1999, ARCH INTERN MED, V159, P2177, DOI 10.1001/archinte.159.18.2177; Thompson D, 2001, Obes Rev, V2, P189, DOI 10.1046/j.1467-789x.2001.00037.x; Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x; Wagner M.B., 1998, J PEDIAT, V74, P247; Wang GJ, 2002, AM J PREV MED, V23, P1, DOI 10.1016/S0749-3797(02)00448-8; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; World Health Organization (WHO), 2012, WORLD HLTH STAT 2012; Yang P, 2009, EUR J CANCER, V45, P2867, DOI 10.1016/j.ejca.2009.04.019	51	117	121	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121160	10.1371/journal.pone.0121160	http://dx.doi.org/10.1371/journal.pone.0121160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25658694	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600061
J	Borner, J; Kis-Katos, K; Hargrave, J; Konig, K				Boerner, Jan; Kis-Katos, Krisztina; Hargrave, Jorge; Koenig, Konstantin			Post-Crackdown Effectiveness of Field-Based Forest Law Enforcement in the Brazilian Amazon	PLOS ONE			English	Article							PROPENSITY SCORE; PROTECTED AREAS; DEFORESTATION; POLICY; ISSUES; FIRE; BEEF	Regulatory enforcement of forest conservation laws is often dismissed as an ineffective approach to reducing tropical forest loss. Yet, effective enforcement is often a precondition for alternative conservation measures, such as payments for environmental services, to achieve desired outcomes. Fair and efficient policies to reducing emissions from deforestation and forest degradation (REDD) will thus crucially depend on understanding the determinants and requirements of enforcement effectiveness. Among potential REDD candidate countries, Brazil is considered to possess the most advanced deforestation monitoring and enforcement infrastructure. This study explores a unique dataset of over 15 thousand point coordinates of enforcement missions in the Brazilian Amazon during 2009 and 2010, after major reductions of deforestation in the region. We study whether local deforestation patterns have been affected by field-based enforcement and to what extent these effects vary across administrative boundaries. Spatial matching and regression techniques are applied at different spatial resolutions. We find that field-based enforcement operations have not been universally effective in deterring deforestation during our observation period. Inspections have been most effective in reducing large-scale deforestation in the states of Mato Grosso and Para, where average conservation effects were 4.0 and 9.9 hectares per inspection, respectively. Despite regional and actor-specific heterogeneity in inspection effectiveness, field-based law enforcement is highly cost-effective on average and might be enhanced by closer collaboration between national and state-level authorities.	[Boerner, Jan] Univ Bonn, Res Dev Ctr, Bonn, Germany; [Boerner, Jan] Ctr Int Forestry Res, Bogor, Indonesia; [Kis-Katos, Krisztina] Univ Freiburg, Inst Econ Res, D-79106 Freiburg, Germany; [Hargrave, Jorge] Boston Consulting Grp Inc, Sao Paulo, Brazil; [Koenig, Konstantin] Humboldt Univ, Integrat Res Inst Transformat Human Environm Syst, D-10099 Berlin, Germany	University of Bonn; CGIAR; Center for International Forestry Research (CIFOR); University of Freiburg; Boston Consulting Group (BCG); Humboldt University of Berlin	Borner, J (corresponding author), Univ Bonn, Res Dev Ctr, Bonn, Germany.	jborner@uni-bonn.de	Wunder, Sven/ABE-7773-2020; Börner, Jan JB/I-2139-2015; Kis-Katos, Krisztina/ABC-3624-2021; Börner, Jan/ABF-8775-2021	Wunder, Sven/0000-0002-9422-0260; Börner, Jan/0000-0003-3034-5360	Robert Bosch Foundation [32.5.8043.0012.0]; European Commission [DCI-ENV/2011/269520]	Robert Bosch Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Robert Bosch Foundation (Grant: 32.5.8043.0012.0; www.bosch-stiftung.de) and the European Commission (Grant: DCI-ENV/2011/269520; http://ec.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers HJ, 2010, RESOUR ENERGY ECON, V32, P165, DOI 10.1016/j.reseneeco.2009.11.011; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Anselin L, 2002, AGR ECON-BLACKWELL, V27, P247, DOI 10.1111/j.1574-0862.2002.tb00120.x; Arima EY, 2007, J REGIONAL SCI, V47, P541, DOI 10.1111/j.1467-9787.2007.00519.x; Arima EY, 2014, LAND USE POLICY, V41, P465, DOI 10.1016/j.landusepol.2014.06.026; Assunu║ao JJ., 2013, DETERRING DEFORESTAT; Barretto AGOP, 2013, GLOBAL CHANGE BIOL, V19, P1804, DOI 10.1111/gcb.12174; Bartolini F, 2012, J AGR ECON, V63, P310, DOI 10.1111/j.1477-9552.2012.00339.x; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Borner J, 2014, GLOBAL ENVIRON CHANG, V29, P294, DOI 10.1016/j.gloenvcha.2014.04.021; Borner J., 2011, REDD STICKS CARROTS; Bowman MS, 2012, LAND USE POLICY, V29, P558, DOI 10.1016/j.landusepol.2011.09.009; CEPAL-IPEA-GIZ, 2011, AVALIACAO PLANO ACAO, DOI [10.1016/j.rpsm.2014.10.004, DOI 10.1016/J.RPSM.2014.10.004]; CLARKE HR, 1993, RESOUR ENERGY ECON, V15, P271, DOI 10.1016/0928-7655(93)90009-J; Dalla-Nora EL, 2014, LAND USE POLICY, V39, P403, DOI 10.1016/j.landusepol.2014.02.004; Aguiar APD, 2007, ECOL MODEL, V209, P169, DOI 10.1016/j.ecolmodel.2007.06.019; Ezzine-de-Blas D, 2011, ENVIRON SCI POLICY, V14, P188, DOI 10.1016/j.envsci.2010.11.009; Ferraro PJ, 2014, P NATL ACAD SCI USA, V111, P4332, DOI 10.1073/pnas.1307712111; Garoupa Nuno, 1997, J ECON SURV, V11, P267, DOI DOI 10.1111/1467-6419.00034; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Godar J, 2014, P NATL ACAD SCI USA; Godar J, 2012, FOREST ECOL MANAG, V267, P58, DOI 10.1016/j.foreco.2011.11.046; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI [DOI 10.1080/10618600.1993.10474623, DOI 10.7326/0003-4819-152-6-201003160-00008]; Hargrave J, 2013, ENVIRON RESOUR ECON, V54, P471, DOI 10.1007/s10640-012-9610-2; Honey-Roses J, 2011, CONSERV BIOL, V25, P1032, DOI 10.1111/j.1523-1739.2011.01729.x; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Kirby KR, 2006, FUTURES, V38, P432, DOI 10.1016/j.futures.2005.07.011; Mitchell Polinsky A., 2000, AM LAW ECON REV, V2, P223, DOI [10.1093/aler/2.2.223, DOI 10.1093/ALER/2.2.223]; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Pacheco P, 2012, GEOFORUM, V43, P864, DOI 10.1016/j.geoforum.2012.02.003; Piquero AR, 2011, ANNU REV LAW SOC SCI, V7, P335, DOI 10.1146/annurev-lawsocsci-102510-105404; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Robinson EJZ., 2010, J NAT RES POLICY RES, V2, P25, DOI 10.1080/19390450903350820; Rosa IMD, 2012, CONSERV BIOL, V26, P932, DOI 10.1111/j.1523-1739.2012.01901.x; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Sparovek G, 2012, ENVIRON SCI POLICY, V16, P65, DOI 10.1016/j.envsci.2011.10.008; STIGLER GJ, 1970, J POLIT ECON, V78, P526, DOI 10.1086/259646; Weber JG, 2011, LAND ECON, V87, P661, DOI 10.3368/le.87.4.661; Wooldridge JM, 2003, AM ECON REV, V93, P133, DOI 10.1257/000282803321946930	46	86	87	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121544	10.1371/journal.pone.0121544	http://dx.doi.org/10.1371/journal.pone.0121544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875656	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800022
J	Kim, H; Suzuki, T; Kim, M; Kojima, N; Ota, N; Shimotoyodome, A; Hase, T; Hosoi, E; Yoshida, H				Kim, Hunkyung; Suzuki, Takao; Kim, Miji; Kojima, Narumi; Ota, Noriyasu; Shimotoyodome, Akira; Hase, Tadashi; Hosoi, Erika; Yoshida, Hideyo			Effects of Exercise and Milk Fat Globule Membrane (MFGM) Supplementation on Body Composition, Physical Function, and Hematological Parameters in Community-Dwelling Frail Japanese Women: A Randomized Double Blind, Placebo-Controlled, Follow-Up Trial	PLOS ONE			English	Article							GROWTH-FACTOR; RESISTANCE EXERCISE; OLDER-PEOPLE; WEIGHT-LOSS; BDNF; SARCOPENIA; MYOSTATIN; STRENGTH; MOBILITY; ADULTS	Objective To investigate the combined and separate effects of exercise and milk fat globule membrane (MFGM) supplementation on frailty, physical function, physical activity level, and hematological parameters in community-dwelling elderly Japanese women. Methods A total of 131 frail, elderly women over 75 years were randomly assigned to one of four groups: exercise and MFGM supplementation (Ex+MFGM), exercise and placebo (Ex+Plac), MFGM supplementation, or the placebo group. The exercise group attended a 60-minute training program twice a week for three months, and the MFGM group ingested 1g of the MFGM supplement in pill form, daily for 3 months. The primary outcome measure was change in frailty status based on Fried's frailty phenotype. Secondary outcome measures included body composition, physical function and hematological parameters, and interview survey components assessing lifestyle factors. Participants were followed for 4 months post-intervention. Results Significant groupxtime interactions were observed for usual walking speed (P = 0.005), timed up & go (P < 0.001), and insulin-like growth factor-binding protein 3/insulin-like growth factor 1 ratio (P = 0.013). The frailty components revealed that weight loss, exhaustion, low physical activity, and slow walking speed were reversed, but low muscle strength did not significantly changed. Frailty reversal rate was significantly higher in the Ex+MFGM (57.6%) than in the MFGM (28.1%) or placebo (30.3%) groups at post-intervention (chi(2) = 8.827, P = 0.032), and at the follow-up was also significantly greater in the Ex+MFGM (45.5%) and Ex+Plac (39.4%) groups compared with the placebo (15.2%) group (chi(2) = 8.607, P = 0.035). The exercise+MFGM group had the highest odds ratio (OR) for frailty reversal at post-intervention and follow-up (OR = 3.12, 95% confidence interval (CI) = 1.13-8.60; and OR = 4.67, 95% CI = 1.45-15.08, respectively). Conclusion This study suggests that interventions including exercise and nutrition can improve frailty status. Statistically significant additive effects of MFGM with exercise could not be confirmed in this population, and further investigation in larger samples is necessary.	[Kim, Hunkyung; Kim, Miji; Kojima, Narumi; Hosoi, Erika; Yoshida, Hideyo] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo, Japan; [Suzuki, Takao] Natl Inst Longev Sci, Obu, Aichi, Japan; [Ota, Noriyasu; Shimotoyodome, Akira; Hase, Tadashi] Kao Corp, Biol Sci Labs, Hlth Sci, Ichikai, Tochigi, Japan	Tokyo Metropolitan Institute of Gerontology; KAO Corporation	Kim, H (corresponding author), Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo, Japan.	kimhk@tmig.or.jp	Kim, Heejin/HII-8568-2022; Lee, Sei Won/AAG-9977-2019	shimotoyodome, akira/0000-0001-7567-8316	Ministry of Health and Welfare of Japan; Japan Society for the Promotion of Science [22300243]	Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a research grant of the Ministry of Health and Welfare of Japan and a Grant-in-Aid for Scientific Research B of the Japan Society for the Promotion of Science (22300243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors Noriyasu Ota, Akira Shimotoyodome and Tadashi Hase are employed by Kao Corporation. Kao Corporation provided support in the form of salaries for authors NO, AS and TH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bermon S, 1999, ACTA PHYSIOL SCAND, V165, P51; Borst SE, 2002, J AM GERIATR SOC, V50, P884, DOI 10.1046/j.1532-5415.2002.50215.x; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Cameron ID, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-65; Chan DCD, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-58; Clegg A, 2014, AGE AGEING; Coelho FM, 2012, ARCH GERONTOL GERIAT, V54, P415, DOI 10.1016/j.archger.2011.05.014; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; El-Loly Mohamed Mansour, 2011, Polish Journal of Food and Nutrition Sciences, V61, P7; Elliot TA, 2006, MED SCI SPORT EXER, V38, P667, DOI 10.1249/01.mss.0000210190.64458.25; Fallah N, 2011, J AM GERIATR SOC, V59, P524, DOI 10.1111/j.1532-5415.2011.03300.x; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gezen-Ak D, 2013, J ALZHEIMERS DIS, V37, P185, DOI 10.3233/JAD-130497; Hand BD, 2007, J APPL PHYSIOL, V103, P1678, DOI 10.1152/japplphysiol.00420.2007; Haramizu S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-339; Hittel DS, 2010, MED SCI SPORT EXER, V42, P2023, DOI 10.1249/MSS.0b013e3181e0b9a8; Josse AR, 2010, MED SCI SPORT EXER, V42, P1122, DOI 10.1249/MSS.0b013e3181c854f6; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Li CM, 2010, ARCH GERONTOL GERIAT, V50, pS39, DOI 10.1016/S0167-4943(10)70011-X; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Morley JE, 2011, J AM MED DIR ASSOC, V12, P403, DOI 10.1016/j.jamda.2011.04.014; Parkhouse WS, 2000, MECH AGEING DEV, V113, P75, DOI 10.1016/S0047-6374(99)00103-7; Raji MA, 2010, J GERONTOL A-BIOL, V65, P1228, DOI 10.1093/gerona/glq121; Rothman MD, 2008, J AM GERIATR SOC, V56, P2211, DOI 10.1111/j.1532-5415.2008.02008.x; Ryan AS, 2013, OBESITY, V21, P1350, DOI 10.1002/oby.20216; Shimada H, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00069; Syddall H, 2003, AGE AGEING, V32, P650, DOI 10.1093/ageing/afg111; Theou Olga, 2011, J Aging Res, V2011, P569194, DOI 10.4061/2011/569194; Tylavsky F, 2003, J APPL PHYSIOL, V94, P959, DOI 10.1152/japplphysiol.00732.2002; van Kan GA, 2010, CLIN GERIATR MED, V26, P275, DOI 10.1016/j.cger.2010.02.002; Vaughan S, 2014, AGE AGEING; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Walker KS, 2004, MED SCI SPORT EXER, V36, P787, DOI 10.1249/01.MSS.0000126384.04778.29; Wilkinson SB, 2007, AM J CLIN NUTR, V85, P1031, DOI 10.1093/ajcn/85.4.1031; Woods NF, 2005, J AM GERIATR SOC, V53, P1321, DOI 10.1111/j.1532-5415.2005.53405.x; Wu K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028520	39	128	145	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116256	10.1371/journal.pone.0116256	http://dx.doi.org/10.1371/journal.pone.0116256			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659147	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900033
J	Benzaquem, DC; Oliveira, C; Batista, JD; Zuanon, J; Porto, JIR				Benzaquem, Denise Correa; Oliveira, Claudio; Batista, Jaqueline da Silva; Zuanon, Jansen; Rebelo Porto, Jorge Ivan			DNA Barcoding in Pencilfishes (Lebiasinidae: Nannostomus) Reveals Cryptic Diversity across the Brazilian Amazon	PLOS ONE			English	Article							FRESH-WATER FISHES; INDO-WEST PACIFIC; CHARACIFORMES CHARACIDAE; TAXONOMY; NOV	Nannostomus is comprised of 20 species. Popularly known as pencilfishes the vast majority of these species lives in the flooded forests of the Amazon basin and are popular in the ornamental trade. Among the lebiasinids, it is the only genus to have undergone more than one taxonomic revision. Even so, it still possesses poorly defined species. Here, we report the results of an application of DNA barcoding to the identification of pencilfishes and highlight the deeply divergent clades within four nominal species. We surveyed the sequence variation in the mtDNA cytochrome c oxidase subunit I gene among 110 individuals representing 14 nominal species that were collected from several rivers along the Amazon basin. The mean Kimura-2-parameter distances within species and genus were 2% and 19,0%, respectively. The deep lineage divergences detected in N. digrammus, N. trifasciatus, N. unifasciatus and N. eques suggest the existence of hidden diversity in Nannostomus species. For N. digrammus and N. trifasciatus, in particular, the estimated divergences in some lineages were so high that doubt about their conspecific status is raised.	[Benzaquem, Denise Correa; Rebelo Porto, Jorge Ivan] Inst Nacl de Pesquisas da Amazonia, Lab Genet Anim, BR-69067375 Manaus, Amazonas, Brazil; [Oliveira, Claudio] UNESP, Inst Biociencias, Dept Morfol, BR-18618970 Botucatu, SP, Brazil; [Batista, Jaqueline da Silva] Inst Nacl de Pesquisas da Amazonia, Lab Temat Biol Mol, Lab Fisiol Comportamental & Evolucao, BR-69067375 Manaus, Amazonas, Brazil; [Zuanon, Jansen] Inst Nacl de Pesquisas da Amazonia, Lab Sistemat & Ecol Peixes, BR-69067375 Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Universidade Estadual Paulista; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Porto, JIR (corresponding author), Inst Nacl de Pesquisas da Amazonia, Lab Genet Anim, Av Andre Araujo 2-936, BR-69067375 Manaus, Amazonas, Brazil.	jirporto@inpa.gov.br	Porto, Jorge/T-4694-2019; Oliveira, Claudio/D-7713-2012; Porto, Jorge/K-1441-2014; da Silva Batista, Jacqueline/AAD-4349-2020; Zuanon, Jansen A. S./E-5791-2013	Oliveira, Claudio/0000-0002-7010-8880; Porto, Jorge/0000-0003-1393-6492; da Silva Batista, Jacqueline/0000-0002-6649-6200; Zuanon, Jansen A. S./0000-0001-8354-2750; santos, leonor maria pacheco/0000-0002-6739-6260; Silva, Everton/0000-0001-8747-4185	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Rede BrBOL) [564953/2010-5]; FAPEAM/CNPq/PRONEX [003/2009]; CNPq/FAPEAM (INCT CENBAM); CNPq/FAPEAM (SISBIOTA Rede BIOPHAM) [563348/2010-0]; Fundacao de Amparo a Pesquisa do Estado do Amazonas; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Rede BrBOL)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FAPEAM/CNPq/PRONEX; CNPq/FAPEAM (INCT CENBAM); CNPq/FAPEAM (SISBIOTA Rede BIOPHAM); Fundacao de Amparo a Pesquisa do Estado do Amazonas; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Rede BrBOL #564953/2010-5); FAPEAM/CNPq/PRONEX (Call 003/2009), CNPq/FAPEAM (INCT CENBAM), CNPq/FAPEAM (SISBIOTA Rede BIOPHAM #563348/2010-0). Fundacao de Amparo a Pesquisa do Estado do Amazonas and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) provided PhD fellowship to DCB. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) provided fellowship to CO and JZ. DNA sequencing core facility was provided by Instituto Nacional de Pesquisas da Amazonia (INPA) and Universidade Estadual de Sao Paulo (UNESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Allen Gerald R., 2013, Journal of the Ocean Science Foundation, V6, P33; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Benine RC, 2009, NEOTROP ICHTHYOL, V7, P161, DOI 10.1590/S1679-62252009000200005; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Borsa P, 2013, CR BIOL, V336, P82, DOI 10.1016/j.crvi.2013.01.004; Carvalho LN, 2007, TROPICAL BIOL CONSER, P1, DOI [10.1007/s12033-007-0062-9, DOI 10.1007/S12033-007-0062-9]; Clare EL, 2011, PLOS ONE; de Carvalho DC, 2011, MITOCHONDR DNA, V22, P80, DOI 10.3109/19401736.2011.588214; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; Froese R., 2021, FISHBASE WORLD WIDE; Galimberti A, 2012, MOL ECOL RESOUR, V12, P403, DOI 10.1111/j.1755-0998.2011.03110.x; Gery J, 1877, CHARACOIDS WORLD, P672; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Johnson NF, 2011, INVERTEBR SYST, V25, P471, DOI 10.1071/IS11052; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; Kelly RP, 2007, MOL ECOL NOTES, V7, P177, DOI 10.1111/j.1471-8286.2006.01641.x; Kullander S.O., 2003, CHECK LIST FRESHWATE, P605; Lara A, 2010, MOL ECOL RESOUR, V10, P421, DOI 10.1111/j.1755-0998.2009.02785.x; Lundberg John G., 1998, P13; Mabragana E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028655; Melo BF, 2011, NEOTROP ICHTHYOL, V9, P49, DOI 10.1590/S1679-62252011000100002; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nwani CD, 2011, MITOCHONDR DNA, V22, P43, DOI 10.3109/19401736.2010.536537; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Paepke Hans-Joachim, 2001, Verhandlungen der Gesellschaft fuer Ichthyologie (GfI) e V, V2, P143; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Puckridge M, 2013, MOL ECOL RESOUR, V13, P32, DOI 10.1111/1755-0998.12022; Renaud AK, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-24; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosso JJ, 2012, MOL ECOL RESOUR, V12, P999, DOI 10.1111/1755-0998.12010; Roxo FF, 2012, ZOOTAXA, P1; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Sambrook J., 2001, MOL CLONING LAB MANU; Silva GSC, 2013, J FISH BIOL, V82, P1613, DOI 10.1111/jfb.12094; Sistrom MJ, 2009, J ZOOL, V278, P287, DOI 10.1111/j.1469-7998.2009.00576.x; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terencio ML, 2012, J FISH BIOL, V81, P110, DOI 10.1111/j.1095-8649.2012.03320.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdez-Moreno M, 2009, J FISH BIOL, V74, P377, DOI 10.1111/j.1095-8649.2008.02077.x; Victor BC, 2010, ZOOL STUD, V49, P865; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Weitzman H, 1982, BIOL DIVERSIFICATION; WEITZMAN S H, 1978, Smithsonian Contributions to Zoology, P1; Weitzman SH, 1975, SMITHSONIAN CONTRIBU, V186, P1; Weitzman SH, 2003, CHECK LIST FRESHWATE; WEITZMAN STANLEY H., 1966, PROC U S NAT MUS, V119, P1; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Zarske A, 2013, VERTEBR ZOOL, V63, P125; Zarske A, 2011, VERTEBR ZOOL, V61, P283; Zarske Axel, 2009, Vertebrate Zoology, V59, P11; Zhou XH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016733, 10.1371/journal.pone.0017812]	65	117	121	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0112217	10.1371/journal.pone.0112217	http://dx.doi.org/10.1371/journal.pone.0112217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658694	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900002
J	Kim, HJ; Baek, S; Kim, HJ; Lee, JS; Oh, YM; Lee, SD; Lee, SW				Kim, Hyun Jung; Baek, Seunghee; Kim, Hee Jin; Lee, Jae Seung; Oh, Yeon-Mok; Lee, Sang-Do; Lee, Sei Won			The Impact of Smoking on Airflow Limitation in Subjects with History of Asthma and Inactive Tuberculosis	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CIGARETTE-SMOKING; GLOBAL BURDEN; LUNG-DISEASE; RISK; HYPERRESPONSIVENESS; INFLAMMATION; PREVALENCE; HEALTH; KOREA	Background Although smoking is the most important and modifiable cause of chronic obstructive pulmonary disease (COPD), other risk factors including asthma and tuberculosis (TB) are also associated. It is common for COPD patients to have more than one of these risk factors. The aims of this study were to determine the prevalence of airflow limitation (FEV1/FVC<0.7) according to the risk factors and to investigate their impact and interaction in airflow limitation. Methods From the Korean National Health and Nutrition Examination Survey between 2008 and 2012, we analyzed participants over 40 years of age by spirometry, chest radiograph and questionnaire about asthma and smoking history. Results Of 12,631 participants, 1,548 (12.3%) had airflow limitation. The prevalence of airflow limitation in smokers (>= 10 pack-year), asthmatics, and those with inactive TB was 23.9%, 32.1%, and 33.6%. The prevalence increased with the number of risk factors: 86.1% had airflow limitation if they had all three risk factors. Impacts of inactive TB and asthma on airflow limitation were equivalent to 47 and 69 pack-years of smoking, respectively. Airflow limitation resulted from lower levels of smoking in those with inactive TB and asthma. A potential interaction between smoking and inactive tuberculosis in the development of airflow limitation was identified (p = 0.054). Conclusions Asthma and inactive TB lesions increase susceptibility to smoking in the development of airflow limitation. People with these risk factors should be seen as a major target population for anti-smoking campaigns to prevent COPD.	[Kim, Hyun Jung; Lee, Jae Seung; Oh, Yeon-Mok; Lee, Sang-Do; Lee, Sei Won] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea; [Kim, Hyun Jung; Lee, Jae Seung; Oh, Yeon-Mok; Lee, Sang-Do; Lee, Sei Won] Univ Ulsan, Coll Med, Asan Med Ctr, Clin Res Ctr Chron Obstruct Airway Dis, Seoul, South Korea; [Kim, Hyun Jung] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Baek, Seunghee] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Kim, Hee Jin] Korean Inst TB, Osong, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Kyungpook National University; University of Ulsan; Asan Medical Center	Lee, SW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea.	iseiwon@gmail.com	Kim, Heejin/HII-8568-2022; Lee, Sei Won/AAG-9977-2019	shimotoyodome, akira/0000-0001-7567-8316	National Strategic Coordinating Center for Clinical Research, Ministry for Health & Welfare Affairs, Republic of Korea [HI10C2020]	National Strategic Coordinating Center for Clinical Research, Ministry for Health & Welfare Affairs, Republic of Korea	This study was supported by a grant of the National Strategic Coordinating Center for Clinical Research, Ministry for Health & Welfare Affairs, Republic of Korea (HI10C2020) to SWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1990, CATEGORICAL DATA ANA, pXV; ANDERSON DO, 1962, NEW ENGL J MED, V267, P787, DOI 10.1056/NEJM196210182671601; [Anonymous], 2009, LANCET, V374, P663, DOI 10.1016/S0140-6736(09)61535-X; Boulet LP, 2000, AM J RESP CRIT CARE, V162, P1308, DOI 10.1164/ajrccm.162.4.9910051; BURROWS B, 1977, AM REV RESPIR DIS, V115, P195; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; COX DR, 1984, INT STAT REV, V52, P1, DOI 10.2307/1403235; DAVIS RM, 1989, AM REV RESPIR DIS, V140, pS82, DOI 10.1164/ajrccm/140.3_Pt_2.S82; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Elkington PTG, 2006, THORAX, V61, P259, DOI 10.1136/thx.2005.051979; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Global Institute for Chronic Obstructive Lung Disease, 2013, GLOB STRAT DIAGN MAN; Hagstad S, 2014, CHEST, V145, P1298, DOI 10.1378/chest.13-1349; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC; JEFFERY PK, 1992, AM REV RESPIR DIS, V145, P890, DOI 10.1164/ajrccm/145.4_Pt_1.890; Kim DS, 2005, AM J RESP CRIT CARE, V172, P842, DOI 10.1164/rccm.200502-259OC; Kim S, 2013, ALLERGY, V68, P1435, DOI 10.1111/all.12256; Lam KBH, 2010, CHEST, V137, P593, DOI 10.1378/chest.09-1435; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Lee SW, 2011, J KOREAN MED SCI, V26, P268, DOI 10.3346/jkms.2011.26.2.268; LUNDGREN R, 1988, EUR RESPIR J, V1, P883; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Murray CJL, 2007, LANCET, V370, P109, DOI 10.1016/S0140-6736(07)61064-2; National Herat Lung and Blood Institue, 2004, MORB MORT CHARTB CAR; OSWALD NC, 1955, LANCET, V2, P843; Perret JL, 2013, AM J RESP CRIT CARE, V187, P42, DOI 10.1164/rccm.201205-0788OC; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Silva GE, 2004, CHEST, V126, P59, DOI 10.1378/chest.126.1.59; SNIDER GL, 1971, AM REV RESPIR DIS, V103, P625; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Soriano JB, 2003, CHEST, V124, P474, DOI 10.1378/chest.124.2.474; Straus SE, 2000, JAMA-J AM MED ASSOC, V283, P1853, DOI 10.1001/jama.283.14.1853; Tai A, 2014, THORAX, V69, P805, DOI 10.1136/thoraxjnl-2013-204815; The United States of America Department of State DoHcHS Centers for Disease Control and Preventionn, INSTR PAN PHYS COMPL; TOREN K, 1993, CHEST, V104, P600, DOI 10.1378/chest.104.2.600; Ward C, 2002, THORAX, V57, P309, DOI 10.1136/thorax.57.4.309; Yoo KH, 2011, RESPIROLOGY, V16, P659, DOI 10.1111/j.1440-1843.2011.01951.x	42	128	145	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125020	10.1371/journal.pone.0125020	http://dx.doi.org/10.1371/journal.pone.0125020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25659147	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659100090
J	Borner, J; Marinho, E; Wunder, S				Boerner, Jan; Marinho, Eduardo; Wunder, Sven			Mixing Carrots and Sticks to Conserve Forests in the Brazilian Amazon: A Spatial Probabilistic Modeling Approach	PLOS ONE			English	Article							ENVIRONMENTAL SERVICES; POLICY MIX; DEFORESTATION; PAYMENTS	Annual forest loss in the Brazilian Amazon had in 2012 declined to less than 5,000 sqkm, from over 27,000 in 2004. Mounting empirical evidence suggests that changes in Brazilian law enforcement strategy and the related governance system may account for a large share of the overall success in curbing deforestation rates. At the same time, Brazil is experimenting with alternative approaches to compensate farmers for conservation actions through economic incentives, such as payments for environmental services, at various administrative levels. We develop a spatially explicit simulation model for deforestation decisions in response to policy incentives and disincentives. The model builds on elements of optimal enforcement theory and introduces the notion of imperfect payment contract enforcement in the context of avoided deforestation. We implement the simulations using official deforestation statistics and data collected from field-based forest law enforcement operations in the Amazon region. We show that a large-scale integration of payments with the existing regulatory enforcement strategy involves a tradeoff between the cost-effectiveness of forest conservation and landholder incomes. Introducing payments as a complementary policy measure increases policy implementation cost, reduces income losses for those hit hardest by law enforcement, and can provide additional income to some land users. The magnitude of the tradeoff varies in space, depending on deforestation patterns, conservation opportunity and enforcement costs. Enforcement effectiveness becomes a key determinant of efficiency in the overall policy mix.	[Boerner, Jan] Univ Bonn, Ctr Dev Res ZEF, D-53113 Bonn, Germany; [Boerner, Jan; Marinho, Eduardo; Wunder, Sven] Ctr Int Forestry Res CIFOR, Rio De Janeiro, Brazil	University of Bonn; CGIAR; Center for International Forestry Research (CIFOR)	Borner, J (corresponding author), Univ Bonn, Ctr Dev Res ZEF, Walter Flex Str 3, D-53113 Bonn, Germany.	jborner@uni-bonn.de	Wunder, Sven/ABE-7773-2020; Börner, Jan JB/I-2139-2015; Kis-Katos, Krisztina/ABC-3624-2021; Börner, Jan/ABF-8775-2021	Wunder, Sven/0000-0002-9422-0260; Börner, Jan/0000-0003-3034-5360	Robert Bosch Foundation; European Commission [DCI-ENV/2011/269520]; Forest, Trees, and Agroforestry Program	Robert Bosch Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Forest, Trees, and Agroforestry Program	This work was funded by the Robert Bosch Foundation (www.bosch-stiftung.de), European Commission (http://ec.europa.eu/index_en.htm; Grant number: DCI-ENV/2011/269520), and Forest, Trees, and Agroforestry Program (http://foreststreesagroforestry.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers HJ, 2010, RESOUR ENERGY ECON, V32, P165, DOI 10.1016/j.reseneeco.2009.11.011; Angelsen A, 2010, P NATL ACAD SCI USA, V107, P19639, DOI 10.1073/pnas.0912014107; Armsworth PR, 2012, ECOL LETT, V15, P406, DOI 10.1111/j.1461-0248.2012.01747.x; Assuncao J., 2013, DOES CREDIT AFFECT D; Assuncao Juliano., 2012, DEFORESTATION SLOWDO; Barton DN, 2013, SOC NATUR RESOUR, V26, P1185, DOI 10.1080/08941920.2013.799727; Barton DN, 2014, TECHINCAL BRIEF; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Borner J, 2014, GLOBAL ENVIRON CHANG, V29, P294, DOI 10.1016/j.gloenvcha.2014.04.021; Borner J, 2010, ECOL ECON, V69, P1272, DOI 10.1016/j.ecolecon.2009.11.003; Borner J., 2013, GOVERNING PROVISION, P21, DOI [10.1007/978-94-007-5176-7_2, DOI 10.1007/978-94-007-5176-7]; Borner J, 2013, COMPENSACAO PORSERVI; Borner J, 2014, GLOBAL ENV IN PRESS; Cattaneo A., 2002, RES REPORT; Ezzine-de-Blas D, 2011, ENVIRON SCI POLICY, V14, P188, DOI 10.1016/j.envsci.2010.11.009; Garoupa Nuno, 1997, J ECON SURV, V11, P267, DOI DOI 10.1111/1467-6419.00034; Godar J, 2014, P NATL ACAD SCI USA; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hargrave J, 2013, ENVIRON RESOUR ECON, V54, P471, DOI 10.1007/s10640-012-9610-2; Lambin EF, 2014, GLOBAL ENVIRON CHANG, V28, P129, DOI 10.1016/j.gloenvcha.2014.06.007; Lehmann P, 2012, J ECON SURV, V26, P71, DOI 10.1111/j.1467-6419.2010.00628.x; Merger Eduard, 2012, Carbon Balance Manag, V7, P9, DOI 10.1186/1750-0680-7-9; MMA, 2009, BRAZ REDD STRAT DOC; Moxey A, 2014, LAND USE POLICY, V39, P397, DOI 10.1016/j.landusepol.2014.04.008; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Pagiola S, 2008, ECOL ECON, V65, P712, DOI 10.1016/j.ecolecon.2007.07.033; Persson UM, 2013, WORLD DEV, V43, P124, DOI 10.1016/j.worlddev.2012.10.006; Prager K, 2011, LAND DEGRAD DEV, V22, P111, DOI 10.1002/ldr.1038; Sandmo A, 2002, ENVIRON RESOUR ECON, V23, P85, DOI 10.1023/A:1020236324130; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Sohngen B, 2004, CAN J FOREST RES, V34, P829, DOI [10.1139/x03-249, 10.1139/X03-249]; Sparovek G, 2012, ENVIRON SCI POLICY, V16, P65, DOI 10.1016/j.envsci.2011.10.008; Tinbergen Jan, 1952, THEORY EC POLICY; Wunscher T, 2008, ECOL ECON, V65, P822, DOI 10.1016/j.ecolecon.2007.11.014; Wunder S, 2014, EARTHSCAN FOR LIBR, P202; Wunder S, 2013, CONSERV LETT, V6, P230, DOI 10.1111/conl.12034	37	86	87	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0116846	10.1371/journal.pone.0116846	http://dx.doi.org/10.1371/journal.pone.0116846			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25875656	Green Published, Green Submitted, gold			2022-12-27	WOS:000349250700007
J	Duan, JL; Hu, HH; Wang, G; Arao, T				Duan, Jiali; Hu, Huanhuan; Wang, Guan; Arao, Takashi			Study on Current Levels of Physical Activity and Sedentary Behavior among Middle School Students in Beijing, China	PLOS ONE			English	Article							BLOOD-PRESSURE; METABOLIC SYNDROME; SCREEN-TIME; ADOLESCENTS; CHILDREN; INACTIVITY; OBESITY; NUTRITION; OVERWEIGHT; HEALTH	Introduction This study aimed to determine current levels of physical activity and sedentary behavior in middle school students on the basis of grade, sex, student attitudes toward physical education, and residence location. Methods In 2013, a cross-sectional study of 1793 students aged 12 to 15 years was conducted across eight middle schools in Beijing, China. Four schools were selected from an urban district and another four schools were from a suburban district. Physical activity and sedentary behavior data were collected using the commonly used school-based Chinese version of the China Health and Nutrition Survey. Results The mean age of sampled students was 13.3 +/- 1.0 years; 51.5% were boys. Approximately 76.6% of students reported having three 45-minute physical education classes every week. A total of 35.6% students spent >= 1 h/day performing moderate to vigorous physical activity (MVPA) during school, and 34.9% spent >= 1 h/day in MVPA outside school time. Approximately half (49.7%) of the students engaged in reading, writing, or drawing for >= 2 h/day, and 42.9% reported screen time for >= 2 h/day. Although boys spent more time engaged in physical activity than girls did, they also spent more time exhibiting sedentary behavior. Each 10-unit increase in attitudes toward physical education was associated with an increased odds of 1.15 (95% CI: 1.09-1.20) for spending more than 1 h/day on MVPA. Students in suburban schools reported engaging in physical activity less when compared with those in urban schools. Conclusion The majority of our students did not meet the current physical activity recommendations, and about half of the students spent excessive time engaging in sedentary behaviors. Findings from this study highlight a positive association between student attitudes toward physical education and physical activity. Studies are needed to further explore the role of student attitudes toward physical education in promoting physical activity among Chinese students.	[Duan, Jiali; Wang, Guan] Beijing Ctr Dis Control & Prevent, Inst Sch Hlth, Beijing, Peoples R China; [Hu, Huanhuan] Waseda Univ, Sch Sport Sci, Lab Exercise Epidemiol, Saitama, Japan; [Arao, Takashi] Waseda Univ, Fac Sport Sci, Lab Exercise Epidemiol, Saitama, Japan	Waseda University; Waseda University	Hu, HH (corresponding author), Waseda Univ, Sch Sport Sci, Lab Exercise Epidemiol, Saitama, Japan.	hu.huanhuan@yahoo.com	Duan, Jiaobo/AAA-8651-2019		GCOE in Waseda University	GCOE in Waseda University	This research was supported by grant of GCOE in Waseda University (http://www.sport-sciences-gcoe-waseda.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Albarwani S, 2009, METAB SYNDR RELAT D, V7, P369, DOI 10.1089/met.2008.0052; Bucksch J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-351; Cao H, 2011, PREV MED, V53, P316, DOI 10.1016/j.ypmed.2011.09.002; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Chen Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-744; Cothran DJ, 1998, J TEACH PHYS EDUC, V17, P307, DOI 10.1123/jtpe.17.3.307; Cui ZH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-93; Ding HY, 2014, QUEST, V66, P117, DOI 10.1080/00336297.2013.821415; Ennis, 2003, STUDENT LEARNING PHY, P207; Gordon-Larsen P, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e83; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hobbs M, 2015, BRIT J SPORT MED, V49, P1179, DOI 10.1136/bjsports-2014-093754; Hu HH, 2014, ADV PHYS ED, V4, P181, DOI DOI 10.4236/APE.2014.44022; Jiang XX, 2014, J EPIDEMIOL, V24, P397, DOI 10.2188/jea.JE20140006; Kristjansdottir G, 2001, ACTA PAEDIATR, V90, P429, DOI 10.1111/j.1651-2227.2001.tb00445.x; Lam JWK, 2010, PREV MED, V51, P96, DOI 10.1016/j.ypmed.2010.04.017; Leary SD, 2008, HYPERTENSION, V51, P92, DOI 10.1161/HYPERTENSIONAHA.107.099051; Leatherdale ST, 2008, INT J PEDIATR OBES, V3, P93, DOI 10.1080/17477160701830879; LeBlanc AGW, 2010, PEDIATR EXERC SCI, V22, P523, DOI 10.1123/pes.22.4.523; Lees C, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.130010; Li M, 2007, J ADOLESCENT HEALTH, V41, P99, DOI 10.1016/j.jadohealth.2007.02.005; Liang YJ, 2011, BLOOD PRESSURE, V20, P45, DOI 10.3109/08037051.2010.524085; Liu JH, 2008, J RURAL HEALTH, V24, P407, DOI 10.1111/j.1748-0361.2008.00188.x; Liu WJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-780; Lutfiyya MN, 2007, OBESITY, V15, P2348, DOI 10.1038/oby.2007.278; Martinez-Gomez D, 2011, ARCH DIS CHILD, V96, P240, DOI 10.1136/adc.2010.187161; PORTMAN PA, 1995, J TEACH PHYS EDUC, V14, P445, DOI 10.1123/jtpe.14.4.445; Rey-Lopez JP, 2008, NUTR METAB CARDIOVAS, V18, P242, DOI 10.1016/j.numecd.2007.07.008; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Schmitz KH, 2002, PREV MED, V34, P266, DOI 10.1006/pmed.2001.0982; Shi ZM, 2006, PREV MED, V43, P218, DOI 10.1016/j.ypmed.2006.04.017; Sigmundova D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-731; Silva K, 2014, INT J PUBLIC HEALTH, V59, P77, DOI 10.1007/s00038-013-0464-3; Springer AE, 2009, PREV CHRONIC DIS, V6; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Tandon PS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-88; Tian BenChun, 2007, International Electronic Journal of Health Education, V10, P35; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P65, DOI 10.1139/H11-013; Tudor-Locke C, 2003, INT J OBESITY, V27, P1093, DOI 10.1038/sj.ijo.0802377; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Wang CKJ, 2010, INT J SPORT EXERC PS, V8, P284, DOI 10.1080/1612197X.2010.9671954; Welk GJ, 1999, QUEST, V51, P5, DOI 10.1080/00336297.1999.10484297; Wu Tsu-Yin, 2006, J Sch Nurs, V22, P25, DOI 10.1177/10598405060220010501; Zhang YX, 2013, ANN HUM BIOL, V40, P88, DOI 10.3109/03014460.2012.740073	45	34	38	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133544	10.1371/journal.pone.0133544	http://dx.doi.org/10.1371/journal.pone.0133544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	25664813	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198200066
J	Duan, JB; Fu, JF; Gao, HJ; Chen, CS; Fu, JF; Shi, X; Liu, XF				Duan, Jiaobo; Fu, Jufang; Gao, Hongjie; Chen, Changsheng; Fu, Jianfang; Shi, Xin; Liu, Xufeng			Factor Analysis of the Caregiver Quality of Life Index-Cancer (CQOLC) Scale for Chinese Cancer Caregivers: A Preliminary Reliability and Validity Study of the CQOLC-Chinese Version	PLOS ONE			English	Article							FAMILY CAREGIVER; SURVIVORS; HOME	The English version of the Caregiver Quality of Life Index-Cancer (CQOLC) was translated into simplified Chinese (CQOLC-C), following cultural translation, back-translation and pretest steps. Three hundred and sixty one cancer caregivers participated in this study. Cronbach's alpha was used to assess CQOLC-C reliability. Exploratory factor analyses (EFA) was used to generate two models of the measure's factor structure, and confirmatory factor analyses (CFA) were used to test each model, such that the best model to explain the latent structure of the CQOLC-C was identified. EFA using different factor extraction methods yielded two models including four and eight factors. According to the CFA results, model 2 was better fit for the original study data, based on the RMSEA criterion [ 0.058(90% CI = 0.051-0.065)],X-2 (531) = 853.92, p < 0.0001; CFI (0.96), NNFI (0.96), IFI (0.97), and NFI (0.92). We also examined the effect of removing three items on the CQOLC-C factor structure and discuss the resulting differences from other versions. These results indicate that the CQOLC-C's factor structure does not fully fit the original theorized model. This study provides preliminary support for further use of the CQOLC-C. However, the present work provides only partial support for the relevance and construct validity of the scale for Chinese caregivers.	[Duan, Jiaobo; Liu, Xufeng] Fourth Mil Med Univ, Sch Psychol, Xian 710032, Shaanxi, Peoples R China; [Fu, Jufang] Fourth Mil Med Univ, Infect Control Ctr, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Gao, Hongjie] Fourth Mil Med Univ, Sch Prevent Med, Dept Hlth Serv, Xian 710032, Shaanxi, Peoples R China; [Chen, Changsheng] Fourth Mil Med Univ, Sch Prevent Med, Dept Stat, Xian 710032, Shaanxi, Peoples R China; [Fu, Jianfang] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol, Xian 710032, Shaanxi, Peoples R China; [Shi, Xin] Fourth Mil Med Univ, Sch Pharm, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Liu, XF (corresponding author), Fourth Mil Med Univ, Sch Psychol, Xian 710032, Shaanxi, Peoples R China.	lllfmmu@fmmu.edu.cn	Duan, Jiaobo/AAA-8651-2019		Fourth Military Medical University Scientific Research Projects	Fourth Military Medical University Scientific Research Projects	This study received external funding from the Fourth Military Medical University Scientific Research Projects. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACWF (All Chinese Women's Federation), 2008, NAT RUR LEFT BEH CHI; Bektas HA, 2009, J CLIN NURS, V18, P3003, DOI 10.1111/j.1365-2702.2009.02915.x; Bergelt C, 2008, QUAL LIFE RES, V17, P653, DOI 10.1007/s11136-008-9349-y; Cella D F, 1996, Oncology (Williston Park), V10, P233; Chen WQ, 2011, CANC FAR US CHINESE; Cong HW, 2007, MEASUREMENTS APPL QU, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Ferrell B, 1991, Hosp J, V7, P9; Ferrell B R, 1995, Oncol Nurs Forum, V22, P1211; Ferrell BR, 1995, QUAL LIFE RES, V4, P523, DOI 10.1007/BF00634747; Fu YD, 2012, XUE SHU YUE KAN, V5, P9; Given BA, 2001, CA-CANCER J CLIN, V51, P213, DOI 10.3322/canjclin.51.4.213; Haley William E, 2003, J Palliat Med, V6, P215; HINDS C, 1985, J ADV NURS, V10, P575, DOI 10.1111/j.1365-2648.1985.tb00550.x; Hodges LJ, 2005, SOC SCI MED, V60, P1, DOI 10.1016/j.socscimed.2004.04.018; Huang LL, 2012, EC RES GUIDE, V21, P238; John F, 2003, J PAIN SYMPTOM MANAG, V26, P922; Kim Y, 2008, CANCER-AM CANCER SOC, V112, P2556, DOI 10.1002/cncr.23449; Lafaye A, 2013, QUAL LIFE RES, V22, P119, DOI 10.1007/s11136-012-0113-y; Li DH, 2012, LIAONING DA XUE XUE, P22; Lu QQ, 2010, SIXIANG ZHENG ZHI GO, P10; McMillan S C, 1994, Oncol Nurs Forum, V21, P1189; National Office of Aging Beijing, 2010, URB RUR AG PEOPL STA; Otis WB, 2010, 16 INT C CANC NURS U, P1; Ozer ZC, 2009, QUAL LIFE RES, V18, P913, DOI 10.1007/s11136-009-9503-1; Panke JT, 2004, OXFORD TXB PALLIATIV; Pitceathly C, 2003, EUR J CANCER, V39, P1517, DOI 10.1016/S0959-8049(03)00309-5; Rhee YS, 2005, QUAL LIFE RES, V14, P899, DOI 10.1007/s11136-004-1264-2; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Shultz K. S., 2004, MEASUREMENT THEORY A; Su CT, 2002, AM J OCCUP THER, V56, P581, DOI 10.5014/ajot.56.5.581; Tang WR, 2009, CANCER NURS, V32, P220, DOI 10.1097/NCC.0b013e31819b5ae8; Weitzner M A, 1997, Cancer Pract, V5, P25; Weitzner MA, 1999, QUAL LIFE RES, V8, P55, DOI 10.1023/A:1026407010614; Weitzner MA, 1999, J PAIN SYMPTOM MANAG, V17, P418, DOI 10.1016/S0885-3924(99)00014-7; Weitzner MA, 1999, J PALLIAT CARE, V15, P13, DOI 10.1177/082585979901500203; Xia Q, 2012, ZHONGGUO JIA TING JI, V2, P13	36	34	38	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0116438	10.1371/journal.pone.0116438	http://dx.doi.org/10.1371/journal.pone.0116438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UO	25664813	gold, Green Published, Green Submitted			2022-12-27	WOS:000349123100009
